,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
11710,GO:0044281,4.78512092028641e-24,1,60,1974,small molecule metabolic process,BP,EBP;PDK4;PECR;PHYH;TH;MSRA;MRI1;HSD17B3;MRAP;APOC1;EXTL1;ACSF2;PNP;ABCG1;BDH2;ACADVL;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;ACAT1;ACAT2;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;NUDT7;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;STAR;PEPD;ACP5;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
2977,GO:0006082,1.24147438851791e-22,1,44,1031,organic acid metabolic process,BP,PDK4;PECR;PHYH;TH;MSRA;MRI1;APOC1;EXTL1;ACSF2;PNP;BDH2;ACADVL;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;CPT2;HSD17B10;ETFB;HACL1;ACAT1;ACAT2;IDUA;ECHDC2;SARDH;HEXB;FABP3;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;STAR;PEPD;ECI1;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
11406,GO:0043436,5.99568899192187e-22,1,43,1016,oxoacid metabolic process,BP,PDK4;PECR;PHYH;TH;MSRA;MRI1;APOC1;EXTL1;ACSF2;BDH2;ACADVL;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;CPT2;HSD17B10;ETFB;HACL1;ACAT1;ACAT2;IDUA;ECHDC2;SARDH;HEXB;FABP3;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;STAR;PEPD;ECI1;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
6685,GO:0019752,7.71909715150968e-22,1,41,909,carboxylic acid metabolic process,BP,PDK4;PECR;PHYH;TH;MSRA;MRI1;APOC1;ACSF2;BDH2;ACADVL;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;CPT2;HSD17B10;ETFB;HACL1;ACAT1;ACAT2;IDUA;ECHDC2;SARDH;FABP3;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;STAR;PEPD;ECI1;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
3340,GO:0006629,2.11408085717345e-21,1,47,1307,lipid metabolic process,BP,EBP;PDK4;PECR;PHYH;DPM3;TH;ZFYVE21;HSD17B3;APOC1;HSD17B11;ACSF2;ABCG1;BDH2;ACADVL;ACAA2;ACSM5;RGN;FADS1;GHR;FGF18;ASAH2;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;RBP4;CYP17A1;ANG;ACAT1;ACAT2;ECHDC2;HEXB;FABP3;HSD3B2;NUDT7;CPT1C;PON2;IDH1;DECR1;STAR;GLA;ECI1;CYP11A1;DHCR7;ELOVL6;ETFDH
3341,GO:0006631,9.32792287572769e-20,1,26,330,fatty acid metabolic process,BP,PDK4;PECR;PHYH;TH;APOC1;ACSF2;BDH2;ACADVL;ACAA2;ACSM5;RGN;FADS1;GHR;CPT2;ETFB;HACL1;ACAT1;ACAT2;ECHDC2;FABP3;CPT1C;PON2;DECR1;ECI1;ELOVL6;ETFDH
11692,GO:0044255,1.7266455985729e-18,1,39,1021,cellular lipid metabolic process,BP,PDK4;PECR;PHYH;DPM3;TH;ZFYVE21;APOC1;ACSF2;ABCG1;BDH2;ACADVL;ACAA2;ACSM5;RGN;FADS1;GHR;FGF18;ASAH2;CPT2;PLA2G16;ETFB;HACL1;RBP4;ANG;ACAT1;ACAT2;ECHDC2;HEXB;FABP3;NUDT7;CPT1C;PON2;IDH1;DECR1;STAR;GLA;ECI1;ELOVL6;ETFDH
8735,GO:0032787,2.02622905404666e-18,1,30,540,monocarboxylic acid metabolic process,BP,PDK4;PECR;PHYH;TH;APOC1;ACSF2;BDH2;ACADVL;ACAA2;ACSM5;RGN;FADS1;GHR;CPT2;ETFB;HACL1;ACAT1;ACAT2;IDUA;ECHDC2;FABP3;CPT1C;PON2;IDH1;DECR1;STAR;ECI1;SLC1A3;ELOVL6;ETFDH
2757,GO:0005739,7.59346569123349e-18,1,47,1569,mitochondrion,CC,PDK4;PECR;TMEM160;PHYH;TH;MSRA;MRPL14;MRPL16;ACSF2;ABCG1;PYCARD;CCDC51;G0S2;ACADVL;ACAA2;ACSM5;FADS1;ASAH2;CPT2;HSD17B10;ETFB;CYP17A1;RNASEL;BOLA1;ACAT1;ACAT2;TSFM;ECHDC2;SARDH;NOL3;HSD3B2;NUDT6;CPT1C;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;LDHD;STAR;ECI1;CYP11A1;CYB5A;PTS;ETFDH
6599,GO:0019395,8.20202258741493e-18,1,16,95,fatty acid oxidation,BP,PDK4;PHYH;BDH2;ACADVL;ACAA2;CPT2;ETFB;HACL1;ACAT1;ACAT2;ECHDC2;FABP3;CPT1C;DECR1;ECI1;ETFDH
9447,GO:0034440,1.1907639731902e-17,1,16,97,lipid oxidation,BP,PDK4;PHYH;BDH2;ACADVL;ACAA2;CPT2;ETFB;HACL1;ACAT1;ACAT2;ECHDC2;FABP3;CPT1C;DECR1;ECI1;ETFDH
11682,GO:0044242,1.25155386474279e-16,1,19,189,cellular lipid catabolic process,BP,PHYH;APOC1;BDH2;ACADVL;ACAA2;CPT2;ETFB;HACL1;ACAT1;ACAT2;ECHDC2;HEXB;FABP3;CPT1C;IDH1;DECR1;GLA;ECI1;ETFDH
11870,GO:0044710,3.44684357528862e-16,1,72,4067,single-organism metabolic process,BP,EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;MRI1;HSD17B3;MRAP;APOC1;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;ACADVL;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;ANG;ACAT1;ACAT2;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;HSD3B2;NUDT7;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;LDHD;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
14626,GO:0055114,5.40480749393864e-16,1,35,940,oxidation-reduction process,BP,PDK4;PECR;PHYH;IFI30;TH;MSRA;HSD17B3;HSD17B11;BDH2;ACADVL;ACAA2;FADS1;CPT2;HSD17B10;ETFB;HACL1;CYP17A1;ACAT1;ACAT2;AOX1;ECHDC2;SARDH;FABP3;HSD3B2;CPT1C;PCBD1;MDH1;IDH1;DECR1;LDHD;ECI1;CYP11A1;DHCR7;CYB5A;ETFDH
7341,GO:0030258,1.35313044571893e-15,1,20,254,lipid modification,BP,PDK4;PHYH;ZFYVE21;APOC1;ABCG1;BDH2;ACADVL;ACAA2;FGF18;CPT2;ETFB;HACL1;ACAT1;ACAT2;ECHDC2;FABP3;CPT1C;DECR1;ECI1;ETFDH
5736,GO:0016042,3.39880352559456e-15,1,21,296,lipid catabolic process,BP,PHYH;APOC1;HSD17B11;BDH2;ACADVL;ACAA2;CPT2;PLA2G16;ETFB;HACL1;ACAT1;ACAT2;ECHDC2;HEXB;FABP3;CPT1C;IDH1;DECR1;GLA;ECI1;ETFDH
4356,GO:0009062,4.48412182886686e-15,1,14,92,fatty acid catabolic process,BP,PHYH;BDH2;ACADVL;ACAA2;CPT2;ETFB;HACL1;ACAT1;ACAT2;ECHDC2;CPT1C;DECR1;ECI1;ETFDH
16999,GO:0072329,4.57365694310322e-15,1,15,114,monocarboxylic acid catabolic process,BP,PHYH;BDH2;ACADVL;ACAA2;CPT2;ETFB;HACL1;ACAT1;ACAT2;IDUA;ECHDC2;CPT1C;DECR1;ECI1;ETFDH
5746,GO:0016054,5.05252308250551e-14,1,18,224,organic acid catabolic process,BP,PHYH;BDH2;ACADVL;ACAA2;CPT2;HSD17B10;ETFB;HACL1;ACAT1;ACAT2;IDUA;ECHDC2;SARDH;CPT1C;PCBD1;DECR1;ECI1;ETFDH
12625,GO:0046395,5.05252308250551e-14,1,18,224,carboxylic acid catabolic process,BP,PHYH;BDH2;ACADVL;ACAA2;CPT2;HSD17B10;ETFB;HACL1;ACAT1;ACAT2;IDUA;ECHDC2;SARDH;CPT1C;PCBD1;DECR1;ECI1;ETFDH
3343,GO:0006635,8.36444969615133e-14,1,12,69,fatty acid beta-oxidation,BP,BDH2;ACADVL;ACAA2;CPT2;ETFB;ACAT1;ACAT2;ECHDC2;CPT1C;DECR1;ECI1;ETFDH
11809,GO:0044444,2.04395843472308e-13,1,103,8745,cytoplasmic part,CC,EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;CCDC51;G0S2;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;ASAH2;TICAM1;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
11872,GO:0044712,3.40478415580235e-13,1,31,922,single-organism catabolic process,BP,PHYH;APOC1;HSD17B11;PNP;BDH2;ACADVL;ACAA2;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;ACAT1;ACAT2;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;NUDT7;CPT1C;PCBD1;IDH1;DECR1;PEPD;GLA;ECI1;DERA;ETFDH
4247,GO:0008610,3.50221549871616e-13,1,26,628,lipid biosynthetic process,BP,EBP;PDK4;PECR;DPM3;HSD17B3;APOC1;HSD17B11;ABCG1;ACADVL;ACAA2;ACSM5;RGN;FADS1;FGF18;PLA2G16;CYP17A1;ANG;ACAT2;HEXB;FABP3;HSD3B2;IDH1;STAR;CYP11A1;DHCR7;ELOVL6
11871,GO:0044711,4.11819999318133e-13,1,38,1404,single-organism biosynthetic process,BP,EBP;PDK4;PECR;DPM3;TH;MRI1;HSD17B3;MRAP;APOC1;HSD17B11;EXTL1;PNP;ABCG1;BDH2;ACADVL;ACAA2;MGST2;ACSM5;RGN;FADS1;FGF18;NNMT;PLA2G16;RBP4;CYP17A1;ANG;ACAT1;ACAT2;HEXB;FABP3;HSD3B2;MDH1;IDH1;STAR;CYP11A1;DHCR7;SLC1A3;ELOVL6
11712,GO:0044283,1.32902035785527e-12,1,23,496,small molecule biosynthetic process,BP,EBP;PDK4;PECR;MRI1;HSD17B3;APOC1;PNP;ABCG1;BDH2;ACADVL;ACAA2;MGST2;ACSM5;RGN;FADS1;RBP4;ACAT1;ACAT2;MDH1;STAR;DHCR7;SLC1A3;ELOVL6
11711,GO:0044282,5.10095010389791e-12,1,19,336,small molecule catabolic process,BP,PHYH;BDH2;ACADVL;ACAA2;CPT2;HSD17B10;ETFB;HACL1;GALT;ACAT1;ACAT2;IDUA;ECHDC2;SARDH;CPT1C;PCBD1;DECR1;ECI1;ETFDH
5951,GO:0016491,4.36773165686606e-11,1,25,701,oxidoreductase activity,MF,PECR;PHYH;IFI30;TH;MSRA;HSD17B3;HSD17B11;BDH2;ACADVL;MGST2;FADS1;HSD17B10;CYP17A1;AOX1;SARDH;HSD3B2;PCBD1;MDH1;IDH1;DECR1;LDHD;CYP11A1;DHCR7;CYB5A;ETFDH
2773,GO:0005759,1.67668189656261e-09,0.999999999774997,18,410,mitochondrial matrix,CC,PDK4;MRPL14;MRPL16;ACSF2;ACADVL;ACAA2;ACSM5;HSD17B10;ETFB;RNASEL;ACAT1;TSFM;SARDH;DECR1;PUS1;ECI1;CYP11A1;ETFDH
1654,GO:0003824,2.31322377121832e-09,0.999999999240825,72,5495,catalytic activity,MF,CFB;EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;MRI1;HSD17B3;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;ACADVL;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;ASAH2;NNMT;CPT2;PLA2G16;HSD17B10;HACL1;GALT;CYP17A1;RNASEL;ANG;ACAT1;ACAT2;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;PON2;IDH1;DECR1;PUS1;LDHD;MDP1;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;LYPLAL1;ELOVL6;ETFDH
2756,GO:0005737,3.27398629288046e-09,0.999999999100802,107,10558,cytoplasm,CC,EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;CCDC51;G0S2;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;ASAH2;TICAM1;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
13086,GO:0048037,5.25335991801347e-09,0.999999999449103,14,252,cofactor binding,MF,PHYH;TH;BDH2;ACADVL;HACL1;ACAT1;AOX1;ACCS;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
13564,GO:0050662,7.21374284917466e-09,0.999999999387046,12,177,coenzyme binding,MF,TH;BDH2;ACADVL;HACL1;ACAT1;AOX1;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
11799,GO:0044429,1.56471600313069e-08,0.999999996610001,25,919,mitochondrial part,CC,PDK4;MRPL14;MRPL16;ACSF2;ACADVL;ACAA2;ACSM5;CPT2;HSD17B10;ETFB;RNASEL;ACAT1;TSFM;SARDH;HSD3B2;CPT1C;IFI27;DECR1;PUS1;LDHD;STAR;ECI1;CYP11A1;CYB5A;ETFDH
3392,GO:0006694,3.14737038732395e-08,0.999999997311833,11,162,steroid biosynthetic process,BP,EBP;HSD17B3;HSD17B11;ABCG1;ACAA2;CYP17A1;ACAT2;HSD3B2;STAR;CYP11A1;DHCR7
3415,GO:0006732,5.00101156872872e-08,0.999999993621049,14,303,coenzyme metabolic process,BP,PDK4;ACSF2;PNP;ACSM5;NNMT;ACAT1;SHPK;NUDT7;PCBD1;MDH1;IDH1;DERA;PTS;ELOVL6
5779,GO:0016125,6.1021491601612e-08,0.999999995247494,10,137,sterol metabolic process,BP,EBP;APOC1;ABCG1;ACADVL;ACAA2;CYP17A1;ACAT2;STAR;CYP11A1;DHCR7
6026,GO:0016614,7.23548033773251e-08,0.999999994262571,10,135,oxidoreductase activity, acting on CH-OH group of donors,MF,HSD17B3;HSD17B11;BDH2;HSD17B10;AOX1;HSD3B2;MDH1;IDH1;LDHD;CYB5A
13929,GO:0051186,1.06244068993305e-07,0.999999984268161,15,373,cofactor metabolic process,BP,PDK4;ACSF2;PNP;BDH2;ACSM5;NNMT;ACAT1;SHPK;NUDT7;PCBD1;MDH1;IDH1;DERA;PTS;ELOVL6
18832,GO:1901564,1.47372712165641e-07,0.999999953285807,38,2159,organonitrogen compound metabolic process,BP,TH;MSRA;MRPL14;MRPL16;MRI1;MRAP;APOC1;EXTL1;PNP;BDH2;MGST2;PSMB10;GHR;ASAH2;NNMT;PLA2G16;HSD17B10;ANG;ACAT1;TSFM;IDUA;AOX1;SARDH;SHPK;HEXB;FABP3;NUDT7;CPT1C;PCBD1;MDH1;IDH1;PEPD;ACP5;GLA;DERA;PTS;RBMS3;SLC1A3
4350,GO:0009056,2.03216732407123e-07,0.999999934670909,38,2223,catabolic process,BP,PHYH;APOC1;WDR45;TBC1D14;HSD17B11;PNP;BDH2;ACADVL;ACAA2;PSMB10;RGN;TICAM1;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;ACAT1;ACAT2;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;NUDT7;CPT1C;PCBD1;PON2;IDH1;DECR1;PEPD;GLA;ECI1;DERA;LYPLAL1;ETFDH
4002,GO:0008202,2.04105112104246e-07,0.999999973221695,13,288,steroid metabolic process,BP,EBP;HSD17B3;APOC1;HSD17B11;ABCG1;ACADVL;ACAA2;CYP17A1;ACAT2;HSD3B2;STAR;CYP11A1;DHCR7
4003,GO:0008203,2.11092590028856e-07,0.999999984226607,9,119,cholesterol metabolic process,BP,EBP;APOC1;ABCG1;ACADVL;ACAA2;ACAT2;STAR;CYP11A1;DHCR7
6140,GO:0016829,2.23762967692684e-07,0.999999979806354,10,154,lyase activity,MF,MGST2;HACL1;CYP17A1;ACAT1;ECHDC2;PCBD1;PUS1;ECI1;DERA;PTS
11687,GO:0044248,2.54966979914954e-07,0.999999921744003,34,1867,cellular catabolic process,BP,PHYH;APOC1;WDR45;TBC1D14;PNP;BDH2;ACADVL;ACAA2;PSMB10;RGN;TICAM1;CPT2;HSD17B10;ETFB;HACL1;GALT;ACAT1;ACAT2;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;NUDT7;CPT1C;PCBD1;PON2;IDH1;DECR1;GLA;ECI1;DERA;ETFDH
19254,GO:1902652,3.02161933381091e-07,0.999999976381315,9,124,secondary alcohol metabolic process,BP,EBP;APOC1;ABCG1;ACADVL;ACAA2;ACAT2;STAR;CYP11A1;DHCR7
11805,GO:0044438,3.3966547533508e-07,0.999999978401132,8,91,microbody part,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1
11806,GO:0044439,3.3966547533508e-07,0.999999978401132,8,91,peroxisomal part,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1
3452,GO:0006790,3.54852363981727e-07,0.999999946392945,14,358,sulfur compound metabolic process,BP,PDK4;MSRA;MRI1;EXTL1;ACSF2;MGST2;ACSM5;GHR;ACAT1;IDUA;HEXB;NUDT7;IDH1;ELOVL6
12859,GO:0046890,4.24616087322983e-07,0.999999965349031,9,129,regulation of lipid biosynthetic process,BP,PDK4;APOC1;ABCG1;ACADVL;RGN;FABP3;IDH1;STAR;DHCR7
18840,GO:1901575,4.54821002277549e-07,0.999999858761529,33,1816,organic substance catabolic process,BP,PHYH;APOC1;HSD17B11;PNP;BDH2;ACADVL;ACAA2;PSMB10;RGN;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;ACAT1;ACAT2;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;NUDT7;CPT1C;PCBD1;IDH1;DECR1;GLA;ECI1;DERA;LYPLAL1;ETFDH
10836,GO:0042446,4.74593322880946e-07,0.99999997604829,7,65,hormone biosynthetic process,BP,HSD17B3;HSD17B11;CYP17A1;HSD3B2;STAR;CYP11A1;DHCR7
17000,GO:0072330,1.08127875535968e-06,0.999999882988146,10,185,monocarboxylic acid biosynthetic process,BP,PDK4;PECR;APOC1;ACADVL;ACSM5;RGN;FADS1;STAR;SLC1A3;ELOVL6
11274,GO:0043227,1.27427587733704e-06,0.999999572576683,108,11597,membrane-bounded organelle,CC,CFB;EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;ASAH2;TICAM1;ARL6IP4;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;MDP1;TFPI;STAR;SNX21;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH
5745,GO:0016053,1.3160503162222e-06,0.999999813633819,12,285,organic acid biosynthetic process,BP,PDK4;PECR;MRI1;APOC1;ACADVL;MGST2;ACSM5;RGN;FADS1;STAR;SLC1A3;ELOVL6
12624,GO:0046394,1.3160503162222e-06,0.999999813633819,12,285,carboxylic acid biosynthetic process,BP,PDK4;PECR;MRI1;APOC1;ACADVL;MGST2;ACSM5;RGN;FADS1;STAR;SLC1A3;ELOVL6
3342,GO:0006633,2.51434422964145e-06,0.999999787874943,8,118,fatty acid biosynthetic process,BP,PDK4;PECR;APOC1;ACADVL;ACSM5;RGN;FADS1;ELOVL6
6028,GO:0016616,2.66372560929044e-06,0.999999773715607,8,115,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B3;HSD17B11;BDH2;HSD17B10;HSD3B2;MDH1;IDH1;CYB5A
11273,GO:0043226,3.59307217135046e-06,0.999998839250591,112,12482,organelle,CC,CFB;EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;MDP1;TFPI;STAR;SNX21;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
2790,GO:0005777,3.59373273192956e-06,0.999999680993105,8,124,peroxisome,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1
10922,GO:0042579,3.59373273192956e-06,0.999999680993105,8,124,microbody,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1
3970,GO:0008152,4.01917997379227e-06,0.999998457402904,101,10623,metabolic process,BP,CFB;EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;WDR45;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;FABP3;NOL3;HSD3B2;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;IDH1;DECR1;PUS1;PTMS;LDHD;MDP1;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;RBMS3;HNF1A;LYPLAL1;SLC1A3;ELOVL6;ETFDH
18854,GO:1901615,5.79064153037812e-06,0.999998879270277,14,457,organic hydroxy compound metabolic process,BP,EBP;PECR;TH;HSD17B3;APOC1;ABCG1;ACADVL;ACAA2;RBP4;CYP17A1;ACAT2;STAR;CYP11A1;DHCR7
11528,GO:0043648,6.86213485753195e-06,0.999999467904273,7,96,dicarboxylic acid metabolic process,BP,PHYH;TH;GHR;MDH1;IDH1;STAR;SLC1A3
2969,GO:0006066,8.31791389927088e-06,0.999998713753615,11,289,alcohol metabolic process,BP,EBP;PECR;APOC1;ABCG1;ACADVL;ACAA2;RBP4;ACAT2;STAR;CYP11A1;DHCR7
1749,GO:0003988,8.93060739451747e-06,0.999999949061323,3,6,acetyl-CoA C-acyltransferase activity,MF,ACAA2;ACAT1;ACAT2
18833,GO:1901565,8.9748036295036e-06,0.999998455839602,12,346,organonitrogen compound catabolic process,BP,APOC1;PNP;HSD17B10;ACAT1;IDUA;AOX1;SARDH;HEXB;NUDT7;PCBD1;GLA;DERA
13931,GO:0051188,9.07754791204938e-06,0.999998905149602,9,184,cofactor biosynthetic process,BP,PDK4;ACSF2;PNP;BDH2;NNMT;ACAT1;PCBD1;PTS;ELOVL6
4386,GO:0009108,1.07441341490075e-05,0.999998884739546,8,143,coenzyme biosynthetic process,BP,PDK4;ACSF2;PNP;NNMT;ACAT1;PCBD1;PTS;ELOVL6
3245,GO:0006520,1.11633708477014e-05,0.999998035926481,12,349,cellular amino acid metabolic process,BP,TH;MSRA;MRI1;PSMB10;GHR;HSD17B10;ACAT1;SARDH;PCBD1;PEPD;PTS;SLC1A3
5904,GO:0016408,1.13051616177221e-05,0.999999749395997,4,19,C-acyltransferase activity,MF,ACAA2;ACSM5;ACAT1;ACAT2
11278,GO:0043231,1.48645240674462e-05,0.999993705686167,95,9934,intracellular membrane-bounded organelle,CC,EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;EXTL1;ACSF2;PNP;ABCG1;EBF1;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;ASAH2;TICAM1;ARL6IP4;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;HEXB;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;ACP5;GLA;ECI1;CYP11A1;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;CNIH4;ELOVL6;ETFDH
9599,GO:0034754,1.85806731083939e-05,0.999998307823807,7,110,cellular hormone metabolic process,BP,HSD17B3;HSD17B11;RBP4;CYP17A1;HSD3B2;STAR;CYP11A1
8207,GO:0031966,2.0848520815519e-05,0.999994913739064,16,634,mitochondrial membrane,CC,PDK4;MRPL14;MRPL16;ACADVL;ACAA2;CPT2;ACAT1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;CYB5A;ETFDH
9094,GO:0033539,2.39829387928181e-05,0.99999977449032,3,8,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACADVL;ETFB;ETFDH
3393,GO:0006695,3.12058689505518e-05,0.999998357247746,5,50,cholesterol biosynthetic process,BP,EBP;ABCG1;ACAA2;ACAT2;DHCR7
10700,GO:0042180,3.3336673533657e-05,0.999995231581316,9,217,cellular ketone metabolic process,BP,PDK4;HSD17B3;APOC1;ACADVL;PSMB10;RGN;CYP17A1;FABP3;STAR
6034,GO:0016628,3.39471566272523e-05,0.999998960739983,4,25,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,PECR;BDH2;DECR1;DHCR7
19255,GO:1902653,3.46291345940611e-05,0.99999813411306,5,51,secondary alcohol biosynthetic process,BP,EBP;ABCG1;ACAA2;ACAT2;DHCR7
9190,GO:0033764,3.93976688800497e-05,0.999998746531844,4,25,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B3;HSD17B11;HSD17B10;HSD3B2
2758,GO:0005740,4.04993236375273e-05,0.999989539853412,16,669,mitochondrial envelope,CC,PDK4;MRPL14;MRPL16;ACADVL;ACAA2;CPT2;ACAT1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;CYB5A;ETFDH
11276,GO:0043229,4.15843554628896e-05,0.999982966672282,104,11553,intracellular organelle,CC,EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;HEXB;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;CNIH4;ELOVL6;ETFDH;TMOD4
4007,GO:0008209,4.96228259292641e-05,0.999998302477685,4,28,androgen metabolic process,BP,HSD17B3;HSD17B11;CYP17A1;HSD3B2
16654,GO:0071704,5.04341510538229e-05,0.999977544607553,95,10155,organic substance metabolic process,BP,CFB;EBP;PDK4;PECR;ALG5;PHYH;DPM3;TH;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;IDH1;DECR1;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;RBMS3;HNF1A;LYPLAL1;SLC1A3;ELOVL6;ETFDH
5780,GO:0016126,5.101322218961e-05,0.999997002375971,5,55,sterol biosynthetic process,BP,EBP;ABCG1;ACAA2;ACAT2;DHCR7
5820,GO:0016229,5.38502147178299e-05,0.999998125711542,4,27,steroid dehydrogenase activity,MF,HSD17B3;HSD17B11;HSD17B10;HSD3B2
11678,GO:0044237,5.46464298192606e-05,0.999975311247722,93,9871,cellular metabolic process,BP,PDK4;PECR;ALG5;PHYH;DPM3;TH;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;WDR45;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;FABP3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;CYB5A;PTS;RBMS3;HNF1A;LYPLAL1;SLC1A3;ELOVL6;ETFDH
17077,GO:0072524,5.5062354184363e-05,0.999994004516391,7,134,pyridine-containing compound metabolic process,BP,PNP;NNMT;AOX1;SHPK;MDH1;IDH1;DERA
12609,GO:0046356,6.06847365153306e-05,1,2,2,acetyl-CoA catabolic process,BP,ACAT1;NUDT7
6033,GO:0016627,6.06880328348259e-05,0.999996295873374,5,56,oxidoreductase activity, acting on the CH-CH group of donors,MF,PECR;BDH2;ACADVL;DECR1;DHCR7
3345,GO:0006637,6.22263588451643e-05,0.999994604212329,6,93,acyl-CoA metabolic process,BP,PDK4;ACSF2;ACSM5;ACAT1;NUDT7;ELOVL6
9805,GO:0035383,6.22263588451643e-05,0.999994604212329,6,93,thioester metabolic process,BP,PDK4;ACSF2;ACSM5;ACAT1;NUDT7;ELOVL6
3398,GO:0006702,6.52444255693747e-05,0.999999040131888,3,11,androgen biosynthetic process,BP,HSD17B3;CYP17A1;HSD3B2
10835,GO:0042445,6.87711368789365e-05,0.999990646434477,8,185,hormone metabolic process,BP,HSD17B3;HSD17B11;RBP4;CYP17A1;HSD3B2;STAR;CYP11A1;DHCR7
11679,GO:0044238,7.73105202994972e-05,0.999964373742209,92,9787,primary metabolic process,BP,CFB;EBP;PDK4;PECR;ALG5;PHYH;DPM3;TH;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;KRT10;ACAA2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;RBMS3;HNF1A;LYPLAL1;SLC1A3;ELOVL6;ETFDH
6163,GO:0016863,9.31443852666926e-05,0.99999841970206,3,12,intramolecular oxidoreductase activity, transposing C=C bonds,MF,EBP;HSD3B2;ECI1
11795,GO:0044424,0.000104714031269801,0.999961281897091,113,13251,intracellular part,CC,EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
6145,GO:0016835,0.000105576853813686,0.999992707032646,5,62,carbon-oxygen lyase activity,MF,ECHDC2;PCBD1;PUS1;ECI1;PTS
18856,GO:1901617,0.000105819624777119,0.999984654241325,8,199,organic hydroxy compound biosynthetic process,BP,EBP;TH;HSD17B3;ABCG1;ACAA2;ACAT2;STAR;DHCR7
6740,GO:0019866,0.00011867759660197,0.999971251970683,13,506,organelle inner membrane,CC,PDK4;MRPL14;MRPL16;ACADVL;ACAA2;CPT2;ACAT1;HSD3B2;IFI27;LDHD;STAR;ECI1;ETFDH
6534,GO:0019216,0.000139729987568514,0.999975758977142,9,269,regulation of lipid metabolic process,BP,PDK4;APOC1;ABCG1;ACADVL;RGN;FABP3;IDH1;STAR;DHCR7
10751,GO:0042304,0.000144216314293911,0.999993322558481,4,37,regulation of fatty acid biosynthetic process,BP,PDK4;APOC1;ACADVL;RGN
18847,GO:1901605,0.00014466373450775,0.999978023023287,8,206,alpha-amino acid metabolic process,BP,TH;MSRA;MRI1;GHR;ACAT1;SARDH;PCBD1;SLC1A3
4857,GO:0010565,0.000149820278622197,0.999980745092197,7,156,regulation of cellular ketone metabolic process,BP,PDK4;APOC1;ACADVL;PSMB10;RGN;FABP3;STAR
9083,GO:0033489,0.000156233098347001,0.999999625897419,2,3,cholesterol biosynthetic process via desmosterol,BP,EBP;DHCR7
9084,GO:0033490,0.000156233098347001,0.999999625897419,2,3,cholesterol biosynthetic process via lathosterol,BP,EBP;DHCR7
1746,GO:0003985,0.000174459293061038,0.999999558374679,2,3,acetyl-CoA C-acetyltransferase activity,MF,ACAT1;ACAT2
6449,GO:0018963,0.000177551384567733,0.999999546550665,2,3,phthalate metabolic process,BP,TH;STAR
2905,GO:0005975,0.000179672506558447,0.999954538039198,13,549,carbohydrate metabolic process,BP,PDK4;DPM3;RGN;GALT;RBP4;IDUA;SHPK;HEXB;MDH1;IDH1;GLA;DERA;CYB5A
2761,GO:0005743,0.000180650019178009,0.999957213642489,12,454,mitochondrial inner membrane,CC,PDK4;MRPL14;MRPL16;ACADVL;ACAA2;CPT2;ACAT1;HSD3B2;LDHD;STAR;ECI1;ETFDH
19035,GO:1902109,0.000181503086061805,0.999999531287542,2,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,ACAA2;NOL3
2228,GO:0004769,0.000181560531255263,0.999999531064415,2,3,steroid delta-isomerase activity,MF,EBP;HSD3B2
2992,GO:0006103,0.000185848996792414,0.999995782689193,3,16,2-oxoglutarate metabolic process,BP,PHYH;GHR;IDH1
6535,GO:0019217,0.000229980085599933,0.999981015132386,5,78,regulation of fatty acid metabolic process,BP,PDK4;APOC1;ACADVL;RGN;FABP3
6536,GO:0019218,0.000232273175033432,0.999980814218617,5,75,regulation of steroid metabolic process,BP,APOC1;ABCG1;ACADVL;STAR;DHCR7
18690,GO:1901136,0.000257443919864379,0.999963758759977,7,171,carbohydrate derivative catabolic process,BP,PNP;GALT;IDUA;HEXB;NUDT7;GLA;DERA
8208,GO:0031967,0.00028011552438668,0.999904507948213,19,1063,organelle envelope,CC,EBP;PDK4;MRPL14;MRPL16;ACADVL;ACAA2;MGST2;CPT2;ACAT1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;DHCR7;CYB5A;ETFDH
8212,GO:0031975,0.00028011552438668,0.999904507948213,19,1063,envelope,CC,EBP;PDK4;MRPL14;MRPL16;ACADVL;ACAA2;MGST2;CPT2;ACAT1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;DHCR7;CYB5A;ETFDH
2793,GO:0005782,0.000296864928040584,0.999983206795158,4,43,peroxisomal matrix,CC,PHYH;HACL1;NUDT7;IDH1
8178,GO:0031907,0.000296864928040584,0.999983206795158,4,43,microbody lumen,CC,PHYH;HACL1;NUDT7;IDH1
6146,GO:0016836,0.000307187207801291,0.999982465047366,4,43,hydro-lyase activity,MF,ECHDC2;PCBD1;PUS1;ECI1
1826,GO:0004095,0.000312132843721068,0.999998503223805,2,4,carnitine O-palmitoyltransferase activity,MF,CPT2;CPT1C
10102,GO:0035877,0.000315864095345351,0.999998476221012,2,4,death effector domain binding,MF,FADD;NOL3
10058,GO:0035795,0.000320707617632132,0.999998440927361,2,4,negative regulation of mitochondrial membrane permeability,BP,ACAA2;NOL3
20596,GO:1905709,0.000320707617632132,0.999998440927361,2,4,negative regulation of membrane permeability,BP,ACAA2;NOL3
6160,GO:0016860,0.000349357875042923,0.999979309697409,4,45,intramolecular oxidoreductase activity,MF,EBP;MRI1;HSD3B2;ECI1
5933,GO:0016453,0.000350660725599896,0.999998216722199,2,4,C-acetyltransferase activity,MF,ACAT1;ACAT2
6582,GO:0019362,0.000360119949639014,0.999956333557308,6,129,pyridine nucleotide metabolic process,BP,PNP;NNMT;SHPK;MDH1;IDH1;DERA
12673,GO:0046496,0.000360119949639014,0.999956333557308,6,129,nicotinamide nucleotide metabolic process,BP,PNP;NNMT;SHPK;MDH1;IDH1;DERA
17785,GO:0097169,0.000361260188894828,0.999998134984883,2,4,AIM2 inflammasome complex,CC,PYCARD;CASP4
6141,GO:0016830,0.000393603292640991,0.999975909100513,4,46,carbon-carbon lyase activity,MF,HACL1;CYP17A1;ACAT1;DERA
2794,GO:0005783,0.000431859018601651,0.999828594068602,24,1601,endoplasmic reticulum,CC,EBP;ALG5;DPM3;TH;HSD17B3;MRAP;APOC1;EXTL1;ABCG1;PYCARD;MGST2;FADS1;PLA2G16;CYP17A1;NOL3;HSD3B2;CPT1C;CASP4;TMEM98;TFPI;DHCR7;CYB5A;CNIH4;ELOVL6
15838,GO:0070265,0.00043757494457202,0.999972387232261,4,48,necrotic cell death,BP,FADD;TRADD;TICAM1;NOL3
3272,GO:0006549,0.000458522247216464,0.99999689997154,2,5,isoleucine metabolic process,BP,GHR;ACAT1
2699,GO:0005622,0.000469983231269461,0.999811235779997,113,13536,intracellular,CC,EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
6090,GO:0016746,0.000470134839482673,0.999914562140499,8,247,transferase activity, transferring acyl groups,MF,ACAA2;ACSM5;CPT2;PLA2G16;ACAT1;ACAT2;CPT1C;ELOVL6
5912,GO:0016416,0.000484421026380555,0.999996632668606,2,5,O-palmitoyltransferase activity,MF,CPT2;CPT1C
11707,GO:0044273,0.000500423156259986,0.999967200680743,4,50,sulfur compound catabolic process,BP,ACAT1;IDUA;HEXB;NUDT7
3998,GO:0008198,0.000530288131435564,0.999982028493038,3,22,ferrous iron binding,MF,PHYH;TH;ACP5
4370,GO:0009081,0.000570397649036386,0.999980085914706,3,23,branched-chain amino acid metabolic process,BP,GHR;HSD17B10;ACAT1
17435,GO:0090181,0.000602855994827551,0.999978546627838,3,23,regulation of cholesterol metabolic process,BP,ABCG1;ACADVL;DHCR7
12439,GO:0045940,0.000630019758534656,0.999977235963304,3,23,positive regulation of steroid metabolic process,BP,APOC1;ABCG1;STAR
3416,GO:0006733,0.000635340703456286,0.999913978852082,6,143,oxidoreduction coenzyme metabolic process,BP,PNP;NNMT;SHPK;MDH1;IDH1;DERA
13995,GO:0051287,0.000658938317665872,0.999953378660674,4,53,NAD binding,MF,BDH2;AOX1;MDH1;IDH1
6064,GO:0016705,0.000703307830222242,0.999902859457402,6,146,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,PHYH;TH;FADS1;CYP17A1;PCBD1;CYP11A1
4009,GO:0008211,0.000708360072090096,0.999973235919762,3,24,glucocorticoid metabolic process,BP,CYP17A1;HSD3B2;STAR
2791,GO:0005778,0.000742352433162559,0.999945586067662,4,57,peroxisomal membrane,CC,PECR;PXMP2;PXMP4;PLA2G16
8174,GO:0031903,0.000742352433162559,0.999945586067662,4,57,microbody membrane,CC,PECR;PXMP2;PXMP4;PLA2G16
17101,GO:0072559,0.00077230142419666,0.999992604393639,2,6,NLRP3 inflammasome complex,CC,PYCARD;CASP4
15478,GO:0061370,0.00077933394395014,0.99999250270669,2,6,testosterone biosynthetic process,BP,HSD17B3;STAR
5902,GO:0016406,0.00078025276732525,0.999992489386333,2,6,carnitine O-acyltransferase activity,MF,CPT2;CPT1C
2636,GO:0005506,0.000791557595047524,0.99988814198944,6,147,iron ion binding,MF,PHYH;TH;CYP17A1;AOX1;ACP5;CYP11A1
21638,GO:2001236,0.000796671328348796,0.999887214649925,6,151,regulation of extrinsic apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2;NOL3;DEPTOR
15127,GO:0060696,0.000809902701006744,0.999992055285781,2,6,regulation of phospholipid catabolic process,BP,APOC1;IDH1
11706,GO:0044272,0.00081391241356092,0.999860437715058,7,209,sulfur compound biosynthetic process,BP,PDK4;MRI1;EXTL1;ACSF2;MGST2;ACAT1;ELOVL6
17326,GO:0089720,0.00082681044207032,0.999991804077353,2,6,caspase binding,MF,FADD;NOL3
11894,GO:0044763,0.000837406340423582,0.999567331160045,91,10179,single-organism cellular process,BP,PDK4;PECR;ALG5;PHYH;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;G0S2;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;RBP4;CYP17A1;RNASEL;ANG;FAM110C;ACAT1;ACAT2;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;GRIA3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;TMEM176A;IDH1;DECR1;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;DOK1;SLC1A3;ELOVL6;LINGO1;ETFDH;TMOD4
12586,GO:0046320,0.000841561084737166,0.9999658934806,3,27,regulation of fatty acid oxidation,BP,PDK4;ACADVL;FABP3
12553,GO:0046165,0.000892736954940853,0.999899774771197,5,102,alcohol biosynthetic process,BP,EBP;ABCG1;ACAA2;ACAT2;DHCR7
6091,GO:0016747,0.000905486123503481,0.999841849730027,7,211,transferase activity, transferring acyl groups other than amino-acyl groups,MF,ACAA2;ACSM5;CPT2;ACAT1;ACAT2;CPT1C;ELOVL6
5118,GO:0010939,0.000952773841241315,0.999959814624253,3,26,regulation of necrotic cell death,BP,FADD;TRADD;NOL3
12858,GO:0046889,0.000970334128224377,0.999923388505505,4,60,positive regulation of lipid biosynthetic process,BP,ABCG1;RGN;FABP3;STAR
17868,GO:0097342,0.00109392809168191,0.999986803215193,2,7,ripoptosome,CC,FADD;TICAM1
522,GO:0001561,0.00111914980629762,0.999986341852834,2,7,fatty acid alpha-oxidation,BP,PHYH;HACL1
9806,GO:0035384,0.00112707569167795,0.999907152228483,4,63,thioester biosynthetic process,BP,PDK4;ACSF2;ACAT1;ELOVL6
16596,GO:0071616,0.00112707569167795,0.999907152228483,4,63,acyl-CoA biosynthetic process,BP,PDK4;ACSF2;ACAT1;ELOVL6
3413,GO:0006729,0.00118547648785473,0.999985103271127,2,7,tetrahydrobiopterin biosynthetic process,BP,PCBD1;PTS
12548,GO:0046146,0.00118547648785473,0.999985103271127,2,7,tetrahydrobiopterin metabolic process,BP,PCBD1;PTS
8429,GO:0032365,0.00119535429935704,0.999944820988494,3,30,intracellular lipid transport,BP,ABCG1;CPT2;STAR
4606,GO:0009635,0.00120200851783226,0.999984788926671,2,7,response to herbicide,BP,TH;STAR
1755,GO:0003996,0.00121902159338602,0.999984463123038,2,7,acyl-CoA ligase activity,MF,ACSF2;ACSM5
6071,GO:0016714,0.0012255103403329,0.999984338247622,2,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,TH;PCBD1
11880,GO:0044723,0.00126136063438189,0.999674168858426,10,436,single-organism carbohydrate metabolic process,BP,PDK4;RGN;GALT;RBP4;IDUA;HEXB;MDH1;IDH1;GLA;CYB5A
12153,GO:0045350,0.00129202737080966,0.999982380698387,2,8,interferon-beta biosynthetic process,BP,TICAM1;NMI
12160,GO:0045357,0.00129202737080966,0.999982380698387,2,8,regulation of interferon-beta biosynthetic process,BP,TICAM1;NMI
2800,GO:0005789,0.00141034404175669,0.999494331121962,16,951,endoplasmic reticulum membrane,CC,EBP;ALG5;DPM3;HSD17B3;MRAP;EXTL1;ABCG1;MGST2;FADS1;CYP17A1;HSD3B2;CPT1C;CASP4;DHCR7;CYB5A;ELOVL6
3420,GO:0006739,0.00155481382331661,0.999921143021401,3,31,NADP metabolic process,BP,SHPK;IDH1;DERA
1890,GO:0004300,0.001555079410658,0.999976698708299,2,8,enoyl-CoA hydratase activity,MF,ECHDC2;ECI1
10696,GO:0042175,0.00172996506353819,0.999366930985181,16,971,nuclear outer membrane-endoplasmic reticulum membrane network,CC,EBP;ALG5;DPM3;HSD17B3;MRAP;EXTL1;ABCG1;MGST2;FADS1;CYP17A1;HSD3B2;CPT1C;CASP4;DHCR7;CYB5A;ELOVL6
3347,GO:0006639,0.00174693678691803,0.99977091017117,5,119,acylglycerol metabolic process,BP,APOC1;RGN;PLA2G16;ANG;FABP3
2979,GO:0006084,0.00179506396327655,0.999903669985773,3,34,acetyl-CoA metabolic process,BP,PDK4;ACAT1;NUDT7
14610,GO:0055091,0.00180146186897959,0.999970078722189,2,9,phospholipid homeostasis,BP,ABCG1;FABP3
3346,GO:0006638,0.00181273575713266,0.999760223933238,5,120,neutral lipid metabolic process,BP,APOC1;RGN;PLA2G16;ANG;FABP3
12634,GO:0046434,0.00184130008009006,0.999755482989241,5,122,organophosphate catabolic process,BP,APOC1;PNP;NUDT7;IDH1;DERA
7842,GO:0031264,0.00190052750098764,0.999967560719595,2,9,death-inducing signaling complex,CC,FADD;TRADD
13562,GO:0050660,0.00190231344408035,0.99981830476675,4,73,flavin adenine dinucleotide binding,MF,ACADVL;AOX1;LDHD;ETFDH
12373,GO:0045834,0.00191232168921495,0.999743801790887,5,123,positive regulation of lipid metabolic process,BP,APOC1;ABCG1;RGN;FABP3;STAR
2990,GO:0006101,0.00192138308676561,0.999894401018828,3,34,citrate metabolic process,BP,GHR;MDH1;IDH1
12894,GO:0046951,0.00196613147573852,0.999965855575298,2,9,ketone body biosynthetic process,BP,BDH2;ACAT1
16186,GO:0070900,0.00197538069552922,0.999965612795819,2,9,mitochondrial tRNA modification,BP,HSD17B10;PUS1
18646,GO:1900864,0.00197538069552922,0.999965612795819,2,9,mitochondrial RNA modification,BP,HSD17B10;PUS1
16552,GO:0071550,0.00198517692958256,0.999965355021333,2,9,death-inducing signaling complex assembly,BP,FADD;TRADD
6143,GO:0016832,0.00198831738139772,0.999965272246262,2,9,aldehyde-lyase activity,MF,CYP17A1;DERA
4006,GO:0008207,0.00202236259640813,0.999886833042775,3,34,C21-steroid hormone metabolic process,BP,CYP17A1;STAR;CYP11A1
16410,GO:0071345,0.00202606054484674,0.99933123941729,13,704,cellular response to cytokine stimulus,BP,IFI30;FADD;TRADD;PYCARD;PSMB10;GHR;RNASEL;NMI;SHPK;NOL3;IFI27;TFPI;STAR
11811,GO:0044446,0.00221003254389027,0.99875717288506,76,8256,intracellular organelle part,CC,EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;HSD17B3;MRAP;TBC1D14;PXMP2;PXMP4;EXTL1;ACSF2;PNP;ABCG1;PYCARD;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;FADS1;FGF18;TICAM1;ARL6IP4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;SARDH;HEXB;GRIA3;NOL3;HSD3B2;NUDT7;CPT1C;PCBD1;CASP4;IFI27;IDH1;DECR1;PUS1;LDHD;STAR;SNX21;GLA;ECI1;CYP11A1;RPH3AL;DERA;DHCR7;CYB5A;ELOVL6;ETFDH;TMOD4
3434,GO:0006766,0.00232525265896387,0.999674041113068,5,126,vitamin metabolic process,BP,RGN;AOX1;ACP5;CYP11A1;CYB5A
15839,GO:0070266,0.00233134576123179,0.999862372684789,3,36,necroptotic process,BP,FADD;TRADD;TICAM1
6265,GO:0017085,0.00234755102037851,0.999954397089617,2,10,response to insecticide,BP,TH;STAR
18880,GO:1901658,0.00237568442208038,0.999859057772985,3,35,glycosyl compound catabolic process,BP,PNP;GLA;DERA
3999,GO:0008199,0.00244579257306031,0.999951483811913,2,10,ferric iron binding,MF,TH;ACP5
3408,GO:0006720,0.00254722839286407,0.999635291332829,5,127,isoprenoid metabolic process,BP,PECR;PHYH;TH;RBP4;STAR
9391,GO:0034356,0.00260682410494301,0.999945652811989,2,11,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,PNP;NNMT
3533,GO:0006919,0.00261162538329349,0.999727143378443,4,79,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD;TRADD;PYCARD;IFI27
17013,GO:0072350,0.00268567873816104,0.999832825278368,3,38,tricarboxylic acid metabolic process,BP,GHR;MDH1;IDH1
15611,GO:0061702,0.00276820108528725,0.999940489562988,2,11,inflammasome complex,CC,PYCARD;CASP4
6728,GO:0019852,0.00279264079714318,0.999939693782365,2,11,L-ascorbic acid metabolic process,BP,RGN;CYB5A
6657,GO:0019637,0.00279659705196658,0.998892458977395,17,1112,organophosphate metabolic process,BP,DPM3;ZFYVE21;MRAP;APOC1;PNP;FADS1;FGF18;NNMT;PLA2G16;ACAT1;SHPK;HEXB;FABP3;NUDT7;MDH1;IDH1;DERA
17780,GO:0097164,0.00282591632665411,0.999484788814403,6,190,ammonium ion metabolic process,BP,TH;APOC1;PLA2G16;SARDH;FABP3;CPT1C
11793,GO:0044422,0.00283637840016969,0.998385391800064,77,8458,organelle part,CC,EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;HSD17B3;MRAP;TBC1D14;PXMP2;PXMP4;EXTL1;ACSF2;PNP;ABCG1;PYCARD;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;FADS1;FGF18;TICAM1;ARL6IP4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;SARDH;HEXB;GRIA3;NOL3;HSD3B2;NUDT7;CPT1C;PCBD1;CASP4;IFI27;IDH1;DECR1;PUS1;LDHD;TFPI;STAR;SNX21;GLA;ECI1;CYP11A1;RPH3AL;DERA;DHCR7;CYB5A;ELOVL6;ETFDH;TMOD4
12893,GO:0046950,0.00294714713117832,0.999934580288254,2,11,cellular ketone body metabolic process,BP,BDH2;ACAT1
4271,GO:0008654,0.0029550857895138,0.999362871053388,7,266,phospholipid biosynthetic process,BP,DPM3;FADS1;FGF18;PLA2G16;HEXB;FABP3;IDH1
12154,GO:0045351,0.00312236390064104,0.999927609809373,2,12,type I interferon biosynthetic process,BP,TICAM1;NMI
5062,GO:0010872,0.0031411882123115,0.999927960263818,2,11,regulation of cholesterol esterification,BP,APOC1;ABCG1
3435,GO:0006767,0.00326809182618788,0.999636005294329,4,84,water-soluble vitamin metabolic process,BP,RGN;AOX1;ACP5;CYB5A
2996,GO:0006107,0.00329204272342045,0.999921579980165,2,12,oxaloacetate metabolic process,BP,GHR;MDH1
16286,GO:0071071,0.00329899979795701,0.999921329250452,2,12,regulation of phospholipid biosynthetic process,BP,FABP3;IDH1
11970,GO:0045019,0.00330372111359998,0.999921158940873,2,12,negative regulation of nitric oxide biosynthetic process,BP,RGN;GLA
20064,GO:1904406,0.00330372111359998,0.999921158940873,2,12,negative regulation of nitric oxide metabolic process,BP,RGN;GLA
8670,GO:0032688,0.00331065150959546,0.999920908716609,2,12,negative regulation of interferon-beta production,BP,PYCARD;NMI
4352,GO:0009058,0.00332365635019424,0.998097969632206,59,6057,biosynthetic process,BP,EBP;PDK4;PECR;ALG5;DPM3;TH;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;ACADVL;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;TICAM1;NNMT;PLA2G16;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;HEXB;FABP3;HSD3B2;ACCS;PCBD1;MDH1;IFI27;IDH1;PTMS;STAR;GLA;CYP11A1;DHCR7;PTS;RBMS3;HNF1A;SLC1A3;ELOVL6
4558,GO:0009404,0.00333302837953017,0.999920098946198,2,12,toxin metabolic process,BP,TH;STAR
15035,GO:0060547,0.00334857224765185,0.999919534791574,2,12,negative regulation of necrotic cell death,BP,FADD;NOL3
9180,GO:0033700,0.00336533497496942,0.999918924881868,2,12,phospholipid efflux,BP,APOC1;ABCG1
11051,GO:0042802,0.00339908308378247,0.998556333086226,19,1331,identical protein binding,MF,MRI1;FADD;TRADD;ABCG1;PYCARD;GHR;HACL1;ANG;NMI;ACAT1;HEXB;NOL3;ACCS;PCBD1;PON2;IDH1;GLA;S100B;PTS
17854,GO:0097300,0.00340571248133904,0.999768471470156,3,41,programmed necrotic cell death,BP,FADD;TRADD;TICAM1
4387,GO:0009109,0.00342034695393374,0.999916912259465,2,12,coenzyme catabolic process,BP,ACAT1;NUDT7
9086,GO:0033500,0.00345843570433246,0.999342540928953,6,204,carbohydrate homeostasis,BP,PDK4;TH;RBP4;STAR;RPH3AL;HNF1A
10934,GO:0042593,0.00345843570433246,0.999342540928953,6,204,glucose homeostasis,BP,PDK4;TH;RBP4;STAR;RPH3AL;HNF1A
19078,GO:1902224,0.00351998536292673,0.999913224305348,2,12,ketone body metabolic process,BP,BDH2;ACAT1
17650,GO:0090646,0.00352317332736186,0.999913105406737,2,12,mitochondrial tRNA processing,BP,HSD17B10;PUS1
3351,GO:0006644,0.00354291681915688,0.999022767717211,9,427,phospholipid metabolic process,BP,DPM3;ZFYVE21;APOC1;FADS1;FGF18;PLA2G16;HEXB;FABP3;IDH1
12663,GO:0046479,0.00358801918018804,0.999910674871139,2,12,glycosphingolipid catabolic process,BP,HEXB;GLA
3399,GO:0006703,0.00366138569120929,0.999907897463365,2,12,estrogen biosynthetic process,BP,HSD17B11;STAR
12207,GO:0045540,0.0036746593842999,0.999906316314929,2,13,regulation of cholesterol biosynthetic process,BP,ABCG1;DHCR7
17852,GO:0097296,0.0039316340977895,0.999896228691448,2,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD;TRADD
8645,GO:0032648,0.00398917139921669,0.999711832928492,3,45,regulation of interferon-beta production,BP,PYCARD;TICAM1;NMI
17797,GO:0097191,0.00406504198744937,0.999201147010311,6,209,extrinsic apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2;NOL3;DEPTOR
8760,GO:0032813,0.00412400525586068,0.99969917862435,3,43,tumor necrosis factor receptor superfamily binding,MF,FADD;TRADD;NOL3
6155,GO:0016853,0.00413037173922111,0.999336901978753,5,141,isomerase activity,MF,EBP;MRI1;HSD3B2;PUS1;ECI1
11259,GO:0043202,0.00419742523344554,0.999497725320298,4,90,lysosomal lumen,CC,IFI30;IDUA;HEXB;GLA
15991,GO:0070525,0.00421708313621637,0.999884616517872,2,13,tRNA threonylcarbamoyladenosine metabolic process,BP,HSD17B10;PUS1
5901,GO:0016405,0.00422024274214984,0.99988448563823,2,13,CoA-ligase activity,MF,ACSF2;ACSM5
12684,GO:0046514,0.00423950245556421,0.999883686749444,2,13,ceramide catabolic process,BP,HEXB;GLA
13563,GO:0050661,0.00431531973236778,0.999679411157934,3,45,NADP binding,MF,IDH1;DECR1;DHCR7
7305,GO:0030207,0.00436182682580395,0.999877383277581,2,14,chondroitin sulfate catabolic process,BP,IDUA;HEXB
5082,GO:0010893,0.00438544848073271,0.999876376667315,2,14,positive regulation of steroid biosynthetic process,BP,ABCG1;STAR
2647,GO:0005523,0.00443268203318591,0.999874355425113,2,14,tropomyosin binding,MF,PYCARD;TMOD4
16337,GO:0071222,0.004469375084059,0.999268405471652,5,148,cellular response to lipopolysaccharide,BP,PYCARD;TICAM1;SHPK;TFPI;STAR
8617,GO:0032608,0.004532792135849,0.999656628047148,3,47,interferon-beta production,BP,PYCARD;TICAM1;NMI
12308,GO:0045717,0.00454606591627651,0.999869457824714,2,14,negative regulation of fatty acid biosynthetic process,BP,APOC1;ACADVL
2026,GO:0004497,0.00471379397499284,0.999417090900983,4,91,monooxygenase activity,MF,TH;CYP17A1;PCBD1;CYP11A1
5698,GO:0015936,0.00479470850868148,0.999858495358555,2,14,coenzyme A metabolic process,BP,ACAT1;NUDT7
6595,GO:0019377,0.0048426665719944,0.999856346254709,2,14,glycolipid catabolic process,BP,HEXB;GLA
9441,GO:0034433,0.0050645992356984,0.999846257384784,2,14,steroid esterification,BP,APOC1;ABCG1
9442,GO:0034434,0.0050645992356984,0.999846257384784,2,14,sterol esterification,BP,APOC1;ABCG1
9443,GO:0034435,0.0050645992356984,0.999846257384784,2,14,cholesterol esterification,BP,APOC1;ABCG1
9134,GO:0033612,0.00508785516762318,0.999843898227428,2,15,receptor serine/threonine kinase binding,MF,FADD;PYCARD
17076,GO:0072523,0.0051077588835927,0.999595130237161,3,50,purine-containing compound catabolic process,BP,PNP;AOX1;NUDT7
17587,GO:0090407,0.00522769758247332,0.998248037296587,11,615,organophosphate biosynthetic process,BP,DPM3;MRAP;PNP;FADS1;FGF18;NNMT;PLA2G16;ACAT1;HEXB;FABP3;IDH1
16334,GO:0071219,0.00527461837108965,0.999101545329577,5,154,cellular response to molecule of bacterial origin,BP,PYCARD;TICAM1;SHPK;TFPI;STAR
2457,GO:0005123,0.00527996243163862,0.999834882538115,2,15,death receptor binding,MF,FADD;NOL3
352,GO:0000963,0.00541668668120622,0.999828360850426,2,15,mitochondrial RNA processing,BP,HSD17B10;PUS1
10908,GO:0042559,0.00556618402679506,0.999821131178092,2,15,pteridine-containing compound biosynthetic process,BP,PCBD1;PTS
9409,GO:0034375,0.00560342198409559,0.99981931445786,2,15,high-density lipoprotein particle remodeling,BP,APOC1;ABCG1
17770,GO:0097153,0.00561643555594054,0.999818678080648,2,15,cysteine-type endopeptidase activity involved in apoptotic process,MF,PYCARD;CASP4
21640,GO:2001238,0.00576892393046094,0.999522292402922,3,50,positive regulation of extrinsic apoptotic signaling pathway,BP,FADD;PYCARD;G0S2
9263,GO:0034097,0.00579011651383303,0.997833853012217,13,798,response to cytokine,BP,IFI30;FADD;TRADD;PYCARD;PSMB10;GHR;RNASEL;NMI;SHPK;NOL3;IFI27;TFPI;STAR
5004,GO:0010803,0.00581670536151723,0.999516904472383,3,50,regulation of tumor necrosis factor-mediated signaling pathway,BP,TRADD;PYCARD;NOL3
6727,GO:0019843,0.00597487771081443,0.999499363183815,3,49,rRNA binding,MF,MRPL16;RNASEL;ANG
13677,GO:0050810,0.00609162029503921,0.999485186544109,3,51,regulation of steroid biosynthetic process,BP,ABCG1;STAR;DHCR7
122,GO:0000248,0.00622727943472724,1,1,1,C-5 sterol desaturase activity,MF,FADS1
12194,GO:0045485,0.00622727943472724,1,1,1,omega-6 fatty acid desaturase activity,MF,FADS1
16095,GO:0070704,0.00622727943472724,1,1,1,sterol desaturase activity,MF,FADS1
12183,GO:0045428,0.0062802516377682,0.999462975464315,3,52,regulation of nitric oxide biosynthetic process,BP,RGN;TICAM1;GLA
8430,GO:0032366,0.00632015876626265,0.999780219851359,2,17,intracellular sterol transport,BP,ABCG1;STAR
8431,GO:0032367,0.00632015876626265,0.999780219851359,2,17,intracellular cholesterol transport,BP,ABCG1;STAR
4349,GO:0009055,0.00633348087016172,0.999147223857034,4,97,electron carrier activity,MF,ETFB;AOX1;CYB5A;ETFDH
2988,GO:0006098,0.00640440090931283,0.999777155954139,2,16,pentose-phosphate shunt,BP,SHPK;DERA
8545,GO:0032496,0.0064908929648956,0.998381928493934,7,299,response to lipopolysaccharide,BP,TH;PYCARD;MGST2;TICAM1;SHPK;TFPI;STAR
6683,GO:0019748,0.00656256811981095,0.999429862082996,3,52,secondary metabolic process,BP,TH;BDH2;STAR
13497,GO:0050277,0.0066207576353985,1,1,1,sedoheptulokinase activity,MF,SHPK
3400,GO:0006704,0.00670432195011751,0.99975964308996,2,17,glucocorticoid biosynthetic process,BP,CYP17A1;HSD3B2
6287,GO:0017127,0.00683705470839483,0.999752387231388,2,17,cholesterol transporter activity,MF,ABCG1;STAR
3297,GO:0006575,0.00685413781599689,0.998756430828601,5,161,cellular modified amino acid metabolic process,BP,MGST2;GHR;PLA2G16;SARDH;IDH1
7930,GO:0031406,0.00688666692849203,0.998748985989177,5,162,carboxylic acid binding,MF,PHYH;TH;APOC1;FABP3;SLC1A3
21665,GO:2001269,0.00690836690579258,0.999748458309615,2,17,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD;TRADD
6515,GO:0019184,0.00693739660688784,0.999746852827934,2,17,nonribosomal peptide biosynthetic process,BP,BDH2;MGST2
18841,GO:1901576,0.00694188464381387,0.995865770704286,57,5982,organic substance biosynthetic process,BP,EBP;PDK4;PECR;ALG5;DPM3;TH;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;ACADVL;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;TICAM1;NNMT;PLA2G16;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;HEXB;FABP3;HSD3B2;PCBD1;MDH1;IFI27;IDH1;PTMS;STAR;CYP11A1;DHCR7;PTS;RBMS3;HNF1A;SLC1A3;ELOVL6
11203,GO:0043122,0.00696976182820462,0.998466769953831,6,234,regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD;TRADD;PYCARD;TICAM1;NOL3;S100B
3348,GO:0006641,0.00702379255327385,0.999024429255726,4,104,triglyceride metabolic process,BP,APOC1;RGN;PLA2G16;FABP3
11241,GO:0043177,0.00705468009239471,0.998710912443855,5,163,organic acid binding,MF,PHYH;TH;APOC1;FABP3;SLC1A3
4176,GO:0008480,0.00713893927716339,1,1,1,sarcosine dehydrogenase activity,MF,SARDH
18664,GO:1901052,0.00713893927716339,1,1,1,sarcosine metabolic process,BP,SARDH
18665,GO:1901053,0.00713893927716339,1,1,1,sarcosine catabolic process,BP,SARDH
15677,GO:0065008,0.00717995176910328,0.996018466713324,36,3394,regulation of biological quality,BP,PDK4;IFI30;DPM3;TH;SLC31A2;FADD;HSD17B3;HSD17B11;ABCG1;BDH2;PYCARD;ACADVL;ACAA2;PSMB10;RGN;FXYD1;RBP4;CYP17A1;RNASEL;ANG;HEXB;FABP3;GRIA3;NOL3;HSD3B2;DEPTOR;FAM46A;TFPI;STAR;CYP11A1;RPH3AL;S100B;DHCR7;HNF1A;SLC1A3;TMOD4
2788,GO:0005775,0.00720687674203429,0.998676211376818,5,164,vacuolar lumen,CC,IFI30;PYCARD;IDUA;HEXB;GLA
4533,GO:0009311,0.0072077328393171,0.999351305411439,3,54,oligosaccharide metabolic process,BP,IDUA;HEXB;GLA
9949,GO:0035623,0.00720802176474773,1,1,1,renal glucose absorption,BP,HNF1A
12688,GO:0046523,0.00733444503842447,1,1,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,MRI1
4624,GO:0009720,0.00743949346219153,1,1,1,detection of hormone stimulus,BP,ABCG1
4501,GO:0009237,0.0074887932094163,1,1,1,siderophore metabolic process,BP,BDH2
6564,GO:0019290,0.0074887932094163,1,1,1,siderophore biosynthetic process,BP,BDH2
11802,GO:0044432,0.0076055243583975,0.996747920219818,16,1135,endoplasmic reticulum part,CC,EBP;ALG5;DPM3;HSD17B3;MRAP;EXTL1;ABCG1;MGST2;FADS1;CYP17A1;HSD3B2;CPT1C;CASP4;DHCR7;CYB5A;ELOVL6
4683,GO:0009918,0.0076617066664297,1,1,1,sterol delta7 reductase activity,MF,DHCR7
5784,GO:0016131,0.0076617066664297,1,1,1,brassinosteroid metabolic process,BP,DHCR7
5785,GO:0016132,0.0076617066664297,1,1,1,brassinosteroid biosynthetic process,BP,DHCR7
13004,GO:0047598,0.0076617066664297,1,1,1,7-dehydrocholesterol reductase activity,MF,DHCR7
18834,GO:1901566,0.00769772903290914,0.99653586045421,18,1317,organonitrogen compound biosynthetic process,BP,TH;MRPL14;MRPL16;MRI1;MRAP;EXTL1;PNP;BDH2;MGST2;NNMT;ANG;ACAT1;TSFM;FABP3;PCBD1;PTS;RBMS3;SLC1A3
3017,GO:0006148,0.00775638693946585,1,1,1,inosine catabolic process,BP,PNP
3419,GO:0006738,0.00775638693946585,1,1,1,nicotinamide riboside catabolic process,BP,PNP
12672,GO:0046495,0.00775638693946585,1,1,1,nicotinamide riboside metabolic process,BP,PNP
16055,GO:0070637,0.00775638693946585,1,1,1,pyridine nucleoside metabolic process,BP,PNP
16056,GO:0070638,0.00775638693946585,1,1,1,pyridine nucleoside catabolic process,BP,PNP
6290,GO:0017133,0.00777246038577411,1,1,1,mitochondrial electron transfer flavoprotein complex,CC,ETFDH
11549,GO:0043783,0.00777246038577411,1,1,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,ETFDH
12109,GO:0045251,0.00777246038577411,1,1,1,electron transfer flavoprotein complex,CC,ETFDH
1716,GO:0003940,0.00780354370211399,1,1,1,L-iduronidase activity,MF,IDUA
7307,GO:0030209,0.00780354370211399,1,1,1,dermatan sulfate catabolic process,BP,IDUA
16801,GO:0072019,0.0078108151141443,1,1,1,proximal convoluted tubule development,BP,ACAT1
16944,GO:0072229,0.0078108151141443,1,1,1,metanephric proximal convoluted tubule development,BP,ACAT1
19323,GO:1902858,0.0078108151141443,1,1,1,propionyl-CoA metabolic process,BP,ACAT1
19324,GO:1902860,0.0078108151141443,1,1,1,propionyl-CoA biosynthetic process,BP,ACAT1
4115,GO:0008386,0.00782458420396818,1,1,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,CYP11A1
1923,GO:0004341,0.00782652421216064,1,1,1,gluconolactonase activity,MF,RGN
19695,GO:1903610,0.00782652421216064,1,1,1,regulation of calcium-dependent ATPase activity,BP,RGN
19696,GO:1903611,0.00782652421216064,1,1,1,negative regulation of calcium-dependent ATPase activity,BP,RGN
19705,GO:1903627,0.00782652421216064,1,1,1,regulation of dUTP diphosphatase activity,BP,RGN
19706,GO:1903629,0.00782652421216064,1,1,1,positive regulation of dUTP diphosphatase activity,BP,RGN
19708,GO:1903631,0.00782652421216064,1,1,1,negative regulation of aminoacyl-tRNA ligase activity,BP,RGN
19710,GO:1903633,0.00782652421216064,1,1,1,regulation of leucine-tRNA ligase activity,BP,RGN
19711,GO:1903634,0.00782652421216064,1,1,1,negative regulation of leucine-tRNA ligase activity,BP,RGN
3910,GO:0008049,0.00782720865376536,1,1,1,male courtship behavior,BP,HEXB
2039,GO:0004511,0.00782727323479793,1,1,1,tyrosine 3-monooxygenase activity,MF,TH
3307,GO:0006585,0.00782727323479793,1,1,1,dopamine biosynthetic process from tyrosine,BP,TH
18396,GO:0102009,0.00782761052360972,1,1,1,proline dipeptidase activity,MF,PEPD
2036,GO:0004508,0.00782824643275615,1,1,1,steroid 17-alpha-monooxygenase activity,MF,CYP17A1
12988,GO:0047442,0.00782824643275615,1,1,1,17-alpha-hydroxyprogesterone aldolase activity,MF,CYP17A1
21228,GO:2000454,0.00782869920324462,1,1,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
19129,GO:1902311,0.00782969266465978,1,1,1,regulation of copper ion transmembrane transport,BP,SLC31A2
1856,GO:0004139,0.00782990566737454,1,1,1,deoxyribose-phosphate aldolase activity,MF,DERA
2202,GO:0004730,0.00782997239217161,1,1,1,pseudouridylate synthase activity,MF,PUS1
16188,GO:0070902,0.00782997239217161,1,1,1,mitochondrial tRNA pseudouridine synthesis,BP,PUS1
13152,GO:0048244,0.00782997255676817,1,1,1,phytanoyl-CoA dioxygenase activity,MF,PHYH
121,GO:0000247,0.0078299728313129,1,1,1,C-8 sterol isomerase activity,MF,EBP
1683,GO:0003874,0.0078299728313129,1,1,1,6-pyruvoyltetrahydropterin synthase activity,MF,PTS
2090,GO:0004581,0.0078299728313129,1,1,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,ALG5
3941,GO:0008108,0.0078299728313129,1,1,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,GALT
3944,GO:0008112,0.0078299728313129,1,1,1,nicotinamide N-methyltransferase activity,MF,NNMT
4279,GO:0008709,0.0078299728313129,1,1,1,cholate 7-alpha-dehydrogenase activity,MF,HSD17B10
5088,GO:0010900,0.0078299728313129,1,1,1,negative regulation of phosphatidylcholine catabolic process,BP,APOC1
5303,GO:0014876,0.0078299728313129,1,1,1,response to injury involved in regulation of muscle adaptation,BP,NOL3
5700,GO:0015938,0.0078299728313129,1,1,1,coenzyme A catabolic process,BP,NUDT7
6147,GO:0016838,0.0078299728313129,1,1,1,carbon-oxygen lyase activity, acting on phosphates,MF,PTS
6235,GO:0017024,0.0078299728313129,1,1,1,myosin I binding,MF,PYCARD
7571,GO:0030760,0.0078299728313129,1,1,1,pyridine N-methyltransferase activity,MF,NNMT
9213,GO:0033869,0.0078299728313129,1,1,1,nucleoside bisphosphate catabolic process,BP,NUDT7
9235,GO:0034031,0.0078299728313129,1,1,1,ribonucleoside bisphosphate catabolic process,BP,NUDT7
9238,GO:0034034,0.0078299728313129,1,1,1,purine nucleoside bisphosphate catabolic process,BP,NUDT7
9524,GO:0034632,0.0078299728313129,1,1,1,retinol transporter activity,MF,RBP4
9525,GO:0034633,0.0078299728313129,1,1,1,retinol transport,BP,RBP4
12161,GO:0045358,0.0078299728313129,1,1,1,negative regulation of interferon-beta biosynthetic process,BP,NMI
12839,GO:0046864,0.0078299728313129,1,1,1,isoprenoid transport,BP,RBP4
12840,GO:0046865,0.0078299728313129,1,1,1,terpenoid transport,BP,RBP4
12924,GO:0047015,0.0078299728313129,1,1,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,HSD17B10
13041,GO:0047860,0.0078299728313129,1,1,1,diiodophenylpyruvate reductase activity,MF,MDH1
14472,GO:0052692,0.0078299728313129,1,1,1,raffinose alpha-galactosidase activity,MF,GLA
6539,GO:0019221,0.00787829241468153,0.997363268121481,10,552,cytokine-mediated signaling pathway,BP,IFI30;FADD;TRADD;PYCARD;PSMB10;GHR;RNASEL;NMI;NOL3;IFI27
8712,GO:0032760,0.00804831519357133,0.999244644989647,3,57,positive regulation of tumor necrosis factor production,BP,FADD;PYCARD;TICAM1
19751,GO:1903725,0.00817081241865579,0.999228027416142,3,59,regulation of phospholipid metabolic process,BP,APOC1;FABP3;IDH1
17796,GO:0097190,0.00818499159619374,0.997244662610843,10,565,apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2;ACAA2;TICAM1;NOL3;DEPTOR;CASP4;IFI27
5786,GO:0016137,0.0081996016518082,0.999671939347558,2,18,glycoside metabolic process,BP,TH;GLA
955,GO:0002237,0.008291055739683,0.99783493528875,7,314,response to molecule of bacterial origin,BP,TH;PYCARD;MGST2;TICAM1;SHPK;TFPI;STAR
4357,GO:0009063,0.00846190893608933,0.998759257523596,4,108,cellular amino acid catabolic process,BP,HSD17B10;ACAT1;SARDH;PCBD1
19606,GO:1903427,0.00847537159845489,0.999653357058162,2,19,negative regulation of reactive oxygen species biosynthetic process,BP,RGN;GLA
2980,GO:0006085,0.00851937865019959,0.999649101735221,2,20,acetyl-CoA biosynthetic process,BP,PDK4;ACAT1
15032,GO:0060544,0.0085817973072835,0.999646723191583,2,19,regulation of necroptotic process,BP,FADD;TRADD
16331,GO:0071216,0.00875658774861908,0.998312533126669,5,175,cellular response to biotic stimulus,BP,PYCARD;TICAM1;SHPK;TFPI;STAR
19668,GO:1903557,0.00887870813074306,0.999135403832202,3,59,positive regulation of tumor necrosis factor superfamily cytokine production,BP,FADD;PYCARD;TICAM1
10896,GO:0042537,0.00908511909411302,0.999614765355005,2,19,benzene-containing compound metabolic process,BP,TH;STAR
3278,GO:0006555,0.00910172349006728,0.999612018904895,2,20,methionine metabolic process,BP,MSRA;MRI1
2570,GO:0005319,0.00911216557057145,0.998633138850123,4,116,lipid transporter activity,MF,ABCG1;RBP4;FABP3;STAR
11432,GO:0043496,0.00914707883898565,0.999609076908821,2,20,regulation of protein homodimerization activity,BP,TICAM1;PCBD1
10861,GO:0042493,0.00917331324969606,0.99729413343317,8,405,response to drug,BP,EBP;TH;PNP;NNMT;FABP3;STAR;RPH3AL;SLC1A3
4372,GO:0009083,0.00921378399544082,0.999604736073716,2,20,branched-chain amino acid catabolic process,BP,HSD17B10;ACAT1
9231,GO:0033993,0.00923696324626428,0.99633622629793,13,859,response to lipid,BP,PDK4;TH;ABCG1;PYCARD;MGST2;TICAM1;RBP4;SHPK;FABP3;IDH1;TFPI;STAR;S100B
11316,GO:0043280,0.00928264971663412,0.998600826098407,4,113,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD;TRADD;PYCARD;IFI27
7760,GO:0031090,0.00952479488295874,0.994834643201643,30,2705,organelle membrane,CC,PDK4;PECR;TH;ZFYVE21;MRPL14;MRPL16;PXMP2;PXMP4;ABCG1;ACADVL;ACAA2;MGST2;TICAM1;CPT2;PLA2G16;ACAT1;GRIA3;HSD3B2;CPT1C;IFI27;LDHD;TFPI;STAR;SNX21;ECI1;CYP11A1;RPH3AL;DHCR7;CYB5A;ETFDH
21202,GO:2000406,0.00968350079765028,0.999573702602541,2,20,positive regulation of T cell migration,BP,FADD;PYCARD
13930,GO:0051187,0.00987752186571631,0.999560648120726,2,20,cofactor catabolic process,BP,ACAT1;NUDT7
4120,GO:0008395,0.00990890424494184,0.999558523778591,2,20,steroid hydroxylase activity,MF,CYP17A1;CYP11A1
6666,GO:0019682,0.00996106283624931,0.99955498518759,2,20,glyceraldehyde-3-phosphate metabolic process,BP,SHPK;DERA
3872,GO:0007617,0.0100630967748081,0.999546275902248,2,21,mating behavior,BP,TH;HEXB
14062,GO:0051412,0.0100819567223882,0.999544982112429,2,21,response to corticosterone,BP,TH;STAR
3840,GO:0007548,0.0103714031136621,0.997515823935615,6,257,sex differentiation,BP,HSD17B3;RBP4;CYP17A1;ANG;IDH1;STAR
7260,GO:0030149,0.0104948438008315,0.999516339515261,2,21,sphingolipid catabolic process,BP,HEXB;GLA
3460,GO:0006809,0.0105160545089343,0.998908365182895,3,63,nitric oxide biosynthetic process,BP,RGN;TICAM1;GLA
16436,GO:0071378,0.0107053695337504,0.999498157083275,2,23,cellular response to growth hormone stimulus,BP,GHR;STAR
4439,GO:0009166,0.0108017405896583,0.998867095242126,3,64,nucleotide catabolic process,BP,PNP;NUDT7;DERA
5066,GO:0010876,0.011034155430898,0.996954955893463,7,341,lipid localization,BP,APOC1;ABCG1;CPT2;RBP4;HEXB;FABP3;STAR
12666,GO:0046486,0.01106538111806,0.996626386806429,8,423,glycerolipid metabolic process,BP,DPM3;ZFYVE21;APOC1;RGN;FGF18;PLA2G16;ANG;FABP3
12423,GO:0045922,0.0111160634402584,0.999470261017866,2,22,negative regulation of fatty acid metabolic process,BP,APOC1;ACADVL
3729,GO:0007249,0.0114731387076306,0.997191478832296,6,260,I-kappaB kinase/NF-kappaB signaling,BP,FADD;TRADD;PYCARD;TICAM1;NOL3;S100B
6663,GO:0019674,0.0116903268157731,0.998737783815383,3,64,NAD metabolic process,BP,PNP;NNMT;MDH1
21663,GO:2001267,0.0116988828759002,0.999427411949622,2,22,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD;TRADD
3350,GO:0006643,0.0117589415014586,0.997562958248211,5,185,membrane lipid metabolic process,BP,DPM3;TH;ASAH2;HEXB;GLA
4567,GO:0009435,0.0119115257808158,0.999409619020457,2,23,NAD biosynthetic process,BP,PNP;NNMT
21562,GO:2001056,0.0120181200091844,0.998044610387899,4,122,positive regulation of cysteine-type endopeptidase activity,BP,FADD;TRADD;PYCARD;IFI27
2291,GO:0004854,0.0120400722564594,0.999963824533822,1,2,xanthine dehydrogenase activity,MF,AOX1
4392,GO:0009115,0.0120400722564594,0.999963824533822,1,2,xanthine catabolic process,BP,AOX1
6080,GO:0016726,0.0120400722564594,0.999963824533822,1,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,AOX1
16777,GO:0071955,0.0120522648685187,0.999963751004403,1,2,recycling endosome to Golgi transport,BP,TBC1D14
2921,GO:0005996,0.0121586555415275,0.996986000505034,6,262,monosaccharide metabolic process,BP,PDK4;RGN;GALT;RBP4;MDH1;CYB5A
3396,GO:0006700,0.0121744128166236,0.9993896648733,2,23,C21-steroid hormone biosynthetic process,BP,STAR;CYP11A1
12567,GO:0046209,0.0122933262976115,0.998646055208581,3,67,nitric oxide metabolic process,BP,RGN;TICAM1;GLA
6615,GO:0019439,0.0124980056012927,0.996107222961396,8,420,aromatic compound catabolic process,BP,PNP;RGN;GALT;AOX1;NUDT7;PCBD1;PON2;DERA
2446,GO:0005102,0.0125102850275588,0.994074832264634,18,1400,receptor binding,MF,PECR;FADD;MRAP;TRADD;PYCARD;FGF18;HACL1;ANG;IDUA;NOL3;NUDT6;NUDT7;IDH1;GLA;S100B;DOK1;CNIH4;LINGO1
4008,GO:0008210,0.0126585685409461,0.999352315024516,2,23,estrogen metabolic process,BP,HSD17B11;STAR
6726,GO:0019842,0.0127916342621479,0.997880446236719,4,122,vitamin binding,MF,PHYH;HACL1;RBP4;ACCS
11317,GO:0043281,0.0130750902613804,0.997216943906073,5,192,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD;TRADD;PYCARD;NOL3;IFI27
19605,GO:1903426,0.0133249287777822,0.998487514660415,3,68,regulation of reactive oxygen species biosynthetic process,BP,RGN;TICAM1;GLA
12653,GO:0046466,0.0133494003269857,0.999295663063354,2,24,membrane lipid catabolic process,BP,HEXB;GLA
11052,GO:0042803,0.0133899458339655,0.994878729927018,11,705,protein homodimerization activity,MF,ABCG1;PYCARD;GHR;ANG;ACAT1;HEXB;ACCS;IDH1;GLA;S100B;PTS
16949,GO:0072237,0.0137778757943148,0.999952586226469,1,2,metanephric proximal tubule development,BP,ACAT1
2203,GO:0004731,0.0137792709613687,0.999952576589923,1,2,purine-nucleoside phosphorylase activity,MF,PNP
5247,GO:0014736,0.0137969192132386,0.999952454606705,1,2,negative regulation of muscle atrophy,BP,NOL3
1779,GO:0004031,0.0138184991100392,0.999952305233865,1,2,aldehyde oxidase activity,MF,AOX1
21563,GO:2001057,0.0139584638596117,0.998386854985314,3,70,reactive nitrogen species metabolic process,BP,RGN;TICAM1;GLA
15793,GO:0070195,0.0140360143184633,0.999950786450972,1,2,growth hormone receptor complex,CC,GHR
9244,GO:0034041,0.0141116234029229,0.999950252901028,1,2,sterol-transporting ATPase activity,MF,ABCG1
9445,GO:0034437,0.0142311018709949,0.999949403871378,1,2,glycoprotein transporter activity,MF,ABCG1
6041,GO:0016645,0.0144093072817925,0.99920656624685,2,25,oxidoreductase activity, acting on the CH-NH group of donors,MF,SARDH;ETFDH
12921,GO:0046997,0.014433528690948,0.999947948882767,1,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,SARDH
18752,GO:1901292,0.0144455054276998,0.998308575452878,3,71,nucleoside phosphate catabolic process,BP,PNP;NUDT7;DERA
9041,GO:0033306,0.0144634279013464,0.999947732214364,1,2,phytol metabolic process,BP,PECR
19475,GO:1903173,0.0144634279013464,0.999947732214364,1,2,fatty alcohol metabolic process,BP,PECR
13572,GO:0050671,0.0144694834397778,0.997512253660368,4,127,positive regulation of lymphocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
19193,GO:1902524,0.0144910082798209,0.999947531947705,1,2,positive regulation of protein K48-linked ubiquitination,BP,NMI
1674,GO:0003858,0.0144919579244989,0.999947525045275,1,2,3-hydroxybutyrate dehydrogenase activity,MF,BDH2
2069,GO:0004557,0.0145013895901187,0.999947456467001,1,2,alpha-galactosidase activity,MF,GLA
6172,GO:0016878,0.0145215530107829,0.999197121846649,2,25,acid-thiol ligase activity,MF,ACSF2;ACSM5
8279,GO:0032090,0.0146938129323341,0.999946047493951,1,2,Pyrin domain binding,MF,PYCARD
13909,GO:0051156,0.0147872983764501,0.99917460645553,2,25,glucose 6-phosphate metabolic process,BP,SHPK;DERA
8843,GO:0032946,0.0148734285651506,0.997421607282262,4,128,positive regulation of mononuclear cell proliferation,BP,FADD;PNP;PYCARD;TICAM1
1877,GO:0004174,0.0149220072736661,0.99994435225046,1,2,electron-transferring-flavoprotein dehydrogenase activity,MF,ETFDH
6044,GO:0016649,0.0149220072736661,0.99994435225046,1,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,ETFDH
21199,GO:2000403,0.0149408173584278,0.999161500388709,2,25,positive regulation of lymphocyte migration,BP,FADD;PYCARD
9401,GO:0034367,0.0150612696882875,0.999151166707218,2,25,macromolecular complex remodeling,BP,APOC1;ABCG1
9402,GO:0034368,0.0150612696882875,0.999151166707218,2,25,protein-lipid complex remodeling,BP,APOC1;ABCG1
9403,GO:0034369,0.0150612696882875,0.999151166707218,2,25,plasma lipoprotein particle remodeling,BP,APOC1;ABCG1
21200,GO:2000404,0.0150653006254008,0.999150820124031,2,25,regulation of T cell migration,BP,FADD;PYCARD
6581,GO:0019359,0.0151491647745187,0.999141517988371,2,26,nicotinamide nucleotide biosynthetic process,BP,PNP;NNMT
6583,GO:0019363,0.0151491647745187,0.999141517988371,2,26,pyridine nucleotide biosynthetic process,BP,PNP;NNMT
14034,GO:0051352,0.0152768933999509,0.999941663312537,1,2,negative regulation of ligase activity,BP,RGN
6294,GO:0017143,0.0152797373761739,0.999941641505766,1,2,insecticide metabolic process,BP,STAR
10705,GO:0042214,0.0153068077076367,0.999941433732862,1,2,terpene metabolic process,BP,TH
19703,GO:1903625,0.0153977543208075,0.999940732965265,1,2,negative regulation of DNA catabolic process,BP,RGN
14376,GO:0051990,0.0154102633653076,0.999940636251191,1,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,IDH1
1994,GO:0004458,0.0154529467881674,0.999940305644751,1,2,D-lactate dehydrogenase (cytochrome) activity,MF,LDHD
6190,GO:0016898,0.0154529467881674,0.999940305644751,1,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,LDHD
11977,GO:0045029,0.0154664930801163,0.99994020052789,1,2,UDP-activated nucleotide receptor activity,MF,P2RY14
21204,GO:2000409,0.0154971681159792,0.999939962150487,1,2,positive regulation of T cell extravasation,BP,FADD
21226,GO:2000451,0.0154971681159792,0.999939962150487,1,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
9435,GO:0034418,0.0155048953654291,0.999939902026243,1,2,urate biosynthetic process,BP,PNP
7359,GO:0030283,0.0155168038099488,0.99993980930954,1,2,testosterone dehydrogenase [NAD(P)] activity,MF,HSD17B10
12523,GO:0046102,0.0155260980386379,0.999939736896537,1,2,inosine metabolic process,BP,PNP
3954,GO:0008124,0.0155365016156205,0.999939655788358,1,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,PCBD1
1990,GO:0004450,0.0155469338257901,0.999939574401744,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH1
2987,GO:0006097,0.0155469338257901,0.999939574401744,1,2,glyoxylate cycle,BP,IDH1
17734,GO:0097089,0.0155510534003999,0.999939542247765,1,2,methyl-branched fatty acid metabolic process,BP,PHYH
11242,GO:0043178,0.0155581770999921,0.998126040082118,3,73,alcohol binding,MF,ABCG1;RBP4;STAR
8136,GO:0031780,0.0155704912743308,0.999939390415563,1,2,corticotropin hormone receptor binding,MF,MRAP
8139,GO:0031783,0.0155704912743308,0.999939390415563,1,2,type 5 melanocortin receptor binding,MF,MRAP
3068,GO:0006258,0.0155741760031121,0.999939361611944,1,2,UDP-glucose catabolic process,BP,GALT
3273,GO:0006550,0.0155801033201446,0.999939315263485,1,2,isoleucine catabolic process,BP,ACAT1
14483,GO:0052740,0.0155872790913661,0.999939259128898,1,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,PLA2G16
14417,GO:0052314,0.0155882178518631,0.999939251783232,1,2,phytoalexin metabolic process,BP,TH
9993,GO:0035698,0.0155945193365245,0.999939202463434,1,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
21227,GO:2000452,0.0155945193365245,0.999939202463434,1,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
6729,GO:0019853,0.0155956903624031,0.999939193295949,1,2,L-ascorbic acid biosynthetic process,BP,RGN
19707,GO:1903630,0.0155956903624031,0.999939193295949,1,2,regulation of aminoacyl-tRNA ligase activity,BP,RGN
10819,GO:0042418,0.0155964335653217,0.999939187477354,1,2,epinephrine biosynthetic process,BP,TH
8403,GO:0032311,0.0155967095883963,0.999939185316276,1,2,angiogenin-PRI complex,CC,ANG
1153,GO:0002582,0.0155991121866461,0.999939166503888,1,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
1156,GO:0002585,0.0155991121866461,0.999939166503888,1,2,positive regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
1159,GO:0002588,0.0155991121866461,0.999939166503888,1,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
1999,GO:0004464,0.0155991121866461,0.999939166503888,1,2,leukotriene-C4 synthase activity,MF,MGST2
3945,GO:0008113,0.0155991121866461,0.999939166503888,1,2,peptide-methionine (S)-S-oxide reductase activity,MF,MSRA
4275,GO:0008670,0.0155991121866461,0.999939166503888,1,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,DECR1
12158,GO:0045355,0.0155991121866461,0.999939166503888,1,2,negative regulation of interferon-alpha biosynthetic process,BP,NMI
13028,GO:0047750,0.0155991121866461,0.999939166503888,1,2,cholestenol delta-isomerase activity,MF,EBP
16000,GO:0070538,0.0155991121866461,0.999939166503888,1,2,oleic acid binding,MF,FABP3
8382,GO:0032281,0.0157540524579204,0.999086631555728,2,27,AMPA glutamate receptor complex,CC,GRIA3;CPT1C
2635,GO:0005504,0.0158156054421709,0.999085450761771,2,25,fatty acid binding,MF,APOC1;FABP3
12018,GO:0045087,0.0159147989980547,0.993478085732949,12,808,innate immune response,BP,CFB;IFI30;FADD;PYCARD;PSMB10;TICAM1;RNASEL;NMI;CASP4;IFI27;STAR;S100B
3367,GO:0006665,0.0166301717232673,0.997017942485634,4,134,sphingolipid metabolic process,BP,TH;ASAH2;HEXB;GLA
14471,GO:0052689,0.0166954491344799,0.997003495882915,4,132,carboxylic ester hydrolase activity,MF,RGN;PLA2G16;PON2;LYPLAL1
16070,GO:0070665,0.0168866041577942,0.996958545201364,4,133,positive regulation of leukocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
10653,GO:0042104,0.0170238650785035,0.998971890407208,2,27,positive regulation of activated T cell proliferation,BP,FADD;PYCARD
21635,GO:2001233,0.0170546371368277,0.994873725950504,7,362,regulation of apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2;ACAA2;NOL3;DEPTOR
15709,GO:0070062,0.0170715789478149,0.99036511227677,29,2675,extracellular exosome,CC,CFB;MSRA;APOC1;PNP;BDH2;KRT10;ACAA2;ETFB;RBP4;ANG;ACAT1;ACAT2;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;IDH1;DECR1;MDP1;PEPD;ACP5;GLA;ECI1;DERA;CYB5A;LYPLAL1
3374,GO:0006672,0.0171081478744157,0.997864388724365,3,74,ceramide metabolic process,BP,ASAH2;HEXB;GLA
5447,GO:0015248,0.0171594814583777,0.998957205957412,2,28,sterol transporter activity,MF,ABCG1;STAR
21011,GO:2000116,0.0172578283574698,0.996059861760876,5,206,regulation of cysteine-type endopeptidase activity,BP,FADD;TRADD;PYCARD;NOL3;IFI27
7374,GO:0030301,0.0174485187981687,0.997804347530013,3,76,cholesterol transport,BP,APOC1;ABCG1;STAR
5125,GO:0010950,0.0174970302032657,0.99681399984833,4,136,positive regulation of endopeptidase activity,BP,FADD;TRADD;PYCARD;IFI27
8211,GO:0031974,0.0178527976226671,0.988999480938553,45,4694,membrane-enclosed lumen,CC,PDK4;PHYH;IFI30;MSRA;MRPL14;MRPL16;MRI1;TBC1D14;ACSF2;PNP;PYCARD;LAGE3;ACADVL;ACAA2;ACSM5;PSMB10;FGF18;ARL6IP4;CPT2;HSD17B10;ETFB;HACL1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;SARDH;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;IDH1;DECR1;PUS1;STAR;GLA;ECI1;CYP11A1;DERA;ETFDH
11280,GO:0043233,0.0178527976226671,0.988999480938553,45,4694,organelle lumen,CC,PDK4;PHYH;IFI30;MSRA;MRPL14;MRPL16;MRI1;TBC1D14;ACSF2;PNP;PYCARD;LAGE3;ACADVL;ACAA2;ACSM5;PSMB10;FGF18;ARL6IP4;CPT2;HSD17B10;ETFB;HACL1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;SARDH;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;IDH1;DECR1;PUS1;STAR;GLA;ECI1;CYP11A1;DERA;ETFDH
15688,GO:0070013,0.0178527976226671,0.988999480938553,45,4694,intracellular organelle lumen,CC,PDK4;PHYH;IFI30;MSRA;MRPL14;MRPL16;MRI1;TBC1D14;ACSF2;PNP;PYCARD;LAGE3;ACADVL;ACAA2;ACSM5;PSMB10;FGF18;ARL6IP4;CPT2;HSD17B10;ETFB;HACL1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;SARDH;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;IDH1;DECR1;PUS1;STAR;GLA;ECI1;CYP11A1;DERA;ETFDH
4437,GO:0009164,0.0180247726695563,0.998878133858023,2,27,nucleoside catabolic process,BP,PNP;DERA
19669,GO:1903561,0.0182351485838542,0.989649681757838,29,2690,extracellular vesicle,CC,CFB;MSRA;APOC1;PNP;BDH2;KRT10;ACAA2;ETFB;RBP4;ANG;ACAT1;ACAT2;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;IDH1;DECR1;MDP1;PEPD;ACP5;GLA;ECI1;DERA;CYB5A;LYPLAL1
9976,GO:0035666,0.018296086545028,0.998849859156249,2,28,TRIF-dependent toll-like receptor signaling pathway,BP,FADD;TICAM1
11277,GO:0043230,0.0183264172914324,0.989593378725987,29,2691,extracellular organelle,CC,CFB;MSRA;APOC1;PNP;BDH2;KRT10;ACAA2;ETFB;RBP4;ANG;ACAT1;ACAT2;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;IDH1;DECR1;MDP1;PEPD;ACP5;GLA;ECI1;DERA;CYB5A;LYPLAL1
17078,GO:0072525,0.0185012785311979,0.998827849324319,2,29,pyridine-containing compound biosynthetic process,BP,PNP;NNMT
6496,GO:0019098,0.0185558748759591,0.998822558764915,2,29,reproductive behavior,BP,TH;HEXB
11012,GO:0042745,0.0186037281265415,0.998820171799599,2,28,circadian sleep/wake cycle,BP,TH;STAR
18781,GO:1901361,0.0187508402640318,0.993715118451374,8,452,organic cyclic compound catabolic process,BP,HSD17B11;PNP;RGN;GALT;AOX1;NUDT7;PCBD1;DERA
348,GO:0000959,0.0189844652905775,0.998780736323389,2,29,mitochondrial RNA metabolic process,BP,HSD17B10;PUS1
2944,GO:0006029,0.0190100117471243,0.997525411676199,3,82,proteoglycan metabolic process,BP,EXTL1;IDUA;HEXB
4626,GO:0009726,0.0193750478547782,0.999874764031122,1,3,detection of endogenous stimulus,BP,ABCG1
10229,GO:0036094,0.0194983017525502,0.989275740012204,25,2314,small molecule binding,MF,PDK4;PHYH;TH;APOC1;ACSF2;PNP;ABCG1;BDH2;ACADVL;ACSM5;HACL1;RBP4;RNASEL;AOX1;SHPK;FABP3;ACCS;MDH1;IDH1;DECR1;LDHD;STAR;DHCR7;SLC1A3;ETFDH
782,GO:0001959,0.0197380282540682,0.99627214788245,4,141,regulation of cytokine-mediated signaling pathway,BP,FADD;TRADD;PYCARD;NOL3
5016,GO:0010817,0.0197608834092185,0.9933115164764,8,465,regulation of hormone levels,BP,HSD17B3;HSD17B11;RBP4;CYP17A1;HSD3B2;STAR;CYP11A1;DHCR7
12527,GO:0046110,0.0197765012343355,0.999869496652279,1,3,xanthine metabolic process,BP,AOX1
12656,GO:0046470,0.0199544523148128,0.997357838266719,3,78,phosphatidylcholine metabolic process,BP,APOC1;PLA2G16;FABP3
18879,GO:1901657,0.0200404205869708,0.996198164830769,4,140,glycosyl compound metabolic process,BP,TH;PNP;GLA;DERA
9243,GO:0034040,0.0200410854208331,0.99986596524264,1,3,lipid-transporting ATPase activity,MF,ABCG1
13530,GO:0050508,0.0201506429767672,0.999864489047398,1,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,EXTL1
4366,GO:0009072,0.0201564564120405,0.998663770631318,2,29,aromatic amino acid family metabolic process,BP,TH;PCBD1
20168,GO:1904646,0.0201924787925946,0.999863923192598,1,3,cellular response to beta-amyloid,BP,CASP4
2820,GO:0005829,0.0203543517098237,0.98737847299454,44,4626,cytosol,CC,IFI30;TH;ZFYVE21;MSRA;MRI1;FADD;TRADD;TBC1D14;HSD17B11;PNP;BDH2;PYCARD;ACADVL;KRT10;PSMB10;RGN;GHR;TICAM1;NNMT;PXK;PLA2G16;ETFB;GALT;RBP4;RNASEL;NMI;ACAT2;AOX1;CMBL;FABP3;NOL3;PCBD1;MDH1;CASP4;IDH1;DECR1;STAR;ACP5;DERA;DHCR7;CYB5A;PTS;DOK1;LYPLAL1
8214,GO:0031982,0.0204808803362473,0.987479388686897,40,4076,vesicle,CC,CFB;EBP;TH;ZFYVE21;MSRA;SLC31A2;APOC1;TBC1D14;PNP;ABCG1;BDH2;PYCARD;KRT10;ACAA2;TICAM1;ETFB;RBP4;ANG;ACAT1;ACAT2;IDUA;AOX1;HEXB;CMBL;FABP3;GRIA3;PCBD1;MDH1;IDH1;DECR1;MDP1;SNX21;PEPD;ACP5;GLA;ECI1;RPH3AL;DERA;CYB5A;LYPLAL1
21647,GO:2001245,0.0204920740410235,0.99985983621208,1,3,regulation of phosphatidylcholine biosynthetic process,BP,FABP3
4580,GO:0009449,0.0204942489352056,0.999859806319739,1,3,gamma-aminobutyric acid biosynthetic process,BP,SLC1A3
6117,GO:0016790,0.0205208345899806,0.998626639916065,2,29,thiolester hydrolase activity,MF,NUDT7;LYPLAL1
2989,GO:0006099,0.0208359367296574,0.998591747425603,2,30,tricarboxylic acid cycle,BP,MDH1;IDH1
4607,GO:0009636,0.0208504822537624,0.995004088012782,5,214,response to toxic substance,BP,TH;MGST2;RGN;PON2;STAR
14048,GO:0051385,0.0211762313451255,0.998554010499703,2,31,response to mineralocorticoid,BP,TH;STAR
5087,GO:0010899,0.0213512570424866,0.999847776886206,1,3,regulation of phosphatidylcholine catabolic process,BP,APOC1
14874,GO:0060337,0.0213952484812284,0.997089983634849,3,80,type I interferon signaling pathway,BP,FADD;RNASEL;IFI27
16422,GO:0071357,0.0213952484812284,0.997089983634849,3,80,cellular response to type I interferon,BP,FADD;RNASEL;IFI27
3874,GO:0007619,0.0214425161663614,0.999846466472487,1,3,courtship behavior,BP,HEXB
975,GO:0002277,0.0215127036303832,0.999845454774093,1,3,myeloid dendritic cell activation involved in immune response,BP,PYCARD
18959,GO:1901896,0.0215162959486043,0.999845402903336,1,3,positive regulation of calcium-transporting ATPase activity,BP,RGN
10815,GO:0042414,0.0215170347471607,0.999845392234472,1,3,epinephrine metabolic process,BP,TH
5246,GO:0014735,0.0215195896017924,0.999845355337387,1,3,regulation of muscle atrophy,BP,NOL3
3421,GO:0006740,0.021528653811351,0.999845224396654,1,3,NADPH regeneration,BP,IDH1
6031,GO:0016623,0.0215409647009647,0.999845046465073,1,3,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,AOX1
5683,GO:0015918,0.0216216600258897,0.997045013533213,3,83,sterol transport,BP,APOC1;ABCG1;STAR
13416,GO:0048807,0.0216459576882095,0.999843524787689,1,3,female genitalia morphogenesis,BP,RBP4
1872,GO:0004165,0.0218101450412532,0.99984113014579,1,3,dodecenoyl-CoA delta-isomerase activity,MF,ECI1
2494,GO:0005164,0.0218453578868346,0.998485991660321,2,30,tumor necrosis factor receptor binding,MF,FADD;TRADD
10907,GO:0042558,0.021892463304763,0.998478480505209,2,31,pteridine-containing compound metabolic process,BP,PCBD1;PTS
10146,GO:0035963,0.0219357189819589,0.999839286278237,1,3,cellular response to interleukin-13,BP,SHPK
9444,GO:0034436,0.0219505063847735,0.999839068439956,1,3,glycoprotein transport,BP,ABCG1
14617,GO:0055099,0.0219922351764661,0.999838452915323,1,3,response to high density lipoprotein particle,BP,ABCG1
2801,GO:0005790,0.022204067170779,0.998440543021664,2,33,smooth endoplasmic reticulum,CC,TH;HSD3B2
16431,GO:0071373,0.0224122102569701,0.999832191949059,1,3,cellular response to luteinizing hormone stimulus,BP,STAR
17099,GO:0072557,0.0225731404587973,0.999829760941217,1,3,IPAF inflammasome complex,CC,CASP4
15176,GO:0060759,0.0227320633668473,0.995517550664686,4,147,regulation of response to cytokine stimulus,BP,FADD;TRADD;PYCARD;NOL3
12532,GO:0046121,0.0228024566702952,0.999826266377698,1,3,deoxyribonucleoside catabolic process,BP,DERA
16159,GO:0070859,0.0228683864429329,0.999825255030332,1,3,positive regulation of bile acid biosynthetic process,BP,STAR
19998,GO:1904253,0.0228683864429329,0.999825255030332,1,3,positive regulation of bile acid metabolic process,BP,STAR
3498,GO:0006869,0.022907062922645,0.993461491943712,6,309,lipid transport,BP,APOC1;ABCG1;CPT2;RBP4;FABP3;STAR
4494,GO:0009227,0.0229495267411193,0.99982400628594,1,3,nucleotide-sugar catabolic process,BP,GALT
855,GO:0002060,0.0229817550214159,0.999823509048042,1,3,purine nucleobase binding,MF,PNP
7547,GO:0030678,0.0230406347411914,0.999822598784814,1,3,mitochondrial ribonuclease P complex,CC,HSD17B10
6568,GO:0019318,0.0230595428623607,0.994327957547342,5,224,hexose metabolic process,BP,PDK4;RGN;GALT;RBP4;MDH1
2033,GO:0004505,0.0230629161864513,0.999822253703123,1,3,phenylalanine 4-monooxygenase activity,MF,PCBD1
5782,GO:0016128,0.0231267470082178,0.999821263253831,1,3,phytosteroid metabolic process,BP,DHCR7
5783,GO:0016129,0.0231267470082178,0.999821263253831,1,3,phytosteroid biosynthetic process,BP,DHCR7
5349,GO:0015065,0.0231762983824453,0.999820492458345,1,3,uridine nucleotide receptor activity,MF,P2RY14
16553,GO:0071553,0.0231762983824453,0.999820492458345,1,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,P2RY14
9992,GO:0035697,0.023203431481514,0.9998200696798,1,3,CD8-positive, alpha-beta T cell extravasation,BP,FADD
21203,GO:2000407,0.023203431481514,0.9998200696798,1,3,regulation of T cell extravasation,BP,FADD
21225,GO:2000449,0.023203431481514,0.9998200696798,1,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
6513,GO:0019166,0.0232440476098951,0.999819435874173,1,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,PECR
16249,GO:0070996,0.0232794884877635,0.999818881907119,1,3,type 1 melanocortin receptor binding,MF,MRAP
14482,GO:0052739,0.0232959618718841,0.999818624124061,1,3,phosphatidylserine 1-acylhydrolase activity,MF,PLA2G16
8918,GO:0033076,0.0232970773258143,0.99981860666223,1,3,isoquinoline alkaloid metabolic process,BP,TH
18889,GO:1901671,0.023304491428263,0.999818490576859,1,3,positive regulation of superoxide dismutase activity,BP,RGN
20258,GO:1904833,0.023304491428263,0.999818490576859,1,3,positive regulation of removal of superoxide radicals,BP,RGN
12709,GO:0046573,0.0233077185194435,0.999818440037365,1,3,lactonohydrolase activity,MF,PON2
18394,GO:0102007,0.0233077185194435,0.999818440037365,1,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,PON2
2091,GO:0004582,0.0233078870091642,0.999818437398451,1,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,DPM3
2451,GO:0005111,0.0233078870091642,0.999818437398451,1,3,type 2 fibroblast growth factor receptor binding,MF,FGF18
8987,GO:0033185,0.0233078870091642,0.999818437398451,1,3,dolichol-phosphate-mannose synthase complex,CC,DPM3
12933,GO:0047045,0.0233078870091642,0.999818437398451,1,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,HSD17B3
15083,GO:0060612,0.0236562376697467,0.998279306185581,2,34,adipose tissue development,BP,PLA2G16;ACAT1
11862,GO:0044699,0.0237280248743623,0.985860146979434,102,12673,single-organism process,BP,EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;ACAT2;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;GRIA3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;TMEM176A;IDH1;DECR1;LDHD;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;SLC1A3;ELOVL6;LINGO1;ETFDH;TMOD4
2375,GO:0004971,0.0240625852293236,0.999782373792188,1,4,AMPA glutamate receptor activity,MF,GRIA3
19594,GO:1903409,0.0242451551086551,0.996537061707628,3,86,reactive oxygen species biosynthetic process,BP,RGN;TICAM1;GLA
9381,GO:0034340,0.0243111966900141,0.996525813182068,3,84,response to type I interferon,BP,FADD;RNASEL;IFI27
12642,GO:0046449,0.0243669137821398,0.999776805159385,1,4,creatinine metabolic process,BP,GHR
14939,GO:0060416,0.0243974523551284,0.998193698278044,2,35,response to growth hormone,BP,GHR;STAR
1259,GO:0002756,0.0244388166432411,0.998193753257545,2,33,MyD88-independent toll-like receptor signaling pathway,BP,FADD;TICAM1
12612,GO:0046364,0.0244454205299733,0.996499324259169,3,84,monosaccharide biosynthetic process,BP,RGN;RBP4;MDH1
19353,GO:1902930,0.0248557430417709,0.998143790514596,2,34,regulation of alcohol biosynthetic process,BP,ABCG1;DHCR7
14023,GO:0051341,0.024961246103191,0.996395161437425,3,86,regulation of oxidoreductase activity,BP,RGN;GLA;PTS
3015,GO:0006145,0.0251720709341171,0.999761729397218,1,4,purine nucleobase catabolic process,BP,AOX1
9210,GO:0033865,0.0253407717844305,0.998090546712848,2,33,nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
9216,GO:0033875,0.0253407717844305,0.998090546712848,2,33,ribonucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
9236,GO:0034032,0.0253407717844305,0.998090546712848,2,33,purine nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
11187,GO:0043094,0.0253819959654469,0.998085781004453,2,33,cellular metabolic compound salvage,BP,MRI1;PNP
17125,GO:0072593,0.0255519711838229,0.993545532029369,5,228,reactive oxygen species metabolic process,BP,PDK4;RGN;TICAM1;AOX1;GLA
3570,GO:0006979,0.0255744963110772,0.99165451231133,7,397,response to oxidative stress,BP,MSRA;RGN;NOL3;PON2;IDH1;STAR;ETFDH
16119,GO:0070777,0.025675132282027,0.999752057267326,1,4,D-aspartate transport,BP,SLC1A3
16121,GO:0070779,0.025675132282027,0.999752057267326,1,4,D-aspartate import,BP,SLC1A3
11825,GO:0044464,0.0260272730805372,0.987978791161733,119,15425,cell part,CC,CFB;EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;PRRT1;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
127,GO:0000255,0.0261497288976113,0.999742754039481,1,4,allantoin metabolic process,BP,GHR
5127,GO:0010952,0.0262803333975139,0.994581145739534,4,154,positive regulation of peptidase activity,BP,FADD;TRADD;PYCARD;IFI27
2066,GO:0004553,0.0264116079604525,0.996100951991278,3,88,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,IDUA;HEXB;GLA
2209,GO:0004740,0.0264496065031264,0.999736786387983,1,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK4
3453,GO:0006793,0.0267464100855137,0.984067767047738,31,3069,phosphorus metabolic process,BP,PDK4;DPM3;ZFYVE21;MRAP;APOC1;ACSF2;PNP;PYCARD;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;NNMT;PLA2G16;GALT;RNASEL;ANG;ACAT1;SHPK;HEXB;FABP3;NUDT7;DEPTOR;MDH1;IDH1;MDP1;ACP5;DERA;ELOVL6
6074,GO:0016717,0.0269518443077948,0.999726636667438,1,4,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,FADS1
16705,GO:0071827,0.0270166968521995,0.997887900440809,2,35,plasma lipoprotein particle organization,BP,APOC1;ABCG1
20267,GO:1904849,0.0274053300418214,0.999717305285351,1,4,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
21294,GO:2000546,0.0274053300418214,0.999717305285351,1,4,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
15750,GO:0070125,0.0274267644009155,0.99589647149096,3,84,mitochondrial translational elongation,BP,MRPL14;MRPL16;TSFM
13457,GO:0048878,0.0275206799502057,0.987378501635989,13,1004,chemical homeostasis,BP,PDK4;TH;SLC31A2;ABCG1;BDH2;RGN;RBP4;HEXB;FABP3;NOL3;STAR;RPH3AL;HNF1A
9515,GO:0034617,0.0276239835208004,0.999712749429099,1,4,tetrahydrobiopterin binding,MF,TH
4551,GO:0009395,0.0276651147657074,0.997806976193014,2,36,phospholipid catabolic process,BP,APOC1;IDH1
9910,GO:0035578,0.0277222585787444,0.995831127830564,3,88,azurophil granule lumen,CC,PYCARD;HEXB;GLA
142,GO:0000285,0.0279241676502098,0.999706434774109,1,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
9570,GO:0034699,0.0282921371059216,0.999698599393831,1,4,response to luteinizing hormone,BP,STAR
2004,GO:0004470,0.0285776071989943,0.999692448765152,1,4,malic enzyme activity,MF,MDH1
19009,GO:1902042,0.0288665095255956,0.997659050538204,2,36,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD;TRADD
9615,GO:0034774,0.0288964997331321,0.991304393744483,6,312,secretory granule lumen,CC,PNP;PYCARD;HEXB;IDH1;GLA;DERA
2700,GO:0005623,0.0290099483166761,0.986444964198314,119,15450,cell,CC,CFB;EBP;PDK4;PECR;TMEM160;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;PRRT1;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
11504,GO:0043603,0.0290405580120335,0.987028534978987,12,882,cellular amide metabolic process,BP,MRPL14;MRPL16;BDH2;MGST2;GHR;ASAH2;ANG;TSFM;HEXB;IDH1;GLA;RBMS3
16388,GO:0071312,0.0290405752528039,0.997634670506982,2,37,cellular response to alkaloid,BP,TH;STAR
10701,GO:0042181,0.0290687952953867,0.997633805369721,2,36,ketone biosynthetic process,BP,HSD17B3;STAR
16187,GO:0070901,0.0290711342720045,0.999681667049912,1,4,mitochondrial tRNA methylation,BP,HSD17B10
15817,GO:0070236,0.0291142388880586,0.999680716445637,1,4,negative regulation of activation-induced cell death of T cells,BP,FADD
3355,GO:0006651,0.0291824684232117,0.99967920881753,1,4,diacylglycerol biosynthetic process,BP,ANG
17100,GO:0072558,0.0291850257901308,0.99967915223898,1,4,NLRP1 inflammasome complex,CC,PYCARD
12772,GO:0046684,0.02922654366917,0.999678233001036,1,4,response to pyrethroid,BP,TH
12895,GO:0046952,0.0292525406842432,0.999677656729147,1,4,ketone body catabolic process,BP,ACAT1
5905,GO:0016409,0.0292534991251189,0.997607978090755,2,37,palmitoyltransferase activity,MF,CPT2;CPT1C
3404,GO:0006710,0.0293705920774006,0.999675033333718,1,4,androgen catabolic process,BP,HSD17B11
10145,GO:0035962,0.0295952572771955,0.999670010970366,1,4,response to interleukin-13,BP,SHPK
20663,GO:1905953,0.0296060667791039,0.997560950225781,2,38,negative regulation of lipid localization,BP,APOC1;ABCG1
2976,GO:0006081,0.0296441114104028,0.995424159468834,3,90,cellular aldehyde metabolic process,BP,SHPK;IDH1;DERA
7784,GO:0031119,0.0297911553018067,0.999665599859642,1,4,tRNA pseudouridine synthesis,BP,PUS1
2001,GO:0004466,0.0298940467115095,0.999663271132858,1,4,long-chain-acyl-CoA dehydrogenase activity,MF,ACADVL
20796,GO:1990481,0.0300510843395443,0.999659701143544,1,4,mRNA pseudouridine synthesis,BP,PUS1
6442,GO:0018894,0.0300569398655944,0.999659567659146,1,4,dibenzo-p-dioxin metabolic process,BP,STAR
1157,GO:0002586,0.0301146665410755,0.999658250284728,1,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
19520,GO:1903273,0.0302566641379384,0.999654998806213,1,4,regulation of sodium ion export,BP,FXYD1
19521,GO:1903275,0.0302566641379384,0.999654998806213,1,4,positive regulation of sodium ion export,BP,FXYD1
19522,GO:1903276,0.0302566641379384,0.999654998806213,1,4,regulation of sodium ion export from cell,BP,FXYD1
19523,GO:1903278,0.0302566641379384,0.999654998806213,1,4,positive regulation of sodium ion export from cell,BP,FXYD1
12382,GO:0045843,0.0304076716403572,0.9974587350009,2,38,negative regulation of striated muscle tissue development,BP,RBP4;S100B
2448,GO:0005105,0.0305108217394197,0.999649140133773,1,4,type 1 fibroblast growth factor receptor binding,MF,FGF18
851,GO:0002054,0.0306157974613555,0.999646705719307,1,4,nucleobase binding,MF,PNP
578,GO:0001666,0.0306230630893931,0.990657819710221,6,326,response to hypoxia,BP,TH;ACAA2;PSMB10;ANG;NOL3;S100B
6440,GO:0018879,0.0306253561016776,0.999646483628365,1,4,biphenyl metabolic process,BP,STAR
5638,GO:0015842,0.0306624661302304,0.999645620722538,1,4,aminergic neurotransmitter loading into synaptic vesicle,BP,TH
3873,GO:0007618,0.0306737921329808,0.997424469844771,2,38,mating,BP,TH;HEXB
876,GO:0002084,0.0307701609693327,0.999643110499766,1,4,protein depalmitoylation,BP,LYPLAL1
8491,GO:0032431,0.0308229993693732,0.999641875624785,1,4,activation of phospholipase A2 activity,BP,ANG
18767,GO:1901318,0.0308260266788852,0.999641804808728,1,4,negative regulation of flagellated sperm motility,BP,RGN
18888,GO:1901668,0.0308316720639571,0.999641672730632,1,4,regulation of superoxide dismutase activity,BP,RGN
17167,GO:0072683,0.0308531188202117,0.999641170742515,1,4,T cell extravasation,BP,FADD
6208,GO:0016936,0.0308537276340993,0.999641156487268,1,4,galactoside binding,MF,GLA
7215,GO:0030060,0.03089667743401,0.999640150102846,1,4,L-malate dehydrogenase activity,MF,MDH1
7984,GO:0031501,0.0308983879375572,0.999640109993369,1,4,mannosyltransferase complex,CC,DPM3
45,GO:0000096,0.030920468574562,0.997392561628918,2,38,sulfur amino acid metabolic process,BP,MSRA;MRI1
8135,GO:0031779,0.030928584810551,0.999639401536087,1,4,melanocortin receptor binding,MF,MRAP
8137,GO:0031781,0.030928584810551,0.999639401536087,1,4,type 3 melanocortin receptor binding,MF,MRAP
8138,GO:0031782,0.030928584810551,0.999639401536087,1,4,type 4 melanocortin receptor binding,MF,MRAP
21601,GO:2001181,0.030939943724627,0.999639134858721,1,4,positive regulation of interleukin-10 secretion,BP,PYCARD
1747,GO:0003986,0.0309500158979081,0.999638898307084,1,4,acetyl-CoA hydrolase activity,MF,NUDT7
5100,GO:0010915,0.0309567626555698,0.999638739811105,1,4,regulation of very-low-density lipoprotein particle clearance,BP,APOC1
5101,GO:0010916,0.0309567626555698,0.999638739811105,1,4,negative regulation of very-low-density lipoprotein particle clearance,BP,APOC1
16703,GO:0071825,0.0312789500352747,0.997345940604761,2,38,protein-lipid complex subunit organization,BP,APOC1;ABCG1
6349,GO:0018103,0.0319534362141803,0.999589491373045,1,5,protein C-linked glycosylation,BP,DPM3
6386,GO:0018211,0.0319534362141803,0.999589491373045,1,5,peptidyl-tryptophan modification,BP,DPM3
6407,GO:0018317,0.0319534362141803,0.999589491373045,1,5,protein C-linked glycosylation via tryptophan,BP,DPM3
6422,GO:0018406,0.0319534362141803,0.999589491373045,1,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,DPM3
14605,GO:0055086,0.0319645542957956,0.986673764027132,10,695,nucleobase-containing small molecule metabolic process,BP,MRAP;PNP;NNMT;ACAT1;AOX1;SHPK;NUDT7;MDH1;IDH1;DERA
18848,GO:1901606,0.0324587717085214,0.994808508950701,3,93,alpha-amino acid catabolic process,BP,ACAT1;SARDH;PCBD1
13722,GO:0050873,0.0327419528783566,0.997149763411707,2,39,brown fat cell differentiation,BP,MRAP;NUDT7
7302,GO:0030204,0.0332512216979587,0.997075843393932,2,41,chondroitin sulfate metabolic process,BP,IDUA;HEXB
6171,GO:0016877,0.0332694701634112,0.997078798612118,2,39,ligase activity, forming carbon-sulfur bonds,MF,ACSF2;ACSM5
3354,GO:0006650,0.0332991247549173,0.989640170012969,6,337,glycerophospholipid metabolic process,BP,DPM3;ZFYVE21;APOC1;FGF18;PLA2G16;FABP3
18945,GO:1901862,0.0333169724335257,0.997069590385325,2,40,negative regulation of muscle tissue development,BP,RBP4;S100B
14750,GO:0060157,0.0333798391815135,0.999551759352866,1,5,urinary bladder development,BP,RBP4
12209,GO:0045542,0.0334559610735259,0.999549698467607,1,5,positive regulation of cholesterol biosynthetic process,BP,ABCG1
9054,GO:0033344,0.0334629509624472,0.99704980793012,2,40,cholesterol efflux,BP,APOC1;ABCG1
13320,GO:0048635,0.0334878625914782,0.997046427221297,2,40,negative regulation of muscle organ development,BP,RBP4;S100B
10652,GO:0042102,0.033549900078949,0.994562883587817,3,95,positive regulation of T cell proliferation,BP,FADD;PNP;PYCARD
6640,GO:0019534,0.0336180184339289,0.999545295047235,1,5,toxin transporter activity,MF,ABCG1
10300,GO:0036293,0.0336519753559536,0.989505467428841,6,334,response to decreased oxygen levels,BP,TH;ACAA2;PSMB10;ANG;NOL3;S100B
8999,GO:0033209,0.0336583332253564,0.992506408474497,4,162,tumor necrosis factor-mediated signaling pathway,BP,TRADD;PYCARD;PSMB10;NOL3
12470,GO:0046006,0.0337580626016871,0.997012512205225,2,39,regulation of activated T cell proliferation,BP,FADD;PYCARD
21197,GO:2000401,0.033892514527964,0.996994177633266,2,39,regulation of lymphocyte migration,BP,FADD;PYCARD
5768,GO:0016101,0.033942029115547,0.994473496386749,3,96,diterpenoid metabolic process,BP,PECR;RBP4;STAR
4579,GO:0009448,0.0340243469117907,0.999534158762184,1,5,gamma-aminobutyric acid metabolic process,BP,SLC1A3
21536,GO:2001015,0.0341574826581169,0.999530480179612,1,5,negative regulation of skeletal muscle cell differentiation,BP,S100B
11057,GO:0042816,0.034223108001217,0.999528661532222,1,5,vitamin B6 metabolic process,BP,AOX1
19956,GO:1904177,0.0342286053809838,0.999528509023825,1,5,regulation of adipose tissue development,BP,PLA2G16
14601,GO:0055081,0.0342768260679007,0.996935875564621,2,41,anion homeostasis,BP,ABCG1;FABP3
7697,GO:0030976,0.034286727934342,0.999526895056407,1,5,thiamine pyrophosphate binding,MF,HACL1
16797,GO:0072014,0.0347069611518689,0.999515142646995,1,5,proximal tubule development,BP,ACAT1
11969,GO:0045017,0.0348752740898647,0.990434754517052,5,254,glycerolipid biosynthetic process,BP,DPM3;RGN;FGF18;ANG;FABP3
13556,GO:0050654,0.0349394221681575,0.996841494424428,2,42,chondroitin sulfate proteoglycan metabolic process,BP,IDUA;HEXB
8669,GO:0032687,0.0349733617574395,0.999507616626097,1,5,negative regulation of interferon-alpha production,BP,NMI
11152,GO:0043028,0.0351054743471319,0.996821076091713,2,41,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,PYCARD;NOL3
12139,GO:0045333,0.0354788707936175,0.991968931929833,4,165,cellular respiration,BP,ETFB;MDH1;IDH1;ETFDH
12647,GO:0046460,0.0355298875962076,0.996758914611823,2,42,neutral lipid biosynthetic process,BP,RGN;ANG
12650,GO:0046463,0.0355298875962076,0.996758914611823,2,42,acylglycerol biosynthetic process,BP,RGN;ANG
2571,GO:0005324,0.0357311657915891,0.999485886450183,1,5,long-chain fatty acid transporter activity,MF,FABP3
2074,GO:0004563,0.0357629561546639,0.99948496444887,1,5,beta-N-acetylhexosaminidase activity,MF,HEXB
21639,GO:2001237,0.0358438706145463,0.994034912160353,3,100,negative regulation of extrinsic apoptotic signaling pathway,BP,FADD;TRADD;NOL3
1151,GO:0002580,0.0359486248203148,0.99947956284016,1,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
14026,GO:0051344,0.0360510976607982,0.999476569377508,1,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,RGN
14782,GO:0060205,0.0360661250327142,0.988570992246855,6,329,cytoplasmic vesicle lumen,CC,PNP;PYCARD;HEXB;IDH1;GLA;DERA
7216,GO:0030061,0.0361227864158752,0.999474470007598,1,5,mitochondrial crista,CC,STAR
6628,GO:0019509,0.0363511297687535,0.999467754657481,1,5,L-methionine salvage from methylthioadenosine,BP,MRI1
8664,GO:0032680,0.0364226137408589,0.993900820368843,3,100,regulation of tumor necrosis factor production,BP,FADD;PYCARD;TICAM1
8215,GO:0031983,0.036536491415073,0.98838655013859,6,330,vesicle lumen,CC,PNP;PYCARD;HEXB;IDH1;GLA;DERA
9781,GO:0035338,0.0365417458641585,0.996618519148636,2,41,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSF2;ELOVL6
6239,GO:0017040,0.0365427953400115,0.999462084554575,1,5,ceramidase activity,MF,ASAH2
21615,GO:2001199,0.0367259383243411,0.9994566380823,1,5,negative regulation of dendritic cell differentiation,BP,TMEM176A
13798,GO:0051005,0.0367671371090456,0.999455409037936,1,5,negative regulation of lipoprotein lipase activity,BP,APOC1
20699,GO:1990111,0.0367850203212897,0.999454875106253,1,5,spermatoproteasome complex,CC,PSMB10
8435,GO:0032371,0.0367955789660826,0.99657932707877,2,42,regulation of sterol transport,BP,APOC1;ABCG1
8438,GO:0032374,0.0367955789660826,0.99657932707877,2,42,regulation of cholesterol transport,BP,APOC1;ABCG1
8209,GO:0031968,0.037059672773154,0.991490856975293,4,174,organelle outer membrane,CC,CPT1C;IFI27;DHCR7;CYB5A
4348,GO:0009052,0.0373139936818669,0.999438961619802,1,5,pentose-phosphate shunt, non-oxidative branch,BP,SHPK
4625,GO:0009725,0.037556321043946,0.983199578207686,11,837,response to hormone,BP,PDK4;TH;ABCG1;GHR;RNASEL;ANG;ACAT1;FABP3;IDH1;STAR;S100B
17079,GO:0072526,0.0376255410117687,0.99942948031561,1,5,pyridine-containing compound catabolic process,BP,PNP
3857,GO:0007598,0.0376629042449603,0.999428337823695,1,5,blood coagulation, extrinsic pathway,BP,TFPI
8531,GO:0032480,0.0376881565440739,0.996447699649116,2,43,negative regulation of type I interferon production,BP,PYCARD;NMI
17162,GO:0072678,0.0377380645132635,0.996446380772987,2,41,T cell migration,BP,FADD;PYCARD
4082,GO:0008328,0.0377559757936997,0.996432434426636,2,45,ionotropic glutamate receptor complex,CC,GRIA3;CPT1C
17005,GO:0072338,0.0378605778801023,0.999398461617476,1,6,cellular lactam metabolic process,BP,GHR
21637,GO:2001235,0.0380933801697347,0.991179211160141,4,172,positive regulation of apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2
6741,GO:0019867,0.0381732701170817,0.991152519474571,4,176,outer membrane,CC,CPT1C;IFI27;DHCR7;CYB5A
13415,GO:0048806,0.0382224662009228,0.996366938428301,2,44,genitalia development,BP,HSD17B3;RBP4
5709,GO:0015980,0.0382575095047067,0.989246950201074,5,252,energy derivation by oxidation of organic compounds,BP,ACADVL;ETFB;MDH1;IDH1;ETFDH
2991,GO:0006102,0.0382797391121144,0.999409308470214,1,5,isocitrate metabolic process,BP,IDH1
12892,GO:0046949,0.0382935212580365,0.996362303701571,2,42,fatty-acyl-CoA biosynthetic process,BP,ACSF2;ELOVL6
1672,GO:0003854,0.0382945878409833,0.999408846485687,1,5,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,HSD3B2
8637,GO:0032640,0.0383191188056973,0.993453088756558,3,102,tumor necrosis factor production,BP,FADD;PYCARD;TICAM1
1988,GO:0004448,0.0383249418194776,0.999407901519631,1,5,isocitrate dehydrogenase activity,MF,IDH1
4171,GO:0008474,0.0383608628918309,0.999406782250877,1,5,palmitoyl-(protein) hydrolase activity,MF,LYPLAL1
18086,GO:0098599,0.0383608628918309,0.999406782250877,1,5,palmitoyl hydrolase activity,MF,LYPLAL1
18135,GO:0098734,0.0383608628918309,0.999406782250877,1,5,macromolecule depalmitoylation,BP,LYPLAL1
8490,GO:0032430,0.0383641433814481,0.999406679980223,1,5,positive regulation of phospholipase A2 activity,BP,ANG
5516,GO:0015485,0.0390441740275709,0.996248694837355,2,43,cholesterol binding,MF,ABCG1;STAR
8710,GO:0032757,0.0390792244392075,0.996243499042359,2,43,positive regulation of interleukin-8 production,BP,FADD;PYCARD
18874,GO:1901652,0.0391258634195674,0.98604111667153,7,442,response to peptide,BP,PDK4;TH;GHR;RNASEL;FABP3;CASP4;STAR
5022,GO:0010823,0.0391888331016766,0.996227234100243,2,43,negative regulation of mitochondrion organization,BP,ACAA2;NOL3
19666,GO:1903555,0.0393471464523932,0.993206591383679,3,103,regulation of tumor necrosis factor superfamily cytokine production,BP,FADD;PYCARD;TICAM1
3969,GO:0008150,0.0394715379096759,0.983378589912984,122,16026,biological_process,BP,CFB;EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;WDR45;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;TMEM176A;IDH1;DECR1;PUS1;PTMS;LDHD;MDP1;TFPI;STAR;SNX21;WBP1;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;PRRT1;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
2600,GO:0005375,0.0394930039880459,0.999345039995813,1,6,copper ion transmembrane transporter activity,MF,SLC31A2
9829,GO:0035434,0.0394930039880459,0.999345039995813,1,6,copper ion transmembrane transport,BP,SLC31A2
13668,GO:0050798,0.03972274663965,0.996147642913095,2,43,activated T cell proliferation,BP,FADD;PYCARD
15970,GO:0070482,0.0401847781965119,0.986932760701953,6,349,response to oxygen levels,BP,TH;ACAA2;PSMB10;ANG;NOL3;S100B
4719,GO:0010033,0.0403024305781266,0.975597929684935,28,2793,response to organic substance,BP,PDK4;IFI30;TH;FADD;TRADD;ABCG1;PYCARD;ACADVL;MGST2;PSMB10;GHR;FGF18;TICAM1;NNMT;RBP4;RNASEL;ANG;NMI;ACAT1;SHPK;FABP3;NOL3;CASP4;IFI27;IDH1;TFPI;STAR;S100B
780,GO:0001957,0.0403161196489292,0.999317227508498,1,6,intramembranous ossification,BP,FGF18
10218,GO:0036072,0.0403161196489292,0.999317227508498,1,6,direct ossification,BP,FGF18
12530,GO:0046113,0.0403400195428597,0.999316411167788,1,6,nucleobase catabolic process,BP,AOX1
3388,GO:0006690,0.0403858630206396,0.992958376152702,3,101,icosanoid metabolic process,BP,MGST2;FADS1;PON2
18836,GO:1901568,0.0403858630206396,0.992958376152702,3,101,fatty acid derivative metabolic process,BP,MGST2;FADS1;PON2
6399,GO:0018279,0.0405651196845327,0.996020849463888,2,43,protein N-linked glycosylation via asparagine,BP,ALG5;DPM3
11204,GO:0043123,0.0406348217976611,0.990394380904564,4,178,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD;TRADD;TICAM1;S100B
15289,GO:0060992,0.0406760433003644,0.99930488123321,1,6,response to fungicide,BP,STAR
17458,GO:0090205,0.0406863016003976,0.999304527699908,1,6,positive regulation of cholesterol metabolic process,BP,ABCG1
11097,GO:0042940,0.0407430205943927,0.999302571335836,1,6,D-amino acid transport,BP,SLC1A3
11472,GO:0043546,0.040863956931841,0.999298390645907,1,6,molybdopterin cofactor binding,MF,AOX1
13842,GO:0051055,0.0409502549058414,0.995959261709533,2,44,negative regulation of lipid biosynthetic process,BP,APOC1;ACADVL
3040,GO:0006195,0.0410203025762377,0.995942738565862,2,46,purine nucleotide catabolic process,BP,PNP;NUDT7
14769,GO:0060179,0.0410584038956371,0.999291642115206,1,6,male mating behavior,BP,HEXB
12644,GO:0046456,0.0411022936200949,0.99593921933912,2,43,icosanoid biosynthetic process,BP,MGST2;FADS1
18838,GO:1901570,0.0411022936200949,0.99593921933912,2,43,fatty acid derivative biosynthetic process,BP,MGST2;FADS1
17453,GO:0090199,0.0411379393405684,0.995933781275278,2,43,regulation of release of cytochrome c from mitochondria,BP,PYCARD;NOL3
10708,GO:0042221,0.0411677174164565,0.973598201233384,38,4006,response to chemical,BP,EBP;PDK4;IFI30;TH;FADD;TRADD;PNP;ABCG1;PYCARD;ACADVL;ACAA2;MGST2;PSMB10;RGN;GHR;FGF18;TICAM1;NNMT;RBP4;RNASEL;ANG;NMI;ACAT1;SHPK;CMBL;FABP3;NOL3;CASP4;IFI27;PON2;IDH1;TFPI;STAR;RPH3AL;S100B;CYB5A;DOK1;SLC1A3
21180,GO:2000378,0.0412045495878744,0.995920460356784,2,44,negative regulation of reactive oxygen species metabolic process,BP,RGN;GLA
825,GO:0002020,0.0412553879134499,0.992738381586142,3,108,protease binding,MF,FADD;PYCARD;NOL3
18215,GO:0098878,0.0413242463515264,0.99589347070622,2,47,neurotransmitter receptor complex,CC,GRIA3;CPT1C
12152,GO:0045349,0.0413271030795541,0.999282262520147,1,6,interferon-alpha biosynthetic process,BP,NMI
12157,GO:0045354,0.0413271030795541,0.999282262520147,1,6,regulation of interferon-alpha biosynthetic process,BP,NMI
10824,GO:0042426,0.0413528540886067,0.999281360325269,1,6,choline catabolic process,BP,SARDH
3261,GO:0006537,0.0419258793831968,0.999261135106436,1,6,glutamate biosynthetic process,BP,SLC1A3
6374,GO:0018196,0.0419657492493021,0.995803511041516,2,44,peptidyl-asparagine modification,BP,ALG5;DPM3
13257,GO:0048512,0.0419880209644508,0.995800071202472,2,44,circadian behavior,BP,TH;STAR
4107,GO:0008375,0.0420054797491828,0.995794275830177,2,45,acetylglucosaminyltransferase activity,MF,EXTL1;HEXB
2932,GO:0006011,0.0420249907661877,0.999257607964715,1,6,UDP-glucose metabolic process,BP,GALT
13794,GO:0050999,0.0420620379953499,0.99578552758905,2,45,regulation of nitric-oxide synthase activity,BP,GLA;PTS
13120,GO:0048168,0.0421653111404073,0.995760976814727,2,48,regulation of neuronal synaptic plasticity,BP,STAR;S100B
5077,GO:0010887,0.0421897869309768,0.999251724345621,1,6,negative regulation of cholesterol storage,BP,ABCG1
7351,GO:0030274,0.0423021612704609,0.999247698766816,1,6,LIM domain binding,MF,RPH3AL
6096,GO:0016757,0.0423068456583928,0.987780544021973,5,261,transferase activity, transferring glycosyl groups,MF,ALG5;DPM3;EXTL1;PNP;HEXB
3457,GO:0006805,0.0423316068120277,0.99247941479192,3,103,xenobiotic metabolic process,BP,MGST2;CMBL;STAR
10114,GO:0035900,0.0423861459892334,0.999244683015015,1,6,response to isolation stress,BP,TH
12763,GO:0046660,0.0425200790460724,0.992425635502763,3,109,female sex differentiation,BP,RBP4;ANG;IDH1
15816,GO:0070235,0.0425270320010448,0.999239610251137,1,6,regulation of activation-induced cell death of T cells,BP,FADD
8110,GO:0031730,0.0426567945546038,0.99923492272098,1,6,CCR5 chemokine receptor binding,MF,CNIH4
20167,GO:1904645,0.042798191038958,0.999229798244498,1,6,response to beta-amyloid,BP,CASP4
11834,GO:0044539,0.0430249500906684,0.99922154373356,1,6,long-chain fatty acid import,BP,FABP3
9779,GO:0035336,0.0430309385154981,0.995634638525848,2,45,long-chain fatty-acyl-CoA metabolic process,BP,ACSF2;ELOVL6
18957,GO:1901894,0.0431399794184668,0.99921733930745,1,6,regulation of calcium-transporting ATPase activity,BP,RGN
16656,GO:0071706,0.0433838885185247,0.992212909685633,3,107,tumor necrosis factor superfamily cytokine production,BP,FADD;PYCARD;TICAM1
4106,GO:0008374,0.0436115808592592,0.995540158829646,2,46,O-acyltransferase activity,MF,CPT2;CPT1C
3877,GO:0007622,0.0437652969234074,0.995518994236323,2,45,rhythmic behavior,BP,TH;STAR
7843,GO:0031265,0.0438406140844714,0.999191481599895,1,6,CD95 death-inducing signaling complex,CC,FADD
4396,GO:0009120,0.0438686383964647,0.999190438435364,1,6,deoxyribonucleoside metabolic process,BP,DERA
3409,GO:0006721,0.0439873350281555,0.992062883401224,3,106,terpenoid metabolic process,BP,PECR;RBP4;STAR
7258,GO:0030145,0.0440709220937038,0.99546431346264,2,47,manganese ion binding,MF,NUDT7;PEPD
3018,GO:0006152,0.0443282743475536,0.99917323145589,1,6,purine nucleoside catabolic process,BP,PNP
12539,GO:0046130,0.0443282743475536,0.99917323145589,1,6,purine ribonucleoside catabolic process,BP,PNP
17969,GO:0097527,0.0443394908134181,0.999172809252747,1,6,necroptotic signaling pathway,BP,FADD
12769,GO:0046677,0.0443935495686496,0.995415970602211,2,46,response to antibiotic,BP,STAR;SLC1A3
12662,GO:0046477,0.0444898299080794,0.99916713969237,1,6,glycosylceramide catabolic process,BP,GLA
3772,GO:0007341,0.0445129956880605,0.999166264315922,1,6,penetration of zona pellucida,BP,HEXB
10821,GO:0042421,0.0446690622216111,0.999160354754928,1,6,norepinephrine biosynthetic process,BP,TH
3387,GO:0006689,0.0448755257278189,0.999152504229285,1,6,ganglioside catabolic process,BP,HEXB
9454,GO:0034447,0.0451265923137222,0.999142907604434,1,6,very-low-density lipoprotein particle clearance,BP,APOC1
1154,GO:0002583,0.0452428441798077,0.999138445423808,1,6,regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
1908,GO:0004321,0.0455496369903749,0.999126612911938,1,6,fatty-acyl-CoA synthase activity,MF,ACSM5
2460,GO:0005126,0.0455589403686301,0.986576305720065,5,260,cytokine receptor binding,MF,FADD;TRADD;PYCARD;NOL3;CNIH4
13536,GO:0050543,0.0457313042441057,0.999119567546473,1,6,icosatetraenoic acid binding,MF,FABP3
1804,GO:0004064,0.0459566585028779,0.999110787860803,1,6,arylesterase activity,MF,PON2
9681,GO:0035094,0.0459723667129933,0.995158221534048,2,47,response to nicotine,BP,TH;STAR
13088,GO:0048039,0.0460044884376292,0.999108918722949,1,6,ubiquinone binding,MF,ETFDH
14793,GO:0060228,0.0460736761936366,0.999106211408986,1,6,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOC1
12931,GO:0047035,0.0460757337418545,0.999106130833159,1,6,testosterone dehydrogenase (NAD+) activity,MF,HSD17B3
2930,GO:0006006,0.0461691120973749,0.988630660606571,4,187,glucose metabolic process,BP,PDK4;RGN;RBP4;MDH1
16497,GO:0071466,0.0463861046216499,0.991451963656249,3,107,cellular response to xenobiotic stimulus,BP,MGST2;CMBL;STAR
13731,GO:0050885,0.046426665267702,0.995072149325956,2,51,neuromuscular process controlling balance,BP,HEXB;SLC1A3
4394,GO:0009117,0.0464481381510906,0.980355111315243,9,641,nucleotide metabolic process,BP,MRAP;PNP;NNMT;ACAT1;SHPK;NUDT7;MDH1;IDH1;DERA
12390,GO:0045862,0.0464742700969855,0.984354032863001,6,357,positive regulation of proteolysis,BP,FADD;TRADD;PYCARD;PSMB10;RGN;IFI27
17269,GO:0086036,0.0465242604130641,0.999062790398827,1,7,regulation of cardiac muscle cell membrane potential,BP,FXYD1
12162,GO:0045359,0.0465256513791079,0.999062733840001,1,7,positive regulation of interferon-beta biosynthetic process,BP,TICAM1
8836,GO:0032934,0.0473085980644916,0.994935539907334,2,48,sterol binding,MF,ABCG1;STAR
6715,GO:0019825,0.0473677346843717,0.994932383553057,2,46,oxygen binding,MF,TH;CYP17A1
11688,GO:0044249,0.0474594912957363,0.968036652845882,52,5897,cellular biosynthetic process,BP,PDK4;PECR;ALG5;DPM3;TH;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;TICAM1;NNMT;PLA2G16;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;FABP3;HSD3B2;PCBD1;IFI27;IDH1;PTMS;STAR;GLA;CYP11A1;PTS;RBMS3;HNF1A;SLC1A3;ELOVL6
3900,GO:0008033,0.0476315041476086,0.991128852869451,3,108,tRNA processing,BP,LAGE3;HSD17B10;PUS1
3427,GO:0006749,0.0477450767968422,0.994869770942575,2,46,glutathione metabolic process,BP,MGST2;IDH1
6637,GO:0019530,0.0478855963808809,0.999006604329535,1,7,taurine metabolic process,BP,GHR
6669,GO:0019694,0.0478855963808809,0.999006604329535,1,7,alkanesulfonate metabolic process,BP,GHR
11760,GO:0044351,0.0478929828998473,0.999006294921359,1,7,macropinocytosis,BP,PYCARD
14165,GO:0051597,0.0479682223755059,0.999003140476047,1,7,response to methylmercury,BP,S100B
14443,GO:0052548,0.048299903027592,0.983588269759234,6,358,regulation of endopeptidase activity,BP,FADD;TRADD;PYCARD;NOL3;IFI27;TFPI
14212,GO:0051694,0.0485128884377461,0.998980153175568,1,7,pointed-end actin filament capping,BP,TMOD4
3366,GO:0006664,0.04856042116236,0.990882549406935,3,111,glycolipid metabolic process,BP,DPM3;HEXB;GLA
9780,GO:0035337,0.0485694012814532,0.994725117903446,2,48,fatty-acyl-CoA metabolic process,BP,ACSF2;ELOVL6
17713,GO:0097049,0.0488573573102555,0.998965477180432,1,7,motor neuron apoptotic process,BP,FADD
3430,GO:0006753,0.0488600995205755,0.979140227758848,9,647,nucleoside phosphate metabolic process,BP,MRAP;PNP;NNMT;ACAT1;SHPK;NUDT7;MDH1;IDH1;DERA
10039,GO:0035766,0.0489406812422671,0.998961911133947,1,7,cell chemotaxis to fibroblast growth factor,BP,FGF18
10041,GO:0035768,0.0489406812422671,0.998961911133947,1,7,endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
20265,GO:1904847,0.0489406812422671,0.998961911133947,1,7,regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
21292,GO:2000544,0.0489406812422671,0.998961911133947,1,7,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
2472,GO:0005138,0.048982601613356,0.998960114686441,1,7,interleukin-6 receptor binding,MF,PYCARD
16024,GO:0070569,0.0490337179726524,0.99895792201328,1,7,uridylyltransferase activity,MF,GALT
9286,GO:0034128,0.0491042298740436,0.998954893490289,1,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
19752,GO:1903726,0.0492549484018771,0.998948405026165,1,7,negative regulation of phospholipid metabolic process,BP,APOC1
8530,GO:0032479,0.0493127011995288,0.990679721481498,3,115,regulation of type I interferon production,BP,PYCARD;TICAM1;NMI
2567,GO:0005314,0.0493634496618171,0.998943721349082,1,7,high-affinity glutamate transmembrane transporter activity,MF,SLC1A3
19634,GO:1903509,0.0495183952842659,0.990629199851799,3,112,liposaccharide metabolic process,BP,DPM3;HEXB;GLA
4684,GO:0009922,0.0496122583498163,0.998932940944314,1,7,fatty acid elongase activity,MF,ELOVL6
6585,GO:0019367,0.0496122583498163,0.998932940944314,1,7,fatty acid elongation, saturated fatty acid,BP,ELOVL6
18403,GO:0102336,0.0496122583498163,0.998932940944314,1,7,3-oxo-arachidoyl-CoA synthase activity,MF,ELOVL6
18404,GO:0102337,0.0496122583498163,0.998932940944314,1,7,3-oxo-cerotoyl-CoA synthase activity,MF,ELOVL6
18405,GO:0102338,0.0496122583498163,0.998932940944314,1,7,3-oxo-lignoceronyl-CoA synthase activity,MF,ELOVL6
12665,GO:0046485,0.0497924894941161,0.998925097010695,1,7,ether lipid metabolic process,BP,PLA2G16
16288,GO:0071073,0.0498213319680297,0.998923839023107,1,7,positive regulation of phospholipid biosynthetic process,BP,FABP3
10372,GO:0036462,0.0498543502694656,0.998922397982329,1,7,TRAIL-activated apoptotic signaling pathway,BP,FADD
13796,GO:0051001,0.0499096907402041,0.998919980514225,1,7,negative regulation of nitric-oxide synthase activity,BP,GLA
9529,GO:0034638,0.0500082440591968,0.998915668514869,1,7,phosphatidylcholine catabolic process,BP,APOC1
8615,GO:0032606,0.0504689815985019,0.990371909754526,3,116,type I interferon production,BP,PYCARD;TICAM1;NMI
7633,GO:0030868,0.0506357582123397,0.998888007349418,1,7,smooth endoplasmic reticulum membrane,CC,HSD3B2
17909,GO:0097425,0.0506357582123397,0.998888007349418,1,7,smooth endoplasmic reticulum part,CC,HSD3B2
11718,GO:0044297,0.05078648031326,0.980828338922327,7,472,cell body,CC,TH;FADD;CYP17A1;ANG;STAR;S100B;SLC1A3
6122,GO:0016798,0.0510108601431186,0.990231088634958,3,113,hydrolase activity, acting on glycosyl bonds,MF,IDUA;HEXB;GLA
3437,GO:0006771,0.0512662401404217,0.998859857318179,1,7,riboflavin metabolic process,BP,ACP5
11192,GO:0043102,0.0512834468011219,0.998859084034189,1,7,amino acid salvage,BP,MRI1
16365,GO:0071267,0.0512834468011219,0.998859084034189,1,7,L-methionine salvage,BP,MRI1
4264,GO:0008637,0.0514394779422194,0.990116220118788,3,113,apoptotic mitochondrial changes,BP,PYCARD;ACAA2;NOL3
18125,GO:0098700,0.0515402515791671,0.998847511185215,1,7,neurotransmitter loading into synaptic vesicle,BP,TH
8688,GO:0032722,0.0516568428472564,0.994189778266528,2,50,positive regulation of chemokine production,BP,PYCARD;TICAM1
14689,GO:0060059,0.051909356314711,0.998806794581423,1,8,embryonic retina morphogenesis in camera-type eye,BP,RBP4
7222,GO:0030091,0.0519662961475131,0.998828180100083,1,7,protein repair,BP,MSRA
5153,GO:0010985,0.0520362239378545,0.998824991559932,1,7,negative regulation of lipoprotein particle clearance,BP,APOC1
6070,GO:0016713,0.0522458858332265,0.998815404969786,1,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,CYP11A1
21599,GO:2001179,0.0522794760655505,0.998813865392965,1,7,regulation of interleukin-10 secretion,BP,PYCARD
13032,GO:0047760,0.0523436029340028,0.998810923363602,1,7,butyrate-CoA ligase activity,MF,ACSM5
6596,GO:0019388,0.0526684083719022,0.998795964702543,1,7,galactose catabolic process,BP,GALT
6097,GO:0016758,0.0526798758616319,0.986464711902144,4,193,transferase activity, transferring hexosyl groups,MF,ALG5;DPM3;EXTL1;HEXB
4657,GO:0009820,0.0527408384833744,0.998792615971205,1,7,alkaloid metabolic process,BP,TH
4562,GO:0009410,0.052907293881864,0.989719819616623,3,113,response to xenobiotic stimulus,BP,MGST2;CMBL;STAR
18658,GO:1901029,0.0531295086964043,0.998774565085726,1,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,ACAA2
5256,GO:0014745,0.0531580201349662,0.998748086825569,1,8,negative regulation of muscle adaptation,BP,NOL3
1993,GO:0004457,0.053353831201626,0.998764084689283,1,7,lactate dehydrogenase activity,MF,LDHD
9415,GO:0034382,0.0533693907765948,0.998763356052188,1,7,chylomicron remnant clearance,BP,APOC1
16706,GO:0071830,0.0533693907765948,0.998763356052188,1,7,triglyceride-rich lipoprotein particle clearance,BP,APOC1
6153,GO:0016846,0.0534124610364743,0.998761337977451,1,7,carbon-sulfur lyase activity,MF,MGST2
9839,GO:0035457,0.0542577644438862,0.998695188170607,1,8,cellular response to interferon-alpha,BP,STAR
13571,GO:0050670,0.0548215885188231,0.985731938921012,4,194,regulation of lymphocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
6178,GO:0016885,0.0549968244828204,0.998659010439913,1,8,ligase activity, forming carbon-carbon bonds,MF,ACAT1
5169,GO:0012505,0.0550950785092071,0.963902635491233,37,4018,endomembrane system,CC,EBP;ALG5;DPM3;TH;ZFYVE21;SLC31A2;HSD17B3;MRAP;APOC1;TBC1D14;EXTL1;PNP;ABCG1;PYCARD;MGST2;FADS1;TICAM1;PLA2G16;GALT;CYP17A1;HEXB;NOL3;HSD3B2;CPT1C;CASP4;IFI27;IDH1;TMEM98;TFPI;SNX21;GLA;RPH3AL;DERA;DHCR7;CYB5A;CNIH4;ELOVL6
163,GO:0000315,0.055259819391361,0.993553086288177,2,49,organellar large ribosomal subunit,CC,MRPL14;MRPL16
2776,GO:0005762,0.055259819391361,0.993553086288177,2,49,mitochondrial large ribosomal subunit,CC,MRPL14;MRPL16
19405,GO:1903011,0.0552808271252113,0.998644973780045,1,8,negative regulation of bone development,BP,RGN
8841,GO:0032944,0.0557118368082961,0.985423954464292,4,195,regulation of mononuclear cell proliferation,BP,FADD;PNP;PYCARD;TICAM1
9412,GO:0034379,0.0559685455350841,0.998610674274936,1,8,very-low-density lipoprotein particle assembly,BP,APOC1
14339,GO:0051938,0.0561880346674812,0.998577789453533,1,9,L-glutamate import,BP,SLC1A3
19352,GO:1902916,0.0562007939203031,0.99859899205763,1,8,positive regulation of protein polyubiquitination,BP,NMI
18689,GO:1901135,0.0562115591809422,0.970664343182118,14,1210,carbohydrate derivative metabolic process,BP,ALG5;DPM3;TH;MRAP;EXTL1;PNP;GALT;ACAT1;IDUA;SHPK;HEXB;NUDT7;GLA;DERA
4564,GO:0009414,0.0563162886788921,0.998593163996328,1,8,response to water deprivation,BP,TH
21636,GO:2001234,0.0563686427402409,0.985194669844203,4,197,negative regulation of apoptotic signaling pathway,BP,FADD;TRADD;ACAA2;NOL3
4360,GO:0009066,0.0563735041859478,0.993339095333304,2,52,aspartate family amino acid metabolic process,BP,MSRA;MRI1
9285,GO:0034127,0.0565472388973471,0.998581472766425,1,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
10342,GO:0036376,0.0565900010881229,0.998579302619586,1,8,sodium ion export from cell,BP,FXYD1
4761,GO:0010243,0.0566409665587509,0.973947885535683,10,792,response to organonitrogen compound,BP,PDK4;TH;FADD;MGST2;GHR;NNMT;RNASEL;FABP3;CASP4;STAR
13789,GO:0050994,0.0566524471969339,0.993281044072269,2,54,regulation of lipid catabolic process,BP,APOC1;IDH1
18662,GO:1901033,0.056703595629689,0.998573529551789,1,8,positive regulation of response to reactive oxygen species,BP,RGN
12588,GO:0046322,0.0569463159737176,0.998561153981079,1,8,negative regulation of fatty acid oxidation,BP,ACADVL
14024,GO:0051342,0.057056581927963,0.998555513801242,1,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,RGN
7457,GO:0030497,0.057056715161887,0.998555506979411,1,8,fatty acid elongation,BP,ELOVL6
8572,GO:0032543,0.0571224042673253,0.988554356205288,3,114,mitochondrial translation,BP,MRPL14;MRPL16;TSFM
18903,GO:1901698,0.0574735300207981,0.972438789396365,11,900,response to nitrogen compound,BP,PDK4;TH;FADD;MGST2;GHR;TICAM1;NNMT;RNASEL;FABP3;CASP4;STAR
10999,GO:0042726,0.0575240305914259,0.998531478169113,1,8,flavin-containing compound metabolic process,BP,ACP5
11510,GO:0043615,0.0581659141082112,0.998498142739609,1,8,astrocyte cell migration,BP,HEXB
5689,GO:0015925,0.0585811086623322,0.998476376242458,1,8,galactosidase activity,MF,GLA
6027,GO:0016615,0.0585980239169638,0.998475486066547,1,8,malate dehydrogenase activity,MF,MDH1
2997,GO:0006108,0.0586054914223633,0.998475092999747,1,8,malate metabolic process,BP,MDH1
16363,GO:0071265,0.0587147937641567,0.998469333723674,1,8,L-methionine biosynthetic process,BP,MRI1
5787,GO:0016139,0.0587148148557652,0.998469332611259,1,8,glycoside catabolic process,BP,GLA
16392,GO:0071316,0.0588855387237732,0.998460314730182,1,8,cellular response to nicotine,BP,TH
5680,GO:0015914,0.0589747001406378,0.992838544455842,2,57,phospholipid transport,BP,APOC1;ABCG1
19702,GO:1903624,0.0590021518388313,0.998454139477428,1,8,regulation of DNA catabolic process,BP,RGN
12679,GO:0046503,0.059103558634078,0.992824134601251,2,54,glycerolipid catabolic process,BP,APOC1;FABP3
17134,GO:0072608,0.0594119966036498,0.998432335777433,1,8,interleukin-10 secretion,BP,PYCARD
5619,GO:0015810,0.0595188221580071,0.99840210851328,1,9,aspartate transport,BP,SLC1A3
9365,GO:0034308,0.0601222493078874,0.992634638699874,2,53,primary alcohol metabolic process,BP,PECR;RBP4
14022,GO:0051340,0.0601873235827808,0.998390660861941,1,8,regulation of ligase activity,BP,RGN
6014,GO:0016595,0.0602943276595666,0.998359702279535,1,9,glutamate binding,MF,SLC1A3
6161,GO:0016861,0.0604341692231092,0.998377275080007,1,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,MRI1
16377,GO:0071287,0.0605516958544819,0.998345503213696,1,9,cellular response to manganese ion,BP,TH
10660,GO:0042116,0.0606214709793091,0.992528650223988,2,56,macrophage activation,BP,TICAM1;SHPK
14696,GO:0060068,0.0610123590777687,0.998319931879824,1,9,vagina development,BP,RBP4
6052,GO:0016667,0.0613324794493251,0.992399064738723,2,54,oxidoreductase activity, acting on a sulfur group of donors,MF,IFI30;MSRA
16091,GO:0070700,0.0615316825564632,0.998290863518049,1,9,BMP receptor binding,MF,PYCARD
19008,GO:1902041,0.0615387220720399,0.992352125248329,2,56,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD;TRADD
16068,GO:0070663,0.0616224103125657,0.983335935962816,4,202,regulation of leukocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
3295,GO:0006573,0.0619216446020283,0.998268868101471,1,9,valine metabolic process,BP,GHR
6805,GO:0020037,0.062091454827176,0.987120643200339,3,123,heme binding,MF,CYP17A1;CYP11A1;CYB5A
6670,GO:0019695,0.0622259554119918,0.998251603686209,1,9,choline metabolic process,BP,SARDH
691,GO:0001836,0.0622556781770341,0.992220360844646,2,54,release of cytochrome c from mitochondria,BP,PYCARD;NOL3
10789,GO:0042364,0.0622690243616776,0.998249153174051,1,9,water-soluble vitamin biosynthetic process,BP,RGN
8719,GO:0032768,0.062413222020668,0.992182408069196,2,56,regulation of monooxygenase activity,BP,GLA;PTS
978,GO:0002281,0.0625135292763118,0.998235208153491,1,9,macrophage activation involved in immune response,BP,TICAM1
15034,GO:0060546,0.0626056993757168,0.998229936643435,1,9,negative regulation of necroptotic process,BP,FADD
9732,GO:0035251,0.0628621844830045,0.998215225024568,1,9,UDP-glucosyltransferase activity,MF,ALG5
10684,GO:0042159,0.0629922413886444,0.998207741308556,1,9,lipoprotein catabolic process,BP,LYPLAL1
5273,GO:0014823,0.0633050347462546,0.992004379050765,2,57,response to activity,BP,TH;STAR
12668,GO:0046488,0.0634600826571993,0.982665064503879,4,213,phosphatidylinositol metabolic process,BP,DPM3;ZFYVE21;FGF18;PLA2G16
6116,GO:0016788,0.0635310727766177,0.971496157989589,9,697,hydrolase activity, acting on ester bonds,MF,RGN;PLA2G16;RNASEL;ANG;NUDT7;PON2;MDP1;ACP5;LYPLAL1
14442,GO:0052547,0.0635760457186492,0.976891728550209,6,384,regulation of peptidase activity,BP,FADD;TRADD;PYCARD;NOL3;IFI27;TFPI
9037,GO:0033293,0.0637280411894662,0.991928341180294,2,55,monocarboxylic acid binding,MF,APOC1;FABP3
11404,GO:0043434,0.0639860119266472,0.976701367974382,6,396,response to peptide hormone,BP,PDK4;TH;GHR;RNASEL;FABP3;STAR
1150,GO:0002579,0.0640626627486029,0.998145537597183,1,9,positive regulation of antigen processing and presentation,BP,PYCARD
12774,GO:0046686,0.0640655837223793,0.991861696425694,2,55,response to cadmium ion,BP,STAR;CYB5A
11025,GO:0042761,0.0641974069706783,0.998137630331717,1,9,very long-chain fatty acid biosynthetic process,BP,ELOVL6
1752,GO:0003993,0.064539194094934,0.99811749569592,1,9,acid phosphatase activity,MF,ACP5
15988,GO:0070513,0.0647188672621883,0.998106866657419,1,9,death domain binding,MF,TRADD
10682,GO:0042157,0.0648218960044152,0.982174433433592,4,207,lipoprotein metabolic process,BP,DPM3;APOC1;ABCG1;LYPLAL1
18386,GO:0101002,0.0649458406703857,0.986280342733415,3,124,ficolin-1-rich granule,CC,PNP;IDH1;DERA
20249,GO:1904813,0.0649458406703857,0.986280342733415,3,124,ficolin-1-rich granule lumen,CC,PNP;IDH1;DERA
21614,GO:2001198,0.0654711057667557,0.998062032773234,1,9,regulation of dendritic cell differentiation,BP,TMEM176A
3863,GO:0007605,0.0655485787639763,0.986091011421462,3,131,sensory perception of sound,BP,TH;HEXB;SLC1A3
16157,GO:0070857,0.0655940649033396,0.998054653155053,1,9,regulation of bile acid biosynthetic process,BP,STAR
17685,GO:0097006,0.0659878388716496,0.99147064049354,2,57,regulation of plasma lipoprotein particle levels,BP,APOC1;ABCG1
3293,GO:0006570,0.0663268861708284,0.998010373109256,1,9,tyrosine metabolic process,BP,TH
1673,GO:0003857,0.066389755178636,0.998006550494068,1,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,HSD17B10
11014,GO:0042747,0.066411263774347,0.998005241845809,1,9,circadian sleep/wake cycle, REM sleep,BP,STAR
14877,GO:0060340,0.0671351419523115,0.997935986574037,1,10,positive regulation of type I interferon-mediated signaling pathway,BP,FADD
16153,GO:0070851,0.0671779240234488,0.985604177972613,3,130,growth factor receptor binding,MF,PYCARD;FGF18;LINGO1
5643,GO:0015850,0.0672226991796824,0.981288336684207,4,212,organic hydroxy compound transport,BP,APOC1;ABCG1;RBP4;STAR
7270,GO:0030162,0.0673293093309259,0.969454851080342,9,693,regulation of proteolysis,BP,CFB;FADD;TRADD;PYCARD;PSMB10;RGN;NOL3;IFI27;TFPI
16225,GO:0070970,0.0673741031034432,0.997921074611942,1,10,interleukin-2 secretion,BP,PNP
16475,GO:0071436,0.0680478909602825,0.997878731335709,1,10,sodium ion export,BP,FXYD1
5063,GO:0010873,0.068107425540395,0.997900653848815,1,9,positive regulation of cholesterol esterification,BP,APOC1
6079,GO:0016725,0.0686308832743501,0.997841740294941,1,10,oxidoreductase activity, acting on CH or CH2 groups,MF,AOX1
2994,GO:0006105,0.0690043574549567,0.997817870696948,1,10,succinate metabolic process,BP,GHR
2914,GO:0005984,0.0690329365973605,0.997816038585529,1,10,disaccharide metabolic process,BP,IDUA
2943,GO:0006027,0.0690523896581152,0.990834116769808,2,60,glycosaminoglycan catabolic process,BP,IDUA;HEXB
20668,GO:1990001,0.0691058787010408,0.997811358936841,1,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,NOL3
14674,GO:0060044,0.0694748896654449,0.997787605959387,1,10,negative regulation of cardiac muscle cell proliferation,BP,RBP4
12191,GO:0045471,0.0695672580388195,0.984878990264839,3,130,response to ethanol,BP,TH;RBP4;STAR
10837,GO:0042447,0.0700251059556974,0.997751944332909,1,10,hormone catabolic process,BP,HSD17B11
11023,GO:0042759,0.0700730278735532,0.997748824462733,1,10,long-chain fatty acid biosynthetic process,BP,ELOVL6
13860,GO:0051092,0.0702556294245788,0.98466503851826,3,132,positive regulation of NF-kappaB transcription factor activity,BP,TRADD;PYCARD;TICAM1
10816,GO:0042415,0.0703335933971624,0.997731821913437,1,10,norepinephrine metabolic process,BP,TH
972,GO:0002274,0.0705952042737987,0.969357367304657,8,596,myeloid leukocyte activation,BP,PNP;PYCARD;TICAM1;SHPK;HEXB;IDH1;GLA;DERA
3458,GO:0006807,0.0706800972550584,0.950608952487566,56,6563,nitrogen compound metabolic process,BP,TH;MSRA;MRPL14;MRPL16;MRI1;FADD;MRAP;APOC1;TRADD;EXTL1;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;MGST2;PSMB10;RGN;FADS1;GHR;ASAH2;TICAM1;ARL6IP4;NNMT;PLA2G16;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;IDUA;AOX1;SARDH;SHPK;HEXB;FABP3;NOL3;NUDT7;CPT1C;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;PEPD;ACP5;GLA;DERA;PTS;RBMS3;HNF1A;SLC1A3
13115,GO:0048156,0.070763016253024,0.997703657569433,1,10,tau protein binding,MF,S100B
19034,GO:1902108,0.0707750523865736,0.990478762634844,2,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,ACAA2;NOL3
11150,GO:0043025,0.0710170599463028,0.973455494606938,6,412,neuronal cell body,CC,TH;CYP17A1;ANG;STAR;S100B;SLC1A3
17808,GO:0097202,0.0710635747398388,0.997683838737474,1,10,activation of cysteine-type endopeptidase activity,BP,FADD
18176,GO:0098805,0.071081012017645,0.960019131493936,16,1511,whole membrane,CC,PECR;TH;ZFYVE21;FADD;TRADD;PXMP2;PXMP4;TICAM1;PLA2G16;GRIA3;CPT1C;IFI27;SNX21;RPH3AL;DHCR7;CYB5A
8662,GO:0032677,0.0715865483822039,0.990304053486041,2,60,regulation of interleukin-8 production,BP,FADD;PYCARD
13611,GO:0050714,0.0717038157537356,0.97961027108196,4,214,positive regulation of protein secretion,BP,PYCARD;RBP4;ANG;RPH3AL
4334,GO:0008970,0.071803554955686,0.997634671328028,1,10,phosphatidylcholine 1-acylhydrolase activity,MF,PLA2G16
8489,GO:0032429,0.0720237799229929,0.997619936134377,1,10,regulation of phospholipase A2 activity,BP,ANG
21016,GO:2000121,0.072664310503115,0.997576810942445,1,10,regulation of removal of superoxide radicals,BP,RGN
6768,GO:0019915,0.0728162033120726,0.990035388446208,2,62,lipid storage,BP,ABCG1;HEXB
12011,GO:0045080,0.0728534264432497,0.997564002131869,1,10,positive regulation of chemokine biosynthetic process,BP,TICAM1
19996,GO:1904251,0.0729140878512217,0.997559886182537,1,10,regulation of bile acid metabolic process,BP,STAR
7546,GO:0030677,0.0730319640663644,0.997551877921121,1,10,ribonuclease P complex,CC,HSD17B10
12867,GO:0046906,0.07338818579553,0.983693643384137,3,132,tetrapyrrole binding,MF,CYP17A1;CYP11A1;CYB5A
18875,GO:1901653,0.0734071221370121,0.975280456264871,5,315,cellular response to peptide,BP,PDK4;GHR;RNASEL;CASP4;STAR
18780,GO:1901360,0.0735713736582961,0.948743055051668,51,5915,organic cyclic compound metabolic process,BP,EBP;TH;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;ACAA2;PSMB10;RGN;FADS1;GHR;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;CYP17A1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;AOX1;SHPK;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;STAR;ACP5;CYP11A1;DERA;DHCR7;PTS;HNF1A
3996,GO:0008194,0.0736106051590405,0.983622414941213,3,133,UDP-glycosyltransferase activity,MF,ALG5;EXTL1;HEXB
2786,GO:0005773,0.0736109179557737,0.966019662586216,9,715,vacuole,CC,IFI30;TBC1D14;PYCARD;TICAM1;IDUA;HEXB;PON2;ACP5;GLA
3487,GO:0006853,0.0737746975151929,0.997476453882781,1,11,carnitine shuttle,BP,CPT2
2086,GO:0004576,0.0738494771471863,0.997495966355826,1,10,oligosaccharyl transferase activity,MF,ALG5
16430,GO:0071372,0.0743158117040377,0.997438764156892,1,11,cellular response to follicle-stimulating hormone stimulus,BP,STAR
10201,GO:0036041,0.0744470139122755,0.997454688491573,1,10,long-chain fatty acid binding,MF,FABP3
5699,GO:0015937,0.0744921505496015,0.997451556343235,1,10,coenzyme A biosynthetic process,BP,ACAT1
5675,GO:0015909,0.074673250617308,0.989635709247176,2,62,long-chain fatty acid transport,BP,CPT2;FABP3
18849,GO:1901607,0.0748996056715517,0.989590415397257,2,61,alpha-amino acid biosynthetic process,BP,MRI1;SLC1A3
17866,GO:0097340,0.0749250836790245,0.997395982999736,1,11,inhibition of cysteine-type endopeptidase activity,BP,NOL3
17867,GO:0097341,0.0749250836790245,0.997395982999736,1,11,zymogen inhibition,BP,NOL3
18906,GO:1901701,0.0749458460751902,0.962395401341069,11,948,cellular response to oxygen-containing compound,BP,PDK4;TH;PYCARD;RGN;GHR;TICAM1;RNASEL;SHPK;CASP4;TFPI;STAR
3281,GO:0006558,0.0751577427827888,0.997405138989422,1,10,L-phenylalanine metabolic process,BP,PCBD1
3282,GO:0006559,0.0751577427827888,0.997405138989422,1,10,L-phenylalanine catabolic process,BP,PCBD1
19076,GO:1902221,0.0751577427827888,0.997405138989422,1,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,PCBD1
19077,GO:1902222,0.0751577427827888,0.997405138989422,1,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,PCBD1
14122,GO:0051536,0.0752033669241118,0.98952053585002,2,62,iron-sulfur cluster binding,MF,AOX1;ETFDH
14126,GO:0051540,0.0752033669241118,0.98952053585002,2,62,metal cluster binding,MF,AOX1;ETFDH
13326,GO:0048642,0.0754623515446573,0.997357955122292,1,11,negative regulation of skeletal muscle tissue development,BP,S100B
1892,GO:0004303,0.0754776688208205,0.997382674371156,1,10,estradiol 17-beta-dehydrogenase activity,MF,HSD17B11
4600,GO:0009617,0.0755243539897758,0.968844185286957,7,497,response to bacterium,BP,TH;PYCARD;MGST2;TICAM1;SHPK;TFPI;STAR
2942,GO:0006026,0.0755649961707984,0.989437941538492,2,63,aminoglycan catabolic process,BP,IDUA;HEXB
3171,GO:0006414,0.075615697677926,0.982995110718484,3,130,translational elongation,BP,MRPL14;MRPL16;TSFM
12352,GO:0045792,0.0758878988286872,0.997327633429458,1,11,negative regulation of cell size,BP,DEPTOR
18604,GO:1900407,0.0762812126158961,0.98928108471694,2,63,regulation of cellular response to oxidative stress,BP,RGN;NOL3
3385,GO:0006687,0.0763553863456188,0.989264790436757,2,63,glycosphingolipid metabolic process,BP,HEXB;GLA
11315,GO:0043279,0.0765082249170177,0.982700062579842,3,137,response to alkaloid,BP,TH;FADD;STAR
9747,GO:0035269,0.0766525712238386,0.997272700214171,1,11,protein O-linked mannosylation,BP,DPM3
4114,GO:0008385,0.0766867141568946,0.997270234000896,1,11,IkappaB kinase complex,CC,PYCARD
5974,GO:0016528,0.0767967217900243,0.989156819784155,2,66,sarcoplasm,CC,FABP3;NOL3
2859,GO:0005890,0.0769262110041798,0.997252902391148,1,11,sodium:potassium-exchanging ATPase complex,CC,FXYD1
8720,GO:0032769,0.0772306771703649,0.997230787600965,1,11,negative regulation of monooxygenase activity,BP,GLA
12917,GO:0046983,0.0772737205101072,0.958704504983434,13,1157,protein dimerization activity,MF,ABCG1;PYCARD;GHR;RBP4;ANG;ACAT1;HEXB;ACCS;IDH1;GLA;S100B;PTS;HNF1A
3319,GO:0006600,0.0773225345417135,0.997224097640994,1,11,creatine metabolic process,BP,GHR
1900,GO:0004312,0.0773536020777209,0.99722183311502,1,11,fatty acid synthase activity,MF,ELOVL6
10749,GO:0042301,0.0775735174879231,0.997205776189865,1,11,phosphate ion binding,MF,PNP
11108,GO:0042977,0.0776208615419945,0.997202313171011,1,11,activation of JAK2 kinase activity,BP,GHR
17451,GO:0090197,0.0778902633222403,0.99718256550084,1,11,positive regulation of chemokine secretion,BP,PYCARD
7816,GO:0031223,0.0779866287604036,0.997152531764186,1,12,auditory behavior,BP,SLC1A3
3535,GO:0006924,0.0783317268578824,0.997150050641079,1,11,activation-induced cell death of T cells,BP,FADD
3159,GO:0006400,0.0783451965133617,0.988828168122927,2,62,tRNA modification,BP,HSD17B10;PUS1
7888,GO:0031330,0.0784128925913792,0.982083223374993,3,141,negative regulation of cellular catabolic process,BP,APOC1;TBC1D14;RGN
4827,GO:0010510,0.0784191164387139,0.997120383034023,1,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
14581,GO:0055037,0.0785586834672051,0.982034705374883,3,142,recycling endosome,CC,SLC31A2;TBC1D14;ABCG1
8694,GO:0032729,0.0785666399588551,0.988774763983602,2,63,positive regulation of interferon-gamma production,BP,FADD;PYCARD
5057,GO:0010867,0.0789405884139097,0.997104891036059,1,11,positive regulation of triglyceride biosynthetic process,BP,RGN
12783,GO:0046700,0.0790217344198003,0.969660391641091,6,406,heterocycle catabolic process,BP,PNP;RGN;GALT;AOX1;NUDT7;DERA
12629,GO:0046415,0.0790298139177447,0.997098242389088,1,11,urate metabolic process,BP,PNP
3364,GO:0006662,0.0792165437509668,0.997084302757192,1,11,glycerol ether metabolic process,BP,PLA2G16
14269,GO:0051798,0.0792746219503828,0.997079960121378,1,11,positive regulation of hair follicle development,BP,TRADD
10679,GO:0042147,0.079437093443745,0.98856465841456,2,67,retrograde transport, endosome to Golgi,BP,ZFYVE21;TBC1D14
5583,GO:0015740,0.0796020222539906,0.997031502157647,1,12,C4-dicarboxylate transport,BP,SLC1A3
4354,GO:0009060,0.0796962226359275,0.988521272118969,2,63,aerobic respiration,BP,MDH1;IDH1
16411,GO:0071346,0.0798681605772587,0.981620014352533,3,136,cellular response to interferon-gamma,BP,IFI30;NMI;STAR
6055,GO:0016671,0.0799420734271893,0.997029814092726,1,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRA
11792,GO:0044421,0.0799796164761303,0.946412306539546,34,3687,extracellular region part,CC,CFB;MSRA;APOC1;PNP;BDH2;KRT10;ACAA2;GHR;FGF18;ETFB;RBP4;ANG;ACAT1;ACAT2;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;IDH1;DECR1;MDP1;TFPI;PEPD;ACP5;GLA;ECI1;DERA;S100B;CYB5A;LYPLAL1;LINGO1
6016,GO:0016597,0.0808775245116496,0.988245975672688,2,65,amino acid binding,MF,TH;SLC1A3
7283,GO:0030176,0.0813219806335951,0.981144060795907,3,137,integral component of endoplasmic reticulum membrane,CC,DPM3;DHCR7;ELOVL6
11704,GO:0044270,0.0813229512385186,0.968546984515722,6,409,cellular nitrogen compound catabolic process,BP,PNP;RGN;GALT;AOX1;NUDT7;DERA
8728,GO:0032780,0.0815092462553585,0.996910340025896,1,11,negative regulation of ATPase activity,BP,RGN
13814,GO:0051024,0.0818906079086003,0.996880898987566,1,11,positive regulation of immunoglobulin secretion,BP,RBP4
12192,GO:0045472,0.0819269857971007,0.996852747657701,1,12,response to ether,BP,TH
18766,GO:1901317,0.0820411993319547,0.996869233681502,1,11,regulation of flagellated sperm motility,BP,RGN
8709,GO:0032755,0.0820970820418818,0.987967326281861,2,65,positive regulation of interleukin-6 production,BP,PYCARD;TICAM1
13659,GO:0050786,0.0821168203658972,0.996863367352433,1,11,RAGE receptor binding,MF,S100B
2295,GO:0004859,0.0827095428307494,0.996817190356889,1,11,phospholipase inhibitor activity,MF,APOC1
4057,GO:0008289,0.0834622353190153,0.962464208801311,8,631,lipid binding,MF,APOC1;ABCG1;PXK;RBP4;FABP3;STAR;SNX21;RPH3AL
10772,GO:0042340,0.0839255454085761,0.9966947756717,1,12,keratan sulfate catabolic process,BP,HEXB
3401,GO:0006705,0.0839975219401509,0.996689011919441,1,12,mineralocorticoid biosynthetic process,BP,HSD3B2
4010,GO:0008212,0.0839975219401509,0.996689011919441,1,12,mineralocorticoid metabolic process,BP,HSD3B2
8635,GO:0032637,0.0840617212702584,0.987509260992164,2,66,interleukin-8 production,BP,FADD;PYCARD
4594,GO:0009607,0.0841550071549156,0.958408953690736,10,827,response to biotic stimulus,BP,TH;FADD;PYCARD;MGST2;TICAM1;RNASEL;SHPK;TFPI;STAR;PRRT1
8436,GO:0032372,0.0843938503908911,0.996657181749238,1,12,negative regulation of sterol transport,BP,APOC1
8439,GO:0032375,0.0843938503908911,0.996657181749238,1,12,negative regulation of cholesterol transport,BP,APOC1
8639,GO:0032642,0.0845848864077125,0.987387239095001,2,66,regulation of chemokine production,BP,PYCARD;TICAM1
10817,GO:0042416,0.084585758860482,0.996641712564606,1,12,dopamine biosynthetic process,BP,TH
4375,GO:0009086,0.0847355112291368,0.99662961583864,1,12,methionine biosynthetic process,BP,MRI1
13774,GO:0050954,0.084817189109524,0.979973600492184,3,146,sensory perception of mechanical stimulus,BP,TH;HEXB;SLC1A3
17450,GO:0090196,0.0848315177793405,0.996621848785072,1,12,regulation of chemokine secretion,BP,PYCARD
13679,GO:0050812,0.0851299232619461,0.996574507896436,1,13,regulation of acyl-CoA biosynthetic process,BP,PDK4
4623,GO:0009719,0.0852320363211975,0.950814879800514,16,1551,response to endogenous stimulus,BP,PDK4;TH;FADD;ABCG1;MGST2;GHR;FGF18;NNMT;RNASEL;ANG;ACAT1;FABP3;CASP4;IDH1;STAR;S100B
10959,GO:0042635,0.0852458841078204,0.9965882200632,1,12,positive regulation of hair cycle,BP,TRADD
2933,GO:0006012,0.0854697129118337,0.996569983205256,1,12,galactose metabolic process,BP,GALT
11698,GO:0044262,0.0854838299000879,0.974203745151377,4,234,cellular carbohydrate metabolic process,BP,PDK4;RGN;IDUA;IDH1
7203,GO:0030041,0.085831005740113,0.979634165385738,3,146,actin filament polymerization,BP,PYCARD;ANG;TMOD4
2811,GO:0005811,0.085876948992812,0.987076063171119,2,68,lipid particle,CC,HSD17B11;G0S2
16725,GO:0071872,0.0860336331059879,0.99650017869425,1,13,cellular response to epinephrine stimulus,BP,STAR
21545,GO:2001028,0.0864632170506097,0.996464556741358,1,13,positive regulation of endothelial cell chemotaxis,BP,FGF18
19350,GO:1902914,0.086705641982409,0.996444372099736,1,13,regulation of protein polyubiquitination,BP,NMI
4971,GO:0010745,0.0870213411362288,0.99641799751141,1,13,negative regulation of macrophage derived foam cell differentiation,BP,ABCG1
7303,GO:0030205,0.0871725570309657,0.996405328731779,1,13,dermatan sulfate metabolic process,BP,IDUA
9408,GO:0034374,0.0872955263119286,0.996419344479946,1,12,low-density lipoprotein particle remodeling,BP,ABCG1
5075,GO:0010885,0.0875535027622237,0.996373310822386,1,13,regulation of cholesterol storage,BP,ABCG1
5986,GO:0016556,0.0875639728955617,0.996396914015553,1,12,mRNA modification,BP,PUS1
7820,GO:0031227,0.0879231883899411,0.978934718307686,3,142,intrinsic component of endoplasmic reticulum membrane,CC,DPM3;DHCR7;ELOVL6
9691,GO:0035112,0.0879569578666333,0.996339240967208,1,13,genitalia morphogenesis,BP,RBP4
13996,GO:0051289,0.088125324283873,0.986537580971957,2,69,protein homotetramerization,BP,PCBD1;DECR1
3223,GO:0006487,0.0886072466599318,0.986429928904376,2,67,protein N-linked glycosylation,BP,ALG5;DPM3
16087,GO:0070696,0.0886187705839964,0.996282997256827,1,13,transmembrane receptor protein serine/threonine kinase binding,MF,PYCARD
6762,GO:0019904,0.0888782414749703,0.959482430650696,8,652,protein domain specific binding,MF,TH;FADD;TRADD;EBF1;PYCARD;NOL3;WBP1;RPH3AL
14173,GO:0051607,0.0889079177749439,0.972815172926988,4,231,defense response to virus,BP,FADD;PYCARD;TICAM1;RNASEL
8972,GO:0033162,0.0889106419211547,0.996283297442743,1,12,melanosome membrane,CC,TH
11964,GO:0045009,0.0889106419211547,0.996283297442743,1,12,chitosome,CC,TH
10956,GO:0042632,0.0889952263153032,0.986332477245204,2,68,cholesterol homeostasis,BP,ABCG1;FABP3
14611,GO:0055092,0.0889952263153032,0.986332477245204,2,68,sterol homeostasis,BP,ABCG1;FABP3
3887,GO:0007638,0.0890498892593134,0.996224421362985,1,14,mechanosensory behavior,BP,SLC1A3
12276,GO:0045651,0.0891356359534091,0.996238763293667,1,13,positive regulation of macrophage differentiation,BP,FADD
14047,GO:0051384,0.0892102610540008,0.978493275222186,3,144,response to glucocorticoid,BP,TH;STAR;S100B
5744,GO:0016052,0.0892382406702805,0.978480370940864,3,146,carbohydrate catabolic process,BP,GALT;HEXB;DERA
11838,GO:0044548,0.0893114294834208,0.996223656976329,1,13,S100 protein binding,MF,S100B
973,GO:0002275,0.0895790243204066,0.961551201574016,7,524,myeloid cell activation involved in immune response,BP,PNP;PYCARD;TICAM1;HEXB;IDH1;GLA;DERA
10234,GO:0036109,0.0897165267412432,0.996188726814902,1,13,alpha-linolenic acid metabolic process,BP,FADS1
19332,GO:1902882,0.0897204789644787,0.986153243579534,2,69,regulation of response to oxidative stress,BP,RGN;NOL3
1213,GO:0002693,0.0897990763943885,0.996181588428209,1,13,positive regulation of cellular extravasation,BP,FADD
3503,GO:0006878,0.0899003780260115,0.996172819040461,1,13,cellular copper ion homeostasis,BP,SLC31A2
11107,GO:0042976,0.0901128357300971,0.996154393382933,1,13,activation of Janus kinase activity,BP,GHR
15922,GO:0070402,0.0903052590491322,0.996137665707353,1,13,NADPH binding,MF,DECR1
1284,GO:0002793,0.0904594277744701,0.972177248611205,4,232,positive regulation of peptide secretion,BP,PYCARD;RBP4;ANG;RPH3AL
21671,GO:2001275,0.0908298748824581,0.996069292471611,1,14,positive regulation of glucose import in response to insulin stimulus,BP,RNASEL
15925,GO:0070405,0.0911030636587119,0.985820920957018,2,68,ammonium ion binding,MF,TH;APOC1
17449,GO:0090195,0.0911367891789935,0.996064947252674,1,13,chemokine secretion,BP,PYCARD
12864,GO:0046902,0.0912282479650607,0.985786184456029,2,69,regulation of mitochondrial membrane permeability,BP,ACAA2;NOL3
5310,GO:0014889,0.0913680730182066,0.996044596332559,1,13,muscle atrophy,BP,NOL3
11810,GO:0044445,0.0914099184453755,0.971789000394086,4,228,cytosolic part,CC,FADD;PYCARD;TICAM1;CASP4
5445,GO:0015245,0.0916105216652324,0.996023204651487,1,13,fatty acid transporter activity,MF,FABP3
4535,GO:0009313,0.0923971820965953,0.995953384647183,1,13,oligosaccharide catabolic process,BP,HEXB
5065,GO:0010875,0.0930211722643183,0.995873873662136,1,14,positive regulation of cholesterol efflux,BP,ABCG1
4702,GO:0009982,0.0931630941563664,0.995884801238799,1,13,pseudouridine synthase activity,MF,PUS1
5693,GO:0015929,0.0931788752438065,0.995883381845821,1,13,hexosaminidase activity,MF,HEXB
6443,GO:0018904,0.0934909191516193,0.995855263692565,1,13,ether metabolic process,BP,PLA2G16
4569,GO:0009437,0.0935528979075008,0.995849667004361,1,13,carnitine metabolic process,BP,CPT1C
15753,GO:0070129,0.0935711200033207,0.995848020802719,1,13,regulation of mitochondrial translation,BP,TSFM
12589,GO:0046323,0.0936733751897058,0.985163449136465,2,74,glucose import,BP,RNASEL;HNF1A
17806,GO:0097200,0.0938017489817412,0.995827156319411,1,13,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP4
2566,GO:0005313,0.0939759844137046,0.995787187180922,1,14,L-glutamate transmembrane transporter activity,MF,SLC1A3
5402,GO:0015172,0.0939759844137046,0.995787187180922,1,14,acidic amino acid transmembrane transporter activity,MF,SLC1A3
17322,GO:0089711,0.0939759844137046,0.995787187180922,1,14,L-glutamate transmembrane transport,BP,SLC1A3
21248,GO:2000484,0.0940268752280099,0.995806737372862,1,13,positive regulation of interleukin-8 secretion,BP,PYCARD
6725,GO:0019841,0.094156399298376,0.995794966129066,1,13,retinol binding,MF,RBP4
10952,GO:0042627,0.0943490879208628,0.99577742279204,1,13,chylomicron,CC,APOC1
6199,GO:0016918,0.0943639544548179,0.995776067695086,1,13,retinal binding,MF,RBP4
12004,GO:0045073,0.094475872928371,0.995765858997253,1,13,regulation of chemokine biosynthetic process,BP,TICAM1
4565,GO:0009415,0.094704504295119,0.995720417200141,1,14,response to water,BP,TH
10667,GO:0042129,0.0950589721975398,0.976461816298336,3,147,regulation of T cell proliferation,BP,FADD;PNP;PYCARD
9723,GO:0035240,0.0950979045165332,0.995708887209631,1,13,dopamine binding,MF,TH
12372,GO:0045833,0.095139169995661,0.984808690939717,2,71,negative regulation of lipid metabolic process,BP,APOC1;ACADVL
3554,GO:0006954,0.0953835837320628,0.955853700254813,8,635,inflammatory response,BP,CFB;PYCARD;TICAM1;PXK;NMI;AOX1;SHPK;CASP4
2772,GO:0005758,0.0955668973634229,0.984714072544441,2,68,mitochondrial intermembrane space,CC,HSD3B2;STAR
10933,GO:0042592,0.0955866400132797,0.943918421900702,16,1571,homeostatic process,BP,PDK4;TH;SLC31A2;FADD;ABCG1;BDH2;ACADVL;RGN;RBP4;ANG;HEXB;FABP3;NOL3;STAR;RPH3AL;HNF1A
21179,GO:2000377,0.0960945227064235,0.976091768641386,3,150,regulation of reactive oxygen species metabolic process,BP,RGN;TICAM1;GLA
14883,GO:0060347,0.0962442891958867,0.995577501617999,1,14,heart trabecula formation,BP,RBP4
11186,GO:0043092,0.0965164491000429,0.995529897784011,1,15,L-amino acid import,BP,SLC1A3
8786,GO:0032868,0.0965401009714666,0.969630275471488,4,244,response to insulin,BP,PDK4;RNASEL;FABP3;STAR
13241,GO:0048477,0.0966066017938559,0.984434481971311,2,72,oogenesis,BP,ANG;HEXB
11530,GO:0043650,0.0969606964429006,0.995510177830567,1,14,dicarboxylic acid biosynthetic process,BP,SLC1A3
7311,GO:0030214,0.0969908647797991,0.995507331206219,1,14,hyaluronan catabolic process,BP,HEXB
3557,GO:0006957,0.0971129083854297,0.995495805860166,1,14,complement activation, alternative pathway,BP,CFB
18606,GO:1900409,0.0975427325871784,0.995455092831969,1,14,positive regulation of cellular response to oxidative stress,BP,RGN
7681,GO:0030949,0.0979026972950058,0.995398120500452,1,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
6076,GO:0016722,0.0979328793096662,0.99539522928681,1,15,oxidoreductase activity, oxidizing metal ions,MF,ETFDH
14924,GO:0060397,0.0983136171835096,0.995358676480877,1,15,JAK-STAT cascade involved in growth hormone signaling pathway,BP,GHR
2759,GO:0005741,0.0985941035586927,0.97519856863055,3,153,mitochondrial outer membrane,CC,CPT1C;IFI27;CYB5A
3375,GO:0006677,0.0991286564383782,0.995303227930061,1,14,glycosylceramide metabolic process,BP,GLA
4727,GO:0010042,0.0994000196433016,0.995253551182452,1,15,response to manganese ion,BP,TH
5302,GO:0014874,0.0994181387933653,0.995251787524869,1,15,response to stimulus involved in regulation of muscle adaptation,BP,NOL3
2981,GO:0006086,0.0996865053538759,0.995225625777955,1,15,acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
16347,GO:0071236,0.0997312238846885,0.995221259130251,1,15,cellular response to antibiotic,BP,STAR
2645,GO:0005521,0.0997946755963088,0.995215059678592,1,15,lamin binding,MF,IFI27
2780,GO:0005766,0.0998789629595738,0.974741577090341,3,151,primary lysosome,CC,PYCARD;HEXB;GLA
10924,GO:0042582,0.0998789629595738,0.974741577090341,3,151,azurophil granule,CC,PYCARD;HEXB;GLA
16110,GO:0070742,0.0999080907778109,0.995203968224297,1,15,C2H2 zinc finger domain binding,MF,EBF1
10935,GO:0042594,0.100075309613331,0.974662299329734,3,156,response to starvation,BP,PDK4;FADS1;ACAT1
12313,GO:0045723,0.100165173991655,0.995202571889611,1,14,positive regulation of fatty acid biosynthetic process,BP,RGN
12602,GO:0046339,0.100414380718968,0.995154292831905,1,15,diacylglycerol metabolic process,BP,ANG
746,GO:0001916,0.10042418663484,0.995177246042616,1,14,positive regulation of T cell mediated cytotoxicity,BP,FADD
7357,GO:0030280,0.100628735306809,0.995157196632481,1,14,structural constituent of epidermis,MF,KRT10
548,GO:0001608,0.100678952819943,0.995152267814627,1,14,G-protein coupled nucleotide receptor activity,MF,P2RY14
9921,GO:0035589,0.100678952819943,0.995152267814627,1,14,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,P2RY14
11976,GO:0045028,0.100678952819943,0.995152267814627,1,14,G-protein coupled purinergic nucleotide receptor activity,MF,P2RY14
8611,GO:0032602,0.100830068717513,0.983345833092981,2,73,chemokine production,BP,PYCARD;TICAM1
5068,GO:0010878,0.101053406427151,0.995091214166492,1,15,cholesterol storage,BP,ABCG1
5868,GO:0016307,0.101066457298242,0.995068731065695,1,16,phosphatidylinositol phosphate kinase activity,MF,ZFYVE21
17628,GO:0090559,0.101202147601306,0.983244755954266,2,74,regulation of membrane permeability,BP,ACAA2;NOL3
4273,GO:0008656,0.101255634153238,0.995071163820373,1,15,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,PYCARD
10619,GO:0042033,0.101571577822052,0.995064222340448,1,14,chemokine biosynthetic process,BP,TICAM1
17616,GO:0090533,0.102276155475816,0.994969333607002,1,15,cation-transporting ATPase complex,CC,FXYD1
21475,GO:2000811,0.102652739402503,0.994909621809901,1,16,negative regulation of anoikis,BP,PDK4
8559,GO:0032515,0.103357038785368,0.994860299330507,1,15,negative regulation of phosphoprotein phosphatase activity,BP,RGN
18905,GO:1901700,0.103411973517739,0.93965913878786,15,1464,response to oxygen-containing compound,BP,PDK4;TH;FADD;PYCARD;MGST2;RGN;GHR;TICAM1;RBP4;RNASEL;SHPK;FABP3;CASP4;TFPI;STAR
528,GO:0001573,0.103470952595948,0.994848737427444,1,15,ganglioside metabolic process,BP,HEXB
14575,GO:0055022,0.103576496246889,0.994838013009885,1,15,negative regulation of cardiac muscle tissue growth,BP,RBP4
15378,GO:0061117,0.103576496246889,0.994838013009885,1,15,negative regulation of heart growth,BP,RBP4
7301,GO:0030203,0.10364465985796,0.973362328053374,3,159,glycosaminoglycan metabolic process,BP,EXTL1;IDUA;HEXB
18992,GO:1902001,0.104282076863453,0.99474345766171,1,16,fatty acid transmembrane transport,BP,CPT2
2658,GO:0005543,0.10452038205752,0.960977858026955,5,353,phospholipid binding,MF,APOC1;ABCG1;PXK;SNX21;RPH3AL
19334,GO:1902884,0.104570250284798,0.994736467385578,1,15,positive regulation of response to oxidative stress,BP,RGN
9746,GO:0035268,0.10461024619015,0.994709654113869,1,16,protein mannosylation,BP,DPM3
15855,GO:0070293,0.104757431581456,0.994717225267939,1,15,renal absorption,BP,HNF1A
1643,GO:0003746,0.104806027205454,0.9947122236942,1,15,translation elongation factor activity,MF,TSFM
21535,GO:2001014,0.105375015477528,0.994630440346349,1,16,regulation of skeletal muscle cell differentiation,BP,S100B
14774,GO:0060192,0.105475662024062,0.99464305244878,1,15,negative regulation of lipase activity,BP,APOC1
16724,GO:0071871,0.105674996361584,0.994599201410041,1,16,response to epinephrine,BP,STAR
19010,GO:1902043,0.105825216642402,0.994583522562043,1,16,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
2985,GO:0006094,0.105901616362458,0.981997753421906,2,75,gluconeogenesis,BP,RBP4;MDH1
13557,GO:0050655,0.10629531266983,0.994534304630354,1,16,dermatan sulfate proteoglycan metabolic process,BP,IDUA
3428,GO:0006750,0.10642483498765,0.994544203707114,1,15,glutathione biosynthetic process,BP,MGST2
4269,GO:0008652,0.106531833609973,0.981828470584875,2,75,cellular amino acid biosynthetic process,BP,MRI1;SLC1A3
8422,GO:0032354,0.106599349819433,0.994502349218326,1,16,response to follicle-stimulating hormone,BP,STAR
11191,GO:0043101,0.106886291987456,0.994495806595729,1,15,purine-containing compound salvage,BP,PNP
2667,GO:0005576,0.107386489952088,0.924588517777071,39,4413,extracellular region,CC,CFB;IFI30;MSRA;APOC1;HSD17B11;PNP;BDH2;PYCARD;KRT10;ACAA2;GHR;FGF18;ETFB;RBP4;ANG;ACAT1;ACAT2;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;CASP4;PON2;IDH1;DECR1;MDP1;TFPI;PEPD;ACP5;GLA;ECI1;DERA;S100B;CYB5A;LYPLAL1;LINGO1
2984,GO:0006091,0.107536398026399,0.959518485417016,5,342,generation of precursor metabolites and energy,BP,ACADVL;ETFB;MDH1;IDH1;ETFDH
13797,GO:0051004,0.107817904566484,0.994397421432834,1,15,regulation of lipoprotein lipase activity,BP,APOC1
16003,GO:0070542,0.107894876724395,0.981447517773055,2,78,response to fatty acid,BP,PDK4;FABP3
5152,GO:0010984,0.108127663815863,0.994364507357366,1,15,regulation of lipoprotein particle clearance,BP,APOC1
12691,GO:0046527,0.108546272418698,0.994295419480221,1,16,glucosyltransferase activity,MF,ALG5
13636,GO:0050755,0.108612111416853,0.99431282995876,1,15,chemokine metabolic process,BP,TICAM1
7768,GO:0031100,0.109078531993305,0.981129437364345,2,77,animal organ regeneration,BP,RGN;NNMT
11184,GO:0043090,0.10911668435598,0.994212245218381,1,17,amino acid import,BP,SLC1A3
3552,GO:0006952,0.109225211820162,0.935731918951818,15,1444,defense response,BP,CFB;IFI30;FADD;PYCARD;PSMB10;TICAM1;PXK;RNASEL;NMI;AOX1;SHPK;CASP4;IFI27;STAR;S100B
7904,GO:0031347,0.109381953863236,0.947824657649857,8,661,regulation of defense response,BP,CFB;FADD;PYCARD;PSMB10;TICAM1;NMI;SHPK;CASP4
14592,GO:0055070,0.109499710749477,0.994192628923161,1,16,copper ion homeostasis,BP,SLC31A2
8763,GO:0032816,0.109968600572654,0.994141726630977,1,16,positive regulation of natural killer cell activation,BP,TICAM1
10885,GO:0042523,0.11000865823696,0.994137367264826,1,16,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,GHR
5056,GO:0010866,0.110333596776657,0.994101942596103,1,16,regulation of triglyceride biosynthetic process,BP,RGN
1754,GO:0003995,0.110627171613037,0.994069841479427,1,16,acyl-CoA dehydrogenase activity,MF,ACADVL
8204,GO:0031960,0.110932864658459,0.970654670642535,3,159,response to corticosteroid,BP,TH;STAR;S100B
1148,GO:0002577,0.111495064444157,0.993974409592946,1,16,regulation of antigen processing and presentation,BP,PYCARD
2939,GO:0006022,0.111552572029846,0.970411551854945,3,164,aminoglycan metabolic process,BP,EXTL1;IDUA;HEXB
4257,GO:0008625,0.111604896551088,0.980425959339279,2,79,extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD;TRADD
14773,GO:0060191,0.111690744205128,0.980402165412468,2,79,regulation of lipase activity,BP,APOC1;ANG
7485,GO:0030540,0.11181168702501,0.993916512272216,1,17,female genitalia development,BP,RBP4
6127,GO:0016805,0.11181399195507,0.993939141174464,1,16,dipeptidase activity,MF,PEPD
17455,GO:0090201,0.112277286660728,0.99388771662539,1,16,negative regulation of release of cytochrome c from mitochondria,BP,NOL3
9382,GO:0034341,0.112533802233396,0.970050573761058,3,158,response to interferon-gamma,BP,IFI30;NMI;STAR
1885,GO:0004197,0.112580729990999,0.980150649414852,2,80,cysteine-type endopeptidase activity,MF,PYCARD;CASP4
10838,GO:0042448,0.112675976518357,0.993843281493024,1,16,progesterone metabolic process,BP,CYP17A1
13165,GO:0048261,0.112817191893743,0.993804204169793,1,17,negative regulation of receptor-mediated endocytosis,BP,APOC1
46,GO:0000097,0.112867713356225,0.993821852037651,1,16,sulfur amino acid biosynthetic process,BP,MRI1
6569,GO:0019319,0.112872574233575,0.980077771419881,2,78,hexose biosynthetic process,BP,RBP4;MDH1
13272,GO:0048535,0.113314145975242,0.993771805884629,1,16,lymph node development,BP,FADD
15711,GO:0070064,0.113337239058296,0.993724802383425,1,18,proline-rich region binding,MF,GHR
2842,GO:0005865,0.113408912019387,0.993761155260792,1,16,striated muscle thin filament,CC,TMOD4
1293,GO:0002821,0.113427681380107,0.979922678974155,2,78,positive regulation of adaptive immune response,BP,FADD;PYCARD
9211,GO:0033866,0.113629826410791,0.993736290103528,1,16,nucleoside bisphosphate biosynthetic process,BP,ACAT1
9234,GO:0034030,0.113629826410791,0.993736290103528,1,16,ribonucleoside bisphosphate biosynthetic process,BP,ACAT1
9237,GO:0034033,0.113629826410791,0.993736290103528,1,16,purine nucleoside bisphosphate biosynthetic process,BP,ACAT1
7354,GO:0030277,0.113710632357925,0.993703512901923,1,17,maintenance of gastrointestinal epithelium,BP,RBP4
5589,GO:0015748,0.113725197250994,0.979822582668437,2,82,organophosphate ester transport,BP,APOC1;ABCG1
8210,GO:0031970,0.113824263796299,0.979820660524312,2,76,organelle envelope lumen,CC,HSD3B2;STAR
10263,GO:0036149,0.114096539272867,0.993683589101986,1,16,phosphatidylinositol acyl-chain remodeling,BP,PLA2G16
2789,GO:0005776,0.114100130910207,0.979717313461734,2,82,autophagosome,CC,TBC1D14;TICAM1
3454,GO:0006796,0.114138781838821,0.923401042010471,27,2984,phosphate-containing compound metabolic process,BP,PDK4;DPM3;ZFYVE21;MRAP;APOC1;PNP;PYCARD;PSMB10;RGN;FADS1;GHR;FGF18;NNMT;PLA2G16;RNASEL;ANG;ACAT1;SHPK;HEXB;FABP3;NUDT7;DEPTOR;MDH1;IDH1;MDP1;ACP5;DERA
5078,GO:0010888,0.114447221540411,0.993619861270042,1,17,negative regulation of lipid storage,BP,ABCG1
2374,GO:0004970,0.114576615665234,0.993564649143478,1,19,ionotropic glutamate receptor activity,MF,GRIA3
5005,GO:0010804,0.114690565987001,0.993616178233041,1,16,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,NOL3
12660,GO:0046475,0.115044482187358,0.993551609217834,1,17,glycerophospholipid catabolic process,BP,APOC1
6590,GO:0019372,0.115273088655751,0.993549709710649,1,16,lipoxygenase pathway,BP,PON2
2530,GO:0005234,0.115629555789783,0.99344317624702,1,19,extracellular-glutamate-gated ion channel activity,MF,GRIA3
10674,GO:0042136,0.116050306348711,0.993435810679754,1,17,neurotransmitter biosynthetic process,BP,TH
6588,GO:0019370,0.116120032115717,0.993452427547187,1,16,leukotriene biosynthetic process,BP,MGST2
12757,GO:0046651,0.116234322194084,0.96100142038518,4,253,lymphocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
3472,GO:0006825,0.11628500141566,0.993386638079666,1,18,copper ion transport,BP,SLC31A2
7392,GO:0030324,0.116301925359277,0.968588151850265,3,169,lung development,BP,FGF18;RBP4;DHCR7
10932,GO:0042590,0.116626692609889,0.979024451639683,2,77,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,IFI30;PSMB10
14619,GO:0055102,0.116627328835097,0.993393793510974,1,16,lipase inhibitor activity,MF,APOC1
17029,GO:0072376,0.11673860800017,0.978983417415708,2,79,protein activation cascade,BP,CFB;TFPI
15814,GO:0070233,0.116787345513436,0.993350272780518,1,17,negative regulation of T cell apoptotic process,BP,FADD
4927,GO:0010667,0.117273144257272,0.993293576242782,1,17,negative regulation of cardiac muscle cell apoptotic process,BP,NOL3
4373,GO:0009084,0.117438520169889,0.993274218142776,1,17,glutamine family amino acid biosynthetic process,BP,SLC1A3
11531,GO:0043651,0.117968812112191,0.993211947919466,1,17,linoleic acid metabolic process,BP,FADS1
19125,GO:1902307,0.118153713337609,0.993167453916292,1,18,positive regulation of sodium ion transmembrane transport,BP,FXYD1
16046,GO:0070613,0.118580850214006,0.978442837434357,2,82,regulation of protein processing,BP,CFB;NOL3
8840,GO:0032943,0.118718013527675,0.959869790506342,4,255,mononuclear cell proliferation,BP,FADD;PNP;PYCARD;TICAM1
480,GO:0001501,0.119084496895381,0.949080025442258,6,473,skeletal system development,BP,EBP;EXTL1;RGN;FGF18;RBP4;HEXB
3299,GO:0006577,0.119368821125207,0.993046106948395,1,17,amino-acid betaine metabolic process,BP,CPT1C
11542,GO:0043691,0.119891731495997,0.992983627045434,1,17,reverse cholesterol transport,BP,ABCG1
16429,GO:0071371,0.120069588303776,0.992938854625257,1,18,cellular response to gonadotropin stimulus,BP,STAR
5964,GO:0016505,0.1206123065237,0.992873382444426,1,18,peptidase activator activity involved in apoptotic process,MF,PYCARD
3526,GO:0006907,0.121037640850449,0.992821850006155,1,18,pinocytosis,BP,PYCARD
19547,GO:1903317,0.121052520918776,0.977722568992926,2,83,regulation of protein maturation,BP,CFB;NOL3
13087,GO:0048038,0.12181375839974,0.992751458063899,1,17,quinone binding,MF,ETFDH
14268,GO:0051797,0.122249311545988,0.992673980697207,1,18,regulation of hair follicle development,BP,TRADD
9837,GO:0035455,0.122305696093793,0.992667061201927,1,18,response to interferon-alpha,BP,STAR
7391,GO:0030323,0.122449974833325,0.966179962963677,3,173,respiratory tube development,BP,FGF18;RBP4;DHCR7
10841,GO:0042454,0.122821267533682,0.992628174857206,1,17,ribonucleoside catabolic process,BP,PNP
21669,GO:2001273,0.122938350867135,0.992567191678638,1,19,regulation of glucose import in response to insulin stimulus,BP,RNASEL
161,GO:0000313,0.123169497123843,0.977125323071725,2,78,organellar ribosome,CC,MRPL14;MRPL16
2775,GO:0005761,0.123169497123843,0.977125323071725,2,78,mitochondrial ribosome,CC,MRPL14;MRPL16
4773,GO:0010288,0.123369032699279,0.992535927715957,1,18,response to lead ion,BP,STAR
11026,GO:0042762,0.123513574610052,0.992495806218542,1,19,regulation of sulfur metabolic process,BP,PDK4
13813,GO:0051023,0.12367239047726,0.992523178372831,1,17,regulation of immunoglobulin secretion,BP,RBP4
21181,GO:2000379,0.12408581672015,0.976826940062271,2,84,positive regulation of reactive oxygen species metabolic process,BP,RGN;TICAM1
8409,GO:0032332,0.124105756319646,0.992421942608889,1,19,positive regulation of chondrocyte differentiation,BP,FGF18
21543,GO:2001026,0.12433535056626,0.992393202976786,1,19,regulation of endothelial cell chemotaxis,BP,FGF18
13969,GO:0051251,0.124606712838777,0.957148580212194,4,261,positive regulation of lymphocyte activation,BP,FADD;PNP;PYCARD;TICAM1
8437,GO:0032373,0.125246854923998,0.992278541835342,1,19,positive regulation of sterol transport,BP,ABCG1
8440,GO:0032376,0.125246854923998,0.992278541835342,1,19,positive regulation of cholesterol transport,BP,ABCG1
6168,GO:0016874,0.125844846483303,0.964834998171516,3,170,ligase activity,MF,ACSF2;ACSM5;ACAT1
7937,GO:0031418,0.126025748031831,0.992202964617785,1,18,L-ascorbic acid binding,MF,PHYH
6085,GO:0016740,0.126367513540628,0.91795191324535,21,2269,transferase activity,MF,PDK4;ALG5;DPM3;ZFYVE21;EXTL1;PNP;ACAA2;MGST2;ACSM5;FGF18;NNMT;CPT2;PLA2G16;GALT;RNASEL;ACAT1;ACAT2;SHPK;HEXB;CPT1C;ELOVL6
3971,GO:0008154,0.12676387723008,0.964458958004265,3,174,actin polymerization or depolymerization,BP,PYCARD;ANG;TMOD4
2692,GO:0005605,0.126985978448015,0.992017055458324,1,21,basal lamina,CC,ANG
14870,GO:0060333,0.127050491556361,0.975942492504857,2,84,interferon-gamma-mediated signaling pathway,BP,IFI30;NMI
703,GO:0001848,0.12724770238342,0.992023691020731,1,19,complement binding,MF,CFB
3158,GO:0006399,0.127421470747155,0.964209910744446,3,166,tRNA metabolic process,BP,LAGE3;HSD17B10;PUS1
13669,GO:0050801,0.128125422934307,0.936664638252266,8,698,ion homeostasis,BP,PDK4;SLC31A2;ABCG1;BDH2;RGN;HEXB;FABP3;NOL3
496,GO:0001522,0.128144153539414,0.991931999024583,1,18,pseudouridine synthesis,BP,PUS1
3551,GO:0006950,0.12831232272483,0.910864401045733,31,3506,response to stress,BP,CFB;PDK4;IFI30;TH;MSRA;FADD;PYCARD;ACADVL;ACAA2;PSMB10;RGN;FADS1;TICAM1;PXK;RNASEL;ANG;NMI;ACAT1;AOX1;SHPK;NOL3;CASP4;IFI27;PON2;FAM46A;IDH1;TFPI;STAR;S100B;SLC1A3;ETFDH
14814,GO:0060261,0.128415631676067,0.99187292143899,1,19,positive regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
5094,GO:0010906,0.128589468741225,0.975456740550169,2,89,regulation of glucose metabolic process,BP,PDK4;RGN
2123,GO:0004622,0.128987652872707,0.991798537409681,1,19,lysophospholipase activity,MF,LYPLAL1
3014,GO:0006144,0.129005885075287,0.991796160691137,1,19,purine nucleobase metabolic process,BP,AOX1
10884,GO:0042522,0.129023211615101,0.991793901697996,1,19,regulation of tyrosine phosphorylation of Stat5 protein,BP,GHR
14220,GO:0051707,0.129023496938315,0.93323662962495,9,790,response to other organism,BP,TH;FADD;PYCARD;MGST2;TICAM1;RNASEL;SHPK;TFPI;STAR
17160,GO:0072676,0.129031025813735,0.975349044161066,2,83,lymphocyte migration,BP,FADD;PYCARD
16946,GO:0072234,0.129147394359141,0.991755858797716,1,20,metanephric nephron tubule development,BP,ACAT1
14693,GO:0060065,0.129149833635879,0.991755539588874,1,20,uterus development,BP,RBP4
16421,GO:0071356,0.129165797001608,0.955013279868899,4,260,cellular response to tumor necrosis factor,BP,TRADD;PYCARD;PSMB10;NOL3
4517,GO:0009264,0.12923199850421,0.991790962636272,1,18,deoxyribonucleotide catabolic process,BP,DERA
9541,GO:0034655,0.129349533781258,0.948498845536323,5,364,nucleobase-containing compound catabolic process,BP,PNP;RGN;GALT;NUDT7;DERA
13113,GO:0048148,0.129465273994197,0.991736156134034,1,19,behavioral response to cocaine,BP,FADD
19404,GO:1903010,0.12955858572868,0.991723939848964,1,19,regulation of bone development,BP,RGN
11262,GO:0043207,0.129650578687748,0.932842822453842,9,791,response to external biotic stimulus,BP,TH;FADD;PYCARD;MGST2;TICAM1;RNASEL;SHPK;TFPI;STAR
7812,GO:0031210,0.13005544740361,0.991658731495006,1,19,phosphatidylcholine binding,MF,APOC1
13792,GO:0050997,0.13005544740361,0.991658731495006,1,19,quaternary ammonium group binding,MF,APOC1
10344,GO:0036379,0.130225827642678,0.991636308785359,1,19,myofilament,CC,TMOD4
10649,GO:0042098,0.130666302098855,0.962885577857214,3,171,T cell proliferation,BP,FADD;PNP;PYCARD
19055,GO:1902176,0.131685422652436,0.991442923221946,1,19,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,NOL3
5064,GO:0010874,0.131844780304546,0.991398903323485,1,20,regulation of cholesterol efflux,BP,ABCG1
16463,GO:0071417,0.13209318431527,0.941901036201106,6,491,cellular response to organonitrogen compound,BP,PDK4;TH;GHR;RNASEL;CASP4;STAR
13977,GO:0051259,0.132177788649852,0.941860456790951,6,478,protein oligomerization,BP,TRADD;HACL1;ACAT1;NOL3;PCBD1;DECR1
5444,GO:0015238,0.133310277867297,0.991201631035838,1,20,drug transmembrane transporter activity,MF,EBP
9395,GO:0034361,0.133399171330764,0.991212895093027,1,19,very-low-density lipoprotein particle,CC,APOC1
9418,GO:0034385,0.133399171330764,0.991212895093027,1,19,triglyceride-rich plasma lipoprotein particle,CC,APOC1
17461,GO:0090208,0.133533512000503,0.99119472747071,1,19,positive regulation of triglyceride metabolic process,BP,RGN
944,GO:0002218,0.133601092871176,0.952893335266208,4,271,activation of innate immune response,BP,FADD;PYCARD;PSMB10;TICAM1
5674,GO:0015908,0.133626303902583,0.973916087194769,2,88,fatty acid transport,BP,CPT2;FABP3
21452,GO:2000778,0.133831786597944,0.991154319562199,1,19,positive regulation of interleukin-6 secretion,BP,PYCARD
980,GO:0002283,0.134000965071547,0.940839714834174,6,474,neutrophil activation involved in immune response,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
11337,GO:0043312,0.134000965071547,0.940839714834174,6,474,neutrophil degranulation,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
16174,GO:0070887,0.134139452864821,0.91002477899342,24,2645,cellular response to chemical stimulus,BP,PDK4;IFI30;TH;FADD;TRADD;PYCARD;ACADVL;ACAA2;MGST2;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;NMI;SHPK;CMBL;NOL3;CASP4;IFI27;TFPI;STAR;S100B
13790,GO:0050995,0.134363993030161,0.991058334015886,1,20,negative regulation of lipid catabolic process,BP,APOC1
12274,GO:0045649,0.134440673987264,0.991047858436896,1,20,regulation of macrophage differentiation,BP,FADD
18771,GO:1901338,0.134786746745748,0.991024293814353,1,19,catecholamine binding,MF,TH
16066,GO:0070661,0.13498740729087,0.952232336385816,4,268,leukocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
9410,GO:0034377,0.135029302087699,0.990967229402365,1,20,plasma lipoprotein particle assembly,BP,APOC1
4924,GO:0010664,0.135134024479028,0.990952844862996,1,20,negative regulation of striated muscle cell apoptotic process,BP,NOL3
11774,GO:0044381,0.135314631076927,0.990906317336782,1,21,glucose import in response to insulin stimulus,BP,RNASEL
12621,GO:0046386,0.135510205094698,0.990925123632405,1,19,deoxyribose phosphate catabolic process,BP,DERA
19355,GO:1902932,0.135721344157688,0.990871947955139,1,20,positive regulation of alcohol biosynthetic process,BP,ABCG1
11736,GO:0044321,0.135868526984612,0.990851615680486,1,20,response to leptin,BP,STAR
5859,GO:0016289,0.135953089759985,0.990864130635307,1,19,CoA hydrolase activity,MF,NUDT7
4235,GO:0008585,0.136374560664089,0.973044433049232,2,91,female gonad development,BP,ANG;IDH1
10784,GO:0042359,0.136673251455515,0.990740027205274,1,20,vitamin D metabolic process,BP,CYP11A1
10663,GO:0042119,0.136790547801428,0.939264579623502,6,477,neutrophil activation,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
4616,GO:0009651,0.136893608470379,0.990709346696142,1,20,response to salt stress,BP,TH
11233,GO:0043168,0.136916565045268,0.908607622739812,23,2575,anion binding,MF,PDK4;PHYH;TH;APOC1;ACSF2;PNP;ABCG1;ACADVL;ACSM5;PXK;HACL1;RNASEL;ANG;AOX1;SHPK;FABP3;ACCS;DECR1;LDHD;SNX21;RPH3AL;SLC1A3;ETFDH
13596,GO:0050699,0.136961970649759,0.990677594674111,1,21,WW domain binding,MF,WBP1
8644,GO:0032647,0.137973064586448,0.990535727504843,1,21,regulation of interferon-alpha production,BP,NMI
16412,GO:0071347,0.138148452542816,0.972497594873967,2,88,cellular response to interleukin-1,BP,PYCARD;TFPI
5539,GO:0015645,0.138192449345943,0.990527420761164,1,20,fatty acid ligase activity,MF,ACSM5
11117,GO:0042987,0.138501052159997,0.990461196286221,1,21,amyloid precursor protein catabolic process,BP,ABCG1
11840,GO:0044550,0.138556667805082,0.990453327585046,1,21,secondary metabolite biosynthetic process,BP,BDH2
3869,GO:0007613,0.138907979183685,0.972226269464575,2,95,memory,BP,TH;S100B
4622,GO:0009713,0.13893746449459,0.990422228333009,1,20,catechol-containing compound biosynthetic process,BP,TH
10822,GO:0042423,0.13893746449459,0.990422228333009,1,20,catecholamine biosynthetic process,BP,TH
12019,GO:0045088,0.139531568574254,0.943124211457914,5,377,regulation of innate immune response,BP,FADD;PYCARD;PSMB10;TICAM1;NMI
7923,GO:0031398,0.139561800096262,0.959192172266194,3,176,positive regulation of protein ubiquitination,BP,PSMB10;TICAM1;NMI
14923,GO:0060396,0.139610958742985,0.990282527847718,1,22,growth hormone receptor signaling pathway,BP,GHR
15751,GO:0070126,0.140407180689413,0.97179265636723,2,85,mitochondrial translational termination,BP,MRPL14;MRPL16
2062,GO:0004540,0.140810430083084,0.971639427001833,2,90,ribonuclease activity,MF,RNASEL;ANG
3488,GO:0006855,0.141139937159307,0.99006261364676,1,22,drug transmembrane transport,BP,EBP
2629,GO:0005496,0.141595030251561,0.971382667234312,2,91,steroid binding,MF,ABCG1;STAR
16895,GO:0072170,0.141652697203594,0.989988281266733,1,22,metanephric tubule development,BP,ACAT1
12836,GO:0046854,0.141657125730626,0.971341444906399,2,96,phosphatidylinositol phosphorylation,BP,ZFYVE21;FGF18
10285,GO:0036230,0.141953719632198,0.936323083032788,6,482,granulocyte activation,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
858,GO:0002063,0.1421070768245,0.989902317665399,1,23,chondrocyte development,BP,FGF18
483,GO:0001504,0.14214719582398,0.989916319124525,1,22,neurotransmitter uptake,BP,SLC1A3
519,GO:0001556,0.142699180156577,0.989857596577563,1,21,oocyte maturation,BP,ANG
13302,GO:0048596,0.143016602384043,0.989769033361269,1,23,embryonic camera-type eye morphogenesis,BP,TH
13058,GO:0048002,0.143433867576527,0.957548651814571,3,178,antigen processing and presentation of peptide antigen,BP,IFI30;PYCARD;PSMB10
1103,GO:0002495,0.143543969518893,0.970743249492021,2,93,antigen processing and presentation of peptide antigen via MHC class II,BP,IFI30;PYCARD
16490,GO:0071456,0.143844813178035,0.957367304483734,3,181,cellular response to hypoxia,BP,ACAA2;PSMB10;S100B
10264,GO:0036150,0.143917986706613,0.989678693371103,1,21,phosphatidylserine acyl-chain remodeling,BP,PLA2G16
13744,GO:0050905,0.144355183241631,0.970462234883028,2,97,neuromuscular process,BP,HEXB;SLC1A3
2106,GO:0004602,0.144430670394743,0.989627659211908,1,20,glutathione peroxidase activity,MF,MGST2
11141,GO:0043014,0.144457601724476,0.989576486927711,1,22,alpha-tubulin binding,MF,FAM110C
14123,GO:0051537,0.144466302031024,0.989597669362833,1,21,2 iron, 2 sulfur cluster binding,MF,AOX1
6448,GO:0018958,0.14453657390564,0.970419948582,2,93,phenol-containing compound metabolic process,BP,TH;STAR
8616,GO:0032607,0.144730513893082,0.989535951759101,1,22,interferon-alpha production,BP,NMI
14613,GO:0055094,0.144914375367218,0.989508596248221,1,22,response to lipoprotein particle,BP,ABCG1
4361,GO:0009067,0.144957441662053,0.989524809772911,1,21,aspartate family amino acid biosynthetic process,BP,MRI1
1107,GO:0002504,0.145614164031103,0.970062946402033,2,94,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,IFI30;PYCARD
744,GO:0001914,0.145646580960507,0.989422123922164,1,21,regulation of T cell mediated cytotoxicity,BP,FADD
21246,GO:2000482,0.145742383197477,0.98940780687904,1,21,regulation of interleukin-8 secretion,BP,PYCARD
1079,GO:0002446,0.145939909157366,0.93402887612606,6,486,neutrophil mediated immunity,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
18209,GO:0098869,0.146164302477741,0.969900638908595,2,90,cellular oxidant detoxification,BP,MGST2;RGN
7484,GO:0030539,0.146298648960277,0.989301426693365,1,22,male genitalia development,BP,HSD17B3
9767,GO:0035308,0.146306437200651,0.989300255048694,1,22,negative regulation of protein dephosphorylation,BP,RGN
21062,GO:2000209,0.146365658088008,0.989270285897497,1,23,regulation of anoikis,BP,PDK4
11869,GO:0044708,0.146404352678044,0.939409914883267,5,396,single-organism behavior,BP,TH;FADD;STAR;S100B;SLC1A3
16952,GO:0072243,0.146474186851697,0.989253913581168,1,23,metanephric nephron epithelium development,BP,ACAT1
12702,GO:0046545,0.146478599544028,0.969774499771259,2,95,development of primary female sexual characteristics,BP,ANG;IDH1
13615,GO:0050718,0.146485851032239,0.989273245661844,1,22,positive regulation of interleukin-1 beta secretion,BP,PYCARD
1379,GO:0003006,0.146486431911485,0.929121968708458,7,607,developmental process involved in reproduction,BP,HSD17B3;RBP4;CYP17A1;ANG;HEXB;IDH1;STAR
13672,GO:0050804,0.146587728713798,0.946539250965061,4,292,modulation of synaptic transmission,BP,PXK;STAR;S100B;SLC1A3
10706,GO:0042219,0.146735127013817,0.989258844398814,1,21,cellular modified amino acid catabolic process,BP,SARDH
5622,GO:0015813,0.14705188173396,0.989166542067232,1,23,L-glutamate transport,BP,SLC1A3
12733,GO:0046621,0.147479303826711,0.989101657105734,1,23,negative regulation of organ growth,BP,RBP4
550,GO:0001614,0.147976517998441,0.98907102265533,1,21,purinergic nucleotide receptor activity,MF,P2RY14
5961,GO:0016502,0.147976517998441,0.98907102265533,1,21,nucleotide receptor activity,MF,P2RY14
586,GO:0001676,0.148098695539777,0.9692527110687,2,92,long-chain fatty acid metabolic process,BP,FADS1;ELOVL6
5163,GO:0010996,0.148353174453172,0.988968360590775,1,23,response to auditory stimulus,BP,SLC1A3
8432,GO:0032368,0.14849807063895,0.969106565475582,2,95,regulation of lipid transport,BP,APOC1;ABCG1
4367,GO:0009074,0.148795731843442,0.988946131802445,1,21,aromatic amino acid family catabolic process,BP,PCBD1
13191,GO:0048305,0.148824595472973,0.988941717777607,1,21,immunoglobulin secretion,BP,RBP4
5329,GO:0015012,0.14883065939764,0.988875209820499,1,24,heparan sulfate proteoglycan biosynthetic process,BP,EXTL1
10872,GO:0042506,0.149253983321149,0.988851954331186,1,22,tyrosine phosphorylation of Stat5 protein,BP,GHR
4388,GO:0009110,0.149412809782802,0.988827521281022,1,22,vitamin biosynthetic process,BP,RGN
2121,GO:0004620,0.149432105278121,0.968795662635193,2,95,phospholipase activity,MF,PLA2G16;LYPLAL1
8646,GO:0032649,0.149632508499168,0.968742592741766,2,92,regulation of interferon-gamma production,BP,FADD;PYCARD
18156,GO:0098773,0.149647222631298,0.968723882054019,2,95,skin epidermis development,BP,TRADD;KRT10
14036,GO:0051354,0.149740304854492,0.988777051672389,1,22,negative regulation of oxidoreductase activity,BP,GLA
2825,GO:0005839,0.149784002101487,0.988794467485982,1,21,proteasome core complex,CC,PSMB10
19927,GO:1904064,0.151036669948383,0.968245530707602,2,98,positive regulation of cation transmembrane transport,BP,RGN;FXYD1
20863,GO:1990748,0.151096611726889,0.968252525509695,2,92,cellular detoxification,BP,MGST2;RGN
18055,GO:0098533,0.151121055164853,0.988540492575214,1,23,ATPase dependent transmembrane transport complex,CC,FXYD1
4381,GO:0009100,0.151121720714683,0.93683435754449,5,396,glycoprotein metabolic process,BP,ALG5;DPM3;EXTL1;IDUA;HEXB
143,GO:0000287,0.151596411691133,0.953997573564169,3,190,magnesium ion binding,MF,HACL1;NUDT7;IDH1
17601,GO:0090484,0.151742189100832,0.988443290073919,1,23,drug transporter activity,MF,EBP
17855,GO:0097305,0.152001369968666,0.953826005625871,3,187,response to alcohol,BP,TH;RBP4;STAR
9511,GO:0034612,0.152120299202977,0.943787938246105,4,278,response to tumor necrosis factor,BP,TRADD;PYCARD;PSMB10;NOL3
14579,GO:0055026,0.152137915810757,0.988381135010704,1,23,negative regulation of cardiac muscle tissue development,BP,RBP4
1889,GO:0004298,0.152204417754106,0.988418390811896,1,21,threonine-type endopeptidase activity,MF,PSMB10
15682,GO:0070003,0.152204417754106,0.988418390811896,1,21,threonine-type peptidase activity,MF,PSMB10
2706,GO:0005640,0.152577928516035,0.988311816575229,1,23,nuclear outer membrane,CC,DHCR7
8787,GO:0032869,0.152713161571235,0.953505624519958,3,191,cellular response to insulin stimulus,BP,PDK4;RNASEL;STAR
15674,GO:0065005,0.153108922114968,0.988227874062592,1,23,protein-lipid complex assembly,BP,APOC1
9922,GO:0035590,0.153179811923011,0.988239708065069,1,22,purinergic nucleotide receptor signaling pathway,BP,P2RY14
1092,GO:0002474,0.153213721863551,0.967533616191989,2,93,antigen processing and presentation of peptide antigen via MHC class I,BP,IFI30;PSMB10
1211,GO:0002691,0.153369536601095,0.988186558058753,1,23,regulation of cellular extravasation,BP,FADD
5743,GO:0016051,0.153516232715375,0.953162146949596,3,186,carbohydrate biosynthetic process,BP,RGN;RBP4;MDH1
963,GO:0002252,0.153958153639814,0.91182697230586,11,1065,immune effector process,BP,CFB;FADD;PNP;PYCARD;TICAM1;RBP4;RNASEL;HEXB;IDH1;GLA;DERA
6611,GO:0019430,0.153993355286651,0.988110660730069,1,22,removal of superoxide radicals,BP,RGN
16433,GO:0071375,0.154305194183195,0.942665657204059,4,293,cellular response to peptide hormone stimulus,BP,PDK4;GHR;RNASEL;STAR
16,GO:0000030,0.154556166794287,0.987997466805849,1,23,mannosyltransferase activity,MF,DPM3
10301,GO:0036294,0.154621703087849,0.952670097853136,3,188,cellular response to decreased oxygen levels,BP,ACAA2;PSMB10;S100B
9721,GO:0035235,0.156389329363204,0.987641210580653,1,26,ionotropic glutamate receptor signaling pathway,BP,GRIA3
15030,GO:0060541,0.156468298496332,0.951839179151325,3,194,respiratory system development,BP,FGF18;RBP4;DHCR7
10620,GO:0042035,0.156509668033163,0.966390113516959,2,97,regulation of cytokine biosynthetic process,BP,TICAM1;NMI
20320,GO:1904949,0.156725062856449,0.987625600146724,1,24,ATPase complex,CC,FXYD1
5610,GO:0015800,0.15749150156403,0.987479963838495,1,25,acidic amino acid transport,BP,SLC1A3
18901,GO:1901685,0.157704312682044,0.98751252087876,1,22,glutathione derivative metabolic process,BP,MGST2
18902,GO:1901687,0.157704312682044,0.98751252087876,1,22,glutathione derivative biosynthetic process,BP,MGST2
11163,GO:0043043,0.158032392991269,0.922048195090693,7,605,peptide biosynthetic process,BP,MRPL14;MRPL16;BDH2;MGST2;ANG;TSFM;RBMS3
4929,GO:0010669,0.158072635372698,0.987405230323622,1,24,epithelial structure maintenance,BP,RBP4
1216,GO:0002696,0.158084141890704,0.940748716103589,4,286,positive regulation of leukocyte activation,BP,FADD;PNP;PYCARD;TICAM1
18467,GO:1900078,0.158773846762994,0.987268853256703,1,25,positive regulation of cellular response to insulin stimulus,BP,RNASEL
9920,GO:0035588,0.159117281250108,0.987255784085686,1,23,G-protein coupled purinergic receptor signaling pathway,BP,P2RY14
13613,GO:0050716,0.159134923314621,0.987230055601768,1,24,positive regulation of interleukin-1 secretion,BP,PYCARD
13301,GO:0048593,0.159259304297598,0.965413325833116,2,103,camera-type eye morphogenesis,BP,TH;RBP4
3919,GO:0008066,0.159435337025543,0.98712178276782,1,27,glutamate receptor activity,MF,GRIA3
20362,GO:1905039,0.159494298042428,0.965340035188989,2,101,carboxylic acid transmembrane transport,BP,CPT2;SLC1A3
5903,GO:0016407,0.160286738484775,0.965072662352117,2,99,acetyltransferase activity,MF,ACAT1;ACAT2
13926,GO:0051183,0.161160249224083,0.986892505246422,1,24,vitamin transporter activity,MF,RBP4
18146,GO:0098754,0.161333089903808,0.964720779370852,2,96,detoxification,BP,MGST2;RGN
10115,GO:0035902,0.161658499007481,0.986808746193389,1,24,response to immobilization stress,BP,TH
8433,GO:0032369,0.161725549101125,0.986775779830063,1,25,negative regulation of lipid transport,BP,APOC1
14880,GO:0060343,0.162195052080628,0.986696431353211,1,25,trabecula formation,BP,RBP4
10958,GO:0042634,0.162701400345579,0.986610572555532,1,25,regulation of hair cycle,BP,TRADD
7679,GO:0030947,0.163908534726571,0.986384152679708,1,26,regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
4925,GO:0010665,0.164131436608607,0.986366499782129,1,25,regulation of cardiac muscle cell apoptotic process,BP,NOL3
1942,GO:0004364,0.164308274918869,0.986382846373421,1,23,glutathione transferase activity,MF,MGST2
10807,GO:0042402,0.164927031255555,0.986252233117164,1,24,cellular biogenic amine catabolic process,BP,SARDH
781,GO:0001958,0.164931605205163,0.986208102206237,1,26,endochondral ossification,BP,FGF18
10219,GO:0036075,0.164931605205163,0.986208102206237,1,26,replacement ossification,BP,FGF18
16929,GO:0072207,0.16498699383352,0.986198536510048,1,26,metanephric epithelium development,BP,ACAT1
166,GO:0000323,0.16513295304127,0.917611814910894,7,624,lytic vacuole,CC,IFI30;PYCARD;IDUA;HEXB;PON2;ACP5;GLA
2778,GO:0005764,0.16513295304127,0.917611814910894,7,624,lysosome,CC,IFI30;PYCARD;IDUA;HEXB;PON2;ACP5;GLA
10383,GO:0036477,0.165248960090892,0.917530169622689,7,644,somatodendritic compartment,CC,TH;CYP17A1;ANG;CPT1C;STAR;S100B;SLC1A3
19552,GO:1903322,0.165354965440425,0.947837262788446,3,191,positive regulation of protein modification by small protein conjugation or removal,BP,PSMB10;TICAM1;NMI
4675,GO:0009895,0.165459922790656,0.947774819346781,3,198,negative regulation of catabolic process,BP,APOC1;TBC1D14;RGN
17544,GO:0090322,0.165648047780208,0.986127819449109,1,24,regulation of superoxide metabolic process,BP,RGN
13670,GO:0050802,0.165954653464655,0.986074732556384,1,24,circadian sleep/wake cycle, sleep,BP,STAR
8069,GO:0031667,0.165955286682504,0.928545019176925,5,403,response to nutrient levels,BP,PDK4;TH;FADS1;ACAT1;STAR
11151,GO:0043027,0.166414818962763,0.985971906900332,1,25,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,NOL3
16485,GO:0071450,0.167207411519073,0.9858567011566,1,24,cellular response to oxygen radical,BP,RGN
16486,GO:0071451,0.167207411519073,0.9858567011566,1,24,cellular response to superoxide,BP,RGN
2752,GO:0005730,0.168071771241046,0.907863380782014,9,861,nucleolus,CC,MRI1;PYCARD;ACADVL;FGF18;ARL6IP4;CPT2;ANG;ACAT2;NOL3
11518,GO:0043624,0.168076008101776,0.946586191941466,3,192,cellular protein complex disassembly,BP,MRPL14;MRPL16;TMOD4
10040,GO:0035767,0.168212165049215,0.985635441877443,1,26,endothelial cell chemotaxis,BP,FGF18
7158,GO:0022904,0.168501749264145,0.962167298171395,2,97,respiratory electron transport chain,BP,ETFB;ETFDH
8661,GO:0032675,0.168605020626442,0.962110497821919,2,101,regulation of interleukin-6 production,BP,PYCARD;TICAM1
13716,GO:0050867,0.168988076597878,0.935077824721665,4,294,positive regulation of cell activation,BP,FADD;PNP;PYCARD;TICAM1
1882,GO:0004181,0.169082792874973,0.985503237993236,1,25,metallocarboxypeptidase activity,MF,PEPD
16450,GO:0071396,0.169265978223084,0.920204404009671,6,522,cellular response to lipid,BP,PDK4;PYCARD;TICAM1;SHPK;TFPI;STAR
21024,GO:2000144,0.169453261672295,0.985415550825371,1,26,positive regulation of DNA-templated transcription, initiation,BP,HNF1A
12825,GO:0046834,0.169491794768014,0.961758983489937,2,108,lipid phosphorylation,BP,ZFYVE21;FGF18
4532,GO:0009310,0.169955942216379,0.985348069858622,1,25,amine catabolic process,BP,SARDH
16487,GO:0071453,0.170177652852045,0.945603926875914,3,197,cellular response to oxygen levels,BP,ACAA2;PSMB10;S100B
17133,GO:0072606,0.170198189913088,0.985304863430021,1,25,interleukin-8 secretion,BP,PYCARD
2447,GO:0005104,0.17060007950684,0.98521077726979,1,26,fibroblast growth factor receptor binding,MF,FGF18
12185,GO:0045444,0.170942215808543,0.945244773569687,3,199,fat cell differentiation,BP,MRAP;RNASEL;NUDT7
14813,GO:0060260,0.170985076977866,0.985141690853189,1,26,regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
5107,GO:0010922,0.17109728248598,0.985100799219355,1,27,positive regulation of phosphatase activity,BP,RGN
8314,GO:0032148,0.171346256116857,0.985076722129422,1,26,activation of protein kinase B activity,BP,ANG
13306,GO:0048608,0.171424629818516,0.925413813503583,5,412,reproductive structure development,BP,HSD17B3;RBP4;ANG;IDH1;STAR
4766,GO:0010259,0.171498866186557,0.985028403459936,1,27,multicellular organism aging,BP,TH
19207,GO:1902555,0.171670694765588,0.98504076984375,1,25,endoribonuclease complex,CC,HSD17B10
20476,GO:1905348,0.171670694765588,0.98504076984375,1,25,endonuclease complex,CC,HSD17B10
8618,GO:0032609,0.172730218931393,0.96060996600283,2,101,interferon-gamma production,BP,FADD;PYCARD
9611,GO:0034767,0.173025621049782,0.960473993221054,2,107,positive regulation of ion transmembrane transport,BP,RGN;FXYD1
3244,GO:0006518,0.173582831694595,0.907870561048396,8,735,peptide metabolic process,BP,MRPL14;MRPL16;BDH2;MGST2;ANG;TSFM;IDH1;RBMS3
7869,GO:0031304,0.173650140123685,0.984681791518266,1,25,intrinsic component of mitochondrial inner membrane,CC,ETFDH
7870,GO:0031305,0.173650140123685,0.984681791518266,1,25,integral component of mitochondrial inner membrane,CC,ETFDH
7157,GO:0022900,0.173903774392157,0.960188778777853,2,99,electron transport chain,BP,ETFB;ETFDH
3146,GO:0006376,0.173918954684614,0.984609559367904,1,26,mRNA splice site selection,BP,NOL3
3705,GO:0007202,0.173924361040785,0.984608569545056,1,26,activation of phospholipase C activity,BP,ANG
9918,GO:0035586,0.174028622575086,0.984612633897121,1,25,purinergic receptor activity,MF,P2RY14
3761,GO:0007292,0.174368870884433,0.959992957131316,2,104,female gamete generation,BP,ANG;HEXB
15512,GO:0061458,0.174959119917265,0.923373004247761,5,415,reproductive system development,BP,HSD17B3;RBP4;ANG;IDH1;STAR
9569,GO:0034698,0.175056079685059,0.984378924884697,1,27,response to gonadotropin,BP,STAR
3586,GO:0007006,0.175074403265147,0.959736973847192,2,103,mitochondrial membrane organization,BP,ACAA2;NOL3
21,GO:0000038,0.175147977786056,0.984383667088265,1,26,very long-chain fatty acid metabolic process,BP,ELOVL6
4922,GO:0010662,0.175945358212524,0.984214252692213,1,27,regulation of striated muscle cell apoptotic process,BP,NOL3
1781,GO:0004033,0.17603756722167,0.984242759796141,1,25,aldo-keto reductase (NADP) activity,MF,CYB5A
18655,GO:1901021,0.176803326774616,0.984033957284513,1,28,positive regulation of calcium ion transmembrane transporter activity,BP,RGN
7453,GO:0030488,0.176876794694546,0.984062929304997,1,26,tRNA methylation,BP,HSD17B10
3172,GO:0006415,0.177311956423158,0.95892068936692,2,100,translational termination,BP,MRPL14;MRPL16
3555,GO:0006955,0.177357441451378,0.884056505211019,17,1821,immune response,BP,CFB;IFI30;FADD;PNP;PYCARD;PSMB10;TICAM1;RNASEL;NMI;HEXB;CASP4;IFI27;IDH1;STAR;GLA;DERA;S100B
797,GO:0001975,0.177477817212527,0.983928308722436,1,27,response to amphetamine,BP,TH
7100,GO:0022410,0.17752478637226,0.983941810806225,1,26,circadian sleep/wake cycle process,BP,STAR
6165,GO:0016866,0.177622846588344,0.98392343920666,1,26,intramolecular transferase activity,MF,PUS1
10266,GO:0036152,0.178062859314104,0.98384086414299,1,26,phosphatidylethanolamine acyl-chain remodeling,BP,PLA2G16
9281,GO:0034122,0.179404418659151,0.983543762972401,1,28,negative regulation of toll-like receptor signaling pathway,BP,TICAM1
11324,GO:0043299,0.179699470244228,0.913822922711303,6,519,leukocyte degranulation,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
8368,GO:0032266,0.180041328197105,0.983402690626729,1,29,phosphatidylinositol-3-phosphate binding,MF,SNX21
14607,GO:0055088,0.18054515356458,0.957677642040216,2,106,lipid homeostasis,BP,ABCG1;FABP3
8761,GO:0032814,0.180863658701717,0.983286774555066,1,27,regulation of natural killer cell activation,BP,TICAM1
10265,GO:0036151,0.181089907371183,0.983243425717054,1,27,phosphatidylcholine acyl-chain remodeling,BP,PLA2G16
14597,GO:0055076,0.181423081389714,0.957336223613674,2,108,transition metal ion homeostasis,BP,SLC31A2;BDH2
9398,GO:0034364,0.181458070616875,0.983196065752051,1,26,high-density lipoprotein particle,CC,APOC1
4919,GO:0010659,0.181714181921349,0.98310180279687,1,28,cardiac muscle cell apoptotic process,BP,NOL3
5672,GO:0015893,0.182026720921285,0.983021247437625,1,29,drug transport,BP,EBP
17957,GO:0097502,0.18209550388253,0.983028234319659,1,28,mannosylation,BP,DPM3
11282,GO:0043235,0.182853823838927,0.927623594993184,4,320,receptor complex,CC,TRADD;GHR;GRIA3;CPT1C
1848,GO:0004129,0.183046974706939,0.982889656078866,1,26,cytochrome-c oxidase activity,MF,CYB5A
5328,GO:0015002,0.183046974706939,0.982889656078866,1,26,heme-copper terminal oxidase activity,MF,CYB5A
6058,GO:0016676,0.183046974706939,0.982889656078866,1,26,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,CYB5A
17031,GO:0072378,0.183406307716578,0.982796137692899,1,27,blood coagulation, fibrin clot formation,BP,TFPI
8634,GO:0032635,0.183738346008333,0.956459804574081,2,107,interleukin-6 production,BP,PYCARD;TICAM1
7299,GO:0030201,0.183821209033533,0.982653186416895,1,30,heparan sulfate proteoglycan metabolic process,BP,EXTL1
11111,GO:0042981,0.18389445959653,0.886069760443155,13,1363,regulation of apoptotic process,BP,PDK4;FADD;TRADD;PYCARD;G0S2;ACAA2;RGN;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
3402,GO:0006706,0.184168152474665,0.98264764483645,1,27,steroid catabolic process,BP,HSD17B11
4526,GO:0009303,0.184196145671766,0.982619878879707,1,28,rRNA transcription,BP,ANG
5263,GO:0014808,0.184254768580779,0.982587639479045,1,29,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,NOL3
16403,GO:0071333,0.184330944053388,0.956219208239454,2,110,cellular response to glucose stimulus,BP,TH;STAR
13603,GO:0050706,0.184615872512028,0.982537660453757,1,28,regulation of interleukin-1 beta secretion,BP,PYCARD
8693,GO:0032728,0.184689106010519,0.982502427243349,1,29,positive regulation of interferon-beta production,BP,TICAM1
15323,GO:0061036,0.184878107630302,0.982465277394006,1,29,positive regulation of cartilage development,BP,FGF18
15810,GO:0070229,0.184878267689951,0.982486155089577,1,28,negative regulation of lymphocyte apoptotic process,BP,FADD
155,GO:0000303,0.185111318457967,0.98246285989946,1,27,response to superoxide,BP,RGN
4128,GO:0008406,0.185168051836245,0.938477706195345,3,207,gonad development,BP,ANG;IDH1;STAR
10641,GO:0042089,0.185186617361765,0.955900173539767,2,108,cytokine biosynthetic process,BP,TICAM1;NMI
3389,GO:0006691,0.186044724679449,0.982278950765573,1,27,leukotriene metabolic process,BP,MGST2
7471,GO:0030515,0.186328585115713,0.982200001742308,1,28,snoRNA binding,MF,NUDT7
9608,GO:0034764,0.186442097744734,0.955398431185894,2,112,positive regulation of transmembrane transport,BP,RGN;FXYD1
19176,GO:1902475,0.186538102493563,0.982137171101242,1,29,L-alpha-amino acid transmembrane transport,BP,SLC1A3
19635,GO:1903510,0.187045213700826,0.95516535092998,2,112,mucopolysaccharide metabolic process,BP,IDUA;HEXB
19800,GO:1903825,0.187087644471373,0.955153417072565,2,111,organic acid transmembrane transport,BP,CPT2;SLC1A3
6115,GO:0016787,0.187114492526225,0.871694713957012,21,2385,hydrolase activity,MF,CFB;ABCG1;PYCARD;PSMB10;RGN;ASAH2;PLA2G16;RNASEL;ANG;IDUA;HEXB;CMBL;NUDT6;NUDT7;CASP4;PON2;MDP1;PEPD;ACP5;GLA;LYPLAL1
16715,GO:0071855,0.187358091987064,0.982018429622064,1,27,neuropeptide receptor binding,MF,MRAP
743,GO:0001913,0.188214184939875,0.981824233265603,1,28,T cell mediated cytotoxicity,BP,FADD
4969,GO:0010743,0.188352228376633,0.981774856180727,1,29,regulation of macrophage derived foam cell differentiation,BP,ABCG1
427,GO:0001101,0.188508874170713,0.924534407962299,4,313,response to acid chemical,BP,PDK4;TH;RBP4;FABP3
10621,GO:0042036,0.188605742200589,0.981745672575229,1,28,negative regulation of cytokine biosynthetic process,BP,NMI
10916,GO:0042572,0.189014541510785,0.981663457835832,1,28,retinol metabolic process,BP,RBP4
12667,GO:0046487,0.18916108793049,0.981633937047082,1,28,glyoxylate metabolic process,BP,IDH1
6057,GO:0016675,0.189368061639856,0.981615764889151,1,27,oxidoreductase activity, acting on a heme group of donors,MF,CYB5A
10671,GO:0042133,0.18951048360866,0.981541481752772,1,29,neurotransmitter metabolic process,BP,TH
1077,GO:0002444,0.189796578773027,0.907521039997127,6,528,myeloid leukocyte mediated immunity,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
3866,GO:0007610,0.19008631775826,0.907326800017473,6,547,behavior,BP,TH;FADD;HEXB;STAR;S100B;SLC1A3
19637,GO:1903514,0.190651022429944,0.981289365841037,1,30,calcium ion transport from endoplasmic reticulum to cytosol,BP,NOL3
10655,GO:0042107,0.190833505357329,0.953699185063037,2,110,cytokine metabolic process,BP,TICAM1;NMI
2489,GO:0005158,0.19095814343342,0.981207262853324,1,31,insulin receptor binding,MF,DOK1
17454,GO:0090200,0.191128090045194,0.981235220555815,1,28,positive regulation of release of cytochrome c from mitochondria,BP,PYCARD
12020,GO:0045089,0.191309792688068,0.92298537774473,4,313,positive regulation of innate immune response,BP,FADD;PYCARD;PSMB10;TICAM1
4930,GO:0010675,0.19188195840133,0.953268968039241,2,114,regulation of cellular carbohydrate metabolic process,BP,PDK4;RGN
4599,GO:0009615,0.191924005033105,0.922648303555664,4,310,response to virus,BP,FADD;PYCARD;TICAM1;RNASEL
4593,GO:0009605,0.192142933982975,0.871341374360123,18,2000,response to external stimulus,BP,CFB;PDK4;TH;FADD;PYCARD;MGST2;FADS1;FGF18;TICAM1;RNASEL;ACAT1;SHPK;CASP4;FAM46A;TFPI;STAR;DOK1;SLC1A3
16401,GO:0071331,0.192662308174014,0.952965918949839,2,113,cellular response to hexose stimulus,BP,TH;STAR
19054,GO:1902175,0.192665899603611,0.980897580655545,1,29,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,NOL3
3260,GO:0006536,0.192679740293253,0.980894730068203,1,29,glutamate metabolic process,BP,SLC1A3
11175,GO:0043067,0.192826902429464,0.879475132282009,13,1377,regulation of programmed cell death,BP,PDK4;FADD;TRADD;PYCARD;G0S2;ACAA2;RGN;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
17132,GO:0072604,0.193096655280299,0.980808755956929,1,29,interleukin-6 secretion,BP,PYCARD
5809,GO:0016202,0.193096690148447,0.952785383814307,2,115,regulation of striated muscle tissue development,BP,RBP4;S100B
4918,GO:0010658,0.193281502068028,0.98074924773507,1,30,striated muscle cell apoptotic process,BP,NOL3
8696,GO:0032731,0.193558762888242,0.980691834573966,1,30,positive regulation of interleukin-1 beta production,BP,PYCARD
12424,GO:0045923,0.193867577324772,0.980627778933942,1,30,positive regulation of fatty acid metabolic process,BP,RGN
8698,GO:0032733,0.194102832374645,0.980600409229962,1,29,positive regulation of interleukin-10 production,BP,PYCARD
4989,GO:0010765,0.194341312284064,0.980509128774562,1,31,positive regulation of sodium ion transport,BP,FXYD1
12049,GO:0045137,0.194549757968031,0.933866799890808,3,212,development of primary sexual characteristics,BP,ANG;IDH1;STAR
16399,GO:0071326,0.195207522367305,0.951952430278148,2,114,cellular response to monosaccharide stimulus,BP,TH;STAR
4438,GO:0009165,0.195365366463002,0.9207305311014,4,309,nucleotide biosynthetic process,BP,MRAP;PNP;NNMT;ACAT1
10693,GO:0042168,0.195521621295358,0.980304559943027,1,29,heme metabolic process,BP,BDH2
10844,GO:0042462,0.195524209196345,0.980261788512761,1,31,eye photoreceptor cell development,BP,TH
4916,GO:0010656,0.195724323697252,0.980240229596734,1,30,negative regulation of muscle cell apoptotic process,BP,NOL3
15380,GO:0061134,0.196031990762131,0.933140361909864,3,207,peptidase regulator activity,MF,PYCARD;NOL3;TFPI
13719,GO:0050870,0.196606846251891,0.932851352290464,3,208,positive regulation of T cell activation,BP,FADD;PNP;PYCARD
643,GO:0001773,0.19697145239039,0.979999738457208,1,29,myeloid dendritic cell activation,BP,PYCARD
13091,GO:0048048,0.197142144022541,0.979901306510323,1,32,embryonic eye morphogenesis,BP,TH
18944,GO:1901861,0.197458602824781,0.951039094067316,2,117,regulation of muscle tissue development,BP,RBP4;S100B
5095,GO:0010907,0.198148687092537,0.979687351964125,1,32,positive regulation of glucose metabolic process,BP,RGN
11312,GO:0043276,0.199217443659844,0.979458832179146,1,32,anoikis,BP,PDK4
5020,GO:0010821,0.199329153952155,0.931478512130165,3,212,regulation of mitochondrion organization,BP,PYCARD;ACAA2;NOL3
11154,GO:0043030,0.199532879671311,0.979432296791758,1,30,regulation of macrophage activation,BP,SHPK
6667,GO:0019692,0.199766453539076,0.9794049531535,1,29,deoxyribose phosphate metabolic process,BP,DERA
18753,GO:1901293,0.200154458959783,0.918031372248835,4,312,nucleoside phosphate biosynthetic process,BP,MRAP;PNP;NNMT;ACAT1
3604,GO:0007031,0.200552532121707,0.979191548081145,1,31,peroxisome organization,BP,PLA2G16
13112,GO:0048147,0.20067602787853,0.979164878247899,1,31,negative regulation of fibroblast proliferation,BP,IFI30
5227,GO:0014072,0.200783489177258,0.97914165613486,1,31,response to isoquinoline alkaloid,BP,FADD
11314,GO:0043278,0.200783489177258,0.97914165613486,1,31,response to morphine,BP,FADD
2487,GO:0005154,0.200900546867611,0.97909614912961,1,32,epidermal growth factor receptor binding,MF,LINGO1
11112,GO:0042982,0.201014548364781,0.97909167742052,1,31,amyloid precursor protein metabolic process,BP,ABCG1
3360,GO:0006658,0.201096996235718,0.979095415069862,1,30,phosphatidylserine metabolic process,BP,PLA2G16
21100,GO:2000279,0.201101919251763,0.979072761999006,1,31,negative regulation of DNA biosynthetic process,BP,RGN
16014,GO:0070555,0.201155925078597,0.949564559093026,2,113,response to interleukin-1,BP,PYCARD;TFPI
11457,GO:0043531,0.201363098819056,0.978995874420704,1,32,ADP binding,MF,ABCG1
785,GO:0001963,0.201668667058154,0.978971548375069,1,30,synaptic transmission, dopaminergic,BP,TH
15858,GO:0070296,0.201837014677004,0.978892866754107,1,32,sarcoplasmic reticulum calcium ion transport,BP,NOL3
7447,GO:0030449,0.202018054513502,0.978873864985208,1,31,regulation of complement activation,BP,CFB
4706,GO:0009991,0.202647899108465,0.90687145940297,5,433,response to extracellular stimulus,BP,PDK4;TH;FADS1;ACAT1;STAR
4428,GO:0009154,0.202937823528555,0.978633193618707,1,33,purine ribonucleotide catabolic process,BP,NUDT7
156,GO:0000305,0.202941196681329,0.978694399915747,1,30,response to oxygen radical,BP,RGN
2565,GO:0005310,0.203121066509666,0.978612400837216,1,32,dicarboxylic acid transmembrane transporter activity,MF,SLC1A3
5570,GO:0015711,0.2033209709087,0.906455987899197,5,437,organic anion transport,BP,APOC1;ABCG1;CPT2;FABP3;SLC1A3
16721,GO:0071868,0.203729457324368,0.978459308958266,1,33,cellular response to monoamine stimulus,BP,STAR
16723,GO:0071870,0.203729457324368,0.978459308958266,1,33,cellular response to catecholamine stimulus,BP,STAR
10590,GO:0040018,0.203751806114973,0.978473898409969,1,32,positive regulation of multicellular organism growth,BP,GHR
13319,GO:0048634,0.204109508995308,0.948330403051575,2,119,regulation of muscle organ development,BP,RBP4;S100B
1367,GO:0002931,0.204518675342136,0.978304850925939,1,32,response to ischemia,BP,NOL3
16418,GO:0071353,0.204627796287687,0.978301688122615,1,31,cellular response to interleukin-4,BP,SHPK
1231,GO:0002711,0.205557002242807,0.978095961197894,1,31,positive regulation of T cell mediated immunity,BP,FADD
13674,GO:0050806,0.205709644278086,0.947662899635518,2,121,positive regulation of synaptic transmission,BP,S100B;SLC1A3
3108,GO:0006308,0.205723740902149,0.978058933712832,1,31,DNA catabolic process,BP,RGN
14211,GO:0051693,0.206231359780128,0.977904733485217,1,33,actin filament capping,BP,TMOD4
2632,GO:0005501,0.206507415115499,0.97788444948373,1,31,retinoid binding,MF,RBP4
15487,GO:0061384,0.206790193429741,0.97777981668861,1,33,heart trabecula morphogenesis,BP,RBP4
1207,GO:0002687,0.207099081773448,0.947125903104621,2,113,positive regulation of leukocyte migration,BP,FADD;PYCARD
13961,GO:0051239,0.208095674178107,0.853969196159516,22,2576,regulation of multicellular organismal process,BP,PDK4;TH;FADD;APOC1;TRADD;PNP;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;PLA2G16;FXYD1;RBP4;NMI;NOL3;FAM46A;TMEM176A;STAR;S100B;LINGO1
9919,GO:0035587,0.20823161577744,0.977497916372172,1,31,purinergic receptor signaling pathway,BP,P2RY14
21087,GO:2000257,0.208277211140634,0.977465943290974,1,32,regulation of protein activation cascade,BP,CFB
2698,GO:0005615,0.208567300238237,0.867694270460801,13,1364,extracellular space,CC,CFB;APOC1;KRT10;GHR;FGF18;RBP4;ANG;HEXB;FABP3;MDH1;TFPI;S100B;LINGO1
18660,GO:1901031,0.208611542220736,0.977390483388785,1,32,regulation of response to reactive oxygen species,BP,RGN
4514,GO:0009261,0.208912425669215,0.977282648919046,1,34,ribonucleotide catabolic process,BP,NUDT7
16368,GO:0071276,0.209122756292199,0.977296713604207,1,31,cellular response to cadmium ion,BP,STAR
13601,GO:0050704,0.20917309310938,0.977263430693876,1,32,regulation of interleukin-1 secretion,BP,PYCARD
4520,GO:0009267,0.209284671498973,0.946183095964019,2,120,cellular response to starvation,BP,PDK4;FADS1
11020,GO:0042755,0.209771944355892,0.977127512476497,1,32,eating behavior,BP,TH
5696,GO:0015934,0.209841735083828,0.946000183876779,2,110,large ribosomal subunit,CC,MRPL14;MRPL16
4393,GO:0009116,0.210131160236216,0.94584808750435,2,116,nucleoside metabolic process,BP,PNP;DERA
4515,GO:0009262,0.210317883999263,0.977025348186335,1,31,deoxyribonucleotide metabolic process,BP,DERA
1033,GO:0002366,0.211181203020714,0.887531910337613,7,663,leukocyte activation involved in immune response,BP,PNP;PYCARD;TICAM1;HEXB;IDH1;GLA;DERA
3933,GO:0008092,0.211445718303986,0.882164919641062,8,823,cytoskeletal protein binding,MF,PYCARD;PXK;ANG;FAM110C;FABP3;RPH3AL;S100B;TMOD4
742,GO:0001912,0.211477246655415,0.976738055790191,1,32,positive regulation of leukocyte mediated cytotoxicity,BP,FADD
14673,GO:0060043,0.212076869696581,0.976559245526387,1,34,regulation of cardiac muscle cell proliferation,BP,RBP4
19424,GO:1903039,0.21218000336477,0.924897690895102,3,217,positive regulation of leukocyte cell-cell adhesion,BP,FADD;PNP;PYCARD
7747,GO:0031076,0.212447028093107,0.976455007616403,1,35,embryonic camera-type eye development,BP,TH
9414,GO:0034381,0.212840981793157,0.976424031859353,1,32,plasma lipoprotein particle clearance,BP,APOC1
16397,GO:0071322,0.213100036232589,0.944575271159083,2,121,cellular response to carbohydrate stimulus,BP,TH;STAR
11173,GO:0043065,0.213102550490167,0.892533818833871,6,560,positive regulation of apoptotic process,BP,FADD;TRADD;PYCARD;G0S2;IFI27;S100B
968,GO:0002263,0.213162566710121,0.88618710575797,7,665,cell activation involved in immune response,BP,PNP;PYCARD;TICAM1;HEXB;IDH1;GLA;DERA
4582,GO:0009451,0.213175878615651,0.944567213308609,2,116,RNA modification,BP,HSD17B10;PUS1
19651,GO:1903532,0.213210771473556,0.910520223188412,4,327,positive regulation of secretion by cell,BP,PYCARD;RBP4;ANG;RPH3AL
10771,GO:0042339,0.213240338363565,0.976310275045278,1,33,keratan sulfate metabolic process,BP,HEXB
13998,GO:0051291,0.21348373985762,0.944427126411856,2,118,protein heterooligomerization,BP,TRADD;PCBD1
3235,GO:0006506,0.214044610271774,0.976144971048832,1,32,GPI anchor biosynthetic process,BP,DPM3
5864,GO:0016298,0.214046960380933,0.944183702328691,2,119,lipase activity,MF,PLA2G16;LYPLAL1
17907,GO:0097421,0.214150132330788,0.976120420570212,1,32,liver regeneration,BP,RGN
2124,GO:0004623,0.214338406548382,0.976076583047824,1,32,phospholipase A2 activity,MF,PLA2G16
21458,GO:2000785,0.214362090394953,0.97602916041858,1,34,regulation of autophagosome assembly,BP,TBC1D14
12299,GO:0045684,0.214659756094025,0.975980010477457,1,33,positive regulation of epidermis development,BP,TRADD
16551,GO:0071549,0.216116964634984,0.975638361371695,1,33,cellular response to dexamethasone stimulus,BP,STAR
5946,GO:0016482,0.216389536796386,0.943154472436034,2,126,cytosolic transport,BP,ZFYVE21;TBC1D14
12041,GO:0045124,0.216426323219591,0.975544784448974,1,34,regulation of bone resorption,BP,PDK4
15813,GO:0070232,0.216795327864071,0.975478419027976,1,33,regulation of T cell apoptotic process,BP,FADD
4968,GO:0010742,0.216854843503926,0.975443569478584,1,34,macrophage derived foam cell differentiation,BP,ABCG1
17365,GO:0090077,0.216854843503926,0.975443569478584,1,34,foam cell differentiation,BP,ABCG1
12659,GO:0046474,0.216957524408782,0.922378394523565,3,227,glycerophospholipid biosynthetic process,BP,DPM3;FGF18;FABP3
17460,GO:0090207,0.217252688581922,0.975370261957336,1,33,regulation of triglyceride metabolic process,BP,RGN
12872,GO:0046914,0.217256570518184,0.863654598557289,12,1303,transition metal ion binding,MF,PHYH;TH;RGN;GALT;CYP17A1;ANG;AOX1;NUDT7;PEPD;ACP5;CYP11A1;S100B
12327,GO:0045742,0.217282780419953,0.975342264896193,1,34,positive regulation of epidermal growth factor receptor signaling pathway,BP,DOK1
6613,GO:0019433,0.218004962924941,0.975191798875907,1,33,triglyceride catabolic process,BP,FABP3
5055,GO:0010863,0.218029188107522,0.975145213832654,1,35,positive regulation of phospholipase C activity,BP,ANG
6293,GO:0017137,0.218168350389197,0.942379129957818,2,129,Rab GTPase binding,MF,TBC1D14;RPH3AL
6724,GO:0019840,0.218530785824552,0.975066639904119,1,33,isoprenoid binding,MF,RBP4
18904,GO:1901699,0.218547668975639,0.888942800907076,6,574,cellular response to nitrogen compound,BP,PDK4;TH;GHR;RNASEL;CASP4;STAR
587,GO:0001678,0.218631179029511,0.942201840789646,2,124,cellular glucose homeostasis,BP,TH;STAR
784,GO:0001961,0.218939276165297,0.974947981526256,1,34,positive regulation of cytokine-mediated signaling pathway,BP,FADD
10818,GO:0042417,0.21924980672562,0.974873688436716,1,34,dopamine metabolic process,BP,TH
13063,GO:0048009,0.219274688442888,0.9748287708763,1,36,insulin-like growth factor receptor signaling pathway,BP,GHR
5947,GO:0016485,0.219591200890955,0.921000129020426,3,222,protein processing,BP,CFB;FADD;NOL3
11176,GO:0043068,0.219667446536509,0.888207370121073,6,566,positive regulation of programmed cell death,BP,FADD;TRADD;PYCARD;G0S2;IFI27;S100B
13976,GO:0051258,0.220164264643043,0.920685556308133,3,227,protein polymerization,BP,PYCARD;ANG;TMOD4
3234,GO:0006505,0.220176263325886,0.974672753946436,1,33,GPI anchor metabolic process,BP,DPM3
21022,GO:2000142,0.220575708099634,0.974534845774533,1,35,regulation of DNA-templated transcription, initiation,BP,HNF1A
20662,GO:1905952,0.220828304479551,0.941257522492057,2,123,regulation of lipid localization,BP,APOC1;ABCG1
16720,GO:0071867,0.220859753749905,0.974447066996908,1,36,response to monoamine,BP,STAR
16722,GO:0071869,0.220859753749905,0.974447066996908,1,36,response to catecholamine,BP,STAR
4880,GO:0010608,0.221707280436891,0.894989929149197,5,450,posttranscriptional regulation of gene expression,BP,PSMB10;RNASEL;ANG;TSFM;RBMS3
16075,GO:0070670,0.221796075574541,0.974259972530004,1,34,response to interleukin-4,BP,SHPK
16387,GO:0071310,0.222007883793094,0.846406675844237,19,2192,cellular response to organic substance,BP,PDK4;IFI30;TH;FADD;TRADD;PYCARD;ACADVL;PSMB10;GHR;FGF18;TICAM1;RNASEL;NMI;SHPK;NOL3;CASP4;IFI27;TFPI;STAR
4492,GO:0009225,0.222149690851233,0.974174102399253,1,34,nucleotide-sugar metabolic process,BP,GALT
13599,GO:0050702,0.222202316517076,0.974140735113846,1,35,interleukin-1 beta secretion,BP,PYCARD
3395,GO:0006699,0.222361543337947,0.974122582373806,1,34,bile acid biosynthetic process,BP,STAR
11632,GO:0044106,0.222440222935163,0.94058190252827,2,118,cellular amine metabolic process,BP,PSMB10;SARDH
6242,GO:0017046,0.222746881702032,0.974008053564535,1,35,peptide hormone binding,MF,GHR
7309,GO:0030212,0.223397276257676,0.973849100686036,1,35,hyaluronan metabolic process,BP,HEXB
1611,GO:0003674,0.22358949061014,0.862229439447516,119,16005,molecular_function,MF,CFB;EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;IDH1;DECR1;PUS1;LDHD;MDP1;TFPI;STAR;SNX21;WBP1;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
15508,GO:0061448,0.223670077598988,0.918813216613654,3,230,connective tissue development,BP,FGF18;PLA2G16;ACAT1
3469,GO:0006820,0.224063996231739,0.885282222035613,6,573,anion transport,BP,APOC1;ABCG1;CPT2;FXYD1;FABP3;SLC1A3
15177,GO:0060760,0.225066729001932,0.973438668933069,1,35,positive regulation of response to cytokine stimulus,BP,FADD
12329,GO:0045744,0.226360993760999,0.973118069145021,1,35,negative regulation of G-protein coupled receptor protein signaling pathway,BP,RPH3AL
6746,GO:0019882,0.226500336606383,0.917311280747361,3,223,antigen processing and presentation,BP,IFI30;PYCARD;PSMB10
7607,GO:0030835,0.227108644070514,0.972892423337191,1,37,negative regulation of actin filament depolymerization,BP,TMOD4
1214,GO:0002694,0.227116105076469,0.891551217079276,5,446,regulation of leukocyte activation,BP,FADD;PNP;PYCARD;TICAM1;SHPK
8697,GO:0032732,0.227288193452276,0.972866774122876,1,36,positive regulation of interleukin-1 production,BP,PYCARD
13859,GO:0051091,0.227307613246107,0.916860638612827,3,230,positive regulation of sequence-specific DNA binding transcription factor activity,BP,TRADD;PYCARD;TICAM1
3358,GO:0006656,0.227409138643454,0.972856891652297,1,35,phosphatidylcholine biosynthetic process,BP,FABP3
3745,GO:0007268,0.227731943262377,0.882822822134505,6,584,chemical synaptic transmission,BP,TH;PXK;GRIA3;STAR;S100B;SLC1A3
18240,GO:0098916,0.227731943262377,0.882822822134505,6,584,anterograde trans-synaptic signaling,BP,TH;PXK;GRIA3;STAR;S100B;SLC1A3
6262,GO:0017080,0.227810600594303,0.972736070227366,1,36,sodium channel regulator activity,MF,FXYD1
18583,GO:1900274,0.228200177762215,0.972618997747182,1,37,regulation of phospholipase C activity,BP,ANG
7322,GO:0030225,0.228748209358315,0.972500621670897,1,36,macrophage differentiation,BP,FADD
7444,GO:0030431,0.229126126651457,0.972426061045625,1,35,sleep,BP,STAR
11537,GO:0043666,0.229351840399573,0.972328879697459,1,37,regulation of phosphoprotein phosphatase activity,BP,RGN
3417,GO:0006734,0.229376719548319,0.972362870724814,1,35,NADH metabolic process,BP,MDH1
18706,GO:1901186,0.22940599879009,0.972334777932563,1,36,positive regulation of ERBB signaling pathway,BP,DOK1
18335,GO:0099536,0.229682750899789,0.881511472243529,6,586,synaptic signaling,BP,TH;PXK;GRIA3;STAR;S100B;SLC1A3
18336,GO:0099537,0.229682750899789,0.881511472243529,6,586,trans-synaptic signaling,BP,TH;PXK;GRIA3;STAR;S100B;SLC1A3
13273,GO:0048536,0.229717197220691,0.972256127233958,1,36,spleen development,BP,FADD
11505,GO:0043604,0.230460246301806,0.874280515108261,7,676,amide biosynthetic process,BP,MRPL14;MRPL16;BDH2;MGST2;ANG;TSFM;RBMS3
8054,GO:0031647,0.230725642862345,0.915010552346471,3,230,regulation of protein stability,BP,IFI30;DPM3;PYCARD
5963,GO:0016504,0.230789137956054,0.971984273077294,1,36,peptidase activator activity,MF,PYCARD
948,GO:0002224,0.23096822921378,0.93677886239048,2,126,toll-like receptor signaling pathway,BP,FADD;TICAM1
12368,GO:0045824,0.231389834801375,0.971831294984179,1,36,negative regulation of innate immune response,BP,NMI
8423,GO:0032355,0.231448335958919,0.936568827175036,2,125,response to estradiol,BP,TH;TFPI
11677,GO:0044236,0.232023010791344,0.936292355702357,2,129,multicellular organism metabolic process,BP,GHR;PEPD
1172,GO:0002639,0.232231134808704,0.971637490150013,1,35,positive regulation of immunoglobulin production,BP,RBP4
13334,GO:0048662,0.232566587359093,0.971530288885474,1,36,negative regulation of smooth muscle cell proliferation,BP,ANG
18991,GO:1901998,0.232788650346971,0.971473289549108,1,36,toxin transport,BP,ABCG1
11286,GO:0043241,0.232864059411044,0.91385245714147,3,227,protein complex disassembly,BP,MRPL14;MRPL16;TMOD4
572,GO:0001659,0.233408674017155,0.971293540595396,1,37,temperature homeostasis,BP,ACADVL
10879,GO:0042517,0.233897026050626,0.971187854439379,1,36,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,GHR
18857,GO:1901618,0.234015365814554,0.971136912313041,1,37,organic hydroxy compound transmembrane transporter activity,MF,ABCG1
7900,GO:0031343,0.23457400521216,0.9710127469534,1,36,positive regulation of cell killing,BP,FADD
12819,GO:0046825,0.234722202609363,0.970934423461986,1,38,regulation of protein export from nucleus,BP,IFI27
5129,GO:0010955,0.234905954776911,0.97090614269517,1,37,negative regulation of protein processing,BP,NOL3
19548,GO:1903318,0.234905954776911,0.97090614269517,1,37,negative regulation of protein maturation,BP,NOL3
3442,GO:0006778,0.235113563509398,0.97087276722226,1,36,porphyrin-containing compound metabolic process,BP,BDH2
2046,GO:0004519,0.235716871971202,0.934645010410809,2,125,endonuclease activity,MF,RNASEL;ANG
4390,GO:0009112,0.236745690594726,0.970426229874411,1,37,nucleobase metabolic process,BP,AOX1
5229,GO:0014075,0.236990371621331,0.970342285837809,1,38,response to amine,BP,TH
17606,GO:0090501,0.237398875233902,0.93387024984309,2,127,RNA phosphodiester bond hydrolysis,BP,RNASEL;ANG
728,GO:0001889,0.238590536810364,0.933311580244583,2,130,liver development,BP,RGN;ACAT1
11182,GO:0043086,0.239442868188617,0.862273170896997,8,811,negative regulation of catalytic activity,BP,APOC1;PYCARD;PSMB10;RGN;NOL3;DEPTOR;TFPI;GLA
9392,GO:0034358,0.24001648766264,0.969562333062614,1,37,plasma lipoprotein particle,CC,APOC1
20874,GO:1990777,0.24001648766264,0.969562333062614,1,37,lipoprotein particle,CC,APOC1
18605,GO:1900408,0.240724844145815,0.969353016454483,1,38,negative regulation of cellular response to oxidative stress,BP,NOL3
19333,GO:1902883,0.240724844145815,0.969353016454483,1,38,negative regulation of response to oxidative stress,BP,NOL3
19489,GO:1903202,0.240724844145815,0.969353016454483,1,38,negative regulation of oxidative stress-induced cell death,BP,NOL3
7649,GO:0030890,0.240885867662662,0.969309958823715,1,38,positive regulation of B cell proliferation,BP,TICAM1
8732,GO:0032784,0.241104223523341,0.969251517332624,1,38,regulation of DNA-templated transcription, elongation,BP,TSFM
12592,GO:0046326,0.241134277755276,0.969205576054134,1,40,positive regulation of glucose import,BP,RNASEL
12873,GO:0046915,0.241226301502799,0.969218817273201,1,38,transition metal ion transmembrane transporter activity,MF,SLC31A2
1881,GO:0004180,0.24126569833058,0.969228768885657,1,37,carboxypeptidase activity,MF,PEPD
4530,GO:0009308,0.241822008517452,0.931850670180792,2,125,amine metabolic process,BP,PSMB10;SARDH
10843,GO:0042461,0.241863825330835,0.969009616302775,1,40,photoreceptor cell development,BP,TH
7932,GO:0031410,0.242110083301585,0.831671824231062,18,2095,cytoplasmic vesicle,CC,EBP;TH;ZFYVE21;SLC31A2;TBC1D14;PNP;ABCG1;PYCARD;TICAM1;ANG;IDUA;HEXB;GRIA3;IDH1;SNX21;GLA;RPH3AL;DERA
4522,GO:0009295,0.243162277457039,0.968697680188295,1,38,nucleoid,CC,ACADVL
10965,GO:0042645,0.243162277457039,0.968697680188295,1,38,mitochondrial nucleoid,CC,ACADVL
13074,GO:0048020,0.243181014261796,0.968735441472449,1,36,CCR chemokine receptor binding,MF,CNIH4
1291,GO:0002819,0.243209353957304,0.931193364432891,2,128,regulation of adaptive immune response,BP,FADD;PYCARD
18023,GO:0097708,0.243898100123839,0.830219078860129,18,2098,intracellular vesicle,CC,EBP;TH;ZFYVE21;SLC31A2;TBC1D14;PNP;ABCG1;PYCARD;TICAM1;ANG;IDUA;HEXB;GRIA3;IDH1;SNX21;GLA;RPH3AL;DERA
12749,GO:0046638,0.244585508635423,0.968311486895476,1,38,positive regulation of alpha-beta T cell differentiation,BP,PNP
7605,GO:0030833,0.244933957564868,0.930367308378042,2,133,regulation of actin filament polymerization,BP,PYCARD;TMOD4
11756,GO:0044344,0.245215851447892,0.930235819687337,2,133,cellular response to fibroblast growth factor stimulus,BP,FGF18;STAR
3344,GO:0006636,0.245326379519166,0.968109417075799,1,38,unsaturated fatty acid biosynthetic process,BP,FADS1
8231,GO:0032007,0.24589314539599,0.96791495901659,1,40,negative regulation of TOR signaling,BP,DEPTOR
3209,GO:0006469,0.246272379014486,0.906390231238886,3,238,negative regulation of protein kinase activity,BP,PYCARD;RGN;DEPTOR
15303,GO:0061008,0.246558854778819,0.929607906899909,2,133,hepaticobiliary system development,BP,RGN;ACAT1
14030,GO:0051348,0.24669629470361,0.890346685876002,4,345,negative regulation of transferase activity,BP,PYCARD;PSMB10;RGN;DEPTOR
428,GO:0001102,0.246807395378476,0.967682994137546,1,39,RNA polymerase II activating transcription factor binding,MF,IFI27
6612,GO:0019432,0.247559850189667,0.96745602108401,1,40,triglyceride biosynthetic process,BP,RGN
13305,GO:0048599,0.247890430804875,0.96738406850838,1,39,oocyte development,BP,ANG
18809,GO:1901505,0.248101458122558,0.967346213279325,1,38,carbohydrate derivative transporter activity,MF,ABCG1
19033,GO:1902107,0.248623848917301,0.928642479690583,2,132,positive regulation of leukocyte differentiation,BP,FADD;PNP
627,GO:0001754,0.248790545185027,0.967096144262666,1,41,eye photoreceptor cell differentiation,BP,TH
19031,GO:1902105,0.249173326054007,0.904748981656128,3,239,regulation of leukocyte differentiation,BP,FADD;PNP;TMEM176A
19753,GO:1903727,0.249559971966039,0.966881716213291,1,41,positive regulation of phospholipid metabolic process,BP,FABP3
13300,GO:0048592,0.249821635442331,0.92804477233398,2,139,eye morphogenesis,BP,TH;RBP4
1880,GO:0004177,0.250068869004398,0.966758345856788,1,40,aminopeptidase activity,MF,PEPD
19925,GO:1904062,0.250454997072986,0.904008016101631,3,245,regulation of cation transmembrane transport,BP,SLC31A2;RGN;FXYD1
2998,GO:0006109,0.250723500811423,0.927626577623041,2,137,regulation of carbohydrate metabolic process,BP,PDK4;RGN
4704,GO:0009987,0.250814908675923,0.81999444254152,109,14598,cellular process,BP,EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;WDR45;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;TMEM176A;IDH1;DECR1;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;ELOVL6;LINGO1;ETFDH;TMOD4
6065,GO:0016706,0.250980980794296,0.966483674998409,1,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,PHYH
12648,GO:0046461,0.25121876152934,0.966455888630145,1,39,neutral lipid catabolic process,BP,FABP3
12651,GO:0046464,0.25121876152934,0.966455888630145,1,39,acylglycerol catabolic process,BP,FABP3
12184,GO:0045429,0.25140274464704,0.966384103410196,1,40,positive regulation of nitric oxide biosynthetic process,BP,TICAM1
20065,GO:1904407,0.25140274464704,0.966384103410196,1,40,positive regulation of nitric oxide metabolic process,BP,TICAM1
13598,GO:0050701,0.251555658934019,0.966341052377115,1,40,interleukin-1 secretion,BP,PYCARD
8873,GO:0032994,0.251679950967809,0.966326137895668,1,39,protein-lipid complex,CC,APOC1
5867,GO:0016303,0.252004985525351,0.966159552995104,1,43,1-phosphatidylinositol-3-kinase activity,MF,FGF18
10805,GO:0042398,0.252076818268934,0.966214261405183,1,39,cellular modified amino acid biosynthetic process,BP,MGST2
11153,GO:0043029,0.25308507017013,0.965908786730167,1,40,T cell homeostasis,BP,FADD
14125,GO:0051539,0.253229880879757,0.965867699694257,1,40,4 iron, 4 sulfur cluster binding,MF,ETFDH
5204,GO:0014047,0.253709410273553,0.965693522903998,1,42,glutamate secretion,BP,SLC1A3
14875,GO:0060338,0.254049363139884,0.965634671673222,1,40,regulation of type I interferon-mediated signaling pathway,BP,FADD
14169,GO:0051602,0.254137232569235,0.965609632937673,1,40,response to electrical stimulus,BP,TH
3363,GO:0006661,0.25429055814288,0.925912988623305,2,140,phosphatidylinositol biosynthetic process,BP,DPM3;FGF18
12563,GO:0046189,0.254445985724087,0.965521572335558,1,40,phenol-containing compound biosynthetic process,BP,TH
1041,GO:0002376,0.254664037970633,0.81579437320298,22,2604,immune system process,BP,CFB;EBP;IFI30;FADD;PNP;PYCARD;PSMB10;TICAM1;RBP4;RNASEL;NMI;SHPK;HEXB;CASP4;IFI27;TMEM176A;IDH1;PTMS;STAR;GLA;DERA;S100B
796,GO:0001974,0.25512056726145,0.965290392756095,1,42,blood vessel remodeling,BP,NOL3
9743,GO:0035264,0.255225982913422,0.925464270312909,2,140,multicellular organism growth,BP,GHR;DHCR7
14604,GO:0055085,0.255540542672294,0.83418558760225,12,1348,transmembrane transport,BP,EBP;SLC31A2;ABCG1;PSMB10;RGN;CPT2;FXYD1;RNASEL;GRIA3;NOL3;CYB5A;SLC1A3
18077,GO:0098588,0.256531938109258,0.82352900854745,16,1865,bounding membrane of organelle,CC,PECR;TH;ZFYVE21;PXMP2;PXMP4;ABCG1;TICAM1;PLA2G16;GRIA3;HSD3B2;CPT1C;IFI27;SNX21;RPH3AL;DHCR7;CYB5A
12358,GO:0045806,0.256573894824636,0.964891399933752,1,41,negative regulation of endocytosis,BP,APOC1
12833,GO:0046850,0.25759902847258,0.96457603271462,1,42,regulation of bone remodeling,BP,PDK4
4102,GO:0008360,0.258289435327367,0.923981983917872,2,141,regulation of cell shape,BP,HEXB;S100B
5121,GO:0010942,0.258805760998082,0.861475863097046,6,598,positive regulation of cell death,BP,FADD;TRADD;PYCARD;G0S2;IFI27;S100B
17701,GO:0097028,0.259221850163789,0.964143491030902,1,40,dendritic cell differentiation,BP,TMEM176A
5073,GO:0010883,0.259247080657675,0.964096542686755,1,42,regulation of lipid storage,BP,ABCG1
13690,GO:0050829,0.259303026234855,0.964119808155778,1,40,defense response to Gram-negative bacterium,BP,PYCARD
5725,GO:0016020,0.259378550949579,0.794631989739009,66,8566,membrane,CC,CFB;EBP;PDK4;PECR;TMEM160;TMEM164;ALG5;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;FADD;P2RY14;HSD17B3;MRAP;TRADD;PXMP2;PXMP4;EXTL1;ABCG1;CCDC51;ACADVL;KRT10;ACAA2;MGST2;FADS1;GHR;ASAH2;TICAM1;CPT2;PXK;PLA2G16;HSD17B10;FXYD1;TMEM223;CYP17A1;ACAT1;HEXB;GRIA3;NOL3;HSD3B2;CPT1C;CASP4;IFI27;PON2;TMEM176A;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;ECI1;CYP11A1;RPH3AL;PRRT1;DHCR7;CYB5A;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH
4708,GO:0009994,0.259412794198383,0.964067465927438,1,41,oocyte differentiation,BP,ANG
11426,GO:0043488,0.259523018324489,0.923406650606597,2,136,regulation of mRNA stability,BP,PSMB10;RNASEL
16550,GO:0071548,0.259598943325219,0.964013068723666,1,41,response to dexamethasone,BP,STAR
9356,GO:0034260,0.259781632586047,0.963921763166805,1,43,negative regulation of GTPase activity,BP,RGN
13119,GO:0048167,0.260958762883268,0.922670608007875,2,144,regulation of synaptic plasticity,BP,STAR;S100B
16675,GO:0071774,0.261174965552875,0.922587598552743,2,139,response to fibroblast growth factor,BP,FGF18;STAR
5027,GO:0010828,0.261451221682153,0.96341306503428,1,44,positive regulation of glucose transport,BP,RNASEL
8407,GO:0032330,0.261458986454092,0.963428643126108,1,43,regulation of chondrocyte differentiation,BP,FGF18
13834,GO:0051047,0.261492299806496,0.881005167573242,4,358,positive regulation of secretion,BP,PYCARD;RBP4;ANG;RPH3AL
5120,GO:0010941,0.261757235780989,0.826360481617812,13,1470,regulation of cell death,BP,PDK4;FADD;TRADD;PYCARD;G0S2;ACAA2;RGN;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
11881,GO:0044724,0.262462456633027,0.921962512142858,2,138,single-organism carbohydrate catabolic process,BP,GALT;HEXB
3439,GO:0006775,0.262541715522267,0.963147035331392,1,41,fat-soluble vitamin metabolic process,BP,CYP11A1
21003,GO:2000107,0.263737374207052,0.962771905348331,1,42,negative regulation of leukocyte apoptotic process,BP,FADD
7099,GO:0022409,0.263904429483733,0.896251699720751,3,244,positive regulation of cell-cell adhesion,BP,FADD;PNP;PYCARD
14668,GO:0060038,0.264522220649308,0.962500179546221,1,44,cardiac muscle cell proliferation,BP,RBP4
4529,GO:0009306,0.264794466575635,0.866643169538529,5,480,protein secretion,BP,PNP;PYCARD;RBP4;ANG;RPH3AL
8045,GO:0031638,0.265283036816764,0.962329960997339,1,41,zymogen activation,BP,FADD
783,GO:0001960,0.265530791857053,0.962235371649668,1,42,negative regulation of cytokine-mediated signaling pathway,BP,NOL3
11625,GO:0044088,0.266497566992754,0.961906358343075,1,44,regulation of vacuole organization,BP,TBC1D14
7887,GO:0031329,0.266582007547939,0.855975790927999,6,606,regulation of cellular catabolic process,BP,APOC1;TBC1D14;PSMB10;RGN;TICAM1;IDH1
13963,GO:0051241,0.267047014019086,0.836725059035871,9,976,negative regulation of multicellular organismal process,BP,APOC1;PYCARD;RGN;RBP4;NMI;NOL3;TMEM176A;S100B;LINGO1
11989,GO:0045055,0.268367697405562,0.84713878938529,7,723,regulated exocytosis,BP,PNP;PYCARD;HEXB;IDH1;GLA;RPH3AL;DERA
8650,GO:0032653,0.268554294531672,0.961321132785309,1,42,regulation of interleukin-10 production,BP,PYCARD
2666,GO:0005575,0.269929319057044,0.874411277918592,125,16973,cellular_component,CC,CFB;EBP;PDK4;PECR;TMEM160;TMEM164;ALG5;PHYH;IFI30;DPM3;TH;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;ACAA2;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;TMEM223;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;TMEM176A;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;MDP1;TFPI;STAR;SNX21;WBP1;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;PRRT1;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
4093,GO:0008347,0.270414405976245,0.960713479581366,1,44,glial cell migration,BP,HEXB
13980,GO:0051262,0.270912194109743,0.917763845373099,2,140,protein tetramerization,BP,PCBD1;DECR1
13714,GO:0050865,0.271174807990901,0.862279174670443,5,479,regulation of cell activation,BP,FADD;PNP;PYCARD;TICAM1;SHPK
13275,GO:0048538,0.271263577664814,0.960433781614401,1,45,thymus development,BP,FADD
1076,GO:0002443,0.271488469353802,0.844847882440465,7,717,leukocyte mediated immunity,BP,FADD;PNP;PYCARD;HEXB;IDH1;GLA;DERA
2663,GO:0005548,0.271841838061066,0.960220657493433,1,47,phospholipid transporter activity,MF,ABCG1
9160,GO:0033673,0.272012621983685,0.891448862901263,3,251,negative regulation of kinase activity,BP,PYCARD;RGN;DEPTOR
11031,GO:0042771,0.272317440843384,0.960145858948807,1,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,PYCARD
10878,GO:0042516,0.27275418776337,0.96001051802896,1,43,regulation of tyrosine phosphorylation of Stat3 protein,BP,GHR
9765,GO:0035306,0.273177491207066,0.959840972773868,1,45,positive regulation of dephosphorylation,BP,RGN
14672,GO:0060042,0.273513403280511,0.959718559658054,1,46,retina morphogenesis in camera-type eye,BP,RBP4
4561,GO:0009409,0.273552951790482,0.959742779380931,1,44,response to cold,BP,ACADVL
13405,GO:0048771,0.273755453276946,0.916313364944447,2,144,tissue remodeling,BP,PDK4;NOL3
16353,GO:0071248,0.273832613566691,0.916283818171868,2,142,cellular response to metal ion,BP,TH;STAR
9708,GO:0035176,0.274466918980673,0.959403606892272,1,47,social behavior,BP,TH
14217,GO:0051703,0.274466918980673,0.959403606892272,1,47,intraspecies interaction between organisms,BP,TH
2105,GO:0004601,0.274707813487488,0.959401975804268,1,43,peroxidase activity,MF,MGST2
4262,GO:0008631,0.274834581708165,0.959342578003246,1,44,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,NOL3
13643,GO:0050766,0.274927958152871,0.959294467567433,1,45,positive regulation of phagocytosis,BP,PYCARD
6194,GO:0016903,0.275103892099758,0.959258201353294,1,44,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,AOX1
21363,GO:2000649,0.275723459558389,0.959026592587922,1,46,regulation of sodium ion transmembrane transporter activity,BP,FXYD1
7606,GO:0030834,0.276414376545409,0.958808912053286,1,46,regulation of actin filament depolymerization,BP,TMOD4
14574,GO:0055021,0.277655007451322,0.958416415383065,1,46,regulation of cardiac muscle tissue growth,BP,RBP4
7921,GO:0031396,0.277806409888256,0.887976075087591,3,252,regulation of protein ubiquitination,BP,PSMB10;TICAM1;NMI
8729,GO:0032781,0.277887217603743,0.958400592355604,1,43,positive regulation of ATPase activity,BP,RGN
13325,GO:0048641,0.277927638039351,0.958329883895644,1,46,regulation of skeletal muscle tissue development,BP,S100B
14171,GO:0051604,0.278113438680213,0.887793370907108,3,251,protein maturation,BP,CFB;FADD;NOL3
18113,GO:0098656,0.27818655835806,0.887724237078847,3,262,anion transmembrane transport,BP,CPT2;FXYD1;SLC1A3
10869,GO:0042503,0.278190181933496,0.958284243018025,1,44,tyrosine phosphorylation of Stat3 protein,BP,GHR
16395,GO:0071320,0.278473416426539,0.958138634315133,1,47,cellular response to cAMP,BP,STAR
11803,GO:0044433,0.278744367400343,0.815754531179465,12,1367,cytoplasmic vesicle part,CC,TH;ZFYVE21;PNP;PYCARD;TICAM1;HEXB;GRIA3;IDH1;SNX21;GLA;RPH3AL;DERA
15486,GO:0061383,0.279390671309901,0.957845965488255,1,47,trabecula morphogenesis,BP,RBP4
11425,GO:0043487,0.279502490503978,0.913386386280566,2,144,regulation of RNA stability,BP,PSMB10;RNASEL
5592,GO:0015758,0.279510338196633,0.913363676046703,2,148,glucose transport,BP,RNASEL;HNF1A
8622,GO:0032613,0.279589540028402,0.95783838461249,1,44,interleukin-10 production,BP,PYCARD
10773,GO:0042345,0.280769167248766,0.95744079824344,1,45,regulation of NF-kappaB import into nucleus,BP,NOL3
10776,GO:0042348,0.280769167248766,0.95744079824344,1,45,NF-kappaB import into nucleus,BP,NOL3
4005,GO:0008206,0.281757236824179,0.95712265528209,1,45,bile acid metabolic process,BP,STAR
14485,GO:0052742,0.281945856418874,0.956990549341309,1,49,phosphatidylinositol kinase activity,MF,FGF18
12040,GO:0045123,0.281998144309188,0.957025908422218,1,46,cellular extravasation,BP,FADD
7609,GO:0030837,0.282071537032523,0.956984013580425,1,47,negative regulation of actin filament polymerization,BP,TMOD4
7402,GO:0030335,0.282549922433982,0.867270821193603,4,379,positive regulation of cell migration,BP,FADD;PYCARD;FGF18;FAM110C
11350,GO:0043330,0.282917599501696,0.956767305901737,1,44,response to exogenous dsRNA,BP,TICAM1
8648,GO:0032651,0.283880104609217,0.956415389283645,1,46,regulation of interleukin-1 beta production,BP,PYCARD
10227,GO:0036092,0.284254513455984,0.956223964138874,1,50,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF18
5167,GO:0012501,0.284321275808863,0.800684531713733,16,1885,programmed cell death,BP,PDK4;FADD;TRADD;PYCARD;G0S2;KRT10;ACAA2;RGN;ASAH2;TICAM1;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
13278,GO:0048545,0.28436060721366,0.866072768402538,4,376,response to steroid hormone,BP,TH;IDH1;STAR;S100B
18657,GO:1901028,0.284711658350296,0.956163425256951,1,45,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,ACAA2
2659,GO:0005544,0.284806290512905,0.956113149804914,1,46,calcium-dependent phospholipid binding,MF,RPH3AL
4267,GO:0008645,0.285238345591384,0.910392148949771,2,150,hexose transport,BP,RNASEL;HNF1A
5572,GO:0015718,0.285358847672675,0.910348073930212,2,146,monocarboxylic acid transport,BP,CPT2;FABP3
14886,GO:0060350,0.285365813097763,0.955893569659082,1,48,endochondral bone morphogenesis,BP,FGF18
3222,GO:0006486,0.285459457804326,0.883307045884466,3,261,protein glycosylation,BP,ALG5;DPM3;EXTL1
11393,GO:0043413,0.285459457804326,0.883307045884466,3,261,macromolecule glycosylation,BP,ALG5;DPM3;EXTL1
4931,GO:0010676,0.286128845353618,0.955642909209355,1,48,positive regulation of cellular carbohydrate metabolic process,BP,RGN
13648,GO:0050771,0.28717588846682,0.955280337542891,1,49,negative regulation of axonogenesis,BP,LINGO1
3532,GO:0006915,0.287570443650576,0.800233243553112,15,1763,apoptotic process,BP,PDK4;FADD;TRADD;PYCARD;G0S2;ACAA2;RGN;ASAH2;TICAM1;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
15178,GO:0060761,0.287798978942385,0.955128509267161,1,46,negative regulation of response to cytokine stimulus,BP,NOL3
21644,GO:2001242,0.288200978479863,0.908871336600638,2,144,regulation of intrinsic apoptotic signaling pathway,BP,PYCARD;NOL3
19607,GO:1903428,0.288785973899076,0.954782027075423,1,47,positive regulation of reactive oxygen species biosynthetic process,BP,TICAM1
2529,GO:0005231,0.288877917843085,0.954733183310389,1,48,excitatory extracellular ligand-gated ion channel activity,MF,GRIA3
16205,GO:0070936,0.28897888499026,0.954699572916823,1,48,protein K48-linked ubiquitination,BP,NMI
4920,GO:0010660,0.289197331281334,0.954645108269486,1,47,regulation of muscle cell apoptotic process,BP,NOL3
17075,GO:0072522,0.289501228515046,0.880839396811069,3,254,purine-containing compound biosynthetic process,BP,MRAP;PNP;ACAT1
1203,GO:0002683,0.289793016974027,0.862447928928469,4,373,negative regulation of immune system process,BP,FADD;TICAM1;NMI;TMEM176A
9280,GO:0034121,0.289865592091714,0.954403797488204,1,48,regulation of toll-like receptor signaling pathway,BP,TICAM1
14035,GO:0051353,0.290015606114939,0.954372054172985,1,47,positive regulation of oxidoreductase activity,BP,RGN
6843,GO:0021545,0.290086850064684,0.954329824042419,1,48,cranial nerve development,BP,SLC1A3
6098,GO:0016763,0.290335983373159,0.954264894019614,1,47,transferase activity, transferring pentosyl groups,MF,PNP
5590,GO:0015749,0.290340084808247,0.907706920999062,2,152,monosaccharide transport,BP,RNASEL;HNF1A
7204,GO:0030042,0.29045211498638,0.954189853096739,1,49,actin filament depolymerization,BP,TMOD4
4603,GO:0009628,0.29066924087488,0.813737768432606,10,1129,response to abiotic stimulus,BP,TH;FADD;ACADVL;ACAA2;PSMB10;ANG;NOL3;STAR;S100B;SLC1A3
6061,GO:0016684,0.290869484297811,0.954105451290434,1,46,oxidoreductase activity, acting on peroxide as acceptor,MF,MGST2
14600,GO:0055080,0.291190201333224,0.838175155495281,6,624,cation homeostasis,BP,PDK4;SLC31A2;BDH2;RGN;HEXB;NOL3
7129,GO:0022824,0.292811518667045,0.953395339537437,1,49,transmitter-gated ion channel activity,MF,GRIA3
7134,GO:0022835,0.292811518667045,0.953395339537437,1,49,transmitter-gated channel activity,MF,GRIA3
8866,GO:0032984,0.293512070600355,0.878344745557155,3,258,macromolecular complex disassembly,BP,MRPL14;MRPL16;TMOD4
16700,GO:0071822,0.294335026517177,0.799965833399818,13,1516,protein complex subunit organization,BP,MRPL14;MRPL16;FADD;TRADD;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
3917,GO:0008064,0.294886152969822,0.905292480607741,2,152,regulation of actin polymerization or depolymerization,BP,PYCARD;TMOD4
7277,GO:0030170,0.296110491841942,0.952309044242578,1,47,pyridoxal phosphate binding,MF,ACCS
15848,GO:0070279,0.296110491841942,0.952309044242578,1,47,vitamin B6 binding,MF,ACCS
3585,GO:0007005,0.296996127787906,0.844155773181396,5,495,mitochondrion organization,BP,PYCARD;ACAA2;HSD17B10;NOL3;PUS1
7604,GO:0030832,0.297108802906226,0.904097158067928,2,153,regulation of actin filament length,BP,PYCARD;TMOD4
1261,GO:0002758,0.298125948714981,0.875447164035841,3,264,innate immune response-activating signal transduction,BP,FADD;PSMB10;TICAM1
16521,GO:0071496,0.29881455075181,0.875005329813561,3,268,cellular response to external stimulus,BP,PDK4;FADD;FADS1
15812,GO:0070231,0.299355602383694,0.951169942849734,1,48,T cell apoptotic process,BP,FADD
10707,GO:0042220,0.299589228841714,0.951051854193923,1,50,response to cocaine,BP,FADD
4832,GO:0010518,0.300062860458622,0.950886896074697,1,50,positive regulation of phospholipase activity,BP,ANG
9571,GO:0034702,0.30097811056572,0.873626584907899,3,275,ion channel complex,CC,FXYD1;GRIA3;CPT1C
17227,GO:0080134,0.301262119013231,0.801107637862863,11,1266,regulation of response to stress,BP,CFB;FADD;PYCARD;PSMB10;RGN;TICAM1;NMI;SHPK;NOL3;CASP4;FAM46A
9470,GO:0034470,0.301480965197128,0.854528025855318,4,372,ncRNA processing,BP,LAGE3;HSD17B10;RNASEL;PUS1
15724,GO:0070085,0.301908375281845,0.873052068870188,3,269,glycosylation,BP,ALG5;DPM3;EXTL1
13605,GO:0050708,0.302201899907975,0.854013729493099,4,386,regulation of protein secretion,BP,PYCARD;RBP4;ANG;RPH3AL
12764,GO:0046661,0.302362641982764,0.901246576763222,2,155,male sex differentiation,BP,HSD17B3;STAR
9425,GO:0034394,0.302526594141749,0.949989023403946,1,52,protein localization to cell surface,BP,MRAP
3306,GO:0006584,0.302579985606476,0.950023364447478,1,49,catecholamine metabolic process,BP,TH
4621,GO:0009712,0.302579985606476,0.950023364447478,1,49,catechol-containing compound metabolic process,BP,TH
13837,GO:0051050,0.302619111896116,0.814666508637062,8,889,positive regulation of transport,BP,ABCG1;PYCARD;RGN;FXYD1;RBP4;RNASEL;ANG;RPH3AL
2703,GO:0005637,0.302858283419938,0.949889142063605,1,51,nuclear inner membrane,CC,IFI27
8065,GO:0031663,0.302949563667032,0.949893164475697,1,49,lipopolysaccharide-mediated signaling pathway,BP,TICAM1
14028,GO:0051346,0.302973048725345,0.853487838595398,4,384,negative regulation of hydrolase activity,BP,APOC1;RGN;NOL3;TFPI
9576,GO:0034707,0.303082130440154,0.949827926421816,1,50,chloride channel complex,CC,FXYD1
8371,GO:0032270,0.303115254755981,0.795945820602043,12,1396,positive regulation of cellular protein metabolic process,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;IFI27;RBMS3
16787,GO:0072001,0.303250933848664,0.872181766975432,3,278,renal system development,BP,RGN;RBP4;ACAT1
14941,GO:0060420,0.303584291299985,0.949632735254147,1,51,regulation of heart growth,BP,RBP4
4911,GO:0010647,0.304000304110994,0.791982827057925,13,1530,positive regulation of cell communication,BP,FADD;TRADD;PYCARD;G0S2;PSMB10;GHR;FGF18;TICAM1;RBP4;FAM110C;S100B;DOK1;SLC1A3
3606,GO:0007033,0.304491727943848,0.900075197121052,2,157,vacuole organization,BP,TBC1D14;HEXB
6570,GO:0019320,0.305025343593826,0.949158302435603,1,49,hexose catabolic process,BP,GALT
1360,GO:0002920,0.305537750657574,0.948975965245428,1,49,regulation of humoral immune response,BP,CFB
19200,GO:1902533,0.306462423932707,0.811658493554744,8,885,positive regulation of intracellular signal transduction,BP,FADD;TRADD;PYCARD;GHR;FGF18;TICAM1;FAM110C;S100B
21027,GO:2000147,0.306543866875292,0.851017907717158,4,393,positive regulation of cell motility,BP,FADD;PYCARD;FGF18;FAM110C
964,GO:0002253,0.306625855250514,0.837210526868386,5,507,activation of immune response,BP,CFB;FADD;PYCARD;PSMB10;TICAM1
1266,GO:0002763,0.306858608400468,0.948485285146575,1,50,positive regulation of myeloid leukocyte differentiation,BP,FADD
16452,GO:0071398,0.306896672506203,0.948435937216301,1,52,cellular response to fatty acid,BP,PDK4
13934,GO:0051193,0.307607894826471,0.948180617646765,1,52,regulation of cofactor metabolic process,BP,PDK4
13937,GO:0051196,0.307607894826471,0.948180617646765,1,52,regulation of coenzyme metabolic process,BP,PDK4
18154,GO:0098771,0.308029904859192,0.825646271995322,6,638,inorganic ion homeostasis,BP,PDK4;SLC31A2;BDH2;RGN;HEXB;NOL3
12002,GO:0045071,0.3080792230475,0.948047006611178,1,50,negative regulation of viral genome replication,BP,RNASEL
1281,GO:0002790,0.308145112292182,0.836103829331501,5,511,peptide secretion,BP,PNP;PYCARD;RBP4;ANG;RPH3AL
12189,GO:0045453,0.308437520380963,0.94789956509051,1,51,bone resorption,BP,PDK4
3298,GO:0006576,0.308455371639174,0.947930662225418,1,49,cellular biogenic amine metabolic process,BP,SARDH
4917,GO:0010657,0.309423308298779,0.947543442078752,1,51,muscle cell apoptotic process,BP,NOL3
12746,GO:0046635,0.309917870154283,0.947382820787613,1,50,positive regulation of alpha-beta T cell activation,BP,PNP
20074,GO:1904427,0.310423462659336,0.947162810444834,1,52,positive regulation of calcium ion transmembrane transport,BP,RGN
7173,GO:0023056,0.310490837291194,0.786583803900766,13,1538,positive regulation of signaling,BP,FADD;TRADD;PYCARD;G0S2;PSMB10;GHR;FGF18;TICAM1;RBP4;FAM110C;S100B;DOK1;SLC1A3
18952,GO:1901880,0.310670774921166,0.947055614340627,1,53,negative regulation of protein depolymerization,BP,TMOD4
740,GO:0001910,0.310955880736654,0.947005729178454,1,50,regulation of leukocyte mediated cytotoxicity,BP,FADD
2048,GO:0004521,0.31323748956995,0.946171456382592,1,50,endoribonuclease activity,MF,RNASEL
5406,GO:0015179,0.313770095425049,0.945938325265149,1,52,L-amino acid transmembrane transporter activity,MF,SLC1A3
1229,GO:0002709,0.315887473329216,0.945173859097485,1,51,regulation of T cell mediated immunity,BP,FADD
5292,GO:0014855,0.316438410399463,0.944915409919584,1,54,striated muscle cell proliferation,BP,RBP4
12692,GO:0046530,0.317016214279356,0.944683374698924,1,55,photoreceptor cell differentiation,BP,TH
1170,GO:0002637,0.317339075212291,0.944633508229974,1,51,regulation of immunoglobulin production,BP,RBP4
17799,GO:0097193,0.317349069371076,0.863129186838842,3,273,intrinsic apoptotic signaling pathway,BP,PYCARD;NOL3;CASP4
487,GO:0001510,0.317430356099092,0.944599428092572,1,51,RNA methylation,BP,HSD17B10
11804,GO:0044437,0.317694294859004,0.829111388572445,5,517,vacuolar part,CC,IFI30;PYCARD;IDUA;HEXB;GLA
5490,GO:0015370,0.318267687610363,0.944231908210699,1,54,solute:sodium symporter activity,MF,SLC1A3
13967,GO:0051249,0.318696891295393,0.842551471109777,4,390,regulation of lymphocyte activation,BP,FADD;PNP;PYCARD;TICAM1
8434,GO:0032370,0.319608315271687,0.943745496062444,1,53,positive regulation of lipid transport,BP,ABCG1
4728,GO:0010043,0.320662994641972,0.943365666550366,1,52,response to zinc ion,BP,TH
12748,GO:0046637,0.321066969815361,0.943194347686319,1,53,regulation of alpha-beta T cell differentiation,BP,PNP
19550,GO:1903320,0.321131104580695,0.860653746150454,3,274,regulation of protein modification by small protein conjugation or removal,BP,PSMB10;TICAM1;NMI
13986,GO:0051272,0.322094404549991,0.840134939496365,4,403,positive regulation of cellular component movement,BP,FADD;PYCARD;FGF18;FAM110C
1205,GO:0002685,0.322887785963994,0.889781025175217,2,156,regulation of leukocyte migration,BP,FADD;PYCARD
14834,GO:0060291,0.323309306429505,0.942289072724553,1,56,long-term synaptic potentiation,BP,S100B
19488,GO:1903201,0.323653728104263,0.942191349232454,1,54,regulation of oxidative stress-induced cell death,BP,NOL3
1634,GO:0003723,0.323674233048895,0.775525777381495,13,1541,RNA binding,MF,MRPL14;MRPL16;ACAA2;ARL6IP4;HSD17B10;RNASEL;ANG;TSFM;NOL3;NUDT7;FAM46A;PUS1;RBMS3
19123,GO:1902305,0.325107617465515,0.941598910414884,1,56,regulation of sodium ion transmembrane transport,BP,FXYD1
14027,GO:0051345,0.325259564914965,0.796732931487075,8,925,positive regulation of hydrolase activity,BP,FADD;TRADD;TBC1D14;PYCARD;RGN;FGF18;ANG;IFI27
8877,GO:0033002,0.325483083290981,0.888252275179857,2,164,muscle cell proliferation,BP,RBP4;ANG
11287,GO:0043242,0.325547650927372,0.941429314986772,1,56,negative regulation of protein complex disassembly,BP,TMOD4
13958,GO:0051235,0.325780010789425,0.85756639427687,3,284,maintenance of location,BP,ABCG1;HEXB;NOL3
11205,GO:0043124,0.3258714107239,0.941304352707929,1,56,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,PYCARD
17871,GO:0097345,0.325963447365723,0.941321648370694,1,53,mitochondrial outer membrane permeabilization,BP,ACAA2
3611,GO:0007040,0.32625680185961,0.941172406675853,1,55,lysosome organization,BP,HEXB
17234,GO:0080171,0.32625680185961,0.941172406675853,1,55,lytic vacuole organization,BP,HEXB
5226,GO:0014070,0.327314034152212,0.795092393212795,8,908,response to organic cyclic compound,BP,TH;FADD;TICAM1;ACAT1;IDH1;TFPI;STAR;S100B
19740,GO:1903708,0.327570981542323,0.887055808970256,2,162,positive regulation of hemopoiesis,BP,FADD;PNP
2637,GO:0005507,0.32819438733897,0.940438300907719,1,54,copper ion binding,MF,ANG
7273,GO:0030166,0.328265489066788,0.940342911890541,1,58,proteoglycan biosynthetic process,BP,EXTL1
15809,GO:0070228,0.328699733727731,0.940241334026187,1,54,regulation of lymphocyte apoptotic process,BP,FADD
15706,GO:0070059,0.329288696287122,0.939993343935693,1,55,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,CASP4
4022,GO:0008235,0.329577594590783,0.939880292303587,1,55,metalloexopeptidase activity,MF,PEPD
18174,GO:0098802,0.329917408339202,0.88566143981313,2,169,plasma membrane receptor complex,CC,GRIA3;CPT1C
1640,GO:0003730,0.330122343275383,0.93963259266401,1,57,mRNA 3'-UTR binding,MF,RBMS3
508,GO:0001541,0.33020157287976,0.939635699001274,1,55,ovarian follicle development,BP,ANG
19036,GO:1902110,0.331246011837345,0.939243179858827,1,54,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,ACAA2
19267,GO:1902686,0.331246011837345,0.939243179858827,1,54,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,ACAA2
3456,GO:0006801,0.331285906074529,0.939227465290393,1,54,superoxide metabolic process,BP,RGN
6099,GO:0016765,0.331373043840899,0.939212006114063,1,53,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,MGST2
946,GO:0002221,0.331860544307132,0.884545583519694,2,165,pattern recognition receptor signaling pathway,BP,FADD;TICAM1
6234,GO:0017022,0.33199040814278,0.93889674183078,1,57,myosin binding,MF,PYCARD
8372,GO:0032271,0.332203810896807,0.884340094185829,2,166,regulation of protein polymerization,BP,PYCARD;TMOD4
8620,GO:0032611,0.332891514820156,0.938557018361988,1,56,interleukin-1 beta production,BP,PYCARD
13622,GO:0050727,0.333027181639232,0.852745454197851,3,280,regulation of inflammatory response,BP,CFB;SHPK;CASP4
2661,GO:0005546,0.333095530175239,0.938459001351956,1,57,phosphatidylinositol-4,5-bisphosphate binding,MF,SNX21
14019,GO:0051336,0.33352766540459,0.774468487377399,11,1321,regulation of hydrolase activity,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;RGN;FGF18;ANG;NOL3;IFI27;TFPI
18747,GO:1901264,0.333622035928372,0.938303160905126,1,54,carbohydrate derivative transport,BP,ABCG1
7647,GO:0030888,0.333714323415468,0.938230262863031,1,56,regulation of B cell proliferation,BP,TICAM1
16348,GO:0071241,0.333842897020713,0.88338344788862,2,165,cellular response to inorganic substance,BP,TH;STAR
3928,GO:0008083,0.334060229334469,0.883285005761703,2,159,growth factor activity,MF,FGF18;NUDT6
13978,GO:0051260,0.334127167681935,0.851999619463639,3,283,protein homooligomerization,BP,ACAT1;PCBD1;DECR1
8602,GO:0032592,0.334891572583391,0.937797482002299,1,54,integral component of mitochondrial membrane,CC,ETFDH
1219,GO:0002699,0.33530020357615,0.882540119588799,2,162,positive regulation of immune effector process,BP,FADD;RBP4
119,GO:0000245,0.335635681282094,0.937481332554047,1,55,spliceosomal complex assembly,BP,NOL3
3556,GO:0006956,0.335684083976929,0.937461947090396,1,55,complement activation,BP,CFB
4504,GO:0009247,0.336395674892551,0.937176551327167,1,55,glycolipid biosynthetic process,BP,DPM3
2702,GO:0005635,0.337286335846865,0.829240868116676,4,412,nuclear envelope,CC,EBP;MGST2;IFI27;DHCR7
1641,GO:0003735,0.337442616018535,0.881315579459878,2,154,structural constituent of ribosome,MF,MRPL14;MRPL16
5975,GO:0016529,0.337851765319916,0.936521066713004,1,59,sarcoplasmic reticulum,CC,NOL3
8071,GO:0031669,0.338423441408731,0.880658762163893,2,169,cellular response to nutrient levels,BP,PDK4;FADS1
4824,GO:0010507,0.338609938471059,0.936214214694993,1,59,negative regulation of autophagy,BP,TBC1D14
8373,GO:0032272,0.338785608400867,0.936159475507797,1,58,negative regulation of protein polymerization,BP,TMOD4
9530,GO:0034641,0.338926277785763,0.725773723903712,47,6132,cellular nitrogen compound metabolic process,BP,TH;MRPL14;MRPL16;FADD;MRAP;TRADD;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;MGST2;PSMB10;RGN;FADS1;GHR;ASAH2;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;AOX1;SARDH;SHPK;HEXB;NOL3;NUDT7;CPT1C;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;ACP5;GLA;DERA;PTS;RBMS3;HNF1A
18069,GO:0098573,0.338994404582613,0.93612789806582,1,55,intrinsic component of mitochondrial membrane,CC,ETFDH
3204,GO:0006461,0.339974905646576,0.769054648136051,11,1312,protein complex assembly,BP,FADD;TRADD;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
15843,GO:0070271,0.339974905646576,0.769054648136051,11,1312,protein complex biogenesis,BP,FADD;TRADD;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
10057,GO:0035794,0.34060086728249,0.935456110722114,1,56,positive regulation of mitochondrial membrane permeability,BP,ACAA2
8628,GO:0032623,0.341096811286492,0.93523569091836,1,57,interleukin-2 production,BP,PNP
18318,GO:0099503,0.341154035828613,0.783895794809326,8,905,secretory vesicle,CC,TH;PNP;PYCARD;HEXB;IDH1;GLA;RPH3AL;DERA
4634,GO:0009749,0.341179321230295,0.879011979884302,2,170,response to glucose,BP,TH;STAR
7906,GO:0031349,0.341739634559419,0.826010608636711,4,406,positive regulation of defense response,BP,FADD;PYCARD;PSMB10;TICAM1
14589,GO:0055065,0.342052622929174,0.810839835765254,5,537,metal ion homeostasis,BP,SLC31A2;BDH2;RGN;HEXB;NOL3
2301,GO:0004866,0.342598442268549,0.878190782007916,2,164,endopeptidase inhibitor activity,MF,NOL3;TFPI
1096,GO:0002478,0.343673776042415,0.877540235131145,2,165,antigen processing and presentation of exogenous peptide antigen,BP,IFI30;PSMB10
1878,GO:0004175,0.343919691461956,0.824418464291154,4,405,endopeptidase activity,MF,CFB;PYCARD;PSMB10;CASP4
20210,GO:1904724,0.343988044868663,0.934084562916662,1,55,tertiary granule lumen,CC,IDH1
8886,GO:0033013,0.344824187676463,0.93370151039514,1,57,tetrapyrrole metabolic process,BP,BDH2
1282,GO:0002791,0.344834917063246,0.823737623426778,4,412,regulation of peptide secretion,BP,PYCARD;RBP4;ANG;RPH3AL
3737,GO:0007259,0.344896280791266,0.876799397726929,2,166,JAK-STAT cascade,BP,GHR;NMI
18021,GO:0097696,0.344896280791266,0.876799397726929,2,166,STAT cascade,BP,GHR;NMI
8649,GO:0032652,0.344918318377107,0.933644821899528,1,58,regulation of interleukin-1 production,BP,PYCARD
20597,GO:1905710,0.345780697839199,0.933304448844558,1,57,positive regulation of membrane permeability,BP,ACAA2
14884,GO:0060348,0.346035391617439,0.876074514014773,2,174,bone development,BP,RGN;FGF18
16441,GO:0071385,0.34671514261928,0.932897360073995,1,58,cellular response to glucocorticoid stimulus,BP,STAR
7898,GO:0031341,0.346719194628685,0.932913525648731,1,57,regulation of cell killing,BP,FADD
15322,GO:0061035,0.347218104552302,0.932653241221479,1,60,regulation of cartilage development,BP,FGF18
11252,GO:0043195,0.347337849946121,0.93258695907699,1,61,terminal bouton,CC,TH
12590,GO:0046324,0.347599463246221,0.932477404138854,1,61,regulation of glucose import,BP,RNASEL
2303,GO:0004869,0.348288066068274,0.932257057361368,1,57,cysteine-type endopeptidase inhibitor activity,MF,NOL3
4831,GO:0010517,0.348626471228931,0.932062627460406,1,60,regulation of phospholipase activity,BP,ANG
7767,GO:0031099,0.350397496211463,0.873442556409985,2,170,regeneration,BP,RGN;NNMT
10589,GO:0040017,0.351591244478028,0.818744869482691,4,421,positive regulation of locomotion,BP,FADD;PYCARD;FGF18;FAM110C
12613,GO:0046365,0.351828322479625,0.930743628574179,1,58,monosaccharide catabolic process,BP,GALT
10890,GO:0042531,0.351945382380788,0.930693857235942,1,58,positive regulation of tyrosine phosphorylation of STAT protein,BP,GHR
12414,GO:0045913,0.352360152779488,0.930449566657545,1,62,positive regulation of carbohydrate metabolic process,BP,RGN
9763,GO:0035304,0.352839177787256,0.930261345311062,1,61,regulation of protein dephosphorylation,BP,RGN
14219,GO:0051705,0.352994287145125,0.930163293276539,1,63,multi-organism behavior,BP,TH
10656,GO:0042108,0.353892564111475,0.929827579668811,1,60,positive regulation of cytokine biosynthetic process,BP,TICAM1
7256,GO:0030141,0.354054252401764,0.780806001175335,7,787,secretory granule,CC,PNP;PYCARD;HEXB;IDH1;GLA;RPH3AL;DERA
6668,GO:0019693,0.354300642811741,0.801431808844453,5,535,ribose phosphate metabolic process,BP,MRAP;ACAT1;SHPK;NUDT7;DERA
11174,GO:0043066,0.354361434450459,0.780551466023504,7,795,negative regulation of apoptotic process,BP,PDK4;FADD;TRADD;ACAA2;RGN;NOL3;STAR
4633,GO:0009746,0.354638509152272,0.870817279921287,2,175,response to hexose,BP,TH;STAR
10798,GO:0042379,0.355812372022121,0.929056746341202,1,57,chemokine receptor binding,MF,CNIH4
9544,GO:0034660,0.355925722156958,0.800177902310061,5,529,ncRNA metabolic process,BP,LAGE3;HSD17B10;RNASEL;ANG;PUS1
8781,GO:0032845,0.356115642292618,0.86989600793813,2,177,negative regulation of homeostatic process,BP,FADD;NOL3
12888,GO:0046942,0.357986574380723,0.835573552744067,3,297,carboxylic acid transport,BP,CPT2;FABP3;SLC1A3
10122,GO:0035914,0.358490136806427,0.927807788222873,1,62,skeletal muscle cell differentiation,BP,S100B
13192,GO:0048306,0.35855436618173,0.927813697875594,1,60,calcium-dependent protein binding,MF,S100B
13371,GO:0048708,0.358585276696438,0.92776633274998,1,62,astrocyte differentiation,BP,S100B
484,GO:0001505,0.359318377838867,0.867894200195372,2,180,regulation of neurotransmitter levels,BP,TH;SLC1A3
15381,GO:0061135,0.359411301484844,0.867882622699083,2,170,endopeptidase regulator activity,MF,NOL3;TFPI
19431,GO:1903052,0.359683891747263,0.867703010179215,2,172,positive regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10;RGN
6361,GO:0018149,0.360022994249284,0.927190300590022,1,59,peptide cross-linking,BP,KRT10
6748,GO:0019884,0.361923051629323,0.86630335934368,2,172,antigen processing and presentation of exogenous antigen,BP,IFI30;PSMB10
16440,GO:0071384,0.361973241839703,0.926297979531448,1,61,cellular response to corticosteroid stimulus,BP,STAR
10910,GO:0042562,0.362403064704649,0.9260912890815,1,62,hormone binding,MF,GHR
4017,GO:0008219,0.362606452680552,0.733498258789021,16,1990,cell death,BP,PDK4;FADD;TRADD;PYCARD;G0S2;KRT10;ACAA2;RGN;ASAH2;TICAM1;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
13565,GO:0050663,0.362926341723333,0.865664347883653,2,174,cytokine secretion,BP,PNP;PYCARD
5616,GO:0015807,0.363039374069858,0.925793383353212,1,63,L-amino acid transport,BP,SLC1A3
7434,GO:0030414,0.363287696755194,0.865446914722384,2,172,peptidase inhibitor activity,MF,NOL3;TFPI
4021,GO:0008234,0.363658049236448,0.865181269420438,2,179,cysteine-type peptidase activity,MF,PYCARD;CASP4
6306,GO:0017158,0.363861903477117,0.925396982403036,1,65,regulation of calcium ion-dependent exocytosis,BP,RPH3AL
13836,GO:0051049,0.36404568322067,0.737673854336573,14,1748,regulation of transport,BP,SLC31A2;APOC1;TBC1D14;ABCG1;PYCARD;ACAA2;RGN;FXYD1;RBP4;RNASEL;ANG;NOL3;IFI27;RPH3AL
3478,GO:0006836,0.364205114781769,0.864819222324325,2,183,neurotransmitter transport,BP,TH;SLC1A3
9135,GO:0033613,0.364464957349893,0.925144458953543,1,64,activating transcription factor binding,MF,IFI27
5108,GO:0010923,0.364803674566655,0.924977943732866,1,65,negative regulation of phosphatase activity,BP,RGN
7499,GO:0030574,0.3657600176615,0.924535734600386,1,66,collagen catabolic process,BP,PEPD
966,GO:0002260,0.366305570359481,0.924338930103607,1,63,lymphocyte homeostasis,BP,FADD
8475,GO:0032414,0.366450939537996,0.924226349092114,1,66,positive regulation of ion transmembrane transporter activity,BP,RGN
11177,GO:0043069,0.366741348976879,0.770405654282298,7,806,negative regulation of programmed cell death,BP,PDK4;FADD;TRADD;ACAA2;RGN;NOL3;STAR
14775,GO:0060193,0.36692021184708,0.92406337217923,1,63,positive regulation of lipase activity,BP,ANG
8240,GO:0032024,0.36754716616829,0.923781687282924,1,63,positive regulation of insulin secretion,BP,RBP4
9362,GO:0034284,0.367597873613884,0.862686962832446,2,180,response to monosaccharide,BP,TH;STAR
10586,GO:0040014,0.367605796402616,0.923722985775777,1,65,regulation of multicellular organism growth,BP,GHR
15909,GO:0070374,0.367946734916395,0.862493503403072,2,174,positive regulation of ERK1 and ERK2 cascade,BP,PYCARD;FGF18
10401,GO:0036498,0.36806312237339,0.923532955361107,1,64,IRE1-mediated unfolded protein response,BP,ACADVL
4266,GO:0008643,0.368065216129629,0.86238567899191,2,181,carbohydrate transport,BP,RNASEL;HNF1A
11413,GO:0043462,0.36859935992022,0.923342203396425,1,61,regulation of ATPase activity,BP,RGN
4699,GO:0009968,0.368693022638707,0.75468672055754,9,1080,negative regulation of signal transduction,BP,FADD;TRADD;PYCARD;ACAA2;PSMB10;TICAM1;NOL3;DEPTOR;RPH3AL
12884,GO:0046934,0.36882697765894,0.923156707151545,1,66,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGF18
13641,GO:0050764,0.369149526421686,0.923042419518616,1,64,regulation of phagocytosis,BP,PYCARD
13082,GO:0048029,0.369213515463098,0.923047121689939,1,62,monosaccharide binding,MF,PHYH
11376,GO:0043393,0.36954553003823,0.861448075048848,2,180,regulation of protein binding,BP,TICAM1;PCBD1
18465,GO:1900076,0.369595614556442,0.922824385688244,1,65,regulation of cellular response to insulin stimulus,BP,RNASEL
8473,GO:0032412,0.369666262744133,0.86135330494077,2,184,regulation of ion transmembrane transporter activity,BP,RGN;FXYD1
19183,GO:1902495,0.369723998398024,0.827220106173074,3,310,transmembrane transporter complex,CC,FXYD1;GRIA3;CPT1C
3246,GO:0006521,0.369759240338837,0.922836066516957,1,60,regulation of cellular amino acid metabolic process,BP,PSMB10
3881,GO:0007626,0.370047728865994,0.861101321233422,2,186,locomotory behavior,BP,TH;HEXB
568,GO:0001655,0.37100476134054,0.826294847642732,3,313,urogenital system development,BP,RGN;RBP4;ACAT1
7895,GO:0031338,0.3711716281346,0.922092536604058,1,66,regulation of vesicle fusion,BP,TBC1D14
502,GO:0001533,0.371856504134927,0.921828907573315,1,63,cornified envelope,CC,KRT10
13256,GO:0048511,0.371864756208393,0.825692232671659,3,306,rhythmic process,BP,TH;ANG;STAR
14577,GO:0055024,0.371893026416165,0.921763378924512,1,66,regulation of cardiac muscle tissue development,BP,RBP4
18876,GO:1901654,0.371976698228827,0.859894155978818,2,180,response to ketone,BP,TH;STAR
11436,GO:0043502,0.372354170187852,0.921537193362091,1,67,regulation of muscle adaptation,BP,NOL3
18951,GO:1901879,0.372594509997572,0.92144252314384,1,66,regulation of protein depolymerization,BP,TMOD4
18114,GO:0098657,0.373056352768947,0.921215451056112,1,67,import into cell,BP,SLC1A3
12537,GO:0046128,0.3731861109121,0.921187215331504,1,65,purine ribonucleoside metabolic process,BP,PNP
14602,GO:0055082,0.373470392863895,0.774334256983495,6,690,cellular chemical homeostasis,BP,TH;SLC31A2;RGN;HEXB;NOL3;STAR
8277,GO:0032088,0.373776992972893,0.92093228459433,1,64,negative regulation of NF-kappaB transcription factor activity,BP,PYCARD
5642,GO:0015849,0.374856171763251,0.823537604800011,3,305,organic acid transport,BP,CPT2;FABP3;SLC1A3
3480,GO:0006839,0.375203340042789,0.823307870226087,3,296,mitochondrial transport,BP,ACAA2;CPT2;NOL3
9985,GO:0035690,0.376486899442113,0.919664227670207,1,65,cellular response to drug,BP,TH
14571,GO:0055017,0.376571000472096,0.919593334637549,1,67,cardiac muscle tissue growth,BP,RBP4
4053,GO:0008284,0.376743951940216,0.762105846451596,7,816,positive regulation of cell proliferation,BP,FADD;PNP;PYCARD;FGF18;TICAM1;ANG;S100B
9266,GO:0034103,0.376766969271768,0.919518019823664,1,66,regulation of tissue remodeling,BP,PDK4
8568,GO:0032535,0.376865471003327,0.822064597011204,3,313,regulation of cellular component size,BP,PYCARD;DEPTOR;TMOD4
1558,GO:0003333,0.378820506861937,0.918544852462144,1,67,amino acid transmembrane transport,BP,SLC1A3
17607,GO:0090502,0.37926925779056,0.918383957848152,1,64,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,RNASEL
4903,GO:0010639,0.379466469462642,0.820177945994787,3,311,negative regulation of organelle organization,BP,ACAA2;NOL3;TMOD4
15089,GO:0060627,0.380826098159826,0.796576292110818,4,441,regulation of vesicle-mediated transport,BP,APOC1;TBC1D14;PYCARD;RPH3AL
13712,GO:0050863,0.38113194746731,0.818983474315927,3,302,regulation of T cell activation,BP,FADD;PNP;PYCARD
14499,GO:0052813,0.381675853650616,0.917171581725694,1,69,phosphatidylinositol bisphosphate kinase activity,MF,FGF18
13965,GO:0051247,0.381806513943235,0.728952384164988,12,1485,positive regulation of protein metabolic process,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;IFI27;RBMS3
17074,GO:0072521,0.382419747098871,0.779220165811012,5,555,purine-containing compound metabolic process,BP,MRAP;PNP;ACAT1;AOX1;NUDT7
8919,GO:0033077,0.383123014099825,0.916501283722521,1,68,T cell differentiation in thymus,BP,FADD
763,GO:0001938,0.38345225592084,0.916344863232434,1,68,positive regulation of endothelial cell proliferation,BP,ANG
24,GO:0000045,0.384016444435239,0.916061054686219,1,69,autophagosome assembly,BP,TBC1D14
20753,GO:1990351,0.384527911426257,0.816460453480453,3,317,transporter complex,CC,FXYD1;GRIA3;CPT1C
10833,GO:0042440,0.384896239903009,0.915689052175317,1,66,pigment metabolic process,BP,BDH2
19780,GO:1903779,0.384937881180123,0.915606463426965,1,70,regulation of cardiac conduction,BP,FXYD1
14593,GO:0055072,0.385611119205887,0.915314892869387,1,68,iron ion homeostasis,BP,BDH2
4723,GO:0010038,0.385749559358442,0.815581902127836,3,308,response to metal ion,BP,TH;STAR;CYB5A
7156,GO:0022898,0.385799685858106,0.850854885989259,2,190,regulation of transmembrane transporter activity,BP,RGN;FXYD1
3563,GO:0006970,0.386001081986561,0.915128047130325,1,68,response to osmotic stress,BP,TH
4873,GO:0010595,0.386108421967088,0.91506104701545,1,69,positive regulation of endothelial cell migration,BP,FGF18
10738,GO:0042278,0.386723255877263,0.914781380070787,1,68,purine nucleoside metabolic process,BP,PNP
243,GO:0000502,0.387431131136196,0.914490546235625,1,65,proteasome complex,CC,PSMB10
5133,GO:0010959,0.38750470433497,0.814275818740779,3,313,regulation of metal ion transport,BP,SLC31A2;RGN;FXYD1
10665,GO:0042127,0.389965083021361,0.721747862145123,12,1489,regulation of cell proliferation,BP,IFI30;FADD;PNP;PYCARD;RGN;FGF18;TICAM1;RBP4;ANG;FABP3;S100B;DHCR7
8621,GO:0032612,0.390901458356816,0.912759174978785,1,68,interleukin-1 production,BP,PYCARD
6908,GO:0021675,0.391038418576621,0.91264600829666,1,71,nerve development,BP,SLC1A3
3878,GO:0007623,0.391141991914979,0.847310057617683,2,189,circadian rhythm,BP,TH;STAR
7154,GO:0022892,0.391222839517305,0.735340119319303,9,1110,substrate-specific transporter activity,MF,SLC31A2;ABCG1;FXYD1;RBP4;FABP3;GRIA3;STAR;CYB5A;SLC1A3
20485,GO:1905369,0.392201927473844,0.912157466410981,1,66,endopeptidase complex,CC,PSMB10
10379,GO:0036473,0.392581056742525,0.911922255107472,1,69,cell death in response to oxidative stress,BP,NOL3
733,GO:0001894,0.393291437412945,0.845870592901476,2,189,tissue homeostasis,BP,PDK4;RBP4
8364,GO:0032259,0.393372866676848,0.809919299319689,3,313,methylation,BP,NNMT;HSD17B10;ETFB
11573,GO:0043933,0.393508212584586,0.708553499868426,15,1895,macromolecular complex subunit organization,BP,MRPL14;MRPL16;FADD;APOC1;TRADD;ABCG1;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
13886,GO:0051129,0.394012711980726,0.769806572903175,5,581,negative regulation of cellular component organization,BP,APOC1;ACAA2;NOL3;LINGO1;TMOD4
13720,GO:0050871,0.39421408580041,0.911119601833322,1,69,positive regulation of B cell activation,BP,TICAM1
10874,GO:0042509,0.394380722988903,0.91107030364072,1,67,regulation of tyrosine phosphorylation of STAT protein,BP,GHR
12297,GO:0045682,0.394614179888174,0.910922287399564,1,69,regulation of epidermis development,BP,TRADD
19568,GO:1903364,0.395238898834329,0.844574480010253,2,186,positive regulation of cellular protein catabolic process,BP,PSMB10;RGN
10446,GO:0038034,0.395322980943667,0.910572085908048,1,69,signal transduction in absence of ligand,BP,FADD
17798,GO:0097192,0.395322980943667,0.910572085908048,1,69,extrinsic apoptotic signaling pathway in absence of ligand,BP,FADD
3511,GO:0006887,0.395334696892726,0.74643979011859,7,833,exocytosis,BP,PNP;PYCARD;HEXB;IDH1;GLA;RPH3AL;DERA
13948,GO:0051222,0.395440325652377,0.785144527735033,4,443,positive regulation of protein transport,BP,PYCARD;RBP4;ANG;RPH3AL
9572,GO:0034703,0.39621300198336,0.84386865150319,2,197,cation channel complex,CC,GRIA3;CPT1C
11820,GO:0044455,0.396445156269269,0.843794575665607,2,179,mitochondrial membrane part,CC,STAR;ETFDH
20360,GO:1905037,0.396456784728617,0.909963874222294,1,72,autophagosome organization,BP,TBC1D14
13452,GO:0048871,0.397131975775169,0.807089918022461,3,320,multicellular organismal homeostasis,BP,PDK4;ACADVL;RBP4
11779,GO:0044391,0.398162520480734,0.84264256453364,2,177,ribosomal subunit,CC,MRPL14;MRPL16
3978,GO:0008170,0.39882672337567,0.908812816643946,1,70,N-methyltransferase activity,MF,NNMT
15808,GO:0070227,0.398942468613607,0.908770953739075,1,69,lymphocyte apoptotic process,BP,FADD
8532,GO:0032481,0.399489219107877,0.908465225054065,1,71,positive regulation of type I interferon production,BP,TICAM1
9641,GO:0035004,0.399902782610492,0.908213084760295,1,74,phosphatidylinositol 3-kinase activity,MF,FGF18
4995,GO:0010771,0.400693265701068,0.907815315089655,1,74,negative regulation of cell morphogenesis involved in differentiation,BP,LINGO1
3715,GO:0007215,0.400937271561055,0.907664450379277,1,76,glutamate receptor signaling pathway,BP,GRIA3
11683,GO:0044243,0.402135746066174,0.907086801452236,1,74,multicellular organismal catabolic process,BP,PEPD
4358,GO:0009064,0.403119659601919,0.906649088293147,1,70,glutamine family amino acid metabolic process,BP,SLC1A3
3592,GO:0007015,0.403282664447511,0.802430257601141,3,328,actin filament organization,BP,PYCARD;ANG;TMOD4
9764,GO:0035305,0.403322247770793,0.906484986748565,1,74,negative regulation of dephosphorylation,BP,RGN
14940,GO:0060419,0.403699588020213,0.906307810037597,1,73,heart growth,BP,RBP4
1194,GO:0002673,0.403738138690516,0.906334850178169,1,70,regulation of acute inflammatory response,BP,CFB
12832,GO:0046849,0.40399923968125,0.906170423362306,1,72,bone remodeling,BP,PDK4
8472,GO:0032411,0.404026304276331,0.906126773297192,1,74,positive regulation of transporter activity,BP,RGN
18653,GO:1901019,0.404654044366717,0.905821468289894,1,73,regulation of calcium ion transmembrane transporter activity,BP,RGN
13324,GO:0048640,0.4047716569287,0.905746651999738,1,74,negative regulation of developmental growth,BP,RBP4
19422,GO:1903037,0.409565836174328,0.797663699061951,3,317,regulation of leukocyte cell-cell adhesion,BP,FADD;PNP;PYCARD
20664,GO:1905954,0.410477123412536,0.90282143566719,1,73,positive regulation of lipid localization,BP,ABCG1
3738,GO:0007260,0.411126855521857,0.902514941249337,1,71,tyrosine phosphorylation of STAT protein,BP,GHR
13949,GO:0051223,0.411473856039533,0.742636833141358,6,719,regulation of protein transport,BP,PYCARD;RBP4;ANG;NOL3;IFI27;RPH3AL
11521,GO:0043627,0.411668247326008,0.902200777256359,1,73,response to estrogen,BP,STAR
16360,GO:0071260,0.412685495867658,0.901653480554088,1,74,cellular response to mechanical stimulus,BP,FADD
20806,GO:1990542,0.412751326762725,0.90168304855976,1,70,mitochondrial transmembrane transport,BP,CPT2
8070,GO:0031668,0.412962932204819,0.832347477475924,2,198,cellular response to extracellular stimulus,BP,PDK4;FADS1
12387,GO:0045859,0.413745071598706,0.740696637080964,6,723,regulation of protein kinase activity,BP,PYCARD;RGN;GHR;FGF18;ANG;DEPTOR
7798,GO:0031146,0.414188277045242,0.900912020369758,1,71,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSMB10
3173,GO:0006417,0.414312589442567,0.793983557718591,3,329,regulation of translation,BP,ANG;TSFM;RBMS3
12633,GO:0046427,0.414605466255156,0.900675991458631,1,72,positive regulation of JAK-STAT cascade,BP,GHR
20295,GO:1904894,0.414605466255156,0.900675991458631,1,72,positive regulation of STAT cascade,BP,GHR
12223,GO:0045582,0.41496628770749,0.900469799020722,1,73,positive regulation of T cell differentiation,BP,PNP
7386,GO:0030317,0.415570544922663,0.900166654868987,1,72,flagellated sperm motility,BP,RGN
4674,GO:0009894,0.415731191234976,0.738998455804764,6,723,regulation of catabolic process,BP,APOC1;TBC1D14;PSMB10;RGN;TICAM1;IDH1
1222,GO:0002702,0.415760609072237,0.900066159450574,1,72,positive regulation of production of molecular mediator of immune response,BP,RBP4
19738,GO:1903706,0.415811612516122,0.792837561729169,3,323,regulation of hemopoiesis,BP,FADD;PNP;TMEM176A
18782,GO:1901362,0.416741050420049,0.660507614137247,33,4382,organic cyclic compound biosynthetic process,BP,EBP;TH;FADD;HSD17B3;MRAP;TRADD;HSD17B11;PNP;ABCG1;EBF1;PYCARD;ACAA2;PSMB10;RGN;FADS1;TICAM1;NNMT;CYP17A1;RNASEL;ANG;NMI;ACAT1;ACAT2;TSFM;HEXB;HSD3B2;PCBD1;IFI27;STAR;CYP11A1;DHCR7;PTS;HNF1A
2528,GO:0005230,0.416764528528875,0.899487370519966,1,75,extracellular ligand-gated ion channel activity,MF,GRIA3
1228,GO:0002708,0.418037128406137,0.898841521691183,1,73,positive regulation of lymphocyte mediated immunity,BP,FADD
4631,GO:0009743,0.418239135496716,0.828626713049585,2,200,response to carbohydrate,BP,TH;STAR
4382,GO:0009101,0.418686804274188,0.79058532385006,3,332,glycoprotein biosynthetic process,BP,ALG5;DPM3;EXTL1
8470,GO:0032409,0.419018916963497,0.828061741176371,2,203,regulation of transporter activity,BP,RGN;FXYD1
12745,GO:0046634,0.419826806767134,0.897869301709763,1,74,regulation of alpha-beta T cell activation,BP,PNP
4598,GO:0009612,0.420042372388144,0.827340049708844,2,202,response to mechanical stimulus,BP,FADD;SLC1A3
14075,GO:0051436,0.421270612203445,0.897142969341461,1,71,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
1217,GO:0002697,0.422487829996731,0.787636502874455,3,324,regulation of immune effector process,BP,CFB;FADD;RBP4
18028,GO:0097722,0.4236675469225,0.895798168830464,1,74,sperm motility,BP,RGN
1296,GO:0002824,0.424259890136313,0.895476493810642,1,74,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
3169,GO:0006412,0.425443934660742,0.743651461474707,5,581,translation,BP,MRPL14;MRPL16;ANG;TSFM;RBMS3
11181,GO:0043085,0.425601319688117,0.68970016545055,12,1554,positive regulation of catalytic activity,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;MGST2;PSMB10;RGN;GHR;FGF18;ANG;IFI27
14078,GO:0051439,0.425807648214993,0.894666202973404,1,72,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
4698,GO:0009967,0.426041463946987,0.693708454785309,11,1402,positive regulation of signal transduction,BP,FADD;TRADD;PYCARD;G0S2;PSMB10;GHR;FGF18;TICAM1;FAM110C;S100B;DOK1
7226,GO:0030100,0.426191097869911,0.822937710744582,2,204,regulation of endocytosis,BP,APOC1;PYCARD
2045,GO:0004518,0.42640421994021,0.822806450104764,2,199,nuclease activity,MF,RNASEL;ANG
13697,GO:0050848,0.427377410740848,0.893726827196121,1,77,regulation of calcium-mediated signaling,BP,RGN
11289,GO:0043244,0.427842496638137,0.893442004923404,1,79,regulation of protein complex disassembly,BP,TMOD4
5401,GO:0015171,0.428186364818809,0.893267194015717,1,78,amino acid transmembrane transporter activity,MF,SLC1A3
12816,GO:0046822,0.428545256984707,0.821232181018714,2,206,regulation of nucleocytoplasmic transport,BP,NOL3;IFI27
1084,GO:0002456,0.428560239430011,0.893091304671913,1,76,T cell mediated immunity,BP,FADD
10630,GO:0042058,0.42941260103248,0.892590698306301,1,78,regulation of epidermal growth factor receptor signaling pathway,BP,DOK1
9335,GO:0034220,0.429778938988705,0.708222632777678,8,1015,ion transmembrane transport,BP,SLC31A2;RGN;CPT2;FXYD1;GRIA3;NOL3;CYB5A;SLC1A3
9678,GO:0035091,0.430634163147085,0.819698687836653,2,211,phosphatidylinositol binding,MF,PXK;SNX21
19356,GO:1902936,0.430862054905291,0.891758803997389,1,80,phosphatidylinositol bisphosphate binding,MF,SNX21
18302,GO:0099094,0.430879234206756,0.891735355016714,1,81,ligand-gated cation channel activity,MF,GRIA3
8281,GO:0032092,0.431219982346815,0.891574182110222,1,79,positive regulation of protein binding,BP,TICAM1
18059,GO:0098542,0.43125118288063,0.756103370424408,4,451,defense response to other organism,BP,FADD;PYCARD;TICAM1;RNASEL
17647,GO:0090630,0.431373948255692,0.89144673504126,1,82,activation of GTPase activity,BP,TBC1D14
13163,GO:0048259,0.431709197702238,0.891287676794644,1,80,regulation of receptor-mediated endocytosis,BP,APOC1
1097,GO:0002479,0.433317153112445,0.890482350699584,1,74,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,PSMB10
12000,GO:0045069,0.433907553421285,0.890073702519528,1,79,regulation of viral genome replication,BP,RNASEL
15494,GO:0061418,0.434399666294573,0.889843339245015,1,76,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMB10
2544,GO:0005254,0.43461793780818,0.889660481400311,1,80,chloride channel activity,MF,FXYD1
7227,GO:0030101,0.435061383569686,0.889471526764084,1,76,natural killer cell activation,BP,TICAM1
12268,GO:0045639,0.435314850943394,0.889282963028169,1,79,positive regulation of myeloid cell differentiation,BP,FADD
12732,GO:0046620,0.435574358351027,0.889108005904317,1,81,regulation of organ growth,BP,RBP4
3860,GO:0007601,0.436101580715352,0.815729843767324,2,206,visual perception,BP,TH;RBP4
15686,GO:0070011,0.436187311341397,0.734459604953122,5,596,peptidase activity, acting on L-amino acid peptides,MF,CFB;PYCARD;PSMB10;CASP4;PEPD
19206,GO:1902554,0.436766208735896,0.888449185897896,1,80,serine/threonine protein kinase complex,CC,PYCARD
7594,GO:0030819,0.436903473852568,0.888401187103897,1,78,positive regulation of cAMP biosynthetic process,BP,MRAP
12133,GO:0045321,0.437225905890316,0.694562726729503,9,1129,leukocyte activation,BP,FADD;PNP;PYCARD;TICAM1;SHPK;HEXB;IDH1;GLA;DERA
21002,GO:2000106,0.43838714301622,0.887544597457217,1,79,regulation of leukocyte apoptotic process,BP,FADD
9012,GO:0033238,0.439240591429914,0.887105489638589,1,76,regulation of cellular amine metabolic process,BP,PSMB10
3867,GO:0007611,0.439289477547866,0.813349343644336,2,214,learning or memory,BP,TH;S100B
17800,GO:0097194,0.439893522206929,0.88667133345535,1,80,execution phase of apoptosis,BP,CASP4
7107,GO:0022602,0.439913382518527,0.886645511187697,1,81,ovulation cycle process,BP,ANG
832,GO:0002028,0.440118263591969,0.886514279203689,1,82,regulation of sodium ion transport,BP,FXYD1
3959,GO:0008135,0.440524301531559,0.886310645759349,1,80,translation factor activity, RNA binding,MF,TSFM
14076,GO:0051437,0.441599685619573,0.885756284943434,1,76,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,PSMB10
3501,GO:0006875,0.441601424298527,0.747409158047188,4,472,cellular metal ion homeostasis,BP,SLC31A2;RGN;HEXB;NOL3
14313,GO:0051897,0.442086158292751,0.885399905113986,1,81,positive regulation of protein kinase B signaling,BP,FAM110C
11434,GO:0043500,0.442222089898745,0.885307433773337,1,82,muscle adaptation,BP,NOL3
17002,GO:0072332,0.442252210902557,0.885318991582764,1,80,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PYCARD
5635,GO:0015837,0.442447111965757,0.88522181382378,1,79,amine transport,BP,TH
13773,GO:0050953,0.44306142334748,0.810573757320151,2,209,sensory perception of light stimulus,BP,TH;RBP4
13944,GO:0051213,0.444814071114277,0.883809739372598,1,82,dioxygenase activity,MF,PHYH
3908,GO:0008047,0.445022599982717,0.744501651306336,4,484,enzyme activator activity,MF,APOC1;TBC1D14;PYCARD;MGST2
2517,GO:0005215,0.44502356610606,0.681485107107217,10,1294,transporter activity,MF,EBP;SLC31A2;ABCG1;FXYD1;RBP4;FABP3;GRIA3;STAR;CYB5A;SLC1A3
15036,GO:0060548,0.44520449656277,0.70286877653125,7,872,negative regulation of cell death,BP,PDK4;FADD;TRADD;ACAA2;RGN;NOL3;STAR
7892,GO:0031334,0.445372024136619,0.80884594416796,2,210,positive regulation of protein complex assembly,BP,PYCARD;HNF1A
18877,GO:1901655,0.445658174650405,0.883305282240861,1,83,cellular response to ketone,BP,STAR
2691,GO:0005604,0.44601085853104,0.883021793493994,1,89,basement membrane,CC,ANG
3559,GO:0006959,0.446847396439321,0.807791349108002,2,199,humoral immune response,BP,CFB;PSMB10
4721,GO:0010035,0.447111339566503,0.742745090183475,4,473,response to inorganic substance,BP,TH;RGN;STAR;CYB5A
8230,GO:0032006,0.447153664652168,0.882433353580768,1,83,regulation of TOR signaling,BP,DEPTOR
11387,GO:0043406,0.447391445889877,0.807316099690231,2,214,positive regulation of MAP kinase activity,BP,GHR;FGF18
11226,GO:0043154,0.447443501036902,0.88229273690124,1,81,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NOL3
20174,GO:1904667,0.447614671993581,0.882254831117074,1,77,negative regulation of ubiquitin protein ligase activity,BP,PSMB10
17374,GO:0090087,0.447892385216049,0.710948664932884,6,747,regulation of peptide transport,BP,PYCARD;RBP4;ANG;NOL3;IFI27;RPH3AL
12874,GO:0046916,0.448023579239297,0.881938590386456,1,82,cellular transition metal ion homeostasis,BP,SLC31A2
4647,GO:0009791,0.448945239249798,0.881329485064271,1,87,post-embryonic development,BP,DHCR7
5813,GO:0016209,0.449407690684245,0.881171214899769,1,79,antioxidant activity,MF,MGST2
646,GO:0001776,0.449847848462563,0.880852407006255,1,83,leukocyte homeostasis,BP,FADD
5144,GO:0010972,0.452479237613957,0.87934042082038,1,80,negative regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
13110,GO:0048145,0.452561318635309,0.879246914667261,1,83,regulation of fibroblast proliferation,BP,IFI30
14885,GO:0060349,0.453091588516409,0.878903466336357,1,85,bone morphogenesis,BP,FGF18
14058,GO:0051402,0.453473659973614,0.80271793429372,2,215,neuron apoptotic process,BP,FADD;STAR
3477,GO:0006835,0.453999101912158,0.878348924967337,1,86,dicarboxylic acid transport,BP,SLC1A3
7610,GO:0030838,0.454127181345258,0.878314365805334,1,83,positive regulation of actin filament polymerization,BP,PYCARD
6129,GO:0016811,0.454727877484125,0.877955439542182,1,83,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,ASAH2
739,GO:0001909,0.455151312407662,0.877731832143734,1,81,leukocyte mediated cytotoxicity,BP,FADD
13109,GO:0048144,0.456168666993873,0.877077439029598,1,84,fibroblast proliferation,BP,IFI30
7292,GO:0030193,0.45625596007161,0.87703942289115,1,83,regulation of blood coagulation,BP,FAM46A
18455,GO:1900046,0.45625596007161,0.87703942289115,1,83,regulation of hemostasis,BP,FAM46A
17505,GO:0090277,0.456357840038516,0.876978199072034,1,83,positive regulation of peptide hormone secretion,BP,RBP4
83,GO:0000166,0.456462316147921,0.650507768904331,15,2024,nucleotide binding,MF,PDK4;ACSF2;ABCG1;BDH2;ACADVL;ACSM5;RNASEL;AOX1;SHPK;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
18748,GO:1901265,0.457344556275712,0.649675753992685,15,2025,nucleoside phosphate binding,MF,PDK4;ACSF2;ABCG1;BDH2;ACADVL;ACSM5;RNASEL;AOX1;SHPK;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
19032,GO:1902106,0.457548948446768,0.876246496457799,1,84,negative regulation of leukocyte differentiation,BP,TMEM176A
11308,GO:0043270,0.458501533597179,0.798873828834421,2,216,positive regulation of ion transport,BP,RGN;FXYD1
7797,GO:0031145,0.458844012219447,0.875524240198868,1,80,anaphase-promoting complex-dependent catabolic process,BP,PSMB10
12251,GO:0045621,0.459156695993987,0.875274222680208,1,84,positive regulation of lymphocyte differentiation,BP,PNP
7314,GO:0030217,0.46008056856225,0.797659955605303,2,216,T cell differentiation,BP,FADD;PNP
19295,GO:1902750,0.461038085686536,0.874160250639115,1,82,negative regulation of cell cycle G2/M phase transition,BP,PSMB10
7591,GO:0030816,0.461905370705705,0.873600988295965,1,84,positive regulation of cAMP metabolic process,BP,MRAP
767,GO:0001942,0.462140961802093,0.873428377883173,1,86,hair follicle development,BP,TRADD
4020,GO:0008233,0.462623103465077,0.71134268454225,5,614,peptidase activity,MF,CFB;PYCARD;PSMB10;CASP4;PEPD
21645,GO:2001243,0.463086352278496,0.872877799508014,1,84,negative regulation of intrinsic apoptotic signaling pathway,BP,NOL3
569,GO:0001656,0.463187470497599,0.872759719238846,1,88,metanephros development,BP,ACAT1
18898,GO:1901681,0.463329542528617,0.79515467159549,2,215,sulfur compound binding,MF,HACL1;ANG
13979,GO:0051261,0.46370695244568,0.872440574152533,1,88,protein depolymerization,BP,TMOD4
11351,GO:0043331,0.46383576604349,0.872403005414435,1,85,response to dsRNA,BP,TICAM1
3667,GO:0007159,0.463928444646308,0.754032419558876,3,346,leukocyte cell-cell adhesion,BP,FADD;PNP;PYCARD
7889,GO:0031331,0.464072476513148,0.753898579371734,3,352,positive regulation of cellular catabolic process,BP,PSMB10;RGN;TICAM1
4054,GO:0008285,0.464830741369767,0.709371280668011,5,623,negative regulation of cell proliferation,BP,IFI30;RGN;RBP4;ANG;FABP3
13339,GO:0048667,0.465222558610744,0.727117677873509,4,512,cell morphogenesis involved in neuron differentiation,BP,S100B;DOK1;SLC1A3;LINGO1
21012,GO:2000117,0.467839824818326,0.869911592537978,1,86,negative regulation of cysteine-type endopeptidase activity,BP,NOL3
3753,GO:0007281,0.468043143299604,0.79147647163456,2,217,germ cell development,BP,ANG;HEXB
7094,GO:0022404,0.468915133524708,0.869213223162051,1,88,molting cycle process,BP,TRADD
7095,GO:0022405,0.468915133524708,0.869213223162051,1,88,hair cycle process,BP,TRADD
19837,GO:1903901,0.469312256404465,0.868993127859219,1,86,negative regulation of viral life cycle,BP,RNASEL
14082,GO:0051444,0.469664970982893,0.868817214708373,1,83,negative regulation of ubiquitin-protein transferase activity,BP,PSMB10
857,GO:0002062,0.469817662858577,0.868608952332306,1,91,chondrocyte differentiation,BP,FGF18
13064,GO:0048010,0.471172465619943,0.867758620025485,1,91,vascular endothelial growth factor receptor signaling pathway,BP,FGF18
3891,GO:0008016,0.471984030705002,0.788348721171408,2,225,regulation of heart contraction,BP,TH;FXYD1
20175,GO:1904668,0.471999593847453,0.867336098584997,1,84,positive regulation of ubiquitin protein ligase activity,BP,PSMB10
13683,GO:0050818,0.472083667592157,0.867239028082473,1,87,regulation of coagulation,BP,FAM46A
11120,GO:0042990,0.472301103017516,0.867074147448002,1,89,regulation of transcription factor import into nucleus,BP,NOL3
5371,GO:0015108,0.472324918941196,0.867032578099451,1,91,chloride transmembrane transporter activity,MF,FXYD1
19177,GO:1902476,0.472324918941196,0.867032578099451,1,91,chloride transmembrane transport,BP,FXYD1
674,GO:0001818,0.473411700999401,0.787250985362296,2,218,negative regulation of cytokine production,BP,PYCARD;NMI
4912,GO:0010648,0.473649053940165,0.661028471580809,9,1182,negative regulation of cell communication,BP,FADD;TRADD;PYCARD;ACAA2;PSMB10;TICAM1;NOL3;DEPTOR;RPH3AL
11296,GO:0043254,0.47455822911773,0.74503301545268,3,360,regulation of protein complex assembly,BP,PYCARD;HNF1A;TMOD4
1225,GO:0002705,0.47463852512543,0.865622279772934,1,87,positive regulation of leukocyte mediated immunity,BP,FADD
11475,GO:0043549,0.474650890989321,0.686835351464134,6,772,regulation of kinase activity,BP,PYCARD;RGN;GHR;FGF18;ANG;DEPTOR
11134,GO:0043005,0.475116614893064,0.675622736735253,7,931,neuron projection,CC,TH;FADD;CYP17A1;ANG;CPT1C;STAR;SLC1A3
11121,GO:0042991,0.475510132297866,0.865026177834803,1,90,transcription factor import into nucleus,BP,NOL3
1380,GO:0003007,0.475622242480909,0.785458417455701,2,228,heart morphogenesis,BP,TH;RBP4
16837,GO:0072080,0.476940409440123,0.864086646564979,1,92,nephron tubule development,BP,ACAT1
6750,GO:0019886,0.477334078558395,0.863861096312235,1,90,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,IFI30
1042,GO:0002377,0.477586886290129,0.863726836692017,1,88,immunoglobulin production,BP,RBP4
20484,GO:1905368,0.47759677555385,0.863749517482781,1,86,peptidase complex,CC,PSMB10
2319,GO:0004896,0.477862031074015,0.863550432542021,1,88,cytokine receptor activity,MF,GHR
7174,GO:0023057,0.477905684344013,0.657038544799084,9,1186,negative regulation of signaling,BP,FADD;TRADD;PYCARD;ACAA2;PSMB10;TICAM1;NOL3;DEPTOR;RPH3AL
10650,GO:0042100,0.47872265793547,0.862997727011682,1,88,B cell proliferation,BP,TICAM1
12743,GO:0046632,0.480097298445748,0.86208398367387,1,90,alpha-beta T cell differentiation,BP,PNP
18704,GO:1901184,0.481090659978902,0.861427968626042,1,91,regulation of ERBB signaling pathway,BP,DOK1
14159,GO:0051591,0.482182556043087,0.860693163972353,1,93,response to cAMP,BP,STAR
3228,GO:0006493,0.48242689683356,0.860521505832399,1,94,protein O-linked glycosylation,BP,DPM3
497,GO:0001523,0.482619579073758,0.860463075112426,1,89,retinoid metabolic process,BP,RBP4
13858,GO:0051090,0.482848906194875,0.737929273771723,3,362,regulation of sequence-specific DNA binding transcription factor activity,BP,TRADD;PYCARD;TICAM1
13664,GO:0050793,0.482994609866831,0.622358778887717,16,2180,regulation of developmental process,BP,FADD;TRADD;PNP;ABCG1;PSMB10;RGN;FADS1;GHR;FGF18;PLA2G16;RBP4;HEXB;TMEM176A;STAR;S100B;LINGO1
20322,GO:1904951,0.483497950673107,0.711029042774932,4,498,positive regulation of establishment of protein localization,BP,PYCARD;RBP4;ANG;RPH3AL
1202,GO:0002682,0.483570734644646,0.645538381069632,10,1306,regulation of immune system process,BP,CFB;FADD;PNP;PYCARD;PSMB10;TICAM1;RBP4;NMI;SHPK;TMEM176A
15455,GO:0061326,0.484028657471375,0.859477196859188,1,94,renal tubule development,BP,ACAT1
7105,GO:0022600,0.484877116699962,0.858961646509511,1,91,digestive system process,BP,RBP4
13966,GO:0051248,0.485463565757321,0.657225826738757,8,1048,negative regulation of protein metabolic process,BP,PYCARD;PSMB10;RGN;ANG;NMI;NOL3;DEPTOR;TFPI
9352,GO:0034248,0.485530393222682,0.735604857270774,3,366,regulation of cellular amide metabolic process,BP,ANG;TSFM;RBMS3
18169,GO:0098797,0.486107912768424,0.777039483027093,2,230,plasma membrane protein complex,CC,FADD;TRADD
18118,GO:0098662,0.48720526459766,0.689161589256741,5,648,inorganic cation transmembrane transport,BP,SLC31A2;RGN;FXYD1;NOL3;CYB5A
7438,GO:0030424,0.487236910657896,0.734101318466765,3,378,axon,CC,TH;CYP17A1;CPT1C
672,GO:0001816,0.487586603485706,0.688825231327325,5,635,cytokine production,BP,FADD;PNP;PYCARD;TICAM1;NMI
1204,GO:0002684,0.488049178681378,0.663615421734628,7,904,positive regulation of immune system process,BP,CFB;FADD;PNP;PYCARD;PSMB10;TICAM1;RBP4
19348,GO:1902911,0.488235142983872,0.856711103478271,1,94,protein kinase complex,CC,PYCARD
154,GO:0000302,0.48870477027757,0.774954700154468,2,224,response to reactive oxygen species,BP,RGN;STAR
4228,GO:0008565,0.489493155395796,0.855864318877931,1,95,protein transporter activity,MF,ABCG1
2543,GO:0005253,0.489931429191038,0.855585956320739,1,94,anion channel activity,MF,FXYD1
761,GO:0001936,0.491057343123658,0.854823083303625,1,95,regulation of endothelial cell proliferation,BP,ANG
9778,GO:0035335,0.492375692104165,0.85391654204125,1,97,peptidyl-tyrosine dephosphorylation,BP,MDP1
20980,GO:2000060,0.493081874597506,0.853536527303663,1,90,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
11418,GO:0043473,0.494229257824442,0.852696943820478,1,95,pigmentation,BP,TH
14706,GO:0060079,0.494460733739526,0.852503233172886,1,98,excitatory postsynaptic potential,BP,GRIA3
2302,GO:0004867,0.494505221630054,0.852565297866944,1,91,serine-type endopeptidase inhibitor activity,MF,TFPI
5126,GO:0010951,0.494894987129522,0.769878999336529,2,225,negative regulation of endopeptidase activity,BP,NOL3;TFPI
4395,GO:0009119,0.494990579972068,0.852210287931304,1,93,ribonucleoside metabolic process,BP,PNP
13297,GO:0048585,0.495656697169622,0.634014609808528,10,1339,negative regulation of response to stimulus,BP,FADD;TRADD;PYCARD;ACAA2;PSMB10;TICAM1;NMI;NOL3;DEPTOR;RPH3AL
21099,GO:2000278,0.496124206481589,0.851430543096422,1,94,regulation of DNA biosynthetic process,BP,RGN
2197,GO:0004725,0.49630107091603,0.851259489108326,1,98,protein tyrosine phosphatase activity,MF,MDP1
13662,GO:0050790,0.496729102311212,0.606438725819045,17,2320,regulation of catalytic activity,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;MGST2;PSMB10;RGN;GHR;FGF18;ANG;NOL3;DEPTOR;IFI27;TFPI;GLA;PTS
9929,GO:0035601,0.497032696865487,0.850775637606732,1,97,protein deacylation,BP,LYPLAL1
14331,GO:0051928,0.497060631717848,0.85078236874648,1,95,positive regulation of calcium ion transport,BP,RGN
16653,GO:0071702,0.498640708394384,0.599968669108826,19,2596,organic substance transport,BP,TH;APOC1;TBC1D14;PNP;ABCG1;PYCARD;CPT2;RBP4;RNASEL;ANG;FABP3;NOL3;IFI27;STAR;SNX21;RPH3AL;HNF1A;SLC1A3;CNIH4
19429,GO:1903050,0.499154126174923,0.766337258018936,2,229,regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10;RGN
5026,GO:0010827,0.499321656125101,0.849191292850871,1,99,regulation of glucose transport,BP,RNASEL
13943,GO:0051209,0.499637812936423,0.848975048059267,1,99,release of sequestered calcium ion into cytosol,BP,NOL3
13992,GO:0051283,0.499637812936423,0.848975048059267,1,99,negative regulation of sequestering of calcium ion,BP,NOL3
2826,GO:0005840,0.500227629773397,0.765488132174574,2,219,ribosome,CC,MRPL14;MRPL16
18159,GO:0098781,0.500564131830603,0.848391355363886,1,95,ncRNA transcription,BP,ANG
18134,GO:0098732,0.500991934847711,0.848058994417771,1,98,macromolecule deacylation,BP,LYPLAL1
11629,GO:0044092,0.501521580705371,0.642015639589511,8,1056,negative regulation of molecular function,BP,APOC1;PYCARD;PSMB10;RGN;NOL3;DEPTOR;TFPI;GLA
10737,GO:0042277,0.501626731814651,0.764269283105058,2,231,peptide binding,MF,GHR;ANG
15798,GO:0070201,0.502042703024545,0.661419148248372,6,791,regulation of establishment of protein localization,BP,PYCARD;RBP4;ANG;NOL3;IFI27;RPH3AL
4261,GO:0008630,0.502509571062571,0.84705312154735,1,95,intrinsic apoptotic signaling pathway in response to DNA damage,BP,PYCARD
7508,GO:0030594,0.502528609672356,0.847039987888927,1,95,neurotransmitter receptor activity,MF,GRIA3
13861,GO:0051093,0.502940449647765,0.660570299941206,6,796,negative regulation of developmental process,BP,ABCG1;RGN;RBP4;TMEM176A;S100B;LINGO1
8181,GO:0031929,0.502998981279041,0.846676251083669,1,98,TOR signaling,BP,DEPTOR
13991,GO:0051282,0.50315178191475,0.84654592391257,1,100,regulation of sequestering of calcium ion,BP,NOL3
20173,GO:1904666,0.503628825549685,0.846321453607294,1,92,regulation of ubiquitin protein ligase activity,BP,PSMB10
13655,GO:0050778,0.50399645667112,0.673661626255525,5,643,positive regulation of immune response,BP,CFB;FADD;PYCARD;PSMB10;TICAM1
4825,GO:0010508,0.504407351708281,0.845676308570718,1,100,positive regulation of autophagy,BP,TICAM1
3966,GO:0008144,0.504433634205942,0.845708799975548,1,96,drug binding,MF,PNP
5896,GO:0016363,0.504747449690395,0.845452521765686,1,99,nuclear matrix,CC,RNASEL
3210,GO:0006470,0.505273266342762,0.761173820011438,2,241,protein dephosphorylation,BP,RGN;MDP1
5106,GO:0010921,0.506398381668223,0.844278677599155,1,101,regulation of phosphatase activity,BP,RGN
1649,GO:0003779,0.50662017982709,0.716996476329295,3,393,actin binding,MF,PXK;ANG;TMOD4
7579,GO:0030804,0.507247875609696,0.843748520335531,1,96,positive regulation of cyclic nucleotide biosynthetic process,BP,MRAP
14020,GO:0051338,0.508896414065404,0.64388879885102,7,933,regulation of transferase activity,BP,PYCARD;PSMB10;RGN;GHR;FGF18;ANG;DEPTOR
16739,GO:0071887,0.509010953891645,0.842498996796179,1,97,leukocyte apoptotic process,BP,FADD
3509,GO:0006885,0.510139374718892,0.841678518939387,1,99,regulation of pH,BP,PDK4
4025,GO:0008238,0.511137377149204,0.840986390194531,1,98,exopeptidase activity,MF,PEPD
2782,GO:0005768,0.511222171509457,0.652728686270122,6,803,endosome,CC,ZFYVE21;SLC31A2;TBC1D14;ABCG1;TICAM1;SNX21
6676,GO:0019725,0.511605518474565,0.652368457898823,6,797,cellular homeostasis,BP,TH;SLC31A2;RGN;HEXB;NOL3;STAR
11146,GO:0043021,0.512509472707783,0.840000960749791,1,99,ribonucleoprotein complex binding,MF,RNASEL
13733,GO:0050890,0.513188880070786,0.75444750454668,2,246,cognition,BP,TH;S100B
10633,GO:0042063,0.513388962266005,0.754303688316627,2,239,gliogenesis,BP,HEXB;S100B
13942,GO:0051208,0.513778383141193,0.839048683378068,1,103,sequestering of calcium ion,BP,NOL3
9103,GO:0033559,0.514322428163702,0.838749877290526,1,96,unsaturated fatty acid metabolic process,BP,FADS1
12349,GO:0045785,0.514736312957823,0.709724315422161,3,378,positive regulation of cell adhesion,BP,FADD;PNP;PYCARD
17636,GO:0090596,0.515192902056656,0.752736982278181,2,245,sensory organ morphogenesis,BP,TH;RBP4
12317,GO:0045727,0.515197050395186,0.8380720204514,1,100,positive regulation of translation,BP,RBMS3
3500,GO:0006874,0.516004957336923,0.708572610711741,3,379,cellular calcium ion homeostasis,BP,RGN;HEXB;NOL3
6304,GO:0017156,0.516201055923365,0.837303459380487,1,104,calcium ion regulated exocytosis,BP,RPH3AL
340,GO:0000932,0.516221736088452,0.83732492136997,1,101,P-body,CC,GHR
3470,GO:0006821,0.516228708740172,0.837295472109813,1,103,chloride transport,BP,FXYD1
20957,GO:2000026,0.516331894407822,0.603932832448993,12,1660,regulation of multicellular organismal development,BP,FADD;TRADD;PNP;PSMB10;RGN;FGF18;PLA2G16;RBP4;TMEM176A;STAR;S100B;LINGO1
5872,GO:0016311,0.516690041686944,0.707930434287842,3,389,dephosphorylation,BP,RGN;MDP1;ACP5
5467,GO:0015294,0.517445544235789,0.836420239039486,1,103,solute:cation symporter activity,MF,SLC1A3
4808,GO:0010466,0.517812309759815,0.750526269480446,2,235,negative regulation of peptidase activity,BP,NOL3;TFPI
2294,GO:0004857,0.518014325234039,0.706760044740602,3,373,enzyme inhibitor activity,MF,APOC1;NOL3;TFPI
9506,GO:0034599,0.519553451881299,0.749003784810432,2,240,cellular response to oxidative stress,BP,RGN;NOL3
17982,GO:0097553,0.519983359904277,0.834561198016084,1,105,calcium ion transmembrane import into cytosol,BP,NOL3
19256,GO:1902656,0.519983359904277,0.834561198016084,1,105,calcium ion import into cytosol,BP,NOL3
5806,GO:0016197,0.520659097492064,0.748023840797608,2,246,endosomal transport,BP,ZFYVE21;TBC1D14
11261,GO:0043204,0.52133985534161,0.833586525335469,1,104,perikaryon,CC,TH
6118,GO:0016791,0.521646368848773,0.747164221721826,2,247,phosphatase activity,MF,MDP1;ACP5
8852,GO:0032963,0.521741028067739,0.833294050897841,1,104,collagen metabolic process,BP,PEPD
3462,GO:0006811,0.521933317869058,0.603150215959749,11,1514,ion transport,BP,SLC31A2;APOC1;ABCG1;RGN;CPT2;FXYD1;FABP3;GRIA3;NOL3;CYB5A;SLC1A3
10985,GO:0042698,0.522672638757928,0.832625716638793,1,103,ovulation cycle,BP,ANG
7070,GO:0021987,0.524472599528853,0.831258378449582,1,107,cerebral cortex development,BP,TH
15907,GO:0070372,0.524619682977324,0.744604646127545,2,240,regulation of ERK1 and ERK2 cascade,BP,PYCARD;FGF18
19344,GO:1902904,0.52494201518308,0.830936340023467,1,105,negative regulation of supramolecular fiber organization,BP,TMOD4
8838,GO:0032940,0.525715249461841,0.604861485002741,10,1364,secretion by cell,BP,PNP;PYCARD;RBP4;ANG;HEXB;IDH1;GLA;RPH3AL;DERA;SLC1A3
6045,GO:0016651,0.525843717452628,0.830361199334021,1,98,oxidoreductase activity, acting on NAD(P)H,MF,DECR1
8374,GO:0032273,0.526484895307343,0.829822377894739,1,103,positive regulation of protein polymerization,BP,PYCARD
8562,GO:0032526,0.526503938666961,0.82980829789262,1,103,response to retinoic acid,BP,RBP4
11740,GO:0044325,0.526522909858771,0.829746391660081,1,107,ion channel binding,MF,FXYD1
13612,GO:0050715,0.526626072599927,0.829743352588765,1,101,positive regulation of cytokine secretion,BP,PYCARD
5422,GO:0015197,0.526878546531252,0.829494876229129,1,106,peptide transporter activity,MF,ABCG1
15672,GO:0065003,0.527322337841474,0.593135359292503,12,1645,macromolecular complex assembly,BP,FADD;APOC1;TRADD;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
2983,GO:0006090,0.527438244425146,0.829116567528391,1,103,pyruvate metabolic process,BP,PDK4
4426,GO:0009152,0.52912810727947,0.740658264919159,2,239,purine ribonucleotide biosynthetic process,BP,MRAP;ACAT1
9609,GO:0034765,0.529999950507237,0.695705059876058,3,397,regulation of ion transmembrane transport,BP,SLC31A2;RGN;FXYD1
758,GO:0001933,0.530188394999713,0.695546416179464,3,389,negative regulation of protein phosphorylation,BP,PYCARD;RGN;DEPTOR
10951,GO:0042626,0.530363544140535,0.826867397434423,1,109,ATPase activity, coupled to transmembrane movement of substances,MF,ABCG1
6486,GO:0019079,0.530560578726171,0.826766780101142,1,105,viral genome replication,BP,RNASEL
7152,GO:0022890,0.531314946686303,0.666934516134417,4,540,inorganic cation transmembrane transporter activity,MF,SLC31A2;GRIA3;CYB5A;SLC1A3
7585,GO:0030810,0.531317088474504,0.826225087174879,1,103,positive regulation of nucleotide biosynthetic process,BP,MRAP
18596,GO:1900373,0.531317088474504,0.826225087174879,1,103,positive regulation of purine nucleotide biosynthetic process,BP,MRAP
4220,GO:0008543,0.531576872652209,0.825993391049647,1,106,fibroblast growth factor receptor signaling pathway,BP,FGF18
10904,GO:0042552,0.531808240739255,0.82580790366053,1,107,myelination,BP,HEXB
5355,GO:0015078,0.532033012782232,0.825713779032465,1,101,hydrogen ion transmembrane transporter activity,MF,CYB5A
1385,GO:0003012,0.532744718768885,0.693156252223649,3,397,muscle system process,BP,FXYD1;NOL3;TMOD4
10845,GO:0042470,0.532998603275685,0.824949087683969,1,104,melanosome,CC,TH
13404,GO:0048770,0.532998603275685,0.824949087683969,1,104,pigment granule,CC,TH
11791,GO:0044420,0.533979370868672,0.824084834473387,1,115,extracellular matrix component,CC,ANG
580,GO:0001669,0.534168036955422,0.824092385848558,1,102,acrosomal vesicle,CC,HEXB
18350,GO:0099565,0.534226257039435,0.823951751991338,1,110,chemical synaptic transmission, postsynaptic,BP,GRIA3
4898,GO:0010634,0.534606584213973,0.823675368449384,1,109,positive regulation of epithelial cell migration,BP,FGF18
3021,GO:0006163,0.534675395713877,0.663756304020967,4,523,purine nucleotide metabolic process,BP,MRAP;PNP;ACAT1;NUDT7
675,GO:0001819,0.535512746262356,0.690595364241004,3,387,positive regulation of cytokine production,BP,FADD;PYCARD;TICAM1
9376,GO:0034332,0.535524137597219,0.82292526965262,1,114,adherens junction organization,BP,ANG
7576,GO:0030801,0.535680392966835,0.822921533299743,1,104,positive regulation of cyclic nucleotide metabolic process,BP,MRAP
3022,GO:0006164,0.535985647676143,0.73457200282208,2,242,purine nucleotide biosynthetic process,BP,MRAP;ACAT1
1387,GO:0003014,0.536286458440754,0.822424383724218,1,107,renal system process,BP,HNF1A
19540,GO:1903305,0.536433143638715,0.822301011194616,1,108,regulation of regulated secretory pathway,BP,RPH3AL
13266,GO:0048523,0.536851349482673,0.546441661184409,30,4185,negative regulation of cellular process,BP,PDK4;IFI30;FADD;APOC1;TRADD;TBC1D14;ABCG1;PYCARD;ACADVL;ACAA2;PSMB10;RGN;TICAM1;PLA2G16;RBP4;RNASEL;ANG;NMI;FABP3;NOL3;DEPTOR;IFI27;TMEM176A;TFPI;STAR;GLA;RPH3AL;S100B;LINGO1;TMOD4
22,GO:0000041,0.53700613875303,0.821888688257462,1,106,transition metal ion transport,BP,SLC31A2
11394,GO:0043414,0.537550582625153,0.733139198714394,2,251,macromolecule methylation,BP,HSD17B10;ETFB
13713,GO:0050864,0.537660715222603,0.821389538626989,1,106,regulation of B cell activation,BP,TICAM1
6136,GO:0016820,0.537730512303439,0.821277964987171,1,111,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,ABCG1
11696,GO:0044259,0.537835501691722,0.821220465118549,1,109,multicellular organismal macromolecule metabolic process,BP,PEPD
14595,GO:0055074,0.538508630971999,0.68777921268862,3,392,calcium ion homeostasis,BP,RGN;HEXB;NOL3
16793,GO:0072009,0.538694553457589,0.8205520828219,1,110,nephron epithelium development,BP,ACAT1
16038,GO:0070588,0.538951077340508,0.73185554309976,2,259,calcium ion transmembrane transport,BP,RGN;NOL3
7097,GO:0022407,0.53922636419686,0.687111284027687,3,389,regulation of cell-cell adhesion,BP,FADD;PNP;PYCARD
14677,GO:0060047,0.539260633211081,0.731592505098317,2,255,heart contraction,BP,TH;FXYD1
8290,GO:0032101,0.539625698181625,0.639702901195555,5,672,regulation of response to external stimulus,BP,CFB;FGF18;SHPK;CASP4;FAM46A
11538,GO:0043679,0.539749375179489,0.819754776079868,1,109,axon terminus,CC,TH
7327,GO:0030234,0.539764328929271,0.613928429246208,7,961,enzyme regulator activity,MF,APOC1;TBC1D14;PYCARD;MGST2;RGN;NOL3;TFPI
2941,GO:0006024,0.53993823631669,0.819598184490567,1,110,glycosaminoglycan biosynthetic process,BP,EXTL1
13268,GO:0048525,0.540061737294569,0.819550718135169,1,106,negative regulation of viral process,BP,RNASEL
13296,GO:0048584,0.540608383048126,0.572098144580786,14,1941,positive regulation of response to stimulus,BP,CFB;FADD;TRADD;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;FAM110C;S100B;DOK1
11896,GO:0044765,0.541239514346541,0.553925538121835,21,2931,single-organism transport,BP,EBP;TH;APOC1;PNP;ABCG1;PYCARD;CPT2;RBP4;RNASEL;ANG;HEXB;FABP3;NOL3;IDH1;STAR;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3
10750,GO:0042303,0.541314008324957,0.818562452925834,1,108,molting cycle,BP,TRADD
10957,GO:0042633,0.541314008324957,0.818562452925834,1,108,hair cycle,BP,TRADD
3749,GO:0007272,0.541431004210183,0.81844881597882,1,110,ensheathment of neurons,BP,HEXB
4104,GO:0008366,0.541431004210183,0.81844881597882,1,110,axon ensheathment,BP,HEXB
19237,GO:1902600,0.541887233254327,0.818169562710642,1,104,hydrogen ion transmembrane transport,BP,CYB5A
2803,GO:0005793,0.543425420112962,0.816917308867581,1,109,endoplasmic reticulum-Golgi intermediate compartment,CC,CNIH4
14081,GO:0051443,0.543490999801419,0.816928143060674,1,104,positive regulation of ubiquitin-protein transferase activity,BP,PSMB10
3783,GO:0007368,0.543540108786702,0.81681663867075,1,110,determination of left/right symmetry,BP,ALG5
2940,GO:0006023,0.543561535848287,0.816788545906712,1,111,aminoglycan biosynthetic process,BP,EXTL1
12435,GO:0045936,0.543719723800954,0.655048826224208,4,541,negative regulation of phosphate metabolic process,BP,APOC1;PYCARD;RGN;DEPTOR
576,GO:0001664,0.543930999269987,0.727423061477724,2,245,G-protein coupled receptor binding,MF,MRAP;CNIH4
11868,GO:0044707,0.544766933659001,0.530400282287163,42,5907,single-multicellular organism process,BP,EBP;PDK4;ALG5;TH;FADD;HSD17B3;APOC1;TRADD;EXTL1;PNP;ABCG1;EBF1;PYCARD;ACADVL;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;NNMT;PLA2G16;FXYD1;RBP4;ANG;NMI;ACAT1;HEXB;NOL3;FAM46A;TMEM176A;IDH1;TFPI;STAR;PEPD;S100B;DHCR7;PTS;HNF1A;DOK1;SLC1A3;LINGO1
6230,GO:0017016,0.544801596672229,0.726549023148885,2,268,Ras GTPase binding,MF,TBC1D14;RPH3AL
3883,GO:0007631,0.544806230971818,0.815867984877451,1,107,feeding behavior,BP,TH
20978,GO:2000058,0.545169130492082,0.815610262317687,1,105,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
4855,GO:0010563,0.545321290007896,0.653499068512975,4,542,negative regulation of phosphorus metabolic process,BP,APOC1;PYCARD;RGN;DEPTOR
1388,GO:0003015,0.545333636547662,0.72610174725283,2,258,heart process,BP,TH;FXYD1
7109,GO:0022604,0.545633856112341,0.681011432958888,3,414,regulation of cell morphogenesis,BP,HEXB;S100B;LINGO1
9629,GO:0034976,0.546090841495657,0.725429049716875,2,254,response to endoplasmic reticulum stress,BP,ACADVL;CASP4
14698,GO:0060071,0.546732736399619,0.814339264321671,1,109,Wnt signaling pathway, planar cell polarity pathway,BP,PSMB10
760,GO:0001935,0.546820392391033,0.8142472197102,1,111,endothelial cell proliferation,BP,ANG
8796,GO:0032879,0.547008734402171,0.556727011477493,17,2401,regulation of localization,BP,SLC31A2;FADD;APOC1;TBC1D14;ABCG1;PYCARD;ACAA2;RGN;FGF18;FXYD1;RBP4;RNASEL;ANG;FAM110C;NOL3;IFI27;RPH3AL
12320,GO:0045732,0.547032176788028,0.724584402958635,2,251,positive regulation of protein catabolic process,BP,PSMB10;RGN
3798,GO:0007409,0.547707449961223,0.67903685576508,3,416,axonogenesis,BP,S100B;DOK1;LINGO1
19566,GO:1903362,0.547821944444066,0.723864918438431,2,251,regulation of cellular protein catabolic process,BP,PSMB10;RGN
4406,GO:0009132,0.547841140598192,0.813469895384031,1,109,nucleoside diphosphate metabolic process,BP,NUDT7
678,GO:0001822,0.547913169175094,0.723737062213269,2,263,kidney development,BP,RGN;ACAT1
14108,GO:0051494,0.549168722420053,0.812378735201952,1,113,negative regulation of cytoskeleton organization,BP,TMOD4
13580,GO:0050680,0.549293580640311,0.812280248664923,1,113,negative regulation of epithelial cell proliferation,BP,RGN
17430,GO:0090175,0.549538096484676,0.812121741747904,1,110,regulation of establishment of planar polarity,BP,PSMB10
12359,GO:0045807,0.549998238874048,0.811735076694368,1,112,positive regulation of endocytosis,BP,PYCARD
1264,GO:0002761,0.550177027707277,0.811616949649639,1,110,regulation of myeloid leukocyte differentiation,BP,FADD
7102,GO:0022412,0.551293955435465,0.720677532433107,2,254,cellular process involved in reproduction in multicellular organism,BP,ANG;HEXB
737,GO:0001906,0.551313009963072,0.81076651132081,1,106,cell killing,BP,FADD
12793,GO:0046717,0.552044921327746,0.810124221493335,1,111,acid secretion,BP,SLC1A3
11630,GO:0044093,0.552678621817053,0.563679859792281,13,1841,positive regulation of molecular function,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;MGST2;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;IFI27
13332,GO:0048660,0.552774852444341,0.809531757983082,1,112,regulation of smooth muscle cell proliferation,BP,ANG
3674,GO:0007166,0.55368420773882,0.547560262449858,18,2540,cell surface receptor signaling pathway,BP,PDK4;IFI30;FADD;P2RY14;TRADD;PYCARD;G0S2;PSMB10;GHR;FGF18;TICAM1;RNASEL;NMI;GRIA3;NOL3;DEPTOR;IFI27;DOK1
9606,GO:0034762,0.554953845061689,0.672109999102435,3,411,regulation of transmembrane transport,BP,SLC31A2;RGN;FXYD1
4872,GO:0010594,0.556096436415432,0.80683941828388,1,115,regulation of endothelial cell migration,BP,FGF18
7891,GO:0031333,0.556703268478354,0.806362169810465,1,114,negative regulation of protein complex assembly,BP,TMOD4
1220,GO:0002700,0.556769043639526,0.806355842517541,1,110,regulation of production of molecular mediator of immune response,BP,RBP4
12596,GO:0046330,0.556849815399164,0.806221978848814,1,116,positive regulation of JNK cascade,BP,PYCARD
18319,GO:0099504,0.557031214965118,0.806054367697587,1,118,synaptic vesicle cycle,BP,TH
17062,GO:0072503,0.557195223450109,0.669964759449372,3,403,cellular divalent inorganic cation homeostasis,BP,RGN;HEXB;NOL3
15906,GO:0070371,0.557553463965556,0.714891696350825,2,256,ERK1 and ERK2 cascade,BP,PYCARD;FGF18
21025,GO:2000145,0.557830691569947,0.621782742204943,5,704,regulation of cell motility,BP,FADD;PYCARD;RGN;FGF18;FAM110C
5501,GO:0015399,0.558013923431546,0.805271493760929,1,117,primary active transmembrane transporter activity,MF,ABCG1
5503,GO:0015405,0.558013923431546,0.805271493760929,1,117,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCG1
4513,GO:0009260,0.558301789811477,0.714211938758601,2,252,ribonucleotide biosynthetic process,BP,MRAP;ACAT1
8172,GO:0031901,0.558600220049208,0.804818929343776,1,115,early endosome membrane,CC,SNX21
10800,GO:0042383,0.559464393011742,0.804096348632475,1,117,sarcolemma,CC,FXYD1
418,GO:0001085,0.559608516258911,0.804012526794062,1,114,RNA polymerase II transcription factor binding,MF,IFI27
5147,GO:0010977,0.560081081452096,0.803584568310797,1,118,negative regulation of neuron projection development,BP,LINGO1
4676,GO:0009896,0.560361654304769,0.666893676076141,3,406,positive regulation of catabolic process,BP,PSMB10;RGN;TICAM1
7883,GO:0031325,0.560692471670991,0.536189498685622,20,2825,positive regulation of cellular metabolic process,BP,FADD;MRAP;APOC1;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;HEXB;FABP3;PCBD1;IFI27;STAR;RBMS3;HNF1A
11512,GO:0043618,0.560969052134413,0.802952927714738,1,110,regulation of transcription from RNA polymerase II promoter in response to stress,BP,PSMB10
12856,GO:0046887,0.561059016336558,0.802855516455819,1,112,positive regulation of hormone secretion,BP,RBP4
13331,GO:0048659,0.56231699586736,0.801793452943868,1,115,smooth muscle cell proliferation,BP,ANG
4789,GO:0010389,0.562512781574978,0.801679917878445,1,111,regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
15841,GO:0070268,0.562865415985486,0.801403360059083,1,110,cornification,BP,KRT10
1485,GO:0003206,0.563174520423309,0.801068764884746,1,117,cardiac chamber morphogenesis,BP,RBP4
9759,GO:0035295,0.56411751549678,0.635051701039327,4,566,tube development,BP,FGF18;RBP4;ACAT1;DHCR7
12622,GO:0046390,0.565036125875751,0.707898649315045,2,255,ribose phosphate biosynthetic process,BP,MRAP;ACAT1
14893,GO:0060359,0.565697046314724,0.799003469143616,1,116,response to ammonium ion,BP,FADD
9005,GO:0033218,0.566017150065576,0.706954758157833,2,260,amide binding,MF,GHR;ANG
4823,GO:0010506,0.566109207726028,0.706842151909941,2,267,regulation of autophagy,BP,TBC1D14;TICAM1
4713,GO:0010008,0.56638742772784,0.661010117742299,3,411,endosome membrane,CC,ZFYVE21;TICAM1;SNX21
13382,GO:0048732,0.567272841510355,0.660134806802049,3,415,gland development,BP,FADD;RGN;ACAT1
12742,GO:0046631,0.568690917270206,0.796531633113392,1,115,alpha-beta T cell activation,BP,PNP
7179,GO:0030003,0.569152564776402,0.630053092986483,4,556,cellular cation homeostasis,BP,SLC31A2;RGN;HEXB;NOL3
4662,GO:0009855,0.569444070473264,0.795870016670262,1,118,determination of bilateral symmetry,BP,ALG5
9354,GO:0034250,0.569616680822074,0.79574818288109,1,116,positive regulation of cellular amide metabolic process,BP,RBMS3
19473,GO:1903169,0.569743233425399,0.795620199671516,1,118,regulation of calcium ion transmembrane transport,BP,RGN
19643,GO:1903522,0.569887087416616,0.703257394618733,2,269,regulation of blood circulation,BP,TH;FXYD1
8370,GO:0032269,0.570458610542927,0.583216547964108,7,986,negative regulation of cellular protein metabolic process,BP,PYCARD;PSMB10;RGN;ANG;NOL3;DEPTOR;TFPI
13960,GO:0051238,0.571754086486727,0.793913956262038,1,120,sequestering of metal ion,BP,NOL3
11430,GO:0043492,0.572581158018262,0.793176930935433,1,124,ATPase activity, coupled to movement of substances,MF,ABCG1
4651,GO:0009799,0.572837329617187,0.793013298191168,1,119,specification of symmetry,BP,ALG5
4055,GO:0008286,0.57369837572535,0.79227606887923,1,120,insulin receptor signaling pathway,BP,PDK4
13840,GO:0051053,0.573710624400692,0.79227653959001,1,119,negative regulation of DNA metabolic process,BP,RGN
9429,GO:0034399,0.573752903582691,0.792219367468147,1,121,nuclear periphery,CC,RNASEL
19343,GO:1902903,0.575263261708503,0.698111694932583,2,272,regulation of supramolecular fiber organization,BP,PYCARD;TMOD4
7985,GO:0031503,0.575637141716489,0.790644909296473,1,119,protein complex localization,BP,NOL3
3680,GO:0007173,0.575665301996069,0.790599406819107,1,121,epidermal growth factor receptor signaling pathway,BP,DOK1
12654,GO:0046467,0.575806678622633,0.790534702242523,1,116,membrane lipid biosynthetic process,BP,DPM3
11514,GO:0043620,0.576171125212782,0.790236625574325,1,115,regulation of DNA-templated transcription in response to stress,BP,PSMB10
18117,GO:0098661,0.576653257248134,0.789738211146448,1,123,inorganic anion transmembrane transport,BP,FXYD1
12221,GO:0045580,0.577182338495986,0.789341050224094,1,118,regulation of T cell differentiation,BP,PNP
1226,GO:0002706,0.577217647427846,0.789333760882483,1,116,regulation of lymphocyte mediated immunity,BP,FADD
4288,GO:0008757,0.577598029759182,0.78898634564067,1,118,S-adenosylmethionine-dependent methyltransferase activity,MF,NNMT
17103,GO:0072562,0.577693868922087,0.788951028759513,1,114,blood microparticle,CC,CFB
13370,GO:0048706,0.577946322330948,0.788655945030628,1,121,embryonic skeletal system development,BP,RBP4
14312,GO:0051896,0.577985288071483,0.788633421248897,1,120,regulation of protein kinase B signaling,BP,FAM110C
7691,GO:0030968,0.578559466990024,0.788153227687198,1,119,endoplasmic reticulum unfolded protein response,BP,ACADVL
620,GO:0001736,0.579137466219467,0.787647010432627,1,120,establishment of planar polarity,BP,PSMB10
3672,GO:0007164,0.579137466219467,0.787647010432627,1,120,establishment of tissue polarity,BP,PSMB10
1294,GO:0002822,0.580370095979947,0.78662194395601,1,117,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
563,GO:0001650,0.580725514384356,0.78627140437966,1,121,fibrillar center,CC,MRI1
7592,GO:0030817,0.580765021971409,0.786270558224971,1,118,regulation of cAMP biosynthetic process,BP,MRAP
8369,GO:0032268,0.581442478543026,0.524412132172824,16,2281,regulation of cellular protein metabolic process,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;TSFM;NOL3;DEPTOR;IFI27;TFPI;RBMS3
7171,GO:0023051,0.581541889676232,0.513020215315809,21,3019,regulation of signaling,BP,FADD;TRADD;PYCARD;G0S2;ACAA2;PSMB10;RGN;GHR;FGF18;TICAM1;PXK;FXYD1;RBP4;FAM110C;NOL3;DEPTOR;STAR;RPH3AL;S100B;DOK1;SLC1A3
15678,GO:0065009,0.583004822518113,0.513397678068339,20,2865,regulation of molecular function,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;MGST2;PSMB10;RGN;GHR;FGF18;TICAM1;FXYD1;ANG;NOL3;DEPTOR;PCBD1;IFI27;TFPI;GLA;PTS
8846,GO:0032956,0.583086122149184,0.69052577126418,2,278,regulation of actin cytoskeleton organization,BP,PYCARD;TMOD4
18977,GO:1901981,0.583095265408829,0.784181583988708,1,125,phosphatidylinositol phosphate binding,MF,SNX21
4536,GO:0009314,0.583354682379167,0.644161035971872,3,421,response to radiation,BP,TH;STAR;SLC1A3
13322,GO:0048638,0.583677754103983,0.689942315854595,2,280,regulation of developmental growth,BP,GHR;RBP4
17493,GO:0090263,0.5837969621694,0.783636863726564,1,119,positive regulation of canonical Wnt signaling pathway,BP,PSMB10
14929,GO:0060402,0.583851322366523,0.783535619749186,1,124,calcium ion transport into cytosol,BP,NOL3
947,GO:0002223,0.584390790565022,0.783120661539301,1,119,stimulatory C-type lectin receptor signaling pathway,BP,PSMB10
10766,GO:0042326,0.584527155413712,0.642982023591293,3,421,negative regulation of phosphorylation,BP,PYCARD;RGN;DEPTOR
10461,GO:0038061,0.58557837403172,0.782097196206356,1,118,NIK/NF-kappaB signaling,BP,PSMB10
6108,GO:0016779,0.585934270867088,0.78174182370888,1,122,nucleotidyltransferase activity,MF,GALT
11726,GO:0044306,0.58608273965021,0.781590841367464,1,124,neuron projection terminus,CC,TH
7147,GO:0022857,0.586360635470425,0.566928119887995,7,1011,transmembrane transporter activity,MF,EBP;SLC31A2;ABCG1;FXYD1;GRIA3;CYB5A;SLC1A3
7844,GO:0031267,0.586582940472512,0.687071762721586,2,289,small GTPase binding,MF,TBC1D14;RPH3AL
645,GO:0001775,0.587216380958791,0.54928030059415,9,1279,cell activation,BP,FADD;PNP;PYCARD;TICAM1;SHPK;HEXB;IDH1;GLA;DERA
17065,GO:0072507,0.587292648772431,0.640190909473422,3,422,divalent inorganic cation homeostasis,BP,RGN;HEXB;NOL3
17529,GO:0090305,0.587438882298036,0.686292921117532,2,271,nucleic acid phosphodiester bond hydrolysis,BP,RNASEL;ANG
19294,GO:1902749,0.588524520695935,0.779503768662423,1,119,regulation of cell cycle G2/M phase transition,BP,PSMB10
3499,GO:0006873,0.58853906534924,0.6104318065003,4,570,cellular ion homeostasis,BP,SLC31A2;RGN;HEXB;NOL3
13654,GO:0050777,0.589315161138476,0.778795917160798,1,120,negative regulation of immune response,BP,NMI
3028,GO:0006171,0.589854481059354,0.778308740296646,1,121,cAMP biosynthetic process,BP,MRAP
3868,GO:0007612,0.589860209812728,0.778230287284124,1,128,learning,BP,TH
3131,GO:0006354,0.590268681502266,0.777931666333898,1,122,DNA-templated transcription, elongation,BP,TSFM
13919,GO:0051174,0.590583023265798,0.533901144989837,11,1586,regulation of phosphorus metabolic process,BP,PDK4;MRAP;APOC1;PYCARD;RGN;GHR;FGF18;ANG;FABP3;DEPTOR;IDH1
12039,GO:0045121,0.590746549581757,0.682999313759977,2,281,membrane raft,CC,FADD;TRADD
9517,GO:0034620,0.590892862757313,0.777368365659149,1,123,cellular response to unfolded protein,BP,ACADVL
945,GO:0002220,0.590913949578186,0.777371579077208,1,121,innate immune response activating cell surface receptor signaling pathway,BP,PSMB10
10900,GO:0042542,0.59121486660491,0.777082987365827,1,123,response to hydrogen peroxide,BP,STAR
4048,GO:0008277,0.591686701812855,0.776664362522821,1,123,regulation of G-protein coupled receptor protein signaling pathway,BP,RPH3AL
8206,GO:0031965,0.591775715700153,0.681984696920928,2,280,nuclear membrane,CC,IFI27;DHCR7
18205,GO:0098857,0.592520562281573,0.681239886713018,2,282,membrane microdomain,CC,FADD;TRADD
16751,GO:0071901,0.59317749016861,0.775338115430941,1,123,negative regulation of protein serine/threonine kinase activity,BP,PYCARD
5835,GO:0016247,0.593479581133533,0.775057938106624,1,124,channel regulator activity,MF,FXYD1
14705,GO:0060078,0.595780758766244,0.772908040854387,1,133,regulation of postsynaptic membrane potential,BP,GRIA3
3845,GO:0007568,0.596246722845585,0.677546263401942,2,278,aging,BP,TH;RGN
10476,GO:0038095,0.596319347236875,0.77251429050987,1,124,Fc-epsilon receptor signaling pathway,BP,PSMB10
13578,GO:0050678,0.596554582931234,0.677224986445967,2,282,regulation of epithelial cell proliferation,BP,RGN;ANG
15327,GO:0061041,0.598056829345975,0.770926852632967,1,126,regulation of wound healing,BP,FAM46A
11138,GO:0043010,0.598975783453565,0.674780598074465,2,288,camera-type eye development,BP,TH;RBP4
13286,GO:0048562,0.599208799150036,0.674563386370612,2,283,embryonic organ morphogenesis,BP,TH;RBP4
6103,GO:0016773,0.600924615920119,0.57784257647168,5,752,phosphotransferase activity, alcohol group as acceptor,MF,PDK4;ZFYVE21;FGF18;RNASEL;SHPK
14077,GO:0051438,0.601514703819273,0.767819980189414,1,123,regulation of ubiquitin-protein transferase activity,BP,PSMB10
9762,GO:0035303,0.601681234741248,0.767584519202749,1,131,regulation of dephosphorylation,BP,RGN
14928,GO:0060401,0.601805166486943,0.767481256794141,1,130,cytosolic calcium ion transport,BP,NOL3
3747,GO:0007270,0.60219711229477,0.767103552828339,1,132,neuron-neuron synaptic transmission,BP,TH
15550,GO:0061564,0.602310357886188,0.62478802498844,3,450,axon development,BP,S100B;DOK1;LINGO1
673,GO:0001817,0.602495284595878,0.596000765942319,4,576,regulation of cytokine production,BP,FADD;PYCARD;TICAM1;NMI
4671,GO:0009891,0.602691644764866,0.51652857120125,12,1746,positive regulation of biosynthetic process,BP,FADD;MRAP;ABCG1;RGN;TICAM1;RNASEL;HEXB;FABP3;PCBD1;STAR;RBMS3;HNF1A
11403,GO:0043433,0.603154691504313,0.766277452264576,1,127,negative regulation of sequence-specific DNA binding transcription factor activity,BP,PYCARD
12771,GO:0046683,0.603839571147775,0.76562858593093,1,129,response to organophosphorus,BP,STAR
13653,GO:0050776,0.604141064731147,0.559837380948374,6,860,regulation of immune response,BP,CFB;FADD;PYCARD;PSMB10;TICAM1;NMI
13759,GO:0050921,0.604857439636897,0.76473483544874,1,125,positive regulation of chemotaxis,BP,FGF18
5831,GO:0016241,0.604918683936463,0.76462618881656,1,130,regulation of macroautophagy,BP,TBC1D14
12664,GO:0046483,0.604962833036113,0.46995143118994,40,5674,heterocycle metabolic process,BP,TH;FADD;MRAP;TRADD;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;PSMB10;RGN;FADS1;GHR;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;AOX1;SHPK;HEXB;NOL3;NUDT7;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;STAR;ACP5;DERA;PTS;HNF1A
101,GO:0000209,0.604968184306082,0.66874636962536,2,284,protein polyubiquitination,BP,PSMB10;NMI
18691,GO:1901137,0.605061340617016,0.573534734314674,5,723,carbohydrate derivative biosynthetic process,BP,ALG5;DPM3;MRAP;EXTL1;ACAT1
13964,GO:0051246,0.605298977686135,0.496996358109841,17,2455,regulation of protein metabolic process,BP,CFB;FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;TSFM;NOL3;DEPTOR;IFI27;TFPI;RBMS3
17356,GO:0090066,0.605354345351177,0.621652630610457,3,439,regulation of anatomical structure size,BP,PYCARD;DEPTOR;TMOD4
7925,GO:0031400,0.605622045820467,0.592728087038253,4,580,negative regulation of protein modification process,BP,PYCARD;PSMB10;RGN;DEPTOR
4854,GO:0010562,0.606057432180968,0.546402717300884,7,1022,positive regulation of phosphorus metabolic process,BP,MRAP;PYCARD;RGN;GHR;FGF18;ANG;FABP3
12436,GO:0045937,0.606057432180968,0.546402717300884,7,1022,positive regulation of phosphate metabolic process,BP,MRAP;PYCARD;RGN;GHR;FGF18;ANG;FABP3
8780,GO:0032844,0.606384237305013,0.620582003753212,3,439,regulation of homeostatic process,BP,PDK4;FADD;NOL3
6758,GO:0019900,0.60664724061047,0.591634995353702,4,596,kinase binding,MF,TRADD;TBC1D14;GHR;TICAM1
5754,GO:0016072,0.607181330077404,0.666534840639448,2,273,rRNA metabolic process,BP,RNASEL;ANG
14671,GO:0060041,0.608199571170394,0.761542274981989,1,135,retina development in camera-type eye,BP,RBP4
18116,GO:0098660,0.608308430475336,0.570102026611551,5,744,inorganic ion transmembrane transport,BP,SLC31A2;RGN;FXYD1;NOL3;CYB5A
7103,GO:0022414,0.608783657215751,0.526764006862709,9,1304,reproductive process,BP,TH;HSD17B3;RGN;RBP4;CYP17A1;ANG;HEXB;IDH1;STAR
3461,GO:0006810,0.609099391210383,0.470109514070782,33,4735,transport,BP,EBP;TH;ZFYVE21;SLC31A2;APOC1;TBC1D14;PNP;ABCG1;PYCARD;ACAA2;PSMB10;RGN;GHR;CPT2;FXYD1;RBP4;RNASEL;ANG;HEXB;FABP3;GRIA3;NOL3;IFI27;IDH1;STAR;SNX21;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3;CNIH4
3531,GO:0006914,0.609356286142978,0.617484825149564,3,438,autophagy,BP,WDR45;TBC1D14;TICAM1
4673,GO:0009893,0.609730084578382,0.483811809152382,21,3038,positive regulation of metabolic process,BP,FADD;MRAP;APOC1;TRADD;ABCG1;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;HEXB;FABP3;PCBD1;IFI27;STAR;RBMS3;HNF1A
2,GO:0000003,0.609793974685173,0.525698678831154,9,1305,reproduction,BP,TH;HSD17B3;RGN;RBP4;CYP17A1;ANG;HEXB;IDH1;STAR
621,GO:0001738,0.610089816101282,0.759819931406325,1,131,morphogenesis of a polarized epithelium,BP,PSMB10
336,GO:0000922,0.610327780528119,0.759597574623864,1,131,spindle pole,CC,FAM110C
12889,GO:0046943,0.610464723237894,0.75946954792321,1,131,carboxylic acid transmembrane transporter activity,MF,SLC1A3
15457,GO:0061337,0.611198359410609,0.758734323282784,1,136,cardiac conduction,BP,FXYD1
11454,GO:0043524,0.613267724338468,0.75681848000058,1,133,negative regulation of neuron apoptotic process,BP,STAR
4566,GO:0009416,0.613436612654265,0.66006666775544,2,289,response to light stimulus,BP,TH;SLC1A3
18112,GO:0098655,0.614025344078487,0.564056687864212,5,745,cation transmembrane transport,BP,SLC31A2;RGN;FXYD1;NOL3;CYB5A
12458,GO:0045981,0.615110387637676,0.755108017747117,1,130,positive regulation of nucleotide metabolic process,BP,MRAP
18621,GO:1900544,0.615110387637676,0.755108017747117,1,130,positive regulation of purine nucleotide metabolic process,BP,MRAP
2429,GO:0005057,0.61583851015117,0.754339627540911,1,138,signal transducer activity, downstream of receptor,MF,DOK1
4234,GO:0008584,0.615866920557853,0.7543604043994,1,133,male gonad development,BP,STAR
12703,GO:0046546,0.615866920557853,0.7543604043994,1,133,development of primary male sexual characteristics,BP,STAR
5805,GO:0016192,0.616374743635751,0.502133514143575,12,1770,vesicle-mediated transport,BP,ZFYVE21;APOC1;TBC1D14;PNP;PYCARD;GHR;HEXB;IDH1;GLA;RPH3AL;DERA;CNIH4
5368,GO:0015103,0.616833106291084,0.753422625894365,1,135,inorganic anion transmembrane transporter activity,MF,FXYD1
3495,GO:0006865,0.617183071187907,0.753089421544143,1,135,amino acid transport,BP,SLC1A3
11807,GO:0044440,0.618027405675909,0.608353963121648,3,443,endosomal part,CC,ZFYVE21;TICAM1;SNX21
8791,GO:0032874,0.618580817106787,0.751736327004226,1,137,positive regulation of stress-activated MAPK cascade,BP,PYCARD
8313,GO:0032147,0.618658528053471,0.654639408399028,2,294,activation of protein kinase activity,BP,GHR;ANG
13805,GO:0051015,0.618862624053589,0.751448176211186,1,139,actin filament binding,MF,TMOD4
19739,GO:1903707,0.618972672823595,0.751420517957348,1,131,negative regulation of hemopoiesis,BP,TMEM176A
16790,GO:0072006,0.619825838609656,0.750525099445983,1,139,nephron development,BP,ACAT1
15863,GO:0070304,0.621413814075407,0.749007247918354,1,138,positive regulation of stress-activated protein kinase signaling cascade,BP,PYCARD
1125,GO:0002526,0.622279821693901,0.748240746454399,1,131,acute inflammatory response,BP,CFB
3155,GO:0006396,0.622459225309637,0.540407525901541,6,872,RNA processing,BP,LAGE3;ARL6IP4;HSD17B10;RNASEL;NOL3;PUS1
7817,GO:0031224,0.623345153787512,0.453119246602275,36,5117,intrinsic component of membrane,CC,EBP;TMEM160;TMEM164;ALG5;DPM3;SLC31A2;P2RY14;MRAP;PXMP2;PXMP4;EXTL1;ABCG1;CCDC51;MGST2;FADS1;GHR;ASAH2;PLA2G16;FXYD1;TMEM223;GRIA3;HSD3B2;CPT1C;IFI27;TMEM176A;TMEM98;TFPI;ACP5;PRRT1;DHCR7;CYB5A;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH
7589,GO:0030814,0.623413613741959,0.747123420388149,1,133,regulation of cAMP metabolic process,BP,MRAP
7440,GO:0030426,0.624102238290079,0.746379058409851,1,141,growth cone,CC,ANG
16830,GO:0072073,0.62467071607793,0.745835763310253,1,140,kidney epithelium development,BP,ACAT1
16250,GO:0070997,0.625118296586814,0.647865734382439,2,296,neuron death,BP,FADD;STAR
7482,GO:0030534,0.625210640125581,0.745310331171918,1,140,adult behavior,BP,FADD
16752,GO:0071902,0.626898717120137,0.645982879633096,2,297,positive regulation of protein serine/threonine kinase activity,BP,GHR;FGF18
12232,GO:0045596,0.628180981875793,0.568721505250632,4,603,negative regulation of cell differentiation,BP,ABCG1;TMEM176A;S100B;LINGO1
2640,GO:0005515,0.628536345552438,0.441066522936618,74,10444,protein binding,MF,CFB;EBP;PECR;PHYH;IFI30;DPM3;TH;ZFYVE21;MRI1;FADD;MRAP;TRADD;TBC1D14;PXMP2;PXMP4;ACSF2;ABCG1;EBF1;PYCARD;G0S2;LAGE3;ACAA2;MGST2;PSMB10;GHR;FGF18;TICAM1;ARL6IP4;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;HEXB;FABP3;NOL3;NUDT6;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;IFI27;PON2;FAM46A;IDH1;LDHD;STAR;WBP1;PEPD;GLA;RPH3AL;S100B;CYB5A;PTS;HNF1A;DOK1;CNIH4;ELOVL6;LINGO1;TMOD4
3769,GO:0007338,0.628823340630351,0.741853208668464,1,132,single fertilization,BP,HEXB
19199,GO:1902532,0.629114868739478,0.596499153432339,3,451,negative regulation of intracellular signal transduction,BP,PYCARD;NOL3;DEPTOR
19037,GO:1902115,0.630583428912981,0.740029949014363,1,141,regulation of organelle assembly,BP,TBC1D14
5726,GO:0016021,0.63111151416094,0.445640260354567,35,4993,integral component of membrane,CC,EBP;TMEM160;TMEM164;ALG5;DPM3;SLC31A2;P2RY14;MRAP;PXMP2;PXMP4;EXTL1;ABCG1;CCDC51;MGST2;FADS1;GHR;ASAH2;PLA2G16;FXYD1;TMEM223;GRIA3;HSD3B2;CPT1C;IFI27;TMEM176A;TMEM98;ACP5;PRRT1;DHCR7;CYB5A;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH
10012,GO:0035725,0.631166559530766,0.739426137536748,1,144,sodium ion transmembrane transport,BP,FXYD1
9744,GO:0035265,0.63151070923196,0.739103173506647,1,142,organ growth,BP,RBP4
7902,GO:0031345,0.631608459233593,0.739006302173003,1,142,negative regulation of cell projection organization,BP,LINGO1
10150,GO:0035967,0.632164682690591,0.738492017570158,1,138,cellular response to topologically incorrect protein,BP,ACADVL
19223,GO:1902578,0.632550754335761,0.459788299968102,21,3072,single-organism localization,BP,EBP;TH;APOC1;PNP;ABCG1;PYCARD;CPT2;RBP4;RNASEL;ANG;HEXB;FABP3;NOL3;IDH1;STAR;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3
10658,GO:0042110,0.632558033588717,0.592790053894356,3,446,T cell activation,BP,FADD;PNP;PYCARD
8788,GO:0032870,0.632811418981467,0.563702537487955,4,610,cellular response to hormone stimulus,BP,PDK4;GHR;RNASEL;STAR
5466,GO:0015293,0.633496248618067,0.737139578569836,1,141,symporter activity,MF,SLC1A3
15001,GO:0060491,0.633504308506893,0.737122356639066,1,142,regulation of cell projection assembly,BP,FAM110C
7922,GO:0031397,0.633777707477022,0.736927312383558,1,134,negative regulation of protein ubiquitination,BP,PSMB10
5222,GO:0014066,0.634377137513717,0.73624262943069,1,143,regulation of phosphatidylinositol 3-kinase signaling,BP,FGF18
5458,GO:0015276,0.634402280307999,0.736226603552303,1,142,ligand-gated ion channel activity,MF,GRIA3
7133,GO:0022834,0.634402280307999,0.736226603552303,1,142,ligand-gated channel activity,MF,GRIA3
11624,GO:0044087,0.634537416903895,0.542008828539393,5,771,regulation of cellular component biogenesis,BP,TBC1D14;PYCARD;FAM110C;HNF1A;TMOD4
7441,GO:0030427,0.635482308282084,0.735110624442933,1,146,site of polarized growth,CC,ANG
11232,GO:0043167,0.635501867989363,0.438085848155085,40,5840,ion binding,MF,PDK4;PHYH;TH;ZFYVE21;APOC1;ACSF2;PNP;ABCG1;EBF1;ACADVL;ACSM5;RGN;PXK;HACL1;GALT;CYP17A1;RNASEL;ANG;ACAT1;AOX1;SHPK;FABP3;NOL3;NUDT7;ACCS;PON2;IDH1;DECR1;LDHD;MDP1;SNX21;PEPD;ACP5;CYP11A1;RPH3AL;S100B;CYB5A;PTS;SLC1A3;ETFDH
5228,GO:0014074,0.636087480828765,0.734539608776191,1,142,response to purine-containing compound,BP,STAR
18170,GO:0098798,0.636344860331044,0.734401858071584,1,130,mitochondrial protein complex,CC,ETFDH
329,GO:0000904,0.636624802231476,0.559526705493204,4,634,cell morphogenesis involved in differentiation,BP,S100B;DOK1;SLC1A3;LINGO1
10498,GO:0038127,0.637720826368932,0.732887909200605,1,143,ERBB signaling pathway,BP,DOK1
13984,GO:0051270,0.637788333668978,0.538467457367339,5,772,regulation of cellular component movement,BP,FADD;PYCARD;RGN;FGF18;FAM110C
4195,GO:0008509,0.638412604405852,0.633652014735937,2,304,anion transmembrane transporter activity,MF,FXYD1;SLC1A3
7577,GO:0030802,0.638425060193619,0.732224684087899,1,138,regulation of cyclic nucleotide biosynthetic process,BP,MRAP
10584,GO:0040012,0.638632684626471,0.537547175951575,5,770,regulation of locomotion,BP,FADD;PYCARD;RGN;FGF18;FAM110C
12865,GO:0046903,0.638847718249562,0.48829807343666,10,1489,secretion,BP,PNP;PYCARD;RBP4;ANG;HEXB;IDH1;GLA;RPH3AL;DERA;SLC1A3
13810,GO:0051020,0.638887702432899,0.633099160178728,2,317,GTPase binding,MF,TBC1D14;RPH3AL
6128,GO:0016810,0.639385170046641,0.731244216918182,1,139,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,ASAH2
2583,GO:0005342,0.639841137889942,0.730763198330514,1,141,organic acid transmembrane transporter activity,MF,SLC1A3
4910,GO:0010646,0.640762427057412,0.452900072347626,20,2967,regulation of cell communication,BP,FADD;TRADD;PYCARD;G0S2;ACAA2;PSMB10;RGN;GHR;FGF18;TICAM1;PXK;RBP4;FAM110C;NOL3;DEPTOR;STAR;RPH3AL;S100B;DOK1;SLC1A3
13647,GO:0050770,0.641271054729995,0.729239262317834,1,149,regulation of axonogenesis,BP,LINGO1
1260,GO:0002757,0.641334631497793,0.583209593644131,3,454,immune response-activating signal transduction,BP,FADD;PSMB10;TICAM1
14590,GO:0055067,0.641893409191459,0.728667504032262,1,142,monovalent inorganic cation homeostasis,BP,PDK4
729,GO:0001890,0.642514216423448,0.728024789892829,1,143,placenta development,BP,ANG
3237,GO:0006508,0.64300950902202,0.478373028080714,11,1634,proteolysis,BP,CFB;FADD;TRADD;PYCARD;PSMB10;RGN;NOL3;CASP4;IFI27;TFPI;PEPD
98,GO:0000187,0.644512614523172,0.725969175708518,1,144,activation of MAPK activity,BP,GHR
4103,GO:0008361,0.644670321468296,0.725763014216481,1,149,regulation of cell size,BP,DEPTOR
11429,GO:0043491,0.645412785523206,0.725043688549689,1,144,protein kinase B signaling,BP,FAM110C
4755,GO:0010212,0.645950263737535,0.724490004707937,1,144,response to ionizing radiation,BP,STAR
3229,GO:0006497,0.646618993257218,0.723828134803195,1,141,protein lipidation,BP,DPM3
13686,GO:0050821,0.647145876417112,0.72326468188362,1,143,protein stabilization,BP,IFI30
11391,GO:0043410,0.648043820536222,0.575793752519262,3,463,positive regulation of MAPK cascade,BP,PYCARD;GHR;FGF18
3744,GO:0007267,0.648155707591999,0.478194131081422,10,1519,cell-cell signaling,BP,TH;PSMB10;FADS1;FGF18;PXK;RBP4;GRIA3;STAR;S100B;SLC1A3
1120,GO:0002521,0.648173713430951,0.575651427140539,3,462,leukocyte differentiation,BP,FADD;PNP;TMEM176A
12388,GO:0045860,0.648183939071536,0.575629975579057,3,468,positive regulation of protein kinase activity,BP,GHR;FGF18;ANG
12249,GO:0045619,0.648429172251832,0.72193506909895,1,143,regulation of lymphocyte differentiation,BP,PNP
5357,GO:0015081,0.649607196857081,0.720639241569628,1,151,sodium ion transmembrane transporter activity,MF,SLC1A3
6299,GO:0017148,0.649756282947253,0.720492424803806,1,150,negative regulation of translation,BP,ANG
15985,GO:0070509,0.649789173626757,0.720466752672019,1,149,calcium ion import,BP,NOL3
3830,GO:0007519,0.650656643960762,0.719579414164206,1,147,skeletal muscle tissue development,BP,S100B
3894,GO:0008021,0.650795490691328,0.719452457206368,1,145,synaptic vesicle,CC,TH
18155,GO:0098772,0.650956939103767,0.481453633483059,9,1372,molecular function regulator,MF,APOC1;TBC1D14;PYCARD;MGST2;RGN;FGF18;FXYD1;NOL3;TFPI
6674,GO:0019722,0.651280468402917,0.71892735206491,1,147,calcium-mediated signaling,BP,RGN
9513,GO:0034614,0.652080195506782,0.718117188258458,1,144,cellular response to reactive oxygen species,BP,RGN
7905,GO:0031348,0.65219762905132,0.717994052640653,1,144,negative regulation of defense response,BP,NMI
12756,GO:0046649,0.65220121830487,0.5423769229272,4,613,lymphocyte activation,BP,FADD;PNP;PYCARD;TICAM1
16750,GO:0071900,0.652466930592362,0.570866249439241,3,467,regulation of protein serine/threonine kinase activity,BP,PYCARD;GHR;FGF18
8858,GO:0032970,0.653197179079294,0.617407196932363,2,318,regulation of actin filament-based process,BP,PYCARD;TMOD4
19649,GO:1903530,0.653398718942966,0.541037427498052,4,617,regulation of secretion by cell,BP,PYCARD;RBP4;ANG;RPH3AL
11234,GO:0043169,0.654135565722409,0.428300598089816,27,4015,cation binding,MF,PHYH;TH;ZFYVE21;APOC1;EBF1;ACSM5;RGN;HACL1;GALT;CYP17A1;RNASEL;ANG;ACAT1;AOX1;NOL3;NUDT7;PON2;IDH1;MDP1;PEPD;ACP5;CYP11A1;RPH3AL;S100B;CYB5A;PTS;ETFDH
1484,GO:0003205,0.655261112023414,0.714688150941676,1,153,cardiac chamber development,BP,RBP4
612,GO:0001726,0.655290972996867,0.714648292900424,1,154,ruffle,CC,S100B
12389,GO:0045861,0.656091051885913,0.614225578433807,2,304,negative regulation of proteolysis,BP,NOL3;TFPI
3156,GO:0006397,0.656337216997656,0.566543101582823,3,461,mRNA processing,BP,ARL6IP4;RNASEL;NOL3
9902,GO:0035567,0.657762215302342,0.712067833462989,1,149,non-canonical Wnt signaling pathway,BP,PSMB10
19551,GO:1903321,0.657779376109025,0.712104793727072,1,143,negative regulation of protein modification by small protein conjugation or removal,BP,PSMB10
4001,GO:0008201,0.658468439766628,0.711332927197966,1,147,heparin binding,MF,ANG
12631,GO:0046425,0.659545732713069,0.71020023424322,1,145,regulation of JAK-STAT cascade,BP,GHR
20293,GO:1904892,0.659545732713069,0.71020023424322,1,145,regulation of STAT cascade,BP,GHR
19419,GO:1903034,0.659581955736907,0.710124987717904,1,149,regulation of response to wounding,BP,FAM46A
3525,GO:0006906,0.660129547943889,0.709512313122064,1,152,vesicle fusion,BP,TBC1D14
11468,GO:0043542,0.660611493196286,0.708986832967182,1,153,endothelial cell migration,BP,FGF18
18594,GO:1900371,0.6610046821216,0.708617290322386,1,147,regulation of purine nucleotide biosynthetic process,BP,MRAP
19198,GO:1902531,0.661516168368223,0.458183328435529,11,1683,regulation of intracellular signal transduction,BP,FADD;TRADD;PYCARD;RGN;GHR;FGF18;TICAM1;FAM110C;NOL3;DEPTOR;S100B
13323,GO:0048639,0.661980950613938,0.70749731766869,1,155,positive regulation of developmental growth,BP,GHR
7224,GO:0030098,0.662270020794766,0.607249330033707,2,314,lymphocyte differentiation,BP,FADD;PNP
11796,GO:0044425,0.662307072856305,0.408377475280259,43,6187,membrane part,CC,EBP;TMEM160;TMEM164;ALG5;DPM3;TH;SLC31A2;FADD;P2RY14;HSD17B3;MRAP;TRADD;PXMP2;PXMP4;EXTL1;ABCG1;CCDC51;MGST2;FADS1;GHR;ASAH2;PLA2G16;FXYD1;TMEM223;CYP17A1;GRIA3;HSD3B2;CPT1C;CASP4;IFI27;TMEM176A;TMEM98;TFPI;STAR;ACP5;PRRT1;DHCR7;CYB5A;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH
13738,GO:0050896,0.662855067751865,0.404478576041048,56,8010,response to stimulus,BP,CFB;EBP;PDK4;IFI30;TH;MSRA;FADD;P2RY14;TRADD;PNP;ABCG1;PYCARD;G0S2;ACADVL;ACAA2;MGST2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;NNMT;PXK;RBP4;RNASEL;ANG;FAM110C;NMI;ACAT1;AOX1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;DEPTOR;CASP4;IFI27;PON2;FAM46A;IDH1;TFPI;STAR;GLA;RPH3AL;PRRT1;DERA;S100B;CYB5A;DOK1;SLC1A3;LINGO1;ETFDH
4597,GO:0009611,0.663425299377074,0.529764544501033,4,626,response to wounding,BP,NOL3;FAM46A;TFPI;SLC1A3
12916,GO:0046982,0.663584296371546,0.558350170265922,3,466,protein heterodimerization activity,MF,ABCG1;RBP4;HEXB
7583,GO:0030808,0.663681438957741,0.705721441445806,1,148,regulation of nucleotide biosynthetic process,BP,MRAP
6102,GO:0016772,0.6640382139125,0.494805938943925,6,955,transferase activity, transferring phosphorus-containing groups,MF,PDK4;ZFYVE21;FGF18;GALT;RNASEL;SHPK
12496,GO:0046058,0.664122681621899,0.705225583921212,1,150,cAMP metabolic process,BP,MRAP
13237,GO:0048469,0.665819170527032,0.703382653810688,1,150,cell maturation,BP,ANG
8797,GO:0032880,0.666310531102528,0.492265928424227,6,937,regulation of protein localization,BP,PYCARD;RBP4;ANG;NOL3;IFI27;RPH3AL
7284,GO:0030177,0.66665696378774,0.702460509988996,1,151,positive regulation of Wnt signaling pathway,BP,PSMB10
13132,GO:0048193,0.666883196385916,0.601975290739751,2,326,Golgi vesicle transport,BP,TBC1D14;CNIH4
2628,GO:0005488,0.667138688359803,0.410513043744747,96,13522,binding,MF,CFB;EBP;PDK4;PECR;PHYH;IFI30;DPM3;TH;ZFYVE21;MRPL14;MRPL16;MRI1;FADD;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;LAGE3;ACADVL;ACAA2;MGST2;ACSM5;PSMB10;RGN;GHR;FGF18;TICAM1;ARL6IP4;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;ACAT2;TSFM;IDUA;AOX1;SHPK;HEXB;FABP3;NOL3;NUDT6;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;IFI27;PON2;FAM46A;IDH1;DECR1;PUS1;LDHD;MDP1;STAR;SNX21;WBP1;PEPD;ACP5;GLA;CYP11A1;RPH3AL;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
11386,GO:0043405,0.667652535618283,0.601111601380567,2,321,regulation of MAP kinase activity,BP,GHR;FGF18
15028,GO:0060538,0.667924521468671,0.701048738912997,1,154,skeletal muscle organ development,BP,S100B
13866,GO:0051098,0.668716776584848,0.599903633862726,2,318,regulation of binding,BP,TICAM1;PCBD1
10683,GO:0042158,0.66982286345412,0.698999089415703,1,150,lipoprotein biosynthetic process,BP,DPM3
13867,GO:0051099,0.670026943423529,0.698747916982428,1,153,positive regulation of binding,BP,TICAM1
14029,GO:0051347,0.67081099598289,0.521360321223541,4,635,positive regulation of transferase activity,BP,PSMB10;GHR;FGF18;ANG
13604,GO:0050707,0.671101213524502,0.697580285648097,1,151,regulation of cytokine secretion,BP,PYCARD
11616,GO:0044057,0.671797566095098,0.548932758472516,3,484,regulation of system process,BP,TH;FXYD1;NOL3
13957,GO:0051234,0.671984255313701,0.403629408691501,33,4853,establishment of localization,BP,EBP;TH;ZFYVE21;SLC31A2;APOC1;TBC1D14;PNP;ABCG1;PYCARD;ACAA2;PSMB10;RGN;GHR;CPT2;FXYD1;RBP4;RNASEL;ANG;HEXB;FABP3;GRIA3;NOL3;IFI27;IDH1;STAR;SNX21;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3;CNIH4
17429,GO:0090174,0.672341871688084,0.696155755090199,1,157,organelle membrane fusion,BP,TBC1D14
3543,GO:0006936,0.672634393633001,0.595379265544668,2,326,muscle contraction,BP,FXYD1;TMOD4
14463,GO:0052652,0.673199875098212,0.695246012575582,1,152,cyclic purine nucleotide metabolic process,BP,MRAP
12594,GO:0046328,0.674109604006099,0.694166621293975,1,160,regulation of JNK cascade,BP,PYCARD
4460,GO:0009190,0.67573999897254,0.692404524409098,1,153,cyclic nucleotide biosynthetic process,BP,MRAP
5866,GO:0016301,0.67620401897403,0.495530377189838,5,816,kinase activity,MF,PDK4;ZFYVE21;FGF18;RNASEL;SHPK
6841,GO:0021543,0.676414787499216,0.691581977975833,1,161,pallium development,BP,TH
1223,GO:0002703,0.676902431176481,0.691101550344062,1,153,regulation of leukocyte mediated immunity,BP,FADD
3218,GO:0006479,0.676971999507185,0.690972727611777,1,159,protein methylation,BP,ETFB
4011,GO:0008213,0.676971999507185,0.690972727611777,1,159,protein alkylation,BP,ETFB
13579,GO:0050679,0.677515933883266,0.690369602558876,1,158,positive regulation of epithelial cell proliferation,BP,ANG
567,GO:0001654,0.677519391071682,0.589699618722781,2,333,eye development,BP,TH;RBP4
5233,GO:0014706,0.677674648353916,0.589524426684871,2,331,striated muscle tissue development,BP,RBP4;S100B
5221,GO:0014065,0.678622185471314,0.689099147074073,1,161,phosphatidylinositol 3-kinase signaling,BP,FGF18
7401,GO:0030334,0.678850995222738,0.512107169708233,4,653,regulation of cell migration,BP,FADD;PYCARD;FGF18;FAM110C
7818,GO:0031225,0.679455123642684,0.688234399459231,1,152,anchored component of membrane,CC,TFPI
9353,GO:0034249,0.679480155230093,0.688122099710457,1,162,negative regulation of cellular amide metabolic process,BP,ANG
11561,GO:0043901,0.680415248691266,0.687129698423847,1,154,negative regulation of multi-organism process,BP,RNASEL
5714,GO:0015992,0.682262351845206,0.68504811317032,1,152,proton transport,BP,CYB5A
19345,GO:1902905,0.682744089130833,0.684438460406942,1,159,positive regulation of supramolecular fiber organization,BP,PYCARD
4080,GO:0008324,0.683038599204501,0.507261022885475,4,649,cation transmembrane transporter activity,MF,SLC31A2;GRIA3;CYB5A;SLC1A3
15914,GO:0070382,0.683503225338488,0.683571295272589,1,159,exocytic vesicle,CC,TH
12842,GO:0046872,0.683688444862331,0.397569553802938,26,3929,metal ion binding,MF,PHYH;TH;ZFYVE21;EBF1;ACSM5;RGN;HACL1;GALT;CYP17A1;RNASEL;ANG;ACAT1;AOX1;NOL3;NUDT7;PON2;IDH1;MDP1;PEPD;ACP5;CYP11A1;RPH3AL;S100B;CYB5A;PTS;ETFDH
7574,GO:0030799,0.685773813153056,0.680975038954017,1,158,regulation of cyclic nucleotide metabolic process,BP,MRAP
17928,GO:0097458,0.686029384313004,0.449771390078493,8,1285,neuron part,CC,TH;FADD;CYP17A1;ANG;CPT1C;STAR;S100B;SLC1A3
3468,GO:0006818,0.686684504820199,0.679960364358406,1,154,hydrogen transport,BP,CYB5A
6305,GO:0017157,0.686762780434234,0.679802593708495,1,162,regulation of exocytosis,BP,RPH3AL
1267,GO:0002764,0.687633466975664,0.530482796884855,3,487,immune response-regulating signaling pathway,BP,FADD;PSMB10;TICAM1
4678,GO:0009898,0.688408400983693,0.677883414639818,1,164,cytoplasmic side of plasma membrane,CC,TH
9161,GO:0033674,0.688425595087812,0.529530899556725,3,498,positive regulation of kinase activity,BP,GHR;FGF18;ANG
13667,GO:0050796,0.689675965137571,0.676411399275436,1,164,regulation of insulin secretion,BP,RBP4
17377,GO:0090090,0.689779513617721,0.676314988867194,1,161,negative regulation of canonical Wnt signaling pathway,BP,PSMB10
11817,GO:0044452,0.689852431854584,0.676230131302964,1,161,nucleolar part,CC,MRI1
13574,GO:0050673,0.690520677081422,0.57436850068739,2,335,epithelial cell proliferation,BP,RGN;ANG
1073,GO:0002440,0.692062747554308,0.673658000816596,1,160,production of molecular mediator of immune response,BP,RBP4
3574,GO:0006986,0.692684992356298,0.672920440079568,1,161,response to unfolded protein,BP,ACADVL
10921,GO:0042578,0.693154932727307,0.571202397512738,2,340,phosphoric ester hydrolase activity,MF,MDP1;ACP5
16130,GO:0070820,0.693168858414928,0.672352458607853,1,161,tertiary granule,CC,IDH1
7886,GO:0031328,0.693670005867969,0.422355929723767,11,1717,positive regulation of cellular biosynthetic process,BP,FADD;MRAP;RGN;TICAM1;RNASEL;HEXB;FABP3;PCBD1;STAR;RBMS3;HNF1A
5021,GO:0010822,0.69380411685401,0.671597407859174,1,162,positive regulation of mitochondrion organization,BP,PYCARD
5564,GO:0015698,0.694116147202499,0.671182911749127,1,168,inorganic anion transport,BP,FXYD1
7867,GO:0031301,0.694203746177507,0.671143403907423,1,160,integral component of organelle membrane,CC,ETFDH
3411,GO:0006725,0.694213685834696,0.37590588919792,39,5710,cellular aromatic compound metabolic process,BP,TH;FADD;MRAP;TRADD;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;PSMB10;RGN;FADS1;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;AOX1;SHPK;HEXB;NOL3;NUDT7;PCBD1;MDH1;IFI27;PON2;IDH1;PUS1;PTMS;STAR;DERA;PTS;HNF1A
13626,GO:0050731,0.694261948977639,0.671050216513801,1,163,positive regulation of peptidyl-tyrosine phosphorylation,BP,GHR
10752,GO:0042306,0.694311861401951,0.670967673701138,1,166,regulation of protein import into nucleus,BP,NOL3
7538,GO:0030666,0.69594665037524,0.669044588594125,1,165,endocytic vesicle membrane,CC,GRIA3
7926,GO:0031401,0.696082981739698,0.447165819525613,7,1114,positive regulation of protein modification process,BP,PYCARD;PSMB10;GHR;FGF18;TICAM1;ANG;NMI
15027,GO:0060537,0.698202927593491,0.565102785226678,2,345,muscle tissue development,BP,RBP4;S100B
3677,GO:0007169,0.698261814401847,0.489369786971314,4,671,transmembrane receptor protein tyrosine kinase signaling pathway,BP,PDK4;GHR;FGF18;DOK1
2194,GO:0004721,0.698271181038306,0.666245340839553,1,170,phosphoprotein phosphatase activity,MF,MDP1
3828,GO:0007517,0.698490158168843,0.564759987357428,2,343,muscle organ development,BP,RBP4;S100B
6538,GO:0019220,0.700188664073858,0.420191519526937,10,1573,regulation of phosphate metabolic process,BP,MRAP;APOC1;PYCARD;RGN;GHR;FGF18;ANG;FABP3;DEPTOR;IDH1
3512,GO:0006888,0.700656384851652,0.66340120511182,1,169,ER to Golgi vesicle-mediated transport,BP,CNIH4
20141,GO:1904589,0.700948657714269,0.663050468128946,1,169,regulation of protein import,BP,NOL3
9023,GO:0033267,0.701004647841908,0.662946312928561,1,174,axon part,CC,TH
7101,GO:0022411,0.703045380146902,0.512061550053847,3,500,cellular component disassembly,BP,MRPL14;MRPL16;TMOD4
4896,GO:0010632,0.703712054893112,0.659690209352463,1,173,regulation of epithelial cell migration,BP,FGF18
2669,GO:0005578,0.704151551865702,0.557837634513221,2,351,proteinaceous extracellular matrix,CC,ANG;LINGO1
2638,GO:0005509,0.704341137997811,0.482122627334059,4,676,calcium ion binding,MF,RGN;NOL3;RPH3AL;S100B
11264,GO:0043209,0.705723032911784,0.657295850645804,1,167,myelin sheath,CC,MDH1
17818,GO:0097223,0.706493654701988,0.656389585915435,1,163,sperm part,CC,HEXB
7126,GO:0022804,0.708834748217581,0.552073092512881,2,350,active transmembrane transporter activity,MF,ABCG1;SLC1A3
4584,GO:0009566,0.709894004900149,0.652199520687094,1,166,fertilization,BP,HEXB
7532,GO:0030658,0.710205738732677,0.651769059854487,1,172,transport vesicle membrane,CC,RPH3AL
13758,GO:0050920,0.711597943698481,0.650073287771706,1,169,regulation of chemotaxis,BP,FGF18
961,GO:0002250,0.711618042833215,0.548652687632127,2,338,adaptive immune response,BP,FADD;PYCARD
10373,GO:0036464,0.711732676481082,0.64986880544036,1,174,cytoplasmic ribonucleoprotein granule,CC,GHR
3851,GO:0007586,0.71196725079735,0.649632020692852,1,167,digestion,BP,RBP4
3142,GO:0006367,0.712566485738339,0.648843201892159,1,173,transcription initiation from RNA polymerase II promoter,BP,HNF1A
3855,GO:0007596,0.712678004471993,0.547319063495309,2,343,blood coagulation,BP,FAM46A;TFPI
18078,GO:0098589,0.713047408085397,0.546826976221889,2,355,membrane region,CC,FADD;TRADD
13701,GO:0050852,0.713426928292139,0.647813057634804,1,168,T cell receptor signaling pathway,BP,PSMB10
3849,GO:0007584,0.713573922632579,0.647599371930176,1,172,response to nutrient,BP,STAR
6757,GO:0019899,0.714636461169304,0.398441838980069,11,1773,enzyme binding,MF,TH;FADD;TRADD;TBC1D14;PYCARD;GHR;TICAM1;ACAT1;NOL3;RPH3AL;CYB5A
13945,GO:0051216,0.714879910716127,0.645942371432658,1,176,cartilage development,BP,FGF18
14715,GO:0060090,0.715630754575118,0.6449896523795,1,178,binding, bridging,MF,TRADD
7866,GO:0031300,0.715956947466989,0.64464063914308,1,170,intrinsic component of organelle membrane,CC,ETFDH
18067,GO:0098562,0.716830583601563,0.643493058451937,1,177,cytoplasmic side of membrane,CC,TH
3326,GO:0006611,0.717450287336661,0.642721628682515,1,176,protein export from nucleus,BP,IFI27
1639,GO:0003729,0.717907230851382,0.642146617288941,1,176,mRNA binding,MF,RBMS3
13682,GO:0050817,0.718751092325379,0.539692390751278,2,347,coagulation,BP,FAM46A;TFPI
13833,GO:0051046,0.718894572575892,0.464533922845006,4,673,regulation of secretion,BP,PYCARD;RBP4;ANG;RPH3AL
12289,GO:0045665,0.71995922765382,0.639519746783513,1,181,negative regulation of neuron differentiation,BP,LINGO1
2188,GO:0004713,0.720143153587957,0.639293668553414,1,180,protein tyrosine kinase activity,MF,FGF18
4703,GO:0009986,0.720262727706146,0.462852912745274,4,682,cell surface,CC,ABCG1;GHR;TFPI;SLC1A3
3858,GO:0007599,0.720487133390468,0.537495722384058,2,348,hemostasis,BP,FAM46A;TFPI
18723,GO:1901215,0.720551587202773,0.638797102234208,1,177,negative regulation of neuron death,BP,STAR
4424,GO:0009150,0.720640998624371,0.490477448807865,3,507,purine ribonucleotide metabolic process,BP,MRAP;ACAT1;NUDT7
6759,GO:0019901,0.721863620458955,0.488925207423681,3,528,protein kinase binding,MF,TBC1D14;GHR;TICAM1
4052,GO:0008283,0.722024276804217,0.38550101398586,12,1890,cell proliferation,BP,IFI30;FADD;PNP;PYCARD;RGN;FGF18;TICAM1;RBP4;ANG;FABP3;S100B;DHCR7
20466,GO:1905330,0.722247314258134,0.636633406309977,1,178,regulation of morphogenesis of an epithelium,BP,PSMB10
5354,GO:0015077,0.722421067312146,0.535026984165552,2,354,monovalent inorganic cation transmembrane transporter activity,MF,CYB5A;SLC1A3
19836,GO:1903900,0.72312674146587,0.635532842509073,1,175,regulation of viral life cycle,BP,RNASEL
4711,GO:0010001,0.723944867019497,0.634464166307716,1,178,glial cell differentiation,BP,S100B
8968,GO:0033157,0.724071799090804,0.532920506524586,2,356,regulation of intracellular protein transport,BP,NOL3;IFI27
12231,GO:0045595,0.725335758356337,0.397111985448354,9,1471,regulation of cell differentiation,BP,FADD;PNP;ABCG1;FADS1;FGF18;TMEM176A;STAR;S100B;LINGO1
17914,GO:0097435,0.726334719545445,0.483324533185576,3,534,supramolecular fiber organization,BP,PYCARD;ANG;TMOD4
3976,GO:0008168,0.726566624801661,0.631107937052036,1,176,methyltransferase activity,MF,NNMT
14806,GO:0060249,0.726744305494015,0.529508812095064,2,354,anatomical structure homeostasis,BP,PDK4;RBP4
3466,GO:0006816,0.727419312499215,0.528622730208564,2,362,calcium ion transport,BP,RGN;NOL3
19227,GO:1902582,0.72761411302167,0.453798717663577,4,694,single-organism intracellular transport,BP,ABCG1;CPT2;NOL3;STAR
10149,GO:0035966,0.728024388389935,0.629208120918882,1,178,response to topologically incorrect protein,BP,ACADVL
13385,GO:0048738,0.728848123890591,0.628083776239996,1,186,cardiac muscle tissue development,BP,RBP4
5753,GO:0016071,0.730375728190348,0.450395240437646,4,674,mRNA metabolic process,BP,ARL6IP4;RNASEL;NOL3;PUS1
14109,GO:0051495,0.730814228148988,0.625549847024805,1,182,positive regulation of cytoskeleton organization,BP,PYCARD
4024,GO:0008237,0.731405092883936,0.624770403786941,1,183,metallopeptidase activity,MF,PEPD
6353,GO:0018108,0.731496784664634,0.523372012816499,2,360,peptidyl-tyrosine phosphorylation,BP,GHR;FGF18
7188,GO:0030017,0.73178290644241,0.624255357091611,1,186,sarcomere,CC,TMOD4
10043,GO:0035770,0.733396047235023,0.622144056014788,1,185,ribonucleoprotein granule,CC,GHR
9958,GO:0035637,0.734065394588745,0.621229265469772,1,190,multicellular organismal signaling,BP,FXYD1
6387,GO:0018212,0.734575665443514,0.519369758628541,2,362,peptidyl-tyrosine modification,BP,GHR;FGF18
328,GO:0000902,0.734825244400672,0.425953590141675,5,883,cell morphogenesis,BP,HEXB;S100B;DOK1;SLC1A3;LINGO1
7249,GO:0030133,0.73508729610264,0.51870558923376,2,361,transport vesicle,CC,TH;RPH3AL
3733,GO:0007254,0.737685805760615,0.616430512397388,1,190,JNK cascade,BP,PYCARD
10801,GO:0042391,0.737887229146778,0.515015934556192,2,373,regulation of membrane potential,BP,FXYD1;GRIA3
5353,GO:0015075,0.738081477922454,0.421949363058442,5,861,ion transmembrane transporter activity,MF,SLC31A2;FXYD1;GRIA3;CYB5A;SLC1A3
1146,GO:0002573,0.738875147864651,0.614876534517376,1,185,myeloid leukocyte differentiation,BP,FADD
4199,GO:0008514,0.739202226790939,0.614432241905809,1,186,organic anion transmembrane transporter activity,MF,SLC1A3
12266,GO:0045637,0.739372250804972,0.61421839630644,1,184,regulation of myeloid cell differentiation,BP,FADD
4512,GO:0009259,0.739416999771799,0.466737874088749,3,522,ribonucleotide metabolic process,BP,MRAP;ACAT1;NUDT7
7119,GO:0022618,0.739554051687471,0.613981920963073,1,183,ribonucleoprotein complex assembly,BP,NOL3
10474,GO:0038093,0.739994883190525,0.61337717625508,1,185,Fc receptor signaling pathway,BP,PSMB10
20956,GO:2000021,0.740725862297923,0.612368823239477,1,189,regulation of ion homeostasis,BP,NOL3
16343,GO:0071229,0.741983915328679,0.610668271225719,1,190,cellular response to acid chemical,BP,PDK4
6641,GO:0019538,0.742373439251697,0.325104746647604,35,5268,protein metabolic process,BP,CFB;PDK4;ALG5;DPM3;MSRA;MRPL14;MRPL16;FADD;APOC1;TRADD;EXTL1;ABCG1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;ETFB;RNASEL;ANG;NMI;TSFM;IDUA;HEXB;NOL3;DEPTOR;CASP4;IFI27;MDP1;TFPI;PEPD;RBMS3;LYPLAL1
13299,GO:0048589,0.742611064958828,0.462589755202433,3,551,developmental growth,BP,GHR;RBP4;DHCR7
13418,GO:0048812,0.744072280018439,0.460690006461657,3,561,neuron projection morphogenesis,BP,S100B;DOK1;LINGO1
17504,GO:0090276,0.745809908173544,0.605471945128665,1,191,regulation of peptide hormone secretion,BP,RBP4
16747,GO:0071897,0.746193235967911,0.604955353992653,1,190,DNA biosynthetic process,BP,RGN
11453,GO:0043523,0.746535155338682,0.604481676070222,1,191,regulation of neuron apoptotic process,BP,STAR
8466,GO:0032403,0.747272861298004,0.42912205624916,4,710,protein complex binding,MF,FADD;TRADD;DOK1;TMOD4
7221,GO:0030073,0.747991869470165,0.602473392963036,1,193,insulin secretion,BP,RBP4
6086,GO:0016741,0.748041701773113,0.602444658367483,1,187,transferase activity, transferring one-carbon groups,MF,NNMT
13913,GO:0051168,0.74815638789978,0.602253949793386,1,192,nuclear export,BP,IFI27
11921,GO:0044801,0.748467019995853,0.601827160287875,1,192,single-organism membrane fusion,BP,TBC1D14
7533,GO:0030659,0.750057615391547,0.425569507825939,4,711,cytoplasmic vesicle membrane,CC,TH;GRIA3;SNX21;RPH3AL
4457,GO:0009187,0.751365995989207,0.597825492867738,1,192,cyclic nucleotide metabolic process,BP,MRAP
3803,GO:0007417,0.751847562154656,0.404754330370062,5,886,central nervous system development,BP,TH;ACAT1;STAR;S100B;PTS
7200,GO:0030036,0.751971704096587,0.450404817069656,3,562,actin cytoskeleton organization,BP,PYCARD;ANG;TMOD4
2655,GO:0005539,0.752511858808228,0.596234429372998,1,192,glycosaminoglycan binding,MF,ANG
8789,GO:0032872,0.752862346227241,0.5957087190945,1,198,regulation of stress-activated MAPK cascade,BP,PYCARD
10697,GO:0042176,0.753456088939138,0.494279175222031,2,371,regulation of protein catabolic process,BP,PSMB10;RGN
7285,GO:0030178,0.7537533416957,0.594498069929864,1,193,negative regulation of Wnt signaling pathway,BP,PSMB10
1888,GO:0004252,0.754238495197063,0.593867404646534,1,186,serine-type endopeptidase activity,MF,CFB
15861,GO:0070302,0.754704176152714,0.59313121688254,1,199,regulation of stress-activated protein kinase signaling cascade,BP,PYCARD
7223,GO:0030097,0.755464366758755,0.418630482737323,4,712,hemopoiesis,BP,EBP;FADD;PNP;TMEM176A
11956,GO:0044877,0.755995110938434,0.399519295688846,5,880,macromolecular complex binding,MF,FADD;TRADD;RNASEL;DOK1;TMOD4
16520,GO:0071495,0.756105325467446,0.375504844620719,7,1204,cellular response to endogenous stimulus,BP,PDK4;TH;GHR;FGF18;RNASEL;CASP4;STAR
525,GO:0001568,0.756378018548313,0.444605393592131,3,564,blood vessel development,BP,FGF18;ANG;DHCR7
13069,GO:0048015,0.756730981771018,0.590273392935271,1,201,phosphatidylinositol-mediated signaling,BP,FGF18
721,GO:0001882,0.756972786838817,0.489501042916923,2,371,nucleoside binding,MF,PNP;ACSM5
17019,GO:0072359,0.758622322218112,0.396173196764482,5,901,circulatory system development,BP,TH;FGF18;RBP4;ANG;DHCR7
11864,GO:0044702,0.759095013750766,0.371816233686868,7,1182,single organism reproductive process,BP,HSD17B3;RGN;RBP4;ANG;HEXB;IDH1;STAR
13442,GO:0048858,0.759171225273644,0.440894658111405,3,575,cell projection morphogenesis,BP,S100B;DOK1;LINGO1
11517,GO:0043623,0.759232314026448,0.440846764962139,3,548,cellular protein complex assembly,BP,PYCARD;ANG;TMOD4
14329,GO:0051924,0.759364444082975,0.586575063651165,1,197,regulation of calcium ion transport,BP,RGN
18986,GO:1901991,0.760756635346471,0.584614449192371,1,194,negative regulation of mitotic cell cycle phase transition,BP,PSMB10
17488,GO:0090257,0.760921985488262,0.584334974915022,1,201,regulation of muscle system process,BP,NOL3
11814,GO:0044449,0.761243902476524,0.583863832665005,1,203,contractile fiber part,CC,TMOD4
4669,GO:0009889,0.761480419705545,0.309726870491881,27,4178,regulation of biosynthetic process,BP,PDK4;FADD;MRAP;APOC1;TRADD;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;PCBD1;IFI27;IDH1;STAR;GLA;DHCR7;RBMS3;HNF1A
13071,GO:0048017,0.761803828455325,0.583058212645217,1,204,inositol lipid-mediated signaling,BP,FGF18
16704,GO:0071826,0.762216314140829,0.58252354779806,1,195,ribonucleoprotein complex subunit organization,BP,NOL3
11040,GO:0042787,0.764931270907834,0.578591030170932,1,200,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
2852,GO:0005882,0.764935386003144,0.578656581057591,1,189,intermediate filament,CC,KRT10
5170,GO:0012506,0.765186211102609,0.405999082610461,4,727,vesicle membrane,CC,TH;GRIA3;SNX21;RPH3AL
13258,GO:0048513,0.765771003215731,0.313764563548104,20,3169,animal organ development,BP,EBP;TH;FADD;HSD17B3;TRADD;PNP;KRT10;PSMB10;RGN;FGF18;NNMT;PLA2G16;RBP4;ANG;ACAT1;TMEM176A;IDH1;STAR;S100B;DHCR7
13369,GO:0048705,0.767402617892977,0.574988325232402,1,204,skeletal system morphogenesis,BP,FGF18
13177,GO:0048284,0.768648710983917,0.573173926451901,1,204,organelle fusion,BP,TBC1D14
7187,GO:0030016,0.769574017664379,0.571798924647717,1,208,myofibril,CC,TMOD4
12094,GO:0045216,0.769701935481545,0.571578410427927,1,214,cell-cell junction organization,BP,ANG
13262,GO:0048519,0.771716837062455,0.295365318070801,30,4623,negative regulation of biological process,BP,PDK4;IFI30;FADD;APOC1;TRADD;TBC1D14;ABCG1;PYCARD;ACADVL;ACAA2;PSMB10;RGN;TICAM1;PLA2G16;RBP4;RNASEL;ANG;NMI;FABP3;NOL3;DEPTOR;IFI27;TMEM176A;TFPI;STAR;GLA;RPH3AL;S100B;LINGO1;TMOD4
498,GO:0001525,0.773216197171363,0.466901939056021,2,400,angiogenesis,BP,FGF18;ANG
18983,GO:1901988,0.775215125414094,0.563512482340005,1,202,negative regulation of cell cycle phase transition,BP,PSMB10
12090,GO:0045211,0.777078097188623,0.560647453742106,1,217,postsynaptic membrane,CC,GRIA3
16559,GO:0071560,0.777513680686833,0.560022511720098,1,212,cellular response to transforming growth factor beta stimulus,BP,STAR
3799,GO:0007411,0.777559917924957,0.559920722292737,1,218,axon guidance,BP,DOK1
8870,GO:0032990,0.778551812692748,0.414715130063974,3,593,cell part morphogenesis,BP,S100B;DOK1;LINGO1
3527,GO:0006909,0.779769621115658,0.556648230730186,1,209,phagocytosis,BP,PYCARD
16558,GO:0071559,0.780273797054961,0.55585904474739,1,214,response to transforming growth factor beta,BP,STAR
17944,GO:0097485,0.78064152778862,0.555271129680458,1,220,neuron projection guidance,BP,DOK1
768,GO:0001944,0.780816144809369,0.411606372975746,3,587,vasculature development,BP,FGF18;ANG;DHCR7
13740,GO:0050900,0.78084873304132,0.456059657357148,2,391,leukocyte migration,BP,FADD;PYCARD
13700,GO:0050851,0.781210273891908,0.55449393090562,1,205,antigen receptor-mediated signaling pathway,BP,PSMB10
8551,GO:0032502,0.783584762607486,0.277378635670243,37,5693,developmental process,BP,EBP;ALG5;TH;FADD;HSD17B3;MRAP;TRADD;EXTL1;PNP;ABCG1;EBF1;BDH2;ACADVL;KRT10;PSMB10;RGN;FADS1;GHR;FGF18;NNMT;PLA2G16;RBP4;CYP17A1;RNASEL;ANG;ACAT1;HEXB;NUDT7;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
11867,GO:0044706,0.783616142843417,0.550806426802553,1,210,multi-multicellular organism process,BP,HEXB
17228,GO:0080135,0.78409372203804,0.407083354001298,3,579,regulation of cellular response to stress,BP,PYCARD;RGN;NOL3
18534,GO:1900180,0.784736048983062,0.549071854913656,1,214,regulation of protein localization to nucleus,BP,NOL3
18619,GO:1900542,0.784755431232051,0.549064700800093,1,210,regulation of purine nucleotide metabolic process,BP,MRAP
13295,GO:0048583,0.785363048937826,0.287844683993428,22,3506,regulation of response to stimulus,BP,CFB;FADD;TRADD;PYCARD;G0S2;ACAA2;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;FAM110C;NMI;SHPK;NOL3;DEPTOR;CASP4;FAM46A;RPH3AL;S100B;DOK1
11319,GO:0043292,0.786109571408772,0.546942301455623,1,218,contractile fiber,CC,TMOD4
8902,GO:0033036,0.786245644649913,0.295248261266818,17,2775,macromolecule localization,BP,MRAP;APOC1;TBC1D14;PNP;ABCG1;PYCARD;CPT2;RBP4;ANG;HEXB;FABP3;NOL3;IFI27;STAR;SNX21;RPH3AL;CNIH4
11307,GO:0043269,0.78629848131221,0.404016072872136,3,582,regulation of ion transport,BP,SLC31A2;RGN;FXYD1
2784,GO:0005770,0.787060415813712,0.545505246101256,1,213,late endosome,CC,SLC31A2
4519,GO:0009266,0.787072397955381,0.545481194939697,1,214,response to temperature stimulus,BP,ACADVL
3465,GO:0006814,0.787074990707828,0.545444837878579,1,220,sodium ion transport,BP,FXYD1
4023,GO:0008236,0.788846205418228,0.542778091999038,1,207,serine-type peptidase activity,MF,CFB
5887,GO:0016337,0.788869480306192,0.400427690226619,3,582,single organismal cell-cell adhesion,BP,FADD;PNP;PYCARD
17018,GO:0072358,0.789437370208637,0.39961724812167,3,596,cardiovascular system development,BP,FGF18;ANG;DHCR7
4677,GO:0009897,0.790159449207899,0.540702768477152,1,213,external side of plasma membrane,CC,ABCG1
16141,GO:0070838,0.790226786222235,0.442423217836818,2,411,divalent metal ion transport,BP,RGN;NOL3
14107,GO:0051493,0.790609841322807,0.441857995906874,2,413,regulation of cytoskeleton organization,BP,PYCARD;TMOD4
1087,GO:0002460,0.791839274497435,0.538080375897386,1,213,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
1082,GO:0002449,0.792262062033815,0.537423875028255,1,212,lymphocyte mediated immunity,BP,FADD
13962,GO:0051240,0.792463641103512,0.321823811284663,8,1403,positive regulation of multicellular organismal process,BP,FADD;TRADD;PNP;PYCARD;GHR;FGF18;TICAM1;STAR
13271,GO:0048534,0.792524548816425,0.369457364426901,4,752,hematopoietic or lymphoid organ development,BP,EBP;FADD;PNP;TMEM176A
13625,GO:0050730,0.792915313775725,0.536376704767575,1,216,regulation of peptidyl-tyrosine phosphorylation,BP,GHR
6314,GO:0017171,0.793476574335663,0.535528412128968,1,210,serine hydrolase activity,MF,CFB
11499,GO:0043588,0.794175109902109,0.436641353836401,2,398,skin development,BP,TRADD;KRT10
10659,GO:0042113,0.794269641790289,0.534234502560308,1,218,B cell activation,BP,TICAM1
7153,GO:0022891,0.794330282635852,0.349614095203907,5,925,substrate-specific transmembrane transporter activity,MF,SLC31A2;FXYD1;GRIA3;CYB5A;SLC1A3
17068,GO:0072511,0.794905031388863,0.435527559627584,2,415,divalent inorganic cation transport,BP,RGN;NOL3
3013,GO:0006140,0.795917286566526,0.531634889508634,1,217,regulation of nucleotide metabolic process,BP,MRAP
4111,GO:0008380,0.795964502698314,0.433985793814377,2,401,RNA splicing,BP,ARL6IP4;NOL3
2885,GO:0005938,0.796340422317874,0.530901659397536,1,229,cell cortex,CC,FAM110C
12427,GO:0045926,0.796546009663247,0.530631876326291,1,218,negative regulation of growth,BP,RBP4
13338,GO:0048666,0.7969175687401,0.346132693099845,5,954,neuron development,BP,TH;S100B;DOK1;SLC1A3;LINGO1
21026,GO:2000146,0.796994551891725,0.529887379194048,1,224,negative regulation of cell motility,BP,RGN
4895,GO:0010631,0.797277388086764,0.529422148782257,1,227,epithelial cell migration,BP,FGF18
17776,GO:0097159,0.798507785846097,0.260203221865752,37,5716,organic cyclic compound binding,MF,PDK4;TH;MRPL14;MRPL16;ACSF2;PNP;ABCG1;EBF1;BDH2;ACADVL;ACAA2;ACSM5;ARL6IP4;HSD17B10;HACL1;CYP17A1;RNASEL;ANG;TSFM;AOX1;SHPK;NOL3;NUDT7;ACCS;MDH1;FAM46A;IDH1;DECR1;PUS1;LDHD;STAR;CYP11A1;DHCR7;CYB5A;RBMS3;HNF1A;ETFDH
15312,GO:0061025,0.79872812525763,0.52712781780966,1,223,membrane fusion,BP,TBC1D14
6777,GO:0019953,0.799086016943514,0.360455351223429,4,747,sexual reproduction,BP,TH;RGN;ANG;HEXB
13291,GO:0048568,0.799878755388007,0.428121333057433,2,417,embryonic organ development,BP,TH;RBP4
17402,GO:0090132,0.800112246966855,0.524879281440328,1,229,epithelium migration,BP,FGF18
18062,GO:0098552,0.80060436263625,0.427044188639063,2,412,side of membrane,CC,TH;ABCG1
6771,GO:0019932,0.800742352626127,0.523886316085086,1,225,second-messenger-mediated signaling,BP,RGN
2518,GO:0005216,0.801514681431917,0.425657019439835,2,423,ion channel activity,MF,FXYD1;GRIA3
5464,GO:0015291,0.802519025822284,0.52100901284641,1,227,secondary active transmembrane transporter activity,MF,SLC1A3
13453,GO:0048872,0.80270920433662,0.520711295628073,1,225,homeostasis of number of cells,BP,FADD
13307,GO:0048609,0.80302364666732,0.354998006668569,4,755,multicellular organismal reproductive process,BP,TH;RGN;ANG;HEXB
7884,GO:0031326,0.803877328908803,0.261456509389722,26,4131,regulation of cellular biosynthetic process,BP,PDK4;FADD;MRAP;APOC1;TRADD;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;PCBD1;IFI27;IDH1;STAR;GLA;RBMS3;HNF1A
5531,GO:0015629,0.804443260499224,0.421224764101811,2,433,actin cytoskeleton,CC,MSRA;TMOD4
3519,GO:0006897,0.805191127790216,0.377221436110445,3,603,endocytosis,BP,APOC1;PYCARD;GHR
13645,GO:0050768,0.805954556681768,0.515394277010936,1,232,negative regulation of neurogenesis,BP,LINGO1
11898,GO:0044767,0.806698998184653,0.2511793649918,36,5610,single-organism developmental process,BP,EBP;ALG5;TH;FADD;HSD17B3;MRAP;TRADD;EXTL1;PNP;ABCG1;EBF1;BDH2;ACADVL;KRT10;PSMB10;RGN;FADS1;GHR;FGF18;NNMT;PLA2G16;RBP4;RNASEL;ANG;ACAT1;HEXB;NUDT7;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
4697,GO:0009966,0.808163700580351,0.270913498333666,16,2670,regulation of signal transduction,BP,FADD;TRADD;PYCARD;G0S2;ACAA2;PSMB10;RGN;GHR;FGF18;TICAM1;FAM110C;NOL3;DEPTOR;RPH3AL;S100B;DOK1
43,GO:0000086,0.808428798843724,0.511355141813838,1,227,G2/M transition of mitotic cell cycle,BP,PSMB10
6835,GO:0021537,0.80868207463868,0.510898228081954,1,235,telencephalon development,BP,TH
5730,GO:0016032,0.808919808414446,0.32988883651462,5,928,viral process,BP,FADD;PYCARD;PSMB10;TICAM1;RNASEL
12085,GO:0045202,0.809004670741629,0.346619706642502,4,797,synapse,CC,TH;GRIA3;CPT1C;PRRT1
8869,GO:0032989,0.809138670581536,0.329567218339835,5,973,cellular component morphogenesis,BP,HEXB;S100B;DOK1;SLC1A3;LINGO1
17400,GO:0090130,0.809181894281325,0.510072712951511,1,235,tissue migration,BP,FGF18
17514,GO:0090287,0.809534274658683,0.509494666108388,1,234,regulation of cellular response to growth factor stimulus,BP,FGF18
19182,GO:1902494,0.809806762669097,0.306987426388068,7,1259,catalytic complex,CC,DPM3;FADD;PYCARD;PSMB10;TICAM1;HSD17B10;FXYD1
7220,GO:0030072,0.810022070300462,0.508701325301656,1,231,peptide hormone secretion,BP,RBP4
3129,GO:0006352,0.810125459942323,0.508539817789783,1,229,DNA-templated transcription, initiation,BP,HNF1A
9374,GO:0034330,0.810219305265401,0.508322932700581,1,242,cell junction organization,BP,ANG
9895,GO:0035556,0.810570503111216,0.270280683648265,15,2530,intracellular signal transduction,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;FAM110C;NMI;NOL3;DEPTOR;CASP4;S100B;DOK1
12843,GO:0046873,0.810689155226645,0.411706008892844,2,436,metal ion transmembrane transporter activity,MF,SLC31A2;SLC1A3
16427,GO:0071363,0.810754997652632,0.369146590405069,3,610,cellular response to growth factor stimulus,BP,TH;FGF18;STAR
8552,GO:0032504,0.81077937045097,0.344148817309296,4,764,multicellular organism reproduction,BP,TH;RGN;ANG;HEXB
7480,GO:0030529,0.810987307783168,0.343861947493196,4,756,intracellular ribonucleoprotein complex,CC,MRPL14;MRPL16;GHR;HSD17B10
2159,GO:0004672,0.811260123028657,0.368395873398961,3,624,protein kinase activity,MF,PDK4;FGF18;RNASEL
20910,GO:1990904,0.811656374381526,0.34291884450378,4,757,ribonucleoprotein complex,CC,MRPL14;MRPL16;GHR;HSD17B10
7136,GO:0022838,0.812398322282904,0.409083974859172,2,433,substrate-specific channel activity,MF,FXYD1;GRIA3
4876,GO:0010604,0.813081855774059,0.262811358940948,17,2817,positive regulation of macromolecule metabolic process,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;HEXB;PCBD1;IFI27;STAR;RBMS3;HNF1A
9099,GO:0033554,0.813129764755547,0.283949398693281,10,1745,cellular response to stress,BP,PDK4;PYCARD;ACADVL;ACAA2;PSMB10;RGN;FADS1;NOL3;CASP4;S100B
12032,GO:0045111,0.81353260742504,0.502896172897154,1,222,intermediate filament cytoskeleton,CC,KRT10
11895,GO:0044764,0.813551077514728,0.323532757424714,5,934,multi-organism cellular process,BP,FADD;PYCARD;PSMB10;TICAM1;RNASEL
5338,GO:0015031,0.813892964121239,0.278638136645028,11,1900,protein transport,BP,TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
4993,GO:0010769,0.81435973758114,0.501401384641929,1,244,regulation of cell morphogenesis involved in differentiation,BP,LINGO1
12428,GO:0045927,0.814625835018624,0.500985719997454,1,237,positive regulation of growth,BP,GHR
11009,GO:0042742,0.815765452688405,0.499140105430058,1,222,defense response to bacterium,BP,PYCARD
15210,GO:0060828,0.816155629030788,0.498420238687751,1,234,regulation of canonical Wnt signaling pathway,BP,PSMB10
7940,GO:0031424,0.816309628927303,0.498231343000359,1,220,keratinization,BP,KRT10
6929,GO:0021700,0.816985032660841,0.497002034156095,1,237,developmental maturation,BP,ANG
13985,GO:0051271,0.8171231373032,0.496758598919868,1,239,negative regulation of cellular component movement,BP,RGN
13238,GO:0048471,0.817693682768417,0.358952139431302,3,621,perinuclear region of cytoplasm,CC,PLA2G16;S100B;DOK1
2438,GO:0005088,0.818362194308408,0.49460888783558,1,249,Ras guanyl-nucleotide exchange factor activity,MF,FGF18
3752,GO:0007276,0.819577086123645,0.356182231172916,3,603,gamete generation,BP,RGN;ANG;HEXB
18783,GO:1901363,0.819893497548312,0.235740389263156,36,5633,heterocyclic compound binding,MF,PDK4;TH;MRPL14;MRPL16;ACSF2;PNP;ABCG1;EBF1;BDH2;ACADVL;ACAA2;ACSM5;ARL6IP4;HSD17B10;HACL1;CYP17A1;RNASEL;ANG;TSFM;AOX1;SHPK;NOL3;NUDT7;ACCS;MDH1;FAM46A;IDH1;DECR1;PUS1;LDHD;CYP11A1;DHCR7;CYB5A;RBMS3;HNF1A;ETFDH
7114,GO:0022613,0.820138100039291,0.397077680236059,2,420,ribonucleoprotein complex biogenesis,BP,RNASEL;NOL3
11626,GO:0044089,0.820189961344398,0.396958549646996,2,441,positive regulation of cellular component biogenesis,BP,PYCARD;HNF1A
16439,GO:0071383,0.820989574292825,0.490155708679943,1,240,cellular response to steroid hormone stimulus,BP,STAR
7177,GO:0030001,0.821097031227476,0.329478308359062,4,797,metal ion transport,BP,SLC31A2;RGN;FXYD1;NOL3
11936,GO:0044839,0.82115400530768,0.489891892898664,1,236,cell cycle G2/M phase transition,BP,PSMB10
1119,GO:0002520,0.822063339264887,0.328098232722589,4,789,immune system development,BP,EBP;FADD;PNP;TMEM176A
11473,GO:0043547,0.823571502835299,0.350198318593968,3,640,positive regulation of GTPase activity,BP,TBC1D14;RGN;FGF18
16655,GO:0071705,0.825369173041864,0.257186916030761,13,2230,nitrogen compound transport,BP,TH;TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;SLC1A3;CNIH4
7439,GO:0030425,0.825817441598584,0.38804922491192,2,454,dendrite,CC,TH;CPT1C
14059,GO:0051403,0.826830344520323,0.479996405386461,1,247,stress-activated MAPK cascade,BP,PYCARD
13862,GO:0051094,0.827359343522475,0.292546242788332,6,1140,positive regulation of developmental process,BP,FADD;TRADD;PNP;GHR;FGF18;STAR
12852,GO:0046883,0.827701622229728,0.478486397915436,1,243,regulation of hormone secretion,BP,RBP4
7194,GO:0030029,0.828997211307222,0.342037429375254,3,646,actin filament-based process,BP,PYCARD;ANG;TMOD4
14355,GO:0051961,0.830000233801964,0.474399741783745,1,251,negative regulation of nervous system development,BP,LINGO1
7924,GO:0031399,0.831006692926253,0.265694613726523,9,1619,regulation of protein modification process,BP,PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;DEPTOR
5634,GO:0015833,0.831445311042488,0.256138175745498,11,1934,peptide transport,BP,TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
15606,GO:0061695,0.831520334917866,0.471715848881336,1,248,transferase complex, transferring phosphorus-containing groups,CC,PYCARD
16151,GO:0070848,0.832043449367769,0.337429121056605,3,635,response to growth factor,BP,TH;FGF18;STAR
13838,GO:0051051,0.832439284530074,0.377454953121506,2,442,negative regulation of transport,BP,APOC1;ACAA2
18088,GO:0098602,0.832857193564507,0.336192386492049,3,633,single organism cell adhesion,BP,FADD;PNP;PYCARD
13451,GO:0048870,0.832864703620883,0.276065910141554,7,1317,cell motility,BP,FADD;PYCARD;RGN;FGF18;ANG;FAM110C;HEXB
14205,GO:0051674,0.832864703620883,0.276065910141554,7,1317,localization of cell,BP,FADD;PYCARD;RGN;FGF18;ANG;FAM110C;HEXB
7766,GO:0031098,0.834418405432285,0.466514845552644,1,253,stress-activated protein kinase signaling cascade,BP,PYCARD
20958,GO:2000027,0.83448952119186,0.466412723154195,1,247,regulation of organ morphogenesis,BP,PSMB10
7264,GO:0030155,0.834518097842105,0.333656952778195,3,634,regulation of cell adhesion,BP,FADD;PNP;PYCARD
10585,GO:0040013,0.835051279432795,0.465376916581462,1,253,negative regulation of locomotion,BP,RGN
11782,GO:0044403,0.837109095998821,0.29047023465554,5,968,symbiosis, encompassing mutualism through parasitism,BP,FADD;PYCARD;PSMB10;TICAM1;RNASEL
11790,GO:0044419,0.838198136233444,0.288910768736439,5,970,interspecies interaction between organisms,BP,FADD;PYCARD;PSMB10;TICAM1;RNASEL
14865,GO:0060326,0.83853652555002,0.459100685910452,1,245,cell chemotaxis,BP,FGF18
4221,GO:0008544,0.838783974291427,0.367124899279928,2,440,epidermis development,BP,TRADD;KRT10
5827,GO:0016236,0.83881536253961,0.458562194176827,1,252,macroautophagy,BP,TBC1D14
412,GO:0001077,0.840160898092389,0.456090728059611,1,255,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
3530,GO:0006913,0.84017621937422,0.36480750959812,2,457,nucleocytoplasmic transport,BP,NOL3;IFI27
12868,GO:0046907,0.840238332613369,0.253423795228374,9,1646,intracellular transport,BP,ZFYVE21;TBC1D14;ABCG1;CPT2;NOL3;IFI27;STAR;RPH3AL;CNIH4
3140,GO:0006364,0.840276513385901,0.455935340048907,1,242,rRNA processing,BP,RNASEL
7251,GO:0030135,0.84029410737775,0.455838492983355,1,257,coated vesicle,CC,IDUA
5453,GO:0015267,0.841045658054896,0.363367422876736,2,461,channel activity,MF,FXYD1;GRIA3
11076,GO:0042886,0.841159343210281,0.243487240157288,11,1954,amide transport,BP,TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
7125,GO:0022803,0.84193858742147,0.361890026557593,2,462,passive transmembrane transporter activity,MF,FXYD1;GRIA3
12233,GO:0045597,0.842425883463708,0.298319786482467,4,824,positive regulation of cell differentiation,BP,FADD;PNP;FGF18;STAR
17001,GO:0072331,0.842934230133487,0.450986258193709,1,255,signal transduction by p53 class mediator,BP,PYCARD
14218,GO:0051704,0.845396666839987,0.231555077031029,13,2241,multi-organism process,BP,TH;FADD;PYCARD;MGST2;PSMB10;RGN;TICAM1;RNASEL;ANG;SHPK;HEXB;TFPI;STAR
4951,GO:0010721,0.846075814385271,0.445108290300807,1,264,negative regulation of cell development,BP,LINGO1
13922,GO:0051179,0.847047264890835,0.20306556120173,37,5858,localization,BP,EBP;TH;ZFYVE21;SLC31A2;FADD;MRAP;APOC1;TBC1D14;PNP;ABCG1;PYCARD;ACAA2;PSMB10;RGN;GHR;FGF18;CPT2;FXYD1;RBP4;RNASEL;ANG;FAM110C;HEXB;FABP3;GRIA3;NOL3;IFI27;IDH1;STAR;SNX21;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3;CNIH4
2445,GO:0005096,0.847229122686046,0.442921114721803,1,271,GTPase activator activity,MF,TBC1D14
13914,GO:0051169,0.847321995365812,0.352916148577313,2,465,nuclear transport,BP,NOL3;IFI27
3706,GO:0007204,0.847362146968608,0.44272128016267,1,258,positive regulation of cytosolic calcium ion concentration,BP,NOL3
18722,GO:1901214,0.848536568618616,0.440494860589683,1,262,regulation of neuron death,BP,STAR
11389,GO:0043408,0.848571886485056,0.311840501077305,3,649,regulation of MAPK cascade,BP,PYCARD;GHR;FGF18
3805,GO:0007420,0.849199271920995,0.310837453103751,3,666,brain development,BP,TH;ACAT1;STAR
13663,GO:0050792,0.849252081486568,0.439159523477665,1,258,regulation of viral process,BP,RNASEL
3323,GO:0006606,0.850978408948158,0.435850018812498,1,267,protein import into nucleus,BP,NOL3
11889,GO:0044744,0.850978408948158,0.435850018812498,1,267,protein targeting to nucleus,BP,NOL3
7335,GO:0030246,0.850998633132806,0.435854856646541,1,256,carbohydrate binding,MF,PHYH
13259,GO:0048514,0.85272936001968,0.343757217247255,2,481,blood vessel morphogenesis,BP,FGF18;ANG
8292,GO:0032103,0.853440199113108,0.431180867920894,1,258,positive regulation of response to external stimulus,BP,FGF18
19233,GO:1902593,0.854196221150853,0.429681391653292,1,270,single-organism nuclear import,BP,NOL3
5533,GO:0015631,0.854431127444729,0.429210954878719,1,275,tubulin binding,MF,FAM110C
11702,GO:0044267,0.854619433834118,0.198071902472861,29,4698,cellular protein metabolic process,BP,PDK4;ALG5;DPM3;MSRA;MRPL14;MRPL16;FADD;TRADD;EXTL1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;ETFB;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;DEPTOR;IFI27;MDP1;TFPI;RBMS3;LYPLAL1
5943,GO:0016477,0.855010133897706,0.253660711860171,6,1193,cell migration,BP,FADD;PYCARD;FGF18;ANG;FAM110C;HEXB
5123,GO:0010948,0.855074278885814,0.428019266031093,1,262,negative regulation of cell cycle process,BP,PSMB10
2857,GO:0005887,0.855480469319455,0.238190609298839,8,1513,integral component of plasma membrane,CC,EBP;SLC31A2;P2RY14;ABCG1;GHR;FXYD1;GRIA3;CPT1C
12429,GO:0045930,0.856234543524291,0.425766626403656,1,264,negative regulation of mitotic cell cycle,BP,PSMB10
3825,GO:0007507,0.856322322403614,0.33760525152096,2,488,heart development,BP,TH;RBP4
7254,GO:0030139,0.856940682548555,0.424373086799151,1,270,endocytic vesicle,CC,GRIA3
13265,GO:0048522,0.858348876716525,0.194174068518289,28,4576,positive regulation of cellular process,BP,FADD;MRAP;APOC1;TRADD;PNP;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;RBP4;RNASEL;ANG;FAM110C;NMI;HEXB;FABP3;PCBD1;IFI27;STAR;RPH3AL;S100B;RBMS3;HNF1A;DOK1;SLC1A3
4668,GO:0009888,0.859229307314064,0.223296639042438,10,1837,tissue development,BP,TRADD;BDH2;ACADVL;KRT10;PSMB10;FGF18;PLA2G16;RBP4;ACAT1;S100B
8450,GO:0032386,0.860196335686583,0.330927278396884,2,480,regulation of intracellular transport,BP,NOL3;IFI27
17723,GO:0097060,0.860209043891613,0.417929364149124,1,285,synaptic membrane,CC,GRIA3
82,GO:0000165,0.86091229184913,0.270291884686156,4,846,MAPK cascade,BP,PYCARD;PSMB10;GHR;FGF18
13381,GO:0048731,0.862562728212892,0.19044585388868,26,4323,system development,BP,EBP;TH;FADD;HSD17B3;TRADD;EXTL1;PNP;KRT10;PSMB10;RGN;FGF18;NNMT;PLA2G16;RBP4;ANG;ACAT1;HEXB;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
6003,GO:0016579,0.863460992030207,0.411524466066385,1,276,protein deubiquitination,BP,PSMB10
11183,GO:0043087,0.863533990059665,0.28784726160123,3,695,regulation of GTPase activity,BP,TBC1D14;RGN;FGF18
10583,GO:0040011,0.863895150604001,0.22646256533901,8,1541,locomotion,BP,FADD;PYCARD;RGN;FGF18;ANG;FAM110C;HEXB;DOK1
3520,GO:0006898,0.864111466585961,0.410220773422842,1,278,receptor-mediated endocytosis,BP,APOC1
3890,GO:0008015,0.864692637270568,0.323065540155357,2,487,blood circulation,BP,TH;FXYD1
18352,GO:0099568,0.865263639567051,0.407885855069523,1,287,cytoplasmic region,CC,FAM110C
1386,GO:0003013,0.867657541282413,0.31782906262508,2,491,circulatory system process,BP,TH;FXYD1
7078,GO:0022008,0.868925311062125,0.225590754035062,7,1405,neurogenesis,BP,TH;HEXB;STAR;S100B;DOK1;SLC1A3;LINGO1
6022,GO:0016604,0.869050152505806,0.278814139548866,3,686,nuclear body,CC,LAGE3;ARL6IP4;AOX1
3070,GO:0006260,0.869450445134869,0.399447243765177,1,281,DNA replication,BP,PTMS
14949,GO:0060429,0.870033443925548,0.231795199290969,6,1200,epithelium development,BP,TRADD;BDH2;ACADVL;KRT10;PSMB10;ACAT1
14697,GO:0060070,0.870856424018157,0.396569679738685,1,283,canonical Wnt signaling pathway,BP,PSMB10
14861,GO:0060322,0.871587501174396,0.274606935360432,3,699,head development,BP,TH;ACAT1;STAR
11563,GO:0043903,0.872171804853297,0.393880070536131,1,280,regulation of symbiosis, encompassing mutualism through parasitism,BP,RNASEL
19652,GO:1903533,0.872350295668706,0.393499105781276,1,284,regulation of protein targeting,BP,NOL3
12848,GO:0046879,0.872613882899332,0.392952747543123,1,285,hormone secretion,BP,RBP4
7882,GO:0031324,0.872857565802031,0.195412314625463,13,2336,negative regulation of cellular metabolic process,BP,APOC1;TBC1D14;PYCARD;ACADVL;PSMB10;RGN;ANG;NMI;NOL3;DEPTOR;IFI27;TFPI;GLA
13915,GO:0051170,0.873130996611691,0.39187596331394,1,288,nuclear import,BP,NOL3
3807,GO:0007423,0.873398973646799,0.307558120381744,2,504,sensory organ development,BP,TH;RBP4
3463,GO:0006812,0.873791692403128,0.236269749245035,5,1043,cation transport,BP,SLC31A2;RGN;FXYD1;NOL3;CYB5A
16329,GO:0071214,0.87429874091258,0.389458758616442,1,288,cellular response to abiotic stimulus,BP,FADD
13724,GO:0050878,0.874443758747688,0.305685506976044,2,495,regulation of body fluid levels,BP,FAM46A;TFPI
2512,GO:0005198,0.875003698501332,0.268931150443224,3,677,structural molecule activity,MF,MRPL14;MRPL16;KRT10
759,GO:0001934,0.8750170305518,0.248196126214467,4,868,positive regulation of protein phosphorylation,BP,PYCARD;GHR;FGF18;ANG
7559,GO:0030695,0.875993045992558,0.385894636727753,1,300,GTPase regulator activity,MF,TBC1D14
7539,GO:0030667,0.876074920989552,0.385761018606058,1,288,secretory granule membrane,CC,RPH3AL
2783,GO:0005769,0.876844699486889,0.384134521606737,1,293,early endosome,CC,SNX21
1630,GO:0003713,0.877396349585141,0.382974232529927,1,294,transcription coactivator activity,MF,PCBD1
16060,GO:0070646,0.877781058741953,0.382175200132199,1,291,protein modification by small protein removal,BP,PSMB10
7159,GO:0023014,0.879282835403684,0.241380382006133,4,880,signal transduction by protein phosphorylation,BP,PYCARD;PSMB10;GHR;FGF18
2816,GO:0005819,0.879813183242897,0.377871708301756,1,295,spindle,CC,FAM110C
14100,GO:0051480,0.880032879021668,0.377418260889032,1,291,regulation of cytosolic calcium ion concentration,BP,NOL3
12072,GO:0045184,0.880186928756748,0.191061635370639,11,2049,establishment of protein localization,BP,TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
11125,GO:0042995,0.880627751317281,0.197873718022945,9,1762,cell projection,CC,TH;MRI1;FADD;CYP17A1;ANG;CPT1C;STAR;S100B;SLC1A3
10948,GO:0042623,0.880647407754956,0.376070286154152,1,305,ATPase activity, coupled,MF,ABCG1
12128,GO:0045296,0.881473053620783,0.374328820346828,1,299,cadherin binding,MF,IDH1
19225,GO:1902580,0.881985998026431,0.237025545659765,4,894,single-organism cellular localization,BP,ABCG1;CPT2;NOL3;STAR
13261,GO:0048518,0.882582049294185,0.1623234304272,31,5094,positive regulation of biological process,BP,CFB;FADD;MRAP;APOC1;TRADD;PNP;ABCG1;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;FXYD1;RBP4;RNASEL;ANG;FAM110C;NMI;HEXB;FABP3;PCBD1;IFI27;STAR;RPH3AL;S100B;RBMS3;HNF1A;DOK1;SLC1A3
4681,GO:0009914,0.883521321360894,0.369945527411443,1,297,hormone transport,BP,RBP4
7901,GO:0031344,0.884093214375605,0.28797255223294,2,527,regulation of cell projection organization,BP,FAM110C;LINGO1
7819,GO:0031226,0.884348376904167,0.197315643326336,8,1576,intrinsic component of plasma membrane,CC,EBP;SLC31A2;P2RY14;ABCG1;GHR;FXYD1;GRIA3;CPT1C
3012,GO:0006139,0.88565068839038,0.157122954786593,34,5512,nucleobase-containing compound metabolic process,BP,FADD;MRAP;TRADD;PNP;ABCG1;EBF1;PYCARD;LAGE3;PSMB10;RGN;FADS1;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;AOX1;SHPK;HEXB;NOL3;NUDT7;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;DERA;HNF1A
7712,GO:0031012,0.886256763234029,0.283950974187481,2,517,extracellular matrix,CC,ANG;LINGO1
11922,GO:0044802,0.886316792448618,0.24970839371443,3,717,single-organism membrane organization,BP,TBC1D14;ACAA2;NOL3
5549,GO:0015672,0.886436774881003,0.283618892331582,2,513,monovalent inorganic cation transport,BP,FXYD1;CYB5A
7313,GO:0030216,0.886683986239933,0.363127607811907,1,287,keratinocyte differentiation,BP,KRT10
7234,GO:0030111,0.887567572523653,0.361148896907258,1,303,regulation of Wnt signaling pathway,BP,PSMB10
1629,GO:0003712,0.888901077355136,0.278980969188658,2,521,transcription cofactor activity,MF,NMI;PCBD1
7108,GO:0022603,0.888962008448823,0.225673954159957,4,911,regulation of anatomical structure morphogenesis,BP,PSMB10;HEXB;S100B;LINGO1
10721,GO:0042254,0.889947882847585,0.355949195504449,1,292,ribosome biogenesis,BP,RNASEL
579,GO:0001667,0.890002038992794,0.355773650335379,1,311,ameboidal-type cell migration,BP,FGF18
2546,GO:0005261,0.890362336703048,0.35497412269378,1,312,cation channel activity,MF,GRIA3
3742,GO:0007265,0.89038107497761,0.35491650795932,1,318,Ras protein signal transduction,BP,DOK1
2435,GO:0005085,0.890382075515918,0.354909047245276,1,320,guanyl-nucleotide exchange factor activity,MF,FGF18
16458,GO:0071407,0.890828189276202,0.275329998016951,2,527,cellular response to organic cyclic compound,BP,TH;STAR
7111,GO:0022607,0.892211211425932,0.16704056876232,14,2570,cellular component assembly,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;HACL1;ANG;FAM110C;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
10632,GO:0042060,0.892867524053544,0.271455112934407,2,522,wound healing,BP,FAM46A;TFPI
7621,GO:0030855,0.893161379635346,0.237829670797828,3,708,epithelial cell differentiation,BP,BDH2;ACADVL;KRT10
10767,GO:0042327,0.893496971431836,0.218204120761364,4,904,positive regulation of phosphorylation,BP,PYCARD;GHR;FGF18;ANG
8550,GO:0032501,0.894395969060312,0.143520700370799,43,6860,multicellular organismal process,BP,EBP;PDK4;ALG5;TH;FADD;HSD17B3;APOC1;TRADD;EXTL1;PNP;ABCG1;EBF1;PYCARD;ACADVL;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;NNMT;PLA2G16;FXYD1;RBP4;ANG;NMI;ACAT1;HEXB;NOL3;FAM46A;TMEM176A;IDH1;TFPI;STAR;PEPD;S100B;DHCR7;PTS;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
178,GO:0000377,0.897064699493059,0.339945771269391,1,306,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,NOL3
190,GO:0000398,0.897064699493059,0.339945771269391,1,306,mRNA splicing, via spliceosome,BP,NOL3
757,GO:0001932,0.897242623445826,0.190636359731694,6,1264,regulation of protein phosphorylation,BP,PYCARD;RGN;GHR;FGF18;ANG;DEPTOR
6238,GO:0017038,0.89724430538664,0.339509217712084,1,316,protein import,BP,NOL3
18985,GO:1901990,0.897310919522452,0.339376400849964,1,309,regulation of mitotic cell cycle phase transition,BP,PSMB10
14191,GO:0051649,0.898212849301995,0.168954774878273,10,1947,establishment of localization in cell,BP,TH;ZFYVE21;TBC1D14;ABCG1;CPT2;NOL3;IFI27;STAR;RPH3AL;CNIH4
177,GO:0000375,0.899429977555535,0.334523709843689,1,309,RNA splicing, via transesterification reactions,BP,NOL3
7885,GO:0031327,0.901424321592151,0.177465535619721,7,1445,negative regulation of cellular biosynthetic process,BP,APOC1;ACADVL;RGN;ANG;NMI;IFI27;GLA
3542,GO:0006935,0.901619164243863,0.254493977993351,2,539,chemotaxis,BP,FGF18;DOK1
13364,GO:0048699,0.902076925242587,0.183082804383251,6,1311,generation of neurons,BP,TH;STAR;S100B;DOK1;SLC1A3;LINGO1
10769,GO:0042330,0.902249749756333,0.253253334047286,2,540,taxis,BP,FGF18;DOK1
7135,GO:0022836,0.902355040949796,0.327703710787246,1,327,gated channel activity,MF,GRIA3
11865,GO:0044703,0.902623741823555,0.202914013733884,4,909,multi-organism reproductive process,BP,TH;RGN;ANG;HEXB
3859,GO:0007600,0.902877202319627,0.202494188843859,4,886,sensory perception,BP,TH;RBP4;HEXB;SLC1A3
8907,GO:0033043,0.903740802337301,0.189076210092922,5,1117,regulation of organelle organization,BP,TBC1D14;PYCARD;ACAA2;NOL3;TMOD4
1063,GO:0002429,0.903963698864242,0.323963932598429,1,318,immune response-activating cell surface receptor signaling pathway,BP,PSMB10
11705,GO:0044271,0.904176248372809,0.13647454186335,28,4709,cellular nitrogen compound biosynthetic process,BP,MRPL14;MRPL16;FADD;MRAP;TRADD;PNP;ABCG1;EBF1;BDH2;PYCARD;MGST2;PSMB10;RGN;FADS1;TICAM1;NNMT;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;PCBD1;IFI27;GLA;PTS;RBMS3;HNF1A
7263,GO:0030154,0.905689488241301,0.139440197409332,21,3698,cell differentiation,BP,TH;FADD;MRAP;PNP;ABCG1;BDH2;ACADVL;KRT10;FADS1;FGF18;RNASEL;ANG;HEXB;NUDT7;TMEM176A;STAR;S100B;DHCR7;DOK1;SLC1A3;LINGO1
18425,GO:0120025,0.905714944609609,0.165759733434334,8,1661,plasma membrane bounded cell projection,CC,TH;FADD;CYP17A1;ANG;CPT1C;STAR;S100B;SLC1A3
3208,GO:0006468,0.906524217661035,0.160389790968888,9,1808,protein phosphorylation,BP,PDK4;PYCARD;PSMB10;RGN;GHR;FGF18;RNASEL;ANG;DEPTOR
15067,GO:0060589,0.906747374547933,0.317339510918224,1,338,nucleoside-triphosphatase regulator activity,MF,TBC1D14
12350,GO:0045786,0.907441006924716,0.242943422158027,2,544,negative regulation of cell cycle,BP,PSMB10;PLA2G16
19802,GO:1903827,0.9078150606736,0.242185019354856,2,553,regulation of cellular protein localization,BP,NOL3;IFI27
13236,GO:0048468,0.907936039906262,0.158293966857259,9,1834,cell development,BP,TH;FGF18;ANG;HEXB;STAR;S100B;DOK1;SLC1A3;LINGO1
4670,GO:0009890,0.909021594194453,0.165781410305423,7,1465,negative regulation of biosynthetic process,BP,APOC1;ACADVL;RGN;ANG;NMI;IFI27;GLA
7225,GO:0030099,0.909265727784681,0.311339190064946,1,329,myeloid cell differentiation,BP,FADD
18165,GO:0098793,0.909394148329195,0.311011461853059,1,337,presynapse,CC,TH
13304,GO:0048598,0.909547440070292,0.238692843511764,2,561,embryonic morphogenesis,BP,TH;RBP4
7832,GO:0031252,0.909659514569892,0.310350239962072,1,347,cell leading edge,CC,S100B
15343,GO:0061061,0.909672745735987,0.238438138986209,2,563,muscle structure development,BP,RBP4;S100B
5871,GO:0016310,0.911259089257437,0.147158326089751,11,2145,phosphorylation,BP,PDK4;ZFYVE21;PYCARD;PSMB10;RGN;GHR;FGF18;RNASEL;ANG;SHPK;DEPTOR
20389,GO:1905114,0.911917320120769,0.233887777114632,2,565,cell surface receptor signaling pathway involved in cell-cell signaling,BP,PSMB10;GRIA3
18982,GO:1901987,0.912339847581732,0.303890057519503,1,330,regulation of cell cycle phase transition,BP,PSMB10
3675,GO:0007167,0.912645362600582,0.185696349183652,4,963,enzyme linked receptor protein signaling pathway,BP,PDK4;GHR;FGF18;DOK1
18089,GO:0098609,0.914627117399978,0.1990332185372,3,771,cell-cell adhesion,BP,FADD;PNP;PYCARD
7211,GO:0030054,0.914727409703278,0.170955776851537,5,1164,cell junction,CC,IFI30;ZFYVE21;GRIA3;CPT1C;PRRT1
4667,GO:0009887,0.915879168473163,0.180047677544118,4,966,animal organ morphogenesis,BP,TH;PSMB10;FGF18;RBP4
9518,GO:0034622,0.91864652202434,0.175180854096861,4,947,cellular macromolecular complex assembly,BP,PYCARD;ANG;NOL3;TMOD4
11275,GO:0043228,0.91962300628794,0.120758765510796,21,3749,non-membrane-bounded organelle,CC,MSRA;MRPL14;MRPL16;MRI1;TRADD;HSD17B11;PNP;PYCARD;G0S2;ACADVL;KRT10;GHR;FGF18;ARL6IP4;CPT2;PXK;ANG;FAM110C;ACAT2;NOL3;TMOD4
11279,GO:0043232,0.91962300628794,0.120758765510796,21,3749,intracellular non-membrane-bounded organelle,CC,MSRA;MRPL14;MRPL16;MRI1;TRADD;HSD17B11;PNP;PYCARD;G0S2;ACADVL;KRT10;GHR;FGF18;ARL6IP4;CPT2;PXK;ANG;FAM110C;ACAT2;NOL3;TMOD4
13885,GO:0051128,0.919885014937178,0.134554189397632,11,2195,regulation of cellular component organization,BP,APOC1;TBC1D14;PYCARD;ACAA2;FAM110C;HEXB;NOL3;S100B;HNF1A;LINGO1;TMOD4
11623,GO:0044085,0.920064991906224,0.12672326260497,15,2815,cellular component biogenesis,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;HACL1;RNASEL;ANG;FAM110C;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
4680,GO:0009913,0.92025498924555,0.284191133936313,1,335,epidermal cell differentiation,BP,KRT10
7658,GO:0030900,0.92098626621043,0.282280518472395,1,360,forebrain development,BP,TH
9485,GO:0034504,0.921113598534881,0.281968244726632,1,354,protein localization to nucleus,BP,NOL3
371,GO:0000989,0.921658252706664,0.213698293206827,2,582,transcription factor activity, transcription factor binding,MF,NMI;PCBD1
472,GO:0001228,0.921730059454053,0.280399710171522,1,352,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,HNF1A
4351,GO:0009057,0.92303601538475,0.156930884705543,5,1153,macromolecule catabolic process,BP,PSMB10;RGN;IDUA;HEXB;LYPLAL1
7804,GO:0031175,0.923279079499206,0.182673475470389,3,811,neuron projection development,BP,S100B;DOK1;LINGO1
6024,GO:0016607,0.923568043564187,0.275675477486693,1,355,nuclear speck,CC,ARL6IP4
1270,GO:0002768,0.92390031942474,0.274827875264185,1,350,immune response-regulating cell surface receptor signaling pathway,BP,PSMB10
3751,GO:0007275,0.924905725559772,0.109358502639757,28,4864,multicellular organism development,BP,EBP;ALG5;TH;FADD;HSD17B3;TRADD;EXTL1;PNP;EBF1;KRT10;PSMB10;RGN;FGF18;NNMT;PLA2G16;RBP4;ANG;ACAT1;HEXB;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
7286,GO:0030182,0.925285676894408,0.153069548851498,5,1196,neuron differentiation,BP,TH;S100B;DOK1;SLC1A3;LINGO1
370,GO:0000988,0.925311596188453,0.205931592821008,2,590,transcription factor activity, protein binding,MF,NMI;PCBD1
7271,GO:0030163,0.926346631566791,0.176776819302747,3,792,protein catabolic process,BP,PSMB10;RGN;LYPLAL1
5742,GO:0016050,0.926562935368999,0.267871463047223,1,365,vesicle organization,BP,TBC1D14
10765,GO:0042325,0.927580148122918,0.141904054248747,6,1349,regulation of phosphorylation,BP,PYCARD;RGN;GHR;FGF18;ANG;DEPTOR
482,GO:0001503,0.927748508022029,0.264753914771445,1,366,ossification,BP,FGF18
367,GO:0000982,0.928286920806719,0.263332452974776,1,366,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
5992,GO:0016567,0.928564916922597,0.172464370403786,3,800,protein ubiquitination,BP,PSMB10;TICAM1;NMI
2649,GO:0005525,0.928909570838195,0.261700522415539,1,357,GTP binding,MF,ACSM5
13839,GO:0051052,0.929055359762247,0.261300283974368,1,364,regulation of DNA metabolic process,BP,RGN
8575,GO:0032550,0.930583926232538,0.257232759967735,1,360,purine ribonucleoside binding,MF,ACSM5
2847,GO:0005874,0.930806813699816,0.256606637324569,1,376,microtubule,CC,FAM110C
13646,GO:0050769,0.931728108358097,0.25412762775081,1,378,positive regulation of neurogenesis,BP,STAR
722,GO:0001883,0.932207364796397,0.252861605393825,1,363,purine nucleoside binding,MF,ACSM5
8574,GO:0032549,0.932343116010239,0.252492932985557,1,364,ribonucleoside binding,MF,ACSM5
11229,GO:0043161,0.932746724885997,0.251389801744551,1,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,PSMB10
10581,GO:0040008,0.933970528141907,0.18706347035536,2,607,regulation of growth,BP,GHR;RBP4
5145,GO:0010975,0.934818097977104,0.24571002605581,1,391,regulation of neuron projection development,BP,LINGO1
2814,GO:0005815,0.935659496022031,0.183295978355767,2,620,microtubule organizing center,CC,PXK;FAM110C
2881,GO:0005925,0.935747762199217,0.243166343061359,1,384,focal adhesion,CC,ZFYVE21
2648,GO:0005524,0.936001002095101,0.127712891697863,6,1426,ATP binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
11560,GO:0043900,0.936418624114928,0.241332607242597,1,373,regulation of multi-organism process,BP,RNASEL
2880,GO:0005924,0.937160266452641,0.239253271371586,1,387,cell-substrate adherens junction,CC,ZFYVE21
14170,GO:0051603,0.937235371968924,0.179765928704007,2,617,proteolysis involved in cellular protein catabolic process,BP,PSMB10;RGN
8586,GO:0032561,0.93761062109711,0.238020224467494,1,375,guanyl ribonucleotide binding,MF,ACSM5
6456,GO:0019001,0.938072653972656,0.236729728198203,1,376,guanyl nucleotide binding,MF,ACSM5
18166,GO:0098794,0.938610395651637,0.235187314037578,1,400,postsynapse,CC,GRIA3
7212,GO:0030055,0.93869076839667,0.234975762607704,1,391,cell-substrate junction,CC,ZFYVE21
11863,GO:0044700,0.939041888465738,0.0881967398582495,35,5938,single organism signaling,BP,EBP;PDK4;IFI30;TH;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;ACAA2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;FXYD1;RBP4;RNASEL;FAM110C;NMI;GRIA3;NOL3;DEPTOR;CASP4;IFI27;STAR;RPH3AL;S100B;DOK1;SLC1A3;LINGO1
3537,GO:0006928,0.939330763632543,0.113281281817187,8,1768,movement of cell or subcellular component,BP,FADD;PYCARD;RGN;FGF18;ANG;FAM110C;HEXB;DOK1
6180,GO:0016887,0.939834389874307,0.231736528396788,1,406,ATPase activity,MF,ABCG1
7172,GO:0023052,0.940108814777339,0.0867769419577324,35,5945,signaling,BP,EBP;PDK4;IFI30;TH;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;ACAA2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;FXYD1;RBP4;RNASEL;FAM110C;NMI;GRIA3;NOL3;DEPTOR;CASP4;IFI27;STAR;RPH3AL;S100B;DOK1;SLC1A3;LINGO1
13918,GO:0051173,0.940750354481076,0.110973886122126,8,1750,positive regulation of nitrogen compound metabolic process,BP,FADD;MRAP;TICAM1;RNASEL;HEXB;PCBD1;RBMS3;HNF1A
12441,GO:0045944,0.94082587654525,0.134594189494644,4,1031,positive regulation of transcription from RNA polymerase II promoter,BP,FADD;RNASEL;HEXB;HNF1A
6540,GO:0019222,0.940959628450476,0.085408488165105,36,6101,regulation of metabolic process,BP,CFB;PDK4;FADD;MRAP;APOC1;TRADD;TBC1D14;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;NOL3;DEPTOR;PCBD1;IFI27;FAM46A;IDH1;TFPI;STAR;GLA;DHCR7;PTS;RBMS3;HNF1A
13450,GO:0048869,0.941610981668466,0.090443955592862,21,3868,cellular developmental process,BP,TH;FADD;MRAP;PNP;ABCG1;BDH2;ACADVL;KRT10;FADS1;FGF18;RNASEL;ANG;HEXB;NUDT7;TMEM176A;STAR;S100B;DHCR7;DOK1;SLC1A3;LINGO1
3662,GO:0007154,0.942639193393188,0.0833998916985415,35,5959,cell communication,BP,EBP;PDK4;IFI30;TH;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;ACAA2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;RBP4;RNASEL;ANG;FAM110C;NMI;GRIA3;NOL3;DEPTOR;CASP4;IFI27;STAR;RPH3AL;S100B;DOK1;SLC1A3;LINGO1
4849,GO:0010557,0.942905071363104,0.111148456216241,7,1587,positive regulation of macromolecule biosynthetic process,BP,FADD;TICAM1;RNASEL;HEXB;PCBD1;RBMS3;HNF1A
13644,GO:0050767,0.943076885333818,0.166432600065961,2,647,regulation of neurogenesis,BP,STAR;LINGO1
1381,GO:0003008,0.943623847366359,0.103294591243454,9,1906,system process,BP,TH;FXYD1;RBP4;HEXB;NOL3;S100B;HNF1A;SLC1A3;TMOD4
2701,GO:0005634,0.943889332260827,0.0807325976228769,40,6684,nucleus,CC,EBP;TH;MSRA;MRI1;FADD;TRADD;TBC1D14;PNP;EBF1;PYCARD;LAGE3;ACADVL;KRT10;MGST2;PSMB10;RGN;FGF18;ARL6IP4;CPT2;RNASEL;ANG;FAM110C;NMI;ACAT2;TSFM;AOX1;F8A1;NOL3;NUDT6;PCBD1;IFI27;PON2;DECR1;PUS1;PTMS;DERA;S100B;DHCR7;HNF1A;DOK1
8584,GO:0032559,0.944781216041324,0.112555953394405,6,1461,adenyl ribonucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
4820,GO:0010498,0.945169676513595,0.216441157440386,1,398,proteasomal protein catabolic process,BP,PSMB10
13723,GO:0050877,0.945880138608339,0.116604032604051,5,1203,neurological system process,BP,TH;RBP4;HEXB;S100B;SLC1A3
7176,GO:0023061,0.946453737689553,0.212667271265961,1,407,signal release,BP,RBP4
17218,GO:0080090,0.946993018393828,0.0782975451998546,32,5552,regulation of primary metabolic process,BP,CFB;PDK4;FADD;MRAP;APOC1;TRADD;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;NOL3;DEPTOR;PCBD1;IFI27;IDH1;TFPI;STAR;DHCR7;RBMS3;HNF1A
18168,GO:0098796,0.947131107595724,0.156982326330841,2,631,membrane protein complex,CC,FADD;TRADD
13440,GO:0048856,0.947235802056799,0.0785491543470552,30,5288,anatomical structure development,BP,EBP;ALG5;TH;FADD;HSD17B3;TRADD;EXTL1;PNP;EBF1;BDH2;ACADVL;KRT10;PSMB10;RGN;FGF18;NNMT;PLA2G16;RBP4;ANG;ACAT1;HEXB;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
7496,GO:0030554,0.947470967977149,0.107829779894914,6,1472,adenyl nucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
11821,GO:0044456,0.947732973292287,0.155543741818316,2,663,synapse part,CC,TH;GRIA3
11798,GO:0044428,0.948029446262828,0.0807872869807488,22,4050,nuclear part,CC,EBP;MSRA;MRI1;TBC1D14;PYCARD;LAGE3;ACADVL;MGST2;PSMB10;FGF18;ARL6IP4;CPT2;RNASEL;ANG;NMI;ACAT2;AOX1;NOL3;PCBD1;IFI27;DECR1;DHCR7
18321,GO:0099512,0.948367306592076,0.132367284793771,3,861,supramolecular fiber,CC,KRT10;FAM110C;TMOD4
18322,GO:0099513,0.9493269895868,0.151769206607529,2,647,polymeric cytoskeletal fiber,CC,KRT10;FAM110C
11694,GO:0044257,0.949374344403208,0.151653588753375,2,652,cellular protein catabolic process,BP,PSMB10;RGN
18298,GO:0099081,0.95006409653337,0.128779291271719,3,868,supramolecular polymer,CC,KRT10;FAM110C;TMOD4
18297,GO:0099080,0.950293203411162,0.128292743091146,3,869,supramolecular complex,CC,KRT10;FAM110C;TMOD4
3937,GO:0008104,0.950521005491909,0.0862885599258897,12,2482,protein localization,BP,MRAP;TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
3790,GO:0007389,0.951030037801599,0.198994117301131,1,413,pattern specification process,BP,ALG5
8503,GO:0032446,0.953826977542503,0.120724383749522,3,882,protein modification by small protein conjugation,BP,PSMB10;TICAM1;NMI
14356,GO:0051962,0.954126792226967,0.189476243478009,1,434,positive regulation of nervous system development,BP,STAR
4672,GO:0009892,0.954164006377453,0.079246430894544,13,2643,negative regulation of metabolic process,BP,APOC1;TBC1D14;PYCARD;ACADVL;PSMB10;RGN;ANG;NMI;NOL3;DEPTOR;IFI27;TFPI;GLA
4950,GO:0010720,0.955936885962164,0.183826749767354,1,437,positive regulation of cell development,BP,STAR
13694,GO:0050839,0.956223903209333,0.182923469430836,1,438,cell adhesion molecule binding,MF,IDH1
6614,GO:0019438,0.957375198572668,0.0669642387400678,23,4252,aromatic compound biosynthetic process,BP,TH;FADD;MRAP;TRADD;PNP;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;NNMT;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;PCBD1;IFI27;PTS;HNF1A
11392,GO:0043412,0.95885957801445,0.0657632294600748,21,3985,macromolecule modification,BP,PDK4;ALG5;DPM3;MSRA;EXTL1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;HSD17B10;ETFB;RNASEL;ANG;NMI;DEPTOR;PUS1;MDP1;LYPLAL1
10580,GO:0040007,0.959065493817312,0.109266173751517,3,907,growth,BP,GHR;RBP4;DHCR7
3510,GO:0006886,0.960383150613436,0.096058649382542,4,1108,intracellular protein transport,BP,TBC1D14;NOL3;IFI27;RPH3AL
6475,GO:0019058,0.96083976441529,0.168141350654256,1,438,viral life cycle,BP,RNASEL
2304,GO:0004871,0.9612059195326,0.0794168533120375,7,1637,signal transducer activity,MF,EBP;P2RY14;TRADD;GHR;TICAM1;GRIA3;DOK1
4893,GO:0010628,0.962714146484634,0.0767049804026855,7,1687,positive regulation of gene expression,BP,FADD;RNASEL;HEXB;PCBD1;STAR;RBMS3;HNF1A
13330,GO:0048646,0.964101411026782,0.0979532428913727,3,941,anatomical structure formation involved in morphogenesis,BP,FGF18;RBP4;ANG
5747,GO:0016055,0.964124933222108,0.157262464163394,1,461,Wnt signaling pathway,BP,PSMB10
18426,GO:0198738,0.964413143198735,0.156294877145021,1,462,cell-cell signaling by wnt,BP,PSMB10
7881,GO:0031323,0.964840198808313,0.0536279496922107,32,5697,regulation of cellular metabolic process,BP,PDK4;FADD;MRAP;APOC1;TRADD;TBC1D14;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;NOL3;DEPTOR;PCBD1;IFI27;IDH1;TFPI;STAR;GLA;RBMS3;HNF1A
14354,GO:0051960,0.964934985923112,0.112860922904098,2,729,regulation of nervous system development,BP,STAR;LINGO1
12400,GO:0045893,0.965249157174511,0.0798049991488916,5,1335,positive regulation of transcription, DNA-templated,BP,FADD;RNASEL;HEXB;PCBD1;HNF1A
19633,GO:1903508,0.965249157174511,0.0798049991488916,5,1335,positive regulation of nucleic acid-templated transcription,BP,FADD;RNASEL;HEXB;PCBD1;HNF1A
3741,GO:0007264,0.965845132951437,0.151438735098525,1,482,small GTPase mediated signal transduction,BP,DOK1
19230,GO:1902589,0.965939046560054,0.0741183176360239,6,1542,single-organism organelle organization,BP,TBC1D14;PYCARD;ACAA2;ANG;NOL3;TMOD4
7196,GO:0030031,0.966041353934544,0.150777786596713,1,474,cell projection assembly,BP,FAM110C
20732,GO:1990234,0.96653604044172,0.108660862015841,2,719,transferase complex,CC,DPM3;PYCARD
2872,GO:0005912,0.966814504777367,0.148131163293003,1,479,adherens junction,CC,ZFYVE21
3206,GO:0006464,0.967360226831217,0.0541523090173542,19,3744,cellular protein modification process,BP,PDK4;ALG5;DPM3;MSRA;EXTL1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;ETFB;RNASEL;ANG;NMI;DEPTOR;MDP1;LYPLAL1
10278,GO:0036211,0.967360226831217,0.0541523090173542,19,3744,protein modification process,BP,PDK4;ALG5;DPM3;MSRA;EXTL1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;ETFB;RNASEL;ANG;NMI;DEPTOR;MDP1;LYPLAL1
6371,GO:0018193,0.967799236076581,0.080541377269245,4,1149,peptidyl-amino acid modification,BP,ALG5;DPM3;GHR;FGF18
19263,GO:1902680,0.968968445697939,0.0723753355985693,5,1357,positive regulation of RNA biosynthetic process,BP,FADD;RNASEL;HEXB;PCBD1;HNF1A
14830,GO:0060284,0.969399119483664,0.101014708694027,2,747,regulation of cell development,BP,STAR;LINGO1
13916,GO:0051171,0.969731050857895,0.0492790789750187,22,4223,regulation of nitrogen compound metabolic process,BP,FADD;MRAP;APOC1;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;PCBD1;IFI27;GLA;RBMS3;HNF1A
14184,GO:0051641,0.970344249966417,0.0556657081888571,11,2455,cellular localization,BP,TH;ZFYVE21;MRAP;TBC1D14;ABCG1;CPT2;NOL3;IFI27;STAR;RPH3AL;CNIH4
17882,GO:0097367,0.970419441779872,0.0584056649807713,9,2130,carbohydrate derivative binding,MF,PDK4;ACSF2;PNP;ABCG1;ACSM5;RNASEL;ANG;SHPK;GLA
3792,GO:0007399,0.970458522106106,0.0583364871264502,9,2141,nervous system development,BP,TH;ACAT1;HEXB;STAR;S100B;PTS;DOK1;SLC1A3;LINGO1
15766,GO:0070161,0.970790575918172,0.134226395674202,1,498,anchoring junction,CC,ZFYVE21
4590,GO:0009593,0.972322334063295,0.128765870821274,1,454,detection of chemical stimulus,BP,ABCG1
11823,GO:0044459,0.972757057944935,0.0515795084885083,11,2478,plasma membrane part,CC,EBP;TH;SLC31A2;FADD;P2RY14;TRADD;ABCG1;GHR;FXYD1;GRIA3;CPT1C
4617,GO:0009653,0.972921676323056,0.0525268675770964,10,2328,anatomical structure morphogenesis,BP,TH;PSMB10;FGF18;RBP4;ANG;HEXB;S100B;DOK1;SLC1A3;LINGO1
3776,GO:0007346,0.972996718482271,0.126289043919076,1,492,regulation of mitotic cell cycle,BP,PSMB10
3754,GO:0007283,0.973535651437171,0.12432431294319,1,488,spermatogenesis,BP,RGN
6359,GO:0018130,0.973647673490504,0.0433874336979774,22,4246,heterocycle biosynthetic process,BP,FADD;MRAP;TRADD;PNP;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;NNMT;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;PCBD1;IFI27;PTS;HNF1A
13145,GO:0048232,0.973719214814358,0.123650832973091,1,489,male gamete generation,BP,RGN
819,GO:0002009,0.973887388354371,0.123019440915521,1,509,morphogenesis of an epithelium,BP,PSMB10
11902,GO:0044772,0.974554826939845,0.120563214898649,1,501,mitotic cell cycle phase transition,BP,PSMB10
15311,GO:0061024,0.975005233632233,0.0722644794777176,3,1001,membrane organization,BP,TBC1D14;ACAA2;NOL3
13972,GO:0051254,0.975270323789036,0.0594407637137089,5,1403,positive regulation of RNA metabolic process,BP,FADD;RNASEL;HEXB;PCBD1;HNF1A
4809,GO:0010467,0.975936118187113,0.0386285158016863,27,5049,gene expression,BP,CFB;MRPL14;MRPL16;FADD;TRADD;ABCG1;EBF1;PYCARD;LAGE3;PSMB10;FADS1;TICAM1;ARL6IP4;HSD17B10;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;PCBD1;IFI27;FAM46A;PUS1;STAR;RBMS3;HNF1A
3958,GO:0008134,0.976222257840943,0.114323550042152,1,517,transcription factor binding,MF,IFI27
12288,GO:0045664,0.976379571728596,0.113722550747317,1,529,regulation of neuron differentiation,BP,LINGO1
11816,GO:0044451,0.97705115313469,0.0672247563296406,3,1010,nucleoplasm part,CC,LAGE3;ARL6IP4;AOX1
2317,GO:0004888,0.979043696971467,0.0557063344603566,4,1184,transmembrane signaling receptor activity,MF,EBP;P2RY14;GHR;GRIA3
11900,GO:0044770,0.979536622706262,0.101568732462568,1,530,cell cycle phase transition,BP,PSMB10
8213,GO:0031981,0.980460590192143,0.0341948247791686,18,3713,nuclear lumen,CC,MSRA;MRI1;TBC1D14;PYCARD;LAGE3;ACADVL;PSMB10;FGF18;ARL6IP4;CPT2;RNASEL;ANG;NMI;ACAT2;AOX1;NOL3;PCBD1;DECR1
7195,GO:0030030,0.980565915051532,0.0521831383156172,4,1276,cell projection organization,BP,FAM110C;S100B;DOK1;LINGO1
362,GO:0000977,0.980705423403603,0.0969398638321841,1,542,RNA polymerase II regulatory region sequence-specific DNA binding,MF,HNF1A
9540,GO:0034654,0.980811468573658,0.0326589618680178,21,4183,nucleobase-containing compound biosynthetic process,BP,FADD;MRAP;TRADD;PNP;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;NNMT;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;PCBD1;IFI27;HNF1A
388,GO:0001012,0.980825080936308,0.0964620915953543,1,543,RNA polymerase II regulatory region DNA binding,MF,HNF1A
11137,GO:0043009,0.98098071638809,0.0958357120592771,1,552,chordate embryonic development,BP,RBP4
12434,GO:0045935,0.981045317529455,0.0443289739255554,6,1645,positive regulation of nucleobase-containing compound metabolic process,BP,FADD;MRAP;RNASEL;HEXB;PCBD1;HNF1A
3239,GO:0006511,0.981167790102747,0.0950884147892972,1,548,ubiquitin-dependent protein catabolic process,BP,PSMB10
14878,GO:0060341,0.981227355443704,0.0674946798915579,2,811,regulation of cellular localization,BP,NOL3;IFI27
4648,GO:0009792,0.981367957217251,0.0942812036388856,1,555,embryo development ending in birth or egg hatching,BP,RBP4
6775,GO:0019941,0.982138660782094,0.0911654302253979,1,555,modification-dependent protein catabolic process,BP,PSMB10
15676,GO:0065007,0.982221860736994,0.0272299021305572,68,10987,biological regulation,BP,CFB;EBP;PDK4;IFI30;DPM3;TH;SLC31A2;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;HSD17B11;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;ACADVL;ACAA2;MGST2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;PLA2G16;FXYD1;RBP4;CYP17A1;RNASEL;ANG;FAM110C;NMI;TSFM;SHPK;HEXB;FABP3;GRIA3;NOL3;HSD3B2;DEPTOR;PCBD1;CASP4;IFI27;FAM46A;TMEM176A;IDH1;TFPI;STAR;GLA;CYP11A1;RPH3AL;S100B;DHCR7;PTS;RBMS3;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
4041,GO:0008270,0.982504293098004,0.0533590881137206,3,1061,zinc ion binding,MF,RGN;GALT;S100B
11524,GO:0043632,0.982936939760036,0.0878993364945401,1,561,modification-dependent macromolecule catabolic process,BP,PSMB10
16771,GO:0071944,0.983235043932827,0.0277940440896424,26,5014,cell periphery,CC,CFB;EBP;TH;SLC31A2;FADD;P2RY14;MRAP;TRADD;ABCG1;KRT10;MGST2;GHR;ASAH2;PXK;HSD17B10;FXYD1;FAM110C;GRIA3;CPT1C;CASP4;PON2;TFPI;RPH3AL;PRRT1;SLC1A3;LINGO1
18361,GO:0099600,0.983992992314536,0.0441061514807716,4,1234,transmembrane receptor activity,MF,EBP;P2RY14;GHR;GRIA3
16061,GO:0070647,0.984104705710031,0.0491532667837136,3,1072,protein modification by small protein conjugation or removal,BP,PSMB10;TICAM1;NMI
13917,GO:0051172,0.984535875780377,0.0394206808762483,5,1487,negative regulation of nitrogen compound metabolic process,BP,APOC1;RGN;ANG;IFI27;GLA
4856,GO:0010564,0.984603120254493,0.0809589572093431,1,568,regulation of cell cycle process,BP,PSMB10
4902,GO:0010638,0.985763925801439,0.076010857771997,1,584,positive regulation of organelle organization,BP,PYCARD
3590,GO:0007010,0.985787467905312,0.0446497507623884,3,1111,cytoskeleton organization,BP,PYCARD;ANG;TMOD4
5752,GO:0016070,0.98631241250625,0.0236964206250136,22,4437,RNA metabolic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;LAGE3;PSMB10;RGN;FADS1;TICAM1;ARL6IP4;HSD17B10;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;PCBD1;IFI27;PUS1;HNF1A
9960,GO:0035639,0.986404823224971,0.033023321703487,6,1749,purine ribonucleoside triphosphate binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
2856,GO:0005886,0.986540569901775,0.0228115606059979,25,4920,plasma membrane,CC,CFB;EBP;TH;SLC31A2;FADD;P2RY14;MRAP;TRADD;ABCG1;KRT10;MGST2;GHR;ASAH2;PXK;HSD17B10;FXYD1;GRIA3;CPT1C;CASP4;PON2;TFPI;RPH3AL;PRRT1;SLC1A3;LINGO1
2836,GO:0005856,0.987069698445008,0.0300168623618625,7,1934,cytoskeleton,CC,MSRA;TRADD;PNP;KRT10;PXK;FAM110C;TMOD4
13379,GO:0048729,0.987200232432024,0.0697522977370306,1,607,tissue morphogenesis,BP,PSMB10
9533,GO:0034645,0.987513011752106,0.0214251832952973,24,4781,cellular macromolecule biosynthetic process,BP,ALG5;DPM3;MRPL14;MRPL16;FADD;TRADD;EXTL1;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;PTMS;RBMS3;HNF1A
21580,GO:2001141,0.98775523085162,0.0228121993631487,16,3508,regulation of RNA biosynthetic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
10437,GO:0038023,0.988169346874787,0.0338787199157439,4,1290,signaling receptor activity,MF,EBP;P2RY14;GHR;GRIA3
361,GO:0000976,0.988758924222916,0.0627768832380628,1,618,transcription regulatory region sequence-specific DNA binding,MF,HNF1A
8580,GO:0032555,0.988928653523408,0.0275057850518883,6,1791,purine ribonucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
6260,GO:0017076,0.989656905824954,0.0258854150379237,6,1804,purine nucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
3673,GO:0007165,0.989809967164824,0.0172801977878504,28,5449,signal transduction,BP,EBP;PDK4;IFI30;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;ACAA2;PSMB10;RGN;GHR;FGF18;ASAH2;TICAM1;RNASEL;FAM110C;NMI;GRIA3;NOL3;DEPTOR;CASP4;IFI27;RPH3AL;S100B;DOK1;LINGO1
8578,GO:0032553,0.989855022732881,0.0254421783980604,6,1808,ribonucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
4850,GO:0010558,0.990674433977107,0.0274919122575086,4,1374,negative regulation of macromolecule biosynthetic process,BP,RGN;ANG;NMI;IFI27
4646,GO:0009790,0.99073430391413,0.0372235648728843,2,931,embryo development,BP,TH;RBP4
17126,GO:0072594,0.991163216519804,0.0515650847356652,1,641,establishment of protein localization to organelle,BP,NOL3
8724,GO:0032774,0.991177215242116,0.0166312085316903,17,3751,RNA biosynthetic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
4810,GO:0010468,0.991305665522064,0.0158444515459501,20,4258,regulation of gene expression,BP,CFB;FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;ANG;TSFM;HEXB;NOL3;PCBD1;IFI27;FAM46A;STAR;RBMS3;HNF1A
2804,GO:0005794,0.991312646756395,0.0258280707294961,4,1399,Golgi apparatus,CC,TBC1D14;ABCG1;GALT;GLA
20893,GO:1990837,0.991373805981605,0.0505509568306751,1,653,sequence-specific double-stranded DNA binding,MF,HNF1A
11700,GO:0044265,0.99158359853837,0.0342953781299491,2,927,cellular macromolecule catabolic process,BP,PSMB10;RGN
16198,GO:0070925,0.991742528432412,0.0487649477642568,1,664,organelle assembly,BP,TBC1D14
3069,GO:0006259,0.99179670312289,0.0335526403615524,2,927,DNA metabolic process,BP,RGN;PTMS
14225,GO:0051716,0.991804056114058,0.0136485375473911,35,6569,cellular response to stimulus,BP,EBP;PDK4;IFI30;TH;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;ACAA2;MGST2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;RNASEL;FAM110C;NMI;SHPK;CMBL;GRIA3;NOL3;DEPTOR;CASP4;IFI27;TFPI;STAR;RPH3AL;S100B;DOK1;LINGO1
4848,GO:0010556,0.991886215238386,0.0151959531634318,18,3946,regulation of macromolecule biosynthetic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;RBMS3;HNF1A
3128,GO:0006351,0.992079797047781,0.0152623356872394,16,3617,transcription, DNA-templated,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
11824,GO:0044463,0.992280777193277,0.0318496574788546,2,964,cell projection part,CC,TH;ANG
14172,GO:0051606,0.992282669958175,0.0461297449324181,1,625,detection of stimulus,BP,ABCG1
13970,GO:0051252,0.99228654262109,0.0148935963622157,16,3624,regulation of RNA metabolic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
3322,GO:0006605,0.992389387779024,0.0455947230778615,1,662,protein targeting,BP,NOL3
3141,GO:0006366,0.992683978605221,0.0179904739528765,7,2029,transcription from RNA polymerase II promoter,BP,FADD;PSMB10;RNASEL;NMI;HEXB;IFI27;HNF1A
18011,GO:0097659,0.992686012534223,0.0141787406965244,16,3636,nucleic acid-templated transcription,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
69,GO:0000139,0.992758925314451,0.0437549791876307,1,678,Golgi membrane,CC,ABCG1
366,GO:0000981,0.992808543910952,0.0435072969354853,1,676,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,HNF1A
3134,GO:0006357,0.99289932819591,0.0184834817266079,6,1840,regulation of transcription from RNA polymerase II promoter,BP,FADD;PSMB10;RNASEL;HEXB;IFI27;HNF1A
4353,GO:0009059,0.99315918253172,0.0122302001209587,24,4943,macromolecule biosynthetic process,BP,ALG5;DPM3;MRPL14;MRPL16;FADD;TRADD;EXTL1;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;PTMS;RBMS3;HNF1A
19631,GO:1903506,0.993305883976272,0.0132687169524195,15,3489,regulation of nucleic acid-templated transcription,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
21008,GO:2000112,0.993405614558605,0.01270050912399,17,3834,regulation of cellular macromolecule biosynthetic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;TSFM;HEXB;PCBD1;IFI27;RBMS3;HNF1A
11800,GO:0044430,0.993599051792364,0.0197201460896092,4,1452,cytoskeletal part,CC,KRT10;PXK;FAM110C;TMOD4
14232,GO:0051726,0.993613169649353,0.0270734974058064,2,969,regulation of cell cycle,BP,PSMB10;PLA2G16
4877,GO:0010605,0.993722794412635,0.0144251475865751,9,2423,negative regulation of macromolecule metabolic process,BP,PYCARD;PSMB10;RGN;ANG;NMI;NOL3;DEPTOR;IFI27;TFPI
9512,GO:0034613,0.994227749139477,0.0164381417796449,5,1682,cellular protein localization,BP,MRAP;TBC1D14;NOL3;IFI27;RPH3AL
16101,GO:0070727,0.994552641356032,0.0156072960854077,5,1692,cellular macromolecule localization,BP,MRAP;TBC1D14;NOL3;IFI27;RPH3AL
1620,GO:0003690,0.994901362964328,0.0326778602216224,1,723,double-stranded DNA binding,MF,HNF1A
5532,GO:0015630,0.99535049525063,0.0205843994702203,2,1035,microtubule cytoskeleton,CC,PXK;FAM110C
8871,GO:0032991,0.99558203971588,0.00834697261501158,21,4576,macromolecular complex,CC,DPM3;MRPL14;MRPL16;FADD;APOC1;TRADD;PXMP2;PYCARD;PSMB10;GHR;TICAM1;PXK;HSD17B10;FXYD1;RBP4;ANG;GRIA3;CPT1C;CASP4;HNF1A;ETFDH
60,GO:0000122,0.995627252737624,0.0287286966937067,1,742,negative regulation of transcription from RNA polymerase II promoter,BP,IFI27
11281,GO:0043234,0.995838248411417,0.00930945825102564,11,2889,protein complex,CC,FADD;TRADD;PXMP2;PYCARD;PSMB10;PXK;RBP4;ANG;CASP4;HNF1A;ETFDH
17528,GO:0090304,0.995901676330947,0.0076362162021789,23,4910,nucleic acid metabolic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;LAGE3;PSMB10;RGN;FADS1;TICAM1;ARL6IP4;HSD17B10;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;PCBD1;IFI27;PUS1;PTMS;HNF1A
3663,GO:0007155,0.995920668988663,0.0150368855416035,3,1311,cell adhesion,BP,FADD;PNP;PYCARD
21009,GO:2000113,0.995982473084991,0.014836171924472,3,1293,negative regulation of cellular macromolecule biosynthetic process,BP,RGN;ANG;IFI27
3566,GO:0006974,0.996099300293268,0.0260949602208102,1,751,cellular response to DNA damage stimulus,BP,PYCARD
7112,GO:0022610,0.996100136999608,0.0144511954468814,3,1318,biological adhesion,BP,FADD;PNP;PYCARD
6278,GO:0017111,0.996136648780098,0.025882058710038,1,772,nucleoside-triphosphatase activity,MF,ABCG1
6537,GO:0019219,0.996326997187446,0.00737116107943708,17,3966,regulation of nucleobase-containing compound metabolic process,BP,FADD;MRAP;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
11663,GO:0044212,0.996356909475247,0.0246315545543949,1,771,transcription regulatory region DNA binding,MF,HNF1A
360,GO:0000975,0.996415133612022,0.0242984904559392,1,773,regulatory region DNA binding,MF,HNF1A
406,GO:0001067,0.996437709390391,0.024169064179708,1,774,regulatory region nucleic acid binding,MF,HNF1A
3132,GO:0006355,0.996494248836113,0.0074188159821311,14,3465,regulation of transcription, DNA-templated,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;TSFM;HEXB;PCBD1;IFI27;HNF1A
13661,GO:0050789,0.996925845671302,0.00520130394496507,60,10394,regulation of biological process,BP,CFB;EBP;PDK4;IFI30;TH;SLC31A2;FADD;P2RY14;MRAP;APOC1;TRADD;TBC1D14;PNP;ABCG1;EBF1;PYCARD;G0S2;ACADVL;ACAA2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;PLA2G16;FXYD1;RBP4;RNASEL;ANG;FAM110C;NMI;TSFM;SHPK;HEXB;FABP3;GRIA3;NOL3;DEPTOR;PCBD1;CASP4;IFI27;FAM46A;TMEM176A;IDH1;TFPI;STAR;GLA;RPH3AL;S100B;DHCR7;PTS;RBMS3;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
2305,GO:0004872,0.997113227942477,0.00969710679212044,4,1537,receptor activity,MF,EBP;P2RY14;GHR;GRIA3
14714,GO:0060089,0.997113227942477,0.00969710679212044,4,1537,molecular transducer activity,MF,EBP;P2RY14;GHR;GRIA3
5939,GO:0016462,0.99712352420422,0.0201612941900116,1,810,pyrophosphatase activity,MF,ABCG1
6135,GO:0016818,0.997170476016005,0.0198811598567083,1,812,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,ABCG1
6134,GO:0016817,0.997216654890902,0.0196048445378162,1,814,hydrolase activity, acting on acid anhydrides,MF,ABCG1
13887,GO:0051130,0.997300064165663,0.0128226108333447,2,1116,positive regulation of cellular component organization,BP,PYCARD;HNF1A
5737,GO:0016043,0.997478815553825,0.00469070322911983,27,5728,cellular component organization,BP,MRPL14;MRPL16;FADD;APOC1;TRADD;TBC1D14;ABCG1;PYCARD;ACAA2;PLA2G16;HSD17B10;HACL1;ANG;FAM110C;ACAT1;HEXB;NOL3;DEPTOR;PCBD1;DECR1;PUS1;S100B;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
2341,GO:0004930,0.997731293577882,0.0164721023023377,1,775,G-protein coupled receptor activity,MF,P2RY14
16710,GO:0071840,0.99791075131022,0.00390313135756228,28,5922,cellular component organization or biogenesis,BP,MRPL14;MRPL16;FADD;APOC1;TRADD;TBC1D14;ABCG1;PYCARD;ACAA2;PLA2G16;HSD17B10;HACL1;RNASEL;ANG;FAM110C;ACAT1;HEXB;NOL3;DEPTOR;PCBD1;DECR1;PUS1;S100B;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
19262,GO:1902679,0.998228342134685,0.00885586641210026,2,1159,negative regulation of RNA biosynthetic process,BP,RGN;IFI27
11801,GO:0044431,0.99838791728919,0.0122826839693581,1,878,Golgi apparatus part,CC,ABCG1
19428,GO:1903047,0.998402397865782,0.0121877954789406,1,874,mitotic cell cycle process,BP,PSMB10
11235,GO:0043170,0.998493253410475,0.00267532337457018,46,8633,macromolecule metabolic process,BP,CFB;PDK4;ALG5;DPM3;MSRA;MRPL14;MRPL16;FADD;APOC1;TRADD;EXTL1;ABCG1;EBF1;PYCARD;LAGE3;KRT10;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;ARL6IP4;HSD17B10;ETFB;RNASEL;ANG;NMI;TSFM;IDUA;HEXB;NOL3;DEPTOR;PCBD1;CASP4;IFI27;FAM46A;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;RBMS3;HNF1A;LYPLAL1
9059,GO:0033365,0.9985331263429,0.0113227977625427,1,884,protein localization to organelle,BP,NOL3
1612,GO:0003676,0.998556172135845,0.00318488685999936,15,3818,nucleic acid binding,MF,MRPL14;MRPL16;EBF1;ACAA2;ARL6IP4;HSD17B10;RNASEL;ANG;TSFM;NOL3;NUDT7;FAM46A;PUS1;RBMS3;HNF1A
14811,GO:0060255,0.998588821060313,0.00273320037918274,26,5664,regulation of macromolecule metabolic process,BP,CFB;FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;DEPTOR;PCBD1;IFI27;FAM46A;TFPI;STAR;RBMS3;HNF1A
13971,GO:0051253,0.998720779036253,0.00664054025401873,2,1206,negative regulation of RNA metabolic process,BP,RGN;IFI27
18079,GO:0098590,0.998742973473692,0.00990722107131106,1,932,plasma membrane region,CC,GRIA3
3691,GO:0007186,0.998763946037725,0.00644238066439951,2,1157,G-protein coupled receptor signaling pathway,BP,P2RY14;RPH3AL
13665,GO:0050794,0.998805301040965,0.00212540785794746,54,9810,regulation of cellular process,BP,EBP;PDK4;IFI30;FADD;P2RY14;MRAP;APOC1;TRADD;TBC1D14;PNP;ABCG1;EBF1;PYCARD;G0S2;ACADVL;ACAA2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;PLA2G16;RBP4;RNASEL;ANG;FAM110C;NMI;TSFM;SHPK;HEXB;FABP3;GRIA3;NOL3;DEPTOR;PCBD1;CASP4;IFI27;TMEM176A;IDH1;TFPI;STAR;GLA;RPH3AL;S100B;DHCR7;RBMS3;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
2711,GO:0005654,0.998837621597985,0.00285705180141923,11,3159,nucleoplasm,CC,MSRA;MRI1;TBC1D14;LAGE3;PSMB10;ARL6IP4;CPT2;NMI;AOX1;PCBD1;DECR1
139,GO:0000278,0.999106223006904,0.00736771988322779,1,952,mitotic cell cycle,BP,PSMB10
11486,GO:0043565,0.999153871277765,0.00702416308517729,1,957,sequence-specific DNA binding,MF,HNF1A
11697,GO:0044260,0.999397672842046,0.00113548801265274,40,7982,cellular macromolecule metabolic process,BP,PDK4;ALG5;DPM3;MSRA;MRPL14;MRPL16;FADD;TRADD;EXTL1;ABCG1;EBF1;PYCARD;LAGE3;KRT10;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;ARL6IP4;HSD17B10;ETFB;RNASEL;ANG;NMI;TSFM;IDUA;HEXB;NOL3;DEPTOR;PCBD1;IFI27;PUS1;PTMS;MDP1;TFPI;RBMS3;HNF1A;LYPLAL1
4894,GO:0010629,0.99951314690477,0.0022380287572435,3,1614,negative regulation of gene expression,BP,ANG;NOL3;IFI27
12433,GO:0045934,0.99952196647245,0.00275938181150779,2,1347,negative regulation of nucleobase-containing compound metabolic process,BP,RGN;IFI27
12399,GO:0045892,0.999723326238925,0.00262642146794393,1,1103,negative regulation of transcription, DNA-templated,BP,IFI27
19632,GO:1903507,0.999798468257251,0.001981563614925,1,1143,negative regulation of nucleic acid-templated transcription,BP,IFI27
1625,GO:0003700,0.999842222776409,0.0015927922055376,1,1183,transcription factor activity, sequence-specific DNA binding,MF,HNF1A
409,GO:0001071,0.99984352495596,0.00158104108081536,1,1184,nucleic acid binding transcription factor activity,MF,HNF1A
7093,GO:0022402,0.999916760075808,0.000897708093439978,1,1261,cell cycle process,BP,PSMB10
3579,GO:0006996,0.999927832859255,0.000218625303091542,10,3492,organelle organization,BP,TBC1D14;PYCARD;ACAA2;PLA2G16;HSD17B10;ANG;HEXB;NOL3;PUS1;TMOD4
3617,GO:0007049,0.999936532440364,0.000442122082482584,2,1635,cell cycle,BP,PSMB10;PLA2G16
1613,GO:0003677,0.999997646349967,1.61449312657193e-05,3,2382,DNA binding,MF,EBF1;ANG;HNF1A
8953,GO:0033139,0.999999999999978,0.83761685212636,0,23,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
14118,GO:0051531,0.999999999999998,0.896031957449887,0,16,NFAT protein import into nucleus,BP,
6678,GO:0019731,0.999999999999999,0.738665694786398,0,39,antibacterial humoral response,BP,
1,GO:0000002,1,0.838532801983923,0,25,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.992233128017427,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.985329093544572,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000012,1,0.943962182203385,0,8,single strand break repair,BP,
6,GO:0000014,1,0.95230662731433,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
7,GO:0000015,1,0.969242227319352,0,4,phosphopyruvate hydratase complex,CC,
8,GO:0000016,1,0.993986332266966,0,1,lactase activity,MF,
9,GO:0000018,1,0.637293395477751,0,63,regulation of DNA recombination,BP,
10,GO:0000019,1,0.964234257404182,0,5,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.931243116013616,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.981107274576203,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.978781317723686,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.845832670808323,0,22,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.88934934800296,0,15,ribosomal small subunit assembly,BP,
17,GO:0000032,1,0.992170321724734,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.977014430732763,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.984830651462637,0,2,acyl binding,MF,
20,GO:0000036,1,0.992170027168696,0,1,ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process,MF,
23,GO:0000042,1,0.887492927997511,0,19,protein targeting to Golgi,BP,
25,GO:0000049,1,0.698967341098187,0,49,tRNA binding,MF,
26,GO:0000050,1,0.920230378047045,0,11,urea cycle,BP,
27,GO:0000052,1,0.946300693395477,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.992170896855612,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.914024509266137,0,12,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.948792904726197,0,7,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.956132927867003,0,6,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.710888174616912,0,47,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.885703565481141,0,16,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.97982274012317,0,3,L-ornithine transmembrane transporter activity,MF,
35,GO:0000066,1,0.985751384629445,0,2,mitochondrial ornithine transport,BP,
36,GO:0000070,1,0.394219717859252,0,129,mitotic sister chromatid segregation,BP,
37,GO:0000075,1,0.209976795515895,0,214,cell cycle checkpoint,BP,
38,GO:0000076,1,0.880377098254062,0,17,DNA replication checkpoint,BP,
39,GO:0000077,1,0.349220699604059,0,145,DNA damage checkpoint,BP,
40,GO:0000079,1,0.550027328078236,0,81,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
41,GO:0000082,1,0.180795203073217,0,236,G1/S transition of mitotic cell cycle,BP,
42,GO:0000083,1,0.83487370081479,0,25,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
44,GO:0000095,1,0.992201761126188,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
47,GO:0000098,1,0.928777314326472,0,10,sulfur amino acid catabolic process,BP,
48,GO:0000099,1,0.952445133887526,0,7,sulfur amino acid transmembrane transporter activity,MF,
49,GO:0000101,1,0.958209404818371,0,6,sulfur amino acid transport,BP,
50,GO:0000103,1,0.97801468016012,0,3,sulfate assimilation,BP,
51,GO:0000104,1,0.969308062819154,0,4,succinate dehydrogenase activity,MF,
52,GO:0000105,1,0.985305813038272,0,2,histidine biosynthetic process,BP,
53,GO:0000109,1,0.895830132410139,0,15,nucleotide-excision repair complex,CC,
54,GO:0000110,1,0.979164316596099,0,3,nucleotide-excision repair factor 1 complex,CC,
55,GO:0000111,1,0.993168294074626,0,1,nucleotide-excision repair factor 2 complex,CC,
56,GO:0000117,1,0.993985923768429,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000118,1,0.65869597284493,0,61,histone deacetylase complex,CC,
58,GO:0000120,1,0.963290974535965,0,5,RNA polymerase I transcription factor complex,CC,
59,GO:0000121,1,0.992689771048506,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000123,1,0.568720652014462,0,78,histone acetyltransferase complex,CC,
62,GO:0000124,1,0.920338384594308,0,11,SAGA complex,CC,
63,GO:0000125,1,0.964906158125554,0,5,PCAF complex,CC,
64,GO:0000126,1,0.987202765557182,0,2,transcription factor TFIIIB complex,CC,
65,GO:0000127,1,0.958492799462339,0,6,transcription factor TFIIIC complex,CC,
66,GO:0000132,1,0.892483357155498,0,16,establishment of mitotic spindle orientation,BP,
67,GO:0000137,1,0.958755577447793,0,6,Golgi cis cisterna,CC,
68,GO:0000138,1,0.96411555231008,0,5,Golgi trans cisterna,CC,
70,GO:0000145,1,0.881204955668139,0,18,exocyst,CC,
71,GO:0000146,1,0.874889647042981,0,22,microfilament motor activity,MF,
72,GO:0000149,1,0.446543462139811,0,114,SNARE binding,MF,
73,GO:0000150,1,0.939970909496853,0,8,recombinase activity,MF,
74,GO:0000151,1,0.127961620485018,0,286,ubiquitin ligase complex,CC,
75,GO:0000152,1,0.75663270151707,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.917498401687788,0,12,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.815324645491854,0,27,rRNA modification,BP,
78,GO:0000155,1,0.960860230167034,0,6,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.864774504576014,0,20,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.954380244724739,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.932777307169699,0,10,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.992170027168696,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.986188416015572,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.986188416015572,0,2,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.992170027168696,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.818777414189642,0,28,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.919070667114131,0,11,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.929039804723411,0,10,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.849908762732895,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.969287059840891,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.934523625433695,0,10,rDNA binding,MF,
94,GO:0000183,1,0.743253164101569,0,39,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.404542925004872,0,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.923159579901502,0,11,activation of MAPKKK activity,BP,
97,GO:0000186,1,0.716376740051814,0,49,activation of MAPKK activity,BP,
99,GO:0000188,1,0.823697689843386,0,26,inactivation of MAPK activity,BP,
100,GO:0000189,1,0.979553536327249,0,3,MAPK import into nucleus,BP,
102,GO:0000210,1,0.993039120058076,0,1,NAD+ diphosphatase activity,MF,
103,GO:0000212,1,0.925419972988079,0,11,meiotic spindle organization,BP,
104,GO:0000213,1,0.969106870891589,0,4,tRNA-intron endonuclease activity,MF,
105,GO:0000214,1,0.969102518275111,0,4,tRNA-intron endonuclease complex,CC,
106,GO:0000215,1,0.992170027168696,0,1,tRNA 2'-phosphotransferase activity,MF,
107,GO:0000217,1,0.847676537506679,0,23,DNA secondary structure binding,MF,
108,GO:0000220,1,0.957680027377228,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
109,GO:0000221,1,0.97904350265743,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
110,GO:0000224,1,0.992285778912992,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
111,GO:0000225,1,0.992170027168696,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000226,1,0.0513856245089793,0,418,microtubule cytoskeleton organization,BP,
113,GO:0000228,1,0.023983035422647,0,508,nuclear chromosome,CC,
114,GO:0000229,1,0.984400887813367,0,2,cytoplasmic chromosome,CC,
115,GO:0000235,1,0.967041618250504,0,5,astral microtubule,CC,
116,GO:0000242,1,0.87216939002841,0,20,pericentriolar material,CC,
117,GO:0000243,1,0.940127407576698,0,8,commitment complex,CC,
118,GO:0000244,1,0.916934598105635,0,12,spliceosomal tri-snRNP complex assembly,BP,
120,GO:0000246,1,0.993706495031802,0,1,delta24(24-1) sterol reductase activity,MF,
123,GO:0000250,1,0.993688755915506,0,1,lanosterol synthase activity,MF,
124,GO:0000252,1,0.992170027168696,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
125,GO:0000253,1,0.976692112990833,0,3,3-keto sterol reductase activity,MF,
126,GO:0000254,1,0.992294630214608,0,1,C-4 methylsterol oxidase activity,MF,
128,GO:0000256,1,0.992170027168696,0,1,allantoin catabolic process,BP,
129,GO:0000257,1,0.992170027168696,0,1,nitrilase activity,MF,
130,GO:0000262,1,0.992170027168696,0,1,mitochondrial chromosome,CC,
131,GO:0000266,1,0.793661294710084,0,33,mitochondrial fission,BP,
132,GO:0000268,1,0.963908396594737,0,5,peroxisome targeting sequence binding,MF,
133,GO:0000270,1,0.946454214881746,0,7,peptidoglycan metabolic process,BP,
134,GO:0000271,1,0.622522664662107,0,67,polysaccharide biosynthetic process,BP,
135,GO:0000272,1,0.81580679065438,0,29,polysaccharide catabolic process,BP,
136,GO:0000274,1,0.992170027168696,0,1,mitochondrial proton-transporting ATP synthase, stator stalk,CC,
137,GO:0000275,1,0.969044407180955,0,4,mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),CC,
138,GO:0000276,1,0.924566118951398,0,10,mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),CC,
140,GO:0000280,1,0.0167781113220176,0,560,nuclear division,BP,
141,GO:0000281,1,0.779698842381721,0,36,mitotic cytokinesis,BP,
144,GO:0000288,1,0.596455873157327,0,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
145,GO:0000289,1,0.787104949567506,0,34,nuclear-transcribed mRNA poly(A) tail shortening,BP,
146,GO:0000290,1,0.938234356791112,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
147,GO:0000291,1,0.774595917926927,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
148,GO:0000293,1,0.978753594381322,0,3,ferric-chelate reductase activity,MF,
149,GO:0000294,1,0.986394819349299,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
150,GO:0000295,1,0.921284293152205,0,11,adenine nucleotide transmembrane transporter activity,MF,
151,GO:0000296,1,0.992213177645671,0,1,spermine transport,BP,
152,GO:0000298,1,0.97080956241711,0,4,endopolyphosphatase activity,MF,
153,GO:0000301,1,0.855482923481987,0,24,retrograde transport, vesicle recycling within Golgi,BP,
157,GO:0000306,1,0.98016899169749,0,3,extrinsic component of vacuolar membrane,CC,
158,GO:0000307,1,0.74936142294557,0,39,cyclin-dependent protein kinase holoenzyme complex,CC,
159,GO:0000308,1,0.987450041803082,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
160,GO:0000309,1,0.979618889955843,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
162,GO:0000314,1,0.815177331637133,0,26,organellar small ribosomal subunit,CC,
164,GO:0000320,1,0.981517279781622,0,3,re-entry into mitotic cell cycle,BP,
165,GO:0000322,1,0.978496842807757,0,3,storage vacuole,CC,
167,GO:0000333,1,0.987543787591318,0,2,telomerase catalytic core complex,CC,
168,GO:0000334,1,0.992170027168696,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
169,GO:0000338,1,0.925784328894548,0,10,protein deneddylation,BP,
170,GO:0000339,1,0.899315991231318,0,15,RNA cap binding,MF,
171,GO:0000340,1,0.952902908606768,0,7,RNA 7-methylguanosine cap binding,MF,
172,GO:0000346,1,0.907828835526478,0,13,transcription export complex,CC,
173,GO:0000347,1,0.955811799511897,0,6,THO complex,CC,
174,GO:0000349,1,0.992226560394727,0,1,generation of catalytic spliceosome for first transesterification step,BP,
175,GO:0000350,1,0.976710422876016,0,3,generation of catalytic spliceosome for second transesterification step,BP,
176,GO:0000354,1,0.986857175927153,0,2,cis assembly of pre-catalytic spliceosome,BP,
179,GO:0000379,1,0.976751722406271,0,3,tRNA-type intron splice site recognition and cleavage,BP,
180,GO:0000380,1,0.707005236687783,0,48,alternative mRNA splicing, via spliceosome,BP,
181,GO:0000381,1,0.766087482386568,0,37,regulation of alternative mRNA splicing, via spliceosome,BP,
182,GO:0000384,1,0.984401113340526,0,2,first spliceosomal transesterification activity,MF,
183,GO:0000386,1,0.985344022390266,0,2,second spliceosomal transesterification activity,MF,
184,GO:0000387,1,0.751730808438797,0,38,spliceosomal snRNP assembly,BP,
185,GO:0000389,1,0.957197826750063,0,6,mRNA 3'-splice site recognition,BP,
186,GO:0000390,1,0.984719683676258,0,2,spliceosomal complex disassembly,BP,
187,GO:0000393,1,0.96911663158819,0,4,spliceosomal conformational changes to generate catalytic conformation,BP,
188,GO:0000394,1,0.878239577081109,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
189,GO:0000395,1,0.955309239176366,0,6,mRNA 5'-splice site recognition,BP,
191,GO:0000400,1,0.889446643691583,0,16,four-way junction DNA binding,MF,
192,GO:0000403,1,0.974447208401248,0,4,Y-form DNA binding,MF,
193,GO:0000404,1,0.993168294074626,0,1,heteroduplex DNA loop binding,MF,
194,GO:0000405,1,0.954082298061552,0,7,bubble DNA binding,MF,
196,GO:0000408,1,0.977477641307612,0,3,EKC/KEOPS complex,CC,
197,GO:0000409,1,0.993986332270126,0,1,regulation of transcription by galactose,BP,
198,GO:0000411,1,0.993986332270126,0,1,positive regulation of transcription by galactose,BP,
199,GO:0000413,1,0.748807344532464,0,38,protein peptidyl-prolyl isomerization,BP,
200,GO:0000414,1,0.974080351346218,0,4,regulation of histone H3-K36 methylation,BP,
201,GO:0000415,1,0.993986332267416,0,1,negative regulation of histone H3-K36 methylation,BP,
202,GO:0000416,1,0.993274437753837,0,1,positive regulation of histone H3-K36 methylation,BP,
203,GO:0000421,1,0.815876124270034,0,28,autophagosome membrane,CC,
204,GO:0000422,1,0.57790136136855,0,77,mitophagy,BP,
205,GO:0000423,1,0.88781725205607,0,17,macromitophagy,BP,
206,GO:0000428,1,0.402364530294325,0,125,DNA-directed RNA polymerase complex,CC,
207,GO:0000429,1,0.970889649774135,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000430,1,0.976764664179358,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
209,GO:0000431,1,0.993986332270126,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
210,GO:0000432,1,0.976764664179358,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
211,GO:0000433,1,0.992243323265942,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
212,GO:0000435,1,0.993986332270126,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
213,GO:0000436,1,0.970889649774135,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
214,GO:0000437,1,0.992243323265942,0,1,carbon catabolite repression of transcription from RNA polymerase II promoter,BP,
215,GO:0000438,1,0.976696922088917,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
216,GO:0000439,1,0.941773928900243,0,8,core TFIIH complex,CC,
217,GO:0000444,1,0.970951249315716,0,4,MIS12/MIND type complex,CC,
218,GO:0000445,1,0.955811799511897,0,6,THO complex part of transcription export complex,CC,
219,GO:0000447,1,0.934230791239469,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
220,GO:0000448,1,0.986267910998443,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
221,GO:0000451,1,0.986181614216409,0,2,rRNA 2'-O-methylation,BP,
222,GO:0000453,1,0.986181614216409,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
223,GO:0000454,1,0.976692388820631,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
224,GO:0000459,1,0.963206359767001,0,5,exonucleolytic trimming involved in rRNA processing,BP,
225,GO:0000460,1,0.806252455833253,0,29,maturation of 5.8S rRNA,BP,
226,GO:0000461,1,0.984400887813367,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000462,1,0.762827818252654,0,36,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000463,1,0.933631023006716,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000466,1,0.873688472468087,0,18,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
230,GO:0000467,1,0.963206359767001,0,5,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000469,1,0.84394656498614,0,23,cleavage involved in rRNA processing,BP,
232,GO:0000470,1,0.855060570280127,0,21,maturation of LSU-rRNA,BP,
233,GO:0000472,1,0.978857235914533,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000478,1,0.904118623658187,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
235,GO:0000479,1,0.904118623658187,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
236,GO:0000480,1,0.957157211749987,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
237,GO:0000481,1,0.993165322589107,0,1,maturation of 5S rRNA,BP,
238,GO:0000491,1,0.956788068648288,0,6,small nucleolar ribonucleoprotein complex assembly,BP,
239,GO:0000492,1,0.971671024530143,0,4,box C/D snoRNP assembly,BP,
240,GO:0000493,1,0.984686544691712,0,2,box H/ACA snoRNP assembly,BP,
241,GO:0000494,1,0.992170027168696,0,1,box C/D snoRNA 3'-end processing,BP,
242,GO:0000495,1,0.992302413607848,0,1,box H/ACA snoRNA 3'-end processing,BP,
244,GO:0000506,1,0.940078539391005,0,8,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
245,GO:0000578,1,0.778856464105125,0,35,embryonic axis specification,BP,
246,GO:0000700,1,0.969748556122893,0,4,mismatch base pair DNA N-glycosylase activity,MF,
247,GO:0000701,1,0.984402030418408,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
248,GO:0000702,1,0.976695048008096,0,3,oxidized base lesion DNA N-glycosylase activity,MF,
249,GO:0000703,1,0.984400887813367,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
250,GO:0000706,1,0.97102489139767,0,4,meiotic DNA double-strand break processing,BP,
251,GO:0000707,1,0.954863072534094,0,6,meiotic DNA recombinase assembly,BP,
252,GO:0000710,1,0.986633329343831,0,2,meiotic mismatch repair,BP,
253,GO:0000711,1,0.985289219488978,0,2,meiotic DNA repair synthesis,BP,
254,GO:0000712,1,0.919146980231969,0,12,resolution of meiotic recombination intermediates,BP,
255,GO:0000715,1,0.843111004386499,0,23,nucleotide-excision repair, DNA damage recognition,BP,
256,GO:0000717,1,0.851323532118836,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
257,GO:0000718,1,0.992170094332629,0,1,nucleotide-excision repair, DNA damage removal,BP,
258,GO:0000720,1,0.978569299841915,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
260,GO:0000723,1,0.342718641248611,0,147,telomere maintenance,BP,
261,GO:0000724,1,0.494476135125611,0,97,double-strand break repair via homologous recombination,BP,
262,GO:0000725,1,0.490645077494047,0,98,recombinational repair,BP,
263,GO:0000726,1,0.581061411348047,0,74,non-recombinational repair,BP,
264,GO:0000727,1,0.963289424789749,0,5,double-strand break repair via break-induced replication,BP,
265,GO:0000729,1,0.849132559808013,0,23,DNA double-strand break processing,BP,
266,GO:0000730,1,0.925647839634912,0,10,DNA recombinase assembly,BP,
267,GO:0000731,1,0.618386191504968,0,68,DNA synthesis involved in DNA repair,BP,
268,GO:0000732,1,0.841164279572948,0,25,strand displacement,BP,
269,GO:0000733,1,0.938676020005247,0,9,DNA strand renaturation,BP,
270,GO:0000737,1,0.843012822369394,0,23,DNA catabolic process, endonucleolytic,BP,
271,GO:0000738,1,0.985234209348682,0,2,DNA catabolic process, exonucleolytic,BP,
272,GO:0000741,1,0.992170165072275,0,1,karyogamy,BP,
273,GO:0000768,1,0.714722163116739,0,47,syncytium formation by plasma membrane fusion,BP,
274,GO:0000773,1,0.992170027168696,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
275,GO:0000774,1,0.929637367098994,0,10,adenyl-nucleotide exchange factor activity,MF,
276,GO:0000775,1,0.282265188587648,0,176,chromosome, centromeric region,CC,
277,GO:0000776,1,0.415535558130087,0,121,kinetochore,CC,
278,GO:0000777,1,0.50139762538624,0,94,condensed chromosome kinetochore,CC,
279,GO:0000778,1,0.94118374138575,0,8,condensed nuclear chromosome kinetochore,CC,
280,GO:0000779,1,0.466764478033689,0,104,condensed chromosome, centromeric region,CC,
281,GO:0000780,1,0.901227013745714,0,14,condensed nuclear chromosome, centromeric region,CC,
282,GO:0000781,1,0.307938030159047,0,161,chromosome, telomeric region,CC,
283,GO:0000782,1,0.921367632941473,0,11,telomere cap complex,CC,
284,GO:0000783,1,0.921367632941473,0,11,nuclear telomere cap complex,CC,
285,GO:0000784,1,0.395719636181318,0,126,nuclear chromosome, telomeric region,CC,
286,GO:0000785,1,0.0347128953915187,0,459,chromatin,CC,
287,GO:0000786,1,0.455688692995048,0,101,nucleosome,CC,
288,GO:0000788,1,0.750097238996191,0,37,nuclear nucleosome,CC,
289,GO:0000789,1,0.992170027168696,0,1,cytoplasmic chromatin,CC,
290,GO:0000790,1,0.111137133969509,0,300,nuclear chromatin,CC,
291,GO:0000791,1,0.789069255255354,0,32,euchromatin,CC,
292,GO:0000792,1,0.604317001693353,0,71,heterochromatin,CC,
293,GO:0000793,1,0.247401426650219,0,192,condensed chromosome,CC,
294,GO:0000794,1,0.569344748464892,0,78,condensed nuclear chromosome,CC,
295,GO:0000795,1,0.791793843439245,0,32,synaptonemal complex,CC,
296,GO:0000796,1,0.957790416924794,0,7,condensin complex,CC,
297,GO:0000797,1,0.993911882354258,0,1,condensin core heterodimer,CC,
298,GO:0000798,1,0.965477099608263,0,5,nuclear cohesin complex,CC,
299,GO:0000799,1,0.9818185653285,0,3,nuclear condensin complex,CC,
300,GO:0000800,1,0.920707436863778,0,12,lateral element,CC,
301,GO:0000801,1,0.942073490112031,0,8,central element,CC,
302,GO:0000802,1,0.993065314982726,0,1,transverse filament,CC,
303,GO:0000803,1,0.828750407644845,0,26,sex chromosome,CC,
304,GO:0000805,1,0.95014262680001,0,7,X chromosome,CC,
305,GO:0000806,1,0.986213618352203,0,2,Y chromosome,CC,
306,GO:0000808,1,0.933613862262451,0,9,origin recognition complex,CC,
307,GO:0000811,1,0.978545587933531,0,3,GINS complex,CC,
308,GO:0000812,1,0.93638063570342,0,9,Swr1 complex,CC,
309,GO:0000813,1,0.926891506360657,0,10,ESCRT I complex,CC,
310,GO:0000814,1,0.978274053990939,0,3,ESCRT II complex,CC,
311,GO:0000815,1,0.918625448787221,0,11,ESCRT III complex,CC,
312,GO:0000819,1,0.225848893974284,0,206,sister chromatid segregation,BP,
313,GO:0000820,1,0.965000615946641,0,5,regulation of glutamine family amino acid metabolic process,BP,
314,GO:0000821,1,0.98624186859652,0,2,regulation of arginine metabolic process,BP,
315,GO:0000822,1,0.980526000532053,0,3,inositol hexakisphosphate binding,MF,
316,GO:0000823,1,0.992170493586488,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
317,GO:0000824,1,0.992170493586488,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
318,GO:0000825,1,0.992170493586488,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
319,GO:0000827,1,0.966684465637245,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
320,GO:0000828,1,0.966684465637245,0,5,inositol hexakisphosphate kinase activity,MF,
321,GO:0000829,1,0.966684465637245,0,5,inositol heptakisphosphate kinase activity,MF,
322,GO:0000831,1,0.992396608288384,0,1,inositol hexakisphosphate 6-kinase activity,MF,
323,GO:0000832,1,0.966684465637245,0,5,inositol hexakisphosphate 5-kinase activity,MF,
324,GO:0000835,1,0.95970415850828,0,6,ER ubiquitin ligase complex,CC,
325,GO:0000836,1,0.965638714751917,0,5,Hrd1p ubiquitin ligase complex,CC,
326,GO:0000839,1,0.978926807043967,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
327,GO:0000900,1,0.91531331741065,0,13,translation repressor activity, nucleic acid binding,MF,
330,GO:0000910,1,0.379566734351265,0,137,cytokinesis,BP,
331,GO:0000912,1,0.98002181846238,0,3,assembly of actomyosin apparatus involved in cytokinesis,BP,
332,GO:0000915,1,0.98002181846238,0,3,actomyosin contractile ring assembly,BP,
333,GO:0000917,1,0.992171281480172,0,1,barrier septum assembly,BP,
334,GO:0000920,1,0.879433770253675,0,17,cell separation after cytokinesis,BP,
335,GO:0000921,1,0.993900882826304,0,1,septin ring assembly,BP,
337,GO:0000923,1,0.959045145619241,0,6,equatorial microtubule organizing center,CC,
338,GO:0000930,1,0.876620403512563,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.951728990251178,0,7,gamma-tubulin large complex,CC,
341,GO:0000938,1,0.972615900957947,0,4,GARP complex,CC,
342,GO:0000939,1,0.984524522725182,0,2,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.91761763672073,0,12,condensed chromosome outer kinetochore,CC,
344,GO:0000942,1,0.969983818759095,0,4,condensed nuclear chromosome outer kinetochore,CC,
345,GO:0000956,1,0.228798448447042,0,198,nuclear-transcribed mRNA catabolic process,BP,
346,GO:0000957,1,0.972673553630373,0,4,mitochondrial RNA catabolic process,BP,
347,GO:0000958,1,0.986158820954326,0,2,mitochondrial mRNA catabolic process,BP,
349,GO:0000960,1,0.972673553630373,0,4,regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000961,1,0.986326940275833,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000962,1,0.986158820954326,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000964,1,0.98618742358398,0,2,mitochondrial RNA 5'-end processing,BP,
354,GO:0000965,1,0.978476198806136,0,3,mitochondrial RNA 3'-end processing,BP,
355,GO:0000966,1,0.958936676966876,0,6,RNA 5'-end processing,BP,
356,GO:0000967,1,0.978857235914533,0,3,rRNA 5'-end processing,BP,
357,GO:0000972,1,0.959112317377987,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
358,GO:0000973,1,0.978990241607278,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000974,1,0.919797395757362,0,11,Prp19 complex,CC,
363,GO:0000978,1,0.0926044653624968,0,330,RNA polymerase II core promoter proximal region sequence-specific DNA binding,MF,
364,GO:0000979,1,0.658548053617893,0,59,RNA polymerase II core promoter sequence-specific DNA binding,MF,
365,GO:0000980,1,0.626742901864668,0,65,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
368,GO:0000983,1,0.859466324845289,0,22,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,
369,GO:0000987,1,0.0852392601098733,0,342,core promoter proximal region sequence-specific DNA binding,MF,
372,GO:0000990,1,0.946715969095184,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.986203080772739,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.986282453645538,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.847059385296872,0,23,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.992170351964843,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.973932844106378,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0000997,1,0.993357540605559,0,1,mitochondrial RNA polymerase core promoter sequence-specific DNA binding,MF,
379,GO:0000999,1,0.992249876522219,0,1,RNA polymerase III type 1 promoter transcriptional preinitiation complex assembly,BP,
380,GO:0001002,1,0.986282453645538,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
381,GO:0001003,1,0.986282453645538,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
382,GO:0001004,1,0.992249876522219,0,1,transcription factor activity, RNA polymerase III promoter sequence-specific binding, TFIIIB recruiting,MF,
383,GO:0001005,1,0.992249876522219,0,1,transcription factor activity, RNA polymerase III type 1 promoter sequence-specific binding, TFIIIB recruiting,MF,
384,GO:0001007,1,0.966039523636546,0,5,transcription factor activity, RNA polymerase III transcription factor binding,MF,
385,GO:0001009,1,0.992249876522219,0,1,transcription from RNA polymerase III type 2 promoter,BP,
386,GO:0001010,1,0.977124024868623,0,3,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
387,GO:0001011,1,0.993986332277106,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
389,GO:0001013,1,0.946310437709104,0,8,RNA polymerase I regulatory region DNA binding,MF,
390,GO:0001016,1,0.951742870807373,0,7,RNA polymerase III regulatory region DNA binding,MF,
391,GO:0001018,1,0.993357540605559,0,1,mitochondrial RNA polymerase regulatory region DNA binding,MF,
392,GO:0001022,1,0.992249876522219,0,1,transcription initiation from RNA polymerase III type 1 promoter,BP,
393,GO:0001025,1,0.970280619081182,0,5,RNA polymerase III transcription factor binding,MF,
394,GO:0001026,1,0.987202765557182,0,2,TFIIIB-type transcription factor activity,MF,
395,GO:0001030,1,0.966823054002486,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
396,GO:0001031,1,0.966823054002486,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
397,GO:0001032,1,0.972600827033343,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
398,GO:0001034,1,0.984480691047365,0,2,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
399,GO:0001042,1,0.96897126339658,0,5,RNA polymerase I core binding,MF,
400,GO:0001044,1,0.993357540605559,0,1,mitochondrial RNA polymerase regulatory region sequence-specific DNA binding,MF,
401,GO:0001046,1,0.465611670778621,0,109,core promoter sequence-specific DNA binding,MF,
402,GO:0001047,1,0.321006509319608,0,161,core promoter binding,MF,
403,GO:0001054,1,0.936567525769959,0,9,RNA polymerase I activity,MF,
404,GO:0001055,1,0.927436616166194,0,10,RNA polymerase II activity,MF,
405,GO:0001056,1,0.9007996380477,0,14,RNA polymerase III activity,MF,
407,GO:0001069,1,0.993972926410556,0,1,regulatory region RNA binding,MF,
408,GO:0001070,1,0.992290150211835,0,1,RNA binding transcription factor activity,MF,
410,GO:0001075,1,0.941893012333895,0,9,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
411,GO:0001076,1,0.357712129993369,0,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,
413,GO:0001078,1,0.433022799090465,0,117,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
414,GO:0001079,1,0.992190392480105,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
415,GO:0001080,1,0.992190392480105,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
416,GO:0001082,1,0.992216726639161,0,1,transcription factor activity, RNA polymerase I transcription factor binding,MF,
417,GO:0001083,1,0.968480035638938,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
419,GO:0001087,1,0.993986332277106,0,1,transcription factor activity, TFIIB-class binding,MF,
420,GO:0001091,1,0.927209006250014,0,11,RNA polymerase II basal transcription factor binding,MF,
421,GO:0001093,1,0.980272312576655,0,3,TFIIB-class transcription factor binding,MF,
422,GO:0001094,1,0.95233125879577,0,7,TFIID-class transcription factor binding,MF,
423,GO:0001096,1,0.99322526300032,0,1,TFIIF-class transcription factor binding,MF,
424,GO:0001098,1,0.779163391113876,0,35,basal transcription machinery binding,MF,
425,GO:0001099,1,0.779163391113876,0,35,basal RNA polymerase II transcription machinery binding,MF,
426,GO:0001100,1,0.992294630214608,0,1,negative regulation of exit from mitosis,BP,
429,GO:0001103,1,0.818100077543901,0,28,RNA polymerase II repressing transcription factor binding,MF,
430,GO:0001104,1,0.518439207487858,0,93,RNA polymerase II transcription cofactor activity,MF,
431,GO:0001105,1,0.774281169438329,0,37,RNA polymerase II transcription coactivator activity,MF,
432,GO:0001106,1,0.824455313436536,0,27,RNA polymerase II transcription corepressor activity,MF,
433,GO:0001128,1,0.992170027168696,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
434,GO:0001129,1,0.974340584058102,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
435,GO:0001132,1,0.974340584058102,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
436,GO:0001133,1,0.992182213557173,0,1,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
437,GO:0001134,1,0.905059003579781,0,14,transcription factor activity, transcription factor recruiting,MF,
438,GO:0001135,1,0.946574641005407,0,8,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
439,GO:0001147,1,0.987037916087758,0,2,transcription termination site sequence-specific DNA binding,MF,
440,GO:0001153,1,0.992249876522219,0,1,transcription factor activity, RNA polymerase III transcription factor recruiting,MF,
441,GO:0001156,1,0.982066433201215,0,3,TFIIIC-class transcription factor binding,MF,
442,GO:0001158,1,0.55080049732762,0,83,enhancer sequence-specific DNA binding,MF,
443,GO:0001159,1,0.083392344961735,0,345,core promoter proximal region DNA binding,MF,
444,GO:0001160,1,0.987037916087758,0,2,transcription termination site DNA binding,MF,
445,GO:0001161,1,0.922175889955201,0,11,intronic transcription regulatory region sequence-specific DNA binding,MF,
446,GO:0001162,1,0.941578439788834,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
447,GO:0001163,1,0.946310437709104,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
448,GO:0001164,1,0.946310437709104,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
449,GO:0001165,1,0.99384008787091,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
450,GO:0001167,1,0.992216726639161,0,1,RNA polymerase I transcription factor activity, sequence-specific DNA binding,MF,
451,GO:0001169,1,0.992216726639161,0,1,transcription factor activity, RNA polymerase I CORE element sequence-specific binding,MF,
452,GO:0001172,1,0.987543787593542,0,2,transcription, RNA-templated,BP,
453,GO:0001179,1,0.992171526522124,0,1,RNA polymerase I transcription factor binding,MF,
454,GO:0001180,1,0.977854929594196,0,3,transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript,BP,
455,GO:0001181,1,0.993302873139241,0,1,transcription factor activity, core RNA polymerase I binding,MF,
456,GO:0001186,1,0.992216726639161,0,1,transcription factor activity, RNA polymerase I transcription factor recruiting,MF,
457,GO:0001187,1,0.992216726639161,0,1,transcription factor activity, RNA polymerase I CORE element binding transcription factor recruiting,MF,
458,GO:0001188,1,0.98444871221397,0,2,RNA polymerase I transcriptional preinitiation complex assembly,BP,
459,GO:0001189,1,0.98444871221397,0,2,RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript,BP,
460,GO:0001190,1,0.679938347565558,0,55,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
461,GO:0001191,1,0.539837014950391,0,87,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
462,GO:0001205,1,0.829901874902109,0,26,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
463,GO:0001206,1,0.933136479516276,0,10,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
464,GO:0001207,1,0.992807034257299,0,1,histone displacement,BP,
465,GO:0001221,1,0.786955968162657,0,34,transcription cofactor binding,MF,
466,GO:0001222,1,0.928457990346993,0,10,transcription corepressor binding,MF,
467,GO:0001223,1,0.878376507664401,0,19,transcription coactivator binding,MF,
468,GO:0001224,1,0.980663873376017,0,3,RNA polymerase II transcription cofactor binding,MF,
469,GO:0001225,1,0.987736908695272,0,2,RNA polymerase II transcription coactivator binding,MF,
470,GO:0001226,1,0.992839838812566,0,1,RNA polymerase II transcription corepressor binding,MF,
471,GO:0001227,1,0.276180642583509,0,179,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
473,GO:0001300,1,0.985462498828726,0,2,chronological cell aging,BP,
474,GO:0001302,1,0.959023981339331,0,6,replicative cell aging,BP,
475,GO:0001306,1,0.986203080779088,0,2,age-dependent response to oxidative stress,BP,
476,GO:0001315,1,0.992170027168696,0,1,age-dependent response to reactive oxygen species,BP,
477,GO:0001325,1,0.899809637106237,0,15,formation of extrachromosomal circular DNA,BP,
478,GO:0001401,1,0.992170260671717,0,1,mitochondrial sorting and assembly machinery complex,CC,
479,GO:0001405,1,0.978213097051771,0,3,presequence translocase-associated import motor,CC,
481,GO:0001502,1,0.859819491617844,0,21,cartilage condensation,BP,
485,GO:0001507,1,0.984945513548643,0,2,acetylcholine catabolic process in synaptic cleft,BP,
486,GO:0001508,1,0.406238395586353,0,131,action potential,BP,
488,GO:0001512,1,0.992170027168696,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
489,GO:0001514,1,0.937653308536738,0,9,selenocysteine incorporation,BP,
490,GO:0001515,1,0.969168498094799,0,4,opioid peptide activity,MF,
491,GO:0001516,1,0.843244703373909,0,23,prostaglandin biosynthetic process,BP,
492,GO:0001517,1,0.951194831334911,0,7,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
493,GO:0001518,1,0.917074828107016,0,14,voltage-gated sodium channel complex,CC,
494,GO:0001519,1,0.985500994267916,0,2,peptide amidation,BP,
495,GO:0001520,1,0.941155962606123,0,8,outer dense fiber,CC,
499,GO:0001527,1,0.933165828525456,0,10,microfibril,CC,
500,GO:0001530,1,0.855472443013023,0,21,lipopolysaccharide binding,MF,
501,GO:0001532,1,0.99281727908318,0,1,interleukin-21 receptor activity,MF,
503,GO:0001534,1,0.97817233408368,0,3,radial spoke,CC,
504,GO:0001536,1,0.98565988071182,0,2,radial spoke stalk,CC,
505,GO:0001537,1,0.963303727179341,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
506,GO:0001539,1,0.841419107250163,0,24,cilium or flagellum-dependent cell motility,BP,
507,GO:0001540,1,0.787770124974414,0,33,beta-amyloid binding,MF,
509,GO:0001542,1,0.946712450348408,0,8,ovulation from ovarian follicle,BP,
510,GO:0001543,1,0.99398633227334,0,1,ovarian follicle rupture,BP,
511,GO:0001544,1,0.993986332272208,0,1,initiation of primordial ovarian follicle growth,BP,
512,GO:0001545,1,0.985091352671637,0,2,primary ovarian follicle growth,BP,
513,GO:0001546,1,0.976749093796925,0,3,preantral ovarian follicle growth,BP,
514,GO:0001547,1,0.960849294620352,0,6,antral ovarian follicle growth,BP,
515,GO:0001550,1,0.98787634103891,0,2,ovarian cumulus expansion,BP,
516,GO:0001553,1,0.933639392080576,0,10,luteinization,BP,
517,GO:0001554,1,0.968644652541627,0,5,luteolysis,BP,
518,GO:0001555,1,0.984738221591838,0,2,oocyte growth,BP,
520,GO:0001558,1,0.0671474955848322,0,373,regulation of cell growth,BP,
521,GO:0001560,1,0.981638856530861,0,3,regulation of cell growth by extracellular stimulus,BP,
523,GO:0001562,1,0.855442678697662,0,21,response to protozoan,BP,
524,GO:0001567,1,0.984402440885708,0,2,cholesterol 25-hydroxylase activity,MF,
526,GO:0001569,1,0.80823053337179,0,30,branching involved in blood vessel morphogenesis,BP,
527,GO:0001570,1,0.609875299917487,0,71,vasculogenesis,BP,
529,GO:0001574,1,0.951777026171878,0,7,ganglioside biosynthetic process,BP,
530,GO:0001575,1,0.98441724191886,0,2,globoside metabolic process,BP,
531,GO:0001576,1,0.992183857473324,0,1,globoside biosynthetic process,BP,
532,GO:0001578,1,0.627610730943291,0,65,microtubule bundle formation,BP,
533,GO:0001579,1,0.985691244436102,0,2,medium-chain fatty acid transport,BP,
534,GO:0001580,1,0.77311579483528,0,33,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
535,GO:0001581,1,0.986639726171053,0,2,detection of chemical stimulus involved in sensory perception of sour taste,BP,
536,GO:0001582,1,0.984632860979278,0,2,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
537,GO:0001587,1,0.993891823945108,0,1,Gq/11-coupled serotonin receptor activity,MF,
538,GO:0001588,1,0.969834646336898,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
539,GO:0001591,1,0.939197583279385,0,8,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
540,GO:0001594,1,0.946451405121615,0,7,trace-amine receptor activity,MF,
541,GO:0001595,1,0.969404623345106,0,4,angiotensin receptor activity,MF,
542,GO:0001596,1,0.992220917592298,0,1,angiotensin type I receptor activity,MF,
543,GO:0001601,1,0.977900410246522,0,3,peptide YY receptor activity,MF,
544,GO:0001602,1,0.969263846698476,0,4,pancreatic polypeptide receptor activity,MF,
545,GO:0001604,1,0.992170027168696,0,1,urotensin II receptor activity,MF,
546,GO:0001605,1,0.993944487169586,0,1,adrenomedullin receptor activity,MF,
547,GO:0001607,1,0.985058410128107,0,2,neuromedin U receptor activity,MF,
549,GO:0001609,1,0.947333696438753,0,7,G-protein coupled adenosine receptor activity,MF,
551,GO:0001616,1,0.992170027168696,0,1,growth hormone secretagogue receptor activity,MF,
552,GO:0001618,1,0.636405734330016,0,64,virus receptor activity,MF,
553,GO:0001621,1,0.992170027168696,0,1,ADP receptor activity,MF,
554,GO:0001626,1,0.992828048936454,0,1,nociceptin receptor activity,MF,
555,GO:0001631,1,0.992288149862422,0,1,cysteinyl leukotriene receptor activity,MF,
556,GO:0001632,1,0.985280227031404,0,2,leukotriene B4 receptor activity,MF,
557,GO:0001635,1,0.986352099127909,0,2,calcitonin gene-related peptide receptor activity,MF,
558,GO:0001637,1,0.83882837532952,0,23,G-protein coupled chemoattractant receptor activity,MF,
559,GO:0001640,1,0.968058192071487,0,5,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
560,GO:0001641,1,0.986068730413632,0,2,group II metabotropic glutamate receptor activity,MF,
561,GO:0001642,1,0.993652924080928,0,1,group III metabotropic glutamate receptor activity,MF,
562,GO:0001649,1,0.238511093100824,0,201,osteoblast differentiation,BP,
564,GO:0001651,1,0.992170027168696,0,1,dense fibrillar component,CC,
565,GO:0001652,1,0.96915139321855,0,4,granular component,CC,
566,GO:0001653,1,0.392227772916624,0,124,peptide receptor activity,MF,
570,GO:0001657,1,0.502686058925748,0,97,ureteric bud development,BP,
571,GO:0001658,1,0.65776338402061,0,59,branching involved in ureteric bud morphogenesis,BP,
573,GO:0001660,1,0.931243252154829,0,10,fever generation,BP,
574,GO:0001661,1,0.959870040413858,0,6,conditioned taste aversion,BP,
575,GO:0001662,1,0.808872173228335,0,30,behavioral fear response,BP,
577,GO:0001665,1,0.954154942541442,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
581,GO:0001671,1,0.84152844325142,0,23,ATPase activator activity,MF,
582,GO:0001672,1,0.943170274940304,0,9,regulation of chromatin assembly or disassembly,BP,
583,GO:0001673,1,0.901370570099187,0,14,male germ cell nucleus,CC,
584,GO:0001674,1,0.978297455842708,0,3,female germ cell nucleus,CC,
585,GO:0001675,1,0.919271118574673,0,12,acrosome assembly,BP,
588,GO:0001680,1,0.992210393719652,0,1,tRNA 3'-terminal CCA addition,BP,
589,GO:0001681,1,0.99245128710747,0,1,sialate O-acetylesterase activity,MF,
590,GO:0001682,1,0.91963789180043,0,11,tRNA 5'-leader removal,BP,
591,GO:0001692,1,0.969121381775805,0,4,histamine metabolic process,BP,
592,GO:0001694,1,0.984473041599448,0,2,histamine biosynthetic process,BP,
593,GO:0001695,1,0.992170027168696,0,1,histamine catabolic process,BP,
594,GO:0001696,1,0.883235654810971,0,17,gastric acid secretion,BP,
595,GO:0001697,1,0.992435755294651,0,1,histamine-induced gastric acid secretion,BP,
596,GO:0001698,1,0.984664551300273,0,2,gastrin-induced gastric acid secretion,BP,
597,GO:0001701,1,0.112827049452452,0,307,in utero embryonic development,BP,
598,GO:0001702,1,0.822757862105521,0,28,gastrulation with mouth forming second,BP,
599,GO:0001704,1,0.435226215391867,0,118,formation of primary germ layer,BP,
600,GO:0001705,1,0.97136407881712,0,4,ectoderm formation,BP,
601,GO:0001706,1,0.681929954159621,0,54,endoderm formation,BP,
602,GO:0001707,1,0.615877557125633,0,68,mesoderm formation,BP,
603,GO:0001708,1,0.566602547870919,0,77,cell fate specification,BP,
604,GO:0001709,1,0.741864070843517,0,41,cell fate determination,BP,
605,GO:0001710,1,0.867318564127191,0,19,mesodermal cell fate commitment,BP,
606,GO:0001711,1,0.888590059996221,0,16,endodermal cell fate commitment,BP,
607,GO:0001712,1,0.978989937283477,0,3,ectodermal cell fate commitment,BP,
608,GO:0001714,1,0.932409283935626,0,9,endodermal cell fate specification,BP,
609,GO:0001715,1,0.993385508500084,0,1,ectodermal cell fate specification,BP,
610,GO:0001716,1,0.992180906933962,0,1,L-amino-acid oxidase activity,MF,
611,GO:0001725,1,0.714245935138133,0,49,stress fiber,CC,
613,GO:0001727,1,0.965489459232569,0,5,lipid kinase activity,MF,
614,GO:0001729,1,0.986353383002395,0,2,ceramide kinase activity,MF,
615,GO:0001730,1,0.979392087300583,0,3,2'-5'-oligoadenylate synthetase activity,MF,
616,GO:0001731,1,0.944558993191231,0,8,formation of translation preinitiation complex,BP,
617,GO:0001732,1,0.986198476114568,0,2,formation of cytoplasmic translation initiation complex,BP,
618,GO:0001733,1,0.969837180345914,0,4,galactosylceramide sulfotransferase activity,MF,
619,GO:0001735,1,0.986317219365357,0,2,prenylcysteine oxidase activity,MF,
622,GO:0001739,1,0.956563528464703,0,6,sex chromatin,CC,
623,GO:0001740,1,0.963428662440264,0,5,Barr body,CC,
624,GO:0001741,1,0.910251904357187,0,13,XY body,CC,
625,GO:0001743,1,0.979704520725128,0,3,optic placode formation,BP,
626,GO:0001750,1,0.573354377974806,0,78,photoreceptor outer segment,CC,
628,GO:0001755,1,0.778061453847928,0,35,neural crest cell migration,BP,
629,GO:0001756,1,0.624363936760188,0,66,somitogenesis,BP,
630,GO:0001757,1,0.963958347175942,0,5,somite specification,BP,
631,GO:0001758,1,0.9480168492291,0,7,retinal dehydrogenase activity,MF,
632,GO:0001759,1,0.86791583883411,0,19,organ induction,BP,
633,GO:0001760,1,0.992170027168696,0,1,aminocarboxymuconate-semialdehyde decarboxylase activity,MF,
634,GO:0001763,1,0.25753016814896,0,193,morphogenesis of a branching structure,BP,
635,GO:0001764,1,0.40618194718543,0,130,neuron migration,BP,
636,GO:0001765,1,0.927314580075367,0,10,membrane raft assembly,BP,
637,GO:0001766,1,0.934837352877238,0,9,membrane raft polarization,BP,
638,GO:0001767,1,0.938739992076682,0,9,establishment of lymphocyte polarity,BP,
639,GO:0001768,1,0.944421964233147,0,8,establishment of T cell polarity,BP,
640,GO:0001770,1,0.993986332271049,0,1,establishment of natural killer cell polarity,BP,
641,GO:0001771,1,0.911360252556496,0,13,immunological synapse formation,BP,
642,GO:0001772,1,0.789710316601725,0,33,immunological synapse,CC,
644,GO:0001774,1,0.878395483370437,0,18,microglial cell activation,BP,
647,GO:0001777,1,0.969630071942505,0,4,T cell homeostatic proliferation,BP,
648,GO:0001778,1,0.949251031307518,0,8,plasma membrane repair,BP,
649,GO:0001779,1,0.867154477441217,0,20,natural killer cell differentiation,BP,
650,GO:0001780,1,0.913193911553673,0,13,neutrophil homeostasis,BP,
651,GO:0001781,1,0.950619840928805,0,7,neutrophil apoptotic process,BP,
652,GO:0001782,1,0.820678642689062,0,28,B cell homeostasis,BP,
653,GO:0001783,1,0.846315699986123,0,23,B cell apoptotic process,BP,
654,GO:0001784,1,0.784989963094103,0,35,phosphotyrosine binding,MF,
655,GO:0001785,1,0.984873960569751,0,2,prostaglandin J receptor activity,MF,
656,GO:0001786,1,0.770374031196558,0,37,phosphatidylserine binding,MF,
657,GO:0001787,1,0.914637344237861,0,12,natural killer cell proliferation,BP,
658,GO:0001791,1,0.992170027168696,0,1,IgM binding,MF,
659,GO:0001792,1,0.993700382899207,0,1,polymeric immunoglobulin receptor activity,MF,
660,GO:0001794,1,0.986178773241734,0,2,type IIa hypersensitivity,BP,
661,GO:0001796,1,0.986178773241734,0,2,regulation of type IIa hypersensitivity,BP,
662,GO:0001798,1,0.986178773241734,0,2,positive regulation of type IIa hypersensitivity,BP,
663,GO:0001802,1,0.984553062886585,0,2,type III hypersensitivity,BP,
664,GO:0001803,1,0.984553062886585,0,2,regulation of type III hypersensitivity,BP,
665,GO:0001805,1,0.984553062886585,0,2,positive regulation of type III hypersensitivity,BP,
666,GO:0001806,1,0.971277934601665,0,4,type IV hypersensitivity,BP,
667,GO:0001807,1,0.978489988976192,0,3,regulation of type IV hypersensitivity,BP,
668,GO:0001808,1,0.986212842998497,0,2,negative regulation of type IV hypersensitivity,BP,
669,GO:0001809,1,0.992170027168696,0,1,positive regulation of type IV hypersensitivity,BP,
670,GO:0001810,1,0.976843105630151,0,3,regulation of type I hypersensitivity,BP,
671,GO:0001812,1,0.976843105630151,0,3,positive regulation of type I hypersensitivity,BP,
676,GO:0001820,1,0.921169789351583,0,11,serotonin secretion,BP,
677,GO:0001821,1,0.925749309080727,0,10,histamine secretion,BP,
679,GO:0001823,1,0.484122190319622,0,102,mesonephros development,BP,
680,GO:0001824,1,0.657193798375405,0,58,blastocyst development,BP,
681,GO:0001825,1,0.816781989455648,0,28,blastocyst formation,BP,
682,GO:0001826,1,0.94607744326045,0,8,inner cell mass cell differentiation,BP,
683,GO:0001827,1,0.980206775561259,0,3,inner cell mass cell fate commitment,BP,
684,GO:0001828,1,0.980233481279745,0,3,inner cell mass cellular morphogenesis,BP,
685,GO:0001829,1,0.902962060203355,0,14,trophectodermal cell differentiation,BP,
686,GO:0001831,1,0.986216360766105,0,2,trophectodermal cellular morphogenesis,BP,
687,GO:0001832,1,0.895900479378914,0,16,blastocyst growth,BP,
688,GO:0001833,1,0.932747242113825,0,10,inner cell mass cell proliferation,BP,
689,GO:0001834,1,0.993986332271892,0,1,trophectodermal cell proliferation,BP,
690,GO:0001835,1,0.992801682381572,0,1,blastocyst hatching,BP,
692,GO:0001837,1,0.416087133991236,0,123,epithelial to mesenchymal transition,BP,
693,GO:0001838,1,0.431102165758104,0,120,embryonic epithelial tube formation,BP,
694,GO:0001839,1,0.950760810801807,0,7,neural plate morphogenesis,BP,
695,GO:0001840,1,0.932753707506687,0,10,neural plate development,BP,
696,GO:0001841,1,0.499289694122296,0,100,neural tube formation,BP,
697,GO:0001842,1,0.958325321442315,0,6,neural fold formation,BP,
698,GO:0001843,1,0.555287362272908,0,85,neural tube closure,BP,
699,GO:0001844,1,0.795498036498189,0,31,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
700,GO:0001845,1,0.922673940593828,0,11,phagolysosome assembly,BP,
701,GO:0001846,1,0.91832989138208,0,12,opsonin binding,MF,
702,GO:0001847,1,0.970991996656959,0,4,opsonin receptor activity,MF,
704,GO:0001849,1,0.94421672746148,0,8,complement component C1q binding,MF,
705,GO:0001850,1,0.992170919634412,0,1,complement component C3a binding,MF,
706,GO:0001851,1,0.98620396792935,0,2,complement component C3b binding,MF,
707,GO:0001855,1,0.986203080789279,0,2,complement component C4b binding,MF,
708,GO:0001856,1,0.99222368955414,0,1,complement component C5a binding,MF,
709,GO:0001861,1,0.993986332281662,0,1,complement component C4b receptor activity,MF,
710,GO:0001865,1,0.946929236785699,0,8,NK T cell differentiation,BP,
711,GO:0001866,1,0.956025329298907,0,6,NK T cell proliferation,BP,
712,GO:0001867,1,0.928495699475962,0,10,complement activation, lectin pathway,BP,
713,GO:0001868,1,0.986092346425597,0,2,regulation of complement activation, lectin pathway,BP,
714,GO:0001869,1,0.986092346425597,0,2,negative regulation of complement activation, lectin pathway,BP,
715,GO:0001871,1,0.855983760665453,0,21,pattern binding,MF,
716,GO:0001872,1,0.992173766473286,0,1,(1->3)-beta-D-glucan binding,MF,
717,GO:0001875,1,0.965552473371561,0,5,lipopolysaccharide receptor activity,MF,
718,GO:0001878,1,0.954745402326631,0,6,response to yeast,BP,
719,GO:0001880,1,0.971808824367082,0,4,Mullerian duct regression,BP,
720,GO:0001881,1,0.79681694836567,0,32,receptor recycling,BP,
723,GO:0001884,1,0.986320365615544,0,2,pyrimidine nucleoside binding,MF,
724,GO:0001885,1,0.693773494706939,0,53,endothelial cell development,BP,
725,GO:0001886,1,0.934340070818766,0,10,endothelial cell morphogenesis,BP,
726,GO:0001887,1,0.971084662190717,0,4,selenium compound metabolic process,BP,
727,GO:0001888,1,0.986501120150686,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
730,GO:0001891,1,0.879364562256414,0,18,phagocytic cup,CC,
731,GO:0001892,1,0.532476509439247,0,88,embryonic placenta development,BP,
732,GO:0001893,1,0.801998109697081,0,31,maternal placenta development,BP,
734,GO:0001895,1,0.64852297200841,0,60,retina homeostasis,BP,
735,GO:0001897,1,0.984625601040578,0,2,cytolysis by symbiont of host cells,BP,
736,GO:0001905,1,0.981261721528096,0,3,activation of membrane attack complex,BP,
738,GO:0001907,1,0.970983965594784,0,4,killing by symbiont of host cells,BP,
741,GO:0001911,1,0.907402090898106,0,13,negative regulation of leukocyte mediated cytotoxicity,BP,
745,GO:0001915,1,0.964821005121004,0,5,negative regulation of T cell mediated cytotoxicity,BP,
747,GO:0001917,1,0.748914558337985,0,40,photoreceptor inner segment,CC,
748,GO:0001918,1,0.99241553049716,0,1,farnesylated protein binding,MF,
749,GO:0001919,1,0.855790962994438,0,22,regulation of receptor recycling,BP,
750,GO:0001920,1,0.971255394932267,0,4,negative regulation of receptor recycling,BP,
751,GO:0001921,1,0.913998498938547,0,13,positive regulation of receptor recycling,BP,
752,GO:0001922,1,0.981397260231489,0,3,B-1 B cell homeostasis,BP,
753,GO:0001923,1,0.979807038293799,0,3,B-1 B cell differentiation,BP,
754,GO:0001927,1,0.98008732498077,0,3,exocyst assembly,BP,
755,GO:0001928,1,0.992206993848105,0,1,regulation of exocyst assembly,BP,
756,GO:0001931,1,0.909984137724054,0,13,uropod,CC,
762,GO:0001937,1,0.803968212618218,0,31,negative regulation of endothelial cell proliferation,BP,
764,GO:0001939,1,0.944640943799151,0,8,female pronucleus,CC,
765,GO:0001940,1,0.965273264437627,0,5,male pronucleus,CC,
766,GO:0001941,1,0.811038058702301,0,30,postsynaptic membrane organization,BP,
769,GO:0001945,1,0.848629375868731,0,24,lymph vessel development,BP,
770,GO:0001946,1,0.895484633978856,0,16,lymphangiogenesis,BP,
771,GO:0001947,1,0.6653789362351,0,58,heart looping,BP,
772,GO:0001948,1,0.493053810770587,0,100,glycoprotein binding,MF,
773,GO:0001949,1,0.992247450179394,0,1,sebaceous gland cell differentiation,BP,
774,GO:0001951,1,0.972578326497652,0,4,intestinal D-glucose absorption,BP,
775,GO:0001952,1,0.523974528172616,0,94,regulation of cell-matrix adhesion,BP,
776,GO:0001953,1,0.827674097679252,0,28,negative regulation of cell-matrix adhesion,BP,
777,GO:0001954,1,0.730986740542553,0,45,positive regulation of cell-matrix adhesion,BP,
778,GO:0001955,1,0.94628118918164,0,8,blood vessel maturation,BP,
779,GO:0001956,1,0.927584456967868,0,11,positive regulation of neurotransmitter secretion,BP,
786,GO:0001964,1,0.840461359144352,0,25,startle response,BP,
787,GO:0001965,1,0.867767854588647,0,19,G-protein alpha-subunit binding,MF,
788,GO:0001966,1,0.992170027168696,0,1,thigmotaxis,BP,
789,GO:0001967,1,0.914341724794778,0,13,suckling behavior,BP,
790,GO:0001968,1,0.835159658333164,0,26,fibronectin binding,MF,
791,GO:0001969,1,0.981261721528096,0,3,regulation of activation of membrane attack complex,BP,
792,GO:0001970,1,0.987199004843283,0,2,positive regulation of activation of membrane attack complex,BP,
793,GO:0001971,1,0.993986332273894,0,1,negative regulation of activation of membrane attack complex,BP,
794,GO:0001972,1,0.883159139261861,0,17,retinoic acid binding,MF,
795,GO:0001973,1,0.913723332374118,0,12,adenosine receptor signaling pathway,BP,
798,GO:0001976,1,0.908243989991641,0,13,neurological system process involved in regulation of systemic arterial blood pressure,BP,
799,GO:0001977,1,0.880997411544366,0,17,renal system process involved in regulation of blood volume,BP,
800,GO:0001978,1,0.984425473967055,0,2,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
801,GO:0001979,1,0.992170043753478,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
802,GO:0001980,1,0.992170027168696,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
803,GO:0001983,1,0.984425473967055,0,2,baroreceptor response to increased systemic arterial blood pressure,BP,
804,GO:0001984,1,0.992170027168696,0,1,artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,BP,
805,GO:0001985,1,0.992194805846492,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
806,GO:0001990,1,0.754829221739914,0,38,regulation of systemic arterial blood pressure by hormone,BP,
807,GO:0001991,1,0.870602798518721,0,19,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
808,GO:0001992,1,0.964447840626424,0,5,regulation of systemic arterial blood pressure by vasopressin,BP,
809,GO:0001993,1,0.934099231938388,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
810,GO:0001994,1,0.969330803160153,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
811,GO:0001996,1,0.971126466662652,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
812,GO:0001997,1,0.984713686925388,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
813,GO:0001999,1,0.96438355102919,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
814,GO:0002001,1,0.96438355102919,0,5,renin secretion into blood stream,BP,
815,GO:0002002,1,0.909619056745845,0,13,regulation of angiotensin levels in blood,BP,
816,GO:0002003,1,0.915149303115143,0,12,angiotensin maturation,BP,
817,GO:0002005,1,0.980061921236551,0,3,angiotensin catabolic process in blood,BP,
818,GO:0002007,1,0.992170043753478,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
820,GO:0002011,1,0.715207449888528,0,49,morphogenesis of an epithelial sheet,BP,
821,GO:0002016,1,0.934296998863842,0,9,regulation of blood volume by renin-angiotensin,BP,
822,GO:0002017,1,0.98475378262919,0,2,regulation of blood volume by renal aldosterone,BP,
823,GO:0002018,1,0.969534205392208,0,4,renin-angiotensin regulation of aldosterone production,BP,
824,GO:0002019,1,0.977554057063435,0,3,regulation of renal output by angiotensin,BP,
826,GO:0002021,1,0.852961393614175,0,22,response to dietary excess,BP,
827,GO:0002023,1,0.977557099008496,0,3,reduction of food intake in response to dietary excess,BP,
828,GO:0002024,1,0.935694788835309,0,9,diet induced thermogenesis,BP,
829,GO:0002025,1,0.977146004882568,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
830,GO:0002026,1,0.825901694238547,0,27,regulation of the force of heart contraction,BP,
831,GO:0002027,1,0.537707539629514,0,88,regulation of heart rate,BP,
833,GO:0002029,1,0.89822000867794,0,14,desensitization of G-protein coupled receptor protein signaling pathway,BP,
834,GO:0002031,1,0.912446621783546,0,12,G-protein coupled receptor internalization,BP,
835,GO:0002032,1,0.984412908183541,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
836,GO:0002033,1,0.992489063278691,0,1,angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
837,GO:0002034,1,0.969571972275914,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
838,GO:0002035,1,0.970986080735616,0,4,brain renin-angiotensin system,BP,
839,GO:0002036,1,0.972646643528852,0,4,regulation of L-glutamate transport,BP,
840,GO:0002037,1,0.992187464507847,0,1,negative regulation of L-glutamate transport,BP,
841,GO:0002038,1,0.992208292351586,0,1,positive regulation of L-glutamate transport,BP,
842,GO:0002039,1,0.618707519037886,0,68,p53 binding,MF,
843,GO:0002040,1,0.632159865616124,0,67,sprouting angiogenesis,BP,
844,GO:0002041,1,0.992213381253759,0,1,intussusceptive angiogenesis,BP,
845,GO:0002042,1,0.795580060005981,0,33,cell migration involved in sprouting angiogenesis,BP,
846,GO:0002043,1,0.925417986631319,0,11,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
847,GO:0002046,1,0.976692313394457,0,3,opsin binding,MF,
848,GO:0002051,1,0.974741552715545,0,4,osteoblast fate commitment,BP,
849,GO:0002052,1,0.86710917017429,0,20,positive regulation of neuroblast proliferation,BP,
850,GO:0002053,1,0.829015617535007,0,27,positive regulation of mesenchymal cell proliferation,BP,
852,GO:0002055,1,0.992170027168696,0,1,adenine binding,MF,
853,GO:0002058,1,0.992187799978542,0,1,uracil binding,MF,
854,GO:0002059,1,0.992187799978542,0,1,thymine binding,MF,
856,GO:0002061,1,0.992187799978542,0,1,pyrimidine nucleobase binding,MF,
859,GO:0002064,1,0.262840377604489,0,190,epithelial cell development,BP,
860,GO:0002065,1,0.483888122360279,0,101,columnar/cuboidal epithelial cell differentiation,BP,
861,GO:0002066,1,0.691257449181096,0,52,columnar/cuboidal epithelial cell development,BP,
862,GO:0002067,1,0.722522697963294,0,45,glandular epithelial cell differentiation,BP,
863,GO:0002068,1,0.848863022521402,0,23,glandular epithelial cell development,BP,
864,GO:0002069,1,0.955741660575693,0,6,columnar/cuboidal epithelial cell maturation,BP,
865,GO:0002070,1,0.907285123715466,0,13,epithelial cell maturation,BP,
866,GO:0002071,1,0.984911119925723,0,2,glandular epithelial cell maturation,BP,
867,GO:0002072,1,0.949167599968049,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
868,GO:0002074,1,0.967065211064559,0,5,extraocular skeletal muscle development,BP,
869,GO:0002076,1,0.881901506267498,0,18,osteoblast development,BP,
870,GO:0002077,1,0.992170027168696,0,1,acrosome matrix dispersal,BP,
871,GO:0002079,1,0.971550115599509,0,4,inner acrosomal membrane,CC,
872,GO:0002080,1,0.829403209013203,0,25,acrosomal membrane,CC,
873,GO:0002081,1,0.970939473695485,0,4,outer acrosomal membrane,CC,
874,GO:0002082,1,0.893978202111795,0,15,regulation of oxidative phosphorylation,BP,
875,GO:0002083,1,0.992170027168696,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
877,GO:0002085,1,0.971509313875706,0,4,inhibition of neuroepithelial cell differentiation,BP,
878,GO:0002086,1,0.985378607004238,0,2,diaphragm contraction,BP,
879,GO:0002087,1,0.914353901140153,0,13,regulation of respiratory gaseous exchange by neurological system process,BP,
880,GO:0002088,1,0.642452533830575,0,63,lens development in camera-type eye,BP,
881,GO:0002089,1,0.883075858139103,0,18,lens morphogenesis in camera-type eye,BP,
882,GO:0002090,1,0.787815589030005,0,34,regulation of receptor internalization,BP,
883,GO:0002091,1,0.953486039721866,0,7,negative regulation of receptor internalization,BP,
884,GO:0002092,1,0.858946119852944,0,22,positive regulation of receptor internalization,BP,
885,GO:0002093,1,0.912537618086175,0,13,auditory receptor cell morphogenesis,BP,
886,GO:0002094,1,0.985074784659083,0,2,polyprenyltransferase activity,MF,
887,GO:0002097,1,0.909319615821933,0,13,tRNA wobble base modification,BP,
888,GO:0002098,1,0.935305527710331,0,9,tRNA wobble uridine modification,BP,
889,GO:0002100,1,0.993986332266811,0,1,tRNA wobble adenosine to inosine editing,BP,
890,GO:0002101,1,0.978114039511544,0,3,tRNA wobble cytosine modification,BP,
891,GO:0002102,1,0.810528177543688,0,30,podosome,CC,
892,GO:0002113,1,0.992212369588385,0,1,interleukin-33 binding,MF,
893,GO:0002114,1,0.985615350146041,0,2,interleukin-33 receptor activity,MF,
894,GO:0002115,1,0.93424180760216,0,10,store-operated calcium entry,BP,
895,GO:0002116,1,0.955993013172181,0,7,semaphorin receptor complex,CC,
896,GO:0002118,1,0.935530034551111,0,9,aggressive behavior,BP,
897,GO:0002121,1,0.985751312362477,0,2,inter-male aggressive behavior,BP,
898,GO:0002125,1,0.970463261591952,0,4,maternal aggressive behavior,BP,
899,GO:0002127,1,0.992170027168696,0,1,wobble base cytosine methylation,BP,
900,GO:0002133,1,0.987975683363676,0,2,polycystin complex,CC,
901,GO:0002134,1,0.986320365615544,0,2,UTP binding,MF,
902,GO:0002135,1,0.992288548141565,0,1,CTP binding,MF,
903,GO:0002138,1,0.941579219986142,0,8,retinoic acid biosynthetic process,BP,
904,GO:0002139,1,0.980280295309556,0,3,stereocilia coupling link,CC,
905,GO:0002140,1,0.993986332272497,0,1,stereocilia tip link,CC,
906,GO:0002141,1,0.986211686723351,0,2,stereocilia ankle link,CC,
907,GO:0002142,1,0.993986332295618,0,1,stereocilia ankle link complex,CC,
908,GO:0002143,1,0.976781798176527,0,3,tRNA wobble position uridine thiolation,BP,
909,GO:0002148,1,0.992773639713341,0,1,hypochlorous acid metabolic process,BP,
910,GO:0002149,1,0.992773639713341,0,1,hypochlorous acid biosynthetic process,BP,
911,GO:0002151,1,0.952727353842417,0,7,G-quadruplex RNA binding,MF,
912,GO:0002152,1,0.992975094076952,0,1,bile acid conjugation,BP,
913,GO:0002153,1,0.992245515365897,0,1,steroid receptor RNA activator RNA binding,MF,
914,GO:0002154,1,0.965074941805336,0,5,thyroid hormone mediated signaling pathway,BP,
915,GO:0002155,1,0.970915045751087,0,4,regulation of thyroid hormone mediated signaling pathway,BP,
916,GO:0002158,1,0.942311122961772,0,8,osteoclast proliferation,BP,
917,GO:0002159,1,0.973357875026288,0,4,desmosome assembly,BP,
918,GO:0002161,1,0.925786539766469,0,11,aminoacyl-tRNA editing activity,MF,
919,GO:0002162,1,0.943685824135712,0,9,dystroglycan binding,MF,
920,GO:0002169,1,0.985573196434352,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
921,GO:0002174,1,0.992520582922431,0,1,mammary stem cell proliferation,BP,
922,GO:0002175,1,0.974500998317367,0,4,protein localization to paranode region of axon,BP,
923,GO:0002176,1,0.954206292836216,0,6,male germ cell proliferation,BP,
924,GO:0002177,1,0.954547266432646,0,6,manchette,CC,
925,GO:0002178,1,0.920824298859683,0,11,palmitoyltransferase complex,CC,
926,GO:0002181,1,0.707874089783684,0,47,cytoplasmic translation,BP,
927,GO:0002182,1,0.988007658687182,0,2,cytoplasmic translational elongation,BP,
928,GO:0002183,1,0.850761603255706,0,22,cytoplasmic translational initiation,BP,
929,GO:0002184,1,0.986480574729074,0,2,cytoplasmic translational termination,BP,
930,GO:0002188,1,0.980713706982328,0,3,translation reinitiation,BP,
931,GO:0002189,1,0.976829302909594,0,3,ribose phosphate diphosphokinase complex,CC,
932,GO:0002190,1,0.8942184656692,0,15,cap-independent translational initiation,BP,
933,GO:0002191,1,0.978472754240245,0,3,cap-dependent translational initiation,BP,
934,GO:0002192,1,0.915317183835114,0,12,IRES-dependent translational initiation,BP,
935,GO:0002193,1,0.980329612330751,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
936,GO:0002194,1,0.992631976713582,0,1,hepatocyte cell migration,BP,
937,GO:0002196,1,0.992172493550135,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
938,GO:0002199,1,0.932700328584428,0,9,zona pellucida receptor complex,CC,
939,GO:0002200,1,0.66033456076897,0,58,somatic diversification of immune receptors,BP,
940,GO:0002204,1,0.748671812388992,0,40,somatic recombination of immunoglobulin genes involved in immune response,BP,
941,GO:0002208,1,0.748671812388992,0,40,somatic diversification of immunoglobulins involved in immune response,BP,
942,GO:0002209,1,0.808872173228335,0,30,behavioral defense response,BP,
943,GO:0002215,1,0.977750925728979,0,3,defense response to nematode,BP,
949,GO:0002225,1,0.961457123503244,0,5,positive regulation of antimicrobial peptide production,BP,
950,GO:0002227,1,0.849211861851797,0,21,innate immune response in mucosa,BP,
951,GO:0002228,1,0.652893424491366,0,57,natural killer cell mediated immunity,BP,
952,GO:0002230,1,0.869224536643603,0,19,positive regulation of defense response to virus by host,BP,
953,GO:0002232,1,0.976710097034767,0,3,leukocyte chemotaxis involved in inflammatory response,BP,
954,GO:0002236,1,0.992218681905899,0,1,detection of misfolded protein,BP,
956,GO:0002238,1,0.97867034702646,0,3,response to molecule of fungal origin,BP,
957,GO:0002244,1,0.510668657120102,0,95,hematopoietic progenitor cell differentiation,BP,
958,GO:0002246,1,0.956713782160314,0,6,wound healing involved in inflammatory response,BP,
959,GO:0002248,1,0.964266097267415,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
960,GO:0002249,1,0.957664661670143,0,6,lymphocyte anergy,BP,
962,GO:0002251,1,0.782762490809096,0,32,organ or tissue specific immune response,BP,
965,GO:0002254,1,0.976762839563883,0,3,kinin cascade,BP,
967,GO:0002262,1,0.411364301748588,0,124,myeloid cell homeostasis,BP,
969,GO:0002264,1,0.992170935039127,0,1,endothelial cell activation involved in immune response,BP,
970,GO:0002266,1,0.984858240598815,0,2,follicular dendritic cell activation,BP,
971,GO:0002268,1,0.984858240598815,0,2,follicular dendritic cell differentiation,BP,
974,GO:0002276,1,0.992186007071722,0,1,basophil activation involved in immune response,BP,
976,GO:0002278,1,0.954470977357724,0,6,eosinophil activation involved in immune response,BP,
977,GO:0002279,1,0.720138909830629,0,45,mast cell activation involved in immune response,BP,
979,GO:0002282,1,0.984995548165767,0,2,microglial cell activation involved in immune response,BP,
981,GO:0002285,1,0.319969813985532,0,155,lymphocyte activation involved in immune response,BP,
982,GO:0002286,1,0.505151762605627,0,92,T cell activation involved in immune response,BP,
983,GO:0002287,1,0.678209313629693,0,53,alpha-beta T cell activation involved in immune response,BP,
984,GO:0002290,1,0.992466234349486,0,1,gamma-delta T cell activation involved in immune response,BP,
985,GO:0002291,1,0.941810796506306,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
986,GO:0002292,1,0.648562269811881,0,59,T cell differentiation involved in immune response,BP,
987,GO:0002293,1,0.678209313629693,0,53,alpha-beta T cell differentiation involved in immune response,BP,
988,GO:0002294,1,0.683431413652422,0,52,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
989,GO:0002295,1,0.894660333861468,0,15,T-helper cell lineage commitment,BP,
990,GO:0002296,1,0.985728292225482,0,2,T-helper 1 cell lineage commitment,BP,
991,GO:0002298,1,0.984400888915038,0,2,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
992,GO:0002299,1,0.992170027168696,0,1,alpha-beta intraepithelial T cell differentiation,BP,
993,GO:0002300,1,0.992170027168696,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
994,GO:0002302,1,0.98461081389767,0,2,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
995,GO:0002304,1,0.984501746480242,0,2,gamma-delta intraepithelial T cell differentiation,BP,
996,GO:0002305,1,0.984501746480242,0,2,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
997,GO:0002309,1,0.963125934029616,0,5,T cell proliferation involved in immune response,BP,
998,GO:0002312,1,0.634489080770794,0,63,B cell activation involved in immune response,BP,
999,GO:0002313,1,0.884107131258049,0,17,mature B cell differentiation involved in immune response,BP,
1000,GO:0002314,1,0.977824966268029,0,3,germinal center B cell differentiation,BP,
1001,GO:0002315,1,0.940014366919384,0,9,marginal zone B cell differentiation,BP,
1002,GO:0002316,1,0.993694182434192,0,1,follicular B cell differentiation,BP,
1003,GO:0002317,1,0.969057760109214,0,4,plasma cell differentiation,BP,
1004,GO:0002318,1,0.953048290287545,0,7,myeloid progenitor cell differentiation,BP,
1005,GO:0002320,1,0.876282054791856,0,19,lymphoid progenitor cell differentiation,BP,
1006,GO:0002322,1,0.966546062173992,0,5,B cell proliferation involved in immune response,BP,
1007,GO:0002323,1,0.793121637866516,0,30,natural killer cell activation involved in immune response,BP,
1008,GO:0002325,1,0.969045116557633,0,4,natural killer cell differentiation involved in immune response,BP,
1009,GO:0002326,1,0.973573884755075,0,4,B cell lineage commitment,BP,
1010,GO:0002327,1,0.950954841470058,0,8,immature B cell differentiation,BP,
1011,GO:0002328,1,0.935466490966634,0,10,pro-B cell differentiation,BP,
1012,GO:0002329,1,0.968344234969576,0,5,pre-B cell differentiation,BP,
1013,GO:0002331,1,0.980343026793163,0,3,pre-B cell allelic exclusion,BP,
1014,GO:0002332,1,0.993985913025372,0,1,transitional stage B cell differentiation,BP,
1015,GO:0002333,1,0.993985913025372,0,1,transitional one stage B cell differentiation,BP,
1016,GO:0002335,1,0.860866481026896,0,21,mature B cell differentiation,BP,
1017,GO:0002337,1,0.985774083020893,0,2,B-1a B cell differentiation,BP,
1018,GO:0002339,1,0.976868985539281,0,3,B cell selection,BP,
1019,GO:0002343,1,0.992323393862121,0,1,peripheral B cell selection,BP,
1020,GO:0002344,1,0.992323393862121,0,1,B cell affinity maturation,BP,
1021,GO:0002347,1,0.885725255137724,0,16,response to tumor cell,BP,
1022,GO:0002349,1,0.954785726182777,0,6,histamine production involved in inflammatory response,BP,
1023,GO:0002351,1,0.978737879810531,0,3,serotonin production involved in inflammatory response,BP,
1024,GO:0002352,1,0.984426966389597,0,2,B cell negative selection,BP,
1025,GO:0002353,1,0.976762839563883,0,3,plasma kallikrein-kinin cascade,BP,
1026,GO:0002355,1,0.992246851373183,0,1,detection of tumor cell,BP,
1027,GO:0002357,1,0.984631774419492,0,2,defense response to tumor cell,BP,
1028,GO:0002358,1,0.984472471796448,0,2,B cell homeostatic proliferation,BP,
1029,GO:0002360,1,0.838159616691944,0,24,T cell lineage commitment,BP,
1030,GO:0002361,1,0.96172201236735,0,5,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1031,GO:0002362,1,0.9922229873615,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1032,GO:0002363,1,0.881819012625632,0,17,alpha-beta T cell lineage commitment,BP,
1034,GO:0002367,1,0.564406597543394,0,78,cytokine production involved in immune response,BP,
1035,GO:0002368,1,0.984601346993738,0,2,B cell cytokine production,BP,
1036,GO:0002369,1,0.80686139118135,0,29,T cell cytokine production,BP,
1037,GO:0002370,1,0.986168969322127,0,2,natural killer cell cytokine production,BP,
1038,GO:0002371,1,0.961152276232966,0,6,dendritic cell cytokine production,BP,
1039,GO:0002373,1,0.992170027168696,0,1,plasmacytoid dendritic cell cytokine production,BP,
1040,GO:0002374,1,0.883081008334644,0,17,cytokine secretion involved in immune response,BP,
1043,GO:0002378,1,0.980170000156403,0,3,immunoglobulin biosynthetic process,BP,
1044,GO:0002380,1,0.993806684041964,0,1,immunoglobulin secretion involved in immune response,BP,
1045,GO:0002381,1,0.715434266436172,0,46,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1046,GO:0002384,1,0.985830646786198,0,2,hepatic immune response,BP,
1047,GO:0002385,1,0.794033577421234,0,30,mucosal immune response,BP,
1048,GO:0002386,1,0.98592263244392,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1049,GO:0002396,1,0.961456705274962,0,5,MHC protein complex assembly,BP,
1050,GO:0002397,1,0.992173025479447,0,1,MHC class I protein complex assembly,BP,
1051,GO:0002399,1,0.969043237344425,0,4,MHC class II protein complex assembly,BP,
1052,GO:0002407,1,0.831259843328117,0,25,dendritic cell chemotaxis,BP,
1053,GO:0002408,1,0.970837556009917,0,4,myeloid dendritic cell chemotaxis,BP,
1054,GO:0002414,1,0.97054163814464,0,4,immunoglobulin transcytosis in epithelial cells,BP,
1055,GO:0002415,1,0.98592263244392,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1056,GO:0002416,1,0.992170245355046,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1057,GO:0002418,1,0.906449908975909,0,13,immune response to tumor cell,BP,
1058,GO:0002420,1,0.941891569864802,0,8,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1059,GO:0002423,1,0.941891569864802,0,8,natural killer cell mediated immune response to tumor cell,BP,
1060,GO:0002424,1,0.985246515877106,0,2,T cell mediated immune response to tumor cell,BP,
1061,GO:0002426,1,0.984430919168614,0,2,immunoglobulin production in mucosal tissue,BP,
1062,GO:0002428,1,0.978036610829126,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1064,GO:0002430,1,0.920558457281966,0,11,complement receptor mediated signaling pathway,BP,
1065,GO:0002431,1,0.578925335549922,0,77,Fc receptor mediated stimulatory signaling pathway,BP,
1066,GO:0002432,1,0.993770408352215,0,1,granuloma formation,BP,
1067,GO:0002433,1,0.604995036756039,0,71,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1068,GO:0002434,1,0.984501568023485,0,2,immune complex clearance,BP,
1069,GO:0002436,1,0.984501568023485,0,2,immune complex clearance by monocytes and macrophages,BP,
1070,GO:0002437,1,0.736423260442522,0,41,inflammatory response to antigenic stimulus,BP,
1071,GO:0002438,1,0.861362571736612,0,20,acute inflammatory response to antigenic stimulus,BP,
1072,GO:0002439,1,0.969085788514679,0,4,chronic inflammatory response to antigenic stimulus,BP,
1074,GO:0002441,1,0.954785726182777,0,6,histamine secretion involved in inflammatory response,BP,
1075,GO:0002442,1,0.978737879810531,0,3,serotonin secretion involved in inflammatory response,BP,
1078,GO:0002445,1,0.986178773241734,0,2,type II hypersensitivity,BP,
1080,GO:0002447,1,0.954470977357724,0,6,eosinophil mediated immunity,BP,
1081,GO:0002448,1,0.709915010542212,0,47,mast cell mediated immunity,BP,
1083,GO:0002455,1,0.73129143453001,0,42,humoral immune response mediated by circulating immunoglobulin,BP,
1085,GO:0002457,1,0.964223748695223,0,5,T cell antigen processing and presentation,BP,
1086,GO:0002458,1,0.984469712847694,0,2,peripheral T cell tolerance induction,BP,
1088,GO:0002461,1,0.976809620967492,0,3,tolerance induction dependent upon immune response,BP,
1089,GO:0002465,1,0.984469712847694,0,2,peripheral tolerance induction,BP,
1090,GO:0002467,1,0.899149071365961,0,15,germinal center formation,BP,
1091,GO:0002468,1,0.945054485122624,0,8,dendritic cell antigen processing and presentation,BP,
1093,GO:0002475,1,0.929771071022605,0,10,antigen processing and presentation via MHC class Ib,BP,
1094,GO:0002476,1,0.985755914457942,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1095,GO:0002477,1,0.992170027168696,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1098,GO:0002480,1,0.940536179532167,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1099,GO:0002481,1,0.992170027168696,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1100,GO:0002483,1,0.944962806262463,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1101,GO:0002488,1,0.993535661543522,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1102,GO:0002489,1,0.993535661543522,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1104,GO:0002501,1,0.969046166304195,0,4,peptide antigen assembly with MHC protein complex,BP,
1105,GO:0002502,1,0.992173025479447,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1106,GO:0002503,1,0.976692112990833,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1108,GO:0002505,1,0.984400887813367,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1109,GO:0002506,1,0.984400887813367,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1110,GO:0002507,1,0.838460632207202,0,24,tolerance induction,BP,
1111,GO:0002508,1,0.984574567563812,0,2,central tolerance induction,BP,
1112,GO:0002509,1,0.992186430082057,0,1,central tolerance induction to self antigen,BP,
1113,GO:0002510,1,0.992328661417844,0,1,central B cell tolerance induction,BP,
1114,GO:0002513,1,0.963637261364727,0,5,tolerance induction to self antigen,BP,
1115,GO:0002514,1,0.9862422408777,0,2,B cell tolerance induction,BP,
1116,GO:0002517,1,0.908948151871654,0,13,T cell tolerance induction,BP,
1117,GO:0002518,1,0.992170027168696,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1118,GO:0002519,1,0.984450488629802,0,2,natural killer cell tolerance induction,BP,
1121,GO:0002522,1,0.984494497773537,0,2,leukocyte migration involved in immune response,BP,
1122,GO:0002523,1,0.89989519131203,0,14,leukocyte migration involved in inflammatory response,BP,
1123,GO:0002524,1,0.935684058316404,0,9,hypersensitivity,BP,
1124,GO:0002525,1,0.977248217495514,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1126,GO:0002528,1,0.986585501075556,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1127,GO:0002532,1,0.714294766658073,0,46,production of molecular mediator involved in inflammatory response,BP,
1128,GO:0002534,1,0.82345547727439,0,27,cytokine production involved in inflammatory response,BP,
1129,GO:0002536,1,0.969077506913811,0,4,respiratory burst involved in inflammatory response,BP,
1130,GO:0002537,1,0.988008195296952,0,2,nitric oxide production involved in inflammatory response,BP,
1131,GO:0002538,1,0.985066601609944,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1132,GO:0002540,1,0.985066601609944,0,2,leukotriene production involved in inflammatory response,BP,
1133,GO:0002541,1,0.976795201698298,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1134,GO:0002542,1,0.984448202725346,0,2,Factor XII activation,BP,
1135,GO:0002543,1,0.986174723083905,0,2,activation of blood coagulation via clotting cascade,BP,
1136,GO:0002544,1,0.849115919326535,0,22,chronic inflammatory response,BP,
1137,GO:0002545,1,0.984962080675627,0,2,chronic inflammatory response to non-antigenic stimulus,BP,
1138,GO:0002548,1,0.63703732068107,0,59,monocyte chemotaxis,BP,
1139,GO:0002551,1,0.923018013993969,0,11,mast cell chemotaxis,BP,
1140,GO:0002553,1,0.954785726182777,0,6,histamine secretion by mast cell,BP,
1141,GO:0002554,1,0.978737879810531,0,3,serotonin secretion by platelet,BP,
1142,GO:0002562,1,0.689387237903667,0,52,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1143,GO:0002566,1,0.916614513950078,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1144,GO:0002568,1,0.967459350284132,0,5,somatic diversification of T cell receptor genes,BP,
1145,GO:0002572,1,0.986172523690897,0,2,pro-T cell differentiation,BP,
1147,GO:0002576,1,0.398917912043391,0,126,platelet degranulation,BP,
1149,GO:0002578,1,0.956840141452465,0,6,negative regulation of antigen processing and presentation,BP,
1152,GO:0002581,1,0.979330535375004,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1155,GO:0002584,1,0.969890165708714,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1158,GO:0002587,1,0.985256224969529,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1160,GO:0002589,1,0.984405791816771,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1161,GO:0002590,1,0.984405791816771,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1162,GO:0002604,1,0.945054485122624,0,8,regulation of dendritic cell antigen processing and presentation,BP,
1163,GO:0002605,1,0.993986332250535,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1164,GO:0002606,1,0.950774376631269,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1165,GO:0002625,1,0.984406045970893,0,2,regulation of T cell antigen processing and presentation,BP,
1166,GO:0002626,1,0.992174221678293,0,1,negative regulation of T cell antigen processing and presentation,BP,
1167,GO:0002634,1,0.938030915912108,0,9,regulation of germinal center formation,BP,
1168,GO:0002635,1,0.986360768424044,0,2,negative regulation of germinal center formation,BP,
1169,GO:0002636,1,0.976692112990833,0,3,positive regulation of germinal center formation,BP,
1171,GO:0002638,1,0.943220386811864,0,8,negative regulation of immunoglobulin production,BP,
1173,GO:0002640,1,0.992294630214608,0,1,regulation of immunoglobulin biosynthetic process,BP,
1174,GO:0002642,1,0.992294630214608,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1175,GO:0002643,1,0.883919680696443,0,17,regulation of tolerance induction,BP,
1176,GO:0002644,1,0.984615575098821,0,2,negative regulation of tolerance induction,BP,
1177,GO:0002645,1,0.937224922033365,0,9,positive regulation of tolerance induction,BP,
1178,GO:0002646,1,0.992328661417844,0,1,regulation of central tolerance induction,BP,
1179,GO:0002648,1,0.992328661417844,0,1,positive regulation of central tolerance induction,BP,
1180,GO:0002649,1,0.993866895563678,0,1,regulation of tolerance induction to self antigen,BP,
1181,GO:0002651,1,0.993866895563678,0,1,positive regulation of tolerance induction to self antigen,BP,
1182,GO:0002652,1,0.984503038860672,0,2,regulation of tolerance induction dependent upon immune response,BP,
1183,GO:0002654,1,0.9922229873615,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1184,GO:0002658,1,0.9922229873615,0,1,regulation of peripheral tolerance induction,BP,
1185,GO:0002660,1,0.9922229873615,0,1,positive regulation of peripheral tolerance induction,BP,
1186,GO:0002661,1,0.9862422408777,0,2,regulation of B cell tolerance induction,BP,
1187,GO:0002663,1,0.9862422408777,0,2,positive regulation of B cell tolerance induction,BP,
1188,GO:0002664,1,0.923195433269868,0,11,regulation of T cell tolerance induction,BP,
1189,GO:0002665,1,0.992370359992395,0,1,negative regulation of T cell tolerance induction,BP,
1190,GO:0002666,1,0.950189922546521,0,7,positive regulation of T cell tolerance induction,BP,
1191,GO:0002667,1,0.957664661670143,0,6,regulation of T cell anergy,BP,
1192,GO:0002668,1,0.992370359992395,0,1,negative regulation of T cell anergy,BP,
1193,GO:0002669,1,0.978532537717569,0,3,positive regulation of T cell anergy,BP,
1195,GO:0002674,1,0.915485208053945,0,12,negative regulation of acute inflammatory response,BP,
1196,GO:0002675,1,0.816939519470583,0,27,positive regulation of acute inflammatory response,BP,
1197,GO:0002676,1,0.920703569956955,0,11,regulation of chronic inflammatory response,BP,
1198,GO:0002677,1,0.95762683092963,0,6,negative regulation of chronic inflammatory response,BP,
1199,GO:0002678,1,0.969045192801813,0,4,positive regulation of chronic inflammatory response,BP,
1200,GO:0002679,1,0.94309738002145,0,8,respiratory burst involved in defense response,BP,
1201,GO:0002681,1,0.967459350284132,0,5,somatic recombination of T cell receptor gene segments,BP,
1206,GO:0002686,1,0.785642578792421,0,33,negative regulation of leukocyte migration,BP,
1208,GO:0002688,1,0.466538219373794,0,101,regulation of leukocyte chemotaxis,BP,
1209,GO:0002689,1,0.903571217120612,0,14,negative regulation of leukocyte chemotaxis,BP,
1210,GO:0002690,1,0.528177499913764,0,84,positive regulation of leukocyte chemotaxis,BP,
1212,GO:0002692,1,0.944950994953352,0,8,negative regulation of cellular extravasation,BP,
1215,GO:0002695,1,0.346905873536044,0,143,negative regulation of leukocyte activation,BP,
1218,GO:0002698,1,0.471955310537496,0,102,negative regulation of immune effector process,BP,
1221,GO:0002701,1,0.80216037064319,0,30,negative regulation of production of molecular mediator of immune response,BP,
1224,GO:0002704,1,0.72203553039019,0,44,negative regulation of leukocyte mediated immunity,BP,
1227,GO:0002707,1,0.781470165737461,0,33,negative regulation of lymphocyte mediated immunity,BP,
1230,GO:0002710,1,0.88696783597132,0,16,negative regulation of T cell mediated immunity,BP,
1232,GO:0002712,1,0.727626702783591,0,43,regulation of B cell mediated immunity,BP,
1233,GO:0002713,1,0.935453837860731,0,9,negative regulation of B cell mediated immunity,BP,
1234,GO:0002714,1,0.799851977368242,0,30,positive regulation of B cell mediated immunity,BP,
1235,GO:0002715,1,0.783541852118352,0,33,regulation of natural killer cell mediated immunity,BP,
1236,GO:0002716,1,0.921141724316806,0,11,negative regulation of natural killer cell mediated immunity,BP,
1237,GO:0002717,1,0.863112167404376,0,20,positive regulation of natural killer cell mediated immunity,BP,
1238,GO:0002718,1,0.630584677723266,0,63,regulation of cytokine production involved in immune response,BP,
1239,GO:0002719,1,0.843776321609887,0,23,negative regulation of cytokine production involved in immune response,BP,
1240,GO:0002720,1,0.774217420018546,0,35,positive regulation of cytokine production involved in immune response,BP,
1241,GO:0002721,1,0.992323393862121,0,1,regulation of B cell cytokine production,BP,
1242,GO:0002724,1,0.849584065741897,0,22,regulation of T cell cytokine production,BP,
1243,GO:0002725,1,0.94696714066648,0,7,negative regulation of T cell cytokine production,BP,
1244,GO:0002726,1,0.903016639667971,0,14,positive regulation of T cell cytokine production,BP,
1245,GO:0002727,1,0.986168969322127,0,2,regulation of natural killer cell cytokine production,BP,
1246,GO:0002728,1,0.993792576497327,0,1,negative regulation of natural killer cell cytokine production,BP,
1247,GO:0002729,1,0.992329146180804,0,1,positive regulation of natural killer cell cytokine production,BP,
1248,GO:0002730,1,0.966987937893899,0,5,regulation of dendritic cell cytokine production,BP,
1249,GO:0002731,1,0.986199384586843,0,2,negative regulation of dendritic cell cytokine production,BP,
1250,GO:0002732,1,0.993803794797847,0,1,positive regulation of dendritic cell cytokine production,BP,
1251,GO:0002736,1,0.992170027168696,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1252,GO:0002737,1,0.992170027168696,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1253,GO:0002739,1,0.901976975770005,0,14,regulation of cytokine secretion involved in immune response,BP,
1254,GO:0002740,1,0.955712515114756,0,6,negative regulation of cytokine secretion involved in immune response,BP,
1255,GO:0002741,1,0.950644978445673,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1256,GO:0002752,1,0.984411013136194,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1257,GO:0002753,1,0.688984899058433,0,53,cytoplasmic pattern recognition receptor signaling pathway,BP,
1258,GO:0002755,1,0.772144207572265,0,36,MyD88-dependent toll-like receptor signaling pathway,BP,
1262,GO:0002759,1,0.947454346849022,0,7,regulation of antimicrobial humoral response,BP,
1263,GO:0002760,1,0.961457123503244,0,5,positive regulation of antimicrobial humoral response,BP,
1265,GO:0002762,1,0.730166624083927,0,44,negative regulation of myeloid leukocyte differentiation,BP,
1268,GO:0002765,1,0.954992262288473,0,6,immune response-inhibiting signal transduction,BP,
1269,GO:0002767,1,0.962521564160329,0,5,immune response-inhibiting cell surface receptor signaling pathway,BP,
1271,GO:0002769,1,0.992170027168696,0,1,natural killer cell inhibitory signaling pathway,BP,
1272,GO:0002774,1,0.977776668537186,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1273,GO:0002775,1,0.947453289589396,0,7,antimicrobial peptide production,BP,
1274,GO:0002777,1,0.984400887813367,0,2,antimicrobial peptide biosynthetic process,BP,
1275,GO:0002778,1,0.947453289589396,0,7,antibacterial peptide production,BP,
1276,GO:0002780,1,0.984400887813367,0,2,antibacterial peptide biosynthetic process,BP,
1277,GO:0002784,1,0.954933072124259,0,6,regulation of antimicrobial peptide production,BP,
1278,GO:0002785,1,0.993216488866995,0,1,negative regulation of antimicrobial peptide production,BP,
1279,GO:0002786,1,0.954933072124259,0,6,regulation of antibacterial peptide production,BP,
1280,GO:0002787,1,0.993216488866995,0,1,negative regulation of antibacterial peptide production,BP,
1283,GO:0002792,1,0.44631003977833,0,111,negative regulation of peptide secretion,BP,
1285,GO:0002803,1,0.961457123503244,0,5,positive regulation of antibacterial peptide production,BP,
1286,GO:0002805,1,0.984400887813367,0,2,regulation of antimicrobial peptide biosynthetic process,BP,
1287,GO:0002807,1,0.984400887813367,0,2,positive regulation of antimicrobial peptide biosynthetic process,BP,
1288,GO:0002808,1,0.984400887813367,0,2,regulation of antibacterial peptide biosynthetic process,BP,
1289,GO:0002815,1,0.984400887813367,0,2,biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1290,GO:0002816,1,0.984400887813367,0,2,regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1292,GO:0002820,1,0.753365804271272,0,38,negative regulation of adaptive immune response,BP,
1295,GO:0002823,1,0.770941244029865,0,35,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1297,GO:0002825,1,0.847345129761211,0,22,regulation of T-helper 1 type immune response,BP,
1298,GO:0002826,1,0.949321454843668,0,7,negative regulation of T-helper 1 type immune response,BP,
1299,GO:0002827,1,0.892620989656279,0,15,positive regulation of T-helper 1 type immune response,BP,
1300,GO:0002828,1,0.818736147973082,0,27,regulation of type 2 immune response,BP,
1301,GO:0002829,1,0.92248377807504,0,11,negative regulation of type 2 immune response,BP,
1302,GO:0002830,1,0.89460772593914,0,15,positive regulation of type 2 immune response,BP,
1303,GO:0002831,1,0.375978450144673,0,134,regulation of response to biotic stimulus,BP,
1304,GO:0002832,1,0.781998382092449,0,34,negative regulation of response to biotic stimulus,BP,
1305,GO:0002833,1,0.756544794055254,0,38,positive regulation of response to biotic stimulus,BP,
1306,GO:0002834,1,0.92072276265291,0,11,regulation of response to tumor cell,BP,
1307,GO:0002835,1,0.985296861180429,0,2,negative regulation of response to tumor cell,BP,
1308,GO:0002836,1,0.941085205199171,0,8,positive regulation of response to tumor cell,BP,
1309,GO:0002837,1,0.92072276265291,0,11,regulation of immune response to tumor cell,BP,
1310,GO:0002838,1,0.985296861180429,0,2,negative regulation of immune response to tumor cell,BP,
1311,GO:0002839,1,0.941085205199171,0,8,positive regulation of immune response to tumor cell,BP,
1312,GO:0002840,1,0.985246515877106,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1313,GO:0002842,1,0.992218681905899,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1314,GO:0002849,1,0.9922229873615,0,1,regulation of peripheral T cell tolerance induction,BP,
1315,GO:0002851,1,0.9922229873615,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1316,GO:0002855,1,0.941891569864802,0,8,regulation of natural killer cell mediated immune response to tumor cell,BP,
1317,GO:0002856,1,0.985296861180429,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1318,GO:0002857,1,0.955951974855663,0,6,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1319,GO:0002858,1,0.941891569864802,0,8,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1320,GO:0002859,1,0.985296861180429,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1321,GO:0002860,1,0.955951974855663,0,6,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1322,GO:0002861,1,0.854321110591255,0,21,regulation of inflammatory response to antigenic stimulus,BP,
1323,GO:0002862,1,0.926904642685222,0,10,negative regulation of inflammatory response to antigenic stimulus,BP,
1324,GO:0002863,1,0.921737119572949,0,11,positive regulation of inflammatory response to antigenic stimulus,BP,
1325,GO:0002864,1,0.915625845120664,0,12,regulation of acute inflammatory response to antigenic stimulus,BP,
1326,GO:0002865,1,0.971371007513659,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1327,GO:0002866,1,0.94262451642693,0,8,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1328,GO:0002870,1,0.957664661670143,0,6,T cell anergy,BP,
1329,GO:0002874,1,0.976692113335833,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1330,GO:0002875,1,0.992170027168696,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1331,GO:0002876,1,0.984400888161062,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1332,GO:0002877,1,0.977248217495514,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1333,GO:0002878,1,0.992724664568839,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1334,GO:0002879,1,0.98441101357194,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1335,GO:0002880,1,0.984962080675627,0,2,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1336,GO:0002881,1,0.992733611957819,0,1,negative regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1337,GO:0002882,1,0.992172028576362,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1338,GO:0002883,1,0.942633850560587,0,8,regulation of hypersensitivity,BP,
1339,GO:0002884,1,0.986212842998497,0,2,negative regulation of hypersensitivity,BP,
1340,GO:0002885,1,0.955816463721061,0,6,positive regulation of hypersensitivity,BP,
1341,GO:0002886,1,0.756719025282227,0,38,regulation of myeloid leukocyte mediated immunity,BP,
1342,GO:0002887,1,0.929683258397967,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1343,GO:0002888,1,0.875425413721389,0,18,positive regulation of myeloid leukocyte mediated immunity,BP,
1344,GO:0002889,1,0.727626702783591,0,43,regulation of immunoglobulin mediated immune response,BP,
1345,GO:0002890,1,0.935453837860731,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1346,GO:0002891,1,0.799851977368242,0,30,positive regulation of immunoglobulin mediated immune response,BP,
1347,GO:0002892,1,0.986178773241734,0,2,regulation of type II hypersensitivity,BP,
1348,GO:0002894,1,0.986178773241734,0,2,positive regulation of type II hypersensitivity,BP,
1349,GO:0002895,1,0.992328661417844,0,1,regulation of central B cell tolerance induction,BP,
1350,GO:0002897,1,0.992328661417844,0,1,positive regulation of central B cell tolerance induction,BP,
1351,GO:0002901,1,0.969522441826247,0,4,mature B cell apoptotic process,BP,
1352,GO:0002902,1,0.877266822044796,0,18,regulation of B cell apoptotic process,BP,
1353,GO:0002903,1,0.915745839110704,0,12,negative regulation of B cell apoptotic process,BP,
1354,GO:0002904,1,0.978480302607457,0,3,positive regulation of B cell apoptotic process,BP,
1355,GO:0002905,1,0.969522441826247,0,4,regulation of mature B cell apoptotic process,BP,
1356,GO:0002906,1,0.969522441826247,0,4,negative regulation of mature B cell apoptotic process,BP,
1357,GO:0002911,1,0.957664661670143,0,6,regulation of lymphocyte anergy,BP,
1358,GO:0002912,1,0.992370359992395,0,1,negative regulation of lymphocyte anergy,BP,
1359,GO:0002913,1,0.978532537717569,0,3,positive regulation of lymphocyte anergy,BP,
1361,GO:0002921,1,0.924125219222948,0,11,negative regulation of humoral immune response,BP,
1362,GO:0002922,1,0.891282058548031,0,15,positive regulation of humoral immune response,BP,
1363,GO:0002923,1,0.933603595274834,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1364,GO:0002924,1,0.963437029053368,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1365,GO:0002925,1,0.969043237686748,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1366,GO:0002930,1,0.986185943359728,0,2,trabecular meshwork development,BP,
1368,GO:0002933,1,0.961840864515899,0,5,lipid hydroxylation,BP,
1369,GO:0002934,1,0.941679822362948,0,9,desmosome organization,BP,
1370,GO:0002940,1,0.992195586342543,0,1,tRNA N2-guanine methylation,BP,
1371,GO:0002943,1,0.976729147548373,0,3,tRNA dihydrouridine synthesis,BP,
1372,GO:0002944,1,0.986242725173664,0,2,cyclin K-CDK12 complex,CC,
1373,GO:0002945,1,0.986242725166923,0,2,cyclin K-CDK13 complex,CC,
1374,GO:0002946,1,0.992170027168696,0,1,tRNA C5-cytosine methylation,BP,
1375,GO:0002947,1,0.993605927665848,0,1,tumor necrosis factor receptor superfamily complex,CC,
1376,GO:0002949,1,0.976741892041344,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1377,GO:0002950,1,0.979598566794454,0,3,ceramide phosphoethanolamine synthase activity,MF,
1378,GO:0003002,1,0.0915649420253449,0,327,regionalization,BP,
1382,GO:0003009,1,0.767157322934317,0,37,skeletal muscle contraction,BP,
1383,GO:0003010,1,0.965866073369252,0,5,voluntary skeletal muscle contraction,BP,
1384,GO:0003011,1,0.979415800463653,0,3,involuntary skeletal muscle contraction,BP,
1389,GO:0003016,1,0.817011697553359,0,29,respiratory system process,BP,
1390,GO:0003017,1,0.99398633228095,0,1,lymph circulation,BP,
1391,GO:0003018,1,0.330048469500896,0,152,vascular process in circulatory system,BP,
1392,GO:0003025,1,0.970963726252275,0,4,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1393,GO:0003026,1,0.992294630214608,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1394,GO:0003027,1,0.992170043753478,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1395,GO:0003029,1,0.992170043753478,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1396,GO:0003032,1,0.985001120037133,0,2,detection of oxygen,BP,
1397,GO:0003044,1,0.699436145884638,0,48,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1398,GO:0003050,1,0.986725367701178,0,2,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1399,GO:0003051,1,0.978335549773604,0,3,angiotensin-mediated drinking behavior,BP,
1400,GO:0003056,1,0.958293020385062,0,6,regulation of vascular smooth muscle contraction,BP,
1401,GO:0003057,1,0.962017145514812,0,5,regulation of the force of heart contraction by chemical signal,BP,
1402,GO:0003058,1,0.992170027168696,0,1,hormonal regulation of the force of heart contraction,BP,
1403,GO:0003062,1,0.959500101238254,0,6,regulation of heart rate by chemical signal,BP,
1404,GO:0003064,1,0.984973442043553,0,2,regulation of heart rate by hormone,BP,
1405,GO:0003065,1,0.992170454953576,0,1,positive regulation of heart rate by epinephrine,BP,
1406,GO:0003068,1,0.992170027168696,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1407,GO:0003069,1,0.992170027168696,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1408,GO:0003070,1,0.992170027168696,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1409,GO:0003071,1,0.835061288627013,0,24,renal system process involved in regulation of systemic arterial blood pressure,BP,
1410,GO:0003072,1,0.969571972275914,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1411,GO:0003073,1,0.539061106170843,0,84,regulation of systemic arterial blood pressure,BP,
1412,GO:0003081,1,0.831127022414905,0,25,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1413,GO:0003083,1,0.992170027168696,0,1,negative regulation of renal output by angiotensin,BP,
1414,GO:0003084,1,0.936312646389701,0,9,positive regulation of systemic arterial blood pressure,BP,
1415,GO:0003085,1,0.89979860341971,0,14,negative regulation of systemic arterial blood pressure,BP,
1416,GO:0003091,1,0.782495545109822,0,35,renal water homeostasis,BP,
1417,GO:0003093,1,0.915843611453796,0,12,regulation of glomerular filtration,BP,
1418,GO:0003094,1,0.886234816137173,0,17,glomerular filtration,BP,
1419,GO:0003095,1,0.976873748642767,0,3,pressure natriuresis,BP,
1420,GO:0003096,1,0.964782129705651,0,5,renal sodium ion transport,BP,
1421,GO:0003097,1,0.956788560584726,0,6,renal water transport,BP,
1422,GO:0003099,1,0.977002481586272,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1423,GO:0003100,1,0.963427174336893,0,5,regulation of systemic arterial blood pressure by endothelin,BP,
1424,GO:0003104,1,0.970246505592918,0,4,positive regulation of glomerular filtration,BP,
1425,GO:0003105,1,0.956901849281086,0,6,negative regulation of glomerular filtration,BP,
1426,GO:0003106,1,0.992170027168696,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1427,GO:0003127,1,0.987975683342814,0,2,detection of nodal flow,BP,
1428,GO:0003128,1,0.928069724113572,0,10,heart field specification,BP,
1429,GO:0003129,1,0.962308086526283,0,5,heart induction,BP,
1430,GO:0003130,1,0.984930721553977,0,2,BMP signaling pathway involved in heart induction,BP,
1431,GO:0003131,1,0.992441219375176,0,1,mesodermal-endodermal cell signaling,BP,
1432,GO:0003133,1,0.984930721553977,0,2,endodermal-mesodermal cell signaling,BP,
1433,GO:0003134,1,0.984930721553977,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1434,GO:0003136,1,0.992516661359673,0,1,negative regulation of heart induction by canonical Wnt signaling pathway,BP,
1435,GO:0003137,1,0.992170027168696,0,1,Notch signaling pathway involved in heart induction,BP,
1436,GO:0003138,1,0.993986332267048,0,1,primary heart field specification,BP,
1437,GO:0003139,1,0.942453088189221,0,8,secondary heart field specification,BP,
1438,GO:0003140,1,0.941854689098422,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1439,GO:0003142,1,0.992225592354327,0,1,cardiogenic plate morphogenesis,BP,
1440,GO:0003143,1,0.638375260084717,0,64,embryonic heart tube morphogenesis,BP,
1441,GO:0003144,1,0.992170115314398,0,1,embryonic heart tube formation,BP,
1442,GO:0003147,1,0.992170027168696,0,1,neural crest cell migration involved in heart formation,BP,
1443,GO:0003148,1,0.855801346797606,0,22,outflow tract septum morphogenesis,BP,
1444,GO:0003149,1,0.939499177195283,0,9,membranous septum morphogenesis,BP,
1445,GO:0003150,1,0.966670756345945,0,5,muscular septum morphogenesis,BP,
1446,GO:0003151,1,0.611454963333169,0,69,outflow tract morphogenesis,BP,
1447,GO:0003156,1,0.785219956913433,0,33,regulation of animal organ formation,BP,
1448,GO:0003157,1,0.923383316141214,0,11,endocardium development,BP,
1449,GO:0003158,1,0.46484244985955,0,109,endothelium development,BP,
1450,GO:0003159,1,0.897322791667867,0,15,morphogenesis of an endothelium,BP,
1451,GO:0003160,1,0.956225343591272,0,6,endocardium morphogenesis,BP,
1452,GO:0003161,1,0.913491596236633,0,13,cardiac conduction system development,BP,
1453,GO:0003162,1,0.980274853483828,0,3,atrioventricular node development,BP,
1454,GO:0003163,1,0.980176378302613,0,3,sinoatrial node development,BP,
1455,GO:0003164,1,0.965891728916984,0,5,His-Purkinje system development,BP,
1456,GO:0003165,1,0.98620600692032,0,2,Purkinje myocyte development,BP,
1457,GO:0003166,1,0.97173699706424,0,4,bundle of His development,BP,
1458,GO:0003167,1,0.993892757332137,0,1,atrioventricular bundle cell differentiation,BP,
1459,GO:0003168,1,0.992173236388616,0,1,Purkinje myocyte differentiation,BP,
1460,GO:0003169,1,0.987098528477173,0,2,coronary vein morphogenesis,BP,
1462,GO:0003171,1,0.845231803643472,0,24,atrioventricular valve development,BP,
1463,GO:0003172,1,0.993986332267048,0,1,sinoatrial valve development,BP,
1464,GO:0003174,1,0.926476235280526,0,11,mitral valve development,BP,
1465,GO:0003175,1,0.959048255616549,0,6,tricuspid valve development,BP,
1466,GO:0003176,1,0.956114324610082,0,6,aortic valve development,BP,
1467,GO:0003177,1,0.919200179372262,0,12,pulmonary valve development,BP,
1468,GO:0003179,1,0.790392711192166,0,34,heart valve morphogenesis,BP,
1469,GO:0003180,1,0.956114324610082,0,6,aortic valve morphogenesis,BP,
1470,GO:0003181,1,0.864918545017328,0,21,atrioventricular valve morphogenesis,BP,
1471,GO:0003183,1,0.933275913144605,0,10,mitral valve morphogenesis,BP,
1472,GO:0003184,1,0.919200179372262,0,12,pulmonary valve morphogenesis,BP,
1473,GO:0003185,1,0.993986332267048,0,1,sinoatrial valve morphogenesis,BP,
1474,GO:0003186,1,0.966618854948707,0,5,tricuspid valve morphogenesis,BP,
1475,GO:0003188,1,0.911883238959533,0,13,heart valve formation,BP,
1476,GO:0003190,1,0.952481565418167,0,7,atrioventricular valve formation,BP,
1477,GO:0003192,1,0.980890122373897,0,3,mitral valve formation,BP,
1478,GO:0003193,1,0.984944700959493,0,2,pulmonary valve formation,BP,
1479,GO:0003195,1,0.985196788904421,0,2,tricuspid valve formation,BP,
1480,GO:0003197,1,0.759556798228856,0,39,endocardial cushion development,BP,
1481,GO:0003198,1,0.884984565238992,0,17,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1482,GO:0003199,1,0.970947072891751,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1483,GO:0003203,1,0.813620227572101,0,29,endocardial cushion morphogenesis,BP,
1486,GO:0003207,1,0.918292435864499,0,12,cardiac chamber formation,BP,
1487,GO:0003208,1,0.607669776762681,0,71,cardiac ventricle morphogenesis,BP,
1488,GO:0003209,1,0.809040722376381,0,30,cardiac atrium morphogenesis,BP,
1489,GO:0003210,1,0.992170027168696,0,1,cardiac atrium formation,BP,
1490,GO:0003211,1,0.932138212902415,0,10,cardiac ventricle formation,BP,
1491,GO:0003213,1,0.988008547478096,0,2,cardiac right atrium morphogenesis,BP,
1492,GO:0003214,1,0.904500594467264,0,14,cardiac left ventricle morphogenesis,BP,
1493,GO:0003215,1,0.874891242043493,0,19,cardiac right ventricle morphogenesis,BP,
1494,GO:0003218,1,0.985422792534432,0,2,cardiac left ventricle formation,BP,
1495,GO:0003219,1,0.970876602528,0,4,cardiac right ventricle formation,BP,
1496,GO:0003220,1,0.988008547519898,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1497,GO:0003221,1,0.980090333268881,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1498,GO:0003222,1,0.895595587975245,0,16,ventricular trabecula myocardium morphogenesis,BP,
1499,GO:0003223,1,0.955506179057416,0,7,ventricular compact myocardium morphogenesis,BP,
1500,GO:0003226,1,0.993986332286744,0,1,right ventricular compact myocardium morphogenesis,BP,
1501,GO:0003228,1,0.949449053314948,0,7,atrial cardiac muscle tissue development,BP,
1502,GO:0003229,1,0.695766083762957,0,52,ventricular cardiac muscle tissue development,BP,
1503,GO:0003230,1,0.78827116623498,0,34,cardiac atrium development,BP,
1504,GO:0003231,1,0.447076187732023,0,116,cardiac ventricle development,BP,
1505,GO:0003235,1,0.992170027168696,0,1,sinus venosus development,BP,
1506,GO:0003236,1,0.992170027168696,0,1,sinus venosus morphogenesis,BP,
1507,GO:0003241,1,0.971250734814316,0,4,growth involved in heart morphogenesis,BP,
1508,GO:0003245,1,0.984840104749324,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1509,GO:0003247,1,0.992170027168696,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1510,GO:0003249,1,0.988008547504167,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1511,GO:0003250,1,0.988008547504167,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1512,GO:0003251,1,0.993986332279134,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1513,GO:0003252,1,0.993986332293407,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1514,GO:0003253,1,0.969134255314827,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1515,GO:0003254,1,0.750440318331194,0,41,regulation of membrane depolarization,BP,
1516,GO:0003256,1,0.953679346100798,0,7,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1517,GO:0003257,1,0.973854839420635,0,4,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1518,GO:0003259,1,0.992170027168696,0,1,cardioblast anterior-lateral migration,BP,
1519,GO:0003260,1,0.992170027168696,0,1,cardioblast migration,BP,
1520,GO:0003263,1,0.935218814645153,0,9,cardioblast proliferation,BP,
1521,GO:0003264,1,0.929591782744537,0,10,regulation of cardioblast proliferation,BP,
1522,GO:0003266,1,0.936746404700982,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1523,GO:0003270,1,0.993986332281635,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1524,GO:0003272,1,0.85446114651981,0,22,endocardial cushion formation,BP,
1525,GO:0003273,1,0.973122012405602,0,4,cell migration involved in endocardial cushion formation,BP,
1526,GO:0003274,1,0.980501411953653,0,3,endocardial cushion fusion,BP,
1527,GO:0003275,1,0.979273615836624,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1528,GO:0003278,1,0.956548138444434,0,6,apoptotic process involved in heart morphogenesis,BP,
1529,GO:0003279,1,0.520415619517178,0,95,cardiac septum development,BP,
1530,GO:0003281,1,0.656104345864293,0,62,ventricular septum development,BP,
1531,GO:0003283,1,0.876544961008645,0,19,atrial septum development,BP,
1532,GO:0003284,1,0.966558081617741,0,5,septum primum development,BP,
1533,GO:0003285,1,0.985187402470064,0,2,septum secundum development,BP,
1534,GO:0003289,1,0.973649576160443,0,4,atrial septum primum morphogenesis,BP,
1535,GO:0003290,1,0.992959488927935,0,1,atrial septum secundum morphogenesis,BP,
1536,GO:0003292,1,0.986206212218878,0,2,cardiac septum cell differentiation,BP,
1537,GO:0003294,1,0.992718098684504,0,1,atrial ventricular junction remodeling,BP,
1538,GO:0003298,1,0.873005884225316,0,19,physiological muscle hypertrophy,BP,
1539,GO:0003299,1,0.877957562029249,0,19,muscle hypertrophy in response to stress,BP,
1540,GO:0003300,1,0.633162709148121,0,66,cardiac muscle hypertrophy,BP,
1541,GO:0003301,1,0.873005884225316,0,19,physiological cardiac muscle hypertrophy,BP,
1542,GO:0003306,1,0.929449817385681,0,10,Wnt signaling pathway involved in heart development,BP,
1543,GO:0003307,1,0.962082314222406,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1544,GO:0003308,1,0.969619369792482,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1545,GO:0003309,1,0.848007389187609,0,23,type B pancreatic cell differentiation,BP,
1546,GO:0003310,1,0.950282017908623,0,7,pancreatic A cell differentiation,BP,
1547,GO:0003311,1,0.993053229935835,0,1,pancreatic D cell differentiation,BP,
1548,GO:0003312,1,0.984565801251586,0,2,pancreatic PP cell differentiation,BP,
1549,GO:0003318,1,0.992170027168696,0,1,cell migration to the midline involved in heart development,BP,
1550,GO:0003321,1,0.948744251061998,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1551,GO:0003322,1,0.993986332270077,0,1,pancreatic A cell development,BP,
1552,GO:0003323,1,0.873254777749607,0,19,type B pancreatic cell development,BP,
1553,GO:0003326,1,0.984565801251586,0,2,pancreatic A cell fate commitment,BP,
1554,GO:0003327,1,0.992182389405322,0,1,type B pancreatic cell fate commitment,BP,
1555,GO:0003329,1,0.984565801251586,0,2,pancreatic PP cell fate commitment,BP,
1556,GO:0003330,1,0.976945359940737,0,3,regulation of extracellular matrix constituent secretion,BP,
1557,GO:0003331,1,0.976945359940737,0,3,positive regulation of extracellular matrix constituent secretion,BP,
1559,GO:0003334,1,0.925335745736971,0,11,keratinocyte development,BP,
1560,GO:0003335,1,0.98451769842549,0,2,corneocyte development,BP,
1561,GO:0003336,1,0.992287752476639,0,1,corneocyte desquamation,BP,
1562,GO:0003337,1,0.912037748385154,0,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1563,GO:0003338,1,0.793448870320961,0,33,metanephros morphogenesis,BP,
1564,GO:0003339,1,0.94444449546334,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1565,GO:0003340,1,0.978423715462697,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1566,GO:0003341,1,0.704716787540082,0,48,cilium movement,BP,
1567,GO:0003342,1,0.984819388953875,0,2,proepicardium development,BP,
1568,GO:0003343,1,0.984819388953875,0,2,septum transversum development,BP,
1569,GO:0003344,1,0.941745651385377,0,9,pericardium morphogenesis,BP,
1570,GO:0003345,1,0.993408080055231,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1571,GO:0003348,1,0.957893247927748,0,6,cardiac endothelial cell differentiation,BP,
1572,GO:0003350,1,0.978496773996225,0,3,pulmonary myocardium development,BP,
1573,GO:0003351,1,0.87340349464768,0,19,epithelial cilium movement,BP,
1574,GO:0003352,1,0.923524868853114,0,11,regulation of cilium movement,BP,
1575,GO:0003353,1,0.992576336255652,0,1,positive regulation of cilium movement,BP,
1576,GO:0003356,1,0.930435990171945,0,10,regulation of cilium beat frequency,BP,
1577,GO:0003357,1,0.950667336437773,0,7,noradrenergic neuron differentiation,BP,
1578,GO:0003358,1,0.977464691750588,0,3,noradrenergic neuron development,BP,
1579,GO:0003359,1,0.992262432956955,0,1,noradrenergic neuron fate commitment,BP,
1580,GO:0003360,1,0.952881748428509,0,7,brainstem development,BP,
1581,GO:0003363,1,0.993986332265415,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1582,GO:0003365,1,0.988008547481236,0,2,establishment of cell polarity involved in ameboidal cell migration,BP,
1583,GO:0003366,1,0.986441373848082,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1584,GO:0003373,1,0.95400839212305,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1585,GO:0003374,1,0.95400839212305,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1586,GO:0003376,1,0.914960342933085,0,12,sphingosine-1-phosphate signaling pathway,BP,
1587,GO:0003382,1,0.818488381698518,0,29,epithelial cell morphogenesis,BP,
1588,GO:0003383,1,0.98201418795787,0,3,apical constriction,BP,
1589,GO:0003400,1,0.992192824690033,0,1,regulation of COPII vesicle coating,BP,
1590,GO:0003401,1,0.805577006603677,0,31,axis elongation,BP,
1591,GO:0003402,1,0.960743838562417,0,6,planar cell polarity pathway involved in axis elongation,BP,
1592,GO:0003404,1,0.98518393765137,0,2,optic vesicle morphogenesis,BP,
1593,GO:0003406,1,0.972809433143992,0,4,retinal pigment epithelium development,BP,
1594,GO:0003407,1,0.67061302852671,0,57,neural retina development,BP,
1595,GO:0003408,1,0.980663716057116,0,3,optic cup formation involved in camera-type eye development,BP,
1596,GO:0003409,1,0.992850681459347,0,1,optic cup structural organization,BP,
1597,GO:0003413,1,0.933412750469348,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1598,GO:0003414,1,0.993371143165214,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1599,GO:0003415,1,0.973639588296026,0,4,chondrocyte hypertrophy,BP,
1600,GO:0003416,1,0.860151162161757,0,21,endochondral bone growth,BP,
1601,GO:0003417,1,0.896484109626623,0,15,growth plate cartilage development,BP,
1602,GO:0003418,1,0.958756182117469,0,6,growth plate cartilage chondrocyte differentiation,BP,
1603,GO:0003419,1,0.969521009446707,0,4,growth plate cartilage chondrocyte proliferation,BP,
1604,GO:0003420,1,0.984886172371191,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1605,GO:0003421,1,0.993411145903599,0,1,growth plate cartilage axis specification,BP,
1606,GO:0003422,1,0.986825626412854,0,2,growth plate cartilage morphogenesis,BP,
1607,GO:0003429,1,0.993371143165214,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1608,GO:0003430,1,0.986357884810824,0,2,growth plate cartilage chondrocyte growth,BP,
1609,GO:0003431,1,0.972774262105169,0,4,growth plate cartilage chondrocyte development,BP,
1610,GO:0003433,1,0.958782878553613,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1614,GO:0003678,1,0.724778423914494,0,47,DNA helicase activity,MF,
1615,GO:0003680,1,0.94114557485281,0,8,AT DNA binding,MF,
1616,GO:0003682,1,0.0345419118588801,0,470,chromatin binding,MF,
1617,GO:0003684,1,0.645162137418442,0,62,damaged DNA binding,MF,
1618,GO:0003688,1,0.907184094198325,0,13,DNA replication origin binding,MF,
1619,GO:0003689,1,0.941541750489472,0,8,DNA clamp loader activity,MF,
1621,GO:0003691,1,0.93555908707181,0,9,double-stranded telomeric DNA binding,MF,
1622,GO:0003692,1,0.992195087797019,0,1,left-handed Z-DNA binding,MF,
1623,GO:0003696,1,0.950117104244859,0,7,satellite DNA binding,MF,
1624,GO:0003697,1,0.514840872197185,0,91,single-stranded DNA binding,MF,
1626,GO:0003705,1,0.505291085329231,0,94,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1627,GO:0003707,1,0.663646185388716,0,58,steroid hormone receptor activity,MF,
1628,GO:0003708,1,0.95145681315077,0,7,retinoic acid receptor activity,MF,
1631,GO:0003714,1,0.211638130662882,0,216,transcription corepressor activity,MF,
1632,GO:0003720,1,0.950811666867983,0,7,telomerase activity,MF,
1633,GO:0003721,1,0.993518782405315,0,1,telomerase RNA reverse transcriptase activity,MF,
1635,GO:0003724,1,0.620916007021599,0,68,RNA helicase activity,MF,
1636,GO:0003725,1,0.65486934885793,0,60,double-stranded RNA binding,MF,
1637,GO:0003726,1,0.980245507445337,0,3,double-stranded RNA adenosine deaminase activity,MF,
1638,GO:0003727,1,0.592460397897401,0,72,single-stranded RNA binding,MF,
1642,GO:0003743,1,0.693309172107821,0,50,translation initiation factor activity,MF,
1644,GO:0003747,1,0.958133915444298,0,6,translation release factor activity,MF,
1645,GO:0003755,1,0.748807344532464,0,38,peptidyl-prolyl cis-trans isomerase activity,MF,
1646,GO:0003756,1,0.878717296644398,0,18,protein disulfide isomerase activity,MF,
1647,GO:0003774,1,0.421936405080833,0,130,motor activity,MF,
1648,GO:0003777,1,0.602365146510716,0,76,microtubule motor activity,MF,
1650,GO:0003785,1,0.830276207970014,0,26,actin monomer binding,MF,
1651,GO:0003796,1,0.917139935465552,0,11,lysozyme activity,MF,
1652,GO:0003810,1,0.93427655827785,0,9,protein-glutamine gamma-glutamyltransferase activity,MF,
1653,GO:0003823,1,0.614367272116817,0,64,antigen binding,MF,
1655,GO:0003826,1,0.984558833229487,0,2,alpha-ketoacid dehydrogenase activity,MF,
1656,GO:0003827,1,0.992508881957906,0,1,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1657,GO:0003828,1,0.960679618153603,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1658,GO:0003829,1,0.979308871342758,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1659,GO:0003830,1,0.993947371580576,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1660,GO:0003831,1,0.945393937528493,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1661,GO:0003835,1,0.987725415609248,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1662,GO:0003836,1,0.957317893011426,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1663,GO:0003837,1,0.992182213557173,0,1,beta-ureidopropionase activity,MF,
1664,GO:0003839,1,0.969164958321263,0,4,gamma-glutamylcyclotransferase activity,MF,
1665,GO:0003840,1,0.954365103520943,0,6,gamma-glutamyltransferase activity,MF,
1666,GO:0003841,1,0.890084191102298,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1667,GO:0003842,1,0.992801682381572,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1668,GO:0003844,1,0.992668731047171,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1669,GO:0003845,1,0.984402822047744,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1670,GO:0003846,1,0.955076349049186,0,6,2-acylglycerol O-acyltransferase activity,MF,
1671,GO:0003847,1,0.962391448639449,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1675,GO:0003860,1,0.992173551773947,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1676,GO:0003863,1,0.984558833229487,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1677,GO:0003865,1,0.976978829513552,0,3,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1678,GO:0003867,1,0.993929645472371,0,1,4-aminobutyrate transaminase activity,MF,
1679,GO:0003868,1,0.992170027827762,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1680,GO:0003870,1,0.984463096648436,0,2,5-aminolevulinate synthase activity,MF,
1681,GO:0003872,1,0.977982417264524,0,3,6-phosphofructokinase activity,MF,
1682,GO:0003873,1,0.973216756360819,0,4,6-phosphofructo-2-kinase activity,MF,
1684,GO:0003875,1,0.985212618030818,0,2,ADP-ribosylarginine hydrolase activity,MF,
1685,GO:0003876,1,0.979410061954935,0,3,AMP deaminase activity,MF,
1686,GO:0003878,1,0.993743111015143,0,1,ATP citrate synthase activity,MF,
1687,GO:0003880,1,0.986124587085354,0,2,protein C-terminal carboxyl O-methyltransferase activity,MF,
1688,GO:0003881,1,0.992171825893236,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1689,GO:0003882,1,0.99225488024433,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1690,GO:0003883,1,0.985816882393835,0,2,CTP synthase activity,MF,
1691,GO:0003884,1,0.984400887813367,0,2,D-amino-acid oxidase activity,MF,
1692,GO:0003886,1,0.98128138247584,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1693,GO:0003887,1,0.831733634124254,0,26,DNA-directed DNA polymerase activity,MF,
1694,GO:0003896,1,0.978519917767862,0,3,DNA primase activity,MF,
1695,GO:0003899,1,0.744637739024261,0,40,DNA-directed 5'-3' RNA polymerase activity,MF,
1696,GO:0003905,1,0.992170027168696,0,1,alkylbase DNA N-glycosylase activity,MF,
1697,GO:0003906,1,0.897316599046305,0,14,DNA-(apurinic or apyrimidinic site) lyase activity,MF,
1698,GO:0003908,1,0.992170027168696,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1699,GO:0003909,1,0.950348194549164,0,7,DNA ligase activity,MF,
1700,GO:0003910,1,0.957834864268312,0,6,DNA ligase (ATP) activity,MF,
1701,GO:0003912,1,0.992179885931469,0,1,DNA nucleotidylexotransferase activity,MF,
1702,GO:0003916,1,0.952850363962874,0,7,DNA topoisomerase activity,MF,
1703,GO:0003917,1,0.972046956345579,0,4,DNA topoisomerase type I activity,MF,
1704,GO:0003918,1,0.980255705921505,0,3,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1705,GO:0003919,1,0.992175466744087,0,1,FMN adenylyltransferase activity,MF,
1706,GO:0003920,1,0.984402873670592,0,2,GMP reductase activity,MF,
1707,GO:0003921,1,0.992259426366292,0,1,GMP synthase activity,MF,
1708,GO:0003922,1,0.992259426366292,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1709,GO:0003923,1,0.963430869274472,0,5,GPI-anchor transamidase activity,MF,
1710,GO:0003924,1,0.137826376823548,0,266,GTPase activity,MF,
1711,GO:0003933,1,0.992174552329761,0,1,GTP cyclohydrolase activity,MF,
1712,GO:0003934,1,0.992174552329761,0,1,GTP cyclohydrolase I activity,MF,
1713,GO:0003937,1,0.992184732153989,0,1,IMP cyclohydrolase activity,MF,
1714,GO:0003938,1,0.984506288834941,0,2,IMP dehydrogenase activity,MF,
1715,GO:0003939,1,0.992282282316394,0,1,L-iditol 2-dehydrogenase activity,MF,
1717,GO:0003941,1,0.976785098163244,0,3,L-serine ammonia-lyase activity,MF,
1718,GO:0003943,1,0.985885021351931,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1719,GO:0003944,1,0.992198408455567,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1720,GO:0003945,1,0.970556011710968,0,4,N-acetyllactosamine synthase activity,MF,
1721,GO:0003947,1,0.992586046224704,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1722,GO:0003948,1,0.992183857473324,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1723,GO:0003950,1,0.855384819815878,0,22,NAD+ ADP-ribosyltransferase activity,MF,
1724,GO:0003951,1,0.898048279681245,0,16,NAD+ kinase activity,MF,
1725,GO:0003952,1,0.992252666157398,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1726,GO:0003953,1,0.976692112990833,0,3,NAD+ nucleosidase activity,MF,
1727,GO:0003954,1,0.743617777713172,0,38,NADH dehydrogenase activity,MF,
1728,GO:0003955,1,0.985323744944909,0,2,NAD(P)H dehydrogenase (quinone) activity,MF,
1729,GO:0003956,1,0.961453799076647,0,5,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1730,GO:0003957,1,0.993870302914218,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1731,GO:0003958,1,0.959637685687234,0,6,NADPH-hemoprotein reductase activity,MF,
1732,GO:0003960,1,0.969077740038824,0,4,NADPH:quinone reductase activity,MF,
1733,GO:0003962,1,0.992170154337142,0,1,cystathionine gamma-synthase activity,MF,
1734,GO:0003963,1,0.992294630214608,0,1,RNA-3'-phosphate cyclase activity,MF,
1735,GO:0003964,1,0.950811666867983,0,7,RNA-directed DNA polymerase activity,MF,
1736,GO:0003968,1,0.987543787593542,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1737,GO:0003973,1,0.984401033586019,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1738,GO:0003974,1,0.992170027168696,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1739,GO:0003975,1,0.99218990353333,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1740,GO:0003976,1,0.978499438407579,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1741,GO:0003977,1,0.98519404922387,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1742,GO:0003978,1,0.992170027168696,0,1,UDP-glucose 4-epimerase activity,MF,
1743,GO:0003979,1,0.992748772866644,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1744,GO:0003980,1,0.987959948082678,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1745,GO:0003983,1,0.99218978253185,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1748,GO:0003987,1,0.979120546927956,0,3,acetate-CoA ligase activity,MF,
1750,GO:0003989,1,0.988008547496917,0,2,acetyl-CoA carboxylase activity,MF,
1751,GO:0003990,1,0.984614679816079,0,2,acetylcholinesterase activity,MF,
1753,GO:0003994,1,0.985556840509724,0,2,aconitate hydratase activity,MF,
1756,GO:0003997,1,0.956154186415621,0,6,acyl-CoA oxidase activity,MF,
1757,GO:0003998,1,0.984400887813367,0,2,acylphosphatase activity,MF,
1758,GO:0003999,1,0.992170027168696,0,1,adenine phosphoribosyltransferase activity,MF,
1759,GO:0004000,1,0.930767626910905,0,10,adenosine deaminase activity,MF,
1760,GO:0004001,1,0.99218086641826,0,1,adenosine kinase activity,MF,
1761,GO:0004003,1,0.798933529420714,0,33,ATP-dependent DNA helicase activity,MF,
1762,GO:0004004,1,0.62555242732944,0,67,ATP-dependent RNA helicase activity,MF,
1763,GO:0004008,1,0.988008547476944,0,2,copper-exporting ATPase activity,MF,
1764,GO:0004012,1,0.890248489470554,0,19,phospholipid-translocating ATPase activity,MF,
1765,GO:0004013,1,0.992213585501374,0,1,adenosylhomocysteinase activity,MF,
1766,GO:0004014,1,0.992814836623527,0,1,adenosylmethionine decarboxylase activity,MF,
1767,GO:0004016,1,0.939236111040716,0,10,adenylate cyclase activity,MF,
1768,GO:0004017,1,0.949598925550746,0,7,adenylate kinase activity,MF,
1769,GO:0004018,1,0.992170027168696,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1770,GO:0004019,1,0.984628574995989,0,2,adenylosuccinate synthase activity,MF,
1771,GO:0004020,1,0.985733812050048,0,2,adenylylsulfate kinase activity,MF,
1772,GO:0004021,1,0.985673814946351,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1773,GO:0004022,1,0.93205571758156,0,9,alcohol dehydrogenase (NAD) activity,MF,
1774,GO:0004024,1,0.954146383412592,0,6,alcohol dehydrogenase activity, zinc-dependent,MF,
1775,GO:0004027,1,0.984400887813367,0,2,alcohol sulfotransferase activity,MF,
1776,GO:0004028,1,0.962573153143961,0,5,3-chloroallyl aldehyde dehydrogenase activity,MF,
1777,GO:0004029,1,0.902828955883785,0,14,aldehyde dehydrogenase (NAD) activity,MF,
1778,GO:0004030,1,0.948835940161915,0,7,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1780,GO:0004032,1,0.946457021635661,0,7,alditol:NADP+ 1-oxidoreductase activity,MF,
1782,GO:0004034,1,0.992265851840136,0,1,aldose 1-epimerase activity,MF,
1783,GO:0004035,1,0.969686660860537,0,4,alkaline phosphatase activity,MF,
1784,GO:0004037,1,0.992170027168696,0,1,allantoicase activity,MF,
1785,GO:0004040,1,0.978118307826483,0,3,amidase activity,MF,
1786,GO:0004042,1,0.992182389405322,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1787,GO:0004043,1,0.993114515466179,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1788,GO:0004044,1,0.993295329328107,0,1,amidophosphoribosyltransferase activity,MF,
1789,GO:0004045,1,0.976814787232004,0,3,aminoacyl-tRNA hydrolase activity,MF,
1790,GO:0004046,1,0.961549948996685,0,5,aminoacylase activity,MF,
1791,GO:0004047,1,0.984413066549262,0,2,aminomethyltransferase activity,MF,
1792,GO:0004051,1,0.992294218414588,0,1,arachidonate 5-lipoxygenase activity,MF,
1793,GO:0004052,1,0.977037187062819,0,3,arachidonate 12-lipoxygenase activity,MF,
1794,GO:0004053,1,0.984406727743525,0,2,arginase activity,MF,
1795,GO:0004055,1,0.992170896855612,0,1,argininosuccinate synthase activity,MF,
1796,GO:0004056,1,0.992176583163649,0,1,argininosuccinate lyase activity,MF,
1797,GO:0004057,1,0.992199656285403,0,1,arginyltransferase activity,MF,
1798,GO:0004058,1,0.992178307193692,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1799,GO:0004059,1,0.992170027168696,0,1,aralkylamine N-acetyltransferase activity,MF,
1800,GO:0004060,1,0.976700034020041,0,3,arylamine N-acetyltransferase activity,MF,
1801,GO:0004061,1,0.992170041209416,0,1,arylformamidase activity,MF,
1802,GO:0004062,1,0.917471113767195,0,11,aryl sulfotransferase activity,MF,
1803,GO:0004063,1,0.984401057622533,0,2,aryldialkylphosphatase activity,MF,
1805,GO:0004065,1,0.91833115259862,0,12,arylsulfatase activity,MF,
1806,GO:0004066,1,0.984542525245949,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1807,GO:0004067,1,0.984466037727235,0,2,asparaginase activity,MF,
1808,GO:0004068,1,0.993214535499846,0,1,aspartate 1-decarboxylase activity,MF,
1809,GO:0004069,1,0.976793800819484,0,3,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1810,GO:0004070,1,0.993986332271311,0,1,aspartate carbamoyltransferase activity,MF,
1811,GO:0004074,1,0.984400887813367,0,2,biliverdin reductase activity,MF,
1812,GO:0004075,1,0.966506435317997,0,5,biotin carboxylase activity,MF,
1813,GO:0004077,1,0.993986332265571,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1814,GO:0004078,1,0.993986332265571,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1815,GO:0004079,1,0.993986332265571,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1816,GO:0004080,1,0.993986332265571,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1817,GO:0004081,1,0.984625099557387,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1818,GO:0004082,1,0.969047174370287,0,4,bisphosphoglycerate mutase activity,MF,
1819,GO:0004084,1,0.986203080784392,0,2,branched-chain-amino-acid transaminase activity,MF,
1820,GO:0004085,1,0.992173236388616,0,1,butyryl-CoA dehydrogenase activity,MF,
1821,GO:0004087,1,0.993986317082102,0,1,carbamoyl-phosphate synthase (ammonia) activity,MF,
1822,GO:0004088,1,0.988008532375869,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1823,GO:0004089,1,0.906833687401237,0,13,carbonate dehydratase activity,MF,
1824,GO:0004090,1,0.969043241885221,0,4,carbonyl reductase (NADPH) activity,MF,
1825,GO:0004092,1,0.992437455831719,0,1,carnitine O-acetyltransferase activity,MF,
1827,GO:0004096,1,0.976742390921425,0,3,catalase activity,MF,
1828,GO:0004098,1,0.992172663197987,0,1,cerebroside-sulfatase activity,MF,
1829,GO:0004102,1,0.992260421200392,0,1,choline O-acetyltransferase activity,MF,
1830,GO:0004103,1,0.984588106032363,0,2,choline kinase activity,MF,
1831,GO:0004104,1,0.977090047308803,0,3,cholinesterase activity,MF,
1832,GO:0004105,1,0.986200555440837,0,2,choline-phosphate cytidylyltransferase activity,MF,
1833,GO:0004108,1,0.992557620167389,0,1,citrate (Si)-synthase activity,MF,
1834,GO:0004109,1,0.984697811340298,0,2,coproporphyrinogen oxidase activity,MF,
1835,GO:0004111,1,0.955670868116126,0,6,creatine kinase activity,MF,
1836,GO:0004112,1,0.844152042068749,0,25,cyclic-nucleotide phosphodiesterase activity,MF,
1837,GO:0004113,1,0.993969966303349,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1838,GO:0004114,1,0.849279754832733,0,24,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1839,GO:0004115,1,0.907008913655169,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1840,GO:0004117,1,0.977602608292131,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1841,GO:0004118,1,0.981740958054277,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1842,GO:0004119,1,0.98763643639811,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1843,GO:0004122,1,0.992312759411149,0,1,cystathionine beta-synthase activity,MF,
1844,GO:0004123,1,0.992170154337142,0,1,cystathionine gamma-lyase activity,MF,
1845,GO:0004126,1,0.939479756615229,0,8,cytidine deaminase activity,MF,
1846,GO:0004127,1,0.969998785693556,0,4,cytidylate kinase activity,MF,
1847,GO:0004128,1,0.947926097715953,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1849,GO:0004131,1,0.992170027168696,0,1,cytosine deaminase activity,MF,
1850,GO:0004132,1,0.992179002064802,0,1,dCMP deaminase activity,MF,
1851,GO:0004133,1,0.993986332271627,0,1,glycogen debranching enzyme activity,MF,
1852,GO:0004134,1,0.993986332271627,0,1,4-alpha-glucanotransferase activity,MF,
1853,GO:0004135,1,0.993986332271627,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1854,GO:0004137,1,0.986311826552634,0,2,deoxycytidine kinase activity,MF,
1855,GO:0004138,1,0.992170027168696,0,1,deoxyguanosine kinase activity,MF,
1857,GO:0004140,1,0.984455157396429,0,2,dephospho-CoA kinase activity,MF,
1858,GO:0004142,1,0.978354004049713,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1859,GO:0004143,1,0.93111640892324,0,11,diacylglycerol kinase activity,MF,
1860,GO:0004144,1,0.962598621689893,0,5,diacylglycerol O-acyltransferase activity,MF,
1861,GO:0004145,1,0.9767124066769,0,3,diamine N-acetyltransferase activity,MF,
1862,GO:0004146,1,0.993447293752693,0,1,dihydrofolate reductase activity,MF,
1863,GO:0004148,1,0.993137491452272,0,1,dihydrolipoyl dehydrogenase activity,MF,
1864,GO:0004149,1,0.992457640659739,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1865,GO:0004151,1,0.993986332271311,0,1,dihydroorotase activity,MF,
1866,GO:0004152,1,0.992182039384568,0,1,dihydroorotate dehydrogenase activity,MF,
1867,GO:0004155,1,0.992170027168696,0,1,6,7-dihydropteridine reductase activity,MF,
1868,GO:0004157,1,0.986062094780136,0,2,dihydropyrimidinase activity,MF,
1869,GO:0004161,1,0.98465819747764,0,2,dimethylallyltranstransferase activity,MF,
1870,GO:0004163,1,0.992170555790819,0,1,diphosphomevalonate decarboxylase activity,MF,
1871,GO:0004164,1,0.992170473991716,0,1,diphthine synthase activity,MF,
1873,GO:0004167,1,0.976747651372622,0,3,dopachrome isomerase activity,MF,
1874,GO:0004168,1,0.992197196162805,0,1,dolichol kinase activity,MF,
1875,GO:0004169,1,0.963624220411296,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1876,GO:0004170,1,0.992171801564538,0,1,dUTP diphosphatase activity,MF,
1879,GO:0004176,1,0.97241302537861,0,4,ATP-dependent peptidase activity,MF,
1883,GO:0004185,1,0.963276298626902,0,5,serine-type carboxypeptidase activity,MF,
1884,GO:0004190,1,0.834508901185191,0,24,aspartic-type endopeptidase activity,MF,
1886,GO:0004198,1,0.869007704985613,0,19,calcium-dependent cysteine-type endopeptidase activity,MF,
1887,GO:0004222,1,0.452350315121645,0,112,metalloendopeptidase activity,MF,
1891,GO:0004301,1,0.961566125740431,0,5,epoxide hydrolase activity,MF,
1893,GO:0004304,1,0.984407464183313,0,2,estrone sulfotransferase activity,MF,
1894,GO:0004305,1,0.970688333062505,0,4,ethanolamine kinase activity,MF,
1895,GO:0004306,1,0.992171462516774,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1896,GO:0004307,1,0.984433708324611,0,2,ethanolaminephosphotransferase activity,MF,
1897,GO:0004308,1,0.954333109709618,0,6,exo-alpha-sialidase activity,MF,
1898,GO:0004310,1,0.992185746419627,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1899,GO:0004311,1,0.969968011080621,0,4,farnesyltranstransferase activity,MF,
1901,GO:0004313,1,0.993986332277816,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1902,GO:0004314,1,0.986207357979953,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1903,GO:0004315,1,0.986203080785463,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1904,GO:0004316,1,0.993986332277816,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1905,GO:0004317,1,0.993986332277816,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1906,GO:0004319,1,0.993986332277816,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1907,GO:0004320,1,0.986203271969489,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1909,GO:0004322,1,0.960623151677619,0,6,ferroxidase activity,MF,
1910,GO:0004324,1,0.992172478498993,0,1,ferredoxin-NADP+ reductase activity,MF,
1911,GO:0004325,1,0.993986332271944,0,1,ferrochelatase activity,MF,
1912,GO:0004326,1,0.992268294570555,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1913,GO:0004329,1,0.986238574778287,0,2,formate-tetrahydrofolate ligase activity,MF,
1914,GO:0004331,1,0.973216756360819,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1915,GO:0004332,1,0.97676922756185,0,3,fructose-bisphosphate aldolase activity,MF,
1916,GO:0004333,1,0.992170473991716,0,1,fumarate hydratase activity,MF,
1917,GO:0004334,1,0.992170027168696,0,1,fumarylacetoacetase activity,MF,
1918,GO:0004335,1,0.98495028372863,0,2,galactokinase activity,MF,
1919,GO:0004336,1,0.99250042433583,0,1,galactosylceramidase activity,MF,
1920,GO:0004337,1,0.98465819747764,0,2,geranyltranstransferase activity,MF,
1921,GO:0004339,1,0.993986332268204,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1922,GO:0004340,1,0.966012122882783,0,5,glucokinase activity,MF,
1924,GO:0004342,1,0.984447833118714,0,2,glucosamine-6-phosphate deaminase activity,MF,
1925,GO:0004343,1,0.993455717956937,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1926,GO:0004345,1,0.986257009313031,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1927,GO:0004346,1,0.977585016458182,0,3,glucose-6-phosphatase activity,MF,
1928,GO:0004347,1,0.992183762484666,0,1,glucose-6-phosphate isomerase activity,MF,
1929,GO:0004348,1,0.977748526695131,0,3,glucosylceramidase activity,MF,
1930,GO:0004349,1,0.993021977199118,0,1,glutamate 5-kinase activity,MF,
1931,GO:0004350,1,0.993021977199118,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1932,GO:0004351,1,0.978459247956085,0,3,glutamate decarboxylase activity,MF,
1933,GO:0004352,1,0.985309443757903,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1934,GO:0004353,1,0.985309443757903,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1935,GO:0004356,1,0.987764845120699,0,2,glutamate-ammonia ligase activity,MF,
1936,GO:0004357,1,0.985961746006548,0,2,glutamate-cysteine ligase activity,MF,
1937,GO:0004359,1,0.978474064092489,0,3,glutaminase activity,MF,
1938,GO:0004360,1,0.986624236531762,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1939,GO:0004361,1,0.992170061138958,0,1,glutaryl-CoA dehydrogenase activity,MF,
1940,GO:0004362,1,0.992209238237113,0,1,glutathione-disulfide reductase activity,MF,
1941,GO:0004363,1,0.992172758928497,0,1,glutathione synthase activity,MF,
1943,GO:0004365,1,0.984400887813367,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1944,GO:0004366,1,0.986480574725204,0,2,glycerol-3-phosphate O-acyltransferase activity,MF,
1945,GO:0004367,1,0.985967707163203,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1946,GO:0004368,1,0.986506928537866,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1947,GO:0004370,1,0.979499437972345,0,3,glycerol kinase activity,MF,
1948,GO:0004372,1,0.984521315441538,0,2,glycine hydroxymethyltransferase activity,MF,
1949,GO:0004373,1,0.985742664289992,0,2,glycogen (starch) synthase activity,MF,
1950,GO:0004375,1,0.993367528362668,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1951,GO:0004376,1,0.969560521003086,0,4,glycolipid mannosyltransferase activity,MF,
1952,GO:0004377,1,0.992284605430875,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1953,GO:0004378,1,0.992497375134058,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1954,GO:0004379,1,0.987906012471649,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1955,GO:0004380,1,0.992170027168696,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1956,GO:0004381,1,0.992170027168696,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1957,GO:0004382,1,0.985264149023276,0,2,guanosine-diphosphatase activity,MF,
1958,GO:0004383,1,0.894778485365547,0,17,guanylate cyclase activity,MF,
1959,GO:0004385,1,0.918587556633736,0,13,guanylate kinase activity,MF,
1960,GO:0004386,1,0.363993373615952,0,147,helicase activity,MF,
1961,GO:0004392,1,0.984401003909679,0,2,heme oxygenase (decyclizing) activity,MF,
1962,GO:0004394,1,0.993633655700252,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1963,GO:0004395,1,0.992170027168696,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1964,GO:0004396,1,0.966012122882783,0,5,hexokinase activity,MF,
1965,GO:0004397,1,0.992710157412083,0,1,histidine ammonia-lyase activity,MF,
1966,GO:0004398,1,0.992242745961486,0,1,histidine decarboxylase activity,MF,
1967,GO:0004402,1,0.679618317611589,0,54,histone acetyltransferase activity,MF,
1968,GO:0004407,1,0.75684231541225,0,40,histone deacetylase activity,MF,
1969,GO:0004408,1,0.99221277234403,0,1,holocytochrome-c synthase activity,MF,
1970,GO:0004411,1,0.992173494680933,0,1,homogentisate 1,2-dioxygenase activity,MF,
1971,GO:0004415,1,0.955780193137719,0,6,hyalurononglucosaminidase activity,MF,
1972,GO:0004416,1,0.984792029050511,0,2,hydroxyacylglutathione hydrolase activity,MF,
1973,GO:0004418,1,0.992170027168696,0,1,hydroxymethylbilane synthase activity,MF,
1974,GO:0004419,1,0.984508312266708,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1975,GO:0004420,1,0.993813173218733,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1976,GO:0004421,1,0.985330163773677,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1977,GO:0004422,1,0.992170027168696,0,1,hypoxanthine phosphoribosyltransferase activity,MF,
1978,GO:0004423,1,0.993986332264517,0,1,iduronate-2-sulfatase activity,MF,
1979,GO:0004427,1,0.976692112990833,0,3,inorganic diphosphatase activity,MF,
1980,GO:0004430,1,0.974014755498564,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1981,GO:0004435,1,0.831231042769379,0,27,phosphatidylinositol phospholipase C activity,MF,
1982,GO:0004438,1,0.911489719596726,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1983,GO:0004439,1,0.947190614647678,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1984,GO:0004441,1,0.992184096858826,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1985,GO:0004445,1,0.964848437275661,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1986,GO:0004446,1,0.992454101113446,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1987,GO:0004447,1,0.986569741734317,0,2,iodide peroxidase activity,MF,
1989,GO:0004449,1,0.976865069356043,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1991,GO:0004452,1,0.98441931575969,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1992,GO:0004454,1,0.992244779877905,0,1,ketohexokinase activity,MF,
1995,GO:0004459,1,0.961508833278851,0,5,L-lactate dehydrogenase activity,MF,
1996,GO:0004461,1,0.978167963384361,0,3,lactose synthase activity,MF,
1997,GO:0004462,1,0.992180077087248,0,1,lactoylglutathione lyase activity,MF,
1998,GO:0004463,1,0.992182477960255,0,1,leukotriene-A4 hydrolase activity,MF,
2000,GO:0004465,1,0.941798261074872,0,8,lipoprotein lipase activity,MF,
2002,GO:0004467,1,0.910061403667181,0,13,long-chain fatty acid-CoA ligase activity,MF,
2003,GO:0004468,1,0.958184700262215,0,6,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
2005,GO:0004471,1,0.979089900761032,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
2006,GO:0004473,1,0.979089900761032,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
2007,GO:0004474,1,0.993986327695254,0,1,malate synthase activity,MF,
2008,GO:0004475,1,0.992170027168696,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
2009,GO:0004476,1,0.992170321724734,0,1,mannose-6-phosphate isomerase activity,MF,
2010,GO:0004477,1,0.970942845366571,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
2011,GO:0004478,1,0.985445429119909,0,2,methionine adenosyltransferase activity,MF,
2012,GO:0004479,1,0.99238991880095,0,1,methionyl-tRNA formyltransferase activity,MF,
2013,GO:0004482,1,0.993986332266572,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2014,GO:0004484,1,0.993796223457449,0,1,mRNA guanylyltransferase activity,MF,
2015,GO:0004485,1,0.985573196434352,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2016,GO:0004486,1,0.993022985762141,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2017,GO:0004487,1,0.977622854293461,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2018,GO:0004488,1,0.970942845366571,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2019,GO:0004489,1,0.993986332271365,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2020,GO:0004490,1,0.992170027168696,0,1,methylglutaconyl-CoA hydratase activity,MF,
2021,GO:0004491,1,0.992195158617293,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2022,GO:0004492,1,0.992186590615345,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2023,GO:0004493,1,0.992170027168696,0,1,methylmalonyl-CoA epimerase activity,MF,
2024,GO:0004494,1,0.992542116832382,0,1,methylmalonyl-CoA mutase activity,MF,
2025,GO:0004496,1,0.99218243363011,0,1,mevalonate kinase activity,MF,
2027,GO:0004498,1,0.992268294570555,0,1,calcidiol 1-monooxygenase activity,MF,
2028,GO:0004499,1,0.963343426694782,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2029,GO:0004500,1,0.985068212808892,0,2,dopamine beta-monooxygenase activity,MF,
2030,GO:0004502,1,0.993947519604445,0,1,kynurenine 3-monooxygenase activity,MF,
2031,GO:0004503,1,0.992181611231008,0,1,monophenol monooxygenase activity,MF,
2032,GO:0004504,1,0.993276822232559,0,1,peptidylglycine monooxygenase activity,MF,
2034,GO:0004506,1,0.992566722908936,0,1,squalene monooxygenase activity,MF,
2035,GO:0004507,1,0.985563945034658,0,2,steroid 11-beta-monooxygenase activity,MF,
2037,GO:0004509,1,0.992178824839781,0,1,steroid 21-monooxygenase activity,MF,
2038,GO:0004510,1,0.984461704900245,0,2,tryptophan 5-monooxygenase activity,MF,
2040,GO:0004512,1,0.992207918298462,0,1,inositol-3-phosphate synthase activity,MF,
2041,GO:0004513,1,0.992217372458568,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2042,GO:0004514,1,0.986057617188883,0,2,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2043,GO:0004515,1,0.97372643080593,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2044,GO:0004517,1,0.980048325756046,0,3,nitric-oxide synthase activity,MF,
2047,GO:0004520,1,0.687281147743107,0,50,endodeoxyribonuclease activity,MF,
2049,GO:0004522,1,0.969043237344425,0,4,ribonuclease A activity,MF,
2050,GO:0004523,1,0.954517516075422,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2051,GO:0004525,1,0.972520205751565,0,4,ribonuclease III activity,MF,
2052,GO:0004526,1,0.926899778726298,0,10,ribonuclease P activity,MF,
2053,GO:0004527,1,0.592557634099336,0,73,exonuclease activity,MF,
2054,GO:0004528,1,0.964466307444577,0,5,phosphodiesterase I activity,MF,
2055,GO:0004529,1,0.869408587955668,0,19,exodeoxyribonuclease activity,MF,
2056,GO:0004530,1,0.992660578079422,0,1,deoxyribonuclease I activity,MF,
2057,GO:0004531,1,0.984408355721951,0,2,deoxyribonuclease II activity,MF,
2058,GO:0004532,1,0.796465088173033,0,32,exoribonuclease activity,MF,
2059,GO:0004534,1,0.987037916083806,0,2,5'-3' exoribonuclease activity,MF,
2060,GO:0004535,1,0.920780216777298,0,12,poly(A)-specific ribonuclease activity,MF,
2061,GO:0004536,1,0.59667173338983,0,69,deoxyribonuclease activity,MF,
2063,GO:0004549,1,0.892279116389365,0,15,tRNA-specific ribonuclease activity,MF,
2064,GO:0004550,1,0.88387262485979,0,16,nucleoside diphosphate kinase activity,MF,
2065,GO:0004551,1,0.902630411360095,0,14,nucleotide diphosphatase activity,MF,
2067,GO:0004555,1,0.992171570232374,0,1,alpha,alpha-trehalase activity,MF,
2068,GO:0004556,1,0.961481557407051,0,5,alpha-amylase activity,MF,
2070,GO:0004558,1,0.975206343682154,0,4,alpha-1,4-glucosidase activity,MF,
2071,GO:0004559,1,0.91727378022368,0,13,alpha-mannosidase activity,MF,
2072,GO:0004560,1,0.984431931597091,0,2,alpha-L-fucosidase activity,MF,
2073,GO:0004561,1,0.992409750750414,0,1,alpha-N-acetylglucosaminidase activity,MF,
2075,GO:0004564,1,0.993986332265754,0,1,beta-fructofuranosidase activity,MF,
2076,GO:0004565,1,0.955276646165177,0,6,beta-galactosidase activity,MF,
2077,GO:0004566,1,0.978484706362646,0,3,beta-glucuronidase activity,MF,
2078,GO:0004567,1,0.992871466900911,0,1,beta-mannosidase activity,MF,
2079,GO:0004568,1,0.977224127498405,0,3,chitinase activity,MF,
2080,GO:0004569,1,0.993835750309779,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2081,GO:0004571,1,0.953810576209884,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2082,GO:0004572,1,0.987985156061947,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2083,GO:0004573,1,0.992378967566146,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2084,GO:0004574,1,0.987182576022164,0,2,oligo-1,6-glucosidase activity,MF,
2085,GO:0004575,1,0.993986332265754,0,1,sucrose alpha-glucosidase activity,MF,
2087,GO:0004577,1,0.984840968119266,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2088,GO:0004578,1,0.993465729911084,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2089,GO:0004579,1,0.933463431833956,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2092,GO:0004583,1,0.972060713372457,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2093,GO:0004584,1,0.992229784064352,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2094,GO:0004585,1,0.992170027168696,0,1,ornithine carbamoyltransferase activity,MF,
2095,GO:0004586,1,0.992182039384568,0,1,ornithine decarboxylase activity,MF,
2096,GO:0004587,1,0.992175993997153,0,1,ornithine-oxo-acid transaminase activity,MF,
2097,GO:0004588,1,0.99233904998884,0,1,orotate phosphoribosyltransferase activity,MF,
2098,GO:0004590,1,0.99233904998884,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2099,GO:0004591,1,0.980962900551323,0,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2100,GO:0004594,1,0.970120958713826,0,4,pantothenate kinase activity,MF,
2101,GO:0004595,1,0.992214824472965,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2102,GO:0004596,1,0.923850881289624,0,11,peptide alpha-N-acetyltransferase activity,MF,
2103,GO:0004597,1,0.993182624763634,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2104,GO:0004598,1,0.993276822232559,0,1,peptidylamidoglycolate lyase activity,MF,
2107,GO:0004603,1,0.992170027168696,0,1,phenylethanolamine N-methyltransferase activity,MF,
2108,GO:0004605,1,0.978638791421254,0,3,phosphatidate cytidylyltransferase activity,MF,
2109,GO:0004607,1,0.992170027168696,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2110,GO:0004608,1,0.992170027168696,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2111,GO:0004609,1,0.984599945979332,0,2,phosphatidylserine decarboxylase activity,MF,
2112,GO:0004610,1,0.992176996736443,0,1,phosphoacetylglucosamine mutase activity,MF,
2113,GO:0004611,1,0.984587647611758,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2114,GO:0004613,1,0.984587647611758,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2115,GO:0004614,1,0.977408731010804,0,3,phosphoglucomutase activity,MF,
2116,GO:0004615,1,0.984451158003787,0,2,phosphomannomutase activity,MF,
2117,GO:0004616,1,0.977803219630937,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2118,GO:0004617,1,0.992178341054313,0,1,phosphoglycerate dehydrogenase activity,MF,
2119,GO:0004618,1,0.984477709266766,0,2,phosphoglycerate kinase activity,MF,
2120,GO:0004619,1,0.969047174370287,0,4,phosphoglycerate mutase activity,MF,
2122,GO:0004621,1,0.992213076081144,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2125,GO:0004629,1,0.812456026660474,0,30,phospholipase C activity,MF,
2126,GO:0004630,1,0.9565970765243,0,6,phospholipase D activity,MF,
2127,GO:0004631,1,0.992170027168696,0,1,phosphomevalonate kinase activity,MF,
2128,GO:0004632,1,0.992170027168696,0,1,phosphopantothenate--cysteine ligase activity,MF,
2129,GO:0004633,1,0.992200293687213,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2130,GO:0004634,1,0.969242227319352,0,4,phosphopyruvate hydratase activity,MF,
2131,GO:0004637,1,0.992996259697093,0,1,phosphoribosylamine-glycine ligase activity,MF,
2132,GO:0004638,1,0.992893349471198,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2133,GO:0004639,1,0.992893349471198,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2134,GO:0004641,1,0.992996259697093,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2135,GO:0004642,1,0.993981070379842,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2136,GO:0004643,1,0.992184732153989,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2137,GO:0004644,1,0.992996259697093,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2138,GO:0004645,1,0.958227512669476,0,6,phosphorylase activity,MF,
2139,GO:0004647,1,0.976715720425545,0,3,phosphoserine phosphatase activity,MF,
2140,GO:0004648,1,0.992187078492879,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2141,GO:0004649,1,0.985910950762726,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2142,GO:0004651,1,0.986014449043302,0,2,polynucleotide 5'-phosphatase activity,MF,
2143,GO:0004652,1,0.949014830043274,0,8,polynucleotide adenylyltransferase activity,MF,
2144,GO:0004653,1,0.873904263274075,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2145,GO:0004654,1,0.993845740613944,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2146,GO:0004655,1,0.992742126129318,0,1,porphobilinogen synthase activity,MF,
2147,GO:0004656,1,0.969530397143302,0,4,procollagen-proline 4-dioxygenase activity,MF,
2148,GO:0004657,1,0.984430923556346,0,2,proline dehydrogenase activity,MF,
2149,GO:0004658,1,0.984492233861679,0,2,propionyl-CoA carboxylase activity,MF,
2150,GO:0004659,1,0.895813484537819,0,15,prenyltransferase activity,MF,
2151,GO:0004660,1,0.984667593030849,0,2,protein farnesyltransferase activity,MF,
2152,GO:0004661,1,0.963071810204356,0,5,protein geranylgeranyltransferase activity,MF,
2153,GO:0004662,1,0.98460791623936,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2154,GO:0004663,1,0.97046979947467,0,4,Rab geranylgeranyltransferase activity,MF,
2155,GO:0004666,1,0.987793374420523,0,2,prostaglandin-endoperoxide synthase activity,MF,
2156,GO:0004667,1,0.984400887813367,0,2,prostaglandin-D synthase activity,MF,
2157,GO:0004668,1,0.964834196929352,0,5,protein-arginine deiminase activity,MF,
2158,GO:0004671,1,0.993907223934174,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2160,GO:0004673,1,0.953334382494126,0,7,protein histidine kinase activity,MF,
2161,GO:0004674,1,0.0487061654479288,0,431,protein serine/threonine kinase activity,MF,
2162,GO:0004675,1,0.900474780385216,0,16,transmembrane receptor protein serine/threonine kinase activity,MF,
2163,GO:0004676,1,0.993986332270839,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2164,GO:0004677,1,0.9805397059728,0,3,DNA-dependent protein kinase activity,MF,
2165,GO:0004679,1,0.952253537396798,0,7,AMP-activated protein kinase activity,MF,
2166,GO:0004683,1,0.822129863203591,0,28,calmodulin-dependent protein kinase activity,MF,
2167,GO:0004686,1,0.993986332272682,0,1,elongation factor-2 kinase activity,MF,
2168,GO:0004687,1,0.974623977525433,0,4,myosin light chain kinase activity,MF,
2169,GO:0004689,1,0.967994237373986,0,5,phosphorylase kinase activity,MF,
2170,GO:0004690,1,0.940259918219572,0,9,cyclic nucleotide-dependent protein kinase activity,MF,
2171,GO:0004691,1,0.953326022640433,0,7,cAMP-dependent protein kinase activity,MF,
2172,GO:0004692,1,0.986299275416537,0,2,cGMP-dependent protein kinase activity,MF,
2173,GO:0004693,1,0.817944446786241,0,27,cyclin-dependent protein serine/threonine kinase activity,MF,
2174,GO:0004694,1,0.974259925916078,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2175,GO:0004697,1,0.89617151646248,0,16,protein kinase C activity,MF,
2176,GO:0004698,1,0.973105272191391,0,4,calcium-dependent protein kinase C activity,MF,
2177,GO:0004699,1,0.979601264518736,0,3,calcium-independent protein kinase C activity,MF,
2178,GO:0004702,1,0.549969577469153,0,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,
2179,GO:0004703,1,0.961980623854882,0,5,G-protein coupled receptor kinase activity,MF,
2180,GO:0004704,1,0.958719055978996,0,6,NF-kappaB-inducing kinase activity,MF,
2181,GO:0004705,1,0.979528531779639,0,3,JUN kinase activity,MF,
2182,GO:0004706,1,0.980233229927755,0,3,JUN kinase kinase kinase activity,MF,
2183,GO:0004707,1,0.90486983391983,0,14,MAP kinase activity,MF,
2184,GO:0004708,1,0.910801746223528,0,13,MAP kinase kinase activity,MF,
2185,GO:0004709,1,0.87286092293909,0,20,MAP kinase kinase kinase activity,MF,
2186,GO:0004711,1,0.978989757569557,0,3,ribosomal protein S6 kinase activity,MF,
2187,GO:0004712,1,0.750686913707452,0,40,protein serine/threonine/tyrosine kinase activity,MF,
2189,GO:0004714,1,0.652436330255742,0,64,transmembrane receptor protein tyrosine kinase activity,MF,
2190,GO:0004715,1,0.69757002522247,0,50,non-membrane spanning protein tyrosine kinase activity,MF,
2191,GO:0004716,1,0.943623585249433,0,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
2192,GO:0004719,1,0.979364281835559,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2193,GO:0004720,1,0.979623099396664,0,3,protein-lysine 6-oxidase activity,MF,
2195,GO:0004722,1,0.620276650100374,0,67,protein serine/threonine phosphatase activity,MF,
2196,GO:0004723,1,0.96100984513876,0,6,calcium-dependent protein serine/threonine phosphatase activity,MF,
2198,GO:0004726,1,0.94458374800169,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2199,GO:0004727,1,0.984411642844679,0,2,prenylated protein tyrosine phosphatase activity,MF,
2200,GO:0004728,1,0.992307852066953,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2201,GO:0004729,1,0.992170158561663,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2204,GO:0004733,1,0.993015925657587,0,1,pyridoxamine-phosphate oxidase activity,MF,
2205,GO:0004735,1,0.976816983104833,0,3,pyrroline-5-carboxylate reductase activity,MF,
2206,GO:0004736,1,0.993530335733932,0,1,pyruvate carboxylase activity,MF,
2207,GO:0004738,1,0.957269957053677,0,6,pyruvate dehydrogenase activity,MF,
2208,GO:0004739,1,0.977446102625449,0,3,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2210,GO:0004741,1,0.981144665652496,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2211,GO:0004742,1,0.993739830600638,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2212,GO:0004743,1,0.984956052906833,0,2,pyruvate kinase activity,MF,
2213,GO:0004744,1,0.992319637064424,0,1,retinal isomerase activity,MF,
2214,GO:0004745,1,0.869786880630021,0,18,retinol dehydrogenase activity,MF,
2215,GO:0004747,1,0.992170027168696,0,1,ribokinase activity,MF,
2216,GO:0004748,1,0.979729214240087,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2217,GO:0004749,1,0.961647039436489,0,5,ribose phosphate diphosphokinase activity,MF,
2218,GO:0004750,1,0.992215033225238,0,1,ribulose-phosphate 3-epimerase activity,MF,
2219,GO:0004751,1,0.992171064706201,0,1,ribose-5-phosphate isomerase activity,MF,
2220,GO:0004753,1,0.993986332264915,0,1,saccharopine dehydrogenase activity,MF,
2221,GO:0004756,1,0.984579481091623,0,2,selenide, water dikinase activity,MF,
2222,GO:0004757,1,0.992170027168696,0,1,sepiapterin reductase activity,MF,
2223,GO:0004758,1,0.964643096900809,0,5,serine C-palmitoyltransferase activity,MF,
2224,GO:0004760,1,0.992170027168696,0,1,serine-pyruvate transaminase activity,MF,
2225,GO:0004766,1,0.992170027168696,0,1,spermidine synthase activity,MF,
2226,GO:0004767,1,0.957366271414246,0,6,sphingomyelin phosphodiesterase activity,MF,
2227,GO:0004768,1,0.979146576622349,0,3,stearoyl-CoA 9-desaturase activity,MF,
2229,GO:0004771,1,0.970773700113568,0,4,sterol esterase activity,MF,
2230,GO:0004772,1,0.98519031183025,0,2,sterol O-acyltransferase activity,MF,
2231,GO:0004773,1,0.993986332267439,0,1,steryl-sulfatase activity,MF,
2232,GO:0004774,1,0.976771798331079,0,3,succinate-CoA ligase activity,MF,
2233,GO:0004775,1,0.984423640281871,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2234,GO:0004776,1,0.984458443386767,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2235,GO:0004777,1,0.993963843661382,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2236,GO:0004778,1,0.992170027168696,0,1,succinyl-CoA hydrolase activity,MF,
2237,GO:0004779,1,0.985733812050048,0,2,sulfate adenylyltransferase activity,MF,
2238,GO:0004781,1,0.985733812050048,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2239,GO:0004782,1,0.985630973174689,0,2,sulfinoalanine decarboxylase activity,MF,
2240,GO:0004784,1,0.961548027973782,0,5,superoxide dismutase activity,MF,
2241,GO:0004788,1,0.992229029544791,0,1,thiamine diphosphokinase activity,MF,
2242,GO:0004790,1,0.992293397538816,0,1,thioether S-methyltransferase activity,MF,
2243,GO:0004791,1,0.926150211366913,0,10,thioredoxin-disulfide reductase activity,MF,
2244,GO:0004792,1,0.976776598575771,0,3,thiosulfate sulfurtransferase activity,MF,
2245,GO:0004793,1,0.984521315441538,0,2,threonine aldolase activity,MF,
2246,GO:0004794,1,0.984400887813367,0,2,L-threonine ammonia-lyase activity,MF,
2247,GO:0004796,1,0.992186217655884,0,1,thromboxane-A synthase activity,MF,
2248,GO:0004797,1,0.986168600820008,0,2,thymidine kinase activity,MF,
2249,GO:0004798,1,0.984789563498906,0,2,thymidylate kinase activity,MF,
2250,GO:0004799,1,0.992170027168696,0,1,thymidylate synthase activity,MF,
2251,GO:0004800,1,0.978494814147984,0,3,thyroxine 5'-deiodinase activity,MF,
2252,GO:0004801,1,0.992170027168696,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2253,GO:0004802,1,0.977111958697953,0,3,transketolase activity,MF,
2254,GO:0004803,1,0.979783825341224,0,3,transposase activity,MF,
2255,GO:0004806,1,0.853105629466451,0,21,triglyceride lipase activity,MF,
2256,GO:0004807,1,0.992170027168696,0,1,triose-phosphate isomerase activity,MF,
2257,GO:0004809,1,0.976844567298449,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2258,GO:0004810,1,0.992210393719652,0,1,tRNA adenylyltransferase activity,MF,
2259,GO:0004812,1,0.721069720156761,0,44,aminoacyl-tRNA ligase activity,MF,
2260,GO:0004813,1,0.979130645960072,0,3,alanine-tRNA ligase activity,MF,
2261,GO:0004814,1,0.969098101975991,0,4,arginine-tRNA ligase activity,MF,
2262,GO:0004815,1,0.985186566213472,0,2,aspartate-tRNA ligase activity,MF,
2263,GO:0004816,1,0.984742358710518,0,2,asparagine-tRNA ligase activity,MF,
2264,GO:0004817,1,0.984567344693527,0,2,cysteine-tRNA ligase activity,MF,
2265,GO:0004818,1,0.987437589627907,0,2,glutamate-tRNA ligase activity,MF,
2266,GO:0004819,1,0.992253926569845,0,1,glutamine-tRNA ligase activity,MF,
2267,GO:0004820,1,0.984625099557387,0,2,glycine-tRNA ligase activity,MF,
2268,GO:0004821,1,0.984505823838289,0,2,histidine-tRNA ligase activity,MF,
2269,GO:0004822,1,0.986954594170882,0,2,isoleucine-tRNA ligase activity,MF,
2270,GO:0004823,1,0.98762555052971,0,2,leucine-tRNA ligase activity,MF,
2271,GO:0004824,1,0.992186007071722,0,1,lysine-tRNA ligase activity,MF,
2272,GO:0004825,1,0.985076339457963,0,2,methionine-tRNA ligase activity,MF,
2273,GO:0004826,1,0.962070269726488,0,5,phenylalanine-tRNA ligase activity,MF,
2274,GO:0004827,1,0.986221430599055,0,2,proline-tRNA ligase activity,MF,
2275,GO:0004828,1,0.984415720717729,0,2,serine-tRNA ligase activity,MF,
2276,GO:0004829,1,0.9777227415096,0,3,threonine-tRNA ligase activity,MF,
2277,GO:0004830,1,0.984849531935261,0,2,tryptophan-tRNA ligase activity,MF,
2278,GO:0004831,1,0.984930765277839,0,2,tyrosine-tRNA ligase activity,MF,
2279,GO:0004832,1,0.980942742409817,0,3,valine-tRNA ligase activity,MF,
2280,GO:0004833,1,0.976736645393584,0,3,tryptophan 2,3-dioxygenase activity,MF,
2281,GO:0004835,1,0.99396445453968,0,1,tubulin-tyrosine ligase activity,MF,
2282,GO:0004838,1,0.992399074066817,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2283,GO:0004839,1,0.97358166393835,0,4,ubiquitin activating enzyme activity,MF,
2284,GO:0004842,1,0.0489933412662272,0,423,ubiquitin-protein transferase activity,MF,
2285,GO:0004843,1,0.606575674014374,0,73,thiol-dependent ubiquitin-specific protease activity,MF,
2286,GO:0004844,1,0.962073464157348,0,5,uracil DNA N-glycosylase activity,MF,
2287,GO:0004849,1,0.961867711569022,0,5,uridine kinase activity,MF,
2288,GO:0004850,1,0.984474122457525,0,2,uridine phosphorylase activity,MF,
2289,GO:0004852,1,0.992170027168696,0,1,uroporphyrinogen-III synthase activity,MF,
2290,GO:0004853,1,0.992170027168696,0,1,uroporphyrinogen decarboxylase activity,MF,
2292,GO:0004855,1,0.993986311826297,0,1,xanthine oxidase activity,MF,
2293,GO:0004856,1,0.993245628704852,0,1,xylulokinase activity,MF,
2296,GO:0004860,1,0.510317144736588,0,92,protein kinase inhibitor activity,MF,
2297,GO:0004861,1,0.914536403548824,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2298,GO:0004862,1,0.934311880735493,0,9,cAMP-dependent protein kinase inhibitor activity,MF,
2299,GO:0004864,1,0.783883718210508,0,33,protein phosphatase inhibitor activity,MF,
2300,GO:0004865,1,0.940115210207242,0,8,protein serine/threonine phosphatase inhibitor activity,MF,
2306,GO:0004873,1,0.984400887813367,0,2,asialoglycoprotein receptor activity,MF,
2307,GO:0004874,1,0.987925581950681,0,2,aryl hydrocarbon receptor activity,MF,
2308,GO:0004875,1,0.927787280138742,0,10,complement receptor activity,MF,
2309,GO:0004876,1,0.992174484858162,0,1,complement component C3a receptor activity,MF,
2310,GO:0004877,1,0.993986332281662,0,1,complement component C3b receptor activity,MF,
2311,GO:0004878,1,0.98457777480284,0,2,complement component C5a receptor activity,MF,
2312,GO:0004879,1,0.722150454282941,0,46,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,
2313,GO:0004882,1,0.977771224575791,0,3,androgen receptor activity,MF,
2314,GO:0004883,1,0.993986332268653,0,1,glucocorticoid receptor activity,MF,
2315,GO:0004886,1,0.978781435935058,0,3,9-cis retinoic acid receptor activity,MF,
2316,GO:0004887,1,0.95059768938858,0,7,thyroid hormone receptor activity,MF,
2318,GO:0004890,1,0.872272943949956,0,19,GABA-A receptor activity,MF,
2320,GO:0004897,1,0.972801943989297,0,4,ciliary neurotrophic factor receptor activity,MF,
2321,GO:0004900,1,0.992171320310651,0,1,erythropoietin receptor activity,MF,
2322,GO:0004904,1,0.963505622858205,0,5,interferon receptor activity,MF,
2323,GO:0004905,1,0.986203080773734,0,2,type I interferon receptor activity,MF,
2324,GO:0004906,1,0.984448482227345,0,2,interferon-gamma receptor activity,MF,
2325,GO:0004908,1,0.95054861220958,0,7,interleukin-1 receptor activity,MF,
2326,GO:0004909,1,0.986150974636068,0,2,interleukin-1, Type I, activating receptor activity,MF,
2327,GO:0004910,1,0.98479285239858,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2328,GO:0004911,1,0.978643610971023,0,3,interleukin-2 receptor activity,MF,
2329,GO:0004912,1,0.986133687569695,0,2,interleukin-3 receptor activity,MF,
2330,GO:0004913,1,0.984466937891583,0,2,interleukin-4 receptor activity,MF,
2331,GO:0004914,1,0.986141977718278,0,2,interleukin-5 receptor activity,MF,
2332,GO:0004915,1,0.98640666858196,0,2,interleukin-6 receptor activity,MF,
2333,GO:0004917,1,0.984401467769241,0,2,interleukin-7 receptor activity,MF,
2334,GO:0004918,1,0.984721923606659,0,2,interleukin-8 receptor activity,MF,
2335,GO:0004919,1,0.992191649784728,0,1,interleukin-9 receptor activity,MF,
2336,GO:0004920,1,0.964324781939468,0,5,interleukin-10 receptor activity,MF,
2337,GO:0004921,1,0.992749724122032,0,1,interleukin-11 receptor activity,MF,
2338,GO:0004923,1,0.986779318513733,0,2,leukemia inhibitory factor receptor activity,MF,
2339,GO:0004924,1,0.980064494058486,0,3,oncostatin-M receptor activity,MF,
2340,GO:0004925,1,0.993986332292246,0,1,prolactin receptor activity,MF,
2342,GO:0004931,1,0.947449885812259,0,7,extracellular ATP-gated cation channel activity,MF,
2343,GO:0004935,1,0.926780700225298,0,10,adrenergic receptor activity,MF,
2344,GO:0004936,1,0.955953502627198,0,6,alpha-adrenergic receptor activity,MF,
2345,GO:0004937,1,0.976921073046219,0,3,alpha1-adrenergic receptor activity,MF,
2346,GO:0004938,1,0.97854096070629,0,3,alpha2-adrenergic receptor activity,MF,
2347,GO:0004939,1,0.977146004882568,0,3,beta-adrenergic receptor activity,MF,
2348,GO:0004940,1,0.992460489804304,0,1,beta1-adrenergic receptor activity,MF,
2349,GO:0004941,1,0.992179473953618,0,1,beta2-adrenergic receptor activity,MF,
2350,GO:0004945,1,0.969404623345106,0,4,angiotensin type II receptor activity,MF,
2351,GO:0004946,1,0.984400887813367,0,2,bombesin receptor activity,MF,
2352,GO:0004947,1,0.985870105378954,0,2,bradykinin receptor activity,MF,
2353,GO:0004948,1,0.979423663724569,0,3,calcitonin receptor activity,MF,
2354,GO:0004949,1,0.979658998595285,0,3,cannabinoid receptor activity,MF,
2355,GO:0004950,1,0.83882837532952,0,23,chemokine receptor activity,MF,
2356,GO:0004951,1,0.984417648209846,0,2,cholecystokinin receptor activity,MF,
2357,GO:0004952,1,0.910852684166173,0,12,dopamine neurotransmitter receptor activity,MF,
2358,GO:0004953,1,0.892736092795852,0,15,icosanoid receptor activity,MF,
2359,GO:0004954,1,0.920341450859899,0,11,prostanoid receptor activity,MF,
2360,GO:0004955,1,0.927572261772079,0,10,prostaglandin receptor activity,MF,
2361,GO:0004956,1,0.984873960569751,0,2,prostaglandin D receptor activity,MF,
2362,GO:0004957,1,0.955336301855961,0,6,prostaglandin E receptor activity,MF,
2363,GO:0004958,1,0.986321157608921,0,2,prostaglandin F receptor activity,MF,
2364,GO:0004960,1,0.992209142954877,0,1,thromboxane receptor activity,MF,
2365,GO:0004961,1,0.992209142954877,0,1,thromboxane A2 receptor activity,MF,
2366,GO:0004962,1,0.987109991305116,0,2,endothelin receptor activity,MF,
2367,GO:0004963,1,0.985091352671637,0,2,follicle-stimulating hormone receptor activity,MF,
2368,GO:0004964,1,0.992651574161641,0,1,luteinizing hormone receptor activity,MF,
2369,GO:0004965,1,0.981495833296077,0,3,G-protein coupled GABA receptor activity,MF,
2370,GO:0004966,1,0.946681345347851,0,7,galanin receptor activity,MF,
2371,GO:0004967,1,0.977212174956159,0,3,glucagon receptor activity,MF,
2372,GO:0004968,1,0.987705539584649,0,2,gonadotropin-releasing hormone receptor activity,MF,
2373,GO:0004969,1,0.957067324745925,0,6,histamine receptor activity,MF,
2376,GO:0004972,1,0.957827763603055,0,7,NMDA glutamate receptor activity,MF,
2377,GO:0004974,1,0.970024456761426,0,4,leukotriene receptor activity,MF,
2378,GO:0004977,1,0.95538054566041,0,6,melanocortin receptor activity,MF,
2379,GO:0004978,1,0.993198864019823,0,1,corticotropin receptor activity,MF,
2380,GO:0004979,1,0.992171614783988,0,1,beta-endorphin receptor activity,MF,
2381,GO:0004980,1,0.977168859138709,0,3,melanocyte-stimulating hormone receptor activity,MF,
2382,GO:0004982,1,0.969151934601306,0,4,N-formyl peptide receptor activity,MF,
2383,GO:0004983,1,0.941710077240702,0,8,neuropeptide Y receptor activity,MF,
2384,GO:0004984,1,0.0504113414076754,0,376,olfactory receptor activity,MF,
2385,GO:0004985,1,0.941408249616375,0,8,opioid receptor activity,MF,
2386,GO:0004990,1,0.993741852783125,0,1,oxytocin receptor activity,MF,
2387,GO:0004991,1,0.98461748576741,0,2,parathyroid hormone receptor activity,MF,
2388,GO:0004992,1,0.979906756798847,0,3,platelet activating factor receptor activity,MF,
2389,GO:0004993,1,0.818390969743134,0,26,G-protein coupled serotonin receptor activity,MF,
2390,GO:0004994,1,0.963318940040439,0,5,somatostatin receptor activity,MF,
2391,GO:0004995,1,0.977390092903457,0,3,tachykinin receptor activity,MF,
2392,GO:0004996,1,0.98562801524979,0,2,thyroid-stimulating hormone receptor activity,MF,
2393,GO:0004997,1,0.992170027168696,0,1,thyrotropin-releasing hormone receptor activity,MF,
2394,GO:0004998,1,0.986503537728743,0,2,transferrin receptor activity,MF,
2395,GO:0004999,1,0.978223855525357,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2396,GO:0005000,1,0.95008962210555,0,7,vasopressin receptor activity,MF,
2397,GO:0005001,1,0.902909128572548,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2398,GO:0005003,1,0.878864153234142,0,19,ephrin receptor activity,MF,
2399,GO:0005004,1,0.954338696093622,0,7,GPI-linked ephrin receptor activity,MF,
2400,GO:0005005,1,0.947055425069592,0,8,transmembrane-ephrin receptor activity,MF,
2401,GO:0005006,1,0.984731820646315,0,2,epidermal growth factor-activated receptor activity,MF,
2402,GO:0005007,1,0.966986981458145,0,5,fibroblast growth factor-activated receptor activity,MF,
2403,GO:0005008,1,0.993986332268888,0,1,hepatocyte growth factor-activated receptor activity,MF,
2404,GO:0005009,1,0.993986332280452,0,1,insulin-activated receptor activity,MF,
2405,GO:0005010,1,0.982065635495288,0,3,insulin-like growth factor-activated receptor activity,MF,
2406,GO:0005011,1,0.987457367410987,0,2,macrophage colony-stimulating factor receptor activity,MF,
2407,GO:0005017,1,0.980271699682834,0,3,platelet-derived growth factor-activated receptor activity,MF,
2408,GO:0005018,1,0.99398633226852,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2409,GO:0005019,1,0.986203039497274,0,2,platelet-derived growth factor beta-receptor activity,MF,
2410,GO:0005020,1,0.993966693721043,0,1,stem cell factor receptor activity,MF,
2411,GO:0005021,1,0.956306792684743,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2412,GO:0005024,1,0.943563178712224,0,9,transforming growth factor beta-activated receptor activity,MF,
2413,GO:0005025,1,0.974410719673068,0,4,transforming growth factor beta receptor activity, type I,MF,
2414,GO:0005026,1,0.986086150005319,0,2,transforming growth factor beta receptor activity, type II,MF,
2415,GO:0005030,1,0.973053926515168,0,4,neurotrophin receptor activity,MF,
2416,GO:0005031,1,0.834885488403264,0,24,tumor necrosis factor-activated receptor activity,MF,
2417,GO:0005034,1,0.992712489432679,0,1,osmosensor activity,MF,
2418,GO:0005035,1,0.834885488403264,0,24,death receptor activity,MF,
2419,GO:0005041,1,0.917055718778266,0,13,low-density lipoprotein receptor activity,MF,
2420,GO:0005042,1,0.987233576917472,0,2,netrin receptor activity,MF,
2421,GO:0005044,1,0.745833873628825,0,41,scavenger receptor activity,MF,
2422,GO:0005046,1,0.984609072080478,0,2,KDEL sequence binding,MF,
2423,GO:0005047,1,0.970640992963198,0,4,signal recognition particle binding,MF,
2424,GO:0005048,1,0.738078606426578,0,43,signal sequence binding,MF,
2425,GO:0005049,1,0.955756803909759,0,7,nuclear export signal receptor activity,MF,
2426,GO:0005052,1,0.985921519937065,0,2,peroxisome matrix targeting signal-1 binding,MF,
2427,GO:0005053,1,0.992170027168696,0,1,peroxisome matrix targeting signal-2 binding,MF,
2428,GO:0005055,1,0.984481955018747,0,2,laminin receptor activity,MF,
2430,GO:0005068,1,0.926233232685588,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2431,GO:0005070,1,0.663346748847646,0,57,SH3/SH2 adaptor activity,MF,
2432,GO:0005072,1,0.934524341653692,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2433,GO:0005078,1,0.956026808155186,0,7,MAP-kinase scaffold activity,MF,
2434,GO:0005080,1,0.743101535924512,0,42,protein kinase C binding,MF,
2436,GO:0005086,1,0.882288992487347,0,19,ARF guanyl-nucleotide exchange factor activity,MF,
2437,GO:0005087,1,0.969694333821958,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2439,GO:0005089,1,0.599877335223105,0,78,Rho guanyl-nucleotide exchange factor activity,MF,
2440,GO:0005090,1,0.992192824690033,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2441,GO:0005092,1,0.901759671927328,0,14,GDP-dissociation inhibitor activity,MF,
2442,GO:0005093,1,0.984552169895569,0,2,Rab GDP-dissociation inhibitor activity,MF,
2443,GO:0005094,1,0.976693610548633,0,3,Rho GDP-dissociation inhibitor activity,MF,
2444,GO:0005095,1,0.907466873535335,0,14,GTPase inhibitor activity,MF,
2449,GO:0005109,1,0.768424430333265,0,36,frizzled binding,MF,
2450,GO:0005110,1,0.986547646487018,0,2,frizzled-2 binding,MF,
2452,GO:0005112,1,0.871023992818669,0,20,Notch binding,MF,
2453,GO:0005113,1,0.942737263948047,0,8,patched binding,MF,
2454,GO:0005114,1,0.952716748276994,0,7,type II transforming growth factor beta receptor binding,MF,
2455,GO:0005115,1,0.993986332264647,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2456,GO:0005119,1,0.980597612175381,0,3,smoothened binding,MF,
2458,GO:0005124,1,0.992186164837484,0,1,scavenger receptor binding,MF,
2459,GO:0005125,1,0.185936540452316,0,218,cytokine activity,MF,
2461,GO:0005127,1,0.963780382425315,0,5,ciliary neurotrophic factor receptor binding,MF,
2462,GO:0005128,1,0.98504602150745,0,2,erythropoietin receptor binding,MF,
2463,GO:0005129,1,0.992170027168696,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
2464,GO:0005130,1,0.992170027168696,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2465,GO:0005131,1,0.966446726913211,0,5,growth hormone receptor binding,MF,
2466,GO:0005132,1,0.874853303137788,0,17,type I interferon receptor binding,MF,
2467,GO:0005133,1,0.992170027168696,0,1,interferon-gamma receptor binding,MF,
2468,GO:0005134,1,0.962033122689336,0,5,interleukin-2 receptor binding,MF,
2469,GO:0005135,1,0.98504602150745,0,2,interleukin-3 receptor binding,MF,
2470,GO:0005136,1,0.977195872626263,0,3,interleukin-4 receptor binding,MF,
2471,GO:0005137,1,0.98442337663763,0,2,interleukin-5 receptor binding,MF,
2473,GO:0005139,1,0.992182836408944,0,1,interleukin-7 receptor binding,MF,
2474,GO:0005140,1,0.992170027168696,0,1,interleukin-9 receptor binding,MF,
2475,GO:0005141,1,0.992170027168696,0,1,interleukin-10 receptor binding,MF,
2476,GO:0005142,1,0.992227539614232,0,1,interleukin-11 receptor binding,MF,
2477,GO:0005143,1,0.96352153830024,0,5,interleukin-12 receptor binding,MF,
2478,GO:0005144,1,0.992170027168696,0,1,interleukin-13 receptor binding,MF,
2479,GO:0005146,1,0.985667390623327,0,2,leukemia inhibitory factor receptor binding,MF,
2480,GO:0005147,1,0.992171504980013,0,1,oncostatin-M receptor binding,MF,
2481,GO:0005148,1,0.984400887813367,0,2,prolactin receptor binding,MF,
2482,GO:0005149,1,0.88197072803651,0,17,interleukin-1 receptor binding,MF,
2483,GO:0005150,1,0.985377976076187,0,2,interleukin-1, Type I receptor binding,MF,
2484,GO:0005151,1,0.986195555966218,0,2,interleukin-1, Type II receptor binding,MF,
2485,GO:0005152,1,0.978603551899807,0,3,interleukin-1 receptor antagonist activity,MF,
2486,GO:0005153,1,0.992682420182586,0,1,interleukin-8 receptor binding,MF,
2488,GO:0005157,1,0.976769249910469,0,3,macrophage colony-stimulating factor receptor binding,MF,
2490,GO:0005159,1,0.891588844262947,0,16,insulin-like growth factor receptor binding,MF,
2491,GO:0005160,1,0.699265310161162,0,49,transforming growth factor beta receptor binding,MF,
2492,GO:0005161,1,0.911509805262463,0,14,platelet-derived growth factor receptor binding,MF,
2493,GO:0005163,1,0.992170027168696,0,1,nerve growth factor receptor binding,MF,
2495,GO:0005165,1,0.926516746227877,0,11,neurotrophin receptor binding,MF,
2496,GO:0005166,1,0.976854083088302,0,3,neurotrophin p75 receptor binding,MF,
2497,GO:0005167,1,0.955966955075159,0,7,neurotrophin TRK receptor binding,MF,
2498,GO:0005168,1,0.962196863063842,0,6,neurotrophin TRKA receptor binding,MF,
2499,GO:0005169,1,0.987543628994326,0,2,neurotrophin TRKB receptor binding,MF,
2500,GO:0005170,1,0.993977677487998,0,1,neurotrophin TRKC receptor binding,MF,
2501,GO:0005171,1,0.984418346320817,0,2,hepatocyte growth factor receptor binding,MF,
2502,GO:0005172,1,0.932877991360966,0,10,vascular endothelial growth factor receptor binding,MF,
2503,GO:0005173,1,0.981770660475932,0,3,stem cell factor receptor binding,MF,
2504,GO:0005174,1,0.98444305730155,0,2,CD40 receptor binding,MF,
2505,GO:0005175,1,0.992170027168696,0,1,CD27 receptor binding,MF,
2506,GO:0005176,1,0.978331701494901,0,3,ErbB-2 class receptor binding,MF,
2507,GO:0005178,1,0.493344988930112,0,100,integrin binding,MF,
2508,GO:0005179,1,0.425626296081991,0,111,hormone activity,MF,
2509,GO:0005183,1,0.992170061138958,0,1,gonadotropin hormone-releasing hormone activity,MF,
2510,GO:0005184,1,0.809289352694232,0,27,neuropeptide hormone activity,MF,
2511,GO:0005185,1,0.984400887813367,0,2,neurohypophyseal hormone activity,MF,
2513,GO:0005199,1,0.992918328244532,0,1,structural constituent of cell wall,MF,
2514,GO:0005200,1,0.471605175086299,0,104,structural constituent of cytoskeleton,MF,
2515,GO:0005201,1,0.604463965986872,0,75,extracellular matrix structural constituent,MF,
2516,GO:0005212,1,0.854649951732103,0,20,structural constituent of eye lens,MF,
2519,GO:0005217,1,0.831686122269934,0,28,intracellular ligand-gated ion channel activity,MF,
2520,GO:0005219,1,0.974375796293467,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2521,GO:0005220,1,0.982066433224946,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2522,GO:0005221,1,0.939892987406246,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2523,GO:0005222,1,0.974378114827536,0,4,intracellular cAMP activated cation channel activity,MF,
2524,GO:0005223,1,0.972975022603366,0,4,intracellular cGMP activated cation channel activity,MF,
2525,GO:0005225,1,0.947308059222597,0,8,volume-sensitive anion channel activity,MF,
2526,GO:0005227,1,0.805519292801401,0,30,calcium activated cation channel activity,MF,
2527,GO:0005229,1,0.89603693394918,0,16,intracellular calcium activated chloride channel activity,MF,
2531,GO:0005237,1,0.957732360566713,0,6,inhibitory extracellular ligand-gated ion channel activity,MF,
2532,GO:0005242,1,0.853391604432515,0,22,inward rectifier potassium channel activity,MF,
2533,GO:0005243,1,0.900650601920948,0,14,gap junction channel activity,MF,
2534,GO:0005244,1,0.260387293505038,0,192,voltage-gated ion channel activity,MF,
2535,GO:0005245,1,0.755387815906585,0,41,voltage-gated calcium channel activity,MF,
2536,GO:0005246,1,0.787359580607496,0,33,calcium channel regulator activity,MF,
2537,GO:0005247,1,0.920060254316492,0,12,voltage-gated chloride channel activity,MF,
2538,GO:0005248,1,0.865431902170452,0,23,voltage-gated sodium channel activity,MF,
2539,GO:0005249,1,0.53667957087122,0,88,voltage-gated potassium channel activity,MF,
2540,GO:0005250,1,0.972729436921889,0,4,A-type (transient outward) potassium channel activity,MF,
2541,GO:0005251,1,0.868073486661196,0,20,delayed rectifier potassium channel activity,MF,
2542,GO:0005252,1,0.99349430163187,0,1,open rectifier potassium channel activity,MF,
2545,GO:0005260,1,0.993986332266283,0,1,intracellular ATPase-gated chloride channel activity,MF,
2547,GO:0005262,1,0.459002384067957,0,114,calcium channel activity,MF,
2548,GO:0005267,1,0.409361505533019,0,124,potassium channel activity,MF,
2549,GO:0005272,1,0.740472302259403,0,45,sodium channel activity,MF,
2550,GO:0005275,1,0.977239763620742,0,3,amine transmembrane transporter activity,MF,
2551,GO:0005276,1,0.992299643036661,0,1,vesicular hydrogen:amino acid antiporter activity,MF,
2552,GO:0005277,1,0.976871467497418,0,3,acetylcholine transmembrane transporter activity,MF,
2553,GO:0005280,1,0.957132739623678,0,6,hydrogen:amino acid symporter activity,MF,
2554,GO:0005283,1,0.927042067135488,0,11,sodium:amino acid symporter activity,MF,
2555,GO:0005287,1,0.993986332273392,0,1,high-affinity basic amino acid transmembrane transporter activity,MF,
2556,GO:0005289,1,0.993986332273392,0,1,high-affinity arginine transmembrane transporter activity,MF,
2557,GO:0005290,1,0.98472618857339,0,2,L-histidine transmembrane transporter activity,MF,
2558,GO:0005292,1,0.993986332273392,0,1,high-affinity lysine transmembrane transporter activity,MF,
2559,GO:0005294,1,0.979371812062411,0,3,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2560,GO:0005298,1,0.98707693620072,0,2,proline:sodium symporter activity,MF,
2561,GO:0005302,1,0.992710157412083,0,1,L-tyrosine transmembrane transporter activity,MF,
2562,GO:0005307,1,0.993962800443022,0,1,choline:sodium symporter activity,MF,
2563,GO:0005308,1,0.986989193567562,0,2,creatine transmembrane transporter activity,MF,
2564,GO:0005309,1,0.993093464642168,0,1,creatine:sodium symporter activity,MF,
2568,GO:0005315,1,0.972869175142067,0,4,inorganic phosphate transmembrane transporter activity,MF,
2569,GO:0005316,1,0.992837870977145,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2572,GO:0005325,1,0.993218440954526,0,1,peroxisomal fatty-acyl-CoA transporter activity,MF,
2573,GO:0005326,1,0.838214019360584,0,25,neurotransmitter transporter activity,MF,
2574,GO:0005328,1,0.878552077877006,0,19,neurotransmitter:sodium symporter activity,MF,
2575,GO:0005329,1,0.966188254916383,0,5,dopamine transmembrane transporter activity,MF,
2576,GO:0005330,1,0.987332450679258,0,2,dopamine:sodium symporter activity,MF,
2577,GO:0005332,1,0.971309124832069,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2578,GO:0005333,1,0.977526658011668,0,3,norepinephrine transmembrane transporter activity,MF,
2579,GO:0005334,1,0.992909323579839,0,1,norepinephrine:sodium symporter activity,MF,
2580,GO:0005335,1,0.993823381688871,0,1,serotonin:sodium symporter activity,MF,
2581,GO:0005337,1,0.932812889067386,0,9,nucleoside transmembrane transporter activity,MF,
2582,GO:0005338,1,0.93579426402454,0,9,nucleotide-sugar transmembrane transporter activity,MF,
2584,GO:0005343,1,0.838483000789503,0,25,organic acid:sodium symporter activity,MF,
2585,GO:0005344,1,0.897395771943118,0,14,oxygen transporter activity,MF,
2586,GO:0005345,1,0.95590834482255,0,6,purine nucleobase transmembrane transporter activity,MF,
2587,GO:0005346,1,0.921284293152205,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2588,GO:0005347,1,0.935870536883023,0,9,ATP transmembrane transporter activity,MF,
2589,GO:0005350,1,0.977146874706303,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2590,GO:0005351,1,0.895957882726153,0,15,sugar:proton symporter activity,MF,
2591,GO:0005353,1,0.992219791379029,0,1,fructose transmembrane transporter activity,MF,
2592,GO:0005355,1,0.871277743772765,0,19,glucose transmembrane transporter activity,MF,
2593,GO:0005362,1,0.985064261219624,0,2,low-affinity glucose:sodium symporter activity,MF,
2594,GO:0005365,1,0.988008547493672,0,2,myo-inositol transmembrane transporter activity,MF,
2595,GO:0005366,1,0.993986332270628,0,1,myo-inositol:proton symporter activity,MF,
2596,GO:0005367,1,0.993986332291353,0,1,myo-inositol:sodium symporter activity,MF,
2597,GO:0005368,1,0.993986332268125,0,1,taurine transmembrane transporter activity,MF,
2598,GO:0005369,1,0.993986332268125,0,1,taurine:sodium symporter activity,MF,
2599,GO:0005372,1,0.915011535088374,0,12,water transmembrane transporter activity,MF,
2601,GO:0005381,1,0.937312744040046,0,9,iron ion transmembrane transporter activity,MF,
2602,GO:0005384,1,0.972899092992637,0,4,manganese ion transmembrane transporter activity,MF,
2603,GO:0005385,1,0.850198539218397,0,22,zinc ion transmembrane transporter activity,MF,
2604,GO:0005388,1,0.914361805222053,0,14,calcium-transporting ATPase activity,MF,
2605,GO:0005391,1,0.930543682010676,0,10,sodium:potassium-exchanging ATPase activity,MF,
2606,GO:0005395,1,0.993986332272417,0,1,eye pigment precursor transporter activity,MF,
2607,GO:0005402,1,0.895957882726153,0,15,cation:sugar symporter activity,MF,
2608,GO:0005412,1,0.956342874921673,0,6,glucose:sodium symporter activity,MF,
2609,GO:0005415,1,0.976823899718844,0,3,nucleoside:sodium symporter activity,MF,
2610,GO:0005416,1,0.887279289963356,0,17,cation:amino acid symporter activity,MF,
2611,GO:0005427,1,0.986007433747344,0,2,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2612,GO:0005432,1,0.966762256617524,0,5,calcium:sodium antiporter activity,MF,
2613,GO:0005436,1,0.928708606925732,0,10,sodium:phosphate symporter activity,MF,
2614,GO:0005451,1,0.906651402954081,0,14,monovalent cation:proton antiporter activity,MF,
2615,GO:0005452,1,0.841742185157422,0,24,inorganic anion exchanger activity,MF,
2616,GO:0005456,1,0.992170721913545,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2617,GO:0005457,1,0.979188211513104,0,3,GDP-fucose transmembrane transporter activity,MF,
2618,GO:0005459,1,0.984400946654247,0,2,UDP-galactose transmembrane transporter activity,MF,
2619,GO:0005461,1,0.993986332267889,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2620,GO:0005462,1,0.986223694269111,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2621,GO:0005464,1,0.993986332269678,0,1,UDP-xylose transmembrane transporter activity,MF,
2622,GO:0005471,1,0.978268633592306,0,3,ATP:ADP antiporter activity,MF,
2623,GO:0005476,1,0.992171753567242,0,1,carnitine:acyl carnitine antiporter activity,MF,
2624,GO:0005477,1,0.993090452607849,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2625,GO:0005483,1,0.978995420529229,0,3,soluble NSF attachment protein activity,MF,
2626,GO:0005484,1,0.755628236999206,0,38,SNAP receptor activity,MF,
2627,GO:0005487,1,0.824148417667268,0,28,nucleocytoplasmic transporter activity,MF,
2630,GO:0005497,1,0.969486699268395,0,4,androgen binding,MF,
2631,GO:0005499,1,0.957402163407204,0,6,vitamin D binding,MF,
2633,GO:0005502,1,0.977575601007116,0,3,11-cis retinal binding,MF,
2634,GO:0005503,1,0.992175912828971,0,1,all-trans retinal binding,MF,
2639,GO:0005513,1,0.910697191591839,0,13,detection of calcium ion,BP,
2641,GO:0005516,1,0.272394126694937,0,189,calmodulin binding,MF,
2642,GO:0005518,1,0.651322108372864,0,61,collagen binding,MF,
2643,GO:0005519,1,0.993496705480316,0,1,cytoskeletal regulatory protein binding,MF,
2644,GO:0005520,1,0.816154125322565,0,28,insulin-like growth factor binding,MF,
2646,GO:0005522,1,0.94050471953879,0,9,profilin binding,MF,
2650,GO:0005527,1,0.900680567242157,0,14,macrolide binding,MF,
2651,GO:0005528,1,0.900680567242157,0,14,FK506 binding,MF,
2652,GO:0005534,1,0.970066607651666,0,4,galactose binding,MF,
2653,GO:0005536,1,0.923787219296244,0,11,glucose binding,MF,
2654,GO:0005537,1,0.882744357446001,0,17,mannose binding,MF,
2656,GO:0005540,1,0.870068546011432,0,20,hyaluronic acid binding,MF,
2657,GO:0005542,1,0.927530919179517,0,10,folic acid binding,MF,
2660,GO:0005545,1,0.886621721815709,0,18,1-phosphatidylinositol binding,MF,
2662,GO:0005547,1,0.78675970513347,0,35,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2664,GO:0005549,1,0.515870001864163,0,84,odorant binding,MF,
2665,GO:0005550,1,0.992170027168696,0,1,pheromone binding,MF,
2668,GO:0005577,1,0.937028901039267,0,9,fibrinogen complex,CC,
2670,GO:0005579,1,0.950724498042044,0,7,membrane attack complex,CC,
2671,GO:0005581,1,0.542460166861439,0,88,collagen trimer,CC,
2672,GO:0005582,1,0.993976306091888,0,1,collagen type XV trimer,CC,
2673,GO:0005583,1,0.927220559705398,0,12,fibrillar collagen trimer,CC,
2674,GO:0005584,1,0.988005056045801,0,2,collagen type I trimer,CC,
2675,GO:0005585,1,0.993948545287445,0,1,collagen type II trimer,CC,
2676,GO:0005586,1,0.993984669225979,0,1,collagen type III trimer,CC,
2677,GO:0005587,1,0.964452007655488,0,6,collagen type IV trimer,CC,
2678,GO:0005588,1,0.982066433179126,0,3,collagen type V trimer,CC,
2679,GO:0005589,1,0.979976250009845,0,3,collagen type VI trimer,CC,
2680,GO:0005590,1,0.993986332281451,0,1,collagen type VII trimer,CC,
2681,GO:0005591,1,0.992324105190772,0,1,collagen type VIII trimer,CC,
2682,GO:0005592,1,0.988008547470214,0,2,collagen type XI trimer,CC,
2683,GO:0005593,1,0.960355118291707,0,6,FACIT collagen trimer,CC,
2684,GO:0005594,1,0.97789563639732,0,3,collagen type IX trimer,CC,
2685,GO:0005595,1,0.993986332284164,0,1,collagen type XII trimer,CC,
2686,GO:0005596,1,0.993986332268046,0,1,collagen type XIV trimer,CC,
2687,GO:0005597,1,0.993985996998329,0,1,collagen type XVI trimer,CC,
2688,GO:0005598,1,0.992324105190772,0,1,short-chain collagen trimer,CC,
2689,GO:0005600,1,0.992624046284589,0,1,collagen type XIII trimer,CC,
2690,GO:0005602,1,0.984400887813367,0,2,complement component C1 complex,CC,
2693,GO:0005606,1,0.982066433186668,0,3,laminin-1 complex,CC,
2694,GO:0005607,1,0.987978379174459,0,2,laminin-2 complex,CC,
2695,GO:0005608,1,0.988008547479166,0,2,laminin-3 complex,CC,
2696,GO:0005610,1,0.981656819870073,0,3,laminin-5 complex,CC,
2697,GO:0005614,1,0.913570560629553,0,13,interstitial matrix,CC,
2704,GO:0005638,1,0.971516094051053,0,4,lamin filament,CC,
2705,GO:0005639,1,0.902847003283364,0,14,integral component of nuclear inner membrane,CC,
2707,GO:0005641,1,0.943938840931513,0,8,nuclear envelope lumen,CC,
2708,GO:0005642,1,0.967354300628258,0,5,annulate lamellae,CC,
2709,GO:0005643,1,0.60696656996348,0,72,nuclear pore,CC,
2710,GO:0005652,1,0.945083488962224,0,8,nuclear lamina,CC,
2712,GO:0005655,1,0.948838748081399,0,7,nucleolar ribonuclease P complex,CC,
2713,GO:0005656,1,0.984527779293501,0,2,nuclear pre-replicative complex,CC,
2714,GO:0005657,1,0.623789133334659,0,65,replication fork,CC,
2715,GO:0005658,1,0.957021138478517,0,6,alpha DNA polymerase:primase complex,CC,
2716,GO:0005662,1,0.894908974729487,0,15,DNA replication factor A complex,CC,
2717,GO:0005663,1,0.955642932158526,0,6,DNA replication factor C complex,CC,
2718,GO:0005664,1,0.933613862262451,0,9,nuclear origin of replication recognition complex,CC,
2719,GO:0005665,1,0.874256293149459,0,18,DNA-directed RNA polymerase II, core complex,CC,
2720,GO:0005666,1,0.880377970330005,0,17,DNA-directed RNA polymerase III complex,CC,
2721,GO:0005667,1,0.108134351973666,0,304,transcription factor complex,CC,
2722,GO:0005668,1,0.98444722444067,0,2,RNA polymerase transcription factor SL1 complex,CC,
2723,GO:0005669,1,0.772526997951659,0,35,transcription factor TFIID complex,CC,
2724,GO:0005671,1,0.912026506325479,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2725,GO:0005672,1,0.961454360147909,0,5,transcription factor TFIIA complex,CC,
2726,GO:0005673,1,0.992170027168696,0,1,transcription factor TFIIE complex,CC,
2727,GO:0005674,1,0.984524114124747,0,2,transcription factor TFIIF complex,CC,
2728,GO:0005675,1,0.913246529271872,0,12,holo TFIIH complex,CC,
2729,GO:0005677,1,0.940884733474846,0,9,chromatin silencing complex,CC,
2730,GO:0005680,1,0.855768002626199,0,21,anaphase-promoting complex,CC,
2731,GO:0005681,1,0.27396272399024,0,174,spliceosomal complex,CC,
2732,GO:0005682,1,0.865729889529719,0,20,U5 snRNP,CC,
2733,GO:0005683,1,0.946570310179099,0,7,U7 snRNP,CC,
2734,GO:0005684,1,0.777843558800867,0,33,U2-type spliceosomal complex,CC,
2735,GO:0005685,1,0.864418056192993,0,19,U1 snRNP,CC,
2736,GO:0005686,1,0.877699088386324,0,17,U2 snRNP,CC,
2737,GO:0005687,1,0.924522772737304,0,10,U4 snRNP,CC,
2738,GO:0005688,1,0.95409479236323,0,6,U6 snRNP,CC,
2739,GO:0005689,1,0.826133504089888,0,25,U12-type spliceosomal complex,CC,
2740,GO:0005690,1,0.992196164154546,0,1,U4atac snRNP,CC,
2741,GO:0005691,1,0.99375521404605,0,1,U6atac snRNP,CC,
2742,GO:0005694,1,0.00132428804755566,0,897,chromosome,CC,
2743,GO:0005697,1,0.860809918811272,0,21,telomerase holoenzyme complex,CC,
2744,GO:0005712,1,0.986293266659362,0,2,chiasma,CC,
2745,GO:0005713,1,0.985086073309686,0,2,recombination nodule,CC,
2746,GO:0005715,1,0.992260754444587,0,1,late recombination nodule,CC,
2747,GO:0005719,1,0.835653666387957,0,24,nuclear euchromatin,CC,
2748,GO:0005720,1,0.790333407363824,0,33,nuclear heterochromatin,CC,
2749,GO:0005721,1,0.88342342769822,0,18,pericentric heterochromatin,CC,
2750,GO:0005724,1,0.992170027168696,0,1,nuclear telomeric heterochromatin,CC,
2751,GO:0005726,1,0.98032202224034,0,3,perichromatin fibrils,CC,
2753,GO:0005731,1,0.992170072635252,0,1,nucleolus organizer region,CC,
2754,GO:0005732,1,0.883584995135431,0,16,small nucleolar ribonucleoprotein complex,CC,
2755,GO:0005736,1,0.92256915397988,0,11,DNA-directed RNA polymerase I complex,CC,
2760,GO:0005742,1,0.932729458827,0,9,mitochondrial outer membrane translocase complex,CC,
2762,GO:0005744,1,0.926062140076076,0,10,mitochondrial inner membrane presequence translocase complex,CC,
2763,GO:0005745,1,0.98496977030944,0,2,m-AAA complex,CC,
2764,GO:0005746,1,0.550635715655401,0,77,mitochondrial respiratory chain,CC,
2765,GO:0005747,1,0.720860353684577,0,42,mitochondrial respiratory chain complex I,CC,
2766,GO:0005749,1,0.969308062819154,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2767,GO:0005750,1,0.919808018645563,0,11,mitochondrial respiratory chain complex III,CC,
2768,GO:0005751,1,0.909953921875525,0,12,mitochondrial respiratory chain complex IV,CC,
2769,GO:0005753,1,0.854638302156394,0,20,mitochondrial proton-transporting ATP synthase complex,CC,
2770,GO:0005754,1,0.992171224704221,0,1,mitochondrial proton-transporting ATP synthase, catalytic core,CC,
2771,GO:0005757,1,0.992170027168696,0,1,mitochondrial permeability transition pore complex,CC,
2774,GO:0005760,1,0.987605395858979,0,2,gamma DNA polymerase complex,CC,
2777,GO:0005763,1,0.815177331637133,0,26,mitochondrial small ribosomal subunit,CC,
2779,GO:0005765,1,0.0972853414142779,0,322,lysosomal membrane,CC,
2781,GO:0005767,1,0.900901228037525,0,14,secondary lysosome,CC,
2785,GO:0005771,1,0.755779255647532,0,38,multivesicular body,CC,
2787,GO:0005774,1,0.0694984109039802,0,367,vacuolar membrane,CC,
2792,GO:0005779,1,0.90021079442168,0,14,integral component of peroxisomal membrane,CC,
2795,GO:0005784,1,0.969080617453174,0,4,Sec61 translocon complex,CC,
2796,GO:0005785,1,0.955156661899909,0,6,signal recognition particle receptor complex,CC,
2797,GO:0005786,1,0.95526795515842,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2798,GO:0005787,1,0.963265723176148,0,5,signal peptidase complex,CC,
2799,GO:0005788,1,0.248002319656138,0,196,endoplasmic reticulum lumen,CC,
2802,GO:0005791,1,0.609646637850586,0,68,rough endoplasmic reticulum,CC,
2805,GO:0005795,1,0.428503768123472,0,120,Golgi stack,CC,
2806,GO:0005796,1,0.49264993650388,0,97,Golgi lumen,CC,
2807,GO:0005797,1,0.971161014885818,0,4,Golgi medial cisterna,CC,
2808,GO:0005798,1,0.552229191194842,0,83,Golgi-associated vesicle,CC,
2809,GO:0005801,1,0.752841921640108,0,40,cis-Golgi network,CC,
2810,GO:0005802,1,0.271052167833312,0,183,trans-Golgi network,CC,
2812,GO:0005813,1,0.0354869953026058,0,467,centrosome,CC,
2813,GO:0005814,1,0.476853681743458,0,105,centriole,CC,
2815,GO:0005818,1,0.967041618250504,0,5,aster,CC,
2817,GO:0005826,1,0.974309808292861,0,4,actomyosin contractile ring,CC,
2818,GO:0005827,1,0.966161007869493,0,5,polar microtubule,CC,
2819,GO:0005828,1,0.960372656159126,0,6,kinetochore microtubule,CC,
2821,GO:0005832,1,0.918728175784854,0,11,chaperonin-containing T-complex,CC,
2822,GO:0005833,1,0.910313423298765,0,12,hemoglobin complex,CC,
2823,GO:0005834,1,0.773679073107621,0,35,heterotrimeric G-protein complex,CC,
2824,GO:0005838,1,0.84930474297548,0,21,proteasome regulatory particle,CC,
2827,GO:0005844,1,0.731418959050625,0,44,polysome,CC,
2828,GO:0005845,1,0.912843119682656,0,13,mRNA cap binding complex,CC,
2829,GO:0005846,1,0.986211217324015,0,2,nuclear cap binding complex,CC,
2830,GO:0005847,1,0.903436112979489,0,14,mRNA cleavage and polyadenylation specificity factor complex,CC,
2831,GO:0005849,1,0.874053412672051,0,19,mRNA cleavage factor complex,CC,
2832,GO:0005850,1,0.972664892009372,0,4,eukaryotic translation initiation factor 2 complex,CC,
2833,GO:0005851,1,0.955649421477083,0,6,eukaryotic translation initiation factor 2B complex,CC,
2834,GO:0005852,1,0.88071590328132,0,17,eukaryotic translation initiation factor 3 complex,CC,
2835,GO:0005853,1,0.969917021199527,0,4,eukaryotic translation elongation factor 1 complex,CC,
2837,GO:0005858,1,0.924201745837257,0,12,axonemal dynein complex,CC,
2838,GO:0005859,1,0.835003498051841,0,27,muscle myosin complex,CC,
2839,GO:0005861,1,0.940757319235943,0,8,troponin complex,CC,
2840,GO:0005862,1,0.970816746865616,0,4,muscle thin filament tropomyosin,CC,
2841,GO:0005863,1,0.981049604624015,0,3,striated muscle myosin thick filament,CC,
2843,GO:0005868,1,0.85410424163792,0,22,cytoplasmic dynein complex,CC,
2844,GO:0005869,1,0.942119895544064,0,8,dynactin complex,CC,
2845,GO:0005871,1,0.704582697583505,0,52,kinesin complex,CC,
2846,GO:0005873,1,0.987941566670916,0,2,plus-end kinesin complex,CC,
2848,GO:0005875,1,0.377568678546097,0,141,microtubule associated complex,CC,
2849,GO:0005876,1,0.694391563427453,0,52,spindle microtubule,CC,
2850,GO:0005879,1,0.980271740724508,0,3,axonemal microtubule,CC,
2851,GO:0005881,1,0.714172305463829,0,47,cytoplasmic microtubule,CC,
2853,GO:0005883,1,0.94574519888147,0,8,neurofilament,CC,
2854,GO:0005884,1,0.568746214106705,0,81,actin filament,CC,
2855,GO:0005885,1,0.918536486640948,0,11,Arp2/3 protein complex,CC,
2858,GO:0005889,1,0.986309823359658,0,2,hydrogen:potassium-exchanging ATPase complex,CC,
2860,GO:0005891,1,0.771077051728112,0,38,voltage-gated calcium channel complex,CC,
2861,GO:0005892,1,0.881432671798031,0,17,acetylcholine-gated channel complex,CC,
2862,GO:0005895,1,0.992192692093743,0,1,interleukin-5 receptor complex,CC,
2863,GO:0005896,1,0.978682308513787,0,3,interleukin-6 receptor complex,CC,
2864,GO:0005898,1,0.993522654927398,0,1,interleukin-13 receptor complex,CC,
2865,GO:0005899,1,0.982066433188751,0,3,insulin receptor complex,CC,
2866,GO:0005900,1,0.985994589910048,0,2,oncostatin-M receptor complex,CC,
2867,GO:0005901,1,0.623104187789178,0,69,caveola,CC,
2868,GO:0005902,1,0.575404028201532,0,78,microvillus,CC,
2869,GO:0005903,1,0.50353750063305,0,98,brush border,CC,
2870,GO:0005905,1,0.631461270277122,0,67,clathrin-coated pit,CC,
2871,GO:0005911,1,0.0631807851728458,0,394,cell-cell junction,CC,
2873,GO:0005913,1,0.568645984926778,0,81,cell-cell adherens junction,CC,
2874,GO:0005914,1,0.992892352659053,0,1,spot adherens junction,CC,
2875,GO:0005915,1,0.954254463650516,0,7,zonula adherens,CC,
2876,GO:0005916,1,0.934542436457749,0,10,fascia adherens,CC,
2877,GO:0005921,1,0.798705295992551,0,30,gap junction,CC,
2878,GO:0005922,1,0.860071176957325,0,20,connexin complex,CC,
2879,GO:0005923,1,0.471894003596972,0,109,bicellular tight junction,CC,
2882,GO:0005927,1,0.978477725215937,0,3,muscle tendon junction,CC,
2883,GO:0005929,1,0.0308787455421569,0,479,cilium,CC,
2884,GO:0005930,1,0.556009700712965,0,84,axoneme,CC,
2886,GO:0005940,1,0.992572981401073,0,1,septin ring,CC,
2887,GO:0005942,1,0.880896340637522,0,19,phosphatidylinositol 3-kinase complex,CC,
2888,GO:0005943,1,0.987297103253154,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2889,GO:0005944,1,0.98052246674595,0,3,phosphatidylinositol 3-kinase complex, class IB,CC,
2890,GO:0005945,1,0.985545629607567,0,2,6-phosphofructokinase complex,CC,
2891,GO:0005947,1,0.963386690418079,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2892,GO:0005952,1,0.950560944804384,0,7,cAMP-dependent protein kinase complex,CC,
2893,GO:0005953,1,0.98460791623936,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2894,GO:0005954,1,0.992263449933622,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2895,GO:0005955,1,0.973408663876119,0,4,calcineurin complex,CC,
2896,GO:0005956,1,0.984606190513315,0,2,protein kinase CK2 complex,CC,
2897,GO:0005958,1,0.979847118265354,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2898,GO:0005960,1,0.985589084765638,0,2,glycine cleavage complex,CC,
2899,GO:0005964,1,0.967994237373986,0,5,phosphorylase kinase complex,CC,
2900,GO:0005965,1,0.984667593030849,0,2,protein farnesyltransferase complex,CC,
2901,GO:0005967,1,0.979925911109465,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2902,GO:0005968,1,0.972246685413878,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2903,GO:0005969,1,0.993986332275604,0,1,serine-pyruvate aminotransferase complex,CC,
2904,GO:0005971,1,0.985713704882026,0,2,ribonucleoside-diphosphate reductase complex,CC,
2906,GO:0005976,1,0.495706826652966,0,99,polysaccharide metabolic process,BP,
2907,GO:0005977,1,0.602664420261739,0,72,glycogen metabolic process,BP,
2908,GO:0005978,1,0.72369476660302,0,46,glycogen biosynthetic process,BP,
2909,GO:0005979,1,0.839452856021121,0,26,regulation of glycogen biosynthetic process,BP,
2910,GO:0005980,1,0.833734211287418,0,26,glycogen catabolic process,BP,
2911,GO:0005981,1,0.959410642398146,0,6,regulation of glycogen catabolic process,BP,
2912,GO:0005982,1,0.993986332268204,0,1,starch metabolic process,BP,
2913,GO:0005983,1,0.993986332268204,0,1,starch catabolic process,BP,
2915,GO:0005985,1,0.977662235112482,0,3,sucrose metabolic process,BP,
2916,GO:0005986,1,0.984400887813367,0,2,sucrose biosynthetic process,BP,
2917,GO:0005988,1,0.979192453238921,0,3,lactose metabolic process,BP,
2918,GO:0005989,1,0.979192453238921,0,3,lactose biosynthetic process,BP,
2919,GO:0005991,1,0.992171570232374,0,1,trehalose metabolic process,BP,
2920,GO:0005993,1,0.992171570232374,0,1,trehalose catabolic process,BP,
2922,GO:0005997,1,0.970109536182608,0,4,xylulose metabolic process,BP,
2923,GO:0005998,1,0.993245628704852,0,1,xylulose catabolic process,BP,
2924,GO:0005999,1,0.984416691604198,0,2,xylulose biosynthetic process,BP,
2925,GO:0006000,1,0.900425755813583,0,14,fructose metabolic process,BP,
2926,GO:0006001,1,0.969812469073293,0,4,fructose catabolic process,BP,
2927,GO:0006002,1,0.935020818030863,0,9,fructose 6-phosphate metabolic process,BP,
2928,GO:0006003,1,0.973216756360819,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2929,GO:0006004,1,0.897674145817799,0,15,fucose metabolic process,BP,
2931,GO:0006007,1,0.799581077683815,0,30,glucose catabolic process,BP,
2934,GO:0006013,1,0.945162660727449,0,8,mannose metabolic process,BP,
2935,GO:0006014,1,0.976693134467681,0,3,D-ribose metabolic process,BP,
2936,GO:0006015,1,0.969428725287144,0,4,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2937,GO:0006020,1,0.927815339562408,0,11,inositol metabolic process,BP,
2938,GO:0006021,1,0.971617402846477,0,4,inositol biosynthetic process,BP,
2945,GO:0006030,1,0.977224127498405,0,3,chitin metabolic process,BP,
2946,GO:0006032,1,0.977224127498405,0,3,chitin catabolic process,BP,
2947,GO:0006037,1,0.992170027168696,0,1,cell wall chitin metabolic process,BP,
2948,GO:0006040,1,0.780534439159553,0,34,amino sugar metabolic process,BP,
2949,GO:0006041,1,0.978008319743879,0,3,glucosamine metabolic process,BP,
2950,GO:0006043,1,0.992214202091288,0,1,glucosamine catabolic process,BP,
2951,GO:0006044,1,0.897138604547824,0,15,N-acetylglucosamine metabolic process,BP,
2952,GO:0006045,1,0.987352947252051,0,2,N-acetylglucosamine biosynthetic process,BP,
2953,GO:0006047,1,0.901654397398212,0,14,UDP-N-acetylglucosamine metabolic process,BP,
2954,GO:0006048,1,0.935758282559031,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2955,GO:0006049,1,0.992508881957906,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2956,GO:0006050,1,0.984400887813367,0,2,mannosamine metabolic process,BP,
2957,GO:0006051,1,0.984400887813367,0,2,N-acetylmannosamine metabolic process,BP,
2958,GO:0006054,1,0.937634742702551,0,9,N-acetylneuraminate metabolic process,BP,
2959,GO:0006055,1,0.992170027168696,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2960,GO:0006056,1,0.992170321724734,0,1,mannoprotein metabolic process,BP,
2961,GO:0006057,1,0.992170321724734,0,1,mannoprotein biosynthetic process,BP,
2962,GO:0006059,1,0.976802630474195,0,3,hexitol metabolic process,BP,
2963,GO:0006060,1,0.984512270766988,0,2,sorbitol metabolic process,BP,
2964,GO:0006061,1,0.992170027168696,0,1,sorbitol biosynthetic process,BP,
2965,GO:0006062,1,0.992282282316394,0,1,sorbitol catabolic process,BP,
2966,GO:0006063,1,0.844721707840367,0,22,uronic acid metabolic process,BP,
2967,GO:0006064,1,0.962605280295254,0,5,glucuronate catabolic process,BP,
2968,GO:0006065,1,0.97907062084231,0,3,UDP-glucuronate biosynthetic process,BP,
2970,GO:0006067,1,0.850592417040611,0,21,ethanol metabolic process,BP,
2971,GO:0006068,1,0.91079753649573,0,12,ethanol catabolic process,BP,
2972,GO:0006069,1,0.912640905953377,0,12,ethanol oxidation,BP,
2973,GO:0006071,1,0.887378054150461,0,16,glycerol metabolic process,BP,
2974,GO:0006072,1,0.952692652726697,0,7,glycerol-3-phosphate metabolic process,BP,
2975,GO:0006073,1,0.599025860433768,0,73,cellular glucan metabolic process,BP,
2978,GO:0006083,1,0.980456058307754,0,3,acetate metabolic process,BP,
2982,GO:0006089,1,0.915452059782626,0,12,lactate metabolic process,BP,
2986,GO:0006096,1,0.6151971549827,0,67,glycolytic process,BP,
2993,GO:0006104,1,0.970632414518328,0,4,succinyl-CoA metabolic process,BP,
2995,GO:0006106,1,0.976794240771333,0,3,fumarate metabolic process,BP,
2999,GO:0006110,1,0.797934658961209,0,32,regulation of glycolytic process,BP,
3000,GO:0006111,1,0.790609163246468,0,33,regulation of gluconeogenesis,BP,
3001,GO:0006112,1,0.54762984157585,0,85,energy reserve metabolic process,BP,
3002,GO:0006113,1,0.992472769835405,0,1,fermentation,BP,
3003,GO:0006114,1,0.970534078839084,0,4,glycerol biosynthetic process,BP,
3004,GO:0006116,1,0.977075300941402,0,3,NADH oxidation,BP,
3005,GO:0006117,1,0.992302413607848,0,1,acetaldehyde metabolic process,BP,
3006,GO:0006119,1,0.468091643728693,0,99,oxidative phosphorylation,BP,
3007,GO:0006120,1,0.699544352339983,0,46,mitochondrial electron transport, NADH to ubiquinone,BP,
3008,GO:0006121,1,0.976759810897637,0,3,mitochondrial electron transport, succinate to ubiquinone,BP,
3009,GO:0006122,1,0.908768902369448,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
3010,GO:0006123,1,0.878416974651275,0,17,mitochondrial electron transport, cytochrome c to oxygen,BP,
3011,GO:0006127,1,0.99247569897477,0,1,glycerophosphate shuttle,BP,
3016,GO:0006147,1,0.993982189554209,0,1,guanine catabolic process,BP,
3019,GO:0006154,1,0.992170027168696,0,1,adenosine catabolic process,BP,
3020,GO:0006157,1,0.992170027168696,0,1,deoxyadenosine catabolic process,BP,
3023,GO:0006165,1,0.543500663686767,0,83,nucleoside diphosphate phosphorylation,BP,
3024,GO:0006166,1,0.963174060007556,0,5,purine ribonucleoside salvage,BP,
3025,GO:0006167,1,0.946811422872783,0,7,AMP biosynthetic process,BP,
3026,GO:0006168,1,0.984400887813367,0,2,adenine salvage,BP,
3027,GO:0006169,1,0.99218086641826,0,1,adenosine salvage,BP,
3029,GO:0006172,1,0.985413065657245,0,2,ADP biosynthetic process,BP,
3030,GO:0006173,1,0.993147947723938,0,1,dADP biosynthetic process,BP,
3031,GO:0006175,1,0.99218086641826,0,1,dATP biosynthetic process,BP,
3032,GO:0006177,1,0.976884719708449,0,3,GMP biosynthetic process,BP,
3033,GO:0006178,1,0.992170027168696,0,1,guanine salvage,BP,
3034,GO:0006182,1,0.747268013397884,0,41,cGMP biosynthetic process,BP,
3035,GO:0006183,1,0.917468729349241,0,11,GTP biosynthetic process,BP,
3036,GO:0006185,1,0.992170027168696,0,1,dGDP biosynthetic process,BP,
3037,GO:0006188,1,0.931169534992863,0,10,IMP biosynthetic process,BP,
3038,GO:0006189,1,0.958258759851633,0,6,'de novo' IMP biosynthetic process,BP,
3039,GO:0006193,1,0.992170027168696,0,1,ITP catabolic process,BP,
3041,GO:0006196,1,0.987334028604081,0,2,AMP catabolic process,BP,
3042,GO:0006198,1,0.889388493146484,0,18,cAMP catabolic process,BP,
3043,GO:0006203,1,0.977273771923055,0,3,dGTP catabolic process,BP,
3044,GO:0006206,1,0.870008240714913,0,19,pyrimidine nucleobase metabolic process,BP,
3045,GO:0006207,1,0.959629314811912,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3046,GO:0006208,1,0.977239739415658,0,3,pyrimidine nucleobase catabolic process,BP,
3047,GO:0006210,1,0.977239739415658,0,3,thymine catabolic process,BP,
3048,GO:0006211,1,0.993986332282215,0,1,5-methylcytosine catabolic process,BP,
3049,GO:0006212,1,0.984927853303469,0,2,uracil catabolic process,BP,
3050,GO:0006213,1,0.697069637301412,0,47,pyrimidine nucleoside metabolic process,BP,
3051,GO:0006214,1,0.992683337168453,0,1,thymidine catabolic process,BP,
3052,GO:0006216,1,0.932120082780067,0,9,cytidine catabolic process,BP,
3053,GO:0006218,1,0.992170683749517,0,1,uridine catabolic process,BP,
3054,GO:0006220,1,0.706755068142777,0,45,pyrimidine nucleotide metabolic process,BP,
3055,GO:0006221,1,0.794273157112288,0,30,pyrimidine nucleotide biosynthetic process,BP,
3056,GO:0006222,1,0.92671230293846,0,10,UMP biosynthetic process,BP,
3057,GO:0006226,1,0.992171801564538,0,1,dUMP biosynthetic process,BP,
3058,GO:0006227,1,0.984789563498906,0,2,dUDP biosynthetic process,BP,
3059,GO:0006228,1,0.926308138773617,0,10,UTP biosynthetic process,BP,
3060,GO:0006231,1,0.984487639975182,0,2,dTMP biosynthetic process,BP,
3061,GO:0006233,1,0.984789563498906,0,2,dTDP biosynthetic process,BP,
3062,GO:0006235,1,0.96942589612739,0,4,dTTP biosynthetic process,BP,
3063,GO:0006238,1,0.992170027168696,0,1,CMP salvage,BP,
3064,GO:0006241,1,0.897281546710642,0,14,CTP biosynthetic process,BP,
3065,GO:0006244,1,0.910965980226041,0,12,pyrimidine nucleotide catabolic process,BP,
3066,GO:0006253,1,0.992170027168696,0,1,dCTP catabolic process,BP,
3067,GO:0006256,1,0.992517443984523,0,1,UDP catabolic process,BP,
3071,GO:0006261,1,0.382002714419169,0,132,DNA-dependent DNA replication,BP,
3072,GO:0006264,1,0.931885029563305,0,10,mitochondrial DNA replication,BP,
3073,GO:0006265,1,0.938955421667197,0,9,DNA topological change,BP,
3074,GO:0006266,1,0.836323283184492,0,24,DNA ligation,BP,
3075,GO:0006267,1,0.984527779293501,0,2,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3076,GO:0006268,1,0.949608366379961,0,7,DNA unwinding involved in DNA replication,BP,
3077,GO:0006269,1,0.971594090535819,0,4,DNA replication, synthesis of RNA primer,BP,
3078,GO:0006270,1,0.74824201110961,0,39,DNA replication initiation,BP,
3079,GO:0006271,1,0.889888071072141,0,16,DNA strand elongation involved in DNA replication,BP,
3080,GO:0006272,1,0.988005371862586,0,2,leading strand elongation,BP,
3081,GO:0006273,1,0.944119344830691,0,8,lagging strand elongation,BP,
3082,GO:0006274,1,0.992294630214608,0,1,DNA replication termination,BP,
3083,GO:0006275,1,0.45119732253303,0,111,regulation of DNA replication,BP,
3084,GO:0006278,1,0.639635122821631,0,62,RNA-dependent DNA biosynthetic process,BP,
3085,GO:0006281,1,0.0267918454034542,0,493,DNA repair,BP,
3086,GO:0006282,1,0.573080922774367,0,77,regulation of DNA repair,BP,
3087,GO:0006283,1,0.581325046138886,0,73,transcription-coupled nucleotide-excision repair,BP,
3088,GO:0006284,1,0.739403604406151,0,41,base-excision repair,BP,
3089,GO:0006285,1,0.925087201891816,0,10,base-excision repair, AP site formation,BP,
3090,GO:0006286,1,0.984400887813367,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3091,GO:0006287,1,0.965748576195117,0,5,base-excision repair, gap-filling,BP,
3092,GO:0006288,1,0.977469625922879,0,3,base-excision repair, DNA ligation,BP,
3093,GO:0006289,1,0.429522984019874,0,114,nucleotide-excision repair,BP,
3094,GO:0006290,1,0.951748457420116,0,7,pyrimidine dimer repair,BP,
3095,GO:0006293,1,0.860376500689394,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3096,GO:0006294,1,0.808118769299258,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3097,GO:0006295,1,0.860376500689394,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3098,GO:0006296,1,0.762742085380031,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3099,GO:0006297,1,0.844267469149359,0,23,nucleotide-excision repair, DNA gap filling,BP,
3100,GO:0006298,1,0.800225055964632,0,31,mismatch repair,BP,
3101,GO:0006301,1,0.699380155662225,0,50,postreplication repair,BP,
3102,GO:0006302,1,0.234629154136791,0,199,double-strand break repair,BP,
3103,GO:0006303,1,0.612944004791234,0,67,double-strand break repair via nonhomologous end joining,BP,
3104,GO:0006304,1,0.501619617274214,0,95,DNA modification,BP,
3105,GO:0006305,1,0.659803928464145,0,59,DNA alkylation,BP,
3106,GO:0006306,1,0.659803928464145,0,59,DNA methylation,BP,
3107,GO:0006307,1,0.92863960178929,0,10,DNA dealkylation involved in DNA repair,BP,
3109,GO:0006309,1,0.868999964096276,0,19,apoptotic DNA fragmentation,BP,
3110,GO:0006310,1,0.160742800896259,0,250,DNA recombination,BP,
3111,GO:0006311,1,0.978372735320426,0,3,meiotic gene conversion,BP,
3112,GO:0006312,1,0.711948317702552,0,47,mitotic recombination,BP,
3113,GO:0006313,1,0.985887193914264,0,2,transposition, DNA-mediated,BP,
3114,GO:0006323,1,0.250770692242469,0,185,DNA packaging,BP,
3115,GO:0006325,1,0.00570197207397026,0,709,chromatin organization,BP,
3116,GO:0006333,1,0.272002246630142,0,174,chromatin assembly or disassembly,BP,
3117,GO:0006334,1,0.365793226728628,0,132,nucleosome assembly,BP,
3118,GO:0006335,1,0.780803036793734,0,32,DNA replication-dependent nucleosome assembly,BP,
3119,GO:0006336,1,0.696168155447628,0,48,DNA replication-independent nucleosome assembly,BP,
3120,GO:0006337,1,0.878764279165499,0,18,nucleosome disassembly,BP,
3121,GO:0006338,1,0.341345826463999,0,149,chromatin remodeling,BP,
3122,GO:0006342,1,0.428941076451503,0,114,chromatin silencing,BP,
3123,GO:0006343,1,0.993382379108709,0,1,establishment of chromatin silencing,BP,
3124,GO:0006344,1,0.973937019146503,0,4,maintenance of chromatin silencing,BP,
3125,GO:0006346,1,0.865708847313831,0,20,methylation-dependent chromatin silencing,BP,
3126,GO:0006348,1,0.935105374349908,0,9,chromatin silencing at telomere,BP,
3127,GO:0006349,1,0.896163540627695,0,16,regulation of gene expression by genetic imprinting,BP,
3130,GO:0006353,1,0.463213652463152,0,104,DNA-templated transcription, termination,BP,
3133,GO:0006356,1,0.804994466356992,0,31,regulation of transcription from RNA polymerase I promoter,BP,
3135,GO:0006359,1,0.836496044358324,0,25,regulation of transcription from RNA polymerase III promoter,BP,
3136,GO:0006360,1,0.652892926147139,0,59,transcription from RNA polymerase I promoter,BP,
3137,GO:0006361,1,0.787907330625666,0,32,transcription initiation from RNA polymerase I promoter,BP,
3138,GO:0006362,1,0.795208319553674,0,31,transcription elongation from RNA polymerase I promoter,BP,
3139,GO:0006363,1,0.799498699655389,0,30,termination of RNA polymerase I transcription,BP,
3143,GO:0006368,1,0.493177851701924,0,97,transcription elongation from RNA polymerase II promoter,BP,
3144,GO:0006369,1,0.601610716911996,0,69,termination of RNA polymerase II transcription,BP,
3145,GO:0006370,1,0.799931628641748,0,30,7-methylguanosine mRNA capping,BP,
3147,GO:0006378,1,0.760819347234986,0,39,mRNA polyadenylation,BP,
3148,GO:0006379,1,0.832255935923778,0,25,mRNA cleavage,BP,
3149,GO:0006382,1,0.974329845380882,0,4,adenosine to inosine editing,BP,
3150,GO:0006383,1,0.689901378499052,0,51,transcription from RNA polymerase III promoter,BP,
3151,GO:0006384,1,0.946375412350483,0,8,transcription initiation from RNA polymerase III promoter,BP,
3152,GO:0006388,1,0.89749151933037,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3153,GO:0006390,1,0.94944319840621,0,7,transcription from mitochondrial promoter,BP,
3154,GO:0006391,1,0.977865377686021,0,3,transcription initiation from mitochondrial promoter,BP,
3157,GO:0006398,1,0.964961545584317,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3160,GO:0006401,1,0.161556713948496,0,246,RNA catabolic process,BP,
3161,GO:0006402,1,0.200026229308106,0,217,mRNA catabolic process,BP,
3162,GO:0006403,1,0.206868144819045,0,218,RNA localization,BP,
3163,GO:0006404,1,0.97954214763666,0,3,RNA import into nucleus,BP,
3164,GO:0006405,1,0.371791343034724,0,137,RNA export from nucleus,BP,
3165,GO:0006406,1,0.460167178722458,0,108,mRNA export from nucleus,BP,
3166,GO:0006407,1,0.98620308078609,0,2,rRNA export from nucleus,BP,
3167,GO:0006408,1,0.984414813044386,0,2,snRNA export from nucleus,BP,
3168,GO:0006409,1,0.808073481608863,0,31,tRNA export from nucleus,BP,
3170,GO:0006413,1,0.242466762231441,0,188,translational initiation,BP,
3174,GO:0006418,1,0.698669831283639,0,48,tRNA aminoacylation for protein translation,BP,
3175,GO:0006419,1,0.979130645960072,0,3,alanyl-tRNA aminoacylation,BP,
3176,GO:0006420,1,0.969098101975991,0,4,arginyl-tRNA aminoacylation,BP,
3177,GO:0006421,1,0.977759033549764,0,3,asparaginyl-tRNA aminoacylation,BP,
3178,GO:0006422,1,0.992222522652988,0,1,aspartyl-tRNA aminoacylation,BP,
3179,GO:0006423,1,0.984567344693527,0,2,cysteinyl-tRNA aminoacylation,BP,
3180,GO:0006424,1,0.987437589627907,0,2,glutamyl-tRNA aminoacylation,BP,
3181,GO:0006425,1,0.992253926569845,0,1,glutaminyl-tRNA aminoacylation,BP,
3182,GO:0006426,1,0.984625099557387,0,2,glycyl-tRNA aminoacylation,BP,
3183,GO:0006427,1,0.984505823838289,0,2,histidyl-tRNA aminoacylation,BP,
3184,GO:0006428,1,0.986954594170882,0,2,isoleucyl-tRNA aminoacylation,BP,
3185,GO:0006429,1,0.98762555052971,0,2,leucyl-tRNA aminoacylation,BP,
3186,GO:0006430,1,0.992186007071722,0,1,lysyl-tRNA aminoacylation,BP,
3187,GO:0006431,1,0.985076339457963,0,2,methionyl-tRNA aminoacylation,BP,
3188,GO:0006432,1,0.969502777309664,0,4,phenylalanyl-tRNA aminoacylation,BP,
3189,GO:0006433,1,0.986221430599055,0,2,prolyl-tRNA aminoacylation,BP,
3190,GO:0006434,1,0.984415720717729,0,2,seryl-tRNA aminoacylation,BP,
3191,GO:0006435,1,0.9777227415096,0,3,threonyl-tRNA aminoacylation,BP,
3192,GO:0006436,1,0.984849531935261,0,2,tryptophanyl-tRNA aminoacylation,BP,
3193,GO:0006437,1,0.984930765277839,0,2,tyrosyl-tRNA aminoacylation,BP,
3194,GO:0006438,1,0.980942742409817,0,3,valyl-tRNA aminoacylation,BP,
3195,GO:0006446,1,0.60225394531733,0,70,regulation of translational initiation,BP,
3196,GO:0006447,1,0.980081375858774,0,3,regulation of translational initiation by iron,BP,
3197,GO:0006448,1,0.828695236520663,0,26,regulation of translational elongation,BP,
3198,GO:0006449,1,0.945303606134137,0,8,regulation of translational termination,BP,
3199,GO:0006450,1,0.890088527928695,0,16,regulation of translational fidelity,BP,
3200,GO:0006451,1,0.937653308536738,0,9,translational readthrough,BP,
3201,GO:0006452,1,0.979662444374249,0,3,translational frameshifting,BP,
3202,GO:0006457,1,0.18982394966325,0,221,protein folding,BP,
3203,GO:0006458,1,0.78526802049567,0,32,'de novo' protein folding,BP,
3205,GO:0006463,1,0.993290599765674,0,1,steroid hormone receptor complex assembly,BP,
3207,GO:0006465,1,0.866563024739008,0,19,signal peptide processing,BP,
3211,GO:0006471,1,0.851935072013235,0,22,protein ADP-ribosylation,BP,
3212,GO:0006473,1,0.285148037232293,0,173,protein acetylation,BP,
3213,GO:0006474,1,0.894619716179312,0,16,N-terminal protein amino acid acetylation,BP,
3214,GO:0006475,1,0.342323101782597,0,148,internal protein amino acid acetylation,BP,
3215,GO:0006476,1,0.523118877154746,0,92,protein deacetylation,BP,
3216,GO:0006477,1,0.950543193338851,0,7,protein sulfation,BP,
3217,GO:0006478,1,0.984415572657823,0,2,peptidyl-tyrosine sulfation,BP,
3219,GO:0006480,1,0.984524522725182,0,2,N-terminal protein amino acid methylation,BP,
3220,GO:0006481,1,0.986124587085354,0,2,C-terminal protein methylation,BP,
3221,GO:0006482,1,0.833196227798102,0,28,protein demethylation,BP,
3224,GO:0006488,1,0.862823422507542,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3225,GO:0006489,1,0.948980769507116,0,7,dolichyl diphosphate biosynthetic process,BP,
3226,GO:0006490,1,0.856158752858898,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3227,GO:0006491,1,0.886442291443504,0,18,N-glycan processing,BP,
3230,GO:0006498,1,0.959239551951784,0,6,N-terminal protein lipidation,BP,
3231,GO:0006499,1,0.974423896150628,0,4,N-terminal protein myristoylation,BP,
3232,GO:0006500,1,0.984420236045686,0,2,N-terminal protein palmitoylation,BP,
3233,GO:0006501,1,0.599334333244747,0,69,C-terminal protein lipidation,BP,
3236,GO:0006507,1,0.992213076081144,0,1,GPI anchor release,BP,
3238,GO:0006509,1,0.759702000195862,0,39,membrane protein ectodomain proteolysis,BP,
3240,GO:0006513,1,0.674081590875268,0,57,protein monoubiquitination,BP,
3241,GO:0006515,1,0.848499434360437,0,23,misfolded or incompletely synthesized protein catabolic process,BP,
3242,GO:0006516,1,0.884426957440379,0,17,glycoprotein catabolic process,BP,
3243,GO:0006517,1,0.789277102859372,0,34,protein deglycosylation,BP,
3247,GO:0006522,1,0.962731927347665,0,5,alanine metabolic process,BP,
3248,GO:0006524,1,0.962731927347665,0,5,alanine catabolic process,BP,
3249,GO:0006525,1,0.880782340416399,0,17,arginine metabolic process,BP,
3250,GO:0006526,1,0.969062567663373,0,4,arginine biosynthetic process,BP,
3251,GO:0006527,1,0.937905636758424,0,9,arginine catabolic process,BP,
3252,GO:0006528,1,0.961655812228146,0,5,asparagine metabolic process,BP,
3253,GO:0006529,1,0.984542525245949,0,2,asparagine biosynthetic process,BP,
3254,GO:0006530,1,0.984466037727235,0,2,asparagine catabolic process,BP,
3255,GO:0006531,1,0.920199130898966,0,11,aspartate metabolic process,BP,
3256,GO:0006532,1,0.976793800819484,0,3,aspartate biosynthetic process,BP,
3257,GO:0006533,1,0.976793800819484,0,3,aspartate catabolic process,BP,
3258,GO:0006534,1,0.908756190922682,0,13,cysteine metabolic process,BP,
3259,GO:0006535,1,0.992312759411149,0,1,cysteine biosynthetic process from serine,BP,
3262,GO:0006538,1,0.94913844269879,0,7,glutamate catabolic process,BP,
3263,GO:0006540,1,0.984617926219373,0,2,glutamate decarboxylation to succinate,BP,
3264,GO:0006541,1,0.844899848311853,0,24,glutamine metabolic process,BP,
3265,GO:0006542,1,0.987764845120699,0,2,glutamine biosynthetic process,BP,
3266,GO:0006543,1,0.979502360653252,0,3,glutamine catabolic process,BP,
3267,GO:0006544,1,0.89339286942234,0,15,glycine metabolic process,BP,
3268,GO:0006545,1,0.962844268269127,0,5,glycine biosynthetic process,BP,
3269,GO:0006546,1,0.977883176006054,0,3,glycine catabolic process,BP,
3270,GO:0006547,1,0.93507440639023,0,9,histidine metabolic process,BP,
3271,GO:0006548,1,0.949025219019423,0,7,histidine catabolic process,BP,
3274,GO:0006551,1,0.950926057508583,0,7,leucine metabolic process,BP,
3275,GO:0006552,1,0.964233266620686,0,5,leucine catabolic process,BP,
3276,GO:0006553,1,0.922942454454634,0,11,lysine metabolic process,BP,
3277,GO:0006554,1,0.929953810786647,0,10,lysine catabolic process,BP,
3279,GO:0006556,1,0.977741842782104,0,3,S-adenosylmethionine biosynthetic process,BP,
3280,GO:0006557,1,0.992814836623527,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3283,GO:0006560,1,0.933229087219636,0,9,proline metabolic process,BP,
3284,GO:0006561,1,0.955478619182849,0,6,proline biosynthetic process,BP,
3285,GO:0006562,1,0.969689871854458,0,4,proline catabolic process,BP,
3286,GO:0006563,1,0.924780513122608,0,10,L-serine metabolic process,BP,
3287,GO:0006564,1,0.954021970582205,0,6,L-serine biosynthetic process,BP,
3288,GO:0006565,1,0.97691872616282,0,3,L-serine catabolic process,BP,
3289,GO:0006566,1,0.984409137102166,0,2,threonine metabolic process,BP,
3290,GO:0006567,1,0.992170027168696,0,1,threonine catabolic process,BP,
3291,GO:0006568,1,0.907717220837242,0,13,tryptophan metabolic process,BP,
3292,GO:0006569,1,0.920424383742223,0,11,tryptophan catabolic process,BP,
3294,GO:0006572,1,0.96167917172375,0,5,tyrosine catabolic process,BP,
3296,GO:0006574,1,0.969104302232527,0,4,valine catabolic process,BP,
3300,GO:0006578,1,0.948937425880156,0,7,amino-acid betaine biosynthetic process,BP,
3301,GO:0006579,1,0.977366476803799,0,3,amino-acid betaine catabolic process,BP,
3302,GO:0006580,1,0.992358711416109,0,1,ethanolamine metabolic process,BP,
3303,GO:0006581,1,0.984945513548643,0,2,acetylcholine catabolic process,BP,
3304,GO:0006582,1,0.873856746131053,0,19,melanin metabolic process,BP,
3305,GO:0006583,1,0.984468355825803,0,2,melanin biosynthetic process from tyrosine,BP,
3308,GO:0006586,1,0.872763473629949,0,18,indolalkylamine metabolic process,BP,
3309,GO:0006589,1,0.985068212808892,0,2,octopamine biosynthetic process,BP,
3310,GO:0006590,1,0.893478435760342,0,16,thyroid hormone generation,BP,
3311,GO:0006591,1,0.948745110881535,0,7,ornithine metabolic process,BP,
3312,GO:0006592,1,0.993021977199118,0,1,ornithine biosynthetic process,BP,
3313,GO:0006593,1,0.992170027168696,0,1,ornithine catabolic process,BP,
3314,GO:0006595,1,0.890749051465008,0,15,polyamine metabolic process,BP,
3315,GO:0006596,1,0.912002499166273,0,12,polyamine biosynthetic process,BP,
3316,GO:0006597,1,0.985040697731822,0,2,spermine biosynthetic process,BP,
3317,GO:0006598,1,0.953955109768708,0,6,polyamine catabolic process,BP,
3318,GO:0006599,1,0.992170027168696,0,1,phosphagen metabolic process,BP,
3320,GO:0006601,1,0.984536333533021,0,2,creatine biosynthetic process,BP,
3321,GO:0006603,1,0.992170027168696,0,1,phosphocreatine metabolic process,BP,
3324,GO:0006607,1,0.863502762825738,0,22,NLS-bearing protein import into nucleus,BP,
3325,GO:0006610,1,0.948982336879136,0,8,ribosomal protein import into nucleus,BP,
3327,GO:0006612,1,0.261660726493844,0,178,protein targeting to membrane,BP,
3328,GO:0006613,1,0.474821463282076,0,96,cotranslational protein targeting to membrane,BP,
3329,GO:0006614,1,0.491887101964361,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3330,GO:0006616,1,0.955160962403296,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3331,GO:0006617,1,0.984434991815195,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3332,GO:0006620,1,0.958406599428968,0,6,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3333,GO:0006621,1,0.935108211535688,0,9,protein retention in ER lumen,BP,
3334,GO:0006622,1,0.891833923211538,0,17,protein targeting to lysosome,BP,
3335,GO:0006623,1,0.825093638902271,0,28,protein targeting to vacuole,BP,
3336,GO:0006624,1,0.984414282672977,0,2,vacuolar protein processing,BP,
3337,GO:0006625,1,0.885615554763623,0,17,protein targeting to peroxisome,BP,
3338,GO:0006626,1,0.350223406356663,0,141,protein targeting to mitochondrion,BP,
3339,GO:0006627,1,0.948268046225208,0,7,protein processing involved in protein targeting to mitochondrion,BP,
3349,GO:0006642,1,0.973837327868945,0,4,triglyceride mobilization,BP,
3352,GO:0006646,1,0.917375268104015,0,12,phosphatidylethanolamine biosynthetic process,BP,
3353,GO:0006649,1,0.986728903992406,0,2,phospholipid transfer to membrane,BP,
3356,GO:0006654,1,0.780275302646591,0,35,phosphatidic acid biosynthetic process,BP,
3357,GO:0006655,1,0.936187890979651,0,9,phosphatidylglycerol biosynthetic process,BP,
3359,GO:0006657,1,0.949976663644148,0,7,CDP-choline pathway,BP,
3361,GO:0006659,1,0.970171232013334,0,4,phosphatidylserine biosynthetic process,BP,
3362,GO:0006660,1,0.992170384206922,0,1,phosphatidylserine catabolic process,BP,
3365,GO:0006663,1,0.971154978829006,0,4,platelet activating factor biosynthetic process,BP,
3368,GO:0006666,1,0.993968335447342,0,1,3-keto-sphinganine metabolic process,BP,
3369,GO:0006667,1,0.978482212613961,0,3,sphinganine metabolic process,BP,
3370,GO:0006668,1,0.985449447440404,0,2,sphinganine-1-phosphate metabolic process,BP,
3371,GO:0006669,1,0.992542925725412,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3372,GO:0006670,1,0.928887821120588,0,10,sphingosine metabolic process,BP,
3373,GO:0006671,1,0.993759557162157,0,1,phytosphingosine metabolic process,BP,
3376,GO:0006678,1,0.951139280482324,0,7,glucosylceramide metabolic process,BP,
3377,GO:0006679,1,0.986175973757004,0,2,glucosylceramide biosynthetic process,BP,
3378,GO:0006680,1,0.977990803066365,0,3,glucosylceramide catabolic process,BP,
3379,GO:0006681,1,0.963831706665257,0,5,galactosylceramide metabolic process,BP,
3380,GO:0006682,1,0.98472348119027,0,2,galactosylceramide biosynthetic process,BP,
3381,GO:0006683,1,0.99250042433583,0,1,galactosylceramide catabolic process,BP,
3382,GO:0006684,1,0.903540559693424,0,14,sphingomyelin metabolic process,BP,
3383,GO:0006685,1,0.957603536413924,0,6,sphingomyelin catabolic process,BP,
3384,GO:0006686,1,0.95851641413619,0,6,sphingomyelin biosynthetic process,BP,
3386,GO:0006688,1,0.897439397541845,0,15,glycosphingolipid biosynthetic process,BP,
3390,GO:0006692,1,0.782817180384124,0,33,prostanoid metabolic process,BP,
3391,GO:0006693,1,0.782817180384124,0,33,prostaglandin metabolic process,BP,
3394,GO:0006696,1,0.984416484929639,0,2,ergosterol biosynthetic process,BP,
3397,GO:0006701,1,0.950573782989753,0,7,progesterone biosynthetic process,BP,
3403,GO:0006707,1,0.92030354852931,0,11,cholesterol catabolic process,BP,
3405,GO:0006711,1,0.984416330413228,0,2,estrogen catabolic process,BP,
3406,GO:0006713,1,0.992170445640749,0,1,glucocorticoid catabolic process,BP,
3407,GO:0006714,1,0.984400887813367,0,2,sesquiterpenoid metabolic process,BP,
3410,GO:0006722,1,0.992241458127627,0,1,triterpenoid metabolic process,BP,
3412,GO:0006726,1,0.971283371048872,0,4,eye pigment biosynthetic process,BP,
3414,GO:0006730,1,0.784075775955747,0,33,one-carbon metabolic process,BP,
3418,GO:0006735,1,0.823287562062173,0,26,NADH regeneration,BP,
3422,GO:0006741,1,0.978032038643416,0,3,NADP biosynthetic process,BP,
3423,GO:0006742,1,0.985263228090941,0,2,NADP catabolic process,BP,
3424,GO:0006743,1,0.899140818440364,0,14,ubiquinone metabolic process,BP,
3425,GO:0006744,1,0.904742672387966,0,13,ubiquinone biosynthetic process,BP,
3426,GO:0006747,1,0.992175466744087,0,1,FAD biosynthetic process,BP,
3429,GO:0006751,1,0.939472466596102,0,8,glutathione catabolic process,BP,
3431,GO:0006754,1,0.72767596927107,0,42,ATP biosynthetic process,BP,
3432,GO:0006757,1,0.6151971549827,0,67,ATP generation from ADP,BP,
3433,GO:0006760,1,0.831350177826185,0,25,folic acid-containing compound metabolic process,BP,
3436,GO:0006768,1,0.925288864741485,0,11,biotin metabolic process,BP,
3438,GO:0006772,1,0.969367812472323,0,4,thiamine metabolic process,BP,
3440,GO:0006776,1,0.943033480661879,0,8,vitamin A metabolic process,BP,
3441,GO:0006777,1,0.957145583449989,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3443,GO:0006779,1,0.838356749968672,0,24,porphyrin-containing compound biosynthetic process,BP,
3444,GO:0006780,1,0.984423640281871,0,2,uroporphyrinogen III biosynthetic process,BP,
3445,GO:0006781,1,0.992192957802479,0,1,succinyl-CoA pathway,BP,
3446,GO:0006782,1,0.93982510300216,0,8,protoporphyrinogen IX biosynthetic process,BP,
3447,GO:0006783,1,0.863137060685704,0,20,heme biosynthetic process,BP,
3448,GO:0006784,1,0.986603214423282,0,2,heme a biosynthetic process,BP,
3449,GO:0006787,1,0.946566827406668,0,7,porphyrin-containing compound catabolic process,BP,
3450,GO:0006788,1,0.984401003909679,0,2,heme oxidation,BP,
3451,GO:0006789,1,0.984520785303339,0,2,bilirubin conjugation,BP,
3455,GO:0006797,1,0.992454101113446,0,1,polyphosphate metabolic process,BP,
3459,GO:0006808,1,0.977908413983509,0,3,regulation of nitrogen utilization,BP,
3464,GO:0006813,1,0.201705921145982,0,224,potassium ion transport,BP,
3467,GO:0006817,1,0.842421601136814,0,24,phosphate ion transport,BP,
3471,GO:0006824,1,0.962899024461052,0,5,cobalt ion transport,BP,
3473,GO:0006826,1,0.660763686534736,0,57,iron ion transport,BP,
3474,GO:0006828,1,0.927054587702407,0,11,manganese ion transport,BP,
3475,GO:0006829,1,0.827410230146836,0,26,zinc II ion transport,BP,
3476,GO:0006833,1,0.868730860963927,0,19,water transport,BP,
3479,GO:0006837,1,0.888017329476341,0,16,serotonin transport,BP,
3481,GO:0006842,1,0.972409516510563,0,4,tricarboxylic acid transport,BP,
3482,GO:0006843,1,0.992170027168696,0,1,mitochondrial citrate transport,BP,
3483,GO:0006844,1,0.984462901602972,0,2,acyl carnitine transport,BP,
3484,GO:0006848,1,0.970307918080937,0,4,pyruvate transport,BP,
3485,GO:0006850,1,0.977060181581946,0,3,mitochondrial pyruvate transport,BP,
3486,GO:0006851,1,0.942145665187301,0,8,mitochondrial calcium ion transport,BP,
3489,GO:0006857,1,0.937886208479726,0,9,oligopeptide transport,BP,
3490,GO:0006858,1,0.986206490101826,0,2,extracellular transport,BP,
3491,GO:0006860,1,0.992173456963502,0,1,extracellular amino acid transport,BP,
3492,GO:0006862,1,0.8628905175295,0,20,nucleotide transport,BP,
3493,GO:0006863,1,0.948420982437096,0,7,purine nucleobase transport,BP,
3494,GO:0006864,1,0.986083170111211,0,2,pyrimidine nucleotide transport,BP,
3496,GO:0006867,1,0.98472618857339,0,2,asparagine transport,BP,
3497,GO:0006868,1,0.964053651555341,0,5,glutamine transport,BP,
3502,GO:0006876,1,0.993397951175909,0,1,cellular cadmium ion homeostasis,BP,
3504,GO:0006879,1,0.718553582518676,0,46,cellular iron ion homeostasis,BP,
3505,GO:0006880,1,0.961460790989252,0,5,intracellular sequestering of iron ion,BP,
3506,GO:0006882,1,0.834201460850295,0,25,cellular zinc ion homeostasis,BP,
3507,GO:0006883,1,0.913571935634847,0,13,cellular sodium ion homeostasis,BP,
3508,GO:0006884,1,0.889382782116232,0,17,cell volume homeostasis,BP,
3513,GO:0006890,1,0.550502551049513,0,83,retrograde vesicle-mediated transport, Golgi to ER,BP,
3514,GO:0006891,1,0.726375052966905,0,47,intra-Golgi vesicle-mediated transport,BP,
3515,GO:0006892,1,0.545097548312547,0,87,post-Golgi vesicle-mediated transport,BP,
3516,GO:0006893,1,0.726638651972405,0,45,Golgi to plasma membrane transport,BP,
3517,GO:0006895,1,0.888209729399549,0,18,Golgi to endosome transport,BP,
3518,GO:0006896,1,0.933701858838519,0,10,Golgi to vacuole transport,BP,
3521,GO:0006900,1,0.458157591073936,0,109,membrane budding,BP,
3522,GO:0006901,1,0.636475022550438,0,64,vesicle coating,BP,
3523,GO:0006903,1,0.569421969935254,0,80,vesicle targeting,BP,
3524,GO:0006904,1,0.732985153865037,0,43,vesicle docking involved in exocytosis,BP,
3528,GO:0006910,1,0.895317735173933,0,15,phagocytosis, recognition,BP,
3529,GO:0006911,1,0.79829934886019,0,31,phagocytosis, engulfment,BP,
3534,GO:0006921,1,0.803409596723441,0,30,cellular component disassembly involved in execution phase of apoptosis,BP,
3536,GO:0006925,1,0.883039746167514,0,17,inflammatory cell apoptotic process,BP,
3538,GO:0006929,1,0.830914587558901,0,27,substrate-dependent cell migration,BP,
3539,GO:0006930,1,0.946530051027417,0,8,substrate-dependent cell migration, cell extension,BP,
3540,GO:0006931,1,0.972635200221123,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3541,GO:0006933,1,0.970798776289809,0,4,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3544,GO:0006937,1,0.351956349171381,0,146,regulation of muscle contraction,BP,
3545,GO:0006939,1,0.510975708589543,0,94,smooth muscle contraction,BP,
3546,GO:0006940,1,0.676158880796245,0,54,regulation of smooth muscle contraction,BP,
3547,GO:0006941,1,0.316142106195924,0,163,striated muscle contraction,BP,
3548,GO:0006942,1,0.554311330220578,0,84,regulation of striated muscle contraction,BP,
3549,GO:0006948,1,0.99266691529153,0,1,induction by virus of host cell-cell fusion,BP,
3550,GO:0006949,1,0.704125810030978,0,49,syncytium formation,BP,
3553,GO:0006953,1,0.709388999174365,0,46,acute-phase response,BP,
3558,GO:0006958,1,0.790604406146422,0,32,complement activation, classical pathway,BP,
3560,GO:0006963,1,0.984400887813367,0,2,positive regulation of antibacterial peptide biosynthetic process,BP,
3561,GO:0006965,1,0.984400887813367,0,2,positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
3562,GO:0006968,1,0.639209354787814,0,59,cellular defense response,BP,
3564,GO:0006971,1,0.948078321175098,0,8,hypotonic response,BP,
3565,GO:0006972,1,0.857467211604792,0,21,hyperosmotic response,BP,
3567,GO:0006975,1,0.943272781877196,0,8,DNA damage induced protein phosphorylation,BP,
3568,GO:0006977,1,0.646962905171862,0,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3569,GO:0006978,1,0.885524771399472,0,17,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3571,GO:0006982,1,0.976692313394457,0,3,response to lipid hydroperoxide,BP,
3572,GO:0006983,1,0.933995797064126,0,10,ER overload response,BP,
3573,GO:0006984,1,0.737476375843401,0,42,ER-nucleus signaling pathway,BP,
3575,GO:0006987,1,0.944925387827184,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3576,GO:0006990,1,0.970918044633712,0,4,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3577,GO:0006991,1,0.937252427395625,0,9,response to sterol depletion,BP,
3578,GO:0006995,1,0.971572080152777,0,4,cellular response to nitrogen starvation,BP,
3580,GO:0006997,1,0.378537045258274,0,136,nucleus organization,BP,
3581,GO:0006998,1,0.562177583162876,0,81,nuclear envelope organization,BP,
3582,GO:0006999,1,0.907969414694344,0,14,nuclear pore organization,BP,
3583,GO:0007000,1,0.958159449401098,0,6,nucleolus organization,BP,
3584,GO:0007004,1,0.648587766615519,0,60,telomere maintenance via telomerase,BP,
3587,GO:0007007,1,0.87247240683082,0,18,inner mitochondrial membrane organization,BP,
3588,GO:0007008,1,0.94145320682883,0,8,outer mitochondrial membrane organization,BP,
3589,GO:0007009,1,0.143528256516473,0,275,plasma membrane organization,BP,
3591,GO:0007014,1,0.993262476933322,0,1,actin ubiquitination,BP,
3593,GO:0007016,1,0.939034331354823,0,10,cytoskeletal anchoring at plasma membrane,BP,
3594,GO:0007017,1,0.0129066773773911,0,608,microtubule-based process,BP,
3595,GO:0007018,1,0.189655020639048,0,237,microtubule-based movement,BP,
3596,GO:0007019,1,0.810905849642567,0,29,microtubule depolymerization,BP,
3597,GO:0007020,1,0.853902995021008,0,23,microtubule nucleation,BP,
3598,GO:0007021,1,0.955554502364761,0,6,tubulin complex assembly,BP,
3599,GO:0007023,1,0.970631728068759,0,4,post-chaperonin tubulin folding pathway,BP,
3600,GO:0007026,1,0.88520908946724,0,17,negative regulation of microtubule depolymerization,BP,
3601,GO:0007028,1,0.934977247377644,0,10,cytoplasm organization,BP,
3602,GO:0007029,1,0.751479386860496,0,40,endoplasmic reticulum organization,BP,
3603,GO:0007030,1,0.507790930998058,0,98,Golgi organization,BP,
3605,GO:0007032,1,0.607211211563809,0,69,endosome organization,BP,
3607,GO:0007034,1,0.492585062723411,0,101,vacuolar transport,BP,
3608,GO:0007035,1,0.877581237654832,0,18,vacuolar acidification,BP,
3609,GO:0007037,1,0.993985944700782,0,1,vacuolar phosphate transport,BP,
3610,GO:0007039,1,0.942692634072348,0,8,protein catabolic process in the vacuole,BP,
3612,GO:0007041,1,0.578633173277889,0,79,lysosomal transport,BP,
3613,GO:0007042,1,0.954254850305154,0,6,lysosomal lumen acidification,BP,
3614,GO:0007043,1,0.535592673887879,0,90,cell-cell junction assembly,BP,
3615,GO:0007044,1,0.568007819965344,0,85,cell-substrate junction assembly,BP,
3616,GO:0007045,1,0.629732324897708,0,69,cell-substrate adherens junction assembly,BP,
3618,GO:0007050,1,0.18281064344909,0,233,cell cycle arrest,BP,
3619,GO:0007051,1,0.37297791110358,0,139,spindle organization,BP,
3620,GO:0007052,1,0.53653445380623,0,87,mitotic spindle organization,BP,
3621,GO:0007056,1,0.976747518543985,0,3,spindle assembly involved in female meiosis,BP,
3622,GO:0007057,1,0.984456727251417,0,2,spindle assembly involved in female meiosis I,BP,
3623,GO:0007059,1,0.107522902994878,0,308,chromosome segregation,BP,
3624,GO:0007060,1,0.977389408194085,0,3,male meiosis chromosome segregation,BP,
3625,GO:0007062,1,0.438261136383798,0,115,sister chromatid cohesion,BP,
3626,GO:0007063,1,0.88947936076287,0,17,regulation of sister chromatid cohesion,BP,
3627,GO:0007064,1,0.878304730773572,0,19,mitotic sister chromatid cohesion,BP,
3628,GO:0007066,1,0.984400887813367,0,2,female meiosis sister chromatid cohesion,BP,
3629,GO:0007067,1,0.0418818772660761,0,438,mitotic nuclear division,BP,
3630,GO:0007068,1,0.987917028239991,0,2,negative regulation of transcription during mitotic cell cycle,BP,
3631,GO:0007070,1,0.987917028239991,0,2,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
3632,GO:0007072,1,0.992170072635252,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3633,GO:0007076,1,0.910131225303889,0,14,mitotic chromosome condensation,BP,
3634,GO:0007077,1,0.745111283016727,0,42,mitotic nuclear envelope disassembly,BP,
3635,GO:0007079,1,0.9803953679241,0,3,mitotic chromosome movement towards spindle pole,BP,
3636,GO:0007080,1,0.740230088358233,0,40,mitotic metaphase plate congression,BP,
3637,GO:0007084,1,0.926696020035506,0,10,mitotic nuclear envelope reassembly,BP,
3638,GO:0007088,1,0.342285860632162,0,148,regulation of mitotic nuclear division,BP,
3639,GO:0007089,1,0.971720325500138,0,4,traversing start control point of mitotic cell cycle,BP,
3640,GO:0007091,1,0.717304046740037,0,46,metaphase/anaphase transition of mitotic cell cycle,BP,
3641,GO:0007093,1,0.340933650774994,0,147,mitotic cell cycle checkpoint,BP,
3642,GO:0007094,1,0.821276013181821,0,27,mitotic spindle assembly checkpoint,BP,
3643,GO:0007095,1,0.907983183206151,0,14,mitotic G2 DNA damage checkpoint,BP,
3644,GO:0007096,1,0.875103938042664,0,18,regulation of exit from mitosis,BP,
3645,GO:0007097,1,0.942648515792088,0,9,nuclear migration,BP,
3646,GO:0007098,1,0.572551438567611,0,80,centrosome cycle,BP,
3647,GO:0007099,1,0.831123108248899,0,27,centriole replication,BP,
3648,GO:0007100,1,0.911298635491211,0,13,mitotic centrosome separation,BP,
3649,GO:0007113,1,0.976767575647497,0,3,endomitotic cell cycle,BP,
3650,GO:0007126,1,0.306877304551731,0,163,meiotic nuclear division,BP,
3651,GO:0007127,1,0.505929665419899,0,93,meiosis I,BP,
3652,GO:0007129,1,0.759097604150858,0,37,synapsis,BP,
3653,GO:0007130,1,0.868944947058332,0,19,synaptonemal complex assembly,BP,
3654,GO:0007131,1,0.730144634409615,0,43,reciprocal meiotic recombination,BP,
3655,GO:0007135,1,0.941986967729427,0,8,meiosis II,BP,
3656,GO:0007140,1,0.748354412310336,0,40,male meiosis,BP,
3657,GO:0007141,1,0.881159182705969,0,17,male meiosis I,BP,
3658,GO:0007143,1,0.841215705448232,0,24,female meiotic division,BP,
3659,GO:0007144,1,0.956832208151109,0,6,female meiosis I,BP,
3660,GO:0007146,1,0.992294630214608,0,1,meiotic recombination nodule assembly,BP,
3661,GO:0007147,1,0.993180157797307,0,1,female meiosis II,BP,
3664,GO:0007156,1,0.358920275080547,0,152,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
3665,GO:0007157,1,0.758130839625811,0,39,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
3666,GO:0007158,1,0.908530675380411,0,15,neuron cell-cell adhesion,BP,
3668,GO:0007160,1,0.265257056522435,0,193,cell-matrix adhesion,BP,
3669,GO:0007161,1,0.974070409213211,0,4,calcium-independent cell-matrix adhesion,BP,
3670,GO:0007162,1,0.201513784904361,0,223,negative regulation of cell adhesion,BP,
3671,GO:0007163,1,0.329180245321599,0,161,establishment or maintenance of cell polarity,BP,
3676,GO:0007168,1,0.929735608591464,0,10,receptor guanylyl cyclase signaling pathway,BP,
3678,GO:0007171,1,0.913979737208727,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3679,GO:0007172,1,0.945144348196942,0,8,signal complex assembly,BP,
3681,GO:0007174,1,0.992202596494721,0,1,epidermal growth factor catabolic process,BP,
3682,GO:0007175,1,0.926411080427693,0,11,negative regulation of epidermal growth factor-activated receptor activity,BP,
3683,GO:0007176,1,0.838856126397717,0,25,regulation of epidermal growth factor-activated receptor activity,BP,
3684,GO:0007178,1,0.10959292286837,0,309,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
3685,GO:0007179,1,0.306547514659143,0,167,transforming growth factor beta receptor signaling pathway,BP,
3686,GO:0007181,1,0.97886340149373,0,3,transforming growth factor beta receptor complex assembly,BP,
3687,GO:0007182,1,0.959419374231548,0,6,common-partner SMAD protein phosphorylation,BP,
3688,GO:0007183,1,0.907394710213623,0,14,SMAD protein complex assembly,BP,
3689,GO:0007184,1,0.849575593592438,0,23,SMAD protein import into nucleus,BP,
3690,GO:0007185,1,0.956881099497049,0,7,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3692,GO:0007187,1,0.271142935343929,0,176,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,
3693,GO:0007188,1,0.334389909297043,0,149,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,
3694,GO:0007189,1,0.635177663522459,0,62,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
3695,GO:0007190,1,0.760940086584382,0,38,activation of adenylate cyclase activity,BP,
3696,GO:0007191,1,0.929036198159363,0,10,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3697,GO:0007193,1,0.586529057927588,0,74,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
3698,GO:0007194,1,0.814011985602977,0,28,negative regulation of adenylate cyclase activity,BP,
3699,GO:0007195,1,0.920187473549634,0,11,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3700,GO:0007196,1,0.943671784520334,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3701,GO:0007197,1,0.96243973898217,0,5,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3702,GO:0007198,1,0.969725597909299,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3703,GO:0007199,1,0.984849057980005,0,2,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3704,GO:0007200,1,0.438955824344121,0,109,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
3707,GO:0007205,1,0.821268662886768,0,28,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
3708,GO:0007206,1,0.987688399456124,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3709,GO:0007207,1,0.954919497432009,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3710,GO:0007208,1,0.986681238752632,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3711,GO:0007210,1,0.818390969743134,0,26,serotonin receptor signaling pathway,BP,
3712,GO:0007212,1,0.716388612656599,0,45,dopamine receptor signaling pathway,BP,
3713,GO:0007213,1,0.894529055789252,0,15,G-protein coupled acetylcholine receptor signaling pathway,BP,
3714,GO:0007214,1,0.85139203438698,0,23,gamma-aminobutyric acid signaling pathway,BP,
3716,GO:0007216,1,0.9119781004113,0,14,G-protein coupled glutamate receptor signaling pathway,BP,
3717,GO:0007217,1,0.947250106266748,0,7,tachykinin receptor signaling pathway,BP,
3718,GO:0007218,1,0.47471900772835,0,98,neuropeptide signaling pathway,BP,
3719,GO:0007219,1,0.316645911561069,0,159,Notch signaling pathway,BP,
3720,GO:0007220,1,0.89561837839044,0,16,Notch receptor processing,BP,
3721,GO:0007221,1,0.955979978347038,0,7,positive regulation of transcription of Notch receptor target,BP,
3722,GO:0007223,1,0.764981453413886,0,39,Wnt signaling pathway, calcium modulating pathway,BP,
3723,GO:0007224,1,0.434907965650286,0,119,smoothened signaling pathway,BP,
3724,GO:0007225,1,0.993890209450423,0,1,patched ligand maturation,BP,
3725,GO:0007227,1,0.973138884274319,0,4,signal transduction downstream of smoothened,BP,
3726,GO:0007228,1,0.979532351916945,0,3,positive regulation of hh target transcription factor activity,BP,
3727,GO:0007229,1,0.543072939890588,0,89,integrin-mediated signaling pathway,BP,
3728,GO:0007231,1,0.977228391589852,0,3,osmosensory signaling pathway,BP,
3730,GO:0007250,1,0.877186149586993,0,18,activation of NF-kappaB-inducing kinase activity,BP,
3731,GO:0007252,1,0.900444739694275,0,15,I-kappaB phosphorylation,BP,
3732,GO:0007253,1,0.91972839789774,0,11,cytoplasmic sequestering of NF-kappaB,BP,
3734,GO:0007256,1,0.962651203376431,0,6,activation of JNKK activity,BP,
3735,GO:0007257,1,0.792119455035152,0,34,activation of JUN kinase activity,BP,
3736,GO:0007258,1,0.972298974450032,0,4,JUN phosphorylation,BP,
3739,GO:0007262,1,0.947755740326054,0,8,STAT protein import into nucleus,BP,
3740,GO:0007263,1,0.847143040615693,0,23,nitric oxide mediated signal transduction,BP,
3743,GO:0007266,1,0.319141039552146,0,165,Rho protein signal transduction,BP,
3746,GO:0007269,1,0.388773204672651,0,135,neurotransmitter secretion,BP,
3748,GO:0007271,1,0.771021386030875,0,35,synaptic transmission, cholinergic,BP,
3750,GO:0007274,1,0.812708561401386,0,29,neuromuscular synaptic transmission,BP,
3755,GO:0007284,1,0.993837205558125,0,1,spermatogonial cell division,BP,
3756,GO:0007286,1,0.397906013334029,0,125,spermatid development,BP,
3757,GO:0007288,1,0.941339935351386,0,8,sperm axoneme assembly,BP,
3758,GO:0007289,1,0.885525551877739,0,17,spermatid nucleus differentiation,BP,
3759,GO:0007290,1,0.970732002785756,0,4,spermatid nucleus elongation,BP,
3760,GO:0007291,1,0.992170027168696,0,1,sperm individualization,BP,
3762,GO:0007296,1,0.974375796621037,0,4,vitellogenesis,BP,
3763,GO:0007308,1,0.985430922759493,0,2,oocyte construction,BP,
3764,GO:0007309,1,0.985430922759493,0,2,oocyte axis specification,BP,
3765,GO:0007314,1,0.985430922759493,0,2,oocyte anterior/posterior axis specification,BP,
3766,GO:0007315,1,0.985430922759493,0,2,pole plasm assembly,BP,
3767,GO:0007320,1,0.909628596928974,0,13,insemination,BP,
3768,GO:0007321,1,0.992170027168696,0,1,sperm displacement,BP,
3770,GO:0007339,1,0.771971955385417,0,34,binding of sperm to zona pellucida,BP,
3771,GO:0007340,1,0.771930387184561,0,35,acrosome reaction,BP,
3773,GO:0007342,1,0.910564067908239,0,12,fusion of sperm to egg plasma membrane,BP,
3774,GO:0007343,1,0.963314361313844,0,5,egg activation,BP,
3775,GO:0007344,1,0.992170165072275,0,1,pronuclear fusion,BP,
3777,GO:0007349,1,0.992170027168696,0,1,cellularization,BP,
3778,GO:0007350,1,0.88571145620881,0,17,blastoderm segmentation,BP,
3779,GO:0007351,1,0.904289228806427,0,14,tripartite regional subdivision,BP,
3780,GO:0007352,1,0.978780343097047,0,3,zygotic specification of dorsal/ventral axis,BP,
3781,GO:0007354,1,0.962509117709525,0,5,zygotic determination of anterior/posterior axis, embryo,BP,
3782,GO:0007356,1,0.969439710574988,0,4,thorax and anterior abdomen determination,BP,
3784,GO:0007369,1,0.286994672497884,0,176,gastrulation,BP,
3785,GO:0007371,1,0.993288704834345,0,1,ventral midline determination,BP,
3786,GO:0007379,1,0.881137822632622,0,17,segment specification,BP,
3787,GO:0007386,1,0.964131365760164,0,5,compartment pattern specification,BP,
3788,GO:0007387,1,0.992368105271115,0,1,anterior compartment pattern formation,BP,
3789,GO:0007388,1,0.992368105271115,0,1,posterior compartment specification,BP,
3791,GO:0007398,1,0.862100714443851,0,21,ectoderm development,BP,
3793,GO:0007400,1,0.992262432956955,0,1,neuroblast fate determination,BP,
3794,GO:0007402,1,0.984440940726361,0,2,ganglion mother cell fate determination,BP,
3795,GO:0007403,1,0.992975597753917,0,1,glial cell fate determination,BP,
3796,GO:0007405,1,0.690794294019182,0,53,neuroblast proliferation,BP,
3797,GO:0007406,1,0.965381283411971,0,5,negative regulation of neuroblast proliferation,BP,
3800,GO:0007412,1,0.977950024476835,0,3,axon target recognition,BP,
3801,GO:0007413,1,0.867458279646933,0,21,axonal fasciculation,BP,
3802,GO:0007416,1,0.395976034803881,0,136,synapse assembly,BP,
3804,GO:0007418,1,0.972757877579618,0,4,ventral midline development,BP,
3806,GO:0007422,1,0.614996723517248,0,69,peripheral nervous system development,BP,
3808,GO:0007424,1,0.99229380752301,0,1,open tracheal system development,BP,
3809,GO:0007431,1,0.765598151034452,0,38,salivary gland development,BP,
3810,GO:0007435,1,0.788200512998281,0,34,salivary gland morphogenesis,BP,
3811,GO:0007439,1,0.984894556959156,0,2,ectodermal digestive tract development,BP,
3812,GO:0007440,1,0.93454881236143,0,10,foregut morphogenesis,BP,
3813,GO:0007442,1,0.953105451093474,0,7,hindgut morphogenesis,BP,
3814,GO:0007468,1,0.97685504554647,0,3,regulation of rhodopsin gene expression,BP,
3815,GO:0007492,1,0.579644882209746,0,77,endoderm development,BP,
3816,GO:0007493,1,0.985325411163797,0,2,endodermal cell fate determination,BP,
3817,GO:0007494,1,0.926104230282364,0,11,midgut development,BP,
3818,GO:0007495,1,0.992738337601419,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3819,GO:0007497,1,0.987667921895169,0,2,posterior midgut development,BP,
3820,GO:0007498,1,0.409374866154036,0,124,mesoderm development,BP,
3821,GO:0007499,1,0.993858086811102,0,1,ectoderm and mesoderm interaction,BP,
3822,GO:0007500,1,0.977063549663469,0,3,mesodermal cell fate determination,BP,
3823,GO:0007501,1,0.901436332198231,0,14,mesodermal cell fate specification,BP,
3824,GO:0007506,1,0.948132923919114,0,7,gonadal mesoderm development,BP,
3826,GO:0007509,1,0.986312011643291,0,2,mesoderm migration involved in gastrulation,BP,
3827,GO:0007512,1,0.919524738048285,0,12,adult heart development,BP,
3829,GO:0007518,1,0.984462381711039,0,2,myoblast fate determination,BP,
3831,GO:0007520,1,0.760469040120257,0,38,myoblast fusion,BP,
3832,GO:0007521,1,0.986957873142828,0,2,muscle cell fate determination,BP,
3833,GO:0007522,1,0.993986332265362,0,1,visceral muscle development,BP,
3834,GO:0007525,1,0.986340083292635,0,2,somatic muscle development,BP,
3835,GO:0007528,1,0.756416127617339,0,41,neuromuscular junction development,BP,
3836,GO:0007529,1,0.993348402334297,0,1,establishment of synaptic specificity at neuromuscular junction,BP,
3837,GO:0007530,1,0.846051001755675,0,23,sex determination,BP,
3838,GO:0007538,1,0.980221596529248,0,3,primary sex determination,BP,
3839,GO:0007542,1,0.987473355405532,0,2,primary sex determination, germ-line,BP,
3841,GO:0007549,1,0.938802760288228,0,9,dosage compensation,BP,
3842,GO:0007565,1,0.265675022673686,0,182,female pregnancy,BP,
3843,GO:0007566,1,0.707009345884011,0,48,embryo implantation,BP,
3844,GO:0007567,1,0.876480411319956,0,18,parturition,BP,
3846,GO:0007569,1,0.514843005518378,0,93,cell aging,BP,
3847,GO:0007571,1,0.986203080779088,0,2,age-dependent general metabolic decline,BP,
3848,GO:0007576,1,0.992288947315067,0,1,nucleolar fragmentation,BP,
3850,GO:0007585,1,0.637231625435145,0,64,respiratory gaseous exchange,BP,
3852,GO:0007588,1,0.612291889288089,0,66,excretion,BP,
3853,GO:0007589,1,0.534417450943826,0,87,body fluid secretion,BP,
3854,GO:0007595,1,0.759543712589955,0,40,lactation,BP,
3856,GO:0007597,1,0.867581333731414,0,19,blood coagulation, intrinsic pathway,BP,
3861,GO:0007602,1,0.6448335234775,0,59,phototransduction,BP,
3862,GO:0007603,1,0.755922277134036,0,38,phototransduction, visible light,BP,
3864,GO:0007606,1,0.0239009740061843,0,473,sensory perception of chemical stimulus,BP,
3865,GO:0007608,1,0.0416554622750175,0,402,sensory perception of smell,BP,
3870,GO:0007614,1,0.937183265818885,0,9,short-term memory,BP,
3871,GO:0007616,1,0.815800474155345,0,30,long-term memory,BP,
3875,GO:0007620,1,0.865759241436412,0,20,copulation,BP,
3876,GO:0007621,1,0.972239086090588,0,4,negative regulation of female receptivity,BP,
3879,GO:0007624,1,0.993619305928457,0,1,ultradian rhythm,BP,
3880,GO:0007625,1,0.877070559431831,0,18,grooming behavior,BP,
3882,GO:0007628,1,0.824015504819496,0,28,adult walking behavior,BP,
3884,GO:0007632,1,0.705473500802556,0,50,visual behavior,BP,
3885,GO:0007634,1,0.992251729178103,0,1,optokinetic behavior,BP,
3886,GO:0007635,1,0.889124313942524,0,17,chemosensory behavior,BP,
3888,GO:0008009,1,0.692840461362079,0,47,chemokine activity,MF,
3889,GO:0008013,1,0.591177370123196,0,78,beta-catenin binding,MF,
3892,GO:0008017,1,0.237045902595193,0,208,microtubule binding,MF,
3893,GO:0008020,1,0.969699696802223,0,4,G-protein coupled photoreceptor activity,MF,
3895,GO:0008022,1,0.285739166239215,0,176,protein C-terminus binding,MF,
3896,GO:0008023,1,0.728693118218926,0,45,transcription elongation factor complex,CC,
3897,GO:0008024,1,0.945971956920879,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3898,GO:0008026,1,0.50315868677215,0,99,ATP-dependent helicase activity,MF,
3899,GO:0008028,1,0.76266783789527,0,37,monocarboxylic acid transmembrane transporter activity,MF,
3901,GO:0008035,1,0.933497975703129,0,9,high-density lipoprotein particle binding,MF,
3902,GO:0008037,1,0.38715275393241,0,131,cell recognition,BP,
3903,GO:0008038,1,0.794794599114124,0,34,neuron recognition,BP,
3904,GO:0008039,1,0.992170027168696,0,1,synaptic target recognition,BP,
3905,GO:0008043,1,0.984400887813367,0,2,intracellular ferritin complex,CC,
3906,GO:0008045,1,0.840041329294536,0,25,motor neuron axon guidance,BP,
3907,GO:0008046,1,0.956427147861533,0,7,axon guidance receptor activity,MF,
3909,GO:0008048,1,0.961493961706066,0,5,calcium sensitive guanylate cyclase activator activity,MF,
3911,GO:0008050,1,0.986278118515255,0,2,female courtship behavior,BP,
3912,GO:0008052,1,0.992170027168696,0,1,sensory organ boundary specification,BP,
3913,GO:0008053,1,0.869413356075838,0,19,mitochondrial fusion,BP,
3914,GO:0008057,1,0.993986332272812,0,1,eye pigment granule organization,BP,
3915,GO:0008061,1,0.940871372804463,0,8,chitin binding,MF,
3916,GO:0008063,1,0.957692232172479,0,6,Toll signaling pathway,BP,
3918,GO:0008065,1,0.978869576205414,0,3,establishment of blood-nerve barrier,BP,
3920,GO:0008068,1,0.992557620167389,0,1,extracellular-glutamate-gated chloride channel activity,MF,
3921,GO:0008073,1,0.976695098844533,0,3,ornithine decarboxylase inhibitor activity,MF,
3922,GO:0008074,1,0.894778485365547,0,17,guanylate cyclase complex, soluble,CC,
3923,GO:0008076,1,0.538395277666886,0,87,voltage-gated potassium channel complex,CC,
3924,GO:0008078,1,0.970924776155882,0,4,mesodermal cell migration,BP,
3925,GO:0008079,1,0.958133915444298,0,6,translation termination factor activity,MF,
3926,GO:0008080,1,0.548534899081975,0,83,N-acetyltransferase activity,MF,
3927,GO:0008081,1,0.531960083405794,0,90,phosphoric diester hydrolase activity,MF,
3929,GO:0008088,1,0.73197557687999,0,45,axo-dendritic transport,BP,
3930,GO:0008089,1,0.80846981984094,0,30,anterograde axonal transport,BP,
3931,GO:0008090,1,0.938468378155657,0,9,retrograde axonal transport,BP,
3932,GO:0008091,1,0.951955781709432,0,8,spectrin,CC,
3934,GO:0008093,1,0.925362139391814,0,11,cytoskeletal adaptor activity,MF,
3935,GO:0008094,1,0.597830914617042,0,74,DNA-dependent ATPase activity,MF,
3936,GO:0008097,1,0.95445359993726,0,6,5S rRNA binding,MF,
3938,GO:0008105,1,0.893741611333773,0,17,asymmetric protein localization,BP,
3939,GO:0008106,1,0.882707173125889,0,16,alcohol dehydrogenase (NADP+) activity,MF,
3940,GO:0008107,1,0.986376524509756,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3942,GO:0008109,1,0.979141033142785,0,3,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3943,GO:0008111,1,0.992175569601588,0,1,alpha-methylacyl-CoA racemase activity,MF,
3946,GO:0008115,1,0.992243903618009,0,1,sarcosine oxidase activity,MF,
3947,GO:0008116,1,0.993985641810885,0,1,prostaglandin-I synthase activity,MF,
3948,GO:0008117,1,0.993986328973606,0,1,sphinganine-1-phosphate aldolase activity,MF,
3949,GO:0008118,1,0.992201184948542,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3950,GO:0008119,1,0.992800710410636,0,1,thiopurine S-methyltransferase activity,MF,
3951,GO:0008120,1,0.992170027168696,0,1,ceramide glucosyltransferase activity,MF,
3952,GO:0008121,1,0.940551107940636,0,8,ubiquinol-cytochrome-c reductase activity,MF,
3953,GO:0008123,1,0.992474232533686,0,1,cholesterol 7-alpha-monooxygenase activity,MF,
3955,GO:0008126,1,0.99245128710747,0,1,acetylesterase activity,MF,
3956,GO:0008127,1,0.992170027168696,0,1,quercetin 2,3-dioxygenase activity,MF,
3957,GO:0008131,1,0.964787895114295,0,5,primary amine oxidase activity,MF,
3960,GO:0008137,1,0.743617777713172,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3961,GO:0008138,1,0.725445632318934,0,44,protein tyrosine/serine/threonine phosphatase activity,MF,
3962,GO:0008139,1,0.839105537602433,0,26,nuclear localization sequence binding,MF,
3963,GO:0008140,1,0.944255041261186,0,8,cAMP response element binding protein binding,MF,
3964,GO:0008142,1,0.966436093360186,0,5,oxysterol binding,MF,
3965,GO:0008143,1,0.918150118292852,0,12,poly(A) binding,MF,
3967,GO:0008146,1,0.683172870373744,0,52,sulfotransferase activity,MF,
3968,GO:0008147,1,0.984400887813367,0,2,structural constituent of bone,MF,
3972,GO:0008156,1,0.78526389698475,0,34,negative regulation of DNA replication,BP,
3973,GO:0008157,1,0.87828066000477,0,18,protein phosphatase 1 binding,MF,
3974,GO:0008158,1,0.979845666505702,0,3,hedgehog receptor activity,MF,
3975,GO:0008160,1,0.992319171825161,0,1,protein tyrosine phosphatase activator activity,MF,
3977,GO:0008169,1,0.978469468872279,0,3,C-methyltransferase activity,MF,
3979,GO:0008171,1,0.895471502392076,0,15,O-methyltransferase activity,MF,
3980,GO:0008172,1,0.949009701769143,0,7,S-methyltransferase activity,MF,
3981,GO:0008173,1,0.714064151799635,0,45,RNA methyltransferase activity,MF,
3982,GO:0008174,1,0.978500874902792,0,3,mRNA methyltransferase activity,MF,
3983,GO:0008175,1,0.829705946002397,0,25,tRNA methyltransferase activity,MF,
3984,GO:0008176,1,0.984401758233696,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3985,GO:0008177,1,0.976759810897637,0,3,succinate dehydrogenase (ubiquinone) activity,MF,
3986,GO:0008179,1,0.919830395428363,0,12,adenylate cyclase binding,MF,
3987,GO:0008180,1,0.792704182969044,0,32,COP9 signalosome,CC,
3988,GO:0008184,1,0.979237393508447,0,3,glycogen phosphorylase activity,MF,
3989,GO:0008186,1,0.62145201131019,0,68,RNA-dependent ATPase activity,MF,
3990,GO:0008187,1,0.858363762899153,0,21,poly-pyrimidine tract binding,MF,
3991,GO:0008188,1,0.717608966809055,0,44,neuropeptide receptor activity,MF,
3992,GO:0008190,1,0.93987446515442,0,9,eukaryotic initiation factor 4E binding,MF,
3993,GO:0008191,1,0.897930918279094,0,15,metalloendopeptidase inhibitor activity,MF,
3994,GO:0008192,1,0.979701042053385,0,3,RNA guanylyltransferase activity,MF,
3995,GO:0008193,1,0.985817514512601,0,2,tRNA guanylyltransferase activity,MF,
3997,GO:0008195,1,0.98182788514246,0,3,phosphatidate phosphatase activity,MF,
4000,GO:0008200,1,0.799857129967114,0,31,ion channel inhibitor activity,MF,
4004,GO:0008204,1,0.984416484929639,0,2,ergosterol metabolic process,BP,
4012,GO:0008214,1,0.833196227798102,0,28,protein dealkylation,BP,
4013,GO:0008215,1,0.947098281384168,0,7,spermine metabolic process,BP,
4014,GO:0008216,1,0.939693227805972,0,8,spermidine metabolic process,BP,
4015,GO:0008217,1,0.300117079952297,0,165,regulation of blood pressure,BP,
4016,GO:0008218,1,0.977614181630593,0,3,bioluminescence,BP,
4018,GO:0008227,1,0.671424383775762,0,52,G-protein coupled amine receptor activity,MF,
4019,GO:0008228,1,0.91588951959397,0,12,opsonization,BP,
4026,GO:0008239,1,0.935181383859309,0,9,dipeptidyl-peptidase activity,MF,
4027,GO:0008240,1,0.980023841286191,0,3,tripeptidyl-peptidase activity,MF,
4028,GO:0008241,1,0.985137913164696,0,2,peptidyl-dipeptidase activity,MF,
4029,GO:0008242,1,0.913989922804084,0,12,omega peptidase activity,MF,
4030,GO:0008250,1,0.91180937836853,0,12,oligosaccharyltransferase complex,CC,
4031,GO:0008251,1,0.986412223799477,0,2,tRNA-specific adenosine deaminase activity,MF,
4032,GO:0008252,1,0.910055422971502,0,13,nucleotidase activity,MF,
4033,GO:0008253,1,0.922712518744918,0,11,5'-nucleotidase activity,MF,
4034,GO:0008254,1,0.993986332271708,0,1,3'-nucleotidase activity,MF,
4035,GO:0008260,1,0.98534377147488,0,2,3-oxoacid CoA-transferase activity,MF,
4036,GO:0008263,1,0.985116153536572,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
4037,GO:0008265,1,0.992382184418366,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
4038,GO:0008266,1,0.877571191832737,0,18,poly(U) RNA binding,MF,
4039,GO:0008267,1,0.993986332275604,0,1,poly-glutamine tract binding,MF,
4040,GO:0008269,1,0.984431545432814,0,2,JAK pathway signal transduction adaptor activity,MF,
4042,GO:0008271,1,0.912467557549495,0,13,secondary active sulfate transmembrane transporter activity,MF,
4043,GO:0008272,1,0.898867588551081,0,15,sulfate transport,BP,
4044,GO:0008273,1,0.966031623392397,0,5,calcium, potassium:sodium antiporter activity,MF,
4045,GO:0008274,1,0.951728990251178,0,7,gamma-tubulin ring complex,CC,
4046,GO:0008275,1,0.980297077966848,0,3,gamma-tubulin small complex,CC,
4047,GO:0008276,1,0.61937561880636,0,67,protein methyltransferase activity,MF,
4049,GO:0008278,1,0.938842522698353,0,9,cohesin complex,CC,
4050,GO:0008281,1,0.987860440010031,0,2,sulfonylurea receptor activity,MF,
4051,GO:0008282,1,0.972972297396939,0,4,ATP-sensitive potassium channel complex,CC,
4056,GO:0008287,1,0.726036735117738,0,45,protein serine/threonine phosphatase complex,CC,
4058,GO:0008290,1,0.942851360977067,0,8,F-actin capping protein complex,CC,
4059,GO:0008291,1,0.971492302915501,0,4,acetylcholine metabolic process,BP,
4060,GO:0008292,1,0.986342770265383,0,2,acetylcholine biosynthetic process,BP,
4061,GO:0008294,1,0.987621597964443,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4062,GO:0008295,1,0.96969955809195,0,4,spermidine biosynthetic process,BP,
4063,GO:0008296,1,0.927361937381714,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4064,GO:0008297,1,0.949362581895247,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4065,GO:0008298,1,0.913354283355772,0,12,intracellular mRNA localization,BP,
4066,GO:0008299,1,0.830405965419972,0,25,isoprenoid biosynthetic process,BP,
4067,GO:0008300,1,0.94106095669766,0,8,isoprenoid catabolic process,BP,
4068,GO:0008301,1,0.871040671131069,0,19,DNA binding, bending,MF,
4069,GO:0008305,1,0.810249099969679,0,32,integrin complex,CC,
4070,GO:0008306,1,0.601451443473217,0,72,associative learning,BP,
4071,GO:0008307,1,0.725470943209389,0,46,structural constituent of muscle,MF,
4072,GO:0008308,1,0.877660930586041,0,18,voltage-gated anion channel activity,MF,
4073,GO:0008309,1,0.96965230246373,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4074,GO:0008310,1,0.963722726061468,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4075,GO:0008311,1,0.984406516554695,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4076,GO:0008312,1,0.947811390292255,0,7,7S RNA binding,MF,
4077,GO:0008318,1,0.950037903490721,0,7,protein prenyltransferase activity,MF,
4078,GO:0008320,1,0.878402689720738,0,17,protein transmembrane transporter activity,MF,
4079,GO:0008321,1,0.980372066807702,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4081,GO:0008327,1,0.857586454856756,0,21,methyl-CpG binding,MF,
4083,GO:0008329,1,0.881437947074128,0,17,signaling pattern recognition receptor activity,MF,
4084,GO:0008330,1,0.977054390158634,0,3,protein tyrosine/threonine phosphatase activity,MF,
4085,GO:0008331,1,0.925079765535593,0,12,high voltage-gated calcium channel activity,MF,
4086,GO:0008332,1,0.982066433197884,0,3,low voltage-gated calcium channel activity,MF,
4087,GO:0008333,1,0.741938052179767,0,42,endosome to lysosome transport,BP,
4088,GO:0008334,1,0.842483366962761,0,24,histone mRNA metabolic process,BP,
4089,GO:0008336,1,0.992172245940507,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4090,GO:0008340,1,0.922265681301393,0,12,determination of adult lifespan,BP,
4091,GO:0008343,1,0.927110059798306,0,10,adult feeding behavior,BP,
4092,GO:0008344,1,0.578726957205584,0,78,adult locomotory behavior,BP,
4094,GO:0008348,1,0.993216488866995,0,1,negative regulation of antimicrobial humoral response,BP,
4095,GO:0008349,1,0.972613934657563,0,4,MAP kinase kinase kinase kinase activity,MF,
4096,GO:0008352,1,0.992341078820417,0,1,katanin complex,CC,
4097,GO:0008353,1,0.887030272696167,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4098,GO:0008354,1,0.951926835749916,0,7,germ cell migration,BP,
4099,GO:0008355,1,0.98750639457936,0,2,olfactory learning,BP,
4100,GO:0008356,1,0.88617778820225,0,17,asymmetric cell division,BP,
4101,GO:0008358,1,0.985430922759493,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4105,GO:0008373,1,0.859898926435326,0,21,sialyltransferase activity,MF,
4108,GO:0008376,1,0.785600609197092,0,34,acetylgalactosaminyltransferase activity,MF,
4109,GO:0008378,1,0.795808156376401,0,31,galactosyltransferase activity,MF,
4110,GO:0008379,1,0.961453799076647,0,5,thioredoxin peroxidase activity,MF,
4112,GO:0008381,1,0.943344527565248,0,8,mechanically-gated ion channel activity,MF,
4113,GO:0008384,1,0.979519582697497,0,3,IkappaB kinase activity,MF,
4116,GO:0008387,1,0.992210979877727,0,1,steroid 7-alpha-hydroxylase activity,MF,
4117,GO:0008389,1,0.984401282545407,0,2,coumarin 7-hydroxylase activity,MF,
4118,GO:0008391,1,0.882616817375464,0,16,arachidonic acid monooxygenase activity,MF,
4119,GO:0008392,1,0.882616817375464,0,16,arachidonic acid epoxygenase activity,MF,
4121,GO:0008396,1,0.984509478340674,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4122,GO:0008397,1,0.993469869690521,0,1,sterol 12-alpha-hydroxylase activity,MF,
4123,GO:0008398,1,0.992637292017046,0,1,sterol 14-demethylase activity,MF,
4124,GO:0008401,1,0.970827857030548,0,4,retinoic acid 4-hydroxylase activity,MF,
4125,GO:0008403,1,0.992727485565217,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4126,GO:0008404,1,0.992171504980013,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4127,GO:0008405,1,0.992171504980013,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4129,GO:0008408,1,0.710324269608789,0,48,3'-5' exonuclease activity,MF,
4130,GO:0008409,1,0.917136039646535,0,12,5'-3' exonuclease activity,MF,
4131,GO:0008410,1,0.977628505237038,0,3,CoA-transferase activity,MF,
4132,GO:0008413,1,0.984409069998441,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4133,GO:0008417,1,0.911063282066684,0,13,fucosyltransferase activity,MF,
4134,GO:0008418,1,0.992170027168696,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4135,GO:0008419,1,0.992336536595148,0,1,RNA lariat debranching enzyme activity,MF,
4136,GO:0008420,1,0.957142054855533,0,6,CTD phosphatase activity,MF,
4137,GO:0008422,1,0.965930432325384,0,5,beta-glucosidase activity,MF,
4138,GO:0008424,1,0.992839838812566,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4139,GO:0008425,1,0.992170027168696,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4140,GO:0008426,1,0.977795339644556,0,3,protein kinase C inhibitor activity,MF,
4141,GO:0008427,1,0.976747055285165,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4142,GO:0008428,1,0.978617933351072,0,3,ribonuclease inhibitor activity,MF,
4143,GO:0008429,1,0.942597669526454,0,8,phosphatidylethanolamine binding,MF,
4144,GO:0008430,1,0.964841218163942,0,5,selenium binding,MF,
4145,GO:0008431,1,0.97729335382161,0,3,vitamin E binding,MF,
4146,GO:0008432,1,0.953653282848968,0,7,JUN kinase binding,MF,
4147,GO:0008434,1,0.993882289190072,0,1,calcitriol receptor activity,MF,
4148,GO:0008437,1,0.992177302556526,0,1,thyrotropin-releasing hormone activity,MF,
4149,GO:0008440,1,0.929887840473283,0,10,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4150,GO:0008441,1,0.986291291285736,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4151,GO:0008442,1,0.992175805754407,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4152,GO:0008443,1,0.951784379755708,0,7,phosphofructokinase activity,MF,
4153,GO:0008444,1,0.992196456297875,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4154,GO:0008445,1,0.992170027168696,0,1,D-aspartate oxidase activity,MF,
4155,GO:0008446,1,0.992170029421347,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4156,GO:0008448,1,0.99217103951077,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4157,GO:0008449,1,0.981739445535108,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4158,GO:0008453,1,0.984436308339983,0,2,alanine-glyoxylate transaminase activity,MF,
4159,GO:0008454,1,0.978667916620873,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4160,GO:0008455,1,0.992365032749341,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4161,GO:0008456,1,0.993276345545592,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4162,GO:0008457,1,0.993601169612406,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4163,GO:0008458,1,0.992802654692536,0,1,carnitine O-octanoyltransferase activity,MF,
4164,GO:0008459,1,0.986249501577692,0,2,chondroitin 6-sulfotransferase activity,MF,
4165,GO:0008460,1,0.992172791346244,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4166,GO:0008465,1,0.992170027168696,0,1,glycerate dehydrogenase activity,MF,
4167,GO:0008466,1,0.98513008572898,0,2,glycogenin glucosyltransferase activity,MF,
4168,GO:0008467,1,0.947333790164313,0,7,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4169,GO:0008469,1,0.947192785157219,0,7,histone-arginine N-methyltransferase activity,MF,
4170,GO:0008470,1,0.993854111091728,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4172,GO:0008475,1,0.9788467500661,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4173,GO:0008476,1,0.984415572657823,0,2,protein-tyrosine sulfotransferase activity,MF,
4174,GO:0008478,1,0.993986332272496,0,1,pyridoxal kinase activity,MF,
4175,GO:0008479,1,0.954130792335886,0,6,queuine tRNA-ribosyltransferase activity,MF,
4177,GO:0008481,1,0.984772464913066,0,2,sphinganine kinase activity,MF,
4178,GO:0008482,1,0.992222754665927,0,1,sulfite oxidase activity,MF,
4179,GO:0008483,1,0.881522332545805,0,17,transaminase activity,MF,
4180,GO:0008484,1,0.888013234960095,0,17,sulfuric ester hydrolase activity,MF,
4181,GO:0008486,1,0.97080956241711,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4182,GO:0008488,1,0.99272513444379,0,1,gamma-glutamyl carboxylase activity,MF,
4183,GO:0008489,1,0.992494718715689,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4184,GO:0008493,1,0.992171581291078,0,1,tetracycline transporter activity,MF,
4185,GO:0008494,1,0.950811598586587,0,7,translation activator activity,MF,
4186,GO:0008495,1,0.992572562871229,0,1,protoheme IX farnesyltransferase activity,MF,
4187,GO:0008496,1,0.993687316804448,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4188,GO:0008499,1,0.901213654238741,0,14,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4189,GO:0008502,1,0.97670003405213,0,3,melatonin receptor activity,MF,
4190,GO:0008503,1,0.957414391144519,0,6,benzodiazepine receptor activity,MF,
4191,GO:0008504,1,0.937542937946462,0,9,monoamine transmembrane transporter activity,MF,
4192,GO:0008506,1,0.978221507127385,0,3,sucrose:proton symporter activity,MF,
4193,GO:0008507,1,0.993135497313848,0,1,sodium:iodide symporter activity,MF,
4194,GO:0008508,1,0.955049841810922,0,6,bile acid:sodium symporter activity,MF,
4196,GO:0008510,1,0.974976791695816,0,4,sodium:bicarbonate symporter activity,MF,
4197,GO:0008511,1,0.987908352110654,0,2,sodium:potassium:chloride symporter activity,MF,
4198,GO:0008513,1,0.976824894209617,0,3,secondary active organic cation transmembrane transporter activity,MF,
4200,GO:0008515,1,0.978221507127385,0,3,sucrose transmembrane transporter activity,MF,
4201,GO:0008517,1,0.957325483635857,0,6,folic acid transporter activity,MF,
4202,GO:0008518,1,0.992448488883306,0,1,reduced folate carrier activity,MF,
4203,GO:0008519,1,0.819565218111909,0,27,ammonium transmembrane transporter activity,MF,
4204,GO:0008520,1,0.986261482472498,0,2,L-ascorbate:sodium symporter activity,MF,
4205,GO:0008521,1,0.992340570098796,0,1,acetyl-CoA transporter activity,MF,
4206,GO:0008523,1,0.986883109417568,0,2,sodium-dependent multivitamin transmembrane transporter activity,MF,
4207,GO:0008525,1,0.961420594505359,0,6,phosphatidylcholine transporter activity,MF,
4208,GO:0008526,1,0.953097829783435,0,7,phosphatidylinositol transporter activity,MF,
4209,GO:0008527,1,0.823651864820031,0,25,taste receptor activity,MF,
4210,GO:0008528,1,0.395014631797068,0,123,G-protein coupled peptide receptor activity,MF,
4211,GO:0008531,1,0.992365032749341,0,1,riboflavin kinase activity,MF,
4212,GO:0008532,1,0.970429762777599,0,4,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4213,GO:0008534,1,0.98440384581494,0,2,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4214,GO:0008535,1,0.860268925914968,0,20,respiratory chain complex IV assembly,BP,
4215,GO:0008536,1,0.807980284775286,0,32,Ran GTPase binding,MF,
4216,GO:0008537,1,0.977262368168074,0,3,proteasome activator complex,CC,
4217,GO:0008540,1,0.925149670484466,0,10,proteasome regulatory particle, base subcomplex,CC,
4218,GO:0008541,1,0.946471983991949,0,7,proteasome regulatory particle, lid subcomplex,CC,
4219,GO:0008542,1,0.730976466859667,0,45,visual learning,BP,
4222,GO:0008545,1,0.99329438430951,0,1,JUN kinase kinase activity,MF,
4223,GO:0008553,1,0.948720988163368,0,7,hydrogen-exporting ATPase activity, phosphorylative mechanism,MF,
4224,GO:0008554,1,0.993903605402016,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4225,GO:0008555,1,0.993979810988865,0,1,chloride-transporting ATPase activity,MF,
4226,GO:0008556,1,0.923253468305371,0,11,potassium-transporting ATPase activity,MF,
4227,GO:0008559,1,0.955990085948495,0,7,xenobiotic-transporting ATPase activity,MF,
4229,GO:0008568,1,0.946891668047297,0,8,microtubule-severing ATPase activity,MF,
4230,GO:0008569,1,0.973337541212003,0,4,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4231,GO:0008574,1,0.9046568658526,0,16,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4232,GO:0008579,1,0.993974731013941,0,1,JUN kinase phosphatase activity,MF,
4233,GO:0008582,1,0.96566050065754,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4236,GO:0008588,1,0.969921248679484,0,4,release of cytoplasmic sequestered NF-kappaB,BP,
4237,GO:0008589,1,0.636672698526075,0,66,regulation of smoothened signaling pathway,BP,
4238,GO:0008592,1,0.992790041625879,0,1,regulation of Toll signaling pathway,BP,
4239,GO:0008593,1,0.630430760471686,0,64,regulation of Notch signaling pathway,BP,
4240,GO:0008594,1,0.9935288064082,0,1,photoreceptor cell morphogenesis,BP,
4241,GO:0008595,1,0.904289228806427,0,14,anterior/posterior axis specification, embryo,BP,
4242,GO:0008597,1,0.977447224590054,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4243,GO:0008603,1,0.949105661362322,0,7,cAMP-dependent protein kinase regulator activity,MF,
4244,GO:0008607,1,0.971934594052879,0,4,phosphorylase kinase regulator activity,MF,
4245,GO:0008608,1,0.826181117804398,0,26,attachment of spindle microtubules to kinetochore,BP,
4246,GO:0008609,1,0.993986332273946,0,1,alkylglycerone-phosphate synthase activity,MF,
4248,GO:0008611,1,0.972765969212316,0,4,ether lipid biosynthetic process,BP,
4249,GO:0008612,1,0.970817983516491,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4250,GO:0008613,1,0.992170027168696,0,1,diuretic hormone activity,MF,
4251,GO:0008614,1,0.985257147057135,0,2,pyridoxine metabolic process,BP,
4252,GO:0008615,1,0.985257147057135,0,2,pyridoxine biosynthetic process,BP,
4253,GO:0008616,1,0.954130792335886,0,6,queuosine biosynthetic process,BP,
4254,GO:0008617,1,0.992170027168696,0,1,guanosine metabolic process,BP,
4255,GO:0008622,1,0.963340149559253,0,5,epsilon DNA polymerase complex,CC,
4256,GO:0008623,1,0.986280041775666,0,2,CHRAC,CC,
4258,GO:0008626,1,0.970933091080883,0,4,granzyme-mediated apoptotic signaling pathway,BP,
4259,GO:0008627,1,0.95271895071785,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4260,GO:0008628,1,0.969059734381548,0,4,hormone-mediated apoptotic signaling pathway,BP,
4263,GO:0008635,1,0.935549256030068,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4265,GO:0008641,1,0.929979642373663,0,10,small protein activating enzyme activity,MF,
4268,GO:0008649,1,0.90731970320586,0,13,rRNA methyltransferase activity,MF,
4270,GO:0008653,1,0.993465729911084,0,1,lipopolysaccharide metabolic process,BP,
4272,GO:0008655,1,0.919116222219109,0,11,pyrimidine-containing compound salvage,BP,
4274,GO:0008665,1,0.992170027168696,0,1,2'-phosphotransferase activity,MF,
4276,GO:0008689,1,0.992170027168696,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4277,GO:0008700,1,0.992294630214608,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4278,GO:0008705,1,0.993986332287217,0,1,methionine synthase activity,MF,
4280,GO:0008721,1,0.992264474345352,0,1,D-serine ammonia-lyase activity,MF,
4281,GO:0008725,1,0.992170027168696,0,1,DNA-3-methyladenine glycosylase activity,MF,
4282,GO:0008732,1,0.984521315441538,0,2,L-allo-threonine aldolase activity,MF,
4283,GO:0008745,1,0.969046113645578,0,4,N-acetylmuramoyl-L-alanine amidase activity,MF,
4284,GO:0008746,1,0.98608795292866,0,2,NAD(P)+ transhydrogenase activity,MF,
4285,GO:0008747,1,0.992170027168696,0,1,N-acetylneuraminate lyase activity,MF,
4286,GO:0008750,1,0.993870302914218,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4287,GO:0008753,1,0.993002814329435,0,1,NADPH dehydrogenase (quinone) activity,MF,
4289,GO:0008761,1,0.993975756667282,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4290,GO:0008768,1,0.992170027168696,0,1,UDP-sugar diphosphatase activity,MF,
4291,GO:0008775,1,0.992170874467739,0,1,acetate CoA-transferase activity,MF,
4292,GO:0008781,1,0.984401007876187,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4293,GO:0008783,1,0.992197047099341,0,1,agmatinase activity,MF,
4294,GO:0008785,1,0.992170027168696,0,1,alkyl hydroperoxide reductase activity,MF,
4295,GO:0008794,1,0.992170027168696,0,1,arsenate reductase (glutaredoxin) activity,MF,
4296,GO:0008796,1,0.984625099557387,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4297,GO:0008798,1,0.986266944933589,0,2,beta-aspartyl-peptidase activity,MF,
4298,GO:0008802,1,0.993114515466179,0,1,betaine-aldehyde dehydrogenase activity,MF,
4299,GO:0008803,1,0.992170027168696,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4300,GO:0008808,1,0.993344272378398,0,1,cardiolipin synthase activity,MF,
4301,GO:0008811,1,0.992170027168696,0,1,chloramphenicol O-acetyltransferase activity,MF,
4302,GO:0008812,1,0.993194934242513,0,1,choline dehydrogenase activity,MF,
4303,GO:0008817,1,0.993615325937415,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4304,GO:0008821,1,0.933994270791332,0,9,crossover junction endodeoxyribonuclease activity,MF,
4305,GO:0008823,1,0.981349829990746,0,3,cupric reductase activity,MF,
4306,GO:0008829,1,0.992170816652278,0,1,dCTP deaminase activity,MF,
4307,GO:0008832,1,0.992752580435624,0,1,dGTPase activity,MF,
4308,GO:0008843,1,0.992218024205118,0,1,endochitinase activity,MF,
4309,GO:0008852,1,0.99244432135966,0,1,exodeoxyribonuclease I activity,MF,
4310,GO:0008853,1,0.970697752820286,0,4,exodeoxyribonuclease III activity,MF,
4311,GO:0008859,1,0.992170027168696,0,1,exoribonuclease II activity,MF,
4312,GO:0008865,1,0.973513357964059,0,4,fructokinase activity,MF,
4313,GO:0008887,1,0.992789073858973,0,1,glycerate kinase activity,MF,
4314,GO:0008889,1,0.957946686821679,0,6,glycerophosphodiester phosphodiesterase activity,MF,
4315,GO:0008890,1,0.992170027168696,0,1,glycine C-acetyltransferase activity,MF,
4316,GO:0008891,1,0.992170174082838,0,1,glycolate oxidase activity,MF,
4317,GO:0008892,1,0.993982189554209,0,1,guanine deaminase activity,MF,
4318,GO:0008893,1,0.992170027168696,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4319,GO:0008894,1,0.992382772825723,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4320,GO:0008897,1,0.992464792462844,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4321,GO:0008898,1,0.993986332287217,0,1,S-adenosylmethionine-homocysteine S-methyltransferase activity,MF,
4322,GO:0008900,1,0.978582279638732,0,3,hydrogen:potassium-exchanging ATPase activity,MF,
4323,GO:0008903,1,0.992170027168696,0,1,hydroxypyruvate isomerase activity,MF,
4324,GO:0008905,1,0.992170027168696,0,1,mannose-phosphate guanylyltransferase activity,MF,
4325,GO:0008934,1,0.972101102431493,0,4,inositol monophosphate 1-phosphatase activity,MF,
4326,GO:0008940,1,0.9784384128923,0,3,nitrate reductase activity,MF,
4327,GO:0008941,1,0.984509147880303,0,2,nitric oxide dioxygenase activity,MF,
4328,GO:0008948,1,0.971422395950673,0,4,oxaloacetate decarboxylase activity,MF,
4329,GO:0008955,1,0.993478091938874,0,1,peptidoglycan glycosyltransferase activity,MF,
4330,GO:0008962,1,0.992305877394314,0,1,phosphatidylglycerophosphatase activity,MF,
4331,GO:0008963,1,0.99218990353333,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4332,GO:0008967,1,0.984924846998118,0,2,phosphoglycolate phosphatase activity,MF,
4333,GO:0008969,1,0.976971789588596,0,3,phosphohistidine phosphatase activity,MF,
4335,GO:0008973,1,0.992797796553875,0,1,phosphopentomutase activity,MF,
4336,GO:0008988,1,0.984648173044371,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4337,GO:0008995,1,0.992307852066953,0,1,ribonuclease E activity,MF,
4338,GO:0009000,1,0.99225975716226,0,1,selenocysteine lyase activity,MF,
4339,GO:0009007,1,0.993226236254198,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4340,GO:0009008,1,0.967000555677454,0,5,DNA-methyltransferase activity,MF,
4341,GO:0009013,1,0.993963843661382,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4342,GO:0009019,1,0.971171674403366,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4343,GO:0009020,1,0.992174805547159,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4344,GO:0009032,1,0.992170027247971,0,1,thymidine phosphorylase activity,MF,
4345,GO:0009041,1,0.977363847018056,0,3,uridylate kinase activity,MF,
4346,GO:0009048,1,0.953657990126076,0,7,dosage compensation by inactivation of X chromosome,BP,
4347,GO:0009051,1,0.97674957120686,0,3,pentose-phosphate shunt, oxidative branch,BP,
4355,GO:0009061,1,0.992238789488608,0,1,anaerobic respiration,BP,
4359,GO:0009065,1,0.832309808369321,0,25,glutamine family amino acid catabolic process,BP,
4362,GO:0009068,1,0.880977019808223,0,17,aspartate family amino acid catabolic process,BP,
4363,GO:0009069,1,0.751861458582673,0,38,serine family amino acid metabolic process,BP,
4364,GO:0009070,1,0.884160432314465,0,16,serine family amino acid biosynthetic process,BP,
4365,GO:0009071,1,0.925740196754967,0,10,serine family amino acid catabolic process,BP,
4368,GO:0009078,1,0.962731927347665,0,5,pyruvate family amino acid metabolic process,BP,
4369,GO:0009080,1,0.962731927347665,0,5,pyruvate family amino acid catabolic process,BP,
4371,GO:0009082,1,0.986203080784392,0,2,branched-chain amino acid biosynthetic process,BP,
4374,GO:0009085,1,0.992464792462844,0,1,lysine biosynthetic process,BP,
4376,GO:0009087,1,0.992956470832992,0,1,methionine catabolic process,BP,
4377,GO:0009092,1,0.970016141212026,0,4,homoserine metabolic process,BP,
4378,GO:0009093,1,0.976832635796083,0,3,cysteine catabolic process,BP,
4379,GO:0009098,1,0.986203080784392,0,2,leucine biosynthetic process,BP,
4380,GO:0009099,1,0.986203080784392,0,2,valine biosynthetic process,BP,
4383,GO:0009103,1,0.993465729911084,0,1,lipopolysaccharide biosynthetic process,BP,
4384,GO:0009106,1,0.977644603193905,0,3,lipoate metabolic process,BP,
4385,GO:0009107,1,0.984400889651981,0,2,lipoate biosynthetic process,BP,
4389,GO:0009111,1,0.920277336077165,0,11,vitamin catabolic process,BP,
4391,GO:0009113,1,0.921518017334904,0,11,purine nucleobase biosynthetic process,BP,
4397,GO:0009123,1,0.113699798623972,0,291,nucleoside monophosphate metabolic process,BP,
4398,GO:0009124,1,0.525480752860175,0,85,nucleoside monophosphate biosynthetic process,BP,
4399,GO:0009125,1,0.921667355219428,0,11,nucleoside monophosphate catabolic process,BP,
4400,GO:0009126,1,0.13595877007874,0,268,purine nucleoside monophosphate metabolic process,BP,
4401,GO:0009127,1,0.612430947668256,0,65,purine nucleoside monophosphate biosynthetic process,BP,
4402,GO:0009128,1,0.936162322670867,0,9,purine nucleoside monophosphate catabolic process,BP,
4403,GO:0009129,1,0.898088300956208,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4404,GO:0009130,1,0.905181340586683,0,13,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4405,GO:0009131,1,0.992170027168696,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4407,GO:0009133,1,0.955303752492197,0,6,nucleoside diphosphate biosynthetic process,BP,
4408,GO:0009134,1,0.948768083831857,0,7,nucleoside diphosphate catabolic process,BP,
4409,GO:0009135,1,0.532715354067626,0,88,purine nucleoside diphosphate metabolic process,BP,
4410,GO:0009136,1,0.97769642601607,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4411,GO:0009137,1,0.970829329722405,0,4,purine nucleoside diphosphate catabolic process,BP,
4412,GO:0009138,1,0.977419941541312,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4413,GO:0009139,1,0.984789563498906,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4414,GO:0009140,1,0.992517443984523,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4415,GO:0009141,1,0.127374538556749,0,275,nucleoside triphosphate metabolic process,BP,
4416,GO:0009142,1,0.586889698847019,0,70,nucleoside triphosphate biosynthetic process,BP,
4417,GO:0009143,1,0.921836115484142,0,11,nucleoside triphosphate catabolic process,BP,
4418,GO:0009144,1,0.14810759545312,0,255,purine nucleoside triphosphate metabolic process,BP,
4419,GO:0009145,1,0.662241438752499,0,54,purine nucleoside triphosphate biosynthetic process,BP,
4420,GO:0009146,1,0.956239399916856,0,6,purine nucleoside triphosphate catabolic process,BP,
4421,GO:0009147,1,0.84455337451761,0,22,pyrimidine nucleoside triphosphate metabolic process,BP,
4422,GO:0009148,1,0.86458856679185,0,19,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4423,GO:0009149,1,0.992170027168696,0,1,pyrimidine nucleoside triphosphate catabolic process,BP,
4425,GO:0009151,1,0.927551081386184,0,10,purine deoxyribonucleotide metabolic process,BP,
4427,GO:0009153,1,0.977665577681908,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4429,GO:0009155,1,0.956239399916856,0,6,purine deoxyribonucleotide catabolic process,BP,
4430,GO:0009156,1,0.558602185208606,0,77,ribonucleoside monophosphate biosynthetic process,BP,
4431,GO:0009157,1,0.94837452903774,0,7,deoxyribonucleoside monophosphate biosynthetic process,BP,
4432,GO:0009158,1,0.94355366264558,0,8,ribonucleoside monophosphate catabolic process,BP,
4433,GO:0009159,1,0.984524522725182,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4434,GO:0009161,1,0.124867637800893,0,279,ribonucleoside monophosphate metabolic process,BP,
4435,GO:0009162,1,0.926377265453241,0,10,deoxyribonucleoside monophosphate metabolic process,BP,
4436,GO:0009163,1,0.697993246590404,0,47,nucleoside biosynthetic process,BP,
4440,GO:0009167,1,0.137048576522953,0,267,purine ribonucleoside monophosphate metabolic process,BP,
4441,GO:0009168,1,0.612430947668256,0,65,purine ribonucleoside monophosphate biosynthetic process,BP,
4442,GO:0009169,1,0.94355366264558,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4443,GO:0009170,1,0.992170027168696,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4444,GO:0009173,1,0.92671230293846,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4445,GO:0009174,1,0.92671230293846,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4446,GO:0009176,1,0.969130380041535,0,4,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4447,GO:0009177,1,0.976779938150714,0,3,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4448,GO:0009178,1,0.992170027168696,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4449,GO:0009179,1,0.532715354067626,0,88,purine ribonucleoside diphosphate metabolic process,BP,
4450,GO:0009180,1,0.97769642601607,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4451,GO:0009181,1,0.970829329722405,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4452,GO:0009182,1,0.977654895781762,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4453,GO:0009183,1,0.985371210199117,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4454,GO:0009184,1,0.992170027168696,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4455,GO:0009185,1,0.524549334456366,0,90,ribonucleoside diphosphate metabolic process,BP,
4456,GO:0009186,1,0.962781733110447,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4458,GO:0009188,1,0.97769642601607,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4459,GO:0009189,1,0.97038157175455,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4461,GO:0009191,1,0.95601651721465,0,6,ribonucleoside diphosphate catabolic process,BP,
4462,GO:0009192,1,0.992170027168696,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4463,GO:0009193,1,0.992517443984523,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4464,GO:0009195,1,0.992517443984523,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4465,GO:0009196,1,0.984789563498906,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4466,GO:0009197,1,0.984789563498906,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4467,GO:0009199,1,0.149422925134337,0,254,ribonucleoside triphosphate metabolic process,BP,
4468,GO:0009200,1,0.892833488502993,0,15,deoxyribonucleoside triphosphate metabolic process,BP,
4469,GO:0009201,1,0.638729412474087,0,59,ribonucleoside triphosphate biosynthetic process,BP,
4470,GO:0009202,1,0.961843994524486,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
4471,GO:0009203,1,0.992170027168696,0,1,ribonucleoside triphosphate catabolic process,BP,
4472,GO:0009204,1,0.956239399916856,0,6,deoxyribonucleoside triphosphate catabolic process,BP,
4473,GO:0009205,1,0.156226526883821,0,248,purine ribonucleoside triphosphate metabolic process,BP,
4474,GO:0009206,1,0.667476968104478,0,53,purine ribonucleoside triphosphate biosynthetic process,BP,
4475,GO:0009207,1,0.992170027168696,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4476,GO:0009208,1,0.885035628681504,0,16,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4477,GO:0009209,1,0.891881033817892,0,15,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4478,GO:0009211,1,0.954301781411941,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4479,GO:0009212,1,0.96942589612739,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4480,GO:0009213,1,0.992170027168696,0,1,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4481,GO:0009214,1,0.871812747286512,0,21,cyclic nucleotide catabolic process,BP,
4482,GO:0009215,1,0.941328029024255,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
4483,GO:0009216,1,0.99218086641826,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4484,GO:0009217,1,0.963787999491844,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4485,GO:0009218,1,0.832700183314063,0,24,pyrimidine ribonucleotide metabolic process,BP,
4486,GO:0009219,1,0.875944577777852,0,17,pyrimidine deoxyribonucleotide metabolic process,BP,
4487,GO:0009220,1,0.845478481093741,0,22,pyrimidine ribonucleotide biosynthetic process,BP,
4488,GO:0009221,1,0.954385901362071,0,6,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4489,GO:0009222,1,0.992517443984523,0,1,pyrimidine ribonucleotide catabolic process,BP,
4490,GO:0009223,1,0.917838339873819,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4491,GO:0009224,1,0.992170027168696,0,1,CMP biosynthetic process,BP,
4493,GO:0009226,1,0.854692339071201,0,21,nucleotide-sugar biosynthetic process,BP,
4495,GO:0009229,1,0.992229029544791,0,1,thiamine diphosphate biosynthetic process,BP,
4496,GO:0009231,1,0.992365032749341,0,1,riboflavin biosynthetic process,BP,
4497,GO:0009233,1,0.97833233122458,0,3,menaquinone metabolic process,BP,
4498,GO:0009234,1,0.993199845739775,0,1,menaquinone biosynthetic process,BP,
4499,GO:0009235,1,0.856843714698867,0,21,cobalamin metabolic process,BP,
4500,GO:0009236,1,0.98018640348515,0,3,cobalamin biosynthetic process,BP,
4502,GO:0009240,1,0.961484338696878,0,5,isopentenyl diphosphate biosynthetic process,BP,
4503,GO:0009245,1,0.992170027168696,0,1,lipid A biosynthetic process,BP,
4505,GO:0009249,1,0.969043237344425,0,4,protein lipoylation,BP,
4506,GO:0009250,1,0.72369476660302,0,46,glucan biosynthetic process,BP,
4507,GO:0009251,1,0.828713297847186,0,27,glucan catabolic process,BP,
4508,GO:0009253,1,0.946454214881746,0,7,peptidoglycan catabolic process,BP,
4509,GO:0009256,1,0.965584787756468,0,5,10-formyltetrahydrofolate metabolic process,BP,
4510,GO:0009257,1,0.986238574778287,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4511,GO:0009258,1,0.986728903993189,0,2,10-formyltetrahydrofolate catabolic process,BP,
4516,GO:0009263,1,0.91413850856466,0,12,deoxyribonucleotide biosynthetic process,BP,
4518,GO:0009265,1,0.933062556912455,0,9,2'-deoxyribonucleotide biosynthetic process,BP,
4521,GO:0009268,1,0.745238327015115,0,40,response to pH,BP,
4523,GO:0009298,1,0.969093017082558,0,4,GDP-mannose biosynthetic process,BP,
4524,GO:0009299,1,0.851946168866489,0,23,mRNA transcription,BP,
4525,GO:0009301,1,0.621209288065322,0,65,snRNA transcription,BP,
4527,GO:0009304,1,0.951949609546162,0,7,tRNA transcription,BP,
4528,GO:0009305,1,0.993986332265571,0,1,protein biotinylation,BP,
4531,GO:0009309,1,0.843684502573492,0,22,amine biosynthetic process,BP,
4534,GO:0009312,1,0.886464003493301,0,16,oligosaccharide biosynthetic process,BP,
4537,GO:0009328,1,0.977154126521157,0,3,phenylalanine-tRNA ligase complex,CC,
4538,GO:0009330,1,0.987319737458661,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4539,GO:0009331,1,0.980037771717481,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4540,GO:0009346,1,0.993743111015143,0,1,citrate lyase complex,CC,
4541,GO:0009353,1,0.992170027168696,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4542,GO:0009360,1,0.992361717334642,0,1,DNA polymerase III complex,CC,
4543,GO:0009368,1,0.984459183611217,0,2,endopeptidase Clp complex,CC,
4544,GO:0009372,1,0.992830992499847,0,1,quorum sensing,BP,
4545,GO:0009374,1,0.966506435300354,0,5,biotin binding,MF,
4546,GO:0009378,1,0.968080881089324,0,5,four-way junction helicase activity,MF,
4547,GO:0009383,1,0.986192162202423,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4548,GO:0009384,1,0.98619258734359,0,2,N-acylmannosamine kinase activity,MF,
4549,GO:0009386,1,0.984447437389401,0,2,translational attenuation,BP,
4550,GO:0009394,1,0.812420082937582,0,27,2'-deoxyribonucleotide metabolic process,BP,
4552,GO:0009396,1,0.928270617190533,0,10,folic acid-containing compound biosynthetic process,BP,
4553,GO:0009397,1,0.979002040125929,0,3,folic acid-containing compound catabolic process,BP,
4554,GO:0009398,1,0.992365032749341,0,1,FMN biosynthetic process,BP,
4555,GO:0009399,1,0.992170027168696,0,1,nitrogen fixation,BP,
4556,GO:0009400,1,0.992453396137953,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4557,GO:0009403,1,0.992686091348552,0,1,toxin biosynthetic process,BP,
4559,GO:0009405,1,0.988003355662755,0,2,pathogenesis,BP,
4560,GO:0009408,1,0.322382327707197,0,157,response to heat,BP,
4563,GO:0009411,1,0.414268816922692,0,123,response to UV,BP,
4568,GO:0009436,1,0.97684993691324,0,3,glyoxylate catabolic process,BP,
4570,GO:0009438,1,0.961858956418304,0,5,methylglyoxal metabolic process,BP,
4571,GO:0009439,1,0.984400887813367,0,2,cyanate metabolic process,BP,
4572,GO:0009440,1,0.984400887813367,0,2,cyanate catabolic process,BP,
4573,GO:0009441,1,0.978480447513527,0,3,glycolate metabolic process,BP,
4574,GO:0009443,1,0.993986332272496,0,1,pyridoxal 5'-phosphate salvage,BP,
4575,GO:0009444,1,0.993976336044422,0,1,pyruvate oxidation,BP,
4576,GO:0009445,1,0.955434107026814,0,6,putrescine metabolic process,BP,
4577,GO:0009446,1,0.970577762484928,0,4,putrescine biosynthetic process,BP,
4578,GO:0009447,1,0.976692126814207,0,3,putrescine catabolic process,BP,
4581,GO:0009450,1,0.987929845789417,0,2,gamma-aminobutyric acid catabolic process,BP,
4583,GO:0009452,1,0.775969163643112,0,34,7-methylguanosine RNA capping,BP,
4585,GO:0009581,1,0.391331734108383,0,130,detection of external stimulus,BP,
4586,GO:0009582,1,0.38304331761102,0,133,detection of abiotic stimulus,BP,
4587,GO:0009583,1,0.584688976782994,0,73,detection of light stimulus,BP,
4588,GO:0009584,1,0.674881365310698,0,54,detection of visible light,BP,
4589,GO:0009590,1,0.992180625434682,0,1,detection of gravity,BP,
4591,GO:0009595,1,0.861843188463439,0,21,detection of biotic stimulus,BP,
4592,GO:0009597,1,0.964362881522865,0,5,detection of virus,BP,
4595,GO:0009608,1,0.985835946963774,0,2,response to symbiont,BP,
4596,GO:0009609,1,0.985835946963774,0,2,response to symbiotic bacterium,BP,
4601,GO:0009620,1,0.702379223979645,0,46,response to fungus,BP,
4602,GO:0009624,1,0.976835769249843,0,3,response to nematode,BP,
4604,GO:0009629,1,0.93382277340028,0,9,response to gravity,BP,
4605,GO:0009631,1,0.99395901298832,0,1,cold acclimation,BP,
4608,GO:0009637,1,0.986476496939549,0,2,response to blue light,BP,
4609,GO:0009642,1,0.9179609234655,0,12,response to light intensity,BP,
4610,GO:0009644,1,0.986204092589352,0,2,response to high light intensity,BP,
4611,GO:0009645,1,0.993035087127744,0,1,response to low light intensity stimulus,BP,
4612,GO:0009646,1,0.992842792648331,0,1,response to absence of light,BP,
4613,GO:0009648,1,0.846261425018919,0,23,photoperiodism,BP,
4614,GO:0009649,1,0.833065298678758,0,25,entrainment of circadian clock,BP,
4615,GO:0009650,1,0.90732855977413,0,13,UV protection,BP,
4618,GO:0009673,1,0.993214535499846,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4619,GO:0009692,1,0.992315942132114,0,1,ethylene metabolic process,BP,
4620,GO:0009698,1,0.946706496016636,0,7,phenylpropanoid metabolic process,BP,
4627,GO:0009730,1,0.969364003976547,0,4,detection of carbohydrate stimulus,BP,
4628,GO:0009732,1,0.969364003976547,0,4,detection of hexose stimulus,BP,
4629,GO:0009737,1,0.993740843079674,0,1,response to abscisic acid,BP,
4630,GO:0009738,1,0.993740843079674,0,1,abscisic acid-activated signaling pathway,BP,
4632,GO:0009744,1,0.959558891683231,0,6,response to sucrose,BP,
4635,GO:0009750,1,0.942787731383881,0,8,response to fructose,BP,
4636,GO:0009751,1,0.992276984303848,0,1,response to salicylic acid,BP,
4637,GO:0009753,1,0.969043237344425,0,4,response to jasmonic acid,BP,
4638,GO:0009755,1,0.210305171973657,0,218,hormone-mediated signaling pathway,BP,
4639,GO:0009756,1,0.949362844028854,0,7,carbohydrate mediated signaling,BP,
4640,GO:0009757,1,0.963827138343347,0,5,hexose mediated signaling,BP,
4641,GO:0009758,1,0.993986332279133,0,1,carbohydrate utilization,BP,
4642,GO:0009785,1,0.986476496939549,0,2,blue light signaling pathway,BP,
4643,GO:0009786,1,0.978480302627264,0,3,regulation of asymmetric cell division,BP,
4644,GO:0009787,1,0.993740843079674,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4645,GO:0009789,1,0.993740843079674,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4649,GO:0009794,1,0.971205406287007,0,4,regulation of mitotic cell cycle, embryonic,BP,
4650,GO:0009798,1,0.530123935311225,0,88,axis specification,BP,
4652,GO:0009804,1,0.946706496016636,0,7,coumarin metabolic process,BP,
4653,GO:0009810,1,0.992198562480326,0,1,stilbene metabolic process,BP,
4654,GO:0009812,1,0.912184359123976,0,12,flavonoid metabolic process,BP,
4655,GO:0009814,1,0.992197495932474,0,1,defense response, incompatible interaction,BP,
4656,GO:0009817,1,0.992197495932474,0,1,defense response to fungus, incompatible interaction,BP,
4658,GO:0009822,1,0.976925038765936,0,3,alkaloid catabolic process,BP,
4659,GO:0009826,1,0.978481539745953,0,3,unidimensional cell growth,BP,
4660,GO:0009838,1,0.955809631291647,0,6,abscission,BP,
4661,GO:0009841,1,0.992228779457065,0,1,mitochondrial endopeptidase Clp complex,CC,
4663,GO:0009880,1,0.642932495016036,0,62,embryonic pattern specification,BP,
4664,GO:0009881,1,0.899214987067333,0,14,photoreceptor activity,MF,
4665,GO:0009882,1,0.986476496939549,0,2,blue light photoreceptor activity,MF,
4666,GO:0009886,1,0.911775678891381,0,13,post-embryonic animal morphogenesis,BP,
4679,GO:0009912,1,0.957441518591908,0,6,auditory receptor cell fate commitment,BP,
4682,GO:0009917,1,0.992252980068485,0,1,sterol 5-alpha reductase activity,MF,
4685,GO:0009925,1,0.818296634992093,0,29,basal plasma membrane,CC,
4686,GO:0009931,1,0.923787078897888,0,11,calcium-dependent protein serine/threonine kinase activity,MF,
4687,GO:0009946,1,0.976812041957131,0,3,proximal/distal axis specification,BP,
4688,GO:0009948,1,0.692107332392317,0,50,anterior/posterior axis specification,BP,
4689,GO:0009949,1,0.992170027168696,0,1,polarity specification of anterior/posterior axis,BP,
4690,GO:0009950,1,0.895358816068464,0,16,dorsal/ventral axis specification,BP,
4691,GO:0009952,1,0.232231696008004,0,200,anterior/posterior pattern specification,BP,
4692,GO:0009953,1,0.506093751737694,0,94,dorsal/ventral pattern formation,BP,
4693,GO:0009954,1,0.799061326503663,0,31,proximal/distal pattern formation,BP,
4694,GO:0009955,1,0.992197949708862,0,1,adaxial/abaxial pattern specification,BP,
4695,GO:0009956,1,0.993441779386201,0,1,radial pattern formation,BP,
4696,GO:0009957,1,0.979903571404318,0,3,epidermal cell fate specification,BP,
4700,GO:0009972,1,0.932120082780067,0,9,cytidine deamination,BP,
4701,GO:0009975,1,0.875602118032916,0,20,cyclase activity,MF,
4705,GO:0009988,1,0.619361179757507,0,64,cell-cell recognition,BP,
4707,GO:0009992,1,0.992194386898444,0,1,cellular water homeostasis,BP,
4709,GO:0009996,1,0.955486208244243,0,6,negative regulation of cell fate specification,BP,
4710,GO:0009997,1,0.992516661359673,0,1,negative regulation of cardioblast cell fate specification,BP,
4712,GO:0010002,1,0.875245992316098,0,19,cardioblast differentiation,BP,
4714,GO:0010009,1,0.984665115376429,0,2,cytoplasmic side of endosome membrane,CC,
4715,GO:0010015,1,0.992170027168696,0,1,root morphogenesis,BP,
4716,GO:0010021,1,0.99270922546378,0,1,amylopectin biosynthetic process,BP,
4717,GO:0010025,1,0.970837950021953,0,4,wax biosynthetic process,BP,
4718,GO:0010032,1,0.96243014836886,0,6,meiotic chromosome condensation,BP,
4720,GO:0010034,1,0.993089448357678,0,1,response to acetate,BP,
4722,GO:0010037,1,0.992654718861979,0,1,response to carbon dioxide,BP,
4724,GO:0010039,1,0.793011377882482,0,32,response to iron ion,BP,
4725,GO:0010040,1,0.963048507079656,0,5,response to iron(II) ion,BP,
4726,GO:0010041,1,0.963422301309811,0,5,response to iron(III) ion,BP,
4729,GO:0010044,1,0.962662739733104,0,5,response to aluminum ion,BP,
4730,GO:0010045,1,0.993986332273446,0,1,response to nickel cation,BP,
4731,GO:0010046,1,0.970496146785991,0,4,response to mycotoxin,BP,
4732,GO:0010053,1,0.992170027168696,0,1,root epidermal cell differentiation,BP,
4733,GO:0010054,1,0.992170027168696,0,1,trichoblast differentiation,BP,
4734,GO:0010070,1,0.992243903618009,0,1,zygote asymmetric cell division,BP,
4735,GO:0010085,1,0.992183386879296,0,1,polarity specification of proximal/distal axis,BP,
4736,GO:0010092,1,0.809970130111184,0,29,specification of animal organ identity,BP,
4737,GO:0010106,1,0.992174221678293,0,1,cellular response to iron ion starvation,BP,
4738,GO:0010107,1,0.819250585338445,0,28,potassium ion import,BP,
4739,GO:0010124,1,0.992170027168696,0,1,phenylacetate catabolic process,BP,
4740,GO:0010133,1,0.977343811642845,0,3,proline catabolic process to glutamate,BP,
4741,GO:0010138,1,0.961544141240002,0,5,pyrimidine ribonucleotide salvage,BP,
4742,GO:0010155,1,0.87788164357452,0,17,regulation of proton transport,BP,
4743,GO:0010157,1,0.986331083592642,0,2,response to chlorate,BP,
4744,GO:0010159,1,0.979014363486525,0,3,specification of animal organ position,BP,
4745,GO:0010160,1,0.992170027168696,0,1,formation of animal organ boundary,BP,
4746,GO:0010164,1,0.992170027168696,0,1,response to cesium ion,BP,
4747,GO:0010165,1,0.787932525877399,0,34,response to X-ray,BP,
4748,GO:0010166,1,0.970837950021953,0,4,wax metabolic process,BP,
4749,GO:0010171,1,0.727640636593319,0,46,body morphogenesis,BP,
4750,GO:0010172,1,0.930909875183422,0,11,embryonic body morphogenesis,BP,
4751,GO:0010181,1,0.890934359625842,0,16,FMN binding,MF,
4752,GO:0010182,1,0.963827138343347,0,5,sugar mediated signaling pathway,BP,
4753,GO:0010189,1,0.99217002956634,0,1,vitamin E biosynthetic process,BP,
4754,GO:0010193,1,0.962128386617867,0,5,response to ozone,BP,
4756,GO:0010216,1,0.961295198344707,0,6,maintenance of DNA methylation,BP,
4757,GO:0010224,1,0.881335251480577,0,17,response to UV-B,BP,
4758,GO:0010225,1,0.921114223603174,0,12,response to UV-C,BP,
4759,GO:0010226,1,0.846164287080393,0,23,response to lithium ion,BP,
4760,GO:0010232,1,0.992683337168453,0,1,vascular transport,BP,
4762,GO:0010248,1,0.90886793232437,0,13,establishment or maintenance of transmembrane electrochemical gradient,BP,
4763,GO:0010255,1,0.963827138343347,0,5,glucose mediated signaling pathway,BP,
4764,GO:0010256,1,0.0193329423598747,0,553,endomembrane system organization,BP,
4765,GO:0010257,1,0.651199975026768,0,55,NADH dehydrogenase complex assembly,BP,
4767,GO:0010260,1,0.99229879839848,0,1,animal organ senescence,BP,
4768,GO:0010265,1,0.959461217394441,0,6,SCF complex assembly,BP,
4769,GO:0010266,1,0.979044568940131,0,3,response to vitamin B1,BP,
4770,GO:0010269,1,0.956359849750258,0,6,response to selenium ion,BP,
4771,GO:0010273,1,0.98620308078549,0,2,detoxification of copper ion,BP,
4772,GO:0010286,1,0.976881594596345,0,3,heat acclimation,BP,
4774,GO:0010309,1,0.99217002867238,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4775,GO:0010310,1,0.906505210377572,0,13,regulation of hydrogen peroxide metabolic process,BP,
4776,GO:0010314,1,0.92642747779217,0,11,phosphatidylinositol-5-phosphate binding,MF,
4777,GO:0010324,1,0.70787872831547,0,48,membrane invagination,BP,
4778,GO:0010332,1,0.691744682867396,0,52,response to gamma radiation,BP,
4779,GO:0010335,1,0.993805861677762,0,1,response to non-ionic osmotic stress,BP,
4780,GO:0010340,1,0.965772998732555,0,5,carboxyl-O-methyltransferase activity,MF,
4781,GO:0010348,1,0.992294630214608,0,1,lithium:proton antiporter activity,MF,
4782,GO:0010359,1,0.968264669323397,0,5,regulation of anion channel activity,BP,
4783,GO:0010360,1,0.98637586537027,0,2,negative regulation of anion channel activity,BP,
4784,GO:0010369,1,0.907195586420124,0,14,chromocenter,CC,
4785,GO:0010370,1,0.9856035988747,0,2,perinucleolar chromocenter,CC,
4786,GO:0010383,1,0.992170027168696,0,1,cell wall polysaccharide metabolic process,BP,
4787,GO:0010385,1,0.964593747787896,0,5,double-stranded methylated DNA binding,MF,
4788,GO:0010387,1,0.977199002483397,0,3,COP9 signalosome assembly,BP,
4790,GO:0010390,1,0.854138058981855,0,23,histone monoubiquitination,BP,
4791,GO:0010420,1,0.992170027168696,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4792,GO:0010421,1,0.915818029464066,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4793,GO:0010428,1,0.993986332264992,0,1,methyl-CpNpG binding,MF,
4794,GO:0010430,1,0.98612435123989,0,2,fatty acid omega-oxidation,BP,
4795,GO:0010446,1,0.978130554727009,0,3,response to alkaline pH,BP,
4796,GO:0010447,1,0.851493486653412,0,22,response to acidic pH,BP,
4797,GO:0010452,1,0.940000368829138,0,9,histone H3-K36 methylation,BP,
4798,GO:0010453,1,0.811560367888128,0,28,regulation of cell fate commitment,BP,
4799,GO:0010454,1,0.919125598295837,0,11,negative regulation of cell fate commitment,BP,
4800,GO:0010455,1,0.934079073835151,0,9,positive regulation of cell fate commitment,BP,
4801,GO:0010457,1,0.944203735556205,0,9,centriole-centriole cohesion,BP,
4802,GO:0010458,1,0.803241793701412,0,30,exit from mitosis,BP,
4803,GO:0010459,1,0.933717088813921,0,9,negative regulation of heart rate,BP,
4804,GO:0010460,1,0.851735425749165,0,22,positive regulation of heart rate,BP,
4805,GO:0010463,1,0.718628246336027,0,47,mesenchymal cell proliferation,BP,
4806,GO:0010464,1,0.782943776768632,0,35,regulation of mesenchymal cell proliferation,BP,
4807,GO:0010465,1,0.986366615803849,0,2,nerve growth factor receptor activity,MF,
4811,GO:0010469,1,0.418192909059964,0,124,regulation of receptor activity,BP,
4812,GO:0010470,1,0.771354397339644,0,36,regulation of gastrulation,BP,
4813,GO:0010477,1,0.992798767495208,0,1,response to sulfur dioxide,BP,
4814,GO:0010481,1,0.986075831740361,0,2,epidermal cell division,BP,
4815,GO:0010482,1,0.986075831740361,0,2,regulation of epidermal cell division,BP,
4816,GO:0010484,1,0.979586083413692,0,3,H3 histone acetyltransferase activity,MF,
4817,GO:0010485,1,0.886383769594303,0,17,H4 histone acetyltransferase activity,MF,
4818,GO:0010494,1,0.765845535458262,0,39,cytoplasmic stress granule,CC,
4819,GO:0010496,1,0.992177118014353,0,1,intercellular transport,BP,
4821,GO:0010499,1,0.972932559398233,0,4,proteasomal ubiquitin-independent protein catabolic process,BP,
4822,GO:0010501,1,0.721228387663022,0,45,RNA secondary structure unwinding,BP,
4826,GO:0010509,1,0.993984669225979,0,1,polyamine homeostasis,BP,
4828,GO:0010511,1,0.95668578094772,0,6,regulation of phosphatidylinositol biosynthetic process,BP,
4829,GO:0010512,1,0.984937562906567,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4830,GO:0010513,1,0.971319521186531,0,4,positive regulation of phosphatidylinositol biosynthetic process,BP,
4833,GO:0010519,1,0.950698240269916,0,7,negative regulation of phospholipase activity,BP,
4834,GO:0010520,1,0.985621392230642,0,2,regulation of reciprocal meiotic recombination,BP,
4835,GO:0010521,1,0.978254897796942,0,3,telomerase inhibitor activity,MF,
4836,GO:0010522,1,0.543680809697925,0,85,regulation of calcium ion transport into cytosol,BP,
4837,GO:0010523,1,0.884002470538213,0,17,negative regulation of calcium ion transport into cytosol,BP,
4838,GO:0010524,1,0.719447202483866,0,45,positive regulation of calcium ion transport into cytosol,BP,
4839,GO:0010528,1,0.908430108467129,0,13,regulation of transposition,BP,
4840,GO:0010529,1,0.908430108467129,0,13,negative regulation of transposition,BP,
4841,GO:0010531,1,0.992681503736399,0,1,activation of JAK1 kinase activity,BP,
4842,GO:0010533,1,0.939468757265482,0,8,regulation of activation of Janus kinase activity,BP,
4843,GO:0010534,1,0.939468757265482,0,8,regulation of activation of JAK2 kinase activity,BP,
4844,GO:0010535,1,0.954359227921426,0,6,positive regulation of activation of JAK2 kinase activity,BP,
4845,GO:0010536,1,0.954359227921426,0,6,positive regulation of activation of Janus kinase activity,BP,
4846,GO:0010543,1,0.812796842900172,0,29,regulation of platelet activation,BP,
4847,GO:0010544,1,0.88532249016165,0,17,negative regulation of platelet activation,BP,
4851,GO:0010559,1,0.771264138826426,0,36,regulation of glycoprotein biosynthetic process,BP,
4852,GO:0010560,1,0.885870419605784,0,17,positive regulation of glycoprotein biosynthetic process,BP,
4853,GO:0010561,1,0.928385645955088,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4858,GO:0010566,1,0.917451018563376,0,12,regulation of ketone biosynthetic process,BP,
4859,GO:0010569,1,0.86749407835606,0,20,regulation of double-strand break repair via homologous recombination,BP,
4860,GO:0010571,1,0.961428486293406,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4861,GO:0010572,1,0.979322696818887,0,3,positive regulation of platelet activation,BP,
4862,GO:0010573,1,0.792146110003803,0,33,vascular endothelial growth factor production,BP,
4863,GO:0010574,1,0.796947172910321,0,32,regulation of vascular endothelial growth factor production,BP,
4864,GO:0010575,1,0.828851118763142,0,27,positive regulation of vascular endothelial growth factor production,BP,
4865,GO:0010578,1,0.955478754002782,0,6,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4866,GO:0010579,1,0.955478754002782,0,6,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4867,GO:0010586,1,0.885384759269998,0,17,miRNA metabolic process,BP,
4868,GO:0010587,1,0.960217144821203,0,6,miRNA catabolic process,BP,
4869,GO:0010591,1,0.817203391063462,0,28,regulation of lamellipodium assembly,BP,
4870,GO:0010592,1,0.884402281012284,0,17,positive regulation of lamellipodium assembly,BP,
4871,GO:0010593,1,0.972555073373621,0,4,negative regulation of lamellipodium assembly,BP,
4874,GO:0010596,1,0.765179169126824,0,38,negative regulation of endothelial cell migration,BP,
4875,GO:0010603,1,0.94933850710631,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4878,GO:0010606,1,0.969168650939385,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4879,GO:0010607,1,0.99217489991689,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4881,GO:0010609,1,0.984674960184837,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4882,GO:0010610,1,0.993986332278159,0,1,regulation of mRNA stability involved in response to stress,BP,
4883,GO:0010611,1,0.750826255717025,0,41,regulation of cardiac muscle hypertrophy,BP,
4884,GO:0010612,1,0.960349891020881,0,6,regulation of cardiac muscle adaptation,BP,
4885,GO:0010613,1,0.846848959998635,0,24,positive regulation of cardiac muscle hypertrophy,BP,
4886,GO:0010614,1,0.892119982389574,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4887,GO:0010615,1,0.98690100799696,0,2,positive regulation of cardiac muscle adaptation,BP,
4888,GO:0010616,1,0.980779849300072,0,3,negative regulation of cardiac muscle adaptation,BP,
4889,GO:0010621,1,0.976865758949856,0,3,negative regulation of transcription by transcription factor localization,BP,
4890,GO:0010623,1,0.91060301752026,0,13,programmed cell death involved in cell development,BP,
4891,GO:0010624,1,0.966292380613241,0,5,regulation of Schwann cell proliferation,BP,
4892,GO:0010626,1,0.966292380613241,0,5,negative regulation of Schwann cell proliferation,BP,
4897,GO:0010633,1,0.683188198865299,0,54,negative regulation of epithelial cell migration,BP,
4899,GO:0010635,1,0.942940322206511,0,8,regulation of mitochondrial fusion,BP,
4900,GO:0010636,1,0.986331923183412,0,2,positive regulation of mitochondrial fusion,BP,
4901,GO:0010637,1,0.963364804403824,0,5,negative regulation of mitochondrial fusion,BP,
4904,GO:0010640,1,0.859192148253645,0,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4905,GO:0010641,1,0.966679822821,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4906,GO:0010642,1,0.894623294601142,0,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4907,GO:0010643,1,0.97814193539301,0,3,cell communication by chemical coupling,BP,
4908,GO:0010644,1,0.829772003669401,0,27,cell communication by electrical coupling,BP,
4909,GO:0010645,1,0.985454301858154,0,2,regulation of cell communication by chemical coupling,BP,
4913,GO:0010649,1,0.919656873715145,0,12,regulation of cell communication by electrical coupling,BP,
4914,GO:0010650,1,0.987834823917776,0,2,positive regulation of cell communication by electrical coupling,BP,
4915,GO:0010652,1,0.985454301858154,0,2,positive regulation of cell communication by chemical coupling,BP,
4921,GO:0010661,1,0.8913075777593,0,16,positive regulation of muscle cell apoptotic process,BP,
4923,GO:0010663,1,0.946966763004239,0,8,positive regulation of striated muscle cell apoptotic process,BP,
4926,GO:0010666,1,0.946966763004239,0,8,positive regulation of cardiac muscle cell apoptotic process,BP,
4928,GO:0010668,1,0.953146748781159,0,7,ectodermal cell differentiation,BP,
4932,GO:0010677,1,0.783560984413714,0,34,negative regulation of cellular carbohydrate metabolic process,BP,
4933,GO:0010692,1,0.943418057860952,0,9,regulation of alkaline phosphatase activity,BP,
4934,GO:0010693,1,0.980088088196936,0,3,negative regulation of alkaline phosphatase activity,BP,
4935,GO:0010694,1,0.96259073777243,0,6,positive regulation of alkaline phosphatase activity,BP,
4936,GO:0010698,1,0.985378607004238,0,2,acetyltransferase activator activity,MF,
4937,GO:0010700,1,0.949018477768661,0,7,negative regulation of norepinephrine secretion,BP,
4938,GO:0010701,1,0.971698699001091,0,4,positive regulation of norepinephrine secretion,BP,
4939,GO:0010705,1,0.986289589159667,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4940,GO:0010710,1,0.978063229538067,0,3,regulation of collagen catabolic process,BP,
4941,GO:0010711,1,0.992170027168696,0,1,negative regulation of collagen catabolic process,BP,
4942,GO:0010712,1,0.776749038835599,0,34,regulation of collagen metabolic process,BP,
4943,GO:0010713,1,0.941990022202037,0,8,negative regulation of collagen metabolic process,BP,
4944,GO:0010714,1,0.843177803533275,0,23,positive regulation of collagen metabolic process,BP,
4945,GO:0010715,1,0.914787573810529,0,13,regulation of extracellular matrix disassembly,BP,
4946,GO:0010716,1,0.970565173749775,0,4,negative regulation of extracellular matrix disassembly,BP,
4947,GO:0010717,1,0.597776645916345,0,73,regulation of epithelial to mesenchymal transition,BP,
4948,GO:0010718,1,0.76454573122351,0,39,positive regulation of epithelial to mesenchymal transition,BP,
4949,GO:0010719,1,0.824174685813937,0,26,negative regulation of epithelial to mesenchymal transition,BP,
4952,GO:0010722,1,0.993986332271419,0,1,regulation of ferrochelatase activity,BP,
4953,GO:0010724,1,0.971455911573745,0,4,regulation of definitive erythrocyte differentiation,BP,
4954,GO:0010725,1,0.977904784479821,0,3,regulation of primitive erythrocyte differentiation,BP,
4955,GO:0010726,1,0.984957947158641,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4956,GO:0010727,1,0.957044723880368,0,6,negative regulation of hydrogen peroxide metabolic process,BP,
4957,GO:0010728,1,0.978480768444436,0,3,regulation of hydrogen peroxide biosynthetic process,BP,
4958,GO:0010729,1,0.992178684751526,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4959,GO:0010730,1,0.986194944411341,0,2,negative regulation of hydrogen peroxide biosynthetic process,BP,
4960,GO:0010731,1,0.992224279434278,0,1,protein glutathionylation,BP,
4961,GO:0010732,1,0.992224279434278,0,1,regulation of protein glutathionylation,BP,
4962,GO:0010734,1,0.992224279434278,0,1,negative regulation of protein glutathionylation,BP,
4963,GO:0010735,1,0.973422649937664,0,4,positive regulation of transcription via serum response element binding,BP,
4964,GO:0010736,1,0.985944180138758,0,2,serum response element binding,MF,
4965,GO:0010737,1,0.818524762967823,0,29,protein kinase A signaling,BP,
4966,GO:0010738,1,0.879236093461596,0,19,regulation of protein kinase A signaling,BP,
4967,GO:0010739,1,0.959497059826696,0,6,positive regulation of protein kinase A signaling,BP,
4970,GO:0010744,1,0.889085083246216,0,16,positive regulation of macrophage derived foam cell differentiation,BP,
4972,GO:0010746,1,0.974655132226299,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4973,GO:0010748,1,0.974655132226299,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4974,GO:0010749,1,0.974187311349313,0,4,regulation of nitric oxide mediated signal transduction,BP,
4975,GO:0010750,1,0.993794083781815,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
4976,GO:0010751,1,0.980271740708431,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4977,GO:0010752,1,0.987762001882058,0,2,regulation of cGMP-mediated signaling,BP,
4978,GO:0010754,1,0.993986332250535,0,1,negative regulation of cGMP-mediated signaling,BP,
4979,GO:0010755,1,0.919535869337349,0,11,regulation of plasminogen activation,BP,
4980,GO:0010756,1,0.961598783998921,0,5,positive regulation of plasminogen activation,BP,
4981,GO:0010757,1,0.95627039381688,0,6,negative regulation of plasminogen activation,BP,
4982,GO:0010758,1,0.863869492281099,0,20,regulation of macrophage chemotaxis,BP,
4983,GO:0010759,1,0.894012651019155,0,15,positive regulation of macrophage chemotaxis,BP,
4984,GO:0010760,1,0.97240251586903,0,4,negative regulation of macrophage chemotaxis,BP,
4985,GO:0010761,1,0.764671564473738,0,38,fibroblast migration,BP,
4986,GO:0010762,1,0.812502797234662,0,29,regulation of fibroblast migration,BP,
4987,GO:0010763,1,0.925596816233219,0,11,positive regulation of fibroblast migration,BP,
4988,GO:0010764,1,0.942212429864716,0,8,negative regulation of fibroblast migration,BP,
4990,GO:0010766,1,0.913732389151316,0,13,negative regulation of sodium ion transport,BP,
4991,GO:0010767,1,0.980453122934146,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4992,GO:0010768,1,0.993986332267547,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4994,GO:0010770,1,0.407437314206614,0,130,positive regulation of cell morphogenesis involved in differentiation,BP,
4996,GO:0010792,1,0.955660384586882,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4997,GO:0010793,1,0.966039947865938,0,5,regulation of mRNA export from nucleus,BP,
4998,GO:0010795,1,0.992170027168696,0,1,regulation of ubiquinone biosynthetic process,BP,
4999,GO:0010796,1,0.976758894700764,0,3,regulation of multivesicular body size,BP,
5000,GO:0010797,1,0.992170027168696,0,1,regulation of multivesicular body size involved in endosome transport,BP,
5001,GO:0010799,1,0.768285315174305,0,38,regulation of peptidyl-threonine phosphorylation,BP,
5002,GO:0010800,1,0.829269928895014,0,27,positive regulation of peptidyl-threonine phosphorylation,BP,
5003,GO:0010801,1,0.906366389206569,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
5006,GO:0010805,1,0.992302628349193,0,1,regulation of lysine import,BP,
5007,GO:0010807,1,0.966081901912952,0,5,regulation of synaptic vesicle priming,BP,
5008,GO:0010808,1,0.99398633226757,0,1,positive regulation of synaptic vesicle priming,BP,
5009,GO:0010810,1,0.297458437114538,0,174,regulation of cell-substrate adhesion,BP,
5010,GO:0010811,1,0.480381926738651,0,104,positive regulation of cell-substrate adhesion,BP,
5011,GO:0010812,1,0.722145404490297,0,48,negative regulation of cell-substrate adhesion,BP,
5012,GO:0010813,1,0.986178119856257,0,2,neuropeptide catabolic process,BP,
5013,GO:0010814,1,0.993961175892562,0,1,substance P catabolic process,BP,
5014,GO:0010815,1,0.965028933459409,0,5,bradykinin catabolic process,BP,
5015,GO:0010816,1,0.993961175892562,0,1,calcitonin catabolic process,BP,
5017,GO:0010818,1,0.861520540120946,0,20,T cell chemotaxis,BP,
5018,GO:0010819,1,0.921254107273167,0,11,regulation of T cell chemotaxis,BP,
5019,GO:0010820,1,0.928528656790228,0,10,positive regulation of T cell chemotaxis,BP,
5023,GO:0010824,1,0.776520925655117,0,36,regulation of centrosome duplication,BP,
5024,GO:0010825,1,0.959900163729807,0,6,positive regulation of centrosome duplication,BP,
5025,GO:0010826,1,0.933977459367955,0,10,negative regulation of centrosome duplication,BP,
5028,GO:0010829,1,0.896857151593491,0,15,negative regulation of glucose transport,BP,
5029,GO:0010830,1,0.684577828944653,0,52,regulation of myotube differentiation,BP,
5030,GO:0010831,1,0.801958360983255,0,30,positive regulation of myotube differentiation,BP,
5031,GO:0010832,1,0.898568126966821,0,15,negative regulation of myotube differentiation,BP,
5032,GO:0010833,1,0.599151667286576,0,71,telomere maintenance via telomere lengthening,BP,
5033,GO:0010835,1,0.964966855212937,0,5,regulation of protein ADP-ribosylation,BP,
5034,GO:0010836,1,0.992177875337847,0,1,negative regulation of protein ADP-ribosylation,BP,
5035,GO:0010837,1,0.824643875883325,0,28,regulation of keratinocyte proliferation,BP,
5036,GO:0010838,1,0.93848990468693,0,9,positive regulation of keratinocyte proliferation,BP,
5037,GO:0010839,1,0.9236142575323,0,12,negative regulation of keratinocyte proliferation,BP,
5038,GO:0010840,1,0.955616705506912,0,6,regulation of circadian sleep/wake cycle, wakefulness,BP,
5039,GO:0010841,1,0.963159727821405,0,5,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
5040,GO:0010842,1,0.860983859297863,0,22,retina layer formation,BP,
5041,GO:0010845,1,0.985621392230642,0,2,positive regulation of reciprocal meiotic recombination,BP,
5042,GO:0010847,1,0.973480666385205,0,4,regulation of chromatin assembly,BP,
5043,GO:0010848,1,0.986622357702141,0,2,regulation of chromatin disassembly,BP,
5044,GO:0010849,1,0.992196750610153,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
5045,GO:0010851,1,0.933156095940101,0,9,cyclase regulator activity,MF,
5046,GO:0010852,1,0.992213790389495,0,1,cyclase inhibitor activity,MF,
5047,GO:0010853,1,0.946492418459802,0,7,cyclase activator activity,MF,
5048,GO:0010854,1,0.993652924080928,0,1,adenylate cyclase regulator activity,MF,
5049,GO:0010855,1,0.993652924080928,0,1,adenylate cyclase inhibitor activity,MF,
5050,GO:0010857,1,0.916707971779176,0,12,calcium-dependent protein kinase activity,MF,
5051,GO:0010858,1,0.976747055285165,0,3,calcium-dependent protein kinase regulator activity,MF,
5052,GO:0010859,1,0.993752288052282,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5053,GO:0010861,1,0.97456065426417,0,4,thyroid hormone receptor activator activity,MF,
5054,GO:0010862,1,0.704876358679183,0,48,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
5058,GO:0010868,1,0.987208281207411,0,2,negative regulation of triglyceride biosynthetic process,BP,
5059,GO:0010869,1,0.870894686808512,0,20,regulation of receptor biosynthetic process,BP,
5060,GO:0010870,1,0.923185373284526,0,11,positive regulation of receptor biosynthetic process,BP,
5061,GO:0010871,1,0.960952709303936,0,6,negative regulation of receptor biosynthetic process,BP,
5067,GO:0010877,1,0.984438855685389,0,2,lipid transport involved in lipid storage,BP,
5069,GO:0010879,1,0.992208292351586,0,1,cholesterol transport involved in cholesterol storage,BP,
5070,GO:0010880,1,0.839524984078431,0,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5071,GO:0010881,1,0.880741980273619,0,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
5072,GO:0010882,1,0.851298006746264,0,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,
5074,GO:0010884,1,0.853293659113885,0,22,positive regulation of lipid storage,BP,
5076,GO:0010886,1,0.952653665600216,0,7,positive regulation of cholesterol storage,BP,
5079,GO:0010889,1,0.917645673215372,0,12,regulation of sequestering of triglyceride,BP,
5080,GO:0010890,1,0.94921868695972,0,7,positive regulation of sequestering of triglyceride,BP,
5081,GO:0010891,1,0.966751209755168,0,5,negative regulation of sequestering of triglyceride,BP,
5083,GO:0010894,1,0.855474364993388,0,21,negative regulation of steroid biosynthetic process,BP,
5084,GO:0010896,1,0.913407525655885,0,12,regulation of triglyceride catabolic process,BP,
5085,GO:0010897,1,0.970933599381223,0,4,negative regulation of triglyceride catabolic process,BP,
5086,GO:0010898,1,0.940765034053589,0,8,positive regulation of triglyceride catabolic process,BP,
5089,GO:0010901,1,0.961456806331851,0,5,regulation of very-low-density lipoprotein particle remodeling,BP,
5090,GO:0010902,1,0.984403966277803,0,2,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5091,GO:0010903,1,0.976692112990833,0,3,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5092,GO:0010904,1,0.992195158617293,0,1,regulation of UDP-glucose catabolic process,BP,
5093,GO:0010905,1,0.992195158617293,0,1,negative regulation of UDP-glucose catabolic process,BP,
5096,GO:0010908,1,0.986522382626537,0,2,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5097,GO:0010909,1,0.986522382626537,0,2,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5098,GO:0010911,1,0.965980284136021,0,5,regulation of isomerase activity,BP,
5099,GO:0010912,1,0.965980284136021,0,5,positive regulation of isomerase activity,BP,
5102,GO:0010917,1,0.934735004711872,0,9,negative regulation of mitochondrial membrane potential,BP,
5103,GO:0010918,1,0.970277941676595,0,4,positive regulation of mitochondrial membrane potential,BP,
5104,GO:0010919,1,0.902973642500787,0,14,regulation of inositol phosphate biosynthetic process,BP,
5105,GO:0010920,1,0.992459776065546,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5109,GO:0010924,1,0.992459776065546,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5110,GO:0010925,1,0.992459776065546,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5111,GO:0010927,1,0.522833126625103,0,94,cellular component assembly involved in morphogenesis,BP,
5112,GO:0010931,1,0.993986332276658,0,1,macrophage tolerance induction,BP,
5113,GO:0010932,1,0.993986332276658,0,1,regulation of macrophage tolerance induction,BP,
5114,GO:0010933,1,0.993986332276658,0,1,positive regulation of macrophage tolerance induction,BP,
5115,GO:0010934,1,0.90498017827936,0,14,macrophage cytokine production,BP,
5116,GO:0010935,1,0.918111312373038,0,12,regulation of macrophage cytokine production,BP,
5117,GO:0010936,1,0.965539724990371,0,5,negative regulation of macrophage cytokine production,BP,
5119,GO:0010940,1,0.955112614130357,0,6,positive regulation of necrotic cell death,BP,
5122,GO:0010944,1,0.937199257005518,0,9,negative regulation of transcription by competitive promoter binding,BP,
5124,GO:0010949,1,0.984793258190617,0,2,negative regulation of intestinal phytosterol absorption,BP,
5128,GO:0010954,1,0.878881892069294,0,18,positive regulation of protein processing,BP,
5130,GO:0010956,1,0.978376198995651,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5131,GO:0010957,1,0.963125905818898,0,5,negative regulation of vitamin D biosynthetic process,BP,
5132,GO:0010958,1,0.972722035830963,0,4,regulation of amino acid import,BP,
5134,GO:0010960,1,0.930410833192629,0,11,magnesium ion homeostasis,BP,
5135,GO:0010961,1,0.966906033244372,0,5,cellular magnesium ion homeostasis,BP,
5136,GO:0010962,1,0.839452856021121,0,26,regulation of glucan biosynthetic process,BP,
5137,GO:0010963,1,0.984532458716338,0,2,regulation of L-arginine import,BP,
5138,GO:0010965,1,0.717304046740037,0,46,regulation of mitotic sister chromatid separation,BP,
5139,GO:0010966,1,0.965428049070212,0,5,regulation of phosphate transport,BP,
5140,GO:0010967,1,0.992170041209416,0,1,regulation of polyamine biosynthetic process,BP,
5141,GO:0010968,1,0.964933098032269,0,5,regulation of microtubule nucleation,BP,
5142,GO:0010970,1,0.430176052014594,0,121,transport along microtubule,BP,
5143,GO:0010971,1,0.866371182565993,0,20,positive regulation of G2/M transition of mitotic cell cycle,BP,
5146,GO:0010976,1,0.206764461399089,0,227,positive regulation of neuron projection development,BP,
5148,GO:0010979,1,0.978885103021387,0,3,regulation of vitamin D 24-hydroxylase activity,BP,
5149,GO:0010980,1,0.978885103021387,0,3,positive regulation of vitamin D 24-hydroxylase activity,BP,
5150,GO:0010982,1,0.978160098530561,0,3,regulation of high-density lipoprotein particle clearance,BP,
5151,GO:0010983,1,0.985880369189912,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5154,GO:0010986,1,0.970539880812738,0,4,positive regulation of lipoprotein particle clearance,BP,
5155,GO:0010987,1,0.992170027168696,0,1,negative regulation of high-density lipoprotein particle clearance,BP,
5156,GO:0010988,1,0.93353274271936,0,9,regulation of low-density lipoprotein particle clearance,BP,
5157,GO:0010989,1,0.970591424170315,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5158,GO:0010990,1,0.958977732965685,0,6,regulation of SMAD protein complex assembly,BP,
5159,GO:0010991,1,0.96523838379689,0,5,negative regulation of SMAD protein complex assembly,BP,
5160,GO:0010992,1,0.972823887841208,0,4,ubiquitin homeostasis,BP,
5161,GO:0010993,1,0.964029123525409,0,5,regulation of ubiquitin homeostasis,BP,
5162,GO:0010994,1,0.964029123525409,0,5,free ubiquitin chain polymerization,BP,
5164,GO:0010997,1,0.958401548261913,0,6,anaphase-promoting complex binding,MF,
5165,GO:0010998,1,0.9266144365121,0,11,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5166,GO:0010999,1,0.99379515561488,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5168,GO:0012502,1,0.986147023030262,0,2,induction of programmed cell death,BP,
5171,GO:0012507,1,0.66877706424974,0,56,ER to Golgi transport vesicle membrane,CC,
5172,GO:0012510,1,0.904337530922654,0,14,trans-Golgi network transport vesicle membrane,CC,
5173,GO:0014002,1,0.844812643610852,0,24,astrocyte development,BP,
5174,GO:0014003,1,0.759997066963315,0,37,oligodendrocyte development,BP,
5175,GO:0014004,1,0.992765001015256,0,1,microglia differentiation,BP,
5176,GO:0014005,1,0.992765001015256,0,1,microglia development,BP,
5177,GO:0014009,1,0.793232364685536,0,33,glial cell proliferation,BP,
5178,GO:0014010,1,0.960479865583131,0,6,Schwann cell proliferation,BP,
5179,GO:0014011,1,0.992294630214608,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5180,GO:0014012,1,0.956721518964256,0,6,peripheral nervous system axon regeneration,BP,
5181,GO:0014013,1,0.5097910286955,0,92,regulation of gliogenesis,BP,
5182,GO:0014014,1,0.75429958931827,0,38,negative regulation of gliogenesis,BP,
5183,GO:0014015,1,0.713695780145886,0,46,positive regulation of gliogenesis,BP,
5184,GO:0014016,1,0.976971248991425,0,3,neuroblast differentiation,BP,
5185,GO:0014017,1,0.992262432956955,0,1,neuroblast fate commitment,BP,
5186,GO:0014020,1,0.532041554754374,0,91,primary neural tube formation,BP,
5187,GO:0014022,1,0.979234809007255,0,3,neural plate elongation,BP,
5188,GO:0014028,1,0.97220711268889,0,4,notochord formation,BP,
5189,GO:0014029,1,0.918559378889217,0,12,neural crest formation,BP,
5190,GO:0014031,1,0.643355668369761,0,62,mesenchymal cell development,BP,
5191,GO:0014032,1,0.6608732865495,0,58,neural crest cell development,BP,
5192,GO:0014033,1,0.624953858969743,0,66,neural crest cell differentiation,BP,
5193,GO:0014034,1,0.978289333434452,0,3,neural crest cell fate commitment,BP,
5194,GO:0014036,1,0.992170027168696,0,1,neural crest cell fate specification,BP,
5195,GO:0014037,1,0.794819776497685,0,33,Schwann cell differentiation,BP,
5196,GO:0014038,1,0.97861101258566,0,3,regulation of Schwann cell differentiation,BP,
5197,GO:0014040,1,0.986334677239997,0,2,positive regulation of Schwann cell differentiation,BP,
5198,GO:0014041,1,0.929365599200549,0,11,regulation of neuron maturation,BP,
5199,GO:0014042,1,0.975510229925481,0,4,positive regulation of neuron maturation,BP,
5200,GO:0014043,1,0.973602739412112,0,4,negative regulation of neuron maturation,BP,
5202,GO:0014045,1,0.971585068021427,0,4,establishment of endothelial blood-brain barrier,BP,
5203,GO:0014046,1,0.822017569002267,0,27,dopamine secretion,BP,
5205,GO:0014048,1,0.904118837640081,0,14,regulation of glutamate secretion,BP,
5206,GO:0014049,1,0.945420823474,0,8,positive regulation of glutamate secretion,BP,
5207,GO:0014050,1,0.963344885174576,0,5,negative regulation of glutamate secretion,BP,
5208,GO:0014051,1,0.948066616051265,0,8,gamma-aminobutyric acid secretion,BP,
5209,GO:0014052,1,0.966671967863292,0,5,regulation of gamma-aminobutyric acid secretion,BP,
5210,GO:0014053,1,0.993929645472371,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5211,GO:0014054,1,0.972577135804399,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5212,GO:0014055,1,0.977063821434691,0,3,acetylcholine secretion, neurotransmission,BP,
5213,GO:0014056,1,0.977063821434691,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5214,GO:0014057,1,0.98459935471272,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5215,GO:0014059,1,0.822017569002267,0,27,regulation of dopamine secretion,BP,
5216,GO:0014060,1,0.963274024085804,0,5,regulation of epinephrine secretion,BP,
5217,GO:0014061,1,0.893979773943428,0,15,regulation of norepinephrine secretion,BP,
5218,GO:0014062,1,0.948621609215663,0,7,regulation of serotonin secretion,BP,
5219,GO:0014063,1,0.969648721973682,0,4,negative regulation of serotonin secretion,BP,
5220,GO:0014064,1,0.993823381688871,0,1,positive regulation of serotonin secretion,BP,
5223,GO:0014067,1,0.924155721170717,0,11,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5224,GO:0014068,1,0.64296301619991,0,63,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5225,GO:0014069,1,0.275781359847929,0,190,postsynaptic density,CC,
5230,GO:0014701,1,0.943720178925904,0,9,junctional sarcoplasmic reticulum membrane,CC,
5231,GO:0014704,1,0.732501921287956,0,46,intercalated disc,CC,
5232,GO:0014705,1,0.99368092960021,0,1,C zone,CC,
5234,GO:0014707,1,0.976798346923065,0,3,branchiomeric skeletal muscle development,BP,
5235,GO:0014717,1,0.977308253980296,0,3,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5236,GO:0014718,1,0.985021853837002,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5237,GO:0014719,1,0.963822044125473,0,5,skeletal muscle satellite cell activation,BP,
5238,GO:0014721,1,0.965866073369252,0,5,twitch skeletal muscle contraction,BP,
5239,GO:0014722,1,0.963509172423692,0,5,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5240,GO:0014724,1,0.987110524064576,0,2,regulation of twitch skeletal muscle contraction,BP,
5241,GO:0014728,1,0.986504016878276,0,2,regulation of the force of skeletal muscle contraction,BP,
5242,GO:0014731,1,0.956899570979237,0,7,spectrin-associated cytoskeleton,CC,
5243,GO:0014732,1,0.943013944979833,0,8,skeletal muscle atrophy,BP,
5244,GO:0014733,1,0.917394576112619,0,13,regulation of skeletal muscle adaptation,BP,
5245,GO:0014734,1,0.980281370003646,0,3,skeletal muscle hypertrophy,BP,
5248,GO:0014737,1,0.992170136445051,0,1,positive regulation of muscle atrophy,BP,
5249,GO:0014738,1,0.977121427278491,0,3,regulation of muscle hyperplasia,BP,
5250,GO:0014739,1,0.992170027168696,0,1,positive regulation of muscle hyperplasia,BP,
5251,GO:0014740,1,0.984833564087463,0,2,negative regulation of muscle hyperplasia,BP,
5252,GO:0014741,1,0.88003371666706,0,18,negative regulation of muscle hypertrophy,BP,
5253,GO:0014742,1,0.846848959998635,0,24,positive regulation of muscle hypertrophy,BP,
5254,GO:0014743,1,0.740640584170225,0,43,regulation of muscle hypertrophy,BP,
5255,GO:0014744,1,0.965661138144003,0,5,positive regulation of muscle adaptation,BP,
5257,GO:0014801,1,0.992170027168696,0,1,longitudinal sarcoplasmic reticulum,CC,
5258,GO:0014802,1,0.970834102678745,0,4,terminal cisterna,CC,
5259,GO:0014804,1,0.992174947564133,0,1,terminal cisterna lumen,CC,
5260,GO:0014805,1,0.969130568737872,0,4,smooth muscle adaptation,BP,
5261,GO:0014806,1,0.984489592401767,0,2,smooth muscle hyperplasia,BP,
5262,GO:0014807,1,0.934377978892685,0,9,regulation of somitogenesis,BP,
5264,GO:0014809,1,0.970822346896498,0,4,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5265,GO:0014810,1,0.992170027168696,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5266,GO:0014812,1,0.596420750723478,0,74,muscle cell migration,BP,
5267,GO:0014813,1,0.992207732189552,0,1,skeletal muscle satellite cell commitment,BP,
5268,GO:0014816,1,0.959708243155815,0,6,skeletal muscle satellite cell differentiation,BP,
5269,GO:0014819,1,0.925275711008059,0,11,regulation of skeletal muscle contraction,BP,
5270,GO:0014820,1,0.942967590754435,0,8,tonic smooth muscle contraction,BP,
5271,GO:0014821,1,0.879396209365974,0,17,phasic smooth muscle contraction,BP,
5272,GO:0014822,1,0.99229380752301,0,1,detection of wounding,BP,
5274,GO:0014824,1,0.948674950008032,0,7,artery smooth muscle contraction,BP,
5275,GO:0014826,1,0.970693034161379,0,4,vein smooth muscle contraction,BP,
5276,GO:0014827,1,0.969419503349431,0,4,intestine smooth muscle contraction,BP,
5277,GO:0014829,1,0.872768647398457,0,19,vascular smooth muscle contraction,BP,
5278,GO:0014831,1,0.95138227494362,0,7,gastro-intestinal system smooth muscle contraction,BP,
5279,GO:0014832,1,0.951239966961834,0,7,urinary bladder smooth muscle contraction,BP,
5280,GO:0014834,1,0.972161343180305,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5281,GO:0014835,1,0.985979957715668,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5282,GO:0014839,1,0.984402132379157,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5283,GO:0014841,1,0.931277389582824,0,10,skeletal muscle satellite cell proliferation,BP,
5284,GO:0014842,1,0.936914545058914,0,9,regulation of skeletal muscle satellite cell proliferation,BP,
5285,GO:0014843,1,0.993986332269442,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5286,GO:0014846,1,0.987704049313352,0,2,esophagus smooth muscle contraction,BP,
5287,GO:0014848,1,0.951239966961834,0,7,urinary tract smooth muscle contraction,BP,
5288,GO:0014850,1,0.891138249008067,0,16,response to muscle activity,BP,
5289,GO:0014852,1,0.992468766817137,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5290,GO:0014853,1,0.992468766817137,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5291,GO:0014854,1,0.911604713700397,0,13,response to inactivity,BP,
5293,GO:0014856,1,0.923981472325167,0,11,skeletal muscle cell proliferation,BP,
5294,GO:0014857,1,0.929574809447554,0,10,regulation of skeletal muscle cell proliferation,BP,
5295,GO:0014858,1,0.992170027168696,0,1,positive regulation of skeletal muscle cell proliferation,BP,
5296,GO:0014859,1,0.985363615717005,0,2,negative regulation of skeletal muscle cell proliferation,BP,
5297,GO:0014861,1,0.993979989398885,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5298,GO:0014862,1,0.986504016878276,0,2,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5299,GO:0014866,1,0.951396879848342,0,7,skeletal myofibril assembly,BP,
5300,GO:0014870,1,0.933168211181896,0,10,response to muscle inactivity,BP,
5301,GO:0014873,1,0.984532567158036,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5304,GO:0014877,1,0.933168211181896,0,10,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5305,GO:0014878,1,0.972586501489929,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5306,GO:0014883,1,0.953576046882489,0,7,transition between fast and slow fiber,BP,
5307,GO:0014886,1,0.986662732855506,0,2,transition between slow and fast fiber,BP,
5308,GO:0014887,1,0.877957562029249,0,19,cardiac muscle adaptation,BP,
5309,GO:0014888,1,0.755261230226065,0,40,striated muscle adaptation,BP,
5311,GO:0014891,1,0.935826680882227,0,9,striated muscle atrophy,BP,
5312,GO:0014894,1,0.933168211181896,0,10,response to denervation involved in regulation of muscle adaptation,BP,
5313,GO:0014895,1,0.992170027168696,0,1,smooth muscle hypertrophy,BP,
5314,GO:0014896,1,0.614789721109493,0,70,muscle hypertrophy,BP,
5315,GO:0014897,1,0.624402126655241,0,68,striated muscle hypertrophy,BP,
5316,GO:0014898,1,0.877957562029249,0,19,cardiac muscle hypertrophy in response to stress,BP,
5317,GO:0014900,1,0.969469215564976,0,4,muscle hyperplasia,BP,
5318,GO:0014901,1,0.977308253980296,0,3,satellite cell activation involved in skeletal muscle regeneration,BP,
5319,GO:0014902,1,0.499434076388529,0,98,myotube differentiation,BP,
5320,GO:0014904,1,0.795671206703638,0,32,myotube cell development,BP,
5321,GO:0014905,1,0.992170027168696,0,1,myoblast fusion involved in skeletal muscle regeneration,BP,
5322,GO:0014908,1,0.978480856613357,0,3,myotube differentiation involved in skeletal muscle regeneration,BP,
5323,GO:0014909,1,0.64130415525379,0,64,smooth muscle cell migration,BP,
5324,GO:0014910,1,0.678986057515236,0,56,regulation of smooth muscle cell migration,BP,
5325,GO:0014911,1,0.803394344548591,0,32,positive regulation of smooth muscle cell migration,BP,
5326,GO:0014912,1,0.869319348581742,0,20,negative regulation of smooth muscle cell migration,BP,
5327,GO:0014916,1,0.980276212051248,0,3,regulation of lung blood pressure,BP,
5330,GO:0015014,1,0.979800090860253,0,3,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5331,GO:0015015,1,0.966290967322574,0,5,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5332,GO:0015016,1,0.974631434241989,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5333,GO:0015018,1,0.977650288381524,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5334,GO:0015019,1,0.99397037845202,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5335,GO:0015020,1,0.791706007117921,0,31,glucuronosyltransferase activity,MF,
5336,GO:0015026,1,0.775061755891319,0,36,coreceptor activity,MF,
5337,GO:0015030,1,0.700942711221278,0,49,Cajal body,CC,
5339,GO:0015035,1,0.854717846768893,0,21,protein disulfide oxidoreductase activity,MF,
5340,GO:0015036,1,0.743993109018704,0,39,disulfide oxidoreductase activity,MF,
5341,GO:0015037,1,0.903779726600249,0,13,peptide disulfide oxidoreductase activity,MF,
5342,GO:0015038,1,0.961491805524625,0,5,glutathione disulfide oxidoreductase activity,MF,
5343,GO:0015039,1,0.992172478498993,0,1,NADPH-adrenodoxin reductase activity,MF,
5344,GO:0015052,1,0.992331095110023,0,1,beta3-adrenergic receptor activity,MF,
5345,GO:0015054,1,0.992186914817366,0,1,gastrin receptor activity,MF,
5346,GO:0015055,1,0.992170935039127,0,1,secretin receptor activity,MF,
5347,GO:0015056,1,0.984525770941563,0,2,corticotrophin-releasing factor receptor activity,MF,
5348,GO:0015057,1,0.963954469300515,0,5,thrombin-activated receptor activity,MF,
5350,GO:0015067,1,0.992306533507979,0,1,amidinotransferase activity,MF,
5351,GO:0015068,1,0.992306533507979,0,1,glycine amidinotransferase activity,MF,
5352,GO:0015074,1,0.931884559876142,0,10,DNA integration,BP,
5356,GO:0015079,1,0.325293971115279,0,157,potassium ion transmembrane transporter activity,MF,
5358,GO:0015085,1,0.405429296663536,0,133,calcium ion transmembrane transporter activity,MF,
5359,GO:0015086,1,0.993636863993896,0,1,cadmium ion transmembrane transporter activity,MF,
5360,GO:0015087,1,0.993636863993896,0,1,cobalt ion transmembrane transporter activity,MF,
5361,GO:0015088,1,0.99389835650373,0,1,copper uptake transmembrane transporter activity,MF,
5362,GO:0015091,1,0.986433746082715,0,2,ferric iron transmembrane transporter activity,MF,
5363,GO:0015093,1,0.980543936633769,0,3,ferrous iron transmembrane transporter activity,MF,
5364,GO:0015094,1,0.993636863993896,0,1,lead ion transmembrane transporter activity,MF,
5365,GO:0015095,1,0.888218222758687,0,17,magnesium ion transmembrane transporter activity,MF,
5366,GO:0015098,1,0.992172493550135,0,1,molybdate ion transmembrane transporter activity,MF,
5367,GO:0015101,1,0.899753646485096,0,14,organic cation transmembrane transporter activity,MF,
5369,GO:0015105,1,0.992170027168696,0,1,arsenite transmembrane transporter activity,MF,
5370,GO:0015106,1,0.878218355429954,0,19,bicarbonate transmembrane transporter activity,MF,
5372,GO:0015111,1,0.980857390911744,0,3,iodide transmembrane transporter activity,MF,
5373,GO:0015112,1,0.992337037266298,0,1,nitrate transmembrane transporter activity,MF,
5374,GO:0015114,1,0.884872035979924,0,17,phosphate ion transmembrane transporter activity,MF,
5375,GO:0015116,1,0.905319893161394,0,14,sulfate transmembrane transporter activity,MF,
5376,GO:0015117,1,0.992172245940507,0,1,thiosulfate transmembrane transporter activity,MF,
5377,GO:0015119,1,0.978646849331181,0,3,hexose phosphate transmembrane transporter activity,MF,
5378,GO:0015125,1,0.909167334148594,0,13,bile acid transmembrane transporter activity,MF,
5379,GO:0015126,1,0.993903605402016,0,1,canalicular bile acid transmembrane transporter activity,MF,
5380,GO:0015127,1,0.993954967944533,0,1,bilirubin transmembrane transporter activity,MF,
5381,GO:0015129,1,0.965525059460499,0,5,lactate transmembrane transporter activity,MF,
5382,GO:0015130,1,0.993616323617868,0,1,mevalonate transmembrane transporter activity,MF,
5383,GO:0015131,1,0.992172245940507,0,1,oxaloacetate transmembrane transporter activity,MF,
5384,GO:0015132,1,0.993672074147847,0,1,prostaglandin transmembrane transporter activity,MF,
5385,GO:0015136,1,0.992868491067802,0,1,sialic acid transmembrane transporter activity,MF,
5386,GO:0015137,1,0.972409516510563,0,4,citrate transmembrane transporter activity,MF,
5387,GO:0015139,1,0.992466234349486,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5388,GO:0015140,1,0.984403427362684,0,2,malate transmembrane transporter activity,MF,
5389,GO:0015141,1,0.978655953193687,0,3,succinate transmembrane transporter activity,MF,
5390,GO:0015142,1,0.972409516510563,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5391,GO:0015143,1,0.925118238535021,0,10,urate transmembrane transporter activity,MF,
5392,GO:0015144,1,0.738450335219922,0,41,carbohydrate transmembrane transporter activity,MF,
5393,GO:0015145,1,0.852632776408041,0,22,monosaccharide transmembrane transporter activity,MF,
5394,GO:0015149,1,0.864523473253545,0,20,hexose transmembrane transporter activity,MF,
5395,GO:0015152,1,0.992185642957662,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5396,GO:0015154,1,0.978221507127385,0,3,disaccharide transmembrane transporter activity,MF,
5397,GO:0015157,1,0.978221507127385,0,3,oligosaccharide transmembrane transporter activity,MF,
5398,GO:0015165,1,0.95744090626088,0,6,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5399,GO:0015166,1,0.937146717802355,0,9,polyol transmembrane transporter activity,MF,
5400,GO:0015168,1,0.955956905620257,0,6,glycerol transmembrane transporter activity,MF,
5403,GO:0015173,1,0.977623862647016,0,3,aromatic amino acid transmembrane transporter activity,MF,
5404,GO:0015174,1,0.93556943700109,0,9,basic amino acid transmembrane transporter activity,MF,
5405,GO:0015175,1,0.798755057438244,0,31,neutral amino acid transmembrane transporter activity,MF,
5407,GO:0015180,1,0.951161888994643,0,7,L-alanine transmembrane transporter activity,MF,
5408,GO:0015181,1,0.972630441826349,0,4,arginine transmembrane transporter activity,MF,
5409,GO:0015182,1,0.98472618857339,0,2,L-asparagine transmembrane transporter activity,MF,
5410,GO:0015183,1,0.971168088421632,0,4,L-aspartate transmembrane transporter activity,MF,
5411,GO:0015184,1,0.972078073952347,0,4,L-cystine transmembrane transporter activity,MF,
5412,GO:0015185,1,0.963828003499873,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5413,GO:0015186,1,0.97087602305541,0,4,L-glutamine transmembrane transporter activity,MF,
5414,GO:0015187,1,0.942851618036659,0,8,glycine transmembrane transporter activity,MF,
5415,GO:0015189,1,0.978515907671628,0,3,L-lysine transmembrane transporter activity,MF,
5416,GO:0015190,1,0.992409113957912,0,1,L-leucine transmembrane transporter activity,MF,
5417,GO:0015191,1,0.992409113957912,0,1,L-methionine transmembrane transporter activity,MF,
5418,GO:0015193,1,0.953433125497492,0,7,L-proline transmembrane transporter activity,MF,
5419,GO:0015194,1,0.933885258824464,0,9,L-serine transmembrane transporter activity,MF,
5420,GO:0015195,1,0.993714418040605,0,1,L-threonine transmembrane transporter activity,MF,
5421,GO:0015196,1,0.992260754444587,0,1,L-tryptophan transmembrane transporter activity,MF,
5423,GO:0015198,1,0.96744352968352,0,5,oligopeptide transporter activity,MF,
5424,GO:0015199,1,0.969721923117626,0,4,amino-acid betaine transmembrane transporter activity,MF,
5425,GO:0015203,1,0.992170027168696,0,1,polyamine transmembrane transporter activity,MF,
5426,GO:0015204,1,0.972272241352857,0,4,urea transmembrane transporter activity,MF,
5427,GO:0015205,1,0.942770985212956,0,8,nucleobase transmembrane transporter activity,MF,
5428,GO:0015207,1,0.978268633592306,0,3,adenine transmembrane transporter activity,MF,
5429,GO:0015211,1,0.969711358128897,0,4,purine nucleoside transmembrane transporter activity,MF,
5430,GO:0015215,1,0.889144298869904,0,16,nucleotide transmembrane transporter activity,MF,
5431,GO:0015216,1,0.915610525205226,0,12,purine nucleotide transmembrane transporter activity,MF,
5432,GO:0015217,1,0.935870536883023,0,9,ADP transmembrane transporter activity,MF,
5433,GO:0015218,1,0.986083170111211,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5434,GO:0015220,1,0.958820356855533,0,6,choline transmembrane transporter activity,MF,
5435,GO:0015222,1,0.978606135504118,0,3,serotonin transmembrane transporter activity,MF,
5436,GO:0015226,1,0.969721923117626,0,4,carnitine transmembrane transporter activity,MF,
5437,GO:0015227,1,0.984462901602972,0,2,acyl carnitine transmembrane transporter activity,MF,
5438,GO:0015228,1,0.984956409798264,0,2,coenzyme A transmembrane transporter activity,MF,
5439,GO:0015229,1,0.986261482472498,0,2,L-ascorbic acid transporter activity,MF,
5440,GO:0015230,1,0.9848592638623,0,2,FAD transmembrane transporter activity,MF,
5441,GO:0015232,1,0.944894446831126,0,8,heme transporter activity,MF,
5442,GO:0015234,1,0.971161017239651,0,4,thiamine transmembrane transporter activity,MF,
5443,GO:0015235,1,0.978528726948222,0,3,cobalamin transporter activity,MF,
5446,GO:0015247,1,0.988008547488277,0,2,aminophospholipid transporter activity,MF,
5448,GO:0015250,1,0.920921187301057,0,11,water channel activity,MF,
5449,GO:0015252,1,0.955256366191239,0,6,hydrogen ion channel activity,MF,
5450,GO:0015254,1,0.96945581831517,0,4,glycerol channel activity,MF,
5451,GO:0015265,1,0.978502781894079,0,3,urea channel activity,MF,
5452,GO:0015266,1,0.919157606795302,0,11,protein channel activity,MF,
5454,GO:0015269,1,0.869234588294486,0,19,calcium-activated potassium channel activity,MF,
5455,GO:0015271,1,0.918179929675703,0,12,outward rectifier potassium channel activity,MF,
5456,GO:0015272,1,0.965385228258747,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5457,GO:0015275,1,0.979768469689617,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5459,GO:0015277,1,0.966795117825481,0,5,kainate selective glutamate receptor activity,MF,
5460,GO:0015278,1,0.890284401121392,0,18,calcium-release channel activity,MF,
5461,GO:0015279,1,0.926501250321402,0,11,store-operated calcium channel activity,MF,
5462,GO:0015280,1,0.935636219737047,0,9,ligand-gated sodium channel activity,MF,
5463,GO:0015288,1,0.954503566203664,0,6,porin activity,MF,
5465,GO:0015292,1,0.992294630214608,0,1,uniporter activity,MF,
5468,GO:0015295,1,0.815021133197879,0,28,solute:proton symporter activity,MF,
5469,GO:0015296,1,0.710785611990461,0,49,anion:cation symporter activity,MF,
5470,GO:0015297,1,0.572266831981021,0,79,antiporter activity,MF,
5471,GO:0015298,1,0.798484478218602,0,32,solute:cation antiporter activity,MF,
5472,GO:0015299,1,0.873338165417116,0,19,solute:proton antiporter activity,MF,
5473,GO:0015301,1,0.804244969971986,0,31,anion:anion antiporter activity,MF,
5474,GO:0015307,1,0.977399596427833,0,3,drug:proton antiporter activity,MF,
5475,GO:0015315,1,0.978646849331181,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5476,GO:0015319,1,0.992557620167389,0,1,sodium:inorganic phosphate symporter activity,MF,
5477,GO:0015320,1,0.99217003159065,0,1,phosphate ion carrier activity,MF,
5478,GO:0015321,1,0.949898513468048,0,7,sodium-dependent phosphate transmembrane transporter activity,MF,
5479,GO:0015322,1,0.986007433747344,0,2,secondary active oligopeptide transmembrane transporter activity,MF,
5480,GO:0015327,1,0.993986332283136,0,1,cystine:glutamate antiporter activity,MF,
5481,GO:0015328,1,0.993986332283136,0,1,cystine secondary active transmembrane transporter activity,MF,
5482,GO:0015333,1,0.971583396923,0,4,peptide:proton symporter activity,MF,
5483,GO:0015347,1,0.886969768983195,0,16,sodium-independent organic anion transmembrane transporter activity,MF,
5484,GO:0015349,1,0.964420478543659,0,5,thyroid hormone transmembrane transporter activity,MF,
5485,GO:0015350,1,0.986479880820378,0,2,methotrexate transporter activity,MF,
5486,GO:0015361,1,0.992249265252752,0,1,low-affinity sodium:dicarboxylate symporter activity,MF,
5487,GO:0015362,1,0.993562397668961,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5488,GO:0015367,1,0.99217036783163,0,1,oxoglutarate:malate antiporter activity,MF,
5489,GO:0015368,1,0.93391438254616,0,10,calcium:cation antiporter activity,MF,
5491,GO:0015373,1,0.993135497313848,0,1,monovalent anion:sodium symporter activity,MF,
5492,GO:0015375,1,0.985297749428233,0,2,glycine:sodium symporter activity,MF,
5493,GO:0015377,1,0.944981545006346,0,9,cation:chloride symporter activity,MF,
5494,GO:0015378,1,0.9939853832045,0,1,sodium:chloride symporter activity,MF,
5495,GO:0015379,1,0.962341677734995,0,6,potassium:chloride symporter activity,MF,
5496,GO:0015382,1,0.985890027774855,0,2,sodium:sulfate symporter activity,MF,
5497,GO:0015385,1,0.913193742598274,0,13,sodium:proton antiporter activity,MF,
5498,GO:0015386,1,0.927439957717601,0,11,potassium:proton antiporter activity,MF,
5499,GO:0015389,1,0.984441343089351,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5500,GO:0015390,1,0.992200940165832,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5502,GO:0015403,1,0.978826478259081,0,3,thiamine uptake transmembrane transporter activity,MF,
5504,GO:0015410,1,0.99341725357649,0,1,manganese-transporting ATPase activity,MF,
5505,GO:0015420,1,0.993986332267598,0,1,cobalamin-transporting ATPase activity,MF,
5506,GO:0015421,1,0.993086434913031,0,1,oligopeptide-transporting ATPase activity,MF,
5507,GO:0015431,1,0.993986332267598,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5508,GO:0015432,1,0.987036353130758,0,2,bile acid-exporting ATPase activity,MF,
5509,GO:0015433,1,0.986634450035725,0,2,peptide antigen-transporting ATPase activity,MF,
5510,GO:0015439,1,0.992560919638709,0,1,heme-transporting ATPase activity,MF,
5511,GO:0015440,1,0.972499345961004,0,4,peptide-transporting ATPase activity,MF,
5512,GO:0015450,1,0.941460238924005,0,8,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5513,GO:0015459,1,0.725659729083572,0,44,potassium channel regulator activity,MF,
5514,GO:0015464,1,0.846742632331102,0,22,acetylcholine receptor activity,MF,
5515,GO:0015467,1,0.931883483062483,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5517,GO:0015489,1,0.992170027168696,0,1,putrescine transmembrane transporter activity,MF,
5518,GO:0015491,1,0.823483308197127,0,28,cation:cation antiporter activity,MF,
5519,GO:0015495,1,0.992299643036661,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5520,GO:0015499,1,0.992338293333571,0,1,formate transmembrane transporter activity,MF,
5521,GO:0015501,1,0.987302797444033,0,2,glutamate:sodium symporter activity,MF,
5522,GO:0015526,1,0.978646849331181,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5523,GO:0015538,1,0.992868491067802,0,1,sialic acid:proton symporter activity,MF,
5524,GO:0015556,1,0.942990245157461,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5525,GO:0015562,1,0.964434518032883,0,5,efflux transmembrane transporter activity,MF,
5526,GO:0015563,1,0.971325747847348,0,4,uptake transmembrane transporter activity,MF,
5527,GO:0015578,1,0.992256163015383,0,1,mannose transmembrane transporter activity,MF,
5528,GO:0015605,1,0.870141016595524,0,19,organophosphate ester transmembrane transporter activity,MF,
5529,GO:0015607,1,0.993218440954526,0,1,fatty-acyl-CoA transporter activity,MF,
5530,GO:0015616,1,0.979922545379795,0,3,DNA translocase activity,MF,
5534,GO:0015633,1,0.99218443661618,0,1,zinc-transporting ATPase activity,MF,
5535,GO:0015635,1,0.9922175890475,0,1,short-chain fatty acid transporter activity,MF,
5536,GO:0015636,1,0.9922175890475,0,1,short-chain fatty acid uptake transporter activity,MF,
5537,GO:0015639,1,0.993636863993896,0,1,ferrous iron uptake transmembrane transporter activity,MF,
5538,GO:0015643,1,0.921865383993655,0,11,toxic substance binding,MF,
5540,GO:0015651,1,0.941576374588078,0,8,quaternary ammonium group transmembrane transporter activity,MF,
5541,GO:0015658,1,0.992409113957912,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5542,GO:0015659,1,0.992338293333571,0,1,formate uptake transmembrane transporter activity,MF,
5543,GO:0015660,1,0.992338293333571,0,1,formate efflux transmembrane transporter activity,MF,
5544,GO:0015662,1,0.776745255878387,0,37,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5545,GO:0015665,1,0.937146717802355,0,9,alcohol transmembrane transporter activity,MF,
5546,GO:0015669,1,0.863024987146007,0,19,gas transport,BP,
5547,GO:0015670,1,0.969264624852119,0,4,carbon dioxide transport,BP,
5548,GO:0015671,1,0.890416711921457,0,15,oxygen transport,BP,
5550,GO:0015677,1,0.963662838349945,0,6,copper ion import,BP,
5551,GO:0015679,1,0.993986332277868,0,1,plasma membrane copper ion transport,BP,
5552,GO:0015680,1,0.978480302606265,0,3,intracellular copper ion transport,BP,
5553,GO:0015682,1,0.757514478091454,0,38,ferric iron transport,BP,
5554,GO:0015684,1,0.950741656253601,0,7,ferrous iron transport,BP,
5555,GO:0015688,1,0.976838500461755,0,3,iron chelate transport,BP,
5556,GO:0015689,1,0.992172493550135,0,1,molybdate ion transport,BP,
5557,GO:0015691,1,0.972288229051878,0,4,cadmium ion transport,BP,
5558,GO:0015692,1,0.993636863993896,0,1,lead ion transport,BP,
5559,GO:0015693,1,0.882866195876808,0,18,magnesium ion transport,BP,
5560,GO:0015694,1,0.993954967944533,0,1,mercury ion transport,BP,
5561,GO:0015695,1,0.85337474494569,0,21,organic cation transport,BP,
5562,GO:0015696,1,0.51430620208801,0,90,ammonium transport,BP,
5563,GO:0015697,1,0.928537192705662,0,10,quaternary ammonium group transport,BP,
5565,GO:0015701,1,0.730075795409532,0,44,bicarbonate transport,BP,
5566,GO:0015705,1,0.969093718337984,0,5,iodide transport,BP,
5567,GO:0015706,1,0.992337037266298,0,1,nitrate transport,BP,
5568,GO:0015707,1,0.993397951175909,0,1,nitrite transport,BP,
5569,GO:0015709,1,0.992172245940507,0,1,thiosulfate transport,BP,
5571,GO:0015712,1,0.956301248032727,0,6,hexose phosphate transport,BP,
5573,GO:0015721,1,0.80433453485981,0,30,bile acid and bile salt transport,BP,
5574,GO:0015722,1,0.9805752783074,0,3,canalicular bile acid transport,BP,
5575,GO:0015723,1,0.993954967944533,0,1,bilirubin transport,BP,
5576,GO:0015724,1,0.992338293333571,0,1,formate transport,BP,
5577,GO:0015727,1,0.959457895743619,0,6,lactate transport,BP,
5578,GO:0015728,1,0.993616323617868,0,1,mevalonate transport,BP,
5579,GO:0015729,1,0.992172245940507,0,1,oxaloacetate transport,BP,
5580,GO:0015732,1,0.896222727679108,0,15,prostaglandin transport,BP,
5581,GO:0015734,1,0.993986332268125,0,1,taurine transport,BP,
5582,GO:0015739,1,0.992868491067802,0,1,sialic acid transport,BP,
5584,GO:0015742,1,0.977000224289028,0,3,alpha-ketoglutarate transport,BP,
5585,GO:0015743,1,0.992172245940507,0,1,malate transport,BP,
5586,GO:0015744,1,0.978655953193687,0,3,succinate transport,BP,
5587,GO:0015746,1,0.972409516510563,0,4,citrate transport,BP,
5588,GO:0015747,1,0.925234872565876,0,10,urate transport,BP,
5591,GO:0015755,1,0.984556396755557,0,2,fructose transport,BP,
5593,GO:0015760,1,0.956301248032727,0,6,glucose-6-phosphate transport,BP,
5594,GO:0015761,1,0.992256163015383,0,1,mannose transport,BP,
5595,GO:0015766,1,0.978221507127385,0,3,disaccharide transport,BP,
5596,GO:0015770,1,0.978221507127385,0,3,sucrose transport,BP,
5597,GO:0015772,1,0.978221507127385,0,3,oligosaccharide transport,BP,
5598,GO:0015780,1,0.943182720742026,0,8,nucleotide-sugar transport,BP,
5599,GO:0015781,1,0.95744090626088,0,6,pyrimidine nucleotide-sugar transport,BP,
5600,GO:0015782,1,0.992170721913545,0,1,CMP-N-acetylneuraminate transport,BP,
5601,GO:0015783,1,0.979188211513104,0,3,GDP-fucose transport,BP,
5602,GO:0015785,1,0.984400946654247,0,2,UDP-galactose transport,BP,
5603,GO:0015787,1,0.993986332267889,0,1,UDP-glucuronic acid transport,BP,
5604,GO:0015788,1,0.986223694269111,0,2,UDP-N-acetylglucosamine transport,BP,
5605,GO:0015790,1,0.993986332269678,0,1,UDP-xylose transport,BP,
5606,GO:0015791,1,0.924367292215999,0,11,polyol transport,BP,
5607,GO:0015793,1,0.955956905620257,0,6,glycerol transport,BP,
5608,GO:0015797,1,0.992338293333571,0,1,mannitol transport,BP,
5609,GO:0015798,1,0.982066433215188,0,3,myo-inositol transport,BP,
5611,GO:0015801,1,0.963282563586748,0,5,aromatic amino acid transport,BP,
5612,GO:0015802,1,0.907839028000415,0,13,basic amino acid transport,BP,
5613,GO:0015803,1,0.972627471714847,0,4,branched-chain amino acid transport,BP,
5614,GO:0015804,1,0.777510456770031,0,35,neutral amino acid transport,BP,
5615,GO:0015805,1,0.992201761126188,0,1,S-adenosyl-L-methionine transport,BP,
5617,GO:0015808,1,0.951161888994643,0,7,L-alanine transport,BP,
5618,GO:0015809,1,0.943810155113662,0,8,arginine transport,BP,
5620,GO:0015811,1,0.972078073952347,0,4,L-cystine transport,BP,
5621,GO:0015812,1,0.919455443140773,0,12,gamma-aminobutyric acid transport,BP,
5623,GO:0015816,1,0.931534338524712,0,10,glycine transport,BP,
5624,GO:0015817,1,0.98472618857339,0,2,histidine transport,BP,
5625,GO:0015819,1,0.970982634098145,0,4,lysine transport,BP,
5626,GO:0015820,1,0.980068223937972,0,3,leucine transport,BP,
5627,GO:0015821,1,0.992409113957912,0,1,methionine transport,BP,
5628,GO:0015822,1,0.97982274012317,0,3,ornithine transport,BP,
5629,GO:0015824,1,0.941989824877663,0,9,proline transport,BP,
5630,GO:0015825,1,0.933885258824464,0,9,L-serine transport,BP,
5631,GO:0015826,1,0.993714418040605,0,1,threonine transport,BP,
5632,GO:0015827,1,0.977706416128555,0,3,tryptophan transport,BP,
5633,GO:0015828,1,0.992710157412083,0,1,tyrosine transport,BP,
5636,GO:0015838,1,0.956296043569096,0,6,amino-acid betaine transport,BP,
5637,GO:0015840,1,0.957103113531231,0,6,urea transport,BP,
5639,GO:0015844,1,0.590116424830531,0,72,monoamine transport,BP,
5640,GO:0015846,1,0.956739440335753,0,6,polyamine transport,BP,
5641,GO:0015847,1,0.992170027168696,0,1,putrescine transport,BP,
5644,GO:0015851,1,0.935385728843737,0,9,nucleobase transport,BP,
5645,GO:0015853,1,0.970607507352973,0,4,adenine transport,BP,
5646,GO:0015855,1,0.977146874706303,0,3,pyrimidine nucleobase transport,BP,
5647,GO:0015858,1,0.939912025493744,0,8,nucleoside transport,BP,
5648,GO:0015860,1,0.984523923196687,0,2,purine nucleoside transmembrane transport,BP,
5649,GO:0015862,1,0.992222060671059,0,1,uridine transport,BP,
5650,GO:0015864,1,0.984483191435634,0,2,pyrimidine nucleoside transport,BP,
5651,GO:0015865,1,0.895122297233284,0,15,purine nucleotide transport,BP,
5652,GO:0015866,1,0.935870536883023,0,9,ADP transport,BP,
5653,GO:0015867,1,0.922157521151062,0,11,ATP transport,BP,
5654,GO:0015868,1,0.900670089992107,0,14,purine ribonucleotide transport,BP,
5655,GO:0015870,1,0.962050440744205,0,5,acetylcholine transport,BP,
5656,GO:0015871,1,0.947316679760785,0,8,choline transport,BP,
5657,GO:0015872,1,0.752491509316532,0,39,dopamine transport,BP,
5658,GO:0015874,1,0.86227100182413,0,20,norepinephrine transport,BP,
5659,GO:0015876,1,0.992340570098796,0,1,acetyl-CoA transport,BP,
5660,GO:0015878,1,0.992854138110045,0,1,biotin transport,BP,
5661,GO:0015879,1,0.962142863444775,0,5,carnitine transport,BP,
5662,GO:0015880,1,0.984956409798264,0,2,coenzyme A transport,BP,
5663,GO:0015881,1,0.986989193567562,0,2,creatine transport,BP,
5664,GO:0015882,1,0.986261482472498,0,2,L-ascorbic acid transport,BP,
5665,GO:0015883,1,0.9848592638623,0,2,FAD transport,BP,
5666,GO:0015884,1,0.949827107309089,0,7,folic acid transport,BP,
5667,GO:0015886,1,0.937496941622777,0,9,heme transport,BP,
5668,GO:0015887,1,0.992854138110045,0,1,pantothenate transmembrane transport,BP,
5669,GO:0015888,1,0.963864298188833,0,5,thiamine transport,BP,
5670,GO:0015889,1,0.942532677280219,0,8,cobalamin transport,BP,
5671,GO:0015891,1,0.976838500461755,0,3,siderophore transport,BP,
5673,GO:0015904,1,0.992171581291078,0,1,tetracycline transport,BP,
5676,GO:0015910,1,0.985486380099446,0,2,peroxisomal long-chain fatty acid import,BP,
5677,GO:0015911,1,0.967082078429001,0,5,plasma membrane long-chain fatty acid transport,BP,
5678,GO:0015912,1,0.9922175890475,0,1,short-chain fatty acid transport,BP,
5679,GO:0015913,1,0.9922175890475,0,1,short-chain fatty acid import,BP,
5681,GO:0015916,1,0.992340570098796,0,1,fatty-acyl-CoA transport,BP,
5682,GO:0015917,1,0.982066433192759,0,3,aminophospholipid transport,BP,
5684,GO:0015919,1,0.950991086460438,0,7,peroxisomal membrane transport,BP,
5685,GO:0015920,1,0.984583462854502,0,2,lipopolysaccharide transport,BP,
5686,GO:0015922,1,0.992170027168696,0,1,aspartate oxidase activity,MF,
5687,GO:0015923,1,0.910730564931908,0,14,mannosidase activity,MF,
5688,GO:0015924,1,0.9423464773307,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5690,GO:0015926,1,0.923066879349209,0,12,glucosidase activity,MF,
5691,GO:0015927,1,0.992171570232374,0,1,trehalase activity,MF,
5692,GO:0015928,1,0.984431931597091,0,2,fucosidase activity,MF,
5694,GO:0015931,1,0.198567309185149,0,224,nucleobase-containing compound transport,BP,
5695,GO:0015932,1,0.768210544148122,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5697,GO:0015935,1,0.590944668457641,0,68,small ribosomal subunit,CC,
5701,GO:0015939,1,0.95028771799784,0,7,pantothenate metabolic process,BP,
5702,GO:0015942,1,0.956146494913679,0,6,formate metabolic process,BP,
5703,GO:0015949,1,0.847489802024955,0,22,nucleobase-containing small molecule interconversion,BP,
5704,GO:0015959,1,0.949446833187195,0,7,diadenosine polyphosphate metabolic process,BP,
5705,GO:0015960,1,0.977999969017628,0,3,diadenosine polyphosphate biosynthetic process,BP,
5706,GO:0015961,1,0.97080956241711,0,4,diadenosine polyphosphate catabolic process,BP,
5707,GO:0015965,1,0.977999969017628,0,3,diadenosine tetraphosphate metabolic process,BP,
5708,GO:0015966,1,0.977999969017628,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5710,GO:0015985,1,0.824976655248517,0,25,energy coupled proton transport, down electrochemical gradient,BP,
5711,GO:0015986,1,0.824976655248517,0,25,ATP synthesis coupled proton transport,BP,
5712,GO:0015988,1,0.818198521865964,0,27,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5713,GO:0015991,1,0.818198521865964,0,27,ATP hydrolysis coupled proton transport,BP,
5715,GO:0015993,1,0.986205638889245,0,2,molecular hydrogen transport,BP,
5716,GO:0016004,1,0.922359131448783,0,11,phospholipase activator activity,MF,
5717,GO:0016005,1,0.986291298361921,0,2,phospholipase A2 activator activity,MF,
5718,GO:0016010,1,0.862137038326146,0,21,dystrophin-associated glycoprotein complex,CC,
5719,GO:0016011,1,0.951410634771087,0,7,dystroglycan complex,CC,
5720,GO:0016012,1,0.957168800109169,0,6,sarcoglycan complex,CC,
5721,GO:0016013,1,0.970876125748565,0,4,syntrophin complex,CC,
5722,GO:0016015,1,0.947886395732817,0,7,morphogen activity,MF,
5723,GO:0016018,1,0.92828967932238,0,10,cyclosporin A binding,MF,
5724,GO:0016019,1,0.961456653025558,0,5,peptidoglycan receptor activity,MF,
5727,GO:0016024,1,0.92764420084477,0,11,CDP-diacylglycerol biosynthetic process,BP,
5728,GO:0016028,1,0.993190015620724,0,1,rhabdomere,CC,
5729,GO:0016031,1,0.985157297228806,0,2,tRNA import into mitochondrion,BP,
5731,GO:0016034,1,0.992170027168696,0,1,maleylacetoacetate isomerase activity,MF,
5732,GO:0016035,1,0.980271740757568,0,3,zeta DNA polymerase complex,CC,
5733,GO:0016036,1,0.992209142954877,0,1,cellular response to phosphate starvation,BP,
5734,GO:0016037,1,0.992400935068583,0,1,light absorption,BP,
5735,GO:0016038,1,0.992400935068583,0,1,absorption of visible light,BP,
5738,GO:0016045,1,0.919001233640545,0,12,detection of bacterium,BP,
5739,GO:0016046,1,0.993985977977592,0,1,detection of fungus,BP,
5740,GO:0016048,1,0.880631450663503,0,18,detection of temperature stimulus,BP,
5741,GO:0016049,1,0.032796397861833,0,473,cell growth,BP,
5748,GO:0016056,1,0.789080927590787,0,32,rhodopsin mediated signaling pathway,BP,
5749,GO:0016062,1,0.984947438836456,0,2,adaptation of rhodopsin mediated signaling,BP,
5750,GO:0016064,1,0.484813311757696,0,98,immunoglobulin mediated immune response,BP,
5751,GO:0016068,1,0.976843105630151,0,3,type I hypersensitivity,BP,
5755,GO:0016073,1,0.56551581328508,0,77,snRNA metabolic process,BP,
5756,GO:0016074,1,0.904623428786959,0,13,snoRNA metabolic process,BP,
5757,GO:0016075,1,0.894844189184544,0,15,rRNA catabolic process,BP,
5758,GO:0016077,1,0.993986332265624,0,1,snoRNA catabolic process,BP,
5759,GO:0016078,1,0.978398067084628,0,3,tRNA catabolic process,BP,
5760,GO:0016079,1,0.576035920856408,0,80,synaptic vesicle exocytosis,BP,
5761,GO:0016080,1,0.975199887644878,0,4,synaptic vesicle targeting,BP,
5762,GO:0016081,1,0.946226950768942,0,8,synaptic vesicle docking,BP,
5763,GO:0016082,1,0.915327585250135,0,13,synaptic vesicle priming,BP,
5764,GO:0016093,1,0.941505533566807,0,8,polyprenol metabolic process,BP,
5765,GO:0016094,1,0.986797751912578,0,2,polyprenol biosynthetic process,BP,
5766,GO:0016095,1,0.97686001598584,0,3,polyprenol catabolic process,BP,
5767,GO:0016098,1,0.954648788715697,0,6,monoterpenoid metabolic process,BP,
5769,GO:0016102,1,0.941579219986142,0,8,diterpenoid biosynthetic process,BP,
5770,GO:0016103,1,0.97067824972336,0,4,diterpenoid catabolic process,BP,
5771,GO:0016107,1,0.984400887813367,0,2,sesquiterpenoid catabolic process,BP,
5772,GO:0016108,1,0.992461920177581,0,1,tetraterpenoid metabolic process,BP,
5773,GO:0016114,1,0.927126956556849,0,10,terpenoid biosynthetic process,BP,
5774,GO:0016115,1,0.95553303849803,0,6,terpenoid catabolic process,BP,
5775,GO:0016116,1,0.992461920177581,0,1,carotenoid metabolic process,BP,
5776,GO:0016119,1,0.992461920177581,0,1,carotene metabolic process,BP,
5777,GO:0016121,1,0.992461920177581,0,1,carotene catabolic process,BP,
5778,GO:0016122,1,0.992461920177581,0,1,xanthophyll metabolic process,BP,
5781,GO:0016127,1,0.92030354852931,0,11,sterol catabolic process,BP,
5788,GO:0016149,1,0.978934168292236,0,3,translation release factor activity, codon specific,MF,
5789,GO:0016151,1,0.984432202763951,0,2,nickel cation binding,MF,
5790,GO:0016153,1,0.992919830257688,0,1,urocanate hydratase activity,MF,
5791,GO:0016154,1,0.992170027247971,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5792,GO:0016155,1,0.986728903993189,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5793,GO:0016160,1,0.955697756602208,0,6,amylase activity,MF,
5794,GO:0016165,1,0.984614061319937,0,2,linoleate 13S-lipoxygenase activity,MF,
5795,GO:0016167,1,0.978892301060178,0,3,glial cell-derived neurotrophic factor receptor activity,MF,
5796,GO:0016174,1,0.960733005785399,0,6,NAD(P)H oxidase activity,MF,
5797,GO:0016175,1,0.936255034111472,0,9,superoxide-generating NADPH oxidase activity,MF,
5798,GO:0016176,1,0.950214860220823,0,7,superoxide-generating NADPH oxidase activator activity,MF,
5799,GO:0016180,1,0.877353195676286,0,18,snRNA processing,BP,
5800,GO:0016182,1,0.993910504589606,0,1,synaptic vesicle budding from endosome,BP,
5801,GO:0016185,1,0.986830000540345,0,2,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5802,GO:0016188,1,0.93904248987181,0,9,synaptic vesicle maturation,BP,
5803,GO:0016189,1,0.993986332275604,0,1,synaptic vesicle to endosome fusion,BP,
5804,GO:0016191,1,0.96687561342847,0,5,synaptic vesicle uncoating,BP,
5807,GO:0016198,1,0.953043917654691,0,7,axon choice point recognition,BP,
5808,GO:0016199,1,0.967563327726197,0,5,axon midline choice point recognition,BP,
5810,GO:0016203,1,0.993986332272497,0,1,muscle attachment,BP,
5811,GO:0016206,1,0.984885859324199,0,2,catechol O-methyltransferase activity,MF,
5812,GO:0016208,1,0.920236650217158,0,11,AMP binding,MF,
5814,GO:0016211,1,0.987764845120699,0,2,ammonia ligase activity,MF,
5815,GO:0016212,1,0.984516316935086,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5816,GO:0016213,1,0.992711089852587,0,1,linoleoyl-CoA desaturase activity,MF,
5817,GO:0016215,1,0.979146576622349,0,3,acyl-CoA desaturase activity,MF,
5818,GO:0016222,1,0.984821431175905,0,2,procollagen-proline 4-dioxygenase complex,CC,
5819,GO:0016226,1,0.871940699198034,0,18,iron-sulfur cluster assembly,BP,
5821,GO:0016230,1,0.985337044504468,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5822,GO:0016231,1,0.993961506598965,0,1,beta-N-acetylglucosaminidase activity,MF,
5823,GO:0016232,1,0.992432710440934,0,1,HNK-1 sulfotransferase activity,MF,
5824,GO:0016233,1,0.67978419378388,0,53,telomere capping,BP,
5825,GO:0016234,1,0.590350422643254,0,75,inclusion body,CC,
5826,GO:0016235,1,0.763636782719199,0,38,aggresome,CC,
5828,GO:0016237,1,0.987181858591688,0,2,lysosomal microautophagy,BP,
5829,GO:0016239,1,0.682609314547369,0,55,positive regulation of macroautophagy,BP,
5830,GO:0016240,1,0.972426236163497,0,4,autophagosome docking,BP,
5832,GO:0016242,1,0.844724333555289,0,24,negative regulation of macroautophagy,BP,
5833,GO:0016243,1,0.993518005325115,0,1,regulation of autophagosome size,BP,
5834,GO:0016246,1,0.932569515559628,0,10,RNA interference,BP,
5836,GO:0016248,1,0.794556912030686,0,32,channel inhibitor activity,MF,
5837,GO:0016250,1,0.992402181272597,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5838,GO:0016254,1,0.893654635511776,0,15,preassembly of GPI anchor in ER membrane,BP,
5839,GO:0016255,1,0.950134648326998,0,7,attachment of GPI anchor to protein,BP,
5840,GO:0016256,1,0.986202608681532,0,2,N-glycan processing to lysosome,BP,
5841,GO:0016259,1,0.97851966915848,0,3,selenocysteine metabolic process,BP,
5842,GO:0016260,1,0.992207732189552,0,1,selenocysteine biosynthetic process,BP,
5843,GO:0016262,1,0.978602152403045,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5844,GO:0016263,1,0.984405219070267,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5845,GO:0016264,1,0.918230866087396,0,12,gap junction assembly,BP,
5846,GO:0016266,1,0.678563581659109,0,55,O-glycan processing,BP,
5847,GO:0016267,1,0.984405219070267,0,2,O-glycan processing, core 1,BP,
5848,GO:0016269,1,0.992269000039996,0,1,O-glycan processing, core 3,BP,
5849,GO:0016272,1,0.946451405121615,0,7,prefoldin complex,CC,
5850,GO:0016273,1,0.918297253879816,0,11,arginine N-methyltransferase activity,MF,
5851,GO:0016274,1,0.918297253879816,0,11,protein-arginine N-methyltransferase activity,MF,
5852,GO:0016277,1,0.992240749279768,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5853,GO:0016278,1,0.739757419236291,0,43,lysine N-methyltransferase activity,MF,
5854,GO:0016279,1,0.745515031958976,0,42,protein-lysine N-methyltransferase activity,MF,
5855,GO:0016281,1,0.939323149929884,0,9,eukaryotic translation initiation factor 4F complex,CC,
5856,GO:0016282,1,0.993804623432668,0,1,eukaryotic 43S preinitiation complex,CC,
5857,GO:0016286,1,0.969352387655583,0,4,small conductance calcium-activated potassium channel activity,MF,
5858,GO:0016287,1,0.992356275536468,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5860,GO:0016290,1,0.92538638451829,0,10,palmitoyl-CoA hydrolase activity,MF,
5861,GO:0016295,1,0.986203271969489,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5862,GO:0016296,1,0.986203271969489,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5863,GO:0016297,1,0.986203271969489,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5865,GO:0016300,1,0.971188925716259,0,4,tRNA (uracil) methyltransferase activity,MF,
5869,GO:0016308,1,0.954020970672496,0,7,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5870,GO:0016309,1,0.980174901408748,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5873,GO:0016312,1,0.972803946863426,0,4,inositol bisphosphate phosphatase activity,MF,
5874,GO:0016314,1,0.980201969277352,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5875,GO:0016316,1,0.987607770856347,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5876,GO:0016320,1,0.986203080783948,0,2,endoplasmic reticulum membrane fusion,BP,
5877,GO:0016321,1,0.977227335219658,0,3,female meiosis chromosome segregation,BP,
5878,GO:0016322,1,0.9318266200357,0,10,neuron remodeling,BP,
5879,GO:0016323,1,0.242897319413732,0,201,basolateral plasma membrane,CC,
5880,GO:0016324,1,0.144727902213131,0,274,apical plasma membrane,CC,
5881,GO:0016327,1,0.876112798343122,0,18,apicolateral plasma membrane,CC,
5882,GO:0016328,1,0.69484632650216,0,52,lateral plasma membrane,CC,
5883,GO:0016331,1,0.361260409315409,0,145,morphogenesis of embryonic epithelium,BP,
5884,GO:0016332,1,0.993441353959129,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5885,GO:0016333,1,0.992524130270188,0,1,morphogenesis of follicular epithelium,BP,
5886,GO:0016334,1,0.992524130270188,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5888,GO:0016338,1,0.838848779769253,0,23,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5889,GO:0016339,1,0.823380917581749,0,28,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5890,GO:0016340,1,0.988008437704263,0,2,calcium-dependent cell-matrix adhesion,BP,
5891,GO:0016342,1,0.941259117876164,0,9,catenin complex,CC,
5892,GO:0016344,1,0.979949024412163,0,3,meiotic chromosome movement towards spindle pole,BP,
5893,GO:0016358,1,0.268582704129889,0,194,dendrite development,BP,
5894,GO:0016361,1,0.972631537681214,0,4,activin receptor activity, type I,MF,
5895,GO:0016362,1,0.988008547515527,0,2,activin receptor activity, type II,MF,
5897,GO:0016401,1,0.984500283736732,0,2,palmitoyl-CoA oxidase activity,MF,
5898,GO:0016402,1,0.977088035460341,0,3,pristanoyl-CoA oxidase activity,MF,
5899,GO:0016403,1,0.985736461248788,0,2,dimethylargininase activity,MF,
5900,GO:0016404,1,0.98623881380587,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5906,GO:0016410,1,0.482340142177521,0,100,N-acyltransferase activity,MF,
5907,GO:0016411,1,0.830451548989946,0,26,acylglycerol O-acyltransferase activity,MF,
5908,GO:0016412,1,0.992170027221239,0,1,serine O-acyltransferase activity,MF,
5909,GO:0016413,1,0.94995195703706,0,7,O-acetyltransferase activity,MF,
5910,GO:0016414,1,0.992802654692536,0,1,O-octanoyltransferase activity,MF,
5911,GO:0016415,1,0.985028599991464,0,2,octanoyltransferase activity,MF,
5913,GO:0016417,1,0.804140739106919,0,30,S-acyltransferase activity,MF,
5914,GO:0016418,1,0.987763516746534,0,2,S-acetyltransferase activity,MF,
5915,GO:0016419,1,0.986207357979953,0,2,S-malonyltransferase activity,MF,
5916,GO:0016420,1,0.986207357979953,0,2,malonyltransferase activity,MF,
5917,GO:0016421,1,0.958649553150434,0,6,CoA carboxylase activity,MF,
5918,GO:0016422,1,0.98442158361671,0,2,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5919,GO:0016423,1,0.920966988234739,0,11,tRNA (guanine) methyltransferase activity,MF,
5920,GO:0016426,1,0.977425452954777,0,3,tRNA (adenine) methyltransferase activity,MF,
5921,GO:0016427,1,0.948833880514121,0,7,tRNA (cytosine) methyltransferase activity,MF,
5922,GO:0016428,1,0.971345170581703,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5923,GO:0016429,1,0.977425452954777,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5924,GO:0016433,1,0.954284353025286,0,6,rRNA (adenine) methyltransferase activity,MF,
5925,GO:0016434,1,0.986192162202423,0,2,rRNA (cytosine) methyltransferase activity,MF,
5926,GO:0016435,1,0.986181614216409,0,2,rRNA (guanine) methyltransferase activity,MF,
5927,GO:0016441,1,0.634796871931723,0,65,posttranscriptional gene silencing,BP,
5928,GO:0016442,1,0.932403921548885,0,10,RISC complex,CC,
5929,GO:0016444,1,0.689387237903667,0,52,somatic cell DNA recombination,BP,
5930,GO:0016445,1,0.707014533756904,0,48,somatic diversification of immunoglobulins,BP,
5931,GO:0016446,1,0.922163603287519,0,11,somatic hypermutation of immunoglobulin genes,BP,
5932,GO:0016447,1,0.733654796075056,0,43,somatic recombination of immunoglobulin gene segments,BP,
5934,GO:0016454,1,0.964643096900809,0,5,C-palmitoyltransferase activity,MF,
5935,GO:0016458,1,0.165089577722219,0,248,gene silencing,BP,
5936,GO:0016459,1,0.630354458323531,0,70,myosin complex,CC,
5937,GO:0016460,1,0.803204614825262,0,33,myosin II complex,CC,
5938,GO:0016461,1,0.935646088260817,0,10,unconventional myosin complex,CC,
5940,GO:0016469,1,0.702481850308036,0,46,proton-transporting two-sector ATPase complex,CC,
5941,GO:0016471,1,0.887431327094815,0,16,vacuolar proton-transporting V-type ATPase complex,CC,
5942,GO:0016476,1,0.978712124799132,0,3,regulation of embryonic cell shape,BP,
5944,GO:0016479,1,0.972000820162807,0,4,negative regulation of transcription from RNA polymerase I promoter,BP,
5945,GO:0016480,1,0.976887721318739,0,3,negative regulation of transcription from RNA polymerase III promoter,BP,
5948,GO:0016486,1,0.791248937835953,0,32,peptide hormone processing,BP,
5949,GO:0016487,1,0.984400887813367,0,2,farnesol metabolic process,BP,
5950,GO:0016488,1,0.984400887813367,0,2,farnesol catabolic process,BP,
5952,GO:0016492,1,0.985828312014861,0,2,G-protein coupled neurotensin receptor activity,MF,
5953,GO:0016493,1,0.919044289177572,0,11,C-C chemokine receptor activity,MF,
5954,GO:0016494,1,0.947036242440943,0,7,C-X-C chemokine receptor activity,MF,
5955,GO:0016495,1,0.992733611957819,0,1,C-X3-C chemokine receptor activity,MF,
5956,GO:0016496,1,0.992804600328246,0,1,substance P receptor activity,MF,
5957,GO:0016497,1,0.992244194939418,0,1,substance K receptor activity,MF,
5958,GO:0016499,1,0.984408822068493,0,2,orexin receptor activity,MF,
5959,GO:0016500,1,0.923550363663309,0,11,protein-hormone receptor activity,MF,
5960,GO:0016501,1,0.992183294060276,0,1,prostacyclin receptor activity,MF,
5962,GO:0016503,1,0.969043237344425,0,4,pheromone receptor activity,MF,
5965,GO:0016507,1,0.992616167913547,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5966,GO:0016508,1,0.978568184995667,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5967,GO:0016509,1,0.97727352848934,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5968,GO:0016514,1,0.901056884062406,0,15,SWI/SNF complex,CC,
5969,GO:0016517,1,0.992176214086523,0,1,interleukin-12 receptor activity,MF,
5970,GO:0016519,1,0.992179181654031,0,1,gastric inhibitory peptide receptor activity,MF,
5971,GO:0016520,1,0.970678481711497,0,4,growth hormone-releasing hormone receptor activity,MF,
5972,GO:0016521,1,0.992724664568839,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5973,GO:0016525,1,0.61080294083389,0,70,negative regulation of angiogenesis,BP,
5976,GO:0016530,1,0.964978009629539,0,5,metallochaperone activity,MF,
5977,GO:0016531,1,0.970817531582688,0,4,copper chaperone activity,MF,
5978,GO:0016532,1,0.98620308078549,0,2,superoxide dismutase copper chaperone activity,MF,
5979,GO:0016533,1,0.977982833810921,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5980,GO:0016534,1,0.985701716312323,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5981,GO:0016538,1,0.804130918125828,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5982,GO:0016539,1,0.984412806697314,0,2,intein-mediated protein splicing,BP,
5983,GO:0016540,1,0.923998667522011,0,11,protein autoprocessing,BP,
5984,GO:0016553,1,0.931279397399836,0,10,base conversion or substitution editing,BP,
5985,GO:0016554,1,0.970759698943216,0,4,cytidine to uridine editing,BP,
5987,GO:0016557,1,0.976926794558061,0,3,peroxisome membrane biogenesis,BP,
5988,GO:0016558,1,0.916926277119778,0,12,protein import into peroxisome matrix,BP,
5989,GO:0016559,1,0.935481060272126,0,9,peroxisome fission,BP,
5990,GO:0016560,1,0.979820328910739,0,3,protein import into peroxisome matrix, docking,BP,
5991,GO:0016561,1,0.9852856694698,0,2,protein import into peroxisome matrix, translocation,BP,
5993,GO:0016569,1,0.0253154932796386,0,516,covalent chromatin modification,BP,
5994,GO:0016570,1,0.0540879924120154,0,410,histone modification,BP,
5995,GO:0016571,1,0.428148042004375,0,121,histone methylation,BP,
5996,GO:0016572,1,0.780263580109184,0,34,histone phosphorylation,BP,
5997,GO:0016573,1,0.369873378228113,0,138,histone acetylation,BP,
5998,GO:0016574,1,0.764682477417843,0,39,histone ubiquitination,BP,
5999,GO:0016575,1,0.569535847236615,0,80,histone deacetylation,BP,
6000,GO:0016576,1,0.958796559752576,0,6,histone dephosphorylation,BP,
6001,GO:0016577,1,0.846332099649416,0,26,histone demethylation,BP,
6002,GO:0016578,1,0.862937720136077,0,21,histone deubiquitination,BP,
6004,GO:0016580,1,0.914520467268578,0,13,Sin3 complex,CC,
6005,GO:0016581,1,0.890629129222572,0,17,NuRD complex,CC,
6006,GO:0016584,1,0.943032367821951,0,8,nucleosome positioning,BP,
6007,GO:0016586,1,0.993802129979742,0,1,RSC complex,CC,
6008,GO:0016589,1,0.953878506415281,0,7,NURF complex,CC,
6009,GO:0016590,1,0.99398633226544,0,1,ACF complex,CC,
6010,GO:0016591,1,0.482528038568304,0,100,DNA-directed RNA polymerase II, holoenzyme,CC,
6011,GO:0016592,1,0.776952454820259,0,35,mediator complex,CC,
6012,GO:0016593,1,0.952924497906591,0,7,Cdc73/Paf1 complex,CC,
6013,GO:0016594,1,0.897161591289611,0,15,glycine binding,MF,
6015,GO:0016596,1,0.992294630214608,0,1,thienylcyclohexylpiperidine binding,MF,
6017,GO:0016598,1,0.984431266633089,0,2,protein arginylation,BP,
6018,GO:0016600,1,0.941091611352318,0,9,flotillin complex,CC,
6019,GO:0016601,1,0.816486810438329,0,30,Rac protein signal transduction,BP,
6020,GO:0016602,1,0.971677946357331,0,4,CCAAT-binding factor complex,CC,
6021,GO:0016603,1,0.984422941911272,0,2,glutaminyl-peptide cyclotransferase activity,MF,
6023,GO:0016605,1,0.513043616244311,0,95,PML body,CC,
6025,GO:0016608,1,0.984400887813367,0,2,growth hormone-releasing hormone activity,MF,
6029,GO:0016618,1,0.992170027168696,0,1,hydroxypyruvate reductase activity,MF,
6030,GO:0016620,1,0.773028836158814,0,35,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
6032,GO:0016624,1,0.944024720266914,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
6035,GO:0016634,1,0.934142457163571,0,9,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
6036,GO:0016635,1,0.969122144371433,0,4,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
6037,GO:0016638,1,0.870347275099202,0,19,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
6038,GO:0016639,1,0.977593609276172,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
6039,GO:0016641,1,0.903342162113693,0,14,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
6040,GO:0016642,1,0.993367528362668,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
6042,GO:0016646,1,0.890659609604143,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
6043,GO:0016647,1,0.976777075003832,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
6046,GO:0016652,1,0.98608795292866,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
6047,GO:0016653,1,0.916736740000706,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
6048,GO:0016655,1,0.671851930203662,0,51,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
6049,GO:0016657,1,0.984402873670592,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
6050,GO:0016661,1,0.963311656617333,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
6051,GO:0016662,1,0.992312759411149,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6053,GO:0016668,1,0.891414631397602,0,15,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
6054,GO:0016670,1,0.951991628998667,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
6056,GO:0016672,1,0.984400887813367,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
6059,GO:0016679,1,0.933320411929435,0,9,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
6060,GO:0016681,1,0.940551107940636,0,8,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
6062,GO:0016701,1,0.825797002830574,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
6063,GO:0016702,1,0.832323383091433,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
6066,GO:0016708,1,0.984509147880303,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6067,GO:0016709,1,0.772446864052594,0,35,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6068,GO:0016711,1,0.992315942132114,0,1,flavonoid 3'-monooxygenase activity,MF,
6069,GO:0016712,1,0.827190487000915,0,25,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6072,GO:0016715,1,0.972128148147079,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6073,GO:0016716,1,0.984716411120358,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,MF,
6075,GO:0016721,1,0.961548027973782,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6077,GO:0016723,1,0.946421424777826,0,8,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6078,GO:0016724,1,0.960623151677619,0,6,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6081,GO:0016727,1,0.993986311826297,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6082,GO:0016728,1,0.979729214240087,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6083,GO:0016730,1,0.992172478498993,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6084,GO:0016731,1,0.992172478498993,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6087,GO:0016742,1,0.94238376125289,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6088,GO:0016743,1,0.986203080778985,0,2,carboxyl- or carbamoyltransferase activity,MF,
6089,GO:0016744,1,0.96945982056172,0,4,transferase activity, transferring aldehyde or ketonic groups,MF,
6092,GO:0016748,1,0.977037017559304,0,3,succinyltransferase activity,MF,
6093,GO:0016749,1,0.984463096648436,0,2,N-succinyltransferase activity,MF,
6094,GO:0016751,1,0.992457640659739,0,1,S-succinyltransferase activity,MF,
6095,GO:0016755,1,0.84398252788816,0,22,transferase activity, transferring amino-acyl groups,MF,
6100,GO:0016768,1,0.992170037703238,0,1,spermine synthase activity,MF,
6101,GO:0016769,1,0.867877436508147,0,19,transferase activity, transferring nitrogenous groups,MF,
6104,GO:0016774,1,0.977607164702399,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6105,GO:0016775,1,0.911058466456233,0,13,phosphotransferase activity, nitrogenous group as acceptor,MF,
6106,GO:0016776,1,0.755991302716301,0,39,phosphotransferase activity, phosphate group as acceptor,MF,
6107,GO:0016778,1,0.954171835083691,0,6,diphosphotransferase activity,MF,
6109,GO:0016780,1,0.877737113310324,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6110,GO:0016781,1,0.984579481091623,0,2,phosphotransferase activity, paired acceptors,MF,
6111,GO:0016782,1,0.598639703478949,0,69,transferase activity, transferring sulfur-containing groups,MF,
6112,GO:0016783,1,0.917479559044359,0,11,sulfurtransferase activity,MF,
6113,GO:0016784,1,0.992170027168696,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6114,GO:0016785,1,0.993985996998329,0,1,transferase activity, transferring selenium-containing groups,MF,
6119,GO:0016793,1,0.992752580435624,0,1,triphosphoric monoester hydrolase activity,MF,
6120,GO:0016794,1,0.992170027168696,0,1,diphosphoric monoester hydrolase activity,MF,
6121,GO:0016796,1,0.708703464741402,0,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6123,GO:0016799,1,0.845671811563876,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6124,GO:0016801,1,0.932061108058473,0,9,hydrolase activity, acting on ether bonds,MF,
6125,GO:0016802,1,0.992213585501374,0,1,trialkylsulfonium hydrolase activity,MF,
6126,GO:0016803,1,0.939379061637345,0,8,ether hydrolase activity,MF,
6130,GO:0016812,1,0.959523614927021,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6131,GO:0016813,1,0.921645647781548,0,11,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6132,GO:0016814,1,0.782425976592239,0,33,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6133,GO:0016815,1,0.992170027168696,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6137,GO:0016822,1,0.976692116157444,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6138,GO:0016823,1,0.976692116157444,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6139,GO:0016826,1,0.992402181272597,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6142,GO:0016831,1,0.786463401245217,0,32,carboxy-lyase activity,MF,
6144,GO:0016833,1,0.969270732967727,0,4,oxo-acid-lyase activity,MF,
6148,GO:0016840,1,0.933443798370651,0,9,carbon-nitrogen lyase activity,MF,
6149,GO:0016841,1,0.962071337645479,0,5,ammonia-lyase activity,MF,
6150,GO:0016842,1,0.977788237036288,0,3,amidine-lyase activity,MF,
6151,GO:0016843,1,0.992294630214608,0,1,amine-lyase activity,MF,
6152,GO:0016844,1,0.992294630214608,0,1,strictosidine synthase activity,MF,
6154,GO:0016849,1,0.876782548946142,0,20,phosphorus-oxygen lyase activity,MF,
6156,GO:0016854,1,0.909333425683985,0,13,racemase and epimerase activity,MF,
6157,GO:0016855,1,0.992264474345352,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6158,GO:0016857,1,0.938301864075007,0,9,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6159,GO:0016859,1,0.737211809169823,0,40,cis-trans isomerase activity,MF,
6162,GO:0016862,1,0.992170027168696,0,1,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6164,GO:0016864,1,0.878717296644398,0,18,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6166,GO:0016868,1,0.926806271005958,0,10,intramolecular transferase activity, phosphotransferases,MF,
6167,GO:0016872,1,0.992207918298462,0,1,intramolecular lyase activity,MF,
6169,GO:0016875,1,0.721069720156761,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6170,GO:0016876,1,0.721069720156761,0,44,ligase activity, forming aminoacyl-tRNA and related compounds,MF,
6173,GO:0016879,1,0.716229221159996,0,47,ligase activity, forming carbon-nitrogen bonds,MF,
6174,GO:0016880,1,0.987764845120699,0,2,acid-ammonia (or amide) ligase activity,MF,
6175,GO:0016881,1,0.883990262408168,0,17,acid-amino acid ligase activity,MF,
6176,GO:0016882,1,0.985220700742058,0,2,cyclo-ligase activity,MF,
6177,GO:0016884,1,0.938456489511876,0,9,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6179,GO:0016886,1,0.943022507979576,0,8,ligase activity, forming phosphoric ester bonds,MF,
6181,GO:0016888,1,0.928595943132685,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6182,GO:0016889,1,0.912220509365892,0,12,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6183,GO:0016890,1,0.985995668013813,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6184,GO:0016891,1,0.823066532907936,0,26,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6185,GO:0016892,1,0.931742505758466,0,9,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6186,GO:0016893,1,0.776219551926783,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6187,GO:0016894,1,0.849911484735041,0,21,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6188,GO:0016895,1,0.869408587955668,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6189,GO:0016896,1,0.80894381413757,0,30,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6191,GO:0016899,1,0.977817271441478,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6192,GO:0016900,1,0.984400887813367,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6193,GO:0016901,1,0.964812072056022,0,5,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6195,GO:0016907,1,0.96243973898217,0,5,G-protein coupled acetylcholine receptor activity,MF,
6196,GO:0016909,1,0.979528531779639,0,3,SAP kinase activity,MF,
6197,GO:0016913,1,0.992173129739338,0,1,follicle-stimulating hormone activity,MF,
6198,GO:0016917,1,0.856115167041561,0,22,GABA receptor activity,MF,
6200,GO:0016920,1,0.993986332270997,0,1,pyroglutamyl-peptidase activity,MF,
6201,GO:0016922,1,0.865868780848761,0,21,ligand-dependent nuclear receptor binding,MF,
6202,GO:0016925,1,0.537444757768037,0,88,protein sumoylation,BP,
6203,GO:0016926,1,0.953440742394662,0,7,protein desumoylation,BP,
6204,GO:0016929,1,0.953440742394662,0,7,SUMO-specific protease activity,MF,
6205,GO:0016933,1,0.963528378304768,0,5,extracellular-glycine-gated ion channel activity,MF,
6206,GO:0016934,1,0.963528378304768,0,5,extracellular-glycine-gated chloride channel activity,MF,
6207,GO:0016935,1,0.985831173095553,0,2,glycine-gated chloride channel complex,CC,
6209,GO:0016938,1,0.992533671836895,0,1,kinesin I complex,CC,
6210,GO:0016939,1,0.980677791877446,0,3,kinesin II complex,CC,
6211,GO:0016941,1,0.979128612506172,0,3,natriuretic peptide receptor activity,MF,
6212,GO:0016942,1,0.965135826765177,0,5,insulin-like growth factor binding protein complex,CC,
6213,GO:0016964,1,0.993986332304205,0,1,alpha-2 macroglobulin receptor activity,MF,
6214,GO:0016971,1,0.978747837044553,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6215,GO:0016972,1,0.972768994711792,0,4,thiol oxidase activity,MF,
6216,GO:0016973,1,0.90317398504999,0,14,poly(A)+ mRNA export from nucleus,BP,
6217,GO:0016979,1,0.984400889651981,0,2,lipoate-protein ligase activity,MF,
6218,GO:0016990,1,0.992210393719652,0,1,arginine deiminase activity,MF,
6219,GO:0016992,1,0.992170029021722,0,1,lipoate synthase activity,MF,
6220,GO:0016997,1,0.954333109709618,0,6,alpha-sialidase activity,MF,
6221,GO:0016998,1,0.976692112990833,0,3,cell wall macromolecule catabolic process,BP,
6222,GO:0016999,1,0.986171974098263,0,2,antibiotic metabolic process,BP,
6223,GO:0017002,1,0.955171434599816,0,7,activin-activated receptor activity,MF,
6224,GO:0017003,1,0.99221277234403,0,1,protein-heme linkage,BP,
6225,GO:0017004,1,0.822147707895623,0,26,cytochrome complex assembly,BP,
6226,GO:0017005,1,0.993194934242513,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6227,GO:0017006,1,0.99221277234403,0,1,protein-tetrapyrrole linkage,BP,
6228,GO:0017014,1,0.920258470724588,0,12,protein nitrosylation,BP,
6229,GO:0017015,1,0.505130639697618,0,97,regulation of transforming growth factor beta receptor signaling pathway,BP,
6231,GO:0017017,1,0.906459511930856,0,13,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6232,GO:0017018,1,0.976097902095561,0,4,myosin phosphatase activity,MF,
6233,GO:0017020,1,0.992468766817137,0,1,myosin phosphatase regulator activity,MF,
6236,GO:0017025,1,0.846696717032122,0,23,TBP-class protein binding,MF,
6237,GO:0017034,1,0.968516512070446,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6240,GO:0017042,1,0.986203085867986,0,2,glycosylceramidase activity,MF,
6241,GO:0017045,1,0.992170027168696,0,1,corticotropin-releasing hormone activity,MF,
6243,GO:0017048,1,0.567358257995382,0,83,Rho GTPase binding,MF,
6244,GO:0017049,1,0.890858317094347,0,16,GTP-Rho binding,MF,
6245,GO:0017050,1,0.984772464913066,0,2,D-erythro-sphingosine kinase activity,MF,
6246,GO:0017053,1,0.554032025962795,0,85,transcriptional repressor complex,CC,
6247,GO:0017055,1,0.985273162245387,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6248,GO:0017056,1,0.878533591956122,0,19,structural constituent of nuclear pore,MF,
6249,GO:0017057,1,0.986203080788287,0,2,6-phosphogluconolactonase activity,MF,
6250,GO:0017059,1,0.942184712630871,0,8,serine C-palmitoyltransferase complex,CC,
6251,GO:0017060,1,0.977183049382231,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6252,GO:0017061,1,0.993930403285884,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6253,GO:0017062,1,0.963240923987023,0,5,respiratory chain complex III assembly,BP,
6254,GO:0017064,1,0.984424095840003,0,2,fatty acid amide hydrolase activity,MF,
6255,GO:0017065,1,0.992170027168696,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6256,GO:0017069,1,0.782536462932811,0,33,snRNA binding,MF,
6257,GO:0017070,1,0.935254067345608,0,9,U6 snRNA binding,MF,
6258,GO:0017071,1,0.993206219708688,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6259,GO:0017075,1,0.877753165448038,0,19,syntaxin-1 binding,MF,
6261,GO:0017077,1,0.976743454491842,0,3,oxidative phosphorylation uncoupler activity,MF,
6263,GO:0017081,1,0.885185600584793,0,17,chloride channel regulator activity,MF,
6264,GO:0017084,1,0.993021977199118,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6266,GO:0017089,1,0.976754825993069,0,3,glycolipid transporter activity,MF,
6267,GO:0017090,1,0.9925221574323,0,1,meprin A complex,CC,
6268,GO:0017091,1,0.848792195928434,0,23,AU-rich element binding,MF,
6269,GO:0017095,1,0.981384365875575,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6270,GO:0017096,1,0.992170027168696,0,1,acetylserotonin O-methyltransferase activity,MF,
6271,GO:0017098,1,0.984581627152363,0,2,sulfonylurea receptor binding,MF,
6272,GO:0017099,1,0.985343001316499,0,2,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6273,GO:0017101,1,0.922926459652424,0,11,aminoacyl-tRNA synthetase multienzyme complex,CC,
6274,GO:0017102,1,0.985043082512491,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6275,GO:0017108,1,0.95598237154952,0,6,5'-flap endonuclease activity,MF,
6276,GO:0017109,1,0.985961746006548,0,2,glutamate-cysteine ligase complex,CC,
6277,GO:0017110,1,0.906528292260616,0,13,nucleoside-diphosphatase activity,MF,
6279,GO:0017112,1,0.711307424098627,0,49,Rab guanyl-nucleotide exchange factor activity,MF,
6280,GO:0017113,1,0.992683337168453,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6281,GO:0017116,1,0.985319715870303,0,2,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6282,GO:0017119,1,0.910019393225554,0,13,Golgi transport complex,CC,
6283,GO:0017121,1,0.916151625448824,0,12,phospholipid scrambling,BP,
6284,GO:0017124,1,0.438601612575004,0,118,SH3 domain binding,MF,
6285,GO:0017125,1,0.993891153454082,0,1,deoxycytidyl transferase activity,MF,
6286,GO:0017126,1,0.993977704641508,0,1,nucleologenesis,BP,
6288,GO:0017128,1,0.930161350842356,0,10,phospholipid scramblase activity,MF,
6289,GO:0017129,1,0.985519390171431,0,2,triglyceride binding,MF,
6291,GO:0017134,1,0.854095446351294,0,23,fibroblast growth factor binding,MF,
6292,GO:0017136,1,0.899204294248641,0,15,NAD-dependent histone deacetylase activity,MF,
6295,GO:0017144,1,0.787201407885613,0,32,drug metabolic process,BP,
6296,GO:0017145,1,0.789884428330588,0,34,stem cell division,BP,
6297,GO:0017146,1,0.93912487682235,0,10,NMDA selective glutamate receptor complex,CC,
6298,GO:0017147,1,0.808422706241641,0,30,Wnt-protein binding,MF,
6300,GO:0017150,1,0.976729147548373,0,3,tRNA dihydrouridine synthase activity,MF,
6301,GO:0017151,1,0.944679572494623,0,8,DEAD/H-box RNA helicase binding,MF,
6302,GO:0017153,1,0.978731931391511,0,3,sodium:dicarboxylate symporter activity,MF,
6303,GO:0017154,1,0.933171895299996,0,11,semaphorin receptor activity,MF,
6307,GO:0017159,1,0.98561076127802,0,2,pantetheine hydrolase activity,MF,
6308,GO:0017160,1,0.915441024207463,0,13,Ral GTPase binding,MF,
6309,GO:0017161,1,0.987607770856347,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6310,GO:0017162,1,0.940411755855445,0,9,aryl hydrocarbon receptor binding,MF,
6311,GO:0017166,1,0.94362141759102,0,9,vinculin binding,MF,
6312,GO:0017168,1,0.993539440206858,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6313,GO:0017169,1,0.948170329052447,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6315,GO:0017172,1,0.992170027168696,0,1,cysteine dioxygenase activity,MF,
6316,GO:0017174,1,0.992170027168696,0,1,glycine N-methyltransferase activity,MF,
6317,GO:0017176,1,0.962398556644289,0,5,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6318,GO:0017177,1,0.993437089993706,0,1,glucosidase II complex,CC,
6319,GO:0017182,1,0.956199458332813,0,6,peptidyl-diphthamide metabolic process,BP,
6320,GO:0017183,1,0.956199458332813,0,6,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6321,GO:0017185,1,0.972163287056831,0,4,peptidyl-lysine hydroxylation,BP,
6322,GO:0017186,1,0.984422941911272,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6323,GO:0017187,1,0.919244065775861,0,11,peptidyl-glutamic acid carboxylation,BP,
6324,GO:0017188,1,0.993986332264807,0,1,aspartate N-acetyltransferase activity,MF,
6325,GO:0017196,1,0.959110941299511,0,6,N-terminal peptidyl-methionine acetylation,BP,
6326,GO:0017198,1,0.984400887813367,0,2,N-terminal peptidyl-serine acetylation,BP,
6327,GO:0018002,1,0.984400887813367,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6328,GO:0018003,1,0.984400887813367,0,2,peptidyl-lysine N6-acetylation,BP,
6329,GO:0018008,1,0.987906012471649,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6330,GO:0018009,1,0.99218883215118,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6331,GO:0018011,1,0.992294630214608,0,1,N-terminal peptidyl-alanine methylation,BP,
6332,GO:0018012,1,0.992294630214608,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6333,GO:0018013,1,0.992294630214608,0,1,N-terminal peptidyl-glycine methylation,BP,
6334,GO:0018016,1,0.992294630214608,0,1,N-terminal peptidyl-proline dimethylation,BP,
6335,GO:0018022,1,0.492268071525725,0,102,peptidyl-lysine methylation,BP,
6336,GO:0018023,1,0.801722165911611,0,32,peptidyl-lysine trimethylation,BP,
6337,GO:0018024,1,0.785653292070525,0,35,histone-lysine N-methyltransferase activity,MF,
6338,GO:0018025,1,0.992294630214608,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6339,GO:0018026,1,0.957281323207936,0,6,peptidyl-lysine monomethylation,BP,
6340,GO:0018027,1,0.898207942426595,0,15,peptidyl-lysine dimethylation,BP,
6341,GO:0018032,1,0.993276822232559,0,1,protein amidation,BP,
6342,GO:0018057,1,0.992687010477427,0,1,peptidyl-lysine oxidation,BP,
6343,GO:0018063,1,0.99221277234403,0,1,cytochrome c-heme linkage,BP,
6344,GO:0018065,1,0.939095935458815,0,8,protein-cofactor linkage,BP,
6345,GO:0018076,1,0.976022379043008,0,4,N-terminal peptidyl-lysine acetylation,BP,
6346,GO:0018094,1,0.992958482806244,0,1,protein polyglycylation,BP,
6347,GO:0018095,1,0.944123271397109,0,8,protein polyglutamylation,BP,
6348,GO:0018101,1,0.964834196929352,0,5,protein citrullination,BP,
6350,GO:0018105,1,0.143351615238571,0,272,peptidyl-serine phosphorylation,BP,
6351,GO:0018106,1,0.992170027168696,0,1,peptidyl-histidine phosphorylation,BP,
6352,GO:0018107,1,0.471815356368285,0,108,peptidyl-threonine phosphorylation,BP,
6354,GO:0018114,1,0.992264474345352,0,1,threonine racemase activity,MF,
6355,GO:0018117,1,0.992170027168696,0,1,protein adenylylation,BP,
6356,GO:0018119,1,0.920258470724588,0,12,peptidyl-cysteine S-nitrosylation,BP,
6357,GO:0018125,1,0.977465282644778,0,3,peptidyl-cysteine methylation,BP,
6358,GO:0018126,1,0.884443537962274,0,17,protein hydroxylation,BP,
6360,GO:0018146,1,0.816666559614031,0,28,keratan sulfate biosynthetic process,BP,
6362,GO:0018153,1,0.984742652469423,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6363,GO:0018158,1,0.934020633262964,0,9,protein oxidation,BP,
6364,GO:0018160,1,0.992170027168696,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6365,GO:0018169,1,0.992170027168696,0,1,ribosomal S6-glutamic acid ligase activity,MF,
6366,GO:0018171,1,0.978387783067565,0,3,peptidyl-cysteine oxidation,BP,
6367,GO:0018175,1,0.992170027168696,0,1,protein nucleotidylation,BP,
6368,GO:0018190,1,0.992170027221239,0,1,protein octanoylation,BP,
6369,GO:0018191,1,0.992170027221239,0,1,peptidyl-serine octanoylation,BP,
6370,GO:0018192,1,0.992255841119061,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6372,GO:0018194,1,0.992294630214608,0,1,peptidyl-alanine modification,BP,
6373,GO:0018195,1,0.840001265622305,0,23,peptidyl-arginine modification,BP,
6375,GO:0018197,1,0.980809906199658,0,3,peptidyl-aspartic acid modification,BP,
6376,GO:0018198,1,0.822093871590576,0,27,peptidyl-cysteine modification,BP,
6377,GO:0018199,1,0.969401431473265,0,4,peptidyl-glutamine modification,BP,
6378,GO:0018200,1,0.800552061335074,0,30,peptidyl-glutamic acid modification,BP,
6379,GO:0018201,1,0.980293110091838,0,3,peptidyl-glycine modification,BP,
6380,GO:0018202,1,0.943002265925368,0,8,peptidyl-histidine modification,BP,
6381,GO:0018205,1,0.0858676391486618,0,342,peptidyl-lysine modification,BP,
6382,GO:0018206,1,0.916056796038573,0,12,peptidyl-methionine modification,BP,
6383,GO:0018208,1,0.684628348168326,0,50,peptidyl-proline modification,BP,
6384,GO:0018209,1,0.1271171342232,0,288,peptidyl-serine modification,BP,
6385,GO:0018210,1,0.458840895136592,0,112,peptidyl-threonine modification,BP,
6388,GO:0018214,1,0.919244065775861,0,11,protein carboxylation,BP,
6389,GO:0018216,1,0.891335117936162,0,15,peptidyl-arginine methylation,BP,
6390,GO:0018217,1,0.993518005325115,0,1,peptidyl-aspartic acid phosphorylation,BP,
6391,GO:0018230,1,0.956407798451847,0,6,peptidyl-L-cysteine S-palmitoylation,BP,
6392,GO:0018231,1,0.956407798451847,0,6,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6393,GO:0018242,1,0.972577918498362,0,4,protein O-linked glycosylation via serine,BP,
6394,GO:0018243,1,0.97265973854516,0,4,protein O-linked glycosylation via threonine,BP,
6395,GO:0018262,1,0.984742652469423,0,2,isopeptide cross-linking,BP,
6396,GO:0018271,1,0.993986332265571,0,1,biotin-protein ligase activity,MF,
6397,GO:0018272,1,0.992170154337142,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6398,GO:0018277,1,0.985641247276171,0,2,protein deamination,BP,
6400,GO:0018282,1,0.986266589372315,0,2,metal incorporation into metallo-sulfur cluster,BP,
6401,GO:0018283,1,0.986266589372315,0,2,iron incorporation into metallo-sulfur cluster,BP,
6402,GO:0018293,1,0.992170027168696,0,1,protein-FAD linkage,BP,
6403,GO:0018298,1,0.905906821430984,0,13,protein-chromophore linkage,BP,
6404,GO:0018307,1,0.984486035010998,0,2,enzyme active site formation,BP,
6405,GO:0018312,1,0.985737947840834,0,2,peptidyl-serine ADP-ribosylation,BP,
6406,GO:0018315,1,0.993694182434192,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6408,GO:0018323,1,0.992170027168696,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6409,GO:0018342,1,0.929911903777847,0,10,protein prenylation,BP,
6410,GO:0018343,1,0.97719851386978,0,3,protein farnesylation,BP,
6411,GO:0018344,1,0.949879056271882,0,7,protein geranylgeranylation,BP,
6412,GO:0018345,1,0.840969033886168,0,24,protein palmitoylation,BP,
6413,GO:0018350,1,0.992236866243913,0,1,protein esterification,BP,
6414,GO:0018352,1,0.984462078231418,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6415,GO:0018364,1,0.984400887813367,0,2,peptidyl-glutamine methylation,BP,
6416,GO:0018377,1,0.967693622808453,0,5,protein myristoylation,BP,
6417,GO:0018393,1,0.355635000496999,0,143,internal peptidyl-lysine acetylation,BP,
6418,GO:0018394,1,0.343096129134627,0,148,peptidyl-lysine acetylation,BP,
6419,GO:0018395,1,0.993173241686921,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6420,GO:0018400,1,0.993986332268836,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6421,GO:0018401,1,0.963839162996565,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6423,GO:0018410,1,0.569869525132196,0,76,C-terminal protein amino acid modification,BP,
6424,GO:0018423,1,0.992170027168696,0,1,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6425,GO:0018444,1,0.986480574729074,0,2,translation release factor complex,CC,
6426,GO:0018455,1,0.992170027168696,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6427,GO:0018467,1,0.992333059891156,0,1,formaldehyde dehydrogenase activity,MF,
6428,GO:0018478,1,0.992195158617293,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6429,GO:0018479,1,0.984416330413228,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6430,GO:0018585,1,0.992192101770988,0,1,fluorene oxygenase activity,MF,
6431,GO:0018636,1,0.976692112990833,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6432,GO:0018675,1,0.984402440885708,0,2,(S)-limonene 6-monooxygenase activity,MF,
6433,GO:0018676,1,0.984402440885708,0,2,(S)-limonene 7-monooxygenase activity,MF,
6434,GO:0018685,1,0.969226258824267,0,4,alkane 1-monooxygenase activity,MF,
6435,GO:0018733,1,0.992170027168696,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6436,GO:0018738,1,0.992170027168696,0,1,S-formylglutathione hydrolase activity,MF,
6437,GO:0018773,1,0.992170030385097,0,1,acetylpyruvate hydrolase activity,MF,
6438,GO:0018872,1,0.992261088506856,0,1,arsonoacetate metabolic process,BP,
6439,GO:0018874,1,0.992181193374246,0,1,benzoate metabolic process,BP,
6441,GO:0018885,1,0.992170028111073,0,1,carbon tetrachloride metabolic process,BP,
6444,GO:0018910,1,0.992170028111073,0,1,benzene metabolic process,BP,
6445,GO:0018916,1,0.978083014647263,0,3,nitrobenzene metabolic process,BP,
6446,GO:0018917,1,0.992192101770988,0,1,fluorene metabolic process,BP,
6447,GO:0018931,1,0.984401819725564,0,2,naphthalene metabolic process,BP,
6450,GO:0018964,1,0.99369982288018,0,1,propylene metabolic process,BP,
6451,GO:0018969,1,0.992490566450711,0,1,thiocyanate metabolic process,BP,
6452,GO:0018979,1,0.992170966378327,0,1,trichloroethylene metabolic process,BP,
6453,GO:0018992,1,0.987473355405532,0,2,germ-line sex determination,BP,
6454,GO:0018993,1,0.985165720340995,0,2,somatic sex determination,BP,
6455,GO:0018995,1,0.906370450255763,0,14,host,CC,
6457,GO:0019002,1,0.986195796616291,0,2,GMP binding,MF,
6458,GO:0019003,1,0.654679385551262,0,57,GDP binding,MF,
6459,GO:0019005,1,0.696399265442207,0,50,SCF ubiquitin ligase complex,CC,
6460,GO:0019008,1,0.985850583711274,0,2,molybdopterin synthase complex,CC,
6461,GO:0019012,1,0.969530212283475,0,4,virion,CC,
6462,GO:0019028,1,0.992294630214608,0,1,viral capsid,CC,
6463,GO:0019031,1,0.977060181581946,0,3,viral envelope,CC,
6464,GO:0019034,1,0.987716958764513,0,2,viral replication complex,CC,
6465,GO:0019035,1,0.993986280667794,0,1,viral integration complex,CC,
6466,GO:0019042,1,0.923330358390736,0,11,viral latency,BP,
6467,GO:0019043,1,0.934542780695389,0,9,establishment of viral latency,BP,
6468,GO:0019045,1,0.988008547477231,0,2,latent virus replication,BP,
6469,GO:0019046,1,0.988008547477231,0,2,release from viral latency,BP,
6470,GO:0019048,1,0.781663652262687,0,35,modulation by virus of host morphology or physiology,BP,
6471,GO:0019049,1,0.978700834681886,0,3,evasion or tolerance of host defenses by virus,BP,
6472,GO:0019050,1,0.977002371356897,0,3,suppression by virus of host apoptotic process,BP,
6473,GO:0019054,1,0.854060830043575,0,22,modulation by virus of host process,BP,
6474,GO:0019056,1,0.992473500715898,0,1,modulation by virus of host transcription,BP,
6476,GO:0019060,1,0.963640814884808,0,5,intracellular transport of viral protein in host cell,BP,
6477,GO:0019061,1,0.992210199583924,0,1,uncoating of virus,BP,
6478,GO:0019062,1,0.943845743928433,0,8,virion attachment to host cell,BP,
6479,GO:0019064,1,0.955448310982265,0,6,fusion of virus membrane with host plasma membrane,BP,
6480,GO:0019065,1,0.979151165061539,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6481,GO:0019068,1,0.759672372909099,0,37,virion assembly,BP,
6482,GO:0019072,1,0.987555271978553,0,2,viral genome packaging,BP,
6483,GO:0019074,1,0.987555271978553,0,2,viral RNA genome packaging,BP,
6484,GO:0019075,1,0.984648173044371,0,2,virus maturation,BP,
6485,GO:0019076,1,0.775764807286503,0,35,viral release from host cell,BP,
6487,GO:0019080,1,0.249158201008557,0,185,viral gene expression,BP,
6488,GO:0019081,1,0.929288089753122,0,10,viral translation,BP,
6489,GO:0019082,1,0.993648252737102,0,1,viral protein processing,BP,
6490,GO:0019083,1,0.27005342896246,0,174,viral transcription,BP,
6491,GO:0019085,1,0.986729225755121,0,2,early viral transcription,BP,
6492,GO:0019086,1,0.971335919209219,0,4,late viral transcription,BP,
6493,GO:0019087,1,0.978508523415506,0,3,transformation of host cell by virus,BP,
6494,GO:0019088,1,0.992170027168696,0,1,immortalization of host cell by virus,BP,
6495,GO:0019089,1,0.993986332267547,0,1,transmission of virus,BP,
6497,GO:0019100,1,0.987473355405532,0,2,male germ-line sex determination,BP,
6498,GO:0019101,1,0.992501954224661,0,1,female somatic sex determination,BP,
6499,GO:0019102,1,0.992608776070655,0,1,male somatic sex determination,BP,
6500,GO:0019103,1,0.963348062469409,0,5,pyrimidine nucleotide binding,MF,
6501,GO:0019104,1,0.896497067385603,0,14,DNA N-glycosylase activity,MF,
6502,GO:0019107,1,0.987906012471649,0,2,myristoyltransferase activity,MF,
6503,GO:0019113,1,0.984402440885708,0,2,limonene monooxygenase activity,MF,
6504,GO:0019115,1,0.992175912828971,0,1,benzaldehyde dehydrogenase activity,MF,
6505,GO:0019118,1,0.992170027168696,0,1,phenanthrene-epoxide hydrolase activity,MF,
6506,GO:0019119,1,0.992170027168696,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6507,GO:0019135,1,0.992172149004334,0,1,deoxyhypusine monooxygenase activity,MF,
6508,GO:0019136,1,0.970924593930477,0,4,deoxynucleoside kinase activity,MF,
6509,GO:0019144,1,0.984400887813367,0,2,ADP-sugar diphosphatase activity,MF,
6510,GO:0019145,1,0.992273668061976,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6511,GO:0019153,1,0.992170027168696,0,1,protein-disulfide reductase (glutathione) activity,MF,
6512,GO:0019158,1,0.973513357964059,0,4,mannokinase activity,MF,
6514,GO:0019171,1,0.993986332277816,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6516,GO:0019185,1,0.986254387188494,0,2,snRNA-activating protein complex,CC,
6517,GO:0019187,1,0.993465729911084,0,1,beta-1,4-mannosyltransferase activity,MF,
6518,GO:0019198,1,0.902909128572548,0,16,transmembrane receptor protein phosphatase activity,MF,
6519,GO:0019199,1,0.58729643568321,0,80,transmembrane receptor protein kinase activity,MF,
6520,GO:0019200,1,0.87324236367445,0,19,carbohydrate kinase activity,MF,
6521,GO:0019201,1,0.845811096093972,0,24,nucleotide kinase activity,MF,
6522,GO:0019202,1,0.993021977199118,0,1,amino acid kinase activity,MF,
6523,GO:0019203,1,0.936550853790798,0,9,carbohydrate phosphatase activity,MF,
6524,GO:0019205,1,0.711332032620359,0,47,nucleobase-containing compound kinase activity,MF,
6525,GO:0019206,1,0.906139810595002,0,13,nucleoside kinase activity,MF,
6526,GO:0019207,1,0.238752952244772,0,196,kinase regulator activity,MF,
6527,GO:0019208,1,0.555995303146913,0,81,phosphatase regulator activity,MF,
6528,GO:0019209,1,0.595847938404544,0,72,kinase activator activity,MF,
6529,GO:0019210,1,0.495444819465602,0,96,kinase inhibitor activity,MF,
6530,GO:0019211,1,0.930035359056229,0,10,phosphatase activator activity,MF,
6531,GO:0019212,1,0.772185519060617,0,35,phosphatase inhibitor activity,MF,
6532,GO:0019213,1,0.693432759276149,0,52,deacetylase activity,MF,
6533,GO:0019215,1,0.916367857572444,0,13,intermediate filament binding,MF,
6541,GO:0019226,1,0.62054307171063,0,68,transmission of nerve impulse,BP,
6542,GO:0019227,1,0.952723829751616,0,7,neuronal action potential propagation,BP,
6543,GO:0019228,1,0.799217029551507,0,33,neuronal action potential,BP,
6544,GO:0019229,1,0.655455043254589,0,58,regulation of vasoconstriction,BP,
6545,GO:0019230,1,0.973753048517571,0,4,proprioception,BP,
6546,GO:0019233,1,0.53334432060413,0,88,sensory perception of pain,BP,
6547,GO:0019236,1,0.947675495237988,0,7,response to pheromone,BP,
6548,GO:0019237,1,0.964624876608135,0,5,centromeric DNA binding,MF,
6549,GO:0019238,1,0.955812068166386,0,6,cyclohydrolase activity,MF,
6550,GO:0019239,1,0.81842085317274,0,27,deaminase activity,MF,
6551,GO:0019240,1,0.967575189847686,0,5,citrulline biosynthetic process,BP,
6552,GO:0019242,1,0.992183762484666,0,1,methylglyoxal biosynthetic process,BP,
6553,GO:0019243,1,0.984792029050511,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6554,GO:0019244,1,0.992170027168696,0,1,lactate biosynthetic process from pyruvate,BP,
6555,GO:0019249,1,0.978480302606341,0,3,lactate biosynthetic process,BP,
6556,GO:0019254,1,0.977199193720324,0,3,carnitine metabolic process, CoA-linked,BP,
6557,GO:0019255,1,0.984427405234904,0,2,glucose 1-phosphate metabolic process,BP,
6558,GO:0019262,1,0.969044226271026,0,4,N-acetylneuraminate catabolic process,BP,
6559,GO:0019264,1,0.984521315441538,0,2,glycine biosynthetic process from serine,BP,
6560,GO:0019265,1,0.984436308339983,0,2,glycine biosynthetic process, by transamination of glyoxylate,BP,
6561,GO:0019276,1,0.97827633859118,0,3,UDP-N-acetylgalactosamine metabolic process,BP,
6562,GO:0019285,1,0.986355942147793,0,2,glycine betaine biosynthetic process from choline,BP,
6563,GO:0019287,1,0.9767048478509,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6565,GO:0019303,1,0.984400887813367,0,2,D-ribose catabolic process,BP,
6566,GO:0019310,1,0.992170027168696,0,1,inositol catabolic process,BP,
6567,GO:0019317,1,0.938995401313298,0,9,fucose catabolic process,BP,
6571,GO:0019321,1,0.911166108698802,0,12,pentose metabolic process,BP,
6572,GO:0019322,1,0.96911580911779,0,4,pentose biosynthetic process,BP,
6573,GO:0019323,1,0.962540027058976,0,5,pentose catabolic process,BP,
6574,GO:0019336,1,0.935467398549896,0,9,phenol-containing compound catabolic process,BP,
6575,GO:0019341,1,0.992315942132114,0,1,dibenzo-p-dioxin catabolic process,BP,
6576,GO:0019343,1,0.984542637260965,0,2,cysteine biosynthetic process via cystathionine,BP,
6577,GO:0019344,1,0.976892225241777,0,3,cysteine biosynthetic process,BP,
6578,GO:0019346,1,0.970016141212026,0,4,transsulfuration,BP,
6579,GO:0019348,1,0.963320662439393,0,5,dolichol metabolic process,BP,
6580,GO:0019355,1,0.979618889955843,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6584,GO:0019364,1,0.985263228090941,0,2,pyridine nucleotide catabolic process,BP,
6586,GO:0019368,1,0.964365239482924,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6587,GO:0019369,1,0.680805086296647,0,51,arachidonic acid metabolic process,BP,
6589,GO:0019371,1,0.922005710118984,0,11,cyclooxygenase pathway,BP,
6591,GO:0019373,1,0.857412427375253,0,20,epoxygenase P450 pathway,BP,
6592,GO:0019374,1,0.956282767419792,0,6,galactolipid metabolic process,BP,
6593,GO:0019375,1,0.98472348119027,0,2,galactolipid biosynthetic process,BP,
6594,GO:0019376,1,0.984728717880334,0,2,galactolipid catabolic process,BP,
6597,GO:0019389,1,0.992331584816672,0,1,glucuronoside metabolic process,BP,
6598,GO:0019391,1,0.992331584816672,0,1,glucuronoside catabolic process,BP,
6600,GO:0019400,1,0.866774222735631,0,19,alditol metabolic process,BP,
6601,GO:0019401,1,0.962933055049018,0,5,alditol biosynthetic process,BP,
6602,GO:0019402,1,0.992170027168696,0,1,galactitol metabolic process,BP,
6603,GO:0019405,1,0.958525996692084,0,6,alditol catabolic process,BP,
6604,GO:0019406,1,0.992170027168696,0,1,hexitol biosynthetic process,BP,
6605,GO:0019407,1,0.992282282316394,0,1,hexitol catabolic process,BP,
6606,GO:0019408,1,0.993905307477996,0,1,dolichol biosynthetic process,BP,
6607,GO:0019413,1,0.986410823448669,0,2,acetate biosynthetic process,BP,
6608,GO:0019417,1,0.986581884267948,0,2,sulfur oxidation,BP,
6609,GO:0019418,1,0.976746208828822,0,3,sulfide oxidation,BP,
6610,GO:0019427,1,0.986410823448669,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6616,GO:0019441,1,0.94822065639648,0,7,tryptophan catabolic process to kynurenine,BP,
6617,GO:0019442,1,0.984400904808195,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6618,GO:0019448,1,0.976832635796083,0,3,L-cysteine catabolic process,BP,
6619,GO:0019464,1,0.977883176006054,0,3,glycine decarboxylation via glycine cleavage system,BP,
6620,GO:0019470,1,0.969894937091006,0,4,4-hydroxyproline catabolic process,BP,
6621,GO:0019471,1,0.927491090281344,0,10,4-hydroxyproline metabolic process,BP,
6622,GO:0019474,1,0.971201826022068,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6623,GO:0019477,1,0.971201826022068,0,4,L-lysine catabolic process,BP,
6624,GO:0019478,1,0.984400887813367,0,2,D-amino acid catabolic process,BP,
6625,GO:0019481,1,0.992205725058955,0,1,L-alanine catabolic process, by transamination,BP,
6626,GO:0019482,1,0.970501989144365,0,4,beta-alanine metabolic process,BP,
6627,GO:0019483,1,0.984922307441539,0,2,beta-alanine biosynthetic process,BP,
6629,GO:0019510,1,0.992213585501374,0,1,S-adenosylhomocysteine catabolic process,BP,
6630,GO:0019511,1,0.921582336704311,0,11,peptidyl-proline hydroxylation,BP,
6631,GO:0019516,1,0.984537641847156,0,2,lactate oxidation,BP,
6632,GO:0019518,1,0.992170027168696,0,1,L-threonine catabolic process to glycine,BP,
6633,GO:0019519,1,0.992282282316394,0,1,pentitol metabolic process,BP,
6634,GO:0019520,1,0.984528600448416,0,2,aldonic acid metabolic process,BP,
6635,GO:0019521,1,0.984528600448416,0,2,D-gluconate metabolic process,BP,
6636,GO:0019527,1,0.992282282316394,0,1,pentitol catabolic process,BP,
6638,GO:0019531,1,0.925534669701763,0,11,oxalate transmembrane transporter activity,MF,
6639,GO:0019532,1,0.91828339352451,0,12,oxalate transport,BP,
6642,GO:0019541,1,0.986410823448669,0,2,propionate metabolic process,BP,
6643,GO:0019542,1,0.986410823448669,0,2,propionate biosynthetic process,BP,
6644,GO:0019546,1,0.992210393719652,0,1,arginine deiminase pathway,BP,
6645,GO:0019547,1,0.992170027168696,0,1,arginine catabolic process to ornithine,BP,
6646,GO:0019550,1,0.984503371966661,0,2,glutamate catabolic process to aspartate,BP,
6647,GO:0019551,1,0.984503371966661,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6648,GO:0019556,1,0.970324896323944,0,4,histidine catabolic process to glutamate and formamide,BP,
6649,GO:0019557,1,0.970324896323944,0,4,histidine catabolic process to glutamate and formate,BP,
6650,GO:0019563,1,0.965983190472645,0,5,glycerol catabolic process,BP,
6651,GO:0019566,1,0.992294630214608,0,1,arabinose metabolic process,BP,
6652,GO:0019585,1,0.844721707840367,0,22,glucuronate metabolic process,BP,
6653,GO:0019605,1,0.992181193374246,0,1,butyrate metabolic process,BP,
6654,GO:0019614,1,0.942839315295434,0,8,catechol-containing compound catabolic process,BP,
6655,GO:0019626,1,0.963665047349212,0,5,short-chain fatty acid catabolic process,BP,
6656,GO:0019627,1,0.905886388580399,0,13,urea metabolic process,BP,
6658,GO:0019640,1,0.962605280295254,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6659,GO:0019659,1,0.992472769835405,0,1,glucose catabolic process to lactate,BP,
6660,GO:0019660,1,0.992472769835405,0,1,glycolytic fermentation,BP,
6661,GO:0019661,1,0.992472769835405,0,1,glucose catabolic process to lactate via pyruvate,BP,
6662,GO:0019673,1,0.946500035393982,0,7,GDP-mannose metabolic process,BP,
6664,GO:0019676,1,0.985984719704742,0,2,ammonia assimilation cycle,BP,
6665,GO:0019677,1,0.993039120058076,0,1,NAD catabolic process,BP,
6671,GO:0019706,1,0.82679508151228,0,26,protein-cysteine S-palmitoyltransferase activity,MF,
6672,GO:0019707,1,0.82679508151228,0,26,protein-cysteine S-acyltransferase activity,MF,
6673,GO:0019720,1,0.957145583449989,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6675,GO:0019724,1,0.477317090215881,0,100,B cell mediated immunity,BP,
6677,GO:0019730,1,0.540938145456797,0,79,antimicrobial humoral response,BP,
6679,GO:0019732,1,0.984586107212501,0,2,antifungal humoral response,BP,
6680,GO:0019740,1,0.97179137698159,0,4,nitrogen utilization,BP,
6681,GO:0019742,1,0.992241458127627,0,1,pentacyclic triterpenoid metabolic process,BP,
6682,GO:0019747,1,0.977439682484684,0,3,regulation of isoprenoid metabolic process,BP,
6684,GO:0019751,1,0.472560352092408,0,105,polyol metabolic process,BP,
6686,GO:0019755,1,0.927676270100349,0,10,one-carbon compound transport,BP,
6687,GO:0019763,1,0.962937352153256,0,5,immunoglobulin receptor activity,MF,
6688,GO:0019767,1,0.984400887813367,0,2,IgE receptor activity,MF,
6689,GO:0019770,1,0.992170245355046,0,1,IgG receptor activity,MF,
6690,GO:0019773,1,0.939038201215323,0,8,proteasome core complex, alpha-subunit complex,CC,
6691,GO:0019774,1,0.992170027168696,0,1,proteasome core complex, beta-subunit complex,CC,
6692,GO:0019776,1,0.978897394988515,0,3,Atg8 ligase activity,MF,
6693,GO:0019777,1,0.984458689427682,0,2,Atg12 transferase activity,MF,
6694,GO:0019778,1,0.993939982242919,0,1,Atg12 activating enzyme activity,MF,
6695,GO:0019780,1,0.993986332267942,0,1,FAT10 activating enzyme activity,MF,
6696,GO:0019781,1,0.984417510199622,0,2,NEDD8 activating enzyme activity,MF,
6697,GO:0019782,1,0.99288040651264,0,1,ISG15 activating enzyme activity,MF,
6698,GO:0019783,1,0.433622433014575,0,119,ubiquitin-like protein-specific protease activity,MF,
6699,GO:0019784,1,0.955222401190017,0,6,NEDD8-specific protease activity,MF,
6700,GO:0019785,1,0.985800577946767,0,2,ISG15-specific protease activity,MF,
6701,GO:0019787,1,0.0420135738015427,0,443,ubiquitin-like protein transferase activity,MF,
6702,GO:0019788,1,0.963214305054981,0,5,NEDD8 transferase activity,MF,
6703,GO:0019789,1,0.890242180566429,0,16,SUMO transferase activity,MF,
6704,GO:0019798,1,0.969530397143302,0,4,procollagen-proline dioxygenase activity,MF,
6705,GO:0019799,1,0.992294630214608,0,1,tubulin N-acetyltransferase activity,MF,
6706,GO:0019800,1,0.956140035555723,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6707,GO:0019805,1,0.978442090739651,0,3,quinolinate biosynthetic process,BP,
6708,GO:0019807,1,0.992170027168696,0,1,aspartoacylase activity,MF,
6709,GO:0019808,1,0.977347247850535,0,3,polyamine binding,MF,
6710,GO:0019809,1,0.984421340420776,0,2,spermidine binding,MF,
6711,GO:0019810,1,0.992814836623527,0,1,putrescine binding,MF,
6712,GO:0019811,1,0.993823381688871,0,1,cocaine binding,MF,
6713,GO:0019814,1,0.963299159365761,0,5,immunoglobulin complex,CC,
6714,GO:0019815,1,0.978443598708042,0,3,B cell receptor complex,CC,
6716,GO:0019826,1,0.980061689512071,0,3,oxygen sensor activity,MF,
6717,GO:0019827,1,0.354164681094211,0,148,stem cell population maintenance,BP,
6718,GO:0019828,1,0.98620274189704,0,2,aspartic-type endopeptidase inhibitor activity,MF,
6719,GO:0019829,1,0.635876679419986,0,63,cation-transporting ATPase activity,MF,
6720,GO:0019834,1,0.969043237344425,0,4,phospholipase A2 inhibitor activity,MF,
6721,GO:0019835,1,0.789556802580799,0,31,cytolysis,BP,
6722,GO:0019836,1,0.984625601040578,0,2,hemolysis by symbiont of host erythrocytes,BP,
6723,GO:0019838,1,0.412409253001715,0,127,growth factor binding,MF,
6730,GO:0019855,1,0.940780671940159,0,8,calcium channel inhibitor activity,MF,
6731,GO:0019856,1,0.959629314811912,0,6,pyrimidine nucleobase biosynthetic process,BP,
6732,GO:0019857,1,0.993986332282215,0,1,5-methylcytosine metabolic process,BP,
6733,GO:0019858,1,0.979551636893625,0,3,cytosine metabolic process,BP,
6734,GO:0019859,1,0.977239739415658,0,3,thymine metabolic process,BP,
6735,GO:0019860,1,0.977214983848791,0,3,uracil metabolic process,BP,
6736,GO:0019862,1,0.984400887813367,0,2,IgA binding,MF,
6737,GO:0019863,1,0.961525405935396,0,5,IgE binding,MF,
6738,GO:0019864,1,0.917335330540127,0,11,IgG binding,MF,
6739,GO:0019865,1,0.84997085415659,0,21,immunoglobulin binding,MF,
6742,GO:0019869,1,0.939664258189173,0,9,chloride channel inhibitor activity,MF,
6743,GO:0019870,1,0.95168750820188,0,7,potassium channel inhibitor activity,MF,
6744,GO:0019871,1,0.967380885257446,0,5,sodium channel inhibitor activity,MF,
6745,GO:0019878,1,0.992464792462844,0,1,lysine biosynthetic process via aminoadipic acid,BP,
6747,GO:0019883,1,0.924588252807261,0,11,antigen processing and presentation of endogenous antigen,BP,
6749,GO:0019885,1,0.952423079571583,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6751,GO:0019887,1,0.275947216788674,0,176,protein kinase regulator activity,MF,
6752,GO:0019888,1,0.602228459774368,0,69,protein phosphatase regulator activity,MF,
6753,GO:0019894,1,0.784105293527294,0,35,kinesin binding,MF,
6754,GO:0019896,1,0.948181084272204,0,8,axonal transport of mitochondrion,BP,
6755,GO:0019897,1,0.347177707002495,0,147,extrinsic component of plasma membrane,CC,
6756,GO:0019898,1,0.162409748701953,0,254,extrinsic component of membrane,CC,
6760,GO:0019902,1,0.343220073837563,0,153,phosphatase binding,MF,
6761,GO:0019903,1,0.465601584523783,0,109,protein phosphatase binding,MF,
6763,GO:0019905,1,0.567828912682171,0,81,syntaxin binding,MF,
6764,GO:0019907,1,0.948257773917518,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6765,GO:0019908,1,0.889975109326929,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6766,GO:0019911,1,0.926455027712339,0,10,structural constituent of myelin sheath,MF,
6767,GO:0019912,1,0.984479770116957,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6769,GO:0019918,1,0.976964417580428,0,3,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6770,GO:0019919,1,0.969628227115316,0,4,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6772,GO:0019933,1,0.714059689179997,0,48,cAMP-mediated signaling,BP,
6773,GO:0019934,1,0.919594229487587,0,12,cGMP-mediated signaling,BP,
6774,GO:0019935,1,0.66090091340594,0,59,cyclic-nucleotide-mediated signaling,BP,
6776,GO:0019948,1,0.984666695862241,0,2,SUMO activating enzyme activity,MF,
6778,GO:0019955,1,0.517996915023311,0,91,cytokine binding,MF,
6779,GO:0019956,1,0.871469468517048,0,19,chemokine binding,MF,
6780,GO:0019957,1,0.948206950909424,0,7,C-C chemokine binding,MF,
6781,GO:0019958,1,0.96420274781062,0,5,C-X-C chemokine binding,MF,
6782,GO:0019959,1,0.978687254158688,0,3,interleukin-8 binding,MF,
6783,GO:0019960,1,0.968348093187299,0,5,C-X3-C chemokine binding,MF,
6784,GO:0019961,1,0.98704693926797,0,2,interferon binding,MF,
6785,GO:0019962,1,0.993986332265994,0,1,type I interferon binding,MF,
6786,GO:0019964,1,0.993018951453845,0,1,interferon-gamma binding,MF,
6787,GO:0019966,1,0.944472189496076,0,8,interleukin-1 binding,MF,
6788,GO:0019969,1,0.993269182801633,0,1,interleukin-10 binding,MF,
6789,GO:0019970,1,0.992749724122032,0,1,interleukin-11 binding,MF,
6790,GO:0019972,1,0.984456981790427,0,2,interleukin-12 binding,MF,
6791,GO:0019975,1,0.992170027168696,0,1,interleukin-17 binding,MF,
6792,GO:0019976,1,0.978643610971023,0,3,interleukin-2 binding,MF,
6793,GO:0019981,1,0.98640666858196,0,2,interleukin-6 binding,MF,
6794,GO:0019983,1,0.992191649784728,0,1,interleukin-9 binding,MF,
6795,GO:0019985,1,0.763154636708909,0,38,translesion synthesis,BP,
6796,GO:0019988,1,0.99238991880095,0,1,charged-tRNA amino acid modification,BP,
6797,GO:0019992,1,0.929260058430863,0,11,diacylglycerol binding,MF,
6798,GO:0020003,1,0.992392335882293,0,1,symbiont-containing vacuole,CC,
6799,GO:0020005,1,0.992392335882293,0,1,symbiont-containing vacuole membrane,CC,
6800,GO:0020012,1,0.992366146325104,0,1,evasion or tolerance of host immune response,BP,
6801,GO:0020016,1,0.98026312488917,0,3,ciliary pocket,CC,
6802,GO:0020018,1,0.98026312488917,0,3,ciliary pocket membrane,CC,
6803,GO:0020021,1,0.992170027168696,0,1,immortalization of host cell,BP,
6804,GO:0020027,1,0.894750654501408,0,15,hemoglobin metabolic process,BP,
6806,GO:0021501,1,0.992183573814119,0,1,prechordal plate formation,BP,
6807,GO:0021502,1,0.979392026969753,0,3,neural fold elevation formation,BP,
6808,GO:0021503,1,0.993986332277633,0,1,neural fold bending,BP,
6809,GO:0021508,1,0.993986332269469,0,1,floor plate formation,BP,
6810,GO:0021509,1,0.992176468081181,0,1,roof plate formation,BP,
6811,GO:0021510,1,0.494513087783284,0,98,spinal cord development,BP,
6812,GO:0021511,1,0.848671735297834,0,23,spinal cord patterning,BP,
6813,GO:0021512,1,0.993687893004159,0,1,spinal cord anterior/posterior patterning,BP,
6814,GO:0021513,1,0.859242657262701,0,21,spinal cord dorsal/ventral patterning,BP,
6815,GO:0021514,1,0.891663349270515,0,16,ventral spinal cord interneuron differentiation,BP,
6816,GO:0021515,1,0.684954442542712,0,52,cell differentiation in spinal cord,BP,
6817,GO:0021516,1,0.854251534103739,0,21,dorsal spinal cord development,BP,
6818,GO:0021517,1,0.727303860627904,0,44,ventral spinal cord development,BP,
6819,GO:0021519,1,0.992170027168696,0,1,spinal cord association neuron specification,BP,
6820,GO:0021520,1,0.9151838402197,0,12,spinal cord motor neuron cell fate specification,BP,
6821,GO:0021521,1,0.930832614789457,0,10,ventral spinal cord interneuron specification,BP,
6822,GO:0021522,1,0.793956307970177,0,32,spinal cord motor neuron differentiation,BP,
6823,GO:0021523,1,0.963285846766354,0,5,somatic motor neuron differentiation,BP,
6824,GO:0021524,1,0.976887911463876,0,3,visceral motor neuron differentiation,BP,
6825,GO:0021526,1,0.984467180839147,0,2,medial motor column neuron differentiation,BP,
6826,GO:0021527,1,0.901223989908456,0,14,spinal cord association neuron differentiation,BP,
6827,GO:0021528,1,0.992294630214608,0,1,commissural neuron differentiation in spinal cord,BP,
6828,GO:0021529,1,0.976889952730646,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6829,GO:0021530,1,0.976889952730646,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6830,GO:0021532,1,0.761339834992984,0,38,neural tube patterning,BP,
6831,GO:0021533,1,0.875245009845059,0,19,cell differentiation in hindbrain,BP,
6832,GO:0021534,1,0.923834433731065,0,11,cell proliferation in hindbrain,BP,
6833,GO:0021535,1,0.906946594456819,0,14,cell migration in hindbrain,BP,
6834,GO:0021536,1,0.578725175025593,0,76,diencephalon development,BP,
6836,GO:0021538,1,0.986479201885545,0,2,epithalamus development,BP,
6837,GO:0021539,1,0.984433539665883,0,2,subthalamus development,BP,
6838,GO:0021540,1,0.972907868983224,0,4,corpus callosum morphogenesis,BP,
6839,GO:0021541,1,0.993669384533764,0,1,ammon gyrus development,BP,
6840,GO:0021542,1,0.885226105093521,0,17,dentate gyrus development,BP,
6842,GO:0021544,1,0.854047510176751,0,22,subpallium development,BP,
6844,GO:0021546,1,0.948382933987683,0,7,rhombomere development,BP,
6845,GO:0021547,1,0.992183573814119,0,1,midbrain-hindbrain boundary initiation,BP,
6846,GO:0021548,1,0.931513140504105,0,10,pons development,BP,
6847,GO:0021549,1,0.538920774503366,0,89,cerebellum development,BP,
6848,GO:0021550,1,0.984914704476194,0,2,medulla oblongata development,BP,
6849,GO:0021551,1,0.986244377405064,0,2,central nervous system morphogenesis,BP,
6850,GO:0021553,1,0.980416017112666,0,3,olfactory nerve development,BP,
6851,GO:0021554,1,0.919978156335424,0,12,optic nerve development,BP,
6852,GO:0021555,1,0.970805938436329,0,4,midbrain-hindbrain boundary morphogenesis,BP,
6853,GO:0021557,1,0.969708160938385,0,4,oculomotor nerve development,BP,
6854,GO:0021558,1,0.976692125888869,0,3,trochlear nerve development,BP,
6855,GO:0021559,1,0.924084017435815,0,11,trigeminal nerve development,BP,
6856,GO:0021560,1,0.985209617680774,0,2,abducens nerve development,BP,
6857,GO:0021561,1,0.931549122338227,0,10,facial nerve development,BP,
6858,GO:0021562,1,0.945326221999601,0,8,vestibulocochlear nerve development,BP,
6859,GO:0021563,1,0.965606865273147,0,5,glossopharyngeal nerve development,BP,
6860,GO:0021564,1,0.979255979065874,0,3,vagus nerve development,BP,
6861,GO:0021566,1,0.993934630003237,0,1,hypoglossal nerve development,BP,
6862,GO:0021568,1,0.984401180080771,0,2,rhombomere 2 development,BP,
6863,GO:0021569,1,0.976980836360618,0,3,rhombomere 3 development,BP,
6864,GO:0021570,1,0.984400887813367,0,2,rhombomere 4 development,BP,
6865,GO:0021571,1,0.977702707411127,0,3,rhombomere 5 development,BP,
6866,GO:0021572,1,0.992903327923627,0,1,rhombomere 6 development,BP,
6867,GO:0021575,1,0.766542035058103,0,38,hindbrain morphogenesis,BP,
6868,GO:0021576,1,0.992211571683086,0,1,hindbrain formation,BP,
6869,GO:0021577,1,0.985846652554585,0,2,hindbrain structural organization,BP,
6870,GO:0021578,1,0.959616410697994,0,6,hindbrain maturation,BP,
6871,GO:0021586,1,0.979490923939073,0,3,pons maturation,BP,
6872,GO:0021587,1,0.78962724937094,0,34,cerebellum morphogenesis,BP,
6873,GO:0021588,1,0.992211571683086,0,1,cerebellum formation,BP,
6874,GO:0021589,1,0.985846652554585,0,2,cerebellum structural organization,BP,
6875,GO:0021590,1,0.979712596946364,0,3,cerebellum maturation,BP,
6876,GO:0021591,1,0.836859771907951,0,26,ventricular system development,BP,
6877,GO:0021592,1,0.987996750659268,0,2,fourth ventricle development,BP,
6878,GO:0021593,1,0.98469187219478,0,2,rhombomere morphogenesis,BP,
6879,GO:0021594,1,0.992462995485117,0,1,rhombomere formation,BP,
6880,GO:0021598,1,0.985209617680774,0,2,abducens nerve morphogenesis,BP,
6881,GO:0021599,1,0.985209617680774,0,2,abducens nerve formation,BP,
6882,GO:0021602,1,0.826094969200494,0,27,cranial nerve morphogenesis,BP,
6883,GO:0021603,1,0.943531677063729,0,8,cranial nerve formation,BP,
6884,GO:0021604,1,0.931076650759702,0,10,cranial nerve structural organization,BP,
6885,GO:0021610,1,0.931549122338227,0,10,facial nerve morphogenesis,BP,
6886,GO:0021612,1,0.944462646313777,0,8,facial nerve structural organization,BP,
6887,GO:0021615,1,0.97145016295803,0,4,glossopharyngeal nerve morphogenesis,BP,
6888,GO:0021618,1,0.993934630003237,0,1,hypoglossal nerve morphogenesis,BP,
6889,GO:0021622,1,0.985076266612086,0,2,oculomotor nerve morphogenesis,BP,
6890,GO:0021623,1,0.985076266612086,0,2,oculomotor nerve formation,BP,
6891,GO:0021626,1,0.959616410697994,0,6,central nervous system maturation,BP,
6892,GO:0021631,1,0.962155020436504,0,6,optic nerve morphogenesis,BP,
6893,GO:0021633,1,0.985833147845479,0,2,optic nerve structural organization,BP,
6894,GO:0021634,1,0.993596372063379,0,1,optic nerve formation,BP,
6895,GO:0021636,1,0.966721873105972,0,5,trigeminal nerve morphogenesis,BP,
6896,GO:0021637,1,0.966721873105972,0,5,trigeminal nerve structural organization,BP,
6897,GO:0021639,1,0.992170040269511,0,1,trochlear nerve morphogenesis,BP,
6898,GO:0021642,1,0.992170040269511,0,1,trochlear nerve formation,BP,
6899,GO:0021644,1,0.98518122102556,0,2,vagus nerve morphogenesis,BP,
6900,GO:0021648,1,0.964692861883893,0,5,vestibulocochlear nerve morphogenesis,BP,
6901,GO:0021649,1,0.992266198294153,0,1,vestibulocochlear nerve structural organization,BP,
6902,GO:0021650,1,0.972213416646573,0,4,vestibulocochlear nerve formation,BP,
6903,GO:0021658,1,0.98469187219478,0,2,rhombomere 3 morphogenesis,BP,
6904,GO:0021660,1,0.992462995485117,0,1,rhombomere 3 formation,BP,
6905,GO:0021664,1,0.992462995485117,0,1,rhombomere 5 morphogenesis,BP,
6906,GO:0021666,1,0.992462995485117,0,1,rhombomere 5 formation,BP,
6907,GO:0021670,1,0.921402643162235,0,12,lateral ventricle development,BP,
6909,GO:0021678,1,0.980260035567085,0,3,third ventricle development,BP,
6910,GO:0021679,1,0.992863536011743,0,1,cerebellar molecular layer development,BP,
6911,GO:0021680,1,0.849897484104545,0,24,cerebellar Purkinje cell layer development,BP,
6912,GO:0021681,1,0.918785329520847,0,12,cerebellar granular layer development,BP,
6913,GO:0021682,1,0.993986221841527,0,1,nerve maturation,BP,
6914,GO:0021683,1,0.939102583714375,0,9,cerebellar granular layer morphogenesis,BP,
6915,GO:0021684,1,0.952209521379018,0,7,cerebellar granular layer formation,BP,
6916,GO:0021685,1,0.993986332272078,0,1,cerebellar granular layer structural organization,BP,
6917,GO:0021686,1,0.992170027168696,0,1,cerebellar granular layer maturation,BP,
6918,GO:0021687,1,0.992863536011743,0,1,cerebellar molecular layer morphogenesis,BP,
6919,GO:0021688,1,0.992863536011743,0,1,cerebellar molecular layer formation,BP,
6920,GO:0021691,1,0.987445025118644,0,2,cerebellar Purkinje cell layer maturation,BP,
6921,GO:0021692,1,0.916569936840978,0,13,cerebellar Purkinje cell layer morphogenesis,BP,
6922,GO:0021693,1,0.986892451240885,0,2,cerebellar Purkinje cell layer structural organization,BP,
6923,GO:0021694,1,0.934372551683502,0,10,cerebellar Purkinje cell layer formation,BP,
6924,GO:0021695,1,0.730007900477899,0,45,cerebellar cortex development,BP,
6925,GO:0021696,1,0.823398572534161,0,28,cerebellar cortex morphogenesis,BP,
6926,GO:0021697,1,0.86966859126143,0,20,cerebellar cortex formation,BP,
6927,GO:0021698,1,0.986892451240885,0,2,cerebellar cortex structural organization,BP,
6928,GO:0021699,1,0.979712596946364,0,3,cerebellar cortex maturation,BP,
6930,GO:0021702,1,0.934372551683502,0,10,cerebellar Purkinje cell differentiation,BP,
6931,GO:0021703,1,0.992170040269511,0,1,locus ceruleus development,BP,
6932,GO:0021707,1,0.952209521379018,0,7,cerebellar granule cell differentiation,BP,
6933,GO:0021718,1,0.985701716312323,0,2,superior olivary nucleus development,BP,
6934,GO:0021722,1,0.985701716312323,0,2,superior olivary nucleus maturation,BP,
6935,GO:0021723,1,0.99259542221191,0,1,medullary reticular formation development,BP,
6936,GO:0021730,1,0.98674974420234,0,2,trigeminal sensory nucleus development,BP,
6937,GO:0021732,1,0.992211571683086,0,1,midbrain-hindbrain boundary maturation,BP,
6938,GO:0021740,1,0.98674974420234,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6939,GO:0021747,1,0.981319648522756,0,3,cochlear nucleus development,BP,
6940,GO:0021750,1,0.992262432956955,0,1,vestibular nucleus development,BP,
6941,GO:0021754,1,0.992170027168696,0,1,facial nucleus development,BP,
6942,GO:0021756,1,0.893538179615325,0,16,striatum development,BP,
6943,GO:0021757,1,0.993194934242513,0,1,caudate nucleus development,BP,
6944,GO:0021758,1,0.993194934242513,0,1,putamen development,BP,
6945,GO:0021759,1,0.971808704864452,0,4,globus pallidus development,BP,
6946,GO:0021761,1,0.485308924721966,0,102,limbic system development,BP,
6947,GO:0021762,1,0.737668534007672,0,42,substantia nigra development,BP,
6948,GO:0021763,1,0.992202934704535,0,1,subthalamic nucleus development,BP,
6949,GO:0021764,1,0.973783285303655,0,4,amygdala development,BP,
6950,GO:0021766,1,0.584524165430497,0,76,hippocampus development,BP,
6951,GO:0021767,1,0.986203080788573,0,2,mammillary body development,BP,
6952,GO:0021768,1,0.993051214852774,0,1,nucleus accumbens development,BP,
6953,GO:0021769,1,0.972374894800412,0,4,orbitofrontal cortex development,BP,
6954,GO:0021771,1,0.99398626500693,0,1,lateral geniculate nucleus development,BP,
6955,GO:0021772,1,0.802892044414885,0,32,olfactory bulb development,BP,
6956,GO:0021773,1,0.980294663089574,0,3,striatal medium spiny neuron differentiation,BP,
6957,GO:0021775,1,0.982007940663008,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6958,GO:0021776,1,0.982007940663008,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6959,GO:0021778,1,0.971014190606621,0,4,oligodendrocyte cell fate specification,BP,
6960,GO:0021779,1,0.971014190606621,0,4,oligodendrocyte cell fate commitment,BP,
6961,GO:0021780,1,0.971014190606621,0,4,glial cell fate specification,BP,
6962,GO:0021781,1,0.916132121226166,0,12,glial cell fate commitment,BP,
6963,GO:0021782,1,0.549471985355948,0,83,glial cell development,BP,
6964,GO:0021783,1,0.890842581387677,0,16,preganglionic parasympathetic fiber development,BP,
6965,GO:0021784,1,0.98518122102556,0,2,postganglionic parasympathetic fiber development,BP,
6966,GO:0021785,1,0.955126423322603,0,7,branchiomotor neuron axon guidance,BP,
6967,GO:0021793,1,0.992956470832992,0,1,chemorepulsion of branchiomotor axon,BP,
6968,GO:0021794,1,0.899276247537455,0,15,thalamus development,BP,
6969,GO:0021795,1,0.745487447768073,0,42,cerebral cortex cell migration,BP,
6970,GO:0021796,1,0.963890647059389,0,5,cerebral cortex regionalization,BP,
6971,GO:0021797,1,0.962375992095729,0,5,forebrain anterior/posterior pattern specification,BP,
6972,GO:0021798,1,0.95750538618294,0,6,forebrain dorsal/ventral pattern formation,BP,
6973,GO:0021799,1,0.810114132147468,0,30,cerebral cortex radially oriented cell migration,BP,
6974,GO:0021800,1,0.948664219632716,0,8,cerebral cortex tangential migration,BP,
6975,GO:0021801,1,0.856890960098234,0,22,cerebral cortex radial glia guided migration,BP,
6976,GO:0021812,1,0.98634052199067,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6977,GO:0021813,1,0.99230829346638,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6978,GO:0021814,1,0.95391197073131,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6979,GO:0021815,1,0.967422118043477,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6980,GO:0021816,1,0.986326940272438,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6981,GO:0021817,1,0.980835150806834,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6982,GO:0021819,1,0.919130743540931,0,12,layer formation in cerebral cortex,BP,
6983,GO:0021822,1,0.992189362895389,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6984,GO:0021823,1,0.98796345938421,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6985,GO:0021824,1,0.986298429630361,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6986,GO:0021825,1,0.974425535367515,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6987,GO:0021826,1,0.92967919279885,0,10,substrate-independent telencephalic tangential migration,BP,
6988,GO:0021827,1,0.98796345938421,0,2,postnatal olfactory bulb interneuron migration,BP,
6989,GO:0021828,1,0.986298429630361,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6990,GO:0021830,1,0.936961602324545,0,9,interneuron migration from the subpallium to the cortex,BP,
6991,GO:0021831,1,0.984761636652279,0,2,embryonic olfactory bulb interneuron precursor migration,BP,
6992,GO:0021836,1,0.98796345938421,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6993,GO:0021840,1,0.985528282609621,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6994,GO:0021842,1,0.985528282609621,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6995,GO:0021843,1,0.92967919279885,0,10,substrate-independent telencephalic tangential interneuron migration,BP,
6996,GO:0021846,1,0.828948219287676,0,27,cell proliferation in forebrain,BP,
6997,GO:0021847,1,0.979932874156718,0,3,ventricular zone neuroblast division,BP,
6998,GO:0021849,1,0.986272593151145,0,2,neuroblast division in subventricular zone,BP,
6999,GO:0021852,1,0.984711367262277,0,2,pyramidal neuron migration,BP,
7000,GO:0021853,1,0.95752411637127,0,6,cerebral cortex GABAergic interneuron migration,BP,
7001,GO:0021854,1,0.85111823156283,0,22,hypothalamus development,BP,
7002,GO:0021855,1,0.970943612273037,0,4,hypothalamus cell migration,BP,
7003,GO:0021856,1,0.986298429630361,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
7004,GO:0021858,1,0.992170027168696,0,1,GABAergic neuron differentiation in basal ganglia,BP,
7005,GO:0021859,1,0.935190889651287,0,10,pyramidal neuron differentiation,BP,
7006,GO:0021860,1,0.940851548626333,0,9,pyramidal neuron development,BP,
7007,GO:0021861,1,0.971681873373604,0,4,forebrain radial glial cell differentiation,BP,
7008,GO:0021869,1,0.960199993226101,0,6,forebrain ventricular zone progenitor cell division,BP,
7009,GO:0021870,1,0.993986332265967,0,1,Cajal-Retzius cell differentiation,BP,
7010,GO:0021871,1,0.843681415539079,0,23,forebrain regionalization,BP,
7011,GO:0021872,1,0.640674399172159,0,63,forebrain generation of neurons,BP,
7012,GO:0021873,1,0.946847940214658,0,8,forebrain neuroblast division,BP,
7013,GO:0021874,1,0.992516661359673,0,1,Wnt signaling pathway involved in forebrain neuroblast division,BP,
7014,GO:0021877,1,0.929946737098425,0,10,forebrain neuron fate commitment,BP,
7015,GO:0021879,1,0.676644463102273,0,55,forebrain neuron differentiation,BP,
7016,GO:0021881,1,0.992948929338762,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
7017,GO:0021882,1,0.984486305222326,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
7018,GO:0021884,1,0.805796162346166,0,31,forebrain neuron development,BP,
7019,GO:0021885,1,0.666930618652414,0,58,forebrain cell migration,BP,
7020,GO:0021886,1,0.986298429630361,0,2,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
7021,GO:0021888,1,0.986298429630361,0,2,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
7022,GO:0021889,1,0.914692723422963,0,13,olfactory bulb interneuron differentiation,BP,
7023,GO:0021891,1,0.947921524137511,0,8,olfactory bulb interneuron development,BP,
7024,GO:0021892,1,0.913644516157157,0,12,cerebral cortex GABAergic interneuron differentiation,BP,
7025,GO:0021893,1,0.984486305222326,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
7026,GO:0021894,1,0.942641055007582,0,8,cerebral cortex GABAergic interneuron development,BP,
7027,GO:0021895,1,0.851844030221794,0,22,cerebral cortex neuron differentiation,BP,
7028,GO:0021896,1,0.988001250103241,0,2,forebrain astrocyte differentiation,BP,
7029,GO:0021897,1,0.988001250103241,0,2,forebrain astrocyte development,BP,
7030,GO:0021898,1,0.977543777825386,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
7031,GO:0021902,1,0.958793007721006,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
7032,GO:0021903,1,0.920945225987702,0,11,rostrocaudal neural tube patterning,BP,
7033,GO:0021904,1,0.849503477259831,0,23,dorsal/ventral neural tube patterning,BP,
7034,GO:0021910,1,0.954774074915575,0,7,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7035,GO:0021912,1,0.984400887813367,0,2,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
7036,GO:0021913,1,0.97669348512296,0,3,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
7037,GO:0021914,1,0.972077939050448,0,4,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7038,GO:0021915,1,0.337800518042085,0,155,neural tube development,BP,
7039,GO:0021919,1,0.993091456739726,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
7040,GO:0021920,1,0.992170027168696,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
7041,GO:0021924,1,0.93107881588112,0,10,cell proliferation in external granule layer,BP,
7042,GO:0021930,1,0.93107881588112,0,10,cerebellar granule cell precursor proliferation,BP,
7043,GO:0021932,1,0.931827737162476,0,10,hindbrain radial glia guided cell migration,BP,
7044,GO:0021933,1,0.992170027168696,0,1,radial glia guided migration of cerebellar granule cell,BP,
7045,GO:0021934,1,0.986625937375116,0,2,hindbrain tangential cell migration,BP,
7046,GO:0021935,1,0.99398633229093,0,1,cerebellar granule cell precursor tangential migration,BP,
7047,GO:0021936,1,0.931251777158527,0,10,regulation of cerebellar granule cell precursor proliferation,BP,
7048,GO:0021937,1,0.957633666306699,0,6,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
7049,GO:0021938,1,0.972757877579618,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
7050,GO:0021940,1,0.944440699472346,0,8,positive regulation of cerebellar granule cell precursor proliferation,BP,
7051,GO:0021941,1,0.986041396264744,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
7052,GO:0021942,1,0.964741461416251,0,5,radial glia guided migration of Purkinje cell,BP,
7053,GO:0021943,1,0.973516981723309,0,4,formation of radial glial scaffolds,BP,
7054,GO:0021952,1,0.867228551564019,0,22,central nervous system projection neuron axonogenesis,BP,
7055,GO:0021953,1,0.295576862527842,0,172,central nervous system neuron differentiation,BP,
7056,GO:0021954,1,0.617490488940769,0,70,central nervous system neuron development,BP,
7057,GO:0021955,1,0.830623390805516,0,28,central nervous system neuron axonogenesis,BP,
7058,GO:0021956,1,0.992176876849344,0,1,central nervous system interneuron axonogenesis,BP,
7059,GO:0021957,1,0.961887194831642,0,6,corticospinal tract morphogenesis,BP,
7060,GO:0021960,1,0.966557435587115,0,5,anterior commissure morphogenesis,BP,
7061,GO:0021965,1,0.982015346135709,0,3,spinal cord ventral commissure morphogenesis,BP,
7062,GO:0021966,1,0.986158074441921,0,2,corticospinal neuron axon guidance,BP,
7063,GO:0021972,1,0.99394097351296,0,1,corticospinal neuron axon guidance through spinal cord,BP,
7064,GO:0021978,1,0.920129906529032,0,11,telencephalon regionalization,BP,
7065,GO:0021979,1,0.958496677025602,0,6,hypothalamus cell differentiation,BP,
7066,GO:0021983,1,0.735202364842314,0,42,pituitary gland development,BP,
7067,GO:0021984,1,0.900470559803019,0,14,adenohypophysis development,BP,
7068,GO:0021985,1,0.985972445330535,0,2,neurohypophysis development,BP,
7069,GO:0021986,1,0.986479201885545,0,2,habenula development,BP,
7071,GO:0021988,1,0.797174003676224,0,33,olfactory lobe development,BP,
7072,GO:0021993,1,0.993974464636632,0,1,initiation of neural tube closure,BP,
7073,GO:0021997,1,0.988008547473593,0,2,neural plate axis specification,BP,
7074,GO:0021998,1,0.993173241686921,0,1,neural plate mediolateral regionalization,BP,
7075,GO:0021999,1,0.957784667003114,0,6,neural plate anterior/posterior regionalization,BP,
7076,GO:0022004,1,0.992211571683086,0,1,midbrain-hindbrain boundary maturation during brain development,BP,
7077,GO:0022007,1,0.979234809007255,0,3,convergent extension involved in neural plate elongation,BP,
7079,GO:0022009,1,0.971585068021427,0,4,central nervous system vasculogenesis,BP,
7080,GO:0022010,1,0.895203821654797,0,15,central nervous system myelination,BP,
7081,GO:0022011,1,0.858505873372685,0,22,myelination in peripheral nervous system,BP,
7082,GO:0022012,1,0.993986332276527,0,1,subpallium cell proliferation in forebrain,BP,
7083,GO:0022013,1,0.993986332278159,0,1,pallium cell proliferation in forebrain,BP,
7084,GO:0022018,1,0.993986332276527,0,1,lateral ganglionic eminence cell proliferation,BP,
7085,GO:0022027,1,0.968404510925756,0,5,interkinetic nuclear migration,BP,
7086,GO:0022028,1,0.954941621896704,0,7,tangential migration from the subventricular zone to the olfactory bulb,BP,
7087,GO:0022029,1,0.680632603220899,0,55,telencephalon cell migration,BP,
7088,GO:0022030,1,0.856890960098234,0,22,telencephalon glial cell migration,BP,
7089,GO:0022037,1,0.505423636750438,0,98,metencephalon development,BP,
7090,GO:0022038,1,0.906882690016432,0,14,corpus callosum development,BP,
7091,GO:0022400,1,0.813394373314029,0,28,regulation of rhodopsin mediated signaling pathway,BP,
7092,GO:0022401,1,0.89822000867794,0,14,negative adaptation of signaling pathway,BP,
7096,GO:0022406,1,0.299833899717692,0,169,membrane docking,BP,
7098,GO:0022408,1,0.366216321715262,0,137,negative regulation of cell-cell adhesion,BP,
7104,GO:0022417,1,0.947427614673001,0,7,protein maturation by protein folding,BP,
7106,GO:0022601,1,0.986340498579298,0,2,menstrual cycle phase,BP,
7110,GO:0022605,1,0.957347874912366,0,6,oogenesis stage,BP,
7113,GO:0022612,1,0.430879150792183,0,120,gland morphogenesis,BP,
7115,GO:0022614,1,0.96598882189829,0,5,membrane to membrane docking,BP,
7116,GO:0022615,1,0.949615742558209,0,7,protein to membrane docking,BP,
7117,GO:0022616,1,0.856681226538718,0,22,DNA strand elongation,BP,
7118,GO:0022617,1,0.546473379110885,0,85,extracellular matrix disassembly,BP,
7120,GO:0022622,1,0.992170027168696,0,1,root system development,BP,
7121,GO:0022624,1,0.829969196747212,0,24,proteasome accessory complex,CC,
7122,GO:0022625,1,0.63120870899715,0,59,cytosolic large ribosomal subunit,CC,
7123,GO:0022626,1,0.424634289691273,0,111,cytosolic ribosome,CC,
7124,GO:0022627,1,0.713957922145095,0,44,cytosolic small ribosomal subunit,CC,
7127,GO:0022820,1,0.962341677734995,0,6,potassium ion symporter activity,MF,
7128,GO:0022821,1,0.895918091303891,0,16,potassium ion antiporter activity,MF,
7130,GO:0022829,1,0.852995603082428,0,21,wide pore channel activity,MF,
7131,GO:0022832,1,0.260387293505038,0,192,voltage-gated channel activity,MF,
7132,GO:0022833,1,0.943344527565248,0,8,mechanically gated channel activity,MF,
7137,GO:0022839,1,0.72501024479822,0,45,ion gated channel activity,MF,
7138,GO:0022840,1,0.950440835887642,0,7,leak channel activity,MF,
7139,GO:0022841,1,0.971119753809617,0,4,potassium ion leak channel activity,MF,
7140,GO:0022842,1,0.950440835887642,0,7,narrow pore channel activity,MF,
7141,GO:0022843,1,0.400964470651025,0,130,voltage-gated cation channel activity,MF,
7142,GO:0022848,1,0.88677041148782,0,16,acetylcholine-gated cation-selective channel activity,MF,
7143,GO:0022850,1,0.961490000543581,0,5,serotonin-gated cation-selective channel activity,MF,
7144,GO:0022851,1,0.965361677907316,0,5,GABA-gated chloride ion channel activity,MF,
7145,GO:0022852,1,0.986084633365633,0,2,glycine-gated chloride ion channel activity,MF,
7146,GO:0022853,1,0.418241518096717,0,124,active ion transmembrane transporter activity,MF,
7148,GO:0022858,1,0.951161888994643,0,7,alanine transmembrane transporter activity,MF,
7149,GO:0022865,1,0.992561746410286,0,1,transmembrane electron transfer carrier,MF,
7150,GO:0022884,1,0.862147571199862,0,20,macromolecule transmembrane transporter activity,MF,
7151,GO:0022889,1,0.933885258824464,0,9,serine transmembrane transporter activity,MF,
7155,GO:0022897,1,0.971583396923,0,4,proton-dependent peptide secondary active transmembrane transporter activity,MF,
7160,GO:0023016,1,0.979139280886649,0,3,signal transduction by trans-phosphorylation,BP,
7161,GO:0023019,1,0.874697167112219,0,18,signal transduction involved in regulation of gene expression,BP,
7162,GO:0023021,1,0.977053897673485,0,3,termination of signal transduction,BP,
7163,GO:0023023,1,0.857632303810247,0,20,MHC protein complex binding,MF,
7164,GO:0023024,1,0.977261899955338,0,3,MHC class I protein complex binding,MF,
7165,GO:0023025,1,0.985002858437573,0,2,MHC class Ib protein complex binding,MF,
7166,GO:0023026,1,0.884515179865463,0,16,MHC class II protein complex binding,MF,
7167,GO:0023029,1,0.964060154099683,0,5,MHC class Ib protein binding,MF,
7168,GO:0023030,1,0.985002858437573,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7169,GO:0023035,1,0.944091076193988,0,8,CD40 signaling pathway,BP,
7170,GO:0023041,1,0.95765581362923,0,6,neuronal signal transduction,BP,
7175,GO:0023058,1,0.884688242855289,0,16,adaptation of signaling pathway,BP,
7178,GO:0030002,1,0.912926503920441,0,13,cellular anion homeostasis,BP,
7180,GO:0030004,1,0.468228798332042,0,106,cellular monovalent inorganic cation homeostasis,BP,
7181,GO:0030007,1,0.946862536625005,0,8,cellular potassium ion homeostasis,BP,
7182,GO:0030008,1,0.941529215390743,0,8,TRAPP complex,CC,
7183,GO:0030010,1,0.502120975763151,0,101,establishment of cell polarity,BP,
7184,GO:0030011,1,0.893493145349132,0,16,maintenance of cell polarity,BP,
7185,GO:0030014,1,0.899945669752056,0,15,CCR4-NOT complex,CC,
7186,GO:0030015,1,0.979436148820569,0,3,CCR4-NOT core complex,CC,
7189,GO:0030018,1,0.443787841703383,0,117,Z disc,CC,
7190,GO:0030020,1,0.960318924035451,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7191,GO:0030021,1,0.956130197851103,0,6,extracellular matrix structural constituent conferring compression resistance,MF,
7192,GO:0030023,1,0.969321173282425,0,5,extracellular matrix constituent conferring elasticity,MF,
7193,GO:0030027,1,0.306697811851572,0,172,lamellipodium,CC,
7197,GO:0030032,1,0.680219460097221,0,55,lamellipodium assembly,BP,
7198,GO:0030033,1,0.904404064418397,0,15,microvillus assembly,BP,
7199,GO:0030035,1,0.974409829658596,0,4,microspike assembly,BP,
7201,GO:0030037,1,0.993939815640098,0,1,actin filament reorganization involved in cell cycle,BP,
7202,GO:0030038,1,0.569100185676886,0,81,contractile actin filament bundle assembly,BP,
7205,GO:0030043,1,0.977543572820063,0,3,actin filament fragmentation,BP,
7206,GO:0030046,1,0.966704862742805,0,5,parallel actin filament bundle assembly,BP,
7207,GO:0030047,1,0.979900354829304,0,3,actin modification,BP,
7208,GO:0030048,1,0.443699512995095,0,119,actin filament-based movement,BP,
7209,GO:0030049,1,0.756611723034716,0,39,muscle filament sliding,BP,
7210,GO:0030050,1,0.975102528736585,0,4,vesicle transport along actin filament,BP,
7213,GO:0030056,1,0.964451700166101,0,6,hemidesmosome,CC,
7214,GO:0030057,1,0.84925928551224,0,25,desmosome,CC,
7217,GO:0030062,1,0.955897108190069,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7218,GO:0030070,1,0.978464211506074,0,3,insulin processing,BP,
7219,GO:0030071,1,0.727184814422308,0,44,regulation of mitotic metaphase/anaphase transition,BP,
7228,GO:0030103,1,0.984939135289956,0,2,vasopressin secretion,BP,
7229,GO:0030104,1,0.627581968165791,0,66,water homeostasis,BP,
7230,GO:0030107,1,0.992466234349486,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7231,GO:0030108,1,0.992170027168696,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7232,GO:0030109,1,0.98469740986384,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7233,GO:0030110,1,0.992170027168696,0,1,HLA-C specific inhibitory MHC class I receptor activity,MF,
7235,GO:0030117,1,0.528423899633477,0,91,membrane coat,CC,
7236,GO:0030118,1,0.717646774788985,0,48,clathrin coat,CC,
7237,GO:0030119,1,0.740865547282163,0,43,AP-type membrane coat adaptor complex,CC,
7238,GO:0030120,1,0.711241384181359,0,49,vesicle coat,CC,
7239,GO:0030121,1,0.957689430317966,0,6,AP-1 adaptor complex,CC,
7240,GO:0030122,1,0.914886184940189,0,13,AP-2 adaptor complex,CC,
7241,GO:0030123,1,0.934758699740717,0,10,AP-3 adaptor complex,CC,
7242,GO:0030125,1,0.847432219867819,0,24,clathrin vesicle coat,CC,
7243,GO:0030126,1,0.909554665256687,0,13,COPI vesicle coat,CC,
7244,GO:0030127,1,0.922737163409454,0,12,COPII vesicle coat,CC,
7245,GO:0030128,1,0.909271771602932,0,14,clathrin coat of endocytic vesicle,CC,
7246,GO:0030130,1,0.918677085480203,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7247,GO:0030131,1,0.813185823954567,0,30,clathrin adaptor complex,CC,
7248,GO:0030132,1,0.883042959129497,0,18,clathrin coat of coated pit,CC,
7250,GO:0030134,1,0.58649471077444,0,75,ER to Golgi transport vesicle,CC,
7252,GO:0030136,1,0.285263684674318,0,176,clathrin-coated vesicle,CC,
7253,GO:0030137,1,0.845851452298296,0,23,COPI-coated vesicle,CC,
7255,GO:0030140,1,0.816564583075374,0,29,trans-Golgi network transport vesicle,CC,
7257,GO:0030144,1,0.978295616227052,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7259,GO:0030148,1,0.574272834041517,0,76,sphingolipid biosynthetic process,BP,
7261,GO:0030150,1,0.884215062542096,0,16,protein import into mitochondrial matrix,BP,
7262,GO:0030151,1,0.969545527869416,0,4,molybdenum ion binding,MF,
7265,GO:0030156,1,0.992170027168696,0,1,benzodiazepine receptor binding,MF,
7266,GO:0030157,1,0.910183095536629,0,13,pancreatic juice secretion,BP,
7267,GO:0030158,1,0.979542766543104,0,3,protein xylosyltransferase activity,MF,
7268,GO:0030159,1,0.847389678609479,0,24,receptor signaling complex scaffold activity,MF,
7269,GO:0030160,1,0.974377840331422,0,4,GKAP/Homer scaffold activity,MF,
7272,GO:0030165,1,0.560030259906946,0,84,PDZ domain binding,MF,
7274,GO:0030167,1,0.972044429640942,0,4,proteoglycan catabolic process,BP,
7275,GO:0030168,1,0.325440497893607,0,157,platelet activation,BP,
7276,GO:0030169,1,0.908266823487264,0,14,low-density lipoprotein particle binding,MF,
7278,GO:0030171,1,0.984488677869553,0,2,voltage-gated proton channel activity,MF,
7279,GO:0030172,1,0.976692112990833,0,3,troponin C binding,MF,
7280,GO:0030173,1,0.682653778097016,0,53,integral component of Golgi membrane,CC,
7281,GO:0030174,1,0.963561900298026,0,5,regulation of DNA-dependent DNA replication initiation,BP,
7282,GO:0030175,1,0.531868094681914,0,92,filopodium,CC,
7287,GO:0030183,1,0.444806505987717,0,113,B cell differentiation,BP,
7288,GO:0030184,1,0.992392335882293,0,1,nitric oxide transmembrane transporter activity,MF,
7289,GO:0030185,1,0.976925412255462,0,3,nitric oxide transport,BP,
7290,GO:0030186,1,0.984400887813367,0,2,melatonin metabolic process,BP,
7291,GO:0030187,1,0.984400887813367,0,2,melatonin biosynthetic process,BP,
7293,GO:0030194,1,0.837989208271519,0,24,positive regulation of blood coagulation,BP,
7294,GO:0030195,1,0.698032752704525,0,48,negative regulation of blood coagulation,BP,
7295,GO:0030197,1,0.980059230444244,0,3,extracellular matrix constituent, lubricant activity,MF,
7296,GO:0030198,1,0.117414320874261,0,306,extracellular matrix organization,BP,
7297,GO:0030199,1,0.778113060766792,0,37,collagen fibril organization,BP,
7298,GO:0030200,1,0.977972479233257,0,3,heparan sulfate proteoglycan catabolic process,BP,
7300,GO:0030202,1,0.949802061386125,0,8,heparin metabolic process,BP,
7304,GO:0030206,1,0.841902709348047,0,25,chondroitin sulfate biosynthetic process,BP,
7306,GO:0030208,1,0.920011451611612,0,12,dermatan sulfate biosynthetic process,BP,
7308,GO:0030210,1,0.949802061386125,0,8,heparin biosynthetic process,BP,
7310,GO:0030213,1,0.917620467063574,0,12,hyaluronan biosynthetic process,BP,
7312,GO:0030215,1,0.937163055374713,0,10,semaphorin receptor binding,MF,
7315,GO:0030218,1,0.511653282392153,0,94,erythrocyte differentiation,BP,
7316,GO:0030219,1,0.708850977907527,0,47,megakaryocyte differentiation,BP,
7317,GO:0030220,1,0.881113065495981,0,18,platelet formation,BP,
7318,GO:0030221,1,0.986161096383589,0,2,basophil differentiation,BP,
7319,GO:0030222,1,0.963162858081703,0,5,eosinophil differentiation,BP,
7320,GO:0030223,1,0.964983478157539,0,5,neutrophil differentiation,BP,
7321,GO:0030224,1,0.787822074611426,0,33,monocyte differentiation,BP,
7323,GO:0030226,1,0.988008547488277,0,2,apolipoprotein receptor activity,MF,
7324,GO:0030228,1,0.896098872665689,0,16,lipoprotein particle receptor activity,MF,
7325,GO:0030229,1,0.973363304792928,0,4,very-low-density lipoprotein particle receptor activity,MF,
7326,GO:0030233,1,0.992170027168696,0,1,deoxynucleotide transmembrane transporter activity,MF,
7328,GO:0030235,1,0.938020245468684,0,9,nitric-oxide synthase regulator activity,MF,
7329,GO:0030237,1,0.985985323664383,0,2,female sex determination,BP,
7330,GO:0030238,1,0.905779793625188,0,14,male sex determination,BP,
7331,GO:0030239,1,0.664183727567942,0,59,myofibril assembly,BP,
7332,GO:0030240,1,0.964705933101564,0,5,skeletal muscle thin filament assembly,BP,
7333,GO:0030241,1,0.980271740713262,0,3,skeletal muscle myosin thick filament assembly,BP,
7334,GO:0030242,1,0.973892452898113,0,4,pexophagy,BP,
7336,GO:0030247,1,0.855983760665453,0,21,polysaccharide binding,MF,
7337,GO:0030249,1,0.939119677100552,0,8,guanylate cyclase regulator activity,MF,
7338,GO:0030250,1,0.946492418459802,0,7,guanylate cyclase activator activity,MF,
7339,GO:0030251,1,0.992213790389495,0,1,guanylate cyclase inhibitor activity,MF,
7340,GO:0030252,1,0.898617081739414,0,15,growth hormone secretion,BP,
7342,GO:0030259,1,0.954899032569392,0,6,lipid glycosylation,BP,
7343,GO:0030260,1,0.412930074529528,0,124,entry into host cell,BP,
7344,GO:0030261,1,0.801645429891345,0,31,chromosome condensation,BP,
7345,GO:0030262,1,0.816044507478669,0,28,apoptotic nuclear changes,BP,
7346,GO:0030263,1,0.973935272544155,0,4,apoptotic chromosome condensation,BP,
7347,GO:0030264,1,0.993664262378292,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7348,GO:0030267,1,0.992170027168696,0,1,glyoxylate reductase (NADP) activity,MF,
7349,GO:0030272,1,0.992170027168696,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7350,GO:0030273,1,0.992245073497034,0,1,melanin-concentrating hormone receptor activity,MF,
7352,GO:0030275,1,0.885484142430761,0,17,LRR domain binding,MF,
7353,GO:0030276,1,0.670307722965518,0,58,clathrin binding,MF,
7355,GO:0030278,1,0.276521658094826,0,179,regulation of ossification,BP,
7356,GO:0030279,1,0.617546956616874,0,68,negative regulation of ossification,BP,
7358,GO:0030282,1,0.500780047406851,0,96,bone mineralization,BP,
7360,GO:0030284,1,0.972410828884366,0,4,estrogen receptor activity,MF,
7361,GO:0030285,1,0.898124535473515,0,15,integral component of synaptic vesicle membrane,CC,
7362,GO:0030286,1,0.721439739242365,0,47,dynein complex,CC,
7363,GO:0030289,1,0.977980332293366,0,3,protein phosphatase 4 complex,CC,
7364,GO:0030290,1,0.993130508675134,0,1,sphingolipid activator protein activity,MF,
7365,GO:0030291,1,0.783979184188523,0,33,protein serine/threonine kinase inhibitor activity,MF,
7366,GO:0030292,1,0.978510012812192,0,3,protein tyrosine kinase inhibitor activity,MF,
7367,GO:0030294,1,0.992198639701248,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7368,GO:0030295,1,0.626839524013015,0,65,protein kinase activator activity,MF,
7369,GO:0030296,1,0.889413904786632,0,17,protein tyrosine kinase activator activity,MF,
7370,GO:0030297,1,0.95395079498584,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7371,GO:0030298,1,0.992170027168696,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7372,GO:0030299,1,0.900162500496314,0,14,intestinal cholesterol absorption,BP,
7373,GO:0030300,1,0.947599804107477,0,7,regulation of intestinal cholesterol absorption,BP,
7375,GO:0030302,1,0.992170027168696,0,1,deoxynucleotide transport,BP,
7376,GO:0030305,1,0.985913151143235,0,2,heparanase activity,MF,
7377,GO:0030306,1,0.946981258218439,0,8,ADP-ribosylation factor binding,MF,
7378,GO:0030307,1,0.34088060305847,0,151,positive regulation of cell growth,BP,
7379,GO:0030308,1,0.322976972644357,0,155,negative regulation of cell growth,BP,
7380,GO:0030309,1,0.962536668085414,0,5,poly-N-acetyllactosamine metabolic process,BP,
7381,GO:0030311,1,0.969453929685512,0,4,poly-N-acetyllactosamine biosynthetic process,BP,
7382,GO:0030312,1,0.992205013245353,0,1,external encapsulating structure,CC,
7383,GO:0030314,1,0.955178237805011,0,7,junctional membrane complex,CC,
7384,GO:0030315,1,0.740987422938862,0,44,T-tubule,CC,
7385,GO:0030316,1,0.538322339252829,0,86,osteoclast differentiation,BP,
7387,GO:0030318,1,0.848756603701428,0,24,melanocyte differentiation,BP,
7388,GO:0030320,1,0.912926503920441,0,13,cellular monovalent inorganic anion homeostasis,BP,
7389,GO:0030321,1,0.963599438677731,0,5,transepithelial chloride transport,BP,
7390,GO:0030322,1,0.992204136866912,0,1,stabilization of membrane potential,BP,
7393,GO:0030325,1,0.863427013161143,0,20,adrenal gland development,BP,
7394,GO:0030326,1,0.425316274539318,0,122,embryonic limb morphogenesis,BP,
7395,GO:0030327,1,0.979129111594892,0,3,prenylated protein catabolic process,BP,
7396,GO:0030328,1,0.986317219365357,0,2,prenylcysteine catabolic process,BP,
7397,GO:0030329,1,0.986317219365357,0,2,prenylcysteine metabolic process,BP,
7398,GO:0030330,1,0.470779635218647,0,104,DNA damage response, signal transduction by p53 class mediator,BP,
7399,GO:0030331,1,0.767684111817584,0,38,estrogen receptor binding,MF,
7400,GO:0030332,1,0.843032529760067,0,24,cyclin binding,MF,
7403,GO:0030336,1,0.226319578851156,0,210,negative regulation of cell migration,BP,
7404,GO:0030337,1,0.984524522725182,0,2,DNA polymerase processivity factor activity,MF,
7405,GO:0030342,1,0.992727485565217,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7406,GO:0030343,1,0.984635600372983,0,2,vitamin D3 25-hydroxylase activity,MF,
7407,GO:0030345,1,0.956130197851103,0,6,structural constituent of tooth enamel,MF,
7408,GO:0030346,1,0.957929996006703,0,6,protein phosphatase 2B binding,MF,
7409,GO:0030348,1,0.979798987802887,0,3,syntaxin-3 binding,MF,
7410,GO:0030350,1,0.987139942871452,0,2,iron-responsive element binding,MF,
7411,GO:0030351,1,0.992454101113446,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7412,GO:0030354,1,0.992170027168696,0,1,melanin-concentrating hormone activity,MF,
7413,GO:0030366,1,0.984400887813367,0,2,molybdopterin synthase activity,MF,
7414,GO:0030368,1,0.943931066002344,0,8,interleukin-17 receptor activity,MF,
7415,GO:0030369,1,0.978807821380224,0,3,ICAM-3 receptor activity,MF,
7416,GO:0030371,1,0.849088946455582,0,24,translation repressor activity,MF,
7417,GO:0030372,1,0.993904337751916,0,1,high molecular weight B cell growth factor receptor binding,MF,
7418,GO:0030374,1,0.707780024392433,0,50,ligand-dependent nuclear receptor transcription coactivator activity,MF,
7419,GO:0030375,1,0.97456065426417,0,4,thyroid hormone receptor coactivator activity,MF,
7420,GO:0030377,1,0.992170027168696,0,1,urokinase plasminogen activator receptor activity,MF,
7421,GO:0030378,1,0.992264474345352,0,1,serine racemase activity,MF,
7422,GO:0030379,1,0.99398633227076,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7423,GO:0030380,1,0.992170027168696,0,1,interleukin-17E receptor binding,MF,
7424,GO:0030382,1,0.992170148171663,0,1,sperm mitochondrion organization,BP,
7425,GO:0030387,1,0.992170027168696,0,1,fructosamine-3-kinase activity,MF,
7426,GO:0030388,1,0.947059056662426,0,7,fructose 1,6-bisphosphate metabolic process,BP,
7427,GO:0030389,1,0.992170027168696,0,1,fructosamine metabolic process,BP,
7428,GO:0030393,1,0.992170027168696,0,1,fructoselysine metabolic process,BP,
7429,GO:0030395,1,0.976814894830233,0,3,lactose binding,MF,
7430,GO:0030397,1,0.724510011529113,0,46,membrane disassembly,BP,
7431,GO:0030407,1,0.992172508662733,0,1,formimidoyltransferase activity,MF,
7432,GO:0030409,1,0.992172508662733,0,1,glutamate formimidoyltransferase activity,MF,
7433,GO:0030412,1,0.992172508662733,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7435,GO:0030421,1,0.992170027168696,0,1,defecation,BP,
7436,GO:0030422,1,0.972138358521589,0,4,production of siRNA involved in RNA interference,BP,
7437,GO:0030423,1,0.9784804386401,0,3,targeting of mRNA for destruction involved in RNA interference,BP,
7442,GO:0030429,1,0.992170027168696,0,1,kynureninase activity,MF,
7443,GO:0030430,1,0.971766849394503,0,4,host cell cytoplasm,CC,
7445,GO:0030432,1,0.934561798075287,0,9,peristalsis,BP,
7446,GO:0030433,1,0.600423233932299,0,71,ubiquitin-dependent ERAD pathway,BP,
7448,GO:0030450,1,0.97851377419517,0,3,regulation of complement activation, classical pathway,BP,
7449,GO:0030451,1,0.993986332281662,0,1,regulation of complement activation, alternative pathway,BP,
7450,GO:0030473,1,0.980835150806834,0,3,nuclear migration along microtubule,BP,
7451,GO:0030478,1,0.973670492341682,0,4,actin cap,CC,
7452,GO:0030485,1,0.978337727018746,0,3,smooth muscle contractile fiber,CC,
7454,GO:0030490,1,0.698001917795472,0,48,maturation of SSU-rRNA,BP,
7455,GO:0030492,1,0.961453799076647,0,5,hemoglobin binding,MF,
7456,GO:0030496,1,0.362391510462437,0,142,midbody,CC,
7458,GO:0030500,1,0.626734778608606,0,65,regulation of bone mineralization,BP,
7459,GO:0030501,1,0.779631479100997,0,35,positive regulation of bone mineralization,BP,
7460,GO:0030502,1,0.890209598163794,0,16,negative regulation of bone mineralization,BP,
7461,GO:0030504,1,0.993986332276501,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7462,GO:0030505,1,0.988008547481132,0,2,inorganic diphosphate transport,BP,
7463,GO:0030506,1,0.882141659490856,0,19,ankyrin binding,MF,
7464,GO:0030507,1,0.842817774830329,0,25,spectrin binding,MF,
7465,GO:0030509,1,0.354618140784564,0,146,BMP signaling pathway,BP,
7466,GO:0030510,1,0.564978387741352,0,81,regulation of BMP signaling pathway,BP,
7467,GO:0030511,1,0.838359207051218,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7468,GO:0030512,1,0.637698343431671,0,64,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7469,GO:0030513,1,0.798488152162028,0,32,positive regulation of BMP signaling pathway,BP,
7470,GO:0030514,1,0.726751018215429,0,45,negative regulation of BMP signaling pathway,BP,
7472,GO:0030516,1,0.595225654209974,0,75,regulation of axon extension,BP,
7473,GO:0030517,1,0.845122560335772,0,24,negative regulation of axon extension,BP,
7474,GO:0030518,1,0.415665580542226,0,124,intracellular steroid hormone receptor signaling pathway,BP,
7475,GO:0030520,1,0.711484991193265,0,48,intracellular estrogen receptor signaling pathway,BP,
7476,GO:0030521,1,0.634299333795028,0,65,androgen receptor signaling pathway,BP,
7477,GO:0030522,1,0.154280085918405,0,262,intracellular receptor signaling pathway,BP,
7478,GO:0030523,1,0.993739830600638,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7479,GO:0030526,1,0.993916354222147,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7481,GO:0030532,1,0.618640335970322,0,65,small nuclear ribonucleoprotein complex,CC,
7483,GO:0030538,1,0.978360661610932,0,3,embryonic genitalia morphogenesis,BP,
7486,GO:0030544,1,0.785094728556162,0,33,Hsp70 protein binding,MF,
7487,GO:0030545,1,0.68155511383314,0,53,receptor regulator activity,MF,
7488,GO:0030546,1,0.768485414197114,0,37,receptor activator activity,MF,
7489,GO:0030547,1,0.894106866008116,0,15,receptor inhibitor activity,MF,
7490,GO:0030548,1,0.95641223258824,0,6,acetylcholine receptor regulator activity,MF,
7491,GO:0030549,1,0.992170027168696,0,1,acetylcholine receptor activator activity,MF,
7492,GO:0030550,1,0.971571269705686,0,4,acetylcholine receptor inhibitor activity,MF,
7493,GO:0030551,1,0.775892960358558,0,37,cyclic nucleotide binding,MF,
7494,GO:0030552,1,0.851763747351056,0,24,cAMP binding,MF,
7495,GO:0030553,1,0.907869827960033,0,14,cGMP binding,MF,
7497,GO:0030572,1,0.993344272378398,0,1,phosphatidyltransferase activity,MF,
7498,GO:0030573,1,0.976925182096125,0,3,bile acid catabolic process,BP,
7500,GO:0030575,1,0.934047725346051,0,10,nuclear body organization,BP,
7501,GO:0030576,1,0.985674018995524,0,2,Cajal body organization,BP,
7502,GO:0030578,1,0.97291140319913,0,4,PML body organization,BP,
7503,GO:0030579,1,0.95866073253797,0,6,ubiquitin-dependent SMAD protein catabolic process,BP,
7504,GO:0030580,1,0.992170027168696,0,1,quinone cofactor methyltransferase activity,MF,
7505,GO:0030581,1,0.963640814884808,0,5,symbiont intracellular protein transport in host,BP,
7506,GO:0030586,1,0.992842792648331,0,1,[methionine synthase] reductase activity,MF,
7507,GO:0030593,1,0.522371887869968,0,86,neutrophil chemotaxis,BP,
7509,GO:0030595,1,0.24655994411851,0,187,leukocyte chemotaxis,BP,
7510,GO:0030611,1,0.992170027168696,0,1,arsenate reductase activity,MF,
7511,GO:0030613,1,0.976692112990833,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7512,GO:0030614,1,0.976692112990833,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7513,GO:0030616,1,0.993986332279134,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7514,GO:0030617,1,0.985175346623525,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7515,GO:0030618,1,0.96887830085217,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7516,GO:0030619,1,0.956053340652657,0,6,U1 snRNA binding,MF,
7517,GO:0030620,1,0.961513826088112,0,5,U2 snRNA binding,MF,
7518,GO:0030621,1,0.965105626080527,0,5,U4 snRNA binding,MF,
7519,GO:0030622,1,0.986224577274266,0,2,U4atac snRNA binding,MF,
7520,GO:0030623,1,0.993986332272233,0,1,U5 snRNA binding,MF,
7521,GO:0030624,1,0.99375521404605,0,1,U6atac snRNA binding,MF,
7522,GO:0030626,1,0.985594064677586,0,2,U12 snRNA binding,MF,
7523,GO:0030627,1,0.984702729581445,0,2,pre-mRNA 5'-splice site binding,MF,
7524,GO:0030628,1,0.955649129459527,0,6,pre-mRNA 3'-splice site binding,MF,
7525,GO:0030638,1,0.939826071125684,0,8,polyketide metabolic process,BP,
7526,GO:0030641,1,0.515811892942574,0,92,regulation of cellular pH,BP,
7527,GO:0030643,1,0.938691386218615,0,9,cellular phosphate ion homeostasis,BP,
7528,GO:0030644,1,0.97256572108469,0,4,cellular chloride ion homeostasis,BP,
7529,GO:0030647,1,0.932498035010459,0,9,aminoglycoside antibiotic metabolic process,BP,
7530,GO:0030653,1,0.993954967944533,0,1,beta-lactam antibiotic metabolic process,BP,
7531,GO:0030656,1,0.913810559326422,0,12,regulation of vitamin metabolic process,BP,
7534,GO:0030660,1,0.69671169356194,0,50,Golgi-associated vesicle membrane,CC,
7535,GO:0030662,1,0.310170319379135,0,163,coated vesicle membrane,CC,
7536,GO:0030663,1,0.888354384358785,0,16,COPI-coated vesicle membrane,CC,
7537,GO:0030665,1,0.46946879825679,0,105,clathrin-coated vesicle membrane,CC,
7540,GO:0030669,1,0.697731712020655,0,50,clathrin-coated endocytic vesicle membrane,CC,
7541,GO:0030670,1,0.605506810549009,0,69,phagocytic vesicle membrane,CC,
7542,GO:0030672,1,0.58694162692786,0,74,synaptic vesicle membrane,CC,
7543,GO:0030673,1,0.899385660644023,0,16,axolemma,CC,
7544,GO:0030674,1,0.319324232179219,0,161,protein binding, bridging,MF,
7545,GO:0030676,1,0.906083421734968,0,15,Rac guanyl-nucleotide exchange factor activity,MF,
7548,GO:0030681,1,0.948838748081399,0,7,multimeric ribonuclease P complex,CC,
7549,GO:0030682,1,0.992366146325104,0,1,evasion or tolerance of host defense response,BP,
7550,GO:0030683,1,0.992366146325104,0,1,evasion or tolerance by virus of host immune response,BP,
7551,GO:0030684,1,0.61028371378822,0,67,preribosome,CC,
7552,GO:0030686,1,0.810134675394945,0,29,90S preribosome,CC,
7553,GO:0030687,1,0.848443387306659,0,22,preribosome, large subunit precursor,CC,
7554,GO:0030688,1,0.924177269752536,0,11,preribosome, small subunit precursor,CC,
7555,GO:0030689,1,0.977290100356164,0,3,Noc complex,CC,
7556,GO:0030690,1,0.992430692107096,0,1,Noc1p-Noc2p complex,CC,
7557,GO:0030691,1,0.992430692107096,0,1,Noc2p-Noc3p complex,CC,
7558,GO:0030692,1,0.984744828746871,0,2,Noc4p-Nop14p complex,CC,
7560,GO:0030696,1,0.992717162603179,0,1,tRNA (m5U54) methyltransferase activity,MF,
7561,GO:0030697,1,0.992717162603179,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7562,GO:0030705,1,0.384072050430061,0,138,cytoskeleton-dependent intracellular transport,BP,
7563,GO:0030718,1,0.977905870206154,0,3,germ-line stem cell population maintenance,BP,
7564,GO:0030719,1,0.985430922759493,0,2,P granule organization,BP,
7565,GO:0030728,1,0.865145357653593,0,20,ovulation,BP,
7566,GO:0030729,1,0.992884385285472,0,1,acetoacetate-CoA ligase activity,MF,
7567,GO:0030730,1,0.897885094360533,0,15,sequestering of triglyceride,BP,
7568,GO:0030731,1,0.992170027168696,0,1,guanidinoacetate N-methyltransferase activity,MF,
7569,GO:0030742,1,0.84063219842829,0,24,GTP-dependent protein binding,MF,
7570,GO:0030748,1,0.992293397538816,0,1,amine N-methyltransferase activity,MF,
7572,GO:0030791,1,0.992261088506856,0,1,arsenite methyltransferase activity,MF,
7573,GO:0030792,1,0.992261088506856,0,1,methylarsonite methyltransferase activity,MF,
7575,GO:0030800,1,0.714810616907707,0,46,negative regulation of cyclic nucleotide metabolic process,BP,
7578,GO:0030803,1,0.736104917066939,0,42,negative regulation of cyclic nucleotide biosynthetic process,BP,
7580,GO:0030805,1,0.980587722713233,0,3,regulation of cyclic nucleotide catabolic process,BP,
7581,GO:0030806,1,0.986520959751267,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7582,GO:0030807,1,0.993986332265518,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7584,GO:0030809,1,0.720176597708451,0,45,negative regulation of nucleotide biosynthetic process,BP,
7586,GO:0030811,1,0.980587722713233,0,3,regulation of nucleotide catabolic process,BP,
7587,GO:0030812,1,0.986520959751267,0,2,negative regulation of nucleotide catabolic process,BP,
7588,GO:0030813,1,0.993986332265518,0,1,positive regulation of nucleotide catabolic process,BP,
7590,GO:0030815,1,0.726134183646166,0,44,negative regulation of cAMP metabolic process,BP,
7593,GO:0030818,1,0.747763120187275,0,40,negative regulation of cAMP biosynthetic process,BP,
7595,GO:0030820,1,0.980587722713233,0,3,regulation of cAMP catabolic process,BP,
7596,GO:0030821,1,0.986520959751267,0,2,negative regulation of cAMP catabolic process,BP,
7597,GO:0030822,1,0.993986332265518,0,1,positive regulation of cAMP catabolic process,BP,
7598,GO:0030823,1,0.816055998477769,0,28,regulation of cGMP metabolic process,BP,
7599,GO:0030824,1,0.984444311004932,0,2,negative regulation of cGMP metabolic process,BP,
7600,GO:0030825,1,0.856743666611455,0,21,positive regulation of cGMP metabolic process,BP,
7601,GO:0030826,1,0.849847524136317,0,22,regulation of cGMP biosynthetic process,BP,
7602,GO:0030827,1,0.984444311004932,0,2,negative regulation of cGMP biosynthetic process,BP,
7603,GO:0030828,1,0.868737669070766,0,19,positive regulation of cGMP biosynthetic process,BP,
7608,GO:0030836,1,0.936539019791592,0,9,positive regulation of actin filament depolymerization,BP,
7611,GO:0030842,1,0.993984990010366,0,1,regulation of intermediate filament depolymerization,BP,
7612,GO:0030844,1,0.993984990010366,0,1,positive regulation of intermediate filament depolymerization,BP,
7613,GO:0030845,1,0.992459776065546,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7614,GO:0030846,1,0.993986332289148,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7615,GO:0030849,1,0.986179727832135,0,2,autosome,CC,
7616,GO:0030850,1,0.729859667046944,0,45,prostate gland development,BP,
7617,GO:0030851,1,0.812153107114918,0,29,granulocyte differentiation,BP,
7618,GO:0030852,1,0.906107826411877,0,14,regulation of granulocyte differentiation,BP,
7619,GO:0030853,1,0.947303664498751,0,8,negative regulation of granulocyte differentiation,BP,
7620,GO:0030854,1,0.950002986782553,0,7,positive regulation of granulocyte differentiation,BP,
7622,GO:0030856,1,0.419493201189898,0,121,regulation of epithelial cell differentiation,BP,
7623,GO:0030857,1,0.768760959610338,0,37,negative regulation of epithelial cell differentiation,BP,
7624,GO:0030858,1,0.678494767142378,0,54,positive regulation of epithelial cell differentiation,BP,
7625,GO:0030859,1,0.92125704732146,0,12,polarized epithelial cell differentiation,BP,
7626,GO:0030860,1,0.987139068038362,0,2,regulation of polarized epithelial cell differentiation,BP,
7627,GO:0030862,1,0.987139068038362,0,2,positive regulation of polarized epithelial cell differentiation,BP,
7628,GO:0030863,1,0.581924650557005,0,79,cortical cytoskeleton,CC,
7629,GO:0030864,1,0.68953072718948,0,55,cortical actin cytoskeleton,CC,
7630,GO:0030865,1,0.798701335987847,0,33,cortical cytoskeleton organization,BP,
7631,GO:0030866,1,0.827030227283337,0,28,cortical actin cytoskeleton organization,BP,
7632,GO:0030867,1,0.857286706078231,0,21,rough endoplasmic reticulum membrane,CC,
7634,GO:0030870,1,0.966804309281808,0,5,Mre11 complex,CC,
7635,GO:0030874,1,0.992170072635252,0,1,nucleolar chromatin,CC,
7636,GO:0030877,1,0.925693430285106,0,11,beta-catenin destruction complex,CC,
7637,GO:0030878,1,0.839135288364943,0,24,thyroid gland development,BP,
7638,GO:0030879,1,0.405740966999828,0,129,mammary gland development,BP,
7639,GO:0030880,1,0.396856650701798,0,127,RNA polymerase complex,CC,
7640,GO:0030881,1,0.932918761062137,0,9,beta-2-microglobulin binding,MF,
7641,GO:0030882,1,0.962726198588616,0,5,lipid antigen binding,MF,
7642,GO:0030883,1,0.962726198588616,0,5,endogenous lipid antigen binding,MF,
7643,GO:0030884,1,0.962726198588616,0,5,exogenous lipid antigen binding,MF,
7644,GO:0030885,1,0.961502251479775,0,5,regulation of myeloid dendritic cell activation,BP,
7645,GO:0030886,1,0.976741327304669,0,3,negative regulation of myeloid dendritic cell activation,BP,
7646,GO:0030887,1,0.992170027168696,0,1,positive regulation of myeloid dendritic cell activation,BP,
7648,GO:0030889,1,0.897134227538672,0,15,negative regulation of B cell proliferation,BP,
7650,GO:0030891,1,0.963582941459223,0,5,VCB complex,CC,
7651,GO:0030893,1,0.960027634579559,0,6,meiotic cohesin complex,CC,
7652,GO:0030894,1,0.800139725742998,0,30,replisome,CC,
7653,GO:0030895,1,0.976926939986391,0,3,apolipoprotein B mRNA editing enzyme complex,CC,
7654,GO:0030896,1,0.955680313746429,0,6,checkpoint clamp complex,CC,
7655,GO:0030897,1,0.907877336571016,0,14,HOPS complex,CC,
7656,GO:0030898,1,0.928308416503317,0,12,actin-dependent ATPase activity,MF,
7657,GO:0030899,1,0.986203080787372,0,2,calcium-dependent ATPase activity,MF,
7659,GO:0030901,1,0.512384960996316,0,92,midbrain development,BP,
7660,GO:0030902,1,0.371361998946697,0,141,hindbrain development,BP,
7661,GO:0030903,1,0.876985905233405,0,19,notochord development,BP,
7662,GO:0030904,1,0.867422596680417,0,20,retromer complex,CC,
7663,GO:0030905,1,0.97126952426351,0,4,retromer, tubulation complex,CC,
7664,GO:0030906,1,0.970879142827184,0,4,retromer, cargo-selective complex,CC,
7665,GO:0030908,1,0.984412806697314,0,2,protein splicing,BP,
7666,GO:0030910,1,0.972211062263021,0,4,olfactory placode formation,BP,
7667,GO:0030911,1,0.959338077989303,0,6,TPR domain binding,MF,
7668,GO:0030913,1,0.95370489251742,0,7,paranodal junction assembly,BP,
7669,GO:0030914,1,0.910090297103237,0,13,STAGA complex,CC,
7670,GO:0030915,1,0.957405640553691,0,6,Smc5-Smc6 complex,CC,
7671,GO:0030916,1,0.943758586088304,0,8,otic vesicle formation,BP,
7672,GO:0030917,1,0.935485060526226,0,9,midbrain-hindbrain boundary development,BP,
7673,GO:0030920,1,0.984400887813367,0,2,peptidyl-serine acetylation,BP,
7674,GO:0030934,1,0.982066433197547,0,3,anchoring collagen complex,CC,
7675,GO:0030935,1,0.992324105190772,0,1,sheet-forming collagen trimer,CC,
7676,GO:0030936,1,0.992624046284589,0,1,transmembrane collagen trimer,CC,
7677,GO:0030942,1,0.976835341350812,0,3,endoplasmic reticulum signal peptide binding,MF,
7678,GO:0030943,1,0.977442645732781,0,3,mitochondrion targeting sequence binding,MF,
7680,GO:0030948,1,0.953001830498563,0,7,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7682,GO:0030950,1,0.971695449747037,0,4,establishment or maintenance of actin cytoskeleton polarity,BP,
7683,GO:0030951,1,0.979314307862958,0,3,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7684,GO:0030952,1,0.951590793084595,0,7,establishment or maintenance of cytoskeleton polarity,BP,
7685,GO:0030953,1,0.961045448822167,0,6,astral microtubule organization,BP,
7686,GO:0030955,1,0.90785089755375,0,14,potassium ion binding,MF,
7687,GO:0030956,1,0.985822938811149,0,2,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7688,GO:0030957,1,0.930417687369323,0,10,Tat protein binding,MF,
7689,GO:0030961,1,0.992294630214608,0,1,peptidyl-arginine hydroxylation,BP,
7690,GO:0030964,1,0.720860353684577,0,42,NADH dehydrogenase complex,CC,
7692,GO:0030969,1,0.978567085076272,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7693,GO:0030970,1,0.829412239125982,0,26,retrograde protein transport, ER to cytosol,BP,
7694,GO:0030971,1,0.693381989276785,0,52,receptor tyrosine kinase binding,MF,
7695,GO:0030974,1,0.992170027168696,0,1,thiamine pyrophosphate transport,BP,
7696,GO:0030975,1,0.992229029544791,0,1,thiamine binding,MF,
7698,GO:0030977,1,0.99217069631132,0,1,taurine binding,MF,
7699,GO:0030981,1,0.986355062109819,0,2,cortical microtubule cytoskeleton,CC,
7700,GO:0030983,1,0.918375586458787,0,12,mismatched DNA binding,MF,
7701,GO:0030984,1,0.992170027168696,0,1,kininogen binding,MF,
7702,GO:0030990,1,0.819786514917159,0,28,intraciliary transport particle,CC,
7703,GO:0030991,1,0.954678736474175,0,7,intraciliary transport particle A,CC,
7704,GO:0030992,1,0.877293777734534,0,18,intraciliary transport particle B,CC,
7705,GO:0030997,1,0.979293062690122,0,3,regulation of centriole-centriole cohesion,BP,
7706,GO:0031000,1,0.903511303687878,0,15,response to caffeine,BP,
7707,GO:0031001,1,0.992294630214608,0,1,response to brefeldin A,BP,
7708,GO:0031002,1,0.992170027168696,0,1,actin rod,CC,
7709,GO:0031005,1,0.926166532084243,0,11,filamin binding,MF,
7710,GO:0031010,1,0.929477348301814,0,11,ISWI-type complex,CC,
7711,GO:0031011,1,0.900047142116482,0,14,Ino80 complex,CC,
7713,GO:0031013,1,0.961978253184763,0,5,troponin I binding,MF,
7714,GO:0031014,1,0.969043237344425,0,4,troponin T binding,MF,
7715,GO:0031016,1,0.595723151417923,0,72,pancreas development,BP,
7716,GO:0031017,1,0.955868126352391,0,6,exocrine pancreas development,BP,
7717,GO:0031018,1,0.727638871424244,0,44,endocrine pancreas development,BP,
7718,GO:0031021,1,0.977961470053099,0,3,interphase microtubule organizing center,CC,
7719,GO:0031022,1,0.987475245310624,0,2,nuclear migration along microfilament,BP,
7720,GO:0031023,1,0.450527874111191,0,115,microtubule organizing center organization,BP,
7721,GO:0031032,1,0.321514677547793,0,164,actomyosin structure organization,BP,
7722,GO:0031033,1,0.904348282017754,0,15,myosin filament organization,BP,
7723,GO:0031034,1,0.911475926091922,0,14,myosin filament assembly,BP,
7724,GO:0031038,1,0.992185746419627,0,1,myosin II filament organization,BP,
7725,GO:0031045,1,0.921090164875431,0,12,dense core granule,CC,
7726,GO:0031047,1,0.318752775847268,0,158,gene silencing by RNA,BP,
7727,GO:0031048,1,0.992294630214608,0,1,chromatin silencing by small RNA,BP,
7728,GO:0031049,1,0.992441219375176,0,1,programmed DNA elimination,BP,
7729,GO:0031050,1,0.780951586823235,0,35,dsRNA fragmentation,BP,
7730,GO:0031052,1,0.992441219375176,0,1,chromosome breakage,BP,
7731,GO:0031053,1,0.9402151903942,0,9,primary miRNA processing,BP,
7732,GO:0031054,1,0.910716800854796,0,13,pre-miRNA processing,BP,
7733,GO:0031055,1,0.729708499273949,0,41,chromatin remodeling at centromere,BP,
7734,GO:0031056,1,0.402650959847036,0,128,regulation of histone modification,BP,
7735,GO:0031057,1,0.762353058282462,0,39,negative regulation of histone modification,BP,
7736,GO:0031058,1,0.560916007731266,0,81,positive regulation of histone modification,BP,
7737,GO:0031060,1,0.668340571558501,0,58,regulation of histone methylation,BP,
7738,GO:0031061,1,0.880330579772904,0,19,negative regulation of histone methylation,BP,
7739,GO:0031062,1,0.795071979401723,0,33,positive regulation of histone methylation,BP,
7740,GO:0031063,1,0.835781365734747,0,25,regulation of histone deacetylation,BP,
7741,GO:0031064,1,0.965029443728441,0,5,negative regulation of histone deacetylation,BP,
7742,GO:0031065,1,0.892432459321132,0,16,positive regulation of histone deacetylation,BP,
7743,GO:0031069,1,0.828917253439152,0,26,hair follicle morphogenesis,BP,
7744,GO:0031071,1,0.992233917013323,0,1,cysteine desulfurase activity,MF,
7745,GO:0031072,1,0.505193812396953,0,94,heat shock protein binding,MF,
7746,GO:0031074,1,0.973034098479281,0,4,nucleocytoplasmic shuttling complex,CC,
7748,GO:0031077,1,0.951141294935282,0,7,post-embryonic camera-type eye development,BP,
7749,GO:0031078,1,0.926809961235156,0,11,histone deacetylase activity (H3-K14 specific),MF,
7750,GO:0031080,1,0.932705432603083,0,10,nuclear pore outer ring,CC,
7751,GO:0031081,1,0.99364762661533,0,1,nuclear pore distribution,BP,
7752,GO:0031082,1,0.868075159134859,0,19,BLOC complex,CC,
7753,GO:0031083,1,0.898160914796298,0,14,BLOC-1 complex,CC,
7754,GO:0031084,1,0.980142761114522,0,3,BLOC-2 complex,CC,
7755,GO:0031085,1,0.986114183862834,0,2,BLOC-3 complex,CC,
7756,GO:0031086,1,0.944050840874361,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7757,GO:0031087,1,0.951102598763243,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7758,GO:0031088,1,0.959135138667218,0,6,platelet dense granule membrane,CC,
7759,GO:0031089,1,0.905604299325141,0,13,platelet dense granule lumen,CC,
7761,GO:0031091,1,0.519219265308787,0,90,platelet alpha granule,CC,
7762,GO:0031092,1,0.888362359580335,0,17,platelet alpha granule membrane,CC,
7763,GO:0031093,1,0.616056106067632,0,66,platelet alpha granule lumen,CC,
7764,GO:0031094,1,0.93731794084518,0,10,platelet dense tubular network,CC,
7765,GO:0031095,1,0.951000770142807,0,8,platelet dense tubular network membrane,CC,
7769,GO:0031102,1,0.706493998756126,0,49,neuron projection regeneration,BP,
7770,GO:0031103,1,0.754855732908965,0,40,axon regeneration,BP,
7771,GO:0031104,1,0.99358209335879,0,1,dendrite regeneration,BP,
7772,GO:0031105,1,0.956466951716043,0,6,septin complex,CC,
7773,GO:0031106,1,0.993900882826304,0,1,septin ring organization,BP,
7774,GO:0031109,1,0.550763218540453,0,83,microtubule polymerization or depolymerization,BP,
7775,GO:0031110,1,0.680269734418892,0,53,regulation of microtubule polymerization or depolymerization,BP,
7776,GO:0031111,1,0.828330215635411,0,26,negative regulation of microtubule polymerization or depolymerization,BP,
7777,GO:0031112,1,0.853429318769966,0,22,positive regulation of microtubule polymerization or depolymerization,BP,
7778,GO:0031113,1,0.799648241333325,0,31,regulation of microtubule polymerization,BP,
7779,GO:0031114,1,0.878751992841938,0,18,regulation of microtubule depolymerization,BP,
7780,GO:0031115,1,0.928473348732214,0,10,negative regulation of microtubule polymerization,BP,
7781,GO:0031116,1,0.873188718948685,0,19,positive regulation of microtubule polymerization,BP,
7782,GO:0031117,1,0.977394673384401,0,3,positive regulation of microtubule depolymerization,BP,
7783,GO:0031118,1,0.954050931493032,0,6,rRNA pseudouridine synthesis,BP,
7785,GO:0031120,1,0.969172561684693,0,4,snRNA pseudouridine synthesis,BP,
7786,GO:0031122,1,0.739918339616284,0,44,cytoplasmic microtubule organization,BP,
7787,GO:0031123,1,0.435550627109435,0,114,RNA 3'-end processing,BP,
7788,GO:0031124,1,0.524250316576373,0,89,mRNA 3'-end processing,BP,
7789,GO:0031125,1,0.926067765458766,0,10,rRNA 3'-end processing,BP,
7790,GO:0031126,1,0.946603537895838,0,7,snoRNA 3'-end processing,BP,
7791,GO:0031127,1,0.986376524509756,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7792,GO:0031128,1,0.804335746112001,0,30,developmental induction,BP,
7793,GO:0031129,1,0.993967798802804,0,1,inductive cell-cell signaling,BP,
7794,GO:0031133,1,0.966009164916518,0,5,regulation of axon diameter,BP,
7795,GO:0031134,1,0.986243379481894,0,2,sister chromatid biorientation,BP,
7796,GO:0031143,1,0.884974787610121,0,17,pseudopodium,CC,
7799,GO:0031151,1,0.993986332272842,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7800,GO:0031161,1,0.992701787785817,0,1,phosphatidylinositol catabolic process,BP,
7801,GO:0031163,1,0.871940699198034,0,18,metallo-sulfur cluster assembly,BP,
7802,GO:0031166,1,0.979744126474736,0,3,integral component of vacuolar membrane,CC,
7803,GO:0031167,1,0.886213111537908,0,16,rRNA methylation,BP,
7805,GO:0031177,1,0.986203080785463,0,2,phosphopantetheine binding,MF,
7806,GO:0031179,1,0.985500994267916,0,2,peptide modification,BP,
7807,GO:0031201,1,0.687080010873711,0,51,SNARE complex,CC,
7808,GO:0031204,1,0.98620308077585,0,2,posttranslational protein targeting to membrane, translocation,BP,
7809,GO:0031205,1,0.980270852925228,0,3,endoplasmic reticulum Sec complex,CC,
7810,GO:0031208,1,0.98632983104295,0,2,POZ domain binding,MF,
7811,GO:0031209,1,0.947739062748657,0,8,SCAR complex,CC,
7813,GO:0031211,1,0.942184712630871,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7814,GO:0031213,1,0.987407207212272,0,2,RSF complex,CC,
7815,GO:0031214,1,0.402874396744028,0,126,biomineral tissue development,BP,
7821,GO:0031228,1,0.657206537487664,0,58,intrinsic component of Golgi membrane,CC,
7822,GO:0031229,1,0.902847003283364,0,14,intrinsic component of nuclear inner membrane,CC,
7823,GO:0031231,1,0.90021079442168,0,14,intrinsic component of peroxisomal membrane,CC,
7824,GO:0031232,1,0.949500693591276,0,7,extrinsic component of external side of plasma membrane,CC,
7825,GO:0031233,1,0.828747711413906,0,25,intrinsic component of external side of plasma membrane,CC,
7826,GO:0031234,1,0.471158413988746,0,105,extrinsic component of cytoplasmic side of plasma membrane,CC,
7827,GO:0031235,1,0.911117009532746,0,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7828,GO:0031247,1,0.984653451922137,0,2,actin rod assembly,BP,
7829,GO:0031248,1,0.529917342317984,0,88,protein acetyltransferase complex,CC,
7830,GO:0031249,1,0.992246255662747,0,1,denatured protein binding,MF,
7831,GO:0031251,1,0.987998749384972,0,2,PAN complex,CC,
7833,GO:0031253,1,0.123188079427042,0,295,cell projection membrane,CC,
7834,GO:0031254,1,0.909984137724054,0,13,cell trailing edge,CC,
7835,GO:0031256,1,0.393530609668953,0,134,leading edge membrane,CC,
7836,GO:0031257,1,0.992294630214608,0,1,cell trailing edge membrane,CC,
7837,GO:0031258,1,0.874221142510419,0,19,lamellipodium membrane,CC,
7838,GO:0031259,1,0.992294630214608,0,1,uropod membrane,CC,
7839,GO:0031260,1,0.992170027168696,0,1,pseudopodium membrane,CC,
7840,GO:0031261,1,0.963402769414171,0,5,DNA replication preinitiation complex,CC,
7841,GO:0031262,1,0.969070789212173,0,4,Ndc80 complex,CC,
7845,GO:0031268,1,0.888874746359734,0,16,pseudopodium organization,BP,
7846,GO:0031269,1,0.895895586476663,0,15,pseudopodium assembly,BP,
7847,GO:0031271,1,0.992294630214608,0,1,lateral pseudopodium assembly,BP,
7848,GO:0031272,1,0.908324431608032,0,13,regulation of pseudopodium assembly,BP,
7849,GO:0031274,1,0.915382647140195,0,12,positive regulation of pseudopodium assembly,BP,
7850,GO:0031275,1,0.992294630214608,0,1,regulation of lateral pseudopodium assembly,BP,
7851,GO:0031279,1,0.52142712648842,0,89,regulation of cyclase activity,BP,
7852,GO:0031280,1,0.801329258955828,0,30,negative regulation of cyclase activity,BP,
7853,GO:0031281,1,0.651399330431704,0,59,positive regulation of cyclase activity,BP,
7854,GO:0031282,1,0.906009146148728,0,13,regulation of guanylate cyclase activity,BP,
7855,GO:0031283,1,0.984444311004932,0,2,negative regulation of guanylate cyclase activity,BP,
7856,GO:0031284,1,0.920334800817607,0,11,positive regulation of guanylate cyclase activity,BP,
7857,GO:0031289,1,0.992612683427298,0,1,actin phosphorylation,BP,
7858,GO:0031290,1,0.870057436920674,0,21,retinal ganglion cell axon guidance,BP,
7859,GO:0031291,1,0.993664867827238,0,1,Ran protein signal transduction,BP,
7860,GO:0031293,1,0.891995579363422,0,16,membrane protein intracellular domain proteolysis,BP,
7861,GO:0031294,1,0.55532239176642,0,79,lymphocyte costimulation,BP,
7862,GO:0031295,1,0.568633924122243,0,76,T cell costimulation,BP,
7863,GO:0031296,1,0.969043237344425,0,4,B cell costimulation,BP,
7864,GO:0031297,1,0.842980997105763,0,24,replication fork processing,BP,
7865,GO:0031298,1,0.957763585452199,0,6,replication fork protection complex,CC,
7868,GO:0031302,1,0.993961175892562,0,1,intrinsic component of endosome membrane,CC,
7871,GO:0031306,1,0.837693537689987,0,24,intrinsic component of mitochondrial outer membrane,CC,
7872,GO:0031307,1,0.842883415660293,0,23,integral component of mitochondrial outer membrane,CC,
7873,GO:0031308,1,0.992294630214608,0,1,intrinsic component of nuclear outer membrane,CC,
7874,GO:0031309,1,0.992294630214608,0,1,integral component of nuclear outer membrane,CC,
7875,GO:0031310,1,0.979744126474736,0,3,intrinsic component of vacuolar membrane,CC,
7876,GO:0031312,1,0.814978390099697,0,28,extrinsic component of organelle membrane,CC,
7877,GO:0031313,1,0.957808028374489,0,6,extrinsic component of endosome membrane,CC,
7878,GO:0031314,1,0.956150470476523,0,6,extrinsic component of mitochondrial inner membrane,CC,
7879,GO:0031315,1,0.986495371897806,0,2,extrinsic component of mitochondrial outer membrane,CC,
7880,GO:0031320,1,0.992282282316394,0,1,hexitol dehydrogenase activity,MF,
7890,GO:0031332,1,0.926793693824827,0,11,RNAi effector complex,CC,
7893,GO:0031335,1,0.984541098948715,0,2,regulation of sulfur amino acid metabolic process,BP,
7894,GO:0031337,1,0.992209142954877,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7896,GO:0031339,1,0.967814036863467,0,5,negative regulation of vesicle fusion,BP,
7897,GO:0031340,1,0.94423821408455,0,8,positive regulation of vesicle fusion,BP,
7899,GO:0031342,1,0.886342556493065,0,16,negative regulation of cell killing,BP,
7903,GO:0031346,1,0.118596479124133,0,305,positive regulation of cell projection organization,BP,
7907,GO:0031362,1,0.85994988533439,0,20,anchored component of external side of plasma membrane,CC,
7908,GO:0031365,1,0.819673003198616,0,28,N-terminal protein amino acid modification,BP,
7909,GO:0031369,1,0.811642340674237,0,29,translation initiation factor binding,MF,
7910,GO:0031370,1,0.993891556127846,0,1,eukaryotic initiation factor 4G binding,MF,
7911,GO:0031371,1,0.934637892785591,0,9,ubiquitin conjugating enzyme complex,CC,
7912,GO:0031372,1,0.984520077530896,0,2,UBC13-MMS2 complex,CC,
7913,GO:0031379,1,0.986407602348152,0,2,RNA-directed RNA polymerase complex,CC,
7914,GO:0031380,1,0.992842792648331,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7915,GO:0031386,1,0.94081548337129,0,8,protein tag,MF,
7916,GO:0031389,1,0.992491319388775,0,1,Rad17 RFC-like complex,CC,
7917,GO:0031390,1,0.941100181867308,0,8,Ctf18 RFC-like complex,CC,
7918,GO:0031392,1,0.958559499136547,0,6,regulation of prostaglandin biosynthetic process,BP,
7919,GO:0031393,1,0.986111938007581,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7920,GO:0031394,1,0.972062532734861,0,4,positive regulation of prostaglandin biosynthetic process,BP,
7927,GO:0031402,1,0.915658866203926,0,13,sodium ion binding,MF,
7928,GO:0031403,1,0.986977834593017,0,2,lithium ion binding,MF,
7929,GO:0031404,1,0.936560130101201,0,9,chloride ion binding,MF,
7931,GO:0031407,1,0.992230544989512,0,1,oxylipin metabolic process,BP,
7933,GO:0031414,1,0.932060738149874,0,10,N-terminal protein acetyltransferase complex,CC,
7934,GO:0031415,1,0.964142904570936,0,5,NatA complex,CC,
7935,GO:0031416,1,0.986203080772374,0,2,NatB complex,CC,
7936,GO:0031417,1,0.980260683445274,0,3,NatC complex,CC,
7938,GO:0031419,1,0.935768111425067,0,9,cobalamin binding,MF,
7939,GO:0031420,1,0.877513324396797,0,19,alkali metal ion binding,MF,
7941,GO:0031427,1,0.972103229091975,0,4,response to methotrexate,BP,
7942,GO:0031428,1,0.969057518895235,0,4,box C/D snoRNP complex,CC,
7943,GO:0031429,1,0.961582118415242,0,5,box H/ACA snoRNP complex,CC,
7944,GO:0031430,1,0.818185321524401,0,29,M band,CC,
7945,GO:0031432,1,0.904818910752424,0,14,titin binding,MF,
7946,GO:0031433,1,0.94991090512322,0,7,telethonin binding,MF,
7947,GO:0031434,1,0.905313499561616,0,14,mitogen-activated protein kinase kinase binding,MF,
7948,GO:0031435,1,0.894683837437035,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7949,GO:0031436,1,0.986344065897724,0,2,BRCA1-BARD1 complex,CC,
7950,GO:0031437,1,0.984939313089483,0,2,regulation of mRNA cleavage,BP,
7951,GO:0031438,1,0.992636404576577,0,1,negative regulation of mRNA cleavage,BP,
7952,GO:0031439,1,0.992246255662747,0,1,positive regulation of mRNA cleavage,BP,
7953,GO:0031440,1,0.867407413072934,0,20,regulation of mRNA 3'-end processing,BP,
7954,GO:0031441,1,0.944703895904373,0,8,negative regulation of mRNA 3'-end processing,BP,
7955,GO:0031442,1,0.944285962523111,0,8,positive regulation of mRNA 3'-end processing,BP,
7956,GO:0031443,1,0.987110524068736,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7957,GO:0031444,1,0.97848030260484,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7958,GO:0031445,1,0.98620308079116,0,2,regulation of heterochromatin assembly,BP,
7959,GO:0031446,1,0.993082917956945,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7960,GO:0031448,1,0.993082917956945,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7961,GO:0031449,1,0.993986332265834,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7962,GO:0031453,1,0.98620308079116,0,2,positive regulation of heterochromatin assembly,BP,
7963,GO:0031455,1,0.986355942147793,0,2,glycine betaine metabolic process,BP,
7964,GO:0031456,1,0.986355942147793,0,2,glycine betaine biosynthetic process,BP,
7965,GO:0031460,1,0.993924954425047,0,1,glycine betaine transport,BP,
7966,GO:0031461,1,0.295865440021538,0,171,cullin-RING ubiquitin ligase complex,CC,
7967,GO:0031462,1,0.938292315645264,0,9,Cul2-RING ubiquitin ligase complex,CC,
7968,GO:0031463,1,0.613194837112719,0,70,Cul3-RING ubiquitin ligase complex,CC,
7969,GO:0031464,1,0.930836274513837,0,10,Cul4A-RING E3 ubiquitin ligase complex,CC,
7970,GO:0031465,1,0.96628997608351,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7971,GO:0031466,1,0.957226436354589,0,6,Cul5-RING ubiquitin ligase complex,CC,
7972,GO:0031467,1,0.97255979601661,0,4,Cul7-RING ubiquitin ligase complex,CC,
7973,GO:0031468,1,0.881751426570352,0,17,nuclear envelope reassembly,BP,
7974,GO:0031475,1,0.992170027168696,0,1,myosin V complex,CC,
7975,GO:0031477,1,0.993986332272497,0,1,myosin VII complex,CC,
7976,GO:0031489,1,0.883811987926288,0,17,myosin V binding,MF,
7977,GO:0031490,1,0.535350457524099,0,87,chromatin DNA binding,MF,
7978,GO:0031491,1,0.704033784066839,0,49,nucleosome binding,MF,
7979,GO:0031492,1,0.801639777506472,0,30,nucleosomal DNA binding,MF,
7980,GO:0031493,1,0.97813245990126,0,3,nucleosomal histone binding,MF,
7981,GO:0031494,1,0.992294630214608,0,1,regulation of mating type switching,BP,
7982,GO:0031497,1,0.323668512490357,0,149,chromatin assembly,BP,
7983,GO:0031498,1,0.86699668452325,0,20,chromatin disassembly,BP,
7986,GO:0031506,1,0.992170321724734,0,1,cell wall glycoprotein biosynthetic process,BP,
7987,GO:0031507,1,0.917384268364252,0,12,heterochromatin assembly,BP,
7988,GO:0031508,1,0.96972327685393,0,4,pericentric heterochromatin assembly,BP,
7989,GO:0031509,1,0.976881919756952,0,3,telomeric heterochromatin assembly,BP,
7990,GO:0031510,1,0.976955855653451,0,3,SUMO activating enzyme complex,CC,
7991,GO:0031514,1,0.383788060251383,0,128,motile cilium,CC,
7992,GO:0031515,1,0.977350851194638,0,3,tRNA (m1A) methyltransferase complex,CC,
7993,GO:0031519,1,0.734649761848876,0,44,PcG protein complex,CC,
7994,GO:0031523,1,0.986405896391457,0,2,Myb complex,CC,
7995,GO:0031526,1,0.692332277060529,0,52,brush border membrane,CC,
7996,GO:0031527,1,0.889384859225622,0,17,filopodium membrane,CC,
7997,GO:0031528,1,0.855677873198877,0,22,microvillus membrane,CC,
7998,GO:0031529,1,0.742667048469829,0,41,ruffle organization,BP,
7999,GO:0031531,1,0.976692112990833,0,3,thyrotropin-releasing hormone receptor binding,MF,
8000,GO:0031532,1,0.548309347577176,0,85,actin cytoskeleton reorganization,BP,
8001,GO:0031536,1,0.961608123727566,0,5,positive regulation of exit from mitosis,BP,
8002,GO:0031543,1,0.927161263955442,0,10,peptidyl-proline dioxygenase activity,MF,
8003,GO:0031544,1,0.99259542221191,0,1,peptidyl-proline 3-dioxygenase activity,MF,
8004,GO:0031545,1,0.934081413820347,0,9,peptidyl-proline 4-dioxygenase activity,MF,
8005,GO:0031547,1,0.969724517155394,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
8006,GO:0031548,1,0.987546438392549,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8007,GO:0031549,1,0.993980505047035,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8008,GO:0031550,1,0.993527273668488,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8009,GO:0031554,1,0.993986332289148,0,1,regulation of DNA-templated transcription, termination,BP,
8010,GO:0031559,1,0.993688755915506,0,1,oxidosqualene cyclase activity,MF,
8011,GO:0031570,1,0.324578948717802,0,155,DNA integrity checkpoint,BP,
8012,GO:0031571,1,0.608578446679809,0,68,mitotic G1 DNA damage checkpoint,BP,
8013,GO:0031572,1,0.787140659575034,0,34,G2 DNA damage checkpoint,BP,
8014,GO:0031573,1,0.892228835028248,0,15,intra-S DNA damage checkpoint,BP,
8015,GO:0031577,1,0.773538627571715,0,35,spindle checkpoint,BP,
8016,GO:0031579,1,0.843447046343488,0,23,membrane raft organization,BP,
8017,GO:0031580,1,0.934837352877238,0,9,membrane raft distribution,BP,
8018,GO:0031581,1,0.930291940007198,0,11,hemidesmosome assembly,BP,
8019,GO:0031583,1,0.992184682619676,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
8020,GO:0031584,1,0.956239903897429,0,6,activation of phospholipase D activity,BP,
8021,GO:0031585,1,0.975572637592384,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8022,GO:0031587,1,0.981475767565671,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8023,GO:0031588,1,0.931893932157223,0,10,nucleotide-activated protein kinase complex,CC,
8024,GO:0031589,1,0.125345227301886,0,298,cell-substrate adhesion,BP,
8025,GO:0031590,1,0.984853911837409,0,2,wybutosine metabolic process,BP,
8026,GO:0031591,1,0.984853911837409,0,2,wybutosine biosynthetic process,BP,
8027,GO:0031592,1,0.993986332275238,0,1,centrosomal corona,CC,
8028,GO:0031593,1,0.759240285783386,0,39,polyubiquitin binding,MF,
8029,GO:0031594,1,0.680681992777739,0,55,neuromuscular junction,CC,
8030,GO:0031595,1,0.939882652506753,0,8,nuclear proteasome complex,CC,
8031,GO:0031597,1,0.926892037277692,0,10,cytosolic proteasome complex,CC,
8032,GO:0031616,1,0.933705080552635,0,9,spindle pole centrosome,CC,
8033,GO:0031618,1,0.946905364055128,0,8,nuclear pericentric heterochromatin,CC,
8034,GO:0031620,1,0.944302925190465,0,8,regulation of fever generation,BP,
8035,GO:0031622,1,0.950288578652358,0,7,positive regulation of fever generation,BP,
8036,GO:0031623,1,0.568826458631706,0,79,receptor internalization,BP,
8037,GO:0031624,1,0.796387956509221,0,33,ubiquitin conjugating enzyme binding,MF,
8038,GO:0031625,1,0.126540955266269,0,286,ubiquitin protein ligase binding,MF,
8039,GO:0031626,1,0.99396842386835,0,1,beta-endorphin binding,MF,
8040,GO:0031627,1,0.97836587737143,0,3,telomeric loop formation,BP,
8041,GO:0031628,1,0.935213138002068,0,9,opioid receptor binding,MF,
8042,GO:0031629,1,0.896323996176588,0,15,synaptic vesicle fusion to presynaptic active zone membrane,BP,
8043,GO:0031630,1,0.978859339763664,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
8044,GO:0031635,1,0.986155632468902,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
8046,GO:0031639,1,0.846091527890122,0,22,plasminogen activation,BP,
8047,GO:0031640,1,0.79422114151023,0,30,killing of cells of other organism,BP,
8048,GO:0031641,1,0.809860429822776,0,30,regulation of myelination,BP,
8049,GO:0031642,1,0.952911071304966,0,7,negative regulation of myelination,BP,
8050,GO:0031643,1,0.925056807496058,0,11,positive regulation of myelination,BP,
8051,GO:0031644,1,0.628212809476154,0,65,regulation of neurological system process,BP,
8052,GO:0031645,1,0.890114490069111,0,16,negative regulation of neurological system process,BP,
8053,GO:0031646,1,0.854965951999632,0,22,positive regulation of neurological system process,BP,
8055,GO:0031648,1,0.766852512392996,0,37,protein destabilization,BP,
8056,GO:0031649,1,0.885997958373257,0,17,heat generation,BP,
8057,GO:0031650,1,0.91945483408072,0,12,regulation of heat generation,BP,
8058,GO:0031651,1,0.993631074978444,0,1,negative regulation of heat generation,BP,
8059,GO:0031652,1,0.931218356307456,0,10,positive regulation of heat generation,BP,
8060,GO:0031657,1,0.945594862385012,0,8,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
8061,GO:0031658,1,0.993984910007831,0,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
8062,GO:0031659,1,0.951319360593568,0,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
8063,GO:0031660,1,0.992184048762491,0,1,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8064,GO:0031662,1,0.992184048762491,0,1,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8066,GO:0031664,1,0.869985025364096,0,19,regulation of lipopolysaccharide-mediated signaling pathway,BP,
8067,GO:0031665,1,0.935974147953175,0,9,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
8068,GO:0031666,1,0.943246933270061,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
8072,GO:0031670,1,0.755513614381821,0,39,cellular response to nutrient,BP,
8073,GO:0031672,1,0.752675559144867,0,41,A band,CC,
8074,GO:0031673,1,0.993986332313106,0,1,H zone,CC,
8075,GO:0031674,1,0.400538363688416,0,131,I band,CC,
8076,GO:0031681,1,0.935468155115481,0,9,G-protein beta-subunit binding,MF,
8077,GO:0031682,1,0.992605314257243,0,1,G-protein gamma-subunit binding,MF,
8078,GO:0031683,1,0.864693761446443,0,20,G-protein beta/gamma-subunit complex binding,MF,
8079,GO:0031685,1,0.986272198023248,0,2,adenosine receptor binding,MF,
8080,GO:0031686,1,0.992661481674899,0,1,A1 adenosine receptor binding,MF,
8081,GO:0031690,1,0.885324131470676,0,17,adrenergic receptor binding,MF,
8082,GO:0031691,1,0.984431014695011,0,2,alpha-1A adrenergic receptor binding,MF,
8083,GO:0031692,1,0.977936172155227,0,3,alpha-1B adrenergic receptor binding,MF,
8084,GO:0031694,1,0.969416930959449,0,4,alpha-2A adrenergic receptor binding,MF,
8085,GO:0031695,1,0.992257621513282,0,1,alpha-2B adrenergic receptor binding,MF,
8086,GO:0031696,1,0.985711546166203,0,2,alpha-2C adrenergic receptor binding,MF,
8087,GO:0031697,1,0.981516524390259,0,3,beta-1 adrenergic receptor binding,MF,
8088,GO:0031698,1,0.972604366534025,0,4,beta-2 adrenergic receptor binding,MF,
8089,GO:0031699,1,0.9860106337254,0,2,beta-3 adrenergic receptor binding,MF,
8090,GO:0031700,1,0.992170027168696,0,1,adrenomedullin receptor binding,MF,
8091,GO:0031701,1,0.927001411034033,0,11,angiotensin receptor binding,MF,
8092,GO:0031702,1,0.934294895909232,0,10,type 1 angiotensin receptor binding,MF,
8093,GO:0031703,1,0.992302628349193,0,1,type 2 angiotensin receptor binding,MF,
8094,GO:0031704,1,0.99277171725997,0,1,apelin receptor binding,MF,
8095,GO:0031705,1,0.969194575771527,0,4,bombesin receptor binding,MF,
8096,GO:0031707,1,0.992184682619676,0,1,endothelin A receptor binding,MF,
8097,GO:0031708,1,0.976844636632763,0,3,endothelin B receptor binding,MF,
8098,GO:0031710,1,0.992170027168696,0,1,neuromedin B receptor binding,MF,
8099,GO:0031711,1,0.985188445695003,0,2,bradykinin receptor binding,MF,
8100,GO:0031714,1,0.993961834394357,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8101,GO:0031715,1,0.993961834394357,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8102,GO:0031716,1,0.984400887813367,0,2,calcitonin receptor binding,MF,
8103,GO:0031720,1,0.976692112990833,0,3,haptoglobin binding,MF,
8104,GO:0031721,1,0.992170027168696,0,1,hemoglobin alpha binding,MF,
8105,GO:0031724,1,0.992170027168696,0,1,CXCR5 chemokine receptor binding,MF,
8106,GO:0031726,1,0.961453799076647,0,5,CCR1 chemokine receptor binding,MF,
8107,GO:0031727,1,0.984501568023485,0,2,CCR2 chemokine receptor binding,MF,
8108,GO:0031728,1,0.976692112990833,0,3,CCR3 chemokine receptor binding,MF,
8109,GO:0031729,1,0.984400887813367,0,2,CCR4 chemokine receptor binding,MF,
8111,GO:0031731,1,0.976692112990833,0,3,CCR6 chemokine receptor binding,MF,
8112,GO:0031732,1,0.984400887813367,0,2,CCR7 chemokine receptor binding,MF,
8113,GO:0031735,1,0.976692112990833,0,3,CCR10 chemokine receptor binding,MF,
8114,GO:0031737,1,0.992819234468104,0,1,CX3C chemokine receptor binding,MF,
8115,GO:0031739,1,0.992186914817366,0,1,cholecystokinin receptor binding,MF,
8116,GO:0031741,1,0.992186914817366,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8117,GO:0031748,1,0.943498375253377,0,8,D1 dopamine receptor binding,MF,
8118,GO:0031749,1,0.978320290969031,0,3,D2 dopamine receptor binding,MF,
8119,GO:0031750,1,0.984658530444616,0,2,D3 dopamine receptor binding,MF,
8120,GO:0031751,1,0.992170028033872,0,1,D4 dopamine receptor binding,MF,
8121,GO:0031752,1,0.980042347618797,0,3,D5 dopamine receptor binding,MF,
8122,GO:0031753,1,0.992416826699095,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8123,GO:0031755,1,0.992416826699095,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8124,GO:0031762,1,0.984431014695011,0,2,follicle-stimulating hormone receptor binding,MF,
8125,GO:0031763,1,0.992170027168696,0,1,galanin receptor binding,MF,
8126,GO:0031764,1,0.992170027168696,0,1,type 1 galanin receptor binding,MF,
8127,GO:0031765,1,0.992170027168696,0,1,type 2 galanin receptor binding,MF,
8128,GO:0031766,1,0.992170027168696,0,1,type 3 galanin receptor binding,MF,
8129,GO:0031768,1,0.992170027168696,0,1,ghrelin receptor binding,MF,
8130,GO:0031770,1,0.992170027168696,0,1,growth hormone-releasing hormone receptor binding,MF,
8131,GO:0031771,1,0.992170027168696,0,1,type 1 hypocretin receptor binding,MF,
8132,GO:0031772,1,0.992170027168696,0,1,type 2 hypocretin receptor binding,MF,
8133,GO:0031773,1,0.992170027168696,0,1,kisspeptin receptor binding,MF,
8134,GO:0031775,1,0.993986332276659,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8140,GO:0031798,1,0.993986332273813,0,1,type 1 metabotropic glutamate receptor binding,MF,
8141,GO:0031800,1,0.978215105034106,0,3,type 3 metabotropic glutamate receptor binding,MF,
8142,GO:0031802,1,0.986328173736736,0,2,type 5 metabotropic glutamate receptor binding,MF,
8143,GO:0031811,1,0.993429801223759,0,1,G-protein coupled nucleotide receptor binding,MF,
8144,GO:0031812,1,0.993429801223759,0,1,P2Y1 nucleotide receptor binding,MF,
8145,GO:0031821,1,0.950999275152915,0,7,G-protein coupled serotonin receptor binding,MF,
8146,GO:0031826,1,0.976716408390824,0,3,type 2A serotonin receptor binding,MF,
8147,GO:0031834,1,0.992170027168696,0,1,neurokinin receptor binding,MF,
8148,GO:0031835,1,0.992170027168696,0,1,substance P receptor binding,MF,
8149,GO:0031838,1,0.969043237344425,0,4,haptoglobin-hemoglobin complex,CC,
8150,GO:0031848,1,0.930904508728817,0,10,protection from non-homologous end joining at telomere,BP,
8151,GO:0031849,1,0.962581047830366,0,5,olfactory receptor binding,MF,
8152,GO:0031851,1,0.992170027168696,0,1,kappa-type opioid receptor binding,MF,
8153,GO:0031852,1,0.972585030043915,0,4,mu-type opioid receptor binding,MF,
8154,GO:0031854,1,0.992170027168696,0,1,orexigenic neuropeptide QRFP receptor binding,MF,
8155,GO:0031855,1,0.992170027168696,0,1,oxytocin receptor binding,MF,
8156,GO:0031856,1,0.992170027168696,0,1,parathyroid hormone receptor binding,MF,
8157,GO:0031857,1,0.992170027168696,0,1,type 1 parathyroid hormone receptor binding,MF,
8158,GO:0031858,1,0.992724664568839,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8159,GO:0031859,1,0.992172694855354,0,1,platelet activating factor receptor binding,MF,
8160,GO:0031860,1,0.981158628830034,0,3,telomeric 3' overhang formation,BP,
8161,GO:0031861,1,0.992170027168696,0,1,prolactin-releasing peptide receptor binding,MF,
8162,GO:0031862,1,0.987403295237915,0,2,prostanoid receptor binding,MF,
8163,GO:0031867,1,0.993377446664386,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8164,GO:0031870,1,0.993986332265888,0,1,thromboxane A2 receptor binding,MF,
8165,GO:0031871,1,0.979289591337012,0,3,proteinase activated receptor binding,MF,
8166,GO:0031877,1,0.993986332268891,0,1,somatostatin receptor binding,MF,
8167,GO:0031883,1,0.992185031705443,0,1,taste receptor binding,MF,
8168,GO:0031893,1,0.978149507394837,0,3,vasopressin receptor binding,MF,
8169,GO:0031894,1,0.985842175344579,0,2,V1A vasopressin receptor binding,MF,
8170,GO:0031895,1,0.992170027168696,0,1,V1B vasopressin receptor binding,MF,
8171,GO:0031896,1,0.992197722201075,0,1,V2 vasopressin receptor binding,MF,
8173,GO:0031902,1,0.445976882221423,0,109,late endosome membrane,CC,
8175,GO:0031904,1,0.806678128997469,0,29,endosome lumen,CC,
8176,GO:0031905,1,0.98597134056898,0,2,early endosome lumen,CC,
8177,GO:0031906,1,0.947062072249766,0,7,late endosome lumen,CC,
8179,GO:0031914,1,0.965230549600093,0,5,negative regulation of synaptic plasticity,BP,
8180,GO:0031915,1,0.937213764010129,0,9,positive regulation of synaptic plasticity,BP,
8182,GO:0031930,1,0.992170027168696,0,1,mitochondria-nucleus signaling pathway,BP,
8183,GO:0031931,1,0.952480963896014,0,7,TORC1 complex,CC,
8184,GO:0031932,1,0.916597760697398,0,12,TORC2 complex,CC,
8185,GO:0031933,1,0.978508143976538,0,3,telomeric heterochromatin,CC,
8186,GO:0031935,1,0.867876435515675,0,21,regulation of chromatin silencing,BP,
8187,GO:0031936,1,0.940575300269225,0,9,negative regulation of chromatin silencing,BP,
8188,GO:0031937,1,0.948669282860123,0,8,positive regulation of chromatin silencing,BP,
8189,GO:0031938,1,0.984404143975898,0,2,regulation of chromatin silencing at telomere,BP,
8190,GO:0031940,1,0.992170027168696,0,1,positive regulation of chromatin silencing at telomere,BP,
8191,GO:0031941,1,0.829734563982469,0,27,filamentous actin,CC,
8192,GO:0031943,1,0.937243064468653,0,9,regulation of glucocorticoid metabolic process,BP,
8193,GO:0031944,1,0.964314930385896,0,5,negative regulation of glucocorticoid metabolic process,BP,
8194,GO:0031945,1,0.993434523207477,0,1,positive regulation of glucocorticoid metabolic process,BP,
8195,GO:0031946,1,0.952100640560282,0,7,regulation of glucocorticoid biosynthetic process,BP,
8196,GO:0031947,1,0.964314930385896,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8197,GO:0031948,1,0.993434523207477,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8198,GO:0031952,1,0.75700071673564,0,40,regulation of protein autophosphorylation,BP,
8199,GO:0031953,1,0.924528730328085,0,11,negative regulation of protein autophosphorylation,BP,
8200,GO:0031954,1,0.841725631516268,0,25,positive regulation of protein autophosphorylation,BP,
8201,GO:0031957,1,0.928130834403764,0,10,very long-chain fatty acid-CoA ligase activity,MF,
8202,GO:0031958,1,0.897677028956184,0,16,corticosteroid receptor signaling pathway,BP,
8203,GO:0031959,1,0.993975941982073,0,1,mineralocorticoid receptor signaling pathway,BP,
8205,GO:0031962,1,0.993986332265019,0,1,mineralocorticoid receptor binding,MF,
8216,GO:0031984,1,0.116766088531564,0,300,organelle subcompartment,CC,
8217,GO:0031985,1,0.528918885664184,0,90,Golgi cisterna,CC,
8218,GO:0031987,1,0.938158864801126,0,9,locomotion involved in locomotory behavior,BP,
8219,GO:0031989,1,0.984400887813367,0,2,bombesin receptor signaling pathway,BP,
8220,GO:0031990,1,0.986252993835585,0,2,mRNA export from nucleus in response to heat stress,BP,
8221,GO:0031994,1,0.921799913066388,0,12,insulin-like growth factor I binding,MF,
8222,GO:0031995,1,0.944379413681054,0,8,insulin-like growth factor II binding,MF,
8223,GO:0031996,1,0.902713095330348,0,14,thioesterase binding,MF,
8224,GO:0031997,1,0.978215105034106,0,3,N-terminal myristoylation domain binding,MF,
8225,GO:0031998,1,0.905716942453882,0,15,regulation of fatty acid beta-oxidation,BP,
8226,GO:0031999,1,0.97296659754725,0,4,negative regulation of fatty acid beta-oxidation,BP,
8227,GO:0032000,1,0.941544064950128,0,9,positive regulation of fatty acid beta-oxidation,BP,
8228,GO:0032002,1,0.976941238062225,0,3,interleukin-28 receptor complex,CC,
8229,GO:0032003,1,0.992294630214608,0,1,interleukin-28 receptor binding,MF,
8232,GO:0032008,1,0.79124398610695,0,32,positive regulation of TOR signaling,BP,
8233,GO:0032009,1,0.948642012457018,0,8,early phagosome,CC,
8234,GO:0032010,1,0.962138745854767,0,5,phagolysosome,CC,
8235,GO:0032011,1,0.908830345780237,0,15,ARF protein signal transduction,BP,
8236,GO:0032012,1,0.908830345780237,0,15,regulation of ARF protein signal transduction,BP,
8237,GO:0032020,1,0.955475176960962,0,6,ISG15-protein conjugation,BP,
8238,GO:0032021,1,0.969530212283475,0,4,NELF complex,CC,
8239,GO:0032023,1,0.992210979877727,0,1,trypsinogen activation,BP,
8241,GO:0032025,1,0.934476289048441,0,9,response to cobalt ion,BP,
8242,GO:0032026,1,0.882424299167214,0,18,response to magnesium ion,BP,
8243,GO:0032027,1,0.958578039987181,0,6,myosin light chain binding,MF,
8244,GO:0032028,1,0.992185642957662,0,1,myosin head/neck binding,MF,
8245,GO:0032029,1,0.99398633229222,0,1,myosin tail binding,MF,
8246,GO:0032036,1,0.914673036419322,0,12,myosin heavy chain binding,MF,
8247,GO:0032038,1,0.984400887813367,0,2,myosin II heavy chain binding,MF,
8248,GO:0032039,1,0.926626437905367,0,11,integrator complex,CC,
8249,GO:0032040,1,0.8021333997221,0,30,small-subunit processome,CC,
8250,GO:0032041,1,0.926809961235156,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8251,GO:0032042,1,0.893451980877596,0,16,mitochondrial DNA metabolic process,BP,
8252,GO:0032044,1,0.98549813732286,0,2,DSIF complex,CC,
8253,GO:0032045,1,0.921746234435929,0,12,guanyl-nucleotide exchange factor complex,CC,
8254,GO:0032048,1,0.902401547565997,0,14,cardiolipin metabolic process,BP,
8255,GO:0032049,1,0.94925593221639,0,7,cardiolipin biosynthetic process,BP,
8256,GO:0032050,1,0.96610704515906,0,5,clathrin heavy chain binding,MF,
8257,GO:0032051,1,0.959171784979993,0,6,clathrin light chain binding,MF,
8258,GO:0032052,1,0.933551617680303,0,9,bile acid binding,MF,
8259,GO:0032053,1,0.978668863799448,0,3,ciliary basal body organization,BP,
8260,GO:0032055,1,0.937492321308563,0,9,negative regulation of translation in response to stress,BP,
8261,GO:0032056,1,0.958624560479613,0,6,positive regulation of translation in response to stress,BP,
8262,GO:0032057,1,0.951520060614525,0,7,negative regulation of translational initiation in response to stress,BP,
8263,GO:0032058,1,0.973770954566695,0,4,positive regulation of translational initiation in response to stress,BP,
8264,GO:0032059,1,0.951378272255416,0,7,bleb,CC,
8265,GO:0032060,1,0.932292754730119,0,10,bleb assembly,BP,
8266,GO:0032066,1,0.980500579328631,0,3,nucleolus to nucleoplasm transport,BP,
8267,GO:0032069,1,0.827266489475737,0,26,regulation of nuclease activity,BP,
8268,GO:0032070,1,0.928170123467509,0,10,regulation of deoxyribonuclease activity,BP,
8269,GO:0032071,1,0.942695383663673,0,8,regulation of endodeoxyribonuclease activity,BP,
8270,GO:0032072,1,0.992973583141805,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8271,GO:0032074,1,0.949150942967085,0,7,negative regulation of nuclease activity,BP,
8272,GO:0032075,1,0.896035212929472,0,15,positive regulation of nuclease activity,BP,
8273,GO:0032076,1,0.984598823172264,0,2,negative regulation of deoxyribonuclease activity,BP,
8274,GO:0032077,1,0.963239744462218,0,5,positive regulation of deoxyribonuclease activity,BP,
8275,GO:0032078,1,0.992170027168696,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8276,GO:0032079,1,0.97084317022419,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8278,GO:0032089,1,0.986512005789512,0,2,NACHT domain binding,MF,
8280,GO:0032091,1,0.55550663207094,0,81,negative regulation of protein binding,BP,
8282,GO:0032093,1,0.992294630214608,0,1,SAM domain binding,MF,
8283,GO:0032094,1,0.765131950959871,0,36,response to food,BP,
8284,GO:0032095,1,0.879699037017031,0,17,regulation of response to food,BP,
8285,GO:0032096,1,0.927306353717523,0,10,negative regulation of response to food,BP,
8286,GO:0032097,1,0.969044788238166,0,4,positive regulation of response to food,BP,
8287,GO:0032098,1,0.853466229410449,0,21,regulation of appetite,BP,
8288,GO:0032099,1,0.927306353717523,0,10,negative regulation of appetite,BP,
8289,GO:0032100,1,0.969044788238166,0,4,positive regulation of appetite,BP,
8291,GO:0032102,1,0.166050983855563,0,246,negative regulation of response to external stimulus,BP,
8293,GO:0032104,1,0.843409266614866,0,23,regulation of response to extracellular stimulus,BP,
8294,GO:0032105,1,0.914490212171917,0,12,negative regulation of response to extracellular stimulus,BP,
8295,GO:0032106,1,0.95403701676758,0,6,positive regulation of response to extracellular stimulus,BP,
8296,GO:0032107,1,0.843409266614866,0,23,regulation of response to nutrient levels,BP,
8297,GO:0032108,1,0.914490212171917,0,12,negative regulation of response to nutrient levels,BP,
8298,GO:0032109,1,0.95403701676758,0,6,positive regulation of response to nutrient levels,BP,
8299,GO:0032113,1,0.992170027168696,0,1,regulation of carbohydrate phosphatase activity,BP,
8300,GO:0032116,1,0.986326940292247,0,2,SMC loading complex,CC,
8301,GO:0032119,1,0.916752464554141,0,12,sequestering of zinc ion,BP,
8302,GO:0032127,1,0.986335096722758,0,2,dense core granule membrane,CC,
8303,GO:0032129,1,0.985603820126152,0,2,histone deacetylase activity (H3-K9 specific),MF,
8304,GO:0032133,1,0.961681637090758,0,5,chromosome passenger complex,CC,
8305,GO:0032135,1,0.958802259744472,0,6,DNA insertion or deletion binding,MF,
8306,GO:0032137,1,0.978846398478203,0,3,guanine/thymine mispair binding,MF,
8307,GO:0032138,1,0.973019733455519,0,4,single base insertion or deletion binding,MF,
8308,GO:0032139,1,0.978887467364601,0,3,dinucleotide insertion or deletion binding,MF,
8309,GO:0032142,1,0.980422141835074,0,3,single guanine insertion binding,MF,
8310,GO:0032143,1,0.986481832355567,0,2,single thymine insertion binding,MF,
8311,GO:0032144,1,0.993929645472371,0,1,4-aminobutyrate transaminase complex,CC,
8312,GO:0032145,1,0.993929645472371,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8315,GO:0032153,1,0.666717279879662,0,57,cell division site,CC,
8316,GO:0032154,1,0.709350025130408,0,48,cleavage furrow,CC,
8317,GO:0032155,1,0.666717279879662,0,57,cell division site part,CC,
8318,GO:0032156,1,0.950409540186127,0,7,septin cytoskeleton,CC,
8319,GO:0032173,1,0.992572981401073,0,1,septin collar,CC,
8320,GO:0032181,1,0.986613434020173,0,2,dinucleotide repeat insertion binding,MF,
8321,GO:0032182,1,0.424127533458706,0,121,ubiquitin-like protein binding,MF,
8322,GO:0032183,1,0.895234119358751,0,16,SUMO binding,MF,
8323,GO:0032184,1,0.967215036344646,0,5,SUMO polymer binding,MF,
8324,GO:0032185,1,0.986242144179144,0,2,septin cytoskeleton organization,BP,
8325,GO:0032190,1,0.961540208671505,0,5,acrosin binding,MF,
8326,GO:0032194,1,0.993199845739775,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8327,GO:0032196,1,0.889736211933459,0,16,transposition,BP,
8328,GO:0032197,1,0.993458230968205,0,1,transposition, RNA-mediated,BP,
8329,GO:0032200,1,0.309780714057422,0,160,telomere organization,BP,
8330,GO:0032201,1,0.959470045484504,0,6,telomere maintenance via semi-conservative replication,BP,
8331,GO:0032202,1,0.970445368789435,0,4,telomere assembly,BP,
8332,GO:0032203,1,0.992171452029609,0,1,telomere formation via telomerase,BP,
8333,GO:0032204,1,0.600474442231379,0,71,regulation of telomere maintenance,BP,
8334,GO:0032205,1,0.805177843251859,0,31,negative regulation of telomere maintenance,BP,
8335,GO:0032206,1,0.70535604844905,0,48,positive regulation of telomere maintenance,BP,
8336,GO:0032207,1,0.992492073226113,0,1,regulation of telomere maintenance via recombination,BP,
8337,GO:0032208,1,0.992492073226113,0,1,negative regulation of telomere maintenance via recombination,BP,
8338,GO:0032210,1,0.71158375937707,0,47,regulation of telomere maintenance via telomerase,BP,
8339,GO:0032211,1,0.897242374739752,0,15,negative regulation of telomere maintenance via telomerase,BP,
8340,GO:0032212,1,0.785381627460722,0,33,positive regulation of telomere maintenance via telomerase,BP,
8341,GO:0032213,1,0.985067205817004,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8342,GO:0032214,1,0.985067205817004,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8343,GO:0032217,1,0.977060181581946,0,3,riboflavin transporter activity,MF,
8344,GO:0032218,1,0.977060181581946,0,3,riboflavin transport,BP,
8345,GO:0032222,1,0.934465688032393,0,9,regulation of synaptic transmission, cholinergic,BP,
8346,GO:0032223,1,0.992302843322646,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8347,GO:0032224,1,0.94898265027565,0,7,positive regulation of synaptic transmission, cholinergic,BP,
8348,GO:0032225,1,0.889656767870245,0,16,regulation of synaptic transmission, dopaminergic,BP,
8349,GO:0032226,1,0.948513743716427,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8350,GO:0032227,1,0.980479044625839,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8351,GO:0032228,1,0.808399307391521,0,31,regulation of synaptic transmission, GABAergic,BP,
8352,GO:0032229,1,0.957000760669308,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8353,GO:0032230,1,0.912602035613951,0,13,positive regulation of synaptic transmission, GABAergic,BP,
8354,GO:0032231,1,0.566110526230199,0,82,regulation of actin filament bundle assembly,BP,
8355,GO:0032232,1,0.854610895270834,0,23,negative regulation of actin filament bundle assembly,BP,
8356,GO:0032233,1,0.696670595240417,0,51,positive regulation of actin filament bundle assembly,BP,
8357,GO:0032237,1,0.973641097779881,0,4,activation of store-operated calcium channel activity,BP,
8358,GO:0032239,1,0.914078522213733,0,13,regulation of nucleobase-containing compound transport,BP,
8359,GO:0032240,1,0.988008449100365,0,2,negative regulation of nucleobase-containing compound transport,BP,
8360,GO:0032241,1,0.96998811260727,0,4,positive regulation of nucleobase-containing compound transport,BP,
8361,GO:0032242,1,0.992449186954241,0,1,regulation of nucleoside transport,BP,
8362,GO:0032244,1,0.992449186954241,0,1,positive regulation of nucleoside transport,BP,
8363,GO:0032252,1,0.982015377030282,0,3,secretory granule localization,BP,
8365,GO:0032261,1,0.949096217710124,0,7,purine nucleotide salvage,BP,
8366,GO:0032262,1,0.961544141240002,0,5,pyrimidine nucleotide salvage,BP,
8367,GO:0032264,1,0.971740066168556,0,4,IMP salvage,BP,
8375,GO:0032274,1,0.90497606227197,0,14,gonadotropin secretion,BP,
8376,GO:0032275,1,0.939536369823131,0,9,luteinizing hormone secretion,BP,
8377,GO:0032276,1,0.922144292394593,0,11,regulation of gonadotropin secretion,BP,
8378,GO:0032277,1,0.948787532072261,0,7,negative regulation of gonadotropin secretion,BP,
8379,GO:0032278,1,0.949851171627742,0,7,positive regulation of gonadotropin secretion,BP,
8380,GO:0032279,1,0.268144136233319,0,194,asymmetric synapse,CC,
8381,GO:0032280,1,0.972325209070939,0,4,symmetric synapse,CC,
8383,GO:0032286,1,0.971291236308852,0,4,central nervous system myelin maintenance,BP,
8384,GO:0032287,1,0.952644421692011,0,7,peripheral nervous system myelin maintenance,BP,
8385,GO:0032288,1,0.883325195072628,0,18,myelin assembly,BP,
8386,GO:0032289,1,0.977602060084451,0,3,central nervous system myelin formation,BP,
8387,GO:0032290,1,0.986326940292743,0,2,peripheral nervous system myelin formation,BP,
8388,GO:0032291,1,0.895203821654797,0,15,axon ensheathment in central nervous system,BP,
8389,GO:0032292,1,0.858505873372685,0,22,peripheral nervous system axon ensheathment,BP,
8390,GO:0032296,1,0.972520205751565,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8391,GO:0032298,1,0.992204223838517,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8392,GO:0032299,1,0.976928753753139,0,3,ribonuclease H2 complex,CC,
8393,GO:0032300,1,0.947188466099873,0,8,mismatch repair complex,CC,
8394,GO:0032301,1,0.986481832355567,0,2,MutSalpha complex,CC,
8395,GO:0032302,1,0.986613434020173,0,2,MutSbeta complex,CC,
8396,GO:0032303,1,0.881183688277776,0,17,regulation of icosanoid secretion,BP,
8397,GO:0032304,1,0.978819378928926,0,3,negative regulation of icosanoid secretion,BP,
8398,GO:0032305,1,0.893268390711419,0,15,positive regulation of icosanoid secretion,BP,
8399,GO:0032306,1,0.925418758568574,0,10,regulation of prostaglandin secretion,BP,
8400,GO:0032308,1,0.925418758568574,0,10,positive regulation of prostaglandin secretion,BP,
8401,GO:0032309,1,0.725869217283541,0,43,icosanoid secretion,BP,
8402,GO:0032310,1,0.907424258918004,0,13,prostaglandin secretion,BP,
8404,GO:0032324,1,0.949648605292635,0,7,molybdopterin cofactor biosynthetic process,BP,
8405,GO:0032328,1,0.932336435995472,0,10,alanine transport,BP,
8406,GO:0032329,1,0.926694178980399,0,10,serine transport,BP,
8408,GO:0032331,1,0.878370830928479,0,18,negative regulation of chondrocyte differentiation,BP,
8410,GO:0032341,1,0.937864699578391,0,9,aldosterone metabolic process,BP,
8411,GO:0032342,1,0.937864699578391,0,9,aldosterone biosynthetic process,BP,
8412,GO:0032344,1,0.957366684549209,0,6,regulation of aldosterone metabolic process,BP,
8413,GO:0032345,1,0.970818122381158,0,4,negative regulation of aldosterone metabolic process,BP,
8414,GO:0032346,1,0.986147408353077,0,2,positive regulation of aldosterone metabolic process,BP,
8415,GO:0032347,1,0.957366684549209,0,6,regulation of aldosterone biosynthetic process,BP,
8416,GO:0032348,1,0.970818122381158,0,4,negative regulation of aldosterone biosynthetic process,BP,
8417,GO:0032349,1,0.986147408353077,0,2,positive regulation of aldosterone biosynthetic process,BP,
8418,GO:0032350,1,0.830851693237294,0,26,regulation of hormone metabolic process,BP,
8419,GO:0032351,1,0.956762235773478,0,6,negative regulation of hormone metabolic process,BP,
8420,GO:0032352,1,0.925933906773212,0,11,positive regulation of hormone metabolic process,BP,
8421,GO:0032353,1,0.964314930385896,0,5,negative regulation of hormone biosynthetic process,BP,
8424,GO:0032356,1,0.94681569357429,0,8,oxidized DNA binding,MF,
8425,GO:0032357,1,0.94681569357429,0,8,oxidized purine DNA binding,MF,
8426,GO:0032358,1,0.992170027168696,0,1,oxidized pyrimidine DNA binding,MF,
8427,GO:0032361,1,0.992177118014353,0,1,pyridoxal phosphate catabolic process,BP,
8428,GO:0032364,1,0.958217917175338,0,6,oxygen homeostasis,BP,
8441,GO:0032377,1,0.951160036224338,0,7,regulation of intracellular lipid transport,BP,
8442,GO:0032378,1,0.993192967637625,0,1,negative regulation of intracellular lipid transport,BP,
8443,GO:0032379,1,0.977038016944415,0,3,positive regulation of intracellular lipid transport,BP,
8444,GO:0032380,1,0.951160036224338,0,7,regulation of intracellular sterol transport,BP,
8445,GO:0032381,1,0.993192967637625,0,1,negative regulation of intracellular sterol transport,BP,
8446,GO:0032382,1,0.977038016944415,0,3,positive regulation of intracellular sterol transport,BP,
8447,GO:0032383,1,0.951160036224338,0,7,regulation of intracellular cholesterol transport,BP,
8448,GO:0032384,1,0.993192967637625,0,1,negative regulation of intracellular cholesterol transport,BP,
8449,GO:0032385,1,0.977038016944415,0,3,positive regulation of intracellular cholesterol transport,BP,
8451,GO:0032387,1,0.424927574982333,0,118,negative regulation of intracellular transport,BP,
8452,GO:0032388,1,0.135008760593513,0,278,positive regulation of intracellular transport,BP,
8453,GO:0032389,1,0.971954142737177,0,4,MutLalpha complex,CC,
8454,GO:0032391,1,0.789247850100036,0,34,photoreceptor connecting cilium,CC,
8455,GO:0032392,1,0.569749953865993,0,80,DNA geometric change,BP,
8456,GO:0032393,1,0.932288316203254,0,9,MHC class I receptor activity,MF,
8457,GO:0032394,1,0.984524522725182,0,2,MHC class Ib receptor activity,MF,
8458,GO:0032395,1,0.925185857898144,0,10,MHC class II receptor activity,MF,
8459,GO:0032396,1,0.969674269116027,0,4,inhibitory MHC class I receptor activity,MF,
8460,GO:0032397,1,0.992170027168696,0,1,activating MHC class I receptor activity,MF,
8461,GO:0032398,1,0.992170030038307,0,1,MHC class Ib protein complex,CC,
8462,GO:0032399,1,0.976692112990833,0,3,HECT domain binding,MF,
8463,GO:0032400,1,0.829845222890933,0,25,melanosome localization,BP,
8464,GO:0032401,1,0.842745021403801,0,23,establishment of melanosome localization,BP,
8465,GO:0032402,1,0.847850274619969,0,22,melanosome transport,BP,
8467,GO:0032404,1,0.94310109144205,0,8,mismatch repair complex binding,MF,
8468,GO:0032405,1,0.965250808116674,0,5,MutLalpha complex binding,MF,
8469,GO:0032407,1,0.963576322275015,0,5,MutSalpha complex binding,MF,
8471,GO:0032410,1,0.634033471929269,0,63,negative regulation of transporter activity,BP,
8474,GO:0032413,1,0.671169375545627,0,55,negative regulation of ion transmembrane transporter activity,BP,
8476,GO:0032415,1,0.955271330770227,0,6,regulation of sodium:proton antiporter activity,BP,
8477,GO:0032416,1,0.984408045288502,0,2,negative regulation of sodium:proton antiporter activity,BP,
8478,GO:0032417,1,0.970405369952311,0,4,positive regulation of sodium:proton antiporter activity,BP,
8479,GO:0032418,1,0.645332322140418,0,60,lysosome localization,BP,
8480,GO:0032419,1,0.992202596494721,0,1,extrinsic component of lysosome membrane,CC,
8481,GO:0032420,1,0.774573197629948,0,36,stereocilium,CC,
8482,GO:0032421,1,0.730137006077134,0,44,stereocilium bundle,CC,
8483,GO:0032422,1,0.984566124646747,0,2,purine-rich negative regulatory element binding,MF,
8484,GO:0032423,1,0.979486892911791,0,3,regulation of mismatch repair,BP,
8485,GO:0032425,1,0.985721653545751,0,2,positive regulation of mismatch repair,BP,
8486,GO:0032426,1,0.942765094254676,0,8,stereocilium tip,CC,
8487,GO:0032427,1,0.986063672029794,0,2,GBD domain binding,MF,
8488,GO:0032428,1,0.993130508675134,0,1,beta-N-acetylgalactosaminidase activity,MF,
8492,GO:0032432,1,0.683716812103721,0,55,actin filament bundle,CC,
8493,GO:0032433,1,0.917412869371493,0,13,filopodium tip,CC,
8494,GO:0032434,1,0.465173498429762,0,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8495,GO:0032435,1,0.84655700666421,0,23,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8496,GO:0032436,1,0.581520854426691,0,75,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8497,GO:0032437,1,0.972660579814394,0,4,cuticular plate,CC,
8498,GO:0032438,1,0.833914661436512,0,25,melanosome organization,BP,
8499,GO:0032439,1,0.97338168995501,0,4,endosome localization,BP,
8500,GO:0032440,1,0.992170027168696,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8501,GO:0032444,1,0.980295742072433,0,3,activin responsive factor complex,CC,
8502,GO:0032445,1,0.992219791379029,0,1,fructose import,BP,
8504,GO:0032448,1,0.992170027168696,0,1,DNA hairpin binding,MF,
8505,GO:0032449,1,0.980182072521061,0,3,CBM complex,CC,
8506,GO:0032450,1,0.981107274576203,0,3,maltose alpha-glucosidase activity,MF,
8507,GO:0032451,1,0.797583958690042,0,34,demethylase activity,MF,
8508,GO:0032452,1,0.859512484755081,0,24,histone demethylase activity,MF,
8509,GO:0032453,1,0.962602752099328,0,6,histone demethylase activity (H3-K4 specific),MF,
8510,GO:0032454,1,0.944111997097976,0,9,histone demethylase activity (H3-K9 specific),MF,
8511,GO:0032455,1,0.971884731399148,0,4,nerve growth factor processing,BP,
8512,GO:0032456,1,0.800532622977902,0,32,endocytic recycling,BP,
8513,GO:0032458,1,0.993410270758763,0,1,slow endocytic recycling,BP,
8514,GO:0032459,1,0.779775892806988,0,34,regulation of protein oligomerization,BP,
8515,GO:0032460,1,0.89585288457003,0,15,negative regulation of protein oligomerization,BP,
8516,GO:0032461,1,0.869328699174376,0,19,positive regulation of protein oligomerization,BP,
8517,GO:0032462,1,0.888937531178537,0,16,regulation of protein homooligomerization,BP,
8518,GO:0032463,1,0.928580883864291,0,10,negative regulation of protein homooligomerization,BP,
8519,GO:0032464,1,0.950104712891302,0,7,positive regulation of protein homooligomerization,BP,
8520,GO:0032465,1,0.623116702713992,0,66,regulation of cytokinesis,BP,
8521,GO:0032466,1,0.950978547719958,0,7,negative regulation of cytokinesis,BP,
8522,GO:0032467,1,0.766749633804147,0,37,positive regulation of cytokinesis,BP,
8523,GO:0032468,1,0.99305020722581,0,1,Golgi calcium ion homeostasis,BP,
8524,GO:0032469,1,0.867266991186555,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
8525,GO:0032470,1,0.987110524075327,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8526,GO:0032471,1,0.948683719908023,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8527,GO:0032472,1,0.985279307936954,0,2,Golgi calcium ion transport,BP,
8528,GO:0032473,1,0.993986332281396,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8529,GO:0032474,1,0.987330484596123,0,2,otolith morphogenesis,BP,
8533,GO:0032482,1,0.958857182746038,0,6,Rab protein signal transduction,BP,
8534,GO:0032483,1,0.973959090553572,0,4,regulation of Rab protein signal transduction,BP,
8535,GO:0032484,1,0.980910807950195,0,3,Ral protein signal transduction,BP,
8536,GO:0032485,1,0.980910807950195,0,3,regulation of Ral protein signal transduction,BP,
8537,GO:0032486,1,0.916832033639733,0,13,Rap protein signal transduction,BP,
8538,GO:0032487,1,0.98111209164547,0,3,regulation of Rap protein signal transduction,BP,
8539,GO:0032488,1,0.942502838856333,0,8,Cdc42 protein signal transduction,BP,
8540,GO:0032489,1,0.963214305068761,0,5,regulation of Cdc42 protein signal transduction,BP,
8541,GO:0032490,1,0.926507329525738,0,11,detection of molecule of bacterial origin,BP,
8542,GO:0032493,1,0.950896426311141,0,7,response to bacterial lipoprotein,BP,
8543,GO:0032494,1,0.942756602073111,0,8,response to peptidoglycan,BP,
8544,GO:0032495,1,0.908771046903163,0,14,response to muramyl dipeptide,BP,
8546,GO:0032497,1,0.970996309961644,0,4,detection of lipopolysaccharide,BP,
8547,GO:0032498,1,0.993803794797847,0,1,detection of muramyl dipeptide,BP,
8548,GO:0032499,1,0.986021961557034,0,2,detection of peptidoglycan,BP,
8549,GO:0032500,1,0.993803794797847,0,1,muramyl dipeptide binding,MF,
8553,GO:0032506,1,0.876183908858714,0,19,cytokinetic process,BP,
8554,GO:0032507,1,0.54288853304448,0,85,maintenance of protein location in cell,BP,
8555,GO:0032508,1,0.607809258834003,0,71,DNA duplex unwinding,BP,
8556,GO:0032509,1,0.917291540084393,0,12,endosome transport via multivesicular body sorting pathway,BP,
8557,GO:0032510,1,0.971836257795438,0,4,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8558,GO:0032511,1,0.957095793836062,0,6,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8560,GO:0032516,1,0.901973644212102,0,15,positive regulation of phosphoprotein phosphatase activity,BP,
8561,GO:0032525,1,0.929666541939192,0,10,somite rostral/caudal axis specification,BP,
8563,GO:0032527,1,0.768178741755524,0,37,protein exit from endoplasmic reticulum,BP,
8564,GO:0032528,1,0.855695019379852,0,23,microvillus organization,BP,
8565,GO:0032530,1,0.913433305333327,0,13,regulation of microvillus organization,BP,
8566,GO:0032532,1,0.950702879173127,0,7,regulation of microvillus length,BP,
8567,GO:0032534,1,0.960813054749451,0,6,regulation of microvillus assembly,BP,
8569,GO:0032536,1,0.912347849390551,0,13,regulation of cell projection size,BP,
8570,GO:0032541,1,0.972096388969859,0,4,cortical endoplasmic reticulum,CC,
8571,GO:0032542,1,0.985386970467152,0,2,sulfiredoxin activity,MF,
8573,GO:0032545,1,0.985871647528918,0,2,CURI complex,CC,
8576,GO:0032551,1,0.986320365615544,0,2,pyrimidine ribonucleoside binding,MF,
8577,GO:0032552,1,0.955375599018226,0,6,deoxyribonucleotide binding,MF,
8579,GO:0032554,1,0.962917432957347,0,5,purine deoxyribonucleotide binding,MF,
8581,GO:0032556,1,0.992170027168696,0,1,pyrimidine deoxyribonucleotide binding,MF,
8582,GO:0032557,1,0.978616163320982,0,3,pyrimidine ribonucleotide binding,MF,
8583,GO:0032558,1,0.969948727935648,0,4,adenyl deoxyribonucleotide binding,MF,
8585,GO:0032560,1,0.992752580435624,0,1,guanyl deoxyribonucleotide binding,MF,
8587,GO:0032564,1,0.969948727935648,0,4,dATP binding,MF,
8588,GO:0032567,1,0.992752580435624,0,1,dGTP binding,MF,
8589,GO:0032570,1,0.740459166829541,0,41,response to progesterone,BP,
8590,GO:0032571,1,0.964377155918097,0,5,response to vitamin K,BP,
8591,GO:0032574,1,0.993485425541519,0,1,5'-3' RNA helicase activity,MF,
8592,GO:0032575,1,0.993485425541519,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8593,GO:0032580,1,0.596078100420395,0,73,Golgi cisterna membrane,CC,
8594,GO:0032581,1,0.992171215411441,0,1,ER-dependent peroxisome organization,BP,
8595,GO:0032584,1,0.956552603663797,0,6,growth cone membrane,CC,
8596,GO:0032585,1,0.93525888856642,0,9,multivesicular body membrane,CC,
8597,GO:0032587,1,0.575491295582936,0,80,ruffle membrane,CC,
8598,GO:0032588,1,0.560766152328953,0,80,trans-Golgi network membrane,CC,
8599,GO:0032589,1,0.779091425839396,0,36,neuron projection membrane,CC,
8600,GO:0032590,1,0.860182360839413,0,21,dendrite membrane,CC,
8601,GO:0032591,1,0.942154343162496,0,9,dendritic spine membrane,CC,
8603,GO:0032593,1,0.951549225970895,0,7,insulin-responsive compartment,CC,
8604,GO:0032594,1,0.934429420726524,0,9,protein transport within lipid bilayer,BP,
8605,GO:0032595,1,0.992193904126244,0,1,B cell receptor transport within lipid bilayer,BP,
8606,GO:0032596,1,0.95658817645031,0,6,protein transport into membrane raft,BP,
8607,GO:0032597,1,0.992193904126244,0,1,B cell receptor transport into membrane raft,BP,
8608,GO:0032599,1,0.992193904126244,0,1,protein transport out of membrane raft,BP,
8609,GO:0032600,1,0.992193904126244,0,1,chemokine receptor transport out of membrane raft,BP,
8610,GO:0032601,1,0.984400887813367,0,2,connective tissue growth factor production,BP,
8612,GO:0032603,1,0.992170027168696,0,1,fractalkine production,BP,
8613,GO:0032604,1,0.895832528540835,0,15,granulocyte macrophage colony-stimulating factor production,BP,
8614,GO:0032605,1,0.992752580435624,0,1,hepatocyte growth factor production,BP,
8619,GO:0032610,1,0.947365499172541,0,7,interleukin-1 alpha production,BP,
8623,GO:0032615,1,0.688365719169215,0,51,interleukin-12 production,BP,
8624,GO:0032616,1,0.855959178155209,0,21,interleukin-13 production,BP,
8625,GO:0032618,1,0.984401262029482,0,2,interleukin-15 production,BP,
8626,GO:0032620,1,0.827977322983742,0,25,interleukin-17 production,BP,
8627,GO:0032621,1,0.952339856144419,0,7,interleukin-18 production,BP,
8629,GO:0032625,1,0.993115015893865,0,1,interleukin-21 production,BP,
8630,GO:0032627,1,0.941788077807021,0,8,interleukin-23 production,BP,
8631,GO:0032632,1,0.972031748492111,0,4,interleukin-3 production,BP,
8632,GO:0032633,1,0.789630762632438,0,32,interleukin-4 production,BP,
8633,GO:0032634,1,0.862242279844984,0,20,interleukin-5 production,BP,
8636,GO:0032639,1,0.984822555801498,0,2,TRAIL production,BP,
8638,GO:0032641,1,0.97737239890728,0,3,lymphotoxin A production,BP,
8640,GO:0032643,1,0.992170027168696,0,1,regulation of connective tissue growth factor production,BP,
8641,GO:0032644,1,0.992170027168696,0,1,regulation of fractalkine production,BP,
8642,GO:0032645,1,0.895832528540835,0,15,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8643,GO:0032646,1,0.992752580435624,0,1,regulation of hepatocyte growth factor production,BP,
8647,GO:0032650,1,0.954844594050024,0,6,regulation of interleukin-1 alpha production,BP,
8651,GO:0032655,1,0.698562809380862,0,49,regulation of interleukin-12 production,BP,
8652,GO:0032656,1,0.869537899451676,0,19,regulation of interleukin-13 production,BP,
8653,GO:0032658,1,0.992170401098731,0,1,regulation of interleukin-15 production,BP,
8654,GO:0032660,1,0.847396121425687,0,22,regulation of interleukin-17 production,BP,
8655,GO:0032661,1,0.964632107794518,0,5,regulation of interleukin-18 production,BP,
8656,GO:0032663,1,0.693271323014413,0,50,regulation of interleukin-2 production,BP,
8657,GO:0032667,1,0.941788077807021,0,8,regulation of interleukin-23 production,BP,
8658,GO:0032672,1,0.978492900591914,0,3,regulation of interleukin-3 production,BP,
8659,GO:0032673,1,0.817385263833712,0,27,regulation of interleukin-4 production,BP,
8660,GO:0032674,1,0.869054385947225,0,19,regulation of interleukin-5 production,BP,
8663,GO:0032679,1,0.984822555801498,0,2,regulation of TRAIL production,BP,
8665,GO:0032681,1,0.992370359992395,0,1,regulation of lymphotoxin A production,BP,
8666,GO:0032682,1,0.886826776870362,0,16,negative regulation of chemokine production,BP,
8667,GO:0032685,1,0.992816301861936,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8668,GO:0032686,1,0.992752580435624,0,1,negative regulation of hepatocyte growth factor production,BP,
8671,GO:0032689,1,0.791002666611818,0,31,negative regulation of interferon-gamma production,BP,
8672,GO:0032690,1,0.992170027168696,0,1,negative regulation of interleukin-1 alpha production,BP,
8673,GO:0032691,1,0.91463394344635,0,12,negative regulation of interleukin-1 beta production,BP,
8674,GO:0032692,1,0.87386862598753,0,18,negative regulation of interleukin-1 production,BP,
8675,GO:0032693,1,0.886641588359355,0,16,negative regulation of interleukin-10 production,BP,
8676,GO:0032695,1,0.899763096504833,0,15,negative regulation of interleukin-12 production,BP,
8677,GO:0032696,1,0.963414664641687,0,5,negative regulation of interleukin-13 production,BP,
8678,GO:0032700,1,0.921247687933837,0,11,negative regulation of interleukin-17 production,BP,
8679,GO:0032701,1,0.985042141126281,0,2,negative regulation of interleukin-18 production,BP,
8680,GO:0032703,1,0.87283975485044,0,18,negative regulation of interleukin-2 production,BP,
8681,GO:0032707,1,0.986263904371772,0,2,negative regulation of interleukin-23 production,BP,
8682,GO:0032712,1,0.992220015278462,0,1,negative regulation of interleukin-3 production,BP,
8683,GO:0032713,1,0.956457581810635,0,6,negative regulation of interleukin-4 production,BP,
8684,GO:0032714,1,0.948628755489451,0,7,negative regulation of interleukin-5 production,BP,
8685,GO:0032715,1,0.768982398895608,0,36,negative regulation of interleukin-6 production,BP,
8686,GO:0032717,1,0.888558672837148,0,16,negative regulation of interleukin-8 production,BP,
8687,GO:0032720,1,0.731023231014259,0,42,negative regulation of tumor necrosis factor production,BP,
8689,GO:0032723,1,0.992170027168696,0,1,positive regulation of connective tissue growth factor production,BP,
8690,GO:0032724,1,0.992170027168696,0,1,positive regulation of fractalkine production,BP,
8691,GO:0032725,1,0.909445906962868,0,13,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8692,GO:0032727,1,0.893295558536264,0,16,positive regulation of interferon-alpha production,BP,
8695,GO:0032730,1,0.962382268921065,0,5,positive regulation of interleukin-1 alpha production,BP,
8699,GO:0032735,1,0.786681217701226,0,32,positive regulation of interleukin-12 production,BP,
8700,GO:0032736,1,0.902585245853955,0,14,positive regulation of interleukin-13 production,BP,
8701,GO:0032738,1,0.992170401098731,0,1,positive regulation of interleukin-15 production,BP,
8702,GO:0032740,1,0.90560257471182,0,13,positive regulation of interleukin-17 production,BP,
8703,GO:0032741,1,0.986395080811351,0,2,positive regulation of interleukin-18 production,BP,
8704,GO:0032743,1,0.807071485808351,0,30,positive regulation of interleukin-2 production,BP,
8705,GO:0032747,1,0.962421034384428,0,5,positive regulation of interleukin-23 production,BP,
8706,GO:0032752,1,0.986166089449839,0,2,positive regulation of interleukin-3 production,BP,
8707,GO:0032753,1,0.847988480014427,0,22,positive regulation of interleukin-4 production,BP,
8708,GO:0032754,1,0.923376249447263,0,11,positive regulation of interleukin-5 production,BP,
8711,GO:0032759,1,0.984822555801498,0,2,positive regulation of TRAIL production,BP,
8713,GO:0032761,1,0.992370359992395,0,1,positive regulation of lymphotoxin A production,BP,
8714,GO:0032762,1,0.951248252687762,0,7,mast cell cytokine production,BP,
8715,GO:0032763,1,0.964569299375547,0,5,regulation of mast cell cytokine production,BP,
8716,GO:0032764,1,0.985308181411665,0,2,negative regulation of mast cell cytokine production,BP,
8717,GO:0032765,1,0.978954291044847,0,3,positive regulation of mast cell cytokine production,BP,
8718,GO:0032767,1,0.979585533438171,0,3,copper-dependent protein binding,MF,
8721,GO:0032770,1,0.821060955674178,0,27,positive regulation of monooxygenase activity,BP,
8722,GO:0032771,1,0.993704836810665,0,1,regulation of monophenol monooxygenase activity,BP,
8723,GO:0032773,1,0.993704836810665,0,1,positive regulation of monophenol monooxygenase activity,BP,
8725,GO:0032775,1,0.993226236254198,0,1,DNA methylation on adenine,BP,
8726,GO:0032776,1,0.973596876491252,0,4,DNA methylation on cytosine,BP,
8727,GO:0032777,1,0.970411422344806,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8730,GO:0032782,1,0.959019944283179,0,6,bile acid secretion,BP,
8731,GO:0032783,1,0.986020309673956,0,2,ELL-EAF complex,CC,
8733,GO:0032785,1,0.915854136235582,0,12,negative regulation of DNA-templated transcription, elongation,BP,
8734,GO:0032786,1,0.854178611060358,0,22,positive regulation of DNA-templated transcription, elongation,BP,
8736,GO:0032788,1,0.992170027168696,0,1,saturated monocarboxylic acid metabolic process,BP,
8737,GO:0032789,1,0.992170027168696,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8738,GO:0032790,1,0.942192401332413,0,8,ribosome disassembly,BP,
8739,GO:0032792,1,0.964952679225804,0,5,negative regulation of CREB transcription factor activity,BP,
8740,GO:0032793,1,0.90711907175328,0,14,positive regulation of CREB transcription factor activity,BP,
8741,GO:0032794,1,0.909691123180939,0,14,GTPase activating protein binding,MF,
8742,GO:0032795,1,0.970520971466324,0,4,heterotrimeric G-protein binding,MF,
8743,GO:0032796,1,0.986203080780918,0,2,uropod organization,BP,
8744,GO:0032797,1,0.922780780882396,0,11,SMN complex,CC,
8745,GO:0032798,1,0.984648173044371,0,2,Swi5-Sfr1 complex,CC,
8746,GO:0032799,1,0.906569107285686,0,14,low-density lipoprotein receptor particle metabolic process,BP,
8747,GO:0032800,1,0.84478674787476,0,24,receptor biosynthetic process,BP,
8748,GO:0032801,1,0.86047338612566,0,22,receptor catabolic process,BP,
8749,GO:0032802,1,0.96433019016064,0,5,low-density lipoprotein particle receptor catabolic process,BP,
8750,GO:0032803,1,0.96433019016064,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8751,GO:0032804,1,0.985867628004563,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8752,GO:0032805,1,0.985415880322065,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8753,GO:0032806,1,0.83867924499906,0,24,carboxy-terminal domain protein kinase complex,CC,
8754,GO:0032807,1,0.978071242856875,0,3,DNA ligase IV complex,CC,
8755,GO:0032808,1,0.959351466557262,0,6,lacrimal gland development,BP,
8756,GO:0032809,1,0.874081966395453,0,19,neuronal cell body membrane,CC,
8757,GO:0032810,1,0.986155841396287,0,2,sterol response element binding,MF,
8758,GO:0032811,1,0.97087771832322,0,4,negative regulation of epinephrine secretion,BP,
8759,GO:0032812,1,0.992170027168696,0,1,positive regulation of epinephrine secretion,BP,
8762,GO:0032815,1,0.946989160061511,0,7,negative regulation of natural killer cell activation,BP,
8764,GO:0032817,1,0.934906171748947,0,9,regulation of natural killer cell proliferation,BP,
8765,GO:0032819,1,0.948566201983691,0,7,positive regulation of natural killer cell proliferation,BP,
8766,GO:0032823,1,0.917751283431478,0,12,regulation of natural killer cell differentiation,BP,
8767,GO:0032824,1,0.976694006921213,0,3,negative regulation of natural killer cell differentiation,BP,
8768,GO:0032825,1,0.952866631427965,0,7,positive regulation of natural killer cell differentiation,BP,
8769,GO:0032826,1,0.969045116557633,0,4,regulation of natural killer cell differentiation involved in immune response,BP,
8770,GO:0032827,1,0.976694006921213,0,3,negative regulation of natural killer cell differentiation involved in immune response,BP,
8771,GO:0032829,1,0.976744254474244,0,3,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8772,GO:0032831,1,0.976744254474244,0,3,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8773,GO:0032832,1,0.984400888915038,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8774,GO:0032834,1,0.984400888915038,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8775,GO:0032835,1,0.649825882920096,0,63,glomerulus development,BP,
8776,GO:0032836,1,0.937981575307674,0,10,glomerular basement membrane development,BP,
8777,GO:0032838,1,0.648583012063911,0,62,cell projection cytoplasm,CC,
8778,GO:0032839,1,0.857942151046014,0,22,dendrite cytoplasm,CC,
8779,GO:0032841,1,0.993168294074626,0,1,calcitonin binding,MF,
8782,GO:0032846,1,0.227964073070476,0,203,positive regulation of homeostatic process,BP,
8783,GO:0032847,1,0.964041166811556,0,5,regulation of cellular pH reduction,BP,
8784,GO:0032848,1,0.993385061896905,0,1,negative regulation of cellular pH reduction,BP,
8785,GO:0032849,1,0.970462213613919,0,4,positive regulation of cellular pH reduction,BP,
8790,GO:0032873,1,0.747552253874677,0,41,negative regulation of stress-activated MAPK cascade,BP,
8792,GO:0032875,1,0.95573808239042,0,7,regulation of DNA endoreduplication,BP,
8793,GO:0032876,1,0.975104618828541,0,4,negative regulation of DNA endoreduplication,BP,
8794,GO:0032877,1,0.987295181629792,0,2,positive regulation of DNA endoreduplication,BP,
8795,GO:0032878,1,0.87393884399247,0,20,regulation of establishment or maintenance of cell polarity,BP,
8798,GO:0032881,1,0.782293873971053,0,36,regulation of polysaccharide metabolic process,BP,
8799,GO:0032885,1,0.799943912786819,0,33,regulation of polysaccharide biosynthetic process,BP,
8800,GO:0032886,1,0.338424412797388,0,152,regulation of microtubule-based process,BP,
8801,GO:0032889,1,0.992281132629815,0,1,regulation of vacuole fusion, non-autophagic,BP,
8802,GO:0032890,1,0.707260016794036,0,48,regulation of organic acid transport,BP,
8803,GO:0032891,1,0.886477017458897,0,17,negative regulation of organic acid transport,BP,
8804,GO:0032892,1,0.813270404837849,0,28,positive regulation of organic acid transport,BP,
8805,GO:0032897,1,0.837936149558281,0,24,negative regulation of viral transcription,BP,
8806,GO:0032898,1,0.97265399659026,0,4,neurotrophin production,BP,
8807,GO:0032899,1,0.985920070158843,0,2,regulation of neurotrophin production,BP,
8808,GO:0032900,1,0.992449186954241,0,1,negative regulation of neurotrophin production,BP,
8809,GO:0032901,1,0.993421596342402,0,1,positive regulation of neurotrophin production,BP,
8810,GO:0032902,1,0.986545954660561,0,2,nerve growth factor production,BP,
8811,GO:0032905,1,0.938016672886619,0,9,transforming growth factor beta1 production,BP,
8812,GO:0032906,1,0.947790958263316,0,8,transforming growth factor beta2 production,BP,
8813,GO:0032907,1,0.980295333564849,0,3,transforming growth factor beta3 production,BP,
8814,GO:0032908,1,0.938016672886619,0,9,regulation of transforming growth factor beta1 production,BP,
8815,GO:0032909,1,0.947790958263316,0,8,regulation of transforming growth factor beta2 production,BP,
8816,GO:0032910,1,0.980295333564849,0,3,regulation of transforming growth factor beta3 production,BP,
8817,GO:0032911,1,0.98079901304023,0,3,negative regulation of transforming growth factor beta1 production,BP,
8818,GO:0032912,1,0.986794448462231,0,2,negative regulation of transforming growth factor beta2 production,BP,
8819,GO:0032913,1,0.992193904126244,0,1,negative regulation of transforming growth factor beta3 production,BP,
8820,GO:0032914,1,0.956386578900303,0,6,positive regulation of transforming growth factor beta1 production,BP,
8821,GO:0032915,1,0.984420902610151,0,2,positive regulation of transforming growth factor beta2 production,BP,
8822,GO:0032916,1,0.988008547480399,0,2,positive regulation of transforming growth factor beta3 production,BP,
8823,GO:0032917,1,0.9767124066769,0,3,polyamine acetylation,BP,
8824,GO:0032918,1,0.9767124066769,0,3,spermidine acetylation,BP,
8825,GO:0032919,1,0.992170027168696,0,1,spermine acetylation,BP,
8826,GO:0032920,1,0.992170027168696,0,1,putrescine acetylation,BP,
8827,GO:0032922,1,0.703352378096869,0,51,circadian regulation of gene expression,BP,
8828,GO:0032924,1,0.755220901641525,0,39,activin receptor signaling pathway,BP,
8829,GO:0032925,1,0.846962241837079,0,23,regulation of activin receptor signaling pathway,BP,
8830,GO:0032926,1,0.937515575114023,0,9,negative regulation of activin receptor signaling pathway,BP,
8831,GO:0032927,1,0.946408217956487,0,8,positive regulation of activin receptor signaling pathway,BP,
8832,GO:0032928,1,0.906892597871978,0,13,regulation of superoxide anion generation,BP,
8833,GO:0032929,1,0.984420851334996,0,2,negative regulation of superoxide anion generation,BP,
8834,GO:0032930,1,0.92686581513058,0,10,positive regulation of superoxide anion generation,BP,
8835,GO:0032933,1,0.944216295868447,0,8,SREBP signaling pathway,BP,
8837,GO:0032937,1,0.978548908207895,0,3,SREBP-SCAP-Insig complex,CC,
8839,GO:0032941,1,0.754611174396828,0,38,secretion by tissue,BP,
8842,GO:0032945,1,0.624000243443591,0,64,negative regulation of mononuclear cell proliferation,BP,
8844,GO:0032947,1,0.624730170624385,0,68,protein complex scaffold,MF,
8845,GO:0032954,1,0.986896883912116,0,2,regulation of cytokinetic process,BP,
8847,GO:0032957,1,0.940680477786649,0,9,inositol trisphosphate metabolic process,BP,
8848,GO:0032958,1,0.867600495697494,0,20,inositol phosphate biosynthetic process,BP,
8849,GO:0032959,1,0.953233702692012,0,7,inositol trisphosphate biosynthetic process,BP,
8850,GO:0032960,1,0.965449543612134,0,5,regulation of inositol trisphosphate biosynthetic process,BP,
8851,GO:0032962,1,0.971534363085364,0,4,positive regulation of inositol trisphosphate biosynthetic process,BP,
8853,GO:0032964,1,0.775255723703433,0,35,collagen biosynthetic process,BP,
8854,GO:0032965,1,0.806808223874751,0,29,regulation of collagen biosynthetic process,BP,
8855,GO:0032966,1,0.949427011854963,0,7,negative regulation of collagen biosynthetic process,BP,
8856,GO:0032967,1,0.849840459455776,0,22,positive regulation of collagen biosynthetic process,BP,
8857,GO:0032968,1,0.913781916263533,0,13,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8859,GO:0032971,1,0.970766406302927,0,4,regulation of muscle filament sliding,BP,
8860,GO:0032972,1,0.984400887813367,0,2,regulation of muscle filament sliding speed,BP,
8861,GO:0032976,1,0.992170027168696,0,1,release of matrix enzymes from mitochondria,BP,
8862,GO:0032980,1,0.992244487025709,0,1,keratinocyte activation,BP,
8863,GO:0032981,1,0.651199975026768,0,55,mitochondrial respiratory chain complex I assembly,BP,
8864,GO:0032982,1,0.870325836199599,0,22,myosin filament,CC,
8865,GO:0032983,1,0.98562559344447,0,2,kainate selective glutamate receptor complex,CC,
8867,GO:0032986,1,0.865094535414018,0,20,protein-DNA complex disassembly,BP,
8868,GO:0032988,1,0.907938767586781,0,13,ribonucleoprotein complex disassembly,BP,
8872,GO:0032993,1,0.240306551907779,0,188,protein-DNA complex,CC,
8874,GO:0032996,1,0.992171660184984,0,1,Bcl3-Bcl10 complex,CC,
8875,GO:0032997,1,0.984474190261298,0,2,Fc receptor complex,CC,
8876,GO:0032998,1,0.984474190261298,0,2,Fc-epsilon receptor I complex,CC,
8878,GO:0033003,1,0.761390398544456,0,37,regulation of mast cell activation,BP,
8879,GO:0033004,1,0.913877261353543,0,12,negative regulation of mast cell activation,BP,
8880,GO:0033005,1,0.894770047347106,0,15,positive regulation of mast cell activation,BP,
8881,GO:0033006,1,0.806226175089872,0,29,regulation of mast cell activation involved in immune response,BP,
8882,GO:0033007,1,0.941242579203405,0,8,negative regulation of mast cell activation involved in immune response,BP,
8883,GO:0033008,1,0.907160953233997,0,13,positive regulation of mast cell activation involved in immune response,BP,
8884,GO:0033010,1,0.964257619168218,0,5,paranodal junction,CC,
8885,GO:0033011,1,0.969124819980251,0,4,perinuclear theca,CC,
8887,GO:0033014,1,0.821723211372154,0,27,tetrapyrrole biosynthetic process,BP,
8888,GO:0033015,1,0.946566827406668,0,7,tetrapyrrole catabolic process,BP,
8889,GO:0033017,1,0.773841315520369,0,37,sarcoplasmic reticulum membrane,CC,
8890,GO:0033018,1,0.950456072770703,0,7,sarcoplasmic reticulum lumen,CC,
8891,GO:0033023,1,0.979407166073011,0,3,mast cell homeostasis,BP,
8892,GO:0033024,1,0.979407166073011,0,3,mast cell apoptotic process,BP,
8893,GO:0033025,1,0.979407166073011,0,3,regulation of mast cell apoptotic process,BP,
8894,GO:0033026,1,0.986197360764049,0,2,negative regulation of mast cell apoptotic process,BP,
8895,GO:0033028,1,0.817678484423467,0,28,myeloid cell apoptotic process,BP,
8896,GO:0033029,1,0.9656877902451,0,5,regulation of neutrophil apoptotic process,BP,
8897,GO:0033030,1,0.993986332266335,0,1,negative regulation of neutrophil apoptotic process,BP,
8898,GO:0033031,1,0.971531573836451,0,4,positive regulation of neutrophil apoptotic process,BP,
8899,GO:0033032,1,0.842736599234521,0,24,regulation of myeloid cell apoptotic process,BP,
8900,GO:0033033,1,0.916758437204545,0,12,negative regulation of myeloid cell apoptotic process,BP,
8901,GO:0033034,1,0.945912527911889,0,8,positive regulation of myeloid cell apoptotic process,BP,
8903,GO:0033037,1,0.993986313238534,0,1,polysaccharide localization,BP,
8904,GO:0033038,1,0.86799609840402,0,18,bitter taste receptor activity,MF,
8905,GO:0033040,1,0.986639726171053,0,2,sour taste receptor activity,MF,
8906,GO:0033041,1,0.984632860979278,0,2,sweet taste receptor activity,MF,
8908,GO:0033044,1,0.133499802351147,0,281,regulation of chromosome organization,BP,
8909,GO:0033045,1,0.644424212331047,0,61,regulation of sister chromatid segregation,BP,
8910,GO:0033046,1,0.788761989089992,0,33,negative regulation of sister chromatid segregation,BP,
8911,GO:0033047,1,0.693405693901537,0,51,regulation of mitotic sister chromatid segregation,BP,
8912,GO:0033048,1,0.793542701330977,0,32,negative regulation of mitotic sister chromatid segregation,BP,
8913,GO:0033058,1,0.987720392457739,0,2,directional locomotion,BP,
8914,GO:0033059,1,0.694826047780633,0,50,cellular pigmentation,BP,
8915,GO:0033061,1,0.947502855332346,0,7,DNA recombinase mediator complex,CC,
8916,GO:0033063,1,0.962280014093616,0,5,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8917,GO:0033065,1,0.984544309942374,0,2,Rad51C-XRCC3 complex,CC,
8920,GO:0033078,1,0.978424615547319,0,3,extrathymic T cell differentiation,BP,
8921,GO:0033079,1,0.936355798889669,0,9,immature T cell proliferation,BP,
8922,GO:0033080,1,0.951067650918312,0,7,immature T cell proliferation in thymus,BP,
8923,GO:0033081,1,0.840304905029396,0,24,regulation of T cell differentiation in thymus,BP,
8924,GO:0033082,1,0.986146928776015,0,2,regulation of extrathymic T cell differentiation,BP,
8925,GO:0033083,1,0.942546921694733,0,8,regulation of immature T cell proliferation,BP,
8926,GO:0033084,1,0.957355279053696,0,6,regulation of immature T cell proliferation in thymus,BP,
8927,GO:0033085,1,0.942517824414186,0,8,negative regulation of T cell differentiation in thymus,BP,
8928,GO:0033087,1,0.964861137928246,0,5,negative regulation of immature T cell proliferation,BP,
8929,GO:0033088,1,0.972477228939876,0,4,negative regulation of immature T cell proliferation in thymus,BP,
8930,GO:0033089,1,0.923711705460485,0,11,positive regulation of T cell differentiation in thymus,BP,
8931,GO:0033091,1,0.97687951832973,0,3,positive regulation of immature T cell proliferation,BP,
8932,GO:0033092,1,0.984453436518783,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8933,GO:0033093,1,0.966771847077686,0,5,Weibel-Palade body,CC,
8934,GO:0033106,1,0.992311409681756,0,1,cis-Golgi network membrane,CC,
8935,GO:0033108,1,0.550783447675835,0,77,mitochondrial respiratory chain complex assembly,BP,
8936,GO:0033116,1,0.618073282237109,0,66,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8937,GO:0033119,1,0.829543035837305,0,25,negative regulation of RNA splicing,BP,
8938,GO:0033120,1,0.836360658080431,0,25,positive regulation of RNA splicing,BP,
8939,GO:0033121,1,0.980587722713233,0,3,regulation of purine nucleotide catabolic process,BP,
8940,GO:0033122,1,0.986520959751267,0,2,negative regulation of purine nucleotide catabolic process,BP,
8941,GO:0033123,1,0.993986332265518,0,1,positive regulation of purine nucleotide catabolic process,BP,
8942,GO:0033127,1,0.90794073093642,0,13,regulation of histone phosphorylation,BP,
8943,GO:0033128,1,0.976849115534939,0,3,negative regulation of histone phosphorylation,BP,
8944,GO:0033129,1,0.943320079740219,0,8,positive regulation of histone phosphorylation,BP,
8945,GO:0033130,1,0.945913212248656,0,8,acetylcholine receptor binding,MF,
8946,GO:0033131,1,0.941949910209984,0,8,regulation of glucokinase activity,BP,
8947,GO:0033132,1,0.970281077210212,0,4,negative regulation of glucokinase activity,BP,
8948,GO:0033133,1,0.970807851804872,0,4,positive regulation of glucokinase activity,BP,
8949,GO:0033135,1,0.414784630761868,0,121,regulation of peptidyl-serine phosphorylation,BP,
8950,GO:0033136,1,0.943361366463889,0,8,serine phosphorylation of STAT3 protein,BP,
8951,GO:0033137,1,0.846801348178024,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8952,GO:0033138,1,0.508743522450934,0,92,positive regulation of peptidyl-serine phosphorylation,BP,
8954,GO:0033140,1,0.984642818374512,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8955,GO:0033141,1,0.850697549884313,0,21,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8956,GO:0033142,1,0.986228917401759,0,2,progesterone receptor binding,MF,
8957,GO:0033143,1,0.634532286111751,0,64,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8958,GO:0033144,1,0.804661224915155,0,31,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8959,GO:0033145,1,0.898187304412472,0,15,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8960,GO:0033146,1,0.808761991258483,0,30,regulation of intracellular estrogen receptor signaling pathway,BP,
8961,GO:0033147,1,0.913518774073197,0,13,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8962,GO:0033148,1,0.938943659379983,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8963,GO:0033149,1,0.987250083812157,0,2,FFAT motif binding,MF,
8964,GO:0033150,1,0.976726647784117,0,3,cytoskeletal calyx,CC,
8965,GO:0033151,1,0.915046565854273,0,13,V(D)J recombination,BP,
8966,GO:0033152,1,0.973670449630496,0,4,immunoglobulin V(D)J recombination,BP,
8967,GO:0033153,1,0.967459350284132,0,5,T cell receptor V(D)J recombination,BP,
8969,GO:0033158,1,0.875045624134969,0,19,regulation of protein import into nucleus, translocation,BP,
8970,GO:0033159,1,0.979149325441055,0,3,negative regulation of protein import into nucleus, translocation,BP,
8971,GO:0033160,1,0.921109373197616,0,12,positive regulation of protein import into nucleus, translocation,BP,
8973,GO:0033165,1,0.97979639581256,0,3,interphotoreceptor matrix,CC,
8974,GO:0033167,1,0.993986332285847,0,1,ARC complex,CC,
8975,GO:0033168,1,0.993986332285847,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8976,GO:0033169,1,0.936837546719531,0,10,histone H3-K9 demethylation,BP,
8977,GO:0033170,1,0.941541750489472,0,8,protein-DNA loading ATPase activity,MF,
8978,GO:0033173,1,0.843523472860894,0,24,calcineurin-NFAT signaling cascade,BP,
8979,GO:0033176,1,0.841803851126118,0,23,proton-transporting V-type ATPase complex,CC,
8980,GO:0033177,1,0.85144699406658,0,21,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8981,GO:0033178,1,0.885793388720834,0,16,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8982,GO:0033179,1,0.928233935560095,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8983,GO:0033180,1,0.935927201949624,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8984,GO:0033182,1,0.939948527053052,0,9,regulation of histone ubiquitination,BP,
8985,GO:0033183,1,0.980340372257135,0,3,negative regulation of histone ubiquitination,BP,
8986,GO:0033184,1,0.966256082784229,0,5,positive regulation of histone ubiquitination,BP,
8988,GO:0033186,1,0.9792435856163,0,3,CAF-1 complex,CC,
8989,GO:0033188,1,0.979598566794454,0,3,sphingomyelin synthase activity,MF,
8990,GO:0033189,1,0.881478712135158,0,17,response to vitamin A,BP,
8991,GO:0033192,1,0.974763273734146,0,4,calmodulin-dependent protein phosphatase activity,MF,
8992,GO:0033193,1,0.993944019117899,0,1,Lsd1/2 complex,CC,
8993,GO:0033194,1,0.890785632930918,0,16,response to hydroperoxide,BP,
8994,GO:0033197,1,0.916837971949154,0,12,response to vitamin E,BP,
8995,GO:0033198,1,0.795905171053119,0,31,response to ATP,BP,
8996,GO:0033202,1,0.900047142116482,0,14,DNA helicase complex,CC,
8997,GO:0033204,1,0.992265678925599,0,1,ribonuclease P RNA binding,MF,
8998,GO:0033206,1,0.967039922880377,0,5,meiotic cytokinesis,BP,
9000,GO:0033210,1,0.937178610427774,0,9,leptin-mediated signaling pathway,BP,
9001,GO:0033211,1,0.958865024670164,0,6,adiponectin-activated signaling pathway,BP,
9002,GO:0033212,1,0.992232086165117,0,1,iron assimilation,BP,
9003,GO:0033214,1,0.992232086165117,0,1,iron assimilation by chelation and transport,BP,
9004,GO:0033216,1,0.9667496561806,0,5,ferric iron import,BP,
9006,GO:0033227,1,0.965322019278156,0,5,dsRNA transport,BP,
9007,GO:0033229,1,0.993276345545592,0,1,cysteine transmembrane transporter activity,MF,
9008,GO:0033231,1,0.993506247191203,0,1,carbohydrate export,BP,
9009,GO:0033233,1,0.857080797304563,0,21,regulation of protein sumoylation,BP,
9010,GO:0033234,1,0.92932797567384,0,10,negative regulation of protein sumoylation,BP,
9011,GO:0033235,1,0.92212611298264,0,11,positive regulation of protein sumoylation,BP,
9013,GO:0033239,1,0.973139898369968,0,4,negative regulation of cellular amine metabolic process,BP,
9014,GO:0033240,1,0.934503720466299,0,9,positive regulation of cellular amine metabolic process,BP,
9015,GO:0033241,1,0.993986332279396,0,1,regulation of cellular amine catabolic process,BP,
9016,GO:0033242,1,0.993986332279396,0,1,negative regulation of cellular amine catabolic process,BP,
9017,GO:0033256,1,0.948545262463716,0,7,I-kappaB/NF-kappaB complex,CC,
9018,GO:0033257,1,0.984858240598815,0,2,Bcl3/NF-kappaB2 complex,CC,
9019,GO:0033260,1,0.811939754950634,0,29,nuclear DNA replication,BP,
9020,GO:0033262,1,0.913147065505139,0,13,regulation of nuclear cell cycle DNA replication,BP,
9021,GO:0033263,1,0.974105529498017,0,4,CORVET complex,CC,
9022,GO:0033265,1,0.971067574538944,0,4,choline binding,MF,
9024,GO:0033268,1,0.906060095399488,0,15,node of Ranvier,CC,
9025,GO:0033269,1,0.971671847465709,0,4,internode region of axon,CC,
9026,GO:0033270,1,0.930011468701437,0,11,paranode region of axon,CC,
9027,GO:0033273,1,0.52033555254199,0,90,response to vitamin,BP,
9028,GO:0033274,1,0.993986332271365,0,1,response to vitamin B2,BP,
9029,GO:0033275,1,0.756611723034716,0,39,actin-myosin filament sliding,BP,
9030,GO:0033276,1,0.902893661416359,0,14,transcription factor TFTC complex,CC,
9031,GO:0033277,1,0.98623964488756,0,2,abortive mitotic cell cycle,BP,
9032,GO:0033278,1,0.944047758003383,0,8,cell proliferation in midbrain,BP,
9033,GO:0033280,1,0.779699072323239,0,35,response to vitamin D,BP,
9034,GO:0033290,1,0.993633011695133,0,1,eukaryotic 48S preinitiation complex,CC,
9035,GO:0033291,1,0.992170027168696,0,1,eukaryotic 80S initiation complex,CC,
9036,GO:0033292,1,0.980271740730896,0,3,T-tubule organization,BP,
9038,GO:0033299,1,0.963336881687934,0,5,secretion of lysosomal enzymes,BP,
9039,GO:0033300,1,0.972206920517669,0,4,dehydroascorbic acid transporter activity,MF,
9040,GO:0033301,1,0.993268704465078,0,1,cell cycle comprising mitosis without cytokinesis,BP,
9042,GO:0033313,1,0.941594305887118,0,8,meiotic cell cycle checkpoint,BP,
9043,GO:0033314,1,0.935423552725823,0,9,mitotic DNA replication checkpoint,BP,
9044,GO:0033315,1,0.992170027168696,0,1,meiotic DNA replication checkpoint,BP,
9045,GO:0033316,1,0.992599282199603,0,1,meiotic spindle assembly checkpoint,BP,
9046,GO:0033319,1,0.992184241807436,0,1,UDP-D-xylose metabolic process,BP,
9047,GO:0033320,1,0.992184241807436,0,1,UDP-D-xylose biosynthetic process,BP,
9048,GO:0033326,1,0.978710066121278,0,3,cerebrospinal fluid secretion,BP,
9049,GO:0033327,1,0.931057701860635,0,10,Leydig cell differentiation,BP,
9050,GO:0033328,1,0.99316680860158,0,1,peroxisome membrane targeting sequence binding,MF,
9051,GO:0033341,1,0.986313144041007,0,2,regulation of collagen binding,BP,
9052,GO:0033342,1,0.992280751152868,0,1,negative regulation of collagen binding,BP,
9053,GO:0033343,1,0.993986332274973,0,1,positive regulation of collagen binding,BP,
9055,GO:0033345,1,0.992234313965874,0,1,asparagine catabolic process via L-aspartate,BP,
9056,GO:0033353,1,0.972827025742126,0,4,S-adenosylmethionine cycle,BP,
9057,GO:0033363,1,0.813537629142193,0,29,secretory granule organization,BP,
9058,GO:0033364,1,0.986203080806474,0,2,mast cell secretory granule organization,BP,
9060,GO:0033366,1,0.992170027168696,0,1,protein localization to secretory granule,BP,
9061,GO:0033367,1,0.992170027168696,0,1,protein localization to mast cell secretory granule,BP,
9062,GO:0033368,1,0.992170027168696,0,1,protease localization to mast cell secretory granule,BP,
9063,GO:0033370,1,0.992170027168696,0,1,maintenance of protein location in mast cell secretory granule,BP,
9064,GO:0033371,1,0.992170027168696,0,1,T cell secretory granule organization,BP,
9065,GO:0033373,1,0.992170027168696,0,1,maintenance of protease location in mast cell secretory granule,BP,
9066,GO:0033374,1,0.992170027168696,0,1,protein localization to T cell secretory granule,BP,
9067,GO:0033375,1,0.992170027168696,0,1,protease localization to T cell secretory granule,BP,
9068,GO:0033377,1,0.992170027168696,0,1,maintenance of protein location in T cell secretory granule,BP,
9069,GO:0033379,1,0.992170027168696,0,1,maintenance of protease location in T cell secretory granule,BP,
9070,GO:0033380,1,0.992170027168696,0,1,granzyme B localization to T cell secretory granule,BP,
9071,GO:0033382,1,0.992170027168696,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
9072,GO:0033383,1,0.98465819747764,0,2,geranyl diphosphate metabolic process,BP,
9073,GO:0033384,1,0.98465819747764,0,2,geranyl diphosphate biosynthetic process,BP,
9074,GO:0033385,1,0.992429351717917,0,1,geranylgeranyl diphosphate metabolic process,BP,
9075,GO:0033386,1,0.992429351717917,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
9076,GO:0033387,1,0.985932676277889,0,2,putrescine biosynthetic process from ornithine,BP,
9077,GO:0033388,1,0.992197047099341,0,1,putrescine biosynthetic process from arginine,BP,
9078,GO:0033391,1,0.920823260514039,0,12,chromatoid body,CC,
9079,GO:0033477,1,0.992176641215416,0,1,S-methylmethionine metabolic process,BP,
9080,GO:0033483,1,0.937632102580745,0,9,gas homeostasis,BP,
9081,GO:0033484,1,0.978523648788384,0,3,nitric oxide homeostasis,BP,
9082,GO:0033488,1,0.992637292017046,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
9085,GO:0033499,1,0.992265851840136,0,1,galactose catabolic process via UDP-galactose,BP,
9087,GO:0033503,1,0.964339601515771,0,5,HULC complex,CC,
9088,GO:0033504,1,0.952511880007579,0,7,floor plate development,BP,
9089,GO:0033505,1,0.986216360766028,0,2,floor plate morphogenesis,BP,
9090,GO:0033512,1,0.978794718398502,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
9091,GO:0033514,1,0.992243903618009,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9092,GO:0033522,1,0.877437305501745,0,19,histone H2A ubiquitination,BP,
9093,GO:0033523,1,0.932749634147146,0,10,histone H2B ubiquitination,BP,
9095,GO:0033540,1,0.907141570562936,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9096,GO:0033549,1,0.900654791816903,0,14,MAP kinase phosphatase activity,MF,
9097,GO:0033552,1,0.992170027168696,0,1,response to vitamin B3,BP,
9098,GO:0033553,1,0.972207299272167,0,4,rDNA heterochromatin,CC,
9100,GO:0033555,1,0.626879698078979,0,66,multicellular organismal response to stress,BP,
9101,GO:0033557,1,0.977060181581946,0,3,Slx1-Slx4 complex,CC,
9102,GO:0033558,1,0.75684231541225,0,40,protein deacetylase activity,MF,
9104,GO:0033560,1,0.993447293752693,0,1,folate reductase activity,MF,
9105,GO:0033561,1,0.862414807146281,0,21,regulation of water loss via skin,BP,
9106,GO:0033563,1,0.980271740739052,0,3,dorsal/ventral axon guidance,BP,
9107,GO:0033564,1,0.968805783845472,0,5,anterior/posterior axon guidance,BP,
9108,GO:0033565,1,0.979194241995892,0,3,ESCRT-0 complex,CC,
9109,GO:0033566,1,0.984598995242062,0,2,gamma-tubulin complex localization,BP,
9110,GO:0033567,1,0.971131291967802,0,4,DNA replication, Okazaki fragment processing,BP,
9111,GO:0033570,1,0.993965004701925,0,1,transferrin transmembrane transporter activity,MF,
9112,GO:0033572,1,0.772947659406978,0,35,transferrin transport,BP,
9113,GO:0033574,1,0.72646096856175,0,43,response to testosterone,BP,
9114,GO:0033577,1,0.984839417608678,0,2,protein glycosylation in endoplasmic reticulum,BP,
9115,GO:0033578,1,0.964287611594826,0,5,protein glycosylation in Golgi,BP,
9116,GO:0033588,1,0.956598358494433,0,6,Elongator holoenzyme complex,CC,
9117,GO:0033590,1,0.976945954272054,0,3,response to cobalamin,BP,
9118,GO:0033591,1,0.964547864310152,0,5,response to L-ascorbic acid,BP,
9119,GO:0033592,1,0.966409531134395,0,5,RNA strand annealing activity,MF,
9120,GO:0033593,1,0.993986332290668,0,1,BRCA2-MAGE-D1 complex,CC,
9121,GO:0033594,1,0.96967991408774,0,4,response to hydroxyisoflavone,BP,
9122,GO:0033595,1,0.984923055286801,0,2,response to genistein,BP,
9123,GO:0033596,1,0.981225943403045,0,3,TSC1-TSC2 complex,CC,
9124,GO:0033598,1,0.827645514396484,0,27,mammary gland epithelial cell proliferation,BP,
9125,GO:0033599,1,0.887123124171792,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9126,GO:0033600,1,0.965477085380272,0,5,negative regulation of mammary gland epithelial cell proliferation,BP,
9127,GO:0033601,1,0.95498073595349,0,7,positive regulation of mammary gland epithelial cell proliferation,BP,
9128,GO:0033602,1,0.980382832120461,0,3,negative regulation of dopamine secretion,BP,
9129,GO:0033603,1,0.958508060711507,0,6,positive regulation of dopamine secretion,BP,
9130,GO:0033604,1,0.91718693960238,0,12,negative regulation of catecholamine secretion,BP,
9131,GO:0033605,1,0.924075524823207,0,11,positive regulation of catecholamine secretion,BP,
9132,GO:0033606,1,0.992193904126244,0,1,chemokine receptor transport within lipid bilayer,BP,
9133,GO:0033609,1,0.992294630214608,0,1,oxalate metabolic process,BP,
9136,GO:0033615,1,0.978050395356454,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9137,GO:0033617,1,0.898236591224356,0,14,mitochondrial respiratory chain complex IV assembly,BP,
9138,GO:0033619,1,0.677894191986447,0,55,membrane protein proteolysis,BP,
9139,GO:0033622,1,0.880982150778811,0,18,integrin activation,BP,
9140,GO:0033623,1,0.931545515090324,0,10,regulation of integrin activation,BP,
9141,GO:0033624,1,0.986989832074411,0,2,negative regulation of integrin activation,BP,
9142,GO:0033625,1,0.964257584462217,0,5,positive regulation of integrin activation,BP,
9143,GO:0033626,1,0.993259597028042,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9144,GO:0033627,1,0.679981394722227,0,55,cell adhesion mediated by integrin,BP,
9145,GO:0033628,1,0.756252894404478,0,39,regulation of cell adhesion mediated by integrin,BP,
9146,GO:0033629,1,0.939245891972644,0,9,negative regulation of cell adhesion mediated by integrin,BP,
9147,GO:0033630,1,0.885271386165273,0,17,positive regulation of cell adhesion mediated by integrin,BP,
9148,GO:0033631,1,0.919876229155314,0,12,cell-cell adhesion mediated by integrin,BP,
9149,GO:0033632,1,0.943863694431249,0,8,regulation of cell-cell adhesion mediated by integrin,BP,
9150,GO:0033633,1,0.993916135000529,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9151,GO:0033634,1,0.970939473684939,0,4,positive regulation of cell-cell adhesion mediated by integrin,BP,
9152,GO:0033643,1,0.940585444012557,0,9,host cell part,CC,
9153,GO:0033644,1,0.99364699972125,0,1,host cell membrane,CC,
9154,GO:0033646,1,0.952425449570397,0,7,host intracellular part,CC,
9155,GO:0033647,1,0.96560788881158,0,5,host intracellular organelle,CC,
9156,GO:0033648,1,0.96560788881158,0,5,host intracellular membrane-bounded organelle,CC,
9157,GO:0033650,1,0.992170193264521,0,1,host cell mitochondrion,CC,
9158,GO:0033655,1,0.971766849394503,0,4,host cell cytoplasm part,CC,
9159,GO:0033668,1,0.970766641911402,0,4,negative regulation by symbiont of host apoptotic process,BP,
9162,GO:0033676,1,0.992170027168696,0,1,double-stranded DNA-dependent ATPase activity,MF,
9163,GO:0033677,1,0.984776895700739,0,2,DNA/RNA helicase activity,MF,
9164,GO:0033678,1,0.992342611054298,0,1,5'-3' DNA/RNA helicase activity,MF,
9165,GO:0033680,1,0.992342611054298,0,1,ATP-dependent DNA/RNA helicase activity,MF,
9166,GO:0033682,1,0.992342611054298,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9167,GO:0033683,1,0.750915746167982,0,39,nucleotide-excision repair, DNA incision,BP,
9168,GO:0033684,1,0.951033590894042,0,7,regulation of luteinizing hormone secretion,BP,
9169,GO:0033685,1,0.978504805903132,0,3,negative regulation of luteinizing hormone secretion,BP,
9170,GO:0033686,1,0.971930013300596,0,4,positive regulation of luteinizing hormone secretion,BP,
9171,GO:0033687,1,0.831433676213713,0,26,osteoblast proliferation,BP,
9172,GO:0033688,1,0.850522451314529,0,23,regulation of osteoblast proliferation,BP,
9173,GO:0033689,1,0.941665515227529,0,9,negative regulation of osteoblast proliferation,BP,
9174,GO:0033690,1,0.923348601061858,0,11,positive regulation of osteoblast proliferation,BP,
9175,GO:0033691,1,0.941497727234152,0,9,sialic acid binding,MF,
9176,GO:0033692,1,0.662927170299513,0,58,cellular polysaccharide biosynthetic process,BP,
9177,GO:0033693,1,0.979032301842181,0,3,neurofilament bundle assembly,BP,
9178,GO:0033695,1,0.96978344651454,0,4,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9179,GO:0033699,1,0.992178341054313,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9181,GO:0033735,1,0.992170027168696,0,1,aspartate dehydrogenase activity,MF,
9182,GO:0033737,1,0.992273668061976,0,1,1-pyrroline dehydrogenase activity,MF,
9183,GO:0033743,1,0.970662915161667,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9184,GO:0033746,1,0.993173241686921,0,1,histone demethylase activity (H3-R2 specific),MF,
9185,GO:0033749,1,0.993173241686921,0,1,histone demethylase activity (H4-R3 specific),MF,
9186,GO:0033750,1,0.914024509266137,0,12,ribosome localization,BP,
9187,GO:0033753,1,0.914024509266137,0,12,establishment of ribosome localization,BP,
9188,GO:0033754,1,0.98444575195701,0,2,indoleamine 2,3-dioxygenase activity,MF,
9189,GO:0033762,1,0.710221081323125,0,48,response to glucagon,BP,
9191,GO:0033765,1,0.976978829513552,0,3,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9192,GO:0033768,1,0.99262756456143,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9193,GO:0033778,1,0.993469869690521,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9194,GO:0033780,1,0.992406577664907,0,1,taurochenodeoxycholate 6alpha-hydroxylase activity,MF,
9195,GO:0033781,1,0.992183573814119,0,1,cholesterol 24-hydroxylase activity,MF,
9196,GO:0033787,1,0.992454101113446,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9197,GO:0033791,1,0.992219123694362,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9198,GO:0033798,1,0.992184732153989,0,1,thyroxine 5-deiodinase activity,MF,
9199,GO:0033814,1,0.992170027168696,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9200,GO:0033819,1,0.992170027168696,0,1,lipoyl(octanoyl) transferase activity,MF,
9201,GO:0033823,1,0.992564231268535,0,1,procollagen glucosyltransferase activity,MF,
9202,GO:0033829,1,0.976728177084237,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9203,GO:0033842,1,0.986069232802758,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9204,GO:0033857,1,0.987997724837021,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9205,GO:0033858,1,0.992723725169855,0,1,N-acetylgalactosamine kinase activity,MF,
9206,GO:0033860,1,0.939454503190413,0,8,regulation of NAD(P)H oxidase activity,BP,
9207,GO:0033861,1,0.976752956684147,0,3,negative regulation of NAD(P)H oxidase activity,BP,
9208,GO:0033862,1,0.992561746410286,0,1,UMP kinase activity,MF,
9209,GO:0033864,1,0.961820709525843,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9212,GO:0033867,1,0.992170027168696,0,1,Fas-activated serine/threonine kinase activity,MF,
9214,GO:0033871,1,0.992174264801851,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9215,GO:0033872,1,0.98451917419991,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9217,GO:0033878,1,0.99335206421959,0,1,hormone-sensitive lipase activity,MF,
9218,GO:0033882,1,0.992170027168696,0,1,choloyl-CoA hydrolase activity,MF,
9219,GO:0033883,1,0.984407923564942,0,2,pyridoxal phosphatase activity,MF,
9220,GO:0033885,1,0.992198562480326,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9221,GO:0033897,1,0.992170027168696,0,1,ribonuclease T2 activity,MF,
9222,GO:0033906,1,0.98443323047282,0,2,hyaluronoglucuronidase activity,MF,
9223,GO:0033919,1,0.993437089993706,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9224,GO:0033925,1,0.993805861677762,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9225,GO:0033961,1,0.99217017179449,0,1,cis-stilbene-oxide hydrolase activity,MF,
9226,GO:0033962,1,0.887398893939692,0,18,cytoplasmic mRNA processing body assembly,BP,
9227,GO:0033967,1,0.992170027168696,0,1,box C/D snoRNA metabolic process,BP,
9228,GO:0033979,1,0.992302413607848,0,1,box H/ACA snoRNA metabolic process,BP,
9229,GO:0033981,1,0.992170027168696,0,1,D-dopachrome decarboxylase activity,MF,
9230,GO:0033989,1,0.992356815019901,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9232,GO:0034014,1,0.992213076081144,0,1,response to triglyceride,BP,
9233,GO:0034021,1,0.984400887813367,0,2,response to silicon dioxide,BP,
9239,GO:0034035,1,0.866642844278839,0,19,purine ribonucleoside bisphosphate metabolic process,BP,
9240,GO:0034036,1,0.957737235563543,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9241,GO:0034038,1,0.992170027168696,0,1,deoxyhypusine synthase activity,MF,
9242,GO:0034039,1,0.992173008333194,0,1,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9245,GO:0034045,1,0.908417321450878,0,14,pre-autophagosomal structure membrane,CC,
9246,GO:0034046,1,0.967787750248822,0,5,poly(G) binding,MF,
9247,GO:0034056,1,0.972692696920438,0,4,estrogen response element binding,MF,
9248,GO:0034057,1,0.985869844589217,0,2,RNA strand-exchange activity,MF,
9249,GO:0034058,1,0.94272484956449,0,9,endosomal vesicle fusion,BP,
9250,GO:0034059,1,0.980084319047,0,3,response to anoxia,BP,
9251,GO:0034061,1,0.790764568590294,0,33,DNA polymerase activity,MF,
9252,GO:0034062,1,0.734024198751296,0,42,5'-3' RNA polymerase activity,MF,
9253,GO:0034063,1,0.935286796168679,0,10,stress granule assembly,BP,
9254,GO:0034066,1,0.992170027168696,0,1,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9255,GO:0034067,1,0.809996472184665,0,32,protein localization to Golgi apparatus,BP,
9256,GO:0034080,1,0.752542905834367,0,37,CENP-A containing nucleosome assembly,BP,
9257,GO:0034085,1,0.978529291580995,0,3,establishment of sister chromatid cohesion,BP,
9258,GO:0034086,1,0.940323464313226,0,9,maintenance of sister chromatid cohesion,BP,
9259,GO:0034088,1,0.940323464313226,0,9,maintenance of mitotic sister chromatid cohesion,BP,
9260,GO:0034091,1,0.966748081354739,0,5,regulation of maintenance of sister chromatid cohesion,BP,
9261,GO:0034092,1,0.988008547504246,0,2,negative regulation of maintenance of sister chromatid cohesion,BP,
9262,GO:0034093,1,0.978483503478034,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9264,GO:0034098,1,0.940018673341989,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9265,GO:0034101,1,0.481909311740587,0,102,erythrocyte homeostasis,BP,
9267,GO:0034104,1,0.872909889672003,0,19,negative regulation of tissue remodeling,BP,
9268,GO:0034105,1,0.82722596072919,0,26,positive regulation of tissue remodeling,BP,
9269,GO:0034109,1,0.603335061506176,0,71,homotypic cell-cell adhesion,BP,
9270,GO:0034110,1,0.855205192995434,0,22,regulation of homotypic cell-cell adhesion,BP,
9271,GO:0034111,1,0.911752237092003,0,13,negative regulation of homotypic cell-cell adhesion,BP,
9272,GO:0034112,1,0.970857705885206,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9273,GO:0034113,1,0.707146128306168,0,49,heterotypic cell-cell adhesion,BP,
9274,GO:0034114,1,0.861640651205716,0,20,regulation of heterotypic cell-cell adhesion,BP,
9275,GO:0034115,1,0.934434954461603,0,9,negative regulation of heterotypic cell-cell adhesion,BP,
9276,GO:0034116,1,0.914912801714511,0,12,positive regulation of heterotypic cell-cell adhesion,BP,
9277,GO:0034117,1,0.992170027168696,0,1,erythrocyte aggregation,BP,
9278,GO:0034118,1,0.992170027168696,0,1,regulation of erythrocyte aggregation,BP,
9279,GO:0034120,1,0.992170027168696,0,1,positive regulation of erythrocyte aggregation,BP,
9282,GO:0034123,1,0.876647046057455,0,18,positive regulation of toll-like receptor signaling pathway,BP,
9283,GO:0034124,1,0.969968877073698,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9284,GO:0034125,1,0.984403263545864,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9287,GO:0034130,1,0.992454807068985,0,1,toll-like receptor 1 signaling pathway,BP,
9288,GO:0034134,1,0.92989327548495,0,10,toll-like receptor 2 signaling pathway,BP,
9289,GO:0034135,1,0.963755436797063,0,5,regulation of toll-like receptor 2 signaling pathway,BP,
9290,GO:0034136,1,0.98645126854317,0,2,negative regulation of toll-like receptor 2 signaling pathway,BP,
9291,GO:0034137,1,0.976994868792771,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
9292,GO:0034138,1,0.889291250603914,0,16,toll-like receptor 3 signaling pathway,BP,
9293,GO:0034139,1,0.938051635403972,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9294,GO:0034140,1,0.979997200402651,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9295,GO:0034141,1,0.950001551216224,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9296,GO:0034142,1,0.817306860976037,0,28,toll-like receptor 4 signaling pathway,BP,
9297,GO:0034143,1,0.903043268410084,0,14,regulation of toll-like receptor 4 signaling pathway,BP,
9298,GO:0034144,1,0.965388074307522,0,5,negative regulation of toll-like receptor 4 signaling pathway,BP,
9299,GO:0034145,1,0.93543714326157,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9300,GO:0034146,1,0.987510863051096,0,2,toll-like receptor 5 signaling pathway,BP,
9301,GO:0034147,1,0.993777749217608,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9302,GO:0034148,1,0.993777749217608,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9303,GO:0034150,1,0.993986332264836,0,1,toll-like receptor 6 signaling pathway,BP,
9304,GO:0034154,1,0.965826079542606,0,5,toll-like receptor 7 signaling pathway,BP,
9305,GO:0034155,1,0.993063301520682,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
9306,GO:0034157,1,0.993063301520682,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
9307,GO:0034158,1,0.993660613718805,0,1,toll-like receptor 8 signaling pathway,BP,
9308,GO:0034162,1,0.881797982103864,0,18,toll-like receptor 9 signaling pathway,BP,
9309,GO:0034163,1,0.980154609673286,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
9310,GO:0034164,1,0.993986332268836,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
9311,GO:0034165,1,0.986085246545118,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9312,GO:0034166,1,0.992859576280278,0,1,toll-like receptor 10 signaling pathway,BP,
9313,GO:0034182,1,0.966748081354739,0,5,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9314,GO:0034183,1,0.988008547504246,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9315,GO:0034184,1,0.978483503478034,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9316,GO:0034185,1,0.897538127785683,0,16,apolipoprotein binding,MF,
9317,GO:0034186,1,0.971044280558418,0,4,apolipoprotein A-I binding,MF,
9318,GO:0034188,1,0.988008547488277,0,2,apolipoprotein A-I receptor activity,MF,
9319,GO:0034189,1,0.986397065196459,0,2,very-low-density lipoprotein particle binding,MF,
9320,GO:0034190,1,0.956689501751206,0,6,apolipoprotein receptor binding,MF,
9321,GO:0034191,1,0.970851768674062,0,4,apolipoprotein A-I receptor binding,MF,
9322,GO:0034196,1,0.9629777727977,0,5,acylglycerol transport,BP,
9323,GO:0034197,1,0.9629777727977,0,5,triglyceride transport,BP,
9324,GO:0034198,1,0.771743083369345,0,36,cellular response to amino acid starvation,BP,
9325,GO:0034199,1,0.890899644183348,0,17,activation of protein kinase A activity,BP,
9326,GO:0034201,1,0.965150127811593,0,5,response to oleic acid,BP,
9327,GO:0034203,1,0.99395818591462,0,1,glycolipid translocation,BP,
9328,GO:0034204,1,0.86613731741443,0,23,lipid translocation,BP,
9329,GO:0034205,1,0.906660226589334,0,14,beta-amyloid formation,BP,
9330,GO:0034211,1,0.993986332281396,0,1,GTP-dependent protein kinase activity,MF,
9331,GO:0034212,1,0.636620396863775,0,63,peptide N-acetyltransferase activity,MF,
9332,GO:0034213,1,0.992170027168696,0,1,quinolinate catabolic process,BP,
9333,GO:0034214,1,0.950227523065906,0,7,protein hexamerization,BP,
9334,GO:0034219,1,0.825942554653336,0,26,carbohydrate transmembrane transport,BP,
9336,GO:0034224,1,0.984441895012782,0,2,cellular response to zinc ion starvation,BP,
9337,GO:0034226,1,0.986334890687528,0,2,lysine import,BP,
9338,GO:0034227,1,0.96155693499588,0,5,tRNA thio-modification,BP,
9339,GO:0034230,1,0.993891018976515,0,1,enkephalin processing,BP,
9340,GO:0034231,1,0.993891018976515,0,1,islet amyloid polypeptide processing,BP,
9341,GO:0034235,1,0.949324571874458,0,7,GPI anchor binding,MF,
9342,GO:0034236,1,0.904916926006091,0,14,protein kinase A catalytic subunit binding,MF,
9343,GO:0034237,1,0.898289440744887,0,16,protein kinase A regulatory subunit binding,MF,
9344,GO:0034238,1,0.978251782730256,0,3,macrophage fusion,BP,
9345,GO:0034239,1,0.978251782730256,0,3,regulation of macrophage fusion,BP,
9346,GO:0034241,1,0.978251782730256,0,3,positive regulation of macrophage fusion,BP,
9347,GO:0034242,1,0.978485061949024,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9348,GO:0034243,1,0.849481327514504,0,23,regulation of transcription elongation from RNA polymerase II promoter,BP,
9349,GO:0034244,1,0.928233361166704,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9350,GO:0034245,1,0.993357540605559,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9351,GO:0034247,1,0.984400887813367,0,2,snoRNA splicing,BP,
9355,GO:0034255,1,0.992190392480105,0,1,regulation of urea metabolic process,BP,
9357,GO:0034271,1,0.98618903472715,0,2,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9358,GO:0034272,1,0.98618903472715,0,2,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9359,GO:0034274,1,0.980568940181627,0,3,Atg12-Atg5-Atg16 complex,CC,
9360,GO:0034275,1,0.992170027168696,0,1,kynurenic acid metabolic process,BP,
9361,GO:0034276,1,0.992170027168696,0,1,kynurenic acid biosynthetic process,BP,
9363,GO:0034285,1,0.959558891683231,0,6,response to disaccharide,BP,
9364,GO:0034287,1,0.969364003976547,0,4,detection of monosaccharide stimulus,BP,
9366,GO:0034309,1,0.992170027168696,0,1,primary alcohol biosynthetic process,BP,
9367,GO:0034310,1,0.88955358885113,0,15,primary alcohol catabolic process,BP,
9368,GO:0034311,1,0.921610479550844,0,11,diol metabolic process,BP,
9369,GO:0034312,1,0.942964012795244,0,8,diol biosynthetic process,BP,
9370,GO:0034314,1,0.792856129900653,0,32,Arp2/3 complex-mediated actin nucleation,BP,
9371,GO:0034315,1,0.891520617448451,0,16,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9372,GO:0034316,1,0.964454250076839,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9373,GO:0034329,1,0.269148641586463,0,191,cell junction assembly,BP,
9375,GO:0034331,1,0.947645519604374,0,8,cell junction maintenance,BP,
9377,GO:0034333,1,0.588398367045362,0,79,adherens junction assembly,BP,
9378,GO:0034334,1,0.987775576921407,0,2,adherens junction maintenance,BP,
9379,GO:0034337,1,0.99339927709588,0,1,RNA folding,BP,
9380,GO:0034338,1,0.99245128710747,0,1,short-chain carboxylesterase activity,MF,
9383,GO:0034342,1,0.984542048203744,0,2,response to type III interferon,BP,
9384,GO:0034343,1,0.979620910142338,0,3,type III interferon production,BP,
9385,GO:0034344,1,0.979620910142338,0,3,regulation of type III interferon production,BP,
9386,GO:0034346,1,0.992605746393838,0,1,positive regulation of type III interferon production,BP,
9387,GO:0034349,1,0.898106898625008,0,15,glial cell apoptotic process,BP,
9388,GO:0034350,1,0.944302556237736,0,8,regulation of glial cell apoptotic process,BP,
9389,GO:0034351,1,0.944302556237736,0,8,negative regulation of glial cell apoptotic process,BP,
9390,GO:0034354,1,0.992170027168696,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9393,GO:0034359,1,0.993986332301281,0,1,mature chylomicron,CC,
9394,GO:0034360,1,0.993986332301281,0,1,chylomicron remnant,CC,
9396,GO:0034362,1,0.91597828480309,0,12,low-density lipoprotein particle,CC,
9397,GO:0034363,1,0.970817531605554,0,4,intermediate-density lipoprotein particle,CC,
9399,GO:0034365,1,0.984400887813367,0,2,discoidal high-density lipoprotein particle,CC,
9400,GO:0034366,1,0.939306014451883,0,8,spherical high-density lipoprotein particle,CC,
9404,GO:0034370,1,0.918185461521147,0,11,triglyceride-rich lipoprotein particle remodeling,BP,
9405,GO:0034371,1,0.977801855445316,0,3,chylomicron remodeling,BP,
9406,GO:0034372,1,0.918185461521147,0,11,very-low-density lipoprotein particle remodeling,BP,
9407,GO:0034373,1,0.992170027168696,0,1,intermediate-density lipoprotein particle remodeling,BP,
9411,GO:0034378,1,0.98620277220707,0,2,chylomicron assembly,BP,
9413,GO:0034380,1,0.927785919001339,0,10,high-density lipoprotein particle assembly,BP,
9416,GO:0034383,1,0.875665516617771,0,18,low-density lipoprotein particle clearance,BP,
9417,GO:0034384,1,0.93325437021298,0,9,high-density lipoprotein particle clearance,BP,
9419,GO:0034388,1,0.957673433226573,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9420,GO:0034389,1,0.898328193061545,0,15,lipid particle organization,BP,
9421,GO:0034390,1,0.89522583868708,0,15,smooth muscle cell apoptotic process,BP,
9422,GO:0034391,1,0.89522583868708,0,15,regulation of smooth muscle cell apoptotic process,BP,
9423,GO:0034392,1,0.964994861689962,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9424,GO:0034393,1,0.941247993705624,0,8,positive regulation of smooth muscle cell apoptotic process,BP,
9426,GO:0034395,1,0.985130473360103,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9427,GO:0034397,1,0.911282043336517,0,13,telomere localization,BP,
9428,GO:0034398,1,0.959139004411232,0,6,telomere tethering at nuclear periphery,BP,
9430,GO:0034402,1,0.986252993817399,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9431,GO:0034405,1,0.785707457845964,0,34,response to fluid shear stress,BP,
9432,GO:0034414,1,0.985613905163078,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9433,GO:0034416,1,0.992454101113446,0,1,bisphosphoglycerate phosphatase activity,MF,
9434,GO:0034417,1,0.992454101113446,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9436,GO:0034421,1,0.979076341453739,0,3,post-translational protein acetylation,BP,
9437,GO:0034423,1,0.992327694848073,0,1,autophagosome lumen,CC,
9438,GO:0034427,1,0.948746619725979,0,7,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9439,GO:0034431,1,0.97080956241711,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9440,GO:0034432,1,0.97080956241711,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9446,GO:0034439,1,0.985199199824602,0,2,lipoprotein lipid oxidation,BP,
9448,GO:0034441,1,0.976692628130357,0,3,plasma lipoprotein oxidation,BP,
9449,GO:0034442,1,0.969829191088657,0,4,regulation of lipoprotein oxidation,BP,
9450,GO:0034443,1,0.976692112990833,0,3,negative regulation of lipoprotein oxidation,BP,
9451,GO:0034444,1,0.984400887813367,0,2,regulation of plasma lipoprotein oxidation,BP,
9452,GO:0034445,1,0.984400887813367,0,2,negative regulation of plasma lipoprotein oxidation,BP,
9453,GO:0034446,1,0.580203134488793,0,78,substrate adhesion-dependent cell spreading,BP,
9455,GO:0034448,1,0.992170775060611,0,1,EGO complex,CC,
9456,GO:0034450,1,0.914771506391204,0,13,ubiquitin-ubiquitin ligase activity,MF,
9457,GO:0034451,1,0.841533264919781,0,25,centriolar satellite,CC,
9458,GO:0034452,1,0.941542886903959,0,9,dynactin binding,MF,
9459,GO:0034453,1,0.886954135794384,0,18,microtubule anchoring,BP,
9460,GO:0034454,1,0.962528900709288,0,6,microtubule anchoring at centrosome,BP,
9461,GO:0034455,1,0.986292604955266,0,2,t-UTP complex,CC,
9462,GO:0034456,1,0.985871647528918,0,2,UTP-C complex,CC,
9463,GO:0034457,1,0.976788168012519,0,3,Mpp10 complex,CC,
9464,GO:0034458,1,0.992265851840136,0,1,3'-5' RNA helicase activity,MF,
9465,GO:0034462,1,0.992205546208959,0,1,small-subunit processome assembly,BP,
9466,GO:0034463,1,0.992170027168696,0,1,90S preribosome assembly,BP,
9467,GO:0034464,1,0.935166964807979,0,9,BBSome,CC,
9468,GO:0034465,1,0.971818145625942,0,4,response to carbon monoxide,BP,
9469,GO:0034466,1,0.99240155761802,0,1,chromaffin granule lumen,CC,
9471,GO:0034471,1,0.978857235914533,0,3,ncRNA 5'-end processing,BP,
9472,GO:0034472,1,0.941714205273814,0,8,snRNA 3'-end processing,BP,
9473,GO:0034474,1,0.99398633227068,0,1,U2 snRNA 3'-end processing,BP,
9474,GO:0034475,1,0.961480001614786,0,5,U4 snRNA 3'-end processing,BP,
9475,GO:0034477,1,0.992294630214608,0,1,U6 snRNA 3'-end processing,BP,
9476,GO:0034481,1,0.957509925444303,0,6,chondroitin sulfotransferase activity,MF,
9477,GO:0034483,1,0.900320042879788,0,15,heparan sulfate sulfotransferase activity,MF,
9478,GO:0034485,1,0.973052774505535,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9479,GO:0034486,1,0.992179254155245,0,1,vacuolar transmembrane transport,BP,
9480,GO:0034497,1,0.954797751319803,0,7,protein localization to pre-autophagosomal structure,BP,
9481,GO:0034498,1,0.9518984581695,0,7,early endosome to Golgi transport,BP,
9482,GO:0034499,1,0.987930617758966,0,2,late endosome to Golgi transport,BP,
9483,GO:0034501,1,0.892857650519143,0,15,protein localization to kinetochore,BP,
9484,GO:0034502,1,0.628821602000165,0,63,protein localization to chromosome,BP,
9486,GO:0034505,1,0.862123007864852,0,21,tooth mineralization,BP,
9487,GO:0034506,1,0.993535661543522,0,1,chromosome, centromeric core domain,CC,
9488,GO:0034508,1,0.691779150935506,0,49,centromere complex assembly,BP,
9489,GO:0034511,1,0.965036846086588,0,5,U3 snoRNA binding,MF,
9490,GO:0034513,1,0.961582118415242,0,5,box H/ACA snoRNA binding,MF,
9491,GO:0034516,1,0.992170027168696,0,1,response to vitamin B6,BP,
9492,GO:0034518,1,0.912843119682656,0,13,RNA cap binding complex,CC,
9493,GO:0034545,1,0.992170030385097,0,1,fumarylpyruvate hydrolase activity,MF,
9494,GO:0034551,1,0.963240923987023,0,5,mitochondrial respiratory chain complex III assembly,BP,
9495,GO:0034552,1,0.984400887813367,0,2,respiratory chain complex II assembly,BP,
9496,GO:0034553,1,0.984400887813367,0,2,mitochondrial respiratory chain complex II assembly,BP,
9497,GO:0034584,1,0.979253773757343,0,3,piRNA binding,MF,
9498,GO:0034587,1,0.889428092162492,0,16,piRNA metabolic process,BP,
9499,GO:0034589,1,0.993714418040605,0,1,hydroxyproline transport,BP,
9500,GO:0034590,1,0.993714418040605,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9501,GO:0034593,1,0.837818208506478,0,26,phosphatidylinositol bisphosphate phosphatase activity,MF,
9502,GO:0034594,1,0.959624379017691,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9503,GO:0034595,1,0.916485300300567,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9504,GO:0034596,1,0.934561236736046,0,10,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9505,GO:0034597,1,0.972269533204543,0,4,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9507,GO:0034602,1,0.993715768780852,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9508,GO:0034603,1,0.957269957053677,0,6,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9509,GO:0034604,1,0.957269957053677,0,6,pyruvate dehydrogenase (NAD+) activity,MF,
9510,GO:0034605,1,0.459193740102474,0,110,cellular response to heat,BP,
9514,GO:0034616,1,0.903742028026032,0,14,response to laminar fluid shear stress,BP,
9516,GO:0034618,1,0.957272099599972,0,6,arginine binding,MF,
9519,GO:0034625,1,0.977062432530122,0,3,fatty acid elongation, monounsaturated fatty acid,BP,
9520,GO:0034626,1,0.971977479998869,0,4,fatty acid elongation, polyunsaturated fatty acid,BP,
9521,GO:0034627,1,0.971947271465881,0,4,'de novo' NAD biosynthetic process,BP,
9522,GO:0034628,1,0.979618889955843,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9523,GO:0034629,1,0.820802998559655,0,27,cellular protein complex localization,BP,
9526,GO:0034634,1,0.993986332267598,0,1,glutathione transmembrane transporter activity,MF,
9527,GO:0034635,1,0.986210251252293,0,2,glutathione transport,BP,
9528,GO:0034637,1,0.597640050826897,0,72,cellular carbohydrate biosynthetic process,BP,
9531,GO:0034643,1,0.891097733772737,0,17,establishment of mitochondrion localization, microtubule-mediated,BP,
9532,GO:0034644,1,0.614679009855594,0,69,cellular response to UV,BP,
9534,GO:0034647,1,0.988008547487885,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9535,GO:0034648,1,0.97429042919642,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9536,GO:0034649,1,0.993421596342402,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9537,GO:0034650,1,0.938996763519661,0,9,cortisol metabolic process,BP,
9538,GO:0034651,1,0.938996763519661,0,9,cortisol biosynthetic process,BP,
9539,GO:0034653,1,0.97067824972336,0,4,retinoic acid catabolic process,BP,
9542,GO:0034656,1,0.948311658274332,0,7,nucleobase-containing small molecule catabolic process,BP,
9543,GO:0034657,1,0.978498839721418,0,3,GID complex,CC,
9545,GO:0034661,1,0.848804476148463,0,23,ncRNA catabolic process,BP,
9546,GO:0034663,1,0.929134659881115,0,10,endoplasmic reticulum chaperone complex,CC,
9547,GO:0034665,1,0.987259460786841,0,2,integrin alpha1-beta1 complex,CC,
9548,GO:0034666,1,0.980057272986064,0,3,integrin alpha2-beta1 complex,CC,
9549,GO:0034667,1,0.98729051101419,0,2,integrin alpha3-beta1 complex,CC,
9550,GO:0034668,1,0.993459902615453,0,1,integrin alpha4-beta1 complex,CC,
9551,GO:0034669,1,0.986441373848082,0,2,integrin alpha4-beta7 complex,CC,
9552,GO:0034670,1,0.99398633228361,0,1,chemotaxis to arachidonic acid,BP,
9553,GO:0034673,1,0.980257787507763,0,3,inhibin-betaglycan-ActRII complex,CC,
9554,GO:0034676,1,0.993986324480897,0,1,integrin alpha6-beta4 complex,CC,
9555,GO:0034677,1,0.993310387329544,0,1,integrin alpha7-beta1 complex,CC,
9556,GO:0034678,1,0.980119726438993,0,3,integrin alpha8-beta1 complex,CC,
9557,GO:0034679,1,0.993500695594589,0,1,integrin alpha9-beta1 complex,CC,
9558,GO:0034680,1,0.987318045605618,0,2,integrin alpha10-beta1 complex,CC,
9559,GO:0034681,1,0.987298374005996,0,2,integrin alpha11-beta1 complex,CC,
9560,GO:0034683,1,0.987949313520763,0,2,integrin alphav-beta3 complex,CC,
9561,GO:0034684,1,0.986958870043555,0,2,integrin alphav-beta5 complex,CC,
9562,GO:0034685,1,0.986274226971481,0,2,integrin alphav-beta6 complex,CC,
9563,GO:0034686,1,0.988008547481263,0,2,integrin alphav-beta8 complex,CC,
9564,GO:0034687,1,0.986532214572064,0,2,integrin alphaL-beta2 complex,CC,
9565,GO:0034693,1,0.992258767215617,0,1,U11/U12 snRNP,CC,
9566,GO:0034694,1,0.808320575699841,0,30,response to prostaglandin,BP,
9567,GO:0034695,1,0.842765754701499,0,24,response to prostaglandin E,BP,
9568,GO:0034696,1,0.992184682619676,0,1,response to prostaglandin F,BP,
9573,GO:0034704,1,0.684235131573165,0,55,calcium channel complex,CC,
9574,GO:0034705,1,0.52644398658554,0,90,potassium channel complex,CC,
9575,GO:0034706,1,0.878661711382004,0,20,sodium channel complex,CC,
9577,GO:0034708,1,0.54840718715838,0,83,methyltransferase complex,CC,
9578,GO:0034709,1,0.910095484481308,0,12,methylosome,CC,
9579,GO:0034711,1,0.964838852423424,0,5,inhibin binding,MF,
9580,GO:0034713,1,0.937343112628572,0,9,type I transforming growth factor beta receptor binding,MF,
9581,GO:0034714,1,0.979049816046429,0,3,type III transforming growth factor beta receptor binding,MF,
9582,GO:0034715,1,0.953923339922317,0,6,pICln-Sm protein complex,CC,
9583,GO:0034718,1,0.993981812750806,0,1,SMN-Gemin2 complex,CC,
9584,GO:0034719,1,0.878834509851821,0,17,SMN-Sm protein complex,CC,
9585,GO:0034720,1,0.962602752099328,0,6,histone H3-K4 demethylation,BP,
9586,GO:0034721,1,0.988008547487885,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9587,GO:0034722,1,0.992170027168696,0,1,gamma-glutamyl-peptidase activity,MF,
9588,GO:0034723,1,0.780803036793734,0,32,DNA replication-dependent nucleosome organization,BP,
9589,GO:0034724,1,0.691894644745071,0,49,DNA replication-independent nucleosome organization,BP,
9590,GO:0034727,1,0.987181858591688,0,2,piecemeal microautophagy of nucleus,BP,
9591,GO:0034728,1,0.302418809271628,0,159,nucleosome organization,BP,
9592,GO:0034729,1,0.980016931806021,0,3,histone H3-K79 methylation,BP,
9593,GO:0034736,1,0.98519031183025,0,2,cholesterol O-acyltransferase activity,MF,
9594,GO:0034739,1,0.984405137634664,0,2,histone deacetylase activity (H4-K16 specific),MF,
9595,GO:0034750,1,0.986986838036172,0,2,Scrib-APC-beta-catenin complex,CC,
9596,GO:0034751,1,0.978597200900009,0,3,aryl hydrocarbon receptor complex,CC,
9597,GO:0034752,1,0.993986332266811,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9598,GO:0034753,1,0.993986332266811,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9600,GO:0034755,1,0.924087131844044,0,11,iron ion transmembrane transport,BP,
9601,GO:0034756,1,0.970821636517367,0,4,regulation of iron ion transport,BP,
9602,GO:0034757,1,0.98620308078549,0,2,negative regulation of iron ion transport,BP,
9603,GO:0034758,1,0.984405049732661,0,2,positive regulation of iron ion transport,BP,
9604,GO:0034759,1,0.98620308078549,0,2,regulation of iron ion transmembrane transport,BP,
9605,GO:0034760,1,0.98620308078549,0,2,negative regulation of iron ion transmembrane transport,BP,
9607,GO:0034763,1,0.564233747861629,0,79,negative regulation of transmembrane transport,BP,
9610,GO:0034766,1,0.590498999524216,0,73,negative regulation of ion transmembrane transport,BP,
9612,GO:0034769,1,0.98582094325778,0,2,basement membrane disassembly,BP,
9613,GO:0034770,1,0.962690262172231,0,6,histone H4-K20 methylation,BP,
9614,GO:0034773,1,0.974376813794068,0,4,histone H4-K20 trimethylation,BP,
9616,GO:0034775,1,0.993986332267598,0,1,glutathione transmembrane transport,BP,
9617,GO:0034776,1,0.93377639105147,0,10,response to histamine,BP,
9618,GO:0034875,1,0.96978344651454,0,4,caffeine oxidase activity,MF,
9619,GO:0034899,1,0.992183063895809,0,1,trimethylamine monooxygenase activity,MF,
9620,GO:0034959,1,0.993961175892562,0,1,endothelin maturation,BP,
9621,GO:0034963,1,0.992170027168696,0,1,box C/D snoRNA processing,BP,
9622,GO:0034964,1,0.992302413607848,0,1,box H/ACA snoRNA processing,BP,
9623,GO:0034968,1,0.514963237417826,0,96,histone lysine methylation,BP,
9624,GO:0034969,1,0.919388876822646,0,11,histone arginine methylation,BP,
9625,GO:0034970,1,0.984940151026275,0,2,histone H3-R2 methylation,BP,
9626,GO:0034971,1,0.98480242248983,0,2,histone H3-R17 methylation,BP,
9627,GO:0034972,1,0.992198562480326,0,1,histone H3-R26 methylation,BP,
9628,GO:0034975,1,0.915381652686022,0,12,protein folding in endoplasmic reticulum,BP,
9630,GO:0034979,1,0.899204294248641,0,15,NAD-dependent protein deacetylase activity,MF,
9631,GO:0034982,1,0.926516198248337,0,10,mitochondrial protein processing,BP,
9632,GO:0034983,1,0.952429770445272,0,7,peptidyl-lysine deacetylation,BP,
9633,GO:0034986,1,0.993986332271419,0,1,iron chaperone activity,MF,
9634,GO:0034987,1,0.955974119608819,0,6,immunoglobulin receptor binding,MF,
9635,GO:0034988,1,0.986286479531936,0,2,Fc-gamma receptor I complex binding,MF,
9636,GO:0034991,1,0.971987146951591,0,4,nuclear meiotic cohesin complex,CC,
9637,GO:0034992,1,0.952383249384802,0,7,microtubule organizing center attachment site,CC,
9638,GO:0034993,1,0.952383249384802,0,7,LINC complex,CC,
9639,GO:0034998,1,0.992294630214608,0,1,oligosaccharyltransferase I complex,CC,
9640,GO:0035003,1,0.992213790389495,0,1,subapical complex,CC,
9642,GO:0035005,1,0.956722125381515,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9643,GO:0035014,1,0.953506044357296,0,7,phosphatidylinositol 3-kinase regulator activity,MF,
9644,GO:0035019,1,0.598227946825031,0,72,somatic stem cell population maintenance,BP,
9645,GO:0035020,1,0.923959195345941,0,12,regulation of Rac protein signal transduction,BP,
9646,GO:0035021,1,0.972741825138001,0,4,negative regulation of Rac protein signal transduction,BP,
9647,GO:0035022,1,0.987944807321456,0,2,positive regulation of Rac protein signal transduction,BP,
9648,GO:0035023,1,0.43112988000417,0,123,regulation of Rho protein signal transduction,BP,
9649,GO:0035024,1,0.889396116153358,0,17,negative regulation of Rho protein signal transduction,BP,
9650,GO:0035025,1,0.83318570650073,0,25,positive regulation of Rho protein signal transduction,BP,
9651,GO:0035026,1,0.986758518387021,0,2,leading edge cell differentiation,BP,
9652,GO:0035032,1,0.956716721803237,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9653,GO:0035033,1,0.978480215633163,0,3,histone deacetylase regulator activity,MF,
9654,GO:0035034,1,0.9849708280876,0,2,histone acetyltransferase regulator activity,MF,
9655,GO:0035035,1,0.834636471783932,0,26,histone acetyltransferase binding,MF,
9656,GO:0035036,1,0.710425728810459,0,45,sperm-egg recognition,BP,
9657,GO:0035037,1,0.99381556578181,0,1,sperm entry,BP,
9658,GO:0035038,1,0.984906451979487,0,2,female pronucleus assembly,BP,
9659,GO:0035039,1,0.98444894632718,0,2,male pronucleus assembly,BP,
9660,GO:0035041,1,0.992170027168696,0,1,sperm chromatin decondensation,BP,
9661,GO:0035042,1,0.992170027168696,0,1,fertilization, exchange of chromosomal proteins,BP,
9662,GO:0035048,1,0.993235950062752,0,1,splicing factor protein import into nucleus,BP,
9663,GO:0035050,1,0.593953853695137,0,74,embryonic heart tube development,BP,
9664,GO:0035051,1,0.430303406181263,0,120,cardiocyte differentiation,BP,
9665,GO:0035054,1,0.97801907194779,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9666,GO:0035061,1,0.981733308198935,0,3,interchromatin granule,CC,
9667,GO:0035063,1,0.987267938933068,0,2,nuclear speck organization,BP,
9668,GO:0035064,1,0.689258610030386,0,53,methylated histone binding,MF,
9669,GO:0035065,1,0.695942970886595,0,50,regulation of histone acetylation,BP,
9670,GO:0035066,1,0.809593992717766,0,29,positive regulation of histone acetylation,BP,
9671,GO:0035067,1,0.891422241782368,0,16,negative regulation of histone acetylation,BP,
9672,GO:0035068,1,0.956150470486251,0,6,micro-ribonucleoprotein complex,CC,
9673,GO:0035082,1,0.735593484342067,0,42,axoneme assembly,BP,
9674,GO:0035087,1,0.970939608680606,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9675,GO:0035088,1,0.776572833784566,0,36,establishment or maintenance of apical/basal cell polarity,BP,
9676,GO:0035089,1,0.925289304660596,0,11,establishment of apical/basal cell polarity,BP,
9677,GO:0035090,1,0.917636652331904,0,12,maintenance of apical/basal cell polarity,BP,
9679,GO:0035092,1,0.944832700906177,0,8,sperm chromatin condensation,BP,
9680,GO:0035093,1,0.972595049265646,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9682,GO:0035095,1,0.952062103897409,0,7,behavioral response to nicotine,BP,
9683,GO:0035097,1,0.640577720707798,0,63,histone methyltransferase complex,CC,
9684,GO:0035098,1,0.888168851620861,0,17,ESC/E(Z) complex,CC,
9685,GO:0035101,1,0.978620102222161,0,3,FACT complex,CC,
9686,GO:0035102,1,0.917240989050566,0,12,PRC1 complex,CC,
9687,GO:0035105,1,0.992697155644847,0,1,sterol regulatory element binding protein import into nucleus,BP,
9688,GO:0035106,1,0.978127169245308,0,3,operant conditioning,BP,
9689,GO:0035107,1,0.372103022004133,0,142,appendage morphogenesis,BP,
9690,GO:0035108,1,0.372103022004133,0,142,limb morphogenesis,BP,
9692,GO:0035113,1,0.425316274539318,0,122,embryonic appendage morphogenesis,BP,
9693,GO:0035115,1,0.805391747313045,0,30,embryonic forelimb morphogenesis,BP,
9694,GO:0035116,1,0.814353390510716,0,28,embryonic hindlimb morphogenesis,BP,
9695,GO:0035120,1,0.993986332289623,0,1,post-embryonic appendage morphogenesis,BP,
9696,GO:0035127,1,0.993986332289623,0,1,post-embryonic limb morphogenesis,BP,
9697,GO:0035128,1,0.993986332289623,0,1,post-embryonic forelimb morphogenesis,BP,
9698,GO:0035136,1,0.76318533847456,0,38,forelimb morphogenesis,BP,
9699,GO:0035137,1,0.771019434384341,0,36,hindlimb morphogenesis,BP,
9700,GO:0035145,1,0.864500909203667,0,20,exon-exon junction complex,CC,
9701,GO:0035148,1,0.368970836405238,0,142,tube formation,BP,
9702,GO:0035150,1,0.378780629304584,0,132,regulation of tube size,BP,
9703,GO:0035162,1,0.866312394203104,0,21,embryonic hemopoiesis,BP,
9704,GO:0035166,1,0.979409288223826,0,3,post-embryonic hemopoiesis,BP,
9705,GO:0035173,1,0.892306418485779,0,16,histone kinase activity,MF,
9706,GO:0035174,1,0.957425796528072,0,6,histone serine kinase activity,MF,
9707,GO:0035175,1,0.99217005778918,0,1,histone kinase activity (H3-S10 specific),MF,
9709,GO:0035184,1,0.958240761394354,0,6,histone threonine kinase activity,MF,
9710,GO:0035188,1,0.992801682381572,0,1,hatching,BP,
9711,GO:0035189,1,0.978612632258907,0,3,Rb-E2F complex,CC,
9712,GO:0035194,1,0.638650956044076,0,64,posttranscriptional gene silencing by RNA,BP,
9713,GO:0035195,1,0.657004186807446,0,60,gene silencing by miRNA,BP,
9714,GO:0035196,1,0.786055749777007,0,34,production of miRNAs involved in gene silencing by miRNA,BP,
9715,GO:0035197,1,0.946967344226771,0,8,siRNA binding,MF,
9716,GO:0035198,1,0.90262546461218,0,14,miRNA binding,MF,
9717,GO:0035226,1,0.992638180076462,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9718,GO:0035227,1,0.992638180076462,0,1,regulation of glutamate-cysteine ligase activity,BP,
9719,GO:0035229,1,0.992638180076462,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9720,GO:0035234,1,0.945807172097318,0,8,ectopic germ cell programmed cell death,BP,
9722,GO:0035239,1,0.0870860885302442,0,346,tube morphogenesis,BP,
9724,GO:0035241,1,0.976972888377142,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9725,GO:0035242,1,0.969628227115316,0,4,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9726,GO:0035243,1,0.976964417580428,0,3,protein-arginine omega-N symmetric methyltransferase activity,MF,
9727,GO:0035246,1,0.918297253879816,0,11,peptidyl-arginine N-methylation,BP,
9728,GO:0035247,1,0.94728695776071,0,7,peptidyl-arginine omega-N-methylation,BP,
9729,GO:0035248,1,0.992469855717769,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9730,GO:0035249,1,0.601953252634691,0,74,synaptic transmission, glutamatergic,BP,
9731,GO:0035250,1,0.819688679408375,0,27,UDP-galactosyltransferase activity,MF,
9733,GO:0035252,1,0.958580336221984,0,6,UDP-xylosyltransferase activity,MF,
9734,GO:0035253,1,0.94797442463834,0,8,ciliary rootlet,CC,
9735,GO:0035254,1,0.797863167159151,0,33,glutamate receptor binding,MF,
9736,GO:0035255,1,0.860603268212103,0,22,ionotropic glutamate receptor binding,MF,
9737,GO:0035256,1,0.957284074256546,0,6,G-protein coupled glutamate receptor binding,MF,
9738,GO:0035257,1,0.390829822777609,0,133,nuclear hormone receptor binding,MF,
9739,GO:0035258,1,0.553867800380413,0,84,steroid hormone receptor binding,MF,
9740,GO:0035259,1,0.916661789128274,0,13,glucocorticoid receptor binding,MF,
9741,GO:0035261,1,0.988008547502123,0,2,external genitalia morphogenesis,BP,
9742,GO:0035262,1,0.986247403907067,0,2,gonad morphogenesis,BP,
9745,GO:0035267,1,0.873137158844237,0,18,NuA4 histone acetyltransferase complex,CC,
9748,GO:0035270,1,0.404360904911796,0,124,endocrine system development,BP,
9749,GO:0035272,1,0.712059272836056,0,48,exocrine system development,BP,
9750,GO:0035276,1,0.978511065975874,0,3,ethanol binding,MF,
9751,GO:0035278,1,0.912004271178926,0,13,miRNA mediated inhibition of translation,BP,
9752,GO:0035279,1,0.985491015751861,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9753,GO:0035280,1,0.950398489320334,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9754,GO:0035281,1,0.986197173624354,0,2,pre-miRNA export from nucleus,BP,
9755,GO:0035282,1,0.504241594341251,0,95,segmentation,BP,
9756,GO:0035283,1,0.977702997705287,0,3,central nervous system segmentation,BP,
9757,GO:0035284,1,0.977702997705287,0,3,brain segmentation,BP,
9758,GO:0035290,1,0.979471918925534,0,3,trunk segmentation,BP,
9760,GO:0035296,1,0.405771256343697,0,123,regulation of tube diameter,BP,
9761,GO:0035299,1,0.993767143315714,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9766,GO:0035307,1,0.790963303728786,0,33,positive regulation of protein dephosphorylation,BP,
9768,GO:0035312,1,0.958254389502568,0,6,5'-3' exodeoxyribonuclease activity,MF,
9769,GO:0035313,1,0.89708673385729,0,16,wound healing, spreading of epidermal cells,BP,
9770,GO:0035315,1,0.762801901769401,0,38,hair cell differentiation,BP,
9771,GO:0035325,1,0.93704035157151,0,9,Toll-like receptor binding,MF,
9772,GO:0035326,1,0.504322676720288,0,96,enhancer binding,MF,
9773,GO:0035327,1,0.86049527324567,0,21,transcriptionally active chromatin,CC,
9774,GO:0035329,1,0.790933642913495,0,35,hippo signaling,BP,
9775,GO:0035330,1,0.942394291696611,0,9,regulation of hippo signaling,BP,
9776,GO:0035331,1,0.961077761526597,0,6,negative regulation of hippo signaling,BP,
9777,GO:0035332,1,0.993986332278843,0,1,positive regulation of hippo signaling,BP,
9782,GO:0035339,1,0.969077682415367,0,4,SPOTS complex,CC,
9783,GO:0035349,1,0.984956409798264,0,2,coenzyme A transmembrane transport,BP,
9784,GO:0035350,1,0.9848592638623,0,2,FAD transmembrane transport,BP,
9785,GO:0035354,1,0.985455029155014,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9786,GO:0035355,1,0.993986332264836,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9787,GO:0035356,1,0.949060742281218,0,7,cellular triglyceride homeostasis,BP,
9788,GO:0035357,1,0.868755617034482,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9789,GO:0035358,1,0.917718382156319,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9790,GO:0035359,1,0.978138029458848,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9791,GO:0035360,1,0.951773287151911,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9792,GO:0035363,1,0.985758912732655,0,2,histone locus body,CC,
9793,GO:0035368,1,0.964077648156943,0,5,selenocysteine insertion sequence binding,MF,
9794,GO:0035370,1,0.984568798441481,0,2,UBC13-UEV1A complex,CC,
9795,GO:0035371,1,0.892991818137569,0,17,microtubule plus-end,CC,
9796,GO:0035372,1,0.940840632233995,0,9,protein localization to microtubule,BP,
9797,GO:0035373,1,0.980271740744636,0,3,chondroitin sulfate proteoglycan binding,MF,
9798,GO:0035374,1,0.959669415721978,0,6,chondroitin sulfate binding,MF,
9799,GO:0035375,1,0.993986332274051,0,1,zymogen binding,MF,
9800,GO:0035376,1,0.933713330498594,0,9,sterol import,BP,
9801,GO:0035377,1,0.986424062900222,0,2,transepithelial water transport,BP,
9802,GO:0035378,1,0.984624986267428,0,2,carbon dioxide transmembrane transport,BP,
9803,GO:0035379,1,0.984624986267428,0,2,carbon dioxide transmembrane transporter activity,MF,
9804,GO:0035381,1,0.941749839500534,0,8,ATP-gated ion channel activity,MF,
9807,GO:0035385,1,0.956708691369098,0,7,Roundabout signaling pathway,BP,
9808,GO:0035397,1,0.984901902273655,0,2,helper T cell enhancement of adaptive immune response,BP,
9809,GO:0035400,1,0.993975941982073,0,1,histone tyrosine kinase activity,MF,
9810,GO:0035401,1,0.993975941982073,0,1,histone kinase activity (H3-Y41 specific),MF,
9811,GO:0035402,1,0.985007321857034,0,2,histone kinase activity (H3-T11 specific),MF,
9812,GO:0035403,1,0.988001861660527,0,2,histone kinase activity (H3-T6 specific),MF,
9813,GO:0035404,1,0.928989767815448,0,10,histone-serine phosphorylation,BP,
9814,GO:0035405,1,0.958240761394354,0,6,histone-threonine phosphorylation,BP,
9815,GO:0035406,1,0.993975941982073,0,1,histone-tyrosine phosphorylation,BP,
9816,GO:0035407,1,0.985007321857034,0,2,histone H3-T11 phosphorylation,BP,
9817,GO:0035408,1,0.988001861660527,0,2,histone H3-T6 phosphorylation,BP,
9818,GO:0035409,1,0.993975941982073,0,1,histone H3-Y41 phosphorylation,BP,
9819,GO:0035410,1,0.992170027168696,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9820,GO:0035411,1,0.835604774285886,0,26,catenin import into nucleus,BP,
9821,GO:0035412,1,0.848060137226572,0,24,regulation of catenin import into nucleus,BP,
9822,GO:0035413,1,0.928448561186077,0,11,positive regulation of catenin import into nucleus,BP,
9823,GO:0035414,1,0.926791371270375,0,11,negative regulation of catenin import into nucleus,BP,
9824,GO:0035418,1,0.8063235159388,0,31,protein localization to synapse,BP,
9825,GO:0035419,1,0.986554144666004,0,2,activation of MAPK activity involved in innate immune response,BP,
9826,GO:0035425,1,0.97835678867177,0,3,autocrine signaling,BP,
9827,GO:0035426,1,0.96629759602121,0,5,extracellular matrix-cell signaling,BP,
9828,GO:0035428,1,0.871277743772765,0,19,hexose transmembrane transport,BP,
9830,GO:0035435,1,0.877938880592632,0,18,phosphate ion transmembrane transport,BP,
9831,GO:0035437,1,0.92901622505332,0,10,maintenance of protein localization in endoplasmic reticulum,BP,
9832,GO:0035438,1,0.992170035496111,0,1,cyclic-di-GMP binding,MF,
9833,GO:0035441,1,0.981289264127437,0,3,cell migration involved in vasculogenesis,BP,
9834,GO:0035442,1,0.984567847130588,0,2,dipeptide transmembrane transport,BP,
9835,GO:0035443,1,0.993986332267598,0,1,tripeptide transmembrane transport,BP,
9836,GO:0035445,1,0.992674191786854,0,1,borate transmembrane transport,BP,
9838,GO:0035456,1,0.848437232271357,0,22,response to interferon-beta,BP,
9840,GO:0035458,1,0.902047677677144,0,14,cellular response to interferon-beta,BP,
9841,GO:0035459,1,0.933668685895569,0,10,cargo loading into vesicle,BP,
9842,GO:0035461,1,0.938016483890594,0,9,vitamin transmembrane transport,BP,
9843,GO:0035469,1,0.967288899811688,0,5,determination of pancreatic left/right asymmetry,BP,
9844,GO:0035470,1,0.984401486849777,0,2,positive regulation of vascular wound healing,BP,
9845,GO:0035472,1,0.992651574161641,0,1,choriogonadotropin hormone receptor activity,MF,
9846,GO:0035473,1,0.957376916768787,0,6,lipase binding,MF,
9847,GO:0035478,1,0.992210979877727,0,1,chylomicron binding,MF,
9848,GO:0035480,1,0.992170027168696,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9849,GO:0035481,1,0.992170027168696,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9850,GO:0035482,1,0.9766921130689,0,3,gastric motility,BP,
9851,GO:0035483,1,0.984400887813367,0,2,gastric emptying,BP,
9852,GO:0035490,1,0.992716694742547,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9853,GO:0035491,1,0.992716694742547,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9854,GO:0035493,1,0.891180920487264,0,16,SNARE complex assembly,BP,
9855,GO:0035494,1,0.978157879085038,0,3,SNARE complex disassembly,BP,
9856,GO:0035497,1,0.90924902535498,0,13,cAMP response element binding,MF,
9857,GO:0035498,1,0.993480543526736,0,1,carnosine metabolic process,BP,
9858,GO:0035499,1,0.993480543526736,0,1,carnosine biosynthetic process,BP,
9859,GO:0035500,1,0.985803639476145,0,2,MH2 domain binding,MF,
9860,GO:0035501,1,0.992441219375176,0,1,MH1 domain binding,MF,
9861,GO:0035502,1,0.956333751012053,0,6,metanephric part of ureteric bud development,BP,
9862,GO:0035504,1,0.992170027168696,0,1,regulation of myosin light chain kinase activity,BP,
9863,GO:0035505,1,0.992170027168696,0,1,positive regulation of myosin light chain kinase activity,BP,
9864,GO:0035507,1,0.955871799006558,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9865,GO:0035508,1,0.993985600722979,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9866,GO:0035509,1,0.967476939092367,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9867,GO:0035510,1,0.837991497490649,0,24,DNA dealkylation,BP,
9868,GO:0035511,1,0.963687842759191,0,5,oxidative DNA demethylation,BP,
9869,GO:0035513,1,0.971471750948928,0,4,oxidative RNA demethylation,BP,
9870,GO:0035514,1,0.985928145628474,0,2,DNA demethylase activity,MF,
9871,GO:0035515,1,0.971471750948928,0,4,oxidative RNA demethylase activity,MF,
9872,GO:0035516,1,0.99370924424421,0,1,oxidative DNA demethylase activity,MF,
9873,GO:0035517,1,0.986744845304204,0,2,PR-DUB complex,CC,
9874,GO:0035518,1,0.920150895831647,0,12,histone H2A monoubiquitination,BP,
9875,GO:0035519,1,0.970817531572605,0,4,protein K29-linked ubiquitination,BP,
9876,GO:0035520,1,0.941983391717275,0,9,monoubiquitinated protein deubiquitination,BP,
9877,GO:0035521,1,0.971872746762109,0,4,monoubiquitinated histone deubiquitination,BP,
9878,GO:0035522,1,0.971872746762109,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9879,GO:0035523,1,0.974325111375411,0,4,protein K29-linked deubiquitination,BP,
9880,GO:0035524,1,0.953433125497492,0,7,proline transmembrane transport,BP,
9881,GO:0035525,1,0.992302413607848,0,1,NF-kappaB p50/p65 complex,CC,
9882,GO:0035526,1,0.987678416185413,0,2,retrograde transport, plasma membrane to Golgi,BP,
9883,GO:0035529,1,0.964617660018491,0,5,NADH pyrophosphatase activity,MF,
9884,GO:0035538,1,0.99280898289268,0,1,carbohydrate response element binding,MF,
9885,GO:0035539,1,0.984409069998441,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9886,GO:0035542,1,0.939534891030236,0,9,regulation of SNARE complex assembly,BP,
9887,GO:0035543,1,0.992170027168696,0,1,positive regulation of SNARE complex assembly,BP,
9888,GO:0035544,1,0.987694198549131,0,2,negative regulation of SNARE complex assembly,BP,
9889,GO:0035545,1,0.993461571293014,0,1,determination of left/right asymmetry in nervous system,BP,
9890,GO:0035546,1,0.992466234349486,0,1,interferon-beta secretion,BP,
9891,GO:0035547,1,0.992466234349486,0,1,regulation of interferon-beta secretion,BP,
9892,GO:0035548,1,0.992466234349486,0,1,negative regulation of interferon-beta secretion,BP,
9893,GO:0035552,1,0.978341241775419,0,3,oxidative single-stranded DNA demethylation,BP,
9894,GO:0035553,1,0.979005799123039,0,3,oxidative single-stranded RNA demethylation,BP,
9896,GO:0035561,1,0.867100805186568,0,20,regulation of chromatin binding,BP,
9897,GO:0035562,1,0.947937927791268,0,8,negative regulation of chromatin binding,BP,
9898,GO:0035563,1,0.921232503243068,0,11,positive regulation of chromatin binding,BP,
9899,GO:0035564,1,0.972773160617182,0,4,regulation of kidney size,BP,
9900,GO:0035565,1,0.992422054065019,0,1,regulation of pronephros size,BP,
9901,GO:0035566,1,0.986133159286368,0,2,regulation of metanephros size,BP,
9903,GO:0035568,1,0.992294630214608,0,1,N-terminal peptidyl-proline methylation,BP,
9904,GO:0035570,1,0.992294630214608,0,1,N-terminal peptidyl-serine methylation,BP,
9905,GO:0035572,1,0.992294630214608,0,1,N-terminal peptidyl-serine dimethylation,BP,
9906,GO:0035573,1,0.992294630214608,0,1,N-terminal peptidyl-serine trimethylation,BP,
9907,GO:0035574,1,0.993986332265888,0,1,histone H4-K20 demethylation,BP,
9908,GO:0035575,1,0.993986332265888,0,1,histone demethylase activity (H4-K20 specific),MF,
9909,GO:0035577,1,0.661576970944116,0,57,azurophil granule membrane,CC,
9911,GO:0035579,1,0.526794966075476,0,89,specific granule membrane,CC,
9912,GO:0035580,1,0.638331997104291,0,60,specific granule lumen,CC,
9913,GO:0035581,1,0.946191285204304,0,8,sequestering of extracellular ligand from receptor,BP,
9914,GO:0035582,1,0.970826811777727,0,4,sequestering of BMP in extracellular matrix,BP,
9915,GO:0035583,1,0.982047397013566,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9916,GO:0035584,1,0.889200469423946,0,16,calcium-mediated signaling using intracellular calcium source,BP,
9917,GO:0035585,1,0.993986332299173,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9923,GO:0035591,1,0.577532782941646,0,78,signaling adaptor activity,MF,
9924,GO:0035594,1,0.970107106892165,0,4,ganglioside binding,MF,
9925,GO:0035596,1,0.985064270762856,0,2,methylthiotransferase activity,MF,
9926,GO:0035597,1,0.992178615268564,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9927,GO:0035598,1,0.992830011017474,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9928,GO:0035600,1,0.985064270762856,0,2,tRNA methylthiolation,BP,
9930,GO:0035602,1,0.993586657827084,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9931,GO:0035603,1,0.993586657827084,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9932,GO:0035604,1,0.993586657827084,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9933,GO:0035605,1,0.992170027168696,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9934,GO:0035606,1,0.984400887813367,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9935,GO:0035607,1,0.987610872883565,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9936,GO:0035608,1,0.943815362073245,0,8,protein deglutamylation,BP,
9937,GO:0035609,1,0.964414237220694,0,5,C-terminal protein deglutamylation,BP,
9938,GO:0035610,1,0.965926179989371,0,5,protein side chain deglutamylation,BP,
9939,GO:0035611,1,0.992451637997215,0,1,protein branching point deglutamylation,BP,
9940,GO:0035612,1,0.953176272946939,0,7,AP-2 adaptor complex binding,MF,
9941,GO:0035613,1,0.92590185522472,0,11,RNA stem-loop binding,MF,
9942,GO:0035614,1,0.977084717343992,0,3,snRNA stem-loop binding,MF,
9943,GO:0035615,1,0.927410672758731,0,11,clathrin adaptor activity,MF,
9944,GO:0035616,1,0.980692347703841,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9945,GO:0035617,1,0.978617444556522,0,3,stress granule disassembly,BP,
9946,GO:0035620,1,0.987942703771895,0,2,ceramide transporter activity,MF,
9947,GO:0035621,1,0.986203763985481,0,2,ER to Golgi ceramide transport,BP,
9948,GO:0035622,1,0.993452357000003,0,1,intrahepatic bile duct development,BP,
9950,GO:0035624,1,0.965957669277061,0,5,receptor transactivation,BP,
9951,GO:0035625,1,0.971803073248692,0,4,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9952,GO:0035627,1,0.966955598706217,0,5,ceramide transport,BP,
9953,GO:0035630,1,0.945114415528575,0,8,bone mineralization involved in bone maturation,BP,
9954,GO:0035631,1,0.922661864643653,0,11,CD40 receptor complex,CC,
9955,GO:0035633,1,0.973725505851911,0,4,maintenance of permeability of blood-brain barrier,BP,
9956,GO:0035634,1,0.963226223689722,0,5,response to stilbenoid,BP,
9957,GO:0035635,1,0.8902386639675,0,17,entry of bacterium into host cell,BP,
9959,GO:0035638,1,0.993890209450423,0,1,signal maturation,BP,
9961,GO:0035640,1,0.860132973629171,0,22,exploration behavior,BP,
9962,GO:0035641,1,0.922278359217655,0,12,locomotory exploration behavior,BP,
9963,GO:0035642,1,0.9925543329559,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9964,GO:0035643,1,0.992170043221952,0,1,L-DOPA receptor activity,MF,
9965,GO:0035644,1,0.992578860073473,0,1,phosphoanandamide dephosphorylation,BP,
9966,GO:0035645,1,0.993703727699615,0,1,enteric smooth muscle cell differentiation,BP,
9967,GO:0035646,1,0.929648367631039,0,10,endosome to melanosome transport,BP,
9968,GO:0035650,1,0.976981607068519,0,3,AP-1 adaptor complex binding,MF,
9969,GO:0035651,1,0.978146222726051,0,3,AP-3 adaptor complex binding,MF,
9970,GO:0035655,1,0.963295590990644,0,5,interleukin-18-mediated signaling pathway,BP,
9971,GO:0035659,1,0.992170062901773,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9972,GO:0035662,1,0.976692481132599,0,3,Toll-like receptor 4 binding,MF,
9973,GO:0035663,1,0.978761552481362,0,3,Toll-like receptor 2 binding,MF,
9974,GO:0035664,1,0.992170401098731,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9975,GO:0035665,1,0.992170401098731,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9977,GO:0035668,1,0.986589860895294,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9978,GO:0035669,1,0.986589860895294,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9979,GO:0035671,1,0.961919809480289,0,5,enone reductase activity,MF,
9980,GO:0035672,1,0.958277099259276,0,6,oligopeptide transmembrane transport,BP,
9981,GO:0035673,1,0.973300371070193,0,4,oligopeptide transmembrane transporter activity,MF,
9982,GO:0035674,1,0.984995520711852,0,2,tricarboxylic acid transmembrane transport,BP,
9983,GO:0035684,1,0.992170027168696,0,1,helper T cell extravasation,BP,
9984,GO:0035686,1,0.948483562359312,0,7,sperm fibrous sheath,CC,
9986,GO:0035691,1,0.985952408619774,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9987,GO:0035692,1,0.986159204094494,0,2,macrophage migration inhibitory factor receptor complex,CC,
9988,GO:0035693,1,0.992170027168696,0,1,NOS2-CD74 complex,CC,
9989,GO:0035694,1,0.972695474180602,0,4,mitochondrial protein catabolic process,BP,
9990,GO:0035695,1,0.993715768780852,0,1,mitophagy by induced vacuole formation,BP,
9991,GO:0035696,1,0.979894534116847,0,3,monocyte extravasation,BP,
9994,GO:0035700,1,0.984501914135142,0,2,astrocyte chemotaxis,BP,
9995,GO:0035701,1,0.957758993226071,0,6,hematopoietic stem cell migration,BP,
9996,GO:0035704,1,0.992271495764135,0,1,helper T cell chemotaxis,BP,
9997,GO:0035705,1,0.992271495764135,0,1,T-helper 17 cell chemotaxis,BP,
9998,GO:0035708,1,0.99304012820112,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9999,GO:0035709,1,0.985291958099893,0,2,memory T cell activation,BP,
10000,GO:0035710,1,0.598871767430256,0,70,CD4-positive, alpha-beta T cell activation,BP,
10001,GO:0035711,1,0.985198200376822,0,2,T-helper 1 cell activation,BP,
10002,GO:0035712,1,0.985912839554994,0,2,T-helper 2 cell activation,BP,
10003,GO:0035713,1,0.99304012820112,0,1,response to nitrogen dioxide,BP,
10004,GO:0035714,1,0.99304012820112,0,1,cellular response to nitrogen dioxide,BP,
10005,GO:0035717,1,0.99234726261196,0,1,chemokine (C-C motif) ligand 7 binding,MF,
10006,GO:0035718,1,0.992170027168696,0,1,macrophage migration inhibitory factor binding,MF,
10007,GO:0035720,1,0.979766417669517,0,3,intraciliary anterograde transport,BP,
10008,GO:0035721,1,0.943108134727918,0,9,intraciliary retrograde transport,BP,
10009,GO:0035722,1,0.980267605916461,0,3,interleukin-12-mediated signaling pathway,BP,
10010,GO:0035723,1,0.978970416460639,0,3,interleukin-15-mediated signaling pathway,BP,
10011,GO:0035724,1,0.99398633226952,0,1,CD24 biosynthetic process,BP,
10013,GO:0035726,1,0.951904577847487,0,7,common myeloid progenitor cell proliferation,BP,
10014,GO:0035727,1,0.969907802560829,0,4,lysophosphatidic acid binding,MF,
10015,GO:0035728,1,0.885292380071364,0,17,response to hepatocyte growth factor,BP,
10016,GO:0035729,1,0.897645610882519,0,15,cellular response to hepatocyte growth factor stimulus,BP,
10017,GO:0035730,1,0.992170027168696,0,1,S-nitrosoglutathione binding,MF,
10018,GO:0035731,1,0.992170027168696,0,1,dinitrosyl-iron complex binding,MF,
10019,GO:0035732,1,0.992170027168696,0,1,nitric oxide storage,BP,
10020,GO:0035733,1,0.951667026624828,0,7,hepatic stellate cell activation,BP,
10021,GO:0035735,1,0.766018082574452,0,38,intraciliary transport involved in cilium assembly,BP,
10022,GO:0035739,1,0.964480692133582,0,5,CD4-positive, alpha-beta T cell proliferation,BP,
10023,GO:0035740,1,0.970064846837905,0,4,CD8-positive, alpha-beta T cell proliferation,BP,
10024,GO:0035743,1,0.905912659156302,0,13,CD4-positive, alpha-beta T cell cytokine production,BP,
10025,GO:0035744,1,0.984407923564942,0,2,T-helper 1 cell cytokine production,BP,
10026,GO:0035745,1,0.919999681196814,0,11,T-helper 2 cell cytokine production,BP,
10027,GO:0035746,1,0.992170027168696,0,1,granzyme A production,BP,
10028,GO:0035747,1,0.920613427730674,0,11,natural killer cell chemotaxis,BP,
10029,GO:0035748,1,0.960538951509934,0,6,myelin sheath abaxonal region,CC,
10030,GO:0035749,1,0.959219146754062,0,6,myelin sheath adaxonal region,CC,
10031,GO:0035750,1,0.993979303179081,0,1,protein localization to myelin sheath abaxonal region,BP,
10032,GO:0035751,1,0.926538683518623,0,10,regulation of lysosomal lumen pH,BP,
10033,GO:0035752,1,0.99217267899518,0,1,lysosomal lumen pH elevation,BP,
10034,GO:0035754,1,0.94242876432368,0,8,B cell chemotaxis,BP,
10035,GO:0035755,1,0.992299643036661,0,1,cardiolipin hydrolase activity,MF,
10036,GO:0035757,1,0.992192957802479,0,1,chemokine (C-C motif) ligand 19 binding,MF,
10037,GO:0035758,1,0.992192957802479,0,1,chemokine (C-C motif) ligand 21 binding,MF,
10038,GO:0035759,1,0.984600226043665,0,2,mesangial cell-matrix adhesion,BP,
10042,GO:0035769,1,0.992170027168696,0,1,B cell chemotaxis across high endothelial venule,BP,
10044,GO:0035771,1,0.957019976921282,0,6,interleukin-4-mediated signaling pathway,BP,
10045,GO:0035772,1,0.992170230723253,0,1,interleukin-13-mediated signaling pathway,BP,
10046,GO:0035773,1,0.674637529729598,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
10047,GO:0035774,1,0.831583172207424,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
10048,GO:0035782,1,0.992170027168696,0,1,mature natural killer cell chemotaxis,BP,
10049,GO:0035783,1,0.99304012820112,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
10050,GO:0035786,1,0.992294630214608,0,1,protein complex oligomerization,BP,
10051,GO:0035787,1,0.967117732286901,0,5,cell migration involved in kidney development,BP,
10052,GO:0035788,1,0.972977851157836,0,4,cell migration involved in metanephros development,BP,
10053,GO:0035789,1,0.972977851157836,0,4,metanephric mesenchymal cell migration,BP,
10054,GO:0035790,1,0.981322292014619,0,3,platelet-derived growth factor receptor-alpha signaling pathway,BP,
10055,GO:0035791,1,0.915911397342105,0,13,platelet-derived growth factor receptor-beta signaling pathway,BP,
10056,GO:0035793,1,0.979013734015813,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
10059,GO:0035799,1,0.973248306777979,0,4,ureter maturation,BP,
10060,GO:0035800,1,0.98562801524979,0,2,deubiquitinase activator activity,MF,
10061,GO:0035801,1,0.984803622085828,0,2,adrenal cortex development,BP,
10062,GO:0035802,1,0.984803622085828,0,2,adrenal cortex formation,BP,
10063,GO:0035803,1,0.984400887813367,0,2,egg coat formation,BP,
10064,GO:0035805,1,0.992205013245353,0,1,egg coat,CC,
10065,GO:0035809,1,0.862374828827023,0,20,regulation of urine volume,BP,
10066,GO:0035810,1,0.909445040072663,0,13,positive regulation of urine volume,BP,
10067,GO:0035811,1,0.963214305049445,0,5,negative regulation of urine volume,BP,
10068,GO:0035812,1,0.854611670548921,0,21,renal sodium excretion,BP,
10069,GO:0035813,1,0.854611670548921,0,21,regulation of renal sodium excretion,BP,
10070,GO:0035814,1,0.961762307359963,0,5,negative regulation of renal sodium excretion,BP,
10071,GO:0035815,1,0.908178270514204,0,13,positive regulation of renal sodium excretion,BP,
10072,GO:0035821,1,0.436858156126989,0,113,modification of morphology or physiology of other organism,BP,
10073,GO:0035822,1,0.972488123919612,0,4,gene conversion,BP,
10074,GO:0035825,1,0.730144634409615,0,43,reciprocal DNA recombination,BP,
10075,GO:0035826,1,0.96663510092134,0,5,rubidium ion transport,BP,
10076,GO:0035838,1,0.981726913515189,0,3,growing cell tip,CC,
10077,GO:0035841,1,0.988004295782515,0,2,new growing cell tip,CC,
10078,GO:0035844,1,0.972471874008898,0,4,cloaca development,BP,
10079,GO:0035845,1,0.942650483075596,0,9,photoreceptor cell outer segment organization,BP,
10080,GO:0035846,1,0.992211770211184,0,1,oviduct epithelium development,BP,
10081,GO:0035847,1,0.992211770211184,0,1,uterine epithelium development,BP,
10082,GO:0035849,1,0.992211770211184,0,1,nephric duct elongation,BP,
10083,GO:0035850,1,0.727178415201697,0,46,epithelial cell differentiation involved in kidney development,BP,
10084,GO:0035851,1,0.992548610140938,0,1,Krueppel-associated box domain binding,MF,
10085,GO:0035852,1,0.992211770211184,0,1,horizontal cell localization,BP,
10086,GO:0035853,1,0.993800874746249,0,1,chromosome passenger complex localization to spindle midzone,BP,
10087,GO:0035854,1,0.985149338161135,0,2,eosinophil fate commitment,BP,
10088,GO:0035855,1,0.904120449681213,0,15,megakaryocyte development,BP,
10089,GO:0035859,1,0.915136865325538,0,12,Seh1-associated complex,CC,
10090,GO:0035860,1,0.959726940628301,0,6,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
10091,GO:0035861,1,0.813902224883914,0,29,site of double-strand break,CC,
10092,GO:0035862,1,0.993986332265624,0,1,dITP metabolic process,BP,
10093,GO:0035863,1,0.993986332265624,0,1,dITP catabolic process,BP,
10094,GO:0035864,1,0.917742201314628,0,12,response to potassium ion,BP,
10095,GO:0035865,1,0.951065442121067,0,7,cellular response to potassium ion,BP,
10096,GO:0035867,1,0.97610124913092,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10097,GO:0035869,1,0.673669535089231,0,56,ciliary transition zone,CC,
10098,GO:0035870,1,0.986203080773366,0,2,dITP diphosphatase activity,MF,
10099,GO:0035871,1,0.937038679513703,0,10,protein K11-linked deubiquitination,BP,
10100,GO:0035872,1,0.784025376567865,0,34,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10101,GO:0035873,1,0.959457895743619,0,6,lactate transmembrane transport,BP,
10103,GO:0035878,1,0.929328626869994,0,10,nail development,BP,
10104,GO:0035879,1,0.979651270169633,0,3,plasma membrane lactate transport,BP,
10105,GO:0035880,1,0.977848678440283,0,3,embryonic nail plate morphogenesis,BP,
10106,GO:0035881,1,0.942632801340611,0,8,amacrine cell differentiation,BP,
10107,GO:0035883,1,0.829864091810073,0,26,enteroendocrine cell differentiation,BP,
10108,GO:0035886,1,0.879153406421151,0,18,vascular smooth muscle cell differentiation,BP,
10109,GO:0035887,1,0.992170154337142,0,1,aortic smooth muscle cell differentiation,BP,
10110,GO:0035890,1,0.775764807286503,0,35,exit from host,BP,
10111,GO:0035891,1,0.775764807286503,0,35,exit from host cell,BP,
10112,GO:0035897,1,0.955892827581739,0,6,proteolysis in other organism,BP,
10113,GO:0035898,1,0.978936498154502,0,3,parathyroid hormone secretion,BP,
10116,GO:0035904,1,0.723322737521432,0,48,aorta development,BP,
10117,GO:0035905,1,0.97268528386052,0,4,ascending aorta development,BP,
10118,GO:0035907,1,0.937583338441571,0,9,dorsal aorta development,BP,
10119,GO:0035909,1,0.820251788742951,0,29,aorta morphogenesis,BP,
10120,GO:0035910,1,0.97268528386052,0,4,ascending aorta morphogenesis,BP,
10121,GO:0035912,1,0.944360189316767,0,8,dorsal aorta morphogenesis,BP,
10123,GO:0035915,1,0.992179962100161,0,1,pore formation in membrane of other organism,BP,
10124,GO:0035921,1,0.992184534684508,0,1,desmosome disassembly,BP,
10125,GO:0035922,1,0.984944700959493,0,2,foramen ovale closure,BP,
10126,GO:0035924,1,0.774766380801783,0,37,cellular response to vascular endothelial growth factor stimulus,BP,
10127,GO:0035925,1,0.926403474557086,0,11,mRNA 3'-UTR AU-rich region binding,MF,
10128,GO:0035926,1,0.970898870683002,0,4,chemokine (C-C motif) ligand 2 secretion,BP,
10129,GO:0035927,1,0.963818183750238,0,5,RNA import into mitochondrion,BP,
10130,GO:0035928,1,0.978341887226379,0,3,rRNA import into mitochondrion,BP,
10131,GO:0035929,1,0.866880556261809,0,19,steroid hormone secretion,BP,
10132,GO:0035930,1,0.899390563434527,0,14,corticosteroid hormone secretion,BP,
10133,GO:0035931,1,0.955075127577355,0,6,mineralocorticoid secretion,BP,
10134,GO:0035932,1,0.955075127577355,0,6,aldosterone secretion,BP,
10135,GO:0035933,1,0.941716452693658,0,8,glucocorticoid secretion,BP,
10136,GO:0035934,1,0.976816008884554,0,3,corticosterone secretion,BP,
10137,GO:0035935,1,0.992827068341019,0,1,androgen secretion,BP,
10138,GO:0035936,1,0.986898855507301,0,2,testosterone secretion,BP,
10139,GO:0035938,1,0.980079998126498,0,3,estradiol secretion,BP,
10140,GO:0035939,1,0.978314945289133,0,3,microsatellite binding,MF,
10141,GO:0035945,1,0.992265851840136,0,1,mitochondrial ncRNA surveillance,BP,
10142,GO:0035946,1,0.992265851840136,0,1,mitochondrial mRNA surveillance,BP,
10143,GO:0035947,1,0.958558059588952,0,6,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10144,GO:0035948,1,0.971743851990146,0,4,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10147,GO:0035964,1,0.972251010109934,0,4,COPI-coated vesicle budding,BP,
10148,GO:0035965,1,0.956415576513112,0,6,cardiolipin acyl-chain remodeling,BP,
10151,GO:0035970,1,0.924768993319891,0,11,peptidyl-threonine dephosphorylation,BP,
10152,GO:0035971,1,0.992170027168696,0,1,peptidyl-histidine dephosphorylation,BP,
10153,GO:0035973,1,0.974500367200252,0,4,aggrephagy,BP,
10154,GO:0035976,1,0.962152522223404,0,5,transcription factor AP-1 complex,CC,
10155,GO:0035977,1,0.972807863968944,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10156,GO:0035978,1,0.992441219375176,0,1,histone H2A-S139 phosphorylation,BP,
10157,GO:0035981,1,0.986036772232189,0,2,tongue muscle cell differentiation,BP,
10158,GO:0035983,1,0.979904689032843,0,3,response to trichostatin A,BP,
10159,GO:0035984,1,0.979904689032843,0,3,cellular response to trichostatin A,BP,
10160,GO:0035985,1,0.969314576688897,0,4,senescence-associated heterochromatin focus,CC,
10161,GO:0035986,1,0.976964667934124,0,3,senescence-associated heterochromatin focus assembly,BP,
10162,GO:0035987,1,0.729896611490801,0,45,endodermal cell differentiation,BP,
10163,GO:0035988,1,0.904706580107182,0,14,chondrocyte proliferation,BP,
10164,GO:0035989,1,0.964984630857915,0,5,tendon development,BP,
10165,GO:0035990,1,0.976698813965432,0,3,tendon cell differentiation,BP,
10166,GO:0035992,1,0.976698813965432,0,3,tendon formation,BP,
10167,GO:0035993,1,0.984433902257685,0,2,deltoid tuberosity development,BP,
10168,GO:0035994,1,0.872952379493676,0,19,response to muscle stretch,BP,
10169,GO:0035995,1,0.970817531569647,0,4,detection of muscle stretch,BP,
10170,GO:0035998,1,0.992174552329761,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10171,GO:0035999,1,0.93530332153994,0,9,tetrahydrofolate interconversion,BP,
10172,GO:0036002,1,0.820048492551601,0,27,pre-mRNA binding,MF,
10173,GO:0036003,1,0.843852510901717,0,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10174,GO:0036004,1,0.992170027168696,0,1,GAF domain binding,MF,
10175,GO:0036005,1,0.929839342666827,0,10,response to macrophage colony-stimulating factor,BP,
10176,GO:0036006,1,0.929839342666827,0,10,cellular response to macrophage colony-stimulating factor stimulus,BP,
10177,GO:0036009,1,0.992170027168696,0,1,protein-glutamine N-methyltransferase activity,MF,
10178,GO:0036010,1,0.916106201871362,0,13,protein localization to endosome,BP,
10179,GO:0036015,1,0.964934544656883,0,5,response to interleukin-3,BP,
10180,GO:0036016,1,0.964934544656883,0,5,cellular response to interleukin-3,BP,
10181,GO:0036017,1,0.955652522566441,0,6,response to erythropoietin,BP,
10182,GO:0036018,1,0.963196525487313,0,5,cellular response to erythropoietin,BP,
10183,GO:0036019,1,0.877346211156849,0,19,endolysosome,CC,
10184,GO:0036020,1,0.910088673082905,0,14,endolysosome membrane,CC,
10185,GO:0036021,1,0.971654130572345,0,4,endolysosome lumen,CC,
10186,GO:0036022,1,0.977488292057058,0,3,limb joint morphogenesis,BP,
10187,GO:0036023,1,0.977488292057058,0,3,embryonic skeletal limb joint morphogenesis,BP,
10188,GO:0036024,1,0.992218024205118,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10189,GO:0036025,1,0.992218024205118,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10190,GO:0036026,1,0.992218024205118,0,1,protein C inhibitor-PLAT complex,CC,
10191,GO:0036027,1,0.992218024205118,0,1,protein C inhibitor-PLAU complex,CC,
10192,GO:0036028,1,0.992218024205118,0,1,protein C inhibitor-thrombin complex,CC,
10193,GO:0036029,1,0.992218024205118,0,1,protein C inhibitor-KLK3 complex,CC,
10194,GO:0036030,1,0.992218024205118,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10195,GO:0036031,1,0.992170027168696,0,1,recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex,BP,
10196,GO:0036033,1,0.975791437001306,0,4,mediator complex binding,MF,
10197,GO:0036034,1,0.98463501215843,0,2,mediator complex assembly,BP,
10198,GO:0036035,1,0.884761329627747,0,17,osteoclast development,BP,
10199,GO:0036037,1,0.888034864984268,0,16,CD8-positive, alpha-beta T cell activation,BP,
10200,GO:0036038,1,0.915579848537352,0,12,MKS complex,CC,
10202,GO:0036042,1,0.976692112990833,0,3,long-chain fatty acyl-CoA binding,MF,
10203,GO:0036046,1,0.992706432587746,0,1,protein demalonylation,BP,
10204,GO:0036047,1,0.992706432587746,0,1,peptidyl-lysine demalonylation,BP,
10205,GO:0036048,1,0.992706432587746,0,1,protein desuccinylation,BP,
10206,GO:0036049,1,0.992706432587746,0,1,peptidyl-lysine desuccinylation,BP,
10207,GO:0036053,1,0.992370926334135,0,1,glomerular endothelium fenestra,CC,
10208,GO:0036054,1,0.992706432587746,0,1,protein-malonyllysine demalonylase activity,MF,
10209,GO:0036055,1,0.992706432587746,0,1,protein-succinyllysine desuccinylase activity,MF,
10210,GO:0036056,1,0.949373302477308,0,8,filtration diaphragm,CC,
10211,GO:0036057,1,0.949373302477308,0,8,slit diaphragm,CC,
10212,GO:0036058,1,0.993537553525317,0,1,filtration diaphragm assembly,BP,
10213,GO:0036060,1,0.993537553525317,0,1,slit diaphragm assembly,BP,
10214,GO:0036064,1,0.521265894239244,0,92,ciliary basal body,CC,
10215,GO:0036065,1,0.852221436184757,0,23,fucosylation,BP,
10216,GO:0036066,1,0.929150115956196,0,11,protein O-linked fucosylation,BP,
10217,GO:0036071,1,0.992839838812566,0,1,N-glycan fucosylation,BP,
10220,GO:0036079,1,0.979188211513104,0,3,purine nucleotide-sugar transport,BP,
10221,GO:0036080,1,0.979188211513104,0,3,purine nucleotide-sugar transmembrane transporter activity,MF,
10222,GO:0036085,1,0.992294630214608,0,1,GDP-fucose import into Golgi lumen,BP,
10223,GO:0036088,1,0.992170027168696,0,1,D-serine catabolic process,BP,
10224,GO:0036089,1,0.952525341503246,0,7,cleavage furrow formation,BP,
10225,GO:0036090,1,0.984417404461465,0,2,cleavage furrow ingression,BP,
10226,GO:0036091,1,0.964266182914934,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10228,GO:0036093,1,0.954206292836216,0,6,germ cell proliferation,BP,
10230,GO:0036100,1,0.96961267988183,0,4,leukotriene catabolic process,BP,
10231,GO:0036101,1,0.96961267988183,0,4,leukotriene B4 catabolic process,BP,
10232,GO:0036102,1,0.96961267988183,0,4,leukotriene B4 metabolic process,BP,
10233,GO:0036105,1,0.99316680860158,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10235,GO:0036111,1,0.992356815019901,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10236,GO:0036112,1,0.977249604480356,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10237,GO:0036114,1,0.992170027168696,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10238,GO:0036115,1,0.992170027168696,0,1,fatty-acyl-CoA catabolic process,BP,
10239,GO:0036116,1,0.992170027168696,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10240,GO:0036117,1,0.984589963656113,0,2,hyaluranon cable,CC,
10241,GO:0036118,1,0.978228191813823,0,3,hyaluranon cable assembly,BP,
10242,GO:0036119,1,0.86941227904191,0,20,response to platelet-derived growth factor,BP,
10243,GO:0036120,1,0.875950333540834,0,19,cellular response to platelet-derived growth factor stimulus,BP,
10244,GO:0036122,1,0.936691300337589,0,9,BMP binding,MF,
10245,GO:0036123,1,0.948840552900701,0,7,histone H3-K9 dimethylation,BP,
10246,GO:0036124,1,0.896381305925164,0,16,histone H3-K9 trimethylation,BP,
10247,GO:0036125,1,0.992616167913547,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10248,GO:0036126,1,0.585785560483468,0,71,sperm flagellum,CC,
10249,GO:0036128,1,0.941541036142195,0,8,CatSper complex,CC,
10250,GO:0036130,1,0.992170027168696,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10251,GO:0036131,1,0.992170027168696,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10252,GO:0036132,1,0.978598600136956,0,3,13-prostaglandin reductase activity,MF,
10253,GO:0036134,1,0.992186217655884,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10254,GO:0036135,1,0.986326940278684,0,2,Schwann cell migration,BP,
10255,GO:0036137,1,0.984516316935086,0,2,kynurenine aminotransferase activity,MF,
10256,GO:0036138,1,0.993986332270154,0,1,peptidyl-histidine hydroxylation,BP,
10257,GO:0036139,1,0.993986332270154,0,1,peptidyl-histidine dioxygenase activity,MF,
10258,GO:0036140,1,0.993986332270154,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10259,GO:0036143,1,0.992170027168696,0,1,kringle domain binding,MF,
10260,GO:0036145,1,0.992170375955205,0,1,dendritic cell homeostasis,BP,
10261,GO:0036146,1,0.985850525930879,0,2,cellular response to mycotoxin,BP,
10262,GO:0036148,1,0.882813679872547,0,17,phosphatidylglycerol acyl-chain remodeling,BP,
10267,GO:0036153,1,0.992428015476869,0,1,triglyceride acyl-chain remodeling,BP,
10268,GO:0036155,1,0.949377434965409,0,7,acylglycerol acyl-chain remodeling,BP,
10269,GO:0036156,1,0.988008547524114,0,2,inner dynein arm,CC,
10270,GO:0036157,1,0.964077038830134,0,5,outer dynein arm,CC,
10271,GO:0036158,1,0.913351719120608,0,12,outer dynein arm assembly,BP,
10272,GO:0036159,1,0.937838307441362,0,9,inner dynein arm assembly,BP,
10273,GO:0036164,1,0.992170027168696,0,1,cell-abiotic substrate adhesion,BP,
10274,GO:0036166,1,0.980574864407936,0,3,phenotypic switching,BP,
10275,GO:0036179,1,0.992394160273887,0,1,osteoclast maturation,BP,
10276,GO:0036194,1,0.984400887813367,0,2,muscle cell projection,CC,
10277,GO:0036195,1,0.984400887813367,0,2,muscle cell projection membrane,CC,
10279,GO:0036215,1,0.97999491682665,0,3,response to stem cell factor,BP,
10280,GO:0036216,1,0.97999491682665,0,3,cellular response to stem cell factor stimulus,BP,
10281,GO:0036219,1,0.992170027168696,0,1,GTP diphosphatase activity,MF,
10282,GO:0036220,1,0.992170027168696,0,1,ITP diphosphatase activity,MF,
10283,GO:0036222,1,0.992170027168696,0,1,XTP diphosphatase activity,MF,
10284,GO:0036228,1,0.985993521450971,0,2,protein targeting to nuclear inner membrane,BP,
10286,GO:0036233,1,0.984718082565509,0,2,glycine import,BP,
10287,GO:0036245,1,0.986132444461105,0,2,cellular response to menadione,BP,
10288,GO:0036250,1,0.992173494680933,0,1,peroxisome transport along microtubule,BP,
10289,GO:0036257,1,0.792774481981717,0,31,multivesicular body organization,BP,
10290,GO:0036258,1,0.79883729809794,0,30,multivesicular body assembly,BP,
10291,GO:0036260,1,0.775969163643112,0,34,RNA capping,BP,
10292,GO:0036261,1,0.993246594573786,0,1,7-methylguanosine cap hypermethylation,BP,
10293,GO:0036265,1,0.970818390074288,0,4,RNA (guanine-N7)-methylation,BP,
10294,GO:0036266,1,0.992290754690558,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10295,GO:0036269,1,0.986203080774464,0,2,swimming behavior,BP,
10296,GO:0036284,1,0.992170027168696,0,1,tubulobulbar complex,CC,
10297,GO:0036289,1,0.9590331217859,0,6,peptidyl-serine autophosphorylation,BP,
10298,GO:0036290,1,0.993531099117722,0,1,protein trans-autophosphorylation,BP,
10299,GO:0036292,1,0.985479608082481,0,2,DNA rewinding,BP,
10302,GO:0036295,1,0.951727553123309,0,7,cellular response to increased oxygen levels,BP,
10303,GO:0036296,1,0.872641296248955,0,19,response to increased oxygen levels,BP,
10304,GO:0036297,1,0.731419494879391,0,43,interstrand cross-link repair,BP,
10305,GO:0036301,1,0.970405697081348,0,4,macrophage colony-stimulating factor production,BP,
10306,GO:0036302,1,0.953780111748335,0,7,atrioventricular canal development,BP,
10307,GO:0036303,1,0.883921654283736,0,18,lymph vessel morphogenesis,BP,
10308,GO:0036304,1,0.984620170528662,0,2,umbilical cord morphogenesis,BP,
10309,GO:0036305,1,0.993986142818454,0,1,ameloblast differentiation,BP,
10310,GO:0036306,1,0.992170027168696,0,1,embryonic heart tube elongation,BP,
10311,GO:0036309,1,0.988008547532542,0,2,protein localization to M-band,BP,
10312,GO:0036310,1,0.945956436506347,0,8,annealing helicase activity,MF,
10313,GO:0036312,1,0.936217818923409,0,10,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10314,GO:0036313,1,0.985023831099222,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10315,GO:0036314,1,0.847553300078821,0,24,response to sterol,BP,
10316,GO:0036315,1,0.896496322973819,0,16,cellular response to sterol,BP,
10317,GO:0036317,1,0.992294630214608,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10318,GO:0036323,1,0.993889259226029,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10319,GO:0036324,1,0.98601927216493,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10320,GO:0036326,1,0.993889259226029,0,1,VEGF-A-activated receptor activity,MF,
10321,GO:0036327,1,0.993889259226029,0,1,VEGF-B-activated receptor activity,MF,
10322,GO:0036332,1,0.993889259226029,0,1,placental growth factor-activated receptor activity,MF,
10323,GO:0036333,1,0.992327453820772,0,1,hepatocyte homeostasis,BP,
10324,GO:0036335,1,0.993972853500479,0,1,intestinal stem cell homeostasis,BP,
10325,GO:0036336,1,0.802309372153139,0,30,dendritic cell migration,BP,
10326,GO:0036337,1,0.972638822108915,0,4,Fas signaling pathway,BP,
10327,GO:0036338,1,0.977060181581946,0,3,viral membrane,CC,
10328,GO:0036342,1,0.882670433024611,0,18,post-anal tail morphogenesis,BP,
10329,GO:0036343,1,0.993448139432985,0,1,psychomotor behavior,BP,
10330,GO:0036344,1,0.874207728272366,0,19,platelet morphogenesis,BP,
10331,GO:0036345,1,0.984707144016656,0,2,platelet maturation,BP,
10332,GO:0036351,1,0.992218681905899,0,1,histone H2A-K13 ubiquitination,BP,
10333,GO:0036352,1,0.992218681905899,0,1,histone H2A-K15 ubiquitination,BP,
10334,GO:0036353,1,0.986724939654493,0,2,histone H2A-K119 monoubiquitination,BP,
10335,GO:0036361,1,0.992264474345352,0,1,racemase activity, acting on amino acids and derivatives,MF,
10336,GO:0036363,1,0.986174343687777,0,2,transforming growth factor beta activation,BP,
10337,GO:0036367,1,0.984947438836456,0,2,light adaption,BP,
10338,GO:0036369,1,0.9880085474782,0,2,transcription factor catabolic process,BP,
10339,GO:0036371,1,0.993986332276054,0,1,protein localization to T-tubule,BP,
10340,GO:0036372,1,0.992170027168696,0,1,opsin transport,BP,
10341,GO:0036374,1,0.954365103520943,0,6,glutathione hydrolase activity,MF,
10343,GO:0036378,1,0.977021770934614,0,3,calcitriol biosynthetic process from calciol,BP,
10345,GO:0036387,1,0.984527779293501,0,2,pre-replicative complex,CC,
10346,GO:0036388,1,0.984527779293501,0,2,pre-replicative complex assembly,BP,
10347,GO:0036392,1,0.993262476933322,0,1,chemokine (C-C motif) ligand 20 production,BP,
10348,GO:0036393,1,0.992490566450711,0,1,thiocyanate peroxidase activity,MF,
10349,GO:0036396,1,0.970734546206334,0,4,MIS complex,CC,
10350,GO:0036398,1,0.985136915162935,0,2,TCR signalosome,CC,
10351,GO:0036399,1,0.992830992499847,0,1,TCR signalosome assembly,BP,
10352,GO:0036402,1,0.953923339922317,0,6,proteasome-activating ATPase activity,MF,
10353,GO:0036403,1,0.992324342788236,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10354,GO:0036404,1,0.993986332285847,0,1,conversion of ds siRNA to ss siRNA,BP,
10355,GO:0036413,1,0.986008533183797,0,2,histone H3-R26 citrullination,BP,
10356,GO:0036414,1,0.964834196929352,0,5,histone citrullination,BP,
10357,GO:0036435,1,0.978560276747169,0,3,K48-linked polyubiquitin binding,MF,
10358,GO:0036438,1,0.972107405779217,0,4,maintenance of lens transparency,BP,
10359,GO:0036440,1,0.992557620167389,0,1,citrate synthase activity,MF,
10360,GO:0036442,1,0.848404501050782,0,22,hydrogen-exporting ATPase activity,MF,
10361,GO:0036444,1,0.970485672488466,0,4,mitochondrial calcium uptake,BP,
10362,GO:0036445,1,0.914899364449796,0,13,neuronal stem cell division,BP,
10363,GO:0036446,1,0.980794454547065,0,3,myofibroblast differentiation,BP,
10364,GO:0036449,1,0.9747670674932,0,4,microtubule minus-end,CC,
10365,GO:0036452,1,0.815548596767512,0,27,ESCRT complex,CC,
10366,GO:0036454,1,0.965135826765177,0,5,growth factor complex,CC,
10367,GO:0036455,1,0.992170027168696,0,1,iron-sulfur transferase activity,MF,
10368,GO:0036457,1,0.980271740756842,0,3,keratohyalin granule,CC,
10369,GO:0036458,1,0.992196456297875,0,1,hepatocyte growth factor binding,MF,
10370,GO:0036459,1,0.465824120101619,0,109,thiol-dependent ubiquitinyl hydrolase activity,MF,
10371,GO:0036461,1,0.984400887813367,0,2,BLOC-2 complex binding,MF,
10374,GO:0036465,1,0.755755897256244,0,41,synaptic vesicle recycling,BP,
10375,GO:0036466,1,0.987773868298739,0,2,synaptic vesicle recycling via endosome,BP,
10376,GO:0036468,1,0.992178307193692,0,1,L-dopa decarboxylase activity,MF,
10377,GO:0036470,1,0.992170027168696,0,1,tyrosine 3-monooxygenase activator activity,MF,
10378,GO:0036471,1,0.992170027168696,0,1,cellular response to glyoxal,BP,
10380,GO:0036474,1,0.846046745074488,0,23,cell death in response to hydrogen peroxide,BP,
10381,GO:0036475,1,0.88830868779988,0,17,neuron death in response to oxidative stress,BP,
10382,GO:0036476,1,0.978639671956203,0,3,neuron death in response to hydrogen peroxide,BP,
10384,GO:0036478,1,0.992170027168696,0,1,L-dopa decarboxylase activator activity,MF,
10385,GO:0036479,1,0.993986332281396,0,1,peroxidase inhibitor activity,MF,
10386,GO:0036480,1,0.951893470978504,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10387,GO:0036481,1,0.955169802974605,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10388,GO:0036482,1,0.984571116209316,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10389,GO:0036483,1,0.993830955432793,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10390,GO:0036484,1,0.979471918925534,0,3,trunk neural crest cell migration,BP,
10391,GO:0036486,1,0.979471918925534,0,3,ventral trunk neural crest cell migration,BP,
10392,GO:0036487,1,0.993986332279396,0,1,nitric-oxide synthase inhibitor activity,MF,
10393,GO:0036488,1,0.984401851528757,0,2,CHOP-C/EBP complex,CC,
10394,GO:0036490,1,0.946741171691139,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10395,GO:0036491,1,0.953380003565061,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10396,GO:0036492,1,0.953380003565061,0,7,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10397,GO:0036493,1,0.978527076855359,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10398,GO:0036494,1,0.9939854321572,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10399,GO:0036496,1,0.984464543648118,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10400,GO:0036497,1,0.992234181466195,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10402,GO:0036499,1,0.862532403367706,0,20,PERK-mediated unfolded protein response,BP,
10403,GO:0036500,1,0.930050367086376,0,10,ATF6-mediated unfolded protein response,BP,
10404,GO:0036501,1,0.993758596768178,0,1,UFD1-NPL4 complex,CC,
10405,GO:0036502,1,0.992690692295062,0,1,Derlin-1-VIMP complex,CC,
10406,GO:0036503,1,0.535526869046619,0,87,ERAD pathway,BP,
10407,GO:0036505,1,0.984847601783934,0,2,prosaposin receptor activity,MF,
10408,GO:0036506,1,0.978617126053822,0,3,maintenance of unfolded protein,BP,
10409,GO:0036507,1,0.845393719650392,0,24,protein demannosylation,BP,
10410,GO:0036508,1,0.845393719650392,0,24,protein alpha-1,2-demannosylation,BP,
10411,GO:0036509,1,0.984616265538901,0,2,trimming of terminal mannose on B branch,BP,
10412,GO:0036510,1,0.97869439502416,0,3,trimming of terminal mannose on C branch,BP,
10413,GO:0036511,1,0.984616265538901,0,2,trimming of first mannose on A branch,BP,
10414,GO:0036512,1,0.984616265538901,0,2,trimming of second mannose on A branch,BP,
10415,GO:0036513,1,0.924564962431964,0,11,Derlin-1 retrotranslocation complex,CC,
10416,GO:0036514,1,0.968327265184015,0,5,dopaminergic neuron axon guidance,BP,
10417,GO:0036515,1,0.975618398011169,0,4,serotonergic neuron axon guidance,BP,
10418,GO:0036517,1,0.993986332264647,0,1,chemoattraction of serotonergic neuron axon,BP,
10419,GO:0036518,1,0.986559008440686,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10420,GO:0036520,1,0.992211571683086,0,1,astrocyte-dopaminergic neuron signaling,BP,
10421,GO:0036524,1,0.992170027168696,0,1,protein deglycase activity,MF,
10422,GO:0036525,1,0.992170027168696,0,1,protein deglycation,BP,
10423,GO:0036526,1,0.992170027168696,0,1,peptidyl-cysteine deglycation,BP,
10424,GO:0036527,1,0.992170027168696,0,1,peptidyl-arginine deglycation,BP,
10425,GO:0036528,1,0.992170027168696,0,1,peptidyl-lysine deglycation,BP,
10426,GO:0036529,1,0.992170027168696,0,1,protein deglycation, glyoxal removal,BP,
10427,GO:0036530,1,0.992170027168696,0,1,protein deglycation, methylglyoxal removal,BP,
10428,GO:0036531,1,0.992170027168696,0,1,glutathione deglycation,BP,
10429,GO:0038001,1,0.969579667602679,0,4,paracrine signaling,BP,
10430,GO:0038002,1,0.993978991070126,0,1,endocrine signaling,BP,
10431,GO:0038003,1,0.928083960505263,0,10,opioid receptor signaling pathway,BP,
10432,GO:0038007,1,0.974521760634411,0,4,netrin-activated signaling pathway,BP,
10433,GO:0038009,1,0.992170027168696,0,1,regulation of signal transduction by receptor internalization,BP,
10434,GO:0038016,1,0.985295975769048,0,2,insulin receptor internalization,BP,
10435,GO:0038018,1,0.987853727035668,0,2,Wnt receptor catabolic process,BP,
10436,GO:0038021,1,0.993691334669111,0,1,leptin receptor activity,MF,
10438,GO:0038024,1,0.647529654701973,0,61,cargo receptor activity,MF,
10439,GO:0038025,1,0.986870247520978,0,2,reelin receptor activity,MF,
10440,GO:0038026,1,0.974853280529145,0,4,reelin-mediated signaling pathway,BP,
10441,GO:0038027,1,0.968460026787657,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10442,GO:0038028,1,0.972359113221241,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10443,GO:0038030,1,0.953013123713242,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10444,GO:0038031,1,0.9593135130263,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10445,GO:0038033,1,0.965755713512763,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10447,GO:0038036,1,0.942195976161581,0,8,sphingosine-1-phosphate receptor activity,MF,
10448,GO:0038037,1,0.981829810098774,0,3,G-protein coupled receptor dimeric complex,CC,
10449,GO:0038038,1,0.9939863322701,0,1,G-protein coupled receptor homodimeric complex,CC,
10450,GO:0038039,1,0.987770503864615,0,2,G-protein coupled receptor heterodimeric complex,CC,
10451,GO:0038042,1,0.9939863322701,0,1,dimeric G-protein coupled receptor signaling pathway,BP,
10452,GO:0038043,1,0.986141977718278,0,2,interleukin-5-mediated signaling pathway,BP,
10453,GO:0038044,1,0.967081978606061,0,5,transforming growth factor-beta secretion,BP,
10454,GO:0038046,1,0.99217030733535,0,1,enkephalin receptor activity,MF,
10455,GO:0038047,1,0.992171614783988,0,1,morphine receptor activity,MF,
10456,GO:0038048,1,0.993936921997454,0,1,dynorphin receptor activity,MF,
10457,GO:0038049,1,0.988008547491234,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10458,GO:0038051,1,0.993986332268653,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10459,GO:0038052,1,0.986289667346982,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10460,GO:0038060,1,0.985751588654581,0,2,nitric oxide-cGMP-mediated signaling pathway,BP,
10462,GO:0038062,1,0.986182976079883,0,2,protein tyrosine kinase collagen receptor activity,MF,
10463,GO:0038063,1,0.945364962241999,0,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10464,GO:0038064,1,0.974318167819351,0,4,collagen receptor activity,MF,
10465,GO:0038065,1,0.933987497483187,0,11,collagen-activated signaling pathway,BP,
10466,GO:0038066,1,0.788264852678693,0,34,p38MAPK cascade,BP,
10467,GO:0038083,1,0.693353769564957,0,52,peptidyl-tyrosine autophosphorylation,BP,
10468,GO:0038084,1,0.855840068674618,0,23,vascular endothelial growth factor signaling pathway,BP,
10469,GO:0038085,1,0.972689296882348,0,4,vascular endothelial growth factor binding,MF,
10470,GO:0038086,1,0.981161803673115,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10471,GO:0038089,1,0.959857411599553,0,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10472,GO:0038091,1,0.981161803673115,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10473,GO:0038092,1,0.901773883439513,0,14,nodal signaling pathway,BP,
10475,GO:0038094,1,0.586208961753431,0,75,Fc-gamma receptor signaling pathway,BP,
10477,GO:0038096,1,0.604995036756039,0,71,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10478,GO:0038097,1,0.993976336044422,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10479,GO:0038098,1,0.985868842282788,0,2,sequestering of BMP from receptor via BMP binding,BP,
10480,GO:0038100,1,0.986203080786405,0,2,nodal binding,MF,
10481,GO:0038101,1,0.992170099942422,0,1,sequestering of nodal from receptor via nodal binding,BP,
10482,GO:0038106,1,0.992651574161641,0,1,choriogonadotropin hormone binding,MF,
10483,GO:0038107,1,0.948221116350247,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10484,GO:0038108,1,0.970330855413511,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10485,GO:0038109,1,0.97999491682665,0,3,Kit signaling pathway,BP,
10486,GO:0038110,1,0.965108015044404,0,5,interleukin-2-mediated signaling pathway,BP,
10487,GO:0038111,1,0.984401467769241,0,2,interleukin-7-mediated signaling pathway,BP,
10488,GO:0038112,1,0.984721923606659,0,2,interleukin-8-mediated signaling pathway,BP,
10489,GO:0038113,1,0.992191649784728,0,1,interleukin-9-mediated signaling pathway,BP,
10490,GO:0038114,1,0.99281727908318,0,1,interleukin-21-mediated signaling pathway,BP,
10491,GO:0038115,1,0.992192957802479,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10492,GO:0038116,1,0.992192957802479,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10493,GO:0038117,1,0.992192957802479,0,1,C-C motif chemokine 19 receptor activity,MF,
10494,GO:0038118,1,0.992170027168696,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10495,GO:0038121,1,0.992192957802479,0,1,C-C motif chemokine 21 receptor activity,MF,
10496,GO:0038123,1,0.977738063450656,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10497,GO:0038124,1,0.971590346025909,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10499,GO:0038128,1,0.764223652861457,0,38,ERBB2 signaling pathway,BP,
10500,GO:0038129,1,0.976846187800906,0,3,ERBB3 signaling pathway,BP,
10501,GO:0038131,1,0.992172991252424,0,1,neuregulin receptor activity,MF,
10502,GO:0038132,1,0.969110855884676,0,5,neuregulin binding,MF,
10503,GO:0038133,1,0.992179772409963,0,1,ERBB2-ERBB3 signaling pathway,BP,
10504,GO:0038145,1,0.964515461025227,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10505,GO:0038154,1,0.992749724122032,0,1,interleukin-11-mediated signaling pathway,BP,
10506,GO:0038155,1,0.984669010781884,0,2,interleukin-23-mediated signaling pathway,BP,
10507,GO:0038156,1,0.986133687569695,0,2,interleukin-3-mediated signaling pathway,BP,
10508,GO:0038158,1,0.985247219153621,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10509,GO:0038161,1,0.966579242331689,0,5,prolactin signaling pathway,BP,
10510,GO:0038162,1,0.986184880213384,0,2,erythropoietin-mediated signaling pathway,BP,
10511,GO:0038163,1,0.977707544180458,0,3,thrombopoietin-mediated signaling pathway,BP,
10512,GO:0038164,1,0.993200827166809,0,1,thrombopoietin receptor activity,MF,
10513,GO:0038165,1,0.972390861574662,0,4,oncostatin-M-mediated signaling pathway,BP,
10514,GO:0038166,1,0.930656329019321,0,10,angiotensin-activated signaling pathway,BP,
10515,GO:0038167,1,0.993979039676214,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10516,GO:0038168,1,0.993979039676214,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10517,GO:0038169,1,0.963318940040439,0,5,somatostatin receptor signaling pathway,BP,
10518,GO:0038170,1,0.963318940040439,0,5,somatostatin signaling pathway,BP,
10519,GO:0038171,1,0.960180190296199,0,6,cannabinoid signaling pathway,BP,
10520,GO:0038172,1,0.985615350146041,0,2,interleukin-33-mediated signaling pathway,BP,
10521,GO:0038178,1,0.98457777480284,0,2,complement component C5a signaling pathway,BP,
10522,GO:0038179,1,0.786679622627209,0,34,neurotrophin signaling pathway,BP,
10523,GO:0038180,1,0.947826367657532,0,8,nerve growth factor signaling pathway,BP,
10524,GO:0038181,1,0.978397954454488,0,3,bile acid receptor activity,MF,
10525,GO:0038182,1,0.992170027168696,0,1,G-protein coupled bile acid receptor activity,MF,
10526,GO:0038183,1,0.978397954454488,0,3,bile acid signaling pathway,BP,
10527,GO:0038184,1,0.992170027168696,0,1,cell surface bile acid receptor signaling pathway,BP,
10528,GO:0038185,1,0.992190392480105,0,1,intracellular bile acid receptor signaling pathway,BP,
10529,GO:0038186,1,0.993882289190072,0,1,lithocholic acid receptor activity,MF,
10530,GO:0038187,1,0.881437947074128,0,17,pattern recognition receptor activity,MF,
10531,GO:0038188,1,0.984417648209846,0,2,cholecystokinin signaling pathway,BP,
10532,GO:0038189,1,0.985390221712649,0,2,neuropilin signaling pathway,BP,
10533,GO:0038190,1,0.985390221712649,0,2,VEGF-activated neuropilin signaling pathway,BP,
10534,GO:0038191,1,0.993986081960467,0,1,neuropilin binding,MF,
10535,GO:0038192,1,0.992179181654031,0,1,gastric inhibitory peptide signaling pathway,BP,
10536,GO:0038193,1,0.992209142954877,0,1,thromboxane A2 signaling pathway,BP,
10537,GO:0038194,1,0.98562801524979,0,2,thyroid-stimulating hormone signaling pathway,BP,
10538,GO:0038195,1,0.992170027168696,0,1,urokinase plasminogen activator signaling pathway,BP,
10539,GO:0038201,1,0.898509923842165,0,15,TOR complex,CC,
10540,GO:0038202,1,0.822974889779053,0,27,TORC1 signaling,BP,
10541,GO:0038203,1,0.956417997603249,0,6,TORC2 signaling,BP,
10542,GO:0039003,1,0.987045028388714,0,2,pronephric field specification,BP,
10543,GO:0039007,1,0.993984950395027,0,1,pronephric nephron morphogenesis,BP,
10544,GO:0039008,1,0.993984950395027,0,1,pronephric nephron tubule morphogenesis,BP,
10545,GO:0039017,1,0.987045028388714,0,2,pattern specification involved in pronephros development,BP,
10546,GO:0039019,1,0.979735735964057,0,3,pronephric nephron development,BP,
10547,GO:0039020,1,0.986452232265023,0,2,pronephric nephron tubule development,BP,
10548,GO:0039022,1,0.993984950395027,0,1,pronephric duct development,BP,
10549,GO:0039023,1,0.993984950395027,0,1,pronephric duct morphogenesis,BP,
10550,GO:0039506,1,0.986409149697157,0,2,modulation by virus of host molecular function,BP,
10551,GO:0039507,1,0.986409149697157,0,2,suppression by virus of host molecular function,BP,
10552,GO:0039513,1,0.992397223065217,0,1,suppression by virus of host catalytic activity,BP,
10553,GO:0039516,1,0.992397223065217,0,1,modulation by virus of host catalytic activity,BP,
10554,GO:0039519,1,0.987960994471437,0,2,modulation by virus of host autophagy,BP,
10555,GO:0039520,1,0.993984843764137,0,1,induction by virus of host autophagy,BP,
10556,GO:0039521,1,0.993939982242919,0,1,suppression by virus of host autophagy,BP,
10557,GO:0039526,1,0.977002371356897,0,3,modulation by virus of host apoptotic process,BP,
10558,GO:0039528,1,0.860595376679563,0,22,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10559,GO:0039529,1,0.89314316753467,0,17,RIG-I signaling pathway,BP,
10560,GO:0039530,1,0.937308828334466,0,9,MDA-5 signaling pathway,BP,
10561,GO:0039531,1,0.89722625731243,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10562,GO:0039532,1,0.946192281548798,0,8,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10563,GO:0039533,1,0.958895027239133,0,6,regulation of MDA-5 signaling pathway,BP,
10564,GO:0039534,1,0.978196432279599,0,3,negative regulation of MDA-5 signaling pathway,BP,
10565,GO:0039535,1,0.910181843414174,0,14,regulation of RIG-I signaling pathway,BP,
10566,GO:0039536,1,0.959849203842711,0,6,negative regulation of RIG-I signaling pathway,BP,
10567,GO:0039552,1,0.99398395176119,0,1,RIG-I binding,MF,
10568,GO:0039650,1,0.992397223065217,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10569,GO:0039656,1,0.977453226963058,0,3,modulation by virus of host gene expression,BP,
10570,GO:0039663,1,0.955448310982265,0,6,membrane fusion involved in viral entry into host cell,BP,
10571,GO:0039689,1,0.978085139332695,0,3,negative stranded viral RNA replication,BP,
10572,GO:0039692,1,0.928579812532103,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10573,GO:0039694,1,0.854187535117009,0,22,viral RNA genome replication,BP,
10574,GO:0039702,1,0.853205555893156,0,21,viral budding via host ESCRT complex,BP,
10575,GO:0039703,1,0.854187535117009,0,22,RNA replication,BP,
10576,GO:0039706,1,0.929853937026722,0,10,co-receptor binding,MF,
10577,GO:0039713,1,0.992990210383334,0,1,viral factory,CC,
10578,GO:0039714,1,0.992990210383334,0,1,cytoplasmic viral factory,CC,
10579,GO:0040001,1,0.869379170358276,0,20,establishment of mitotic spindle localization,BP,
10582,GO:0040009,1,0.986246172284332,0,2,regulation of growth rate,BP,
10587,GO:0040015,1,0.931864329275589,0,10,negative regulation of multicellular organism growth,BP,
10588,GO:0040016,1,0.944168716542536,0,8,embryonic cleavage,BP,
10591,GO:0040019,1,0.793015588364189,0,33,positive regulation of embryonic development,BP,
10592,GO:0040020,1,0.814926057265289,0,28,regulation of meiotic nuclear division,BP,
10593,GO:0040023,1,0.918313590987967,0,13,establishment of nucleus localization,BP,
10594,GO:0040029,1,0.149830802134302,0,262,regulation of gene expression, epigenetic,BP,
10595,GO:0040030,1,0.985558239925517,0,2,regulation of molecular function, epigenetic,BP,
10596,GO:0040031,1,0.961792956804099,0,5,snRNA modification,BP,
10597,GO:0040032,1,0.992172316958704,0,1,post-embryonic body morphogenesis,BP,
10598,GO:0040033,1,0.912004271178926,0,13,negative regulation of translation, ncRNA-mediated,BP,
10599,GO:0040034,1,0.915076576355214,0,12,regulation of development, heterochronic,BP,
10600,GO:0040036,1,0.830921150759333,0,26,regulation of fibroblast growth factor receptor signaling pathway,BP,
10601,GO:0040037,1,0.919338536607863,0,12,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10602,GO:0040038,1,0.980893759918757,0,3,polar body extrusion after meiotic divisions,BP,
10603,GO:0040040,1,0.99398633226586,0,1,thermosensory behavior,BP,
10604,GO:0042000,1,0.992244049183172,0,1,translocation of peptides or proteins into host,BP,
10605,GO:0042007,1,0.992170027168696,0,1,interleukin-18 binding,MF,
10606,GO:0042008,1,0.993074371485387,0,1,interleukin-18 receptor activity,MF,
10607,GO:0042011,1,0.99266691529153,0,1,interleukin-16 binding,MF,
10608,GO:0042012,1,0.99266691529153,0,1,interleukin-16 receptor activity,MF,
10609,GO:0042015,1,0.977995785286693,0,3,interleukin-20 binding,MF,
10610,GO:0042017,1,0.992422712247403,0,1,interleukin-22 binding,MF,
10611,GO:0042018,1,0.992422712247403,0,1,interleukin-22 receptor activity,MF,
10612,GO:0042019,1,0.984669010781884,0,2,interleukin-23 binding,MF,
10613,GO:0042020,1,0.984669010781884,0,2,interleukin-23 receptor activity,MF,
10614,GO:0042022,1,0.992176214086523,0,1,interleukin-12 receptor complex,CC,
10615,GO:0042023,1,0.95573808239042,0,7,DNA endoreduplication,BP,
10616,GO:0042025,1,0.98010107656019,0,3,host cell nucleus,CC,
10617,GO:0042026,1,0.834651322561756,0,24,protein refolding,BP,
10618,GO:0042030,1,0.97259507890983,0,4,ATPase inhibitor activity,MF,
10622,GO:0042040,1,0.993694182434192,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10623,GO:0042043,1,0.923568211583614,0,12,neurexin family protein binding,MF,
10624,GO:0042044,1,0.826657349040276,0,26,fluid transport,BP,
10625,GO:0042045,1,0.945627291032338,0,8,epithelial fluid transport,BP,
10626,GO:0042048,1,0.948872136305907,0,8,olfactory behavior,BP,
10627,GO:0042053,1,0.88318746823955,0,17,regulation of dopamine metabolic process,BP,
10628,GO:0042054,1,0.71705620816601,0,47,histone methyltransferase activity,MF,
10629,GO:0042056,1,0.82113771989606,0,26,chemoattractant activity,MF,
10631,GO:0042059,1,0.751631294686696,0,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,
10634,GO:0042069,1,0.88318746823955,0,17,regulation of catecholamine metabolic process,BP,
10635,GO:0042073,1,0.730678287165912,0,45,intraciliary transport,BP,
10636,GO:0042074,1,0.905960753602131,0,14,cell migration involved in gastrulation,BP,
10637,GO:0042078,1,0.970484013457225,0,4,germ-line stem cell division,BP,
10638,GO:0042083,1,0.992170027168696,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10639,GO:0042084,1,0.993986332287217,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10640,GO:0042088,1,0.75335404094375,0,38,T-helper 1 type immune response,BP,
10642,GO:0042090,1,0.944955886147326,0,8,interleukin-12 biosynthetic process,BP,
10643,GO:0042091,1,0.979457529816812,0,3,interleukin-10 biosynthetic process,BP,
10644,GO:0042092,1,0.775683283689845,0,34,type 2 immune response,BP,
10645,GO:0042093,1,0.694292424798093,0,50,T-helper cell differentiation,BP,
10646,GO:0042094,1,0.855940442297768,0,21,interleukin-2 biosynthetic process,BP,
10647,GO:0042095,1,0.881550507176367,0,17,interferon-gamma biosynthetic process,BP,
10648,GO:0042097,1,0.979285805358183,0,3,interleukin-4 biosynthetic process,BP,
10651,GO:0042101,1,0.86825308045486,0,19,T cell receptor complex,CC,
10654,GO:0042105,1,0.96148945631475,0,5,alpha-beta T cell receptor complex,CC,
10657,GO:0042109,1,0.97737239890728,0,3,lymphotoxin A biosynthetic process,BP,
10661,GO:0042117,1,0.942526609708708,0,8,monocyte activation,BP,
10662,GO:0042118,1,0.931084961293742,0,10,endothelial cell activation,BP,
10664,GO:0042126,1,0.969440562092294,0,4,nitrate metabolic process,BP,
10666,GO:0042128,1,0.992222754665927,0,1,nitrate assimilation,BP,
10668,GO:0042130,1,0.685681420987124,0,51,negative regulation of T cell proliferation,BP,
10669,GO:0042131,1,0.992281706486693,0,1,thiamine phosphate phosphatase activity,MF,
10670,GO:0042132,1,0.984400887813367,0,2,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10672,GO:0042134,1,0.984406568866254,0,2,rRNA primary transcript binding,MF,
10673,GO:0042135,1,0.924334502054734,0,11,neurotransmitter catabolic process,BP,
10675,GO:0042137,1,0.984788117301308,0,2,sequestering of neurotransmitter,BP,
10676,GO:0042138,1,0.961784223030045,0,5,meiotic DNA double-strand break formation,BP,
10677,GO:0042140,1,0.992294630214608,0,1,late meiotic recombination nodule assembly,BP,
10678,GO:0042144,1,0.986249579537826,0,2,vacuole fusion, non-autophagic,BP,
10680,GO:0042148,1,0.941636713625544,0,8,strand invasion,BP,
10681,GO:0042149,1,0.782305131492667,0,34,cellular response to glucose starvation,BP,
10685,GO:0042160,1,0.962234152627929,0,5,lipoprotein modification,BP,
10686,GO:0042161,1,0.962234152627929,0,5,lipoprotein oxidation,BP,
10687,GO:0042162,1,0.796051661133913,0,32,telomeric DNA binding,MF,
10688,GO:0042163,1,0.992170027168696,0,1,interleukin-12 beta subunit binding,MF,
10689,GO:0042164,1,0.992226560394727,0,1,interleukin-12 alpha subunit binding,MF,
10690,GO:0042165,1,0.849636050339241,0,22,neurotransmitter binding,MF,
10691,GO:0042166,1,0.880190353241549,0,17,acetylcholine binding,MF,
10692,GO:0042167,1,0.946566827406668,0,7,heme catabolic process,BP,
10694,GO:0042169,1,0.81245859331495,0,30,SH2 domain binding,MF,
10695,GO:0042171,1,0.890084191102298,0,17,lysophosphatidic acid acyltransferase activity,MF,
10698,GO:0042177,1,0.489712540976412,0,99,negative regulation of protein catabolic process,BP,
10699,GO:0042178,1,0.927030328479181,0,10,xenobiotic catabolic process,BP,
10702,GO:0042182,1,0.948341298727193,0,7,ketone catabolic process,BP,
10703,GO:0042196,1,0.984401820660611,0,2,chlorinated hydrocarbon metabolic process,BP,
10704,GO:0042197,1,0.984401820660611,0,2,halogenated hydrocarbon metabolic process,BP,
10709,GO:0042222,1,0.969550959564117,0,4,interleukin-1 biosynthetic process,BP,
10710,GO:0042223,1,0.986166089449839,0,2,interleukin-3 biosynthetic process,BP,
10711,GO:0042225,1,0.992170027168696,0,1,interleukin-5 biosynthetic process,BP,
10712,GO:0042226,1,0.875348847727995,0,18,interleukin-6 biosynthetic process,BP,
10713,GO:0042228,1,0.909780423423991,0,13,interleukin-8 biosynthetic process,BP,
10714,GO:0042231,1,0.986193543206726,0,2,interleukin-13 biosynthetic process,BP,
10715,GO:0042241,1,0.992790041625879,0,1,interleukin-18 biosynthetic process,BP,
10716,GO:0042245,1,0.986062930963372,0,2,RNA repair,BP,
10717,GO:0042246,1,0.675474908976506,0,53,tissue regeneration,BP,
10718,GO:0042247,1,0.992524130270188,0,1,establishment of planar polarity of follicular epithelium,BP,
10719,GO:0042249,1,0.891011353628229,0,17,establishment of planar polarity of embryonic epithelium,BP,
10720,GO:0042253,1,0.96339639604596,0,5,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10722,GO:0042255,1,0.695451566655511,0,48,ribosome assembly,BP,
10723,GO:0042256,1,0.964772514699302,0,5,mature ribosome assembly,BP,
10724,GO:0042262,1,0.961600140441622,0,5,DNA protection,BP,
10725,GO:0042264,1,0.987209635897043,0,2,peptidyl-aspartic acid hydroxylation,BP,
10726,GO:0042265,1,0.993986332270154,0,1,peptidyl-asparagine hydroxylation,BP,
10727,GO:0042267,1,0.672241574423428,0,53,natural killer cell mediated cytotoxicity,BP,
10728,GO:0042268,1,0.933839311353708,0,9,regulation of cytolysis,BP,
10729,GO:0042269,1,0.794586977866796,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10730,GO:0042270,1,0.978118358445584,0,3,protection from natural killer cell mediated cytotoxicity,BP,
10731,GO:0042271,1,0.979983857445409,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10732,GO:0042272,1,0.972612528662649,0,4,nuclear RNA export factor complex,CC,
10733,GO:0042273,1,0.643278586444473,0,58,ribosomal large subunit biogenesis,BP,
10734,GO:0042274,1,0.631181043126815,0,61,ribosomal small subunit biogenesis,BP,
10735,GO:0042275,1,0.992170027168696,0,1,error-free postreplication DNA repair,BP,
10736,GO:0042276,1,0.86532487410344,0,20,error-prone translesion synthesis,BP,
10739,GO:0042281,1,0.985154348854536,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10740,GO:0042282,1,0.993813173218733,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10741,GO:0042284,1,0.984402210223781,0,2,sphingolipid delta-4 desaturase activity,MF,
10742,GO:0042285,1,0.958580336221984,0,6,xylosyltransferase activity,MF,
10743,GO:0042287,1,0.804813273765248,0,29,MHC protein binding,MF,
10744,GO:0042288,1,0.86534762985408,0,19,MHC class I protein binding,MF,
10745,GO:0042289,1,0.963666527851853,0,5,MHC class II protein binding,MF,
10746,GO:0042292,1,0.992255841119061,0,1,URM1 activating enzyme activity,MF,
10747,GO:0042296,1,0.969924903494378,0,4,ISG15 transferase activity,MF,
10748,GO:0042297,1,0.956410667945413,0,7,vocal learning,BP,
10753,GO:0042307,1,0.515193328176352,0,94,positive regulation of protein import into nucleus,BP,
10754,GO:0042308,1,0.631140959316914,0,64,negative regulation of protein import into nucleus,BP,
10755,GO:0042309,1,0.984630619330555,0,2,homoiothermy,BP,
10756,GO:0042310,1,0.583953558527609,0,74,vasoconstriction,BP,
10757,GO:0042311,1,0.801733144277598,0,30,vasodilation,BP,
10758,GO:0042313,1,0.992184682619676,0,1,protein kinase C deactivation,BP,
10759,GO:0042316,1,0.993954967944533,0,1,penicillin metabolic process,BP,
10760,GO:0042320,1,0.955670099267131,0,6,regulation of circadian sleep/wake cycle, REM sleep,BP,
10761,GO:0042321,1,0.961888258627261,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10762,GO:0042322,1,0.984400887813367,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10763,GO:0042323,1,0.984677878599472,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10764,GO:0042324,1,0.992170027168696,0,1,hypocretin receptor binding,MF,
10768,GO:0042328,1,0.986232906007673,0,2,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10770,GO:0042335,1,0.980300146103105,0,3,cuticle development,BP,
10774,GO:0042346,1,0.838594430289778,0,24,positive regulation of NF-kappaB import into nucleus,BP,
10775,GO:0042347,1,0.851889038557299,0,22,negative regulation of NF-kappaB import into nucleus,BP,
10777,GO:0042350,1,0.977955423497139,0,3,GDP-L-fucose biosynthetic process,BP,
10778,GO:0042351,1,0.984400890048526,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10779,GO:0042352,1,0.99345319833538,0,1,GDP-L-fucose salvage,BP,
10780,GO:0042354,1,0.938995401313298,0,9,L-fucose metabolic process,BP,
10781,GO:0042355,1,0.938995401313298,0,9,L-fucose catabolic process,BP,
10782,GO:0042356,1,0.992170027168696,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10783,GO:0042357,1,0.984459904508444,0,2,thiamine diphosphate metabolic process,BP,
10785,GO:0042360,1,0.969256029538039,0,4,vitamin E metabolic process,BP,
10786,GO:0042361,1,0.985031483980622,0,2,menaquinone catabolic process,BP,
10787,GO:0042362,1,0.907113968167877,0,13,fat-soluble vitamin biosynthetic process,BP,
10788,GO:0042363,1,0.934861376234344,0,9,fat-soluble vitamin catabolic process,BP,
10790,GO:0042365,1,0.984407923564942,0,2,water-soluble vitamin catabolic process,BP,
10791,GO:0042368,1,0.920541590463091,0,11,vitamin D biosynthetic process,BP,
10792,GO:0042369,1,0.977747590278521,0,3,vitamin D catabolic process,BP,
10793,GO:0042371,1,0.993199845739775,0,1,vitamin K biosynthetic process,BP,
10794,GO:0042373,1,0.955525615522479,0,6,vitamin K metabolic process,BP,
10795,GO:0042374,1,0.977317809295903,0,3,phylloquinone metabolic process,BP,
10796,GO:0042376,1,0.977317809295903,0,3,phylloquinone catabolic process,BP,
10797,GO:0042377,1,0.985031483980622,0,2,vitamin K catabolic process,BP,
10799,GO:0042382,1,0.958209296818978,0,6,paraspeckles,CC,
10802,GO:0042392,1,0.985079193235742,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10803,GO:0042393,1,0.276681913941629,0,180,histone binding,MF,
10804,GO:0042396,1,0.992170027168696,0,1,phosphagen biosynthetic process,BP,
10806,GO:0042401,1,0.85035112968329,0,21,cellular biogenic amine biosynthetic process,BP,
10808,GO:0042403,1,0.868091307968074,0,20,thyroid hormone metabolic process,BP,
10809,GO:0042404,1,0.992184732153989,0,1,thyroid hormone catabolic process,BP,
10810,GO:0042405,1,0.931572631730977,0,11,nuclear inclusion body,CC,
10811,GO:0042406,1,0.961997942694526,0,5,extrinsic component of endoplasmic reticulum membrane,CC,
10812,GO:0042407,1,0.912968286613445,0,12,cristae formation,BP,
10813,GO:0042412,1,0.984594378250486,0,2,taurine biosynthetic process,BP,
10814,GO:0042413,1,0.992269354037453,0,1,carnitine catabolic process,BP,
10820,GO:0042420,1,0.949852353531791,0,7,dopamine catabolic process,BP,
10823,GO:0042424,1,0.942839315295434,0,8,catecholamine catabolic process,BP,
10825,GO:0042427,1,0.976760609868634,0,3,serotonin biosynthetic process,BP,
10826,GO:0042428,1,0.925171760247949,0,11,serotonin metabolic process,BP,
10827,GO:0042430,1,0.825145628349734,0,26,indole-containing compound metabolic process,BP,
10828,GO:0042431,1,0.99220653731591,0,1,indole metabolic process,BP,
10829,GO:0042435,1,0.961521235521082,0,5,indole-containing compound biosynthetic process,BP,
10830,GO:0042436,1,0.920424383742223,0,11,indole-containing compound catabolic process,BP,
10831,GO:0042438,1,0.879681599655018,0,18,melanin biosynthetic process,BP,
10832,GO:0042439,1,0.977540141186179,0,3,ethanolamine-containing compound metabolic process,BP,
10834,GO:0042441,1,0.971283371048872,0,4,eye pigment metabolic process,BP,
10839,GO:0042450,1,0.992176583163649,0,1,arginine biosynthetic process via ornithine,BP,
10840,GO:0042451,1,0.851386688943343,0,21,purine nucleoside biosynthetic process,BP,
10842,GO:0042455,1,0.741963924792317,0,39,ribonucleoside biosynthetic process,BP,
10846,GO:0042471,1,0.440094789540771,0,115,ear morphogenesis,BP,
10847,GO:0042472,1,0.511094770798233,0,95,inner ear morphogenesis,BP,
10848,GO:0042473,1,0.937398643017327,0,9,outer ear morphogenesis,BP,
10849,GO:0042474,1,0.860558971817012,0,20,middle ear morphogenesis,BP,
10850,GO:0042475,1,0.561557913090997,0,81,odontogenesis of dentin-containing tooth,BP,
10851,GO:0042476,1,0.438738732070898,0,115,odontogenesis,BP,
10852,GO:0042481,1,0.829449667690286,0,25,regulation of odontogenesis,BP,
10853,GO:0042482,1,0.927509774177171,0,10,positive regulation of odontogenesis,BP,
10854,GO:0042483,1,0.971484331800201,0,4,negative regulation of odontogenesis,BP,
10855,GO:0042487,1,0.907472604586781,0,13,regulation of odontogenesis of dentin-containing tooth,BP,
10856,GO:0042488,1,0.978557072751437,0,3,positive regulation of odontogenesis of dentin-containing tooth,BP,
10857,GO:0042489,1,0.984986204926725,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10858,GO:0042490,1,0.671477135118848,0,56,mechanoreceptor differentiation,BP,
10859,GO:0042491,1,0.802829004985645,0,31,auditory receptor cell differentiation,BP,
10860,GO:0042492,1,0.94824838053778,0,8,gamma-delta T cell differentiation,BP,
10862,GO:0042494,1,0.973581111103656,0,4,detection of bacterial lipoprotein,BP,
10863,GO:0042495,1,0.985455029155014,0,2,detection of triacyl bacterial lipopeptide,BP,
10864,GO:0042496,1,0.986975836375851,0,2,detection of diacyl bacterial lipopeptide,BP,
10865,GO:0042497,1,0.9929474217244,0,1,triacyl lipopeptide binding,MF,
10866,GO:0042500,1,0.965118885848503,0,5,aspartic endopeptidase activity, intramembrane cleaving,MF,
10867,GO:0042501,1,0.808078543979046,0,28,serine phosphorylation of STAT protein,BP,
10868,GO:0042502,1,0.992294630214608,0,1,tyrosine phosphorylation of Stat2 protein,BP,
10870,GO:0042504,1,0.962260454755674,0,5,tyrosine phosphorylation of Stat4 protein,BP,
10871,GO:0042505,1,0.977195693697805,0,3,tyrosine phosphorylation of Stat6 protein,BP,
10873,GO:0042508,1,0.861088044401762,0,20,tyrosine phosphorylation of Stat1 protein,BP,
10875,GO:0042510,1,0.879942341878062,0,17,regulation of tyrosine phosphorylation of Stat1 protein,BP,
10876,GO:0042511,1,0.921980294506033,0,11,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,
10877,GO:0042512,1,0.976898127229591,0,3,negative regulation of tyrosine phosphorylation of Stat1 protein,BP,
10880,GO:0042518,1,0.949340630865847,0,7,negative regulation of tyrosine phosphorylation of Stat3 protein,BP,
10881,GO:0042519,1,0.962260454755674,0,5,regulation of tyrosine phosphorylation of Stat4 protein,BP,
10882,GO:0042520,1,0.969356404413929,0,4,positive regulation of tyrosine phosphorylation of Stat4 protein,BP,
10883,GO:0042521,1,0.992681503736399,0,1,negative regulation of tyrosine phosphorylation of Stat4 protein,BP,
10886,GO:0042524,1,0.978654362814345,0,3,negative regulation of tyrosine phosphorylation of Stat5 protein,BP,
10887,GO:0042525,1,0.977195693697805,0,3,regulation of tyrosine phosphorylation of Stat6 protein,BP,
10888,GO:0042526,1,0.984908390343803,0,2,positive regulation of tyrosine phosphorylation of Stat6 protein,BP,
10889,GO:0042527,1,0.992170049074439,0,1,negative regulation of tyrosine phosphorylation of Stat6 protein,BP,
10891,GO:0042532,1,0.927847956185532,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10892,GO:0042533,1,0.870712535791551,0,19,tumor necrosis factor biosynthetic process,BP,
10893,GO:0042534,1,0.870712535791551,0,19,regulation of tumor necrosis factor biosynthetic process,BP,
10894,GO:0042535,1,0.925049468381524,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10895,GO:0042536,1,0.954704490400767,0,6,negative regulation of tumor necrosis factor biosynthetic process,BP,
10897,GO:0042538,1,0.942374228058486,0,8,hyperosmotic salinity response,BP,
10898,GO:0042539,1,0.98674230600256,0,2,hypotonic salinity response,BP,
10899,GO:0042541,1,0.934859765397164,0,9,hemoglobin biosynthetic process,BP,
10901,GO:0042543,1,0.992170027168696,0,1,protein N-linked glycosylation via arginine,BP,
10902,GO:0042546,1,0.992170321724734,0,1,cell wall biogenesis,BP,
10903,GO:0042551,1,0.747032719505425,0,42,neuron maturation,BP,
10905,GO:0042554,1,0.836170313698162,0,24,superoxide anion generation,BP,
10906,GO:0042555,1,0.922056334241669,0,11,MCM complex,CC,
10909,GO:0042560,1,0.979002040125929,0,3,pteridine-containing compound catabolic process,BP,
10911,GO:0042564,1,0.993741852783125,0,1,NLS-dependent protein nuclear import complex,CC,
10912,GO:0042565,1,0.986197173624354,0,2,RNA nuclear export complex,CC,
10913,GO:0042567,1,0.972754102390116,0,4,insulin-like growth factor ternary complex,CC,
10914,GO:0042568,1,0.992170027168696,0,1,insulin-like growth factor binary complex,CC,
10915,GO:0042571,1,0.984524522725182,0,2,immunoglobulin complex, circulating,CC,
10917,GO:0042573,1,0.846824380548022,0,22,retinoic acid metabolic process,BP,
10918,GO:0042574,1,0.922082896271412,0,11,retinal metabolic process,BP,
10919,GO:0042575,1,0.887132334905856,0,17,DNA polymerase complex,CC,
10920,GO:0042577,1,0.985026233571577,0,2,lipid phosphatase activity,MF,
10923,GO:0042581,1,0.318023358617668,0,156,specific granule,CC,
10925,GO:0042583,1,0.94466131832311,0,8,chromaffin granule,CC,
10926,GO:0042584,1,0.959351846441456,0,6,chromaffin granule membrane,CC,
10927,GO:0042585,1,0.985956093425701,0,2,germinal vesicle,CC,
10928,GO:0042586,1,0.992170027168696,0,1,peptide deformylase activity,MF,
10929,GO:0042587,1,0.959918360866872,0,6,glycogen granule,CC,
10930,GO:0042588,1,0.895745192891871,0,15,zymogen granule,CC,
10931,GO:0042589,1,0.922733492272543,0,11,zymogen granule membrane,CC,
10936,GO:0042595,1,0.985603820126152,0,2,behavioral response to starvation,BP,
10937,GO:0042596,1,0.796653405864043,0,32,fear response,BP,
10938,GO:0042599,1,0.880774375085223,0,17,lamellar body,CC,
10939,GO:0042602,1,0.992170027168696,0,1,riboflavin reductase (NADPH) activity,MF,
10940,GO:0042605,1,0.841951351980483,0,23,peptide antigen binding,MF,
10941,GO:0042608,1,0.948280481733276,0,7,T cell receptor binding,MF,
10942,GO:0042609,1,0.948938882690869,0,7,CD4 receptor binding,MF,
10943,GO:0042610,1,0.984429889732629,0,2,CD8 receptor binding,MF,
10944,GO:0042611,1,0.828678931804873,0,24,MHC protein complex,CC,
10945,GO:0042612,1,0.939037546110715,0,8,MHC class I protein complex,CC,
10946,GO:0042613,1,0.88253109242014,0,16,MHC class II protein complex,CC,
10947,GO:0042622,1,0.889755773254527,0,16,photoreceptor outer segment membrane,CC,
10949,GO:0042624,1,0.992170027168696,0,1,ATPase activity, uncoupled,MF,
10950,GO:0042625,1,0.589255175604527,0,75,ATPase coupled ion transmembrane transporter activity,MF,
10953,GO:0042628,1,0.992207639364056,0,1,mating plug formation,BP,
10954,GO:0042629,1,0.852782322893387,0,22,mast cell granule,CC,
10955,GO:0042631,1,0.98051524707957,0,3,cellular response to water deprivation,BP,
10960,GO:0042636,1,0.966562422562548,0,5,negative regulation of hair cycle,BP,
10961,GO:0042637,1,0.972328932458207,0,4,catagen,BP,
10962,GO:0042640,1,0.966797326943245,0,5,anagen,BP,
10963,GO:0042641,1,0.659437048746344,0,61,actomyosin,CC,
10964,GO:0042643,1,0.985817943505102,0,2,actomyosin, actin portion,CC,
10966,GO:0042658,1,0.992170027168696,0,1,MHC class II protein binding, via antigen binding groove,MF,
10967,GO:0042659,1,0.91096030155485,0,13,regulation of cell fate specification,BP,
10968,GO:0042660,1,0.9865476464918,0,2,positive regulation of cell fate specification,BP,
10969,GO:0042661,1,0.949534810499689,0,7,regulation of mesodermal cell fate specification,BP,
10970,GO:0042662,1,0.96910419216874,0,4,negative regulation of mesodermal cell fate specification,BP,
10971,GO:0042663,1,0.969427038271036,0,4,regulation of endodermal cell fate specification,BP,
10972,GO:0042664,1,0.992170027168696,0,1,negative regulation of endodermal cell fate specification,BP,
10973,GO:0042665,1,0.993385508500084,0,1,regulation of ectodermal cell fate specification,BP,
10974,GO:0042666,1,0.993385508500084,0,1,negative regulation of ectodermal cell fate specification,BP,
10975,GO:0042667,1,0.992170027168696,0,1,auditory receptor cell fate specification,BP,
10976,GO:0042668,1,0.976692112990833,0,3,auditory receptor cell fate determination,BP,
10977,GO:0042670,1,0.939120321361001,0,9,retinal cone cell differentiation,BP,
10978,GO:0042684,1,0.992516661359673,0,1,cardioblast cell fate commitment,BP,
10979,GO:0042685,1,0.992516661359673,0,1,cardioblast cell fate specification,BP,
10980,GO:0042686,1,0.992516661359673,0,1,regulation of cardioblast cell fate specification,BP,
10981,GO:0042692,1,0.0784132684696004,0,357,muscle cell differentiation,BP,
10982,GO:0042693,1,0.879703334243417,0,17,muscle cell fate commitment,BP,
10983,GO:0042694,1,0.992170027168696,0,1,muscle cell fate specification,BP,
10984,GO:0042695,1,0.965004731340358,0,5,thelarche,BP,
10986,GO:0042699,1,0.962160752475749,0,5,follicle-stimulating hormone signaling pathway,BP,
10987,GO:0042700,1,0.986550994917033,0,2,luteinizing hormone signaling pathway,BP,
10988,GO:0042701,1,0.970848108518894,0,4,progesterone secretion,BP,
10989,GO:0042703,1,0.992501954224661,0,1,menstruation,BP,
10990,GO:0042704,1,0.986749734177075,0,2,uterine wall breakdown,BP,
10991,GO:0042709,1,0.992228033436212,0,1,succinate-CoA ligase complex,CC,
10992,GO:0042710,1,0.984586107212501,0,2,biofilm formation,BP,
10993,GO:0042711,1,0.911568380718007,0,13,maternal behavior,BP,
10994,GO:0042713,1,0.960784766635998,0,6,sperm ejaculation,BP,
10995,GO:0042719,1,0.961578982775221,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10996,GO:0042720,1,0.984400887813367,0,2,mitochondrial inner membrane peptidase complex,CC,
10997,GO:0042721,1,0.992170027961005,0,1,mitochondrial inner membrane protein insertion complex,CC,
10998,GO:0042723,1,0.94882890898195,0,7,thiamine-containing compound metabolic process,BP,
11000,GO:0042727,1,0.984599776614409,0,2,flavin-containing compound biosynthetic process,BP,
11001,GO:0042728,1,0.993406763692654,0,1,flavin-containing compound catabolic process,BP,
11002,GO:0042730,1,0.814796946511439,0,27,fibrinolysis,BP,
11003,GO:0042731,1,0.972001977212603,0,4,PH domain binding,MF,
11004,GO:0042732,1,0.977751064711948,0,3,D-xylose metabolic process,BP,
11005,GO:0042733,1,0.665912155416738,0,58,embryonic digit morphogenesis,BP,
11006,GO:0042734,1,0.64324493084602,0,66,presynaptic membrane,CC,
11007,GO:0042737,1,0.899931601170284,0,14,drug catabolic process,BP,
11008,GO:0042738,1,0.921403281726092,0,11,exogenous drug catabolic process,BP,
11010,GO:0042743,1,0.729626803619347,0,42,hydrogen peroxide metabolic process,BP,
11011,GO:0042744,1,0.849008222551359,0,22,hydrogen peroxide catabolic process,BP,
11013,GO:0042746,1,0.955616705506912,0,6,circadian sleep/wake cycle, wakefulness,BP,
11015,GO:0042748,1,0.93632087484389,0,9,circadian sleep/wake cycle, non-REM sleep,BP,
11016,GO:0042749,1,0.847048454110525,0,22,regulation of circadian sleep/wake cycle,BP,
11017,GO:0042752,1,0.501777969356766,0,96,regulation of circadian rhythm,BP,
11018,GO:0042753,1,0.877260608571713,0,18,positive regulation of circadian rhythm,BP,
11019,GO:0042754,1,0.910091165143358,0,13,negative regulation of circadian rhythm,BP,
11021,GO:0042756,1,0.926912548218737,0,10,drinking behavior,BP,
11022,GO:0042758,1,0.949233605552135,0,7,long-chain fatty acid catabolic process,BP,
11024,GO:0042760,1,0.964671378417299,0,5,very long-chain fatty acid catabolic process,BP,
11027,GO:0042765,1,0.963430869274472,0,5,GPI-anchor transamidase complex,CC,
11028,GO:0042766,1,0.99398633227679,0,1,nucleosome mobilization,BP,
11029,GO:0042769,1,0.766928421965472,0,36,DNA damage response, detection of DNA damage,BP,
11030,GO:0042770,1,0.425875023201651,0,118,signal transduction in response to DNA damage,BP,
11032,GO:0042772,1,0.878584574732203,0,18,DNA damage response, signal transduction resulting in transcription,BP,
11033,GO:0042773,1,0.52725288066195,0,83,ATP synthesis coupled electron transport,BP,
11034,GO:0042774,1,0.992294630214608,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
11035,GO:0042775,1,0.531367452873623,0,82,mitochondrial ATP synthesis coupled electron transport,BP,
11036,GO:0042776,1,0.861367574758587,0,19,mitochondrial ATP synthesis coupled proton transport,BP,
11037,GO:0042779,1,0.985613905163078,0,2,tRNA 3'-trailer cleavage,BP,
11038,GO:0042780,1,0.963132275886745,0,5,tRNA 3'-end processing,BP,
11039,GO:0042781,1,0.985613905163078,0,2,3'-tRNA processing endoribonuclease activity,MF,
11041,GO:0042788,1,0.953571941780491,0,7,polysomal ribosome,CC,
11042,GO:0042789,1,0.881272275962241,0,18,mRNA transcription from RNA polymerase II promoter,BP,
11043,GO:0042790,1,0.908929294609786,0,13,transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
11044,GO:0042791,1,0.958492799462339,0,6,5S class rRNA transcription from RNA polymerase III type 1 promoter,BP,
11045,GO:0042795,1,0.621209288065322,0,65,snRNA transcription from RNA polymerase II promoter,BP,
11046,GO:0042796,1,0.972207543960852,0,4,snRNA transcription from RNA polymerase III promoter,BP,
11047,GO:0042797,1,0.958492799462339,0,6,tRNA transcription from RNA polymerase III promoter,BP,
11048,GO:0042799,1,0.993986332295487,0,1,histone methyltransferase activity (H4-K20 specific),MF,
11049,GO:0042800,1,0.91118004390179,0,13,histone methyltransferase activity (H3-K4 specific),MF,
11050,GO:0042801,1,0.993986332265675,0,1,polo kinase kinase activity,MF,
11053,GO:0042805,1,0.76460836139241,0,40,actinin binding,MF,
11054,GO:0042806,1,0.969723489935137,0,4,fucose binding,MF,
11055,GO:0042809,1,0.902046444517334,0,15,vitamin D receptor binding,MF,
11056,GO:0042813,1,0.90465603860928,0,15,Wnt-activated receptor activity,MF,
11058,GO:0042819,1,0.979331451981553,0,3,vitamin B6 biosynthetic process,BP,
11059,GO:0042820,1,0.992177118014353,0,1,vitamin B6 catabolic process,BP,
11060,GO:0042822,1,0.979321619561006,0,3,pyridoxal phosphate metabolic process,BP,
11061,GO:0042823,1,0.987043931533958,0,2,pyridoxal phosphate biosynthetic process,BP,
11062,GO:0042824,1,0.971604726050689,0,4,MHC class I peptide loading complex,CC,
11063,GO:0042825,1,0.979270702304667,0,3,TAP complex,CC,
11064,GO:0042826,1,0.485018366670539,0,102,histone deacetylase binding,MF,
11065,GO:0042827,1,0.863106404171887,0,20,platelet dense granule,CC,
11066,GO:0042832,1,0.867297580358431,0,19,defense response to protozoan,BP,
11067,GO:0042834,1,0.929601670731058,0,10,peptidoglycan binding,MF,
11068,GO:0042835,1,0.987476617971311,0,2,BRE binding,MF,
11069,GO:0042839,1,0.992170027168696,0,1,D-glucuronate metabolic process,BP,
11070,GO:0042840,1,0.992170027168696,0,1,D-glucuronate catabolic process,BP,
11071,GO:0042843,1,0.992170027168696,0,1,D-xylose catabolic process,BP,
11072,GO:0042851,1,0.970331375915177,0,4,L-alanine metabolic process,BP,
11073,GO:0042853,1,0.970331375915177,0,4,L-alanine catabolic process,BP,
11074,GO:0042866,1,0.962087719302381,0,5,pyruvate biosynthetic process,BP,
11075,GO:0042883,1,0.993276345545592,0,1,cysteine transport,BP,
11077,GO:0042887,1,0.784409358792329,0,33,amide transmembrane transporter activity,MF,
11078,GO:0042891,1,0.992171581291078,0,1,antibiotic transport,BP,
11079,GO:0042895,1,0.992171581291078,0,1,antibiotic transporter activity,MF,
11080,GO:0042903,1,0.985827823988509,0,2,tubulin deacetylase activity,MF,
11081,GO:0042904,1,0.969913017040425,0,4,9-cis-retinoic acid biosynthetic process,BP,
11082,GO:0042905,1,0.969913017040425,0,4,9-cis-retinoic acid metabolic process,BP,
11083,GO:0042908,1,0.937865252222005,0,10,xenobiotic transport,BP,
11084,GO:0042910,1,0.94379795478362,0,9,xenobiotic transporter activity,MF,
11085,GO:0042918,1,0.993986332268125,0,1,alkanesulfonate transport,BP,
11086,GO:0042921,1,0.90312181126046,0,15,glucocorticoid receptor signaling pathway,BP,
11087,GO:0042922,1,0.992170027168696,0,1,neuromedin U receptor binding,MF,
11088,GO:0042923,1,0.851884160111978,0,21,neuropeptide binding,MF,
11089,GO:0042924,1,0.992181526839924,0,1,neuromedin U binding,MF,
11090,GO:0042927,1,0.992294630214608,0,1,siderophore transporter activity,MF,
11091,GO:0042930,1,0.992294630214608,0,1,enterobactin transport,BP,
11092,GO:0042931,1,0.992294630214608,0,1,enterobactin transporter activity,MF,
11093,GO:0042936,1,0.992699006969237,0,1,dipeptide transporter activity,MF,
11094,GO:0042937,1,0.993986332267598,0,1,tripeptide transporter activity,MF,
11095,GO:0042938,1,0.977378654066388,0,3,dipeptide transport,BP,
11096,GO:0042939,1,0.986210251252293,0,2,tripeptide transport,BP,
11098,GO:0042941,1,0.992174484858162,0,1,D-alanine transport,BP,
11099,GO:0042942,1,0.984538165641147,0,2,D-serine transport,BP,
11100,GO:0042946,1,0.992294630214608,0,1,glucoside transport,BP,
11101,GO:0042947,1,0.992294630214608,0,1,glucoside transmembrane transporter activity,MF,
11102,GO:0042953,1,0.909691760868124,0,14,lipoprotein transport,BP,
11103,GO:0042954,1,0.982066433250679,0,3,lipoprotein transporter activity,MF,
11104,GO:0042959,1,0.993986332268125,0,1,alkanesulfonate transporter activity,MF,
11105,GO:0042974,1,0.844563902075001,0,24,retinoic acid receptor binding,MF,
11106,GO:0042975,1,0.934216208677849,0,10,peroxisome proliferator activated receptor binding,MF,
11109,GO:0042978,1,0.987725692973264,0,2,ornithine decarboxylase activator activity,MF,
11110,GO:0042979,1,0.964704647252606,0,5,ornithine decarboxylase regulator activity,MF,
11113,GO:0042983,1,0.949235245524574,0,7,amyloid precursor protein biosynthetic process,BP,
11114,GO:0042984,1,0.949235245524574,0,7,regulation of amyloid precursor protein biosynthetic process,BP,
11115,GO:0042985,1,0.971116226337899,0,4,negative regulation of amyloid precursor protein biosynthetic process,BP,
11116,GO:0042986,1,0.985181611681116,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
11118,GO:0042988,1,0.993967205514326,0,1,X11-like protein binding,MF,
11119,GO:0042989,1,0.947395604185727,0,7,sequestering of actin monomers,BP,
11122,GO:0042992,1,0.744188708550439,0,41,negative regulation of transcription factor import into nucleus,BP,
11123,GO:0042993,1,0.714552090148436,0,47,positive regulation of transcription factor import into nucleus,BP,
11124,GO:0042994,1,0.849002574139227,0,22,cytoplasmic sequestering of transcription factor,BP,
11126,GO:0042996,1,0.958558196752709,0,6,regulation of Golgi to plasma membrane protein transport,BP,
11127,GO:0042997,1,0.971000985336504,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
11128,GO:0042998,1,0.987188534858425,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
11129,GO:0042999,1,0.993842402218272,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
11130,GO:0043000,1,0.986060269011285,0,2,Golgi to plasma membrane CFTR protein transport,BP,
11131,GO:0043001,1,0.805641295516028,0,30,Golgi to plasma membrane protein transport,BP,
11132,GO:0043002,1,0.993842402218272,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
11133,GO:0043004,1,0.993842402218272,0,1,cytoplasmic sequestering of CFTR protein,BP,
11135,GO:0043006,1,0.984536754387158,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
11136,GO:0043008,1,0.940898182170107,0,8,ATP-dependent protein binding,MF,
11139,GO:0043011,1,0.866359766546664,0,19,myeloid dendritic cell differentiation,BP,
11140,GO:0043012,1,0.992309179090837,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11142,GO:0043015,1,0.843209878598415,0,24,gamma-tubulin binding,MF,
11143,GO:0043016,1,0.992370359992395,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11144,GO:0043017,1,0.992370359992395,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11145,GO:0043020,1,0.927456082488442,0,10,NADPH oxidase complex,CC,
11147,GO:0043022,1,0.72669809452234,0,45,ribosome binding,MF,
11148,GO:0043023,1,0.948508535283911,0,7,ribosomal large subunit binding,MF,
11149,GO:0043024,1,0.91239168647559,0,13,ribosomal small subunit binding,MF,
11155,GO:0043031,1,0.946744827351783,0,7,negative regulation of macrophage activation,BP,
11156,GO:0043032,1,0.892339055053221,0,15,positive regulation of macrophage activation,BP,
11157,GO:0043033,1,0.993986332271627,0,1,isoamylase complex,CC,
11158,GO:0043034,1,0.881009495332671,0,19,costamere,CC,
11159,GO:0043035,1,0.993336441991462,0,1,chromatin insulator sequence binding,MF,
11160,GO:0043038,1,0.683984533220379,0,51,amino acid activation,BP,
11161,GO:0043039,1,0.688737156662652,0,50,tRNA aminoacylation,BP,
11162,GO:0043041,1,0.993119517950716,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11164,GO:0043044,1,0.602489086421227,0,69,ATP-dependent chromatin remodeling,BP,
11165,GO:0043045,1,0.951552575908853,0,7,DNA methylation involved in embryo development,BP,
11166,GO:0043046,1,0.865358371637793,0,20,DNA methylation involved in gamete generation,BP,
11167,GO:0043047,1,0.936611605385387,0,9,single-stranded telomeric DNA binding,MF,
11168,GO:0043048,1,0.992197196162805,0,1,dolichyl monophosphate biosynthetic process,BP,
11169,GO:0043049,1,0.992631976713582,0,1,otic placode formation,BP,
11170,GO:0043060,1,0.992260754444587,0,1,meiotic metaphase I plate congression,BP,
11171,GO:0043062,1,0.116689024315115,0,307,extracellular structure organization,BP,
11172,GO:0043063,1,0.993925054701623,0,1,intercellular bridge organization,BP,
11178,GO:0043073,1,0.881792833044175,0,17,germ cell nucleus,CC,
11179,GO:0043083,1,0.939803262591063,0,9,synaptic cleft,CC,
11180,GO:0043084,1,0.939853775659475,0,9,penile erection,BP,
11185,GO:0043091,1,0.972149161885484,0,4,L-arginine import,BP,
11188,GO:0043095,1,0.992170027168696,0,1,regulation of GTP cyclohydrolase I activity,BP,
11189,GO:0043096,1,0.984400887813367,0,2,purine nucleobase salvage,BP,
11190,GO:0043097,1,0.919116222219109,0,11,pyrimidine nucleoside salvage,BP,
11193,GO:0043103,1,0.992170027168696,0,1,hypoxanthine salvage,BP,
11194,GO:0043105,1,0.992170027168696,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11195,GO:0043111,1,0.992170027168696,0,1,replication fork arrest,BP,
11196,GO:0043112,1,0.346765169370343,0,149,receptor metabolic process,BP,
11197,GO:0043113,1,0.722732835690578,0,47,receptor clustering,BP,
11198,GO:0043114,1,0.816956704504607,0,29,regulation of vascular permeability,BP,
11199,GO:0043116,1,0.93297383396154,0,10,negative regulation of vascular permeability,BP,
11200,GO:0043117,1,0.935757802966502,0,9,positive regulation of vascular permeability,BP,
11201,GO:0043120,1,0.978528362025564,0,3,tumor necrosis factor binding,MF,
11202,GO:0043121,1,0.934244835633739,0,10,neurotrophin binding,MF,
11206,GO:0043125,1,0.972563201391299,0,4,ErbB-3 class receptor binding,MF,
11207,GO:0043126,1,0.992170027168696,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11208,GO:0043128,1,0.992170027168696,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11209,GO:0043129,1,0.952016700743596,0,7,surfactant homeostasis,BP,
11210,GO:0043130,1,0.487842476955315,0,101,ubiquitin binding,MF,
11211,GO:0043132,1,0.984963745540415,0,2,NAD transport,BP,
11212,GO:0043133,1,0.984400887813367,0,2,hindgut contraction,BP,
11213,GO:0043134,1,0.984400887813367,0,2,regulation of hindgut contraction,BP,
11214,GO:0043136,1,0.992689771048506,0,1,glycerol-3-phosphatase activity,MF,
11215,GO:0043137,1,0.978308308817851,0,3,DNA replication, removal of RNA primer,BP,
11216,GO:0043138,1,0.920804663103431,0,12,3'-5' DNA helicase activity,MF,
11217,GO:0043139,1,0.950150186277103,0,7,5'-3' DNA helicase activity,MF,
11218,GO:0043140,1,0.962256282335842,0,6,ATP-dependent 3'-5' DNA helicase activity,MF,
11219,GO:0043141,1,0.96362782118658,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11220,GO:0043142,1,0.916178566518053,0,12,single-stranded DNA-dependent ATPase activity,MF,
11221,GO:0043143,1,0.992228530077066,0,1,regulation of translation by machinery localization,BP,
11222,GO:0043144,1,0.931831083869522,0,9,snoRNA processing,BP,
11223,GO:0043149,1,0.569100185676886,0,81,stress fiber assembly,BP,
11224,GO:0043152,1,0.971163392153999,0,4,induction of bacterial agglutination,BP,
11225,GO:0043153,1,0.871727482377698,0,19,entrainment of circadian clock by photoperiod,BP,
11227,GO:0043159,1,0.977652144200858,0,3,acrosomal matrix,CC,
11228,GO:0043160,1,0.992294630214608,0,1,acrosomal lumen,CC,
11230,GO:0043162,1,0.876605130001797,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11231,GO:0043163,1,0.978899838208274,0,3,cell envelope organization,BP,
11236,GO:0043171,1,0.812759710042441,0,29,peptide catabolic process,BP,
11237,GO:0043173,1,0.90660454013838,0,13,nucleotide salvage,BP,
11238,GO:0043174,1,0.885247012274729,0,16,nucleoside salvage,BP,
11239,GO:0043175,1,0.808022026556799,0,30,RNA polymerase core enzyme binding,MF,
11240,GO:0043176,1,0.920754036639014,0,11,amine binding,MF,
11243,GO:0043179,1,0.992184682619676,0,1,rhythmic excitation,BP,
11244,GO:0043181,1,0.993155402449955,0,1,vacuolar sequestering,BP,
11245,GO:0043183,1,0.985294711841132,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11246,GO:0043184,1,0.95339442396323,0,7,vascular endothelial growth factor receptor 2 binding,MF,
11247,GO:0043185,1,0.992183109713971,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11248,GO:0043186,1,0.891770971524324,0,16,P granule,CC,
11249,GO:0043189,1,0.873137158844237,0,18,H4/H2A histone acetyltransferase complex,CC,
11250,GO:0043190,1,0.945634876485969,0,8,ATP-binding cassette (ABC) transporter complex,CC,
11251,GO:0043194,1,0.923208765634509,0,12,axon initial segment,CC,
11253,GO:0043196,1,0.942360952292913,0,8,varicosity,CC,
11254,GO:0043197,1,0.436717679532997,0,120,dendritic spine,CC,
11255,GO:0043198,1,0.798599098049987,0,33,dendritic shaft,CC,
11256,GO:0043199,1,0.971112061237293,0,4,sulfate binding,MF,
11257,GO:0043200,1,0.466889841026935,0,106,response to amino acid,BP,
11258,GO:0043201,1,0.931918637781583,0,11,response to leucine,BP,
11260,GO:0043203,1,0.949302785360001,0,7,axon hillock,CC,
11263,GO:0043208,1,0.941086691478323,0,8,glycosphingolipid binding,MF,
11265,GO:0043210,1,0.99217069631132,0,1,alkanesulfonate binding,MF,
11266,GO:0043215,1,0.993506247191203,0,1,daunorubicin transport,BP,
11267,GO:0043217,1,0.919465768240888,0,12,myelin maintenance,BP,
11268,GO:0043218,1,0.905081062219923,0,14,compact myelin,CC,
11269,GO:0043219,1,0.972553905501403,0,4,lateral loop,CC,
11270,GO:0043220,1,0.924998281177095,0,11,Schmidt-Lanterman incisure,CC,
11271,GO:0043221,1,0.993402365383889,0,1,SMC family protein binding,MF,
11272,GO:0043225,1,0.921276656483443,0,13,ATPase-coupled anion transmembrane transporter activity,MF,
11283,GO:0043236,1,0.824831295853338,0,28,laminin binding,MF,
11284,GO:0043237,1,0.960095685907517,0,6,laminin-1 binding,MF,
11285,GO:0043240,1,0.944527243741505,0,8,Fanconi anaemia nuclear complex,CC,
11288,GO:0043243,1,0.858574363799133,0,21,positive regulation of protein complex disassembly,BP,
11290,GO:0043247,1,0.919597495364068,0,12,telomere maintenance in response to DNA damage,BP,
11291,GO:0043248,1,0.905228982597497,0,13,proteasome assembly,BP,
11292,GO:0043249,1,0.921198441669523,0,11,erythrocyte maturation,BP,
11293,GO:0043250,1,0.992170027168696,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11294,GO:0043251,1,0.992170027168696,0,1,sodium-dependent organic anion transport,BP,
11295,GO:0043252,1,0.83137824172833,0,25,sodium-independent organic anion transport,BP,
11297,GO:0043255,1,0.584236742462373,0,77,regulation of carbohydrate biosynthetic process,BP,
11298,GO:0043256,1,0.952456944387795,0,8,laminin complex,CC,
11299,GO:0043257,1,0.993986332264836,0,1,laminin-8 complex,CC,
11300,GO:0043259,1,0.982066433194866,0,3,laminin-10 complex,CC,
11301,GO:0043260,1,0.982066433194661,0,3,laminin-11 complex,CC,
11302,GO:0043262,1,0.978051779724266,0,3,adenosine-diphosphatase activity,MF,
11303,GO:0043265,1,0.992697155644847,0,1,ectoplasm,CC,
11304,GO:0043266,1,0.56121793755896,0,81,regulation of potassium ion transport,BP,
11305,GO:0043267,1,0.835736399008739,0,25,negative regulation of potassium ion transport,BP,
11306,GO:0043268,1,0.796417982512254,0,33,positive regulation of potassium ion transport,BP,
11309,GO:0043271,1,0.418399790422326,0,120,negative regulation of ion transport,BP,
11310,GO:0043273,1,0.993981031267988,0,1,CTPase activity,MF,
11311,GO:0043274,1,0.90096517590414,0,15,phospholipase binding,MF,
11313,GO:0043277,1,0.779480393977008,0,35,apoptotic cell clearance,BP,
11318,GO:0043291,1,0.988008547508906,0,2,RAVE complex,CC,
11320,GO:0043293,1,0.98620330671549,0,2,apoptosome,CC,
11321,GO:0043295,1,0.920235816035873,0,11,glutathione binding,MF,
11322,GO:0043296,1,0.429586014856093,0,123,apical junction complex,CC,
11323,GO:0043297,1,0.688740968878152,0,54,apical junction assembly,BP,
11325,GO:0043300,1,0.751419727602108,0,39,regulation of leukocyte degranulation,BP,
11326,GO:0043301,1,0.923193161516666,0,11,negative regulation of leukocyte degranulation,BP,
11327,GO:0043302,1,0.875415888117104,0,18,positive regulation of leukocyte degranulation,BP,
11328,GO:0043303,1,0.720138909830629,0,45,mast cell degranulation,BP,
11329,GO:0043304,1,0.806226175089872,0,29,regulation of mast cell degranulation,BP,
11330,GO:0043305,1,0.948316397721777,0,7,negative regulation of mast cell degranulation,BP,
11331,GO:0043306,1,0.907160953233997,0,13,positive regulation of mast cell degranulation,BP,
11332,GO:0043307,1,0.946996878048361,0,7,eosinophil activation,BP,
11333,GO:0043308,1,0.954470977357724,0,6,eosinophil degranulation,BP,
11334,GO:0043309,1,0.97709442912924,0,3,regulation of eosinophil degranulation,BP,
11335,GO:0043310,1,0.992271495764135,0,1,negative regulation of eosinophil degranulation,BP,
11336,GO:0043311,1,0.984705643377001,0,2,positive regulation of eosinophil degranulation,BP,
11338,GO:0043313,1,0.968127805653648,0,5,regulation of neutrophil degranulation,BP,
11339,GO:0043314,1,0.987995862158084,0,2,negative regulation of neutrophil degranulation,BP,
11340,GO:0043315,1,0.993616323617868,0,1,positive regulation of neutrophil degranulation,BP,
11341,GO:0043316,1,0.98549913721609,0,2,cytotoxic T cell degranulation,BP,
11342,GO:0043317,1,0.993022985762141,0,1,regulation of cytotoxic T cell degranulation,BP,
11343,GO:0043318,1,0.993022985762141,0,1,negative regulation of cytotoxic T cell degranulation,BP,
11344,GO:0043320,1,0.950323753753583,0,7,natural killer cell degranulation,BP,
11345,GO:0043321,1,0.986320498595051,0,2,regulation of natural killer cell degranulation,BP,
11346,GO:0043323,1,0.986320498595051,0,2,positive regulation of natural killer cell degranulation,BP,
11347,GO:0043324,1,0.971283371048872,0,4,pigment metabolic process involved in developmental pigmentation,BP,
11348,GO:0043325,1,0.861315736777644,0,21,phosphatidylinositol-3,4-bisphosphate binding,MF,
11349,GO:0043328,1,0.970612885631805,0,4,protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11352,GO:0043335,1,0.985402190435821,0,2,protein unfolding,BP,
11353,GO:0043337,1,0.993344272378398,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11354,GO:0043353,1,0.952661498350823,0,7,enucleate erythrocyte differentiation,BP,
11355,GO:0043366,1,0.986170131927127,0,2,beta selection,BP,
11356,GO:0043367,1,0.630470383886856,0,63,CD4-positive, alpha-beta T cell differentiation,BP,
11357,GO:0043368,1,0.798836231349081,0,31,positive T cell selection,BP,
11358,GO:0043369,1,0.863143803985917,0,20,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11359,GO:0043370,1,0.754853473521456,0,38,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11360,GO:0043371,1,0.896820720493604,0,15,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11361,GO:0043372,1,0.828163378243437,0,25,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11362,GO:0043373,1,0.887696521158671,0,16,CD4-positive, alpha-beta T cell lineage commitment,BP,
11363,GO:0043374,1,0.923281486125155,0,11,CD8-positive, alpha-beta T cell differentiation,BP,
11364,GO:0043375,1,0.993385061896905,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11365,GO:0043376,1,0.986656069669705,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11366,GO:0043378,1,0.993447293752693,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11367,GO:0043379,1,0.936082187962749,0,9,memory T cell differentiation,BP,
11368,GO:0043380,1,0.941748198569456,0,8,regulation of memory T cell differentiation,BP,
11369,GO:0043381,1,0.992294630214608,0,1,negative regulation of memory T cell differentiation,BP,
11370,GO:0043382,1,0.955675441394048,0,6,positive regulation of memory T cell differentiation,BP,
11371,GO:0043383,1,0.910739616702791,0,13,negative T cell selection,BP,
11372,GO:0043385,1,0.992216941255385,0,1,mycotoxin metabolic process,BP,
11373,GO:0043388,1,0.698546579631059,0,49,positive regulation of DNA binding,BP,
11374,GO:0043390,1,0.992216941255385,0,1,aflatoxin B1 metabolic process,BP,
11375,GO:0043392,1,0.690623650189984,0,51,negative regulation of DNA binding,BP,
11377,GO:0043394,1,0.78837863843923,0,34,proteoglycan binding,MF,
11378,GO:0043395,1,0.879448818579815,0,18,heparan sulfate proteoglycan binding,MF,
11379,GO:0043396,1,0.979021163010058,0,3,corticotropin-releasing hormone secretion,BP,
11380,GO:0043397,1,0.979021163010058,0,3,regulation of corticotropin-releasing hormone secretion,BP,
11381,GO:0043398,1,0.979643467104063,0,3,HLH domain binding,MF,
11382,GO:0043400,1,0.963447086149676,0,5,cortisol secretion,BP,
11383,GO:0043401,1,0.283516931809467,0,178,steroid hormone mediated signaling pathway,BP,
11384,GO:0043402,1,0.98039486109979,0,3,glucocorticoid mediated signaling pathway,BP,
11385,GO:0043403,1,0.814570449501381,0,28,skeletal muscle tissue regeneration,BP,
11388,GO:0043407,1,0.593516731006245,0,71,negative regulation of MAP kinase activity,BP,
11390,GO:0043409,1,0.350854278911973,0,145,negative regulation of MAPK cascade,BP,
11395,GO:0043415,1,0.964577494107153,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11396,GO:0043416,1,0.957022758990286,0,6,regulation of skeletal muscle tissue regeneration,BP,
11397,GO:0043418,1,0.977570484549164,0,3,homocysteine catabolic process,BP,
11398,GO:0043420,1,0.992170027168696,0,1,anthranilate metabolic process,BP,
11399,GO:0043422,1,0.916557093653426,0,12,protein kinase B binding,MF,
11400,GO:0043423,1,0.993738306669615,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11401,GO:0043425,1,0.831777049062725,0,26,bHLH transcription factor binding,MF,
11402,GO:0043426,1,0.965219056637696,0,5,MRF binding,MF,
11405,GO:0043435,1,0.964348807766747,0,5,response to corticotropin-releasing hormone,BP,
11407,GO:0043438,1,0.992476433594884,0,1,acetoacetic acid metabolic process,BP,
11408,GO:0043449,1,0.98606380022077,0,2,cellular alkene metabolic process,BP,
11409,GO:0043455,1,0.92390556062656,0,11,regulation of secondary metabolic process,BP,
11410,GO:0043456,1,0.969047174370287,0,4,regulation of pentose-phosphate shunt,BP,
11411,GO:0043457,1,0.848559707472273,0,23,regulation of cellular respiration,BP,
11412,GO:0043461,1,0.970390964961373,0,4,proton-transporting ATP synthase complex assembly,BP,
11414,GO:0043465,1,0.992472769835405,0,1,regulation of fermentation,BP,
11415,GO:0043467,1,0.569225709194838,0,80,regulation of generation of precursor metabolites and energy,BP,
11416,GO:0043470,1,0.747634150015936,0,41,regulation of carbohydrate catabolic process,BP,
11417,GO:0043471,1,0.922444393220897,0,11,regulation of cellular carbohydrate catabolic process,BP,
11419,GO:0043474,1,0.971283371048872,0,4,pigment metabolic process involved in pigmentation,BP,
11420,GO:0043476,1,0.918494211530599,0,12,pigment accumulation,BP,
11421,GO:0043482,1,0.918494211530599,0,12,cellular pigment accumulation,BP,
11422,GO:0043484,1,0.474020478884951,0,103,regulation of RNA splicing,BP,
11423,GO:0043485,1,0.929648367631039,0,10,endosome to pigment granule transport,BP,
11424,GO:0043486,1,0.696064525322989,0,48,histone exchange,BP,
11427,GO:0043489,1,0.804211292519958,0,31,RNA stabilization,BP,
11428,GO:0043490,1,0.986321404799499,0,2,malate-aspartate shuttle,BP,
11431,GO:0043495,1,0.95335729545793,0,7,protein anchor,MF,
11433,GO:0043497,1,0.943587475286004,0,8,regulation of protein heterodimerization activity,BP,
11435,GO:0043501,1,0.851320765426699,0,23,skeletal muscle adaptation,BP,
11437,GO:0043503,1,0.984401445146774,0,2,skeletal muscle fiber adaptation,BP,
11438,GO:0043504,1,0.979724479899288,0,3,mitochondrial DNA repair,BP,
11439,GO:0043506,1,0.574922163694273,0,80,regulation of JUN kinase activity,BP,
11440,GO:0043507,1,0.650613042183416,0,63,positive regulation of JUN kinase activity,BP,
11441,GO:0043508,1,0.902745902579209,0,14,negative regulation of JUN kinase activity,BP,
11442,GO:0043509,1,0.992193225579856,0,1,activin A complex,CC,
11443,GO:0043511,1,0.984423905978682,0,2,inhibin complex,CC,
11444,GO:0043512,1,0.984423905978682,0,2,inhibin A complex,CC,
11445,GO:0043513,1,0.992170027168696,0,1,inhibin B complex,CC,
11446,GO:0043514,1,0.984456981790427,0,2,interleukin-12 complex,CC,
11447,GO:0043515,1,0.972717212916008,0,4,kinetochore binding,MF,
11448,GO:0043516,1,0.817296806593125,0,28,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11449,GO:0043517,1,0.912383479911249,0,13,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11450,GO:0043518,1,0.902928272472559,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11451,GO:0043519,1,0.992185746419627,0,1,regulation of myosin II filament organization,BP,
11452,GO:0043522,1,0.922266314859188,0,11,leucine zipper domain binding,MF,
11455,GO:0043525,1,0.707712580483142,0,48,positive regulation of neuron apoptotic process,BP,
11456,GO:0043527,1,0.962103189914215,0,5,tRNA methyltransferase complex,CC,
11458,GO:0043532,1,0.970821987071707,0,4,angiostatin binding,MF,
11459,GO:0043533,1,0.966899094410462,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11460,GO:0043534,1,0.584053707949978,0,76,blood vessel endothelial cell migration,BP,
11461,GO:0043535,1,0.679688856796512,0,54,regulation of blood vessel endothelial cell migration,BP,
11462,GO:0043536,1,0.825407113897762,0,27,positive regulation of blood vessel endothelial cell migration,BP,
11463,GO:0043537,1,0.836660247068588,0,25,negative regulation of blood vessel endothelial cell migration,BP,
11464,GO:0043538,1,0.992612683427298,0,1,regulation of actin phosphorylation,BP,
11465,GO:0043539,1,0.833089008029757,0,25,protein serine/threonine kinase activator activity,MF,
11466,GO:0043540,1,0.992170144174095,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11467,GO:0043541,1,0.978596984221779,0,3,UDP-N-acetylglucosamine transferase complex,CC,
11469,GO:0043543,1,0.227918797023494,0,204,protein acylation,BP,
11470,GO:0043544,1,0.993137491452272,0,1,lipoamide binding,MF,
11471,GO:0043545,1,0.949648605292635,0,7,molybdopterin cofactor metabolic process,BP,
11474,GO:0043548,1,0.803382751147297,0,32,phosphatidylinositol 3-kinase binding,MF,
11476,GO:0043550,1,0.717809368918583,0,48,regulation of lipid kinase activity,BP,
11477,GO:0043551,1,0.766162722052062,0,39,regulation of phosphatidylinositol 3-kinase activity,BP,
11478,GO:0043552,1,0.814934284804882,0,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,
11479,GO:0043553,1,0.986098022843287,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11480,GO:0043555,1,0.860864553490592,0,21,regulation of translation in response to stress,BP,
11481,GO:0043558,1,0.88549307268752,0,17,regulation of translational initiation in response to stress,BP,
11482,GO:0043559,1,0.961667994337229,0,6,insulin binding,MF,
11483,GO:0043560,1,0.929352106727213,0,11,insulin receptor substrate binding,MF,
11484,GO:0043562,1,0.971572080152777,0,4,cellular response to nitrogen levels,BP,
11485,GO:0043564,1,0.97752218493717,0,3,Ku70:Ku80 complex,CC,
11487,GO:0043567,1,0.846200230030003,0,23,regulation of insulin-like growth factor receptor signaling pathway,BP,
11488,GO:0043568,1,0.911167687562375,0,13,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11489,GO:0043569,1,0.952662552723317,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11490,GO:0043570,1,0.974001129238083,0,4,maintenance of DNA repeat elements,BP,
11491,GO:0043574,1,0.879604015685569,0,18,peroxisomal transport,BP,
11492,GO:0043576,1,0.860036379509576,0,22,regulation of respiratory gaseous exchange,BP,
11493,GO:0043578,1,0.98083515082965,0,3,nuclear matrix organization,BP,
11494,GO:0043583,1,0.237929825831183,0,201,ear development,BP,
11495,GO:0043584,1,0.900155067994991,0,15,nose development,BP,
11496,GO:0043585,1,0.980553044782621,0,3,nose morphogenesis,BP,
11497,GO:0043586,1,0.865688843827664,0,20,tongue development,BP,
11498,GO:0043587,1,0.937662955844542,0,9,tongue morphogenesis,BP,
11500,GO:0043589,1,0.942258304093918,0,9,skin morphogenesis,BP,
11501,GO:0043596,1,0.731421164312864,0,43,nuclear replication fork,CC,
11502,GO:0043601,1,0.806464899288211,0,29,nuclear replisome,CC,
11503,GO:0043602,1,0.992274765742836,0,1,nitrate catabolic process,BP,
11506,GO:0043605,1,0.976717716198068,0,3,cellular amide catabolic process,BP,
11507,GO:0043606,1,0.970324896323944,0,4,formamide metabolic process,BP,
11508,GO:0043610,1,0.993986332279133,0,1,regulation of carbohydrate utilization,BP,
11509,GO:0043614,1,0.98764801359202,0,2,multi-eIF complex,CC,
11511,GO:0043616,1,0.768626389150131,0,38,keratinocyte proliferation,BP,
11513,GO:0043619,1,0.926047968374915,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11515,GO:0043621,1,0.684836623647926,0,53,protein self-association,MF,
11516,GO:0043622,1,0.973603603362385,0,4,cortical microtubule organization,BP,
11519,GO:0043625,1,0.970669994003282,0,4,delta DNA polymerase complex,CC,
11520,GO:0043626,1,0.992170027168696,0,1,PCNA complex,CC,
11522,GO:0043628,1,0.860033318614037,0,20,ncRNA 3'-end processing,BP,
11523,GO:0043631,1,0.755362403006446,0,40,RNA polyadenylation,BP,
11525,GO:0043633,1,0.963340752713544,0,5,polyadenylation-dependent RNA catabolic process,BP,
11526,GO:0043634,1,0.969307572086323,0,4,polyadenylation-dependent ncRNA catabolic process,BP,
11527,GO:0043647,1,0.627054452673928,0,67,inositol phosphate metabolic process,BP,
11529,GO:0043649,1,0.893401834028228,0,15,dicarboxylic acid catabolic process,BP,
11532,GO:0043652,1,0.951936351543523,0,7,engulfment of apoptotic cell,BP,
11533,GO:0043653,1,0.942976811848005,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
11534,GO:0043654,1,0.950996656348955,0,7,recognition of apoptotic cell,BP,
11535,GO:0043656,1,0.952425449570397,0,7,intracellular region of host,CC,
11536,GO:0043657,1,0.906370450255763,0,14,host cell,CC,
11539,GO:0043682,1,0.988008547476944,0,2,copper-transporting ATPase activity,MF,
11540,GO:0043686,1,0.977047155590948,0,3,co-translational protein modification,BP,
11541,GO:0043687,1,0.485777104809363,0,98,post-translational protein modification,BP,
11543,GO:0043696,1,0.978804083494564,0,3,dedifferentiation,BP,
11544,GO:0043697,1,0.978804083494564,0,3,cell dedifferentiation,BP,
11545,GO:0043733,1,0.992170027168696,0,1,DNA-3-methylbase glycosylase activity,MF,
11546,GO:0043734,1,0.970679551326865,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11547,GO:0043739,1,0.992798767495208,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11548,GO:0043754,1,0.993986332288218,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11550,GO:0043795,1,0.992170027168696,0,1,glyceraldehyde oxidoreductase activity,MF,
11551,GO:0043812,1,0.980069005767319,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11552,GO:0043813,1,0.968991940204639,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11553,GO:0043843,1,0.992294218414588,0,1,ADP-specific glucokinase activity,MF,
11554,GO:0043849,1,0.99250695052759,0,1,Ras palmitoyltransferase activity,MF,
11555,GO:0043855,1,0.939892987406246,0,9,cyclic nucleotide-gated ion channel activity,MF,
11556,GO:0043865,1,0.992409113957912,0,1,methionine transmembrane transporter activity,MF,
11557,GO:0043874,1,0.992177875337847,0,1,acireductone synthase activity,MF,
11558,GO:0043890,1,0.992231827506464,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11559,GO:0043891,1,0.984400887813367,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11562,GO:0043902,1,0.314130648672245,0,159,positive regulation of multi-organism process,BP,
11564,GO:0043914,1,0.993454038941059,0,1,NADPH:sulfur oxidoreductase activity,MF,
11565,GO:0043916,1,0.992170027168696,0,1,DNA-7-methylguanine glycosylase activity,MF,
11566,GO:0043921,1,0.834921041771117,0,25,modulation by host of viral transcription,BP,
11567,GO:0043922,1,0.914492016613829,0,12,negative regulation by host of viral transcription,BP,
11568,GO:0043923,1,0.899820729337611,0,15,positive regulation by host of viral transcription,BP,
11569,GO:0043924,1,0.993986332309207,0,1,suramin binding,MF,
11570,GO:0043928,1,0.786181280527618,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11571,GO:0043931,1,0.903055844291746,0,15,ossification involved in bone maturation,BP,
11572,GO:0043932,1,0.96968795919731,0,4,ossification involved in bone remodeling,BP,
11574,GO:0043946,1,0.992170162878738,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11575,GO:0043947,1,0.992170162878738,0,1,positive regulation by host of symbiont catalytic activity,BP,
11576,GO:0043949,1,0.859628170993663,0,21,regulation of cAMP-mediated signaling,BP,
11577,GO:0043950,1,0.934238224020956,0,9,positive regulation of cAMP-mediated signaling,BP,
11578,GO:0043951,1,0.95928566960922,0,6,negative regulation of cAMP-mediated signaling,BP,
11579,GO:0043954,1,0.834227827454963,0,26,cellular component maintenance,BP,
11580,GO:0043966,1,0.678010950883843,0,54,histone H3 acetylation,BP,
11581,GO:0043967,1,0.658623384043422,0,58,histone H4 acetylation,BP,
11582,GO:0043968,1,0.893570006273135,0,15,histone H2A acetylation,BP,
11583,GO:0043969,1,0.993986332279187,0,1,histone H2B acetylation,BP,
11584,GO:0043970,1,0.925746235324902,0,11,histone H3-K9 acetylation,BP,
11585,GO:0043973,1,0.992198025820749,0,1,histone H3-K4 acetylation,BP,
11586,GO:0043974,1,0.987471884184892,0,2,histone H3-K27 acetylation,BP,
11587,GO:0043981,1,0.916025297713924,0,12,histone H4-K5 acetylation,BP,
11588,GO:0043982,1,0.916025297713924,0,12,histone H4-K8 acetylation,BP,
11589,GO:0043983,1,0.969685589721228,0,4,histone H4-K12 acetylation,BP,
11590,GO:0043984,1,0.887916930762097,0,17,histone H4-K16 acetylation,BP,
11591,GO:0043985,1,0.955765919421244,0,6,histone H4-R3 methylation,BP,
11592,GO:0043987,1,0.970044277145099,0,4,histone H3-S10 phosphorylation,BP,
11593,GO:0043988,1,0.977687143783275,0,3,histone H3-S28 phosphorylation,BP,
11594,GO:0043990,1,0.992655168694511,0,1,histone H2A-S1 phosphorylation,BP,
11595,GO:0043995,1,0.93775930891755,0,9,histone acetyltransferase activity (H4-K5 specific),MF,
11596,GO:0043996,1,0.93775930891755,0,9,histone acetyltransferase activity (H4-K8 specific),MF,
11597,GO:0043997,1,0.992682420182586,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11598,GO:0043998,1,0.992886375919382,0,1,H2A histone acetyltransferase activity,MF,
11599,GO:0044003,1,0.737007006117982,0,43,modification by symbiont of host morphology or physiology,BP,
11600,GO:0044004,1,0.970983965594784,0,4,disruption by symbiont of host cell,BP,
11601,GO:0044007,1,0.993986332267547,0,1,dissemination or transmission of symbiont from host,BP,
11602,GO:0044010,1,0.984586107212501,0,2,single-species biofilm formation,BP,
11603,GO:0044020,1,0.969347148676287,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11604,GO:0044026,1,0.979626187614076,0,3,DNA hypermethylation,BP,
11605,GO:0044027,1,0.986203080778776,0,2,hypermethylation of CpG island,BP,
11606,GO:0044028,1,0.986713968139095,0,2,DNA hypomethylation,BP,
11607,GO:0044029,1,0.986713968139095,0,2,hypomethylation of CpG island,BP,
11608,GO:0044030,1,0.868095013901425,0,20,regulation of DNA methylation,BP,
11609,GO:0044033,1,0.20900485094603,0,209,multi-organism metabolic process,BP,
11610,GO:0044034,1,0.978085139332695,0,3,multi-organism biosynthetic process,BP,
11611,GO:0044035,1,0.992170027168696,0,1,multi-organism catabolic process,BP,
11612,GO:0044036,1,0.961454084583516,0,5,cell wall macromolecule metabolic process,BP,
11613,GO:0044038,1,0.992170321724734,0,1,cell wall macromolecule biosynthetic process,BP,
11614,GO:0044042,1,0.599025860433768,0,73,glucan metabolic process,BP,
11615,GO:0044053,1,0.992244049183172,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11617,GO:0044058,1,0.754471630967728,0,38,regulation of digestive system process,BP,
11618,GO:0044060,1,0.729030799084992,0,43,regulation of endocrine process,BP,
11619,GO:0044062,1,0.837222010999996,0,24,regulation of excretion,BP,
11620,GO:0044065,1,0.901478303060668,0,15,regulation of respiratory system process,BP,
11621,GO:0044068,1,0.837437609812444,0,25,modulation by symbiont of host cellular process,BP,
11622,GO:0044070,1,0.486335211554224,0,101,regulation of anion transport,BP,
11627,GO:0044090,1,0.891996118891046,0,17,positive regulation of vacuole organization,BP,
11628,GO:0044091,1,0.802269048108239,0,32,membrane biogenesis,BP,
11631,GO:0044094,1,0.987716958764513,0,2,host cell nuclear part,CC,
11633,GO:0044107,1,0.961793594867536,0,5,cellular alcohol metabolic process,BP,
11634,GO:0044108,1,0.961793594867536,0,5,cellular alcohol biosynthetic process,BP,
11635,GO:0044110,1,0.864591862700685,0,19,growth involved in symbiotic interaction,BP,
11636,GO:0044111,1,0.986203080775248,0,2,development involved in symbiotic interaction,BP,
11637,GO:0044115,1,0.992170027168696,0,1,development of symbiont involved in interaction with host,BP,
11638,GO:0044116,1,0.864591862700685,0,19,growth of symbiont involved in interaction with host,BP,
11639,GO:0044117,1,0.871422384944707,0,18,growth of symbiont in host,BP,
11640,GO:0044126,1,0.892235119211592,0,15,regulation of growth of symbiont in host,BP,
11641,GO:0044128,1,0.99395672953507,0,1,positive regulation of growth of symbiont in host,BP,
11642,GO:0044130,1,0.897664514714509,0,14,negative regulation of growth of symbiont in host,BP,
11643,GO:0044133,1,0.992170027168696,0,1,growth of symbiont on or near host,BP,
11644,GO:0044139,1,0.992170027168696,0,1,modulation of growth of symbiont on or near host,BP,
11645,GO:0044140,1,0.992170027168696,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11646,GO:0044144,1,0.885242743058088,0,16,modulation of growth of symbiont involved in interaction with host,BP,
11647,GO:0044145,1,0.992170027168696,0,1,modulation of development of symbiont involved in interaction with host,BP,
11648,GO:0044146,1,0.890629921093729,0,15,negative regulation of growth of symbiont involved in interaction with host,BP,
11649,GO:0044147,1,0.992170027168696,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11650,GO:0044148,1,0.99395672953507,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11651,GO:0044154,1,0.949819928695022,0,7,histone H3-K14 acetylation,BP,
11652,GO:0044179,1,0.984625601040578,0,2,hemolysis in other organism,BP,
11653,GO:0044183,1,0.813753634071048,0,27,protein binding involved in protein folding,MF,
11654,GO:0044190,1,0.992170193264521,0,1,host cell mitochondrial envelope,CC,
11655,GO:0044194,1,0.969397244696727,0,4,cytolytic granule,CC,
11656,GO:0044205,1,0.978658861086626,0,3,'de novo' UMP biosynthetic process,BP,
11657,GO:0044206,1,0.961544141240002,0,5,UMP salvage,BP,
11658,GO:0044207,1,0.993633011695133,0,1,translation initiation ternary complex,CC,
11659,GO:0044208,1,0.976918030994325,0,3,'de novo' AMP biosynthetic process,BP,
11660,GO:0044209,1,0.984411642844679,0,2,AMP salvage,BP,
11661,GO:0044210,1,0.985816882393835,0,2,'de novo' CTP biosynthetic process,BP,
11662,GO:0044211,1,0.976711208773893,0,3,CTP salvage,BP,
11664,GO:0044213,1,0.922175889955201,0,11,intronic transcription regulatory region DNA binding,MF,
11665,GO:0044214,1,0.980816399306888,0,3,spanning component of plasma membrane,CC,
11666,GO:0044215,1,0.873253037634156,0,19,other organism,CC,
11667,GO:0044216,1,0.873253037634156,0,19,other organism cell,CC,
11668,GO:0044217,1,0.873253037634156,0,19,other organism part,CC,
11669,GO:0044218,1,0.978395059956889,0,3,other organism cell membrane,CC,
11670,GO:0044220,1,0.993913468533292,0,1,host cell perinuclear region of cytoplasm,CC,
11671,GO:0044221,1,0.99364699972125,0,1,host cell synapse,CC,
11672,GO:0044224,1,0.935557399580114,0,10,juxtaparanode region of axon,CC,
11673,GO:0044228,1,0.993887753398722,0,1,host cell surface,CC,
11674,GO:0044231,1,0.99364699972125,0,1,host cell presynaptic membrane,CC,
11675,GO:0044232,1,0.908927312655122,0,14,organelle membrane contact site,CC,
11676,GO:0044233,1,0.931666378397153,0,10,ER-mitochondrion membrane contact site,CC,
11680,GO:0044240,1,0.96910853043117,0,4,multicellular organismal lipid catabolic process,BP,
11681,GO:0044241,1,0.814253403510651,0,27,lipid digestion,BP,
11684,GO:0044245,1,0.974375796175049,0,4,polysaccharide digestion,BP,
11685,GO:0044246,1,0.771792235339101,0,35,regulation of multicellular organismal metabolic process,BP,
11686,GO:0044247,1,0.828713297847186,0,27,cellular polysaccharide catabolic process,BP,
11689,GO:0044252,1,0.935987764402019,0,9,negative regulation of multicellular organismal metabolic process,BP,
11690,GO:0044253,1,0.843177803533275,0,23,positive regulation of multicellular organismal metabolic process,BP,
11691,GO:0044254,1,0.972905373821384,0,4,multicellular organismal protein catabolic process,BP,
11693,GO:0044256,1,0.972905373821384,0,4,protein digestion,BP,
11695,GO:0044258,1,0.992236866243913,0,1,intestinal lipid catabolic process,BP,
11699,GO:0044264,1,0.544723197577104,0,86,cellular polysaccharide metabolic process,BP,
11701,GO:0044266,1,0.972905373821384,0,4,multicellular organismal macromolecule catabolic process,BP,
11703,GO:0044268,1,0.967053391036282,0,5,multicellular organismal protein metabolic process,BP,
11708,GO:0044275,1,0.722880405167957,0,45,cellular carbohydrate catabolic process,BP,
11709,GO:0044279,1,0.978395059956889,0,3,other organism membrane,CC,
11713,GO:0044284,1,0.992170027168696,0,1,mitochondrial crista junction,CC,
11714,GO:0044291,1,0.665906417699266,0,60,cell-cell contact zone,CC,
11715,GO:0044292,1,0.938160600523999,0,9,dendrite terminus,CC,
11716,GO:0044294,1,0.967436423068939,0,5,dendritic growth cone,CC,
11717,GO:0044295,1,0.898398576518011,0,16,axonal growth cone,CC,
11719,GO:0044298,1,0.874081966395453,0,19,cell body membrane,CC,
11720,GO:0044299,1,0.992170027168696,0,1,C-fiber,CC,
11721,GO:0044300,1,0.966755532611789,0,5,cerebellar mossy fiber,CC,
11722,GO:0044301,1,0.98601927216493,0,2,climbing fiber,CC,
11723,GO:0044302,1,0.985754104588,0,2,dentate gyrus mossy fiber,CC,
11724,GO:0044304,1,0.658857211103681,0,61,main axon,CC,
11725,GO:0044305,1,0.975140343297693,0,4,calyx of Held,CC,
11727,GO:0044307,1,0.993986332295065,0,1,dendritic branch,CC,
11728,GO:0044308,1,0.981955057822179,0,3,axonal spine,CC,
11729,GO:0044309,1,0.431397735009018,0,122,neuron spine,CC,
11730,GO:0044313,1,0.98138551881891,0,3,protein K6-linked deubiquitination,BP,
11731,GO:0044314,1,0.969808543137613,0,4,protein K27-linked ubiquitination,BP,
11732,GO:0044316,1,0.985618829136874,0,2,cone cell pedicle,CC,
11733,GO:0044317,1,0.992170027168696,0,1,rod spherule,CC,
11734,GO:0044319,1,0.832599878612535,0,26,wound healing, spreading of cells,BP,
11735,GO:0044320,1,0.890003273958123,0,16,cellular response to leptin stimulus,BP,
11737,GO:0044322,1,0.838932530650048,0,25,endoplasmic reticulum quality control compartment,CC,
11738,GO:0044323,1,0.973785525906477,0,4,retinoic acid-responsive element binding,MF,
11739,GO:0044324,1,0.984400887813367,0,2,regulation of transcription involved in anterior/posterior axis specification,BP,
11741,GO:0044326,1,0.979421942286242,0,3,dendritic spine neck,CC,
11742,GO:0044327,1,0.960064114718366,0,6,dendritic spine head,CC,
11743,GO:0044331,1,0.896020524319203,0,15,cell-cell adhesion mediated by cadherin,BP,
11744,GO:0044332,1,0.956672598186549,0,7,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11745,GO:0044333,1,0.992171950877309,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11746,GO:0044334,1,0.986522382626537,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11747,GO:0044335,1,0.986203080792675,0,2,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11748,GO:0044336,1,0.977801908285121,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11749,GO:0044337,1,0.9939863322711,0,1,canonical Wnt signaling pathway involved in positive regulation of apoptotic process,BP,
11750,GO:0044338,1,0.985954448274381,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11751,GO:0044339,1,0.973995571518169,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11752,GO:0044340,1,0.958755660927448,0,6,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11753,GO:0044341,1,0.936797126042965,0,9,sodium-dependent phosphate transport,BP,
11754,GO:0044342,1,0.88325773117366,0,17,type B pancreatic cell proliferation,BP,
11755,GO:0044343,1,0.986355115121337,0,2,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11757,GO:0044345,1,0.993792360530137,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11758,GO:0044346,1,0.884099294767959,0,18,fibroblast apoptotic process,BP,
11759,GO:0044349,1,0.992170094332629,0,1,DNA excision,BP,
11761,GO:0044352,1,0.973448779249649,0,4,pinosome,CC,
11762,GO:0044354,1,0.973448779249649,0,4,macropinosome,CC,
11763,GO:0044355,1,0.992170027168696,0,1,clearance of foreign intracellular DNA,BP,
11764,GO:0044356,1,0.992170027168696,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11765,GO:0044359,1,0.948386543547843,0,7,modulation of molecular function in other organism,BP,
11766,GO:0044362,1,0.948386543547843,0,7,negative regulation of molecular function in other organism,BP,
11767,GO:0044364,1,0.79422114151023,0,30,disruption of cells of other organism,BP,
11768,GO:0044374,1,0.993279204091541,0,1,sequence-specific DNA binding, bending,MF,
11769,GO:0044375,1,0.976692112990833,0,3,regulation of peroxisome size,BP,
11770,GO:0044376,1,0.976692199772086,0,3,RNA polymerase II complex import to nucleus,BP,
11771,GO:0044377,1,0.993279204091541,0,1,RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending,MF,
11772,GO:0044378,1,0.986203080774048,0,2,non-sequence-specific DNA binding, bending,MF,
11773,GO:0044380,1,0.781104284663556,0,36,protein localization to cytoskeleton,BP,
11775,GO:0044387,1,0.945301655906673,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11776,GO:0044388,1,0.961713458614416,0,5,small protein activating enzyme binding,MF,
11777,GO:0044389,1,0.121715038334494,0,291,ubiquitin-like protein ligase binding,MF,
11778,GO:0044390,1,0.766152883099675,0,38,ubiquitin-like protein conjugating enzyme binding,MF,
11780,GO:0044393,1,0.978634132266394,0,3,microspike,CC,
11781,GO:0044395,1,0.992309623317894,0,1,protein targeting to vacuolar membrane,BP,
11783,GO:0044406,1,0.922180601091455,0,11,adhesion of symbiont to host,BP,
11784,GO:0044407,1,0.984586107212501,0,2,single-species biofilm formation in or on host organism,BP,
11785,GO:0044409,1,0.412930074529528,0,124,entry into host,BP,
11786,GO:0044413,1,0.978700834681886,0,3,avoidance of host defenses,BP,
11787,GO:0044415,1,0.978700834681886,0,3,evasion or tolerance of host defenses,BP,
11788,GO:0044416,1,0.984428143151737,0,2,induction by symbiont of host defense response,BP,
11789,GO:0044417,1,0.992244049183172,0,1,translocation of molecules into host,BP,
11794,GO:0044423,1,0.969530212283475,0,4,virion part,CC,
11797,GO:0044427,1,0.00285480055145593,0,793,chromosomal part,CC,
11808,GO:0044441,1,0.0725396731896133,0,364,ciliary part,CC,
11812,GO:0044447,1,0.861968055359717,0,22,axoneme part,CC,
11813,GO:0044448,1,0.43805528988004,0,119,cell cortex part,CC,
11815,GO:0044450,1,0.354539283637757,0,147,microtubule organizing center part,CC,
11818,GO:0044453,1,0.8958846988806,0,15,nuclear membrane part,CC,
11819,GO:0044454,1,0.0302524717708695,0,476,nuclear chromosome part,CC,
11822,GO:0044458,1,0.862125311120348,0,20,motile cilium assembly,BP,
11826,GO:0044467,1,0.984767969296836,0,2,glial cell-derived neurotrophic factor secretion,BP,
11827,GO:0044501,1,0.99282902982915,0,1,modulation of signal transduction in other organism,BP,
11828,GO:0044524,1,0.992170154337142,0,1,protein sulfhydration,BP,
11829,GO:0044530,1,0.980276536083417,0,3,supraspliceosomal complex,CC,
11830,GO:0044531,1,0.964872565974683,0,5,modulation of programmed cell death in other organism,BP,
11831,GO:0044532,1,0.964872565974683,0,5,modulation of apoptotic process in other organism,BP,
11832,GO:0044533,1,0.986147023030262,0,2,positive regulation of apoptotic process in other organism,BP,
11833,GO:0044537,1,0.992170392587755,0,1,regulation of circulating fibrinogen levels,BP,
11835,GO:0044540,1,0.992170154337142,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11836,GO:0044546,1,0.926008602175039,0,11,NLRP3 inflammasome complex assembly,BP,
11837,GO:0044547,1,0.964791849809123,0,5,DNA topoisomerase binding,MF,
11839,GO:0044549,1,0.992170027168696,0,1,GTP cyclohydrolase binding,MF,
11841,GO:0044557,1,0.945427710247651,0,8,relaxation of smooth muscle,BP,
11842,GO:0044558,1,0.99394556584038,0,1,uterine smooth muscle relaxation,BP,
11843,GO:0044565,1,0.984798636638972,0,2,dendritic cell proliferation,BP,
11844,GO:0044571,1,0.969105649416295,0,4,[2Fe-2S] cluster assembly,BP,
11845,GO:0044594,1,0.992356815019901,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11846,GO:0044595,1,0.992170027168696,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11847,GO:0044596,1,0.992170027168696,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11848,GO:0044597,1,0.939826071125684,0,8,daunorubicin metabolic process,BP,
11849,GO:0044598,1,0.939826071125684,0,8,doxorubicin metabolic process,BP,
11850,GO:0044599,1,0.992294630214608,0,1,AP-5 adaptor complex,CC,
11851,GO:0044609,1,0.99218883215118,0,1,DBIRD complex,CC,
11852,GO:0044610,1,0.992208292351586,0,1,FMN transmembrane transporter activity,MF,
11853,GO:0044611,1,0.981799309705128,0,3,nuclear pore inner ring,CC,
11854,GO:0044613,1,0.956399764752994,0,6,nuclear pore central transport channel,CC,
11855,GO:0044614,1,0.973253379998602,0,4,nuclear pore cytoplasmic filaments,CC,
11856,GO:0044615,1,0.962674825322981,0,6,nuclear pore nuclear basket,CC,
11857,GO:0044620,1,0.992170027168696,0,1,ACP phosphopantetheine attachment site binding,MF,
11858,GO:0044650,1,0.943845743928433,0,8,adhesion of symbiont to host cell,BP,
11859,GO:0044665,1,0.822027327657575,0,27,MLL1/2 complex,CC,
11860,GO:0044666,1,0.951018495132837,0,7,MLL3/4 complex,CC,
11861,GO:0044691,1,0.98159478839826,0,3,tooth eruption,BP,
11866,GO:0044704,1,0.992207639364056,0,1,single-organism reproductive behavior,BP,
11873,GO:0044713,1,0.992170027168696,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11874,GO:0044714,1,0.992170027168696,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11875,GO:0044715,1,0.984400887813367,0,2,8-oxo-dGDP phosphatase activity,MF,
11876,GO:0044716,1,0.992170027168696,0,1,8-oxo-GDP phosphatase activity,MF,
11877,GO:0044717,1,0.992170027168696,0,1,8-hydroxy-dADP phosphatase activity,MF,
11878,GO:0044721,1,0.992173494680933,0,1,protein import into peroxisome matrix, substrate release,BP,
11879,GO:0044722,1,0.993411145903599,0,1,renal phosphate excretion,BP,
11882,GO:0044725,1,0.986203080796437,0,2,chromatin reprogramming in the zygote,BP,
11883,GO:0044726,1,0.992170027168696,0,1,protection of DNA demethylation of female pronucleus,BP,
11884,GO:0044727,1,0.993986332288907,0,1,DNA demethylation of male pronucleus,BP,
11885,GO:0044728,1,0.590244423651981,0,74,DNA methylation or demethylation,BP,
11886,GO:0044729,1,0.978921909496703,0,3,hemi-methylated DNA-binding,MF,
11887,GO:0044736,1,0.969530212283475,0,4,acid-sensing ion channel activity,MF,
11888,GO:0044743,1,0.729591764191118,0,42,protein transmembrane import into intracellular organelle,BP,
11890,GO:0044745,1,0.993986332273392,0,1,amino acid transmembrane import,BP,
11891,GO:0044752,1,0.978291248625925,0,3,response to human chorionic gonadotropin,BP,
11892,GO:0044753,1,0.986526211358517,0,2,amphisome,CC,
11893,GO:0044754,1,0.936481800012621,0,9,autolysosome,CC,
11897,GO:0044766,1,0.601307650149498,0,71,multi-organism transport,BP,
11899,GO:0044769,1,0.790530816365301,0,31,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11901,GO:0044771,1,0.962372999028469,0,5,meiotic cell cycle phase transition,BP,
11903,GO:0044773,1,0.503435087945752,0,94,mitotic DNA damage checkpoint,BP,
11904,GO:0044774,1,0.479081828494783,0,101,mitotic DNA integrity checkpoint,BP,
11905,GO:0044778,1,0.969170937754157,0,4,meiotic DNA integrity checkpoint,BP,
11906,GO:0044779,1,0.992599282199603,0,1,meiotic spindle checkpoint,BP,
11907,GO:0044782,1,0.110081418608262,0,309,cilium organization,BP,
11908,GO:0044783,1,0.604285753898111,0,69,G1 DNA damage checkpoint,BP,
11909,GO:0044784,1,0.711673037974391,0,47,metaphase/anaphase transition of cell cycle,BP,
11910,GO:0044785,1,0.984826807645473,0,2,metaphase/anaphase transition of meiotic cell cycle,BP,
11911,GO:0044786,1,0.77594448275608,0,36,cell cycle DNA replication,BP,
11912,GO:0044788,1,0.867491506588564,0,20,modulation by host of viral process,BP,
11913,GO:0044789,1,0.967092034469707,0,5,modulation by host of viral release from host cell,BP,
11914,GO:0044791,1,0.967092034469707,0,5,positive regulation by host of viral release from host cell,BP,
11915,GO:0044793,1,0.950212460466636,0,7,negative regulation by host of viral process,BP,
11916,GO:0044794,1,0.913194483561429,0,13,positive regulation by host of viral process,BP,
11917,GO:0044795,1,0.992170027168696,0,1,trans-Golgi network to recycling endosome transport,BP,
11918,GO:0044796,1,0.992170027168696,0,1,DNA polymerase processivity factor complex,CC,
11919,GO:0044798,1,0.358611381227631,0,140,nuclear transcription factor complex,CC,
11920,GO:0044800,1,0.955448310982265,0,6,multi-organism membrane fusion,BP,
11923,GO:0044803,1,0.792195282558355,0,31,multi-organism membrane organization,BP,
11924,GO:0044804,1,0.911196797823352,0,13,nucleophagy,BP,
11925,GO:0044805,1,0.987181858591688,0,2,late nucleophagy,BP,
11926,GO:0044806,1,0.961271999885372,0,6,G-quadruplex DNA unwinding,BP,
11927,GO:0044815,1,0.436338277332585,0,108,DNA packaging complex,CC,
11928,GO:0044818,1,0.85445671982445,0,22,mitotic G2/M transition checkpoint,BP,
11929,GO:0044819,1,0.608578446679809,0,68,mitotic G1/S transition checkpoint,BP,
11930,GO:0044821,1,0.964957837326701,0,5,meiotic telomere tethering at nuclear periphery,BP,
11931,GO:0044827,1,0.927343813641916,0,11,modulation by host of viral genome replication,BP,
11932,GO:0044828,1,0.972828835204718,0,4,negative regulation by host of viral genome replication,BP,
11933,GO:0044829,1,0.95348039983614,0,7,positive regulation by host of viral genome replication,BP,
11934,GO:0044830,1,0.993750815841981,0,1,modulation by host of viral RNA genome replication,BP,
11935,GO:0044837,1,0.98002181846238,0,3,actomyosin contractile ring organization,BP,
11937,GO:0044843,1,0.164310818836597,0,249,cell cycle G1/S phase transition,BP,
11938,GO:0044848,1,0.92719143345756,0,11,biological phase,BP,
11939,GO:0044849,1,0.898165914297585,0,15,estrous cycle,BP,
11940,GO:0044851,1,0.940038049485288,0,9,hair cycle phase,BP,
11941,GO:0044853,1,0.569742482231645,0,82,plasma membrane raft,CC,
11942,GO:0044854,1,0.96220957040662,0,5,plasma membrane raft assembly,BP,
11943,GO:0044855,1,0.992381890622049,0,1,plasma membrane raft distribution,BP,
11944,GO:0044856,1,0.992381890622049,0,1,plasma membrane raft localization,BP,
11945,GO:0044857,1,0.96220957040662,0,5,plasma membrane raft organization,BP,
11946,GO:0044858,1,0.992381890622049,0,1,plasma membrane raft polarization,BP,
11947,GO:0044860,1,0.971147862054083,0,4,protein localization to plasma membrane raft,BP,
11948,GO:0044861,1,0.986205005732838,0,2,protein transport into plasma membrane raft,BP,
11949,GO:0044866,1,0.984404598064473,0,2,modulation by host of viral exo-alpha-sialidase activity,BP,
11950,GO:0044867,1,0.984404598064473,0,2,modulation by host of viral catalytic activity,BP,
11951,GO:0044868,1,0.9784839907163,0,3,modulation by host of viral molecular function,BP,
11952,GO:0044869,1,0.984404598064473,0,2,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11953,GO:0044870,1,0.984404598064473,0,2,modulation by host of viral glycoprotein metabolic process,BP,
11954,GO:0044871,1,0.984404598064473,0,2,negative regulation by host of viral glycoprotein metabolic process,BP,
11955,GO:0044872,1,0.909691760868124,0,14,lipoprotein localization,BP,
11957,GO:0045002,1,0.948177799329401,0,7,double-strand break repair via single-strand annealing,BP,
11958,GO:0045003,1,0.925647839634912,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11959,GO:0045004,1,0.987045936700211,0,2,DNA replication proofreading,BP,
11960,GO:0045005,1,0.819048777022409,0,28,DNA-dependent DNA replication maintenance of fidelity,BP,
11961,GO:0045006,1,0.924682257271091,0,10,DNA deamination,BP,
11962,GO:0045007,1,0.976696181738232,0,3,depurination,BP,
11963,GO:0045008,1,0.939752491542053,0,8,depyrimidination,BP,
11965,GO:0045010,1,0.737522554499051,0,42,actin nucleation,BP,
11966,GO:0045013,1,0.984528157154688,0,2,carbon catabolite repression of transcription,BP,
11967,GO:0045014,1,0.984528157154688,0,2,negative regulation of transcription by glucose,BP,
11968,GO:0045016,1,0.992896341056858,0,1,mitochondrial magnesium ion transport,BP,
11971,GO:0045022,1,0.787789708523098,0,34,early endosome to late endosome transport,BP,
11972,GO:0045023,1,0.930257920269427,0,10,G0 to G1 transition,BP,
11973,GO:0045025,1,0.986158820954326,0,2,mitochondrial degradosome,CC,
11974,GO:0045026,1,0.787769714957865,0,32,plasma membrane fusion,BP,
11975,GO:0045027,1,0.992185031705443,0,1,DNA end binding,MF,
11978,GO:0045030,1,0.992170027168696,0,1,UTP-activated nucleotide receptor activity,MF,
11979,GO:0045031,1,0.984893848065534,0,2,ATP-activated adenosine receptor activity,MF,
11980,GO:0045032,1,0.992661481674899,0,1,ADP-activated adenosine receptor activity,MF,
11981,GO:0045039,1,0.961458207931585,0,5,protein import into mitochondrial inner membrane,BP,
11982,GO:0045040,1,0.955642515017794,0,6,protein import into mitochondrial outer membrane,BP,
11983,GO:0045041,1,0.984449164515467,0,2,protein import into mitochondrial intermembrane space,BP,
11984,GO:0045046,1,0.957486535318887,0,6,protein import into peroxisome membrane,BP,
11985,GO:0045047,1,0.459839046603655,0,100,protein targeting to ER,BP,
11986,GO:0045048,1,0.963393331003718,0,5,protein insertion into ER membrane,BP,
11987,GO:0045053,1,0.98638029728888,0,2,protein retention in Golgi apparatus,BP,
11988,GO:0045054,1,0.97048914120244,0,4,constitutive secretory pathway,BP,
11990,GO:0045056,1,0.917691412603988,0,12,transcytosis,BP,
11991,GO:0045058,1,0.719087493201554,0,46,T cell selection,BP,
11992,GO:0045059,1,0.930025684285603,0,10,positive thymic T cell selection,BP,
11993,GO:0045060,1,0.916792372557975,0,12,negative thymic T cell selection,BP,
11994,GO:0045061,1,0.861077591359454,0,21,thymic T cell selection,BP,
11995,GO:0045062,1,0.992170056200193,0,1,extrathymic T cell selection,BP,
11996,GO:0045063,1,0.883149467424026,0,17,T-helper 1 cell differentiation,BP,
11997,GO:0045064,1,0.887495445007872,0,16,T-helper 2 cell differentiation,BP,
11998,GO:0045065,1,0.977958252918085,0,3,cytotoxic T cell differentiation,BP,
11999,GO:0045066,1,0.854705319402777,0,21,regulatory T cell differentiation,BP,
12001,GO:0045070,1,0.801402787631976,0,32,positive regulation of viral genome replication,BP,
12003,GO:0045072,1,0.888513947826923,0,16,regulation of interferon-gamma biosynthetic process,BP,
12005,GO:0045074,1,0.979457529816812,0,3,regulation of interleukin-10 biosynthetic process,BP,
12006,GO:0045075,1,0.944955886147326,0,8,regulation of interleukin-12 biosynthetic process,BP,
12007,GO:0045076,1,0.87534064406044,0,18,regulation of interleukin-2 biosynthetic process,BP,
12008,GO:0045077,1,0.969407013554195,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
12009,GO:0045078,1,0.916573460608905,0,12,positive regulation of interferon-gamma biosynthetic process,BP,
12010,GO:0045079,1,0.976692114695185,0,3,negative regulation of chemokine biosynthetic process,BP,
12012,GO:0045081,1,0.993168789111512,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
12013,GO:0045082,1,0.986195166462708,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
12014,GO:0045083,1,0.993589101329333,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
12015,GO:0045084,1,0.956811324987936,0,6,positive regulation of interleukin-12 biosynthetic process,BP,
12016,GO:0045085,1,0.969101491567235,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
12017,GO:0045086,1,0.917590243374562,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
12021,GO:0045091,1,0.942250495471044,0,8,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12022,GO:0045092,1,0.993154409191705,0,1,interleukin-18 receptor complex,CC,
12023,GO:0045095,1,0.489112577229395,0,92,keratin filament,CC,
12024,GO:0045098,1,0.984474483768742,0,2,type III intermediate filament,CC,
12025,GO:0045103,1,0.731254527060749,0,44,intermediate filament-based process,BP,
12026,GO:0045104,1,0.736420058429118,0,43,intermediate filament cytoskeleton organization,BP,
12027,GO:0045105,1,0.987162447766191,0,2,intermediate filament polymerization or depolymerization,BP,
12028,GO:0045106,1,0.993984990010366,0,1,intermediate filament depolymerization,BP,
12029,GO:0045108,1,0.993984990010366,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
12030,GO:0045109,1,0.854685426475431,0,22,intermediate filament organization,BP,
12031,GO:0045110,1,0.959484561456211,0,6,intermediate filament bundle assembly,BP,
12033,GO:0045112,1,0.95791194808528,0,6,integrin biosynthetic process,BP,
12034,GO:0045113,1,0.963709044155459,0,5,regulation of integrin biosynthetic process,BP,
12035,GO:0045116,1,0.892851429196571,0,15,protein neddylation,BP,
12036,GO:0045117,1,0.873346812184101,0,18,azole transport,BP,
12037,GO:0045118,1,0.956324321983974,0,6,azole transporter activity,MF,
12038,GO:0045120,1,0.902972161616567,0,14,pronucleus,CC,
12042,GO:0045125,1,0.892412616880807,0,15,bioactive lipid receptor activity,MF,
12043,GO:0045127,1,0.992170027168696,0,1,N-acetylglucosamine kinase activity,MF,
12044,GO:0045130,1,0.992371209904898,0,1,keratan sulfotransferase activity,MF,
12045,GO:0045131,1,0.992558443889819,0,1,pre-mRNA branch point binding,MF,
12046,GO:0045132,1,0.602197091193327,0,70,meiotic chromosome segregation,BP,
12047,GO:0045134,1,0.970440889249544,0,4,uridine-diphosphatase activity,MF,
12048,GO:0045136,1,0.938329120330713,0,9,development of secondary sexual characteristics,BP,
12050,GO:0045141,1,0.92399823283237,0,11,meiotic telomere clustering,BP,
12051,GO:0045142,1,0.993469043251271,0,1,triplex DNA binding,MF,
12052,GO:0045143,1,0.70291677119798,0,48,homologous chromosome segregation,BP,
12053,GO:0045144,1,0.948457967300924,0,7,meiotic sister chromatid segregation,BP,
12054,GO:0045145,1,0.985103567404579,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
12055,GO:0045153,1,0.992170027168696,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
12056,GO:0045155,1,0.986200786547477,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
12057,GO:0045159,1,0.963448113943508,0,5,myosin II binding,MF,
12058,GO:0045160,1,0.993894211634606,0,1,myosin I complex,CC,
12059,GO:0045161,1,0.922182064709762,0,12,neuronal ion channel clustering,BP,
12060,GO:0045162,1,0.9555731639929,0,7,clustering of voltage-gated sodium channels,BP,
12061,GO:0045163,1,0.980345314571672,0,3,clustering of voltage-gated potassium channels,BP,
12062,GO:0045165,1,0.173869434366243,0,240,cell fate commitment,BP,
12063,GO:0045168,1,0.98508900828049,0,2,cell-cell signaling involved in cell fate commitment,BP,
12064,GO:0045171,1,0.73180269295755,0,43,intercellular bridge,CC,
12065,GO:0045174,1,0.984400887813367,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12066,GO:0045176,1,0.930349201328632,0,11,apical protein localization,BP,
12067,GO:0045177,1,0.0909149975817743,0,339,apical part of cell,CC,
12068,GO:0045178,1,0.721993083482131,0,47,basal part of cell,CC,
12069,GO:0045179,1,0.950817943917181,0,7,apical cortex,CC,
12070,GO:0045180,1,0.970253513435709,0,5,basal cortex,CC,
12071,GO:0045182,1,0.773357053735574,0,37,translation regulator activity,MF,
12073,GO:0045185,1,0.513319261092497,0,93,maintenance of protein location,BP,
12074,GO:0045186,1,0.993986332273076,0,1,zonula adherens assembly,BP,
12075,GO:0045187,1,0.858961510297296,0,20,regulation of circadian sleep/wake cycle, sleep,BP,
12076,GO:0045188,1,0.941988318907863,0,8,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12077,GO:0045189,1,0.992170027168696,0,1,connective tissue growth factor biosynthetic process,BP,
12078,GO:0045190,1,0.748671812388992,0,40,isotype switching,BP,
12079,GO:0045191,1,0.815457493947746,0,28,regulation of isotype switching,BP,
12080,GO:0045196,1,0.979654699353574,0,3,establishment or maintenance of neuroblast polarity,BP,
12081,GO:0045197,1,0.81142718789776,0,30,establishment or maintenance of epithelial cell apical/basal polarity,BP,
12082,GO:0045198,1,0.951067235758928,0,7,establishment of epithelial cell apical/basal polarity,BP,
12083,GO:0045199,1,0.917636652331904,0,12,maintenance of epithelial cell apical/basal polarity,BP,
12084,GO:0045200,1,0.979654699353574,0,3,establishment of neuroblast polarity,BP,
12086,GO:0045204,1,0.981044731445839,0,3,MAPK export from nucleus,BP,
12087,GO:0045208,1,0.993118517776141,0,1,MAPK phosphatase export from nucleus,BP,
12088,GO:0045209,1,0.993118517776141,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
12089,GO:0045210,1,0.988004844561871,0,2,FasL biosynthetic process,BP,
12091,GO:0045212,1,0.992302843322646,0,1,neurotransmitter receptor biosynthetic process,BP,
12092,GO:0045213,1,0.976886303921143,0,3,neurotransmitter receptor metabolic process,BP,
12093,GO:0045214,1,0.741648740288649,0,43,sarcomere organization,BP,
12095,GO:0045217,1,0.959377132015209,0,6,cell-cell junction maintenance,BP,
12096,GO:0045218,1,0.979274148404264,0,3,zonula adherens maintenance,BP,
12097,GO:0045219,1,0.993982607136211,0,1,regulation of FasL biosynthetic process,BP,
12098,GO:0045221,1,0.993982607136211,0,1,negative regulation of FasL biosynthetic process,BP,
12099,GO:0045222,1,0.992170027168696,0,1,CD4 biosynthetic process,BP,
12100,GO:0045223,1,0.992170027168696,0,1,regulation of CD4 biosynthetic process,BP,
12101,GO:0045225,1,0.992170027168696,0,1,negative regulation of CD4 biosynthetic process,BP,
12102,GO:0045226,1,0.977531163012665,0,3,extracellular polysaccharide biosynthetic process,BP,
12103,GO:0045229,1,0.978899838208274,0,3,external encapsulating structure organization,BP,
12104,GO:0045234,1,0.9921704185151,0,1,protein palmitoleylation,BP,
12105,GO:0045236,1,0.891004939056867,0,15,CXCR chemokine receptor binding,MF,
12106,GO:0045239,1,0.916986637284506,0,12,tricarboxylic acid cycle enzyme complex,CC,
12107,GO:0045240,1,0.931470696209718,0,10,dihydrolipoyl dehydrogenase complex,CC,
12108,GO:0045244,1,0.992228033436212,0,1,succinate-CoA ligase complex (GDP-forming),CC,
12110,GO:0045252,1,0.959307906449864,0,6,oxoglutarate dehydrogenase complex,CC,
12111,GO:0045254,1,0.943959142219652,0,8,pyruvate dehydrogenase complex,CC,
12112,GO:0045257,1,0.969308062819154,0,4,succinate dehydrogenase complex (ubiquinone),CC,
12113,GO:0045259,1,0.847938326819369,0,21,proton-transporting ATP synthase complex,CC,
12114,GO:0045261,1,0.961458211932549,0,5,proton-transporting ATP synthase complex, catalytic core F(1),CC,
12115,GO:0045263,1,0.917322373757708,0,11,proton-transporting ATP synthase complex, coupling factor F(o),CC,
12116,GO:0045265,1,0.992170027168696,0,1,proton-transporting ATP synthase, stator stalk,CC,
12117,GO:0045267,1,0.992171224704221,0,1,proton-transporting ATP synthase, catalytic core,CC,
12118,GO:0045271,1,0.720860353684577,0,42,respiratory chain complex I,CC,
12119,GO:0045273,1,0.969308062819154,0,4,respiratory chain complex II,CC,
12120,GO:0045275,1,0.919808018645563,0,11,respiratory chain complex III,CC,
12121,GO:0045277,1,0.895749067539937,0,14,respiratory chain complex IV,CC,
12122,GO:0045281,1,0.969308062819154,0,4,succinate dehydrogenase complex,CC,
12123,GO:0045283,1,0.969308062819154,0,4,fumarate reductase complex,CC,
12124,GO:0045292,1,0.881071506179169,0,17,mRNA cis splicing, via spliceosome,BP,
12125,GO:0045293,1,0.970734546206334,0,4,mRNA editing complex,CC,
12126,GO:0045294,1,0.933456257092833,0,10,alpha-catenin binding,MF,
12127,GO:0045295,1,0.939178709201398,0,10,gamma-catenin binding,MF,
12129,GO:0045297,1,0.992207639364056,0,1,post-mating behavior,BP,
12130,GO:0045298,1,0.979289249950958,0,3,tubulin complex,CC,
12131,GO:0045299,1,0.993986332279765,0,1,otolith mineralization,BP,
12132,GO:0045309,1,0.736470356982518,0,44,protein phosphorylated amino acid binding,MF,
12134,GO:0045322,1,0.992546169229192,0,1,unmethylated CpG binding,MF,
12135,GO:0045323,1,0.978518882395879,0,3,interleukin-1 receptor complex,CC,
12136,GO:0045324,1,0.899442141908392,0,15,late endosome to vacuole transport,BP,
12137,GO:0045329,1,0.962067874959945,0,5,carnitine biosynthetic process,BP,
12138,GO:0045332,1,0.871407856804111,0,22,phospholipid translocation,BP,
12140,GO:0045334,1,0.62402108265667,0,65,clathrin-coated endocytic vesicle,CC,
12141,GO:0045335,1,0.479049184620669,0,102,phagocytic vesicle,CC,
12142,GO:0045337,1,0.98465819747764,0,2,farnesyl diphosphate biosynthetic process,BP,
12143,GO:0045338,1,0.97696290324032,0,3,farnesyl diphosphate metabolic process,BP,
12144,GO:0045340,1,0.992170027168696,0,1,mercury ion binding,MF,
12145,GO:0045341,1,0.951865542708274,0,7,MHC class I biosynthetic process,BP,
12146,GO:0045342,1,0.910780222574347,0,13,MHC class II biosynthetic process,BP,
12147,GO:0045343,1,0.951865542708274,0,7,regulation of MHC class I biosynthetic process,BP,
12148,GO:0045345,1,0.959379885533008,0,6,positive regulation of MHC class I biosynthetic process,BP,
12149,GO:0045346,1,0.916837322720547,0,12,regulation of MHC class II biosynthetic process,BP,
12150,GO:0045347,1,0.964122687560181,0,5,negative regulation of MHC class II biosynthetic process,BP,
12151,GO:0045348,1,0.943519713396505,0,8,positive regulation of MHC class II biosynthetic process,BP,
12155,GO:0045352,1,0.992170384206922,0,1,interleukin-1 Type I receptor antagonist activity,MF,
12156,GO:0045353,1,0.992170384206922,0,1,interleukin-1 Type II receptor antagonist activity,MF,
12159,GO:0045356,1,0.973867483979746,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
12163,GO:0045360,1,0.977203811458043,0,3,regulation of interleukin-1 biosynthetic process,BP,
12164,GO:0045362,1,0.977203811458043,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
12165,GO:0045366,1,0.993976720015267,0,1,regulation of interleukin-13 biosynthetic process,BP,
12166,GO:0045368,1,0.993976720015267,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
12167,GO:0045381,1,0.992790041625879,0,1,regulation of interleukin-18 biosynthetic process,BP,
12168,GO:0045399,1,0.986166089449839,0,2,regulation of interleukin-3 biosynthetic process,BP,
12169,GO:0045401,1,0.986166089449839,0,2,positive regulation of interleukin-3 biosynthetic process,BP,
12170,GO:0045402,1,0.979285805358183,0,3,regulation of interleukin-4 biosynthetic process,BP,
12171,GO:0045403,1,0.992795855711929,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12172,GO:0045404,1,0.986392678669206,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12173,GO:0045405,1,0.992170027168696,0,1,regulation of interleukin-5 biosynthetic process,BP,
12174,GO:0045407,1,0.992170027168696,0,1,positive regulation of interleukin-5 biosynthetic process,BP,
12175,GO:0045408,1,0.888792898238688,0,16,regulation of interleukin-6 biosynthetic process,BP,
12176,GO:0045409,1,0.963902299138577,0,5,negative regulation of interleukin-6 biosynthetic process,BP,
12177,GO:0045410,1,0.944108057154029,0,8,positive regulation of interleukin-6 biosynthetic process,BP,
12178,GO:0045414,1,0.915452138841157,0,12,regulation of interleukin-8 biosynthetic process,BP,
12179,GO:0045415,1,0.969442215750562,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12180,GO:0045416,1,0.944321221167831,0,8,positive regulation of interleukin-8 biosynthetic process,BP,
12181,GO:0045423,1,0.971001048690844,0,4,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12182,GO:0045425,1,0.978665256927969,0,3,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12186,GO:0045445,1,0.567632709357216,0,79,myoblast differentiation,BP,
12187,GO:0045446,1,0.529966204576132,0,91,endothelial cell differentiation,BP,
12188,GO:0045448,1,0.971205406287007,0,4,mitotic cell cycle, embryonic,BP,
12190,GO:0045454,1,0.601730302433424,0,68,cell redox homeostasis,BP,
12193,GO:0045475,1,0.925671090476901,0,11,locomotor rhythm,BP,
12195,GO:0045494,1,0.789203034988276,0,34,photoreceptor cell maintenance,BP,
12196,GO:0045495,1,0.891770971524324,0,16,pole plasm,CC,
12197,GO:0045499,1,0.94162795925681,0,9,chemorepellent activity,MF,
12198,GO:0045503,1,0.97212207162974,0,4,dynein light chain binding,MF,
12199,GO:0045504,1,0.97082951271864,0,4,dynein heavy chain binding,MF,
12200,GO:0045505,1,0.94420571272565,0,8,dynein intermediate chain binding,MF,
12201,GO:0045509,1,0.985617705770505,0,2,interleukin-27 receptor activity,MF,
12202,GO:0045513,1,0.992170027168696,0,1,interleukin-27 binding,MF,
12203,GO:0045517,1,0.992170027168696,0,1,interleukin-20 receptor binding,MF,
12204,GO:0045518,1,0.984400887813367,0,2,interleukin-22 receptor binding,MF,
12205,GO:0045519,1,0.984456981790427,0,2,interleukin-23 receptor binding,MF,
12206,GO:0045523,1,0.984400887813367,0,2,interleukin-27 receptor binding,MF,
12208,GO:0045541,1,0.963615440096313,0,5,negative regulation of cholesterol biosynthetic process,BP,
12210,GO:0045545,1,0.95854647396553,0,6,syndecan binding,MF,
12211,GO:0045550,1,0.984400887813367,0,2,geranylgeranyl reductase activity,MF,
12212,GO:0045553,1,0.992594994190453,0,1,TRAIL biosynthetic process,BP,
12213,GO:0045554,1,0.992594994190453,0,1,regulation of TRAIL biosynthetic process,BP,
12214,GO:0045556,1,0.992594994190453,0,1,positive regulation of TRAIL biosynthetic process,BP,
12215,GO:0045569,1,0.971304281944372,0,4,TRAIL binding,MF,
12216,GO:0045575,1,0.984416743556549,0,2,basophil activation,BP,
12217,GO:0045576,1,0.66862377133375,0,55,mast cell activation,BP,
12218,GO:0045577,1,0.84455248761047,0,24,regulation of B cell differentiation,BP,
12219,GO:0045578,1,0.970650744950761,0,4,negative regulation of B cell differentiation,BP,
12220,GO:0045579,1,0.913112495034596,0,13,positive regulation of B cell differentiation,BP,
12222,GO:0045581,1,0.779433691408224,0,34,negative regulation of T cell differentiation,BP,
12224,GO:0045583,1,0.985388450223191,0,2,regulation of cytotoxic T cell differentiation,BP,
12225,GO:0045585,1,0.985388450223191,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12226,GO:0045586,1,0.969044722040737,0,5,regulation of gamma-delta T cell differentiation,BP,
12227,GO:0045588,1,0.981469547813967,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12228,GO:0045589,1,0.868068346552128,0,19,regulation of regulatory T cell differentiation,BP,
12229,GO:0045590,1,0.978477636909985,0,3,negative regulation of regulatory T cell differentiation,BP,
12230,GO:0045591,1,0.911803183442754,0,12,positive regulation of regulatory T cell differentiation,BP,
12234,GO:0045598,1,0.453188350092612,0,110,regulation of fat cell differentiation,BP,
12235,GO:0045599,1,0.741573557275954,0,42,negative regulation of fat cell differentiation,BP,
12236,GO:0045600,1,0.675530824166049,0,54,positive regulation of fat cell differentiation,BP,
12237,GO:0045601,1,0.812550772268379,0,30,regulation of endothelial cell differentiation,BP,
12238,GO:0045602,1,0.956257993267466,0,7,negative regulation of endothelial cell differentiation,BP,
12239,GO:0045603,1,0.892452207066064,0,16,positive regulation of endothelial cell differentiation,BP,
12240,GO:0045604,1,0.704533913440378,0,48,regulation of epidermal cell differentiation,BP,
12241,GO:0045605,1,0.908697460801818,0,13,negative regulation of epidermal cell differentiation,BP,
12242,GO:0045606,1,0.865769971351145,0,20,positive regulation of epidermal cell differentiation,BP,
12243,GO:0045607,1,0.949152781879276,0,7,regulation of auditory receptor cell differentiation,BP,
12244,GO:0045608,1,0.979164316608163,0,3,negative regulation of auditory receptor cell differentiation,BP,
12245,GO:0045609,1,0.992170027168696,0,1,positive regulation of auditory receptor cell differentiation,BP,
12246,GO:0045616,1,0.793771345613198,0,32,regulation of keratinocyte differentiation,BP,
12247,GO:0045617,1,0.94260836587998,0,8,negative regulation of keratinocyte differentiation,BP,
12248,GO:0045618,1,0.90435107254207,0,14,positive regulation of keratinocyte differentiation,BP,
12250,GO:0045620,1,0.733049399939201,0,42,negative regulation of lymphocyte differentiation,BP,
12252,GO:0045622,1,0.800854831039628,0,30,regulation of T-helper cell differentiation,BP,
12253,GO:0045623,1,0.90317181637036,0,14,negative regulation of T-helper cell differentiation,BP,
12254,GO:0045624,1,0.866801568313398,0,19,positive regulation of T-helper cell differentiation,BP,
12255,GO:0045625,1,0.928838691589976,0,10,regulation of T-helper 1 cell differentiation,BP,
12256,GO:0045626,1,0.979400533206319,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12257,GO:0045627,1,0.955869944688354,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12258,GO:0045628,1,0.915440107750749,0,12,regulation of T-helper 2 cell differentiation,BP,
12259,GO:0045629,1,0.971560816622468,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12260,GO:0045630,1,0.942249183307809,0,8,positive regulation of T-helper 2 cell differentiation,BP,
12261,GO:0045631,1,0.949152781879276,0,7,regulation of mechanoreceptor differentiation,BP,
12262,GO:0045632,1,0.971496230396,0,4,negative regulation of mechanoreceptor differentiation,BP,
12263,GO:0045633,1,0.992170027168696,0,1,positive regulation of mechanoreceptor differentiation,BP,
12264,GO:0045634,1,0.954586874335887,0,7,regulation of melanocyte differentiation,BP,
12265,GO:0045636,1,0.96969569460699,0,5,positive regulation of melanocyte differentiation,BP,
12267,GO:0045638,1,0.537021621578026,0,85,negative regulation of myeloid cell differentiation,BP,
12269,GO:0045643,1,0.985401210603884,0,2,regulation of eosinophil differentiation,BP,
12270,GO:0045645,1,0.985401210603884,0,2,positive regulation of eosinophil differentiation,BP,
12271,GO:0045646,1,0.763218922304725,0,38,regulation of erythrocyte differentiation,BP,
12272,GO:0045647,1,0.943855241026922,0,8,negative regulation of erythrocyte differentiation,BP,
12273,GO:0045648,1,0.851944213619262,0,23,positive regulation of erythrocyte differentiation,BP,
12275,GO:0045650,1,0.950296845855168,0,7,negative regulation of macrophage differentiation,BP,
12277,GO:0045652,1,0.806699634638111,0,28,regulation of megakaryocyte differentiation,BP,
12278,GO:0045653,1,0.869569543021872,0,18,negative regulation of megakaryocyte differentiation,BP,
12279,GO:0045654,1,0.948069965806344,0,7,positive regulation of megakaryocyte differentiation,BP,
12280,GO:0045655,1,0.877111149836249,0,18,regulation of monocyte differentiation,BP,
12281,GO:0045656,1,0.95168066199692,0,7,negative regulation of monocyte differentiation,BP,
12282,GO:0045657,1,0.935389513290006,0,9,positive regulation of monocyte differentiation,BP,
12283,GO:0045658,1,0.987135389556874,0,2,regulation of neutrophil differentiation,BP,
12284,GO:0045659,1,0.987135389556874,0,2,negative regulation of neutrophil differentiation,BP,
12285,GO:0045661,1,0.707607419220568,0,48,regulation of myoblast differentiation,BP,
12286,GO:0045662,1,0.856858483633194,0,21,negative regulation of myoblast differentiation,BP,
12287,GO:0045663,1,0.863201412665665,0,21,positive regulation of myoblast differentiation,BP,
12290,GO:0045666,1,0.116740222585945,0,305,positive regulation of neuron differentiation,BP,
12291,GO:0045667,1,0.4679437414536,0,107,regulation of osteoblast differentiation,BP,
12292,GO:0045668,1,0.762179250149403,0,39,negative regulation of osteoblast differentiation,BP,
12293,GO:0045669,1,0.664815862265495,0,57,positive regulation of osteoblast differentiation,BP,
12294,GO:0045670,1,0.631642805281067,0,63,regulation of osteoclast differentiation,BP,
12295,GO:0045671,1,0.838700614059186,0,25,negative regulation of osteoclast differentiation,BP,
12296,GO:0045672,1,0.835352479000726,0,24,positive regulation of osteoclast differentiation,BP,
12298,GO:0045683,1,0.884503262457693,0,17,negative regulation of epidermis development,BP,
12300,GO:0045685,1,0.661087184729491,0,56,regulation of glial cell differentiation,BP,
12301,GO:0045686,1,0.841430406532712,0,23,negative regulation of glial cell differentiation,BP,
12302,GO:0045687,1,0.788992355199333,0,32,positive regulation of glial cell differentiation,BP,
12303,GO:0045703,1,0.992170027168696,0,1,ketoreductase activity,MF,
12304,GO:0045713,1,0.934144591434096,0,10,low-density lipoprotein particle receptor biosynthetic process,BP,
12305,GO:0045714,1,0.941518773868745,0,9,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12306,GO:0045715,1,0.981858771393359,0,3,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12307,GO:0045716,1,0.970891854164809,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12309,GO:0045719,1,0.967197944960915,0,5,negative regulation of glycogen biosynthetic process,BP,
12310,GO:0045720,1,0.984836891986663,0,2,negative regulation of integrin biosynthetic process,BP,
12311,GO:0045721,1,0.909046015797361,0,13,negative regulation of gluconeogenesis,BP,
12312,GO:0045722,1,0.933829622185343,0,10,positive regulation of gluconeogenesis,BP,
12314,GO:0045724,1,0.871096292527179,0,20,positive regulation of cilium assembly,BP,
12315,GO:0045725,1,0.90390288400812,0,15,positive regulation of glycogen biosynthetic process,BP,
12316,GO:0045726,1,0.978982161007135,0,3,positive regulation of integrin biosynthetic process,BP,
12318,GO:0045728,1,0.992191649784728,0,1,respiratory burst after phagocytosis,BP,
12319,GO:0045730,1,0.830817458845749,0,25,respiratory burst,BP,
12321,GO:0045736,1,0.841817806809622,0,24,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12322,GO:0045737,1,0.788852379780713,0,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12323,GO:0045738,1,0.886448299673141,0,17,negative regulation of DNA repair,BP,
12324,GO:0045739,1,0.757868699482195,0,38,positive regulation of DNA repair,BP,
12325,GO:0045740,1,0.675475132195963,0,54,positive regulation of DNA replication,BP,
12326,GO:0045741,1,0.925662528826408,0,11,positive regulation of epidermal growth factor-activated receptor activity,BP,
12328,GO:0045743,1,0.957229728090225,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12330,GO:0045745,1,0.838970991128831,0,24,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
12331,GO:0045746,1,0.821156086266706,0,27,negative regulation of Notch signaling pathway,BP,
12332,GO:0045747,1,0.789661643126434,0,33,positive regulation of Notch signaling pathway,BP,
12333,GO:0045751,1,0.992790041625879,0,1,negative regulation of Toll signaling pathway,BP,
12334,GO:0045759,1,0.950362792622561,0,7,negative regulation of action potential,BP,
12335,GO:0045760,1,0.926781371928665,0,11,positive regulation of action potential,BP,
12336,GO:0045761,1,0.583136300453572,0,74,regulation of adenylate cyclase activity,BP,
12337,GO:0045762,1,0.718065319596522,0,46,positive regulation of adenylate cyclase activity,BP,
12338,GO:0045763,1,0.987972551601471,0,2,negative regulation of cellular amino acid metabolic process,BP,
12339,GO:0045764,1,0.976750674129226,0,3,positive regulation of cellular amino acid metabolic process,BP,
12340,GO:0045765,1,0.228299431812944,0,207,regulation of angiogenesis,BP,
12341,GO:0045766,1,0.428573547103515,0,119,positive regulation of angiogenesis,BP,
12342,GO:0045769,1,0.993986332288584,0,1,negative regulation of asymmetric cell division,BP,
12343,GO:0045773,1,0.765664391493926,0,39,positive regulation of axon extension,BP,
12344,GO:0045776,1,0.727746190043884,0,43,negative regulation of blood pressure,BP,
12345,GO:0045777,1,0.777796134955854,0,34,positive regulation of blood pressure,BP,
12346,GO:0045778,1,0.555186231871047,0,82,positive regulation of ossification,BP,
12347,GO:0045779,1,0.916018465532889,0,12,negative regulation of bone resorption,BP,
12348,GO:0045780,1,0.910089252882159,0,13,positive regulation of bone resorption,BP,
12351,GO:0045787,1,0.0883484167030638,0,334,positive regulation of cell cycle,BP,
12353,GO:0045793,1,0.923857824432111,0,11,positive regulation of cell size,BP,
12354,GO:0045794,1,0.968502967078277,0,5,negative regulation of cell volume,BP,
12355,GO:0045795,1,0.993986332269995,0,1,positive regulation of cell volume,BP,
12356,GO:0045796,1,0.984793258190617,0,2,negative regulation of intestinal cholesterol absorption,BP,
12357,GO:0045799,1,0.980230006884016,0,3,positive regulation of chromatin assembly or disassembly,BP,
12360,GO:0045814,1,0.383255436080165,0,130,negative regulation of gene expression, epigenetic,BP,
12361,GO:0045815,1,0.557564851587829,0,79,positive regulation of gene expression, epigenetic,BP,
12362,GO:0045818,1,0.992170027168696,0,1,negative regulation of glycogen catabolic process,BP,
12363,GO:0045819,1,0.993460737326236,0,1,positive regulation of glycogen catabolic process,BP,
12364,GO:0045820,1,0.925620318925272,0,11,negative regulation of glycolytic process,BP,
12365,GO:0045821,1,0.914157426755671,0,13,positive regulation of glycolytic process,BP,
12366,GO:0045822,1,0.867561933894179,0,20,negative regulation of heart contraction,BP,
12367,GO:0045823,1,0.786512152480926,0,33,positive regulation of heart contraction,BP,
12369,GO:0045827,1,0.992170027168696,0,1,negative regulation of isoprenoid metabolic process,BP,
12370,GO:0045829,1,0.970963158175792,0,4,negative regulation of isotype switching,BP,
12371,GO:0045830,1,0.863525682374851,0,20,positive regulation of isotype switching,BP,
12374,GO:0045835,1,0.921849585763017,0,11,negative regulation of meiotic nuclear division,BP,
12375,GO:0045836,1,0.924002535784458,0,11,positive regulation of meiotic nuclear division,BP,
12376,GO:0045837,1,0.920146340791172,0,11,negative regulation of membrane potential,BP,
12377,GO:0045838,1,0.934923838296872,0,9,positive regulation of membrane potential,BP,
12378,GO:0045839,1,0.742239724601704,0,41,negative regulation of mitotic nuclear division,BP,
12379,GO:0045840,1,0.724601738990182,0,45,positive regulation of mitotic nuclear division,BP,
12380,GO:0045841,1,0.803190541208612,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
12381,GO:0045842,1,0.959697934840971,0,6,positive regulation of mitotic metaphase/anaphase transition,BP,
12383,GO:0045844,1,0.643144681012137,0,63,positive regulation of striated muscle tissue development,BP,
12384,GO:0045848,1,0.992190392480105,0,1,positive regulation of nitrogen utilization,BP,
12385,GO:0045851,1,0.693966273870911,0,49,pH reduction,BP,
12386,GO:0045852,1,0.957409827904871,0,6,pH elevation,BP,
12391,GO:0045869,1,0.947953597602779,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12392,GO:0045870,1,0.993986280667794,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12393,GO:0045872,1,0.98441664648229,0,2,positive regulation of rhodopsin gene expression,BP,
12394,GO:0045875,1,0.982066433205223,0,3,negative regulation of sister chromatid cohesion,BP,
12395,GO:0045876,1,0.950996461990089,0,7,positive regulation of sister chromatid cohesion,BP,
12396,GO:0045879,1,0.842238136120421,0,25,negative regulation of smoothened signaling pathway,BP,
12397,GO:0045880,1,0.832128984431717,0,27,positive regulation of smoothened signaling pathway,BP,
12398,GO:0045887,1,0.993986332272313,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12401,GO:0045896,1,0.981975335650487,0,3,regulation of transcription during mitotic cell cycle,BP,
12402,GO:0045897,1,0.993986206324899,0,1,positive regulation of transcription during mitotic cell cycle,BP,
12403,GO:0045898,1,0.91019172496575,0,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12404,GO:0045899,1,0.929507669792144,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12405,GO:0045900,1,0.972594281362141,0,4,negative regulation of translational elongation,BP,
12406,GO:0045901,1,0.964756567645671,0,5,positive regulation of translational elongation,BP,
12407,GO:0045903,1,0.984409409185832,0,2,positive regulation of translational fidelity,BP,
12408,GO:0045905,1,0.979662444374249,0,3,positive regulation of translational termination,BP,
12409,GO:0045906,1,0.953130064556353,0,7,negative regulation of vasoconstriction,BP,
12410,GO:0045907,1,0.795426019853502,0,31,positive regulation of vasoconstriction,BP,
12411,GO:0045910,1,0.863120273674655,0,21,negative regulation of DNA recombination,BP,
12412,GO:0045911,1,0.845970602212697,0,23,positive regulation of DNA recombination,BP,
12413,GO:0045912,1,0.767356297157791,0,37,negative regulation of carbohydrate metabolic process,BP,
12415,GO:0045914,1,0.984988185416865,0,2,negative regulation of catecholamine metabolic process,BP,
12416,GO:0045915,1,0.956755213145597,0,6,positive regulation of catecholamine metabolic process,BP,
12417,GO:0045916,1,0.945004796366904,0,8,negative regulation of complement activation,BP,
12418,GO:0045917,1,0.979469369389056,0,3,positive regulation of complement activation,BP,
12419,GO:0045918,1,0.970436591040982,0,4,negative regulation of cytolysis,BP,
12420,GO:0045919,1,0.962296490165935,0,5,positive regulation of cytolysis,BP,
12421,GO:0045920,1,0.817445718201461,0,28,negative regulation of exocytosis,BP,
12422,GO:0045921,1,0.57596584857446,0,77,positive regulation of exocytosis,BP,
12425,GO:0045924,1,0.94399125839795,0,8,regulation of female receptivity,BP,
12426,GO:0045925,1,0.978554757292073,0,3,positive regulation of female receptivity,BP,
12430,GO:0045931,1,0.408603092221444,0,126,positive regulation of mitotic cell cycle,BP,
12431,GO:0045932,1,0.868703456140143,0,20,negative regulation of muscle contraction,BP,
12432,GO:0045933,1,0.754590719446813,0,39,positive regulation of muscle contraction,BP,
12437,GO:0045938,1,0.947527065295248,0,7,positive regulation of circadian sleep/wake cycle, sleep,BP,
12438,GO:0045939,1,0.842221284750748,0,23,negative regulation of steroid metabolic process,BP,
12440,GO:0045943,1,0.864654110663372,0,21,positive regulation of transcription from RNA polymerase I promoter,BP,
12442,GO:0045945,1,0.941226340081243,0,9,positive regulation of transcription from RNA polymerase III promoter,BP,
12443,GO:0045947,1,0.860996263976864,0,21,negative regulation of translational initiation,BP,
12444,GO:0045948,1,0.846692989130035,0,23,positive regulation of translational initiation,BP,
12445,GO:0045950,1,0.970069313733539,0,4,negative regulation of mitotic recombination,BP,
12446,GO:0045953,1,0.926898781902237,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12447,GO:0045954,1,0.876702465940007,0,18,positive regulation of natural killer cell mediated cytotoxicity,BP,
12448,GO:0045955,1,0.933049863434015,0,10,negative regulation of calcium ion-dependent exocytosis,BP,
12449,GO:0045956,1,0.865662487300722,0,21,positive regulation of calcium ion-dependent exocytosis,BP,
12450,GO:0045957,1,0.993986332281662,0,1,negative regulation of complement activation, alternative pathway,BP,
12451,GO:0045959,1,0.97851377419517,0,3,negative regulation of complement activation, classical pathway,BP,
12452,GO:0045963,1,0.984988185416865,0,2,negative regulation of dopamine metabolic process,BP,
12453,GO:0045964,1,0.956755213145597,0,6,positive regulation of dopamine metabolic process,BP,
12454,GO:0045974,1,0.912004271178926,0,13,regulation of translation, ncRNA-mediated,BP,
12455,GO:0045976,1,0.986464353390652,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12456,GO:0045977,1,0.992170027168696,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12457,GO:0045980,1,0.618172285779478,0,66,negative regulation of nucleotide metabolic process,BP,
12459,GO:0045986,1,0.905115258617879,0,14,negative regulation of smooth muscle contraction,BP,
12460,GO:0045987,1,0.83586263604921,0,25,positive regulation of smooth muscle contraction,BP,
12461,GO:0045988,1,0.960071906765675,0,6,negative regulation of striated muscle contraction,BP,
12462,GO:0045989,1,0.902920008514547,0,14,positive regulation of striated muscle contraction,BP,
12463,GO:0045990,1,0.957289819854801,0,6,carbon catabolite regulation of transcription,BP,
12464,GO:0045991,1,0.964793185888434,0,5,carbon catabolite activation of transcription,BP,
12465,GO:0045992,1,0.831993821013274,0,26,negative regulation of embryonic development,BP,
12466,GO:0045993,1,0.99379515561488,0,1,negative regulation of translational initiation by iron,BP,
12467,GO:0045994,1,0.986201264008094,0,2,positive regulation of translational initiation by iron,BP,
12468,GO:0045995,1,0.437392619418303,0,117,regulation of embryonic development,BP,
12469,GO:0046005,1,0.976692112990833,0,3,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12471,GO:0046007,1,0.929620473013638,0,10,negative regulation of activated T cell proliferation,BP,
12472,GO:0046010,1,0.977677850524543,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12473,GO:0046013,1,0.977283543406812,0,3,regulation of T cell homeostatic proliferation,BP,
12474,GO:0046015,1,0.95554005973697,0,6,regulation of transcription by glucose,BP,
12475,GO:0046016,1,0.970631598128328,0,4,positive regulation of transcription by glucose,BP,
12476,GO:0046021,1,0.981975335650487,0,3,regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12477,GO:0046022,1,0.993986206324899,0,1,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12478,GO:0046030,1,0.928276807141868,0,11,inositol trisphosphate phosphatase activity,MF,
12479,GO:0046031,1,0.592943436073879,0,72,ADP metabolic process,BP,
12480,GO:0046032,1,0.992170027168696,0,1,ADP catabolic process,BP,
12481,GO:0046033,1,0.914310693926481,0,12,AMP metabolic process,BP,
12482,GO:0046034,1,0.187244630460323,0,224,ATP metabolic process,BP,
12483,GO:0046035,1,0.992170027168696,0,1,CMP metabolic process,BP,
12484,GO:0046036,1,0.897281546710642,0,14,CTP metabolic process,BP,
12485,GO:0046037,1,0.871832434291018,0,20,GMP metabolic process,BP,
12486,GO:0046038,1,0.992170027168696,0,1,GMP catabolic process,BP,
12487,GO:0046039,1,0.825586799282935,0,26,GTP metabolic process,BP,
12488,GO:0046040,1,0.911322492746809,0,13,IMP metabolic process,BP,
12489,GO:0046041,1,0.984561190199551,0,2,ITP metabolic process,BP,
12490,GO:0046048,1,0.992517443984523,0,1,UDP metabolic process,BP,
12491,GO:0046049,1,0.92671230293846,0,10,UMP metabolic process,BP,
12492,GO:0046051,1,0.919200591846371,0,11,UTP metabolic process,BP,
12493,GO:0046054,1,0.992170027168696,0,1,dGMP metabolic process,BP,
12494,GO:0046056,1,0.985371210199117,0,2,dADP metabolic process,BP,
12495,GO:0046057,1,0.992170027168696,0,1,dADP catabolic process,BP,
12497,GO:0046060,1,0.962028967880542,0,5,dATP metabolic process,BP,
12498,GO:0046061,1,0.977265648584938,0,3,dATP catabolic process,BP,
12499,GO:0046065,1,0.992170027168696,0,1,dCTP metabolic process,BP,
12500,GO:0046066,1,0.984400887813367,0,2,dGDP metabolic process,BP,
12501,GO:0046067,1,0.992170027168696,0,1,dGDP catabolic process,BP,
12502,GO:0046068,1,0.680157061058969,0,55,cGMP metabolic process,BP,
12503,GO:0046069,1,0.953789106416759,0,7,cGMP catabolic process,BP,
12504,GO:0046070,1,0.96962037638968,0,4,dGTP metabolic process,BP,
12505,GO:0046072,1,0.984789563498906,0,2,dTDP metabolic process,BP,
12506,GO:0046073,1,0.984487639975182,0,2,dTMP metabolic process,BP,
12507,GO:0046075,1,0.96942589612739,0,4,dTTP metabolic process,BP,
12508,GO:0046077,1,0.984789563498906,0,2,dUDP metabolic process,BP,
12509,GO:0046078,1,0.976693859919729,0,3,dUMP metabolic process,BP,
12510,GO:0046079,1,0.992170027168696,0,1,dUMP catabolic process,BP,
12511,GO:0046080,1,0.992171801564538,0,1,dUTP metabolic process,BP,
12512,GO:0046083,1,0.984400887813367,0,2,adenine metabolic process,BP,
12513,GO:0046084,1,0.984400887813367,0,2,adenine biosynthetic process,BP,
12514,GO:0046085,1,0.949957993549641,0,7,adenosine metabolic process,BP,
12515,GO:0046086,1,0.985789589959972,0,2,adenosine biosynthetic process,BP,
12516,GO:0046087,1,0.932120082780067,0,9,cytidine metabolic process,BP,
12517,GO:0046090,1,0.992170027168696,0,1,deoxyadenosine metabolic process,BP,
12518,GO:0046092,1,0.993951582317658,0,1,deoxycytidine metabolic process,BP,
12519,GO:0046098,1,0.978946757717862,0,3,guanine metabolic process,BP,
12520,GO:0046099,1,0.992170027168696,0,1,guanine biosynthetic process,BP,
12521,GO:0046100,1,0.976713149366325,0,3,hypoxanthine metabolic process,BP,
12522,GO:0046101,1,0.976713149366325,0,3,hypoxanthine biosynthetic process,BP,
12524,GO:0046103,1,0.992170027168696,0,1,inosine biosynthetic process,BP,
12525,GO:0046104,1,0.978952355248549,0,3,thymidine metabolic process,BP,
12526,GO:0046108,1,0.984474122457525,0,2,uridine metabolic process,BP,
12528,GO:0046111,1,0.992170027168696,0,1,xanthine biosynthetic process,BP,
12529,GO:0046112,1,0.884292420117413,0,17,nucleobase biosynthetic process,BP,
12531,GO:0046116,1,0.954130792335886,0,6,queuosine metabolic process,BP,
12533,GO:0046122,1,0.984400887813367,0,2,purine deoxyribonucleoside metabolic process,BP,
12534,GO:0046124,1,0.992170027168696,0,1,purine deoxyribonucleoside catabolic process,BP,
12535,GO:0046125,1,0.978952355248549,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12536,GO:0046127,1,0.992683337168453,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12538,GO:0046129,1,0.851386688943343,0,21,purine ribonucleoside biosynthetic process,BP,
12540,GO:0046131,1,0.781463401287107,0,32,pyrimidine ribonucleoside metabolic process,BP,
12541,GO:0046132,1,0.851319079525985,0,21,pyrimidine ribonucleoside biosynthetic process,BP,
12542,GO:0046133,1,0.917894014943582,0,11,pyrimidine ribonucleoside catabolic process,BP,
12543,GO:0046134,1,0.800920256773801,0,29,pyrimidine nucleoside biosynthetic process,BP,
12544,GO:0046135,1,0.856875193342372,0,20,pyrimidine nucleoside catabolic process,BP,
12545,GO:0046136,1,0.976692113335833,0,3,positive regulation of vitamin metabolic process,BP,
12546,GO:0046137,1,0.955582451721906,0,6,negative regulation of vitamin metabolic process,BP,
12547,GO:0046144,1,0.992170027168696,0,1,D-alanine family amino acid metabolic process,BP,
12549,GO:0046148,1,0.689738967431462,0,51,pigment biosynthetic process,BP,
12550,GO:0046149,1,0.946566827406668,0,7,pigment catabolic process,BP,
12551,GO:0046160,1,0.986603214423282,0,2,heme a metabolic process,BP,
12552,GO:0046164,1,0.710693054181041,0,46,alcohol catabolic process,BP,
12554,GO:0046166,1,0.984416691604198,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12555,GO:0046167,1,0.979499437972345,0,3,glycerol-3-phosphate biosynthetic process,BP,
12556,GO:0046168,1,0.985967707163203,0,2,glycerol-3-phosphate catabolic process,BP,
12557,GO:0046173,1,0.747673505827953,0,40,polyol biosynthetic process,BP,
12558,GO:0046174,1,0.881993173828644,0,18,polyol catabolic process,BP,
12559,GO:0046176,1,0.992294630214608,0,1,aldonic acid catabolic process,BP,
12560,GO:0046177,1,0.992294630214608,0,1,D-gluconate catabolic process,BP,
12561,GO:0046184,1,0.898624049109072,0,15,aldehyde biosynthetic process,BP,
12562,GO:0046185,1,0.918067437800985,0,11,aldehyde catabolic process,BP,
12564,GO:0046203,1,0.984400901744996,0,2,spermidine catabolic process,BP,
12565,GO:0046204,1,0.992170027168696,0,1,nor-spermidine metabolic process,BP,
12566,GO:0046208,1,0.969075506800415,0,4,spermine catabolic process,BP,
12568,GO:0046210,1,0.992274765742836,0,1,nitric oxide catabolic process,BP,
12569,GO:0046218,1,0.920424383742223,0,11,indolalkylamine catabolic process,BP,
12570,GO:0046219,1,0.961521235521082,0,5,indolalkylamine biosynthetic process,BP,
12571,GO:0046222,1,0.992216941255385,0,1,aflatoxin metabolic process,BP,
12572,GO:0046226,1,0.984401132159994,0,2,coumarin catabolic process,BP,
12573,GO:0046247,1,0.992461920177581,0,1,terpene catabolic process,BP,
12574,GO:0046271,1,0.984401132159994,0,2,phenylpropanoid catabolic process,BP,
12575,GO:0046272,1,0.992198562480326,0,1,stilbene catabolic process,BP,
12576,GO:0046292,1,0.978554097841841,0,3,formaldehyde metabolic process,BP,
12577,GO:0046293,1,0.993897973314412,0,1,formaldehyde biosynthetic process,BP,
12578,GO:0046294,1,0.984562653813089,0,2,formaldehyde catabolic process,BP,
12579,GO:0046295,1,0.992170027168696,0,1,glycolate biosynthetic process,BP,
12580,GO:0046296,1,0.992170174082838,0,1,glycolate catabolic process,BP,
12581,GO:0046305,1,0.984594378250486,0,2,alkanesulfonate biosynthetic process,BP,
12582,GO:0046314,1,0.992170027168696,0,1,phosphocreatine biosynthetic process,BP,
12583,GO:0046316,1,0.992294630214608,0,1,gluconokinase activity,MF,
12584,GO:0046317,1,0.99395901298832,0,1,regulation of glucosylceramide biosynthetic process,BP,
12585,GO:0046318,1,0.99395901298832,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12587,GO:0046321,1,0.908629830059473,0,14,positive regulation of fatty acid oxidation,BP,
12591,GO:0046325,1,0.916045621299223,0,12,negative regulation of glucose import,BP,
12593,GO:0046327,1,0.992353060439829,0,1,glycerol biosynthetic process from pyruvate,BP,
12595,GO:0046329,1,0.797449863203701,0,32,negative regulation of JNK cascade,BP,
12597,GO:0046331,1,0.98508900828049,0,2,lateral inhibition,BP,
12598,GO:0046332,1,0.605800180863926,0,73,SMAD binding,MF,
12599,GO:0046333,1,0.985068212808892,0,2,octopamine metabolic process,BP,
12600,GO:0046337,1,0.897422668449098,0,15,phosphatidylethanolamine metabolic process,BP,
12601,GO:0046338,1,0.985513805718376,0,2,phosphatidylethanolamine catabolic process,BP,
12603,GO:0046340,1,0.979646148946802,0,3,diacylglycerol catabolic process,BP,
12604,GO:0046341,1,0.920378194956994,0,12,CDP-diacylglycerol metabolic process,BP,
12605,GO:0046348,1,0.932550004627218,0,9,amino sugar catabolic process,BP,
12606,GO:0046349,1,0.923917593375532,0,11,amino sugar biosynthetic process,BP,
12607,GO:0046351,1,0.963915430717237,0,5,disaccharide biosynthetic process,BP,
12608,GO:0046352,1,0.992171570232374,0,1,disaccharide catabolic process,BP,
12610,GO:0046360,1,0.992186483477374,0,1,2-oxobutyrate biosynthetic process,BP,
12611,GO:0046361,1,0.992186483477374,0,1,2-oxobutyrate metabolic process,BP,
12614,GO:0046368,1,0.970951889837155,0,4,GDP-L-fucose metabolic process,BP,
12615,GO:0046370,1,0.984512270766988,0,2,fructose biosynthetic process,BP,
12616,GO:0046373,1,0.992294630214608,0,1,L-arabinose metabolic process,BP,
12617,GO:0046379,1,0.977531163012665,0,3,extracellular polysaccharide metabolic process,BP,
12618,GO:0046380,1,0.993337365182322,0,1,N-acetylneuraminate biosynthetic process,BP,
12619,GO:0046381,1,0.992170027168696,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12620,GO:0046385,1,0.933062556912455,0,9,deoxyribose phosphate biosynthetic process,BP,
12623,GO:0046391,1,0.969428725287144,0,4,5-phosphoribose 1-diphosphate metabolic process,BP,
12626,GO:0046398,1,0.972684159880014,0,4,UDP-glucuronate metabolic process,BP,
12627,GO:0046403,1,0.992170094332629,0,1,polynucleotide 3'-phosphatase activity,MF,
12628,GO:0046404,1,0.978480504868606,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12630,GO:0046416,1,0.976785098163244,0,3,D-amino acid metabolic process,BP,
12632,GO:0046426,1,0.69939315332968,0,49,negative regulation of JAK-STAT cascade,BP,
12635,GO:0046436,1,0.992170027168696,0,1,D-alanine metabolic process,BP,
12636,GO:0046437,1,0.992264474345352,0,1,D-amino acid biosynthetic process,BP,
12637,GO:0046439,1,0.950284392833768,0,7,L-cysteine metabolic process,BP,
12638,GO:0046440,1,0.971201826022068,0,4,L-lysine metabolic process,BP,
12639,GO:0046443,1,0.992175466744087,0,1,FAD metabolic process,BP,
12640,GO:0046444,1,0.992365032749341,0,1,FMN metabolic process,BP,
12641,GO:0046448,1,0.992252666157398,0,1,tropane alkaloid metabolic process,BP,
12643,GO:0046452,1,0.985682839774376,0,2,dihydrofolate metabolic process,BP,
12645,GO:0046457,1,0.843244703373909,0,23,prostanoid biosynthetic process,BP,
12646,GO:0046459,1,0.908696597231149,0,13,short-chain fatty acid metabolic process,BP,
12649,GO:0046462,1,0.984524877033465,0,2,monoacylglycerol metabolic process,BP,
12652,GO:0046465,1,0.948980769507116,0,7,dolichyl diphosphate metabolic process,BP,
12655,GO:0046469,1,0.957752946549388,0,6,platelet activating factor metabolic process,BP,
12657,GO:0046471,1,0.796837371660835,0,31,phosphatidylglycerol metabolic process,BP,
12658,GO:0046473,1,0.780275302646591,0,35,phosphatidic acid metabolic process,BP,
12661,GO:0046476,1,0.971109011964512,0,4,glycosylceramide biosynthetic process,BP,
12669,GO:0046490,1,0.961484338696878,0,5,isopentenyl diphosphate metabolic process,BP,
12670,GO:0046491,1,0.992170027168696,0,1,L-methylmalonyl-CoA metabolic process,BP,
12671,GO:0046493,1,0.992170027168696,0,1,lipid A metabolic process,BP,
12674,GO:0046498,1,0.957648546955315,0,6,S-adenosylhomocysteine metabolic process,BP,
12675,GO:0046499,1,0.992814836623527,0,1,S-adenosylmethioninamine metabolic process,BP,
12676,GO:0046500,1,0.90958500449091,0,13,S-adenosylmethionine metabolic process,BP,
12677,GO:0046501,1,0.928371113375539,0,10,protoporphyrinogen IX metabolic process,BP,
12678,GO:0046502,1,0.984423640281871,0,2,uroporphyrinogen III metabolic process,BP,
12680,GO:0046504,1,0.972765969212316,0,4,glycerol ether biosynthetic process,BP,
12681,GO:0046511,1,0.98620500573987,0,2,sphinganine biosynthetic process,BP,
12682,GO:0046512,1,0.942964012795244,0,8,sphingosine biosynthetic process,BP,
12683,GO:0046513,1,0.706793732789822,0,47,ceramide biosynthetic process,BP,
12685,GO:0046519,1,0.909988850063983,0,13,sphingoid metabolic process,BP,
12686,GO:0046520,1,0.936728136827121,0,9,sphingoid biosynthetic process,BP,
12687,GO:0046521,1,0.992171614783988,0,1,sphingoid catabolic process,BP,
12689,GO:0046525,1,0.992170091639211,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12690,GO:0046526,1,0.992282282316394,0,1,D-xylulose reductase activity,MF,
12693,GO:0046532,1,0.951470914521732,0,7,regulation of photoreceptor cell differentiation,BP,
12694,GO:0046533,1,0.957417059268713,0,6,negative regulation of photoreceptor cell differentiation,BP,
12695,GO:0046534,1,0.99379149505678,0,1,positive regulation of photoreceptor cell differentiation,BP,
12696,GO:0046538,1,0.969047174370287,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12697,GO:0046539,1,0.992170027168696,0,1,histamine N-methyltransferase activity,MF,
12698,GO:0046540,1,0.867342844324927,0,19,U4/U6 x U5 tri-snRNP complex,CC,
12699,GO:0046541,1,0.905685626977124,0,13,saliva secretion,BP,
12700,GO:0046543,1,0.951779895828024,0,7,development of secondary female sexual characteristics,BP,
12701,GO:0046544,1,0.993958542388851,0,1,development of secondary male sexual characteristics,BP,
12704,GO:0046548,1,0.93992507842525,0,9,retinal rod cell development,BP,
12705,GO:0046549,1,0.939120321361001,0,9,retinal cone cell development,BP,
12706,GO:0046554,1,0.992170027168696,0,1,malate dehydrogenase (NADP+) activity,MF,
12707,GO:0046556,1,0.992294630214608,0,1,alpha-L-arabinofuranosidase activity,MF,
12708,GO:0046570,1,0.992170027168696,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12710,GO:0046577,1,0.993312729310879,0,1,long-chain-alcohol oxidase activity,MF,
12711,GO:0046578,1,0.25689563672648,0,199,regulation of Ras protein signal transduction,BP,
12712,GO:0046579,1,0.72543978193554,0,45,positive regulation of Ras protein signal transduction,BP,
12713,GO:0046580,1,0.742694752963153,0,43,negative regulation of Ras protein signal transduction,BP,
12714,GO:0046581,1,0.961598767030576,0,6,intercellular canaliculus,CC,
12715,GO:0046586,1,0.984808635987256,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12716,GO:0046587,1,0.992580968247041,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12717,GO:0046588,1,0.992170027168696,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12718,GO:0046592,1,0.984413211811487,0,2,polyamine oxidase activity,MF,
12719,GO:0046596,1,0.80498795502001,0,29,regulation of viral entry into host cell,BP,
12720,GO:0046597,1,0.867999459086546,0,19,negative regulation of viral entry into host cell,BP,
12721,GO:0046598,1,0.93364161093207,0,9,positive regulation of viral entry into host cell,BP,
12722,GO:0046599,1,0.901277691270057,0,15,regulation of centriole replication,BP,
12723,GO:0046600,1,0.960679741376838,0,6,negative regulation of centriole replication,BP,
12724,GO:0046601,1,0.9793064572249,0,3,positive regulation of centriole replication,BP,
12725,GO:0046602,1,0.93795181705954,0,9,regulation of mitotic centrosome separation,BP,
12726,GO:0046604,1,0.965864653336765,0,5,positive regulation of mitotic centrosome separation,BP,
12727,GO:0046605,1,0.716909669206352,0,47,regulation of centrosome cycle,BP,
12728,GO:0046606,1,0.933977459367955,0,10,negative regulation of centrosome cycle,BP,
12729,GO:0046607,1,0.927123335815705,0,11,positive regulation of centrosome cycle,BP,
12730,GO:0046618,1,0.964948812209759,0,5,drug export,BP,
12731,GO:0046619,1,0.986662273724069,0,2,optic placode formation involved in camera-type eye formation,BP,
12734,GO:0046622,1,0.733480913583313,0,44,positive regulation of organ growth,BP,
12735,GO:0046623,1,0.993925354875959,0,1,sphingolipid-translocating ATPase activity,MF,
12736,GO:0046624,1,0.966456205684423,0,5,sphingolipid transporter activity,MF,
12737,GO:0046625,1,0.900276864016415,0,14,sphingolipid binding,MF,
12738,GO:0046626,1,0.710538758591448,0,48,regulation of insulin receptor signaling pathway,BP,
12739,GO:0046627,1,0.805869490409693,0,30,negative regulation of insulin receptor signaling pathway,BP,
12740,GO:0046628,1,0.919829196425672,0,12,positive regulation of insulin receptor signaling pathway,BP,
12741,GO:0046629,1,0.913628674429041,0,13,gamma-delta T cell activation,BP,
12744,GO:0046633,1,0.826846408208332,0,26,alpha-beta T cell proliferation,BP,
12747,GO:0046636,1,0.820294408054653,0,27,negative regulation of alpha-beta T cell activation,BP,
12750,GO:0046639,1,0.877515793996534,0,18,negative regulation of alpha-beta T cell differentiation,BP,
12751,GO:0046640,1,0.84382464193141,0,23,regulation of alpha-beta T cell proliferation,BP,
12752,GO:0046641,1,0.867405012826604,0,19,positive regulation of alpha-beta T cell proliferation,BP,
12753,GO:0046642,1,0.964312541209397,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12754,GO:0046643,1,0.955781412647457,0,7,regulation of gamma-delta T cell activation,BP,
12755,GO:0046645,1,0.968037508748897,0,5,positive regulation of gamma-delta T cell activation,BP,
12758,GO:0046653,1,0.882316511022629,0,17,tetrahydrofolate metabolic process,BP,
12759,GO:0046654,1,0.957750932199646,0,6,tetrahydrofolate biosynthetic process,BP,
12760,GO:0046655,1,0.877493321047938,0,18,folic acid metabolic process,BP,
12761,GO:0046657,1,0.992170027168696,0,1,folic acid catabolic process,BP,
12762,GO:0046658,1,0.716197429806683,0,44,anchored component of plasma membrane,CC,
12765,GO:0046666,1,0.970233647122896,0,4,retinal cell programmed cell death,BP,
12766,GO:0046668,1,0.985608630898203,0,2,regulation of retinal cell programmed cell death,BP,
12767,GO:0046671,1,0.993385061896905,0,1,negative regulation of retinal cell programmed cell death,BP,
12768,GO:0046676,1,0.773518249893792,0,36,negative regulation of insulin secretion,BP,
12770,GO:0046680,1,0.992184048762491,0,1,response to DDT,BP,
12773,GO:0046685,1,0.806931706922704,0,29,response to arsenic-containing substance,BP,
12775,GO:0046687,1,0.992170027168696,0,1,response to chromate,BP,
12776,GO:0046688,1,0.830051033135895,0,25,response to copper ion,BP,
12777,GO:0046689,1,0.921526969200388,0,11,response to mercury ion,BP,
12778,GO:0046690,1,0.993035087127744,0,1,response to tellurium ion,BP,
12779,GO:0046691,1,0.992463354401324,0,1,intracellular canaliculus,CC,
12780,GO:0046692,1,0.992170027168696,0,1,sperm competition,BP,
12781,GO:0046696,1,0.957906476874631,0,6,lipopolysaccharide receptor complex,CC,
12782,GO:0046697,1,0.86688541972029,0,20,decidualization,BP,
12784,GO:0046703,1,0.93226445388181,0,9,natural killer cell lectin-like receptor binding,MF,
12785,GO:0046707,1,0.986203080773366,0,2,IDP metabolic process,BP,
12786,GO:0046709,1,0.986203080773366,0,2,IDP catabolic process,BP,
12787,GO:0046710,1,0.911390285628123,0,14,GDP metabolic process,BP,
12788,GO:0046711,1,0.992170027168696,0,1,GDP biosynthetic process,BP,
12789,GO:0046712,1,0.992170027168696,0,1,GDP catabolic process,BP,
12790,GO:0046713,1,0.992674191786854,0,1,borate transport,BP,
12791,GO:0046715,1,0.992674191786854,0,1,borate transmembrane transporter activity,MF,
12792,GO:0046716,1,0.884651457133624,0,17,muscle cell cellular homeostasis,BP,
12794,GO:0046718,1,0.457806260334257,0,109,viral entry into host cell,BP,
12795,GO:0046719,1,0.93856463577646,0,9,regulation by virus of viral protein levels in host cell,BP,
12796,GO:0046724,1,0.984567846593017,0,2,oxalic acid secretion,BP,
12797,GO:0046725,1,0.993122517482038,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12798,GO:0046726,1,0.980731086432717,0,3,positive regulation by virus of viral protein levels in host cell,BP,
12799,GO:0046730,1,0.984428143151737,0,2,induction of host immune response by virus,BP,
12800,GO:0046732,1,0.984428143151737,0,2,active induction of host immune response by virus,BP,
12801,GO:0046745,1,0.992294630214608,0,1,viral capsid secondary envelopment,BP,
12802,GO:0046755,1,0.834262350592364,0,24,viral budding,BP,
12803,GO:0046777,1,0.201596449085487,0,230,protein autophosphorylation,BP,
12804,GO:0046778,1,0.984866705089425,0,2,modification by virus of host mRNA processing,BP,
12805,GO:0046782,1,0.623876208684453,0,64,regulation of viral transcription,BP,
12806,GO:0046784,1,0.941133201703516,0,8,viral mRNA export from host cell nucleus,BP,
12807,GO:0046785,1,0.671088498827644,0,56,microtubule polymerization,BP,
12808,GO:0046786,1,0.993928495965872,0,1,viral replication complex formation and maintenance,BP,
12809,GO:0046789,1,0.992752580435624,0,1,host cell surface receptor binding,MF,
12810,GO:0046790,1,0.942456712742521,0,8,virion binding,MF,
12811,GO:0046794,1,0.615645924822443,0,68,transport of virus,BP,
12812,GO:0046811,1,0.986202993120794,0,2,histone deacetylase inhibitor activity,MF,
12813,GO:0046812,1,0.992752580435624,0,1,host cell surface binding,MF,
12814,GO:0046813,1,0.964801759410491,0,5,receptor-mediated virion attachment to host cell,BP,
12815,GO:0046817,1,0.992170027168696,0,1,chemokine receptor antagonist activity,MF,
12817,GO:0046823,1,0.592420757795772,0,73,negative regulation of nucleocytoplasmic transport,BP,
12818,GO:0046824,1,0.446828319772641,0,114,positive regulation of nucleocytoplasmic transport,BP,
12820,GO:0046826,1,0.950263531507057,0,7,negative regulation of protein export from nucleus,BP,
12821,GO:0046827,1,0.867878078162877,0,20,positive regulation of protein export from nucleus,BP,
12822,GO:0046831,1,0.927157392934058,0,11,regulation of RNA export from nucleus,BP,
12823,GO:0046832,1,0.988008449100365,0,2,negative regulation of RNA export from nucleus,BP,
12824,GO:0046833,1,0.977369360465867,0,3,positive regulation of RNA export from nucleus,BP,
12826,GO:0046835,1,0.86306298013334,0,21,carbohydrate phosphorylation,BP,
12827,GO:0046836,1,0.955970759598875,0,6,glycolipid transport,BP,
12828,GO:0046838,1,0.93387370039165,0,10,phosphorylated carbohydrate dephosphorylation,BP,
12829,GO:0046839,1,0.843645443974193,0,25,phospholipid dephosphorylation,BP,
12830,GO:0046847,1,0.706185792279719,0,51,filopodium assembly,BP,
12831,GO:0046848,1,0.976692112990833,0,3,hydroxyapatite binding,MF,
12834,GO:0046851,1,0.904506371535995,0,14,negative regulation of bone remodeling,BP,
12835,GO:0046852,1,0.910089252882159,0,13,positive regulation of bone remodeling,BP,
12837,GO:0046855,1,0.940786052667046,0,9,inositol phosphate dephosphorylation,BP,
12838,GO:0046856,1,0.850287284897572,0,24,phosphatidylinositol dephosphorylation,BP,
12841,GO:0046870,1,0.957200017885386,0,6,cadmium ion binding,MF,
12844,GO:0046874,1,0.963176684751713,0,5,quinolinate metabolic process,BP,
12845,GO:0046875,1,0.83909061858961,0,25,ephrin receptor binding,MF,
12846,GO:0046877,1,0.941523444897983,0,8,regulation of saliva secretion,BP,
12847,GO:0046878,1,0.969880437409789,0,4,positive regulation of saliva secretion,BP,
12849,GO:0046880,1,0.957349736445201,0,6,regulation of follicle-stimulating hormone secretion,BP,
12850,GO:0046881,1,0.957349736445201,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12851,GO:0046882,1,0.97728850120167,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12853,GO:0046884,1,0.951500982675626,0,7,follicle-stimulating hormone secretion,BP,
12854,GO:0046885,1,0.889100518625004,0,17,regulation of hormone biosynthetic process,BP,
12855,GO:0046886,1,0.946407058397476,0,8,positive regulation of hormone biosynthetic process,BP,
12857,GO:0046888,1,0.634121969666296,0,63,negative regulation of hormone secretion,BP,
12860,GO:0046898,1,0.971242836260162,0,4,response to cycloheximide,BP,
12861,GO:0046899,1,0.98468484508824,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12862,GO:0046900,1,0.992268294570555,0,1,tetrahydrofolylpolyglutamate metabolic process,BP,
12863,GO:0046901,1,0.992268294570555,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12866,GO:0046904,1,0.992170027168696,0,1,calcium oxalate binding,MF,
12869,GO:0046909,1,0.99232673221318,0,1,intermembrane transport,BP,
12870,GO:0046911,1,0.992170027168696,0,1,metal chelating activity,MF,
12871,GO:0046912,1,0.966030002073206,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12875,GO:0046920,1,0.943913192836789,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12876,GO:0046921,1,0.992839838812566,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12877,GO:0046922,1,0.985604926338743,0,2,peptide-O-fucosyltransferase activity,MF,
12878,GO:0046923,1,0.969320951673207,0,4,ER retention sequence binding,MF,
12879,GO:0046928,1,0.698883813774135,0,51,regulation of neurotransmitter secretion,BP,
12880,GO:0046929,1,0.925812444147103,0,11,negative regulation of neurotransmitter secretion,BP,
12881,GO:0046930,1,0.880865946377719,0,17,pore complex,CC,
12882,GO:0046931,1,0.899715888317241,0,15,pore complex assembly,BP,
12883,GO:0046933,1,0.881957379352629,0,16,proton-transporting ATP synthase activity, rotational mechanism,MF,
12885,GO:0046935,1,0.960697513648898,0,6,1-phosphatidylinositol-3-kinase regulator activity,MF,
12886,GO:0046939,1,0.52343631263769,0,88,nucleotide phosphorylation,BP,
12887,GO:0046940,1,0.977100789265676,0,3,nucleoside monophosphate phosphorylation,BP,
12890,GO:0046946,1,0.9788467500661,0,3,hydroxylysine metabolic process,BP,
12891,GO:0046947,1,0.9788467500661,0,3,hydroxylysine biosynthetic process,BP,
12896,GO:0046958,1,0.960507416340791,0,6,nonassociative learning,BP,
12897,GO:0046959,1,0.975031991007232,0,4,habituation,BP,
12898,GO:0046960,1,0.985204740850435,0,2,sensitization,BP,
12899,GO:0046961,1,0.868673457678661,0,19,proton-transporting ATPase activity, rotational mechanism,MF,
12900,GO:0046963,1,0.984422253655735,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12901,GO:0046964,1,0.984422253655735,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12902,GO:0046965,1,0.899890798148781,0,15,retinoid X receptor binding,MF,
12903,GO:0046966,1,0.82758648568693,0,27,thyroid hormone receptor binding,MF,
12904,GO:0046967,1,0.986120808930734,0,2,cytosol to ER transport,BP,
12905,GO:0046968,1,0.979515124062963,0,3,peptide antigen transport,BP,
12906,GO:0046969,1,0.985603820126152,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12907,GO:0046970,1,0.992174264801851,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12908,GO:0046972,1,0.93775930891755,0,9,histone acetyltransferase activity (H4-K16 specific),MF,
12909,GO:0046974,1,0.966330444476337,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12910,GO:0046975,1,0.959215303924684,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12911,GO:0046976,1,0.979340807725727,0,3,histone methyltransferase activity (H3-K27 specific),MF,
12912,GO:0046977,1,0.971601789417677,0,4,TAP binding,MF,
12913,GO:0046978,1,0.971601789417677,0,4,TAP1 binding,MF,
12914,GO:0046979,1,0.977924523958566,0,3,TAP2 binding,MF,
12915,GO:0046980,1,0.993535661543522,0,1,tapasin binding,MF,
12918,GO:0046984,1,0.970997348762081,0,4,regulation of hemoglobin biosynthetic process,BP,
12919,GO:0046985,1,0.977060956230399,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12920,GO:0046986,1,0.99379515561488,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12922,GO:0047006,1,0.984400887813367,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12923,GO:0047012,1,0.992170027168696,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12925,GO:0047016,1,0.992195443232566,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12926,GO:0047017,1,0.984524522725182,0,2,prostaglandin-F synthase activity,MF,
12927,GO:0047020,1,0.992170027168696,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12928,GO:0047021,1,0.992170027168696,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12929,GO:0047023,1,0.976692112990833,0,3,androsterone dehydrogenase activity,MF,
12930,GO:0047025,1,0.985227204446894,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12932,GO:0047042,1,0.992170027168696,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12934,GO:0047057,1,0.984400887813367,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12935,GO:0047066,1,0.992170027168696,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12936,GO:0047086,1,0.976692112990833,0,3,ketosteroid monooxygenase activity,MF,
12937,GO:0047105,1,0.992273668061976,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12938,GO:0047115,1,0.969043237344425,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12939,GO:0047117,1,0.993986332277816,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12940,GO:0047127,1,0.992170027168696,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12941,GO:0047130,1,0.993986332264915,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12942,GO:0047131,1,0.993986332264915,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12943,GO:0047134,1,0.946928981518983,0,7,protein-disulfide reductase activity,MF,
12944,GO:0047144,1,0.939300297643194,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12945,GO:0047150,1,0.992272216455912,0,1,betaine-homocysteine S-methyltransferase activity,MF,
12946,GO:0047159,1,0.993476453657424,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12947,GO:0047166,1,0.992173059968911,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12948,GO:0047173,1,0.993923335090433,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12949,GO:0047179,1,0.984400887813367,0,2,platelet-activating factor acetyltransferase activity,MF,
12950,GO:0047184,1,0.964526616988739,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12951,GO:0047191,1,0.993476453657424,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12952,GO:0047192,1,0.979766216083731,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12953,GO:0047196,1,0.984418522532904,0,2,long-chain-alcohol O-fatty-acyltransferase activity,MF,
12954,GO:0047198,1,0.992170027168696,0,1,cysteine-S-conjugate N-acetyltransferase activity,MF,
12955,GO:0047220,1,0.992412950949336,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12956,GO:0047223,1,0.977271797553667,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12957,GO:0047224,1,0.992269000039996,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12958,GO:0047225,1,0.992200293687213,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
12959,GO:0047237,1,0.979361741936927,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12960,GO:0047238,1,0.966628437707268,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12961,GO:0047256,1,0.993601169612406,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12962,GO:0047263,1,0.992494718715689,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12963,GO:0047273,1,0.992865517324789,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12964,GO:0047275,1,0.985340394177662,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12965,GO:0047277,1,0.992174351933688,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12966,GO:0047280,1,0.993839729630797,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12967,GO:0047288,1,0.984401024645478,0,2,monosialoganglioside sialyltransferase activity,MF,
12968,GO:0047290,1,0.992170027168696,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12969,GO:0047291,1,0.992217372458568,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12970,GO:0047293,1,0.992170027168696,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12971,GO:0047298,1,0.993929645472371,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12972,GO:0047305,1,0.992205725058955,0,1,(R)-3-amino-2-methylpropionate-pyruvate transaminase activity,MF,
12973,GO:0047322,1,0.987981391222616,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12974,GO:0047323,1,0.992188368610558,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12975,GO:0047325,1,0.992806547305041,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12976,GO:0047326,1,0.992170493586488,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12977,GO:0047341,1,0.992974590415791,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12978,GO:0047372,1,0.929713681208474,0,10,acylglycerol lipase activity,MF,
12979,GO:0047374,1,0.977958306614966,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12980,GO:0047389,1,0.98676493806573,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12981,GO:0047390,1,0.993464068713381,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12982,GO:0047391,1,0.98551006903043,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12983,GO:0047394,1,0.992203532191221,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12984,GO:0047395,1,0.992520582922431,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12985,GO:0047408,1,0.99217016953003,0,1,alkenylglycerophosphocholine hydrolase activity,MF,
12986,GO:0047409,1,0.99217016953003,0,1,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12987,GO:0047429,1,0.935654972037548,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12989,GO:0047444,1,0.992170027168696,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12990,GO:0047451,1,0.993986332277816,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12991,GO:0047464,1,0.993950261277736,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12992,GO:0047484,1,0.939274965738103,0,9,regulation of response to osmotic stress,BP,
12993,GO:0047485,1,0.463686929383905,0,106,protein N-terminus binding,MF,
12994,GO:0047493,1,0.979598566794454,0,3,ceramide cholinephosphotransferase activity,MF,
12995,GO:0047496,1,0.776773569397062,0,36,vesicle transport along microtubule,BP,
12996,GO:0047497,1,0.891097733772737,0,17,mitochondrion transport along microtubule,BP,
12997,GO:0047498,1,0.942215287991806,0,8,calcium-dependent phospholipase A2 activity,MF,
12998,GO:0047499,1,0.955631653645352,0,6,calcium-independent phospholipase A2 activity,MF,
12999,GO:0047522,1,0.978598600136956,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
13000,GO:0047536,1,0.992201184948542,0,1,2-aminoadipate transaminase activity,MF,
13001,GO:0047545,1,0.993986332265994,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
13002,GO:0047555,1,0.908409004658084,0,14,3',5'-cyclic-GMP phosphodiesterase activity,MF,
13003,GO:0047560,1,0.993968335447342,0,1,3-dehydrosphinganine reductase activity,MF,
13005,GO:0047617,1,0.877749795495819,0,17,acyl-CoA hydrolase activity,MF,
13006,GO:0047620,1,0.992520582922431,0,1,acylglycerol kinase activity,MF,
13007,GO:0047621,1,0.992170030385097,0,1,acylpyruvate hydrolase activity,MF,
13008,GO:0047623,1,0.979410061954935,0,3,adenosine-phosphate deaminase activity,MF,
13009,GO:0047631,1,0.969164958321263,0,4,ADP-ribose diphosphatase activity,MF,
13010,GO:0047635,1,0.985673814946351,0,2,alanine-oxo-acid transaminase activity,MF,
13011,GO:0047638,1,0.992406577664907,0,1,albendazole monooxygenase activity,MF,
13012,GO:0047658,1,0.992170041209416,0,1,alpha-amino-acid esterase activity,MF,
13013,GO:0047661,1,0.992264474345352,0,1,amino-acid racemase activity,MF,
13014,GO:0047676,1,0.993967297601626,0,1,arachidonate-CoA ligase activity,MF,
13015,GO:0047685,1,0.992170027168696,0,1,amine sulfotransferase activity,MF,
13016,GO:0047693,1,0.992170027168696,0,1,ATP diphosphatase activity,MF,
13017,GO:0047696,1,0.984893867033993,0,2,beta-adrenergic receptor kinase activity,MF,
13018,GO:0047704,1,0.992176297995038,0,1,bile-salt sulfotransferase activity,MF,
13019,GO:0047708,1,0.984412298135018,0,2,biotinidase activity,MF,
13020,GO:0047710,1,0.98608825705281,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
13021,GO:0047714,1,0.992170027168696,0,1,galactolipase activity,MF,
13022,GO:0047718,1,0.976692112990833,0,3,indanol dehydrogenase activity,MF,
13023,GO:0047726,1,0.992274765742836,0,1,iron-cytochrome-c reductase activity,MF,
13024,GO:0047730,1,0.993480543526736,0,1,carnosine synthase activity,MF,
13025,GO:0047734,1,0.992294630214608,0,1,CDP-glycerol diphosphatase activity,MF,
13026,GO:0047743,1,0.992170027168696,0,1,chlordecone reductase activity,MF,
13027,GO:0047747,1,0.992231569567544,0,1,cholate-CoA ligase activity,MF,
13029,GO:0047751,1,0.976978829513552,0,3,cholestenone 5-alpha-reductase activity,MF,
13030,GO:0047756,1,0.97086283702328,0,4,chondroitin 4-sulfotransferase activity,MF,
13031,GO:0047757,1,0.987555271993181,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
13033,GO:0047783,1,0.985563945034658,0,2,corticosterone 18-monooxygenase activity,MF,
13034,GO:0047787,1,0.984588916342659,0,2,delta4-3-oxosteroid 5beta-reductase activity,MF,
13035,GO:0047800,1,0.993266790106647,0,1,cysteamine dioxygenase activity,MF,
13036,GO:0047801,1,0.99218813972461,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
13037,GO:0047837,1,0.992170027168696,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
13038,GO:0047840,1,0.992170027168696,0,1,dCTP diphosphatase activity,MF,
13039,GO:0047844,1,0.976692890253535,0,3,deoxycytidine deaminase activity,MF,
13040,GO:0047856,1,0.992170027168696,0,1,dihydrocoumarin hydrolase activity,MF,
13042,GO:0047865,1,0.992653370247249,0,1,dimethylglycine dehydrogenase activity,MF,
13043,GO:0047874,1,0.992186270589445,0,1,dolichyldiphosphatase activity,MF,
13044,GO:0047888,1,0.992174395943933,0,1,fatty acid peroxidase activity,MF,
13045,GO:0047894,1,0.976692464502254,0,3,flavonol 3-sulfotransferase activity,MF,
13046,GO:0047915,1,0.992170031160269,0,1,ganglioside galactosyltransferase activity,MF,
13047,GO:0047933,1,0.993986332277895,0,1,glucose-1,6-bisphosphate synthase activity,MF,
13048,GO:0047936,1,0.993986332280686,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
13049,GO:0047939,1,0.992170027168696,0,1,L-glucuronate reductase activity,MF,
13050,GO:0047946,1,0.992182126261931,0,1,glutamine N-acyltransferase activity,MF,
13051,GO:0047961,1,0.969072750411826,0,4,glycine N-acyltransferase activity,MF,
13052,GO:0047962,1,0.992170027168696,0,1,glycine N-benzoyltransferase activity,MF,
13053,GO:0047963,1,0.992975094076952,0,1,glycine N-choloyltransferase activity,MF,
13054,GO:0047969,1,0.992170174082838,0,1,glyoxylate oxidase activity,MF,
13055,GO:0047977,1,0.984643616889426,0,2,hepoxilin-epoxide hydrolase activity,MF,
13056,GO:0047982,1,0.992170154337142,0,1,homocysteine desulfhydrase activity,MF,
13057,GO:0047988,1,0.992172600636557,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
13059,GO:0048003,1,0.950658927771389,0,7,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
13060,GO:0048006,1,0.993327181744673,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
13061,GO:0048007,1,0.950658927771389,0,7,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
13062,GO:0048008,1,0.726869548864896,0,47,platelet-derived growth factor receptor signaling pathway,BP,
13065,GO:0048011,1,0.829931273592909,0,26,neurotrophin TRK receptor signaling pathway,BP,
13066,GO:0048012,1,0.890307911163479,0,16,hepatocyte growth factor receptor signaling pathway,BP,
13067,GO:0048013,1,0.541544836333988,0,87,ephrin receptor signaling pathway,BP,
13068,GO:0048014,1,0.98171690007259,0,3,Tie signaling pathway,BP,
13070,GO:0048016,1,0.781398819695122,0,35,inositol phosphate-mediated signaling,BP,
13072,GO:0048018,1,0.854878856427739,0,21,receptor agonist activity,MF,
13073,GO:0048019,1,0.926597297866495,0,10,receptor antagonist activity,MF,
13075,GO:0048021,1,0.953427667838558,0,7,regulation of melanin biosynthetic process,BP,
13076,GO:0048022,1,0.980271740712847,0,3,negative regulation of melanin biosynthetic process,BP,
13077,GO:0048023,1,0.972619888519683,0,4,positive regulation of melanin biosynthetic process,BP,
13078,GO:0048024,1,0.608843263392937,0,68,regulation of mRNA splicing, via spliceosome,BP,
13079,GO:0048025,1,0.861570058147762,0,20,negative regulation of mRNA splicing, via spliceosome,BP,
13080,GO:0048026,1,0.896187728233244,0,15,positive regulation of mRNA splicing, via spliceosome,BP,
13081,GO:0048027,1,0.859909651801376,0,21,mRNA 5'-UTR binding,MF,
13083,GO:0048030,1,0.969165066168117,0,4,disaccharide binding,MF,
13084,GO:0048033,1,0.992572562871229,0,1,heme o metabolic process,BP,
13085,GO:0048034,1,0.992572562871229,0,1,heme O biosynthetic process,BP,
13089,GO:0048040,1,0.992184241807436,0,1,UDP-glucuronate decarboxylase activity,MF,
13090,GO:0048041,1,0.629732324897708,0,69,focal adhesion assembly,BP,
13092,GO:0048050,1,0.955895965357267,0,6,post-embryonic eye morphogenesis,BP,
13093,GO:0048058,1,0.992867003932365,0,1,compound eye corneal lens development,BP,
13094,GO:0048066,1,0.726846180626211,0,45,developmental pigmentation,BP,
13095,GO:0048069,1,0.945021723334263,0,8,eye pigmentation,BP,
13096,GO:0048070,1,0.895835929785149,0,16,regulation of developmental pigmentation,BP,
13097,GO:0048073,1,0.987498782032346,0,2,regulation of eye pigmentation,BP,
13098,GO:0048075,1,0.993717920651087,0,1,positive regulation of eye pigmentation,BP,
13099,GO:0048087,1,0.941373055227419,0,9,positive regulation of developmental pigmentation,BP,
13100,GO:0048096,1,0.939969725087033,0,9,chromatin-mediated maintenance of transcription,BP,
13101,GO:0048101,1,0.985124881606711,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
13102,GO:0048102,1,0.95760393152601,0,6,autophagic cell death,BP,
13103,GO:0048103,1,0.860870196729772,0,22,somatic stem cell division,BP,
13104,GO:0048104,1,0.975377566859278,0,4,establishment of body hair or bristle planar orientation,BP,
13105,GO:0048105,1,0.975377566859278,0,4,establishment of body hair planar orientation,BP,
13106,GO:0048133,1,0.970484013457225,0,4,male germ-line stem cell asymmetric division,BP,
13107,GO:0048137,1,0.992294630214608,0,1,spermatocyte division,BP,
13108,GO:0048143,1,0.964546966859484,0,5,astrocyte activation,BP,
13111,GO:0048146,1,0.688970064409695,0,51,positive regulation of fibroblast proliferation,BP,
13114,GO:0048149,1,0.900797648218529,0,14,behavioral response to ethanol,BP,
13116,GO:0048160,1,0.993854612486899,0,1,primary follicle stage,BP,
13117,GO:0048162,1,0.976749093796925,0,3,multi-layer follicle stage,BP,
13118,GO:0048165,1,0.98787634103891,0,2,fused antrum stage,BP,
13121,GO:0048169,1,0.859418865248258,0,22,regulation of long-term neuronal synaptic plasticity,BP,
13122,GO:0048170,1,0.974332802674352,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
13123,GO:0048172,1,0.911844764801892,0,14,regulation of short-term neuronal synaptic plasticity,BP,
13124,GO:0048174,1,0.993583149764454,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
13125,GO:0048175,1,0.992752580435624,0,1,hepatocyte growth factor biosynthetic process,BP,
13126,GO:0048176,1,0.992752580435624,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
13127,GO:0048178,1,0.992752580435624,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
13128,GO:0048179,1,0.978845684349066,0,3,activin receptor complex,CC,
13129,GO:0048180,1,0.992193225579856,0,1,activin complex,CC,
13130,GO:0048185,1,0.919363554998232,0,12,activin binding,MF,
13131,GO:0048188,1,0.91280961481182,0,13,Set1C/COMPASS complex,CC,
13133,GO:0048194,1,0.940549337845713,0,9,Golgi vesicle budding,BP,
13134,GO:0048199,1,0.62290738953292,0,67,vesicle targeting, to, from or within Golgi,BP,
13135,GO:0048200,1,0.972251010109934,0,4,Golgi transport vesicle coating,BP,
13136,GO:0048203,1,0.98469620447127,0,2,vesicle targeting, trans-Golgi to endosome,BP,
13137,GO:0048205,1,0.972251010109934,0,4,COPI coating of Golgi vesicle,BP,
13138,GO:0048207,1,0.64541000453199,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
13139,GO:0048208,1,0.64541000453199,0,62,COPII vesicle coating,BP,
13140,GO:0048209,1,0.986209254358,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
13141,GO:0048210,1,0.984425409543303,0,2,Golgi vesicle fusion to target membrane,BP,
13142,GO:0048211,1,0.993384615142497,0,1,Golgi vesicle docking,BP,
13143,GO:0048213,1,0.984674608039519,0,2,Golgi vesicle prefusion complex stabilization,BP,
13144,GO:0048227,1,0.943735875719114,0,8,plasma membrane to endosome transport,BP,
13146,GO:0048237,1,0.976706544090589,0,3,rough endoplasmic reticulum lumen,CC,
13147,GO:0048239,1,0.98473665948274,0,2,negative regulation of DNA recombination at telomere,BP,
13148,GO:0048240,1,0.853683508584954,0,21,sperm capacitation,BP,
13149,GO:0048241,1,0.95573070307111,0,6,epinephrine transport,BP,
13150,GO:0048242,1,0.963274024085804,0,5,epinephrine secretion,BP,
13151,GO:0048243,1,0.888586654912297,0,16,norepinephrine secretion,BP,
13153,GO:0048245,1,0.918827781413651,0,11,eosinophil chemotaxis,BP,
13154,GO:0048246,1,0.806073207409358,0,29,macrophage chemotaxis,BP,
13155,GO:0048247,1,0.652039087085289,0,56,lymphocyte chemotaxis,BP,
13156,GO:0048248,1,0.961568292872274,0,5,CXCR3 chemokine receptor binding,MF,
13157,GO:0048250,1,0.984402397098631,0,2,mitochondrial iron ion transport,BP,
13158,GO:0048251,1,0.953529698715143,0,7,elastic fiber assembly,BP,
13159,GO:0048254,1,0.970822880030529,0,4,snoRNA localization,BP,
13160,GO:0048255,1,0.822500966727091,0,28,mRNA stabilization,BP,
13161,GO:0048256,1,0.941686867697129,0,8,flap endonuclease activity,MF,
13162,GO:0048257,1,0.984596115629062,0,2,3'-flap endonuclease activity,MF,
13164,GO:0048260,1,0.727288637232482,0,45,positive regulation of receptor-mediated endocytosis,BP,
13166,GO:0048262,1,0.935926611098631,0,9,determination of dorsal/ventral asymmetry,BP,
13167,GO:0048263,1,0.942926206937363,0,8,determination of dorsal identity,BP,
13168,GO:0048264,1,0.992580124434787,0,1,determination of ventral identity,BP,
13169,GO:0048265,1,0.808175197386695,0,30,response to pain,BP,
13170,GO:0048266,1,0.907179753445727,0,14,behavioral response to pain,BP,
13171,GO:0048268,1,0.896838113022609,0,16,clathrin coat assembly,BP,
13172,GO:0048269,1,0.984678286682967,0,2,methionine adenosyltransferase complex,CC,
13173,GO:0048270,1,0.992183526917986,0,1,methionine adenosyltransferase regulator activity,MF,
13174,GO:0048273,1,0.966366562993154,0,5,mitogen-activated protein kinase p38 binding,MF,
13175,GO:0048278,1,0.64244666327562,0,62,vesicle docking,BP,
13176,GO:0048280,1,0.92832604083973,0,10,vesicle fusion with Golgi apparatus,BP,
13178,GO:0048285,1,0.0126183292274742,0,599,organelle fission,BP,
13179,GO:0048286,1,0.77885759938389,0,36,lung alveolus development,BP,
13180,GO:0048289,1,0.950421785767009,0,7,isotype switching to IgE isotypes,BP,
13181,GO:0048290,1,0.955301523688901,0,6,isotype switching to IgA isotypes,BP,
13182,GO:0048291,1,0.901716243939334,0,14,isotype switching to IgG isotypes,BP,
13183,GO:0048293,1,0.950421785767009,0,7,regulation of isotype switching to IgE isotypes,BP,
13184,GO:0048294,1,0.978608749315815,0,3,negative regulation of isotype switching to IgE isotypes,BP,
13185,GO:0048295,1,0.971201697490919,0,4,positive regulation of isotype switching to IgE isotypes,BP,
13186,GO:0048296,1,0.962141662337373,0,5,regulation of isotype switching to IgA isotypes,BP,
13187,GO:0048297,1,0.992188599416763,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13188,GO:0048298,1,0.969718332749707,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13189,GO:0048302,1,0.908793116004724,0,13,regulation of isotype switching to IgG isotypes,BP,
13190,GO:0048304,1,0.928920822099122,0,10,positive regulation of isotype switching to IgG isotypes,BP,
13193,GO:0048308,1,0.901985974236233,0,14,organelle inheritance,BP,
13194,GO:0048311,1,0.9173315461507,0,13,mitochondrion distribution,BP,
13195,GO:0048312,1,0.948123469164539,0,8,intracellular distribution of mitochondria,BP,
13196,GO:0048313,1,0.901985974236233,0,14,Golgi inheritance,BP,
13197,GO:0048318,1,0.942896549402605,0,8,axial mesoderm development,BP,
13198,GO:0048319,1,0.972876431131953,0,4,axial mesoderm morphogenesis,BP,
13199,GO:0048320,1,0.978763373850514,0,3,axial mesoderm formation,BP,
13200,GO:0048321,1,0.992183386879296,0,1,axial mesodermal cell differentiation,BP,
13201,GO:0048322,1,0.992183386879296,0,1,axial mesodermal cell fate commitment,BP,
13202,GO:0048327,1,0.992183386879296,0,1,axial mesodermal cell fate specification,BP,
13203,GO:0048332,1,0.60840691507551,0,70,mesoderm morphogenesis,BP,
13204,GO:0048333,1,0.795853548518708,0,32,mesodermal cell differentiation,BP,
13205,GO:0048337,1,0.992516661359673,0,1,positive regulation of mesodermal cell fate specification,BP,
13206,GO:0048338,1,0.993173241686921,0,1,mesoderm structural organization,BP,
13207,GO:0048339,1,0.882045570794402,0,18,paraxial mesoderm development,BP,
13208,GO:0048340,1,0.932648783335243,0,10,paraxial mesoderm morphogenesis,BP,
13209,GO:0048341,1,0.950464630037264,0,7,paraxial mesoderm formation,BP,
13210,GO:0048342,1,0.984744830465182,0,2,paraxial mesodermal cell differentiation,BP,
13211,GO:0048343,1,0.984744830465182,0,2,paraxial mesodermal cell fate commitment,BP,
13212,GO:0048352,1,0.993173241686921,0,1,paraxial mesoderm structural organization,BP,
13213,GO:0048364,1,0.992170027168696,0,1,root development,BP,
13214,GO:0048365,1,0.740343577281978,0,44,Rac GTPase binding,MF,
13215,GO:0048368,1,0.895693436425457,0,15,lateral mesoderm development,BP,
13216,GO:0048369,1,0.971920201768547,0,4,lateral mesoderm morphogenesis,BP,
13217,GO:0048370,1,0.971920201768547,0,4,lateral mesoderm formation,BP,
13218,GO:0048371,1,0.979591608265534,0,3,lateral mesodermal cell differentiation,BP,
13219,GO:0048372,1,0.987199923867839,0,2,lateral mesodermal cell fate commitment,BP,
13220,GO:0048377,1,0.987199923867839,0,2,lateral mesodermal cell fate specification,BP,
13221,GO:0048378,1,0.987199923867839,0,2,regulation of lateral mesodermal cell fate specification,BP,
13222,GO:0048382,1,0.970445613376625,0,4,mesendoderm development,BP,
13223,GO:0048384,1,0.802230642177788,0,30,retinoic acid receptor signaling pathway,BP,
13224,GO:0048385,1,0.888914520946755,0,16,regulation of retinoic acid receptor signaling pathway,BP,
13225,GO:0048386,1,0.971541080991041,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13226,GO:0048387,1,0.930761066513351,0,10,negative regulation of retinoic acid receptor signaling pathway,BP,
13227,GO:0048388,1,0.978032362531252,0,3,endosomal lumen acidification,BP,
13228,GO:0048389,1,0.984403479935557,0,2,intermediate mesoderm development,BP,
13229,GO:0048390,1,0.992170392587755,0,1,intermediate mesoderm morphogenesis,BP,
13230,GO:0048391,1,0.992170392587755,0,1,intermediate mesoderm formation,BP,
13231,GO:0048392,1,0.992170392587755,0,1,intermediate mesodermal cell differentiation,BP,
13232,GO:0048403,1,0.981502662504127,0,3,brain-derived neurotrophic factor binding,MF,
13233,GO:0048406,1,0.959079269606621,0,6,nerve growth factor binding,MF,
13234,GO:0048407,1,0.932556992068571,0,11,platelet-derived growth factor binding,MF,
13235,GO:0048408,1,0.977514092596595,0,3,epidermal growth factor binding,MF,
13239,GO:0048475,1,0.528423899633477,0,91,coated membrane,CC,
13240,GO:0048476,1,0.961696649077198,0,5,Holliday junction resolvase complex,CC,
13242,GO:0048478,1,0.959295230189899,0,6,replication fork protection,BP,
13243,GO:0048483,1,0.737251128612813,0,43,autonomic nervous system development,BP,
13244,GO:0048484,1,0.925793183150338,0,11,enteric nervous system development,BP,
13245,GO:0048485,1,0.863145351254781,0,21,sympathetic nervous system development,BP,
13246,GO:0048486,1,0.877310123044533,0,18,parasympathetic nervous system development,BP,
13247,GO:0048487,1,0.780736979453773,0,34,beta-tubulin binding,MF,
13248,GO:0048488,1,0.811211936743756,0,31,synaptic vesicle endocytosis,BP,
13249,GO:0048489,1,0.418326244157961,0,125,synaptic vesicle transport,BP,
13250,GO:0048490,1,0.883615270863479,0,17,anterograde synaptic vesicle transport,BP,
13251,GO:0048495,1,0.968466434571997,0,5,Roundabout binding,MF,
13252,GO:0048496,1,0.9742104702896,0,4,maintenance of animal organ identity,BP,
13253,GO:0048499,1,0.986207209109368,0,2,synaptic vesicle membrane organization,BP,
13254,GO:0048500,1,0.93394556253006,0,9,signal recognition particle,CC,
13255,GO:0048505,1,0.922302727216703,0,11,regulation of timing of cell differentiation,BP,
13260,GO:0048515,1,0.383999436182171,0,130,spermatid differentiation,BP,
13263,GO:0048520,1,0.845791649401885,0,23,positive regulation of behavior,BP,
13264,GO:0048521,1,0.907126356470445,0,13,negative regulation of behavior,BP,
13267,GO:0048524,1,0.463210349286478,0,106,positive regulation of viral process,BP,
13269,GO:0048531,1,0.887148092282449,0,16,beta-1,3-galactosyltransferase activity,MF,
13270,GO:0048532,1,0.886281041491914,0,17,anatomical structure arrangement,BP,
13274,GO:0048537,1,0.950395164685384,0,7,mucosal-associated lymphoid tissue development,BP,
13276,GO:0048539,1,0.951352101077182,0,7,bone marrow development,BP,
13277,GO:0048541,1,0.950395164685384,0,7,Peyer's patch development,BP,
13279,GO:0048546,1,0.707080402115196,0,49,digestive tract morphogenesis,BP,
13280,GO:0048548,1,0.939092274408689,0,9,regulation of pinocytosis,BP,
13281,GO:0048549,1,0.973748530878296,0,4,positive regulation of pinocytosis,BP,
13282,GO:0048550,1,0.964416705534832,0,5,negative regulation of pinocytosis,BP,
13283,GO:0048557,1,0.876796115846621,0,18,embryonic digestive tract morphogenesis,BP,
13284,GO:0048560,1,0.984455617228936,0,2,establishment of anatomical structure orientation,BP,
13285,GO:0048561,1,0.992200615787911,0,1,establishment of animal organ orientation,BP,
13287,GO:0048563,1,0.944375664463936,0,8,post-embryonic animal organ morphogenesis,BP,
13288,GO:0048565,1,0.413192947359127,0,125,digestive tract development,BP,
13289,GO:0048566,1,0.786707152406146,0,33,embryonic digestive tract development,BP,
13290,GO:0048567,1,0.99229380752301,0,1,ectodermal digestive tract morphogenesis,BP,
13292,GO:0048569,1,0.900388925626226,0,15,post-embryonic animal organ development,BP,
13293,GO:0048570,1,0.933323343114731,0,10,notochord morphogenesis,BP,
13294,GO:0048571,1,0.992170027168696,0,1,long-day photoperiodism,BP,
13298,GO:0048588,1,0.284302723845708,0,182,developmental cell growth,BP,
13303,GO:0048597,1,0.976717988930689,0,3,post-embryonic camera-type eye morphogenesis,BP,
13308,GO:0048611,1,0.984894556959156,0,2,embryonic ectodermal digestive tract development,BP,
13309,GO:0048613,1,0.99229380752301,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13310,GO:0048617,1,0.940205615225505,0,9,embryonic foregut morphogenesis,BP,
13311,GO:0048619,1,0.97817466596411,0,3,embryonic hindgut morphogenesis,BP,
13312,GO:0048621,1,0.992184048762491,0,1,post-embryonic digestive tract morphogenesis,BP,
13313,GO:0048625,1,0.964610145491372,0,5,myoblast fate commitment,BP,
13314,GO:0048627,1,0.98502426125498,0,2,myoblast development,BP,
13315,GO:0048630,1,0.944460321316903,0,8,skeletal muscle tissue growth,BP,
13316,GO:0048631,1,0.959423097704786,0,6,regulation of skeletal muscle tissue growth,BP,
13317,GO:0048632,1,0.986464196534305,0,2,negative regulation of skeletal muscle tissue growth,BP,
13318,GO:0048633,1,0.972590735382898,0,4,positive regulation of skeletal muscle tissue growth,BP,
13321,GO:0048636,1,0.643144681012137,0,63,positive regulation of muscle organ development,BP,
13327,GO:0048643,1,0.843002978976979,0,24,positive regulation of skeletal muscle tissue development,BP,
13328,GO:0048644,1,0.576350927470984,0,78,muscle organ morphogenesis,BP,
13329,GO:0048645,1,0.656382037307563,0,58,animal organ formation,BP,
13333,GO:0048661,1,0.5999032326992,0,72,positive regulation of smooth muscle cell proliferation,BP,
13335,GO:0048663,1,0.616357329229465,0,66,neuron fate commitment,BP,
13336,GO:0048664,1,0.925867597475389,0,10,neuron fate determination,BP,
13337,GO:0048665,1,0.799269069657385,0,30,neuron fate specification,BP,
13340,GO:0048668,1,0.849740930604644,0,24,collateral sprouting,BP,
13341,GO:0048669,1,0.966093560559181,0,5,collateral sprouting in absence of injury,BP,
13342,GO:0048670,1,0.883600283085684,0,18,regulation of collateral sprouting,BP,
13343,GO:0048671,1,0.942005067508651,0,9,negative regulation of collateral sprouting,BP,
13344,GO:0048672,1,0.938027536953564,0,9,positive regulation of collateral sprouting,BP,
13345,GO:0048673,1,0.992170027168696,0,1,collateral sprouting of intact axon in response to injury,BP,
13346,GO:0048675,1,0.509627496969665,0,99,axon extension,BP,
13347,GO:0048677,1,0.980554366455069,0,3,axon extension involved in regeneration,BP,
13348,GO:0048678,1,0.639983394350216,0,62,response to axon injury,BP,
13349,GO:0048679,1,0.854629169116688,0,22,regulation of axon regeneration,BP,
13350,GO:0048680,1,0.955395900015383,0,6,positive regulation of axon regeneration,BP,
13351,GO:0048681,1,0.919473011742173,0,12,negative regulation of axon regeneration,BP,
13352,GO:0048682,1,0.980554366455069,0,3,sprouting of injured axon,BP,
13353,GO:0048683,1,0.992170027168696,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13354,GO:0048685,1,0.992170027168696,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13355,GO:0048686,1,0.986487403242415,0,2,regulation of sprouting of injured axon,BP,
13356,GO:0048687,1,0.992473500715898,0,1,positive regulation of sprouting of injured axon,BP,
13357,GO:0048688,1,0.993968861631603,0,1,negative regulation of sprouting of injured axon,BP,
13358,GO:0048690,1,0.986487403242415,0,2,regulation of axon extension involved in regeneration,BP,
13359,GO:0048691,1,0.992473500715898,0,1,positive regulation of axon extension involved in regeneration,BP,
13360,GO:0048692,1,0.993968861631603,0,1,negative regulation of axon extension involved in regeneration,BP,
13361,GO:0048696,1,0.978776296365796,0,3,regulation of collateral sprouting in absence of injury,BP,
13362,GO:0048697,1,0.984744828746871,0,2,positive regulation of collateral sprouting in absence of injury,BP,
13363,GO:0048698,1,0.993939732189209,0,1,negative regulation of collateral sprouting in absence of injury,BP,
13365,GO:0048701,1,0.730927634615348,0,45,embryonic cranial skeleton morphogenesis,BP,
13366,GO:0048702,1,0.952438240977938,0,7,embryonic neurocranium morphogenesis,BP,
13367,GO:0048703,1,0.92649277365461,0,11,embryonic viscerocranium morphogenesis,BP,
13368,GO:0048704,1,0.514327255404829,0,93,embryonic skeletal system morphogenesis,BP,
13372,GO:0048709,1,0.549355278173794,0,82,oligodendrocyte differentiation,BP,
13373,GO:0048710,1,0.832632720510145,0,25,regulation of astrocyte differentiation,BP,
13374,GO:0048711,1,0.921237071244222,0,11,positive regulation of astrocyte differentiation,BP,
13375,GO:0048712,1,0.91485688537817,0,12,negative regulation of astrocyte differentiation,BP,
13376,GO:0048713,1,0.801318499366148,0,30,regulation of oligodendrocyte differentiation,BP,
13377,GO:0048714,1,0.88860487810113,0,16,positive regulation of oligodendrocyte differentiation,BP,
13378,GO:0048715,1,0.921412960297115,0,11,negative regulation of oligodendrocyte differentiation,BP,
13380,GO:0048730,1,0.81017450122,0,29,epidermis morphogenesis,BP,
13383,GO:0048733,1,0.950778962287721,0,7,sebaceous gland development,BP,
13384,GO:0048736,1,0.317685486988346,0,164,appendage development,BP,
13386,GO:0048739,1,0.940107717098216,0,9,cardiac muscle fiber development,BP,
13387,GO:0048741,1,0.812744337448023,0,29,skeletal muscle fiber development,BP,
13388,GO:0048742,1,0.930323195235601,0,10,regulation of skeletal muscle fiber development,BP,
13389,GO:0048743,1,0.949298222316154,0,7,positive regulation of skeletal muscle fiber development,BP,
13390,GO:0048745,1,0.878461763732147,0,19,smooth muscle tissue development,BP,
13391,GO:0048747,1,0.701733969248263,0,50,muscle fiber development,BP,
13392,GO:0048749,1,0.98644728790691,0,2,compound eye development,BP,
13393,GO:0048752,1,0.952964713514266,0,7,semicircular canal morphogenesis,BP,
13394,GO:0048753,1,0.828390557657084,0,26,pigment granule organization,BP,
13395,GO:0048754,1,0.353311068475343,0,148,branching morphogenesis of an epithelial tube,BP,
13396,GO:0048755,1,0.940175438552982,0,9,branching morphogenesis of a nerve,BP,
13397,GO:0048757,1,0.929648367631039,0,10,pigment granule maturation,BP,
13398,GO:0048762,1,0.275654936610876,0,180,mesenchymal cell differentiation,BP,
13399,GO:0048763,1,0.976127305237538,0,4,calcium-induced calcium release activity,MF,
13400,GO:0048764,1,0.992170027168696,0,1,trichoblast maturation,BP,
13401,GO:0048765,1,0.992170027168696,0,1,root hair cell differentiation,BP,
13402,GO:0048767,1,0.992170027168696,0,1,root hair elongation,BP,
13403,GO:0048769,1,0.980271740718351,0,3,sarcomerogenesis,BP,
13406,GO:0048786,1,0.815723190333155,0,31,presynaptic active zone,CC,
13407,GO:0048787,1,0.973692440084214,0,4,presynaptic active zone membrane,CC,
13408,GO:0048788,1,0.988008547554871,0,2,cytoskeleton of presynaptic active zone,CC,
13409,GO:0048789,1,0.99393002522899,0,1,cytoskeletal matrix organization at active zone,BP,
13410,GO:0048790,1,0.992170027168696,0,1,maintenance of presynaptic active zone structure,BP,
13411,GO:0048791,1,0.8176234892925,0,30,calcium ion-regulated exocytosis of neurotransmitter,BP,
13412,GO:0048792,1,0.992983658577413,0,1,spontaneous exocytosis of neurotransmitter,BP,
13413,GO:0048793,1,0.946267409312436,0,8,pronephros development,BP,
13414,GO:0048799,1,0.866501101133796,0,21,animal organ maturation,BP,
13417,GO:0048808,1,0.971252191202823,0,4,male genitalia morphogenesis,BP,
13419,GO:0048813,1,0.453482555605608,0,118,dendrite morphogenesis,BP,
13420,GO:0048814,1,0.608710736743633,0,74,regulation of dendrite morphogenesis,BP,
13421,GO:0048817,1,0.987706890292372,0,2,negative regulation of hair follicle maturation,BP,
13422,GO:0048818,1,0.965025451808789,0,5,positive regulation of hair follicle maturation,BP,
13423,GO:0048819,1,0.946461131688524,0,8,regulation of hair follicle maturation,BP,
13424,GO:0048820,1,0.89555916533658,0,16,hair follicle maturation,BP,
13425,GO:0048821,1,0.848130523961348,0,23,erythrocyte development,BP,
13426,GO:0048822,1,0.986221085256287,0,2,enucleate erythrocyte development,BP,
13427,GO:0048839,1,0.287439065257643,0,175,inner ear development,BP,
13428,GO:0048840,1,0.966701163743658,0,5,otolith development,BP,
13429,GO:0048841,1,0.899165887863306,0,16,regulation of axon extension involved in axon guidance,BP,
13430,GO:0048842,1,0.954365144671677,0,7,positive regulation of axon extension involved in axon guidance,BP,
13431,GO:0048843,1,0.947225244094506,0,8,negative regulation of axon extension involved in axon guidance,BP,
13432,GO:0048844,1,0.673379235020657,0,57,artery morphogenesis,BP,
13433,GO:0048845,1,0.932727893157187,0,10,venous blood vessel morphogenesis,BP,
13434,GO:0048846,1,0.872295030452192,0,21,axon extension involved in axon guidance,BP,
13435,GO:0048850,1,0.980271740710536,0,3,hypophysis morphogenesis,BP,
13436,GO:0048852,1,0.972617011963225,0,4,diencephalon morphogenesis,BP,
13437,GO:0048853,1,0.905029661052936,0,14,forebrain morphogenesis,BP,
13438,GO:0048854,1,0.797924161708854,0,33,brain morphogenesis,BP,
13439,GO:0048855,1,0.993986332267412,0,1,adenohypophysis morphogenesis,BP,
13441,GO:0048857,1,0.639988392694844,0,62,neural nucleus development,BP,
13443,GO:0048859,1,0.963227277869689,0,5,formation of anatomical boundary,BP,
13444,GO:0048861,1,0.972634735343909,0,4,leukemia inhibitory factor signaling pathway,BP,
13445,GO:0048863,1,0.315298134434334,0,162,stem cell differentiation,BP,
13446,GO:0048864,1,0.642681838051705,0,62,stem cell development,BP,
13447,GO:0048865,1,0.940752300567781,0,8,stem cell fate commitment,BP,
13448,GO:0048866,1,0.97674683491337,0,3,stem cell fate specification,BP,
13449,GO:0048867,1,0.976822833740677,0,3,stem cell fate determination,BP,
13454,GO:0048873,1,0.803316726945399,0,30,homeostasis of number of cells within a tissue,BP,
13455,GO:0048874,1,0.992830992499847,0,1,homeostasis of number of cells in a free-living population,BP,
13456,GO:0048875,1,0.938574410601663,0,9,chemical homeostasis within a tissue,BP,
13458,GO:0048880,1,0.97258442342686,0,4,sensory system development,BP,
13459,GO:0048892,1,0.99259542221191,0,1,lateral line nerve development,BP,
13460,GO:0048894,1,0.99259542221191,0,1,efferent axon development in a lateral line nerve,BP,
13461,GO:0048925,1,0.99259542221191,0,1,lateral line system development,BP,
13462,GO:0048934,1,0.913210248308046,0,13,peripheral nervous system neuron differentiation,BP,
13463,GO:0048935,1,0.913210248308046,0,13,peripheral nervous system neuron development,BP,
13464,GO:0048936,1,0.977968705570145,0,3,peripheral nervous system neuron axonogenesis,BP,
13465,GO:0050000,1,0.617813516067703,0,65,chromosome localization,BP,
13466,GO:0050023,1,0.992171548272577,0,1,L-fuconate dehydratase activity,MF,
13467,GO:0050031,1,0.992243903618009,0,1,L-pipecolate oxidase activity,MF,
13468,GO:0050038,1,0.992170027168696,0,1,L-xylulose reductase (NADP+) activity,MF,
13469,GO:0050051,1,0.96961267988183,0,4,leukotriene-B4 20-monooxygenase activity,MF,
13470,GO:0050062,1,0.986206153470563,0,2,long-chain-fatty-acyl-CoA reductase activity,MF,
13471,GO:0050072,1,0.951652788828849,0,7,m7G(5')pppN diphosphatase activity,MF,
13472,GO:0050080,1,0.992196309955591,0,1,malonyl-CoA decarboxylase activity,MF,
13473,GO:0050104,1,0.992170027168696,0,1,L-gulonate 3-dehydrogenase activity,MF,
13474,GO:0050113,1,0.992170027168696,0,1,inositol oxygenase activity,MF,
13475,GO:0050115,1,0.993923335090433,0,1,myosin-light-chain-phosphatase activity,MF,
13476,GO:0050119,1,0.987543787600579,0,2,N-acetylglucosamine deacetylase activity,MF,
13477,GO:0050121,1,0.992170027168696,0,1,N-acylglucosamine 2-epimerase activity,MF,
13478,GO:0050124,1,0.993337365182322,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13479,GO:0050129,1,0.992753533384011,0,1,N-formylglutamate deformylase activity,MF,
13480,GO:0050135,1,0.984400887813367,0,2,NAD(P)+ nucleosidase activity,MF,
13481,GO:0050136,1,0.743617777713172,0,38,NADH dehydrogenase (quinone) activity,MF,
13482,GO:0050144,1,0.992294630214608,0,1,nucleoside deoxyribosyltransferase activity,MF,
13483,GO:0050145,1,0.977100789265676,0,3,nucleoside phosphate kinase activity,MF,
13484,GO:0050146,1,0.993977207121898,0,1,nucleoside phosphotransferase activity,MF,
13485,GO:0050152,1,0.992170027168696,0,1,omega-amidase activity,MF,
13486,GO:0050178,1,0.992170027168696,0,1,phenylpyruvate tautomerase activity,MF,
13487,GO:0050197,1,0.992218462009056,0,1,phytanate-CoA ligase activity,MF,
13488,GO:0050201,1,0.99345319833538,0,1,fucokinase activity,MF,
13489,GO:0050211,1,0.992564231268535,0,1,procollagen galactosyltransferase activity,MF,
13490,GO:0050220,1,0.976695501202423,0,3,prostaglandin-E synthase activity,MF,
13491,GO:0050221,1,0.992170027168696,0,1,prostaglandin-E2 9-reductase activity,MF,
13492,GO:0050252,1,0.977872425962223,0,3,retinol O-fatty-acyltransferase activity,MF,
13493,GO:0050253,1,0.986404895165832,0,2,retinyl-palmitate esterase activity,MF,
13494,GO:0050254,1,0.976738050539847,0,3,rhodopsin kinase activity,MF,
13495,GO:0050262,1,0.984648173044371,0,2,ribosylnicotinamide kinase activity,MF,
13496,GO:0050265,1,0.98054048839365,0,3,RNA uridylyltransferase activity,MF,
13498,GO:0050290,1,0.993890749641491,0,1,sphingomyelin phosphodiesterase D activity,MF,
13499,GO:0050291,1,0.947168020747917,0,7,sphingosine N-acyltransferase activity,MF,
13500,GO:0050294,1,0.969049711908575,0,4,steroid sulfotransferase activity,MF,
13501,GO:0050308,1,0.936550853790798,0,9,sugar-phosphatase activity,MF,
13502,GO:0050309,1,0.977585016458182,0,3,sugar-terminal-phosphatase activity,MF,
13503,GO:0050313,1,0.992170027168696,0,1,sulfur dioxygenase activity,MF,
13504,GO:0050321,1,0.920583529429678,0,12,tau-protein kinase activity,MF,
13505,GO:0050333,1,0.992170503595135,0,1,thiamin-triphosphatase activity,MF,
13506,GO:0050346,1,0.992294630214608,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13507,GO:0050347,1,0.985329093544572,0,2,trans-octaprenyltranstransferase activity,MF,
13508,GO:0050353,1,0.992461920177581,0,1,trimethyllysine dioxygenase activity,MF,
13509,GO:0050355,1,0.993796223457449,0,1,triphosphatase activity,MF,
13510,GO:0050379,1,0.993950261277736,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13511,GO:0050405,1,0.987981391222616,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13512,GO:0050421,1,0.992312759411149,0,1,nitrite reductase (NO-forming) activity,MF,
13513,GO:0050427,1,0.866642844278839,0,19,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13514,GO:0050428,1,0.957737235563543,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13515,GO:0050429,1,0.99398633226789,0,1,calcium-dependent phospholipase C activity,MF,
13516,GO:0050431,1,0.893026001149759,0,17,transforming growth factor beta binding,MF,
13517,GO:0050432,1,0.710241999686117,0,47,catecholamine secretion,BP,
13518,GO:0050433,1,0.723259414851284,0,44,regulation of catecholamine secretion,BP,
13519,GO:0050434,1,0.739842513317263,0,41,positive regulation of viral transcription,BP,
13520,GO:0050435,1,0.832123998275593,0,26,beta-amyloid metabolic process,BP,
13521,GO:0050436,1,0.987446834834608,0,2,microfibril binding,MF,
13522,GO:0050444,1,0.992842792648331,0,1,aquacobalamin reductase (NADPH) activity,MF,
13523,GO:0050462,1,0.992170027168696,0,1,N-acetylneuraminate synthase activity,MF,
13524,GO:0050473,1,0.97863637663488,0,3,arachidonate 15-lipoxygenase activity,MF,
13525,GO:0050479,1,0.992294630214608,0,1,glyceryl-ether monooxygenase activity,MF,
13526,GO:0050480,1,0.992189184885852,0,1,imidazolonepropionase activity,MF,
13527,GO:0050482,1,0.805973095749843,0,29,arachidonic acid secretion,BP,
13528,GO:0050497,1,0.985064270762856,0,2,transferase activity, transferring alkylthio groups,MF,
13529,GO:0050501,1,0.969881816347913,0,4,hyaluronan synthase activity,MF,
13531,GO:0050509,1,0.986232906007673,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13532,GO:0050510,1,0.973188929953033,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13533,GO:0050512,1,0.992183857473324,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13534,GO:0050528,1,0.992237412033237,0,1,acyloxyacyl hydrolase activity,MF,
13535,GO:0050542,1,0.954268875549789,0,6,icosanoid binding,MF,
13537,GO:0050544,1,0.96180185991363,0,5,arachidonic acid binding,MF,
13538,GO:0050560,1,0.992909323579839,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13539,GO:0050561,1,0.993448139432985,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13540,GO:0050567,1,0.985822938811149,0,2,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13541,GO:0050571,1,0.992170027168696,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13542,GO:0050577,1,0.992170027168696,0,1,GDP-L-fucose synthase activity,MF,
13543,GO:0050591,1,0.992406577664907,0,1,quinine 3-monooxygenase activity,MF,
13544,GO:0050610,1,0.984400887813367,0,2,methylarsonate reductase activity,MF,
13545,GO:0050613,1,0.985556864931642,0,2,delta14-sterol reductase activity,MF,
13546,GO:0050614,1,0.993706495031802,0,1,delta24-sterol reductase activity,MF,
13547,GO:0050632,1,0.992170027168696,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13548,GO:0050646,1,0.992170214047121,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13549,GO:0050647,1,0.992170214047121,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13550,GO:0050648,1,0.992170214047121,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13551,GO:0050649,1,0.992406577664907,0,1,testosterone 6-beta-hydroxylase activity,MF,
13552,GO:0050650,1,0.816607071950009,0,29,chondroitin sulfate proteoglycan biosynthetic process,BP,
13553,GO:0050651,1,0.900739366530276,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13554,GO:0050652,1,0.993271572956339,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13555,GO:0050653,1,0.986793206265979,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13558,GO:0050656,1,0.958311640982618,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13559,GO:0050657,1,0.264196931679445,0,186,nucleic acid transport,BP,
13560,GO:0050658,1,0.264196931679445,0,186,RNA transport,BP,
13561,GO:0050659,1,0.987894103995116,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13566,GO:0050664,1,0.90512796404854,0,14,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13567,GO:0050665,1,0.937187179036911,0,9,hydrogen peroxide biosynthetic process,BP,
13568,GO:0050666,1,0.984541098948715,0,2,regulation of homocysteine metabolic process,BP,
13569,GO:0050667,1,0.902565728994073,0,14,homocysteine metabolic process,BP,
13570,GO:0050668,1,0.992209142954877,0,1,positive regulation of homocysteine metabolic process,BP,
13573,GO:0050672,1,0.624000243443591,0,64,negative regulation of lymphocyte proliferation,BP,
13575,GO:0050674,1,0.992170027168696,0,1,urothelial cell proliferation,BP,
13576,GO:0050675,1,0.992170027168696,0,1,regulation of urothelial cell proliferation,BP,
13577,GO:0050677,1,0.992170027168696,0,1,positive regulation of urothelial cell proliferation,BP,
13581,GO:0050681,1,0.743391443133708,0,42,androgen receptor binding,MF,
13582,GO:0050682,1,0.9879988762134,0,2,AF-2 domain binding,MF,
13583,GO:0050683,1,0.993597059851803,0,1,AF-1 domain binding,MF,
13584,GO:0050684,1,0.482141213498356,0,100,regulation of mRNA processing,BP,
13585,GO:0050685,1,0.844737530215233,0,23,positive regulation of mRNA processing,BP,
13586,GO:0050686,1,0.807871995409762,0,29,negative regulation of mRNA processing,BP,
13587,GO:0050687,1,0.865808564333888,0,20,negative regulation of defense response to virus,BP,
13588,GO:0050688,1,0.536579859824668,0,86,regulation of defense response to virus,BP,
13589,GO:0050689,1,0.969220993101231,0,4,negative regulation of defense response to virus by host,BP,
13590,GO:0050690,1,0.815666038110195,0,28,regulation of defense response to virus by virus,BP,
13591,GO:0050691,1,0.793856169863087,0,31,regulation of defense response to virus by host,BP,
13592,GO:0050692,1,0.978935529747795,0,3,DBD domain binding,MF,
13593,GO:0050693,1,0.957866070650569,0,6,LBD domain binding,MF,
13594,GO:0050694,1,0.969837180345914,0,4,galactose 3-O-sulfotransferase activity,MF,
13595,GO:0050698,1,0.98520688989789,0,2,proteoglycan sulfotransferase activity,MF,
13597,GO:0050700,1,0.953209709463338,0,7,CARD domain binding,MF,
13600,GO:0050703,1,0.962189857729456,0,5,interleukin-1 alpha secretion,BP,
13602,GO:0050705,1,0.969785060820785,0,4,regulation of interleukin-1 alpha secretion,BP,
13606,GO:0050709,1,0.466757714999438,0,105,negative regulation of protein secretion,BP,
13607,GO:0050710,1,0.703429484086193,0,48,negative regulation of cytokine secretion,BP,
13608,GO:0050711,1,0.941695563599447,0,8,negative regulation of interleukin-1 secretion,BP,
13609,GO:0050712,1,0.992170027168696,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13610,GO:0050713,1,0.963471468556354,0,5,negative regulation of interleukin-1 beta secretion,BP,
13614,GO:0050717,1,0.977439746082856,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13616,GO:0050719,1,0.992170027168696,0,1,interleukin-1 alpha biosynthetic process,BP,
13617,GO:0050720,1,0.977203811458043,0,3,interleukin-1 beta biosynthetic process,BP,
13618,GO:0050721,1,0.992170027168696,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13619,GO:0050722,1,0.984916593421224,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13620,GO:0050725,1,0.984916593421224,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13621,GO:0050726,1,0.992170027168696,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13623,GO:0050728,1,0.482355463102966,0,99,negative regulation of inflammatory response,BP,
13624,GO:0050729,1,0.477571715651057,0,100,positive regulation of inflammatory response,BP,
13627,GO:0050732,1,0.741949500188538,0,41,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13628,GO:0050733,1,0.948661484250861,0,7,RS domain binding,MF,
13629,GO:0050746,1,0.904424895899856,0,14,regulation of lipoprotein metabolic process,BP,
13630,GO:0050747,1,0.964996599843293,0,5,positive regulation of lipoprotein metabolic process,BP,
13631,GO:0050748,1,0.957363418339206,0,6,negative regulation of lipoprotein metabolic process,BP,
13632,GO:0050750,1,0.889230671786766,0,16,low-density lipoprotein particle receptor binding,MF,
13633,GO:0050751,1,0.992170027168696,0,1,fractalkine biosynthetic process,BP,
13634,GO:0050752,1,0.992170027168696,0,1,regulation of fractalkine biosynthetic process,BP,
13635,GO:0050754,1,0.992170027168696,0,1,positive regulation of fractalkine biosynthetic process,BP,
13637,GO:0050756,1,0.992170027168696,0,1,fractalkine metabolic process,BP,
13638,GO:0050757,1,0.984559977288054,0,2,thymidylate synthase biosynthetic process,BP,
13639,GO:0050758,1,0.984559977288054,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13640,GO:0050760,1,0.992330362407354,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13642,GO:0050765,1,0.922735222671166,0,11,negative regulation of phagocytosis,BP,
13649,GO:0050772,1,0.605327797438591,0,73,positive regulation of axonogenesis,BP,
13650,GO:0050773,1,0.438201558606532,0,122,regulation of dendrite development,BP,
13651,GO:0050774,1,0.903496747190463,0,15,negative regulation of dendrite morphogenesis,BP,
13652,GO:0050775,1,0.802207454548361,0,33,positive regulation of dendrite morphogenesis,BP,
13656,GO:0050779,1,0.870794225200372,0,20,RNA destabilization,BP,
13657,GO:0050780,1,0.89839864038739,0,15,dopamine receptor binding,MF,
13658,GO:0050783,1,0.992252666157398,0,1,cocaine metabolic process,BP,
13660,GO:0050787,1,0.986171960141767,0,2,detoxification of mercury ion,BP,
13666,GO:0050795,1,0.638637116389446,0,62,regulation of behavior,BP,
13671,GO:0050803,1,0.447490233872999,0,117,regulation of synapse structure or activity,BP,
13673,GO:0050805,1,0.631317638586166,0,66,negative regulation of synaptic transmission,BP,
13675,GO:0050807,1,0.459825815794626,0,113,regulation of synapse organization,BP,
13676,GO:0050808,1,0.19438848766872,0,238,synapse organization,BP,
13678,GO:0050811,1,0.905852361597802,0,14,GABA receptor binding,MF,
13680,GO:0050815,1,0.957841690108111,0,6,phosphoserine binding,MF,
13681,GO:0050816,1,0.979581793720152,0,3,phosphothreonine binding,MF,
13684,GO:0050819,1,0.681865703002222,0,51,negative regulation of coagulation,BP,
13685,GO:0050820,1,0.832942871986866,0,25,positive regulation of coagulation,BP,
13687,GO:0050822,1,0.993054237388747,0,1,peptide stabilization,BP,
13688,GO:0050823,1,0.993054237388747,0,1,peptide antigen stabilization,BP,
13689,GO:0050828,1,0.992294630214608,0,1,regulation of liquid surface tension,BP,
13691,GO:0050830,1,0.606526681732022,0,65,defense response to Gram-positive bacterium,BP,
13692,GO:0050832,1,0.784925230321201,0,31,defense response to fungus,BP,
13693,GO:0050833,1,0.970307918080937,0,4,pyruvate transmembrane transporter activity,MF,
13695,GO:0050840,1,0.716295459884677,0,48,extracellular matrix binding,MF,
13696,GO:0050847,1,0.973954944254629,0,4,progesterone receptor signaling pathway,BP,
13698,GO:0050849,1,0.876796895189678,0,18,negative regulation of calcium-mediated signaling,BP,
13699,GO:0050850,1,0.756738311820339,0,38,positive regulation of calcium-mediated signaling,BP,
13702,GO:0050853,1,0.729244033686047,0,44,B cell receptor signaling pathway,BP,
13703,GO:0050854,1,0.720259043504473,0,45,regulation of antigen receptor-mediated signaling pathway,BP,
13704,GO:0050855,1,0.903799300233935,0,14,regulation of B cell receptor signaling pathway,BP,
13705,GO:0050856,1,0.783557617180234,0,33,regulation of T cell receptor signaling pathway,BP,
13706,GO:0050857,1,0.878000598919875,0,18,positive regulation of antigen receptor-mediated signaling pathway,BP,
13707,GO:0050858,1,0.854868289460994,0,21,negative regulation of antigen receptor-mediated signaling pathway,BP,
13708,GO:0050859,1,0.970435362943951,0,4,negative regulation of B cell receptor signaling pathway,BP,
13709,GO:0050860,1,0.874066237683451,0,18,negative regulation of T cell receptor signaling pathway,BP,
13710,GO:0050861,1,0.952951220010343,0,7,positive regulation of B cell receptor signaling pathway,BP,
13711,GO:0050862,1,0.926988786071318,0,10,positive regulation of T cell receptor signaling pathway,BP,
13715,GO:0050866,1,0.30446750183234,0,161,negative regulation of cell activation,BP,
13717,GO:0050868,1,0.510340060956851,0,91,negative regulation of T cell activation,BP,
13718,GO:0050869,1,0.802240134799294,0,30,negative regulation of B cell activation,BP,
13721,GO:0050872,1,0.910517174419272,0,13,white fat cell differentiation,BP,
13725,GO:0050879,1,0.718236392904417,0,47,multicellular organismal movement,BP,
13726,GO:0050880,1,0.381792532218398,0,131,regulation of blood vessel size,BP,
13727,GO:0050881,1,0.718236392904417,0,47,musculoskeletal movement,BP,
13728,GO:0050882,1,0.968952185059572,0,5,voluntary musculoskeletal movement,BP,
13729,GO:0050883,1,0.984492575631969,0,2,musculoskeletal movement, spinal reflex action,BP,
13730,GO:0050884,1,0.895481061874958,0,16,neuromuscular process controlling posture,BP,
13732,GO:0050886,1,0.562109411595106,0,79,endocrine process,BP,
13734,GO:0050891,1,0.64622112150695,0,62,multicellular organismal water homeostasis,BP,
13735,GO:0050892,1,0.787494920803041,0,33,intestinal absorption,BP,
13736,GO:0050893,1,0.97096287429517,0,4,sensory processing,BP,
13737,GO:0050894,1,0.993986332268891,0,1,determination of affect,BP,
13739,GO:0050897,1,0.993986332265624,0,1,cobalt ion binding,MF,
13741,GO:0050901,1,0.858694353521275,0,21,leukocyte tethering or rolling,BP,
13742,GO:0050902,1,0.985156888461736,0,2,leukocyte adhesive activation,BP,
13743,GO:0050904,1,0.97884889438967,0,3,diapedesis,BP,
13745,GO:0050906,1,0.0251439654918856,0,468,detection of stimulus involved in sensory perception,BP,
13746,GO:0050907,1,0.0359583380958221,0,419,detection of chemical stimulus involved in sensory perception,BP,
13747,GO:0050908,1,0.887762765089065,0,17,detection of light stimulus involved in visual perception,BP,
13748,GO:0050909,1,0.622398401755681,0,62,sensory perception of taste,BP,
13749,GO:0050910,1,0.917876634400501,0,12,detection of mechanical stimulus involved in sensory perception of sound,BP,
13750,GO:0050911,1,0.0504113414076754,0,376,detection of chemical stimulus involved in sensory perception of smell,BP,
13751,GO:0050912,1,0.733584008411941,0,40,detection of chemical stimulus involved in sensory perception of taste,BP,
13752,GO:0050913,1,0.746253586601747,0,38,sensory perception of bitter taste,BP,
13753,GO:0050915,1,0.964004038621321,0,5,sensory perception of sour taste,BP,
13754,GO:0050916,1,0.956341522270184,0,6,sensory perception of sweet taste,BP,
13755,GO:0050917,1,0.95665866771355,0,6,sensory perception of umami taste,BP,
13756,GO:0050918,1,0.685732945495334,0,52,positive chemotaxis,BP,
13757,GO:0050919,1,0.865317624226281,0,22,negative chemotaxis,BP,
13760,GO:0050922,1,0.780768054559945,0,35,negative regulation of chemotaxis,BP,
13761,GO:0050923,1,0.975103738436996,0,4,regulation of negative chemotaxis,BP,
13762,GO:0050924,1,0.99394097351296,0,1,positive regulation of negative chemotaxis,BP,
13763,GO:0050925,1,0.988008547469589,0,2,negative regulation of negative chemotaxis,BP,
13764,GO:0050926,1,0.845408192207162,0,23,regulation of positive chemotaxis,BP,
13765,GO:0050927,1,0.850540506539751,0,22,positive regulation of positive chemotaxis,BP,
13766,GO:0050928,1,0.99397342943265,0,1,negative regulation of positive chemotaxis,BP,
13767,GO:0050929,1,0.99394097351296,0,1,induction of negative chemotaxis,BP,
13768,GO:0050930,1,0.912548976557894,0,12,induction of positive chemotaxis,BP,
13769,GO:0050931,1,0.788971367603105,0,34,pigment cell differentiation,BP,
13770,GO:0050932,1,0.939926939775721,0,9,regulation of pigment cell differentiation,BP,
13771,GO:0050942,1,0.954805540519354,0,7,positive regulation of pigment cell differentiation,BP,
13772,GO:0050951,1,0.870003162723225,0,20,sensory perception of temperature stimulus,BP,
13775,GO:0050955,1,0.981680804633141,0,3,thermoception,BP,
13776,GO:0050957,1,0.95344165591892,0,7,equilibrioception,BP,
13777,GO:0050960,1,0.993613659155533,0,1,detection of temperature stimulus involved in thermoception,BP,
13778,GO:0050961,1,0.903809273425628,0,14,detection of temperature stimulus involved in sensory perception,BP,
13779,GO:0050962,1,0.887762765089065,0,17,detection of light stimulus involved in sensory perception,BP,
13780,GO:0050965,1,0.903809273425628,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13781,GO:0050966,1,0.94675589859729,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13782,GO:0050968,1,0.980010272785305,0,3,detection of chemical stimulus involved in sensory perception of pain,BP,
13783,GO:0050974,1,0.84228790138449,0,24,detection of mechanical stimulus involved in sensory perception,BP,
13784,GO:0050975,1,0.978480950205779,0,3,sensory perception of touch,BP,
13785,GO:0050976,1,0.986203733445833,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13786,GO:0050982,1,0.745729597775432,0,42,detection of mechanical stimulus,BP,
13787,GO:0050992,1,0.98441931575969,0,2,dimethylallyl diphosphate biosynthetic process,BP,
13788,GO:0050993,1,0.98441931575969,0,2,dimethylallyl diphosphate metabolic process,BP,
13791,GO:0050996,1,0.82416772408888,0,27,positive regulation of lipid catabolic process,BP,
13793,GO:0050998,1,0.894272478673073,0,16,nitric-oxide synthase binding,MF,
13795,GO:0051000,1,0.866135262985545,0,20,positive regulation of nitric-oxide synthase activity,BP,
13799,GO:0051006,1,0.92625795344387,0,10,positive regulation of lipoprotein lipase activity,BP,
13800,GO:0051010,1,0.931497982101767,0,11,microtubule plus-end binding,MF,
13801,GO:0051011,1,0.951652942880165,0,7,microtubule minus-end binding,MF,
13802,GO:0051012,1,0.986181313916897,0,2,microtubule sliding,BP,
13803,GO:0051013,1,0.958109617881971,0,6,microtubule severing,BP,
13804,GO:0051014,1,0.938468526355775,0,9,actin filament severing,BP,
13806,GO:0051016,1,0.890402172533694,0,16,barbed-end actin filament capping,BP,
13807,GO:0051017,1,0.415593141254097,0,126,actin filament bundle assembly,BP,
13808,GO:0051018,1,0.749273588167414,0,42,protein kinase A binding,MF,
13809,GO:0051019,1,0.853955832951515,0,23,mitogen-activated protein kinase binding,MF,
13811,GO:0051021,1,0.978563489206579,0,3,GDP-dissociation inhibitor binding,MF,
13812,GO:0051022,1,0.978563489206579,0,3,Rho GDP-dissociation inhibitor binding,MF,
13815,GO:0051025,1,0.985025973118038,0,2,negative regulation of immunoglobulin secretion,BP,
13816,GO:0051026,1,0.957150002697466,0,6,chiasma assembly,BP,
13817,GO:0051028,1,0.362105653906539,0,143,mRNA transport,BP,
13818,GO:0051029,1,0.964841489506842,0,5,rRNA transport,BP,
13819,GO:0051030,1,0.976705946882702,0,3,snRNA transport,BP,
13820,GO:0051031,1,0.796059647717976,0,33,tRNA transport,BP,
13821,GO:0051032,1,0.981513254980843,0,3,nucleic acid transmembrane transporter activity,MF,
13822,GO:0051033,1,0.981513254980843,0,3,RNA transmembrane transporter activity,MF,
13823,GO:0051036,1,0.96333339129334,0,5,regulation of endosome size,BP,
13824,GO:0051037,1,0.986675642315805,0,2,regulation of transcription involved in meiotic cell cycle,BP,
13825,GO:0051038,1,0.993824533095325,0,1,negative regulation of transcription involved in meiotic cell cycle,BP,
13826,GO:0051039,1,0.992807034257299,0,1,positive regulation of transcription involved in meiotic cell cycle,BP,
13827,GO:0051040,1,0.985574865695659,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13828,GO:0051041,1,0.992819234468104,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13829,GO:0051042,1,0.992703644198348,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13830,GO:0051043,1,0.861192178255533,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13831,GO:0051044,1,0.904444239052249,0,14,positive regulation of membrane protein ectodomain proteolysis,BP,
13832,GO:0051045,1,0.952214912539056,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
13835,GO:0051048,1,0.247421691970475,0,191,negative regulation of secretion,BP,
13841,GO:0051054,1,0.228667676327144,0,202,positive regulation of DNA metabolic process,BP,
13843,GO:0051056,1,0.132475311599306,0,295,regulation of small GTPase mediated signal transduction,BP,
13844,GO:0051057,1,0.69292890528437,0,52,positive regulation of small GTPase mediated signal transduction,BP,
13845,GO:0051058,1,0.738184297701913,0,44,negative regulation of small GTPase mediated signal transduction,BP,
13846,GO:0051059,1,0.813496091318678,0,28,NF-kappaB binding,MF,
13847,GO:0051066,1,0.984405377815065,0,2,dihydrobiopterin metabolic process,BP,
13848,GO:0051068,1,0.993137491452272,0,1,dihydrolipoamide metabolic process,BP,
13849,GO:0051081,1,0.724510011529113,0,46,nuclear envelope disassembly,BP,
13850,GO:0051082,1,0.454758730617527,0,104,unfolded protein binding,MF,
13851,GO:0051083,1,0.984420987084509,0,2,'de novo' cotranslational protein folding,BP,
13852,GO:0051084,1,0.887359672744219,0,16,'de novo' posttranslational protein folding,BP,
13853,GO:0051085,1,0.914037625109918,0,12,chaperone mediated protein folding requiring cofactor,BP,
13854,GO:0051086,1,0.992175092367501,0,1,chaperone mediated protein folding independent of cofactor,BP,
13855,GO:0051087,1,0.533104592016186,0,86,chaperone binding,MF,
13856,GO:0051088,1,0.980215104823499,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13857,GO:0051089,1,0.993464068713381,0,1,constitutive protein ectodomain proteolysis,BP,
13863,GO:0051095,1,0.937968276122388,0,9,regulation of helicase activity,BP,
13864,GO:0051096,1,0.959053117534174,0,6,positive regulation of helicase activity,BP,
13865,GO:0051097,1,0.978022040606609,0,3,negative regulation of helicase activity,BP,
13868,GO:0051100,1,0.369725016801126,0,137,negative regulation of binding,BP,
13869,GO:0051101,1,0.454471664486851,0,108,regulation of DNA binding,BP,
13870,GO:0051102,1,0.993555815608036,0,1,DNA ligation involved in DNA recombination,BP,
13871,GO:0051103,1,0.921203320396115,0,11,DNA ligation involved in DNA repair,BP,
13872,GO:0051105,1,0.963819574277349,0,5,regulation of DNA ligation,BP,
13873,GO:0051106,1,0.971113015309214,0,4,positive regulation of DNA ligation,BP,
13874,GO:0051107,1,0.992491319388775,0,1,negative regulation of DNA ligation,BP,
13875,GO:0051117,1,0.584704198217406,0,74,ATPase binding,MF,
13876,GO:0051119,1,0.778097856509392,0,34,sugar transmembrane transporter activity,MF,
13877,GO:0051120,1,0.97762663923343,0,3,hepoxilin A3 synthase activity,MF,
13878,GO:0051121,1,0.962626279928121,0,5,hepoxilin metabolic process,BP,
13879,GO:0051122,1,0.962626279928121,0,5,hepoxilin biosynthetic process,BP,
13880,GO:0051123,1,0.805012143110922,0,30,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13881,GO:0051124,1,0.953155625138962,0,7,synaptic growth at neuromuscular junction,BP,
13882,GO:0051125,1,0.842223499037047,0,24,regulation of actin nucleation,BP,
13883,GO:0051126,1,0.956900472745951,0,6,negative regulation of actin nucleation,BP,
13884,GO:0051127,1,0.914538568014405,0,13,positive regulation of actin nucleation,BP,
13888,GO:0051131,1,0.872805283538279,0,18,chaperone-mediated protein complex assembly,BP,
13889,GO:0051132,1,0.927656274643997,0,10,NK T cell activation,BP,
13890,GO:0051133,1,0.940991725558317,0,8,regulation of NK T cell activation,BP,
13891,GO:0051134,1,0.992172217949553,0,1,negative regulation of NK T cell activation,BP,
13892,GO:0051135,1,0.948418800315069,0,7,positive regulation of NK T cell activation,BP,
13893,GO:0051136,1,0.960284517166545,0,6,regulation of NK T cell differentiation,BP,
13894,GO:0051138,1,0.973777103598791,0,4,positive regulation of NK T cell differentiation,BP,
13895,GO:0051139,1,0.993397951175909,0,1,metal ion:proton antiporter activity,MF,
13896,GO:0051140,1,0.969765340616262,0,4,regulation of NK T cell proliferation,BP,
13897,GO:0051142,1,0.969765340616262,0,4,positive regulation of NK T cell proliferation,BP,
13898,GO:0051145,1,0.701423433418551,0,50,smooth muscle cell differentiation,BP,
13899,GO:0051146,1,0.18511758390416,0,238,striated muscle cell differentiation,BP,
13900,GO:0051147,1,0.309436136592695,0,163,regulation of muscle cell differentiation,BP,
13901,GO:0051148,1,0.652682745634903,0,59,negative regulation of muscle cell differentiation,BP,
13902,GO:0051149,1,0.527588394732599,0,89,positive regulation of muscle cell differentiation,BP,
13903,GO:0051150,1,0.836689888361449,0,25,regulation of smooth muscle cell differentiation,BP,
13904,GO:0051151,1,0.924450205568575,0,11,negative regulation of smooth muscle cell differentiation,BP,
13905,GO:0051152,1,0.929444521250884,0,10,positive regulation of smooth muscle cell differentiation,BP,
13906,GO:0051153,1,0.520582693590597,0,90,regulation of striated muscle cell differentiation,BP,
13907,GO:0051154,1,0.812434676922746,0,29,negative regulation of striated muscle cell differentiation,BP,
13908,GO:0051155,1,0.66957931254194,0,55,positive regulation of striated muscle cell differentiation,BP,
13910,GO:0051160,1,0.992282282316394,0,1,L-xylitol catabolic process,BP,
13911,GO:0051164,1,0.992282282316394,0,1,L-xylitol metabolic process,BP,
13912,GO:0051167,1,0.962605280295254,0,5,xylulose 5-phosphate metabolic process,BP,
13920,GO:0051176,1,0.965536739391106,0,5,positive regulation of sulfur metabolic process,BP,
13921,GO:0051177,1,0.948457967300924,0,7,meiotic sister chromatid cohesion,BP,
13923,GO:0051180,1,0.777273675385491,0,34,vitamin transport,BP,
13924,GO:0051181,1,0.829784246962181,0,25,cofactor transport,BP,
13925,GO:0051182,1,0.955722956153239,0,6,coenzyme transport,BP,
13927,GO:0051184,1,0.871023387401038,0,19,cofactor transporter activity,MF,
13928,GO:0051185,1,0.969787873736191,0,4,coenzyme transporter activity,MF,
13932,GO:0051189,1,0.949648605292635,0,7,prosthetic group metabolic process,BP,
13933,GO:0051192,1,0.992170027168696,0,1,prosthetic group binding,MF,
13935,GO:0051194,1,0.907271544486553,0,14,positive regulation of cofactor metabolic process,BP,
13936,GO:0051195,1,0.925620318925272,0,11,negative regulation of cofactor metabolic process,BP,
13938,GO:0051197,1,0.907271544486553,0,14,positive regulation of coenzyme metabolic process,BP,
13939,GO:0051198,1,0.925620318925272,0,11,negative regulation of coenzyme metabolic process,BP,
13940,GO:0051204,1,0.790570498536625,0,32,protein insertion into mitochondrial membrane,BP,
13941,GO:0051205,1,0.716447653918431,0,45,protein insertion into membrane,BP,
13946,GO:0051219,1,0.584847219896712,0,77,phosphoprotein binding,MF,
13947,GO:0051220,1,0.731258866062019,0,43,cytoplasmic sequestering of protein,BP,
13950,GO:0051224,1,0.246727978240296,0,193,negative regulation of protein transport,BP,
13951,GO:0051225,1,0.549596965103449,0,84,spindle assembly,BP,
13952,GO:0051228,1,0.993965884940496,0,1,mitotic spindle disassembly,BP,
13953,GO:0051230,1,0.993965884940496,0,1,spindle disassembly,BP,
13954,GO:0051231,1,0.924006016058847,0,11,spindle elongation,BP,
13955,GO:0051232,1,0.992232866469696,0,1,meiotic spindle elongation,BP,
13956,GO:0051233,1,0.818739461170723,0,28,spindle midzone,CC,
13959,GO:0051236,1,0.259022958367275,0,189,establishment of RNA localization,BP,
13968,GO:0051250,1,0.403049209094832,0,123,negative regulation of lymphocyte activation,BP,
13973,GO:0051255,1,0.930890524187561,0,10,spindle midzone assembly,BP,
13974,GO:0051256,1,0.938154741857989,0,9,mitotic spindle midzone assembly,BP,
13975,GO:0051257,1,0.992260754444587,0,1,meiotic spindle midzone assembly,BP,
13981,GO:0051264,1,0.992428015476869,0,1,mono-olein transacylation activity,MF,
13982,GO:0051265,1,0.992428015476869,0,1,diolein transacylation activity,MF,
13983,GO:0051267,1,0.992795855711929,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13987,GO:0051276,1,0.000280456768977998,0,1106,chromosome organization,BP,
13988,GO:0051279,1,0.6190467913279,0,68,regulation of release of sequestered calcium ion into cytosol,BP,
13989,GO:0051280,1,0.909052922495404,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13990,GO:0051281,1,0.782929477695015,0,34,positive regulation of release of sequestered calcium ion into cytosol,BP,
13993,GO:0051284,1,0.903582115635902,0,14,positive regulation of sequestering of calcium ion,BP,
13994,GO:0051286,1,0.955213775139358,0,7,cell tip,CC,
13997,GO:0051290,1,0.719915809759167,0,43,protein heterotetramerization,BP,
13999,GO:0051292,1,0.941023429238889,0,9,nuclear pore complex assembly,BP,
14000,GO:0051293,1,0.825334175711228,0,28,establishment of spindle localization,BP,
14001,GO:0051294,1,0.869031350505759,0,20,establishment of spindle orientation,BP,
14002,GO:0051295,1,0.967358420861673,0,5,establishment of meiotic spindle localization,BP,
14003,GO:0051296,1,0.992170027168696,0,1,establishment of meiotic spindle orientation,BP,
14004,GO:0051297,1,0.468457427277202,0,109,centrosome organization,BP,
14005,GO:0051298,1,0.657617588047305,0,61,centrosome duplication,BP,
14006,GO:0051299,1,0.905185978427482,0,14,centrosome separation,BP,
14007,GO:0051301,1,0.0188415306759311,0,547,cell division,BP,
14008,GO:0051302,1,0.386325868961823,0,131,regulation of cell division,BP,
14009,GO:0051303,1,0.621574570371464,0,64,establishment of chromosome localization,BP,
14010,GO:0051304,1,0.623566519287517,0,66,chromosome separation,BP,
14011,GO:0051305,1,0.960734471836158,0,6,chromosome movement towards spindle pole,BP,
14012,GO:0051306,1,0.706771035986047,0,48,mitotic sister chromatid separation,BP,
14013,GO:0051307,1,0.892805157727663,0,16,meiotic chromosome separation,BP,
14014,GO:0051308,1,0.992294630214608,0,1,male meiosis chromosome separation,BP,
14015,GO:0051310,1,0.69661928677617,0,48,metaphase plate congression,BP,
14016,GO:0051311,1,0.992260754444587,0,1,meiotic metaphase plate congression,BP,
14017,GO:0051315,1,0.934478668077885,0,9,attachment of mitotic spindle microtubules to kinetochore,BP,
14018,GO:0051321,1,0.217476710471537,0,211,meiotic cell cycle,BP,
14021,GO:0051339,1,0.517036796005635,0,90,regulation of lyase activity,BP,
14025,GO:0051343,1,0.970978160118482,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14031,GO:0051349,1,0.651571782243375,0,59,positive regulation of lyase activity,BP,
14032,GO:0051350,1,0.789343588044044,0,32,negative regulation of lyase activity,BP,
14033,GO:0051351,1,0.954398190648677,0,6,positive regulation of ligase activity,BP,
14037,GO:0051355,1,0.9933511495648,0,1,proprioception involved in equilibrioception,BP,
14038,GO:0051365,1,0.9776465578801,0,3,cellular response to potassium ion starvation,BP,
14039,GO:0051371,1,0.889873254476246,0,18,muscle alpha-actinin binding,MF,
14040,GO:0051373,1,0.96419897053677,0,5,FATZ binding,MF,
14041,GO:0051377,1,0.979661645251285,0,3,mannose-ethanolamine phosphotransferase activity,MF,
14042,GO:0051378,1,0.920754036639014,0,11,serotonin binding,MF,
14043,GO:0051379,1,0.956173643953992,0,6,epinephrine binding,MF,
14044,GO:0051380,1,0.970698852635282,0,4,norepinephrine binding,MF,
14045,GO:0051382,1,0.924591952009686,0,11,kinetochore assembly,BP,
14046,GO:0051383,1,0.89940934664873,0,15,kinetochore organization,BP,
14049,GO:0051386,1,0.923799476007227,0,11,regulation of neurotrophin TRK receptor signaling pathway,BP,
14050,GO:0051387,1,0.969571023074053,0,4,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
14051,GO:0051388,1,0.966244943573874,0,5,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
14052,GO:0051389,1,0.993986332290061,0,1,inactivation of MAPKK activity,BP,
14053,GO:0051391,1,0.993478501023864,0,1,tRNA acetylation,BP,
14054,GO:0051392,1,0.993478501023864,0,1,tRNA N-acetyltransferase activity,MF,
14055,GO:0051393,1,0.807254246526818,0,32,alpha-actinin binding,MF,
14056,GO:0051394,1,0.992170027168696,0,1,regulation of nerve growth factor receptor activity,BP,
14057,GO:0051400,1,0.929337022695524,0,10,BH domain binding,MF,
14060,GO:0051409,1,0.928880630903063,0,10,response to nitrosative stress,BP,
14061,GO:0051410,1,0.963065074183956,0,5,detoxification of nitrogen compound,BP,
14063,GO:0051414,1,0.968448365475305,0,5,response to cortisol,BP,
14064,GO:0051415,1,0.959045145619241,0,6,interphase microtubule nucleation by interphase microtubule organizing center,BP,
14065,GO:0051418,1,0.953275886199634,0,7,microtubule nucleation by microtubule organizing center,BP,
14066,GO:0051424,1,0.992171098945668,0,1,corticotropin-releasing hormone binding,MF,
14067,GO:0051425,1,0.974050252689349,0,4,PTB domain binding,MF,
14068,GO:0051427,1,0.329059804576103,0,156,hormone receptor binding,MF,
14069,GO:0051428,1,0.867051478567972,0,19,peptide hormone receptor binding,MF,
14070,GO:0051429,1,0.955587021471074,0,6,corticotropin-releasing hormone receptor binding,MF,
14071,GO:0051430,1,0.970733081616226,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
14072,GO:0051431,1,0.969043237344425,0,4,corticotropin-releasing hormone receptor 2 binding,MF,
14073,GO:0051433,1,0.993826059850426,0,1,BH2 domain binding,MF,
14074,GO:0051434,1,0.971525435957225,0,4,BH3 domain binding,MF,
14079,GO:0051440,1,0.993180157797307,0,1,regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14080,GO:0051441,1,0.993180157797307,0,1,positive regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14083,GO:0051445,1,0.752353095679782,0,39,regulation of meiotic cell cycle,BP,
14084,GO:0051446,1,0.904579275251369,0,14,positive regulation of meiotic cell cycle,BP,
14085,GO:0051447,1,0.88188627099444,0,17,negative regulation of meiotic cell cycle,BP,
14086,GO:0051450,1,0.9006495782743,0,14,myoblast proliferation,BP,
14087,GO:0051451,1,0.930246238889931,0,10,myoblast migration,BP,
14088,GO:0051452,1,0.699447442541732,0,48,intracellular pH reduction,BP,
14089,GO:0051453,1,0.523051678241807,0,90,regulation of intracellular pH,BP,
14090,GO:0051454,1,0.957409827904871,0,6,intracellular pH elevation,BP,
14091,GO:0051457,1,0.899092509781392,0,15,maintenance of protein location in nucleus,BP,
14092,GO:0051458,1,0.948819145408149,0,7,corticotropin secretion,BP,
14093,GO:0051459,1,0.956188311578755,0,6,regulation of corticotropin secretion,BP,
14094,GO:0051460,1,0.992171098945668,0,1,negative regulation of corticotropin secretion,BP,
14095,GO:0051461,1,0.963735469714026,0,5,positive regulation of corticotropin secretion,BP,
14096,GO:0051462,1,0.963447086149676,0,5,regulation of cortisol secretion,BP,
14097,GO:0051463,1,0.993986332266992,0,1,negative regulation of cortisol secretion,BP,
14098,GO:0051464,1,0.96927741612098,0,4,positive regulation of cortisol secretion,BP,
14099,GO:0051466,1,0.985038659439969,0,2,positive regulation of corticotropin-releasing hormone secretion,BP,
14101,GO:0051481,1,0.905504517261451,0,14,negative regulation of cytosolic calcium ion concentration,BP,
14102,GO:0051482,1,0.811727631524653,0,28,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
14103,GO:0051489,1,0.774440272412308,0,37,regulation of filopodium assembly,BP,
14104,GO:0051490,1,0.977056876060466,0,3,negative regulation of filopodium assembly,BP,
14105,GO:0051491,1,0.836837420342668,0,26,positive regulation of filopodium assembly,BP,
14106,GO:0051492,1,0.614363863847804,0,70,regulation of stress fiber assembly,BP,
14110,GO:0051496,1,0.736405646968764,0,43,positive regulation of stress fiber assembly,BP,
14111,GO:0051497,1,0.871828829855939,0,20,negative regulation of stress fiber assembly,BP,
14112,GO:0051499,1,0.984524522725182,0,2,D-aminoacyl-tRNA deacylase activity,MF,
14113,GO:0051500,1,0.984524522725182,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
14114,GO:0051503,1,0.907783360881496,0,13,adenine nucleotide transport,BP,
14115,GO:0051510,1,0.992170027168696,0,1,regulation of unidimensional cell growth,BP,
14116,GO:0051511,1,0.992170027168696,0,1,negative regulation of unidimensional cell growth,BP,
14117,GO:0051525,1,0.965540852949197,0,5,NFAT protein binding,MF,
14119,GO:0051532,1,0.901457409274856,0,15,regulation of NFAT protein import into nucleus,BP,
14120,GO:0051533,1,0.932183275417944,0,10,positive regulation of NFAT protein import into nucleus,BP,
14121,GO:0051534,1,0.967056602319827,0,5,negative regulation of NFAT protein import into nucleus,BP,
14124,GO:0051538,1,0.977839083715062,0,3,3 iron, 4 sulfur cluster binding,MF,
14127,GO:0051541,1,0.964580130689583,0,5,elastin metabolic process,BP,
14128,GO:0051542,1,0.986261234588054,0,2,elastin biosynthetic process,BP,
14129,GO:0051543,1,0.992228530077066,0,1,regulation of elastin biosynthetic process,BP,
14130,GO:0051545,1,0.992228530077066,0,1,negative regulation of elastin biosynthetic process,BP,
14131,GO:0051546,1,0.900733390676115,0,15,keratinocyte migration,BP,
14132,GO:0051547,1,0.934257336770534,0,10,regulation of keratinocyte migration,BP,
14133,GO:0051548,1,0.988007133699772,0,2,negative regulation of keratinocyte migration,BP,
14134,GO:0051549,1,0.94560275560796,0,8,positive regulation of keratinocyte migration,BP,
14135,GO:0051552,1,0.955965766688255,0,6,flavone metabolic process,BP,
14136,GO:0051560,1,0.888637373424327,0,16,mitochondrial calcium ion homeostasis,BP,
14137,GO:0051561,1,0.941464086392525,0,8,positive regulation of mitochondrial calcium ion concentration,BP,
14138,GO:0051562,1,0.984768483593178,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
14139,GO:0051563,1,0.987053957058315,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
14140,GO:0051567,1,0.80568064117465,0,32,histone H3-K9 methylation,BP,
14141,GO:0051568,1,0.721192085668544,0,47,histone H3-K4 methylation,BP,
14142,GO:0051569,1,0.845561076800222,0,24,regulation of histone H3-K4 methylation,BP,
14143,GO:0051570,1,0.855663458080551,0,23,regulation of histone H3-K9 methylation,BP,
14144,GO:0051571,1,0.909284910862674,0,14,positive regulation of histone H3-K4 methylation,BP,
14145,GO:0051572,1,0.973065960044955,0,4,negative regulation of histone H3-K4 methylation,BP,
14146,GO:0051573,1,0.922082171265782,0,12,negative regulation of histone H3-K9 methylation,BP,
14147,GO:0051574,1,0.934567272397782,0,10,positive regulation of histone H3-K9 methylation,BP,
14148,GO:0051575,1,0.964433142518409,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
14149,GO:0051580,1,0.916332349845545,0,12,regulation of neurotransmitter uptake,BP,
14150,GO:0051581,1,0.979025546371532,0,3,negative regulation of neurotransmitter uptake,BP,
14151,GO:0051582,1,0.97685851940657,0,3,positive regulation of neurotransmitter uptake,BP,
14152,GO:0051583,1,0.921251370179263,0,11,dopamine uptake involved in synaptic transmission,BP,
14153,GO:0051584,1,0.94044470998494,0,8,regulation of dopamine uptake involved in synaptic transmission,BP,
14154,GO:0051585,1,0.992722786240047,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
14155,GO:0051586,1,0.97685851940657,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
14156,GO:0051588,1,0.644962531275686,0,62,regulation of neurotransmitter transport,BP,
14157,GO:0051589,1,0.906382456041934,0,14,negative regulation of neurotransmitter transport,BP,
14158,GO:0051590,1,0.906106315233097,0,14,positive regulation of neurotransmitter transport,BP,
14160,GO:0051592,1,0.443757670858992,0,113,response to calcium ion,BP,
14161,GO:0051593,1,0.919802633585408,0,11,response to folic acid,BP,
14162,GO:0051594,1,0.969364003976547,0,4,detection of glucose,BP,
14163,GO:0051595,1,0.986203080776739,0,2,response to methylglyoxal,BP,
14164,GO:0051596,1,0.984792029050511,0,2,methylglyoxal catabolic process,BP,
14166,GO:0051598,1,0.98606593177789,0,2,meiotic recombination checkpoint,BP,
14167,GO:0051599,1,0.959338932113764,0,6,response to hydrostatic pressure,BP,
14168,GO:0051601,1,0.936010727464571,0,9,exocyst localization,BP,
14174,GO:0051608,1,0.920178363878178,0,11,histamine transport,BP,
14175,GO:0051610,1,0.972977480070694,0,4,serotonin uptake,BP,
14176,GO:0051611,1,0.979025546371532,0,3,regulation of serotonin uptake,BP,
14177,GO:0051612,1,0.979025546371532,0,3,negative regulation of serotonin uptake,BP,
14178,GO:0051615,1,0.993985848573828,0,1,histamine uptake,BP,
14179,GO:0051620,1,0.992722786240047,0,1,norepinephrine uptake,BP,
14180,GO:0051621,1,0.992722786240047,0,1,regulation of norepinephrine uptake,BP,
14181,GO:0051622,1,0.992722786240047,0,1,negative regulation of norepinephrine uptake,BP,
14182,GO:0051639,1,0.948022939736696,0,8,actin filament network formation,BP,
14183,GO:0051640,1,0.0319419419452717,0,482,organelle localization,BP,
14185,GO:0051642,1,0.869106467140211,0,21,centrosome localization,BP,
14186,GO:0051643,1,0.986326940300788,0,2,endoplasmic reticulum localization,BP,
14187,GO:0051645,1,0.916516354174193,0,12,Golgi localization,BP,
14188,GO:0051646,1,0.770007957831107,0,38,mitochondrion localization,BP,
14189,GO:0051647,1,0.868594358089987,0,21,nucleus localization,BP,
14190,GO:0051648,1,0.167269128658324,0,255,vesicle localization,BP,
14192,GO:0051650,1,0.186585875469665,0,239,establishment of vesicle localization,BP,
14193,GO:0051651,1,0.480386411892846,0,102,maintenance of location in cell,BP,
14194,GO:0051653,1,0.797460322770819,0,33,spindle localization,BP,
14195,GO:0051654,1,0.884114216623642,0,18,establishment of mitochondrion localization,BP,
14196,GO:0051656,1,0.0509003287370915,0,416,establishment of organelle localization,BP,
14197,GO:0051657,1,0.934578799967693,0,10,maintenance of organelle location,BP,
14198,GO:0051659,1,0.985342855011768,0,2,maintenance of mitochondrion location,BP,
14199,GO:0051660,1,0.974282892700998,0,4,establishment of centrosome localization,BP,
14200,GO:0051661,1,0.967478583395633,0,5,maintenance of centrosome location,BP,
14201,GO:0051664,1,0.99364762661533,0,1,nuclear pore localization,BP,
14202,GO:0051665,1,0.92774460139175,0,10,membrane raft localization,BP,
14203,GO:0051668,1,0.566675174876959,0,80,localization within membrane,BP,
14204,GO:0051673,1,0.984410745552907,0,2,membrane disruption in other organism,BP,
14206,GO:0051683,1,0.948746656383452,0,7,establishment of Golgi localization,BP,
14207,GO:0051684,1,0.980562693099191,0,3,maintenance of Golgi location,BP,
14208,GO:0051685,1,0.992294630214608,0,1,maintenance of ER location,BP,
14209,GO:0051691,1,0.984400892897429,0,2,cellular oligosaccharide metabolic process,BP,
14210,GO:0051692,1,0.984400892897429,0,2,cellular oligosaccharide catabolic process,BP,
14213,GO:0051695,1,0.993824533095325,0,1,actin filament uncapping,BP,
14214,GO:0051697,1,0.969377543080741,0,4,protein delipidation,BP,
14215,GO:0051701,1,0.2558851141345,0,190,interaction with host,BP,
14216,GO:0051702,1,0.635476524450752,0,62,interaction with symbiont,BP,
14221,GO:0051708,1,0.963640814884808,0,5,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14222,GO:0051709,1,0.950365557317,0,7,regulation of killing of cells of other organism,BP,
14223,GO:0051712,1,0.957357589819167,0,6,positive regulation of killing of cells of other organism,BP,
14224,GO:0051715,1,0.984625601040578,0,2,cytolysis in other organism,BP,
14226,GO:0051717,1,0.986484047949936,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14227,GO:0051721,1,0.844091373854562,0,25,protein phosphatase 2A binding,MF,
14228,GO:0051722,1,0.992258111313232,0,1,protein C-terminal methylesterase activity,MF,
14229,GO:0051723,1,0.992258111313232,0,1,protein methylesterase activity,MF,
14230,GO:0051724,1,0.992208292351586,0,1,NAD transporter activity,MF,
14231,GO:0051725,1,0.971496888065844,0,4,protein de-ADP-ribosylation,BP,
14233,GO:0051728,1,0.992564231268535,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14234,GO:0051729,1,0.992564231268535,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14235,GO:0051731,1,0.97259525030315,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14236,GO:0051732,1,0.992170165072275,0,1,polyribonucleotide kinase activity,MF,
14237,GO:0051733,1,0.978480504868606,0,3,polydeoxyribonucleotide kinase activity,MF,
14238,GO:0051734,1,0.978480504868606,0,3,ATP-dependent polynucleotide kinase activity,MF,
14239,GO:0051736,1,0.992170165072275,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14240,GO:0051747,1,0.992170027168696,0,1,cytosine C-5 DNA demethylase activity,MF,
14241,GO:0051748,1,0.99218978253185,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14242,GO:0051754,1,0.978757730558814,0,3,meiotic sister chromatid cohesion, centromeric,BP,
14243,GO:0051758,1,0.99398633226773,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14244,GO:0051764,1,0.921371927192368,0,12,actin crosslink formation,BP,
14245,GO:0051765,1,0.985032925447973,0,2,inositol tetrakisphosphate kinase activity,MF,
14246,GO:0051766,1,0.923194949890003,0,11,inositol trisphosphate kinase activity,MF,
14247,GO:0051767,1,0.88629936732031,0,17,nitric-oxide synthase biosynthetic process,BP,
14248,GO:0051769,1,0.88629936732031,0,17,regulation of nitric-oxide synthase biosynthetic process,BP,
14249,GO:0051770,1,0.907262012967498,0,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,
14250,GO:0051771,1,0.97691196436219,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14251,GO:0051775,1,0.922395973509273,0,11,response to redox state,BP,
14252,GO:0051780,1,0.993616323617868,0,1,behavioral response to nutrient,BP,
14253,GO:0051781,1,0.551720248346043,0,82,positive regulation of cell division,BP,
14254,GO:0051782,1,0.892276702212003,0,16,negative regulation of cell division,BP,
14255,GO:0051783,1,0.291714005536807,0,170,regulation of nuclear division,BP,
14256,GO:0051784,1,0.68921905896978,0,51,negative regulation of nuclear division,BP,
14257,GO:0051785,1,0.674678774374296,0,55,positive regulation of nuclear division,BP,
14258,GO:0051786,1,0.992865517324789,0,1,all-trans-retinol 13,14-reductase activity,MF,
14259,GO:0051787,1,0.910517096853576,0,13,misfolded protein binding,MF,
14260,GO:0051788,1,0.853475811939918,0,22,response to misfolded protein,BP,
14261,GO:0051790,1,0.971038166570313,0,4,short-chain fatty acid biosynthetic process,BP,
14262,GO:0051791,1,0.962218486275023,0,5,medium-chain fatty acid metabolic process,BP,
14263,GO:0051792,1,0.984400887813367,0,2,medium-chain fatty acid biosynthetic process,BP,
14264,GO:0051793,1,0.992318244242582,0,1,medium-chain fatty acid catabolic process,BP,
14265,GO:0051794,1,0.972328932458207,0,4,regulation of timing of catagen,BP,
14266,GO:0051795,1,0.978489728828623,0,3,positive regulation of timing of catagen,BP,
14267,GO:0051796,1,0.993704836810665,0,1,negative regulation of timing of catagen,BP,
14270,GO:0051799,1,0.973394506484396,0,4,negative regulation of hair follicle development,BP,
14271,GO:0051800,1,0.986202651229364,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14272,GO:0051801,1,0.984625601040578,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14273,GO:0051805,1,0.992366146325104,0,1,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14274,GO:0051806,1,0.412930074529528,0,124,entry into cell of other organism involved in symbiotic interaction,BP,
14275,GO:0051807,1,0.992366146325104,0,1,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14276,GO:0051808,1,0.992244049183172,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14277,GO:0051817,1,0.51048105074842,0,93,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14278,GO:0051818,1,0.912931206184865,0,12,disruption of cells of other organism involved in symbiotic interaction,BP,
14279,GO:0051821,1,0.993986332267547,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14280,GO:0051823,1,0.939853710487022,0,9,regulation of synapse structural plasticity,BP,
14281,GO:0051828,1,0.412930074529528,0,124,entry into other organism involved in symbiotic interaction,BP,
14282,GO:0051832,1,0.978700834681886,0,3,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14283,GO:0051834,1,0.978700834681886,0,3,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14284,GO:0051835,1,0.972617400466902,0,4,positive regulation of synapse structural plasticity,BP,
14285,GO:0051836,1,0.992244049183172,0,1,translocation of molecules into other organism involved in symbiotic interaction,BP,
14286,GO:0051851,1,0.653571377340639,0,58,modification by host of symbiont morphology or physiology,BP,
14287,GO:0051852,1,0.94022577549502,0,8,disruption by host of symbiont cells,BP,
14288,GO:0051861,1,0.865871118990805,0,19,glycolipid binding,MF,
14289,GO:0051864,1,0.968460225198892,0,5,histone demethylase activity (H3-K36 specific),MF,
14290,GO:0051865,1,0.686031457672756,0,53,protein autoubiquitination,BP,
14291,GO:0051866,1,0.985306187067665,0,2,general adaptation syndrome,BP,
14292,GO:0051867,1,0.992170027168696,0,1,general adaptation syndrome, behavioral process,BP,
14293,GO:0051870,1,0.977949608093476,0,3,methotrexate binding,MF,
14294,GO:0051873,1,0.94022577549502,0,8,killing by host of symbiont cells,BP,
14295,GO:0051875,1,0.824847549264157,0,26,pigment granule localization,BP,
14296,GO:0051877,1,0.985086921164948,0,2,pigment granule aggregation in cell center,BP,
14297,GO:0051878,1,0.993065314982726,0,1,lateral element assembly,BP,
14298,GO:0051879,1,0.803486875225118,0,31,Hsp90 protein binding,MF,
14299,GO:0051880,1,0.955940020626488,0,7,G-quadruplex DNA binding,MF,
14300,GO:0051881,1,0.638707131954891,0,60,regulation of mitochondrial membrane potential,BP,
14301,GO:0051882,1,0.851202635152253,0,22,mitochondrial depolarization,BP,
14302,GO:0051883,1,0.912931206184865,0,12,killing of cells in other organism involved in symbiotic interaction,BP,
14303,GO:0051884,1,0.973401795764056,0,4,regulation of timing of anagen,BP,
14304,GO:0051885,1,0.986242057855634,0,2,positive regulation of timing of anagen,BP,
14305,GO:0051886,1,0.99396435350466,0,1,negative regulation of timing of anagen,BP,
14306,GO:0051890,1,0.952536201938078,0,7,regulation of cardioblast differentiation,BP,
14307,GO:0051891,1,0.96581925603332,0,5,positive regulation of cardioblast differentiation,BP,
14308,GO:0051892,1,0.986250565179629,0,2,negative regulation of cardioblast differentiation,BP,
14309,GO:0051893,1,0.714683516587787,0,50,regulation of focal adhesion assembly,BP,
14310,GO:0051894,1,0.85489534921355,0,23,positive regulation of focal adhesion assembly,BP,
14311,GO:0051895,1,0.911889942216713,0,14,negative regulation of focal adhesion assembly,BP,
14314,GO:0051898,1,0.786331385333865,0,34,negative regulation of protein kinase B signaling,BP,
14315,GO:0051899,1,0.520988021647961,0,95,membrane depolarization,BP,
14316,GO:0051900,1,0.869944097367134,0,19,regulation of mitochondrial depolarization,BP,
14317,GO:0051901,1,0.93523882994333,0,9,positive regulation of mitochondrial depolarization,BP,
14318,GO:0051902,1,0.956672373303255,0,6,negative regulation of mitochondrial depolarization,BP,
14319,GO:0051903,1,0.992333059891156,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14320,GO:0051904,1,0.842745021403511,0,23,pigment granule transport,BP,
14321,GO:0051905,1,0.837670269918779,0,24,establishment of pigment granule localization,BP,
14322,GO:0051908,1,0.992753533384011,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14323,GO:0051916,1,0.992545763099276,0,1,granulocyte colony-stimulating factor binding,MF,
14324,GO:0051917,1,0.90010228599142,0,14,regulation of fibrinolysis,BP,
14325,GO:0051918,1,0.927967903650193,0,10,negative regulation of fibrinolysis,BP,
14326,GO:0051919,1,0.969803168047409,0,4,positive regulation of fibrinolysis,BP,
14327,GO:0051920,1,0.939253248582104,0,8,peroxiredoxin activity,MF,
14328,GO:0051923,1,0.887297361958603,0,16,sulfation,BP,
14330,GO:0051926,1,0.677713894866227,0,53,negative regulation of calcium ion transport,BP,
14332,GO:0051930,1,0.807448042377883,0,30,regulation of sensory perception of pain,BP,
14333,GO:0051931,1,0.807448042377883,0,30,regulation of sensory perception,BP,
14334,GO:0051932,1,0.770211836639587,0,38,synaptic transmission, GABAergic,BP,
14335,GO:0051933,1,0.975954097715164,0,4,amino acid neurotransmitter reuptake,BP,
14336,GO:0051934,1,0.921251370179263,0,11,catecholamine uptake involved in synaptic transmission,BP,
14337,GO:0051935,1,0.975954097715164,0,4,glutamate reuptake,BP,
14338,GO:0051937,1,0.645479071647127,0,60,catecholamine transport,BP,
14340,GO:0051939,1,0.993808729016454,0,1,gamma-aminobutyric acid import,BP,
14341,GO:0051940,1,0.94044470998494,0,8,regulation of catecholamine uptake involved in synaptic transmission,BP,
14342,GO:0051941,1,0.988005481790986,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14343,GO:0051944,1,0.97685851940657,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14344,GO:0051945,1,0.992722786240047,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14345,GO:0051946,1,0.988005481790986,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14346,GO:0051952,1,0.59338419304683,0,71,regulation of amine transport,BP,
14347,GO:0051953,1,0.851207779083368,0,22,negative regulation of amine transport,BP,
14348,GO:0051954,1,0.80431439202137,0,30,positive regulation of amine transport,BP,
14349,GO:0051955,1,0.823452249860256,0,27,regulation of amino acid transport,BP,
14350,GO:0051956,1,0.929239252115434,0,10,negative regulation of amino acid transport,BP,
14351,GO:0051957,1,0.898084779646487,0,15,positive regulation of amino acid transport,BP,
14352,GO:0051958,1,0.986479880820378,0,2,methotrexate transport,BP,
14353,GO:0051959,1,0.92295629171222,0,12,dynein light intermediate chain binding,MF,
14357,GO:0051963,1,0.602560840696899,0,75,regulation of synapse assembly,BP,
14358,GO:0051964,1,0.970102553126259,0,5,negative regulation of synapse assembly,BP,
14359,GO:0051965,1,0.678833664044078,0,57,positive regulation of synapse assembly,BP,
14360,GO:0051966,1,0.674296405565918,0,58,regulation of synaptic transmission, glutamatergic,BP,
14361,GO:0051967,1,0.90165552994063,0,14,negative regulation of synaptic transmission, glutamatergic,BP,
14362,GO:0051968,1,0.876239789579478,0,20,positive regulation of synaptic transmission, glutamatergic,BP,
14363,GO:0051969,1,0.888552281789001,0,16,regulation of transmission of nerve impulse,BP,
14364,GO:0051970,1,0.962864073090513,0,5,negative regulation of transmission of nerve impulse,BP,
14365,GO:0051971,1,0.95005274206754,0,7,positive regulation of transmission of nerve impulse,BP,
14366,GO:0051972,1,0.724404528726373,0,44,regulation of telomerase activity,BP,
14367,GO:0051973,1,0.774325916423962,0,35,positive regulation of telomerase activity,BP,
14368,GO:0051974,1,0.935275340391028,0,9,negative regulation of telomerase activity,BP,
14369,GO:0051977,1,0.984426462393775,0,2,lysophospholipid transport,BP,
14370,GO:0051978,1,0.992195802013195,0,1,lysophospholipid transporter activity,MF,
14371,GO:0051983,1,0.562865132764459,0,80,regulation of chromosome segregation,BP,
14372,GO:0051984,1,0.875392289417443,0,19,positive regulation of chromosome segregation,BP,
14373,GO:0051985,1,0.782574591411931,0,34,negative regulation of chromosome segregation,BP,
14374,GO:0051987,1,0.970415188643341,0,4,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14375,GO:0051988,1,0.923239419124271,0,11,regulation of attachment of spindle microtubules to kinetochore,BP,
14377,GO:0051996,1,0.992185746419627,0,1,squalene synthase activity,MF,
14378,GO:0051998,1,0.965772998732555,0,5,protein carboxyl O-methyltransferase activity,MF,
14379,GO:0052026,1,0.992473500715898,0,1,modulation by symbiont of host transcription,BP,
14380,GO:0052027,1,0.99282902982915,0,1,modulation by symbiont of host signal transduction pathway,BP,
14381,GO:0052031,1,0.984428143151737,0,2,modulation by symbiont of host defense response,BP,
14382,GO:0052040,1,0.964872565974683,0,5,modulation by symbiont of host programmed cell death,BP,
14383,GO:0052041,1,0.970766641911402,0,4,negative regulation by symbiont of host programmed cell death,BP,
14384,GO:0052042,1,0.986147023030262,0,2,positive regulation by symbiont of host programmed cell death,BP,
14385,GO:0052047,1,0.986265027286879,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14386,GO:0052053,1,0.992397223065217,0,1,negative regulation by symbiont of host catalytic activity,BP,
14387,GO:0052055,1,0.963419370949826,0,5,modulation by symbiont of host molecular function,BP,
14388,GO:0052056,1,0.986409149697157,0,2,negative regulation by symbiont of host molecular function,BP,
14389,GO:0052066,1,0.993986332270312,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14390,GO:0052097,1,0.992830992499847,0,1,interspecies quorum sensing,BP,
14391,GO:0052106,1,0.992830992499847,0,1,quorum sensing involved in interaction with host,BP,
14392,GO:0052126,1,0.775764807286503,0,35,movement in host environment,BP,
14393,GO:0052148,1,0.992397223065217,0,1,modulation by symbiont of host catalytic activity,BP,
14394,GO:0052150,1,0.964872565974683,0,5,modulation by symbiont of host apoptotic process,BP,
14395,GO:0052151,1,0.986147023030262,0,2,positive regulation by symbiont of host apoptotic process,BP,
14396,GO:0052173,1,0.957491572215181,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
14397,GO:0052182,1,0.992232345544544,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14398,GO:0052190,1,0.993986332270312,0,1,modulation by symbiont of host phagocytosis,BP,
14399,GO:0052191,1,0.993986332270312,0,1,positive regulation by symbiont of host phagocytosis,BP,
14400,GO:0052192,1,0.775764807286503,0,35,movement in environment of other organism involved in symbiotic interaction,BP,
14401,GO:0052199,1,0.97691947424639,0,3,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14402,GO:0052200,1,0.957491572215181,0,6,response to host defenses,BP,
14403,GO:0052203,1,0.969268964447042,0,4,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14404,GO:0052204,1,0.948386543547843,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14405,GO:0052205,1,0.948386543547843,0,7,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14406,GO:0052212,1,0.992232345544544,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14407,GO:0052213,1,0.992232345544544,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14408,GO:0052214,1,0.992170027168696,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14409,GO:0052227,1,0.992170027168696,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14410,GO:0052229,1,0.992170027168696,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14411,GO:0052231,1,0.993986332270312,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14412,GO:0052248,1,0.964872565974683,0,5,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14413,GO:0052250,1,0.99282902982915,0,1,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14414,GO:0052251,1,0.984428143151737,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14415,GO:0052255,1,0.984428143151737,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14416,GO:0052312,1,0.828628179478111,0,26,modulation of transcription in other organism involved in symbiotic interaction,BP,
14418,GO:0052330,1,0.986147023030262,0,2,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14419,GO:0052331,1,0.984625601040578,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14420,GO:0052360,1,0.992170027168696,0,1,catabolism by host of symbiont macromolecule,BP,
14421,GO:0052361,1,0.992170027168696,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14422,GO:0052362,1,0.992170027168696,0,1,catabolism by host of symbiont protein,BP,
14423,GO:0052363,1,0.992170027168696,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14424,GO:0052364,1,0.992170027168696,0,1,catabolism by host of substance in symbiont,BP,
14425,GO:0052370,1,0.993986332270312,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14426,GO:0052381,1,0.992188368610558,0,1,tRNA dimethylallyltransferase activity,MF,
14427,GO:0052403,1,0.984404598064473,0,2,negative regulation by host of symbiont catalytic activity,BP,
14428,GO:0052405,1,0.961457555045752,0,5,negative regulation by host of symbiont molecular function,BP,
14429,GO:0052416,1,0.992170027168696,0,1,metabolism by host of symbiont macromolecule,BP,
14430,GO:0052417,1,0.992170027168696,0,1,metabolism by host of symbiont protein,BP,
14431,GO:0052418,1,0.992170027168696,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14432,GO:0052419,1,0.992170027168696,0,1,metabolism by host of substance in symbiont,BP,
14433,GO:0052422,1,0.969268964447042,0,4,modulation by host of symbiont catalytic activity,BP,
14434,GO:0052428,1,0.954145572223541,0,6,modification by host of symbiont molecular function,BP,
14435,GO:0052433,1,0.964872565974683,0,5,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14436,GO:0052472,1,0.834921041771117,0,25,modulation by host of symbiont transcription,BP,
14437,GO:0052490,1,0.970766641911402,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14438,GO:0052501,1,0.986147023030262,0,2,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14439,GO:0052509,1,0.984428143151737,0,2,positive regulation by symbiont of host defense response,BP,
14440,GO:0052510,1,0.984428143151737,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14441,GO:0052522,1,0.993986332270312,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14444,GO:0052550,1,0.992170030385097,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14445,GO:0052551,1,0.993836479111446,0,1,response to defense-related nitric oxide production by other organism involved in symbiotic interaction,BP,
14446,GO:0052552,1,0.984428143151737,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14447,GO:0052553,1,0.984428143151737,0,2,modulation by symbiont of host immune response,BP,
14448,GO:0052564,1,0.963286144138636,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
14449,GO:0052565,1,0.993836479111446,0,1,response to defense-related host nitric oxide production,BP,
14450,GO:0052567,1,0.992170030385097,0,1,response to defense-related host reactive oxygen species production,BP,
14451,GO:0052572,1,0.963286144138636,0,5,response to host immune response,BP,
14452,GO:0052590,1,0.993986332265124,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14453,GO:0052591,1,0.993986332265124,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14454,GO:0052593,1,0.985902126205944,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14455,GO:0052594,1,0.985902126205944,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14456,GO:0052595,1,0.985902126205944,0,2,aliphatic-amine oxidase activity,MF,
14457,GO:0052596,1,0.985902126205944,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14458,GO:0052629,1,0.93003801610861,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14459,GO:0052642,1,0.984512376052649,0,2,lysophosphatidic acid phosphatase activity,MF,
14460,GO:0052646,1,0.945230931352836,0,8,alditol phosphate metabolic process,BP,
14461,GO:0052650,1,0.932671307098201,0,9,NADP-retinol dehydrogenase activity,MF,
14462,GO:0052651,1,0.984524877033465,0,2,monoacylglycerol catabolic process,BP,
14464,GO:0052654,1,0.986203080784392,0,2,L-leucine transaminase activity,MF,
14465,GO:0052655,1,0.986203080784392,0,2,L-valine transaminase activity,MF,
14466,GO:0052656,1,0.986203080784392,0,2,L-isoleucine transaminase activity,MF,
14467,GO:0052657,1,0.992170027168696,0,1,guanine phosphoribosyltransferase activity,MF,
14468,GO:0052658,1,0.959931092362329,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14469,GO:0052659,1,0.941430955465391,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14470,GO:0052666,1,0.992174805547159,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14473,GO:0052695,1,0.877571091005035,0,17,cellular glucuronidation,BP,
14474,GO:0052696,1,0.961741843176401,0,5,flavonoid glucuronidation,BP,
14475,GO:0052697,1,0.932145174378891,0,9,xenobiotic glucuronidation,BP,
14476,GO:0052723,1,0.966684465637245,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14477,GO:0052724,1,0.966684465637245,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14478,GO:0052725,1,0.992806547305041,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14479,GO:0052726,1,0.992806547305041,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14480,GO:0052731,1,0.992185694631708,0,1,phosphocholine phosphatase activity,MF,
14481,GO:0052732,1,0.992185694631708,0,1,phosphoethanolamine phosphatase activity,MF,
14484,GO:0052741,1,0.984402440885708,0,2,(R)-limonene 6-monooxygenase activity,MF,
14486,GO:0052743,1,0.928700655692488,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14487,GO:0052744,1,0.911489719596726,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
14488,GO:0052745,1,0.878341753500941,0,19,inositol phosphate phosphatase activity,MF,
14489,GO:0052746,1,0.993767143315714,0,1,inositol phosphorylation,BP,
14490,GO:0052794,1,0.969322023447485,0,4,exo-alpha-(2->3)-sialidase activity,MF,
14491,GO:0052795,1,0.969322023447485,0,4,exo-alpha-(2->6)-sialidase activity,MF,
14492,GO:0052796,1,0.969322023447485,0,4,exo-alpha-(2->8)-sialidase activity,MF,
14493,GO:0052798,1,0.992184732153989,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14494,GO:0052803,1,0.920487239889051,0,11,imidazole-containing compound metabolic process,BP,
14495,GO:0052805,1,0.949025219019423,0,7,imidazole-containing compound catabolic process,BP,
14496,GO:0052810,1,0.985676656210216,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14497,GO:0052811,1,0.967371149770655,0,5,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14498,GO:0052812,1,0.979715206956925,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14500,GO:0052815,1,0.985199699572445,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14501,GO:0052816,1,0.992975094076952,0,1,long-chain acyl-CoA hydrolase activity,MF,
14502,GO:0052817,1,0.992975094076952,0,1,very long chain acyl-CoA hydrolase activity,MF,
14503,GO:0052821,1,0.992170027168696,0,1,DNA-7-methyladenine glycosylase activity,MF,
14504,GO:0052822,1,0.992170027168696,0,1,DNA-3-methylguanine glycosylase activity,MF,
14505,GO:0052825,1,0.992806547305041,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14506,GO:0052826,1,0.992454101113446,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14507,GO:0052827,1,0.985314508560662,0,2,inositol pentakisphosphate phosphatase activity,MF,
14508,GO:0052828,1,0.987607770856347,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14509,GO:0052829,1,0.992184096858826,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14510,GO:0052830,1,0.992806547305041,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14511,GO:0052831,1,0.992806547305041,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14512,GO:0052832,1,0.972101102431493,0,4,inositol monophosphate 3-phosphatase activity,MF,
14513,GO:0052833,1,0.972101102431493,0,4,inositol monophosphate 4-phosphatase activity,MF,
14514,GO:0052834,1,0.972101102431493,0,4,inositol monophosphate phosphatase activity,MF,
14515,GO:0052835,1,0.992806547305041,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14516,GO:0052836,1,0.978429840130607,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14517,GO:0052839,1,0.978429840130607,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14518,GO:0052840,1,0.97080956241711,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14519,GO:0052841,1,0.97080956241711,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14520,GO:0052842,1,0.97080956241711,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14521,GO:0052843,1,0.97080956241711,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14522,GO:0052844,1,0.97080956241711,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14523,GO:0052845,1,0.97080956241711,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14524,GO:0052846,1,0.97080956241711,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14525,GO:0052847,1,0.97080956241711,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14526,GO:0052848,1,0.97080956241711,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14527,GO:0052851,1,0.981349829990746,0,3,ferric-chelate reductase (NADPH) activity,MF,
14528,GO:0052852,1,0.984401033586019,0,2,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14529,GO:0052853,1,0.984401033586019,0,2,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14530,GO:0052854,1,0.984401033586019,0,2,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14531,GO:0052858,1,0.993126514482214,0,1,peptidyl-lysine acetyltransferase activity,MF,
14532,GO:0052866,1,0.821567628106884,0,29,phosphatidylinositol phosphate phosphatase activity,MF,
14533,GO:0052869,1,0.992231055845041,0,1,arachidonic acid omega-hydroxylase activity,MF,
14534,GO:0052870,1,0.984856731861142,0,2,tocopherol omega-hydroxylase activity,MF,
14535,GO:0052871,1,0.984856731861142,0,2,alpha-tocopherol omega-hydroxylase activity,MF,
14536,GO:0052872,1,0.992231055845041,0,1,tocotrienol omega-hydroxylase activity,MF,
14537,GO:0052884,1,0.992319637064424,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14538,GO:0052885,1,0.992319637064424,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14539,GO:0052890,1,0.992173236388616,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14540,GO:0052894,1,0.99218243363011,0,1,norspermine:oxygen oxidoreductase activity,MF,
14541,GO:0052895,1,0.99218243363011,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14542,GO:0052899,1,0.992170041209416,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14543,GO:0052901,1,0.984413211811487,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14544,GO:0052902,1,0.992170041209416,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14545,GO:0052903,1,0.992170041209416,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14546,GO:0052904,1,0.992170041209416,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14547,GO:0052906,1,0.993974329932399,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14548,GO:0052907,1,0.992294630214608,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14549,GO:0052909,1,0.992294630214608,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14550,GO:0052917,1,0.992233128017427,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14551,GO:0052918,1,0.993986332267019,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14552,GO:0052925,1,0.992170027168696,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14553,GO:0052926,1,0.993986332267019,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14554,GO:0052927,1,0.992210393719652,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14555,GO:0052928,1,0.992210393719652,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14556,GO:0052929,1,0.992210393719652,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14557,GO:0055001,1,0.349196492087435,0,149,muscle cell development,BP,
14558,GO:0055002,1,0.388225892971783,0,134,striated muscle cell development,BP,
14559,GO:0055003,1,0.893750239248801,0,17,cardiac myofibril assembly,BP,
14560,GO:0055005,1,0.978935947635285,0,3,ventricular cardiac myofibril assembly,BP,
14561,GO:0055006,1,0.641983248580916,0,64,cardiac cell development,BP,
14562,GO:0055007,1,0.508738690720726,0,97,cardiac muscle cell differentiation,BP,
14563,GO:0055008,1,0.64656184658656,0,62,cardiac muscle tissue morphogenesis,BP,
14564,GO:0055009,1,0.949449053314948,0,7,atrial cardiac muscle tissue morphogenesis,BP,
14565,GO:0055010,1,0.720027200864744,0,47,ventricular cardiac muscle tissue morphogenesis,BP,
14566,GO:0055011,1,0.976695288338136,0,3,atrial cardiac muscle cell differentiation,BP,
14567,GO:0055012,1,0.878516215025505,0,18,ventricular cardiac muscle cell differentiation,BP,
14568,GO:0055013,1,0.663419114395412,0,59,cardiac muscle cell development,BP,
14569,GO:0055014,1,0.976695288338136,0,3,atrial cardiac muscle cell development,BP,
14570,GO:0055015,1,0.9078158210504,0,13,ventricular cardiac muscle cell development,BP,
14572,GO:0055018,1,0.992170392587755,0,1,regulation of cardiac muscle fiber development,BP,
14573,GO:0055020,1,0.992170392587755,0,1,positive regulation of cardiac muscle fiber development,BP,
14576,GO:0055023,1,0.818096553456896,0,29,positive regulation of cardiac muscle tissue growth,BP,
14578,GO:0055025,1,0.75747340775515,0,40,positive regulation of cardiac muscle tissue development,BP,
14580,GO:0055029,1,0.405074226257182,0,124,nuclear DNA-directed RNA polymerase complex,CC,
14582,GO:0055038,1,0.669721464253813,0,56,recycling endosome membrane,CC,
14583,GO:0055048,1,0.993986332271602,0,1,anastral spindle assembly,BP,
14584,GO:0055056,1,0.938433193209115,0,9,D-glucose transmembrane transporter activity,MF,
14585,GO:0055057,1,0.914899364449796,0,13,neuroblast division,BP,
14586,GO:0055059,1,0.966272123035858,0,5,asymmetric neuroblast division,BP,
14587,GO:0055062,1,0.919234686517167,0,12,phosphate ion homeostasis,BP,
14588,GO:0055064,1,0.966227706243007,0,5,chloride ion homeostasis,BP,
14591,GO:0055069,1,0.829002753110907,0,26,zinc ion homeostasis,BP,
14594,GO:0055073,1,0.985619271203428,0,2,cadmium ion homeostasis,BP,
14596,GO:0055075,1,0.901221814469974,0,15,potassium ion homeostasis,BP,
14598,GO:0055077,1,0.970211258084093,0,4,gap junction hemi-channel activity,MF,
14599,GO:0055078,1,0.731252016998556,0,43,sodium ion homeostasis,BP,
14603,GO:0055083,1,0.88816993029915,0,17,monovalent inorganic anion homeostasis,BP,
14606,GO:0055087,1,0.979920800148691,0,3,Ski complex,CC,
14608,GO:0055089,1,0.91136338042493,0,13,fatty acid homeostasis,BP,
14609,GO:0055090,1,0.785054467664843,0,32,acylglycerol homeostasis,BP,
14612,GO:0055093,1,0.872641296248955,0,19,response to hyperoxia,BP,
14614,GO:0055095,1,0.9789996021969,0,3,lipoprotein particle mediated signaling,BP,
14615,GO:0055096,1,0.9789996021969,0,3,low-density lipoprotein particle mediated signaling,BP,
14616,GO:0055098,1,0.89443714298271,0,16,response to low-density lipoprotein particle,BP,
14618,GO:0055100,1,0.979193562478822,0,3,adiponectin binding,MF,
14620,GO:0055103,1,0.992795855711929,0,1,ligase regulator activity,MF,
14621,GO:0055105,1,0.961463465849232,0,5,ubiquitin-protein transferase inhibitor activity,MF,
14622,GO:0055106,1,0.886010492834803,0,16,ubiquitin-protein transferase regulator activity,MF,
14623,GO:0055108,1,0.99217575270759,0,1,Golgi to transport vesicle transport,BP,
14624,GO:0055111,1,0.993985990735734,0,1,ingression involved in gastrulation with mouth forming second,BP,
14625,GO:0055113,1,0.993986332288985,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14627,GO:0055117,1,0.604193626246604,0,72,regulation of cardiac muscle contraction,BP,
14628,GO:0055118,1,0.965884969801505,0,5,negative regulation of cardiac muscle contraction,BP,
14629,GO:0055119,1,0.889230053213001,0,17,relaxation of cardiac muscle,BP,
14630,GO:0055120,1,0.992170027168696,0,1,striated muscle dense body,CC,
14631,GO:0055123,1,0.380775404622686,0,136,digestive system development,BP,
14632,GO:0055129,1,0.969883496012034,0,4,L-proline biosynthetic process,BP,
14633,GO:0055130,1,0.992170027168696,0,1,D-alanine catabolic process,BP,
14634,GO:0055131,1,0.954828215822551,0,6,C3HC4-type RING finger domain binding,MF,
14635,GO:0060001,1,0.993986332278738,0,1,minus-end directed microfilament motor activity,MF,
14636,GO:0060002,1,0.981446922989439,0,3,plus-end directed microfilament motor activity,MF,
14637,GO:0060003,1,0.988008547476944,0,2,copper ion export,BP,
14638,GO:0060004,1,0.882221739693606,0,18,reflex,BP,
14639,GO:0060005,1,0.973392479712355,0,4,vestibular reflex,BP,
14640,GO:0060007,1,0.993640052777891,0,1,linear vestibuloocular reflex,BP,
14641,GO:0060008,1,0.880234545682184,0,18,Sertoli cell differentiation,BP,
14642,GO:0060009,1,0.907053948714253,0,14,Sertoli cell development,BP,
14643,GO:0060010,1,0.992868986896003,0,1,Sertoli cell fate commitment,BP,
14644,GO:0060011,1,0.971728117332744,0,4,Sertoli cell proliferation,BP,
14645,GO:0060012,1,0.9493582608882,0,7,synaptic transmission, glycinergic,BP,
14646,GO:0060013,1,0.946808179324918,0,8,righting reflex,BP,
14647,GO:0060014,1,0.98473023588233,0,2,granulosa cell differentiation,BP,
14648,GO:0060016,1,0.992170027168696,0,1,granulosa cell development,BP,
14649,GO:0060017,1,0.951284761619391,0,7,parathyroid gland development,BP,
14650,GO:0060018,1,0.972687904958577,0,4,astrocyte fate commitment,BP,
14651,GO:0060019,1,0.937401984714309,0,9,radial glial cell differentiation,BP,
14652,GO:0060020,1,0.951113540576249,0,7,Bergmann glial cell differentiation,BP,
14653,GO:0060021,1,0.544690183704333,0,87,palate development,BP,
14654,GO:0060022,1,0.960601544402519,0,6,hard palate development,BP,
14655,GO:0060023,1,0.967502383920026,0,5,soft palate development,BP,
14656,GO:0060024,1,0.973859524378773,0,4,rhythmic synaptic transmission,BP,
14657,GO:0060025,1,0.987849609347806,0,2,regulation of synaptic activity,BP,
14658,GO:0060026,1,0.899321323081979,0,15,convergent extension,BP,
14659,GO:0060027,1,0.946612783762094,0,8,convergent extension involved in gastrulation,BP,
14660,GO:0060028,1,0.951971956116275,0,7,convergent extension involved in axis elongation,BP,
14661,GO:0060029,1,0.958167608221202,0,6,convergent extension involved in organogenesis,BP,
14662,GO:0060031,1,0.986206452881031,0,2,mediolateral intercalation,BP,
14663,GO:0060032,1,0.987060974035309,0,2,notochord regression,BP,
14664,GO:0060033,1,0.924849121804306,0,11,anatomical structure regression,BP,
14665,GO:0060034,1,0.993480543526736,0,1,notochord cell differentiation,BP,
14666,GO:0060035,1,0.993480543526736,0,1,notochord cell development,BP,
14667,GO:0060037,1,0.84331890911286,0,24,pharyngeal system development,BP,
14669,GO:0060039,1,0.873406720782802,0,20,pericardium development,BP,
14670,GO:0060040,1,0.970381430368478,0,4,retinal bipolar neuron differentiation,BP,
14675,GO:0060045,1,0.859581169263325,0,22,positive regulation of cardiac muscle cell proliferation,BP,
14676,GO:0060046,1,0.867439373852596,0,19,regulation of acrosome reaction,BP,
14678,GO:0060048,1,0.423370869322219,0,122,cardiac muscle contraction,BP,
14679,GO:0060049,1,0.885107752084663,0,17,regulation of protein glycosylation,BP,
14680,GO:0060050,1,0.944574145584744,0,8,positive regulation of protein glycosylation,BP,
14681,GO:0060051,1,0.976983716911127,0,3,negative regulation of protein glycosylation,BP,
14682,GO:0060052,1,0.939207129096573,0,9,neurofilament cytoskeleton organization,BP,
14683,GO:0060053,1,0.986268712709483,0,2,neurofilament cytoskeleton,CC,
14684,GO:0060054,1,0.949030897346952,0,7,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14685,GO:0060055,1,0.879294063692513,0,18,angiogenesis involved in wound healing,BP,
14686,GO:0060056,1,0.937501120610403,0,9,mammary gland involution,BP,
14687,GO:0060057,1,0.979841228967994,0,3,apoptotic process involved in mammary gland involution,BP,
14688,GO:0060058,1,0.979841228967994,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14690,GO:0060060,1,0.986715152327985,0,2,post-embryonic retina morphogenesis in camera-type eye,BP,
14691,GO:0060061,1,0.978521278332798,0,3,Spemann organizer formation,BP,
14692,GO:0060064,1,0.992170027168696,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14694,GO:0060066,1,0.977526378901828,0,3,oviduct development,BP,
14695,GO:0060067,1,0.98624457472057,0,2,cervix development,BP,
14699,GO:0060072,1,0.987333838560416,0,2,large conductance calcium-activated potassium channel activity,MF,
14700,GO:0060073,1,0.952187223942083,0,7,micturition,BP,
14701,GO:0060074,1,0.893131702561302,0,17,synapse maturation,BP,
14702,GO:0060075,1,0.960903864121918,0,6,regulation of resting membrane potential,BP,
14703,GO:0060076,1,0.845976339032373,0,25,excitatory synapse,CC,
14704,GO:0060077,1,0.918187644952356,0,12,inhibitory synapse,CC,
14707,GO:0060080,1,0.912018586980451,0,14,inhibitory postsynaptic potential,BP,
14708,GO:0060081,1,0.918599552640392,0,12,membrane hyperpolarization,BP,
14709,GO:0060083,1,0.980530958729748,0,3,smooth muscle contraction involved in micturition,BP,
14710,GO:0060084,1,0.978738380768857,0,3,synaptic transmission involved in micturition,BP,
14711,GO:0060086,1,0.985143411528942,0,2,circadian temperature homeostasis,BP,
14712,GO:0060087,1,0.956945594844994,0,6,relaxation of vascular smooth muscle,BP,
14713,GO:0060088,1,0.932768184392751,0,10,auditory receptor cell stereocilium organization,BP,
14716,GO:0060091,1,0.935465331516368,0,9,kinocilium,CC,
14717,GO:0060099,1,0.924472192383867,0,11,regulation of phagocytosis, engulfment,BP,
14718,GO:0060100,1,0.938952526829391,0,9,positive regulation of phagocytosis, engulfment,BP,
14719,GO:0060101,1,0.992172217949553,0,1,negative regulation of phagocytosis, engulfment,BP,
14720,GO:0060112,1,0.984401968526353,0,2,generation of ovulation cycle rhythm,BP,
14721,GO:0060113,1,0.691393536159349,0,52,inner ear receptor cell differentiation,BP,
14722,GO:0060114,1,0.992170027168696,0,1,vestibular receptor cell differentiation,BP,
14723,GO:0060117,1,0.883104766594225,0,18,auditory receptor cell development,BP,
14724,GO:0060118,1,0.992170027168696,0,1,vestibular receptor cell development,BP,
14725,GO:0060119,1,0.765367218193468,0,38,inner ear receptor cell development,BP,
14726,GO:0060120,1,0.957441518591908,0,6,inner ear receptor cell fate commitment,BP,
14727,GO:0060122,1,0.842473662718552,0,24,inner ear receptor stereocilium organization,BP,
14728,GO:0060123,1,0.925062698700448,0,11,regulation of growth hormone secretion,BP,
14729,GO:0060124,1,0.9419632872247,0,8,positive regulation of growth hormone secretion,BP,
14730,GO:0060125,1,0.988008547465162,0,2,negative regulation of growth hormone secretion,BP,
14731,GO:0060126,1,0.962711385074779,0,5,somatotropin secreting cell differentiation,BP,
14732,GO:0060127,1,0.992202934704535,0,1,prolactin secreting cell differentiation,BP,
14733,GO:0060128,1,0.984930358780597,0,2,corticotropin hormone secreting cell differentiation,BP,
14734,GO:0060129,1,0.97846305653413,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14735,GO:0060133,1,0.984400887813367,0,2,somatotropin secreting cell development,BP,
14736,GO:0060134,1,0.91346625614197,0,13,prepulse inhibition,BP,
14737,GO:0060135,1,0.658169715863164,0,59,maternal process involved in female pregnancy,BP,
14738,GO:0060136,1,0.964994195503888,0,5,embryonic process involved in female pregnancy,BP,
14739,GO:0060137,1,0.93663768414879,0,9,maternal process involved in parturition,BP,
14740,GO:0060139,1,0.986147023030262,0,2,positive regulation of apoptotic process by virus,BP,
14741,GO:0060142,1,0.821633251889592,0,26,regulation of syncytium formation by plasma membrane fusion,BP,
14742,GO:0060143,1,0.834667568745043,0,24,positive regulation of syncytium formation by plasma membrane fusion,BP,
14743,GO:0060147,1,0.799754927743557,0,32,regulation of posttranscriptional gene silencing,BP,
14744,GO:0060148,1,0.860779884197669,0,21,positive regulation of posttranscriptional gene silencing,BP,
14745,GO:0060149,1,0.921930953599743,0,12,negative regulation of posttranscriptional gene silencing,BP,
14746,GO:0060151,1,0.987613560903974,0,2,peroxisome localization,BP,
14747,GO:0060152,1,0.987613560903974,0,2,microtubule-based peroxisome localization,BP,
14748,GO:0060154,1,0.978511392493,0,3,cellular process regulating host cell cycle in response to virus,BP,
14749,GO:0060155,1,0.942210164185176,0,8,platelet dense granule organization,BP,
14751,GO:0060158,1,0.903849014430668,0,13,phospholipase C-activating dopamine receptor signaling pathway,BP,
14752,GO:0060159,1,0.929429150625415,0,10,regulation of dopamine receptor signaling pathway,BP,
14753,GO:0060160,1,0.977114202463951,0,3,negative regulation of dopamine receptor signaling pathway,BP,
14754,GO:0060161,1,0.964517790458397,0,5,positive regulation of dopamine receptor signaling pathway,BP,
14755,GO:0060163,1,0.984492575631969,0,2,subpallium neuron fate commitment,BP,
14756,GO:0060164,1,0.969760121658996,0,4,regulation of timing of neuron differentiation,BP,
14757,GO:0060165,1,0.992262432956955,0,1,regulation of timing of subpallium neuron differentiation,BP,
14758,GO:0060166,1,0.977650715851924,0,3,olfactory pit development,BP,
14759,GO:0060167,1,0.978590452921562,0,3,regulation of adenosine receptor signaling pathway,BP,
14760,GO:0060168,1,0.986314093672913,0,2,positive regulation of adenosine receptor signaling pathway,BP,
14761,GO:0060169,1,0.992170027168696,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14762,GO:0060170,1,0.55815416624504,0,81,ciliary membrane,CC,
14763,GO:0060171,1,0.987916976568123,0,2,stereocilium membrane,CC,
14764,GO:0060173,1,0.317685486988346,0,164,limb development,BP,
14765,GO:0060174,1,0.935303463140206,0,10,limb bud formation,BP,
14766,GO:0060175,1,0.993986332271181,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14767,GO:0060177,1,0.909619056745845,0,13,regulation of angiotensin metabolic process,BP,
14768,GO:0060178,1,0.992206993848105,0,1,regulation of exocyst localization,BP,
14770,GO:0060180,1,0.936714193655448,0,9,female mating behavior,BP,
14771,GO:0060184,1,0.992564231268535,0,1,cell cycle switching,BP,
14772,GO:0060187,1,0.987885951670797,0,2,cell pole,CC,
14776,GO:0060197,1,0.978357748161534,0,3,cloacal septation,BP,
14777,GO:0060198,1,0.913159942275816,0,12,clathrin-sculpted vesicle,CC,
14778,GO:0060199,1,0.971140671604647,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14779,GO:0060200,1,0.978475745106063,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14780,GO:0060201,1,0.978475745106063,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14781,GO:0060203,1,0.971140671604647,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14783,GO:0060211,1,0.924498236158426,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14784,GO:0060212,1,0.992170816652278,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14785,GO:0060213,1,0.924498236158426,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14786,GO:0060214,1,0.969548823791737,0,4,endocardium formation,BP,
14787,GO:0060215,1,0.938039534282496,0,9,primitive hemopoiesis,BP,
14788,GO:0060216,1,0.878084758243135,0,19,definitive hemopoiesis,BP,
14789,GO:0060217,1,0.993944019117899,0,1,hemangioblast cell differentiation,BP,
14790,GO:0060218,1,0.885752646428385,0,17,hematopoietic stem cell differentiation,BP,
14791,GO:0060219,1,0.894780928304719,0,16,camera-type eye photoreceptor cell differentiation,BP,
14792,GO:0060221,1,0.978390098936448,0,3,retinal rod cell differentiation,BP,
14794,GO:0060229,1,0.907964974862474,0,13,lipase activator activity,MF,
14795,GO:0060230,1,0.976695167534924,0,3,lipoprotein lipase activator activity,MF,
14796,GO:0060231,1,0.866375840848263,0,20,mesenchymal to epithelial transition,BP,
14797,GO:0060232,1,0.98505600927587,0,2,delamination,BP,
14798,GO:0060235,1,0.972701737808335,0,4,lens induction in camera-type eye,BP,
14799,GO:0060236,1,0.843807689044937,0,23,regulation of mitotic spindle organization,BP,
14800,GO:0060242,1,0.940239347915546,0,9,contact inhibition,BP,
14801,GO:0060243,1,0.993676227687297,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14802,GO:0060244,1,0.971810035937503,0,4,negative regulation of cell proliferation involved in contact inhibition,BP,
14803,GO:0060245,1,0.993288704834345,0,1,detection of cell density,BP,
14804,GO:0060246,1,0.993288704834345,0,1,detection of cell density by contact stimulus,BP,
14805,GO:0060248,1,0.993288704834345,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14807,GO:0060251,1,0.845954443232976,0,24,regulation of glial cell proliferation,BP,
14808,GO:0060252,1,0.932790969340517,0,10,positive regulation of glial cell proliferation,BP,
14809,GO:0060253,1,0.912446027522077,0,13,negative regulation of glial cell proliferation,BP,
14810,GO:0060254,1,0.992170721913545,0,1,regulation of N-terminal protein palmitoylation,BP,
14812,GO:0060259,1,0.867515022038616,0,20,regulation of feeding behavior,BP,
14815,GO:0060262,1,0.992170721913545,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14816,GO:0060263,1,0.920598289955923,0,11,regulation of respiratory burst,BP,
14817,GO:0060264,1,0.969077506913811,0,4,regulation of respiratory burst involved in inflammatory response,BP,
14818,GO:0060265,1,0.984401851528757,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14819,GO:0060266,1,0.976725694684542,0,3,negative regulation of respiratory burst involved in inflammatory response,BP,
14820,GO:0060267,1,0.963221148441679,0,5,positive regulation of respiratory burst,BP,
14821,GO:0060268,1,0.970850912851247,0,4,negative regulation of respiratory burst,BP,
14822,GO:0060271,1,0.113153662615179,0,305,cilium assembly,BP,
14823,GO:0060272,1,0.91496981237191,0,12,embryonic skeletal joint morphogenesis,BP,
14824,GO:0060278,1,0.977337524766504,0,3,regulation of ovulation,BP,
14825,GO:0060279,1,0.98500194637362,0,2,positive regulation of ovulation,BP,
14826,GO:0060280,1,0.992219791379029,0,1,negative regulation of ovulation,BP,
14827,GO:0060281,1,0.937767005948174,0,9,regulation of oocyte development,BP,
14828,GO:0060282,1,0.972265269590568,0,4,positive regulation of oocyte development,BP,
14829,GO:0060283,1,0.972077218702178,0,4,negative regulation of oocyte development,BP,
14831,GO:0060285,1,0.846516391973358,0,23,cilium-dependent cell motility,BP,
14832,GO:0060287,1,0.944995134881781,0,8,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14833,GO:0060290,1,0.945081272928699,0,8,transdifferentiation,BP,
14835,GO:0060292,1,0.855551892480511,0,23,long term synaptic depression,BP,
14836,GO:0060293,1,0.891770971524324,0,16,germ plasm,CC,
14837,GO:0060294,1,0.897018879182156,0,14,cilium movement involved in cell motility,BP,
14838,GO:0060295,1,0.962220751571001,0,5,regulation of cilium movement involved in cell motility,BP,
14839,GO:0060296,1,0.962220751571001,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14840,GO:0060297,1,0.952117902529494,0,7,regulation of sarcomere organization,BP,
14841,GO:0060298,1,0.971283965189481,0,4,positive regulation of sarcomere organization,BP,
14842,GO:0060299,1,0.992170027168696,0,1,negative regulation of sarcomere organization,BP,
14843,GO:0060300,1,0.970575462562662,0,4,regulation of cytokine activity,BP,
14844,GO:0060301,1,0.992266198294153,0,1,positive regulation of cytokine activity,BP,
14845,GO:0060302,1,0.984403034033537,0,2,negative regulation of cytokine activity,BP,
14846,GO:0060304,1,0.992604018863359,0,1,regulation of phosphatidylinositol dephosphorylation,BP,
14847,GO:0060305,1,0.992459776065546,0,1,regulation of cell diameter,BP,
14848,GO:0060306,1,0.817225329326362,0,29,regulation of membrane repolarization,BP,
14849,GO:0060307,1,0.88224893801952,0,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14850,GO:0060309,1,0.984400887813367,0,2,elastin catabolic process,BP,
14851,GO:0060310,1,0.992170027168696,0,1,regulation of elastin catabolic process,BP,
14852,GO:0060311,1,0.992170027168696,0,1,negative regulation of elastin catabolic process,BP,
14853,GO:0060312,1,0.939347602830117,0,9,regulation of blood vessel remodeling,BP,
14854,GO:0060313,1,0.980259153969565,0,3,negative regulation of blood vessel remodeling,BP,
14855,GO:0060314,1,0.837968529783221,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14856,GO:0060315,1,0.922103728528093,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14857,GO:0060316,1,0.944712461937197,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14858,GO:0060317,1,0.79837670705603,0,31,cardiac epithelial to mesenchymal transition,BP,
14859,GO:0060318,1,0.965612579559228,0,5,definitive erythrocyte differentiation,BP,
14860,GO:0060319,1,0.96412981812372,0,5,primitive erythrocyte differentiation,BP,
14862,GO:0060323,1,0.794125531164877,0,33,head morphogenesis,BP,
14863,GO:0060324,1,0.726746506760344,0,46,face development,BP,
14864,GO:0060325,1,0.825007308036947,0,28,face morphogenesis,BP,
14866,GO:0060327,1,0.992391125139131,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14867,GO:0060330,1,0.855962229070588,0,21,regulation of response to interferon-gamma,BP,
14868,GO:0060331,1,0.969056555181739,0,4,negative regulation of response to interferon-gamma,BP,
14869,GO:0060332,1,0.97292802910952,0,4,positive regulation of response to interferon-gamma,BP,
14871,GO:0060334,1,0.86218362700901,0,20,regulation of interferon-gamma-mediated signaling pathway,BP,
14872,GO:0060335,1,0.97292802910952,0,4,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14873,GO:0060336,1,0.969056555181739,0,4,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14876,GO:0060339,1,0.957625489859612,0,6,negative regulation of type I interferon-mediated signaling pathway,BP,
14879,GO:0060342,1,0.984631962003277,0,2,photoreceptor inner segment membrane,CC,
14881,GO:0060345,1,0.992905325785656,0,1,spleen trabecula formation,BP,
14882,GO:0060346,1,0.933709343679321,0,10,bone trabecula formation,BP,
14887,GO:0060351,1,0.849398804701079,0,23,cartilage development involved in endochondral bone morphogenesis,BP,
14888,GO:0060352,1,0.949025459236844,0,7,cell adhesion molecule production,BP,
14889,GO:0060353,1,0.962134158766339,0,5,regulation of cell adhesion molecule production,BP,
14890,GO:0060354,1,0.992170027168696,0,1,negative regulation of cell adhesion molecule production,BP,
14891,GO:0060355,1,0.969728925623669,0,4,positive regulation of cell adhesion molecule production,BP,
14892,GO:0060356,1,0.992208105018815,0,1,leucine import,BP,
14894,GO:0060363,1,0.934289524721106,0,9,cranial suture morphogenesis,BP,
14895,GO:0060364,1,0.97142794558761,0,4,frontal suture morphogenesis,BP,
14896,GO:0060366,1,0.993986332276527,0,1,lambdoid suture morphogenesis,BP,
14897,GO:0060367,1,0.993986332276527,0,1,sagittal suture morphogenesis,BP,
14898,GO:0060368,1,0.950027490860306,0,7,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14899,GO:0060369,1,0.971423000421121,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14900,GO:0060370,1,0.986203067585378,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14901,GO:0060371,1,0.955623000641471,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14902,GO:0060372,1,0.95996552606529,0,6,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14903,GO:0060373,1,0.959639100985341,0,6,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14904,GO:0060374,1,0.967739360880947,0,5,mast cell differentiation,BP,
14905,GO:0060375,1,0.986783164135044,0,2,regulation of mast cell differentiation,BP,
14906,GO:0060377,1,0.992795855711929,0,1,negative regulation of mast cell differentiation,BP,
14907,GO:0060378,1,0.993986332274444,0,1,regulation of brood size,BP,
14908,GO:0060379,1,0.926776323923209,0,11,cardiac muscle cell myoblast differentiation,BP,
14909,GO:0060380,1,0.992181526839924,0,1,regulation of single-stranded telomeric DNA binding,BP,
14910,GO:0060381,1,0.992181526839924,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14911,GO:0060382,1,0.987609168143917,0,2,regulation of DNA strand elongation,BP,
14912,GO:0060383,1,0.993584555441305,0,1,positive regulation of DNA strand elongation,BP,
14913,GO:0060384,1,0.847035515378283,0,25,innervation,BP,
14914,GO:0060385,1,0.965396506419941,0,5,axonogenesis involved in innervation,BP,
14915,GO:0060386,1,0.993986287492262,0,1,synapse assembly involved in innervation,BP,
14916,GO:0060389,1,0.632982535709683,0,63,pathway-restricted SMAD protein phosphorylation,BP,
14917,GO:0060390,1,0.891873480491711,0,16,regulation of SMAD protein import into nucleus,BP,
14918,GO:0060391,1,0.918601196881946,0,12,positive regulation of SMAD protein import into nucleus,BP,
14919,GO:0060392,1,0.976834978288177,0,3,negative regulation of SMAD protein import into nucleus,BP,
14920,GO:0060393,1,0.644745251700289,0,60,regulation of pathway-restricted SMAD protein phosphorylation,BP,
14921,GO:0060394,1,0.928684260217021,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14922,GO:0060395,1,0.669262788617277,0,56,SMAD protein signal transduction,BP,
14925,GO:0060398,1,0.974240677910086,0,4,regulation of growth hormone receptor signaling pathway,BP,
14926,GO:0060399,1,0.980261492678294,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14927,GO:0060400,1,0.993858904926768,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14930,GO:0060404,1,0.993206709488873,0,1,axonemal microtubule depolymerization,BP,
14931,GO:0060405,1,0.959139626527943,0,6,regulation of penile erection,BP,
14932,GO:0060406,1,0.972560868203946,0,4,positive regulation of penile erection,BP,
14933,GO:0060407,1,0.992170027168696,0,1,negative regulation of penile erection,BP,
14934,GO:0060411,1,0.647103704124839,0,62,cardiac septum morphogenesis,BP,
14935,GO:0060412,1,0.779454191628278,0,36,ventricular septum morphogenesis,BP,
14936,GO:0060413,1,0.899620973187435,0,15,atrial septum morphogenesis,BP,
14937,GO:0060414,1,0.980726552357,0,3,aorta smooth muscle tissue morphogenesis,BP,
14938,GO:0060415,1,0.598442446561518,0,73,muscle tissue morphogenesis,BP,
14942,GO:0060421,1,0.794881540350109,0,33,positive regulation of heart growth,BP,
14943,GO:0060422,1,0.992214202091288,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14944,GO:0060423,1,0.977816495592206,0,3,foregut regionalization,BP,
14945,GO:0060424,1,0.977816495592206,0,3,lung field specification,BP,
14946,GO:0060425,1,0.690937764529166,0,52,lung morphogenesis,BP,
14947,GO:0060426,1,0.956071506877332,0,6,lung vasculature development,BP,
14948,GO:0060428,1,0.750048665068312,0,40,lung epithelium development,BP,
14950,GO:0060430,1,0.951130190040921,0,7,lung saccule development,BP,
14951,GO:0060431,1,0.963444368881692,0,5,primary lung bud formation,BP,
14952,GO:0060432,1,0.992170027168696,0,1,lung pattern specification process,BP,
14953,GO:0060433,1,0.923819301089585,0,11,bronchus development,BP,
14954,GO:0060434,1,0.986208416782987,0,2,bronchus morphogenesis,BP,
14955,GO:0060435,1,0.976724511131143,0,3,bronchiole development,BP,
14956,GO:0060436,1,0.992170027168696,0,1,bronchiole morphogenesis,BP,
14957,GO:0060437,1,0.965002322328897,0,5,lung growth,BP,
14958,GO:0060438,1,0.873419631915226,0,19,trachea development,BP,
14959,GO:0060439,1,0.923959584640569,0,11,trachea morphogenesis,BP,
14960,GO:0060440,1,0.957513874290144,0,6,trachea formation,BP,
14961,GO:0060441,1,0.813042936767028,0,29,epithelial tube branching involved in lung morphogenesis,BP,
14962,GO:0060442,1,0.920203494850315,0,12,branching involved in prostate gland morphogenesis,BP,
14963,GO:0060443,1,0.732886452541801,0,45,mammary gland morphogenesis,BP,
14964,GO:0060444,1,0.853109287041442,0,23,branching involved in mammary gland duct morphogenesis,BP,
14965,GO:0060445,1,0.852903154054682,0,23,branching involved in salivary gland morphogenesis,BP,
14966,GO:0060446,1,0.99229380752301,0,1,branching involved in open tracheal system development,BP,
14967,GO:0060447,1,0.97848030261254,0,3,bud outgrowth involved in lung branching,BP,
14968,GO:0060448,1,0.980263933333895,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14969,GO:0060449,1,0.950485315483532,0,7,bud elongation involved in lung branching,BP,
14970,GO:0060450,1,0.992170027168696,0,1,positive regulation of hindgut contraction,BP,
14971,GO:0060452,1,0.922576484213966,0,11,positive regulation of cardiac muscle contraction,BP,
14972,GO:0060453,1,0.929953470739048,0,10,regulation of gastric acid secretion,BP,
14973,GO:0060454,1,0.986487155000105,0,2,positive regulation of gastric acid secretion,BP,
14974,GO:0060455,1,0.962983985918151,0,5,negative regulation of gastric acid secretion,BP,
14975,GO:0060456,1,0.920503572789014,0,11,positive regulation of digestive system process,BP,
14976,GO:0060457,1,0.889358886417295,0,16,negative regulation of digestive system process,BP,
14977,GO:0060458,1,0.984523706425684,0,2,right lung development,BP,
14978,GO:0060459,1,0.976737664471643,0,3,left lung development,BP,
14979,GO:0060460,1,0.984446796011158,0,2,left lung morphogenesis,BP,
14980,GO:0060461,1,0.99229380752301,0,1,right lung morphogenesis,BP,
14981,GO:0060462,1,0.954104226267967,0,7,lung lobe development,BP,
14982,GO:0060463,1,0.954104226267967,0,7,lung lobe morphogenesis,BP,
14983,GO:0060465,1,0.985974246456401,0,2,pharynx development,BP,
14984,GO:0060466,1,0.99398633226952,0,1,activation of meiosis involved in egg activation,BP,
14985,GO:0060467,1,0.95411640979123,0,6,negative regulation of fertilization,BP,
14986,GO:0060468,1,0.984441717441904,0,2,prevention of polyspermy,BP,
14987,GO:0060473,1,0.992170027168696,0,1,cortical granule,CC,
14988,GO:0060474,1,0.969749342335674,0,4,positive regulation of flagellated sperm motility involved in capacitation,BP,
14989,GO:0060478,1,0.970707931659017,0,4,acrosomal vesicle exocytosis,BP,
14990,GO:0060479,1,0.823667949157412,0,27,lung cell differentiation,BP,
14991,GO:0060480,1,0.96904554501191,0,4,lung goblet cell differentiation,BP,
14992,GO:0060481,1,0.962687536478425,0,5,lobar bronchus epithelium development,BP,
14993,GO:0060482,1,0.956371739327471,0,6,lobar bronchus development,BP,
14994,GO:0060484,1,0.931286905853783,0,10,lung-associated mesenchyme development,BP,
14995,GO:0060485,1,0.185007925564838,0,234,mesenchyme development,BP,
14996,GO:0060486,1,0.971767893369845,0,4,Clara cell differentiation,BP,
14997,GO:0060487,1,0.829503200478334,0,26,lung epithelial cell differentiation,BP,
14998,GO:0060488,1,0.988000678948897,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14999,GO:0060489,1,0.988000678948897,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
15000,GO:0060490,1,0.988000678948897,0,2,lateral sprouting involved in lung morphogenesis,BP,
15002,GO:0060492,1,0.977816495592206,0,3,lung induction,BP,
15003,GO:0060495,1,0.992170027168696,0,1,cell-cell signaling involved in lung development,BP,
15004,GO:0060496,1,0.992170027168696,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
15005,GO:0060501,1,0.957951127170482,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
15006,GO:0060502,1,0.931318829922442,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
15007,GO:0060503,1,0.992170392587755,0,1,bud dilation involved in lung branching,BP,
15008,GO:0060509,1,0.966818487195722,0,5,Type I pneumocyte differentiation,BP,
15009,GO:0060510,1,0.964100299957454,0,5,Type II pneumocyte differentiation,BP,
15010,GO:0060512,1,0.822494118559053,0,28,prostate gland morphogenesis,BP,
15011,GO:0060513,1,0.932753352924355,0,10,prostatic bud formation,BP,
15012,GO:0060514,1,0.992608776070655,0,1,prostate induction,BP,
15013,GO:0060515,1,0.992608776070655,0,1,prostate field specification,BP,
15014,GO:0060516,1,0.985673254311997,0,2,primary prostatic bud elongation,BP,
15015,GO:0060517,1,0.993452357000003,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
15016,GO:0060520,1,0.992608776070655,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
15017,GO:0060523,1,0.979877538176296,0,3,prostate epithelial cord elongation,BP,
15018,GO:0060525,1,0.929267402598026,0,11,prostate glandular acinus development,BP,
15019,GO:0060526,1,0.96081975706852,0,6,prostate glandular acinus morphogenesis,BP,
15020,GO:0060527,1,0.96081975706852,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
15021,GO:0060528,1,0.973149363421135,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
15022,GO:0060529,1,0.987483828663134,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
15023,GO:0060532,1,0.987215332575248,0,2,bronchus cartilage development,BP,
15024,GO:0060534,1,0.946094788689774,0,8,trachea cartilage development,BP,
15025,GO:0060535,1,0.972585504843847,0,4,trachea cartilage morphogenesis,BP,
15026,GO:0060536,1,0.917282363271154,0,12,cartilage morphogenesis,BP,
15029,GO:0060539,1,0.942978633983627,0,8,diaphragm development,BP,
15031,GO:0060542,1,0.993986328369309,0,1,regulation of strand invasion,BP,
15033,GO:0060545,1,0.985627858429517,0,2,positive regulation of necroptotic process,BP,
15037,GO:0060549,1,0.992170027168696,0,1,regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15038,GO:0060550,1,0.992170027168696,0,1,positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15039,GO:0060551,1,0.992170027168696,0,1,regulation of fructose 1,6-bisphosphate metabolic process,BP,
15040,GO:0060552,1,0.992170027168696,0,1,positive regulation of fructose 1,6-bisphosphate metabolic process,BP,
15041,GO:0060556,1,0.934913469089285,0,9,regulation of vitamin D biosynthetic process,BP,
15042,GO:0060557,1,0.976692113335833,0,3,positive regulation of vitamin D biosynthetic process,BP,
15043,GO:0060558,1,0.949720506441157,0,7,regulation of calcidiol 1-monooxygenase activity,BP,
15044,GO:0060559,1,0.976692113335833,0,3,positive regulation of calcidiol 1-monooxygenase activity,BP,
15045,GO:0060560,1,0.247940729927603,0,202,developmental growth involved in morphogenesis,BP,
15046,GO:0060561,1,0.847498291529028,0,24,apoptotic process involved in morphogenesis,BP,
15047,GO:0060562,1,0.113283625806647,0,309,epithelial tube morphogenesis,BP,
15048,GO:0060563,1,0.709617181941186,0,48,neuroepithelial cell differentiation,BP,
15049,GO:0060566,1,0.993986332289148,0,1,positive regulation of DNA-templated transcription, termination,BP,
15050,GO:0060571,1,0.834661981220714,0,25,morphogenesis of an epithelial fold,BP,
15051,GO:0060572,1,0.885873769033902,0,17,morphogenesis of an epithelial bud,BP,
15052,GO:0060573,1,0.930832614789457,0,10,cell fate specification involved in pattern specification,BP,
15053,GO:0060574,1,0.97038712783106,0,4,intestinal epithelial cell maturation,BP,
15054,GO:0060575,1,0.882002257979,0,17,intestinal epithelial cell differentiation,BP,
15055,GO:0060576,1,0.928024428508529,0,10,intestinal epithelial cell development,BP,
15056,GO:0060577,1,0.984433539665883,0,2,pulmonary vein morphogenesis,BP,
15057,GO:0060578,1,0.992202934704535,0,1,superior vena cava morphogenesis,BP,
15058,GO:0060579,1,0.90346515500159,0,14,ventral spinal cord interneuron fate commitment,BP,
15059,GO:0060580,1,0.992182389405322,0,1,ventral spinal cord interneuron fate determination,BP,
15060,GO:0060581,1,0.90346515500159,0,14,cell fate commitment involved in pattern specification,BP,
15061,GO:0060582,1,0.992182389405322,0,1,cell fate determination involved in pattern specification,BP,
15062,GO:0060584,1,0.978315042874397,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
15063,GO:0060585,1,0.978315042874397,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
15064,GO:0060586,1,0.937121568803711,0,9,multicellular organismal iron ion homeostasis,BP,
15065,GO:0060587,1,0.985199199824602,0,2,regulation of lipoprotein lipid oxidation,BP,
15066,GO:0060588,1,0.992170027168696,0,1,negative regulation of lipoprotein lipid oxidation,BP,
15068,GO:0060590,1,0.755474585622387,0,38,ATPase regulator activity,MF,
15069,GO:0060591,1,0.96399749328043,0,5,chondroblast differentiation,BP,
15070,GO:0060592,1,0.952945366147152,0,7,mammary gland formation,BP,
15071,GO:0060594,1,0.979877538185432,0,3,mammary gland specification,BP,
15072,GO:0060595,1,0.985806511666193,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
15073,GO:0060596,1,0.980194798981636,0,3,mammary placode formation,BP,
15074,GO:0060598,1,0.992170027168696,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
15075,GO:0060599,1,0.986639211521214,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
15076,GO:0060600,1,0.934687564603885,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
15077,GO:0060601,1,0.915640877216013,0,13,lateral sprouting from an epithelium,BP,
15078,GO:0060602,1,0.868587125677346,0,20,branch elongation of an epithelium,BP,
15079,GO:0060603,1,0.809171505275878,0,31,mammary gland duct morphogenesis,BP,
15080,GO:0060605,1,0.96498250140459,0,5,tube lumen cavitation,BP,
15081,GO:0060606,1,0.550919528693429,0,86,tube closure,BP,
15082,GO:0060611,1,0.992248052089351,0,1,mammary gland fat development,BP,
15084,GO:0060613,1,0.972431959848565,0,4,fat pad development,BP,
15085,GO:0060615,1,0.985806511666193,0,2,mammary gland bud formation,BP,
15086,GO:0060620,1,0.976814787232004,0,3,regulation of cholesterol import,BP,
15087,GO:0060621,1,0.984400887813367,0,2,negative regulation of cholesterol import,BP,
15088,GO:0060623,1,0.976895726963979,0,3,regulation of chromosome condensation,BP,
15090,GO:0060628,1,0.916792078453335,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
15091,GO:0060629,1,0.984686330868422,0,2,regulation of homologous chromosome segregation,BP,
15092,GO:0060631,1,0.949521334078719,0,7,regulation of meiosis I,BP,
15093,GO:0060632,1,0.88441444281601,0,17,regulation of microtubule-based movement,BP,
15094,GO:0060633,1,0.96459359385856,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
15095,GO:0060638,1,0.94547444467946,0,8,mesenchymal-epithelial cell signaling,BP,
15096,GO:0060644,1,0.884170735718224,0,17,mammary gland epithelial cell differentiation,BP,
15097,GO:0060648,1,0.978088358078011,0,3,mammary gland bud morphogenesis,BP,
15098,GO:0060661,1,0.984423508203672,0,2,submandibular salivary gland formation,BP,
15099,GO:0060662,1,0.96498250140459,0,5,salivary gland cavitation,BP,
15100,GO:0060664,1,0.95591858101528,0,6,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
15101,GO:0060665,1,0.972087674469286,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
15102,GO:0060666,1,0.968589730943504,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
15103,GO:0060667,1,0.985806511666193,0,2,branch elongation involved in salivary gland morphogenesis,BP,
15104,GO:0060668,1,0.99316928408768,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
15105,GO:0060669,1,0.853766469345211,0,22,embryonic placenta morphogenesis,BP,
15106,GO:0060670,1,0.923452220730672,0,11,branching involved in labyrinthine layer morphogenesis,BP,
15107,GO:0060671,1,0.979148611526714,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
15108,GO:0060672,1,0.979148611526714,0,3,epithelial cell morphogenesis involved in placental branching,BP,
15109,GO:0060674,1,0.813321975982488,0,29,placenta blood vessel development,BP,
15110,GO:0060675,1,0.634950853929097,0,64,ureteric bud morphogenesis,BP,
15111,GO:0060676,1,0.957679604387271,0,6,ureteric bud formation,BP,
15112,GO:0060677,1,0.947466966169201,0,8,ureteric bud elongation,BP,
15113,GO:0060678,1,0.992207732189552,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15114,GO:0060681,1,0.964791600001241,0,5,branch elongation involved in ureteric bud branching,BP,
15115,GO:0060683,1,0.992404058851162,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
15116,GO:0060684,1,0.948236875500587,0,7,epithelial-mesenchymal cell signaling,BP,
15117,GO:0060685,1,0.959166086100401,0,6,regulation of prostatic bud formation,BP,
15118,GO:0060686,1,0.973937680099695,0,4,negative regulation of prostatic bud formation,BP,
15119,GO:0060687,1,0.95419644373758,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
15120,GO:0060688,1,0.678808904766635,0,54,regulation of morphogenesis of a branching structure,BP,
15121,GO:0060689,1,0.979043760973811,0,3,cell differentiation involved in salivary gland development,BP,
15122,GO:0060690,1,0.992170629164745,0,1,epithelial cell differentiation involved in salivary gland development,BP,
15123,GO:0060691,1,0.992170629164745,0,1,epithelial cell maturation involved in salivary gland development,BP,
15124,GO:0060693,1,0.937497230494801,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
15125,GO:0060694,1,0.984402301603461,0,2,regulation of cholesterol transporter activity,BP,
15126,GO:0060695,1,0.992170027168696,0,1,negative regulation of cholesterol transporter activity,BP,
15128,GO:0060697,1,0.984644804779036,0,2,positive regulation of phospholipid catabolic process,BP,
15129,GO:0060698,1,0.986339382007681,0,2,endoribonuclease inhibitor activity,MF,
15130,GO:0060699,1,0.971026333664133,0,4,regulation of endoribonuclease activity,BP,
15131,GO:0060700,1,0.965185565508046,0,5,regulation of ribonuclease activity,BP,
15132,GO:0060701,1,0.986339382007681,0,2,negative regulation of ribonuclease activity,BP,
15133,GO:0060702,1,0.986339382007681,0,2,negative regulation of endoribonuclease activity,BP,
15134,GO:0060703,1,0.992369512477412,0,1,deoxyribonuclease inhibitor activity,MF,
15135,GO:0060706,1,0.828816764840779,0,26,cell differentiation involved in embryonic placenta development,BP,
15136,GO:0060707,1,0.918441877804184,0,12,trophoblast giant cell differentiation,BP,
15137,GO:0060708,1,0.970495940413147,0,4,spongiotrophoblast differentiation,BP,
15138,GO:0060709,1,0.992466956723238,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
15139,GO:0060710,1,0.957784504664577,0,6,chorio-allantoic fusion,BP,
15140,GO:0060711,1,0.712474825558634,0,47,labyrinthine layer development,BP,
15141,GO:0060712,1,0.897577104655184,0,15,spongiotrophoblast layer development,BP,
15142,GO:0060713,1,0.87223023712761,0,19,labyrinthine layer morphogenesis,BP,
15143,GO:0060715,1,0.986428920921865,0,2,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
15144,GO:0060716,1,0.864566796284208,0,20,labyrinthine layer blood vessel development,BP,
15145,GO:0060717,1,0.961317485986354,0,6,chorion development,BP,
15146,GO:0060718,1,0.967828334426361,0,5,chorionic trophoblast cell differentiation,BP,
15147,GO:0060720,1,0.986203080783505,0,2,spongiotrophoblast cell proliferation,BP,
15148,GO:0060721,1,0.986203080783505,0,2,regulation of spongiotrophoblast cell proliferation,BP,
15149,GO:0060722,1,0.986203080783505,0,2,cell proliferation involved in embryonic placenta development,BP,
15150,GO:0060723,1,0.986203080783505,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
15151,GO:0060729,1,0.965251476907762,0,5,intestinal epithelial structure maintenance,BP,
15152,GO:0060730,1,0.985209463894665,0,2,regulation of intestinal epithelial structure maintenance,BP,
15153,GO:0060731,1,0.992830992499847,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
15154,GO:0060732,1,0.915576077710627,0,12,positive regulation of inositol phosphate biosynthetic process,BP,
15155,GO:0060733,1,0.987332359942484,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
15156,GO:0060734,1,0.98614583580575,0,2,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
15157,GO:0060735,1,0.992170027168696,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
15158,GO:0060736,1,0.930009264893948,0,11,prostate gland growth,BP,
15159,GO:0060737,1,0.973460633525264,0,4,prostate gland morphogenetic growth,BP,
15160,GO:0060738,1,0.984891216996277,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
15161,GO:0060739,1,0.993986332273654,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
15162,GO:0060740,1,0.835413124443374,0,26,prostate gland epithelium morphogenesis,BP,
15163,GO:0060741,1,0.977232187790836,0,3,prostate gland stromal morphogenesis,BP,
15164,GO:0060742,1,0.920166709320647,0,12,epithelial cell differentiation involved in prostate gland development,BP,
15165,GO:0060743,1,0.977721795760365,0,3,epithelial cell maturation involved in prostate gland development,BP,
15166,GO:0060744,1,0.965004731340358,0,5,mammary gland branching involved in thelarche,BP,
15167,GO:0060745,1,0.968304007072683,0,5,mammary gland branching involved in pregnancy,BP,
15168,GO:0060746,1,0.911568380718007,0,13,parental behavior,BP,
15169,GO:0060748,1,0.986091449577224,0,2,tertiary branching involved in mammary gland duct morphogenesis,BP,
15170,GO:0060749,1,0.885052860438063,0,17,mammary gland alveolus development,BP,
15171,GO:0060750,1,0.974375796182124,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
15172,GO:0060751,1,0.966771688811971,0,5,branch elongation involved in mammary gland duct branching,BP,
15173,GO:0060752,1,0.984793258190617,0,2,intestinal phytosterol absorption,BP,
15174,GO:0060753,1,0.956483216630216,0,6,regulation of mast cell chemotaxis,BP,
15175,GO:0060754,1,0.964033725867091,0,5,positive regulation of mast cell chemotaxis,BP,
15179,GO:0060762,1,0.957118823662442,0,6,regulation of branching involved in mammary gland duct morphogenesis,BP,
15180,GO:0060763,1,0.978557259282569,0,3,mammary duct terminal end bud growth,BP,
15181,GO:0060764,1,0.986179415124653,0,2,cell-cell signaling involved in mammary gland development,BP,
15182,GO:0060765,1,0.831129077250029,0,26,regulation of androgen receptor signaling pathway,BP,
15183,GO:0060766,1,0.91805799315311,0,12,negative regulation of androgen receptor signaling pathway,BP,
15184,GO:0060767,1,0.92252333045325,0,11,epithelial cell proliferation involved in prostate gland development,BP,
15185,GO:0060768,1,0.928607026905155,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
15186,GO:0060769,1,0.977917518995964,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
15187,GO:0060770,1,0.955331686088159,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
15188,GO:0060775,1,0.986206452881031,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
15189,GO:0060781,1,0.992170027168696,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
15190,GO:0060782,1,0.992170027168696,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
15191,GO:0060783,1,0.992170027168696,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
15192,GO:0060784,1,0.993452357000003,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
15193,GO:0060788,1,0.898884424866497,0,15,ectodermal placode formation,BP,
15194,GO:0060789,1,0.948993045547915,0,7,hair follicle placode formation,BP,
15195,GO:0060795,1,0.772361843114436,0,35,cell fate commitment involved in formation of primary germ layer,BP,
15196,GO:0060796,1,0.98445602127149,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15197,GO:0060800,1,0.978749486102565,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15198,GO:0060802,1,0.992183386879296,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15199,GO:0060803,1,0.992170027168696,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15200,GO:0060804,1,0.992703644198348,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15201,GO:0060806,1,0.992170034210834,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15202,GO:0060807,1,0.992225592354327,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15203,GO:0060809,1,0.986413388195211,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15204,GO:0060816,1,0.993986332287271,0,1,random inactivation of X chromosome,BP,
15205,GO:0060817,1,0.992198562480326,0,1,inactivation of paternal X chromosome,BP,
15206,GO:0060821,1,0.993986332278843,0,1,inactivation of X chromosome by DNA methylation,BP,
15207,GO:0060823,1,0.98656283562136,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15208,GO:0060825,1,0.984403034189576,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15209,GO:0060827,1,0.993568912326251,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15211,GO:0060829,1,0.993568912326251,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15212,GO:0060830,1,0.979609538593185,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15213,GO:0060831,1,0.915511140973663,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15214,GO:0060836,1,0.95300478005171,0,7,lymphatic endothelial cell differentiation,BP,
15215,GO:0060837,1,0.941779477990811,0,8,blood vessel endothelial cell differentiation,BP,
15216,GO:0060838,1,0.98612170219742,0,2,lymphatic endothelial cell fate commitment,BP,
15217,GO:0060839,1,0.956765500234944,0,6,endothelial cell fate commitment,BP,
15218,GO:0060840,1,0.58551950452723,0,78,artery development,BP,
15219,GO:0060841,1,0.896062549445249,0,16,venous blood vessel development,BP,
15220,GO:0060842,1,0.956614695152511,0,6,arterial endothelial cell differentiation,BP,
15221,GO:0060843,1,0.993986332281635,0,1,venous endothelial cell differentiation,BP,
15222,GO:0060844,1,0.985147220617595,0,2,arterial endothelial cell fate commitment,BP,
15223,GO:0060846,1,0.977527400304944,0,3,blood vessel endothelial cell fate commitment,BP,
15224,GO:0060847,1,0.977527400304944,0,3,endothelial cell fate specification,BP,
15225,GO:0060849,1,0.98612170219742,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15226,GO:0060850,1,0.894086296431606,0,15,regulation of transcription involved in cell fate commitment,BP,
15227,GO:0060853,1,0.992863536011743,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15228,GO:0060856,1,0.929645757821276,0,10,establishment of blood-brain barrier,BP,
15229,GO:0060857,1,0.992210588479864,0,1,establishment of glial blood-brain barrier,BP,
15230,GO:0060872,1,0.940526625712115,0,9,semicircular canal development,BP,
15231,GO:0060873,1,0.993986332276527,0,1,anterior semicircular canal development,BP,
15232,GO:0060875,1,0.993986332276527,0,1,lateral semicircular canal development,BP,
15233,GO:0060876,1,0.984481955018747,0,2,semicircular canal formation,BP,
15234,GO:0060879,1,0.992170027168696,0,1,semicircular canal fusion,BP,
15235,GO:0060896,1,0.939832677290255,0,9,neural plate pattern specification,BP,
15236,GO:0060897,1,0.951243905754826,0,7,neural plate regionalization,BP,
15237,GO:0060900,1,0.922151447135958,0,12,embryonic camera-type eye formation,BP,
15238,GO:0060901,1,0.993704836810665,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15239,GO:0060903,1,0.971452507771787,0,4,positive regulation of meiosis I,BP,
15240,GO:0060904,1,0.993488664405546,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15241,GO:0060907,1,0.950891984312079,0,7,positive regulation of macrophage cytokine production,BP,
15242,GO:0060911,1,0.91297287757969,0,12,cardiac cell fate commitment,BP,
15243,GO:0060912,1,0.977210829047202,0,3,cardiac cell fate specification,BP,
15244,GO:0060913,1,0.976942117399054,0,3,cardiac cell fate determination,BP,
15245,GO:0060914,1,0.848541432554362,0,22,heart formation,BP,
15246,GO:0060915,1,0.985806511666193,0,2,mesenchymal cell differentiation involved in lung development,BP,
15247,GO:0060916,1,0.966554425462078,0,5,mesenchymal cell proliferation involved in lung development,BP,
15248,GO:0060920,1,0.966653931703885,0,5,cardiac pacemaker cell differentiation,BP,
15249,GO:0060921,1,0.980176378302613,0,3,sinoatrial node cell differentiation,BP,
15250,GO:0060922,1,0.986206212218878,0,2,atrioventricular node cell differentiation,BP,
15251,GO:0060923,1,0.941792732043017,0,8,cardiac muscle cell fate commitment,BP,
15252,GO:0060926,1,0.974284096759318,0,4,cardiac pacemaker cell development,BP,
15253,GO:0060927,1,0.992173236388616,0,1,cardiac pacemaker cell fate commitment,BP,
15254,GO:0060928,1,0.986206212218878,0,2,atrioventricular node cell development,BP,
15255,GO:0060929,1,0.992173236388616,0,1,atrioventricular node cell fate commitment,BP,
15256,GO:0060931,1,0.987912438286951,0,2,sinoatrial node cell development,BP,
15257,GO:0060932,1,0.986113422655133,0,2,His-Purkinje system cell differentiation,BP,
15258,GO:0060935,1,0.979538588926265,0,3,cardiac fibroblast cell differentiation,BP,
15259,GO:0060936,1,0.979538588926265,0,3,cardiac fibroblast cell development,BP,
15260,GO:0060938,1,0.979538588926265,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15261,GO:0060939,1,0.979538588926265,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15262,GO:0060940,1,0.985465527547581,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15263,GO:0060947,1,0.953282214541856,0,7,cardiac vascular smooth muscle cell differentiation,BP,
15264,GO:0060948,1,0.979542731513504,0,3,cardiac vascular smooth muscle cell development,BP,
15265,GO:0060956,1,0.957893247927748,0,6,endocardial cell differentiation,BP,
15266,GO:0060957,1,0.99254009808721,0,1,endocardial cell fate commitment,BP,
15267,GO:0060964,1,0.814771705322331,0,29,regulation of gene silencing by miRNA,BP,
15268,GO:0060965,1,0.933565861470335,0,10,negative regulation of gene silencing by miRNA,BP,
15269,GO:0060966,1,0.799754927743557,0,32,regulation of gene silencing by RNA,BP,
15270,GO:0060967,1,0.921930953599743,0,12,negative regulation of gene silencing by RNA,BP,
15271,GO:0060968,1,0.63628310250389,0,64,regulation of gene silencing,BP,
15272,GO:0060969,1,0.86711171139695,0,21,negative regulation of gene silencing,BP,
15273,GO:0060971,1,0.97209720335535,0,4,embryonic heart tube left/right pattern formation,BP,
15274,GO:0060972,1,0.862811536844143,0,21,left/right pattern formation,BP,
15275,GO:0060973,1,0.905683214940907,0,14,cell migration involved in heart development,BP,
15276,GO:0060974,1,0.984400887813367,0,2,cell migration involved in heart formation,BP,
15277,GO:0060975,1,0.992170027168696,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15278,GO:0060976,1,0.753271926502253,0,42,coronary vasculature development,BP,
15279,GO:0060977,1,0.916426755268163,0,13,coronary vasculature morphogenesis,BP,
15280,GO:0060978,1,0.980366726432484,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15281,GO:0060979,1,0.981289305205494,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
15282,GO:0060980,1,0.993199845739775,0,1,cell migration involved in coronary vasculogenesis,BP,
15283,GO:0060981,1,0.993986290666351,0,1,cell migration involved in coronary angiogenesis,BP,
15284,GO:0060982,1,0.946812905154426,0,8,coronary artery morphogenesis,BP,
15285,GO:0060986,1,0.726800242435502,0,44,endocrine hormone secretion,BP,
15286,GO:0060987,1,0.992219791379029,0,1,lipid tube,CC,
15287,GO:0060988,1,0.979121428031328,0,3,lipid tube assembly,BP,
15288,GO:0060989,1,0.993094468409554,0,1,lipid tube assembly involved in organelle fusion,BP,
15290,GO:0060993,1,0.524373531719271,0,92,kidney morphogenesis,BP,
15291,GO:0060994,1,0.985477107164393,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15292,GO:0060995,1,0.986647576122904,0,2,cell-cell signaling involved in kidney development,BP,
15293,GO:0060996,1,0.582885894174913,0,81,dendritic spine development,BP,
15294,GO:0060997,1,0.739793231510502,0,46,dendritic spine morphogenesis,BP,
15295,GO:0060998,1,0.669999993591768,0,60,regulation of dendritic spine development,BP,
15296,GO:0060999,1,0.780375911694965,0,37,positive regulation of dendritic spine development,BP,
15297,GO:0061000,1,0.923545721770953,0,12,negative regulation of dendritic spine development,BP,
15298,GO:0061001,1,0.80085805505548,0,34,regulation of dendritic spine morphogenesis,BP,
15299,GO:0061002,1,0.960753786171921,0,6,negative regulation of dendritic spine morphogenesis,BP,
15300,GO:0061003,1,0.896207433783675,0,17,positive regulation of dendritic spine morphogenesis,BP,
15301,GO:0061004,1,0.934437389496125,0,9,pattern specification involved in kidney development,BP,
15302,GO:0061005,1,0.677472081239467,0,56,cell differentiation involved in kidney development,BP,
15304,GO:0061009,1,0.962819890924566,0,5,common bile duct development,BP,
15305,GO:0061010,1,0.978535286116587,0,3,gall bladder development,BP,
15306,GO:0061011,1,0.992170208697877,0,1,hepatic duct development,BP,
15307,GO:0061013,1,0.801416739895418,0,32,regulation of mRNA catabolic process,BP,
15308,GO:0061014,1,0.83350109520479,0,26,positive regulation of mRNA catabolic process,BP,
15309,GO:0061015,1,0.992170044296599,0,1,snRNA import into nucleus,BP,
15310,GO:0061017,1,0.984651136689717,0,2,hepatoblast differentiation,BP,
15313,GO:0061026,1,0.993986332292773,0,1,cardiac muscle tissue regeneration,BP,
15314,GO:0061027,1,0.984620170528662,0,2,umbilical cord development,BP,
15315,GO:0061028,1,0.770067253639549,0,38,establishment of endothelial barrier,BP,
15316,GO:0061029,1,0.911073755736746,0,13,eyelid development in camera-type eye,BP,
15317,GO:0061030,1,0.970481117256262,0,4,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15318,GO:0061031,1,0.97677921799053,0,3,endodermal digestive tract morphogenesis,BP,
15319,GO:0061032,1,0.984863026178909,0,2,visceral serous pericardium development,BP,
15320,GO:0061033,1,0.985681569525853,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15321,GO:0061034,1,0.987721180604438,0,2,olfactory bulb mitral cell layer development,BP,
15324,GO:0061037,1,0.840665437487686,0,24,negative regulation of cartilage development,BP,
15325,GO:0061038,1,0.959448755605535,0,6,uterus morphogenesis,BP,
15326,GO:0061040,1,0.993986332279134,0,1,female gonad morphogenesis,BP,
15328,GO:0061042,1,0.935934878375679,0,9,vascular wound healing,BP,
15329,GO:0061043,1,0.971149245968451,0,4,regulation of vascular wound healing,BP,
15330,GO:0061044,1,0.992716694742547,0,1,negative regulation of vascular wound healing,BP,
15331,GO:0061045,1,0.627727800311131,0,64,negative regulation of wound healing,BP,
15332,GO:0061046,1,0.95625674951703,0,6,regulation of branching involved in lung morphogenesis,BP,
15333,GO:0061047,1,0.970159240118938,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15334,GO:0061048,1,0.992170027519113,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15335,GO:0061049,1,0.873005884225316,0,19,cell growth involved in cardiac muscle cell development,BP,
15336,GO:0061050,1,0.91691919274951,0,12,regulation of cell growth involved in cardiac muscle cell development,BP,
15337,GO:0061051,1,0.951794219776075,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15338,GO:0061052,1,0.963372528691925,0,5,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15339,GO:0061053,1,0.550625514050117,0,84,somite development,BP,
15340,GO:0061054,1,0.970664315467671,0,4,dermatome development,BP,
15341,GO:0061055,1,0.972651998269796,0,4,myotome development,BP,
15342,GO:0061056,1,0.969341708185903,0,4,sclerotome development,BP,
15344,GO:0061072,1,0.938437659913137,0,9,iris morphogenesis,BP,
15345,GO:0061073,1,0.978678182904171,0,3,ciliary body morphogenesis,BP,
15346,GO:0061074,1,0.955353445278726,0,6,regulation of neural retina development,BP,
15347,GO:0061075,1,0.984486305222326,0,2,positive regulation of neural retina development,BP,
15348,GO:0061076,1,0.992693459181082,0,1,negative regulation of neural retina development,BP,
15349,GO:0061077,1,0.628667408929572,0,62,chaperone-mediated protein folding,BP,
15350,GO:0061078,1,0.992170027168696,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15351,GO:0061081,1,0.923579229865517,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15352,GO:0061082,1,0.854079110436395,0,22,myeloid leukocyte cytokine production,BP,
15353,GO:0061083,1,0.971530932460722,0,4,regulation of protein refolding,BP,
15354,GO:0061084,1,0.971530932460722,0,4,negative regulation of protein refolding,BP,
15355,GO:0061085,1,0.938538305865429,0,9,regulation of histone H3-K27 methylation,BP,
15356,GO:0061086,1,0.972186962712271,0,4,negative regulation of histone H3-K27 methylation,BP,
15357,GO:0061087,1,0.958737995643358,0,6,positive regulation of histone H3-K27 methylation,BP,
15358,GO:0061088,1,0.93128774378164,0,10,regulation of sequestering of zinc ion,BP,
15359,GO:0061090,1,0.992240185590134,0,1,positive regulation of sequestering of zinc ion,BP,
15360,GO:0061091,1,0.981555595207261,0,3,regulation of phospholipid translocation,BP,
15361,GO:0061092,1,0.981555595207261,0,3,positive regulation of phospholipid translocation,BP,
15362,GO:0061097,1,0.634069357569492,0,64,regulation of protein tyrosine kinase activity,BP,
15363,GO:0061098,1,0.770172162622164,0,37,positive regulation of protein tyrosine kinase activity,BP,
15364,GO:0061099,1,0.847472401951422,0,23,negative regulation of protein tyrosine kinase activity,BP,
15365,GO:0061100,1,0.992262432956955,0,1,lung neuroendocrine cell differentiation,BP,
15366,GO:0061101,1,0.941084653175737,0,8,neuroendocrine cell differentiation,BP,
15367,GO:0061102,1,0.984492575631969,0,2,stomach neuroendocrine cell differentiation,BP,
15368,GO:0061103,1,0.992262432956955,0,1,carotid body glomus cell differentiation,BP,
15369,GO:0061104,1,0.984757275215335,0,2,adrenal chromaffin cell differentiation,BP,
15370,GO:0061105,1,0.992170027168696,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15371,GO:0061106,1,0.992170027168696,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15372,GO:0061107,1,0.97682993250763,0,3,seminal vesicle development,BP,
15373,GO:0061108,1,0.992207639364056,0,1,seminal vesicle epithelium development,BP,
15374,GO:0061110,1,0.979516500439729,0,3,dense core granule biogenesis,BP,
15375,GO:0061113,1,0.972319479004634,0,4,pancreas morphogenesis,BP,
15376,GO:0061114,1,0.992631976713582,0,1,branching involved in pancreas morphogenesis,BP,
15377,GO:0061115,1,0.992170027168696,0,1,lung proximal/distal axis specification,BP,
15379,GO:0061133,1,0.954486490317224,0,6,endopeptidase activator activity,MF,
15382,GO:0061136,1,0.354812571557316,0,143,regulation of proteasomal protein catabolic process,BP,
15383,GO:0061138,1,0.281860799263641,0,180,morphogenesis of a branching epithelium,BP,
15384,GO:0061140,1,0.927016072164654,0,10,lung secretory cell differentiation,BP,
15385,GO:0061141,1,0.978636764992333,0,3,lung ciliated cell differentiation,BP,
15386,GO:0061143,1,0.992454807068985,0,1,alveolar primary septum development,BP,
15387,GO:0061144,1,0.992664195911907,0,1,alveolar secondary septum development,BP,
15388,GO:0061145,1,0.987215332575248,0,2,lung smooth muscle development,BP,
15389,GO:0061146,1,0.978982096472706,0,3,Peyer's patch morphogenesis,BP,
15390,GO:0061149,1,0.992170392587755,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15391,GO:0061150,1,0.992170392587755,0,1,renal system segmentation,BP,
15392,GO:0061151,1,0.992170392587755,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15393,GO:0061152,1,0.985277228339231,0,2,trachea submucosa development,BP,
15394,GO:0061153,1,0.985277228339231,0,2,trachea gland development,BP,
15395,GO:0061154,1,0.897322791667867,0,15,endothelial tube morphogenesis,BP,
15396,GO:0061155,1,0.992170392587755,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15397,GO:0061156,1,0.965293294657894,0,5,pulmonary artery morphogenesis,BP,
15398,GO:0061157,1,0.876737418630687,0,19,mRNA destabilization,BP,
15399,GO:0061158,1,0.920922217085029,0,12,3'-UTR-mediated mRNA destabilization,BP,
15400,GO:0061162,1,0.914187043373104,0,13,establishment of monopolar cell polarity,BP,
15401,GO:0061168,1,0.992170027168696,0,1,regulation of hair follicle placode formation,BP,
15402,GO:0061170,1,0.992170027168696,0,1,negative regulation of hair follicle placode formation,BP,
15403,GO:0061178,1,0.702470691494837,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15404,GO:0061179,1,0.941823629399303,0,8,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15405,GO:0061180,1,0.629581627948106,0,66,mammary gland epithelium development,BP,
15406,GO:0061181,1,0.993675636578264,0,1,regulation of chondrocyte development,BP,
15407,GO:0061183,1,0.970664315467671,0,4,regulation of dermatome development,BP,
15408,GO:0061184,1,0.97831970263258,0,3,positive regulation of dermatome development,BP,
15409,GO:0061185,1,0.992176297995038,0,1,negative regulation of dermatome development,BP,
15410,GO:0061187,1,0.988001465816757,0,2,regulation of chromatin silencing at rDNA,BP,
15411,GO:0061188,1,0.988001465816757,0,2,negative regulation of chromatin silencing at rDNA,BP,
15412,GO:0061189,1,0.992170027168696,0,1,positive regulation of sclerotome development,BP,
15413,GO:0061190,1,0.992170027168696,0,1,regulation of sclerotome development,BP,
15414,GO:0061193,1,0.992170027168696,0,1,taste bud development,BP,
15415,GO:0061196,1,0.958426320608932,0,6,fungiform papilla development,BP,
15416,GO:0061197,1,0.965953865859073,0,5,fungiform papilla morphogenesis,BP,
15417,GO:0061198,1,0.979289556128823,0,3,fungiform papilla formation,BP,
15418,GO:0061200,1,0.941631318191479,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15419,GO:0061202,1,0.941631318191479,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15420,GO:0061205,1,0.97825892202534,0,3,paramesonephric duct development,BP,
15421,GO:0061206,1,0.992422054065019,0,1,mesonephros morphogenesis,BP,
15422,GO:0061209,1,0.970058275435358,0,4,cell proliferation involved in mesonephros development,BP,
15423,GO:0061213,1,0.852447147740983,0,22,positive regulation of mesonephros development,BP,
15424,GO:0061215,1,0.992422054065019,0,1,mesonephric nephron development,BP,
15425,GO:0061216,1,0.992170392587755,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15426,GO:0061217,1,0.826263046914353,0,26,regulation of mesonephros development,BP,
15427,GO:0061218,1,0.956181625348716,0,6,negative regulation of mesonephros development,BP,
15428,GO:0061227,1,0.984403479935557,0,2,pattern specification involved in mesonephros development,BP,
15429,GO:0061228,1,0.992422054065019,0,1,mesonephric nephron morphogenesis,BP,
15430,GO:0061235,1,0.992422054065019,0,1,mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis,BP,
15431,GO:0061245,1,0.776572833784566,0,36,establishment or maintenance of bipolar cell polarity,BP,
15432,GO:0061289,1,0.986647576122904,0,2,Wnt signaling pathway involved in kidney development,BP,
15433,GO:0061290,1,0.986647576122904,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15434,GO:0061295,1,0.992422054065019,0,1,regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15435,GO:0061296,1,0.992422054065019,0,1,negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15436,GO:0061298,1,0.90017141883807,0,16,retina vasculature development in camera-type eye,BP,
15437,GO:0061299,1,0.941496018295607,0,9,retina vasculature morphogenesis in camera-type eye,BP,
15438,GO:0061300,1,0.986203080780135,0,2,cerebellum vasculature development,BP,
15439,GO:0061301,1,0.993986332272469,0,1,cerebellum vasculature morphogenesis,BP,
15440,GO:0061302,1,0.963259669247918,0,5,smooth muscle cell-matrix adhesion,BP,
15441,GO:0061303,1,0.942623661314143,0,8,cornea development in camera-type eye,BP,
15442,GO:0061304,1,0.97611385766497,0,4,retinal blood vessel morphogenesis,BP,
15443,GO:0061307,1,0.941877970689267,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
15444,GO:0061308,1,0.941877970689267,0,8,cardiac neural crest cell development involved in heart development,BP,
15445,GO:0061309,1,0.955759935561861,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15446,GO:0061311,1,0.826253845057278,0,26,cell surface receptor signaling pathway involved in heart development,BP,
15447,GO:0061312,1,0.955277262523063,0,6,BMP signaling pathway involved in heart development,BP,
15448,GO:0061314,1,0.937996764402011,0,9,Notch signaling involved in heart development,BP,
15449,GO:0061316,1,0.962628314295691,0,5,canonical Wnt signaling pathway involved in heart development,BP,
15450,GO:0061317,1,0.969439694132136,0,4,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15451,GO:0061318,1,0.8776568937977,0,19,renal filtration cell differentiation,BP,
15452,GO:0061323,1,0.889591760981778,0,16,cell proliferation involved in heart morphogenesis,BP,
15453,GO:0061324,1,0.992975597753917,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15454,GO:0061325,1,0.969921623647969,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15456,GO:0061333,1,0.580551810200217,0,77,renal tubule morphogenesis,BP,
15458,GO:0061339,1,0.914187043373104,0,13,establishment or maintenance of monopolar cell polarity,BP,
15459,GO:0061341,1,0.988000678922982,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15460,GO:0061343,1,0.974604096769849,0,4,cell adhesion involved in heart morphogenesis,BP,
15461,GO:0061346,1,0.988000678922982,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15462,GO:0061347,1,0.993986332264647,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15463,GO:0061348,1,0.993986332264647,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15464,GO:0061349,1,0.993986332264647,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15465,GO:0061350,1,0.993986332264647,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15466,GO:0061351,1,0.407603626742337,0,127,neural precursor cell proliferation,BP,
15467,GO:0061354,1,0.993986332264647,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15468,GO:0061355,1,0.977432921568387,0,3,Wnt protein secretion,BP,
15469,GO:0061356,1,0.977432921568387,0,3,regulation of Wnt protein secretion,BP,
15470,GO:0061357,1,0.985145921238061,0,2,positive regulation of Wnt protein secretion,BP,
15471,GO:0061358,1,0.992171614783988,0,1,negative regulation of Wnt protein secretion,BP,
15472,GO:0061360,1,0.993596372063379,0,1,optic chiasma development,BP,
15473,GO:0061364,1,0.982016529893076,0,3,apoptotic process involved in luteolysis,BP,
15474,GO:0061365,1,0.919001055994213,0,11,positive regulation of triglyceride lipase activity,BP,
15475,GO:0061366,1,0.978642566945547,0,3,behavioral response to chemical pain,BP,
15476,GO:0061368,1,0.978642566945547,0,3,behavioral response to formalin induced pain,BP,
15477,GO:0061369,1,0.993434523207477,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15479,GO:0061371,1,0.640898936016476,0,63,determination of heart left/right asymmetry,BP,
15480,GO:0061373,1,0.986203080788573,0,2,mammillary axonal complex development,BP,
15481,GO:0061374,1,0.992170027168696,0,1,mammillothalamic axonal tract development,BP,
15482,GO:0061377,1,0.885052860438063,0,17,mammary gland lobule development,BP,
15483,GO:0061378,1,0.984410632332873,0,2,corpora quadrigemina development,BP,
15484,GO:0061379,1,0.984410632332873,0,2,inferior colliculus development,BP,
15485,GO:0061381,1,0.992170027168696,0,1,cell migration in diencephalon,BP,
15488,GO:0061386,1,0.988008547477231,0,2,closure of optic fissure,BP,
15489,GO:0061387,1,0.541332080740101,0,89,regulation of extent of cell growth,BP,
15490,GO:0061394,1,0.984410903724057,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15491,GO:0061395,1,0.992170071590886,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15492,GO:0061402,1,0.984670565640234,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15493,GO:0061408,1,0.992191649784728,0,1,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15495,GO:0061419,1,0.97307700262761,0,4,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15496,GO:0061428,1,0.9711277368382,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15497,GO:0061430,1,0.922351010964847,0,12,bone trabecula morphogenesis,BP,
15498,GO:0061433,1,0.992174264801851,0,1,cellular response to caloric restriction,BP,
15499,GO:0061436,1,0.874662950310338,0,19,establishment of skin barrier,BP,
15500,GO:0061437,1,0.830682878702082,0,26,renal system vasculature development,BP,
15501,GO:0061438,1,0.953495977101836,0,7,renal system vasculature morphogenesis,BP,
15502,GO:0061439,1,0.953495977101836,0,7,kidney vasculature morphogenesis,BP,
15503,GO:0061440,1,0.830682878702082,0,26,kidney vasculature development,BP,
15504,GO:0061441,1,0.986265870314222,0,2,renal artery morphogenesis,BP,
15505,GO:0061443,1,0.986570943361273,0,2,endocardial cushion cell differentiation,BP,
15506,GO:0061444,1,0.993986332265543,0,1,endocardial cushion cell development,BP,
15507,GO:0061445,1,0.99254009808721,0,1,endocardial cushion cell fate commitment,BP,
15509,GO:0061450,1,0.941953826779044,0,8,trophoblast cell migration,BP,
15510,GO:0061451,1,0.99259542221191,0,1,retrotrapezoid nucleus development,BP,
15511,GO:0061452,1,0.99259542221191,0,1,retrotrapezoid nucleus neuron differentiation,BP,
15513,GO:0061459,1,0.993986332273392,0,1,L-arginine transmembrane transporter activity,MF,
15514,GO:0061461,1,0.986334890687528,0,2,L-lysine import,BP,
15515,GO:0061462,1,0.827900987971302,0,27,protein localization to lysosome,BP,
15516,GO:0061467,1,0.993329037877809,0,1,basolateral protein localization,BP,
15517,GO:0061469,1,0.937276872736817,0,9,regulation of type B pancreatic cell proliferation,BP,
15518,GO:0061470,1,0.972884361904994,0,4,T follicular helper cell differentiation,BP,
15519,GO:0061474,1,0.992288149862422,0,1,phagolysosome membrane,CC,
15520,GO:0061476,1,0.992654718861979,0,1,response to anticoagulant,BP,
15521,GO:0061481,1,0.992170027168696,0,1,response to TNF agonist,BP,
15522,GO:0061484,1,0.958928636422154,0,6,hematopoietic stem cell homeostasis,BP,
15523,GO:0061485,1,0.993986332273022,0,1,memory T cell proliferation,BP,
15524,GO:0061501,1,0.992294630214608,0,1,cyclic-GMP-AMP synthase activity,MF,
15525,GO:0061502,1,0.974357889927081,0,4,early endosome to recycling endosome transport,BP,
15526,GO:0061505,1,0.980255705921505,0,3,DNA topoisomerase II activity,MF,
15527,GO:0061507,1,0.992170035496111,0,1,cyclic-GMP-AMP binding,MF,
15528,GO:0061511,1,0.973322147983639,0,4,centriole elongation,BP,
15529,GO:0061512,1,0.802102987754757,0,31,protein localization to cilium,BP,
15530,GO:0061513,1,0.978646849331181,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15531,GO:0061515,1,0.68580666801418,0,53,myeloid cell development,BP,
15532,GO:0061517,1,0.984844356906988,0,2,macrophage proliferation,BP,
15533,GO:0061518,1,0.984844356906988,0,2,microglial cell proliferation,BP,
15534,GO:0061519,1,0.993144464776634,0,1,macrophage homeostasis,BP,
15535,GO:0061523,1,0.993206709488873,0,1,cilium disassembly,BP,
15536,GO:0061525,1,0.947366439526059,0,8,hindgut development,BP,
15537,GO:0061526,1,0.969572345137093,0,4,acetylcholine secretion,BP,
15538,GO:0061528,1,0.993929645472371,0,1,aspartate secretion,BP,
15539,GO:0061534,1,0.993986332294723,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15540,GO:0061535,1,0.987957153749624,0,2,glutamate secretion, neurotransmission,BP,
15541,GO:0061536,1,0.99277171725997,0,1,glycine secretion,BP,
15542,GO:0061537,1,0.99277171725997,0,1,glycine secretion, neurotransmission,BP,
15543,GO:0061542,1,0.992170027168696,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15544,GO:0061547,1,0.985742664289992,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15545,GO:0061548,1,0.912099555353719,0,13,ganglion development,BP,
15546,GO:0061549,1,0.938744219706382,0,9,sympathetic ganglion development,BP,
15547,GO:0061550,1,0.96603275742432,0,5,cranial ganglion development,BP,
15548,GO:0061551,1,0.972868037942875,0,4,trigeminal ganglion development,BP,
15549,GO:0061552,1,0.992266198294153,0,1,ganglion morphogenesis,BP,
15551,GO:0061572,1,0.415593141254097,0,126,actin filament bundle organization,BP,
15552,GO:0061574,1,0.978455935542365,0,3,ASAP complex,CC,
15553,GO:0061575,1,0.969056934618568,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15554,GO:0061577,1,0.935129968555837,0,10,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15555,GO:0061578,1,0.939044004946521,0,9,Lys63-specific deubiquitinase activity,MF,
15556,GO:0061580,1,0.993603893325838,0,1,colon epithelial cell migration,BP,
15557,GO:0061582,1,0.987628390633435,0,2,intestinal epithelial cell migration,BP,
15558,GO:0061588,1,0.966717142917811,0,5,calcium activated phospholipid scrambling,BP,
15559,GO:0061589,1,0.972567106860309,0,4,calcium activated phosphatidylserine scrambling,BP,
15560,GO:0061590,1,0.966717142917811,0,5,calcium activated phosphatidylcholine scrambling,BP,
15561,GO:0061591,1,0.966717142917811,0,5,calcium activated galactosylceramide scrambling,BP,
15562,GO:0061598,1,0.993694182434192,0,1,molybdopterin adenylyltransferase activity,MF,
15563,GO:0061599,1,0.993694182434192,0,1,molybdopterin molybdotransferase activity,MF,
15564,GO:0061604,1,0.992255841119061,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15565,GO:0061605,1,0.992255841119061,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15566,GO:0061609,1,0.992248354210777,0,1,fructose-1-phosphate aldolase activity,MF,
15567,GO:0061611,1,0.992170321724734,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15568,GO:0061614,1,0.813478694217646,0,30,pri-miRNA transcription from RNA polymerase II promoter,BP,
15569,GO:0061615,1,0.816831484204413,0,27,glycolytic process through fructose-6-phosphate,BP,
15570,GO:0061617,1,0.954798575098537,0,6,MICOS complex,CC,
15571,GO:0061618,1,0.993986332290929,0,1,sublamina densa,CC,
15572,GO:0061620,1,0.816831484204413,0,27,glycolytic process through glucose-6-phosphate,BP,
15573,GO:0061621,1,0.823287562062173,0,26,canonical glycolysis,BP,
15574,GO:0061622,1,0.984991238872447,0,2,glycolytic process through glucose-1-phosphate,BP,
15575,GO:0061623,1,0.992170027168696,0,1,glycolytic process from galactose,BP,
15576,GO:0061624,1,0.969812469073293,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15577,GO:0061626,1,0.950866688044476,0,7,pharyngeal arch artery morphogenesis,BP,
15578,GO:0061627,1,0.992176641215416,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15579,GO:0061628,1,0.980314377751047,0,3,H3K27me3 modified histone binding,MF,
15580,GO:0061629,1,0.992170027168696,0,1,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15581,GO:0061630,1,0.251314486083106,0,195,ubiquitin protein ligase activity,MF,
15582,GO:0061631,1,0.806754064013104,0,29,ubiquitin conjugating enzyme activity,MF,
15583,GO:0061635,1,0.955219067147742,0,6,regulation of protein complex stability,BP,
15584,GO:0061640,1,0.737698174945845,0,44,cytoskeleton-dependent cytokinesis,BP,
15585,GO:0061641,1,0.752542905834367,0,37,CENP-A containing chromatin organization,BP,
15586,GO:0061642,1,0.993986332264647,0,1,chemoattraction of axon,BP,
15587,GO:0061643,1,0.979609418907194,0,3,chemorepulsion of axon,BP,
15588,GO:0061646,1,0.993934630003237,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15589,GO:0061647,1,0.756214611472368,0,41,histone H3-K9 modification,BP,
15590,GO:0061649,1,0.993854278364538,0,1,ubiquitinated histone binding,MF,
15591,GO:0061650,1,0.800426640108002,0,30,ubiquitin-like protein conjugating enzyme activity,MF,
15592,GO:0061656,1,0.992170027168696,0,1,SUMO conjugating enzyme activity,MF,
15593,GO:0061659,1,0.242059872296798,0,200,ubiquitin-like protein ligase activity,MF,
15594,GO:0061663,1,0.993986332272418,0,1,NEDD8 ligase activity,MF,
15595,GO:0061665,1,0.963563142138764,0,5,SUMO ligase activity,MF,
15596,GO:0061668,1,0.972351225740055,0,4,mitochondrial ribosome assembly,BP,
15597,GO:0061669,1,0.981903784198376,0,3,spontaneous neurotransmitter secretion,BP,
15598,GO:0061670,1,0.992170027168696,0,1,evoked neurotransmitter secretion,BP,
15599,GO:0061673,1,0.986326940278576,0,2,mitotic spindle astral microtubule,CC,
15600,GO:0061676,1,0.973266612009528,0,4,importin-alpha family protein binding,MF,
15601,GO:0061682,1,0.992224397926687,0,1,seminal vesicle morphogenesis,BP,
15602,GO:0061684,1,0.922145435683278,0,11,chaperone-mediated autophagy,BP,
15603,GO:0061687,1,0.972572113154677,0,4,detoxification of inorganic compound,BP,
15604,GO:0061689,1,0.971035981431164,0,4,tricellular tight junction,CC,
15605,GO:0061690,1,0.992170027168696,0,1,lipoamidase activity,MF,
15607,GO:0061697,1,0.992706432587746,0,1,protein-glutaryllysine deglutarylase activity,MF,
15608,GO:0061698,1,0.992706432587746,0,1,protein deglutarylation,BP,
15609,GO:0061699,1,0.992706432587746,0,1,peptidyl-lysine deglutarylation,BP,
15610,GO:0061700,1,0.942462989746862,0,8,GATOR2 complex,CC,
15612,GO:0061709,1,0.993986332268969,0,1,reticulophagy,BP,
15613,GO:0061711,1,0.984450043872888,0,2,N(6)-L-threonylcarbamoyladenine synthase,MF,
15614,GO:0061712,1,0.992830011017474,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15615,GO:0061713,1,0.992170027168696,0,1,anterior neural tube closure,BP,
15616,GO:0061714,1,0.984400887813367,0,2,folic acid receptor activity,MF,
15617,GO:0061718,1,0.823287562062173,0,26,glucose catabolic process to pyruvate,BP,
15618,GO:0061723,1,0.986286794723876,0,2,glycophagy,BP,
15619,GO:0061724,1,0.95830151080164,0,6,lipophagy,BP,
15620,GO:0061726,1,0.57790136136855,0,77,mitochondrion disassembly,BP,
15621,GO:0061727,1,0.984792029050511,0,2,methylglyoxal catabolic process to lactate,BP,
15622,GO:0061731,1,0.979729214240087,0,3,ribonucleoside-diphosphate reductase activity,MF,
15623,GO:0061732,1,0.95599747005807,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15624,GO:0061733,1,0.674365845153112,0,55,peptide-lysine-N-acetyltransferase activity,MF,
15625,GO:0061734,1,0.968933445294516,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15626,GO:0061736,1,0.993986252580758,0,1,engulfment of target by autophagosome,BP,
15627,GO:0061737,1,0.962427393294979,0,5,leukotriene signaling pathway,BP,
15628,GO:0061738,1,0.977474955344445,0,3,late endosomal microautophagy,BP,
15629,GO:0061739,1,0.992795855711929,0,1,protein lipidation involved in autophagosome assembly,BP,
15630,GO:0061740,1,0.985800923701409,0,2,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15631,GO:0061741,1,0.992179254155245,0,1,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15632,GO:0061743,1,0.970225039694013,0,4,motor learning,BP,
15633,GO:0061744,1,0.987422200033716,0,2,motor behavior,BP,
15634,GO:0061749,1,0.987847329004754,0,2,forked DNA-dependent helicase activity,MF,
15635,GO:0061750,1,0.992220917592298,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15636,GO:0061752,1,0.984875522318109,0,2,telomeric repeat-containing RNA binding,MF,
15637,GO:0061753,1,0.993986252580758,0,1,substrate localization to autophagosome,BP,
15638,GO:0061756,1,0.841001298392647,0,24,leukocyte adhesion to vascular endothelial cell,BP,
15639,GO:0061757,1,0.984744829094691,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15640,GO:0061762,1,0.982035411057585,0,3,CAMKK-AMPK signaling cascade,BP,
15641,GO:0061763,1,0.984678130721611,0,2,multivesicular body-lysosome fusion,BP,
15642,GO:0061767,1,0.993986332265019,0,1,negative regulation of lung blood pressure,BP,
15643,GO:0061768,1,0.993917876008142,0,1,magnesium:sodium antiporter activity,MF,
15644,GO:0061769,1,0.984648173044371,0,2,ribosylnicotinate kinase activity,MF,
15645,GO:0061770,1,0.992191649784728,0,1,translation elongation factor binding,MF,
15646,GO:0061771,1,0.992174264801851,0,1,response to caloric restriction,BP,
15647,GO:0061772,1,0.992967540933404,0,1,drug transport across blood-nerve barrier,BP,
15648,GO:0061778,1,0.89603693394918,0,16,intracellular chloride channel activity,MF,
15649,GO:0061782,1,0.993583149764454,0,1,vesicle fusion with vesicle,BP,
15650,GO:0061783,1,0.888732007872874,0,15,peptidoglycan muralytic activity,MF,
15651,GO:0061792,1,0.98088929344722,0,3,secretory granule maturation,BP,
15652,GO:0061798,1,0.993631074978444,0,1,GTP 3',8'-cyclase activity,MF,
15653,GO:0061799,1,0.993631074978444,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15654,GO:0061809,1,0.984400887813367,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15655,GO:0061811,1,0.992170027168696,0,1,ADP-ribosyl cyclase activity,MF,
15656,GO:0061812,1,0.992170027168696,0,1,cyclic ADP-ribose hydrolase,MF,
15657,GO:0061819,1,0.979180453571169,0,3,telomeric DNA-containing double minutes formation,BP,
15658,GO:0061820,1,0.938402174084159,0,9,telomeric D-loop disassembly,BP,
15659,GO:0061821,1,0.975003785061122,0,4,telomeric D-loop binding,MF,
15660,GO:0061825,1,0.993456556363965,0,1,podosome core,CC,
15661,GO:0061827,1,0.992288548141565,0,1,sperm head,CC,
15662,GO:0061833,1,0.985982617732996,0,2,protein localization to tricellular tight junction,BP,
15663,GO:0061842,1,0.862299027260505,0,22,microtubule organizing center localization,BP,
15664,GO:0061844,1,0.947453289589396,0,7,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15665,GO:0061845,1,0.992806547305041,0,1,neuron projection branch point,CC,
15666,GO:0061846,1,0.992806547305041,0,1,dendritic spine cytoplasm,CC,
15667,GO:0061847,1,0.992216941255385,0,1,response to cholecystokinin,BP,
15668,GO:0061849,1,0.987847329004754,0,2,telomeric G-quadruplex DNA binding,MF,
15669,GO:0061850,1,0.992170027168696,0,1,growth cone leading edge,CC,
15670,GO:0065001,1,0.972606795028767,0,4,specification of axis polarity,BP,
15671,GO:0065002,1,0.673646731753472,0,53,intracellular protein transmembrane transport,BP,
15673,GO:0065004,1,0.181504738037294,0,227,protein-DNA complex assembly,BP,
15675,GO:0065006,1,0.984400887813367,0,2,protein-carbohydrate complex assembly,BP,
15679,GO:0065010,1,0.977058688445226,0,3,extracellular membrane-bounded organelle,CC,
15680,GO:0070001,1,0.827965516945558,0,25,aspartic-type peptidase activity,MF,
15681,GO:0070002,1,0.992170027168696,0,1,glutamic-type peptidase activity,MF,
15683,GO:0070006,1,0.883012205917088,0,18,metalloaminopeptidase activity,MF,
15684,GO:0070008,1,0.936075002157805,0,9,serine-type exopeptidase activity,MF,
15685,GO:0070009,1,0.992837870977145,0,1,serine-type aminopeptidase activity,MF,
15687,GO:0070012,1,0.992236053098594,0,1,oligopeptidase activity,MF,
15689,GO:0070016,1,0.933990170241241,0,10,armadillo repeat domain binding,MF,
15690,GO:0070022,1,0.974636108005878,0,4,transforming growth factor beta receptor complex,CC,
15691,GO:0070025,1,0.992312759411149,0,1,carbon monoxide binding,MF,
15692,GO:0070026,1,0.98454251106255,0,2,nitric oxide binding,MF,
15693,GO:0070032,1,0.969108385904906,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15694,GO:0070033,1,0.978409243959199,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15695,GO:0070034,1,0.885505694680915,0,17,telomerase RNA binding,MF,
15696,GO:0070035,1,0.50315868677215,0,99,purine NTP-dependent helicase activity,MF,
15697,GO:0070037,1,0.992170027168696,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15698,GO:0070039,1,0.986181614216409,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15699,GO:0070044,1,0.976729490327511,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15700,GO:0070050,1,0.941595775453528,0,8,neuron cellular homeostasis,BP,
15701,GO:0070051,1,0.979341291500813,0,3,fibrinogen binding,MF,
15702,GO:0070052,1,0.979025030948571,0,3,collagen V binding,MF,
15703,GO:0070053,1,0.970971398419905,0,4,thrombospondin receptor activity,MF,
15704,GO:0070054,1,0.978567085076272,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15705,GO:0070055,1,0.978567085076272,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15707,GO:0070060,1,0.993986332280793,0,1,'de novo' actin filament nucleation,BP,
15708,GO:0070061,1,0.962696364659917,0,5,fructose binding,MF,
15710,GO:0070063,1,0.730881056768982,0,44,RNA polymerase binding,MF,
15712,GO:0070069,1,0.806477182969529,0,28,cytochrome complex,CC,
15713,GO:0070070,1,0.941747446361215,0,9,proton-transporting V-type ATPase complex assembly,BP,
15714,GO:0070071,1,0.913850326674453,0,13,proton-transporting two-sector ATPase complex assembly,BP,
15715,GO:0070072,1,0.941747446361215,0,9,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15716,GO:0070075,1,0.984400887813367,0,2,tear secretion,BP,
15717,GO:0070076,1,0.8625119846664,0,23,histone lysine demethylation,BP,
15718,GO:0070077,1,0.993173241686921,0,1,histone arginine demethylation,BP,
15719,GO:0070078,1,0.993173241686921,0,1,histone H3-R2 demethylation,BP,
15720,GO:0070079,1,0.993173241686921,0,1,histone H4-R3 demethylation,BP,
15721,GO:0070080,1,0.986042538725175,0,2,titin Z domain binding,MF,
15722,GO:0070081,1,0.963440446471675,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15723,GO:0070083,1,0.963440446471675,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15725,GO:0070086,1,0.971330689192998,0,4,ubiquitin-dependent endocytosis,BP,
15726,GO:0070087,1,0.961231998057906,0,6,chromo shadow domain binding,MF,
15727,GO:0070091,1,0.950377597320365,0,7,glucagon secretion,BP,
15728,GO:0070092,1,0.957880285508751,0,6,regulation of glucagon secretion,BP,
15729,GO:0070093,1,0.977484221957308,0,3,negative regulation of glucagon secretion,BP,
15730,GO:0070094,1,0.992170027168696,0,1,positive regulation of glucagon secretion,BP,
15731,GO:0070095,1,0.977268894868057,0,3,fructose-6-phosphate binding,MF,
15732,GO:0070096,1,0.985157297228806,0,2,mitochondrial outer membrane translocase complex assembly,BP,
15733,GO:0070097,1,0.960839832671819,0,6,delta-catenin binding,MF,
15734,GO:0070098,1,0.559605106621069,0,76,chemokine-mediated signaling pathway,BP,
15735,GO:0070099,1,0.946961460149226,0,8,regulation of chemokine-mediated signaling pathway,BP,
15736,GO:0070100,1,0.968235341769952,0,5,negative regulation of chemokine-mediated signaling pathway,BP,
15737,GO:0070101,1,0.978033673133618,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15738,GO:0070102,1,0.93331681953728,0,10,interleukin-6-mediated signaling pathway,BP,
15739,GO:0070103,1,0.98459220270903,0,2,regulation of interleukin-6-mediated signaling pathway,BP,
15740,GO:0070104,1,0.992170049074439,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15741,GO:0070105,1,0.992362818262157,0,1,positive regulation of interleukin-6-mediated signaling pathway,BP,
15742,GO:0070106,1,0.985617705770505,0,2,interleukin-27-mediated signaling pathway,BP,
15743,GO:0070110,1,0.97868843948575,0,3,ciliary neurotrophic factor receptor complex,CC,
15744,GO:0070119,1,0.993610981937261,0,1,ciliary neurotrophic factor binding,MF,
15745,GO:0070120,1,0.96518540123448,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15746,GO:0070121,1,0.993984950395027,0,1,Kupffer's vesicle development,BP,
15747,GO:0070122,1,0.993438797689573,0,1,isopeptidase activity,MF,
15748,GO:0070123,1,0.993986332267704,0,1,transforming growth factor beta receptor activity, type III,MF,
15749,GO:0070124,1,0.98461847409791,0,2,mitochondrial translational initiation,BP,
15752,GO:0070127,1,0.965178588812973,0,5,tRNA aminoacylation for mitochondrial protein translation,BP,
15754,GO:0070130,1,0.992294630214608,0,1,negative regulation of mitochondrial translation,BP,
15755,GO:0070131,1,0.94823714880948,0,7,positive regulation of mitochondrial translation,BP,
15756,GO:0070137,1,0.980754115995744,0,3,ubiquitin-like protein-specific endopeptidase activity,MF,
15757,GO:0070138,1,0.993438797689573,0,1,ubiquitin-like protein-specific isopeptidase activity,MF,
15758,GO:0070139,1,0.980754115995744,0,3,SUMO-specific endopeptidase activity,MF,
15759,GO:0070140,1,0.993438797689573,0,1,SUMO-specific isopeptidase activity,MF,
15760,GO:0070141,1,0.95767817628696,0,6,response to UV-A,BP,
15761,GO:0070142,1,0.973144746797761,0,4,synaptic vesicle budding,BP,
15762,GO:0070143,1,0.993903850001058,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15763,GO:0070145,1,0.992909323579839,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15764,GO:0070159,1,0.99223524657561,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15765,GO:0070160,1,0.461774167753132,0,112,occluding junction,CC,
15767,GO:0070162,1,0.959377992054905,0,6,adiponectin secretion,BP,
15768,GO:0070163,1,0.959377992054905,0,6,regulation of adiponectin secretion,BP,
15769,GO:0070164,1,0.973438727240553,0,4,negative regulation of adiponectin secretion,BP,
15770,GO:0070165,1,0.985558619869101,0,2,positive regulation of adiponectin secretion,BP,
15771,GO:0070166,1,0.906779549910703,0,14,enamel mineralization,BP,
15772,GO:0070167,1,0.589694906028926,0,73,regulation of biomineral tissue development,BP,
15773,GO:0070168,1,0.876483357129856,0,18,negative regulation of biomineral tissue development,BP,
15774,GO:0070169,1,0.756836132839226,0,39,positive regulation of biomineral tissue development,BP,
15775,GO:0070170,1,0.935990819985579,0,9,regulation of tooth mineralization,BP,
15776,GO:0070171,1,0.986293931603855,0,2,negative regulation of tooth mineralization,BP,
15777,GO:0070172,1,0.963875079224567,0,5,positive regulation of tooth mineralization,BP,
15778,GO:0070173,1,0.970989219387558,0,4,regulation of enamel mineralization,BP,
15779,GO:0070175,1,0.986202892798097,0,2,positive regulation of enamel mineralization,BP,
15780,GO:0070176,1,0.99217054506133,0,1,DRM complex,CC,
15781,GO:0070178,1,0.984494601159307,0,2,D-serine metabolic process,BP,
15782,GO:0070179,1,0.992264474345352,0,1,D-serine biosynthetic process,BP,
15783,GO:0070180,1,0.984400887813367,0,2,large ribosomal subunit rRNA binding,MF,
15784,GO:0070181,1,0.942034302999547,0,8,small ribosomal subunit rRNA binding,MF,
15785,GO:0070182,1,0.900081518874558,0,15,DNA polymerase binding,MF,
15786,GO:0070184,1,0.992191649784728,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15787,GO:0070187,1,0.955964921081797,0,6,shelterin complex,CC,
15788,GO:0070189,1,0.940873838636001,0,8,kynurenine metabolic process,BP,
15789,GO:0070191,1,0.992294630214608,0,1,methionine-R-sulfoxide reductase activity,MF,
15790,GO:0070192,1,0.667273952590805,0,56,chromosome organization involved in meiotic cell cycle,BP,
15791,GO:0070193,1,0.855530631551846,0,21,synaptonemal complex organization,BP,
15792,GO:0070194,1,0.992193631142175,0,1,synaptonemal complex disassembly,BP,
15794,GO:0070197,1,0.964957837326701,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15795,GO:0070198,1,0.822230395427162,0,27,protein localization to chromosome, telomeric region,BP,
15796,GO:0070199,1,0.853166603787929,0,21,establishment of protein localization to chromosome,BP,
15797,GO:0070200,1,0.894362591071079,0,15,establishment of protein localization to telomere,BP,
15799,GO:0070202,1,0.925829847646212,0,10,regulation of establishment of protein localization to chromosome,BP,
15800,GO:0070203,1,0.925829847646212,0,10,regulation of establishment of protein localization to telomere,BP,
15801,GO:0070206,1,0.716200331462596,0,46,protein trimerization,BP,
15802,GO:0070207,1,0.825583024525094,0,26,protein homotrimerization,BP,
15803,GO:0070208,1,0.919823291038409,0,12,protein heterotrimerization,BP,
15804,GO:0070212,1,0.980699691113852,0,3,protein poly-ADP-ribosylation,BP,
15805,GO:0070213,1,0.973592757264012,0,4,protein auto-ADP-ribosylation,BP,
15806,GO:0070217,1,0.992170351964843,0,1,transcription factor TFIIIB complex assembly,BP,
15807,GO:0070221,1,0.976746208828822,0,3,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15811,GO:0070230,1,0.860412982441226,0,20,positive regulation of lymphocyte apoptotic process,BP,
15815,GO:0070234,1,0.892705184490682,0,15,positive regulation of T cell apoptotic process,BP,
15818,GO:0070237,1,0.993967933950215,0,1,positive regulation of activation-induced cell death of T cells,BP,
15819,GO:0070238,1,0.992170028278986,0,1,activated T cell autonomous cell death,BP,
15820,GO:0070239,1,0.992170028278986,0,1,regulation of activated T cell autonomous cell death,BP,
15821,GO:0070241,1,0.992170028278986,0,1,positive regulation of activated T cell autonomous cell death,BP,
15822,GO:0070242,1,0.891836881900645,0,16,thymocyte apoptotic process,BP,
15823,GO:0070243,1,0.924066825508055,0,11,regulation of thymocyte apoptotic process,BP,
15824,GO:0070244,1,0.958718048880656,0,6,negative regulation of thymocyte apoptotic process,BP,
15825,GO:0070245,1,0.963868398562018,0,5,positive regulation of thymocyte apoptotic process,BP,
15826,GO:0070246,1,0.992170027168696,0,1,natural killer cell apoptotic process,BP,
15827,GO:0070247,1,0.992170027168696,0,1,regulation of natural killer cell apoptotic process,BP,
15828,GO:0070251,1,0.992218462009056,0,1,pristanate-CoA ligase activity,MF,
15829,GO:0070252,1,0.493906585941669,0,102,actin-mediated cell contraction,BP,
15830,GO:0070253,1,0.969585046000121,0,4,somatostatin secretion,BP,
15831,GO:0070254,1,0.921341888526846,0,11,mucus secretion,BP,
15832,GO:0070255,1,0.93594935876069,0,9,regulation of mucus secretion,BP,
15833,GO:0070256,1,0.984677878599472,0,2,negative regulation of mucus secretion,BP,
15834,GO:0070257,1,0.957847642232905,0,6,positive regulation of mucus secretion,BP,
15835,GO:0070259,1,0.985541593289775,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15836,GO:0070260,1,0.992294630214608,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15837,GO:0070262,1,0.916485458110112,0,12,peptidyl-serine dephosphorylation,BP,
15840,GO:0070267,1,0.99313848823288,0,1,oncosis,BP,
15842,GO:0070269,1,0.954650651770486,0,6,pyroptosis,BP,
15844,GO:0070272,1,0.970390964961373,0,4,proton-transporting ATP synthase complex biogenesis,BP,
15845,GO:0070273,1,0.869726639353977,0,20,phosphatidylinositol-4-phosphate binding,MF,
15846,GO:0070274,1,0.984408292931323,0,2,RES complex,CC,
15847,GO:0070278,1,0.954898262235451,0,6,extracellular matrix constituent secretion,BP,
15849,GO:0070283,1,0.992170029021722,0,1,radical SAM enzyme activity,MF,
15850,GO:0070286,1,0.857777024459879,0,21,axonemal dynein complex assembly,BP,
15851,GO:0070287,1,0.993180157797307,0,1,ferritin receptor activity,MF,
15852,GO:0070288,1,0.984400887813367,0,2,ferritin complex,CC,
15853,GO:0070290,1,0.965855400922146,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15854,GO:0070292,1,0.992645306643004,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
15856,GO:0070294,1,0.972390564414404,0,4,renal sodium ion absorption,BP,
15857,GO:0070295,1,0.97736505481999,0,3,renal water absorption,BP,
15859,GO:0070300,1,0.900717853902159,0,15,phosphatidic acid binding,MF,
15860,GO:0070301,1,0.561542905618243,0,80,cellular response to hydrogen peroxide,BP,
15862,GO:0070303,1,0.747552253874677,0,41,negative regulation of stress-activated protein kinase signaling cascade,BP,
15864,GO:0070305,1,0.955074941688703,0,7,response to cGMP,BP,
15865,GO:0070306,1,0.806892085136083,0,30,lens fiber cell differentiation,BP,
15866,GO:0070307,1,0.90942455129704,0,13,lens fiber cell development,BP,
15867,GO:0070309,1,0.964744621125348,0,5,lens fiber cell morphogenesis,BP,
15868,GO:0070314,1,0.942138837557254,0,8,G1 to G0 transition,BP,
15869,GO:0070315,1,0.977865734973493,0,3,G1 to G0 transition involved in cell differentiation,BP,
15870,GO:0070316,1,0.94327815141431,0,8,regulation of G0 to G1 transition,BP,
15871,GO:0070317,1,0.971463990209346,0,4,negative regulation of G0 to G1 transition,BP,
15872,GO:0070318,1,0.97099268998311,0,4,positive regulation of G0 to G1 transition,BP,
15873,GO:0070320,1,0.992346481618393,0,1,inward rectifier potassium channel inhibitor activity,MF,
15874,GO:0070324,1,0.956591978829726,0,6,thyroid hormone binding,MF,
15875,GO:0070325,1,0.85805996870912,0,21,lipoprotein particle receptor binding,MF,
15876,GO:0070326,1,0.971818626974875,0,4,very-low-density lipoprotein particle receptor binding,MF,
15877,GO:0070327,1,0.936238901542372,0,9,thyroid hormone transport,BP,
15878,GO:0070328,1,0.785054467664843,0,32,triglyceride homeostasis,BP,
15879,GO:0070330,1,0.846571494379875,0,22,aromatase activity,MF,
15880,GO:0070335,1,0.993986332271311,0,1,aspartate binding,MF,
15881,GO:0070336,1,0.986326936406136,0,2,flap-structured DNA binding,MF,
15882,GO:0070337,1,0.993986328369309,0,1,3'-flap-structured DNA binding,MF,
15883,GO:0070339,1,0.956705974476934,0,6,response to bacterial lipopeptide,BP,
15884,GO:0070340,1,0.979528153181514,0,3,detection of bacterial lipopeptide,BP,
15885,GO:0070341,1,0.923066777492967,0,11,fat cell proliferation,BP,
15886,GO:0070342,1,0.992170027168696,0,1,brown fat cell proliferation,BP,
15887,GO:0070343,1,0.970546852516434,0,4,white fat cell proliferation,BP,
15888,GO:0070344,1,0.923066777492967,0,11,regulation of fat cell proliferation,BP,
15889,GO:0070345,1,0.958405712545584,0,6,negative regulation of fat cell proliferation,BP,
15890,GO:0070346,1,0.969238108558295,0,4,positive regulation of fat cell proliferation,BP,
15891,GO:0070347,1,0.992170027168696,0,1,regulation of brown fat cell proliferation,BP,
15892,GO:0070349,1,0.992170027168696,0,1,positive regulation of brown fat cell proliferation,BP,
15893,GO:0070350,1,0.970546852516434,0,4,regulation of white fat cell proliferation,BP,
15894,GO:0070351,1,0.992170027168696,0,1,negative regulation of white fat cell proliferation,BP,
15895,GO:0070352,1,0.984400887813367,0,2,positive regulation of white fat cell proliferation,BP,
15896,GO:0070358,1,0.981138411381381,0,3,actin polymerization-dependent cell motility,BP,
15897,GO:0070361,1,0.992680587831522,0,1,mitochondrial light strand promoter anti-sense binding,MF,
15898,GO:0070362,1,0.992680587831522,0,1,mitochondrial heavy strand promoter anti-sense binding,MF,
15899,GO:0070363,1,0.992173846655962,0,1,mitochondrial light strand promoter sense binding,MF,
15900,GO:0070365,1,0.909635843919748,0,13,hepatocyte differentiation,BP,
15901,GO:0070366,1,0.984410188121763,0,2,regulation of hepatocyte differentiation,BP,
15902,GO:0070367,1,0.992179400304023,0,1,negative regulation of hepatocyte differentiation,BP,
15903,GO:0070368,1,0.992170027168696,0,1,positive regulation of hepatocyte differentiation,BP,
15904,GO:0070369,1,0.986522382626537,0,2,beta-catenin-TCF7L2 complex,CC,
15905,GO:0070370,1,0.976881594596345,0,3,cellular heat acclimation,BP,
15908,GO:0070373,1,0.678011733278805,0,54,negative regulation of ERK1 and ERK2 cascade,BP,
15910,GO:0070375,1,0.978851897400241,0,3,ERK5 cascade,BP,
15911,GO:0070376,1,0.992489814413487,0,1,regulation of ERK5 cascade,BP,
15912,GO:0070377,1,0.992489814413487,0,1,negative regulation of ERK5 cascade,BP,
15913,GO:0070381,1,0.992953453572228,0,1,endosome to plasma membrane transport vesicle,CC,
15915,GO:0070383,1,0.954232845015254,0,6,DNA cytosine deamination,BP,
15916,GO:0070384,1,0.971427024470776,0,4,Harderian gland development,BP,
15917,GO:0070389,1,0.9495552232909,0,7,chaperone cofactor-dependent protein refolding,BP,
15918,GO:0070390,1,0.992170062901773,0,1,transcription export complex 2,CC,
15919,GO:0070391,1,0.934261303670098,0,9,response to lipoteichoic acid,BP,
15920,GO:0070392,1,0.992170027168696,0,1,detection of lipoteichoic acid,BP,
15921,GO:0070401,1,0.984431724638105,0,2,NADP+ binding,MF,
15923,GO:0070403,1,0.906484468966204,0,13,NAD+ binding,MF,
15924,GO:0070404,1,0.984400887813367,0,2,NADH binding,MF,
15926,GO:0070407,1,0.992680587831522,0,1,oxidation-dependent protein catabolic process,BP,
15927,GO:0070408,1,0.993986317082102,0,1,carbamoyl phosphate metabolic process,BP,
15928,GO:0070409,1,0.993986317082102,0,1,carbamoyl phosphate biosynthetic process,BP,
15929,GO:0070410,1,0.926963358661182,0,11,co-SMAD binding,MF,
15930,GO:0070411,1,0.927839499041178,0,11,I-SMAD binding,MF,
15931,GO:0070412,1,0.854589459638455,0,23,R-SMAD binding,MF,
15932,GO:0070417,1,0.960819049003584,0,6,cellular response to cold,BP,
15933,GO:0070418,1,0.993965836685846,0,1,DNA-dependent protein kinase complex,CC,
15934,GO:0070419,1,0.943957710189708,0,8,nonhomologous end joining complex,CC,
15935,GO:0070423,1,0.790216228395727,0,33,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15936,GO:0070424,1,0.946880828141917,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15937,GO:0070425,1,0.986402426988172,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15938,GO:0070426,1,0.978661375662197,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15939,GO:0070427,1,0.972525240555353,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15940,GO:0070428,1,0.987800856980848,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15941,GO:0070429,1,0.993777749217608,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15942,GO:0070430,1,0.993985977977592,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15943,GO:0070431,1,0.937255450803974,0,9,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15944,GO:0070432,1,0.965351728071282,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15945,GO:0070433,1,0.986402426988172,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15946,GO:0070434,1,0.978661375662197,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15947,GO:0070435,1,0.985229304381574,0,2,Shc-EGFR complex,CC,
15948,GO:0070436,1,0.986580070707789,0,2,Grb2-EGFR complex,CC,
15949,GO:0070442,1,0.992170027168696,0,1,integrin alphaIIb-beta3 complex,CC,
15950,GO:0070444,1,0.958200607000092,0,6,oligodendrocyte progenitor proliferation,BP,
15951,GO:0070445,1,0.958200607000092,0,6,regulation of oligodendrocyte progenitor proliferation,BP,
15952,GO:0070446,1,0.992174264801851,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15953,GO:0070447,1,0.992628005064012,0,1,positive regulation of oligodendrocyte progenitor proliferation,BP,
15954,GO:0070449,1,0.992171777456198,0,1,elongin complex,CC,
15955,GO:0070458,1,0.978083014647263,0,3,cellular detoxification of nitrogen compound,BP,
15956,GO:0070459,1,0.956397968653976,0,6,prolactin secretion,BP,
15957,GO:0070460,1,0.993406763692654,0,1,thyroid-stimulating hormone secretion,BP,
15958,GO:0070461,1,0.81794385768063,0,28,SAGA-type complex,CC,
15959,GO:0070462,1,0.993206709488873,0,1,plus-end specific microtubule depolymerization,BP,
15960,GO:0070463,1,0.99302500285058,0,1,tubulin-dependent ATPase activity,MF,
15961,GO:0070469,1,0.530484201853029,0,82,respiratory chain,CC,
15962,GO:0070471,1,0.942998370376706,0,8,uterine smooth muscle contraction,BP,
15963,GO:0070472,1,0.950316208546657,0,7,regulation of uterine smooth muscle contraction,BP,
15964,GO:0070473,1,0.992174484858162,0,1,negative regulation of uterine smooth muscle contraction,BP,
15965,GO:0070474,1,0.957814111378213,0,6,positive regulation of uterine smooth muscle contraction,BP,
15966,GO:0070475,1,0.961825431346646,0,5,rRNA base methylation,BP,
15967,GO:0070476,1,0.992170027168696,0,1,rRNA (guanine-N7)-methylation,BP,
15968,GO:0070478,1,0.993649502665626,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15969,GO:0070481,1,0.992505024514816,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15971,GO:0070483,1,0.992738337601419,0,1,detection of hypoxia,BP,
15972,GO:0070486,1,0.925561222734119,0,11,leukocyte aggregation,BP,
15973,GO:0070487,1,0.966894611337968,0,5,monocyte aggregation,BP,
15974,GO:0070488,1,0.984400887813367,0,2,neutrophil aggregation,BP,
15975,GO:0070489,1,0.992174094064904,0,1,T cell aggregation,BP,
15976,GO:0070491,1,0.66120475596999,0,58,repressing transcription factor binding,MF,
15977,GO:0070492,1,0.921163801738187,0,11,oligosaccharide binding,MF,
15978,GO:0070493,1,0.918219056330516,0,12,thrombin-activated receptor signaling pathway,BP,
15979,GO:0070494,1,0.979025493830089,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15980,GO:0070495,1,0.979025493830089,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15981,GO:0070498,1,0.864775877085564,0,20,interleukin-1-mediated signaling pathway,BP,
15982,GO:0070506,1,0.98475174779436,0,2,high-density lipoprotein particle receptor activity,MF,
15983,GO:0070507,1,0.396115322104578,0,130,regulation of microtubule cytoskeleton organization,BP,
15984,GO:0070508,1,0.933713330498594,0,9,cholesterol import,BP,
15986,GO:0070510,1,0.993986332271234,0,1,regulation of histone H4-K20 methylation,BP,
15987,GO:0070512,1,0.993986332271234,0,1,positive regulation of histone H4-K20 methylation,BP,
15989,GO:0070522,1,0.971634270664482,0,4,ERCC4-ERCC1 complex,CC,
15990,GO:0070524,1,0.992170027168696,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15992,GO:0070527,1,0.682473605589205,0,53,platelet aggregation,BP,
15993,GO:0070528,1,0.830300063990016,0,26,protein kinase C signaling,BP,
15994,GO:0070530,1,0.888839709706398,0,17,K63-linked polyubiquitin binding,MF,
15995,GO:0070531,1,0.949136923841422,0,7,BRCA1-A complex,CC,
15996,GO:0070534,1,0.743554959159669,0,41,protein K63-linked ubiquitination,BP,
15997,GO:0070535,1,0.966858305160933,0,5,histone H2A K63-linked ubiquitination,BP,
15998,GO:0070536,1,0.82883024761508,0,27,protein K63-linked deubiquitination,BP,
15999,GO:0070537,1,0.977526037719086,0,3,histone H2A K63-linked deubiquitination,BP,
16001,GO:0070539,1,0.993066321596551,0,1,linoleic acid binding,MF,
16002,GO:0070541,1,0.986771765847049,0,2,response to platinum ion,BP,
16004,GO:0070543,1,0.986065867810726,0,2,response to linoleic acid,BP,
16005,GO:0070544,1,0.968460225198892,0,5,histone H3-K36 demethylation,BP,
16006,GO:0070545,1,0.970830824529648,0,4,PeBoW complex,CC,
16007,GO:0070546,1,0.977019325461579,0,3,L-phenylalanine aminotransferase activity,MF,
16008,GO:0070547,1,0.992399074066817,0,1,L-tyrosine aminotransferase activity,MF,
16009,GO:0070548,1,0.986624236531762,0,2,L-glutamine aminotransferase activity,MF,
16010,GO:0070551,1,0.992294630214608,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
16011,GO:0070552,1,0.962295169909253,0,5,BRISC complex,CC,
16012,GO:0070553,1,0.992294630214608,0,1,nicotinic acid receptor activity,MF,
16013,GO:0070554,1,0.986113883015543,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
16015,GO:0070557,1,0.984428367662276,0,2,PCNA-p21 complex,CC,
16016,GO:0070560,1,0.992459776065546,0,1,protein secretion by platelet,BP,
16017,GO:0070561,1,0.93876305390208,0,9,vitamin D receptor signaling pathway,BP,
16018,GO:0070562,1,0.958787949191716,0,6,regulation of vitamin D receptor signaling pathway,BP,
16019,GO:0070563,1,0.986187263018503,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
16020,GO:0070564,1,0.984516592424412,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
16021,GO:0070566,1,0.852414748875112,0,23,adenylyltransferase activity,MF,
16022,GO:0070567,1,0.936957260065582,0,9,cytidylyltransferase activity,MF,
16023,GO:0070568,1,0.965198376090027,0,5,guanylyltransferase activity,MF,
16025,GO:0070570,1,0.83590320471878,0,25,regulation of neuron projection regeneration,BP,
16026,GO:0070571,1,0.912331615464757,0,13,negative regulation of neuron projection regeneration,BP,
16027,GO:0070572,1,0.947919713573067,0,7,positive regulation of neuron projection regeneration,BP,
16028,GO:0070573,1,0.977546190721891,0,3,metallodipeptidase activity,MF,
16029,GO:0070574,1,0.972288229051878,0,4,cadmium ion transmembrane transport,BP,
16030,GO:0070576,1,0.977617731178562,0,3,vitamin D 24-hydroxylase activity,MF,
16031,GO:0070577,1,0.896333766272421,0,17,lysine-acetylated histone binding,MF,
16032,GO:0070578,1,0.941231146712693,0,8,RISC-loading complex,CC,
16033,GO:0070579,1,0.974509014484242,0,4,methylcytosine dioxygenase activity,MF,
16034,GO:0070584,1,0.865298320600654,0,20,mitochondrion morphogenesis,BP,
16035,GO:0070585,1,0.253996425761427,0,185,protein localization to mitochondrion,BP,
16036,GO:0070586,1,0.927294738552654,0,10,cell-cell adhesion involved in gastrulation,BP,
16037,GO:0070587,1,0.934434954461603,0,9,regulation of cell-cell adhesion involved in gastrulation,BP,
16039,GO:0070589,1,0.992170321724734,0,1,cellular component macromolecule biosynthetic process,BP,
16040,GO:0070593,1,0.993986332271257,0,1,dendrite self-avoidance,BP,
16041,GO:0070601,1,0.952700680897407,0,7,centromeric sister chromatid cohesion,BP,
16042,GO:0070602,1,0.980119726547795,0,3,regulation of centromeric sister chromatid cohesion,BP,
16043,GO:0070603,1,0.599261412959832,0,73,SWI/SNF superfamily-type complex,CC,
16044,GO:0070611,1,0.992329146180804,0,1,histone methyltransferase activity (H3-R2 specific),MF,
16045,GO:0070612,1,0.992329146180804,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
16047,GO:0070615,1,0.993577849290541,0,1,nucleosome-dependent ATPase activity,MF,
16048,GO:0070618,1,0.992355199688479,0,1,Grb2-Sos complex,CC,
16049,GO:0070625,1,0.992183109713971,0,1,zymogen granule exocytosis,BP,
16050,GO:0070626,1,0.992170027168696,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
16051,GO:0070627,1,0.963439724380377,0,5,ferrous iron import,BP,
16052,GO:0070628,1,0.917385156018916,0,12,proteasome binding,MF,
16053,GO:0070633,1,0.877675646546639,0,18,transepithelial transport,BP,
16054,GO:0070634,1,0.978485668220733,0,3,transepithelial ammonium transport,BP,
16057,GO:0070640,1,0.971144843372299,0,4,vitamin D3 metabolic process,BP,
16058,GO:0070643,1,0.984635600372983,0,2,vitamin D 25-hydroxylase activity,MF,
16059,GO:0070644,1,0.981676249734646,0,3,vitamin D response element binding,MF,
16062,GO:0070649,1,0.980893759918757,0,3,formin-nucleated actin cable assembly,BP,
16063,GO:0070651,1,0.992505024514816,0,1,nonfunctional rRNA decay,BP,
16064,GO:0070652,1,0.945156235369404,0,8,HAUS complex,CC,
16065,GO:0070653,1,0.976692112990833,0,3,high-density lipoprotein particle receptor binding,MF,
16067,GO:0070662,1,0.980699202073131,0,3,mast cell proliferation,BP,
16069,GO:0070664,1,0.61128312950739,0,67,negative regulation of leukocyte proliferation,BP,
16071,GO:0070666,1,0.986652603141066,0,2,regulation of mast cell proliferation,BP,
16072,GO:0070667,1,0.992628005064012,0,1,negative regulation of mast cell proliferation,BP,
16073,GO:0070668,1,0.986652603141066,0,2,positive regulation of mast cell proliferation,BP,
16074,GO:0070669,1,0.939011193312727,0,9,response to interleukin-2,BP,
16076,GO:0070671,1,0.965487898760081,0,5,response to interleukin-12,BP,
16077,GO:0070672,1,0.961362188233983,0,6,response to interleukin-15,BP,
16078,GO:0070673,1,0.934498359134706,0,9,response to interleukin-18,BP,
16079,GO:0070676,1,0.976724618077432,0,3,intralumenal vesicle formation,BP,
16080,GO:0070679,1,0.944155859527258,0,9,inositol 1,4,5 trisphosphate binding,MF,
16081,GO:0070681,1,0.985822938811149,0,2,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
16082,GO:0070682,1,0.97750261226955,0,3,proteasome regulatory particle assembly,BP,
16083,GO:0070684,1,0.992170027168696,0,1,seminal clot liquefaction,BP,
16084,GO:0070685,1,0.992186112134068,0,1,macropinocytic cup,CC,
16085,GO:0070694,1,0.992294630214608,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
16086,GO:0070695,1,0.965989105287299,0,5,FHF complex,CC,
16088,GO:0070697,1,0.9711510291608,0,4,activin receptor binding,MF,
16089,GO:0070698,1,0.984715989523491,0,2,type I activin receptor binding,MF,
16090,GO:0070699,1,0.986226140756466,0,2,type II activin receptor binding,MF,
16092,GO:0070701,1,0.988008547523982,0,2,mucus layer,CC,
16093,GO:0070702,1,0.99398633227863,0,1,inner mucus layer,CC,
16094,GO:0070703,1,0.99398633227863,0,1,outer mucus layer,CC,
16096,GO:0070715,1,0.992830992499847,0,1,sodium-dependent organic cation transport,BP,
16097,GO:0070717,1,0.882957731512787,0,18,poly-purine tract binding,MF,
16098,GO:0070722,1,0.993048191808881,0,1,Tle3-Aes complex,CC,
16099,GO:0070723,1,0.865712672943429,0,21,response to cholesterol,BP,
16100,GO:0070724,1,0.984930593717152,0,2,BMP receptor complex,CC,
16102,GO:0070728,1,0.959354153043139,0,6,leucine binding,MF,
16103,GO:0070733,1,0.992170027168696,0,1,protein adenylyltransferase activity,MF,
16104,GO:0070734,1,0.881482306738357,0,18,histone H3-K27 methylation,BP,
16105,GO:0070735,1,0.992958482806244,0,1,protein-glycine ligase activity,MF,
16106,GO:0070736,1,0.992958482806244,0,1,protein-glycine ligase activity, initiating,MF,
16107,GO:0070739,1,0.957147147291346,0,6,protein-glutamic acid ligase activity,MF,
16108,GO:0070740,1,0.977841270340488,0,3,tubulin-glutamic acid ligase activity,MF,
16109,GO:0070741,1,0.799433026777978,0,31,response to interleukin-6,BP,
16111,GO:0070743,1,0.984456981790427,0,2,interleukin-23 complex,CC,
16112,GO:0070761,1,0.956524541271454,0,6,pre-snoRNP complex,CC,
16113,GO:0070765,1,0.958808442544663,0,6,gamma-secretase complex,CC,
16114,GO:0070772,1,0.99266691529153,0,1,PAS complex,CC,
16115,GO:0070773,1,0.992170027168696,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
16116,GO:0070774,1,0.993759557162157,0,1,phytoceramidase activity,MF,
16117,GO:0070775,1,0.953416214620337,0,7,H3 histone acetyltransferase complex,CC,
16118,GO:0070776,1,0.953416214620337,0,7,MOZ/MORF histone acetyltransferase complex,CC,
16120,GO:0070778,1,0.971168088421632,0,4,L-aspartate transport,BP,
16122,GO:0070780,1,0.985079193235742,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
16123,GO:0070781,1,0.986203080773287,0,2,response to biotin,BP,
16124,GO:0070782,1,0.992191267314068,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
16125,GO:0070813,1,0.963353027222875,0,5,hydrogen sulfide metabolic process,BP,
16126,GO:0070814,1,0.970957340206704,0,4,hydrogen sulfide biosynthetic process,BP,
16127,GO:0070815,1,0.972163287056831,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
16128,GO:0070816,1,0.896210729996676,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
16129,GO:0070818,1,0.992170158561663,0,1,protoporphyrinogen oxidase activity,MF,
16131,GO:0070821,1,0.602630444892665,0,71,tertiary granule membrane,CC,
16132,GO:0070822,1,0.894613158264033,0,16,Sin3-type complex,CC,
16133,GO:0070826,1,0.993636863993896,0,1,paraferritin complex,CC,
16134,GO:0070827,1,0.980366425138069,0,3,chromatin maintenance,BP,
16135,GO:0070828,1,0.900440758395382,0,15,heterochromatin organization,BP,
16136,GO:0070829,1,0.993986332271365,0,1,heterochromatin maintenance,BP,
16137,GO:0070830,1,0.732822747967583,0,45,bicellular tight junction assembly,BP,
16138,GO:0070831,1,0.94403511802936,0,9,basement membrane assembly,BP,
16139,GO:0070836,1,0.969803930024829,0,4,caveola assembly,BP,
16140,GO:0070837,1,0.972206920517669,0,4,dehydroascorbic acid transport,BP,
16142,GO:0070839,1,0.986349752740429,0,2,divalent metal ion export,BP,
16143,GO:0070840,1,0.881707957725653,0,19,dynein complex binding,MF,
16144,GO:0070841,1,0.859482352745167,0,21,inclusion body assembly,BP,
16145,GO:0070842,1,0.973032389720134,0,4,aggresome assembly,BP,
16146,GO:0070843,1,0.993603893325838,0,1,misfolded protein transport,BP,
16147,GO:0070844,1,0.993603893325838,0,1,polyubiquitinated protein transport,BP,
16148,GO:0070845,1,0.993603893325838,0,1,polyubiquitinated misfolded protein transport,BP,
16149,GO:0070846,1,0.993603893325838,0,1,Hsp90 deacetylation,BP,
16150,GO:0070847,1,0.955679388019266,0,6,core mediator complex,CC,
16152,GO:0070849,1,0.749131237255007,0,41,response to epidermal growth factor,BP,
16154,GO:0070852,1,0.951037095800674,0,7,cell body fiber,CC,
16155,GO:0070853,1,0.988008547477674,0,2,myosin VI binding,MF,
16156,GO:0070856,1,0.993986332265941,0,1,myosin VI light chain binding,MF,
16158,GO:0070858,1,0.977185264659436,0,3,negative regulation of bile acid biosynthetic process,BP,
16160,GO:0070860,1,0.992216726639161,0,1,RNA polymerase I core factor complex,CC,
16161,GO:0070861,1,0.862914606498892,0,21,regulation of protein exit from endoplasmic reticulum,BP,
16162,GO:0070862,1,0.936486212005316,0,9,negative regulation of protein exit from endoplasmic reticulum,BP,
16163,GO:0070863,1,0.933532852456739,0,10,positive regulation of protein exit from endoplasmic reticulum,BP,
16164,GO:0070873,1,0.820937986811423,0,29,regulation of glycogen metabolic process,BP,
16165,GO:0070874,1,0.959622845340611,0,6,negative regulation of glycogen metabolic process,BP,
16166,GO:0070875,1,0.897987370143655,0,16,positive regulation of glycogen metabolic process,BP,
16167,GO:0070876,1,0.971011826495623,0,4,SOSS complex,CC,
16168,GO:0070877,1,0.986127069812745,0,2,microprocessor complex,CC,
16169,GO:0070878,1,0.947207114199892,0,8,primary miRNA binding,MF,
16170,GO:0070883,1,0.972589222992651,0,4,pre-miRNA binding,MF,
16171,GO:0070884,1,0.885428121830765,0,17,regulation of calcineurin-NFAT signaling cascade,BP,
16172,GO:0070885,1,0.971440638971878,0,4,negative regulation of calcineurin-NFAT signaling cascade,BP,
16173,GO:0070886,1,0.938164829096048,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16175,GO:0070888,1,0.777537355410408,0,35,E-box binding,MF,
16176,GO:0070889,1,0.984622085458791,0,2,platelet alpha granule organization,BP,
16177,GO:0070890,1,0.986261482472498,0,2,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16178,GO:0070891,1,0.969702353598464,0,4,lipoteichoic acid binding,MF,
16179,GO:0070892,1,0.992182301271294,0,1,lipoteichoic acid receptor activity,MF,
16180,GO:0070893,1,0.986443311372241,0,2,transposon integration,BP,
16181,GO:0070894,1,0.986443311372241,0,2,regulation of transposon integration,BP,
16182,GO:0070895,1,0.986443311372241,0,2,negative regulation of transposon integration,BP,
16183,GO:0070897,1,0.77015212900021,0,36,DNA-templated transcriptional preinitiation complex assembly,BP,
16184,GO:0070898,1,0.98628245366357,0,2,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16185,GO:0070899,1,0.992576756436493,0,1,mitochondrial tRNA wobble uridine modification,BP,
16189,GO:0070903,1,0.992175289819867,0,1,mitochondrial tRNA thio-modification,BP,
16190,GO:0070904,1,0.986261482472498,0,2,transepithelial L-ascorbic acid transport,BP,
16191,GO:0070905,1,0.978254488147835,0,3,serine binding,MF,
16192,GO:0070911,1,0.791856930303898,0,32,global genome nucleotide-excision repair,BP,
16193,GO:0070914,1,0.925196465170124,0,11,UV-damage excision repair,BP,
16194,GO:0070915,1,0.962200278006638,0,5,lysophosphatidic acid receptor activity,MF,
16195,GO:0070918,1,0.780951586823235,0,35,production of small RNA involved in gene silencing by RNA,BP,
16196,GO:0070920,1,0.898653788846395,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
16197,GO:0070922,1,0.94295408008841,0,8,small RNA loading onto RISC,BP,
16199,GO:0070926,1,0.993403246323917,0,1,regulation of ATP:ADP antiporter activity,BP,
16200,GO:0070931,1,0.993986292945861,0,1,Golgi-associated vesicle lumen,CC,
16201,GO:0070932,1,0.869930869987455,0,20,histone H3 deacetylation,BP,
16202,GO:0070933,1,0.940932208016619,0,9,histone H4 deacetylation,BP,
16203,GO:0070934,1,0.968386015451486,0,5,CRD-mediated mRNA stabilization,BP,
16204,GO:0070935,1,0.932268769466727,0,10,3'-UTR-mediated mRNA stabilization,BP,
16206,GO:0070937,1,0.962195150923761,0,6,CRD-mediated mRNA stability complex,CC,
16207,GO:0070938,1,0.927705485310048,0,11,contractile ring,CC,
16208,GO:0070939,1,0.9791791549398,0,3,Dsl1/NZR complex,CC,
16209,GO:0070940,1,0.965651742556867,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16210,GO:0070942,1,0.95421873549434,0,6,neutrophil mediated cytotoxicity,BP,
16211,GO:0070943,1,0.95421873549434,0,6,neutrophil mediated killing of symbiont cell,BP,
16212,GO:0070944,1,0.961751508338413,0,5,neutrophil mediated killing of bacterium,BP,
16213,GO:0070945,1,0.976994503705494,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16214,GO:0070946,1,0.992170027168696,0,1,neutrophil mediated killing of gram-positive bacterium,BP,
16215,GO:0070947,1,0.992170027168696,0,1,neutrophil mediated killing of fungus,BP,
16216,GO:0070948,1,0.992477169145941,0,1,regulation of neutrophil mediated cytotoxicity,BP,
16217,GO:0070949,1,0.992477169145941,0,1,regulation of neutrophil mediated killing of symbiont cell,BP,
16218,GO:0070950,1,0.992477169145941,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16219,GO:0070951,1,0.992477169145941,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16220,GO:0070960,1,0.992477169145941,0,1,positive regulation of neutrophil mediated cytotoxicity,BP,
16221,GO:0070961,1,0.992477169145941,0,1,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16222,GO:0070962,1,0.992477169145941,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16223,GO:0070963,1,0.992477169145941,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16224,GO:0070966,1,0.980230094719654,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16226,GO:0070971,1,0.926226261553455,0,11,endoplasmic reticulum exit site,CC,
16227,GO:0070972,1,0.382194282760664,0,126,protein localization to endoplasmic reticulum,BP,
16228,GO:0070973,1,0.972635392998297,0,4,protein localization to endoplasmic reticulum exit site,BP,
16229,GO:0070974,1,0.992608776070655,0,1,POU domain binding,MF,
16230,GO:0070975,1,0.993986332272446,0,1,FHA domain binding,MF,
16231,GO:0070976,1,0.992367824626514,0,1,TIR domain binding,MF,
16232,GO:0070977,1,0.890340562962521,0,17,bone maturation,BP,
16233,GO:0070979,1,0.821722895638841,0,26,protein K11-linked ubiquitination,BP,
16234,GO:0070980,1,0.992228281403789,0,1,biphenyl catabolic process,BP,
16235,GO:0070981,1,0.992221372792901,0,1,L-asparagine biosynthetic process,BP,
16236,GO:0070982,1,0.992221372792901,0,1,L-asparagine metabolic process,BP,
16237,GO:0070984,1,0.993634941362659,0,1,SET domain binding,MF,
16238,GO:0070985,1,0.984400887813367,0,2,TFIIK complex,CC,
16239,GO:0070986,1,0.915169694005016,0,13,left/right axis specification,BP,
16240,GO:0070987,1,0.876839247790982,0,18,error-free translesion synthesis,BP,
16241,GO:0070988,1,0.67084106730092,0,57,demethylation,BP,
16242,GO:0070989,1,0.913511551409109,0,12,oxidative demethylation,BP,
16243,GO:0070990,1,0.939065538893866,0,8,snRNP binding,MF,
16244,GO:0070991,1,0.985490206437033,0,2,medium-chain-acyl-CoA dehydrogenase activity,MF,
16245,GO:0070992,1,0.984853996574939,0,2,translation initiation complex,CC,
16246,GO:0070993,1,0.98747677442234,0,2,translation preinitiation complex,CC,
16247,GO:0070994,1,0.993835750309779,0,1,detection of oxidative stress,BP,
16248,GO:0070995,1,0.979016591319035,0,3,NADPH oxidation,BP,
16251,GO:0071000,1,0.984492684069318,0,2,response to magnetism,BP,
16252,GO:0071001,1,0.97846546366991,0,3,U4/U6 snRNP,CC,
16253,GO:0071004,1,0.887131245830572,0,16,U2-type prespliceosome,CC,
16254,GO:0071006,1,0.977467068814594,0,3,U2-type catalytic step 1 spliceosome,CC,
16255,GO:0071007,1,0.992226804149052,0,1,U2-type catalytic step 2 spliceosome,CC,
16256,GO:0071008,1,0.969891257505522,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16257,GO:0071010,1,0.866434968123399,0,19,prespliceosome,CC,
16258,GO:0071011,1,0.842080496341281,0,23,precatalytic spliceosome,CC,
16259,GO:0071012,1,0.969812393447738,0,4,catalytic step 1 spliceosome,CC,
16260,GO:0071013,1,0.497866041876041,0,95,catalytic step 2 spliceosome,CC,
16261,GO:0071014,1,0.947297580644673,0,7,post-mRNA release spliceosomal complex,CC,
16262,GO:0071020,1,0.984401142146478,0,2,post-spliceosomal complex,CC,
16263,GO:0071021,1,0.992170056200193,0,1,U2-type post-spliceosomal complex,CC,
16264,GO:0071025,1,0.91226594634219,0,12,RNA surveillance,BP,
16265,GO:0071026,1,0.992265851840136,0,1,cytoplasmic RNA surveillance,BP,
16266,GO:0071027,1,0.926328170463577,0,10,nuclear RNA surveillance,BP,
16267,GO:0071028,1,0.926328170463577,0,10,nuclear mRNA surveillance,BP,
16268,GO:0071029,1,0.969307572086323,0,4,nuclear ncRNA surveillance,BP,
16269,GO:0071030,1,0.984642591229538,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16270,GO:0071031,1,0.984427697805921,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16271,GO:0071033,1,0.961716142420894,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16272,GO:0071034,1,0.971082346552971,0,4,CUT catabolic process,BP,
16273,GO:0071035,1,0.969307572086323,0,4,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16274,GO:0071038,1,0.984427697805921,0,2,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16275,GO:0071042,1,0.993845740613944,0,1,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16276,GO:0071043,1,0.971082346552971,0,4,CUT metabolic process,BP,
16277,GO:0071044,1,0.928115527331513,0,11,histone mRNA catabolic process,BP,
16278,GO:0071045,1,0.992170027168696,0,1,nuclear histone mRNA catabolic process,BP,
16279,GO:0071046,1,0.969307572086323,0,4,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16280,GO:0071047,1,0.993845740613944,0,1,polyadenylation-dependent mRNA catabolic process,BP,
16281,GO:0071048,1,0.984642591229538,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16282,GO:0071049,1,0.984427697805921,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16283,GO:0071051,1,0.961480001614786,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16284,GO:0071062,1,0.979927627113465,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16285,GO:0071065,1,0.985303608187669,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16287,GO:0071072,1,0.97176304876779,0,4,negative regulation of phospholipid biosynthetic process,BP,
16289,GO:0071074,1,0.986205957642759,0,2,eukaryotic initiation factor eIF2 binding,MF,
16290,GO:0071077,1,0.984956409798264,0,2,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16291,GO:0071103,1,0.142308087900449,0,265,DNA conformation change,BP,
16292,GO:0071104,1,0.978497961637835,0,3,response to interleukin-9,BP,
16293,GO:0071105,1,0.986117423438082,0,2,response to interleukin-11,BP,
16294,GO:0071106,1,0.984956409798264,0,2,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16295,GO:0071107,1,0.923094047674903,0,11,response to parathyroid hormone,BP,
16296,GO:0071108,1,0.846708164949828,0,25,protein K48-linked deubiquitination,BP,
16297,GO:0071109,1,0.988008547487099,0,2,superior temporal gyrus development,BP,
16298,GO:0071110,1,0.993986332265571,0,1,histone biotinylation,BP,
16299,GO:0071133,1,0.99270550262398,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16300,GO:0071139,1,0.986346763435479,0,2,resolution of recombination intermediates,BP,
16301,GO:0071140,1,0.986346763435479,0,2,resolution of mitotic recombination intermediates,BP,
16302,GO:0071141,1,0.941955382176252,0,9,SMAD protein complex,CC,
16303,GO:0071144,1,0.988008547483408,0,2,SMAD2-SMAD3 protein complex,CC,
16304,GO:0071146,1,0.992188368610558,0,1,SMAD3-SMAD4 protein complex,CC,
16305,GO:0071148,1,0.987997723128536,0,2,TEAD-1-YAP complex,CC,
16306,GO:0071149,1,0.986214674188829,0,2,TEAD-2-YAP complex,CC,
16307,GO:0071156,1,0.460042624304641,0,105,regulation of cell cycle arrest,BP,
16308,GO:0071157,1,0.86172714834592,0,20,negative regulation of cell cycle arrest,BP,
16309,GO:0071158,1,0.543159808413013,0,83,positive regulation of cell cycle arrest,BP,
16310,GO:0071159,1,0.984532245643489,0,2,NF-kappaB complex,CC,
16311,GO:0071163,1,0.976872934654389,0,3,DNA replication preinitiation complex assembly,BP,
16312,GO:0071164,1,0.993246594573786,0,1,RNA trimethylguanosine synthase activity,MF,
16313,GO:0071166,1,0.399975971265178,0,127,ribonucleoprotein complex localization,BP,
16314,GO:0071167,1,0.993246594573786,0,1,ribonucleoprotein complex import into nucleus,BP,
16315,GO:0071168,1,0.894282086887238,0,15,protein localization to chromatin,BP,
16316,GO:0071169,1,0.95397737321202,0,6,establishment of protein localization to chromatin,BP,
16317,GO:0071170,1,0.992294630214608,0,1,site-specific DNA replication termination,BP,
16318,GO:0071171,1,0.992294630214608,0,1,site-specific DNA replication termination at RTS1 barrier,BP,
16319,GO:0071173,1,0.81485279734937,0,28,spindle assembly checkpoint,BP,
16320,GO:0071174,1,0.808614138221493,0,29,mitotic spindle checkpoint,BP,
16321,GO:0071203,1,0.9728083203095,0,4,WASH complex,CC,
16322,GO:0071204,1,0.957410003138105,0,6,histone pre-mRNA 3'end processing complex,CC,
16323,GO:0071205,1,0.975968833678269,0,4,protein localization to juxtaparanode region of axon,BP,
16324,GO:0071206,1,0.993986332273813,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16325,GO:0071207,1,0.986068776242581,0,2,histone pre-mRNA stem-loop binding,MF,
16326,GO:0071208,1,0.969043305658251,0,4,histone pre-mRNA DCP binding,MF,
16327,GO:0071209,1,0.976814787232004,0,3,U7 snRNA binding,MF,
16328,GO:0071211,1,0.979871904994681,0,3,protein targeting to vacuole involved in autophagy,BP,
16330,GO:0071215,1,0.993740843079674,0,1,cellular response to abscisic acid stimulus,BP,
16332,GO:0071217,1,0.993506247191203,0,1,cellular response to external biotic stimulus,BP,
16333,GO:0071218,1,0.873562563661997,0,19,cellular response to misfolded protein,BP,
16335,GO:0071220,1,0.956705974476934,0,6,cellular response to bacterial lipoprotein,BP,
16336,GO:0071221,1,0.956705974476934,0,6,cellular response to bacterial lipopeptide,BP,
16338,GO:0071223,1,0.934261303670098,0,9,cellular response to lipoteichoic acid,BP,
16339,GO:0071224,1,0.984537204810553,0,2,cellular response to peptidoglycan,BP,
16340,GO:0071225,1,0.966600882898569,0,5,cellular response to muramyl dipeptide,BP,
16341,GO:0071226,1,0.97867034702646,0,3,cellular response to molecule of fungal origin,BP,
16342,GO:0071228,1,0.99251431857346,0,1,cellular response to tumor cell,BP,
16344,GO:0071230,1,0.647274855460066,0,62,cellular response to amino acid stimulus,BP,
16345,GO:0071231,1,0.984400887813367,0,2,cellular response to folic acid,BP,
16346,GO:0071233,1,0.957611016896183,0,7,cellular response to leucine,BP,
16349,GO:0071242,1,0.674681922805889,0,55,cellular response to ammonium ion,BP,
16350,GO:0071243,1,0.89255299393043,0,15,cellular response to arsenic-containing substance,BP,
16351,GO:0071245,1,0.993192475809782,0,1,cellular response to carbon monoxide,BP,
16352,GO:0071247,1,0.992170027168696,0,1,cellular response to chromate,BP,
16354,GO:0071250,1,0.993986332267178,0,1,cellular response to nitrite,BP,
16355,GO:0071253,1,0.95757829676443,0,6,connexin binding,MF,
16356,GO:0071256,1,0.969080617453174,0,4,translocon complex,CC,
16357,GO:0071257,1,0.917284892684628,0,12,cellular response to electrical stimulus,BP,
16358,GO:0071258,1,0.993616323617868,0,1,cellular response to gravity,BP,
16359,GO:0071259,1,0.984492684069318,0,2,cellular response to magnetism,BP,
16361,GO:0071262,1,0.987332359942484,0,2,regulation of translational initiation in response to starvation,BP,
16362,GO:0071264,1,0.987332359942484,0,2,positive regulation of translational initiation in response to starvation,BP,
16364,GO:0071266,1,0.992170154337142,0,1,'de novo' L-methionine biosynthetic process,BP,
16366,GO:0071268,1,0.992213585501374,0,1,homocysteine biosynthetic process,BP,
16367,GO:0071275,1,0.992190515957061,0,1,cellular response to aluminum ion,BP,
16369,GO:0071277,1,0.698065157129038,0,51,cellular response to calcium ion,BP,
16370,GO:0071279,1,0.978480302616713,0,3,cellular response to cobalt ion,BP,
16371,GO:0071280,1,0.914650159024405,0,12,cellular response to copper ion,BP,
16372,GO:0071281,1,0.928418117765877,0,10,cellular response to iron ion,BP,
16373,GO:0071283,1,0.9844148004629,0,2,cellular response to iron(III) ion,BP,
16374,GO:0071284,1,0.979831614013992,0,3,cellular response to lead ion,BP,
16375,GO:0071285,1,0.907693291095946,0,13,cellular response to lithium ion,BP,
16376,GO:0071286,1,0.961162458095027,0,6,cellular response to magnesium ion,BP,
16378,GO:0071288,1,0.978357318838442,0,3,cellular response to mercury ion,BP,
16379,GO:0071294,1,0.874932969871209,0,18,cellular response to zinc ion,BP,
16380,GO:0071295,1,0.819869370171866,0,28,cellular response to vitamin,BP,
16381,GO:0071298,1,0.992974590415791,0,1,cellular response to L-ascorbic acid,BP,
16382,GO:0071300,1,0.622440346231588,0,66,cellular response to retinoic acid,BP,
16383,GO:0071301,1,0.993986332272418,0,1,cellular response to vitamin B1,BP,
16384,GO:0071305,1,0.874023106898971,0,19,cellular response to vitamin D,BP,
16385,GO:0071306,1,0.986204497131373,0,2,cellular response to vitamin E,BP,
16386,GO:0071307,1,0.985107846543526,0,2,cellular response to vitamin K,BP,
16389,GO:0071313,1,0.955335911230981,0,7,cellular response to caffeine,BP,
16390,GO:0071314,1,0.976941294066996,0,3,cellular response to cocaine,BP,
16391,GO:0071315,1,0.972127779557399,0,4,cellular response to morphine,BP,
16393,GO:0071317,1,0.972127779557399,0,4,cellular response to isoquinoline alkaloid,BP,
16394,GO:0071318,1,0.909274302360941,0,13,cellular response to ATP,BP,
16396,GO:0071321,1,0.962614422302501,0,6,cellular response to cGMP,BP,
16398,GO:0071324,1,0.993944487169586,0,1,cellular response to disaccharide stimulus,BP,
16400,GO:0071329,1,0.993944487169586,0,1,cellular response to sucrose stimulus,BP,
16402,GO:0071332,1,0.963604385438687,0,5,cellular response to fructose stimulus,BP,
16404,GO:0071335,1,0.984423508203672,0,2,hair follicle cell proliferation,BP,
16405,GO:0071336,1,0.984423508203672,0,2,regulation of hair follicle cell proliferation,BP,
16406,GO:0071338,1,0.984423508203672,0,2,positive regulation of hair follicle cell proliferation,BP,
16407,GO:0071339,1,0.822027327657575,0,27,MLL1 complex,CC,
16408,GO:0071340,1,0.921606585863854,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16409,GO:0071344,1,0.984400887813367,0,2,diphosphate metabolic process,BP,
16413,GO:0071348,1,0.993900004192079,0,1,cellular response to interleukin-11,BP,
16414,GO:0071349,1,0.980267605916461,0,3,cellular response to interleukin-12,BP,
16415,GO:0071350,1,0.978970416460639,0,3,cellular response to interleukin-15,BP,
16416,GO:0071351,1,0.955750818178365,0,6,cellular response to interleukin-18,BP,
16417,GO:0071352,1,0.957945868379834,0,6,cellular response to interleukin-2,BP,
16419,GO:0071354,1,0.824796144575821,0,27,cellular response to interleukin-6,BP,
16420,GO:0071355,1,0.992191649784728,0,1,cellular response to interleukin-9,BP,
16423,GO:0071359,1,0.688806876630998,0,52,cellular response to dsRNA,BP,
16424,GO:0071360,1,0.914550316486474,0,12,cellular response to exogenous dsRNA,BP,
16425,GO:0071361,1,0.92165080607867,0,12,cellular response to ethanol,BP,
16426,GO:0071362,1,0.959356726599033,0,6,cellular response to ether,BP,
16428,GO:0071364,1,0.770777220071889,0,37,cellular response to epidermal growth factor stimulus,BP,
16432,GO:0071374,1,0.943404980656487,0,8,cellular response to parathyroid hormone stimulus,BP,
16434,GO:0071376,1,0.964348807766747,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16435,GO:0071377,1,0.757590954013102,0,39,cellular response to glucagon stimulus,BP,
16437,GO:0071379,1,0.859252874710009,0,22,cellular response to prostaglandin stimulus,BP,
16438,GO:0071380,1,0.888843254017751,0,17,cellular response to prostaglandin E stimulus,BP,
16442,GO:0071386,1,0.980948199412474,0,3,cellular response to corticosterone stimulus,BP,
16443,GO:0071387,1,0.99396842386835,0,1,cellular response to cortisol stimulus,BP,
16444,GO:0071389,1,0.958123140820095,0,6,cellular response to mineralocorticoid stimulus,BP,
16445,GO:0071391,1,0.920118634324869,0,12,cellular response to estrogen stimulus,BP,
16446,GO:0071392,1,0.773801774564263,0,35,cellular response to estradiol stimulus,BP,
16447,GO:0071393,1,0.99355618305228,0,1,cellular response to progesterone stimulus,BP,
16448,GO:0071394,1,0.937182366021536,0,9,cellular response to testosterone stimulus,BP,
16449,GO:0071395,1,0.969043237344425,0,4,cellular response to jasmonic acid stimulus,BP,
16451,GO:0071397,1,0.915695817685095,0,13,cellular response to cholesterol,BP,
16453,GO:0071400,1,0.98628868755269,0,2,cellular response to oleic acid,BP,
16454,GO:0071401,1,0.992213076081144,0,1,cellular response to triglyceride,BP,
16455,GO:0071402,1,0.891404907000706,0,16,cellular response to lipoprotein particle stimulus,BP,
16456,GO:0071403,1,0.992170027168696,0,1,cellular response to high density lipoprotein particle stimulus,BP,
16457,GO:0071404,1,0.91269285823965,0,13,cellular response to low-density lipoprotein particle stimulus,BP,
16459,GO:0071409,1,0.978822191026829,0,3,cellular response to cycloheximide,BP,
16460,GO:0071412,1,0.992211571683086,0,1,cellular response to genistein,BP,
16461,GO:0071413,1,0.992211571683086,0,1,cellular response to hydroxyisoflavone,BP,
16462,GO:0071415,1,0.949588791034284,0,8,cellular response to purine-containing compound,BP,
16464,GO:0071418,1,0.992170027168696,0,1,cellular response to amine stimulus,BP,
16465,GO:0071420,1,0.955905158305828,0,7,cellular response to histamine,BP,
16466,GO:0071421,1,0.965559568964327,0,5,manganese ion transmembrane transport,BP,
16467,GO:0071422,1,0.978655953193687,0,3,succinate transmembrane transport,BP,
16468,GO:0071423,1,0.992172245940507,0,1,malate transmembrane transport,BP,
16469,GO:0071425,1,0.867485802998518,0,20,hematopoietic stem cell proliferation,BP,
16470,GO:0071426,1,0.40590491854335,0,125,ribonucleoprotein complex export from nucleus,BP,
16471,GO:0071427,1,0.460167178722458,0,108,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16472,GO:0071428,1,0.901404987253639,0,14,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16473,GO:0071431,1,0.808073481608863,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16474,GO:0071435,1,0.915694909081151,0,12,potassium ion export,BP,
16476,GO:0071437,1,0.920743182661773,0,12,invadopodium,CC,
16477,GO:0071438,1,0.95828579619744,0,6,invadopodium membrane,CC,
16478,GO:0071439,1,0.94490462351732,0,8,clathrin complex,CC,
16479,GO:0071440,1,0.964357229477217,0,5,regulation of histone H3-K14 acetylation,BP,
16480,GO:0071441,1,0.993382379108709,0,1,negative regulation of histone H3-K14 acetylation,BP,
16481,GO:0071442,1,0.97078298719938,0,4,positive regulation of histone H3-K14 acetylation,BP,
16482,GO:0071444,1,0.992170027168696,0,1,cellular response to pheromone,BP,
16483,GO:0071447,1,0.945300241349573,0,8,cellular response to hydroperoxide,BP,
16484,GO:0071449,1,0.992170027168696,0,1,cellular response to lipid hydroperoxide,BP,
16488,GO:0071454,1,0.993986332272682,0,1,cellular response to anoxia,BP,
16489,GO:0071455,1,0.951727553123309,0,7,cellular response to hyperoxia,BP,
16491,GO:0071458,1,0.957648370022636,0,6,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16492,GO:0071459,1,0.874580691867702,0,18,protein localization to chromosome, centromeric region,BP,
16493,GO:0071460,1,0.984400887813367,0,2,cellular response to cell-matrix adhesion,BP,
16494,GO:0071461,1,0.984652918863559,0,2,cellular response to redox state,BP,
16495,GO:0071462,1,0.966991142651122,0,5,cellular response to water stimulus,BP,
16496,GO:0071464,1,0.986209252025005,0,2,cellular response to hydrostatic pressure,BP,
16498,GO:0071467,1,0.863488679716583,0,20,cellular response to pH,BP,
16499,GO:0071468,1,0.925078690399919,0,11,cellular response to acidic pH,BP,
16500,GO:0071469,1,0.985850594029317,0,2,cellular response to alkaline pH,BP,
16501,GO:0071470,1,0.814499809699208,0,29,cellular response to osmotic stress,BP,
16502,GO:0071471,1,0.993805861677762,0,1,cellular response to non-ionic osmotic stress,BP,
16503,GO:0071472,1,0.944546655103314,0,8,cellular response to salt stress,BP,
16504,GO:0071474,1,0.943584342577864,0,8,cellular hyperosmotic response,BP,
16505,GO:0071475,1,0.978838830279422,0,3,cellular hyperosmotic salinity response,BP,
16506,GO:0071476,1,0.953816371038893,0,7,cellular hypotonic response,BP,
16507,GO:0071477,1,0.98674230600256,0,2,cellular hypotonic salinity response,BP,
16508,GO:0071478,1,0.308634901898634,0,164,cellular response to radiation,BP,
16509,GO:0071479,1,0.632831433609308,0,64,cellular response to ionizing radiation,BP,
16510,GO:0071480,1,0.830303169889861,0,26,cellular response to gamma radiation,BP,
16511,GO:0071481,1,0.91501312562213,0,13,cellular response to X-ray,BP,
16512,GO:0071482,1,0.465994499830009,0,107,cellular response to light stimulus,BP,
16513,GO:0071483,1,0.986476496939549,0,2,cellular response to blue light,BP,
16514,GO:0071484,1,0.98685936944985,0,2,cellular response to light intensity,BP,
16515,GO:0071485,1,0.992842792648331,0,1,cellular response to absence of light,BP,
16516,GO:0071486,1,0.993973780922755,0,1,cellular response to high light intensity,BP,
16517,GO:0071492,1,0.978604027142086,0,3,cellular response to UV-A,BP,
16518,GO:0071493,1,0.941447826565952,0,8,cellular response to UV-B,BP,
16519,GO:0071494,1,0.981395750626365,0,3,cellular response to UV-C,BP,
16522,GO:0071498,1,0.880989469830059,0,18,cellular response to fluid shear stress,BP,
16523,GO:0071499,1,0.948832076859166,0,7,cellular response to laminar fluid shear stress,BP,
16524,GO:0071500,1,0.956753944154364,0,6,cellular response to nitrosative stress,BP,
16525,GO:0071501,1,0.944216295868447,0,8,cellular response to sterol depletion,BP,
16526,GO:0071502,1,0.964647788404038,0,5,cellular response to temperature stimulus,BP,
16527,GO:0071503,1,0.966538813831868,0,5,response to heparin,BP,
16528,GO:0071504,1,0.97412786356606,0,4,cellular response to heparin,BP,
16529,GO:0071505,1,0.98522114217756,0,2,response to mycophenolic acid,BP,
16530,GO:0071506,1,0.98522114217756,0,2,cellular response to mycophenolic acid,BP,
16531,GO:0071514,1,0.837558770147221,0,25,genetic imprinting,BP,
16532,GO:0071515,1,0.992294630214608,0,1,genetic imprinting at mating-type locus,BP,
16533,GO:0071516,1,0.992294630214608,0,1,establishment of imprinting at mating-type locus,BP,
16534,GO:0071526,1,0.86018726940353,0,23,semaphorin-plexin signaling pathway,BP,
16535,GO:0071527,1,0.992230290634377,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16536,GO:0071528,1,0.993418992682899,0,1,tRNA re-export from nucleus,BP,
16537,GO:0071529,1,0.992304354646868,0,1,cementum mineralization,BP,
16538,GO:0071532,1,0.967214476511824,0,5,ankyrin repeat binding,MF,
16539,GO:0071535,1,0.971596318844802,0,4,RING-like zinc finger domain binding,MF,
16540,GO:0071538,1,0.992216941255385,0,1,SH2 domain-mediated complex assembly,BP,
16541,GO:0071539,1,0.854509947648094,0,23,protein localization to centrosome,BP,
16542,GO:0071540,1,0.993976951345834,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16543,GO:0071541,1,0.948610494556489,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16544,GO:0071542,1,0.762962346492966,0,37,dopaminergic neuron differentiation,BP,
16545,GO:0071543,1,0.97080956241711,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16546,GO:0071544,1,0.992170027168696,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16547,GO:0071545,1,0.927447209613722,0,11,inositol phosphate catabolic process,BP,
16548,GO:0071546,1,0.951691299338684,0,7,pi-body,CC,
16549,GO:0071547,1,0.964085430426158,0,5,piP-body,CC,
16554,GO:0071554,1,0.961454084583516,0,5,cell wall organization or biogenesis,BP,
16555,GO:0071556,1,0.807583033434649,0,28,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16556,GO:0071557,1,0.976108288995522,0,4,histone H3-K27 demethylation,BP,
16557,GO:0071558,1,0.976108288995522,0,4,histone demethylase activity (H3-K27 specific),MF,
16560,GO:0071561,1,0.993951650937981,0,1,nucleus-vacuole junction,CC,
16561,GO:0071564,1,0.919794109837435,0,12,npBAF complex,CC,
16562,GO:0071565,1,0.907984693960003,0,14,nBAF complex,CC,
16563,GO:0071566,1,0.992530079883644,0,1,UFM1 activating enzyme activity,MF,
16564,GO:0071567,1,0.984462850941664,0,2,UFM1 hydrolase activity,MF,
16565,GO:0071568,1,0.984524522725182,0,2,UFM1 transferase activity,MF,
16566,GO:0071569,1,0.954528593331483,0,6,protein ufmylation,BP,
16567,GO:0071573,1,0.992519404241984,0,1,shelterin complex assembly,BP,
16568,GO:0071575,1,0.993154409191705,0,1,integral component of external side of plasma membrane,CC,
16569,GO:0071577,1,0.845079256106756,0,23,zinc II ion transmembrane transport,BP,
16570,GO:0071578,1,0.943370646872776,0,8,zinc II ion transmembrane import,BP,
16571,GO:0071579,1,0.984694121000709,0,2,regulation of zinc ion transport,BP,
16572,GO:0071580,1,0.992177940775553,0,1,regulation of zinc ion transmembrane transport,BP,
16573,GO:0071581,1,0.992177940775553,0,1,regulation of zinc ion transmembrane import,BP,
16574,GO:0071582,1,0.992177940775553,0,1,negative regulation of zinc ion transport,BP,
16575,GO:0071583,1,0.992177940775553,0,1,negative regulation of zinc ion transmembrane transport,BP,
16576,GO:0071584,1,0.992177940775553,0,1,negative regulation of zinc ion transmembrane import,BP,
16577,GO:0071585,1,0.992177940775553,0,1,detoxification of cadmium ion,BP,
16578,GO:0071586,1,0.977226637717771,0,3,CAAX-box protein processing,BP,
16579,GO:0071593,1,0.97848431382072,0,3,lymphocyte aggregation,BP,
16580,GO:0071595,1,0.984648173044371,0,2,Nem1-Spo7 phosphatase complex,CC,
16581,GO:0071596,1,0.982056407333058,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16582,GO:0071598,1,0.978568976256443,0,3,neuronal ribonucleoprotein granule,CC,
16583,GO:0071599,1,0.899759214105625,0,15,otic vesicle development,BP,
16584,GO:0071600,1,0.930704051383667,0,10,otic vesicle morphogenesis,BP,
16585,GO:0071602,1,0.993759557162157,0,1,phytosphingosine biosynthetic process,BP,
16586,GO:0071603,1,0.972270318374923,0,4,endothelial cell-cell adhesion,BP,
16587,GO:0071604,1,0.82019876481063,0,28,transforming growth factor beta production,BP,
16588,GO:0071605,1,0.914769372051353,0,12,monocyte chemotactic protein-1 production,BP,
16589,GO:0071608,1,0.98581695142696,0,2,macrophage inflammatory protein-1 alpha production,BP,
16590,GO:0071609,1,0.943971893699697,0,8,chemokine (C-C motif) ligand 5 production,BP,
16591,GO:0071611,1,0.977134464025206,0,3,granulocyte colony-stimulating factor production,BP,
16592,GO:0071612,1,0.993986332292115,0,1,IP-10 production,BP,
16593,GO:0071613,1,0.984506276724662,0,2,granzyme B production,BP,
16594,GO:0071614,1,0.992171504980013,0,1,linoleic acid epoxygenase activity,MF,
16595,GO:0071615,1,0.992686091348552,0,1,oxidative deethylation,BP,
16597,GO:0071617,1,0.890084191102298,0,17,lysophospholipid acyltransferase activity,MF,
16598,GO:0071619,1,0.992209909548993,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16599,GO:0071621,1,0.453350473600288,0,105,granulocyte chemotaxis,BP,
16600,GO:0071622,1,0.698519862715655,0,47,regulation of granulocyte chemotaxis,BP,
16601,GO:0071623,1,0.986281928332626,0,2,negative regulation of granulocyte chemotaxis,BP,
16602,GO:0071624,1,0.797849199882194,0,29,positive regulation of granulocyte chemotaxis,BP,
16603,GO:0071625,1,0.895804646646215,0,17,vocalization behavior,BP,
16604,GO:0071626,1,0.984400887816991,0,2,mastication,BP,
16605,GO:0071629,1,0.992170027168696,0,1,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome,BP,
16606,GO:0071630,1,0.980391031661782,0,3,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome,BP,
16607,GO:0071633,1,0.984686971930866,0,2,dihydroceramidase activity,MF,
16608,GO:0071634,1,0.825291288172649,0,27,regulation of transforming growth factor beta production,BP,
16609,GO:0071635,1,0.952039524284168,0,7,negative regulation of transforming growth factor beta production,BP,
16610,GO:0071636,1,0.883193420165644,0,17,positive regulation of transforming growth factor beta production,BP,
16611,GO:0071637,1,0.914769372051353,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16612,GO:0071638,1,0.964056514409178,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16613,GO:0071639,1,0.948889495838372,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16614,GO:0071640,1,0.98581695142696,0,2,regulation of macrophage inflammatory protein 1 alpha production,BP,
16615,GO:0071641,1,0.993054237388747,0,1,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16616,GO:0071642,1,0.992712489432679,0,1,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16617,GO:0071649,1,0.951424404726544,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
16618,GO:0071650,1,0.984486354406252,0,2,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16619,GO:0071651,1,0.96642108922393,0,5,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16620,GO:0071655,1,0.977134464025206,0,3,regulation of granulocyte colony-stimulating factor production,BP,
16621,GO:0071656,1,0.992220015278462,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16622,GO:0071657,1,0.9847970834031,0,2,positive regulation of granulocyte colony-stimulating factor production,BP,
16623,GO:0071658,1,0.993986332292115,0,1,regulation of IP-10 production,BP,
16624,GO:0071660,1,0.993986332292115,0,1,positive regulation of IP-10 production,BP,
16625,GO:0071661,1,0.984506276724662,0,2,regulation of granzyme B production,BP,
16626,GO:0071663,1,0.984506276724662,0,2,positive regulation of granzyme B production,BP,
16627,GO:0071664,1,0.979535416628645,0,3,catenin-TCF7L2 complex,CC,
16628,GO:0071665,1,0.992918328244532,0,1,gamma-catenin-TCF7L2 complex,CC,
16629,GO:0071670,1,0.944673028437507,0,8,smooth muscle cell chemotaxis,BP,
16630,GO:0071671,1,0.957408582754215,0,6,regulation of smooth muscle cell chemotaxis,BP,
16631,GO:0071672,1,0.970776089367003,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16632,GO:0071673,1,0.978510238771509,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16633,GO:0071674,1,0.557769576528293,0,77,mononuclear cell migration,BP,
16634,GO:0071675,1,0.742012242977423,0,40,regulation of mononuclear cell migration,BP,
16635,GO:0071676,1,0.958934569238726,0,6,negative regulation of mononuclear cell migration,BP,
16636,GO:0071677,1,0.845113966223008,0,22,positive regulation of mononuclear cell migration,BP,
16637,GO:0071678,1,0.993986332274051,0,1,olfactory bulb axon guidance,BP,
16638,GO:0071679,1,0.95412200467461,0,7,commissural neuron axon guidance,BP,
16639,GO:0071680,1,0.967534515964312,0,5,response to indole-3-methanol,BP,
16640,GO:0071681,1,0.967534515964312,0,5,cellular response to indole-3-methanol,BP,
16641,GO:0071682,1,0.866748060042186,0,19,endocytic vesicle lumen,CC,
16642,GO:0071684,1,0.992801682381572,0,1,organism emergence from protective structure,BP,
16643,GO:0071688,1,0.917681544946571,0,13,striated muscle myosin thick filament assembly,BP,
16644,GO:0071691,1,0.993986332270284,0,1,cardiac muscle thin filament assembly,BP,
16645,GO:0071692,1,0.959163913272134,0,6,protein localization to extracellular region,BP,
16646,GO:0071694,1,0.959163913272134,0,6,maintenance of protein location in extracellular region,BP,
16647,GO:0071695,1,0.694711760406165,0,53,anatomical structure maturation,BP,
16648,GO:0071696,1,0.891926862011563,0,16,ectodermal placode development,BP,
16649,GO:0071697,1,0.898884424866497,0,15,ectodermal placode morphogenesis,BP,
16650,GO:0071698,1,0.972211062263021,0,4,olfactory placode development,BP,
16651,GO:0071699,1,0.972211062263021,0,4,olfactory placode morphogenesis,BP,
16652,GO:0071701,1,0.993916791295257,0,1,regulation of MAPK export from nucleus,BP,
16657,GO:0071707,1,0.992170027168696,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16658,GO:0071709,1,0.827121866253239,0,28,membrane assembly,BP,
16659,GO:0071711,1,0.876163815130851,0,20,basement membrane organization,BP,
16660,GO:0071712,1,0.928700666955955,0,10,ER-associated misfolded protein catabolic process,BP,
16661,GO:0071714,1,0.993672074147847,0,1,icosanoid transmembrane transporter activity,MF,
16662,GO:0071715,1,0.716893305298047,0,45,icosanoid transport,BP,
16663,GO:0071723,1,0.928295699667232,0,10,lipopeptide binding,MF,
16664,GO:0071724,1,0.971590346025909,0,4,response to diacyl bacterial lipopeptide,BP,
16665,GO:0071725,1,0.977738063450656,0,3,response to triacyl bacterial lipopeptide,BP,
16666,GO:0071726,1,0.971590346025909,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16667,GO:0071727,1,0.977738063450656,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16668,GO:0071731,1,0.868611863898246,0,19,response to nitric oxide,BP,
16669,GO:0071732,1,0.887712668501866,0,16,cellular response to nitric oxide,BP,
16670,GO:0071733,1,0.977308253980296,0,3,transcriptional activation by promoter-enhancer looping,BP,
16671,GO:0071763,1,0.965000834431823,0,5,nuclear membrane organization,BP,
16672,GO:0071765,1,0.993664262378292,0,1,nuclear inner membrane organization,BP,
16673,GO:0071772,1,0.330204324107037,0,156,response to BMP,BP,
16674,GO:0071773,1,0.330204324107037,0,156,cellular response to BMP stimulus,BP,
16676,GO:0071782,1,0.891393064938919,0,16,endoplasmic reticulum tubular network,CC,
16677,GO:0071786,1,0.91779332123852,0,12,endoplasmic reticulum tubular network organization,BP,
16678,GO:0071787,1,0.969591733460144,0,4,endoplasmic reticulum tubular network formation,BP,
16679,GO:0071791,1,0.985484699213858,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16680,GO:0071796,1,0.992170027168696,0,1,K6-linked polyubiquitin binding,MF,
16681,GO:0071797,1,0.977816269061261,0,3,LUBAC complex,CC,
16682,GO:0071798,1,0.965314902850227,0,5,response to prostaglandin D,BP,
16683,GO:0071799,1,0.965314902850227,0,5,cellular response to prostaglandin D stimulus,BP,
16684,GO:0071800,1,0.869063419857656,0,20,podosome assembly,BP,
16685,GO:0071801,1,0.906448783602695,0,14,regulation of podosome assembly,BP,
16686,GO:0071802,1,0.993651371777928,0,1,negative regulation of podosome assembly,BP,
16687,GO:0071803,1,0.933099308562475,0,10,positive regulation of podosome assembly,BP,
16688,GO:0071804,1,0.260792855708013,0,189,cellular potassium ion transport,BP,
16689,GO:0071805,1,0.260792855708013,0,189,potassium ion transmembrane transport,BP,
16690,GO:0071806,1,0.638294904091587,0,60,protein transmembrane transport,BP,
16691,GO:0071812,1,0.984953695329397,0,2,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16692,GO:0071813,1,0.843390153882056,0,24,lipoprotein particle binding,MF,
16693,GO:0071814,1,0.843390153882056,0,24,protein-lipid complex binding,MF,
16694,GO:0071816,1,0.969223338211979,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16695,GO:0071817,1,0.963856601387409,0,5,MMXD complex,CC,
16696,GO:0071818,1,0.976873624327631,0,3,BAT3 complex,CC,
16697,GO:0071819,1,0.992170027168696,0,1,DUBm complex,CC,
16698,GO:0071820,1,0.992170027168696,0,1,N-box binding,MF,
16699,GO:0071821,1,0.993986332271311,0,1,FANCM-MHF complex,CC,
16701,GO:0071823,1,0.984400887813367,0,2,protein-carbohydrate complex subunit organization,BP,
16702,GO:0071824,1,0.147537885759913,0,256,protein-DNA complex subunit organization,BP,
16707,GO:0071837,1,0.884744541045079,0,17,HMG box domain binding,MF,
16708,GO:0071838,1,0.957237435766288,0,6,cell proliferation in bone marrow,BP,
16709,GO:0071839,1,0.96244236939769,0,5,apoptotic process in bone marrow,BP,
16711,GO:0071846,1,0.992170027168696,0,1,actin filament debranching,BP,
16712,GO:0071847,1,0.97190477592831,0,4,TNFSF11-mediated signaling pathway,BP,
16713,GO:0071848,1,0.984953695329397,0,2,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16714,GO:0071850,1,0.902738651623665,0,14,mitotic cell cycle arrest,BP,
16716,GO:0071863,1,0.957887243993986,0,6,regulation of cell proliferation in bone marrow,BP,
16717,GO:0071864,1,0.957887243993986,0,6,positive regulation of cell proliferation in bone marrow,BP,
16718,GO:0071865,1,0.963731460284908,0,5,regulation of apoptotic process in bone marrow,BP,
16719,GO:0071866,1,0.963731460284908,0,5,negative regulation of apoptotic process in bone marrow,BP,
16726,GO:0071873,1,0.979411036556538,0,3,response to norepinephrine,BP,
16727,GO:0071874,1,0.985337209421437,0,2,cellular response to norepinephrine stimulus,BP,
16728,GO:0071875,1,0.860630771408273,0,21,adrenergic receptor signaling pathway,BP,
16729,GO:0071877,1,0.960046849965201,0,6,regulation of adrenergic receptor signaling pathway,BP,
16730,GO:0071878,1,0.981490285483401,0,3,negative regulation of adrenergic receptor signaling pathway,BP,
16731,GO:0071879,1,0.979946170814018,0,3,positive regulation of adrenergic receptor signaling pathway,BP,
16732,GO:0071880,1,0.903027831631917,0,14,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16733,GO:0071881,1,0.993403246323917,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16734,GO:0071882,1,0.993403246323917,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16735,GO:0071883,1,0.972655345370639,0,4,activation of MAPK activity by adrenergic receptor signaling pathway,BP,
16736,GO:0071884,1,0.993986332266177,0,1,vitamin D receptor activator activity,MF,
16737,GO:0071885,1,0.984524522725182,0,2,N-terminal protein N-methyltransferase activity,MF,
16738,GO:0071886,1,0.986681238752632,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16740,GO:0071888,1,0.943534767985396,0,8,macrophage apoptotic process,BP,
16741,GO:0071889,1,0.852468415158567,0,23,14-3-3 protein binding,MF,
16742,GO:0071890,1,0.993969883031005,0,1,bicarbonate binding,MF,
16743,GO:0071893,1,0.992170392587755,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16744,GO:0071894,1,0.992973583141805,0,1,histone H2B conserved C-terminal lysine ubiquitination,BP,
16745,GO:0071895,1,0.977919215482416,0,3,odontoblast differentiation,BP,
16746,GO:0071896,1,0.976126801129739,0,4,protein localization to adherens junction,BP,
16748,GO:0071898,1,0.978209086065458,0,3,regulation of estrogen receptor binding,BP,
16749,GO:0071899,1,0.978209086065458,0,3,negative regulation of estrogen receptor binding,BP,
16753,GO:0071907,1,0.953939847048151,0,7,determination of digestive tract left/right asymmetry,BP,
16754,GO:0071908,1,0.99398046318514,0,1,determination of intestine left/right asymmetry,BP,
16755,GO:0071909,1,0.99398046318514,0,1,determination of stomach left/right asymmetry,BP,
16756,GO:0071910,1,0.961438448847015,0,6,determination of liver left/right asymmetry,BP,
16757,GO:0071914,1,0.993379242364611,0,1,prominosome,CC,
16758,GO:0071918,1,0.972272241352857,0,4,urea transmembrane transport,BP,
16759,GO:0071920,1,0.984614003735286,0,2,cleavage body,CC,
16760,GO:0071921,1,0.978529291580995,0,3,cohesin loading,BP,
16761,GO:0071922,1,0.978529291580995,0,3,regulation of cohesin loading,BP,
16762,GO:0071926,1,0.980119908508955,0,3,endocannabinoid signaling pathway,BP,
16763,GO:0071929,1,0.985032997939379,0,2,alpha-tubulin acetylation,BP,
16764,GO:0071930,1,0.980378605375644,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16765,GO:0071931,1,0.992170027168696,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16766,GO:0071933,1,0.946734181014214,0,8,Arp2/3 complex binding,MF,
16767,GO:0071934,1,0.971161017239651,0,4,thiamine transmembrane transport,BP,
16768,GO:0071936,1,0.948546251928324,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16769,GO:0071941,1,0.891791968366619,0,15,nitrogen cycle metabolic process,BP,
16770,GO:0071942,1,0.97909532361294,0,3,XPC complex,CC,
16772,GO:0071947,1,0.974555282738189,0,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16773,GO:0071949,1,0.885017389011897,0,17,FAD binding,MF,
16774,GO:0071951,1,0.99238991880095,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16775,GO:0071953,1,0.970132213767441,0,4,elastic fiber,CC,
16776,GO:0071954,1,0.99304012820112,0,1,chemokine (C-C motif) ligand 11 production,BP,
16778,GO:0071962,1,0.993126514482214,0,1,mitotic sister chromatid cohesion, centromeric,BP,
16779,GO:0071963,1,0.984401020315673,0,2,establishment or maintenance of cell polarity regulating cell shape,BP,
16780,GO:0071964,1,0.992170027168696,0,1,establishment of cell polarity regulating cell shape,BP,
16781,GO:0071971,1,0.949504071356226,0,7,extracellular exosome assembly,BP,
16782,GO:0071976,1,0.992845748945168,0,1,cell gliding,BP,
16783,GO:0071985,1,0.937192231806742,0,9,multivesicular body sorting pathway,BP,
16784,GO:0071986,1,0.954636346333855,0,6,Ragulator complex,CC,
16785,GO:0071987,1,0.97902779367156,0,3,WD40-repeat domain binding,MF,
16786,GO:0071997,1,0.993986332267598,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16788,GO:0072003,1,0.979315708211647,0,3,kidney rudiment formation,BP,
16789,GO:0072004,1,0.987045028388714,0,2,kidney field specification,BP,
16791,GO:0072007,1,0.949091446325483,0,7,mesangial cell differentiation,BP,
16792,GO:0072008,1,0.956581893339898,0,6,glomerular mesangial cell differentiation,BP,
16794,GO:0072010,1,0.851475074107396,0,23,glomerular epithelium development,BP,
16795,GO:0072011,1,0.976889904024083,0,3,glomerular endothelium development,BP,
16796,GO:0072012,1,0.842266091959453,0,24,glomerulus vasculature development,BP,
16798,GO:0072015,1,0.924363150215588,0,12,glomerular visceral epithelial cell development,BP,
16799,GO:0072016,1,0.992328661417844,0,1,glomerular parietal epithelial cell development,BP,
16800,GO:0072017,1,0.923962935674668,0,12,distal tubule development,BP,
16802,GO:0072021,1,0.972604699942748,0,4,ascending thin limb development,BP,
16803,GO:0072023,1,0.984443401170412,0,2,thick ascending limb development,BP,
16804,GO:0072024,1,0.992170027168696,0,1,macula densa development,BP,
16805,GO:0072025,1,0.964190536777322,0,5,distal convoluted tubule development,BP,
16806,GO:0072027,1,0.992285386866287,0,1,connecting tubule development,BP,
16807,GO:0072028,1,0.580370542968488,0,77,nephron morphogenesis,BP,
16808,GO:0072033,1,0.948874679866902,0,8,renal vesicle formation,BP,
16809,GO:0072034,1,0.979637168668983,0,3,renal vesicle induction,BP,
16810,GO:0072036,1,0.993288704834345,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16811,GO:0072038,1,0.95806993734224,0,6,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16812,GO:0072039,1,0.973234941875163,0,4,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16813,GO:0072040,1,0.973234941875163,0,4,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16814,GO:0072044,1,0.914856029538231,0,13,collecting duct development,BP,
16815,GO:0072046,1,0.992170027168696,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16816,GO:0072047,1,0.961676676581394,0,5,proximal/distal pattern formation involved in nephron development,BP,
16817,GO:0072048,1,0.934437389496125,0,9,renal system pattern specification,BP,
16818,GO:0072049,1,0.956902332684303,0,6,comma-shaped body morphogenesis,BP,
16819,GO:0072050,1,0.944049910019325,0,8,S-shaped body morphogenesis,BP,
16820,GO:0072051,1,0.992170027168696,0,1,juxtaglomerular apparatus development,BP,
16821,GO:0072053,1,0.986462664599549,0,2,renal inner medulla development,BP,
16822,GO:0072054,1,0.986462664599549,0,2,renal outer medulla development,BP,
16823,GO:0072055,1,0.993953270845104,0,1,renal cortex development,BP,
16824,GO:0072059,1,0.993953270845104,0,1,cortical collecting duct development,BP,
16825,GO:0072060,1,0.993441353959129,0,1,outer medullary collecting duct development,BP,
16826,GO:0072061,1,0.978291657796828,0,3,inner medullary collecting duct development,BP,
16827,GO:0072069,1,0.979315708211647,0,3,DCT cell differentiation,BP,
16828,GO:0072070,1,0.924238499660454,0,11,loop of Henle development,BP,
16829,GO:0072071,1,0.984403117354866,0,2,kidney interstitial fibroblast differentiation,BP,
16831,GO:0072074,1,0.87951167789653,0,18,kidney mesenchyme development,BP,
16832,GO:0072075,1,0.900385729628384,0,15,metanephric mesenchyme development,BP,
16833,GO:0072076,1,0.98756432213507,0,2,nephrogenic mesenchyme development,BP,
16834,GO:0072077,1,0.875848084013267,0,19,renal vesicle morphogenesis,BP,
16835,GO:0072078,1,0.595715949062962,0,73,nephron tubule morphogenesis,BP,
16836,GO:0072079,1,0.86954776392579,0,19,nephron tubule formation,BP,
16838,GO:0072081,1,0.961676676581394,0,5,specification of nephron tubule identity,BP,
16839,GO:0072086,1,0.969265664906163,0,4,specification of loop of Henle identity,BP,
16840,GO:0072087,1,0.868985109779142,0,20,renal vesicle development,BP,
16841,GO:0072088,1,0.587709376095963,0,75,nephron epithelium morphogenesis,BP,
16842,GO:0072089,1,0.475096999977342,0,106,stem cell proliferation,BP,
16843,GO:0072091,1,0.661386985681222,0,58,regulation of stem cell proliferation,BP,
16844,GO:0072092,1,0.982048120265849,0,3,ureteric bud invasion,BP,
16845,GO:0072093,1,0.975456374788475,0,4,metanephric renal vesicle formation,BP,
16846,GO:0072095,1,0.971243182852568,0,4,regulation of branch elongation involved in ureteric bud branching,BP,
16847,GO:0072096,1,0.992170392587755,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16848,GO:0072097,1,0.992170392587755,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16849,GO:0072098,1,0.984403479935557,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16850,GO:0072099,1,0.992170392587755,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16851,GO:0072100,1,0.992170392587755,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16852,GO:0072101,1,0.992170392587755,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16853,GO:0072102,1,0.948186786787695,0,8,glomerulus morphogenesis,BP,
16854,GO:0072103,1,0.966777304954145,0,5,glomerulus vasculature morphogenesis,BP,
16855,GO:0072104,1,0.966777304954145,0,5,glomerular capillary formation,BP,
16856,GO:0072106,1,0.971447005049466,0,4,regulation of ureteric bud formation,BP,
16857,GO:0072107,1,0.971447005049466,0,4,positive regulation of ureteric bud formation,BP,
16858,GO:0072108,1,0.972896665910041,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16859,GO:0072109,1,0.896129718722473,0,15,glomerular mesangium development,BP,
16860,GO:0072110,1,0.929773680492405,0,10,glomerular mesangial cell proliferation,BP,
16861,GO:0072111,1,0.863071502494407,0,20,cell proliferation involved in kidney development,BP,
16862,GO:0072112,1,0.8776568937977,0,19,glomerular visceral epithelial cell differentiation,BP,
16863,GO:0072114,1,0.986452232265023,0,2,pronephros morphogenesis,BP,
16864,GO:0072124,1,0.935401844038766,0,9,regulation of glomerular mesangial cell proliferation,BP,
16865,GO:0072125,1,0.970777966931272,0,4,negative regulation of glomerular mesangial cell proliferation,BP,
16866,GO:0072126,1,0.963567283740993,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16867,GO:0072127,1,0.992207732189552,0,1,renal capsule development,BP,
16868,GO:0072128,1,0.992207732189552,0,1,renal capsule morphogenesis,BP,
16869,GO:0072129,1,0.992207732189552,0,1,renal capsule formation,BP,
16870,GO:0072130,1,0.992207732189552,0,1,renal capsule specification,BP,
16871,GO:0072131,1,0.972218216446459,0,4,kidney mesenchyme morphogenesis,BP,
16872,GO:0072132,1,0.719525425878862,0,46,mesenchyme morphogenesis,BP,
16873,GO:0072133,1,0.972218216446459,0,4,metanephric mesenchyme morphogenesis,BP,
16874,GO:0072134,1,0.98756432213507,0,2,nephrogenic mesenchyme morphogenesis,BP,
16875,GO:0072135,1,0.978979358770951,0,3,kidney mesenchymal cell proliferation,BP,
16876,GO:0072136,1,0.978979358770951,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16877,GO:0072137,1,0.974363765359473,0,4,condensed mesenchymal cell proliferation,BP,
16878,GO:0072138,1,0.977261344152938,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16879,GO:0072139,1,0.978138648281976,0,3,glomerular parietal epithelial cell differentiation,BP,
16880,GO:0072141,1,0.984403117354866,0,2,renal interstitial fibroblast development,BP,
16881,GO:0072143,1,0.956390350648394,0,6,mesangial cell development,BP,
16882,GO:0072144,1,0.963937948972624,0,5,glomerular mesangial cell development,BP,
16883,GO:0072148,1,0.895668692555553,0,15,epithelial cell fate commitment,BP,
16884,GO:0072156,1,0.981729897271037,0,3,distal tubule morphogenesis,BP,
16885,GO:0072160,1,0.903638537986992,0,15,nephron tubule epithelial cell differentiation,BP,
16886,GO:0072161,1,0.942663028584245,0,8,mesenchymal cell differentiation involved in kidney development,BP,
16887,GO:0072162,1,0.965023636828111,0,5,metanephric mesenchymal cell differentiation,BP,
16888,GO:0072163,1,0.499646819599198,0,98,mesonephric epithelium development,BP,
16889,GO:0072164,1,0.499646819599198,0,98,mesonephric tubule development,BP,
16890,GO:0072165,1,0.992172274168852,0,1,anterior mesonephric tubule development,BP,
16891,GO:0072166,1,0.98480543714246,0,2,posterior mesonephric tubule development,BP,
16892,GO:0072167,1,0.992172274168852,0,1,specification of mesonephric tubule identity,BP,
16893,GO:0072168,1,0.992172274168852,0,1,specification of anterior mesonephric tubule identity,BP,
16894,GO:0072169,1,0.992172274168852,0,1,specification of posterior mesonephric tubule identity,BP,
16896,GO:0072171,1,0.629963036421893,0,65,mesonephric tubule morphogenesis,BP,
16897,GO:0072172,1,0.935590486676174,0,9,mesonephric tubule formation,BP,
16898,GO:0072173,1,0.933058266155988,0,10,metanephric tubule morphogenesis,BP,
16899,GO:0072174,1,0.959370842941388,0,6,metanephric tubule formation,BP,
16900,GO:0072175,1,0.40692113986566,0,128,epithelial tube formation,BP,
16901,GO:0072176,1,0.900295390351522,0,15,nephric duct development,BP,
16902,GO:0072177,1,0.94277537983621,0,8,mesonephric duct development,BP,
16903,GO:0072178,1,0.918453703849421,0,12,nephric duct morphogenesis,BP,
16904,GO:0072179,1,0.963528535569681,0,5,nephric duct formation,BP,
16905,GO:0072180,1,0.969334794572301,0,4,mesonephric duct morphogenesis,BP,
16906,GO:0072181,1,0.984650956525554,0,2,mesonephric duct formation,BP,
16907,GO:0072182,1,0.914650534690368,0,13,regulation of nephron tubule epithelial cell differentiation,BP,
16908,GO:0072183,1,0.985348209207773,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16909,GO:0072184,1,0.992172274168852,0,1,renal vesicle progenitor cell differentiation,BP,
16910,GO:0072185,1,0.984462159829927,0,2,metanephric cap development,BP,
16911,GO:0072186,1,0.984462159829927,0,2,metanephric cap morphogenesis,BP,
16912,GO:0072189,1,0.911930523821986,0,13,ureter development,BP,
16913,GO:0072190,1,0.977957168244111,0,3,ureter urothelium development,BP,
16914,GO:0072191,1,0.970474772971771,0,4,ureter smooth muscle development,BP,
16915,GO:0072192,1,0.992170392587755,0,1,ureter epithelial cell differentiation,BP,
16916,GO:0072193,1,0.970474772971771,0,4,ureter smooth muscle cell differentiation,BP,
16917,GO:0072194,1,0.978449969117772,0,3,kidney smooth muscle tissue development,BP,
16918,GO:0072195,1,0.992170027168696,0,1,kidney smooth muscle cell differentiation,BP,
16919,GO:0072197,1,0.978390459319565,0,3,ureter morphogenesis,BP,
16920,GO:0072198,1,0.976872148823632,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16921,GO:0072199,1,0.976872148823632,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16922,GO:0072200,1,0.992170392587755,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16923,GO:0072201,1,0.944504939521138,0,8,negative regulation of mesenchymal cell proliferation,BP,
16924,GO:0072202,1,0.83378880778104,0,26,cell differentiation involved in metanephros development,BP,
16925,GO:0072203,1,0.930912379286767,0,10,cell proliferation involved in metanephros development,BP,
16926,GO:0072204,1,0.986647576122904,0,2,cell-cell signaling involved in metanephros development,BP,
16927,GO:0072205,1,0.94773580298839,0,8,metanephric collecting duct development,BP,
16928,GO:0072206,1,0.992170027168696,0,1,metanephric juxtaglomerular apparatus development,BP,
16930,GO:0072208,1,0.986172509746046,0,2,metanephric smooth muscle tissue development,BP,
16931,GO:0072209,1,0.98490467773392,0,2,metanephric mesangial cell differentiation,BP,
16932,GO:0072210,1,0.756021812300311,0,40,metanephric nephron development,BP,
16933,GO:0072213,1,0.992207732189552,0,1,metanephric capsule development,BP,
16934,GO:0072214,1,0.993953270845104,0,1,metanephric cortex development,BP,
16935,GO:0072215,1,0.850159931935493,0,23,regulation of metanephros development,BP,
16936,GO:0072216,1,0.905756721687709,0,14,positive regulation of metanephros development,BP,
16937,GO:0072217,1,0.938035526575408,0,9,negative regulation of metanephros development,BP,
16938,GO:0072218,1,0.972604699942748,0,4,metanephric ascending thin limb development,BP,
16939,GO:0072219,1,0.993953270845104,0,1,metanephric cortical collecting duct development,BP,
16940,GO:0072221,1,0.964190536777322,0,5,metanephric distal convoluted tubule development,BP,
16941,GO:0072223,1,0.964606375151018,0,5,metanephric glomerular mesangium development,BP,
16942,GO:0072224,1,0.894233027250649,0,16,metanephric glomerulus development,BP,
16943,GO:0072227,1,0.992170027168696,0,1,metanephric macula densa development,BP,
16945,GO:0072233,1,0.984443401170412,0,2,metanephric thick ascending limb development,BP,
16947,GO:0072235,1,0.952593518390962,0,7,metanephric distal tubule development,BP,
16948,GO:0072236,1,0.966224349248851,0,5,metanephric loop of Henle development,BP,
16950,GO:0072239,1,0.943876010936586,0,8,metanephric glomerulus vasculature development,BP,
16951,GO:0072240,1,0.979315708211647,0,3,metanephric DCT cell differentiation,BP,
16953,GO:0072244,1,0.980124925952807,0,3,metanephric glomerular epithelium development,BP,
16954,GO:0072248,1,0.980124925952807,0,3,metanephric glomerular visceral epithelial cell differentiation,BP,
16955,GO:0072249,1,0.980124925952807,0,3,metanephric glomerular visceral epithelial cell development,BP,
16956,GO:0072254,1,0.98490467773392,0,2,metanephric glomerular mesangial cell differentiation,BP,
16957,GO:0072255,1,0.992476801254136,0,1,metanephric glomerular mesangial cell development,BP,
16958,GO:0072257,1,0.9563163780308,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16959,GO:0072258,1,0.992172274168852,0,1,metanephric interstitial fibroblast differentiation,BP,
16960,GO:0072259,1,0.992172274168852,0,1,metanephric interstitial fibroblast development,BP,
16961,GO:0072262,1,0.979393015518077,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16962,GO:0072265,1,0.992207732189552,0,1,metanephric capsule morphogenesis,BP,
16963,GO:0072266,1,0.992207732189552,0,1,metanephric capsule formation,BP,
16964,GO:0072267,1,0.992207732189552,0,1,metanephric capsule specification,BP,
16965,GO:0072268,1,0.969259072414795,0,4,pattern specification involved in metanephros development,BP,
16966,GO:0072272,1,0.984580467799597,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16967,GO:0072273,1,0.835297651452095,0,26,metanephric nephron morphogenesis,BP,
16968,GO:0072274,1,0.993986332264625,0,1,metanephric glomerular basement membrane development,BP,
16969,GO:0072275,1,0.980304215640026,0,3,metanephric glomerulus morphogenesis,BP,
16970,GO:0072276,1,0.980304215640026,0,3,metanephric glomerulus vasculature morphogenesis,BP,
16971,GO:0072277,1,0.980304215640026,0,3,metanephric glomerular capillary formation,BP,
16972,GO:0072278,1,0.972069076897462,0,4,metanephric comma-shaped body morphogenesis,BP,
16973,GO:0072282,1,0.946643110503397,0,8,metanephric nephron tubule morphogenesis,BP,
16974,GO:0072283,1,0.894069650233498,0,16,metanephric renal vesicle morphogenesis,BP,
16975,GO:0072284,1,0.959014538670286,0,6,metanephric S-shaped body morphogenesis,BP,
16976,GO:0072285,1,0.993288704834345,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16977,GO:0072286,1,0.992285386866287,0,1,metanephric connecting tubule development,BP,
16978,GO:0072287,1,0.993986332301412,0,1,metanephric distal tubule morphogenesis,BP,
16979,GO:0072289,1,0.973335727889982,0,4,metanephric nephron tubule formation,BP,
16980,GO:0072298,1,0.959796631420824,0,6,regulation of metanephric glomerulus development,BP,
16981,GO:0072299,1,0.992575496442136,0,1,negative regulation of metanephric glomerulus development,BP,
16982,GO:0072300,1,0.966977838979003,0,5,positive regulation of metanephric glomerulus development,BP,
16983,GO:0072301,1,0.985319121435063,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16984,GO:0072302,1,0.992575496442136,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16985,GO:0072303,1,0.992689771048506,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16986,GO:0072304,1,0.987045028388714,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16987,GO:0072305,1,0.987045028388714,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16988,GO:0072307,1,0.9563163780308,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16989,GO:0072308,1,0.993122517482038,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16990,GO:0072309,1,0.987045028388714,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16991,GO:0072310,1,0.917267704737581,0,13,glomerular epithelial cell development,BP,
16992,GO:0072311,1,0.870917248864988,0,20,glomerular epithelial cell differentiation,BP,
16993,GO:0072312,1,0.980124925952807,0,3,metanephric glomerular epithelial cell differentiation,BP,
16994,GO:0072313,1,0.980124925952807,0,3,metanephric glomerular epithelial cell development,BP,
16995,GO:0072318,1,0.959311942414246,0,6,clathrin coat disassembly,BP,
16996,GO:0072319,1,0.951821704152478,0,7,vesicle uncoating,BP,
16997,GO:0072320,1,0.985757949062914,0,2,volume-sensitive chloride channel activity,MF,
16998,GO:0072321,1,0.933338621034711,0,9,chaperone-mediated protein transport,BP,
17003,GO:0072334,1,0.984400946654247,0,2,UDP-galactose transmembrane transport,BP,
17004,GO:0072337,1,0.830249536858981,0,26,modified amino acid transport,BP,
17006,GO:0072340,1,0.992170041209416,0,1,cellular lactam catabolic process,BP,
17007,GO:0072341,1,0.616947941099809,0,67,modified amino acid binding,MF,
17008,GO:0072343,1,0.984402301603461,0,2,pancreatic stellate cell proliferation,BP,
17009,GO:0072344,1,0.99275639473849,0,1,rescue of stalled ribosome,BP,
17010,GO:0072345,1,0.972566355808945,0,4,NAADP-sensitive calcium-release channel activity,MF,
17011,GO:0072348,1,0.783021911000724,0,34,sulfur compound transport,BP,
17012,GO:0072349,1,0.879560618022022,0,18,modified amino acid transmembrane transporter activity,MF,
17014,GO:0072354,1,0.984644514034133,0,2,histone kinase activity (H3-T3 specific),MF,
17015,GO:0072355,1,0.984644514034133,0,2,histone H3-T3 phosphorylation,BP,
17016,GO:0072356,1,0.985999840143321,0,2,chromosome passenger complex localization to kinetochore,BP,
17017,GO:0072357,1,0.9545929654851,0,7,PTW/PP1 phosphatase complex,CC,
17020,GO:0072361,1,0.988008547491708,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
17021,GO:0072362,1,0.993986332275261,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17022,GO:0072363,1,0.993986332284718,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17023,GO:0072364,1,0.988008547495005,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17024,GO:0072365,1,0.99398633227858,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17025,GO:0072366,1,0.993986332284718,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17026,GO:0072367,1,0.974474562488985,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
17027,GO:0072368,1,0.98774545350053,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
17028,GO:0072369,1,0.986565749293948,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
17030,GO:0072377,1,0.992518227454839,0,1,blood coagulation, common pathway,BP,
17032,GO:0072379,1,0.976873624327631,0,3,ER membrane insertion complex,CC,
17033,GO:0072383,1,0.950614808528169,0,8,plus-end-directed vesicle transport along microtubule,BP,
17034,GO:0072384,1,0.632603836267382,0,66,organelle transport along microtubule,BP,
17035,GO:0072385,1,0.980060707914375,0,3,minus-end-directed organelle transport along microtubule,BP,
17036,GO:0072386,1,0.944895861892891,0,9,plus-end-directed organelle transport along microtubule,BP,
17037,GO:0072387,1,0.985633419236958,0,2,flavin adenine dinucleotide metabolic process,BP,
17038,GO:0072388,1,0.992175466744087,0,1,flavin adenine dinucleotide biosynthetic process,BP,
17039,GO:0072389,1,0.993406763692654,0,1,flavin adenine dinucleotide catabolic process,BP,
17040,GO:0072393,1,0.950028172440522,0,8,microtubule anchoring at microtubule organizing center,BP,
17041,GO:0072395,1,0.624771248762624,0,64,signal transduction involved in cell cycle checkpoint,BP,
17042,GO:0072396,1,0.958643457227389,0,6,response to cell cycle checkpoint signaling,BP,
17043,GO:0072401,1,0.628564934711841,0,63,signal transduction involved in DNA integrity checkpoint,BP,
17044,GO:0072402,1,0.958643457227389,0,6,response to DNA integrity checkpoint signaling,BP,
17045,GO:0072413,1,0.638258822672812,0,61,signal transduction involved in mitotic cell cycle checkpoint,BP,
17046,GO:0072414,1,0.993986332270971,0,1,response to mitotic cell cycle checkpoint signaling,BP,
17047,GO:0072422,1,0.628564934711841,0,63,signal transduction involved in DNA damage checkpoint,BP,
17048,GO:0072423,1,0.958643457227389,0,6,response to DNA damage checkpoint signaling,BP,
17049,GO:0072425,1,0.986591640687872,0,2,signal transduction involved in G2 DNA damage checkpoint,BP,
17050,GO:0072428,1,0.992171683206526,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
17051,GO:0072429,1,0.970281266977743,0,4,response to intra-S DNA damage checkpoint signaling,BP,
17052,GO:0072431,1,0.6430590568466,0,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
17053,GO:0072432,1,0.993986332270971,0,1,response to G1 DNA damage checkpoint signaling,BP,
17054,GO:0072434,1,0.986591640687872,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
17055,GO:0072487,1,0.971882038528634,0,4,MSL complex,CC,
17056,GO:0072488,1,0.874972679196279,0,18,ammonium transmembrane transport,BP,
17057,GO:0072492,1,0.992170193264521,0,1,host cell mitochondrial intermembrane space,CC,
17058,GO:0072497,1,0.949258464080941,0,8,mesenchymal stem cell differentiation,BP,
17059,GO:0072498,1,0.901367079698903,0,14,embryonic skeletal joint development,BP,
17060,GO:0072501,1,0.938691386218615,0,9,cellular divalent inorganic anion homeostasis,BP,
17061,GO:0072502,1,0.938691386218615,0,9,cellular trivalent inorganic anion homeostasis,BP,
17063,GO:0072505,1,0.919234686517167,0,12,divalent inorganic anion homeostasis,BP,
17064,GO:0072506,1,0.919234686517167,0,12,trivalent inorganic anion homeostasis,BP,
17066,GO:0072509,1,0.301373894420974,0,174,divalent inorganic cation transmembrane transporter activity,MF,
17067,GO:0072510,1,0.986433746082715,0,2,trivalent inorganic cation transmembrane transporter activity,MF,
17069,GO:0072512,1,0.757514478091454,0,38,trivalent inorganic cation transport,BP,
17070,GO:0072513,1,0.971486815144486,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
17071,GO:0072517,1,0.992990210383334,0,1,host cell viral assembly compartment,CC,
17072,GO:0072518,1,0.993986332267704,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17073,GO:0072520,1,0.933121652901197,0,10,seminiferous tubule development,BP,
17080,GO:0072527,1,0.565656474087193,0,75,pyrimidine-containing compound metabolic process,BP,
17081,GO:0072528,1,0.744128730062414,0,39,pyrimidine-containing compound biosynthetic process,BP,
17082,GO:0072529,1,0.787853700070016,0,31,pyrimidine-containing compound catabolic process,BP,
17083,GO:0072530,1,0.932866499779522,0,9,purine-containing compound transmembrane transport,BP,
17084,GO:0072531,1,0.902980430720312,0,14,pyrimidine-containing compound transmembrane transport,BP,
17085,GO:0072534,1,0.987991181091259,0,2,perineuronal net,CC,
17086,GO:0072535,1,0.977280430587035,0,3,tumor necrosis factor (ligand) superfamily member 11 production,BP,
17087,GO:0072536,1,0.984669010781884,0,2,interleukin-23 receptor complex,CC,
17088,GO:0072537,1,0.930343847625784,0,10,fibroblast activation,BP,
17089,GO:0072538,1,0.856011874524988,0,21,T-helper 17 type immune response,BP,
17090,GO:0072539,1,0.869011726167219,0,19,T-helper 17 cell differentiation,BP,
17091,GO:0072540,1,0.914214142538029,0,12,T-helper 17 cell lineage commitment,BP,
17092,GO:0072542,1,0.949867772820077,0,7,protein phosphatase activator activity,MF,
17093,GO:0072544,1,0.992170043221952,0,1,L-DOPA binding,MF,
17094,GO:0072545,1,0.984422358355966,0,2,tyrosine binding,MF,
17095,GO:0072546,1,0.870843890789432,0,18,ER membrane protein complex,CC,
17096,GO:0072553,1,0.960890724643788,0,6,terminal button organization,BP,
17097,GO:0072554,1,0.985221488713879,0,2,blood vessel lumenization,BP,
17098,GO:0072556,1,0.99364699972125,0,1,other organism presynaptic membrane,CC,
17102,GO:0072560,1,0.984911119925723,0,2,type B pancreatic cell maturation,BP,
17104,GO:0072563,1,0.984919795009318,0,2,endothelial microparticle,CC,
17105,GO:0072564,1,0.984413066896963,0,2,blood microparticle formation,BP,
17106,GO:0072566,1,0.984939506515982,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
17107,GO:0072567,1,0.926533291211154,0,10,chemokine (C-X-C motif) ligand 2 production,BP,
17108,GO:0072572,1,0.992189303436884,0,1,poly-ADP-D-ribose binding,MF,
17109,GO:0072573,1,0.993777749217608,0,1,tolerance induction to lipopolysaccharide,BP,
17110,GO:0072574,1,0.88297784380417,0,17,hepatocyte proliferation,BP,
17111,GO:0072575,1,0.88297784380417,0,17,epithelial cell proliferation involved in liver morphogenesis,BP,
17112,GO:0072576,1,0.872379410994432,0,19,liver morphogenesis,BP,
17113,GO:0072577,1,0.721770060530731,0,46,endothelial cell apoptotic process,BP,
17114,GO:0072578,1,0.947306058944966,0,8,neurotransmitter-gated ion channel clustering,BP,
17115,GO:0072579,1,0.993694182434192,0,1,glycine receptor clustering,BP,
17116,GO:0072583,1,0.669455460733193,0,59,clathrin-dependent endocytosis,BP,
17117,GO:0072584,1,0.930788083764671,0,10,caveolin-mediated endocytosis,BP,
17118,GO:0072586,1,0.993810353778897,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
17119,GO:0072587,1,0.993810353778897,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
17120,GO:0072588,1,0.961582118415242,0,5,box H/ACA RNP complex,CC,
17121,GO:0072589,1,0.969172561684693,0,4,box H/ACA scaRNP complex,CC,
17122,GO:0072590,1,0.988008547483513,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
17123,GO:0072591,1,0.993986332264625,0,1,citrate-L-glutamate ligase activity,MF,
17124,GO:0072592,1,0.963324924233126,0,5,oxygen metabolic process,BP,
17127,GO:0072595,1,0.805809474046756,0,30,maintenance of protein localization in organelle,BP,
17128,GO:0072599,1,0.448488306704283,0,104,establishment of protein localization to endoplasmic reticulum,BP,
17129,GO:0072600,1,0.871047400308825,0,22,establishment of protein localization to Golgi,BP,
17130,GO:0072602,1,0.965006658009754,0,5,interleukin-4 secretion,BP,
17131,GO:0072603,1,0.956137466934236,0,6,interleukin-5 secretion,BP,
17135,GO:0072610,1,0.935799764247894,0,9,interleukin-12 secretion,BP,
17136,GO:0072611,1,0.941217387517984,0,8,interleukin-13 secretion,BP,
17137,GO:0072615,1,0.992190392480105,0,1,interleukin-17 secretion,BP,
17138,GO:0072616,1,0.993515278807207,0,1,interleukin-18 secretion,BP,
17139,GO:0072619,1,0.993115015893865,0,1,interleukin-21 secretion,BP,
17140,GO:0072641,1,0.977891113686213,0,3,type I interferon secretion,BP,
17141,GO:0072642,1,0.985315101367962,0,2,interferon-alpha secretion,BP,
17142,GO:0072643,1,0.882109912057128,0,17,interferon-gamma secretion,BP,
17143,GO:0072655,1,0.257293214395797,0,183,establishment of protein localization to mitochondrion,BP,
17144,GO:0072656,1,0.964835278717847,0,5,maintenance of protein location in mitochondrion,BP,
17145,GO:0072657,1,0.0267098665851449,0,493,protein localization to membrane,BP,
17146,GO:0072658,1,0.993986332284452,0,1,maintenance of protein location in membrane,BP,
17147,GO:0072659,1,0.223780386173782,0,212,protein localization to plasma membrane,BP,
17148,GO:0072660,1,0.993986332284452,0,1,maintenance of protein location in plasma membrane,BP,
17149,GO:0072661,1,0.848801882896098,0,24,protein targeting to plasma membrane,BP,
17150,GO:0072662,1,0.885615554763623,0,17,protein localization to peroxisome,BP,
17151,GO:0072663,1,0.885615554763623,0,17,establishment of protein localization to peroxisome,BP,
17152,GO:0072665,1,0.756547906776543,0,40,protein localization to vacuole,BP,
17153,GO:0072666,1,0.808559957795587,0,31,establishment of protein localization to vacuole,BP,
17154,GO:0072669,1,0.946857607825143,0,7,tRNA-splicing ligase complex,CC,
17155,GO:0072671,1,0.992290754690558,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17156,GO:0072672,1,0.959958575040001,0,6,neutrophil extravasation,BP,
17157,GO:0072673,1,0.908138445929206,0,14,lamellipodium morphogenesis,BP,
17158,GO:0072674,1,0.972839391810523,0,4,multinuclear osteoclast differentiation,BP,
17159,GO:0072675,1,0.980394861104987,0,3,osteoclast fusion,BP,
17161,GO:0072677,1,0.891744007382562,0,15,eosinophil migration,BP,
17163,GO:0072679,1,0.962689736019067,0,5,thymocyte migration,BP,
17164,GO:0072680,1,0.99270550262398,0,1,extracellular matrix-dependent thymocyte migration,BP,
17165,GO:0072681,1,0.99270550262398,0,1,fibronectin-dependent thymocyte migration,BP,
17166,GO:0072682,1,0.992961501433465,0,1,eosinophil extravasation,BP,
17168,GO:0072684,1,0.993360271306729,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17169,GO:0072686,1,0.634855794814458,0,65,mitotic spindle,CC,
17170,GO:0072687,1,0.941182912091308,0,8,meiotic spindle,CC,
17171,GO:0072695,1,0.98473665948274,0,2,regulation of DNA recombination at telomere,BP,
17172,GO:0072697,1,0.984922544275273,0,2,protein localization to cell cortex,BP,
17173,GO:0072698,1,0.796539298456207,0,33,protein localization to microtubule cytoskeleton,BP,
17174,GO:0072702,1,0.993985868169838,0,1,response to methyl methanesulfonate,BP,
17175,GO:0072703,1,0.993985868169838,0,1,cellular response to methyl methanesulfonate,BP,
17176,GO:0072706,1,0.992298587813926,0,1,response to sodium dodecyl sulfate,BP,
17177,GO:0072707,1,0.992298587813926,0,1,cellular response to sodium dodecyl sulfate,BP,
17178,GO:0072708,1,0.970441496495783,0,4,response to sorbitol,BP,
17179,GO:0072709,1,0.985518154036934,0,2,cellular response to sorbitol,BP,
17180,GO:0072710,1,0.954401451806906,0,7,response to hydroxyurea,BP,
17181,GO:0072711,1,0.961814837242281,0,6,cellular response to hydroxyurea,BP,
17182,GO:0072714,1,0.992170136445051,0,1,response to selenite ion,BP,
17183,GO:0072715,1,0.992170136445051,0,1,cellular response to selenite ion,BP,
17184,GO:0072716,1,0.97107351082039,0,4,response to actinomycin D,BP,
17185,GO:0072717,1,0.978615372609337,0,3,cellular response to actinomycin D,BP,
17186,GO:0072718,1,0.939155130841813,0,9,response to cisplatin,BP,
17187,GO:0072719,1,0.958721279191501,0,6,cellular response to cisplatin,BP,
17188,GO:0072720,1,0.984648173044371,0,2,response to dithiothreitol,BP,
17189,GO:0072721,1,0.992294630214608,0,1,cellular response to dithiothreitol,BP,
17190,GO:0072733,1,0.969363655027553,0,4,response to staurosporine,BP,
17191,GO:0072734,1,0.969363655027553,0,4,cellular response to staurosporine,BP,
17192,GO:0072737,1,0.984554985019983,0,2,response to diamide,BP,
17193,GO:0072738,1,0.984554985019983,0,2,cellular response to diamide,BP,
17194,GO:0072739,1,0.992294630214608,0,1,response to anisomycin,BP,
17195,GO:0072750,1,0.992170027168696,0,1,cellular response to leptomycin B,BP,
17196,GO:0072752,1,0.993986332268602,0,1,cellular response to rapamycin,BP,
17197,GO:0072755,1,0.993307573030982,0,1,cellular response to benomyl,BP,
17198,GO:0072757,1,0.979415703663523,0,3,cellular response to camptothecin,BP,
17199,GO:0075136,1,0.957491572215181,0,6,response to host,BP,
17200,GO:0075509,1,0.979151165061539,0,3,endocytosis involved in viral entry into host cell,BP,
17201,GO:0075519,1,0.992170027168696,0,1,microtubule-dependent intracellular transport of viral material,BP,
17202,GO:0075521,1,0.992170027168696,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17203,GO:0075522,1,0.949731211193203,0,7,IRES-dependent viral translational initiation,BP,
17204,GO:0075525,1,0.963651350726831,0,5,viral translational termination-reinitiation,BP,
17205,GO:0075528,1,0.984428143151737,0,2,modulation by virus of host immune response,BP,
17206,GO:0075606,1,0.992170027168696,0,1,transport of viral material towards nucleus,BP,
17207,GO:0075713,1,0.941916045948761,0,8,establishment of integrated proviral latency,BP,
17208,GO:0075732,1,0.987824514793867,0,2,viral penetration into host nucleus,BP,
17209,GO:0075733,1,0.628802847152656,0,65,intracellular transport of virus,BP,
17210,GO:0080008,1,0.834970509023946,0,26,Cul4-RING E3 ubiquitin ligase complex,CC,
17211,GO:0080009,1,0.970734546206334,0,4,mRNA methylation,BP,
17212,GO:0080019,1,0.986206153470563,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17213,GO:0080025,1,0.870928201083321,0,20,phosphatidylinositol-3,5-bisphosphate binding,MF,
17214,GO:0080033,1,0.993986332267178,0,1,response to nitrite,BP,
17215,GO:0080048,1,0.992294630214608,0,1,GDP-D-glucose phosphorylase activity,MF,
17216,GO:0080058,1,0.992170027168696,0,1,protein deglutathionylation,BP,
17217,GO:0080084,1,0.966823054002486,0,5,5S rDNA binding,MF,
17219,GO:0080101,1,0.992170027168696,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17220,GO:0080111,1,0.875958891144719,0,18,DNA demethylation,BP,
17221,GO:0080120,1,0.977226637717771,0,3,CAAX-box protein maturation,BP,
17222,GO:0080121,1,0.984956409798264,0,2,AMP transport,BP,
17223,GO:0080122,1,0.984956409798264,0,2,AMP transmembrane transporter activity,MF,
17224,GO:0080129,1,0.992170027168696,0,1,proteasome core complex assembly,BP,
17225,GO:0080130,1,0.977019325461579,0,3,L-phenylalanine:2-oxoglutarate aminotransferase activity,MF,
17226,GO:0080132,1,0.992247450179394,0,1,fatty acid alpha-hydroxylase activity,MF,
17229,GO:0080144,1,0.992172190195043,0,1,amino acid homeostasis,BP,
17230,GO:0080146,1,0.992170154337142,0,1,L-cysteine desulfhydrase activity,MF,
17231,GO:0080147,1,0.992170027168696,0,1,root hair cell development,BP,
17232,GO:0080154,1,0.827607413897566,0,25,regulation of fertilization,BP,
17233,GO:0080163,1,0.992237823319469,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17235,GO:0080182,1,0.917110740214593,0,13,histone H3-K4 trimethylation,BP,
17236,GO:0080184,1,0.962130822411955,0,5,response to phenylpropanoid,BP,
17237,GO:0085018,1,0.992392335882293,0,1,maintenance of symbiont-containing vacuole by host,BP,
17238,GO:0085020,1,0.949413079289025,0,7,protein K6-linked ubiquitination,BP,
17239,GO:0085029,1,0.817713907033269,0,29,extracellular matrix assembly,BP,
17240,GO:0085032,1,0.99282902982915,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17241,GO:0086001,1,0.648490028928964,0,64,cardiac muscle cell action potential,BP,
17242,GO:0086002,1,0.727717100668454,0,47,cardiac muscle cell action potential involved in contraction,BP,
17243,GO:0086003,1,0.679595956209173,0,57,cardiac muscle cell contraction,BP,
17244,GO:0086004,1,0.791983572106968,0,35,regulation of cardiac muscle cell contraction,BP,
17245,GO:0086005,1,0.814436165132426,0,30,ventricular cardiac muscle cell action potential,BP,
17246,GO:0086006,1,0.968258841821647,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17247,GO:0086007,1,0.96938274378839,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17248,GO:0086008,1,0.92156887673401,0,11,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
17249,GO:0086009,1,0.752906406742526,0,40,membrane repolarization,BP,
17250,GO:0086010,1,0.733587494632486,0,48,membrane depolarization during action potential,BP,
17251,GO:0086011,1,0.846810703693311,0,23,membrane repolarization during action potential,BP,
17252,GO:0086012,1,0.867265920968314,0,22,membrane depolarization during cardiac muscle cell action potential,BP,
17253,GO:0086013,1,0.865648416046635,0,20,membrane repolarization during cardiac muscle cell action potential,BP,
17254,GO:0086014,1,0.886553686234352,0,18,atrial cardiac muscle cell action potential,BP,
17255,GO:0086015,1,0.944492233765042,0,9,SA node cell action potential,BP,
17256,GO:0086016,1,0.937713208313766,0,10,AV node cell action potential,BP,
17257,GO:0086017,1,0.972723661137986,0,4,Purkinje myocyte action potential,BP,
17258,GO:0086018,1,0.944492233765042,0,9,SA node cell to atrial cardiac muscle cell signalling,BP,
17259,GO:0086019,1,0.822899831214608,0,29,cell-cell signaling involved in cardiac conduction,BP,
17260,GO:0086020,1,0.986747881782978,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17261,GO:0086021,1,0.986747881782978,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17262,GO:0086023,1,0.960939393781358,0,6,adrenergic receptor signaling pathway involved in heart process,BP,
17263,GO:0086024,1,0.993986332276106,0,1,adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17264,GO:0086026,1,0.886553686234352,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17265,GO:0086027,1,0.937713208313766,0,10,AV node cell to bundle of His cell signaling,BP,
17266,GO:0086028,1,0.953242365743044,0,7,bundle of His cell to Purkinje myocyte signaling,BP,
17267,GO:0086029,1,0.959487712137488,0,6,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
17268,GO:0086030,1,0.99218000033121,0,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
17270,GO:0086037,1,0.993117517438821,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17271,GO:0086039,1,0.993986332276659,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17272,GO:0086040,1,0.993837205558125,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17273,GO:0086041,1,0.993986332271733,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17274,GO:0086042,1,0.95455405385582,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
17275,GO:0086043,1,0.953242365743044,0,7,bundle of His cell action potential,BP,
17276,GO:0086044,1,0.992718098684504,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
17277,GO:0086045,1,0.969553928194835,0,5,membrane depolarization during AV node cell action potential,BP,
17278,GO:0086046,1,0.970288372608949,0,5,membrane depolarization during SA node cell action potential,BP,
17279,GO:0086047,1,0.979860035638189,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17280,GO:0086048,1,0.981068467254436,0,3,membrane depolarization during bundle of His cell action potential,BP,
17281,GO:0086050,1,0.992463354401324,0,1,membrane repolarization during bundle of His cell action potential,BP,
17282,GO:0086052,1,0.992463354401324,0,1,membrane repolarization during SA node cell action potential,BP,
17283,GO:0086053,1,0.986747881782978,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
17284,GO:0086054,1,0.992718098684504,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
17285,GO:0086055,1,0.992718098684504,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
17286,GO:0086056,1,0.981735458465689,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17287,GO:0086057,1,0.993393521267291,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17288,GO:0086059,1,0.988008547479509,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17289,GO:0086060,1,0.993986332277843,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17290,GO:0086061,1,0.993986332277843,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17291,GO:0086062,1,0.986203080785462,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17292,GO:0086063,1,0.993986332277843,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17293,GO:0086064,1,0.852661939281979,0,23,cell communication by electrical coupling involved in cardiac conduction,BP,
17294,GO:0086065,1,0.700943128804199,0,52,cell communication involved in cardiac conduction,BP,
17295,GO:0086066,1,0.886553686234352,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17296,GO:0086067,1,0.932071283683424,0,11,AV node cell to bundle of His cell communication,BP,
17297,GO:0086068,1,0.959487712137488,0,6,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
17298,GO:0086069,1,0.910317831839164,0,14,bundle of His cell to Purkinje myocyte communication,BP,
17299,GO:0086070,1,0.938809840964199,0,10,SA node cell to atrial cardiac muscle cell communication,BP,
17300,GO:0086072,1,0.9922617590897,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17301,GO:0086073,1,0.962000490664623,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
17302,GO:0086075,1,0.979527430233668,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17303,GO:0086076,1,0.992718098684504,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
17304,GO:0086077,1,0.986747881782978,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17305,GO:0086078,1,0.992718098684504,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
17306,GO:0086079,1,0.992718098684504,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
17307,GO:0086080,1,0.930057170827787,0,11,protein binding involved in heterotypic cell-cell adhesion,MF,
17308,GO:0086082,1,0.9922617590897,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17309,GO:0086083,1,0.962000490664623,0,6,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
17310,GO:0086087,1,0.992463354401324,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17311,GO:0086089,1,0.970462318139519,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17312,GO:0086090,1,0.992463354401324,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17313,GO:0086091,1,0.794888523199892,0,34,regulation of heart rate by cardiac conduction,BP,
17314,GO:0086092,1,0.986055143160593,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17315,GO:0086097,1,0.986093117298033,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17316,GO:0086098,1,0.985951599838215,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17317,GO:0086100,1,0.987109991305116,0,2,endothelin receptor signaling pathway,BP,
17318,GO:0086103,1,0.940014044684491,0,9,G-protein coupled receptor signaling pathway involved in heart process,BP,
17319,GO:0089700,1,0.97337884395748,0,4,protein kinase D signaling,BP,
17320,GO:0089701,1,0.962271038333984,0,5,U2AF,CC,
17321,GO:0089709,1,0.98472618857339,0,2,L-histidine transmembrane transport,BP,
17323,GO:0089712,1,0.971168088421632,0,4,L-aspartate transmembrane transport,BP,
17324,GO:0089717,1,0.980816399306888,0,3,spanning component of membrane,CC,
17325,GO:0089718,1,0.993986332273392,0,1,amino acid import across plasma membrane,BP,
17327,GO:0090002,1,0.384392960980866,0,136,establishment of protein localization to plasma membrane,BP,
17328,GO:0090003,1,0.734176823550174,0,44,regulation of establishment of protein localization to plasma membrane,BP,
17329,GO:0090004,1,0.817438503627992,0,29,positive regulation of establishment of protein localization to plasma membrane,BP,
17330,GO:0090005,1,0.917333575003919,0,12,negative regulation of establishment of protein localization to plasma membrane,BP,
17331,GO:0090009,1,0.923161627688847,0,11,primitive streak formation,BP,
17332,GO:0090010,1,0.992183386879296,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17333,GO:0090022,1,0.78772507199085,0,31,regulation of neutrophil chemotaxis,BP,
17334,GO:0090023,1,0.816919608101169,0,26,positive regulation of neutrophil chemotaxis,BP,
17335,GO:0090024,1,0.986281928332626,0,2,negative regulation of neutrophil chemotaxis,BP,
17336,GO:0090025,1,0.847213132652055,0,22,regulation of monocyte chemotaxis,BP,
17337,GO:0090026,1,0.8778265287868,0,17,positive regulation of monocyte chemotaxis,BP,
17338,GO:0090027,1,0.972330357414761,0,4,negative regulation of monocyte chemotaxis,BP,
17339,GO:0090030,1,0.937809972112946,0,9,regulation of steroid hormone biosynthetic process,BP,
17340,GO:0090031,1,0.97852836156991,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17341,GO:0090032,1,0.964314930385896,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17342,GO:0090034,1,0.98582361325091,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17343,GO:0090035,1,0.98582361325091,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17344,GO:0090036,1,0.902129794791422,0,15,regulation of protein kinase C signaling,BP,
17345,GO:0090037,1,0.944319453450576,0,8,positive regulation of protein kinase C signaling,BP,
17346,GO:0090038,1,0.986158581034766,0,2,negative regulation of protein kinase C signaling,BP,
17347,GO:0090042,1,0.951425748601515,0,7,tubulin deacetylation,BP,
17348,GO:0090043,1,0.965107187008675,0,5,regulation of tubulin deacetylation,BP,
17349,GO:0090044,1,0.992170027168696,0,1,positive regulation of tubulin deacetylation,BP,
17350,GO:0090045,1,0.950851155510681,0,7,positive regulation of deacetylase activity,BP,
17351,GO:0090049,1,0.873770154476742,0,19,regulation of cell migration involved in sprouting angiogenesis,BP,
17352,GO:0090050,1,0.951795310743263,0,7,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17353,GO:0090051,1,0.924704861581221,0,11,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17354,GO:0090063,1,0.972513185260207,0,4,positive regulation of microtubule nucleation,BP,
17355,GO:0090065,1,0.993518782405315,0,1,regulation of production of siRNA involved in RNA interference,BP,
17357,GO:0090068,1,0.168511453865789,0,246,positive regulation of cell cycle process,BP,
17358,GO:0090069,1,0.932325153526778,0,10,regulation of ribosome biogenesis,BP,
17359,GO:0090070,1,0.958207339953861,0,6,positive regulation of ribosome biogenesis,BP,
17360,GO:0090071,1,0.972997838369112,0,4,negative regulation of ribosome biogenesis,BP,
17361,GO:0090073,1,0.942961477384592,0,8,positive regulation of protein homodimerization activity,BP,
17362,GO:0090074,1,0.966454004110704,0,5,negative regulation of protein homodimerization activity,BP,
17363,GO:0090075,1,0.81426872466849,0,29,relaxation of muscle,BP,
17364,GO:0090076,1,0.987104224733402,0,2,relaxation of skeletal muscle,BP,
17366,GO:0090079,1,0.870260146793142,0,20,translation regulator activity, nucleic acid binding,MF,
17367,GO:0090080,1,0.967109408658754,0,5,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17368,GO:0090081,1,0.984401445146774,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17369,GO:0090082,1,0.984401445146774,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17370,GO:0090083,1,0.888675469563188,0,16,regulation of inclusion body assembly,BP,
17371,GO:0090084,1,0.921551495696913,0,11,negative regulation of inclusion body assembly,BP,
17372,GO:0090085,1,0.943629691464378,0,8,regulation of protein deubiquitination,BP,
17373,GO:0090086,1,0.976695639859482,0,3,negative regulation of protein deubiquitination,BP,
17375,GO:0090088,1,0.984567847130588,0,2,regulation of oligopeptide transport,BP,
17376,GO:0090089,1,0.984567847130588,0,2,regulation of dipeptide transport,BP,
17378,GO:0090091,1,0.967532392062221,0,5,positive regulation of extracellular matrix disassembly,BP,
17379,GO:0090092,1,0.228399549397747,0,206,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17380,GO:0090094,1,0.984462159829927,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17381,GO:0090095,1,0.992229531847434,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17382,GO:0090096,1,0.992229531847434,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17383,GO:0090100,1,0.491756802070531,0,99,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17384,GO:0090101,1,0.485249201054206,0,102,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17385,GO:0090102,1,0.72816257781003,0,45,cochlea development,BP,
17386,GO:0090103,1,0.847898076682045,0,23,cochlea morphogenesis,BP,
17387,GO:0090104,1,0.993053229935835,0,1,pancreatic epsilon cell differentiation,BP,
17388,GO:0090107,1,0.978492322169072,0,3,regulation of high-density lipoprotein particle assembly,BP,
17389,GO:0090108,1,0.992182213557173,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17390,GO:0090109,1,0.714683516587787,0,50,regulation of cell-substrate junction assembly,BP,
17391,GO:0090110,1,0.966722486709399,0,5,cargo loading into COPII-coated vesicle,BP,
17392,GO:0090113,1,0.992192824690033,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17393,GO:0090114,1,0.628458272291725,0,66,COPII-coated vesicle budding,BP,
17394,GO:0090116,1,0.98128138247584,0,3,C-5 methylation of cytosine,BP,
17395,GO:0090118,1,0.966303331616556,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17396,GO:0090119,1,0.986046253714748,0,2,vesicle-mediated cholesterol transport,BP,
17397,GO:0090122,1,0.992178006575987,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17398,GO:0090128,1,0.928781471922288,0,11,regulation of synapse maturation,BP,
17399,GO:0090129,1,0.947651671735778,0,8,positive regulation of synapse maturation,BP,
17401,GO:0090131,1,0.9626145897589,0,5,mesenchyme migration,BP,
17403,GO:0090133,1,0.992170027168696,0,1,mesendoderm migration,BP,
17404,GO:0090134,1,0.992170027168696,0,1,cell migration involved in mesendoderm migration,BP,
17405,GO:0090135,1,0.978505265309819,0,3,actin filament branching,BP,
17406,GO:0090136,1,0.902794571884086,0,15,epithelial cell-cell adhesion,BP,
17407,GO:0090138,1,0.993218440954526,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17408,GO:0090140,1,0.878558455578366,0,19,regulation of mitochondrial fission,BP,
17409,GO:0090141,1,0.918400336899455,0,12,positive regulation of mitochondrial fission,BP,
17410,GO:0090148,1,0.927883078869548,0,11,membrane fission,BP,
17411,GO:0090149,1,0.9860948581381,0,2,mitochondrial membrane fission,BP,
17412,GO:0090150,1,0.0700367741326894,0,359,establishment of protein localization to membrane,BP,
17413,GO:0090151,1,0.891867611349854,0,15,establishment of protein localization to mitochondrial membrane,BP,
17414,GO:0090152,1,0.992328177640607,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,
17415,GO:0090153,1,0.907774708725692,0,13,regulation of sphingolipid biosynthetic process,BP,
17416,GO:0090154,1,0.942453739424284,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17417,GO:0090155,1,0.9708234557152,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17418,GO:0090156,1,0.976724921217003,0,3,cellular sphingolipid homeostasis,BP,
17419,GO:0090158,1,0.978367553779866,0,3,endoplasmic reticulum membrane organization,BP,
17420,GO:0090160,1,0.967890384863829,0,5,Golgi to lysosome transport,BP,
17421,GO:0090161,1,0.929422954811204,0,11,Golgi ribbon formation,BP,
17422,GO:0090162,1,0.867856864953226,0,21,establishment of epithelial cell polarity,BP,
17423,GO:0090164,1,0.986380297273693,0,2,asymmetric Golgi ribbon formation,BP,
17424,GO:0090166,1,0.957204496747019,0,6,Golgi disassembly,BP,
17425,GO:0090168,1,0.971241462799574,0,4,Golgi reassembly,BP,
17426,GO:0090169,1,0.888318999225273,0,16,regulation of spindle assembly,BP,
17427,GO:0090170,1,0.970241057863557,0,4,regulation of Golgi inheritance,BP,
17428,GO:0090171,1,0.993371143165214,0,1,chondrocyte morphogenesis,BP,
17431,GO:0090176,1,0.99398576467528,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17432,GO:0090177,1,0.903464380867441,0,15,establishment of planar polarity involved in neural tube closure,BP,
17433,GO:0090178,1,0.910599549172105,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17434,GO:0090179,1,0.916239314652329,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17436,GO:0090182,1,0.984412979516633,0,2,regulation of secretion of lysosomal enzymes,BP,
17437,GO:0090183,1,0.672441888623076,0,55,regulation of kidney development,BP,
17438,GO:0090184,1,0.748598012997773,0,40,positive regulation of kidney development,BP,
17439,GO:0090185,1,0.877156962830953,0,18,negative regulation of kidney development,BP,
17440,GO:0090186,1,0.951984782182076,0,7,regulation of pancreatic juice secretion,BP,
17441,GO:0090187,1,0.984412979516633,0,2,positive regulation of pancreatic juice secretion,BP,
17442,GO:0090188,1,0.967062316532822,0,5,negative regulation of pancreatic juice secretion,BP,
17443,GO:0090189,1,0.84526788417645,0,23,regulation of branching involved in ureteric bud morphogenesis,BP,
17444,GO:0090190,1,0.872049413603429,0,19,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17445,GO:0090191,1,0.970639616935704,0,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17446,GO:0090192,1,0.90402505827718,0,14,regulation of glomerulus development,BP,
17447,GO:0090193,1,0.931253092027292,0,10,positive regulation of glomerulus development,BP,
17448,GO:0090194,1,0.970777966931272,0,4,negative regulation of glomerulus development,BP,
17452,GO:0090198,1,0.992477169145941,0,1,negative regulation of chemokine secretion,BP,
17456,GO:0090202,1,0.977308253980296,0,3,gene looping,BP,
17457,GO:0090204,1,0.978480302610671,0,3,protein localization to nuclear pore,BP,
17459,GO:0090206,1,0.963615440096313,0,5,negative regulation of cholesterol metabolic process,BP,
17462,GO:0090209,1,0.943554014772899,0,8,negative regulation of triglyceride metabolic process,BP,
17463,GO:0090210,1,0.985989015185335,0,2,regulation of establishment of blood-brain barrier,BP,
17464,GO:0090212,1,0.985989015185335,0,2,negative regulation of establishment of blood-brain barrier,BP,
17465,GO:0090214,1,0.978480302614717,0,3,spongiotrophoblast layer developmental growth,BP,
17466,GO:0090218,1,0.795917331965903,0,33,positive regulation of lipid kinase activity,BP,
17467,GO:0090219,1,0.978890452434217,0,3,negative regulation of lipid kinase activity,BP,
17468,GO:0090220,1,0.916812760607005,0,12,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17469,GO:0090222,1,0.993986332268941,0,1,centrosome-templated microtubule nucleation,BP,
17470,GO:0090224,1,0.832452117929085,0,25,regulation of spindle organization,BP,
17471,GO:0090230,1,0.957992242756689,0,6,regulation of centromere complex assembly,BP,
17472,GO:0090231,1,0.888666378168101,0,16,regulation of spindle checkpoint,BP,
17473,GO:0090232,1,0.943371456527575,0,8,positive regulation of spindle checkpoint,BP,
17474,GO:0090233,1,0.992350409634924,0,1,negative regulation of spindle checkpoint,BP,
17475,GO:0090234,1,0.978957582013929,0,3,regulation of kinetochore assembly,BP,
17476,GO:0090235,1,0.984619717191182,0,2,regulation of metaphase plate congression,BP,
17477,GO:0090237,1,0.959258434848815,0,6,regulation of arachidonic acid secretion,BP,
17478,GO:0090238,1,0.965099821752559,0,5,positive regulation of arachidonic acid secretion,BP,
17479,GO:0090239,1,0.915565378997459,0,12,regulation of histone H4 acetylation,BP,
17480,GO:0090240,1,0.950066925046297,0,7,positive regulation of histone H4 acetylation,BP,
17481,GO:0090241,1,0.963301148722742,0,5,negative regulation of histone H4 acetylation,BP,
17482,GO:0090244,1,0.972411917258798,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17483,GO:0090245,1,0.967028317075027,0,5,axis elongation involved in somitogenesis,BP,
17484,GO:0090246,1,0.993792360530137,0,1,convergent extension involved in somitogenesis,BP,
17485,GO:0090247,1,0.992307852066953,0,1,cell motility involved in somitogenic axis elongation,BP,
17486,GO:0090249,1,0.992307852066953,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17487,GO:0090251,1,0.99398633229072,0,1,protein localization involved in establishment of planar polarity,BP,
17489,GO:0090258,1,0.980441253909855,0,3,negative regulation of mitochondrial fission,BP,
17490,GO:0090259,1,0.965977140905772,0,5,regulation of retinal ganglion cell axon guidance,BP,
17491,GO:0090260,1,0.987517378812485,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17492,GO:0090261,1,0.969341180463664,0,4,positive regulation of inclusion body assembly,BP,
17494,GO:0090264,1,0.984501568023485,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17495,GO:0090265,1,0.984501568023485,0,2,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17496,GO:0090266,1,0.907387381774903,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17497,GO:0090267,1,0.950177117450317,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17498,GO:0090269,1,0.959243001116029,0,6,fibroblast growth factor production,BP,
17499,GO:0090270,1,0.959243001116029,0,6,regulation of fibroblast growth factor production,BP,
17500,GO:0090271,1,0.980216839111799,0,3,positive regulation of fibroblast growth factor production,BP,
17501,GO:0090272,1,0.978606164411374,0,3,negative regulation of fibroblast growth factor production,BP,
17502,GO:0090273,1,0.984951215828763,0,2,regulation of somatostatin secretion,BP,
17503,GO:0090274,1,0.984951215828763,0,2,positive regulation of somatostatin secretion,BP,
17506,GO:0090278,1,0.745614050285916,0,41,negative regulation of peptide hormone secretion,BP,
17507,GO:0090279,1,0.503664979154971,0,96,regulation of calcium ion import,BP,
17508,GO:0090280,1,0.701336979042324,0,49,positive regulation of calcium ion import,BP,
17509,GO:0090281,1,0.854091087659172,0,21,negative regulation of calcium ion import,BP,
17510,GO:0090283,1,0.978764693320938,0,3,regulation of protein glycosylation in Golgi,BP,
17511,GO:0090284,1,0.993986332271812,0,1,positive regulation of protein glycosylation in Golgi,BP,
17512,GO:0090285,1,0.984686985866521,0,2,negative regulation of protein glycosylation in Golgi,BP,
17513,GO:0090286,1,0.94486778487407,0,8,cytoskeletal anchoring at nuclear membrane,BP,
17515,GO:0090288,1,0.416163756528405,0,124,negative regulation of cellular response to growth factor stimulus,BP,
17516,GO:0090289,1,0.964530575554514,0,5,regulation of osteoclast proliferation,BP,
17517,GO:0090290,1,0.976814787232004,0,3,positive regulation of osteoclast proliferation,BP,
17518,GO:0090291,1,0.987426506872779,0,2,negative regulation of osteoclast proliferation,BP,
17519,GO:0090292,1,0.98083515082965,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17520,GO:0090293,1,0.992190392480105,0,1,nitrogen catabolite regulation of transcription,BP,
17521,GO:0090294,1,0.992190392480105,0,1,nitrogen catabolite activation of transcription,BP,
17522,GO:0090296,1,0.971724445654596,0,4,regulation of mitochondrial DNA replication,BP,
17523,GO:0090297,1,0.992170027168696,0,1,positive regulation of mitochondrial DNA replication,BP,
17524,GO:0090298,1,0.979394319110677,0,3,negative regulation of mitochondrial DNA replication,BP,
17525,GO:0090299,1,0.992170027325964,0,1,regulation of neural crest formation,BP,
17526,GO:0090301,1,0.992170027325964,0,1,negative regulation of neural crest formation,BP,
17527,GO:0090303,1,0.715693479378047,0,46,positive regulation of wound healing,BP,
17530,GO:0090306,1,0.964755615041773,0,5,spindle assembly involved in meiosis,BP,
17531,GO:0090307,1,0.687840316776986,0,52,mitotic spindle assembly,BP,
17532,GO:0090308,1,0.940946719282888,0,9,regulation of methylation-dependent chromatin silencing,BP,
17533,GO:0090309,1,0.974336681573552,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17534,GO:0090310,1,0.978725005870229,0,3,negative regulation of methylation-dependent chromatin silencing,BP,
17535,GO:0090311,1,0.779415918754975,0,35,regulation of protein deacetylation,BP,
17536,GO:0090312,1,0.859563501794581,0,21,positive regulation of protein deacetylation,BP,
17537,GO:0090313,1,0.819373249241247,0,27,regulation of protein targeting to membrane,BP,
17538,GO:0090314,1,0.851004981353248,0,22,positive regulation of protein targeting to membrane,BP,
17539,GO:0090315,1,0.962741769526536,0,5,negative regulation of protein targeting to membrane,BP,
17540,GO:0090316,1,0.176584339178568,0,241,positive regulation of intracellular protein transport,BP,
17541,GO:0090317,1,0.522020709164025,0,90,negative regulation of intracellular protein transport,BP,
17542,GO:0090320,1,0.992210979877727,0,1,regulation of chylomicron remnant clearance,BP,
17543,GO:0090321,1,0.992210979877727,0,1,positive regulation of chylomicron remnant clearance,BP,
17545,GO:0090323,1,0.992170027168696,0,1,prostaglandin secretion involved in immune response,BP,
17546,GO:0090324,1,0.963157997811448,0,5,negative regulation of oxidative phosphorylation,BP,
17547,GO:0090325,1,0.97129605022336,0,4,regulation of locomotion involved in locomotory behavior,BP,
17548,GO:0090326,1,0.992844763242059,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17549,GO:0090327,1,0.993631074978444,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17550,GO:0090329,1,0.736554913463737,0,43,regulation of DNA-dependent DNA replication,BP,
17551,GO:0090330,1,0.900320895231347,0,15,regulation of platelet aggregation,BP,
17552,GO:0090331,1,0.931845987744399,0,10,negative regulation of platelet aggregation,BP,
17553,GO:0090335,1,0.913038511780106,0,13,regulation of brown fat cell differentiation,BP,
17554,GO:0090336,1,0.951436046893662,0,7,positive regulation of brown fat cell differentiation,BP,
17555,GO:0090340,1,0.992182213557173,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17556,GO:0090341,1,0.992170027168696,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17557,GO:0090342,1,0.780107793158292,0,35,regulation of cell aging,BP,
17558,GO:0090343,1,0.935283785035718,0,9,positive regulation of cell aging,BP,
17559,GO:0090344,1,0.887690238489775,0,17,negative regulation of cell aging,BP,
17560,GO:0090345,1,0.984504812595266,0,2,cellular organohalogen metabolic process,BP,
17561,GO:0090346,1,0.984504812595266,0,2,cellular organofluorine metabolic process,BP,
17562,GO:0090347,1,0.992170027168696,0,1,regulation of cellular organohalogen metabolic process,BP,
17563,GO:0090348,1,0.992170027168696,0,1,regulation of cellular organofluorine metabolic process,BP,
17564,GO:0090349,1,0.992170027168696,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17565,GO:0090350,1,0.992170027168696,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17566,GO:0090357,1,0.992170027168696,0,1,regulation of tryptophan metabolic process,BP,
17567,GO:0090360,1,0.97832956521084,0,3,platelet-derived growth factor production,BP,
17568,GO:0090361,1,0.97832956521084,0,3,regulation of platelet-derived growth factor production,BP,
17569,GO:0090362,1,0.986039480942427,0,2,positive regulation of platelet-derived growth factor production,BP,
17570,GO:0090365,1,0.984425404356513,0,2,regulation of mRNA modification,BP,
17571,GO:0090366,1,0.992170027168696,0,1,positive regulation of mRNA modification,BP,
17572,GO:0090367,1,0.992194735690875,0,1,negative regulation of mRNA modification,BP,
17573,GO:0090370,1,0.972276172864682,0,4,negative regulation of cholesterol efflux,BP,
17574,GO:0090381,1,0.977033934623942,0,3,regulation of heart induction,BP,
17575,GO:0090382,1,0.741021892336827,0,41,phagosome maturation,BP,
17576,GO:0090383,1,0.815831158996869,0,27,phagosome acidification,BP,
17577,GO:0090385,1,0.949913113149682,0,7,phagosome-lysosome fusion,BP,
17578,GO:0090386,1,0.993986332273788,0,1,phagosome maturation involved in apoptotic cell clearance,BP,
17579,GO:0090387,1,0.993986332273788,0,1,phagolysosome assembly involved in apoptotic cell clearance,BP,
17580,GO:0090389,1,0.993986332273788,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17581,GO:0090394,1,0.942823019968296,0,9,negative regulation of excitatory postsynaptic potential,BP,
17582,GO:0090398,1,0.677870672866771,0,54,cellular senescence,BP,
17583,GO:0090399,1,0.918659503679248,0,12,replicative senescence,BP,
17584,GO:0090400,1,0.944135681803475,0,8,stress-induced premature senescence,BP,
17585,GO:0090402,1,0.984675577152385,0,2,oncogene-induced cell senescence,BP,
17586,GO:0090403,1,0.971556249823705,0,4,oxidative stress-induced premature senescence,BP,
17588,GO:0090409,1,0.992212974676087,0,1,malonyl-CoA synthetase activity,MF,
17589,GO:0090410,1,0.992212974676087,0,1,malonate catabolic process,BP,
17590,GO:0090416,1,0.992296702876046,0,1,nicotinate transporter activity,MF,
17591,GO:0090420,1,0.984401819725564,0,2,naphthalene-containing compound metabolic process,BP,
17592,GO:0090422,1,0.992170027168696,0,1,thiamine pyrophosphate transporter activity,MF,
17593,GO:0090425,1,0.992631976713582,0,1,acinar cell differentiation,BP,
17594,GO:0090427,1,0.978511414528499,0,3,activation of meiosis,BP,
17595,GO:0090435,1,0.9499852847256,0,7,protein localization to nuclear envelope,BP,
17596,GO:0090467,1,0.972149161885484,0,4,arginine import,BP,
17597,GO:0090472,1,0.993648252737102,0,1,dibasic protein processing,BP,
17598,GO:0090480,1,0.992294630214608,0,1,purine nucleotide-sugar transmembrane transport,BP,
17599,GO:0090481,1,0.964998240572653,0,5,pyrimidine nucleotide-sugar transmembrane transport,BP,
17600,GO:0090482,1,0.945247905675951,0,8,vitamin transmembrane transporter activity,MF,
17602,GO:0090493,1,0.921251370179263,0,11,catecholamine uptake,BP,
17603,GO:0090494,1,0.921251370179263,0,11,dopamine uptake,BP,
17604,GO:0090498,1,0.978638236816918,0,3,extrinsic component of Golgi membrane,CC,
17605,GO:0090500,1,0.963978082004177,0,5,endocardial cushion to mesenchymal transition,BP,
17608,GO:0090503,1,0.784098167423324,0,34,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17609,GO:0090504,1,0.827585743346198,0,27,epiboly,BP,
17610,GO:0090505,1,0.832599878612535,0,26,epiboly involved in wound healing,BP,
17611,GO:0090520,1,0.914960342933085,0,12,sphingolipid mediated signaling pathway,BP,
17612,GO:0090521,1,0.972851497435456,0,4,glomerular visceral epithelial cell migration,BP,
17613,GO:0090526,1,0.987064213650639,0,2,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,
17614,GO:0090527,1,0.960837652178348,0,6,actin filament reorganization,BP,
17615,GO:0090529,1,0.992171281480172,0,1,cell septum assembly,BP,
17617,GO:0090534,1,0.99217005778918,0,1,calcium ion-transporting ATPase complex,CC,
17618,GO:0090537,1,0.987602162654852,0,2,CERF complex,CC,
17619,GO:0090541,1,0.986097106935385,0,2,MIT domain binding,MF,
17620,GO:0090543,1,0.947988130691147,0,7,Flemming body,CC,
17621,GO:0090544,1,0.85137345125444,0,23,BAF-type complex,CC,
17622,GO:0090545,1,0.890629129222572,0,17,CHD-type complex,CC,
17623,GO:0090554,1,0.975628373177426,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17624,GO:0090555,1,0.987947933947075,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17625,GO:0090556,1,0.988008547488277,0,2,phosphatidylserine-translocating ATPase activity,MF,
17626,GO:0090557,1,0.950020037196833,0,8,establishment of endothelial intestinal barrier,BP,
17627,GO:0090558,1,0.992170027168696,0,1,plant epidermis development,BP,
17629,GO:0090560,1,0.992191330743375,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17630,GO:0090568,1,0.807554503402826,0,31,nuclear transcriptional repressor complex,CC,
17631,GO:0090571,1,0.970776968377916,0,4,RNA polymerase II transcription repressor complex,CC,
17632,GO:0090575,1,0.430156498023294,0,115,RNA polymerase II transcription factor complex,CC,
17633,GO:0090576,1,0.946222702780111,0,8,RNA polymerase III transcription factor complex,CC,
17634,GO:0090579,1,0.977308253980296,0,3,dsDNA loop formation,BP,
17635,GO:0090594,1,0.956713782160314,0,6,inflammatory response to wounding,BP,
17637,GO:0090598,1,0.971252191202823,0,4,male anatomical structure morphogenesis,BP,
17638,GO:0090599,1,0.962977388646573,0,6,alpha-glucosidase activity,MF,
17639,GO:0090600,1,0.993437089993706,0,1,alpha-1,3-glucosidase activity,MF,
17640,GO:0090611,1,0.963978033823584,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17641,GO:0090615,1,0.993845740613944,0,1,mitochondrial mRNA processing,BP,
17642,GO:0090616,1,0.993845740613944,0,1,mitochondrial mRNA 3'-end processing,BP,
17643,GO:0090619,1,0.992228281403789,0,1,meiotic spindle pole,CC,
17644,GO:0090624,1,0.992294630214608,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17645,GO:0090625,1,0.992294630214608,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17646,GO:0090627,1,0.992170027168696,0,1,plant epidermal cell differentiation,BP,
17648,GO:0090631,1,0.986197173624354,0,2,pre-miRNA transporter activity,MF,
17649,GO:0090634,1,0.992170027168696,0,1,microglial cell mediated cytotoxicity,BP,
17651,GO:0090648,1,0.993986332266755,0,1,response to environmental enrichment,BP,
17652,GO:0090649,1,0.966618032949756,0,5,response to oxygen-glucose deprivation,BP,
17653,GO:0090650,1,0.966618032949756,0,5,cellular response to oxygen-glucose deprivation,BP,
17654,GO:0090651,1,0.993986332269364,0,1,apical cytoplasm,CC,
17655,GO:0090656,1,0.899809637106237,0,15,t-circle formation,BP,
17656,GO:0090657,1,0.925444850572334,0,11,telomeric loop disassembly,BP,
17657,GO:0090659,1,0.819052665393267,0,29,walking behavior,BP,
17658,GO:0090661,1,0.969172561684693,0,4,box H/ACA telomerase RNP complex,CC,
17659,GO:0090662,1,0.593964479687631,0,74,ATP hydrolysis coupled transmembrane transport,BP,
17660,GO:0090665,1,0.862137038326146,0,21,glycoprotein complex,CC,
17661,GO:0090666,1,0.969175237116587,0,4,scaRNA localization to Cajal body,BP,
17662,GO:0090669,1,0.97779688671222,0,3,telomerase RNA stabilization,BP,
17663,GO:0090670,1,0.883104572469155,0,16,RNA localization to Cajal body,BP,
17664,GO:0090671,1,0.883104572469155,0,16,telomerase RNA localization to Cajal body,BP,
17665,GO:0090672,1,0.883104572469155,0,16,telomerase RNA localization,BP,
17666,GO:0090675,1,0.986751009157061,0,2,intermicrovillar adhesion,BP,
17667,GO:0090676,1,0.992516661359673,0,1,calcium ion transmembrane transport via low voltage-gated calcium channel,BP,
17668,GO:0090677,1,0.992476801254136,0,1,reversible differentiation,BP,
17669,GO:0090678,1,0.992476801254136,0,1,cell dedifferentiation involved in phenotypic switching,BP,
17670,GO:0090713,1,0.936082187962749,0,9,immunological memory process,BP,
17671,GO:0090715,1,0.936082187962749,0,9,immunological memory formation process,BP,
17672,GO:0090722,1,0.972594669958167,0,4,receptor-receptor interaction,MF,
17673,GO:0090723,1,0.891119168617641,0,16,growth cone part,CC,
17674,GO:0090724,1,0.964678481605951,0,5,central region of growth cone,CC,
17675,GO:0090725,1,0.985652153647721,0,2,peripheral region of growth cone,CC,
17676,GO:0090731,1,0.992170027168696,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17677,GO:0090732,1,0.992170027168696,0,1,cofilin-actin rod,CC,
17678,GO:0090734,1,0.813902224883914,0,29,site of DNA damage,CC,
17679,GO:0090735,1,0.925647839634912,0,10,DNA repair complex assembly,BP,
17680,GO:0090737,1,0.899809637106237,0,15,telomere maintenance via telomere trimming,BP,
17681,GO:0093001,1,0.992765001015256,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17682,GO:0095500,1,0.856621377233316,0,21,acetylcholine receptor signaling pathway,BP,
17683,GO:0097001,1,0.949226651587615,0,7,ceramide binding,MF,
17684,GO:0097003,1,0.985726757449142,0,2,adipokinetic hormone receptor activity,MF,
17686,GO:0097009,1,0.799652384879813,0,33,energy homeostasis,BP,
17687,GO:0097010,1,0.979925398939735,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17688,GO:0097011,1,0.935891473437353,0,9,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17689,GO:0097012,1,0.935891473437353,0,9,response to granulocyte macrophage colony-stimulating factor,BP,
17690,GO:0097013,1,0.976753211338874,0,3,phagocytic vesicle lumen,CC,
17691,GO:0097014,1,0.556009700712965,0,84,ciliary plasm,CC,
17692,GO:0097016,1,0.980162480075484,0,3,L27 domain binding,MF,
17693,GO:0097017,1,0.978643571259226,0,3,renal protein absorption,BP,
17694,GO:0097018,1,0.986157038537517,0,2,renal albumin absorption,BP,
17695,GO:0097020,1,0.99291532525602,0,1,COPII adaptor activity,MF,
17696,GO:0097021,1,0.978444215512743,0,3,lymphocyte migration into lymphoid organs,BP,
17697,GO:0097022,1,0.992192957802479,0,1,lymphocyte migration into lymph node,BP,
17698,GO:0097025,1,0.981940722339079,0,3,MPP7-DLG1-LIN7 complex,CC,
17699,GO:0097026,1,0.970839972524728,0,4,dendritic cell dendrite assembly,BP,
17700,GO:0097027,1,0.941561485070882,0,8,ubiquitin-protein transferase activator activity,MF,
17702,GO:0097029,1,0.969365682260972,0,4,mature conventional dendritic cell differentiation,BP,
17703,GO:0097031,1,0.651199975026768,0,55,mitochondrial respiratory chain complex I biogenesis,BP,
17704,GO:0097032,1,0.984400887813367,0,2,mitochondrial respiratory chain complex II biogenesis,BP,
17705,GO:0097033,1,0.963240923987023,0,5,mitochondrial respiratory chain complex III biogenesis,BP,
17706,GO:0097034,1,0.898236591224356,0,14,mitochondrial respiratory chain complex IV biogenesis,BP,
17707,GO:0097035,1,0.780812678927931,0,37,regulation of membrane lipid distribution,BP,
17708,GO:0097037,1,0.992985674313577,0,1,heme export,BP,
17709,GO:0097038,1,0.928073679836553,0,11,perinuclear endoplasmic reticulum,CC,
17710,GO:0097039,1,0.971934978655194,0,4,protein linear polyubiquitination,BP,
17711,GO:0097045,1,0.993900632399216,0,1,phosphatidylserine exposure on blood platelet,BP,
17712,GO:0097048,1,0.958153671616251,0,6,dendritic cell apoptotic process,BP,
17714,GO:0097050,1,0.924583810831774,0,11,type B pancreatic cell apoptotic process,BP,
17715,GO:0097051,1,0.981365906521116,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17716,GO:0097052,1,0.976806645202679,0,3,L-kynurenine metabolic process,BP,
17717,GO:0097053,1,0.992170027168696,0,1,L-kynurenine catabolic process,BP,
17718,GO:0097055,1,0.992197047099341,0,1,agmatine biosynthetic process,BP,
17719,GO:0097056,1,0.970831856596164,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17720,GO:0097057,1,0.984442109537292,0,2,TRAF2-GSTP1 complex,CC,
17721,GO:0097058,1,0.976695323734449,0,3,CRLF-CLCF1 complex,CC,
17722,GO:0097059,1,0.984407552503829,0,2,CNTFR-CLCF1 complex,CC,
17724,GO:0097061,1,0.6788431958013,0,58,dendritic spine organization,BP,
17725,GO:0097062,1,0.917772620069742,0,12,dendritic spine maintenance,BP,
17726,GO:0097065,1,0.984455748475411,0,2,anterior head development,BP,
17727,GO:0097066,1,0.843617167991848,0,24,response to thyroid hormone,BP,
17728,GO:0097067,1,0.902591108057073,0,15,cellular response to thyroid hormone stimulus,BP,
17729,GO:0097068,1,0.965888968747296,0,5,response to thyroxine,BP,
17730,GO:0097069,1,0.985961746006548,0,2,cellular response to thyroxine stimulus,BP,
17731,GO:0097070,1,0.965595399600978,0,5,ductus arteriosus closure,BP,
17732,GO:0097084,1,0.94373022532447,0,8,vascular smooth muscle cell development,BP,
17733,GO:0097086,1,0.993210624977439,0,1,amniotic stem cell differentiation,BP,
17735,GO:0097090,1,0.937510040635213,0,10,presynaptic membrane organization,BP,
17736,GO:0097091,1,0.943458641122976,0,9,synaptic vesicle clustering,BP,
17737,GO:0097094,1,0.884421530597038,0,17,craniofacial suture morphogenesis,BP,
17738,GO:0097100,1,0.964062780595503,0,5,supercoiled DNA binding,MF,
17739,GO:0097101,1,0.977527400304944,0,3,blood vessel endothelial cell fate specification,BP,
17740,GO:0097102,1,0.985184498366707,0,2,endothelial tip cell fate specification,BP,
17741,GO:0097104,1,0.951972877791717,0,8,postsynaptic membrane assembly,BP,
17742,GO:0097105,1,0.95063097632309,0,8,presynaptic membrane assembly,BP,
17743,GO:0097106,1,0.919375480144813,0,13,postsynaptic density organization,BP,
17744,GO:0097107,1,0.970163525489427,0,5,postsynaptic density assembly,BP,
17745,GO:0097108,1,0.980752763450863,0,3,hedgehog family protein binding,MF,
17746,GO:0097109,1,0.967898198262424,0,5,neuroligin family protein binding,MF,
17747,GO:0097110,1,0.706159793236174,0,50,scaffold protein binding,MF,
17748,GO:0097111,1,0.988008547469589,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17749,GO:0097112,1,0.986352223273139,0,2,gamma-aminobutyric acid receptor clustering,BP,
17750,GO:0097113,1,0.966229878100412,0,5,AMPA glutamate receptor clustering,BP,
17751,GO:0097114,1,0.974320591492143,0,4,NMDA glutamate receptor clustering,BP,
17752,GO:0097115,1,0.99393002522899,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17753,GO:0097116,1,0.981941487628886,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17754,GO:0097117,1,0.99398633227139,0,1,guanylate kinase-associated protein clustering,BP,
17755,GO:0097118,1,0.975929899026502,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17756,GO:0097119,1,0.944186853421198,0,9,postsynaptic density protein 95 clustering,BP,
17757,GO:0097120,1,0.908847428962316,0,14,receptor localization to synapse,BP,
17758,GO:0097123,1,0.984437497496574,0,2,cyclin A1-CDK2 complex,CC,
17759,GO:0097124,1,0.984684896048525,0,2,cyclin A2-CDK2 complex,CC,
17760,GO:0097125,1,0.984414937296932,0,2,cyclin B1-CDK1 complex,CC,
17761,GO:0097129,1,0.986203080775875,0,2,cyclin D2-CDK4 complex,CC,
17762,GO:0097134,1,0.984436520056327,0,2,cyclin E1-CDK2 complex,CC,
17763,GO:0097135,1,0.984641854290291,0,2,cyclin E2-CDK2 complex,CC,
17764,GO:0097136,1,0.965360824100023,0,5,Bcl-2 family protein complex,CC,
17765,GO:0097144,1,0.992170027168696,0,1,BAX complex,CC,
17766,GO:0097149,1,0.979499974273721,0,3,centralspindlin complex,CC,
17767,GO:0097150,1,0.875556727565244,0,20,neuronal stem cell population maintenance,BP,
17768,GO:0097151,1,0.958093665369526,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17769,GO:0097152,1,0.910891618097698,0,13,mesenchymal cell apoptotic process,BP,
17771,GO:0097154,1,0.893034410627702,0,15,GABAergic neuron differentiation,BP,
17772,GO:0097155,1,0.981768977289092,0,3,fasciculation of sensory neuron axon,BP,
17773,GO:0097156,1,0.987709305834945,0,2,fasciculation of motor neuron axon,BP,
17774,GO:0097157,1,0.951592521283058,0,7,pre-mRNA intronic binding,MF,
17775,GO:0097158,1,0.992170027168696,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17777,GO:0097160,1,0.992170027168696,0,1,polychlorinated biphenyl binding,MF,
17778,GO:0097161,1,0.993986332267336,0,1,DH domain binding,MF,
17779,GO:0097162,1,0.992827068341019,0,1,MADS box domain binding,MF,
17781,GO:0097165,1,0.966195912366372,0,5,nuclear stress granule,CC,
17782,GO:0097166,1,0.986208667668789,0,2,lens epithelial cell proliferation,BP,
17783,GO:0097167,1,0.972516654302812,0,4,circadian regulation of translation,BP,
17784,GO:0097168,1,0.986076910859672,0,2,mesenchymal stem cell proliferation,BP,
17786,GO:0097176,1,0.992230544989512,0,1,epoxide metabolic process,BP,
17787,GO:0097177,1,0.984400946654247,0,2,mitochondrial ribosome binding,MF,
17788,GO:0097178,1,0.80407514143427,0,30,ruffle assembly,BP,
17789,GO:0097179,1,0.992218024205118,0,1,protease inhibitor complex,CC,
17790,GO:0097180,1,0.992218024205118,0,1,serine protease inhibitor complex,CC,
17791,GO:0097181,1,0.992218024205118,0,1,protein C inhibitor-coagulation factor V complex,CC,
17792,GO:0097182,1,0.992218024205118,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17793,GO:0097183,1,0.992218024205118,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17794,GO:0097186,1,0.864415227177814,0,21,amelogenesis,BP,
17795,GO:0097187,1,0.976965901542014,0,3,dentinogenesis,BP,
17801,GO:0097195,1,0.978375110092987,0,3,pilomotor reflex,BP,
17802,GO:0097196,1,0.984528454977574,0,2,Shu complex,CC,
17803,GO:0097197,1,0.951288645003367,0,7,tetraspanin-enriched microdomain,CC,
17804,GO:0097198,1,0.986610730871304,0,2,histone H3-K36 trimethylation,BP,
17805,GO:0097199,1,0.986428918429946,0,2,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17807,GO:0097201,1,0.907186949969061,0,13,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17809,GO:0097205,1,0.880859084969931,0,18,renal filtration,BP,
17810,GO:0097208,1,0.957095177758539,0,6,alveolar lamellar body,CC,
17811,GO:0097209,1,0.971845005957076,0,4,epidermal lamellar body,CC,
17812,GO:0097210,1,0.966541487562132,0,5,response to gonadotropin-releasing hormone,BP,
17813,GO:0097211,1,0.966541487562132,0,5,cellular response to gonadotropin-releasing hormone,BP,
17814,GO:0097212,1,0.984406568866254,0,2,lysosomal membrane organization,BP,
17815,GO:0097213,1,0.992170027168696,0,1,regulation of lysosomal membrane permeability,BP,
17816,GO:0097214,1,0.992170027168696,0,1,positive regulation of lysosomal membrane permeability,BP,
17817,GO:0097222,1,0.993845740613944,0,1,mitochondrial mRNA polyadenylation,BP,
17819,GO:0097224,1,0.992170165072275,0,1,sperm connecting piece,CC,
17820,GO:0097225,1,0.892273482127061,0,15,sperm midpiece,CC,
17821,GO:0097226,1,0.99221216916282,0,1,sperm mitochondrial sheath,CC,
17822,GO:0097227,1,0.956965918351715,0,6,sperm annulus,CC,
17823,GO:0097228,1,0.863286698322033,0,20,sperm principal piece,CC,
17824,GO:0097229,1,0.992170027168696,0,1,sperm end piece,CC,
17825,GO:0097231,1,0.992170068553963,0,1,cell motility in response to calcium ion,BP,
17826,GO:0097232,1,0.98691911478045,0,2,lamellar body membrane,CC,
17827,GO:0097233,1,0.98691911478045,0,2,alveolar lamellar body membrane,CC,
17828,GO:0097237,1,0.944380999378028,0,8,cellular response to toxic substance,BP,
17829,GO:0097238,1,0.992170027168696,0,1,cellular response to methylglyoxal,BP,
17830,GO:0097240,1,0.964957837326701,0,5,chromosome attachment to the nuclear envelope,BP,
17831,GO:0097241,1,0.984546804520295,0,2,hematopoietic stem cell migration to bone marrow,BP,
17832,GO:0097242,1,0.953422184806111,0,7,beta-amyloid clearance,BP,
17833,GO:0097252,1,0.977927968199493,0,3,oligodendrocyte apoptotic process,BP,
17834,GO:0097254,1,0.992186430082057,0,1,renal tubular secretion,BP,
17835,GO:0097255,1,0.962423246053332,0,5,R2TP complex,CC,
17836,GO:0097258,1,0.984856731861142,0,2,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17837,GO:0097259,1,0.984856731861142,0,2,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17838,GO:0097260,1,0.992354127992258,0,1,eoxin A4 synthase activity,MF,
17839,GO:0097264,1,0.942444571447036,0,8,self proteolysis,BP,
17840,GO:0097267,1,0.93578908686762,0,9,omega-hydroxylase P450 pathway,BP,
17841,GO:0097272,1,0.986203075496634,0,2,ammonia homeostasis,BP,
17842,GO:0097273,1,0.99398632694759,0,1,creatinine homeostasis,BP,
17843,GO:0097274,1,0.987042923661891,0,2,urea homeostasis,BP,
17844,GO:0097275,1,0.99398632694759,0,1,cellular ammonia homeostasis,BP,
17845,GO:0097276,1,0.99398632694759,0,1,cellular creatinine homeostasis,BP,
17846,GO:0097277,1,0.99398632694759,0,1,cellular urea homeostasis,BP,
17847,GO:0097278,1,0.969406853144858,0,4,complement-dependent cytotoxicity,BP,
17848,GO:0097283,1,0.955440253268753,0,6,keratinocyte apoptotic process,BP,
17849,GO:0097284,1,0.903782531038899,0,14,hepatocyte apoptotic process,BP,
17850,GO:0097286,1,0.919605103027816,0,12,iron ion import,BP,
17851,GO:0097291,1,0.992177240691097,0,1,renal phosphate ion absorption,BP,
17853,GO:0097298,1,0.993456556363965,0,1,regulation of nucleus size,BP,
17856,GO:0097306,1,0.689992309964548,0,54,cellular response to alcohol,BP,
17857,GO:0097319,1,0.992219791379029,0,1,carbohydrate import into cell,BP,
17858,GO:0097320,1,0.891134708422318,0,17,plasma membrane tubulation,BP,
17859,GO:0097322,1,0.953029557740271,0,7,7SK snRNA binding,MF,
17860,GO:0097324,1,0.987989026121751,0,2,melanocyte migration,BP,
17861,GO:0097325,1,0.986453603743599,0,2,melanocyte proliferation,BP,
17862,GO:0097326,1,0.993966693721043,0,1,melanocyte adhesion,BP,
17863,GO:0097327,1,0.964482854787934,0,5,response to antineoplastic agent,BP,
17864,GO:0097332,1,0.985438249861711,0,2,response to antipsychotic drug,BP,
17865,GO:0097338,1,0.987058534454231,0,2,response to clozapine,BP,
17869,GO:0097343,1,0.973122852074745,0,4,ripoptosome assembly,BP,
17870,GO:0097344,1,0.992635074579818,0,1,Rix1 complex,CC,
17872,GO:0097346,1,0.856111535901296,0,21,INO80-type complex,CC,
17873,GO:0097350,1,0.972506461651204,0,4,neutrophil clearance,BP,
17874,GO:0097352,1,0.782309334186069,0,34,autophagosome maturation,BP,
17875,GO:0097354,1,0.929911903777847,0,10,prenylation,BP,
17876,GO:0097356,1,0.993986332273156,0,1,perinucleolar compartment,CC,
17877,GO:0097359,1,0.987959948082678,0,2,UDP-glucosylation,BP,
17878,GO:0097360,1,0.972746763894997,0,4,chorionic trophoblast cell proliferation,BP,
17879,GO:0097361,1,0.971457288325157,0,4,CIA complex,CC,
17880,GO:0097362,1,0.985568737702878,0,2,MCM8-MCM9 complex,CC,
17881,GO:0097363,1,0.993983539103336,0,1,protein O-GlcNAc transferase activity,MF,
17883,GO:0097368,1,0.973210983145277,0,4,establishment of Sertoli cell barrier,BP,
17884,GO:0097369,1,0.909473117904184,0,14,sodium ion import,BP,
17885,GO:0097371,1,0.959796453737248,0,6,MDM2/MDM4 family protein binding,MF,
17886,GO:0097372,1,0.992170072635252,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17887,GO:0097374,1,0.984496311713488,0,2,sensory neuron axon guidance,BP,
17888,GO:0097376,1,0.992170027168696,0,1,interneuron axon guidance,BP,
17889,GO:0097381,1,0.869807254847521,0,19,photoreceptor disc membrane,CC,
17890,GO:0097382,1,0.993986332265624,0,1,deoxynucleoside-diphosphatase activity,MF,
17891,GO:0097383,1,0.993986332265624,0,1,dIDP diphosphatase activity,MF,
17892,GO:0097384,1,0.957603611255915,0,6,cellular lipid biosynthetic process,BP,
17893,GO:0097386,1,0.90074751639043,0,15,glial cell projection,CC,
17894,GO:0097393,1,0.993986332289623,0,1,telomeric repeat-containing RNA transcription,BP,
17895,GO:0097394,1,0.993986332289623,0,1,telomeric repeat-containing RNA transcription from RNA pol II promoter,BP,
17896,GO:0097396,1,0.993262476933322,0,1,response to interleukin-17,BP,
17897,GO:0097398,1,0.993262476933322,0,1,cellular response to interleukin-17,BP,
17898,GO:0097400,1,0.993262476933322,0,1,interleukin-17-mediated signaling pathway,BP,
17899,GO:0097401,1,0.992557620167389,0,1,synaptic vesicle lumen acidification,BP,
17900,GO:0097402,1,0.992278480616219,0,1,neuroblast migration,BP,
17901,GO:0097403,1,0.992588594852166,0,1,cellular response to raffinose,BP,
17902,GO:0097409,1,0.992174782146658,0,1,glial cytoplasmic inclusion,CC,
17903,GO:0097411,1,0.967660393372929,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17904,GO:0097413,1,0.955850200887039,0,6,Lewy body,CC,
17905,GO:0097414,1,0.992174782146658,0,1,classical Lewy body,CC,
17906,GO:0097418,1,0.965999021611024,0,5,neurofibrillary tangle,CC,
17908,GO:0097422,1,0.964274611732244,0,5,tubular endosome,CC,
17910,GO:0097427,1,0.986162162205529,0,2,microtubule bundle,CC,
17911,GO:0097428,1,0.946458055976981,0,7,protein maturation by iron-sulfur cluster transfer,BP,
17912,GO:0097431,1,0.914943190578943,0,13,mitotic spindle pole,CC,
17913,GO:0097433,1,0.956849670786182,0,6,dense body,CC,
17915,GO:0097440,1,0.924375559870141,0,12,apical dendrite,CC,
17916,GO:0097441,1,0.979963560506726,0,3,basilar dendrite,CC,
17917,GO:0097442,1,0.993985524954285,0,1,CA3 pyramidal cell dendrite,CC,
17918,GO:0097443,1,0.960632235415875,0,6,sorting endosome,CC,
17919,GO:0097444,1,0.993961888744792,0,1,spine apparatus,CC,
17920,GO:0097447,1,0.984774107348289,0,2,dendritic tree,CC,
17921,GO:0097449,1,0.937835021955144,0,9,astrocyte projection,CC,
17922,GO:0097450,1,0.979388025486868,0,3,astrocyte end-foot,CC,
17923,GO:0097451,1,0.987117911973842,0,2,glial limiting end-foot,CC,
17924,GO:0097452,1,0.972559610591397,0,4,GAIT complex,CC,
17925,GO:0097453,1,0.992242171696588,0,1,mesaxon,CC,
17926,GO:0097454,1,0.978998846007189,0,3,Schwann cell microvillus,CC,
17927,GO:0097457,1,0.993082917956945,0,1,hippocampal mossy fiber,CC,
17929,GO:0097459,1,0.938471999942367,0,9,iron ion import into cell,BP,
17930,GO:0097460,1,0.969610974324743,0,4,ferrous iron import into cell,BP,
17931,GO:0097461,1,0.974380570922071,0,4,ferric iron import into cell,BP,
17932,GO:0097462,1,0.992174782146658,0,1,Lewy neurite,CC,
17933,GO:0097466,1,0.972807863968944,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17934,GO:0097468,1,0.915818029464066,0,12,programmed cell death in response to reactive oxygen species,BP,
17935,GO:0097470,1,0.967861138417191,0,5,ribbon synapse,CC,
17936,GO:0097472,1,0.811736407859519,0,28,cyclin-dependent protein kinase activity,MF,
17937,GO:0097473,1,0.993973780922755,0,1,retinal rod cell apoptotic process,BP,
17938,GO:0097475,1,0.951073638199241,0,7,motor neuron migration,BP,
17939,GO:0097476,1,0.971019285867506,0,4,spinal cord motor neuron migration,BP,
17940,GO:0097477,1,0.978657853143916,0,3,lateral motor column neuron migration,BP,
17941,GO:0097479,1,0.39986282210297,0,132,synaptic vesicle localization,BP,
17942,GO:0097480,1,0.418326244157961,0,125,establishment of synaptic vesicle localization,BP,
17943,GO:0097484,1,0.830219966623354,0,27,dendrite extension,BP,
17945,GO:0097486,1,0.947062072249766,0,7,multivesicular body lumen,CC,
17946,GO:0097487,1,0.978604014733328,0,3,multivesicular body, internal vesicle,CC,
17947,GO:0097489,1,0.99229545654389,0,1,multivesicular body, internal vesicle lumen,CC,
17948,GO:0097490,1,0.973574447007338,0,4,sympathetic neuron projection extension,BP,
17949,GO:0097491,1,0.973574447007338,0,4,sympathetic neuron projection guidance,BP,
17950,GO:0097493,1,0.896535341099611,0,17,structural molecule activity conferring elasticity,MF,
17951,GO:0097494,1,0.986203080786168,0,2,regulation of vesicle size,BP,
17952,GO:0097497,1,0.992712489432679,0,1,blood vessel endothelial cell delamination,BP,
17953,GO:0097498,1,0.986206199901543,0,2,endothelial tube lumen extension,BP,
17954,GO:0097499,1,0.9354470200694,0,9,protein localization to non-motile cilium,BP,
17955,GO:0097500,1,0.963471226158705,0,5,receptor localization to non-motile cilium,BP,
17956,GO:0097501,1,0.97211576392479,0,4,stress response to metal ion,BP,
17958,GO:0097503,1,0.859898926435326,0,21,sialylation,BP,
17959,GO:0097504,1,0.930285385174214,0,10,Gemini of coiled bodies,CC,
17960,GO:0097505,1,0.993986308795543,0,1,Rad6-Rad18 complex,CC,
17961,GO:0097506,1,0.962073464157348,0,5,deaminated base DNA N-glycosylase activity,MF,
17962,GO:0097510,1,0.992180585621358,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17963,GO:0097512,1,0.949663090856597,0,7,cardiac myofibril,CC,
17964,GO:0097513,1,0.982066433180973,0,3,myosin II filament,CC,
17965,GO:0097517,1,0.714245935138133,0,49,contractile actin filament bundle,CC,
17966,GO:0097524,1,0.956601031833901,0,6,sperm plasma membrane,CC,
17967,GO:0097525,1,0.654360367671832,0,57,spliceosomal snRNP complex,CC,
17968,GO:0097526,1,0.833873613349017,0,24,spliceosomal tri-snRNP complex,CC,
17970,GO:0097529,1,0.300011780404134,0,162,myeloid leukocyte migration,BP,
17971,GO:0097530,1,0.421216076776547,0,115,granulocyte migration,BP,
17972,GO:0097531,1,0.911785308730381,0,13,mast cell migration,BP,
17973,GO:0097534,1,0.992360620607141,0,1,lymphoid lineage cell migration,BP,
17974,GO:0097535,1,0.992360620607141,0,1,lymphoid lineage cell migration into thymus,BP,
17975,GO:0097536,1,0.984606278958732,0,2,thymus epithelium morphogenesis,BP,
17976,GO:0097539,1,0.941146875607916,0,9,ciliary transition fiber,CC,
17977,GO:0097541,1,0.992294630214608,0,1,axonemal basal plate,CC,
17978,GO:0097542,1,0.736152786436499,0,44,ciliary tip,CC,
17979,GO:0097543,1,0.986493132250156,0,2,ciliary inversin compartment,CC,
17980,GO:0097546,1,0.826190184970907,0,27,ciliary base,CC,
17981,GO:0097550,1,0.956084720170133,0,6,transcriptional preinitiation complex,CC,
17983,GO:0097573,1,0.992170027168696,0,1,glutathione oxidoreductase activity,MF,
17984,GO:0097576,1,0.772805329632913,0,36,vacuole fusion,BP,
17985,GO:0097577,1,0.961460790989252,0,5,sequestering of iron ion,BP,
17986,GO:0097581,1,0.612107552234647,0,70,lamellipodium organization,BP,
17987,GO:0097598,1,0.98632152263191,0,2,sperm cytoplasmic droplet,CC,
17988,GO:0097602,1,0.901838168357849,0,14,cullin family protein binding,MF,
17989,GO:0097603,1,0.979887848868868,0,3,temperature-gated ion channel activity,MF,
17990,GO:0097604,1,0.986186655719239,0,2,temperature-gated cation channel activity,MF,
17991,GO:0097610,1,0.709350025130408,0,48,cell surface furrow,CC,
17992,GO:0097617,1,0.914167748144226,0,13,annealing activity,MF,
17993,GO:0097623,1,0.94987819082321,0,7,potassium ion export across plasma membrane,BP,
17994,GO:0097625,1,0.993986332273392,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17995,GO:0097626,1,0.993986332273392,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17996,GO:0097627,1,0.993986332273392,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17997,GO:0097629,1,0.979477483186224,0,3,extrinsic component of omegasome membrane,CC,
17998,GO:0097630,1,0.992294630214608,0,1,intrinsic component of omegasome membrane,CC,
17999,GO:0097631,1,0.992294630214608,0,1,integral component of omegasome membrane,CC,
18000,GO:0097632,1,0.986312523919377,0,2,extrinsic component of pre-autophagosomal structure membrane,CC,
18001,GO:0097635,1,0.987872564483907,0,2,extrinsic component of autophagosome membrane,CC,
18002,GO:0097636,1,0.986136956321732,0,2,intrinsic component of autophagosome membrane,CC,
18003,GO:0097637,1,0.986136956321732,0,2,integral component of autophagosome membrane,CC,
18004,GO:0097638,1,0.993986332273392,0,1,L-arginine import across plasma membrane,BP,
18005,GO:0097639,1,0.993986332273392,0,1,L-lysine import across plasma membrane,BP,
18006,GO:0097640,1,0.993986332273392,0,1,L-ornithine import across plasma membrane,BP,
18007,GO:0097642,1,0.971941338288452,0,4,calcitonin family receptor activity,MF,
18008,GO:0097644,1,0.993168294074626,0,1,calcitonin family binding,MF,
18009,GO:0097648,1,0.981829810098774,0,3,G-protein coupled receptor complex,CC,
18010,GO:0097651,1,0.968065087307195,0,5,phosphatidylinositol 3-kinase complex, class I,CC,
18012,GO:0097676,1,0.980292540872999,0,3,histone H3-K36 dimethylation,BP,
18013,GO:0097677,1,0.976836099361436,0,3,STAT family protein binding,MF,
18014,GO:0097680,1,0.979846067812779,0,3,double-strand break repair via classical nonhomologous end joining,BP,
18015,GO:0097681,1,0.988008547509925,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
18016,GO:0097688,1,0.966229878100412,0,5,glutamate receptor clustering,BP,
18017,GO:0097689,1,0.992905325785656,0,1,iron channel activity,MF,
18018,GO:0097692,1,0.993986332266784,0,1,histone H3-K4 monomethylation,BP,
18019,GO:0097694,1,0.980616960473097,0,3,establishment of RNA localization to telomere,BP,
18020,GO:0097695,1,0.980616960473097,0,3,establishment of macromolecular complex localization to telomere,BP,
18022,GO:0097699,1,0.993791061356548,0,1,vascular endothelial cell response to fluid shear stress,BP,
18024,GO:0097709,1,0.958346817153055,0,6,connective tissue replacement,BP,
18025,GO:0097711,1,0.517625057199844,0,93,ciliary basal body docking,BP,
18026,GO:0097718,1,0.804043780942079,0,31,disordered domain specific binding,MF,
18027,GO:0097720,1,0.836909956219429,0,25,calcineurin-mediated signaling,BP,
18029,GO:0097724,1,0.992170942807503,0,1,sperm flagellum movement,BP,
18030,GO:0097726,1,0.992170027168696,0,1,LEM domain binding,MF,
18031,GO:0097729,1,0.585785560483468,0,71,9+2 motile cilium,CC,
18032,GO:0097730,1,0.406533414926037,0,126,non-motile cilium,CC,
18033,GO:0097731,1,0.490703846083114,0,100,9+0 non-motile cilium,CC,
18034,GO:0097732,1,0.935465331516368,0,9,9+2 non-motile cilium,CC,
18035,GO:0097733,1,0.490703846083114,0,100,photoreceptor cell cilium,CC,
18036,GO:0097734,1,0.868017674961001,0,19,extracellular exosome biogenesis,BP,
18037,GO:0097742,1,0.973730021107419,0,4,de novo centriole assembly,BP,
18038,GO:0097746,1,0.405771256343697,0,123,regulation of blood vessel diameter,BP,
18039,GO:0097747,1,0.734024198751296,0,42,RNA polymerase activity,MF,
18040,GO:0097755,1,0.667629618495399,0,55,positive regulation of blood vessel diameter,BP,
18041,GO:0097756,1,0.559056559393868,0,80,negative regulation of blood vessel diameter,BP,
18042,GO:0098501,1,0.963030101786318,0,5,polynucleotide dephosphorylation,BP,
18043,GO:0098502,1,0.976692179115105,0,3,DNA dephosphorylation,BP,
18044,GO:0098503,1,0.992170094332629,0,1,DNA 3' dephosphorylation,BP,
18045,GO:0098504,1,0.992170094332629,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
18046,GO:0098505,1,0.942280795469627,0,8,G-rich strand telomeric DNA binding,MF,
18047,GO:0098506,1,0.992170094332629,0,1,polynucleotide 3' dephosphorylation,BP,
18048,GO:0098507,1,0.986014449043302,0,2,polynucleotide 5' dephosphorylation,BP,
18049,GO:0098518,1,0.978293202797775,0,3,polynucleotide phosphatase activity,MF,
18050,GO:0098519,1,0.963846944304026,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
18051,GO:0098528,1,0.965238094068301,0,5,skeletal muscle fiber differentiation,BP,
18052,GO:0098530,1,0.993986328369309,0,1,positive regulation of strand invasion,BP,
18053,GO:0098531,1,0.722150454282941,0,46,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
18054,GO:0098532,1,0.951603034599468,0,7,histone H3-K27 trimethylation,BP,
18056,GO:0098534,1,0.818152364867088,0,29,centriole assembly,BP,
18057,GO:0098535,1,0.973730021107419,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
18058,GO:0098536,1,0.973202163838236,0,4,deuterosome,CC,
18060,GO:0098543,1,0.913470699271293,0,13,detection of other organism,BP,
18061,GO:0098547,1,0.992205546208959,0,1,lumenal side of Golgi membrane,CC,
18063,GO:0098553,1,0.807583033434649,0,28,lumenal side of endoplasmic reticulum membrane,CC,
18064,GO:0098554,1,0.935978929759168,0,9,cytoplasmic side of endoplasmic reticulum membrane,CC,
18065,GO:0098556,1,0.992170061138958,0,1,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
18066,GO:0098559,1,0.984665115376429,0,2,cytoplasmic side of early endosome membrane,CC,
18068,GO:0098563,1,0.877687621320864,0,18,intrinsic component of synaptic vesicle membrane,CC,
18070,GO:0098574,1,0.98528841096348,0,2,cytoplasmic side of lysosomal membrane,CC,
18071,GO:0098575,1,0.984444933356257,0,2,lumenal side of lysosomal membrane,CC,
18072,GO:0098576,1,0.969877829213939,0,4,lumenal side of membrane,CC,
18073,GO:0098581,1,0.880005032882884,0,18,detection of external biotic stimulus,BP,
18074,GO:0098582,1,0.987221871916938,0,2,innate vocalization behavior,BP,
18075,GO:0098583,1,0.984400887816991,0,2,learned vocalization behavior,BP,
18076,GO:0098586,1,0.754178252923517,0,40,cellular response to virus,BP,
18080,GO:0098592,1,0.978738083835885,0,3,cytoplasmic side of apical plasma membrane,CC,
18081,GO:0098594,1,0.992170027168696,0,1,mucin granule,CC,
18082,GO:0098595,1,0.992205013245353,0,1,perivitelline space,CC,
18083,GO:0098596,1,0.956410667945413,0,7,imitative learning,BP,
18084,GO:0098597,1,0.950657132489038,0,8,observational learning,BP,
18085,GO:0098598,1,0.941486354185168,0,9,learned vocalization behavior or vocal learning,BP,
18087,GO:0098601,1,0.992956470832992,0,1,selenomethionine adenosyltransferase activity,MF,
18090,GO:0098619,1,0.992172569730502,0,1,selenocysteine-tRNA ligase activity,MF,
18091,GO:0098621,1,0.993985996998329,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
18092,GO:0098625,1,0.99334473179855,0,1,methylselenol reductase activity,MF,
18093,GO:0098626,1,0.99334473179855,0,1,methylseleninic acid reductase activity,MF,
18094,GO:0098631,1,0.766068872931791,0,38,protein binding involved in cell adhesion,MF,
18095,GO:0098632,1,0.80171644149758,0,31,protein binding involved in cell-cell adhesion,MF,
18096,GO:0098633,1,0.992283827532767,0,1,collagen fibril binding,MF,
18097,GO:0098634,1,0.955610967901359,0,7,protein binding involved in cell-matrix adhesion,MF,
18098,GO:0098636,1,0.792456297320116,0,35,protein complex involved in cell adhesion,CC,
18099,GO:0098637,1,0.993459902615453,0,1,protein complex involved in cell-matrix adhesion,CC,
18100,GO:0098639,1,0.969496781579023,0,5,collagen binding involved in cell-matrix adhesion,MF,
18101,GO:0098640,1,0.985680741300485,0,2,integrin binding involved in cell-matrix adhesion,MF,
18102,GO:0098641,1,0.872945427657729,0,18,cadherin binding involved in cell-cell adhesion,MF,
18103,GO:0098642,1,0.957046888645072,0,7,network-forming collagen trimer,CC,
18104,GO:0098643,1,0.927220559705398,0,12,banded collagen fibril,CC,
18105,GO:0098644,1,0.882029188410879,0,20,complex of collagen trimers,CC,
18106,GO:0098645,1,0.957046888645072,0,7,collagen network,CC,
18107,GO:0098646,1,0.992324105190772,0,1,collagen sheet,CC,
18108,GO:0098647,1,0.979976250009845,0,3,collagen beaded filament,CC,
18109,GO:0098648,1,0.993986332281451,0,1,collagen anchoring fibril,CC,
18110,GO:0098651,1,0.95127995676678,0,8,basement membrane collagen trimer,CC,
18111,GO:0098652,1,0.993986332281451,0,1,collagen type VII anchoring fibril,CC,
18115,GO:0098659,1,0.791599766086576,0,34,inorganic cation import into cell,BP,
18119,GO:0098664,1,0.818390969743134,0,26,G-protein coupled serotonin receptor signaling pathway,BP,
18120,GO:0098665,1,0.984434987237186,0,2,serotonin receptor complex,CC,
18121,GO:0098668,1,0.94987819082321,0,7,potassium ion export from cell,BP,
18122,GO:0098679,1,0.988008547491708,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18123,GO:0098680,1,0.993518782405315,0,1,template-free RNA nucleotidyltransferase,MF,
18124,GO:0098687,1,0.0900728861239228,0,331,chromosomal region,CC,
18126,GO:0098703,1,0.953781052814945,0,7,calcium ion import across plasma membrane,BP,
18127,GO:0098704,1,0.992219791379029,0,1,carbohydrate import across plasma membrane,BP,
18128,GO:0098706,1,0.992899334333019,0,1,ferric iron import across plasma membrane,BP,
18129,GO:0098711,1,0.992899334333019,0,1,iron ion import across plasma membrane,BP,
18130,GO:0098719,1,0.914979312738341,0,13,sodium ion import across plasma membrane,BP,
18131,GO:0098722,1,0.937744114413635,0,9,asymmetric stem cell division,BP,
18132,GO:0098727,1,0.349294641455346,0,150,maintenance of cell number,BP,
18133,GO:0098728,1,0.970484013457225,0,4,germline stem cell asymmetric division,BP,
18136,GO:0098735,1,0.968369702983916,0,5,positive regulation of the force of heart contraction,BP,
18137,GO:0098736,1,0.993986332279396,0,1,negative regulation of the force of heart contraction,BP,
18138,GO:0098739,1,0.811698391633632,0,30,import across plasma membrane,BP,
18139,GO:0098742,1,0.213683963508181,0,222,cell-cell adhesion via plasma-membrane adhesion molecules,BP,
18140,GO:0098743,1,0.853083127397597,0,22,cell aggregation,BP,
18141,GO:0098745,1,0.992170144174095,0,1,Dcp1-Dcp2 complex,CC,
18142,GO:0098746,1,0.993907698279629,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18143,GO:0098748,1,0.927410672758731,0,11,endocytic adaptor activity,MF,
18144,GO:0098749,1,0.993852936225644,0,1,cerebellar neuron development,BP,
18145,GO:0098751,1,0.799853597241186,0,32,bone cell development,BP,
18147,GO:0098756,1,0.99281727908318,0,1,response to interleukin-21,BP,
18148,GO:0098757,1,0.99281727908318,0,1,cellular response to interleukin-21,BP,
18149,GO:0098758,1,0.977522518325922,0,3,response to interleukin-8,BP,
18150,GO:0098759,1,0.977522518325922,0,3,cellular response to interleukin-8,BP,
18151,GO:0098760,1,0.976843681167921,0,3,response to interleukin-7,BP,
18152,GO:0098761,1,0.976843681167921,0,3,cellular response to interleukin-7,BP,
18153,GO:0098770,1,0.98731319761081,0,2,FBXO family protein binding,MF,
18157,GO:0098779,1,0.939161184267142,0,9,positive regulation of macromitophagy in response to mitochondrial depolarization,BP,
18158,GO:0098780,1,0.878811509005494,0,18,response to mitochondrial depolarisation,BP,
18160,GO:0098782,1,0.992170683749517,0,1,mechanically-gated potassium channel activity,MF,
18161,GO:0098787,1,0.916547122939057,0,12,mRNA cleavage involved in mRNA processing,BP,
18162,GO:0098789,1,0.936632037812853,0,9,pre-mRNA cleavage required for polyadenylation,BP,
18163,GO:0098791,1,0.133277693333865,0,282,Golgi subcompartment,CC,
18164,GO:0098792,1,0.943424892871506,0,8,xenophagy,BP,
18167,GO:0098795,1,0.985491015751861,0,2,mRNA cleavage involved in gene silencing,BP,
18171,GO:0098799,1,0.911919946504236,0,12,outer mitochondrial membrane protein complex,CC,
18172,GO:0098800,1,0.427566466065948,0,109,inner mitochondrial membrane protein complex,CC,
18173,GO:0098801,1,0.779190121797073,0,34,regulation of renal system process,BP,
18175,GO:0098803,1,0.579859753949683,0,70,respiratory chain complex,CC,
18177,GO:0098808,1,0.984529218200494,0,2,mRNA cap binding,MF,
18178,GO:0098809,1,0.992312759411149,0,1,nitrite reductase activity,MF,
18179,GO:0098810,1,0.886670211032399,0,17,neurotransmitter reuptake,BP,
18180,GO:0098811,1,0.679938347565558,0,55,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,
18181,GO:0098813,1,0.145651144522484,0,265,nuclear chromosome segregation,BP,
18182,GO:0098814,1,0.981903784198376,0,3,spontaneous synaptic transmission,BP,
18183,GO:0098815,1,0.801674059389926,0,33,modulation of excitatory postsynaptic potential,BP,
18184,GO:0098821,1,0.967384113802343,0,5,BMP receptor activity,MF,
18185,GO:0098822,1,0.992255841119061,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18186,GO:0098827,1,0.86537176589121,0,20,endoplasmic reticulum subcompartment,CC,
18187,GO:0098828,1,0.958093665369526,0,7,modulation of inhibitory postsynaptic potential,BP,
18188,GO:0098829,1,0.993986332267994,0,1,intestinal folate absorption,BP,
18189,GO:0098830,1,0.993910504589606,0,1,presynaptic endosome,CC,
18190,GO:0098831,1,0.988008547554871,0,2,presynaptic active zone cytoplasmic component,CC,
18191,GO:0098833,1,0.993935696456935,0,1,presynaptic endocytic zone,CC,
18192,GO:0098835,1,0.993935696456935,0,1,presynaptic endocytic zone membrane,CC,
18193,GO:0098837,1,0.984937529442745,0,2,postsynaptic recycling endosome,CC,
18194,GO:0098838,1,0.992448488883306,0,1,reduced folate transmembrane transport,BP,
18195,GO:0098839,1,0.956041053482974,0,7,postsynaptic density membrane,CC,
18196,GO:0098840,1,0.724943109937273,0,46,protein transport along microtubule,BP,
18197,GO:0098843,1,0.993986332273813,0,1,postsynaptic endocytic zone,CC,
18198,GO:0098844,1,0.993986332273813,0,1,postsynaptic endocytic zone membrane,CC,
18199,GO:0098845,1,0.971140794607341,0,4,postsynaptic endosome,CC,
18200,GO:0098847,1,0.922014100267033,0,11,sequence-specific single stranded DNA binding,MF,
18201,GO:0098850,1,0.992174264801851,0,1,extrinsic component of synaptic vesicle membrane,CC,
18202,GO:0098852,1,0.0972853414142779,0,322,lytic vacuole membrane,CC,
18203,GO:0098855,1,0.98104410692483,0,3,HCN channel complex,CC,
18204,GO:0098856,1,0.900162500496314,0,14,intestinal lipid absorption,BP,
18206,GO:0098858,1,0.288016954595525,0,178,actin-based cell projection,CC,
18207,GO:0098862,1,0.382515739742805,0,136,cluster of actin-based cell projections,CC,
18208,GO:0098868,1,0.848706290946985,0,23,bone growth,BP,
18210,GO:0098870,1,0.952723829751616,0,7,action potential propagation,BP,
18211,GO:0098871,1,0.99217003851742,0,1,postsynaptic actin cytoskeleton,CC,
18212,GO:0098875,1,0.993888850077642,0,1,epididymosome,CC,
18213,GO:0098876,1,0.615346245607547,0,68,vesicle-mediated transport to the plasma membrane,BP,
18214,GO:0098877,1,0.922182235536252,0,11,neurotransmitter receptor transport to plasma membrane,BP,
18216,GO:0098881,1,0.971081487731069,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18217,GO:0098883,1,0.992170588866352,0,1,synapse disassembly,BP,
18218,GO:0098884,1,0.993986332273813,0,1,postsynaptic neurotransmitter receptor internalization,BP,
18219,GO:0098885,1,0.988008547477284,0,2,modification of postsynaptic actin cytoskeleton,BP,
18220,GO:0098886,1,0.986302683646763,0,2,modification of dendritic spine,BP,
18221,GO:0098887,1,0.964029346421248,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18222,GO:0098888,1,0.993986332271893,0,1,extrinsic component of presynaptic membrane,CC,
18223,GO:0098890,1,0.993986332271893,0,1,extrinsic component of postsynaptic membrane,CC,
18224,GO:0098895,1,0.993650749510594,0,1,postsynaptic endosome membrane,CC,
18225,GO:0098900,1,0.721614268691156,0,48,regulation of action potential,BP,
18226,GO:0098901,1,0.836325243607777,0,27,regulation of cardiac muscle cell action potential,BP,
18227,GO:0098902,1,0.959503626364696,0,6,regulation of membrane depolarization during action potential,BP,
18228,GO:0098903,1,0.947206480088259,0,8,regulation of membrane repolarization during action potential,BP,
18229,GO:0098904,1,0.979111396100842,0,3,regulation of AV node cell action potential,BP,
18230,GO:0098905,1,0.984944700959493,0,2,regulation of bundle of His cell action potential,BP,
18231,GO:0098906,1,0.992718098684504,0,1,regulation of Purkinje myocyte action potential,BP,
18232,GO:0098907,1,0.988008547516835,0,2,regulation of SA node cell action potential,BP,
18233,GO:0098908,1,0.963706188008371,0,5,regulation of neuronal action potential,BP,
18234,GO:0098909,1,0.945780943306902,0,8,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18235,GO:0098910,1,0.962340626349308,0,6,regulation of atrial cardiac muscle cell action potential,BP,
18236,GO:0098911,1,0.912849053981689,0,14,regulation of ventricular cardiac muscle cell action potential,BP,
18237,GO:0098912,1,0.981735458470034,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18238,GO:0098914,1,0.957075809196246,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18239,GO:0098915,1,0.917124159278106,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18241,GO:0098917,1,0.975708480570846,0,4,retrograde trans-synaptic signaling,BP,
18242,GO:0098918,1,0.992170659099527,0,1,structural constituent of synapse,MF,
18243,GO:0098920,1,0.993986324731416,0,1,retrograde trans-synaptic signaling by lipid,BP,
18244,GO:0098921,1,0.993986324731416,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
18245,GO:0098923,1,0.993986332271339,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18246,GO:0098924,1,0.993986332271339,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18247,GO:0098927,1,0.772205055393562,0,37,vesicle-mediated transport between endosomal compartments,BP,
18248,GO:0098928,1,0.988008547554871,0,2,presynaptic signal transduction,BP,
18249,GO:0098930,1,0.76668041602114,0,38,axonal transport,BP,
18250,GO:0098935,1,0.9808867301501,0,3,dendritic transport,BP,
18251,GO:0098936,1,0.96366024657763,0,6,intrinsic component of postsynaptic membrane,CC,
18252,GO:0098937,1,0.9808867301501,0,3,anterograde dendritic transport,BP,
18253,GO:0098939,1,0.993986332268259,0,1,dendritic transport of mitochondrion,BP,
18254,GO:0098942,1,0.99393002522899,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18255,GO:0098943,1,0.986127842251241,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18256,GO:0098948,1,0.981967524123308,0,3,intrinsic component of postsynaptic specialization membrane,CC,
18257,GO:0098953,1,0.992170027168696,0,1,receptor diffusion trapping,BP,
18258,GO:0098957,1,0.993920748268155,0,1,anterograde axonal transport of mitochondrion,BP,
18259,GO:0098960,1,0.865084205805922,0,20,postsynaptic neurotransmitter receptor activity,MF,
18260,GO:0098967,1,0.971081487731069,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18261,GO:0098968,1,0.993969206660668,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18262,GO:0098969,1,0.928832069646703,0,10,neurotransmitter receptor transport to postsynaptic membrane,BP,
18263,GO:0098970,1,0.992170027168696,0,1,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18264,GO:0098971,1,0.986821762249762,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18265,GO:0098972,1,0.993986332268259,0,1,anterograde dendritic transport of mitochondrion,BP,
18266,GO:0098973,1,0.992170659099527,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18267,GO:0098974,1,0.992170659099527,0,1,postsynaptic actin cytoskeleton organization,BP,
18268,GO:0098976,1,0.992253294773601,0,1,excitatory chemical synaptic transmission,BP,
18269,GO:0098982,1,0.992611813960003,0,1,GABA-ergic synapse,CC,
18270,GO:0098984,1,0.264305069316364,0,196,neuron to neuron synapse,CC,
18271,GO:0098988,1,0.968058192071487,0,5,G-protein coupled glutamate receptor activity,MF,
18272,GO:0098989,1,0.986203080779376,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18273,GO:0098992,1,0.992261423388227,0,1,neuronal dense core vesicle,CC,
18274,GO:0098993,1,0.977263773435208,0,3,anchored component of synaptic vesicle membrane,CC,
18275,GO:0098999,1,0.993650749510594,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18276,GO:0099003,1,0.418326244157961,0,125,vesicle-mediated transport in synapse,BP,
18277,GO:0099004,1,0.982035411057585,0,3,calmodulin dependent kinase signaling pathway,BP,
18278,GO:0099010,1,0.974474213796666,0,4,modification of postsynaptic structure,BP,
18279,GO:0099011,1,0.975624819924014,0,4,neuronal dense core vesicle exocytosis,BP,
18280,GO:0099023,1,0.639763732975102,0,63,tethering complex,CC,
18281,GO:0099024,1,0.748462008360716,0,40,plasma membrane invagination,BP,
18282,GO:0099038,1,0.993925354875959,0,1,ceramide-translocating ATPase activity,MF,
18283,GO:0099039,1,0.993925354875959,0,1,sphingolipid translocation,BP,
18284,GO:0099040,1,0.993925354875959,0,1,ceramide translocation,BP,
18285,GO:0099046,1,0.992170027168696,0,1,clearance of foreign intracellular nucleic acids,BP,
18286,GO:0099053,1,0.978732033934891,0,3,activating signal cointegrator 1 complex,CC,
18287,GO:0099054,1,0.900106764700368,0,16,presynapse assembly,BP,
18288,GO:0099055,1,0.96366024657763,0,6,integral component of postsynaptic membrane,CC,
18289,GO:0099060,1,0.981967524123308,0,3,integral component of postsynaptic specialization membrane,CC,
18290,GO:0099061,1,0.981967524123308,0,3,integral component of postsynaptic density membrane,CC,
18291,GO:0099068,1,0.927568764636093,0,12,postsynapse assembly,BP,
18292,GO:0099072,1,0.957680503630092,0,6,regulation of postsynaptic specialization membrane neurotransmitter receptor levels,BP,
18293,GO:0099073,1,0.986714656017819,0,2,mitochondrion-derived vesicle,CC,
18294,GO:0099074,1,0.985240724640178,0,2,mitochondrion to lysosome transport,BP,
18295,GO:0099075,1,0.985240724640178,0,2,mitochondrion-derived vesicle mediated transport,BP,
18296,GO:0099078,1,0.969171223138006,0,4,BORC complex,CC,
18299,GO:0099082,1,0.993583149764454,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
18300,GO:0099084,1,0.919375480144813,0,13,postsynaptic specialization organization,BP,
18301,GO:0099086,1,0.791793843439245,0,32,synaptonemal structure,CC,
18303,GO:0099095,1,0.917662082939607,0,12,ligand-gated anion channel activity,MF,
18304,GO:0099106,1,0.542015414892687,0,85,ion channel regulator activity,MF,
18305,GO:0099111,1,0.430176052014594,0,121,microtubule-based transport,BP,
18306,GO:0099118,1,0.724943109937273,0,46,microtubule-based protein transport,BP,
18307,GO:0099122,1,0.986186487552353,0,2,RNA polymerase II C-terminal domain binding,MF,
18308,GO:0099131,1,0.621004522343943,0,68,ATP hydrolysis coupled ion transmembrane transport,BP,
18309,GO:0099132,1,0.670117094814404,0,56,ATP hydrolysis coupled cation transmembrane transport,BP,
18310,GO:0099133,1,0.921276656483443,0,13,ATP hydrolysis coupled anion transmembrane transport,BP,
18311,GO:0099142,1,0.993986332266283,0,1,intracellular ATP-gated ion channel activity,MF,
18312,GO:0099400,1,0.993986332281396,0,1,caveola neck,CC,
18313,GO:0099402,1,0.992170027168696,0,1,plant organ development,BP,
18314,GO:0099403,1,0.988008547504246,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18315,GO:0099404,1,0.988008547504246,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18316,GO:0099500,1,0.896323996176588,0,15,vesicle fusion to plasma membrane,BP,
18317,GO:0099501,1,0.58694162692786,0,74,exocytic vesicle membrane,CC,
18320,GO:0099509,1,0.992285386866287,0,1,regulation of presynaptic cytosolic calcium ion concentration,BP,
18323,GO:0099514,1,0.883615270863479,0,17,synaptic vesicle cytoskeletal transport,BP,
18324,GO:0099515,1,0.96288721522273,0,6,actin filament-based transport,BP,
18325,GO:0099516,1,0.662063008953135,0,59,ion antiporter activity,MF,
18326,GO:0099517,1,0.883615270863479,0,17,synaptic vesicle transport along microtubule,BP,
18327,GO:0099518,1,0.757396117544113,0,40,vesicle cytoskeletal trafficking,BP,
18328,GO:0099525,1,0.975624819924014,0,4,presynaptic dense core vesicle exocytosis,BP,
18329,GO:0099526,1,0.988008547554871,0,2,presynapse to nucleus signaling pathway,BP,
18330,GO:0099528,1,0.96243973898217,0,5,G-protein coupled neurotransmitter receptor activity,MF,
18331,GO:0099529,1,0.870323712833939,0,19,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18332,GO:0099530,1,0.99398633227497,0,1,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18333,GO:0099531,1,0.360585170018635,0,145,presynaptic process involved in chemical synaptic transmission,BP,
18334,GO:0099532,1,0.987933172279157,0,2,synaptic vesicle endosomal processing,BP,
18337,GO:0099538,1,0.993583149764454,0,1,synaptic signaling via neuropeptide,BP,
18338,GO:0099540,1,0.993583149764454,0,1,trans-synaptic signaling by neuropeptide,BP,
18339,GO:0099541,1,0.981436086633748,0,3,trans-synaptic signaling by lipid,BP,
18340,GO:0099542,1,0.981436086633748,0,3,trans-synaptic signaling by endocannabinoid,BP,
18341,GO:0099543,1,0.993986332271339,0,1,trans-synaptic signaling by soluble gas,BP,
18342,GO:0099545,1,0.987888217754676,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18343,GO:0099548,1,0.993986332271339,0,1,trans-synaptic signaling by nitric oxide,BP,
18344,GO:0099550,1,0.9813721566156,0,3,trans-synaptic signalling, modulating synaptic transmission,BP,
18345,GO:0099552,1,0.98737442422182,0,2,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18346,GO:0099553,1,0.98737442422182,0,2,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18347,GO:0099557,1,0.993921583607268,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18348,GO:0099558,1,0.984400887813367,0,2,maintenance of synapse structure,BP,
18349,GO:0099563,1,0.959814199034958,0,6,modification of synaptic structure,BP,
18351,GO:0099566,1,0.98800851848388,0,2,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18353,GO:0099569,1,0.988008547554871,0,2,presynaptic cytoskeleton,CC,
18354,GO:0099571,1,0.99217003851742,0,1,postsynaptic cytoskeleton,CC,
18355,GO:0099572,1,0.271436244293921,0,192,postsynaptic specialization,CC,
18356,GO:0099580,1,0.987995003391728,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18357,GO:0099583,1,0.98800851848388,0,2,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18358,GO:0099587,1,0.791599766086576,0,34,inorganic ion import into cell,BP,
18359,GO:0099589,1,0.799288884646197,0,29,serotonin receptor activity,MF,
18360,GO:0099590,1,0.97260574211202,0,4,neurotransmitter receptor internalization,BP,
18362,GO:0099601,1,0.789192395112036,0,34,regulation of neurotransmitter receptor activity,BP,
18363,GO:0099602,1,0.95641223258824,0,6,neurotransmitter receptor regulator activity,MF,
18364,GO:0099604,1,0.890284401121392,0,18,ligand-gated calcium channel activity,MF,
18365,GO:0099607,1,0.99398633227858,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18366,GO:0099609,1,0.988008540688189,0,2,microtubule lateral binding,MF,
18367,GO:0099612,1,0.955784974859185,0,7,protein localization to axon,BP,
18368,GO:0099617,1,0.992944407222998,0,1,matrix side of mitochondrial inner membrane,CC,
18369,GO:0099622,1,0.796449900768272,0,32,cardiac muscle cell membrane repolarization,BP,
18370,GO:0099623,1,0.858301552458919,0,22,regulation of cardiac muscle cell membrane repolarization,BP,
18371,GO:0099624,1,0.938187958292273,0,9,atrial cardiac muscle cell membrane repolarization,BP,
18372,GO:0099625,1,0.855662288190452,0,22,ventricular cardiac muscle cell membrane repolarization,BP,
18373,GO:0099628,1,0.992170027168696,0,1,neurotransmitter receptor diffusion trapping,BP,
18374,GO:0099634,1,0.941122462841975,0,9,postsynaptic specialization membrane,CC,
18375,GO:0099637,1,0.903908764847525,0,14,neurotransmitter receptor transport,BP,
18376,GO:0099638,1,0.950565646232073,0,7,endosome to plasma membrane protein transport,BP,
18377,GO:0099639,1,0.957129520719646,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18378,GO:0099640,1,0.992170027168696,0,1,axo-dendritic protein transport,BP,
18379,GO:0099641,1,0.992170027168696,0,1,anterograde axonal protein transport,BP,
18380,GO:0099643,1,0.388773204672651,0,135,signal release from synapse,BP,
18381,GO:0099738,1,0.897226719725914,0,16,cell cortex region,CC,
18382,GO:0100001,1,0.993979989398885,0,1,regulation of skeletal muscle contraction by action potential,BP,
18383,GO:0100002,1,0.992466956723238,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18384,GO:0100012,1,0.977033934623942,0,3,regulation of heart induction by canonical Wnt signaling pathway,BP,
18385,GO:0100057,1,0.993986332273655,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18387,GO:0101003,1,0.650224372675654,0,60,ficolin-1-rich granule membrane,CC,
18388,GO:0101005,1,0.458517817927578,0,111,ubiquitinyl hydrolase activity,MF,
18389,GO:0101020,1,0.961840864515899,0,5,estrogen 16-alpha-hydroxylase activity,MF,
18390,GO:0101023,1,0.992170027168696,0,1,vascular endothelial cell proliferation,BP,
18391,GO:0101030,1,0.992170027168696,0,1,tRNA-guanine transglycosylation,BP,
18392,GO:0101031,1,0.911529815879185,0,12,chaperone complex,CC,
18393,GO:0102005,1,0.992170027168696,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18395,GO:0102008,1,0.993946022394624,0,1,cytosolic dipeptidase activity,MF,
18397,GO:0102076,1,0.992461920177581,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18398,GO:0102077,1,0.984424095840003,0,2,oleamide hydrolase activity,MF,
18399,GO:0102084,1,0.984885859324199,0,2,L-dopa O-methyltransferase activity,MF,
18400,GO:0102132,1,0.993986332277816,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18401,GO:0102279,1,0.993923335090433,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18402,GO:0102320,1,0.992406577664907,0,1,1,8-cineole 2-exo-monooxygenase activity,MF,
18406,GO:0102339,1,0.992287355983192,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18407,GO:0102340,1,0.992287355983192,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18408,GO:0102341,1,0.992287355983192,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18409,GO:0102342,1,0.992287355983192,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18410,GO:0102390,1,0.992331584816672,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18411,GO:0102391,1,0.944994393716838,0,8,decanoate--CoA ligase activity,MF,
18412,GO:0102483,1,0.992170032292588,0,1,scopolin beta-glucosidase activity,MF,
18413,GO:0102490,1,0.978750337987295,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18414,GO:0102522,1,0.992199340968259,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18415,GO:0102549,1,0.992170027168696,0,1,1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity,MF,
18416,GO:0102571,1,0.993961506598965,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18417,GO:0102704,1,0.992497375134058,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18418,GO:0102867,1,0.992382184418366,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18419,GO:0102991,1,0.947246973623292,0,7,myristoyl-CoA hydrolase activity,MF,
18420,GO:0103046,1,0.993946022394624,0,1,alanylglutamate dipeptidase activity,MF,
18421,GO:0103053,1,0.984535465976495,0,2,1-ethyladenine demethylase activity,MF,
18422,GO:0103073,1,0.984424095840003,0,2,anandamide amidohydrolase activity,MF,
18423,GO:0103095,1,0.984418522532904,0,2,wax ester synthase activity,MF,
18424,GO:0106001,1,0.972578326497652,0,4,intestinal hexose absorption,BP,
18427,GO:1900003,1,0.905674519811626,0,13,regulation of serine-type endopeptidase activity,BP,
18428,GO:1900004,1,0.920030166807668,0,11,negative regulation of serine-type endopeptidase activity,BP,
18429,GO:1900005,1,0.978486002169327,0,3,positive regulation of serine-type endopeptidase activity,BP,
18430,GO:1900006,1,0.645766094526458,0,65,positive regulation of dendrite development,BP,
18431,GO:1900010,1,0.992171098945668,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18432,GO:1900011,1,0.992171098945668,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18433,GO:1900015,1,0.841593751557548,0,24,regulation of cytokine production involved in inflammatory response,BP,
18434,GO:1900016,1,0.936478421302988,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18435,GO:1900017,1,0.928633495511406,0,10,positive regulation of cytokine production involved in inflammatory response,BP,
18436,GO:1900019,1,0.972325666689918,0,4,regulation of protein kinase C activity,BP,
18437,GO:1900020,1,0.972325666689918,0,4,positive regulation of protein kinase C activity,BP,
18438,GO:1900024,1,0.741052602433436,0,42,regulation of substrate adhesion-dependent cell spreading,BP,
18439,GO:1900025,1,0.92542733876712,0,11,negative regulation of substrate adhesion-dependent cell spreading,BP,
18440,GO:1900026,1,0.805883927503079,0,30,positive regulation of substrate adhesion-dependent cell spreading,BP,
18441,GO:1900027,1,0.858384053332452,0,21,regulation of ruffle assembly,BP,
18442,GO:1900028,1,0.963209453274254,0,5,negative regulation of ruffle assembly,BP,
18443,GO:1900029,1,0.951652666501847,0,7,positive regulation of ruffle assembly,BP,
18444,GO:1900034,1,0.593446835126515,0,74,regulation of cellular response to heat,BP,
18445,GO:1900035,1,0.992370926334135,0,1,negative regulation of cellular response to heat,BP,
18446,GO:1900036,1,0.992223220740732,0,1,positive regulation of cellular response to heat,BP,
18447,GO:1900037,1,0.929058225962548,0,10,regulation of cellular response to hypoxia,BP,
18448,GO:1900038,1,0.963879062327568,0,5,negative regulation of cellular response to hypoxia,BP,
18449,GO:1900039,1,0.985173239466739,0,2,positive regulation of cellular response to hypoxia,BP,
18450,GO:1900040,1,0.951549699236575,0,7,regulation of interleukin-2 secretion,BP,
18451,GO:1900041,1,0.970563846561031,0,4,negative regulation of interleukin-2 secretion,BP,
18452,GO:1900042,1,0.980413703124477,0,3,positive regulation of interleukin-2 secretion,BP,
18453,GO:1900044,1,0.954059706139695,0,7,regulation of protein K63-linked ubiquitination,BP,
18454,GO:1900045,1,0.973548862509906,0,4,negative regulation of protein K63-linked ubiquitination,BP,
18456,GO:1900047,1,0.698032752704525,0,48,negative regulation of hemostasis,BP,
18457,GO:1900048,1,0.837989208271519,0,24,positive regulation of hemostasis,BP,
18458,GO:1900052,1,0.992170027168696,0,1,regulation of retinoic acid biosynthetic process,BP,
18459,GO:1900053,1,0.992170027168696,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18460,GO:1900060,1,0.9708234557152,0,4,negative regulation of ceramide biosynthetic process,BP,
18461,GO:1900062,1,0.993263915554426,0,1,regulation of replicative cell aging,BP,
18462,GO:1900063,1,0.980121480781639,0,3,regulation of peroxisome organization,BP,
18463,GO:1900073,1,0.992170027168696,0,1,regulation of neuromuscular synaptic transmission,BP,
18464,GO:1900075,1,0.992170027168696,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18466,GO:1900077,1,0.794810431766012,0,32,negative regulation of cellular response to insulin stimulus,BP,
18468,GO:1900081,1,0.993986332279396,0,1,regulation of arginine catabolic process,BP,
18469,GO:1900082,1,0.993986332279396,0,1,negative regulation of arginine catabolic process,BP,
18470,GO:1900084,1,0.960533648732313,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18471,GO:1900085,1,0.992346481618393,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18472,GO:1900086,1,0.967943702857403,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18473,GO:1900087,1,0.825393945112297,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18474,GO:1900094,1,0.948221116350247,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18475,GO:1900095,1,0.993986332287271,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18476,GO:1900098,1,0.992170629164745,0,1,regulation of plasma cell differentiation,BP,
18477,GO:1900100,1,0.992170629164745,0,1,positive regulation of plasma cell differentiation,BP,
18478,GO:1900101,1,0.853476178977663,0,22,regulation of endoplasmic reticulum unfolded protein response,BP,
18479,GO:1900102,1,0.943345380902913,0,8,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18480,GO:1900103,1,0.911350593395873,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18481,GO:1900104,1,0.978228191813823,0,3,regulation of hyaluranon cable assembly,BP,
18482,GO:1900106,1,0.978228191813823,0,3,positive regulation of hyaluranon cable assembly,BP,
18483,GO:1900107,1,0.948563990160488,0,7,regulation of nodal signaling pathway,BP,
18484,GO:1900108,1,0.977039640401576,0,3,negative regulation of nodal signaling pathway,BP,
18485,GO:1900109,1,0.969140371065404,0,4,regulation of histone H3-K9 dimethylation,BP,
18486,GO:1900110,1,0.984400897877041,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18487,GO:1900111,1,0.984499538795935,0,2,positive regulation of histone H3-K9 dimethylation,BP,
18488,GO:1900112,1,0.926604357833698,0,11,regulation of histone H3-K9 trimethylation,BP,
18489,GO:1900113,1,0.958489135772338,0,6,negative regulation of histone H3-K9 trimethylation,BP,
18490,GO:1900114,1,0.980057730687058,0,3,positive regulation of histone H3-K9 trimethylation,BP,
18491,GO:1900115,1,0.902970499232855,0,14,extracellular regulation of signal transduction,BP,
18492,GO:1900116,1,0.902970499232855,0,14,extracellular negative regulation of signal transduction,BP,
18493,GO:1900117,1,0.846198927452674,0,23,regulation of execution phase of apoptosis,BP,
18494,GO:1900118,1,0.943611508484196,0,8,negative regulation of execution phase of apoptosis,BP,
18495,GO:1900119,1,0.915569943622606,0,12,positive regulation of execution phase of apoptosis,BP,
18496,GO:1900120,1,0.858827615073701,0,21,regulation of receptor binding,BP,
18497,GO:1900121,1,0.916123642224476,0,12,negative regulation of receptor binding,BP,
18498,GO:1900122,1,0.943506969237518,0,8,positive regulation of receptor binding,BP,
18499,GO:1900125,1,0.952997700783816,0,7,regulation of hyaluronan biosynthetic process,BP,
18500,GO:1900126,1,0.979358148748318,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18501,GO:1900127,1,0.973088283442205,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18502,GO:1900130,1,0.99316680860158,0,1,regulation of lipid binding,BP,
18503,GO:1900131,1,0.99316680860158,0,1,negative regulation of lipid binding,BP,
18504,GO:1900133,1,0.971266218386694,0,4,regulation of renin secretion into blood stream,BP,
18505,GO:1900134,1,0.993348402334297,0,1,negative regulation of renin secretion into blood stream,BP,
18506,GO:1900135,1,0.984944210550295,0,2,positive regulation of renin secretion into blood stream,BP,
18507,GO:1900138,1,0.978454500085227,0,3,negative regulation of phospholipase A2 activity,BP,
18508,GO:1900139,1,0.99394997896493,0,1,negative regulation of arachidonic acid secretion,BP,
18509,GO:1900141,1,0.992274033099043,0,1,regulation of oligodendrocyte apoptotic process,BP,
18510,GO:1900142,1,0.992274033099043,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18511,GO:1900145,1,0.963227348544071,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18512,GO:1900146,1,0.984400960021662,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18513,GO:1900147,1,0.986326940278684,0,2,regulation of Schwann cell migration,BP,
18514,GO:1900148,1,0.992294630214608,0,1,negative regulation of Schwann cell migration,BP,
18515,GO:1900149,1,0.993986332271682,0,1,positive regulation of Schwann cell migration,BP,
18516,GO:1900151,1,0.891685255465399,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18517,GO:1900152,1,0.992170816652278,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18518,GO:1900153,1,0.891685255465399,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18519,GO:1900154,1,0.985828990552501,0,2,regulation of bone trabecula formation,BP,
18520,GO:1900155,1,0.985828990552501,0,2,negative regulation of bone trabecula formation,BP,
18521,GO:1900157,1,0.97817029502792,0,3,regulation of bone mineralization involved in bone maturation,BP,
18522,GO:1900158,1,0.985828980084743,0,2,negative regulation of bone mineralization involved in bone maturation,BP,
18523,GO:1900159,1,0.992232086165117,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18524,GO:1900161,1,0.992415854146785,0,1,regulation of phospholipid scramblase activity,BP,
18525,GO:1900163,1,0.992415854146785,0,1,positive regulation of phospholipid scramblase activity,BP,
18526,GO:1900164,1,0.948221116350247,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18527,GO:1900165,1,0.944226401205374,0,8,negative regulation of interleukin-6 secretion,BP,
18528,GO:1900166,1,0.984767969296836,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18529,GO:1900168,1,0.984767969296836,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18530,GO:1900169,1,0.986326940305023,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18531,GO:1900170,1,0.992294630214608,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18532,GO:1900175,1,0.963227348544071,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18533,GO:1900176,1,0.984400960021662,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18535,GO:1900181,1,0.5763555625496,0,77,negative regulation of protein localization to nucleus,BP,
18536,GO:1900182,1,0.409438311458903,0,125,positive regulation of protein localization to nucleus,BP,
18537,GO:1900186,1,0.979247919971056,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18538,GO:1900190,1,0.984586107212501,0,2,regulation of single-species biofilm formation,BP,
18539,GO:1900191,1,0.984586107212501,0,2,negative regulation of single-species biofilm formation,BP,
18540,GO:1900193,1,0.955257724636909,0,6,regulation of oocyte maturation,BP,
18541,GO:1900194,1,0.977959363098945,0,3,negative regulation of oocyte maturation,BP,
18542,GO:1900195,1,0.984437913171533,0,2,positive regulation of oocyte maturation,BP,
18543,GO:1900200,1,0.979564495174672,0,3,mesenchymal cell apoptotic process involved in metanephros development,BP,
18544,GO:1900204,1,0.987045028388714,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18545,GO:1900205,1,0.987045028388714,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18546,GO:1900208,1,0.992170027168696,0,1,regulation of cardiolipin metabolic process,BP,
18547,GO:1900210,1,0.992170027168696,0,1,positive regulation of cardiolipin metabolic process,BP,
18548,GO:1900211,1,0.979564495174672,0,3,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18549,GO:1900212,1,0.979564495174672,0,3,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18550,GO:1900214,1,0.987045028388714,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18551,GO:1900215,1,0.987045028388714,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18552,GO:1900217,1,0.987045028388714,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18553,GO:1900218,1,0.987045028388714,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18554,GO:1900220,1,0.987841741915711,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18555,GO:1900221,1,0.959192322677334,0,6,regulation of beta-amyloid clearance,BP,
18556,GO:1900222,1,0.980011214901646,0,3,negative regulation of beta-amyloid clearance,BP,
18557,GO:1900223,1,0.993986332269864,0,1,positive regulation of beta-amyloid clearance,BP,
18558,GO:1900224,1,0.986216360783036,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18559,GO:1900225,1,0.931878153665341,0,10,regulation of NLRP3 inflammasome complex assembly,BP,
18560,GO:1900226,1,0.971687010108665,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18561,GO:1900227,1,0.966419666509735,0,5,positive regulation of NLRP3 inflammasome complex assembly,BP,
18562,GO:1900228,1,0.984586107212501,0,2,regulation of single-species biofilm formation in or on host organism,BP,
18563,GO:1900229,1,0.984586107212501,0,2,negative regulation of single-species biofilm formation in or on host organism,BP,
18564,GO:1900234,1,0.9933511495648,0,1,regulation of Kit signaling pathway,BP,
18565,GO:1900235,1,0.9933511495648,0,1,negative regulation of Kit signaling pathway,BP,
18566,GO:1900238,1,0.979013734015813,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18567,GO:1900239,1,0.980574864407936,0,3,regulation of phenotypic switching,BP,
18568,GO:1900241,1,0.992476801254136,0,1,positive regulation of phenotypic switching,BP,
18569,GO:1900242,1,0.947205479313786,0,8,regulation of synaptic vesicle endocytosis,BP,
18570,GO:1900243,1,0.993972109807993,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18571,GO:1900244,1,0.980073358874552,0,3,positive regulation of synaptic vesicle endocytosis,BP,
18572,GO:1900245,1,0.972745878137203,0,4,positive regulation of MDA-5 signaling pathway,BP,
18573,GO:1900246,1,0.95357493285247,0,7,positive regulation of RIG-I signaling pathway,BP,
18574,GO:1900247,1,0.988007658687182,0,2,regulation of cytoplasmic translational elongation,BP,
18575,GO:1900248,1,0.988007658687182,0,2,negative regulation of cytoplasmic translational elongation,BP,
18576,GO:1900259,1,0.992172360288366,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18577,GO:1900260,1,0.992172360288366,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18578,GO:1900262,1,0.954466744017928,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18579,GO:1900264,1,0.954466744017928,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18580,GO:1900271,1,0.87183207499537,0,20,regulation of long-term synaptic potentiation,BP,
18581,GO:1900272,1,0.971573959617914,0,4,negative regulation of long-term synaptic potentiation,BP,
18582,GO:1900273,1,0.93000725831406,0,11,positive regulation of long-term synaptic potentiation,BP,
18584,GO:1900275,1,0.987017953379178,0,2,negative regulation of phospholipase C activity,BP,
18585,GO:1900276,1,0.992990210383334,0,1,regulation of proteinase activated receptor activity,BP,
18586,GO:1900279,1,0.99304012820112,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18587,GO:1900281,1,0.99304012820112,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18588,GO:1900363,1,0.93155121981988,0,10,regulation of mRNA polyadenylation,BP,
18589,GO:1900364,1,0.952026007266445,0,7,negative regulation of mRNA polyadenylation,BP,
18590,GO:1900365,1,0.986224574359269,0,2,positive regulation of mRNA polyadenylation,BP,
18591,GO:1900368,1,0.98159856694254,0,3,regulation of RNA interference,BP,
18592,GO:1900369,1,0.987543787593255,0,2,negative regulation of RNA interference,BP,
18593,GO:1900370,1,0.993980378860827,0,1,positive regulation of RNA interference,BP,
18595,GO:1900372,1,0.720176597708451,0,45,negative regulation of purine nucleotide biosynthetic process,BP,
18597,GO:1900376,1,0.953427667838558,0,7,regulation of secondary metabolite biosynthetic process,BP,
18598,GO:1900377,1,0.980271740712847,0,3,negative regulation of secondary metabolite biosynthetic process,BP,
18599,GO:1900378,1,0.972619888519683,0,4,positive regulation of secondary metabolite biosynthetic process,BP,
18600,GO:1900383,1,0.992814348369774,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18601,GO:1900387,1,0.992184534684508,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18602,GO:1900390,1,0.984405049732661,0,2,regulation of iron ion import,BP,
18603,GO:1900402,1,0.941355919301108,0,9,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18607,GO:1900424,1,0.902810558627135,0,14,regulation of defense response to bacterium,BP,
18608,GO:1900425,1,0.971894769378315,0,4,negative regulation of defense response to bacterium,BP,
18609,GO:1900426,1,0.933727089880048,0,9,positive regulation of defense response to bacterium,BP,
18610,GO:1900449,1,0.790049916830568,0,34,regulation of glutamate receptor signaling pathway,BP,
18611,GO:1900451,1,0.960757402158817,0,6,positive regulation of glutamate receptor signaling pathway,BP,
18612,GO:1900452,1,0.956201606144496,0,7,regulation of long term synaptic depression,BP,
18613,GO:1900453,1,0.986246822935432,0,2,negative regulation of long term synaptic depression,BP,
18614,GO:1900454,1,0.987325420964702,0,2,positive regulation of long term synaptic depression,BP,
18615,GO:1900477,1,0.992182836408944,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18616,GO:1900483,1,0.992309623317894,0,1,regulation of protein targeting to vacuolar membrane,BP,
18617,GO:1900533,1,0.992170027168696,0,1,palmitic acid metabolic process,BP,
18618,GO:1900535,1,0.992170027168696,0,1,palmitic acid biosynthetic process,BP,
18620,GO:1900543,1,0.623068888177153,0,65,negative regulation of purine nucleotide metabolic process,BP,
18622,GO:1900619,1,0.971492302915501,0,4,acetate ester metabolic process,BP,
18623,GO:1900620,1,0.986342770265383,0,2,acetate ester biosynthetic process,BP,
18624,GO:1900623,1,0.980864549802476,0,3,regulation of monocyte aggregation,BP,
18625,GO:1900625,1,0.980864549802476,0,3,positive regulation of monocyte aggregation,BP,
18626,GO:1900673,1,0.978370244966943,0,3,olefin metabolic process,BP,
18627,GO:1900719,1,0.99394556584038,0,1,regulation of uterine smooth muscle relaxation,BP,
18628,GO:1900721,1,0.99394556584038,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18629,GO:1900736,1,0.969862131291804,0,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18630,GO:1900737,1,0.992990210383334,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18631,GO:1900738,1,0.976709918380706,0,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18632,GO:1900739,1,0.808065105360631,0,29,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18633,GO:1900740,1,0.808065105360631,0,29,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18634,GO:1900744,1,0.822662155869434,0,28,regulation of p38MAPK cascade,BP,
18635,GO:1900745,1,0.880628667102689,0,18,positive regulation of p38MAPK cascade,BP,
18636,GO:1900746,1,0.933274780882401,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18637,GO:1900747,1,0.972418150922327,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18638,GO:1900748,1,0.981975408688315,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18639,GO:1900750,1,0.913156750330193,0,12,oligopeptide binding,MF,
18640,GO:1900756,1,0.986413679977087,0,2,protein processing in phagocytic vesicle,BP,
18641,GO:1900757,1,0.992170027168696,0,1,regulation of D-amino-acid oxidase activity,BP,
18642,GO:1900758,1,0.992170027168696,0,1,negative regulation of D-amino-acid oxidase activity,BP,
18643,GO:1900825,1,0.965310279644075,0,5,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18644,GO:1900826,1,0.992170027168696,0,1,negative regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18645,GO:1900827,1,0.993986332284452,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18647,GO:1900920,1,0.988005481790986,0,2,regulation of L-glutamate import,BP,
18648,GO:1901004,1,0.992170027168696,0,1,ubiquinone-6 metabolic process,BP,
18649,GO:1901006,1,0.992170027168696,0,1,ubiquinone-6 biosynthetic process,BP,
18650,GO:1901016,1,0.750313481897667,0,41,regulation of potassium ion transmembrane transporter activity,BP,
18651,GO:1901017,1,0.906010811680629,0,14,negative regulation of potassium ion transmembrane transporter activity,BP,
18652,GO:1901018,1,0.908081204948993,0,14,positive regulation of potassium ion transmembrane transporter activity,BP,
18654,GO:1901020,1,0.801024696270077,0,30,negative regulation of calcium ion transmembrane transporter activity,BP,
18656,GO:1901026,1,0.973122852074745,0,4,ripoptosome assembly involved in necroptotic process,BP,
18659,GO:1901030,1,0.761527508261525,0,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18661,GO:1901032,1,0.88990497223914,0,16,negative regulation of response to reactive oxygen species,BP,
18663,GO:1901042,1,0.992302628349193,0,1,positive regulation of L-arginine import,BP,
18666,GO:1901068,1,0.719548092351939,0,46,guanosine-containing compound metabolic process,BP,
18667,GO:1901069,1,0.984400887813367,0,2,guanosine-containing compound catabolic process,BP,
18668,GO:1901070,1,0.903228914816146,0,13,guanosine-containing compound biosynthetic process,BP,
18669,GO:1901071,1,0.869822994011679,0,19,glucosamine-containing compound metabolic process,BP,
18670,GO:1901072,1,0.969614294216459,0,4,glucosamine-containing compound catabolic process,BP,
18671,GO:1901073,1,0.987352947252051,0,2,glucosamine-containing compound biosynthetic process,BP,
18672,GO:1901074,1,0.98638608301237,0,2,regulation of engulfment of apoptotic cell,BP,
18673,GO:1901076,1,0.993986332269864,0,1,positive regulation of engulfment of apoptotic cell,BP,
18674,GO:1901077,1,0.91707689012831,0,12,regulation of relaxation of muscle,BP,
18675,GO:1901078,1,0.972311631158869,0,4,negative regulation of relaxation of muscle,BP,
18676,GO:1901079,1,0.978514064239186,0,3,positive regulation of relaxation of muscle,BP,
18677,GO:1901080,1,0.99394556584038,0,1,regulation of relaxation of smooth muscle,BP,
18678,GO:1901082,1,0.99394556584038,0,1,positive regulation of relaxation of smooth muscle,BP,
18679,GO:1901086,1,0.993954967944533,0,1,benzylpenicillin metabolic process,BP,
18680,GO:1901090,1,0.984964473105676,0,2,regulation of protein tetramerization,BP,
18681,GO:1901091,1,0.984964473105676,0,2,negative regulation of protein tetramerization,BP,
18682,GO:1901093,1,0.984964473105676,0,2,regulation of protein homotetramerization,BP,
18683,GO:1901094,1,0.984964473105676,0,2,negative regulation of protein homotetramerization,BP,
18684,GO:1901096,1,0.941124863733809,0,9,regulation of autophagosome maturation,BP,
18685,GO:1901097,1,0.98529553125667,0,2,negative regulation of autophagosome maturation,BP,
18686,GO:1901098,1,0.961566957424973,0,6,positive regulation of autophagosome maturation,BP,
18687,GO:1901099,1,0.783095412575421,0,33,negative regulation of signal transduction in absence of ligand,BP,
18688,GO:1901128,1,0.99220653731591,0,1,gentamycin metabolic process,BP,
18692,GO:1901142,1,0.959525287495644,0,6,insulin metabolic process,BP,
18693,GO:1901143,1,0.987033165088331,0,2,insulin catabolic process,BP,
18694,GO:1901145,1,0.973234941875163,0,4,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18695,GO:1901146,1,0.992422054065019,0,1,mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
18696,GO:1901147,1,0.987045028388714,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18697,GO:1901159,1,0.962605280295254,0,5,xylulose 5-phosphate biosynthetic process,BP,
18698,GO:1901160,1,0.910929335570264,0,13,primary amino compound metabolic process,BP,
18699,GO:1901162,1,0.969137598749789,0,4,primary amino compound biosynthetic process,BP,
18700,GO:1901163,1,0.941953826779044,0,8,regulation of trophoblast cell migration,BP,
18701,GO:1901164,1,0.963230189386759,0,5,negative regulation of trophoblast cell migration,BP,
18702,GO:1901165,1,0.97791783687121,0,3,positive regulation of trophoblast cell migration,BP,
18703,GO:1901166,1,0.972218171757487,0,4,neural crest cell migration involved in autonomic nervous system development,BP,
18705,GO:1901185,1,0.689270960361182,0,52,negative regulation of ERBB signaling pathway,BP,
18707,GO:1901187,1,0.986261358435691,0,2,regulation of ephrin receptor signaling pathway,BP,
18708,GO:1901189,1,0.992228654678653,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18709,GO:1901193,1,0.992170027168696,0,1,regulation of formation of translation preinitiation complex,BP,
18710,GO:1901194,1,0.992170027168696,0,1,negative regulation of formation of translation preinitiation complex,BP,
18711,GO:1901201,1,0.92319358557018,0,12,regulation of extracellular matrix assembly,BP,
18712,GO:1901202,1,0.992227048603077,0,1,negative regulation of extracellular matrix assembly,BP,
18713,GO:1901203,1,0.943326329920675,0,9,positive regulation of extracellular matrix assembly,BP,
18714,GO:1901204,1,0.988008547482493,0,2,regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18715,GO:1901205,1,0.988008547482493,0,2,negative regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18716,GO:1901206,1,0.993986332271339,0,1,positive regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18717,GO:1901207,1,0.986470091130215,0,2,regulation of heart looping,BP,
18718,GO:1901208,1,0.992929350653873,0,1,negative regulation of heart looping,BP,
18719,GO:1901210,1,0.992929350653873,0,1,regulation of cardiac chamber formation,BP,
18720,GO:1901211,1,0.992929350653873,0,1,negative regulation of cardiac chamber formation,BP,
18721,GO:1901213,1,0.911012743086903,0,13,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18724,GO:1901216,1,0.620740205442724,0,67,positive regulation of neuron death,BP,
18725,GO:1901219,1,0.992929350653873,0,1,regulation of cardiac chamber morphogenesis,BP,
18726,GO:1901220,1,0.992929350653873,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18727,GO:1901222,1,0.68505553480363,0,52,regulation of NIK/NF-kappaB signaling,BP,
18728,GO:1901223,1,0.929930615634271,0,10,negative regulation of NIK/NF-kappaB signaling,BP,
18729,GO:1901224,1,0.751889455919273,0,39,positive regulation of NIK/NF-kappaB signaling,BP,
18730,GO:1901228,1,0.973854839420635,0,4,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18731,GO:1901229,1,0.992307852066953,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18732,GO:1901231,1,0.992307852066953,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18733,GO:1901232,1,0.992307852066953,0,1,regulation of convergent extension involved in axis elongation,BP,
18734,GO:1901233,1,0.992307852066953,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18735,GO:1901246,1,0.984558289514781,0,2,regulation of lung ciliated cell differentiation,BP,
18736,GO:1901247,1,0.992170027168696,0,1,negative regulation of lung ciliated cell differentiation,BP,
18737,GO:1901248,1,0.992328661417844,0,1,positive regulation of lung ciliated cell differentiation,BP,
18738,GO:1901249,1,0.992170027168696,0,1,regulation of lung goblet cell differentiation,BP,
18739,GO:1901251,1,0.992170027168696,0,1,positive regulation of lung goblet cell differentiation,BP,
18740,GO:1901252,1,0.978278276951768,0,3,regulation of intracellular transport of viral material,BP,
18741,GO:1901253,1,0.984430919168614,0,2,negative regulation of intracellular transport of viral material,BP,
18742,GO:1901254,1,0.993750815841981,0,1,positive regulation of intracellular transport of viral material,BP,
18743,GO:1901255,1,0.986203080777105,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18744,GO:1901256,1,0.970405697081348,0,4,regulation of macrophage colony-stimulating factor production,BP,
18745,GO:1901257,1,0.992220015278462,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18746,GO:1901258,1,0.9847970834031,0,2,positive regulation of macrophage colony-stimulating factor production,BP,
18749,GO:1901269,1,0.992170027168696,0,1,lipooligosaccharide metabolic process,BP,
18750,GO:1901271,1,0.992170027168696,0,1,lipooligosaccharide biosynthetic process,BP,
18751,GO:1901291,1,0.992173008333194,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18754,GO:1901295,1,0.984459617168431,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18755,GO:1901296,1,0.992170588866352,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18756,GO:1901297,1,0.992228654678653,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18757,GO:1901298,1,0.930319734129124,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18758,GO:1901299,1,0.956906742599511,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18759,GO:1901300,1,0.972225102330536,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18760,GO:1901301,1,0.986264939670481,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18761,GO:1901303,1,0.992369512477412,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18762,GO:1901304,1,0.992170041209416,0,1,regulation of spermidine biosynthetic process,BP,
18763,GO:1901307,1,0.992170041209416,0,1,positive regulation of spermidine biosynthetic process,BP,
18764,GO:1901314,1,0.980340372257135,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18765,GO:1901315,1,0.980340372257135,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18768,GO:1901320,1,0.992516661359673,0,1,negative regulation of heart induction,BP,
18769,GO:1901321,1,0.984401445146774,0,2,positive regulation of heart induction,BP,
18770,GO:1901337,1,0.992340570098796,0,1,thioester transport,BP,
18772,GO:1901339,1,0.96036173720642,0,6,regulation of store-operated calcium channel activity,BP,
18773,GO:1901340,1,0.993608965634157,0,1,negative regulation of store-operated calcium channel activity,BP,
18774,GO:1901341,1,0.973641097779881,0,4,positive regulation of store-operated calcium channel activity,BP,
18775,GO:1901342,1,0.193454230410061,0,230,regulation of vasculature development,BP,
18776,GO:1901343,1,0.572578056244382,0,79,negative regulation of vasculature development,BP,
18777,GO:1901344,1,0.992170027168696,0,1,response to leptomycin B,BP,
18778,GO:1901350,1,0.993986332270918,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18779,GO:1901355,1,0.986224447130921,0,2,response to rapamycin,BP,
18784,GO:1901373,1,0.992170027168696,0,1,lipid hydroperoxide transport,BP,
18785,GO:1901374,1,0.947142210456336,0,7,acetate ester transport,BP,
18786,GO:1901375,1,0.976871467497418,0,3,acetate ester transmembrane transporter activity,MF,
18787,GO:1901376,1,0.992216941255385,0,1,organic heteropentacyclic compound metabolic process,BP,
18788,GO:1901379,1,0.645922538682995,0,62,regulation of potassium ion transmembrane transport,BP,
18789,GO:1901380,1,0.885660139091529,0,17,negative regulation of potassium ion transmembrane transport,BP,
18790,GO:1901381,1,0.835955661886433,0,26,positive regulation of potassium ion transmembrane transport,BP,
18791,GO:1901382,1,0.972746763894997,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18792,GO:1901383,1,0.986216360775276,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18793,GO:1901385,1,0.791952192910866,0,32,regulation of voltage-gated calcium channel activity,BP,
18794,GO:1901386,1,0.912682881928236,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18795,GO:1901387,1,0.950913153983801,0,7,positive regulation of voltage-gated calcium channel activity,BP,
18796,GO:1901388,1,0.992288548141565,0,1,regulation of transforming growth factor beta activation,BP,
18797,GO:1901389,1,0.992288548141565,0,1,negative regulation of transforming growth factor beta activation,BP,
18798,GO:1901407,1,0.935246222186805,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18799,GO:1901409,1,0.940959468933215,0,8,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18800,GO:1901419,1,0.993740843079674,0,1,regulation of response to alcohol,BP,
18801,GO:1901421,1,0.993740843079674,0,1,positive regulation of response to alcohol,BP,
18802,GO:1901474,1,0.956324321983974,0,6,azole transmembrane transporter activity,MF,
18803,GO:1901475,1,0.970307918080937,0,4,pyruvate transmembrane transport,BP,
18804,GO:1901476,1,0.738450335219922,0,41,carbohydrate transporter activity,MF,
18805,GO:1901490,1,0.967067017503884,0,5,regulation of lymphangiogenesis,BP,
18806,GO:1901491,1,0.980585380217067,0,3,negative regulation of lymphangiogenesis,BP,
18807,GO:1901492,1,0.98621608525206,0,2,positive regulation of lymphangiogenesis,BP,
18808,GO:1901503,1,0.972765969212316,0,4,ether biosynthetic process,BP,
18810,GO:1901509,1,0.972861065189147,0,4,regulation of endothelial tube morphogenesis,BP,
18811,GO:1901522,1,0.832315657007998,0,26,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
18812,GO:1901523,1,0.962139661873402,0,5,icosanoid catabolic process,BP,
18813,GO:1901524,1,0.921227100026213,0,12,regulation of macromitophagy,BP,
18814,GO:1901525,1,0.980913425301982,0,3,negative regulation of macromitophagy,BP,
18815,GO:1901526,1,0.939161184267142,0,9,positive regulation of macromitophagy,BP,
18816,GO:1901529,1,0.981640597756505,0,3,positive regulation of anion channel activity,BP,
18817,GO:1901532,1,0.891679396571576,0,16,regulation of hematopoietic progenitor cell differentiation,BP,
18818,GO:1901533,1,0.948834921550733,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18819,GO:1901534,1,0.986532265633433,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18820,GO:1901535,1,0.977518501348962,0,3,regulation of DNA demethylation,BP,
18821,GO:1901536,1,0.977518501348962,0,3,negative regulation of DNA demethylation,BP,
18822,GO:1901538,1,0.951552575908853,0,7,changes to DNA methylation involved in embryo development,BP,
18823,GO:1901545,1,0.992588594852166,0,1,response to raffinose,BP,
18824,GO:1901550,1,0.919356437835851,0,12,regulation of endothelial cell development,BP,
18825,GO:1901551,1,0.993655089239939,0,1,negative regulation of endothelial cell development,BP,
18826,GO:1901552,1,0.965107225496199,0,5,positive regulation of endothelial cell development,BP,
18827,GO:1901555,1,0.993986332270338,0,1,response to paclitaxel,BP,
18828,GO:1901557,1,0.993506247191203,0,1,response to fenofibrate,BP,
18829,GO:1901558,1,0.986204497133173,0,2,response to metformin,BP,
18830,GO:1901561,1,0.993307573030982,0,1,response to benomyl,BP,
18831,GO:1901563,1,0.973498106638529,0,4,response to camptothecin,BP,
18835,GO:1901567,1,0.954268875549789,0,6,fatty acid derivative binding,MF,
18837,GO:1901569,1,0.962139661873402,0,5,fatty acid derivative catabolic process,BP,
18839,GO:1901571,1,0.716893305298047,0,45,fatty acid derivative transport,BP,
18842,GO:1901580,1,0.993986332289623,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18843,GO:1901581,1,0.993986332289623,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18844,GO:1901582,1,0.993986332289623,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18845,GO:1901585,1,0.992438137829476,0,1,regulation of acid-sensing ion channel activity,BP,
18846,GO:1901594,1,0.993613659155533,0,1,response to capsazepine,BP,
18850,GO:1901608,1,0.992170027168696,0,1,regulation of vesicle transport along microtubule,BP,
18851,GO:1901609,1,0.992170027168696,0,1,negative regulation of vesicle transport along microtubule,BP,
18852,GO:1901611,1,0.949328160147459,0,7,phosphatidylglycerol binding,MF,
18853,GO:1901612,1,0.963369230840657,0,5,cardiolipin binding,MF,
18855,GO:1901616,1,0.630064553496862,0,62,organic hydroxy compound catabolic process,BP,
18858,GO:1901620,1,0.944196360494201,0,8,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18859,GO:1901621,1,0.958964632876946,0,6,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18860,GO:1901622,1,0.992304354646868,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18861,GO:1901623,1,0.861117641335618,0,20,regulation of lymphocyte chemotaxis,BP,
18862,GO:1901624,1,0.970708413780235,0,4,negative regulation of lymphocyte chemotaxis,BP,
18863,GO:1901625,1,0.992294630214608,0,1,cellular response to ergosterol,BP,
18864,GO:1901626,1,0.936582933240008,0,9,regulation of postsynaptic membrane organization,BP,
18865,GO:1901627,1,0.99222345480462,0,1,negative regulation of postsynaptic membrane organization,BP,
18866,GO:1901628,1,0.970899020983137,0,4,positive regulation of postsynaptic membrane organization,BP,
18867,GO:1901629,1,0.986203080783191,0,2,regulation of presynaptic membrane organization,BP,
18868,GO:1901630,1,0.992170027168696,0,1,negative regulation of presynaptic membrane organization,BP,
18869,GO:1901631,1,0.993986332275526,0,1,positive regulation of presynaptic membrane organization,BP,
18870,GO:1901639,1,0.993986332265624,0,1,XDP catabolic process,BP,
18871,GO:1901640,1,0.993986332265624,0,1,XTP binding,MF,
18872,GO:1901641,1,0.993986332265624,0,1,ITP binding,MF,
18873,GO:1901642,1,0.94706617168901,0,7,nucleoside transmembrane transport,BP,
18878,GO:1901656,1,0.985850525930879,0,2,glycoside transport,BP,
18881,GO:1901659,1,0.687391876686671,0,49,glycosyl compound biosynthetic process,BP,
18882,GO:1901660,1,0.961038341861915,0,6,calcium ion export,BP,
18883,GO:1901661,1,0.793927754784349,0,30,quinone metabolic process,BP,
18884,GO:1901662,1,0.977317809295903,0,3,quinone catabolic process,BP,
18885,GO:1901663,1,0.904742672387966,0,13,quinone biosynthetic process,BP,
18886,GO:1901664,1,0.984428143151737,0,2,regulation of NAD+ ADP-ribosyltransferase activity,BP,
18887,GO:1901666,1,0.984428143151737,0,2,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18890,GO:1901673,1,0.900430465573178,0,14,regulation of mitotic spindle assembly,BP,
18891,GO:1901674,1,0.987471884184892,0,2,regulation of histone H3-K27 acetylation,BP,
18892,GO:1901675,1,0.993986332269048,0,1,negative regulation of histone H3-K27 acetylation,BP,
18893,GO:1901676,1,0.993446447353802,0,1,positive regulation of histone H3-K27 acetylation,BP,
18894,GO:1901677,1,0.877938880592632,0,18,phosphate transmembrane transporter activity,MF,
18895,GO:1901678,1,0.915772283926352,0,12,iron coordination entity transport,BP,
18896,GO:1901679,1,0.949030330735648,0,7,nucleotide transmembrane transport,BP,
18897,GO:1901680,1,0.993986332283136,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
18899,GO:1901682,1,0.808018606077302,0,30,sulfur compound transmembrane transporter activity,MF,
18900,GO:1901684,1,0.99220653731591,0,1,arsenate ion transmembrane transport,BP,
18907,GO:1901702,1,0.925118238535021,0,10,salt transmembrane transporter activity,MF,
18908,GO:1901706,1,0.992306972088751,0,1,mesenchymal cell differentiation involved in bone development,BP,
18909,GO:1901707,1,0.992170027168696,0,1,leptomycin B binding,MF,
18910,GO:1901722,1,0.907204039628276,0,13,regulation of cell proliferation involved in kidney development,BP,
18911,GO:1901723,1,0.956269469342856,0,6,negative regulation of cell proliferation involved in kidney development,BP,
18912,GO:1901724,1,0.948708245169574,0,7,positive regulation of cell proliferation involved in kidney development,BP,
18913,GO:1901725,1,0.953980803400036,0,7,regulation of histone deacetylase activity,BP,
18914,GO:1901726,1,0.993986332288581,0,1,negative regulation of histone deacetylase activity,BP,
18915,GO:1901727,1,0.965922742554944,0,5,positive regulation of histone deacetylase activity,BP,
18916,GO:1901738,1,0.992929350653873,0,1,regulation of vitamin A metabolic process,BP,
18917,GO:1901739,1,0.858221674180391,0,20,regulation of myoblast fusion,BP,
18918,GO:1901740,1,0.98440567573066,0,2,negative regulation of myoblast fusion,BP,
18919,GO:1901741,1,0.871831758034736,0,18,positive regulation of myoblast fusion,BP,
18920,GO:1901748,1,0.992271495764135,0,1,leukotriene D4 metabolic process,BP,
18921,GO:1901750,1,0.992271495764135,0,1,leukotriene D4 biosynthetic process,BP,
18922,GO:1901751,1,0.992230544989512,0,1,leukotriene A4 metabolic process,BP,
18923,GO:1901796,1,0.310091720288349,0,163,regulation of signal transduction by p53 class mediator,BP,
18924,GO:1901797,1,0.820130662365786,0,27,negative regulation of signal transduction by p53 class mediator,BP,
18925,GO:1901798,1,0.873432378399689,0,19,positive regulation of signal transduction by p53 class mediator,BP,
18926,GO:1901799,1,0.799959665315601,0,31,negative regulation of proteasomal protein catabolic process,BP,
18927,GO:1901800,1,0.521130136555156,0,90,positive regulation of proteasomal protein catabolic process,BP,
18928,GO:1901804,1,0.992240749279768,0,1,beta-glucoside metabolic process,BP,
18929,GO:1901805,1,0.992240749279768,0,1,beta-glucoside catabolic process,BP,
18930,GO:1901834,1,0.992170144174095,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18931,GO:1901835,1,0.992170144174095,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18932,GO:1901836,1,0.929525322990765,0,10,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18933,GO:1901837,1,0.984428624526193,0,2,negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18934,GO:1901838,1,0.944234899231088,0,8,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18935,GO:1901841,1,0.931531886992048,0,10,regulation of high voltage-gated calcium channel activity,BP,
18936,GO:1901843,1,0.979590074279791,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
18937,GO:1901844,1,0.937991180005031,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18938,GO:1901846,1,0.99381156582741,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18939,GO:1901856,1,0.97751493553691,0,3,negative regulation of cellular respiration,BP,
18940,GO:1901857,1,0.955849107096619,0,6,positive regulation of cellular respiration,BP,
18941,GO:1901858,1,0.958796474401813,0,6,regulation of mitochondrial DNA metabolic process,BP,
18942,GO:1901859,1,0.979394319110677,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
18943,GO:1901860,1,0.986203080774884,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
18946,GO:1901863,1,0.639263690647173,0,64,positive regulation of muscle tissue development,BP,
18947,GO:1901873,1,0.993986332268836,0,1,regulation of post-translational protein modification,BP,
18948,GO:1901874,1,0.993986332268836,0,1,negative regulation of post-translational protein modification,BP,
18949,GO:1901876,1,0.984400918195926,0,2,regulation of calcium ion binding,BP,
18950,GO:1901877,1,0.984400918195926,0,2,negative regulation of calcium ion binding,BP,
18953,GO:1901881,1,0.9027185229042,0,14,positive regulation of protein depolymerization,BP,
18954,GO:1901888,1,0.606041934639614,0,73,regulation of cell junction assembly,BP,
18955,GO:1901889,1,0.88173638005113,0,19,negative regulation of cell junction assembly,BP,
18956,GO:1901890,1,0.812306409512908,0,30,positive regulation of cell junction assembly,BP,
18958,GO:1901895,1,0.985622806807968,0,2,negative regulation of calcium-transporting ATPase activity,BP,
18960,GO:1901897,1,0.952146395571482,0,7,regulation of relaxation of cardiac muscle,BP,
18961,GO:1901898,1,0.987720673043291,0,2,negative regulation of relaxation of cardiac muscle,BP,
18962,GO:1901899,1,0.984475231501653,0,2,positive regulation of relaxation of cardiac muscle,BP,
18963,GO:1901906,1,0.97080956241711,0,4,diadenosine pentaphosphate metabolic process,BP,
18964,GO:1901907,1,0.97080956241711,0,4,diadenosine pentaphosphate catabolic process,BP,
18965,GO:1901908,1,0.97080956241711,0,4,diadenosine hexaphosphate metabolic process,BP,
18966,GO:1901909,1,0.97080956241711,0,4,diadenosine hexaphosphate catabolic process,BP,
18967,GO:1901910,1,0.97080956241711,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
18968,GO:1901911,1,0.97080956241711,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
18969,GO:1901962,1,0.992201761126188,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
18970,GO:1901963,1,0.985200562207999,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
18971,GO:1901964,1,0.992170392587755,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
18972,GO:1901970,1,0.959697934840971,0,6,positive regulation of mitotic sister chromatid separation,BP,
18973,GO:1901976,1,0.794306798696221,0,31,regulation of cell cycle checkpoint,BP,
18974,GO:1901977,1,0.961893090058989,0,5,negative regulation of cell cycle checkpoint,BP,
18975,GO:1901978,1,0.936417519116838,0,9,positive regulation of cell cycle checkpoint,BP,
18976,GO:1901979,1,0.984575971257004,0,2,regulation of inward rectifier potassium channel activity,BP,
18978,GO:1901983,1,0.641706571524012,0,61,regulation of protein acetylation,BP,
18979,GO:1901984,1,0.851970384660611,0,22,negative regulation of protein acetylation,BP,
18980,GO:1901985,1,0.781179784712151,0,34,positive regulation of protein acetylation,BP,
18981,GO:1901986,1,0.992170027168696,0,1,response to ketamine,BP,
18984,GO:1901989,1,0.620734571061137,0,66,positive regulation of cell cycle phase transition,BP,
18987,GO:1901992,1,0.654470152599266,0,59,positive regulation of mitotic cell cycle phase transition,BP,
18988,GO:1901993,1,0.962372999028469,0,5,regulation of meiotic cell cycle phase transition,BP,
18989,GO:1901994,1,0.969847815224939,0,4,negative regulation of meiotic cell cycle phase transition,BP,
18990,GO:1901995,1,0.992294630214608,0,1,positive regulation of meiotic cell cycle phase transition,BP,
18993,GO:1902003,1,0.933583609706377,0,10,regulation of beta-amyloid formation,BP,
18994,GO:1902004,1,0.964847598603636,0,5,positive regulation of beta-amyloid formation,BP,
18995,GO:1902010,1,0.993039120058076,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
18996,GO:1902017,1,0.745563295103472,0,42,regulation of cilium assembly,BP,
18997,GO:1902018,1,0.938800826668883,0,9,negative regulation of cilium assembly,BP,
18998,GO:1902019,1,0.962220751571001,0,5,regulation of cilium-dependent cell motility,BP,
18999,GO:1902022,1,0.970982634098145,0,4,L-lysine transport,BP,
19000,GO:1902023,1,0.972149161885484,0,4,L-arginine transport,BP,
19001,GO:1902024,1,0.98472618857339,0,2,L-histidine transport,BP,
19002,GO:1902031,1,0.956235817487737,0,6,regulation of NADP metabolic process,BP,
19003,GO:1902033,1,0.950649029229733,0,7,regulation of hematopoietic stem cell proliferation,BP,
19004,GO:1902035,1,0.964804078201601,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19005,GO:1902036,1,0.9573079786524,0,6,regulation of hematopoietic stem cell differentiation,BP,
19006,GO:1902037,1,0.977361777866554,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19007,GO:1902038,1,0.992992730777391,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19011,GO:1902044,1,0.986114377643608,0,2,regulation of Fas signaling pathway,BP,
19012,GO:1902045,1,0.992228033436212,0,1,negative regulation of Fas signaling pathway,BP,
19013,GO:1902047,1,0.97054252786865,0,4,polyamine transmembrane transport,BP,
19014,GO:1902065,1,0.937065903562631,0,9,response to L-glutamate,BP,
19015,GO:1902071,1,0.992170027168696,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19016,GO:1902073,1,0.992170027168696,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19017,GO:1902074,1,0.898961697355742,0,14,response to salt,BP,
19018,GO:1902075,1,0.96179951052841,0,5,cellular response to salt,BP,
19019,GO:1902076,1,0.993986332291564,0,1,regulation of lateral motor column neuron migration,BP,
19020,GO:1902078,1,0.993986332291564,0,1,positive regulation of lateral motor column neuron migration,BP,
19021,GO:1902080,1,0.984465365569834,0,2,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19022,GO:1902081,1,0.984465365569834,0,2,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19023,GO:1902083,1,0.974257322223422,0,4,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19024,GO:1902093,1,0.947168426509118,0,7,positive regulation of flagellated sperm motility,BP,
19025,GO:1902098,1,0.993882289190072,0,1,calcitriol binding,MF,
19026,GO:1902099,1,0.721476846977617,0,45,regulation of metaphase/anaphase transition of cell cycle,BP,
19027,GO:1902100,1,0.796890848768323,0,31,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19028,GO:1902101,1,0.959697934840971,0,6,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19029,GO:1902102,1,0.984826807645473,0,2,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19030,GO:1902103,1,0.984826807645473,0,2,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19038,GO:1902116,1,0.814296423578727,0,29,negative regulation of organelle assembly,BP,
19039,GO:1902117,1,0.675057902981633,0,57,positive regulation of organelle assembly,BP,
19040,GO:1902118,1,0.9921704185151,0,1,calcidiol binding,MF,
19041,GO:1902121,1,0.993882289190072,0,1,lithocholic acid binding,MF,
19042,GO:1902122,1,0.992190392480105,0,1,chenodeoxycholic acid binding,MF,
19043,GO:1902159,1,0.986203080773995,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19044,GO:1902161,1,0.993986332266283,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19045,GO:1902162,1,0.984454366862478,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19046,GO:1902164,1,0.984454366862478,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19047,GO:1902165,1,0.892396631757789,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19048,GO:1902166,1,0.906215268940068,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19049,GO:1902167,1,0.992170027168696,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19050,GO:1902170,1,0.871343504290664,0,19,cellular response to reactive nitrogen species,BP,
19051,GO:1902172,1,0.955440253268753,0,6,regulation of keratinocyte apoptotic process,BP,
19052,GO:1902173,1,0.992735500868653,0,1,negative regulation of keratinocyte apoptotic process,BP,
19053,GO:1902174,1,0.977275216230916,0,3,positive regulation of keratinocyte apoptotic process,BP,
19056,GO:1902177,1,0.95672430589537,0,6,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19057,GO:1902178,1,0.993711975396264,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19058,GO:1902186,1,0.800430597636299,0,31,regulation of viral release from host cell,BP,
19059,GO:1902187,1,0.898964897241018,0,15,negative regulation of viral release from host cell,BP,
19060,GO:1902188,1,0.896522082485456,0,15,positive regulation of viral release from host cell,BP,
19061,GO:1902202,1,0.971462765792033,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19062,GO:1902203,1,0.993939481237836,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19063,GO:1902204,1,0.992177649148064,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19064,GO:1902205,1,0.992170049074439,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19065,GO:1902206,1,0.992170049074439,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19066,GO:1902211,1,0.984524544463431,0,2,regulation of prolactin signaling pathway,BP,
19067,GO:1902212,1,0.992170049074439,0,1,negative regulation of prolactin signaling pathway,BP,
19068,GO:1902213,1,0.992294630214608,0,1,positive regulation of prolactin signaling pathway,BP,
19069,GO:1902214,1,0.984401111521914,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
19070,GO:1902215,1,0.992170049074439,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19071,GO:1902216,1,0.992170230723253,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
19072,GO:1902217,1,0.992170027168696,0,1,erythrocyte apoptotic process,BP,
19073,GO:1902218,1,0.965917275416636,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19074,GO:1902219,1,0.973541671176515,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19075,GO:1902220,1,0.992170027168696,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19079,GO:1902225,1,0.992294630214608,0,1,negative regulation of acrosome reaction,BP,
19080,GO:1902226,1,0.976768951685418,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19081,GO:1902227,1,0.984400909548914,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19082,GO:1902228,1,0.992248052089351,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19083,GO:1902229,1,0.766473459498983,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19084,GO:1902230,1,0.820843177936391,0,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19085,GO:1902231,1,0.940889390912919,0,8,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19086,GO:1902232,1,0.984590022129163,0,2,regulation of positive thymic T cell selection,BP,
19087,GO:1902233,1,0.992170049074439,0,1,negative regulation of positive thymic T cell selection,BP,
19088,GO:1902235,1,0.807016344718672,0,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19089,GO:1902236,1,0.88224344039595,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19090,GO:1902237,1,0.927731440269506,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19091,GO:1902238,1,0.993650749510594,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19092,GO:1902239,1,0.993650749510594,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19093,GO:1902250,1,0.992170027168696,0,1,regulation of erythrocyte apoptotic process,BP,
19094,GO:1902251,1,0.992170027168696,0,1,negative regulation of erythrocyte apoptotic process,BP,
19095,GO:1902253,1,0.836764953975576,0,24,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19096,GO:1902254,1,0.876898991076909,0,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19097,GO:1902255,1,0.969046774734276,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19098,GO:1902256,1,0.979273615836624,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19099,GO:1902257,1,0.985217200960137,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19100,GO:1902259,1,0.898757896741057,0,15,regulation of delayed rectifier potassium channel activity,BP,
19101,GO:1902260,1,0.950386270997767,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19102,GO:1902261,1,0.973705792102732,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19103,GO:1902262,1,0.964074334912938,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19104,GO:1902263,1,0.980216017513066,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19105,GO:1902267,1,0.97054252786865,0,4,regulation of polyamine transmembrane transport,BP,
19106,GO:1902268,1,0.976695098844533,0,3,negative regulation of polyamine transmembrane transport,BP,
19107,GO:1902269,1,0.993701779753986,0,1,positive regulation of polyamine transmembrane transport,BP,
19108,GO:1902271,1,0.986100235046106,0,2,D3 vitamins binding,MF,
19109,GO:1902275,1,0.338112649229678,0,154,regulation of chromatin organization,BP,
19110,GO:1902282,1,0.941503359124532,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19111,GO:1902283,1,0.993531099117722,0,1,negative regulation of primary amine oxidase activity,BP,
19112,GO:1902284,1,0.872295030452192,0,21,neuron projection extension involved in neuron projection guidance,BP,
19113,GO:1902285,1,0.960900575376145,0,6,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19114,GO:1902287,1,0.966721873105972,0,5,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19115,GO:1902292,1,0.992170027168696,0,1,cell cycle DNA replication initiation,BP,
19116,GO:1902294,1,0.992294630214608,0,1,cell cycle DNA replication termination,BP,
19117,GO:1902296,1,0.992840823148394,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19118,GO:1902298,1,0.986236728474698,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19119,GO:1902299,1,0.984527779293501,0,2,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19120,GO:1902302,1,0.965863847225758,0,5,regulation of potassium ion export,BP,
19121,GO:1902303,1,0.985428301969174,0,2,negative regulation of potassium ion export,BP,
19122,GO:1902304,1,0.986118046764292,0,2,positive regulation of potassium ion export,BP,
19124,GO:1902306,1,0.926805729358545,0,11,negative regulation of sodium ion transmembrane transport,BP,
19126,GO:1902308,1,0.964973361854154,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19127,GO:1902309,1,0.9802036333333,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19128,GO:1902310,1,0.984464543648118,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19130,GO:1902315,1,0.992170027168696,0,1,nuclear cell cycle DNA replication initiation,BP,
19131,GO:1902317,1,0.992294630214608,0,1,nuclear DNA replication termination,BP,
19132,GO:1902319,1,0.992840823148394,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19133,GO:1902336,1,0.985390221712649,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19134,GO:1902337,1,0.933839419111165,0,10,regulation of apoptotic process involved in morphogenesis,BP,
19135,GO:1902338,1,0.958844777517379,0,6,negative regulation of apoptotic process involved in morphogenesis,BP,
19136,GO:1902339,1,0.979841228967994,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19137,GO:1902340,1,0.984592180969276,0,2,negative regulation of chromosome condensation,BP,
19138,GO:1902356,1,0.992172245940507,0,1,oxaloacetate(2-) transmembrane transport,BP,
19139,GO:1902358,1,0.912173325419206,0,13,sulfate transmembrane transport,BP,
19140,GO:1902359,1,0.984571696393006,0,2,Notch signaling pathway involved in somitogenesis,BP,
19141,GO:1902361,1,0.977060181581946,0,3,mitochondrial pyruvate transmembrane transport,BP,
19142,GO:1902362,1,0.992422054065019,0,1,melanocyte apoptotic process,BP,
19143,GO:1902366,1,0.984571696393006,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19144,GO:1902367,1,0.984571696393006,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19145,GO:1902369,1,0.933892035816989,0,10,negative regulation of RNA catabolic process,BP,
19146,GO:1902373,1,0.946843777874035,0,8,negative regulation of mRNA catabolic process,BP,
19147,GO:1902378,1,0.992266198294153,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19148,GO:1902379,1,0.993986332264647,0,1,chemoattractant activity involved in axon guidance,MF,
19149,GO:1902380,1,0.992246255662747,0,1,positive regulation of endoribonuclease activity,BP,
19150,GO:1902396,1,0.993439650484227,0,1,protein localization to bicellular tight junction,BP,
19151,GO:1902400,1,0.6430590568466,0,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19152,GO:1902402,1,0.638258822672812,0,61,signal transduction involved in mitotic DNA damage checkpoint,BP,
19153,GO:1902403,1,0.638258822672812,0,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19154,GO:1902410,1,0.957439216813109,0,6,mitotic cytokinetic process,BP,
19155,GO:1902412,1,0.979179573692797,0,3,regulation of mitotic cytokinesis,BP,
19156,GO:1902414,1,0.948643922444771,0,8,protein localization to cell junction,BP,
19157,GO:1902415,1,0.935771934596028,0,9,regulation of mRNA binding,BP,
19158,GO:1902416,1,0.950238080048344,0,7,positive regulation of mRNA binding,BP,
19159,GO:1902423,1,0.992190515957061,0,1,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19160,GO:1902425,1,0.992190515957061,0,1,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19161,GO:1902426,1,0.992350409634924,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19162,GO:1902430,1,0.958923121453027,0,6,negative regulation of beta-amyloid formation,BP,
19163,GO:1902442,1,0.993286808146977,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19164,GO:1902443,1,0.993286808146977,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19165,GO:1902444,1,0.992170027168696,0,1,riboflavin binding,MF,
19166,GO:1902445,1,0.976718422764072,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19167,GO:1902455,1,0.958258490660449,0,6,negative regulation of stem cell population maintenance,BP,
19168,GO:1902459,1,0.96696743102462,0,5,positive regulation of stem cell population maintenance,BP,
19169,GO:1902460,1,0.993838651401676,0,1,regulation of mesenchymal stem cell proliferation,BP,
19170,GO:1902462,1,0.993838651401676,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19171,GO:1902463,1,0.976694997751978,0,3,protein localization to cell leading edge,BP,
19172,GO:1902464,1,0.993768546616802,0,1,regulation of histone H3-K27 trimethylation,BP,
19173,GO:1902466,1,0.993768546616802,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19174,GO:1902473,1,0.954864514863379,0,7,regulation of protein localization to synapse,BP,
19175,GO:1902474,1,0.954864514863379,0,7,positive regulation of protein localization to synapse,BP,
19178,GO:1902480,1,0.992247150388811,0,1,protein localization to mitotic spindle,BP,
19179,GO:1902488,1,0.993986332279133,0,1,cholangiocyte apoptotic process,BP,
19180,GO:1902490,1,0.992175912828971,0,1,regulation of sperm capacitation,BP,
19181,GO:1902493,1,0.529917342317984,0,88,acetyltransferase complex,CC,
19184,GO:1902498,1,0.974654814718063,0,4,regulation of protein autoubiquitination,BP,
19185,GO:1902499,1,0.986485459573879,0,2,positive regulation of protein autoubiquitination,BP,
19186,GO:1902504,1,0.992560919638709,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19187,GO:1902510,1,0.948423768066859,0,7,regulation of apoptotic DNA fragmentation,BP,
19188,GO:1902511,1,0.992369512477412,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19189,GO:1902512,1,0.976713400897399,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19190,GO:1902513,1,0.971451443807527,0,4,regulation of organelle transport along microtubule,BP,
19191,GO:1902514,1,0.954338572255275,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19192,GO:1902523,1,0.985915101188524,0,2,positive regulation of protein K63-linked ubiquitination,BP,
19194,GO:1902525,1,0.963585611437824,0,5,regulation of protein monoubiquitination,BP,
19195,GO:1902527,1,0.970134187272415,0,4,positive regulation of protein monoubiquitination,BP,
19196,GO:1902528,1,0.993986332277449,0,1,regulation of protein linear polyubiquitination,BP,
19197,GO:1902530,1,0.993986332277449,0,1,positive regulation of protein linear polyubiquitination,BP,
19201,GO:1902534,1,0.993986252580758,0,1,single-organism membrane invagination,BP,
19202,GO:1902544,1,0.98502474299654,0,2,regulation of DNA N-glycosylase activity,BP,
19203,GO:1902546,1,0.992170027168696,0,1,positive regulation of DNA N-glycosylase activity,BP,
19204,GO:1902547,1,0.927615605682941,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19205,GO:1902548,1,0.96652350733592,0,5,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19208,GO:1902559,1,0.984422253655735,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19209,GO:1902560,1,0.984402873670592,0,2,GMP reductase complex,CC,
19210,GO:1902562,1,0.779897542873053,0,34,H4 histone acetyltransferase complex,CC,
19211,GO:1902563,1,0.960547601327872,0,6,regulation of neutrophil activation,BP,
19212,GO:1902564,1,0.980261318654039,0,3,negative regulation of neutrophil activation,BP,
19213,GO:1902565,1,0.993616323617868,0,1,positive regulation of neutrophil activation,BP,
19214,GO:1902566,1,0.969444568192405,0,4,regulation of eosinophil activation,BP,
19215,GO:1902567,1,0.984503742003129,0,2,negative regulation of eosinophil activation,BP,
19216,GO:1902568,1,0.984705643377001,0,2,positive regulation of eosinophil activation,BP,
19217,GO:1902569,1,0.992172217949553,0,1,negative regulation of activation of JAK2 kinase activity,BP,
19218,GO:1902570,1,0.951197265484464,0,7,protein localization to nucleolus,BP,
19219,GO:1902571,1,0.905674519811626,0,13,regulation of serine-type peptidase activity,BP,
19220,GO:1902572,1,0.920030166807668,0,11,negative regulation of serine-type peptidase activity,BP,
19221,GO:1902573,1,0.978486002169327,0,3,positive regulation of serine-type peptidase activity,BP,
19222,GO:1902576,1,0.970594708956762,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19224,GO:1902579,1,0.601307650149498,0,71,multi-organism localization,BP,
19226,GO:1902581,1,0.623882086561178,0,66,multi-organism cellular localization,BP,
19228,GO:1902583,1,0.623882086561178,0,66,multi-organism intracellular transport,BP,
19229,GO:1902585,1,0.992177118014353,0,1,single-organism intercellular transport,BP,
19231,GO:1902590,1,0.834262350592364,0,24,multi-organism organelle organization,BP,
19232,GO:1902592,1,0.834262350592364,0,24,multi-organism membrane budding,BP,
19234,GO:1902594,1,0.987824514793867,0,2,multi-organism nuclear import,BP,
19235,GO:1902595,1,0.984579868753849,0,2,regulation of DNA replication origin binding,BP,
19236,GO:1902598,1,0.986989193567562,0,2,creatine transmembrane transport,BP,
19238,GO:1902603,1,0.969721923117626,0,4,carnitine transmembrane transport,BP,
19239,GO:1902605,1,0.992385731190235,0,1,heterotrimeric G-protein complex assembly,BP,
19240,GO:1902606,1,0.984400887813367,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19241,GO:1902608,1,0.984400887813367,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19242,GO:1902612,1,0.984619453965962,0,2,regulation of anti-Mullerian hormone signaling pathway,BP,
19243,GO:1902613,1,0.984619453965962,0,2,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19244,GO:1902616,1,0.984462901602972,0,2,acyl carnitine transmembrane transport,BP,
19245,GO:1902617,1,0.974330485234372,0,4,response to fluoride,BP,
19246,GO:1902618,1,0.993986332265334,0,1,cellular response to fluoride,BP,
19247,GO:1902622,1,0.771382729551761,0,34,regulation of neutrophil migration,BP,
19248,GO:1902623,1,0.986281928332626,0,2,negative regulation of neutrophil migration,BP,
19249,GO:1902624,1,0.79997635716219,0,29,positive regulation of neutrophil migration,BP,
19250,GO:1902626,1,0.976692112990833,0,3,assembly of large subunit precursor of preribosome,BP,
19251,GO:1902630,1,0.988008547467023,0,2,regulation of membrane hyperpolarization,BP,
19252,GO:1902631,1,0.993986332270471,0,1,negative regulation of membrane hyperpolarization,BP,
19253,GO:1902636,1,0.9845411718202,0,2,kinociliary basal body,CC,
19257,GO:1902659,1,0.978472569686903,0,3,regulation of glucose mediated signaling pathway,BP,
19258,GO:1902661,1,0.978472569686903,0,3,positive regulation of glucose mediated signaling pathway,BP,
19259,GO:1902667,1,0.868186862564158,0,21,regulation of axon guidance,BP,
19260,GO:1902668,1,0.935396407702704,0,10,negative regulation of axon guidance,BP,
19261,GO:1902669,1,0.954365144671677,0,7,positive regulation of axon guidance,BP,
19264,GO:1902683,1,0.978236468221654,0,3,regulation of receptor localization to synapse,BP,
19265,GO:1902684,1,0.992170027168696,0,1,negative regulation of receptor localization to synapse,BP,
19266,GO:1902685,1,0.993698138438202,0,1,positive regulation of receptor localization to synapse,BP,
19268,GO:1902688,1,0.984701278247928,0,2,regulation of NAD metabolic process,BP,
19269,GO:1902690,1,0.992472769835405,0,1,positive regulation of NAD metabolic process,BP,
19270,GO:1902691,1,0.992664195911907,0,1,respiratory basal cell differentiation,BP,
19271,GO:1902692,1,0.825583668582118,0,27,regulation of neuroblast proliferation,BP,
19272,GO:1902710,1,0.879157053385461,0,18,GABA receptor complex,CC,
19273,GO:1902711,1,0.884481121238183,0,17,GABA-A receptor complex,CC,
19274,GO:1902713,1,0.928540518671195,0,10,regulation of interferon-gamma secretion,BP,
19275,GO:1902714,1,0.969387235520306,0,4,negative regulation of interferon-gamma secretion,BP,
19276,GO:1902715,1,0.950377539200418,0,7,positive regulation of interferon-gamma secretion,BP,
19277,GO:1902722,1,0.986271508257992,0,2,positive regulation of prolactin secretion,BP,
19278,GO:1902723,1,0.985363615717005,0,2,negative regulation of skeletal muscle satellite cell proliferation,BP,
19279,GO:1902725,1,0.986464196531508,0,2,negative regulation of satellite cell differentiation,BP,
19280,GO:1902728,1,0.987950641447197,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19281,GO:1902730,1,0.986522382626537,0,2,positive regulation of proteoglycan biosynthetic process,BP,
19282,GO:1902731,1,0.980411065961692,0,3,negative regulation of chondrocyte proliferation,BP,
19283,GO:1902732,1,0.976773384221023,0,3,positive regulation of chondrocyte proliferation,BP,
19284,GO:1902737,1,0.993750815841981,0,1,dendritic filopodium,CC,
19285,GO:1902739,1,0.985315101367962,0,2,regulation of interferon-alpha secretion,BP,
19286,GO:1902741,1,0.985315101367962,0,2,positive regulation of interferon-alpha secretion,BP,
19287,GO:1902742,1,0.820828926121369,0,29,apoptotic process involved in development,BP,
19288,GO:1902743,1,0.774165284058167,0,36,regulation of lamellipodium organization,BP,
19289,GO:1902744,1,0.966683653099451,0,5,negative regulation of lamellipodium organization,BP,
19290,GO:1902745,1,0.842947772918895,0,24,positive regulation of lamellipodium organization,BP,
19291,GO:1902746,1,0.97089439746786,0,4,regulation of lens fiber cell differentiation,BP,
19292,GO:1902747,1,0.992175647589889,0,1,negative regulation of lens fiber cell differentiation,BP,
19293,GO:1902748,1,0.993986332280977,0,1,positive regulation of lens fiber cell differentiation,BP,
19296,GO:1902751,1,0.859579944642928,0,21,positive regulation of cell cycle G2/M phase transition,BP,
19297,GO:1902765,1,0.986334890687528,0,2,L-arginine import into cell,BP,
19298,GO:1902766,1,0.984404001286594,0,2,skeletal muscle satellite cell migration,BP,
19299,GO:1902769,1,0.993986332288818,0,1,regulation of choline O-acetyltransferase activity,BP,
19300,GO:1902771,1,0.993986332288818,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19301,GO:1902773,1,0.992605314257243,0,1,GTPase activator complex,CC,
19302,GO:1902774,1,0.959701096583117,0,6,late endosome to lysosome transport,BP,
19303,GO:1902775,1,0.980026007741933,0,3,mitochondrial large ribosomal subunit assembly,BP,
19304,GO:1902803,1,0.772958105320747,0,37,regulation of synaptic vesicle transport,BP,
19305,GO:1902804,1,0.945383499069317,0,8,negative regulation of synaptic vesicle transport,BP,
19306,GO:1902805,1,0.967163775375608,0,5,positive regulation of synaptic vesicle transport,BP,
19307,GO:1902806,1,0.342603702552132,0,148,regulation of cell cycle G1/S phase transition,BP,
19308,GO:1902807,1,0.50355242726206,0,95,negative regulation of cell cycle G1/S phase transition,BP,
19309,GO:1902808,1,0.795148467424906,0,32,positive regulation of cell cycle G1/S phase transition,BP,
19310,GO:1902809,1,0.978621083072844,0,3,regulation of skeletal muscle fiber differentiation,BP,
19311,GO:1902811,1,0.986036772232189,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19312,GO:1902822,1,0.971483465571716,0,4,regulation of late endosome to lysosome transport,BP,
19313,GO:1902823,1,0.986873790503079,0,2,negative regulation of late endosome to lysosome transport,BP,
19314,GO:1902824,1,0.984406568866254,0,2,positive regulation of late endosome to lysosome transport,BP,
19315,GO:1902826,1,0.992302628349193,0,1,regulation of L-arginine import into cell,BP,
19316,GO:1902828,1,0.992302628349193,0,1,positive regulation of L-arginine import into cell,BP,
19317,GO:1902837,1,0.956460799207606,0,7,amino acid import into cell,BP,
19318,GO:1902847,1,0.992453396137953,0,1,regulation of neuronal signal transduction,BP,
19319,GO:1902850,1,0.53653445380623,0,87,microtubule cytoskeleton organization involved in mitosis,BP,
19320,GO:1902855,1,0.915733628624472,0,13,regulation of non-motile cilium assembly,BP,
19321,GO:1902856,1,0.980658285269212,0,3,negative regulation of non-motile cilium assembly,BP,
19322,GO:1902857,1,0.941080494521428,0,9,positive regulation of non-motile cilium assembly,BP,
19325,GO:1902861,1,0.99389835650373,0,1,copper ion import into cell,BP,
19326,GO:1902866,1,0.949196534519434,0,7,regulation of retina development in camera-type eye,BP,
19327,GO:1902867,1,0.992693459181082,0,1,negative regulation of retina development in camera-type eye,BP,
19328,GO:1902868,1,0.984486305222326,0,2,positive regulation of retina development in camera-type eye,BP,
19329,GO:1902869,1,0.9772922405681,0,3,regulation of amacrine cell differentiation,BP,
19330,GO:1902870,1,0.992693459181082,0,1,negative regulation of amacrine cell differentiation,BP,
19331,GO:1902871,1,0.984486305222326,0,2,positive regulation of amacrine cell differentiation,BP,
19335,GO:1902890,1,0.992170027168696,0,1,regulation of root hair elongation,BP,
19336,GO:1902891,1,0.992170027168696,0,1,negative regulation of root hair elongation,BP,
19337,GO:1902893,1,0.830457689507129,0,27,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
19338,GO:1902894,1,0.936203180032767,0,10,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
19339,GO:1902895,1,0.874890665271452,0,19,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
19340,GO:1902896,1,0.978518452029179,0,3,terminal web assembly,BP,
19341,GO:1902897,1,0.979899368941883,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19342,GO:1902902,1,0.928739907327077,0,10,negative regulation of autophagosome assembly,BP,
19346,GO:1902908,1,0.985923788392148,0,2,regulation of melanosome transport,BP,
19347,GO:1902910,1,0.993704836810665,0,1,positive regulation of melanosome transport,BP,
19349,GO:1902913,1,0.992170027168696,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19351,GO:1902915,1,0.973548862509906,0,4,negative regulation of protein polyubiquitination,BP,
19354,GO:1902931,1,0.935660466779708,0,9,negative regulation of alcohol biosynthetic process,BP,
19357,GO:1902937,1,0.986033815453907,0,2,inward rectifier potassium channel complex,CC,
19358,GO:1902938,1,0.992487563722793,0,1,regulation of intracellular calcium activated chloride channel activity,BP,
19359,GO:1902939,1,0.992487563722793,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19360,GO:1902941,1,0.987640746749979,0,2,regulation of voltage-gated chloride channel activity,BP,
19361,GO:1902943,1,0.987640746749979,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19362,GO:1902946,1,0.960866597455617,0,6,protein localization to early endosome,BP,
19363,GO:1902947,1,0.978767217421835,0,3,regulation of tau-protein kinase activity,BP,
19364,GO:1902948,1,0.993986332288818,0,1,negative regulation of tau-protein kinase activity,BP,
19365,GO:1902949,1,0.992453396137953,0,1,positive regulation of tau-protein kinase activity,BP,
19366,GO:1902950,1,0.95639314125174,0,6,regulation of dendritic spine maintenance,BP,
19367,GO:1902951,1,0.976910630385729,0,3,negative regulation of dendritic spine maintenance,BP,
19368,GO:1902952,1,0.986057617188883,0,2,positive regulation of dendritic spine maintenance,BP,
19369,GO:1902953,1,0.972428876735271,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19370,GO:1902954,1,0.988008547494063,0,2,regulation of early endosome to recycling endosome transport,BP,
19371,GO:1902955,1,0.993986332288818,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19372,GO:1902956,1,0.969981526282711,0,4,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19373,GO:1902957,1,0.985183567623371,0,2,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19374,GO:1902958,1,0.984571116209316,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19375,GO:1902959,1,0.987368948103984,0,2,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19376,GO:1902960,1,0.993986332288818,0,1,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19377,GO:1902961,1,0.993342893318518,0,1,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19378,GO:1902962,1,0.987368948103984,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19379,GO:1902963,1,0.987368948103984,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19380,GO:1902965,1,0.974234158529249,0,4,regulation of protein localization to early endosome,BP,
19381,GO:1902966,1,0.974234158529249,0,4,positive regulation of protein localization to early endosome,BP,
19382,GO:1902969,1,0.929872011853667,0,10,mitotic DNA replication,BP,
19383,GO:1902975,1,0.992170027168696,0,1,mitotic DNA replication initiation,BP,
19384,GO:1902977,1,0.992173308828905,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19385,GO:1902979,1,0.992294630214608,0,1,mitotic DNA replication termination,BP,
19386,GO:1902983,1,0.992840823148394,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19387,GO:1902988,1,0.980551731083481,0,3,neurofibrillary tangle assembly,BP,
19388,GO:1902990,1,0.979918690099658,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19389,GO:1902991,1,0.913629090627909,0,13,regulation of amyloid precursor protein catabolic process,BP,
19390,GO:1902992,1,0.945227840982402,0,8,negative regulation of amyloid precursor protein catabolic process,BP,
19391,GO:1902993,1,0.964847598603636,0,5,positive regulation of amyloid precursor protein catabolic process,BP,
19392,GO:1902994,1,0.986203080777574,0,2,regulation of phospholipid efflux,BP,
19393,GO:1902995,1,0.986203080777574,0,2,positive regulation of phospholipid efflux,BP,
19394,GO:1902996,1,0.986484758812589,0,2,regulation of neurofibrillary tangle assembly,BP,
19395,GO:1902997,1,0.993986332288818,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19396,GO:1902998,1,0.992453396137953,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19397,GO:1903000,1,0.992170027168696,0,1,regulation of lipid transport across blood brain barrier,BP,
19398,GO:1903002,1,0.992170027168696,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19399,GO:1903003,1,0.971997780443332,0,4,positive regulation of protein deubiquitination,BP,
19400,GO:1903004,1,0.993406763692654,0,1,regulation of protein K63-linked deubiquitination,BP,
19401,GO:1903006,1,0.993406763692654,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19402,GO:1903007,1,0.993406763692654,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19403,GO:1903008,1,0.499621607056338,0,97,organelle disassembly,BP,
19406,GO:1903012,1,0.948709664272037,0,7,positive regulation of bone development,BP,
19407,GO:1903015,1,0.976695799457065,0,3,regulation of exo-alpha-sialidase activity,BP,
19408,GO:1903016,1,0.984404598064473,0,2,negative regulation of exo-alpha-sialidase activity,BP,
19409,GO:1903017,1,0.992170032292588,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19410,GO:1903018,1,0.741565639044772,0,41,regulation of glycoprotein metabolic process,BP,
19411,GO:1903019,1,0.906737942981033,0,13,negative regulation of glycoprotein metabolic process,BP,
19412,GO:1903020,1,0.872141068852942,0,19,positive regulation of glycoprotein metabolic process,BP,
19413,GO:1903025,1,0.930026235984166,0,10,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19414,GO:1903026,1,0.955670248888743,0,6,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19415,GO:1903027,1,0.978513774187158,0,3,regulation of opsonization,BP,
19416,GO:1903028,1,0.993986332273524,0,1,positive regulation of opsonization,BP,
19417,GO:1903031,1,0.98455430680793,0,2,regulation of microtubule plus-end binding,BP,
19418,GO:1903033,1,0.98455430680793,0,2,positive regulation of microtubule plus-end binding,BP,
19420,GO:1903035,1,0.580508756940631,0,75,negative regulation of response to wounding,BP,
19421,GO:1903036,1,0.679565292447304,0,53,positive regulation of response to wounding,BP,
19423,GO:1903038,1,0.483933093958065,0,98,negative regulation of leukocyte cell-cell adhesion,BP,
19425,GO:1903044,1,0.934601619279779,0,9,protein localization to membrane raft,BP,
19426,GO:1903045,1,0.993986081960467,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19427,GO:1903046,1,0.283608969309096,0,174,meiotic cell cycle process,BP,
19430,GO:1903051,1,0.738475482109474,0,42,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19432,GO:1903053,1,0.829843482025316,0,27,regulation of extracellular matrix organization,BP,
19433,GO:1903054,1,0.955586262622714,0,6,negative regulation of extracellular matrix organization,BP,
19434,GO:1903055,1,0.90234997115631,0,15,positive regulation of extracellular matrix organization,BP,
19435,GO:1903056,1,0.986203096746041,0,2,regulation of melanosome organization,BP,
19436,GO:1903059,1,0.964997275706693,0,5,regulation of protein lipidation,BP,
19437,GO:1903060,1,0.992170721913545,0,1,negative regulation of protein lipidation,BP,
19438,GO:1903061,1,0.972613785069352,0,4,positive regulation of protein lipidation,BP,
19439,GO:1903069,1,0.935560932255834,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19440,GO:1903070,1,0.978147016834208,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19441,GO:1903071,1,0.949025942531052,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19442,GO:1903072,1,0.992170027168696,0,1,regulation of death-inducing signaling complex assembly,BP,
19443,GO:1903073,1,0.992170027168696,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19444,GO:1903076,1,0.627049562573017,0,66,regulation of protein localization to plasma membrane,BP,
19445,GO:1903077,1,0.872540133044313,0,19,negative regulation of protein localization to plasma membrane,BP,
19446,GO:1903078,1,0.767088803914056,0,38,positive regulation of protein localization to plasma membrane,BP,
19447,GO:1903080,1,0.992170027168696,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19448,GO:1903082,1,0.992170027168696,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19449,GO:1903093,1,0.984400887813367,0,2,regulation of protein K48-linked deubiquitination,BP,
19450,GO:1903094,1,0.984400887813367,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19451,GO:1903095,1,0.986127069812745,0,2,ribonuclease III complex,CC,
19452,GO:1903096,1,0.992599282199603,0,1,protein localization to meiotic spindle midzone,BP,
19453,GO:1903115,1,0.768789431967024,0,39,regulation of actin filament-based movement,BP,
19454,GO:1903116,1,0.980979010517269,0,3,positive regulation of actin filament-based movement,BP,
19455,GO:1903118,1,0.992230290634377,0,1,urate homeostasis,BP,
19456,GO:1903121,1,0.972600801929284,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19457,GO:1903122,1,0.992170027168696,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19458,GO:1903123,1,0.993986332281396,0,1,regulation of thioredoxin peroxidase activity,BP,
19459,GO:1903124,1,0.993986332281396,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19460,GO:1903125,1,0.993986332281396,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19461,GO:1903126,1,0.992188483773118,0,1,negative regulation of centriole-centriole cohesion,BP,
19462,GO:1903131,1,0.787822074611426,0,33,mononuclear cell differentiation,BP,
19463,GO:1903135,1,0.97822549548416,0,3,cupric ion binding,MF,
19464,GO:1903136,1,0.956404448158323,0,6,cuprous ion binding,MF,
19465,GO:1903140,1,0.919356437835851,0,12,regulation of establishment of endothelial barrier,BP,
19466,GO:1903141,1,0.993655089239939,0,1,negative regulation of establishment of endothelial barrier,BP,
19467,GO:1903142,1,0.965107225496199,0,5,positive regulation of establishment of endothelial barrier,BP,
19468,GO:1903146,1,0.705222729470006,0,49,regulation of mitophagy,BP,
19469,GO:1903147,1,0.965776764268926,0,5,negative regulation of mitophagy,BP,
19470,GO:1903165,1,0.992358711416109,0,1,response to polycyclic arene,BP,
19471,GO:1903167,1,0.992170027168696,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19472,GO:1903168,1,0.992170027168696,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19474,GO:1903170,1,0.78491757780638,0,33,negative regulation of calcium ion transmembrane transport,BP,
19476,GO:1903176,1,0.992170027168696,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19477,GO:1903178,1,0.992170027168696,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19478,GO:1903179,1,0.985070381369775,0,2,regulation of dopamine biosynthetic process,BP,
19479,GO:1903181,1,0.985070381369775,0,2,positive regulation of dopamine biosynthetic process,BP,
19480,GO:1903182,1,0.992170027168696,0,1,regulation of SUMO transferase activity,BP,
19481,GO:1903184,1,0.992170027168696,0,1,L-dopa metabolic process,BP,
19482,GO:1903185,1,0.992170027168696,0,1,L-dopa biosynthetic process,BP,
19483,GO:1903189,1,0.992170027168696,0,1,glyoxal metabolic process,BP,
19484,GO:1903195,1,0.992170027168696,0,1,regulation of L-dopa biosynthetic process,BP,
19485,GO:1903197,1,0.992170027168696,0,1,positive regulation of L-dopa biosynthetic process,BP,
19486,GO:1903198,1,0.992170027168696,0,1,regulation of L-dopa decarboxylase activity,BP,
19487,GO:1903200,1,0.992170027168696,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19490,GO:1903203,1,0.895325093231587,0,16,regulation of oxidative stress-induced neuron death,BP,
19491,GO:1903204,1,0.913294853520966,0,13,negative regulation of oxidative stress-induced neuron death,BP,
19492,GO:1903205,1,0.859452001799883,0,21,regulation of hydrogen peroxide-induced cell death,BP,
19493,GO:1903206,1,0.88990497223914,0,16,negative regulation of hydrogen peroxide-induced cell death,BP,
19494,GO:1903207,1,0.978639671956203,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
19495,GO:1903208,1,0.978639671956203,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
19496,GO:1903209,1,0.916764474625773,0,12,positive regulation of oxidative stress-induced cell death,BP,
19497,GO:1903210,1,0.993986332267178,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19498,GO:1903214,1,0.514348150029359,0,91,regulation of protein targeting to mitochondrion,BP,
19499,GO:1903215,1,0.972148655856937,0,4,negative regulation of protein targeting to mitochondrion,BP,
19500,GO:1903216,1,0.986203080788992,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19501,GO:1903217,1,0.986203080788992,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19502,GO:1903223,1,0.986737053577792,0,2,positive regulation of oxidative stress-induced neuron death,BP,
19503,GO:1903224,1,0.957799395053995,0,6,regulation of endodermal cell differentiation,BP,
19504,GO:1903225,1,0.980271740726559,0,3,negative regulation of endodermal cell differentiation,BP,
19505,GO:1903232,1,0.963127464421418,0,5,melanosome assembly,BP,
19506,GO:1903233,1,0.987957153731641,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19507,GO:1903236,1,0.949570712255656,0,7,regulation of leukocyte tethering or rolling,BP,
19508,GO:1903237,1,0.969046699151463,0,4,negative regulation of leukocyte tethering or rolling,BP,
19509,GO:1903238,1,0.979906797813801,0,3,positive regulation of leukocyte tethering or rolling,BP,
19510,GO:1903242,1,0.960349891020881,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
19511,GO:1903243,1,0.980779849300072,0,3,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19512,GO:1903244,1,0.98690100799696,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19513,GO:1903248,1,0.993986332279396,0,1,regulation of citrulline biosynthetic process,BP,
19514,GO:1903249,1,0.993986332279396,0,1,negative regulation of citrulline biosynthetic process,BP,
19515,GO:1903251,1,0.958552355414353,0,6,multi-ciliated epithelial cell differentiation,BP,
19516,GO:1903261,1,0.971406314418261,0,4,regulation of serine phosphorylation of STAT3 protein,BP,
19517,GO:1903262,1,0.984642818374512,0,2,negative regulation of serine phosphorylation of STAT3 protein,BP,
19518,GO:1903263,1,0.986558664717251,0,2,positive regulation of serine phosphorylation of STAT3 protein,BP,
19519,GO:1903265,1,0.962744188518978,0,5,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19524,GO:1903279,1,0.980123527460905,0,3,regulation of calcium:sodium antiporter activity,BP,
19525,GO:1903280,1,0.993983248188335,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19526,GO:1903281,1,0.986057037401222,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19527,GO:1903282,1,0.992722786240047,0,1,regulation of glutathione peroxidase activity,BP,
19528,GO:1903284,1,0.992722786240047,0,1,positive regulation of glutathione peroxidase activity,BP,
19529,GO:1903285,1,0.992722786240047,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19530,GO:1903286,1,0.971480524666973,0,4,regulation of potassium ion import,BP,
19531,GO:1903288,1,0.977397694354633,0,3,positive regulation of potassium ion import,BP,
19532,GO:1903293,1,0.726036735117738,0,45,phosphatase complex,CC,
19533,GO:1903294,1,0.993934630003237,0,1,regulation of glutamate secretion, neurotransmission,BP,
19534,GO:1903296,1,0.993934630003237,0,1,positive regulation of glutamate secretion, neurotransmission,BP,
19535,GO:1903297,1,0.971290791155175,0,4,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19536,GO:1903298,1,0.971290791155175,0,4,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19537,GO:1903299,1,0.941949910209984,0,8,regulation of hexokinase activity,BP,
19538,GO:1903300,1,0.970281077210212,0,4,negative regulation of hexokinase activity,BP,
19539,GO:1903301,1,0.970807851804872,0,4,positive regulation of hexokinase activity,BP,
19541,GO:1903306,1,0.86134795678385,0,21,negative regulation of regulated secretory pathway,BP,
19542,GO:1903307,1,0.730367965484203,0,44,positive regulation of regulated secretory pathway,BP,
19543,GO:1903311,1,0.387481973285008,0,131,regulation of mRNA metabolic process,BP,
19544,GO:1903312,1,0.758876456566358,0,38,negative regulation of mRNA metabolic process,BP,
19545,GO:1903313,1,0.702630666270813,0,49,positive regulation of mRNA metabolic process,BP,
19546,GO:1903314,1,0.992190392480105,0,1,regulation of nitrogen cycle metabolic process,BP,
19549,GO:1903319,1,0.872278006335306,0,19,positive regulation of protein maturation,BP,
19553,GO:1903332,1,0.950260104477975,0,7,regulation of protein folding,BP,
19554,GO:1903333,1,0.963922162069048,0,5,negative regulation of protein folding,BP,
19555,GO:1903335,1,0.964010709706163,0,5,regulation of vacuolar transport,BP,
19556,GO:1903336,1,0.986873790503079,0,2,negative regulation of vacuolar transport,BP,
19557,GO:1903337,1,0.984406568866254,0,2,positive regulation of vacuolar transport,BP,
19558,GO:1903347,1,0.97385967283731,0,4,negative regulation of bicellular tight junction assembly,BP,
19559,GO:1903348,1,0.979406358505222,0,3,positive regulation of bicellular tight junction assembly,BP,
19560,GO:1903349,1,0.97192902893146,0,4,omegasome membrane,CC,
19561,GO:1903350,1,0.914746443623528,0,13,response to dopamine,BP,
19562,GO:1903351,1,0.914746443623528,0,13,cellular response to dopamine,BP,
19563,GO:1903352,1,0.97982274012317,0,3,L-ornithine transmembrane transport,BP,
19564,GO:1903358,1,0.930411420970744,0,10,regulation of Golgi organization,BP,
19565,GO:1903361,1,0.963316312095887,0,5,protein localization to basolateral plasma membrane,BP,
19567,GO:1903363,1,0.691971997575805,0,51,negative regulation of cellular protein catabolic process,BP,
19569,GO:1903365,1,0.963712749421686,0,5,regulation of fear response,BP,
19570,GO:1903367,1,0.963712749421686,0,5,positive regulation of fear response,BP,
19571,GO:1903371,1,0.982015346127149,0,3,regulation of endoplasmic reticulum tubular network organization,BP,
19572,GO:1903373,1,0.987957153727377,0,2,positive regulation of endoplasmic reticulum tubular network organization,BP,
19573,GO:1903375,1,0.986298429630361,0,2,facioacoustic ganglion development,BP,
19574,GO:1903376,1,0.951893470978504,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19575,GO:1903377,1,0.970989357164802,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19576,GO:1903378,1,0.986737053577792,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19577,GO:1903381,1,0.993830955432793,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19578,GO:1903382,1,0.993830955432793,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19579,GO:1903383,1,0.984571116209316,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19580,GO:1903384,1,0.984571116209316,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19581,GO:1903385,1,0.987039296802094,0,2,regulation of homophilic cell adhesion,BP,
19582,GO:1903387,1,0.993974598329208,0,1,positive regulation of homophilic cell adhesion,BP,
19583,GO:1903391,1,0.701370074514399,0,53,regulation of adherens junction organization,BP,
19584,GO:1903392,1,0.906237506586415,0,15,negative regulation of adherens junction organization,BP,
19585,GO:1903393,1,0.844228239389135,0,25,positive regulation of adherens junction organization,BP,
19586,GO:1903394,1,0.992227048603077,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19587,GO:1903400,1,0.993986332273392,0,1,L-arginine transmembrane transport,BP,
19588,GO:1903401,1,0.978515907671628,0,3,L-lysine transmembrane transport,BP,
19589,GO:1903402,1,0.993411145903599,0,1,regulation of renal phosphate excretion,BP,
19590,GO:1903403,1,0.993411145903599,0,1,negative regulation of renal phosphate excretion,BP,
19591,GO:1903405,1,0.932701308690869,0,9,protein localization to nuclear body,BP,
19592,GO:1903406,1,0.993192475809782,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19593,GO:1903408,1,0.993192475809782,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19595,GO:1903410,1,0.986334890687528,0,2,L-lysine import into cell,BP,
19596,GO:1903411,1,0.993986332273392,0,1,L-ornithine import into cell,BP,
19597,GO:1903412,1,0.978007648965448,0,3,response to bile acid,BP,
19598,GO:1903413,1,0.978007648965448,0,3,cellular response to bile acid,BP,
19599,GO:1903414,1,0.992905325785656,0,1,iron cation export,BP,
19600,GO:1903416,1,0.958997058458426,0,6,response to glycoside,BP,
19601,GO:1903420,1,0.993986332267597,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19602,GO:1903421,1,0.907502218878685,0,14,regulation of synaptic vesicle recycling,BP,
19603,GO:1903422,1,0.981345853653308,0,3,negative regulation of synaptic vesicle recycling,BP,
19604,GO:1903423,1,0.973016420931756,0,4,positive regulation of synaptic vesicle recycling,BP,
19608,GO:1903429,1,0.868643630757715,0,20,regulation of cell maturation,BP,
19609,GO:1903430,1,0.944681406062153,0,8,negative regulation of cell maturation,BP,
19610,GO:1903431,1,0.960326335787349,0,6,positive regulation of cell maturation,BP,
19611,GO:1903432,1,0.85793238459822,0,21,regulation of TORC1 signaling,BP,
19612,GO:1903433,1,0.985869526874822,0,2,regulation of constitutive secretory pathway,BP,
19613,GO:1903434,1,0.993396181085405,0,1,negative regulation of constitutive secretory pathway,BP,
19614,GO:1903435,1,0.992423701494641,0,1,positive regulation of constitutive secretory pathway,BP,
19615,GO:1903436,1,0.986896883912116,0,2,regulation of mitotic cytokinetic process,BP,
19616,GO:1903438,1,0.986896883912116,0,2,positive regulation of mitotic cytokinetic process,BP,
19617,GO:1903441,1,0.949443683997034,0,7,protein localization to ciliary membrane,BP,
19618,GO:1903444,1,0.992712489432679,0,1,negative regulation of brown fat cell differentiation,BP,
19619,GO:1903445,1,0.976843572268445,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19620,GO:1903450,1,0.993986332278474,0,1,regulation of G1 to G0 transition,BP,
19621,GO:1903452,1,0.993986332278474,0,1,positive regulation of G1 to G0 transition,BP,
19622,GO:1903461,1,0.99266510180249,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19623,GO:1903463,1,0.979383434717737,0,3,regulation of mitotic cell cycle DNA replication,BP,
19624,GO:1903464,1,0.985309826085226,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19625,GO:1903465,1,0.993985944700782,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19626,GO:1903487,1,0.984401485132068,0,2,regulation of lactation,BP,
19627,GO:1903488,1,0.992170027168696,0,1,negative regulation of lactation,BP,
19628,GO:1903489,1,0.992170629164745,0,1,positive regulation of lactation,BP,
19629,GO:1903490,1,0.986896883912116,0,2,positive regulation of mitotic cytokinesis,BP,
19630,GO:1903504,1,0.907387381774903,0,13,regulation of mitotic spindle checkpoint,BP,
19636,GO:1903513,1,0.829412239125982,0,26,endoplasmic reticulum to cytosol transport,BP,
19638,GO:1903515,1,0.993986332276659,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19639,GO:1903516,1,0.992492073226113,0,1,regulation of single strand break repair,BP,
19640,GO:1903517,1,0.992492073226113,0,1,negative regulation of single strand break repair,BP,
19641,GO:1903519,1,0.979841228967994,0,3,regulation of mammary gland involution,BP,
19642,GO:1903521,1,0.979841228967994,0,3,positive regulation of mammary gland involution,BP,
19644,GO:1903523,1,0.821347198526429,0,28,negative regulation of blood circulation,BP,
19645,GO:1903524,1,0.628814485630213,0,63,positive regulation of blood circulation,BP,
19646,GO:1903525,1,0.96894112835342,0,5,regulation of membrane tubulation,BP,
19647,GO:1903526,1,0.98700862946244,0,2,negative regulation of membrane tubulation,BP,
19648,GO:1903527,1,0.981696542681919,0,3,positive regulation of membrane tubulation,BP,
19650,GO:1903531,1,0.290867305494729,0,169,negative regulation of secretion by cell,BP,
19653,GO:1903537,1,0.992232866469696,0,1,meiotic cell cycle process involved in oocyte maturation,BP,
19654,GO:1903538,1,0.992232866469696,0,1,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19655,GO:1903539,1,0.928832069646703,0,10,protein localization to postsynaptic membrane,BP,
19656,GO:1903540,1,0.928832069646703,0,10,establishment of protein localization to postsynaptic membrane,BP,
19657,GO:1903541,1,0.895299886565273,0,15,regulation of exosomal secretion,BP,
19658,GO:1903542,1,0.985188642751898,0,2,negative regulation of exosomal secretion,BP,
19659,GO:1903543,1,0.895299886565273,0,15,positive regulation of exosomal secretion,BP,
19660,GO:1903544,1,0.992967540933404,0,1,response to butyrate,BP,
19661,GO:1903545,1,0.992967540933404,0,1,cellular response to butyrate,BP,
19662,GO:1903546,1,0.95015698061514,0,7,protein localization to photoreceptor outer segment,BP,
19663,GO:1903547,1,0.984400887813367,0,2,regulation of growth hormone activity,BP,
19664,GO:1903551,1,0.956806124139029,0,6,regulation of extracellular exosome assembly,BP,
19665,GO:1903553,1,0.971597363555937,0,4,positive regulation of extracellular exosome assembly,BP,
19667,GO:1903556,1,0.71963732088127,0,44,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
19670,GO:1903564,1,0.98104485132486,0,3,regulation of protein localization to cilium,BP,
19671,GO:1903565,1,0.992952448011407,0,1,negative regulation of protein localization to cilium,BP,
19672,GO:1903566,1,0.988008547484562,0,2,positive regulation of protein localization to cilium,BP,
19673,GO:1903567,1,0.992952448011407,0,1,regulation of protein localization to ciliary membrane,BP,
19674,GO:1903568,1,0.992952448011407,0,1,negative regulation of protein localization to ciliary membrane,BP,
19675,GO:1903570,1,0.993070850342945,0,1,regulation of protein kinase D signaling,BP,
19676,GO:1903572,1,0.993070850342945,0,1,positive regulation of protein kinase D signaling,BP,
19677,GO:1903573,1,0.763516750500105,0,37,negative regulation of response to endoplasmic reticulum stress,BP,
19678,GO:1903575,1,0.985169749591353,0,2,cornified envelope assembly,BP,
19679,GO:1903576,1,0.992182039384568,0,1,response to L-arginine,BP,
19680,GO:1903578,1,0.687339638196254,0,52,regulation of ATP metabolic process,BP,
19681,GO:1903579,1,0.871969769201801,0,19,negative regulation of ATP metabolic process,BP,
19682,GO:1903580,1,0.829863070719556,0,26,positive regulation of ATP metabolic process,BP,
19683,GO:1903584,1,0.99375521404605,0,1,regulation of histone deubiquitination,BP,
19684,GO:1903586,1,0.99375521404605,0,1,positive regulation of histone deubiquitination,BP,
19685,GO:1903587,1,0.972336762717305,0,4,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19686,GO:1903588,1,0.978220465375325,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19687,GO:1903589,1,0.993986332266494,0,1,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19688,GO:1903593,1,0.976941220993847,0,3,regulation of histamine secretion by mast cell,BP,
19689,GO:1903595,1,0.976941220993847,0,3,positive regulation of histamine secretion by mast cell,BP,
19690,GO:1903596,1,0.970952412770972,0,4,regulation of gap junction assembly,BP,
19691,GO:1903597,1,0.992912823847982,0,1,negative regulation of gap junction assembly,BP,
19692,GO:1903598,1,0.97788405606534,0,3,positive regulation of gap junction assembly,BP,
19693,GO:1903599,1,0.874217722487634,0,19,positive regulation of mitophagy,BP,
19694,GO:1903608,1,0.953347862719143,0,7,protein localization to cytoplasmic stress granule,BP,
19697,GO:1903613,1,0.993978543860574,0,1,regulation of protein tyrosine phosphatase activity,BP,
19698,GO:1903615,1,0.993978543860574,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19699,GO:1903618,1,0.993518782405315,0,1,regulation of transdifferentiation,BP,
19700,GO:1903620,1,0.993518782405315,0,1,positive regulation of transdifferentiation,BP,
19701,GO:1903621,1,0.992174200226654,0,1,protein localization to photoreceptor connecting cilium,BP,
19704,GO:1903626,1,0.976713400897399,0,3,positive regulation of DNA catabolic process,BP,
19709,GO:1903632,1,0.992170027168696,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19712,GO:1903636,1,0.992170027168696,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19713,GO:1903638,1,0.992170027168696,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19714,GO:1903639,1,0.992170027168696,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19715,GO:1903640,1,0.992170027168696,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19716,GO:1903644,1,0.984522084623074,0,2,regulation of chaperone-mediated protein folding,BP,
19717,GO:1903645,1,0.992170027168696,0,1,negative regulation of chaperone-mediated protein folding,BP,
19718,GO:1903649,1,0.876644551748619,0,19,regulation of cytoplasmic transport,BP,
19719,GO:1903650,1,0.984400887813367,0,2,negative regulation of cytoplasmic transport,BP,
19720,GO:1903651,1,0.942321601321903,0,9,positive regulation of cytoplasmic transport,BP,
19721,GO:1903659,1,0.976808799306961,0,3,regulation of complement-dependent cytotoxicity,BP,
19722,GO:1903660,1,0.976808799306961,0,3,negative regulation of complement-dependent cytotoxicity,BP,
19723,GO:1903670,1,0.824158774599237,0,28,regulation of sprouting angiogenesis,BP,
19724,GO:1903671,1,0.912659578473018,0,13,negative regulation of sprouting angiogenesis,BP,
19725,GO:1903672,1,0.916034968610475,0,13,positive regulation of sprouting angiogenesis,BP,
19726,GO:1903673,1,0.992173165022278,0,1,mitotic cleavage furrow formation,BP,
19727,GO:1903674,1,0.992172923581838,0,1,regulation of cap-dependent translational initiation,BP,
19728,GO:1903676,1,0.992172923581838,0,1,positive regulation of cap-dependent translational initiation,BP,
19729,GO:1903677,1,0.976965023646203,0,3,regulation of cap-independent translational initiation,BP,
19730,GO:1903679,1,0.976965023646203,0,3,positive regulation of cap-independent translational initiation,BP,
19731,GO:1903689,1,0.957101265633133,0,7,regulation of wound healing, spreading of epidermal cells,BP,
19732,GO:1903690,1,0.976158381244265,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19733,GO:1903691,1,0.988008547488985,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19734,GO:1903697,1,0.992902329256895,0,1,negative regulation of microvillus assembly,BP,
19735,GO:1903699,1,0.993986332292274,0,1,tarsal gland development,BP,
19736,GO:1903701,1,0.993967933950215,0,1,substantia propria of cornea development,BP,
19737,GO:1903704,1,0.993518782405315,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19741,GO:1903709,1,0.993986332292274,0,1,uterine gland development,BP,
19742,GO:1903712,1,0.993276345545592,0,1,cysteine transmembrane transport,BP,
19743,GO:1903715,1,0.952816714097059,0,7,regulation of aerobic respiration,BP,
19744,GO:1903717,1,0.993986317082102,0,1,response to ammonia,BP,
19745,GO:1903718,1,0.993986317082102,0,1,cellular response to ammonia,BP,
19746,GO:1903719,1,0.977025359768237,0,3,regulation of I-kappaB phosphorylation,BP,
19747,GO:1903721,1,0.977025359768237,0,3,positive regulation of I-kappaB phosphorylation,BP,
19748,GO:1903722,1,0.98515630187477,0,2,regulation of centriole elongation,BP,
19749,GO:1903723,1,0.992170027168696,0,1,negative regulation of centriole elongation,BP,
19750,GO:1903724,1,0.992931356551711,0,1,positive regulation of centriole elongation,BP,
19754,GO:1903729,1,0.585258442705259,0,76,regulation of plasma membrane organization,BP,
19755,GO:1903742,1,0.992170027168696,0,1,regulation of anterograde synaptic vesicle transport,BP,
19756,GO:1903743,1,0.992170027168696,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19757,GO:1903747,1,0.406606066989782,0,123,regulation of establishment of protein localization to mitochondrion,BP,
19758,GO:1903748,1,0.952237621856955,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19759,GO:1903749,1,0.443183961446164,0,111,positive regulation of establishment of protein localization to mitochondrion,BP,
19760,GO:1903750,1,0.97028962249989,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19761,GO:1903751,1,0.97028962249989,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19762,GO:1903753,1,0.972729504916029,0,4,negative regulation of p38MAPK cascade,BP,
19763,GO:1903755,1,0.992170027168696,0,1,positive regulation of SUMO transferase activity,BP,
19764,GO:1903756,1,0.986124047689849,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19765,GO:1903758,1,0.986124047689849,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19766,GO:1903759,1,0.992712489432679,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19767,GO:1903760,1,0.981352417847486,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19768,GO:1903762,1,0.987329242632722,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19769,GO:1903763,1,0.979527430233668,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19770,GO:1903764,1,0.978894646727788,0,3,regulation of potassium ion export across plasma membrane,BP,
19771,GO:1903765,1,0.992629327524328,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19772,GO:1903766,1,0.992170027168696,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19773,GO:1903767,1,0.984632860979278,0,2,sweet taste receptor complex,CC,
19774,GO:1903768,1,0.984632860979278,0,2,taste receptor complex,CC,
19775,GO:1903770,1,0.992492073226113,0,1,negative regulation of beta-galactosidase activity,BP,
19776,GO:1903772,1,0.961808653987043,0,5,regulation of viral budding via host ESCRT complex,BP,
19777,GO:1903774,1,0.976929844094331,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19778,GO:1903775,1,0.992923336263236,0,1,regulation of DNA double-strand break processing,BP,
19779,GO:1903778,1,0.986341843909105,0,2,protein localization to vacuolar membrane,BP,
19781,GO:1903781,1,0.980996268874497,0,3,positive regulation of cardiac conduction,BP,
19782,GO:1903786,1,0.992383952902976,0,1,regulation of glutathione biosynthetic process,BP,
19783,GO:1903788,1,0.992383952902976,0,1,positive regulation of glutathione biosynthetic process,BP,
19784,GO:1903789,1,0.985063822252927,0,2,regulation of amino acid transmembrane transport,BP,
19785,GO:1903792,1,0.850251166443162,0,23,negative regulation of anion transport,BP,
19786,GO:1903793,1,0.748978628038593,0,40,positive regulation of anion transport,BP,
19787,GO:1903795,1,0.966729900157769,0,5,regulation of inorganic anion transmembrane transport,BP,
19788,GO:1903796,1,0.986518722499164,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19789,GO:1903797,1,0.979942860188982,0,3,positive regulation of inorganic anion transmembrane transport,BP,
19790,GO:1903798,1,0.904520770056591,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19791,GO:1903799,1,0.954105379352886,0,7,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19792,GO:1903800,1,0.94064860778916,0,8,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19793,GO:1903802,1,0.969715228994286,0,5,L-glutamate(1-) import into cell,BP,
19794,GO:1903814,1,0.992170027168696,0,1,regulation of collecting lymphatic vessel constriction,BP,
19795,GO:1903815,1,0.992170027168696,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19796,GO:1903817,1,0.950386270997767,0,7,negative regulation of voltage-gated potassium channel activity,BP,
19797,GO:1903818,1,0.96780932953642,0,5,positive regulation of voltage-gated potassium channel activity,BP,
19798,GO:1903823,1,0.992492073226113,0,1,telomere single strand break repair,BP,
19799,GO:1903824,1,0.992492073226113,0,1,negative regulation of telomere single strand break repair,BP,
19801,GO:1903826,1,0.972630441826349,0,4,arginine transmembrane transport,BP,
19803,GO:1903828,1,0.359700047062472,0,142,negative regulation of cellular protein localization,BP,
19804,GO:1903829,1,0.0762762022829686,0,357,positive regulation of cellular protein localization,BP,
19805,GO:1903830,1,0.888218222758687,0,17,magnesium ion transmembrane transport,BP,
19806,GO:1903831,1,0.856621377233316,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19807,GO:1903837,1,0.992262432956955,0,1,regulation of mRNA 3'-UTR binding,BP,
19808,GO:1903839,1,0.992262432956955,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19809,GO:1903844,1,0.497232148365644,0,99,regulation of cellular response to transforming growth factor beta stimulus,BP,
19810,GO:1903845,1,0.627744947892368,0,66,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
19811,GO:1903846,1,0.838359207051218,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19812,GO:1903847,1,0.987744924780373,0,2,regulation of aorta morphogenesis,BP,
19813,GO:1903849,1,0.987744924780373,0,2,positive regulation of aorta morphogenesis,BP,
19814,GO:1903850,1,0.992341588552881,0,1,regulation of cristae formation,BP,
19815,GO:1903852,1,0.992341588552881,0,1,positive regulation of cristae formation,BP,
19816,GO:1903859,1,0.884614391255746,0,18,regulation of dendrite extension,BP,
19817,GO:1903860,1,0.985700411766054,0,2,negative regulation of dendrite extension,BP,
19818,GO:1903861,1,0.8974584552755,0,16,positive regulation of dendrite extension,BP,
19819,GO:1903862,1,0.947809141066292,0,7,positive regulation of oxidative phosphorylation,BP,
19820,GO:1903867,1,0.947645843852792,0,8,extraembryonic membrane development,BP,
19821,GO:1903874,1,0.980543936633769,0,3,ferrous iron transmembrane transport,BP,
19822,GO:1903881,1,0.993262476933322,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19823,GO:1903883,1,0.993262476933322,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19824,GO:1903884,1,0.993262476933322,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19825,GO:1903886,1,0.993262476933322,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19826,GO:1903888,1,0.992170027168696,0,1,regulation of plant epidermal cell differentiation,BP,
19827,GO:1903889,1,0.992170027168696,0,1,negative regulation of plant epidermal cell differentiation,BP,
19828,GO:1903891,1,0.986722677762312,0,2,regulation of ATF6-mediated unfolded protein response,BP,
19829,GO:1903892,1,0.993190015620724,0,1,negative regulation of ATF6-mediated unfolded protein response,BP,
19830,GO:1903894,1,0.917536580925246,0,12,regulation of IRE1-mediated unfolded protein response,BP,
19831,GO:1903895,1,0.985301337827371,0,2,negative regulation of IRE1-mediated unfolded protein response,BP,
19832,GO:1903896,1,0.944738966786256,0,8,positive regulation of IRE1-mediated unfolded protein response,BP,
19833,GO:1903897,1,0.929885851256766,0,10,regulation of PERK-mediated unfolded protein response,BP,
19834,GO:1903898,1,0.963989596212134,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19835,GO:1903899,1,0.970955916272039,0,4,positive regulation of PERK-mediated unfolded protein response,BP,
19838,GO:1903902,1,0.505334618852325,0,94,positive regulation of viral life cycle,BP,
19839,GO:1903903,1,0.984769021293918,0,2,regulation of establishment of T cell polarity,BP,
19840,GO:1903905,1,0.992329146180804,0,1,positive regulation of establishment of T cell polarity,BP,
19841,GO:1903906,1,0.992381890622049,0,1,regulation of plasma membrane raft polarization,BP,
19842,GO:1903909,1,0.956032505276962,0,6,regulation of receptor clustering,BP,
19843,GO:1903910,1,0.99222345480462,0,1,negative regulation of receptor clustering,BP,
19844,GO:1903911,1,0.970925905382896,0,4,positive regulation of receptor clustering,BP,
19845,GO:1903912,1,0.965074298928067,0,5,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19846,GO:1903916,1,0.992234181466195,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19847,GO:1903917,1,0.992234181466195,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19848,GO:1903918,1,0.993986332273259,0,1,regulation of actin filament severing,BP,
19849,GO:1903919,1,0.993986332273259,0,1,negative regulation of actin filament severing,BP,
19850,GO:1903921,1,0.986413679977087,0,2,regulation of protein processing in phagocytic vesicle,BP,
19851,GO:1903923,1,0.986413679977087,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19852,GO:1903924,1,0.992201103211248,0,1,estradiol binding,MF,
19853,GO:1903925,1,0.992171683206526,0,1,response to bisphenol A,BP,
19854,GO:1903926,1,0.992171683206526,0,1,cellular response to bisphenol A,BP,
19855,GO:1903935,1,0.9627366209011,0,5,response to sodium arsenite,BP,
19856,GO:1903936,1,0.969391656418279,0,4,cellular response to sodium arsenite,BP,
19857,GO:1903937,1,0.987114707123858,0,2,response to acrylamide,BP,
19858,GO:1903939,1,0.992892352659053,0,1,regulation of TORC2 signaling,BP,
19859,GO:1903943,1,0.992174852578224,0,1,regulation of hepatocyte apoptotic process,BP,
19860,GO:1903944,1,0.992174852578224,0,1,negative regulation of hepatocyte apoptotic process,BP,
19861,GO:1903946,1,0.992629327524328,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19862,GO:1903947,1,0.987329242632722,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19863,GO:1903949,1,0.987105524596185,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19864,GO:1903952,1,0.993495103725952,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19865,GO:1903954,1,0.993495103725952,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19866,GO:1903955,1,0.549000380865249,0,82,positive regulation of protein targeting to mitochondrion,BP,
19867,GO:1903959,1,0.799266317951233,0,32,regulation of anion transmembrane transport,BP,
19868,GO:1903960,1,0.94131259472851,0,9,negative regulation of anion transmembrane transport,BP,
19869,GO:1903961,1,0.973989114646353,0,4,positive regulation of anion transmembrane transport,BP,
19870,GO:1903963,1,0.805973095749843,0,29,arachidonate transport,BP,
19871,GO:1903969,1,0.976768951685418,0,3,regulation of response to macrophage colony-stimulating factor,BP,
19872,GO:1903970,1,0.984400909548914,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
19873,GO:1903971,1,0.992248052089351,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
19874,GO:1903972,1,0.976768951685418,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19875,GO:1903973,1,0.984400909548914,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19876,GO:1903974,1,0.992248052089351,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19877,GO:1903975,1,0.933692578276859,0,9,regulation of glial cell migration,BP,
19878,GO:1903976,1,0.969183938523011,0,4,negative regulation of glial cell migration,BP,
19879,GO:1903977,1,0.97865734647868,0,3,positive regulation of glial cell migration,BP,
19880,GO:1903978,1,0.984400887813367,0,2,regulation of microglial cell activation,BP,
19881,GO:1903979,1,0.992170027168696,0,1,negative regulation of microglial cell activation,BP,
19882,GO:1903980,1,0.984400887813367,0,2,positive regulation of microglial cell activation,BP,
19883,GO:1903984,1,0.98027753844736,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19884,GO:1903988,1,0.992905325785656,0,1,ferrous iron export across plasma membrane,BP,
19885,GO:1903989,1,0.984405049732661,0,2,regulation of ferrous iron import into cell,BP,
19886,GO:1903991,1,0.984405049732661,0,2,positive regulation of ferrous iron import into cell,BP,
19887,GO:1903995,1,0.992170027168696,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19888,GO:1903997,1,0.992170027168696,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19889,GO:1903998,1,0.987991609095356,0,2,regulation of eating behavior,BP,
19890,GO:1903999,1,0.993969292202236,0,1,negative regulation of eating behavior,BP,
19891,GO:1904000,1,0.993986332279133,0,1,positive regulation of eating behavior,BP,
19892,GO:1904008,1,0.992170027168696,0,1,response to monosodium glutamate,BP,
19893,GO:1904009,1,0.992170027168696,0,1,cellular response to monosodium glutamate,BP,
19894,GO:1904010,1,0.992170027168696,0,1,response to Aroclor 1254,BP,
19895,GO:1904016,1,0.988008547468385,0,2,response to Thyroglobulin triiodothyronine,BP,
19896,GO:1904017,1,0.988008547468385,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
19897,GO:1904018,1,0.382852369248731,0,135,positive regulation of vasculature development,BP,
19898,GO:1904019,1,0.535711673718323,0,88,epithelial cell apoptotic process,BP,
19899,GO:1904020,1,0.992962507814153,0,1,regulation of G-protein coupled receptor internalization,BP,
19900,GO:1904021,1,0.992962507814153,0,1,negative regulation of G-protein coupled receptor internalization,BP,
19901,GO:1904023,1,0.992472769835405,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
19902,GO:1904025,1,0.992472769835405,0,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,
19903,GO:1904026,1,0.992283827532767,0,1,regulation of collagen fibril organization,BP,
19904,GO:1904027,1,0.992283827532767,0,1,negative regulation of collagen fibril organization,BP,
19905,GO:1904029,1,0.537447651589436,0,84,regulation of cyclin-dependent protein kinase activity,BP,
19906,GO:1904030,1,0.835217731203625,0,25,negative regulation of cyclin-dependent protein kinase activity,BP,
19907,GO:1904031,1,0.770882104399079,0,35,positive regulation of cyclin-dependent protein kinase activity,BP,
19908,GO:1904035,1,0.63634784952319,0,63,regulation of epithelial cell apoptotic process,BP,
19909,GO:1904036,1,0.771273496119022,0,36,negative regulation of epithelial cell apoptotic process,BP,
19910,GO:1904037,1,0.844628977740797,0,24,positive regulation of epithelial cell apoptotic process,BP,
19911,GO:1904041,1,0.992842792648331,0,1,regulation of cystathionine beta-synthase activity,BP,
19912,GO:1904042,1,0.992842792648331,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19913,GO:1904044,1,0.971908087004298,0,4,response to aldosterone,BP,
19914,GO:1904045,1,0.99219902789626,0,1,cellular response to aldosterone,BP,
19915,GO:1904046,1,0.992170027168696,0,1,negative regulation of vascular endothelial growth factor production,BP,
19916,GO:1904047,1,0.977297486870321,0,3,S-adenosyl-L-methionine binding,MF,
19917,GO:1904048,1,0.98784960936576,0,2,regulation of spontaneous neurotransmitter secretion,BP,
19918,GO:1904049,1,0.99398633228511,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
19919,GO:1904050,1,0.993826440032806,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19920,GO:1904054,1,0.993986332279133,0,1,regulation of cholangiocyte proliferation,BP,
19921,GO:1904056,1,0.993986332279133,0,1,positive regulation of cholangiocyte proliferation,BP,
19922,GO:1904057,1,0.98454206370557,0,2,negative regulation of sensory perception of pain,BP,
19923,GO:1904058,1,0.972877843302509,0,4,positive regulation of sensory perception of pain,BP,
19924,GO:1904059,1,0.986857175957408,0,2,regulation of locomotor rhythm,BP,
19926,GO:1904063,1,0.632677793537449,0,63,negative regulation of cation transmembrane transport,BP,
19928,GO:1904071,1,0.987952576434088,0,2,presynaptic active zone assembly,BP,
19929,GO:1904073,1,0.993986332271892,0,1,regulation of trophectodermal cell proliferation,BP,
19930,GO:1904075,1,0.993986332271892,0,1,positive regulation of trophectodermal cell proliferation,BP,
19931,GO:1904098,1,0.978896692402579,0,3,regulation of protein O-linked glycosylation,BP,
19932,GO:1904100,1,0.978896692402579,0,3,positive regulation of protein O-linked glycosylation,BP,
19933,GO:1904106,1,0.984948021517707,0,2,protein localization to microvillus,BP,
19934,GO:1904115,1,0.767012448660357,0,38,axon cytoplasm,CC,
19935,GO:1904116,1,0.979351252168679,0,3,response to vasopressin,BP,
19936,GO:1904117,1,0.979351252168679,0,3,cellular response to vasopressin,BP,
19937,GO:1904118,1,0.992668731047171,0,1,regulation of otic vesicle morphogenesis,BP,
19938,GO:1904120,1,0.992668731047171,0,1,positive regulation of otic vesicle morphogenesis,BP,
19939,GO:1904121,1,0.987947933947075,0,2,phosphatidylethanolamine transporter activity,MF,
19940,GO:1904124,1,0.976768930117069,0,3,microglial cell migration,BP,
19941,GO:1904139,1,0.976768930117069,0,3,regulation of microglial cell migration,BP,
19942,GO:1904140,1,0.992170027168696,0,1,negative regulation of microglial cell migration,BP,
19943,GO:1904141,1,0.992248052089351,0,1,positive regulation of microglial cell migration,BP,
19944,GO:1904149,1,0.992170027168696,0,1,regulation of microglial cell mediated cytotoxicity,BP,
19945,GO:1904151,1,0.992170027168696,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
19946,GO:1904152,1,0.909967231254857,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
19947,GO:1904153,1,0.936486212005316,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
19948,GO:1904154,1,0.97848339749832,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
19949,GO:1904155,1,0.992892851040957,0,1,DN2 thymocyte differentiation,BP,
19950,GO:1904156,1,0.992892851040957,0,1,DN3 thymocyte differentiation,BP,
19951,GO:1904158,1,0.980273591487936,0,3,axonemal central apparatus assembly,BP,
19952,GO:1904167,1,0.993986332286795,0,1,regulation of thyroid hormone receptor activity,BP,
19953,GO:1904168,1,0.993986332286795,0,1,negative regulation of thyroid hormone receptor activity,BP,
19954,GO:1904170,1,0.992699006969237,0,1,regulation of bleb assembly,BP,
19955,GO:1904172,1,0.992699006969237,0,1,positive regulation of bleb assembly,BP,
19957,GO:1904179,1,0.973394647875274,0,4,positive regulation of adipose tissue development,BP,
19958,GO:1904180,1,0.949179072905911,0,7,negative regulation of membrane depolarization,BP,
19959,GO:1904181,1,0.923629863691271,0,11,positive regulation of membrane depolarization,BP,
19960,GO:1904182,1,0.992170027168696,0,1,regulation of pyruvate dehydrogenase activity,BP,
19961,GO:1904192,1,0.993986332279133,0,1,regulation of cholangiocyte apoptotic process,BP,
19962,GO:1904193,1,0.993986332279133,0,1,negative regulation of cholangiocyte apoptotic process,BP,
19963,GO:1904195,1,0.993986332279133,0,1,regulation of granulosa cell proliferation,BP,
19964,GO:1904197,1,0.993986332279133,0,1,positive regulation of granulosa cell proliferation,BP,
19965,GO:1904199,1,0.993568912326251,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19966,GO:1904200,1,0.993986332279133,0,1,iodide transmembrane transport,BP,
19967,GO:1904201,1,0.993986332279133,0,1,regulation of iodide transport,BP,
19968,GO:1904202,1,0.993986332279133,0,1,negative regulation of iodide transport,BP,
19969,GO:1904204,1,0.988008547477651,0,2,regulation of skeletal muscle hypertrophy,BP,
19970,GO:1904205,1,0.993986332266728,0,1,negative regulation of skeletal muscle hypertrophy,BP,
19971,GO:1904206,1,0.993986332279133,0,1,positive regulation of skeletal muscle hypertrophy,BP,
19972,GO:1904207,1,0.985042205519464,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19973,GO:1904209,1,0.985042205519464,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19974,GO:1904210,1,0.992170027168696,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19975,GO:1904211,1,0.986162413418834,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
19976,GO:1904212,1,0.993986332279133,0,1,regulation of iodide transmembrane transport,BP,
19977,GO:1904213,1,0.993986332279133,0,1,negative regulation of iodide transmembrane transport,BP,
19978,GO:1904217,1,0.977214700990476,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19979,GO:1904219,1,0.977214700990476,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19980,GO:1904220,1,0.969683550081012,0,4,regulation of serine C-palmitoyltransferase activity,BP,
19981,GO:1904222,1,0.977214700990476,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
19982,GO:1904226,1,0.992195158617293,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19983,GO:1904227,1,0.992195158617293,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19984,GO:1904229,1,0.986203080779088,0,2,regulation of succinate dehydrogenase activity,BP,
19985,GO:1904231,1,0.986203080779088,0,2,positive regulation of succinate dehydrogenase activity,BP,
19986,GO:1904232,1,0.986203080779088,0,2,regulation of aconitate hydratase activity,BP,
19987,GO:1904234,1,0.986203080779088,0,2,positive regulation of aconitate hydratase activity,BP,
19988,GO:1904235,1,0.993986332277369,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19989,GO:1904237,1,0.993986332277369,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19990,GO:1904238,1,0.942901367018383,0,8,pericyte cell differentiation,BP,
19991,GO:1904239,1,0.992170027168696,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19992,GO:1904240,1,0.992170027168696,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19993,GO:1904245,1,0.98486640121935,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
19994,GO:1904246,1,0.992170144174095,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
19995,GO:1904247,1,0.992639068753198,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
19997,GO:1904252,1,0.977185264659436,0,3,negative regulation of bile acid metabolic process,BP,
19999,GO:1904259,1,0.970285684798397,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20000,GO:1904261,1,0.970285684798397,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20001,GO:1904262,1,0.922405060519445,0,11,negative regulation of TORC1 signaling,BP,
20002,GO:1904263,1,0.950701467812703,0,7,positive regulation of TORC1 signaling,BP,
20003,GO:1904264,1,0.919933872533356,0,12,ubiquitin protein ligase activity involved in ERAD pathway,MF,
20004,GO:1904265,1,0.993986332266835,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20005,GO:1904266,1,0.993986332271682,0,1,regulation of Schwann cell chemotaxis,BP,
20006,GO:1904268,1,0.993986332271682,0,1,positive regulation of Schwann cell chemotaxis,BP,
20007,GO:1904274,1,0.992200940165832,0,1,tricellular tight junction assembly,BP,
20008,GO:1904282,1,0.992174221678293,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20009,GO:1904283,1,0.992174221678293,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20010,GO:1904288,1,0.9730394915382,0,4,BAT3 complex binding,MF,
20011,GO:1904289,1,0.992560919638709,0,1,regulation of mitotic DNA damage checkpoint,BP,
20012,GO:1904292,1,0.824445274821517,0,27,regulation of ERAD pathway,BP,
20013,GO:1904293,1,0.910457632396598,0,13,negative regulation of ERAD pathway,BP,
20014,GO:1904294,1,0.910496549359646,0,13,positive regulation of ERAD pathway,BP,
20015,GO:1904298,1,0.993616323617868,0,1,regulation of transcytosis,BP,
20016,GO:1904300,1,0.993616323617868,0,1,positive regulation of transcytosis,BP,
20017,GO:1904301,1,0.993616323617868,0,1,regulation of maternal process involved in parturition,BP,
20018,GO:1904303,1,0.993616323617868,0,1,positive regulation of maternal process involved in parturition,BP,
20019,GO:1904304,1,0.993616323617868,0,1,regulation of gastro-intestinal system smooth muscle contraction,BP,
20020,GO:1904306,1,0.993616323617868,0,1,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20021,GO:1904313,1,0.985709279620953,0,2,response to methamphetamine hydrochloride,BP,
20022,GO:1904315,1,0.870323712833939,0,19,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20023,GO:1904316,1,0.993616323617868,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20024,GO:1904317,1,0.993616323617868,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20025,GO:1904321,1,0.944149939697975,0,9,response to forskolin,BP,
20026,GO:1904322,1,0.944149939697975,0,9,cellular response to forskolin,BP,
20027,GO:1904327,1,0.986326940276172,0,2,protein localization to cytosolic proteasome complex,BP,
20028,GO:1904338,1,0.929819395488704,0,10,regulation of dopaminergic neuron differentiation,BP,
20029,GO:1904339,1,0.978822191013004,0,3,negative regulation of dopaminergic neuron differentiation,BP,
20030,GO:1904340,1,0.969250864261454,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20031,GO:1904350,1,0.963703129598016,0,5,regulation of protein catabolic process in the vacuole,BP,
20032,GO:1904351,1,0.986408788705629,0,2,negative regulation of protein catabolic process in the vacuole,BP,
20033,GO:1904352,1,0.984624795520938,0,2,positive regulation of protein catabolic process in the vacuole,BP,
20034,GO:1904353,1,0.834172488966607,0,26,regulation of telomere capping,BP,
20035,GO:1904354,1,0.9485294448848,0,8,negative regulation of telomere capping,BP,
20036,GO:1904355,1,0.884814036576174,0,17,positive regulation of telomere capping,BP,
20037,GO:1904356,1,0.677660417155193,0,54,regulation of telomere maintenance via telomere lengthening,BP,
20038,GO:1904357,1,0.855316272278945,0,22,negative regulation of telomere maintenance via telomere lengthening,BP,
20039,GO:1904358,1,0.775244638831086,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
20040,GO:1904373,1,0.992170027168696,0,1,response to kainic acid,BP,
20041,GO:1904375,1,0.62261430817864,0,67,regulation of protein localization to cell periphery,BP,
20042,GO:1904376,1,0.866384329250211,0,20,negative regulation of protein localization to cell periphery,BP,
20043,GO:1904377,1,0.767088803914056,0,38,positive regulation of protein localization to cell periphery,BP,
20044,GO:1904378,1,0.978617126053822,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20045,GO:1904379,1,0.986326940276172,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20046,GO:1904380,1,0.86747014776306,0,20,endoplasmic reticulum mannose trimming,BP,
20047,GO:1904381,1,0.980475862993342,0,3,Golgi apparatus mannose trimming,BP,
20048,GO:1904382,1,0.972807863968944,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20049,GO:1904383,1,0.977423212125432,0,3,response to sodium phosphate,BP,
20050,GO:1904385,1,0.890149762131592,0,16,cellular response to angiotensin,BP,
20051,GO:1904386,1,0.965888968747296,0,5,response to L-phenylalanine derivative,BP,
20052,GO:1904387,1,0.985961746006548,0,2,cellular response to L-phenylalanine derivative,BP,
20053,GO:1904389,1,0.992170027168696,0,1,rod bipolar cell differentiation,BP,
20054,GO:1904391,1,0.992170027168696,0,1,response to ciliary neurotrophic factor,BP,
20055,GO:1904393,1,0.978532998768744,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20056,GO:1904394,1,0.99222345480462,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20057,GO:1904395,1,0.986203080783191,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20058,GO:1904396,1,0.944925065367596,0,8,regulation of neuromuscular junction development,BP,
20059,GO:1904397,1,0.984453900329984,0,2,negative regulation of neuromuscular junction development,BP,
20060,GO:1904398,1,0.980271740726092,0,3,positive regulation of neuromuscular junction development,BP,
20061,GO:1904399,1,0.992170027168696,0,1,heparan sulfate binding,MF,
20062,GO:1904400,1,0.992654718861979,0,1,response to Thyroid stimulating hormone,BP,
20063,GO:1904404,1,0.993986332272418,0,1,response to formaldehyde,BP,
20066,GO:1904408,1,0.992170027168696,0,1,melatonin binding,MF,
20067,GO:1904412,1,0.993173241686921,0,1,regulation of cardiac ventricle development,BP,
20068,GO:1904414,1,0.993173241686921,0,1,positive regulation of cardiac ventricle development,BP,
20069,GO:1904415,1,0.957437427907415,0,6,regulation of xenophagy,BP,
20070,GO:1904417,1,0.957437427907415,0,6,positive regulation of xenophagy,BP,
20071,GO:1904424,1,0.966802162853239,0,5,regulation of GTP binding,BP,
20072,GO:1904425,1,0.993316937308481,0,1,negative regulation of GTP binding,BP,
20073,GO:1904426,1,0.986434038436467,0,2,positive regulation of GTP binding,BP,
20075,GO:1904428,1,0.993986332288009,0,1,negative regulation of tubulin deacetylation,BP,
20076,GO:1904429,1,0.950159631267267,0,7,regulation of t-circle formation,BP,
20077,GO:1904430,1,0.979463827604749,0,3,negative regulation of t-circle formation,BP,
20078,GO:1904431,1,0.970086167143928,0,4,positive regulation of t-circle formation,BP,
20079,GO:1904432,1,0.984405049732661,0,2,regulation of ferrous iron binding,BP,
20080,GO:1904434,1,0.984405049732661,0,2,positive regulation of ferrous iron binding,BP,
20081,GO:1904435,1,0.984405049732661,0,2,regulation of transferrin receptor binding,BP,
20082,GO:1904437,1,0.984405049732661,0,2,positive regulation of transferrin receptor binding,BP,
20083,GO:1904447,1,0.993986332267994,0,1,folic acid import into cell,BP,
20084,GO:1904448,1,0.993929645472371,0,1,regulation of aspartate secretion,BP,
20085,GO:1904450,1,0.993929645472371,0,1,positive regulation of aspartate secretion,BP,
20086,GO:1904454,1,0.993986332275238,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20087,GO:1904455,1,0.9879642696945,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20088,GO:1904456,1,0.992171753567242,0,1,negative regulation of neuronal action potential,BP,
20089,GO:1904457,1,0.992240749279768,0,1,positive regulation of neuronal action potential,BP,
20090,GO:1904464,1,0.992170118627795,0,1,regulation of matrix metallopeptidase secretion,BP,
20091,GO:1904465,1,0.992170118627795,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20092,GO:1904467,1,0.950174067434642,0,7,regulation of tumor necrosis factor secretion,BP,
20093,GO:1904468,1,0.978683698876972,0,3,negative regulation of tumor necrosis factor secretion,BP,
20094,GO:1904469,1,0.970874243900633,0,4,positive regulation of tumor necrosis factor secretion,BP,
20095,GO:1904478,1,0.933526161476918,0,9,regulation of intestinal absorption,BP,
20096,GO:1904479,1,0.970171587394018,0,4,negative regulation of intestinal absorption,BP,
20097,GO:1904481,1,0.992257458651072,0,1,response to tetrahydrofolate,BP,
20098,GO:1904482,1,0.992257458651072,0,1,cellular response to tetrahydrofolate,BP,
20099,GO:1904491,1,0.963225229668986,0,5,protein localization to ciliary transition zone,BP,
20100,GO:1904492,1,0.992312308551114,0,1,Ac-Asp-Glu binding,MF,
20101,GO:1904493,1,0.992312308551114,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20102,GO:1904499,1,0.992975597753917,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20103,GO:1904501,1,0.992975597753917,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20104,GO:1904502,1,0.965834549994549,0,5,regulation of lipophagy,BP,
20105,GO:1904504,1,0.965834549994549,0,5,positive regulation of lipophagy,BP,
20106,GO:1904505,1,0.973145153507207,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20107,GO:1904506,1,0.973145153507207,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20108,GO:1904515,1,0.992892352659053,0,1,positive regulation of TORC2 signaling,BP,
20109,GO:1904526,1,0.956917508285077,0,6,regulation of microtubule binding,BP,
20110,GO:1904527,1,0.985054728243395,0,2,negative regulation of microtubule binding,BP,
20111,GO:1904528,1,0.970989604483882,0,4,positive regulation of microtubule binding,BP,
20112,GO:1904529,1,0.986688941998301,0,2,regulation of actin filament binding,BP,
20113,GO:1904530,1,0.992659223769957,0,1,negative regulation of actin filament binding,BP,
20114,GO:1904531,1,0.993985913025372,0,1,positive regulation of actin filament binding,BP,
20115,GO:1904533,1,0.978995905868913,0,3,regulation of telomeric loop disassembly,BP,
20116,GO:1904534,1,0.985067205817004,0,2,negative regulation of telomeric loop disassembly,BP,
20117,GO:1904535,1,0.993837386802262,0,1,positive regulation of telomeric loop disassembly,BP,
20118,GO:1904542,1,0.992341588552881,0,1,regulation of free ubiquitin chain polymerization,BP,
20119,GO:1904544,1,0.992341588552881,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20120,GO:1904562,1,0.988008547477047,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20121,GO:1904565,1,0.992683795863295,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20122,GO:1904566,1,0.992683795863295,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20123,GO:1904567,1,0.992580968247041,0,1,response to wortmannin,BP,
20124,GO:1904568,1,0.992580968247041,0,1,cellular response to wortmannin,BP,
20125,GO:1904569,1,0.984400996240668,0,2,regulation of selenocysteine incorporation,BP,
20126,GO:1904570,1,0.992170136445051,0,1,negative regulation of selenocysteine incorporation,BP,
20127,GO:1904571,1,0.992170027168696,0,1,positive regulation of selenocysteine incorporation,BP,
20128,GO:1904572,1,0.992170136445051,0,1,negative regulation of mRNA binding,BP,
20129,GO:1904573,1,0.992170136445051,0,1,regulation of selenocysteine insertion sequence binding,BP,
20130,GO:1904574,1,0.992170136445051,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20131,GO:1904576,1,0.984682055078918,0,2,response to tunicamycin,BP,
20132,GO:1904577,1,0.984682055078918,0,2,cellular response to tunicamycin,BP,
20133,GO:1904578,1,0.97860195573592,0,3,response to thapsigargin,BP,
20134,GO:1904579,1,0.97860195573592,0,3,cellular response to thapsigargin,BP,
20135,GO:1904580,1,0.984816319480693,0,2,regulation of intracellular mRNA localization,BP,
20136,GO:1904582,1,0.984816319480693,0,2,positive regulation of intracellular mRNA localization,BP,
20137,GO:1904585,1,0.992191521788715,0,1,response to putrescine,BP,
20138,GO:1904586,1,0.992191521788715,0,1,cellular response to putrescine,BP,
20139,GO:1904587,1,0.965189170565804,0,5,response to glycoprotein,BP,
20140,GO:1904588,1,0.992170027168696,0,1,cellular response to glycoprotein,BP,
20142,GO:1904590,1,0.631140959316914,0,64,negative regulation of protein import,BP,
20143,GO:1904591,1,0.508047295385581,0,96,positive regulation of protein import,BP,
20144,GO:1904594,1,0.993986332289148,0,1,regulation of termination of RNA polymerase II transcription,BP,
20145,GO:1904595,1,0.993986332289148,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20146,GO:1904596,1,0.992170027168696,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20147,GO:1904597,1,0.992170027168696,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20148,GO:1904599,1,0.992170027168696,0,1,advanced glycation end-product binding,MF,
20149,GO:1904602,1,0.984434987237186,0,2,serotonin-activated cation-selective channel complex,CC,
20150,GO:1904603,1,0.992170027168696,0,1,regulation of advanced glycation end-product receptor activity,BP,
20151,GO:1904604,1,0.992170027168696,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20152,GO:1904606,1,0.992974590415791,0,1,fat cell apoptotic process,BP,
20153,GO:1904612,1,0.992654718861979,0,1,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20154,GO:1904616,1,0.986688941998301,0,2,regulation of actin binding,BP,
20155,GO:1904617,1,0.992659223769957,0,1,negative regulation of actin binding,BP,
20156,GO:1904618,1,0.993985913025372,0,1,positive regulation of actin binding,BP,
20157,GO:1904627,1,0.964852666432827,0,5,response to phorbol 13-acetate 12-myristate,BP,
20158,GO:1904628,1,0.964852666432827,0,5,cellular response to phorbol 13-acetate 12-myristate,BP,
20159,GO:1904631,1,0.992203876837144,0,1,response to glucoside,BP,
20160,GO:1904633,1,0.993986332267178,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20161,GO:1904635,1,0.993986332267178,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20162,GO:1904636,1,0.972780982334431,0,4,response to ionomycin,BP,
20163,GO:1904637,1,0.972780982334431,0,4,cellular response to ionomycin,BP,
20164,GO:1904638,1,0.993986332267178,0,1,response to resveratrol,BP,
20165,GO:1904639,1,0.993986332267178,0,1,cellular response to resveratrol,BP,
20166,GO:1904640,1,0.978660829956992,0,3,response to methionine,BP,
20169,GO:1904647,1,0.993986332280873,0,1,response to rotenone,BP,
20170,GO:1904649,1,0.992974590415791,0,1,regulation of fat cell apoptotic process,BP,
20171,GO:1904651,1,0.992974590415791,0,1,positive regulation of fat cell apoptotic process,BP,
20172,GO:1904659,1,0.871277743772765,0,19,glucose transmembrane transport,BP,
20176,GO:1904672,1,0.960019765448751,0,6,regulation of somatic stem cell population maintenance,BP,
20177,GO:1904673,1,0.973234941875163,0,4,negative regulation of somatic stem cell population maintenance,BP,
20178,GO:1904674,1,0.986424251003359,0,2,positive regulation of somatic stem cell population maintenance,BP,
20179,GO:1904675,1,0.992520582922431,0,1,regulation of somatic stem cell division,BP,
20180,GO:1904677,1,0.992520582922431,0,1,positive regulation of somatic stem cell division,BP,
20181,GO:1904680,1,0.819351596082768,0,27,peptide transmembrane transporter activity,MF,
20182,GO:1904681,1,0.992358711416109,0,1,response to 3-methylcholanthrene,BP,
20183,GO:1904683,1,0.961849515806812,0,6,regulation of metalloendopeptidase activity,BP,
20184,GO:1904684,1,0.975318100373565,0,4,negative regulation of metalloendopeptidase activity,BP,
20185,GO:1904685,1,0.986193252037254,0,2,positive regulation of metalloendopeptidase activity,BP,
20186,GO:1904688,1,0.969314027295109,0,4,regulation of cytoplasmic translational initiation,BP,
20187,GO:1904689,1,0.992170027168696,0,1,negative regulation of cytoplasmic translational initiation,BP,
20188,GO:1904690,1,0.976965023646203,0,3,positive regulation of cytoplasmic translational initiation,BP,
20189,GO:1904691,1,0.992188025999194,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20190,GO:1904692,1,0.993197882008506,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20191,GO:1904693,1,0.980864855657731,0,3,midbrain morphogenesis,BP,
20192,GO:1904694,1,0.980394861083972,0,3,negative regulation of vascular smooth muscle contraction,BP,
20193,GO:1904700,1,0.992311409681756,0,1,granulosa cell apoptotic process,BP,
20194,GO:1904701,1,0.992170588866352,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20195,GO:1904705,1,0.839833482381036,0,24,regulation of vascular smooth muscle cell proliferation,BP,
20196,GO:1904706,1,0.94136582842744,0,8,negative regulation of vascular smooth muscle cell proliferation,BP,
20197,GO:1904707,1,0.885199616219171,0,17,positive regulation of vascular smooth muscle cell proliferation,BP,
20198,GO:1904708,1,0.992311409681756,0,1,regulation of granulosa cell apoptotic process,BP,
20199,GO:1904711,1,0.992170588866352,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20200,GO:1904713,1,0.986326940288299,0,2,beta-catenin destruction complex binding,MF,
20201,GO:1904714,1,0.941861898423039,0,8,regulation of chaperone-mediated autophagy,BP,
20202,GO:1904715,1,0.977274332241063,0,3,negative regulation of chaperone-mediated autophagy,BP,
20203,GO:1904716,1,0.992230800059413,0,1,positive regulation of chaperone-mediated autophagy,BP,
20204,GO:1904717,1,0.992253294773601,0,1,regulation of AMPA glutamate receptor clustering,BP,
20205,GO:1904719,1,0.992253294773601,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20206,GO:1904720,1,0.984939313089483,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20207,GO:1904721,1,0.992636404576577,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20208,GO:1904722,1,0.992246255662747,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20209,GO:1904723,1,0.992170588866352,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20211,GO:1904729,1,0.947599804107477,0,7,regulation of intestinal lipid absorption,BP,
20212,GO:1904730,1,0.984793258190617,0,2,negative regulation of intestinal lipid absorption,BP,
20213,GO:1904732,1,0.98620308078549,0,2,regulation of electron carrier activity,BP,
20214,GO:1904734,1,0.992170027168696,0,1,positive regulation of electron carrier activity,BP,
20215,GO:1904738,1,0.909983196829883,0,14,vascular associated smooth muscle cell migration,BP,
20216,GO:1904742,1,0.972606323801822,0,4,regulation of telomeric DNA binding,BP,
20217,GO:1904743,1,0.988008547484169,0,2,negative regulation of telomeric DNA binding,BP,
20218,GO:1904744,1,0.984412298135018,0,2,positive regulation of telomeric DNA binding,BP,
20219,GO:1904746,1,0.958844777517379,0,6,negative regulation of apoptotic process involved in development,BP,
20220,GO:1904747,1,0.979841228967994,0,3,positive regulation of apoptotic process involved in development,BP,
20221,GO:1904748,1,0.933839419111165,0,10,regulation of apoptotic process involved in development,BP,
20222,GO:1904749,1,0.964733316590525,0,5,regulation of protein localization to nucleolus,BP,
20223,GO:1904750,1,0.993986332268888,0,1,negative regulation of protein localization to nucleolus,BP,
20224,GO:1904751,1,0.9705713693654,0,4,positive regulation of protein localization to nucleolus,BP,
20225,GO:1904752,1,0.909983196829883,0,14,regulation of vascular associated smooth muscle cell migration,BP,
20226,GO:1904753,1,0.978691721490588,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
20227,GO:1904754,1,0.929806934866155,0,11,positive regulation of vascular associated smooth muscle cell migration,BP,
20228,GO:1904760,1,0.980794454547065,0,3,regulation of myofibroblast differentiation,BP,
20229,GO:1904761,1,0.987196405835698,0,2,negative regulation of myofibroblast differentiation,BP,
20230,GO:1904762,1,0.993515668949817,0,1,positive regulation of myofibroblast differentiation,BP,
20231,GO:1904764,1,0.992179254155245,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20232,GO:1904772,1,0.992327453820772,0,1,response to tetrachloromethane,BP,
20233,GO:1904779,1,0.959920893372538,0,6,regulation of protein localization to centrosome,BP,
20234,GO:1904780,1,0.9939863322711,0,1,negative regulation of protein localization to centrosome,BP,
20235,GO:1904781,1,0.973279353084158,0,4,positive regulation of protein localization to centrosome,BP,
20236,GO:1904783,1,0.992170027168696,0,1,positive regulation of NMDA glutamate receptor activity,BP,
20237,GO:1904790,1,0.992519404241984,0,1,regulation of shelterin complex assembly,BP,
20238,GO:1904792,1,0.992519404241984,0,1,positive regulation of shelterin complex assembly,BP,
20239,GO:1904793,1,0.992975597753917,0,1,regulation of euchromatin binding,BP,
20240,GO:1904796,1,0.950405887963191,0,7,regulation of core promoter binding,BP,
20241,GO:1904797,1,0.993986332265967,0,1,negative regulation of core promoter binding,BP,
20242,GO:1904798,1,0.956157913567355,0,6,positive regulation of core promoter binding,BP,
20243,GO:1904799,1,0.993479727110809,0,1,regulation of neuron remodeling,BP,
20244,GO:1904800,1,0.993479727110809,0,1,negative regulation of neuron remodeling,BP,
20245,GO:1904803,1,0.992170027168696,0,1,regulation of translation involved in cellular response to UV,BP,
20246,GO:1904806,1,0.984648173044371,0,2,regulation of protein oxidation,BP,
20247,GO:1904808,1,0.984648173044371,0,2,positive regulation of protein oxidation,BP,
20248,GO:1904812,1,0.993478501023864,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20250,GO:1904814,1,0.90590690553752,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20251,GO:1904815,1,0.984750771533039,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20252,GO:1904816,1,0.919944423647745,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20253,GO:1904823,1,0.977146874706303,0,3,purine nucleobase transmembrane transport,BP,
20254,GO:1904826,1,0.993986332273655,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20255,GO:1904828,1,0.993986332273655,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20256,GO:1904829,1,0.992170154337142,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20257,GO:1904831,1,0.992170154337142,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20259,GO:1904835,1,0.992266198294153,0,1,dorsal root ganglion morphogenesis,BP,
20260,GO:1904837,1,0.732360373528411,0,43,beta-catenin-TCF complex assembly,BP,
20261,GO:1904842,1,0.992191649784728,0,1,response to nitroglycerin,BP,
20262,GO:1904843,1,0.992191649784728,0,1,cellular response to nitroglycerin,BP,
20263,GO:1904844,1,0.978245211437971,0,3,response to L-glutamine,BP,
20264,GO:1904845,1,0.978245211437971,0,3,cellular response to L-glutamine,BP,
20266,GO:1904848,1,0.992170027168696,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20268,GO:1904850,1,0.992519404241984,0,1,negative regulation of establishment of protein localization to telomere,BP,
20269,GO:1904851,1,0.93281161163028,0,9,positive regulation of establishment of protein localization to telomere,BP,
20270,GO:1904854,1,0.992232345544544,0,1,proteasome core complex binding,MF,
20271,GO:1904861,1,0.943555085997428,0,9,excitatory synapse assembly,BP,
20272,GO:1904862,1,0.980823395017445,0,3,inhibitory synapse assembly,BP,
20273,GO:1904863,1,0.993345191085099,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20274,GO:1904864,1,0.993345191085099,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20275,GO:1904867,1,0.932701308690869,0,9,protein localization to Cajal body,BP,
20276,GO:1904868,1,0.988008547497964,0,2,telomerase catalytic core complex assembly,BP,
20277,GO:1904869,1,0.940064185207002,0,8,regulation of protein localization to Cajal body,BP,
20278,GO:1904871,1,0.940064185207002,0,8,positive regulation of protein localization to Cajal body,BP,
20279,GO:1904872,1,0.890078912052713,0,15,regulation of telomerase RNA localization to Cajal body,BP,
20280,GO:1904874,1,0.890078912052713,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20281,GO:1904875,1,0.992491319388775,0,1,regulation of DNA ligase activity,BP,
20282,GO:1904876,1,0.992491319388775,0,1,negative regulation of DNA ligase activity,BP,
20283,GO:1904878,1,0.993986332286664,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20284,GO:1904879,1,0.985924633302851,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20285,GO:1904882,1,0.988008547497964,0,2,regulation of telomerase catalytic core complex assembly,BP,
20286,GO:1904884,1,0.988008547497964,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20287,GO:1904885,1,0.966344830112934,0,5,beta-catenin destruction complex assembly,BP,
20288,GO:1904886,1,0.854913683483452,0,22,beta-catenin destruction complex disassembly,BP,
20289,GO:1904887,1,0.993986332281396,0,1,Wnt signalosome assembly,BP,
20290,GO:1904888,1,0.652925015561378,0,61,cranial skeletal system development,BP,
20291,GO:1904889,1,0.992170062901773,0,1,regulation of excitatory synapse assembly,BP,
20292,GO:1904891,1,0.992170062901773,0,1,positive regulation of excitatory synapse assembly,BP,
20294,GO:1904893,1,0.69939315332968,0,49,negative regulation of STAT cascade,BP,
20296,GO:1904895,1,0.992170027519113,0,1,ESCRT complex assembly,BP,
20297,GO:1904896,1,0.927173953786492,0,10,ESCRT complex disassembly,BP,
20298,GO:1904897,1,0.992869978725763,0,1,regulation of hepatic stellate cell proliferation,BP,
20299,GO:1904899,1,0.992869978725763,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20300,GO:1904902,1,0.992170027519113,0,1,ESCRT III complex assembly,BP,
20301,GO:1904903,1,0.927173953786492,0,10,ESCRT III complex disassembly,BP,
20302,GO:1904907,1,0.988008547504246,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20303,GO:1904908,1,0.988008547504246,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20304,GO:1904910,1,0.992519404241984,0,1,regulation of establishment of RNA localization to telomere,BP,
20305,GO:1904911,1,0.992519404241984,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20306,GO:1904913,1,0.992519404241984,0,1,regulation of establishment of macromolecular complex localization to telomere,BP,
20307,GO:1904914,1,0.992519404241984,0,1,negative regulation of establishment of macromolecular complex localization to telomere,BP,
20308,GO:1904923,1,0.911885137804907,0,13,regulation of mitophagy in response to mitochondrial depolarization,BP,
20309,GO:1904924,1,0.986274085508984,0,2,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20310,GO:1904925,1,0.911885137804907,0,13,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
20311,GO:1904928,1,0.987984838844845,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20312,GO:1904929,1,0.960085486982696,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20313,GO:1904933,1,0.986203080772374,0,2,regulation of cell proliferation in midbrain,BP,
20314,GO:1904934,1,0.993986332264647,0,1,negative regulation of cell proliferation in midbrain,BP,
20315,GO:1904935,1,0.992170027168696,0,1,positive regulation of cell proliferation in midbrain,BP,
20316,GO:1904936,1,0.95752411637127,0,6,interneuron migration,BP,
20317,GO:1904938,1,0.968327265184015,0,5,planar cell polarity pathway involved in axon guidance,BP,
20318,GO:1904947,1,0.99259371117049,0,1,folic acid import into mitochondrion,BP,
20319,GO:1904948,1,0.877087897315297,0,18,midbrain dopaminergic neuron differentiation,BP,
20321,GO:1904950,1,0.226398265975852,0,205,negative regulation of establishment of protein localization,BP,
20323,GO:1904953,1,0.916640242640543,0,12,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20324,GO:1904954,1,0.970166068586952,0,4,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20325,GO:1904955,1,0.993986332264647,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20326,GO:1904956,1,0.963238729401443,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20327,GO:1904958,1,0.976901365948602,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20328,GO:1904959,1,0.98620308078549,0,2,regulation of cytochrome-c oxidase activity,BP,
20329,GO:1904960,1,0.992170027168696,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20330,GO:1904970,1,0.966050953740041,0,5,brush border assembly,BP,
20331,GO:1904975,1,0.98747270936949,0,2,response to bleomycin,BP,
20332,GO:1904976,1,0.98747270936949,0,2,cellular response to bleomycin,BP,
20333,GO:1904978,1,0.980211494525097,0,3,regulation of endosome organization,BP,
20334,GO:1904979,1,0.992202596494721,0,1,negative regulation of endosome organization,BP,
20335,GO:1904980,1,0.993986332271049,0,1,positive regulation of endosome organization,BP,
20336,GO:1904990,1,0.992251263356365,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20337,GO:1904992,1,0.992251263356365,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20338,GO:1904994,1,0.922734256684356,0,11,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20339,GO:1904995,1,0.961793220274559,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20340,GO:1904996,1,0.959401542453246,0,6,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20341,GO:1904997,1,0.984744829094691,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20342,GO:1904998,1,0.992516661359673,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20343,GO:1904999,1,0.992170027519113,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20344,GO:1905000,1,0.993986332278052,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20345,GO:1905003,1,0.992170027168696,0,1,picolinic acid metabolic process,BP,
20346,GO:1905004,1,0.992170027168696,0,1,picolinic acid biosynthetic process,BP,
20347,GO:1905005,1,0.95990602768858,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20348,GO:1905006,1,0.986186975485604,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20349,GO:1905007,1,0.96748123561888,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20350,GO:1905008,1,0.992302628349193,0,1,regulation of L-lysine import into cell,BP,
20351,GO:1905010,1,0.992302628349193,0,1,positive regulation of L-lysine import into cell,BP,
20352,GO:1905012,1,0.992170027168696,0,1,regulation of 'de novo' NAD biosynthetic process from tryptophan,BP,
20353,GO:1905024,1,0.974118130137959,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20354,GO:1905025,1,0.992629327524328,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20355,GO:1905026,1,0.987329242632722,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20356,GO:1905030,1,0.865431902170452,0,23,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20357,GO:1905031,1,0.968258909363686,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20358,GO:1905032,1,0.992629327524328,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20359,GO:1905033,1,0.987329242632722,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20361,GO:1905038,1,0.907774708725692,0,13,regulation of membrane lipid metabolic process,BP,
20363,GO:1905040,1,0.992266198294153,0,1,otic placode development,BP,
20364,GO:1905041,1,0.993986332273156,0,1,regulation of epithelium regeneration,BP,
20365,GO:1905044,1,0.992294630214608,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20366,GO:1905045,1,0.992294630214608,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20367,GO:1905048,1,0.912770523290018,0,13,regulation of metallopeptidase activity,BP,
20368,GO:1905049,1,0.961098793043219,0,6,negative regulation of metallopeptidase activity,BP,
20369,GO:1905050,1,0.949730801249453,0,7,positive regulation of metallopeptidase activity,BP,
20370,GO:1905051,1,0.984401151998334,0,2,regulation of base-excision repair,BP,
20371,GO:1905053,1,0.984401151998334,0,2,positive regulation of base-excision repair,BP,
20372,GO:1905062,1,0.992366146325104,0,1,positive regulation of cardioblast proliferation,BP,
20373,GO:1905063,1,0.951824552017411,0,7,regulation of vascular smooth muscle cell differentiation,BP,
20374,GO:1905064,1,0.978152410426437,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20375,GO:1905065,1,0.973088676958899,0,4,positive regulation of vascular smooth muscle cell differentiation,BP,
20376,GO:1905066,1,0.984459617168431,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20377,GO:1905067,1,0.992170588866352,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20378,GO:1905068,1,0.992228654678653,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20379,GO:1905069,1,0.985782577314148,0,2,allantois development,BP,
20380,GO:1905071,1,0.986767999921862,0,2,occluding junction disassembly,BP,
20381,GO:1905073,1,0.986767999921862,0,2,regulation of occluding junction disassembly,BP,
20382,GO:1905075,1,0.986767999921862,0,2,positive regulation of occluding junction disassembly,BP,
20383,GO:1905089,1,0.993986332294221,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20384,GO:1905090,1,0.993986332294221,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20385,GO:1905097,1,0.96817070141255,0,5,regulation of guanyl-nucleotide exchange factor activity,BP,
20386,GO:1905098,1,0.979923257418806,0,3,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20387,GO:1905099,1,0.993986332267336,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20388,GO:1905103,1,0.993518005325115,0,1,integral component of lysosomal membrane,CC,
20390,GO:1905122,1,0.993518005325115,0,1,polyamine import,BP,
20391,GO:1905123,1,0.987449909978427,0,2,regulation of glucosylceramidase activity,BP,
20392,GO:1905132,1,0.984826807645473,0,2,regulation of meiotic chromosome separation,BP,
20393,GO:1905133,1,0.984826807645473,0,2,negative regulation of meiotic chromosome separation,BP,
20394,GO:1905143,1,0.992170027168696,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20395,GO:1905144,1,0.856621377233316,0,21,response to acetylcholine,BP,
20396,GO:1905145,1,0.856621377233316,0,21,cellular response to acetylcholine,BP,
20397,GO:1905146,1,0.972461486471556,0,4,lysosomal protein catabolic process,BP,
20398,GO:1905150,1,0.980729016059775,0,3,regulation of voltage-gated sodium channel activity,BP,
20399,GO:1905152,1,0.993986332265019,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20400,GO:1905153,1,0.918896162955581,0,12,regulation of membrane invagination,BP,
20401,GO:1905154,1,0.986191146495957,0,2,negative regulation of membrane invagination,BP,
20402,GO:1905155,1,0.938952526829391,0,9,positive regulation of membrane invagination,BP,
20403,GO:1905161,1,0.993972109807993,0,1,protein localization to phagocytic vesicle,BP,
20404,GO:1905162,1,0.993972109807993,0,1,regulation of phagosome maturation,BP,
20405,GO:1905165,1,0.978754180451226,0,3,regulation of lysosomal protein catabolic process,BP,
20406,GO:1905166,1,0.986408788705629,0,2,negative regulation of lysosomal protein catabolic process,BP,
20407,GO:1905169,1,0.993972109807993,0,1,regulation of protein localization to phagocytic vesicle,BP,
20408,GO:1905171,1,0.993972109807993,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20409,GO:1905174,1,0.992476801254136,0,1,regulation of vascular smooth muscle cell dedifferentiation,BP,
20410,GO:1905176,1,0.992476801254136,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20411,GO:1905202,1,0.985573196434352,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20412,GO:1905203,1,0.986080809051256,0,2,regulation of connective tissue replacement,BP,
20413,GO:1905204,1,0.992170027168696,0,1,negative regulation of connective tissue replacement,BP,
20414,GO:1905205,1,0.993863103096789,0,1,positive regulation of connective tissue replacement,BP,
20415,GO:1905206,1,0.965810165225232,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20416,GO:1905207,1,0.764376479976505,0,38,regulation of cardiocyte differentiation,BP,
20417,GO:1905208,1,0.898948606535044,0,15,negative regulation of cardiocyte differentiation,BP,
20418,GO:1905209,1,0.850665120664454,0,23,positive regulation of cardiocyte differentiation,BP,
20419,GO:1905214,1,0.924539572043111,0,11,regulation of RNA binding,BP,
20420,GO:1905215,1,0.992170136445051,0,1,negative regulation of RNA binding,BP,
20421,GO:1905216,1,0.944515968695862,0,8,positive regulation of RNA binding,BP,
20422,GO:1905217,1,0.992654718861979,0,1,response to astaxanthin,BP,
20423,GO:1905222,1,0.992692997706838,0,1,atrioventricular canal morphogenesis,BP,
20424,GO:1905223,1,0.993986332267363,0,1,epicardium morphogenesis,BP,
20425,GO:1905224,1,0.987836979672492,0,2,clathrin-coated pit assembly,BP,
20426,GO:1905225,1,0.984881813580364,0,2,response to thyrotropin-releasing hormone,BP,
20427,GO:1905229,1,0.992170027168696,0,1,cellular response to thyrotropin-releasing hormone,BP,
20428,GO:1905230,1,0.993506247191203,0,1,response to borneol,BP,
20429,GO:1905231,1,0.993506247191203,0,1,cellular response to borneol,BP,
20430,GO:1905232,1,0.979927125249471,0,3,cellular response to L-glutamate,BP,
20431,GO:1905233,1,0.993506247191203,0,1,response to codeine,BP,
20432,GO:1905235,1,0.993506247191203,0,1,response to quercetin,BP,
20433,GO:1905237,1,0.98572672579416,0,2,response to cyclosporin A,BP,
20434,GO:1905239,1,0.993947223180825,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20435,GO:1905240,1,0.993947223180825,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20436,GO:1905242,1,0.992352528215009,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
20437,GO:1905243,1,0.992352528215009,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20438,GO:1905244,1,0.986739524641677,0,2,regulation of modification of synaptic structure,BP,
20439,GO:1905245,1,0.987368948103984,0,2,regulation of aspartic-type peptidase activity,BP,
20440,GO:1905246,1,0.993986332288818,0,1,negative regulation of aspartic-type peptidase activity,BP,
20441,GO:1905247,1,0.993342893318518,0,1,positive regulation of aspartic-type peptidase activity,BP,
20442,GO:1905255,1,0.993986332267836,0,1,regulation of RNA binding transcription factor activity,BP,
20443,GO:1905258,1,0.984400887813367,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20444,GO:1905259,1,0.984400887813367,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20445,GO:1905267,1,0.985613905163078,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20446,GO:1905268,1,0.716957176738866,0,48,negative regulation of chromatin organization,BP,
20447,GO:1905269,1,0.535655970780405,0,88,positive regulation of chromatin organization,BP,
20448,GO:1905271,1,0.992170027168696,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20449,GO:1905273,1,0.992170027168696,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20450,GO:1905274,1,0.993986332271682,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20451,GO:1905276,1,0.884580440433991,0,18,regulation of epithelial tube formation,BP,
20452,GO:1905277,1,0.992630651409286,0,1,negative regulation of epithelial tube formation,BP,
20453,GO:1905278,1,0.971447005049466,0,4,positive regulation of epithelial tube formation,BP,
20454,GO:1905279,1,0.993986332281396,0,1,regulation of retrograde transport, endosome to Golgi,BP,
20455,GO:1905285,1,0.993173241686921,0,1,fibrous ring of heart morphogenesis,BP,
20456,GO:1905286,1,0.977295831185824,0,3,serine-type peptidase complex,CC,
20457,GO:1905289,1,0.993986332281396,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20458,GO:1905301,1,0.993826440032806,0,1,regulation of macropinocytosis,BP,
20459,GO:1905302,1,0.993826440032806,0,1,negative regulation of macropinocytosis,BP,
20460,GO:1905304,1,0.993986332279134,0,1,regulation of cardiac myofibril assembly,BP,
20461,GO:1905305,1,0.993986332279134,0,1,negative regulation of cardiac myofibril assembly,BP,
20462,GO:1905313,1,0.992197495932474,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20463,GO:1905314,1,0.892772872035304,0,16,semi-lunar valve development,BP,
20464,GO:1905323,1,0.958511983570749,0,6,telomerase holoenzyme complex assembly,BP,
20465,GO:1905327,1,0.992170027168696,0,1,tracheoesophageal septum formation,BP,
20467,GO:1905331,1,0.883013294250929,0,18,negative regulation of morphogenesis of an epithelium,BP,
20468,GO:1905332,1,0.796358123732478,0,32,positive regulation of morphogenesis of an epithelium,BP,
20469,GO:1905333,1,0.992170027247971,0,1,regulation of gastric motility,BP,
20470,GO:1905335,1,0.993986332299041,0,1,regulation of aggrephagy,BP,
20471,GO:1905337,1,0.993986332299041,0,1,positive regulation of aggrephagy,BP,
20472,GO:1905340,1,0.969365552014065,0,4,regulation of protein localization to kinetochore,BP,
20473,GO:1905341,1,0.992350409634924,0,1,negative regulation of protein localization to kinetochore,BP,
20474,GO:1905342,1,0.969365552014065,0,4,positive regulation of protein localization to kinetochore,BP,
20475,GO:1905344,1,0.992294630214608,0,1,prostaglandin catabolic process,BP,
20477,GO:1905354,1,0.849908762732895,0,22,exoribonuclease complex,CC,
20478,GO:1905355,1,0.993961888744792,0,1,spine apparatus assembly,BP,
20479,GO:1905359,1,0.992599282199603,0,1,protein localization to meiotic spindle,BP,
20480,GO:1905360,1,0.773679073107621,0,35,GTPase complex,CC,
20481,GO:1905361,1,0.933885258824464,0,9,L-serine transporter activity,MF,
20482,GO:1905365,1,0.992202596494721,0,1,regulation of intralumenal vesicle formation,BP,
20483,GO:1905366,1,0.992202596494721,0,1,negative regulation of intralumenal vesicle formation,BP,
20486,GO:1905370,1,0.992241458127627,0,1,serine-type endopeptidase complex,CC,
20487,GO:1905371,1,0.986203080773966,0,2,ceramide phosphoethanolamine metabolic process,BP,
20488,GO:1905373,1,0.986203080773966,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20489,GO:1905383,1,0.977034958474321,0,3,protein localization to presynapse,BP,
20490,GO:1905384,1,0.984746418141698,0,2,regulation of protein localization to presynapse,BP,
20491,GO:1905386,1,0.984746418141698,0,2,positive regulation of protein localization to presynapse,BP,
20492,GO:1905392,1,0.992170027168696,0,1,plant organ morphogenesis,BP,
20493,GO:1905394,1,0.978597385347048,0,3,retromer complex binding,MF,
20494,GO:1905395,1,0.979640226057919,0,3,response to flavonoid,BP,
20495,GO:1905397,1,0.992170027168696,0,1,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20496,GO:1905402,1,0.992170027168696,0,1,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20497,GO:1905404,1,0.992170027168696,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20498,GO:1905407,1,0.985063822252927,0,2,regulation of creatine transmembrane transporter activity,BP,
20499,GO:1905408,1,0.985063822252927,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20500,GO:1905419,1,0.992170942807503,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20501,GO:1905421,1,0.992170027168696,0,1,regulation of plant organ morphogenesis,BP,
20502,GO:1905422,1,0.992170027168696,0,1,negative regulation of plant organ morphogenesis,BP,
20503,GO:1905424,1,0.984611221993695,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20504,GO:1905426,1,0.984611221993695,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20505,GO:1905432,1,0.993583149764454,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20506,GO:1905433,1,0.993583149764454,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20507,GO:1905438,1,0.986203080772374,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20508,GO:1905443,1,0.993807094285753,0,1,regulation of clathrin coat assembly,BP,
20509,GO:1905445,1,0.993807094285753,0,1,positive regulation of clathrin coat assembly,BP,
20510,GO:1905446,1,0.954860732842193,0,6,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20511,GO:1905447,1,0.985183567623371,0,2,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20512,GO:1905448,1,0.969224664877213,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20513,GO:1905449,1,0.986204581964671,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20514,GO:1905451,1,0.986204581964671,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20515,GO:1905453,1,0.992772678292865,0,1,regulation of myeloid progenitor cell differentiation,BP,
20516,GO:1905456,1,0.946233935805071,0,8,regulation of lymphoid progenitor cell differentiation,BP,
20517,GO:1905457,1,0.978480302620419,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20518,GO:1905458,1,0.99349430163187,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20519,GO:1905462,1,0.993584555441305,0,1,regulation of DNA duplex unwinding,BP,
20520,GO:1905464,1,0.993584555441305,0,1,positive regulation of DNA duplex unwinding,BP,
20521,GO:1905468,1,0.993972109807993,0,1,regulation of clathrin-coated pit assembly,BP,
20522,GO:1905469,1,0.993972109807993,0,1,negative regulation of clathrin-coated pit assembly,BP,
20523,GO:1905474,1,0.992170027168696,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20524,GO:1905475,1,0.388345158737013,0,131,regulation of protein localization to membrane,BP,
20525,GO:1905476,1,0.827573535610318,0,26,negative regulation of protein localization to membrane,BP,
20526,GO:1905477,1,0.51155349302212,0,93,positive regulation of protein localization to membrane,BP,
20527,GO:1905483,1,0.993986332291564,0,1,regulation of motor neuron migration,BP,
20528,GO:1905485,1,0.993986332291564,0,1,positive regulation of motor neuron migration,BP,
20529,GO:1905508,1,0.854509947648094,0,23,protein localization to microtubule organizing center,BP,
20530,GO:1905515,1,0.719800443188902,0,47,non-motile cilium assembly,BP,
20531,GO:1905516,1,0.9367916874983,0,9,positive regulation of fertilization,BP,
20532,GO:1905517,1,0.789112739688149,0,32,macrophage migration,BP,
20533,GO:1905518,1,0.99393002522899,0,1,regulation of presynaptic active zone assembly,BP,
20534,GO:1905520,1,0.99393002522899,0,1,positive regulation of presynaptic active zone assembly,BP,
20535,GO:1905521,1,0.851170163189517,0,22,regulation of macrophage migration,BP,
20536,GO:1905522,1,0.97240251586903,0,4,negative regulation of macrophage migration,BP,
20537,GO:1905523,1,0.887831834031098,0,16,positive regulation of macrophage migration,BP,
20538,GO:1905524,1,0.993986332273999,0,1,negative regulation of protein autoubiquitination,BP,
20539,GO:1905535,1,0.993971023400166,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20540,GO:1905537,1,0.993971023400166,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20541,GO:1905546,1,0.992211571683086,0,1,cellular response to phenylpropanoid,BP,
20542,GO:1905547,1,0.992170027168696,0,1,regulation of telomeric heterochromatin assembly,BP,
20543,GO:1905549,1,0.992170027168696,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20544,GO:1905550,1,0.984482574032715,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20545,GO:1905552,1,0.984482574032715,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20546,GO:1905553,1,0.992170027168696,0,1,regulation of blood vessel branching,BP,
20547,GO:1905555,1,0.992170027168696,0,1,positive regulation blood vessel branching,BP,
20548,GO:1905562,1,0.992170027168696,0,1,regulation of vascular endothelial cell proliferation,BP,
20549,GO:1905564,1,0.992170027168696,0,1,positive regulation of vascular endothelial cell proliferation,BP,
20550,GO:1905572,1,0.992446400632965,0,1,ganglioside GM1 transport to membrane,BP,
20551,GO:1905573,1,0.984678055793639,0,2,ganglioside GM1 binding,MF,
20552,GO:1905574,1,0.992446400632965,0,1,ganglioside GM2 binding,MF,
20553,GO:1905575,1,0.992446400632965,0,1,ganglioside GM3 binding,MF,
20554,GO:1905576,1,0.97703817492,0,3,ganglioside GT1b binding,MF,
20555,GO:1905577,1,0.992446400632965,0,1,ganglioside GP1c binding,MF,
20556,GO:1905578,1,0.992252353039287,0,1,regulation of ERBB3 signaling pathway,BP,
20557,GO:1905580,1,0.992252353039287,0,1,positive regulation of ERBB3 signaling pathway,BP,
20558,GO:1905581,1,0.992170027168696,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20559,GO:1905590,1,0.992687010477427,0,1,fibronectin fibril organization,BP,
20560,GO:1905594,1,0.992170027168696,0,1,resveratrol binding,MF,
20561,GO:1905595,1,0.985415880322065,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20562,GO:1905596,1,0.993192967637625,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20563,GO:1905597,1,0.992170027168696,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20564,GO:1905598,1,0.993192967637625,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20565,GO:1905599,1,0.992170027168696,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20566,GO:1905600,1,0.978045476670957,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20567,GO:1905601,1,0.993192967637625,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20568,GO:1905602,1,0.984749500562849,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20569,GO:1905603,1,0.99394556584038,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20570,GO:1905605,1,0.99394556584038,0,1,positive regulation of maintenance of permeability of blood-brain barrier,BP,
20571,GO:1905606,1,0.980747248718509,0,3,regulation of presynapse assembly,BP,
20572,GO:1905608,1,0.99393002522899,0,1,positive regulation of presynapse assembly,BP,
20573,GO:1905610,1,0.993971023400166,0,1,regulation of mRNA cap binding,BP,
20574,GO:1905612,1,0.993971023400166,0,1,positive regulation of mRNA cap binding,BP,
20575,GO:1905616,1,0.986311748458637,0,2,regulation of miRNA mediated inhibition of translation,BP,
20576,GO:1905618,1,0.986311748458637,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20577,GO:1905634,1,0.978529291580995,0,3,regulation of protein localization to chromatin,BP,
20578,GO:1905636,1,0.992170027168696,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20579,GO:1905642,1,0.992170058604936,0,1,negative regulation of DNA methylation,BP,
20580,GO:1905643,1,0.992170058604936,0,1,positive regulation of DNA methylation,BP,
20581,GO:1905651,1,0.987744924780373,0,2,regulation of artery morphogenesis,BP,
20582,GO:1905653,1,0.987744924780373,0,2,positive regulation of artery morphogenesis,BP,
20583,GO:1905661,1,0.985482283380965,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20584,GO:1905663,1,0.985482283380965,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20585,GO:1905664,1,0.984621116432762,0,2,regulation of calcium ion import across plasma membrane,BP,
20586,GO:1905666,1,0.974234158529249,0,4,regulation of protein localization to endosome,BP,
20587,GO:1905668,1,0.974234158529249,0,4,positive regulation of protein localization to endosome,BP,
20588,GO:1905671,1,0.98613046557353,0,2,regulation of lysosome organization,BP,
20589,GO:1905672,1,0.992190515957061,0,1,negative regulation of lysosome organization,BP,
20590,GO:1905687,1,0.99398632545061,0,1,regulation of diacylglycerol kinase activity,BP,
20591,GO:1905689,1,0.99398632545061,0,1,positive regulation of diacylglycerol kinase activity,BP,
20592,GO:1905693,1,0.992190392480105,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20593,GO:1905695,1,0.992190392480105,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20594,GO:1905696,1,0.993971023400166,0,1,regulation of polysome binding,BP,
20595,GO:1905705,1,0.993986332270338,0,1,cellular response to paclitaxel,BP,
20598,GO:1905711,1,0.993344272378398,0,1,response to phosphatidylethanolamine,BP,
20599,GO:1905715,1,0.992287752476639,0,1,regulation of cornification,BP,
20600,GO:1905716,1,0.992287752476639,0,1,negative regulation of cornification,BP,
20601,GO:1905747,1,0.984400887816991,0,2,negative regulation of saliva secretion,BP,
20602,GO:1905748,1,0.984400887816991,0,2,hard palate morphogenesis,BP,
20603,GO:1905764,1,0.979180453571169,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20604,GO:1905765,1,0.979180453571169,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20605,GO:1905767,1,0.993986332269418,0,1,regulation of double-stranded telomeric DNA binding,BP,
20606,GO:1905768,1,0.993986332269418,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20607,GO:1905770,1,0.949534810499689,0,7,regulation of mesodermal cell differentiation,BP,
20608,GO:1905771,1,0.96910419216874,0,4,negative regulation of mesodermal cell differentiation,BP,
20609,GO:1905772,1,0.992516661359673,0,1,positive regulation of mesodermal cell differentiation,BP,
20610,GO:1905774,1,0.993584555441305,0,1,regulation of DNA helicase activity,BP,
20611,GO:1905776,1,0.993584555441305,0,1,positive regulation of DNA helicase activity,BP,
20612,GO:1905777,1,0.985067205817004,0,2,regulation of exonuclease activity,BP,
20613,GO:1905778,1,0.985067205817004,0,2,negative regulation of exonuclease activity,BP,
20614,GO:1905793,1,0.987951819773835,0,2,protein localization to pericentriolar material,BP,
20615,GO:1905794,1,0.993986332285135,0,1,response to puromycin,BP,
20616,GO:1905795,1,0.993986332285135,0,1,cellular response to puromycin,BP,
20617,GO:1905802,1,0.992457640659739,0,1,regulation of cellular response to manganese ion,BP,
20618,GO:1905809,1,0.921622576666627,0,12,negative regulation of synapse organization,BP,
20619,GO:1905818,1,0.711673037974391,0,47,regulation of chromosome separation,BP,
20620,GO:1905819,1,0.796890848768323,0,31,negative regulation of chromosome separation,BP,
20621,GO:1905820,1,0.959697934840971,0,6,positive regulation of chromosome separation,BP,
20622,GO:1905838,1,0.985067205817004,0,2,regulation of telomeric D-loop disassembly,BP,
20623,GO:1905839,1,0.985067205817004,0,2,negative regulation of telomeric D-loop disassembly,BP,
20624,GO:1905853,1,0.992170027168696,0,1,regulation of heparan sulfate binding,BP,
20625,GO:1905855,1,0.992170027168696,0,1,positive regulation of heparan sulfate binding,BP,
20626,GO:1905858,1,0.992170027168696,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20627,GO:1905860,1,0.992170027168696,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20628,GO:1905867,1,0.969594635471515,0,4,epididymis development,BP,
20629,GO:1905871,1,0.992170027168696,0,1,regulation of protein localization to cell leading edge,BP,
20630,GO:1905873,1,0.992170027168696,0,1,positive regulation of protein localization to cell leading edge,BP,
20631,GO:1905874,1,0.972225570986704,0,4,regulation of postsynaptic density organization,BP,
20632,GO:1905875,1,0.992170027168696,0,1,negative regulation of postsynaptic density organization,BP,
20633,GO:1905879,1,0.937767005948174,0,9,regulation of oogenesis,BP,
20634,GO:1905880,1,0.972077218702178,0,4,negative regulation of oogenesis,BP,
20635,GO:1905881,1,0.972265269590568,0,4,positive regulation of oogenesis,BP,
20636,GO:1905890,1,0.992170027168696,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20637,GO:1905891,1,0.992453396137953,0,1,regulation of cellular response to thapsigargin,BP,
20638,GO:1905892,1,0.992453396137953,0,1,negative regulation of cellular response to thapsigargin,BP,
20639,GO:1905894,1,0.992453396137953,0,1,regulation of cellular response to tunicamycin,BP,
20640,GO:1905895,1,0.992453396137953,0,1,negative regulation of cellular response to tunicamycin,BP,
20641,GO:1905897,1,0.607839230971897,0,69,regulation of response to endoplasmic reticulum stress,BP,
20642,GO:1905898,1,0.780450116236331,0,34,positive regulation of response to endoplasmic reticulum stress,BP,
20643,GO:1905899,1,0.992170027168696,0,1,regulation of smooth muscle tissue development,BP,
20644,GO:1905900,1,0.992170027168696,0,1,negative regulation of smooth muscle tissue development,BP,
20645,GO:1905901,1,0.992170027168696,0,1,positive regulation of smooth muscle tissue development,BP,
20646,GO:1905902,1,0.949534810499689,0,7,regulation of mesoderm formation,BP,
20647,GO:1905903,1,0.96910419216874,0,4,negative regulation of mesoderm formation,BP,
20648,GO:1905904,1,0.992516661359673,0,1,positive regulation of mesoderm formation,BP,
20649,GO:1905906,1,0.976992516015689,0,3,regulation of amyloid fibril formation,BP,
20650,GO:1905907,1,0.984682055078918,0,2,negative regulation of amyloid fibril formation,BP,
20651,GO:1905912,1,0.992171169667957,0,1,regulation of calcium ion export from cell,BP,
20652,GO:1905913,1,0.992171169667957,0,1,negative regulation of calcium ion export from cell,BP,
20653,GO:1905918,1,0.992191778287853,0,1,regulation of CoA-transferase activity,BP,
20654,GO:1905920,1,0.992191778287853,0,1,positive regulation of CoA-transferase activity,BP,
20655,GO:1905936,1,0.969164958321263,0,4,regulation of germ cell proliferation,BP,
20656,GO:1905937,1,0.976814787232004,0,3,negative regulation of germ cell proliferation,BP,
20657,GO:1905938,1,0.992170027168696,0,1,positive regulation of germ cell proliferation,BP,
20658,GO:1905939,1,0.884192811867857,0,17,regulation of gonad development,BP,
20659,GO:1905940,1,0.965136146361697,0,5,negative regulation of gonad development,BP,
20660,GO:1905941,1,0.929661054591453,0,10,positive regulation of gonad development,BP,
20661,GO:1905950,1,0.871277743772765,0,19,monosaccharide transmembrane transport,BP,
20665,GO:1905957,1,0.993740843079674,0,1,regulation of cellular response to alcohol,BP,
20666,GO:1905959,1,0.993740843079674,0,1,positive regulation of cellular response to alcohol,BP,
20667,GO:1990000,1,0.92293888829151,0,11,amyloid fibril formation,BP,
20669,GO:1990005,1,0.992170061138958,0,1,granular vesicle,CC,
20670,GO:1990008,1,0.992170061138958,0,1,neurosecretory vesicle,CC,
20671,GO:1990009,1,0.987258836192775,0,2,retinal cell apoptotic process,BP,
20672,GO:1990015,1,0.992242171696588,0,1,ensheathing process,CC,
20673,GO:1990022,1,0.976692199772086,0,3,RNA polymerase III complex localization to nucleus,BP,
20674,GO:1990023,1,0.933778188232157,0,10,mitotic spindle midzone,CC,
20675,GO:1990026,1,0.993082917956945,0,1,hippocampal mossy fiber expansion,CC,
20676,GO:1990029,1,0.992718098684504,0,1,vasomotion,BP,
20677,GO:1990030,1,0.993443479321773,0,1,pericellular basket,CC,
20678,GO:1990031,1,0.992715291883018,0,1,pinceau fiber,CC,
20679,GO:1990032,1,0.993801084346511,0,1,parallel fiber,CC,
20680,GO:1990034,1,0.966854210181831,0,5,calcium ion export from cell,BP,
20681,GO:1990035,1,0.927670743332424,0,11,calcium ion import into cell,BP,
20682,GO:1990036,1,0.978544395588713,0,3,calcium ion import into sarcoplasmic reticulum,BP,
20683,GO:1990037,1,0.976720345563033,0,3,Lewy body core,CC,
20684,GO:1990038,1,0.992174782146658,0,1,Lewy body corona,CC,
20685,GO:1990046,1,0.992170027168696,0,1,stress-induced mitochondrial fusion,BP,
20686,GO:1990047,1,0.992211176517373,0,1,spindle matrix,CC,
20687,GO:1990050,1,0.984400887813367,0,2,phosphatidic acid transporter activity,MF,
20688,GO:1990051,1,0.987002426626962,0,2,activation of protein kinase C activity,BP,
20689,GO:1990071,1,0.993986332270522,0,1,TRAPPII protein complex,CC,
20690,GO:1990072,1,0.992294630214608,0,1,TRAPPIII protein complex,CC,
20691,GO:1990074,1,0.99306732813014,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20692,GO:1990075,1,0.973527737515542,0,4,periciliary membrane compartment,CC,
20693,GO:1990079,1,0.992170027168696,0,1,cartilage homeostasis,BP,
20694,GO:1990081,1,0.992170027168696,0,1,trimethylamine receptor activity,MF,
20695,GO:1990086,1,0.972754636815077,0,4,lens fiber cell apoptotic process,BP,
20696,GO:1990089,1,0.728236334905936,0,45,response to nerve growth factor,BP,
20697,GO:1990090,1,0.743783195259335,0,42,cellular response to nerve growth factor stimulus,BP,
20698,GO:1990108,1,0.993986332278342,0,1,protein linear deubiquitination,BP,
20700,GO:1990117,1,0.992170027168696,0,1,B cell receptor apoptotic signaling pathway,BP,
20701,GO:1990118,1,0.914979312738341,0,13,sodium ion import into cell,BP,
20702,GO:1990123,1,0.969715228994286,0,5,L-glutamate import into cell,BP,
20703,GO:1990124,1,0.94248647849764,0,9,messenger ribonucleoprotein complex,CC,
20704,GO:1990126,1,0.879317589623771,0,18,retrograde transport, endosome to plasma membrane,BP,
20705,GO:1990127,1,0.993650749510594,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20706,GO:1990130,1,0.971018850019484,0,4,GATOR1 complex,CC,
20707,GO:1990134,1,0.99394976626641,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20708,GO:1990136,1,0.992275871147749,0,1,linoleate 9S-lipoxygenase activity,MF,
20709,GO:1990138,1,0.390539161405156,0,137,neuron projection extension,BP,
20710,GO:1990144,1,0.963683886908508,0,5,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20711,GO:1990145,1,0.992830011017474,0,1,maintenance of translational fidelity,BP,
20712,GO:1990164,1,0.985151475592491,0,2,histone H2A phosphorylation,BP,
20713,GO:1990166,1,0.99222940600557,0,1,protein localization to site of double-strand break,BP,
20714,GO:1990167,1,0.980271746022823,0,3,protein K27-linked deubiquitination,BP,
20715,GO:1990168,1,0.980220751607361,0,3,protein K33-linked deubiquitination,BP,
20716,GO:1990169,1,0.98620308078549,0,2,stress response to copper ion,BP,
20717,GO:1990170,1,0.992177940775553,0,1,stress response to cadmium ion,BP,
20718,GO:1990172,1,0.993986332264836,0,1,G-protein coupled receptor catabolic process,BP,
20719,GO:1990173,1,0.932701308690869,0,9,protein localization to nucleoplasm,BP,
20720,GO:1990174,1,0.993393521267291,0,1,phosphodiesterase decapping endonuclease activity,MF,
20721,GO:1990175,1,0.993458230968205,0,1,EH domain binding,MF,
20722,GO:1990180,1,0.992210393719652,0,1,mitochondrial tRNA 3'-end processing,BP,
20723,GO:1990182,1,0.87469776356444,0,18,exosomal secretion,BP,
20724,GO:1990183,1,0.992170027168696,0,1,lymphatic vascular process in circulatory system,BP,
20725,GO:1990186,1,0.992170027168696,0,1,regulation of lymphatic vessel size,BP,
20726,GO:1990188,1,0.992323630727819,0,1,euchromatin binding,MF,
20727,GO:1990189,1,0.9773973729782,0,3,peptide-serine-N-acetyltransferase activity,MF,
20728,GO:1990190,1,0.984400887813367,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20729,GO:1990192,1,0.992170027168696,0,1,collecting lymphatic vessel constriction,BP,
20730,GO:1990204,1,0.482960009777032,0,96,oxidoreductase complex,CC,
20731,GO:1990226,1,0.955614109943524,0,6,histone methyltransferase binding,MF,
20733,GO:1990239,1,0.966999812396682,0,5,steroid hormone binding,MF,
20734,GO:1990246,1,0.984648173044371,0,2,uniplex complex,CC,
20735,GO:1990247,1,0.954107191950705,0,7,N6-methyladenosine-containing RNA binding,MF,
20736,GO:1990253,1,0.961936166226119,0,6,cellular response to leucine starvation,BP,
20737,GO:1990254,1,0.964649577968666,0,5,keratin filament binding,MF,
20738,GO:1990256,1,0.993986332292381,0,1,signal clustering,BP,
20739,GO:1990258,1,0.992170027168696,0,1,histone glutamine methylation,BP,
20740,GO:1990259,1,0.992170027168696,0,1,histone-glutamine methyltransferase activity,MF,
20741,GO:1990262,1,0.984619453965962,0,2,anti-Mullerian hormone signaling pathway,BP,
20742,GO:1990264,1,0.992868491067802,0,1,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20743,GO:1990266,1,0.496529398830804,0,93,neutrophil migration,BP,
20744,GO:1990267,1,0.992773639713341,0,1,response to transition metal nanoparticle,BP,
20745,GO:1990268,1,0.992773639713341,0,1,response to gold nanoparticle,BP,
20746,GO:1990269,1,0.986186487552353,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20747,GO:1990272,1,0.992171614783988,0,1,anti-Mullerian hormone receptor activity,MF,
20748,GO:1990275,1,0.992481972810122,0,1,preribosome binding,MF,
20749,GO:1990314,1,0.950233685320983,0,7,cellular response to insulin-like growth factor stimulus,BP,
20750,GO:1990316,1,0.961878392999902,0,6,ATG1/ULK1 kinase complex,CC,
20751,GO:1990332,1,0.993531099117722,0,1,Ire1 complex,CC,
20752,GO:1990349,1,0.992177118014353,0,1,gap junction-mediated intercellular transport,BP,
20754,GO:1990356,1,0.992170027168696,0,1,sumoylated E2 ligase complex,CC,
20755,GO:1990357,1,0.977786378738963,0,3,terminal web,CC,
20756,GO:1990379,1,0.984426462393775,0,2,lipid transport across blood brain barrier,BP,
20757,GO:1990380,1,0.955367555249666,0,7,Lys48-specific deubiquitinase activity,MF,
20758,GO:1990381,1,0.91948894233529,0,12,ubiquitin-specific protease binding,MF,
20759,GO:1990384,1,0.992170027168696,0,1,hyaloid vascular plexus regression,BP,
20760,GO:1990386,1,0.99217575270759,0,1,mitotic cleavage furrow ingression,BP,
20761,GO:1990390,1,0.993018951453845,0,1,protein K33-linked ubiquitination,BP,
20762,GO:1990391,1,0.768586162416968,0,37,DNA repair complex,CC,
20763,GO:1990393,1,0.967354281573822,0,5,3M complex,CC,
20764,GO:1990399,1,0.993986332273156,0,1,epithelium regeneration,BP,
20765,GO:1990401,1,0.992404058851162,0,1,embryonic lung development,BP,
20766,GO:1990402,1,0.992197495932474,0,1,embryonic liver development,BP,
20767,GO:1990403,1,0.93847435979958,0,9,embryonic brain development,BP,
20768,GO:1990404,1,0.985737947840834,0,2,protein ADP-ribosylase activity,MF,
20769,GO:1990405,1,0.965601674364876,0,5,protein antigen binding,MF,
20770,GO:1990414,1,0.985502713421799,0,2,replication-born double-strand break repair via sister chromatid exchange,BP,
20771,GO:1990415,1,0.984583833942844,0,2,Pex17p-Pex14p docking complex,CC,
20772,GO:1990416,1,0.952236473865688,0,7,cellular response to brain-derived neurotrophic factor stimulus,BP,
20773,GO:1990418,1,0.977285346197293,0,3,response to insulin-like growth factor stimulus,BP,
20774,GO:1990421,1,0.993986332289623,0,1,subtelomeric heterochromatin,CC,
20775,GO:1990423,1,0.979403779685758,0,3,RZZ complex,CC,
20776,GO:1990425,1,0.993986332271339,0,1,ryanodine receptor complex,CC,
20777,GO:1990426,1,0.986236728474698,0,2,mitotic recombination-dependent replication fork processing,BP,
20778,GO:1990427,1,0.993986332272497,0,1,stereocilia tip-link density,CC,
20779,GO:1990428,1,0.993238373082145,0,1,miRNA transport,BP,
20780,GO:1990429,1,0.984583833942844,0,2,peroxisomal importomer complex,CC,
20781,GO:1990430,1,0.972634955328232,0,4,extracellular matrix protein binding,MF,
20782,GO:1990435,1,0.993986332272497,0,1,upper tip-link density,CC,
20783,GO:1990439,1,0.992529681800207,0,1,MAP kinase threonine phosphatase activity,MF,
20784,GO:1990440,1,0.920551584248649,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20785,GO:1990441,1,0.962691360109165,0,5,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20786,GO:1990442,1,0.976692112990833,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
20787,GO:1990446,1,0.953926638512612,0,6,U1 snRNP binding,MF,
20788,GO:1990450,1,0.99218395289895,0,1,linear polyubiquitin binding,MF,
20789,GO:1990451,1,0.992258438858887,0,1,cellular stress response to acidic pH,BP,
20790,GO:1990452,1,0.986111450651033,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
20791,GO:1990454,1,0.961793640617526,0,6,L-type voltage-gated calcium channel complex,CC,
20792,GO:1990459,1,0.941606791739698,0,8,transferrin receptor binding,MF,
20793,GO:1990460,1,0.978604620286425,0,3,leptin receptor binding,MF,
20794,GO:1990462,1,0.992951442549609,0,1,omegasome,CC,
20795,GO:1990478,1,0.992173570943288,0,1,response to ultrasound,BP,
20797,GO:1990498,1,0.993986332278317,0,1,mitotic spindle microtubule,CC,
20798,GO:1990502,1,0.987224802093511,0,2,dense core granule maturation,BP,
20799,GO:1990504,1,0.969756606995204,0,5,dense core granule exocytosis,BP,
20800,GO:1990505,1,0.986236728474698,0,2,mitotic DNA replication maintenance of fidelity,BP,
20801,GO:1990511,1,0.992449186954241,0,1,piRNA biosynthetic process,BP,
20802,GO:1990512,1,0.992809470257102,0,1,Cry-Per complex,CC,
20803,GO:1990519,1,0.986083170111211,0,2,mitochondrial pyrimidine nucleotide import,BP,
20804,GO:1990523,1,0.970548741845256,0,4,bone regeneration,BP,
20805,GO:1990539,1,0.992219791379029,0,1,fructose import across plasma membrane,BP,
20807,GO:1990564,1,0.962061586190459,0,5,protein polyufmylation,BP,
20808,GO:1990565,1,0.99217002867238,0,1,HSP90-CDC37 chaperone complex,CC,
20809,GO:1990569,1,0.986223694269111,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
20810,GO:1990572,1,0.993518782405315,0,1,TERT-RMRP complex,CC,
20811,GO:1990573,1,0.937566706159256,0,9,potassium ion import across plasma membrane,BP,
20812,GO:1990578,1,0.993986332264179,0,1,perinuclear endoplasmic reticulum membrane,CC,
20813,GO:1990579,1,0.993531099117722,0,1,peptidyl-serine trans-autophosphorylation,BP,
20814,GO:1990583,1,0.99217575270759,0,1,phospholipase D activator activity,MF,
20815,GO:1990584,1,0.976692112990833,0,3,cardiac Troponin complex,CC,
20816,GO:1990589,1,0.986203124948298,0,2,ATF4-CREB1 transcription factor complex,CC,
20817,GO:1990590,1,0.984481690768687,0,2,ATF1-ATF4 transcription factor complex,CC,
20818,GO:1990592,1,0.962061586190459,0,5,protein K69-linked ufmylation,BP,
20819,GO:1990595,1,0.992178966431155,0,1,mast cell secretagogue receptor activity,MF,
20820,GO:1990597,1,0.979681135362864,0,3,AIP1-IRE1 complex,CC,
20821,GO:1990599,1,0.979180453571169,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
20822,GO:1990603,1,0.992842792648331,0,1,dark adaptation,BP,
20823,GO:1990604,1,0.973168840568212,0,4,IRE1-TRAF2-ASK1 complex,CC,
20824,GO:1990613,1,0.993074371485387,0,1,mitochondrial membrane fusion,BP,
20825,GO:1990614,1,0.992896341056858,0,1,mitochondrial magnesium ion transmembrane transport,BP,
20826,GO:1990617,1,0.984400931890407,0,2,CHOP-ATF4 complex,CC,
20827,GO:1990619,1,0.985603820126152,0,2,histone H3-K9 deacetylation,BP,
20828,GO:1990622,1,0.984410859646566,0,2,CHOP-ATF3 complex,CC,
20829,GO:1990630,1,0.993531099117722,0,1,IRE1-RACK1-PP2A complex,CC,
20830,GO:1990635,1,0.979688274359939,0,3,proximal dendrite,CC,
20831,GO:1990637,1,0.97121973016797,0,4,response to prolactin,BP,
20832,GO:1990641,1,0.984405049732661,0,2,response to iron ion starvation,BP,
20833,GO:1990646,1,0.984808635987256,0,2,cellular response to prolactin,BP,
20834,GO:1990654,1,0.993929740571077,0,1,sebum secreting cell proliferation,BP,
20835,GO:1990666,1,0.987207725166299,0,2,PCSK9-LDLR complex,CC,
20836,GO:1990667,1,0.985415880322065,0,2,PCSK9-AnxA2 complex,CC,
20837,GO:1990668,1,0.956445932232241,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
20838,GO:1990682,1,0.985815915630238,0,2,CSF1-CSF1R complex,CC,
20839,GO:1990696,1,0.986211686723351,0,2,USH2 complex,CC,
20840,GO:1990697,1,0.992200777691712,0,1,protein depalmitoleylation,BP,
20841,GO:1990698,1,0.985700395253412,0,2,palmitoleoyltransferase activity,MF,
20842,GO:1990699,1,0.992200777691712,0,1,palmitoleyl hydrolase activity,MF,
20843,GO:1990700,1,0.993469043251271,0,1,nucleolar chromatin organization,BP,
20844,GO:1990705,1,0.993986332279133,0,1,cholangiocyte proliferation,BP,
20845,GO:1990707,1,0.993986332289623,0,1,nuclear subtelomeric heterochromatin,CC,
20846,GO:1990708,1,0.993936921997454,0,1,conditioned place preference,BP,
20847,GO:1990709,1,0.980216204575925,0,3,presynaptic active zone organization,BP,
20848,GO:1990712,1,0.943965167354249,0,8,HFE-transferrin receptor complex,CC,
20849,GO:1990715,1,0.985786774538712,0,2,mRNA CDS binding,MF,
20850,GO:1990716,1,0.980271781625832,0,3,axonemal central apparatus,CC,
20851,GO:1990718,1,0.993986332283427,0,1,axonemal central pair projection,CC,
20852,GO:1990723,1,0.992598852621608,0,1,cytoplasmic periphery of the nuclear pore complex,CC,
20853,GO:1990726,1,0.969095658518301,0,4,Lsm1-7-Pat1 complex,CC,
20854,GO:1990729,1,0.992174852578224,0,1,primary miRNA modification,BP,
20855,GO:1990730,1,0.986554381401904,0,2,VCP-NSFL1C complex,CC,
20856,GO:1990736,1,0.993568912326251,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
20857,GO:1990737,1,0.979803057179275,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
20858,GO:1990739,1,0.993986332279133,0,1,granulosa cell proliferation,BP,
20859,GO:1990742,1,0.987510909366831,0,2,microvesicle,CC,
20860,GO:1990743,1,0.993986332285324,0,1,protein sialylation,BP,
20861,GO:1990744,1,0.992174852578224,0,1,primary miRNA methylation,BP,
20862,GO:1990745,1,0.978971837424889,0,3,EARP complex,CC,
20864,GO:1990751,1,0.993986332271682,0,1,Schwann cell chemotaxis,BP,
20865,GO:1990752,1,0.863725013846137,0,22,microtubule end,CC,
20866,GO:1990755,1,0.992294630214608,0,1,mitotic spindle microtubule depolymerization,BP,
20867,GO:1990761,1,0.979482842991818,0,3,growth cone lamellipodium,CC,
20868,GO:1990763,1,0.986304301663763,0,2,arrestin family protein binding,MF,
20869,GO:1990769,1,0.984930338832197,0,2,proximal neuron projection,CC,
20870,GO:1990771,1,0.993986332265995,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
20871,GO:1990773,1,0.992170118627795,0,1,matrix metallopeptidase secretion,BP,
20872,GO:1990774,1,0.943495090995448,0,8,tumor necrosis factor secretion,BP,
20873,GO:1990776,1,0.879235259036646,0,18,response to angiotensin,BP,
20875,GO:1990778,1,0.197500125701558,0,229,protein localization to cell periphery,BP,
20876,GO:1990782,1,0.658994633653897,0,59,protein tyrosine kinase binding,MF,
20877,GO:1990784,1,0.993543946661862,0,1,response to dsDNA,BP,
20878,GO:1990785,1,0.980908394958056,0,3,response to water-immersion restraint stress,BP,
20879,GO:1990786,1,0.993543946661862,0,1,cellular response to dsDNA,BP,
20880,GO:1990790,1,0.992170027168696,0,1,response to glial cell derived neurotrophic factor,BP,
20881,GO:1990791,1,0.978095766757772,0,3,dorsal root ganglion development,BP,
20882,GO:1990792,1,0.992170027168696,0,1,cellular response to glial cell derived neurotrophic factor,BP,
20883,GO:1990796,1,0.992527694465266,0,1,photoreceptor cell terminal bouton,CC,
20884,GO:1990809,1,0.992208292351586,0,1,endoplasmic reticulum tubular network membrane organization,BP,
20885,GO:1990812,1,0.979250736472611,0,3,growth cone filopodium,CC,
20886,GO:1990822,1,0.955836750324109,0,6,basic amino acid transmembrane transport,BP,
20887,GO:1990823,1,0.993900004192079,0,1,response to leukemia inhibitory factor,BP,
20888,GO:1990825,1,0.943116838224113,0,8,sequence-specific mRNA binding,MF,
20889,GO:1990828,1,0.992191521788715,0,1,hepatocyte dedifferentiation,BP,
20890,GO:1990829,1,0.984950769452623,0,2,C-rich single-stranded DNA binding,MF,
20891,GO:1990830,1,0.993900004192079,0,1,cellular response to leukemia inhibitory factor,BP,
20892,GO:1990834,1,0.977697057132234,0,3,response to odorant,BP,
20894,GO:1990839,1,0.992216941255385,0,1,response to endothelin,BP,
20895,GO:1990841,1,0.822233702238175,0,28,promoter-specific chromatin binding,MF,
20896,GO:1990843,1,0.993986332267178,0,1,subsarcolemmal mitochondrion,CC,
20897,GO:1990844,1,0.993986332267178,0,1,interfibrillar mitochondrion,CC,
20898,GO:1990845,1,0.908446522857955,0,13,adaptive thermogenesis,BP,
20899,GO:1990851,1,0.973466129835236,0,4,Wnt-Frizzled-LRP5/6 complex,CC,
20900,GO:1990859,1,0.992216941255385,0,1,cellular response to endothelin,BP,
20901,GO:1990868,1,0.985415858280383,0,2,response to chemokine,BP,
20902,GO:1990869,1,0.985415858280383,0,2,cellular response to chemokine,BP,
20903,GO:1990874,1,0.839833482381036,0,24,vascular smooth muscle cell proliferation,BP,
20904,GO:1990876,1,0.993986332268731,0,1,cytoplasmic side of nuclear pore,CC,
20905,GO:1990879,1,0.984648173044371,0,2,CST complex,CC,
20906,GO:1990882,1,0.993478501023864,0,1,rRNA acetylation,BP,
20907,GO:1990883,1,0.993478501023864,0,1,rRNA cytidine N-acetyltransferase activity,MF,
20908,GO:1990884,1,0.993478501023864,0,1,RNA acetylation,BP,
20909,GO:1990889,1,0.992171570232374,0,1,H4K20me3 modified histone binding,MF,
20911,GO:1990907,1,0.979668514129766,0,3,beta-catenin-TCF complex,CC,
20912,GO:1990909,1,0.930041254515045,0,11,Wnt signalosome,CC,
20913,GO:1990910,1,0.978343834276021,0,3,response to hypobaric hypoxia,BP,
20914,GO:1990911,1,0.992191649784728,0,1,response to psychosocial stress,BP,
20915,GO:1990913,1,0.992288548141565,0,1,sperm head plasma membrane,CC,
20916,GO:1990917,1,0.992288548141565,0,1,ooplasm,CC,
20917,GO:1990918,1,0.978456602783098,0,3,double-strand break repair involved in meiotic recombination,BP,
20918,GO:1990922,1,0.992869978725763,0,1,hepatic stellate cell proliferation,BP,
20919,GO:1990923,1,0.978224063366202,0,3,PET complex,CC,
20920,GO:1990926,1,0.986049176654896,0,2,short-term synaptic potentiation,BP,
20921,GO:1990927,1,0.987829355398161,0,2,calcium ion regulated lysosome exocytosis,BP,
20922,GO:1990928,1,0.979713881193781,0,3,response to amino acid starvation,BP,
20923,GO:1990930,1,0.992170027168696,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
20924,GO:1990931,1,0.99370924424421,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
20925,GO:1990932,1,0.976692112990833,0,3,5.8S rRNA binding,MF,
20926,GO:1990936,1,0.992476801254136,0,1,vascular smooth muscle cell dedifferentiation,BP,
20927,GO:1990938,1,0.993518005325115,0,1,peptidyl-aspartic acid autophosphorylation,BP,
20928,GO:1990939,1,0.875217437200649,0,21,ATP-dependent microtubule motor activity,MF,
20929,GO:1990948,1,0.969043237344425,0,4,ubiquitin ligase inhibitor activity,MF,
20930,GO:1990955,1,0.993584555441305,0,1,G-rich single-stranded DNA binding,MF,
20931,GO:1990962,1,0.993506247191203,0,1,drug transport across blood-brain barrier,BP,
20932,GO:1990963,1,0.993506247191203,0,1,establishment of blood-retinal barrier,BP,
20933,GO:1990966,1,0.972977336161236,0,4,ATP generation from poly-ADP-D-ribose,BP,
20934,GO:1990967,1,0.99217022505881,0,1,multi-organism toxin transport,BP,
20935,GO:1990968,1,0.993986332267836,0,1,modulation by host of RNA binding by virus,BP,
20936,GO:1990969,1,0.993986332267836,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
20937,GO:1990971,1,0.993459902615453,0,1,EMILIN complex,CC,
20938,GO:1990983,1,0.992305659157953,0,1,tRNA demethylation,BP,
20939,GO:1990984,1,0.992305659157953,0,1,tRNA demethylase activity,MF,
20940,GO:2000001,1,0.907392704219091,0,13,regulation of DNA damage checkpoint,BP,
20941,GO:2000002,1,0.969309710565957,0,4,negative regulation of DNA damage checkpoint,BP,
20942,GO:2000004,1,0.992170392587755,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
20943,GO:2000005,1,0.992170392587755,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
20944,GO:2000006,1,0.992170392587755,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
20945,GO:2000007,1,0.992170392587755,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
20946,GO:2000008,1,0.803698089299197,0,31,regulation of protein localization to cell surface,BP,
20947,GO:2000009,1,0.925628181695583,0,11,negative regulation of protein localization to cell surface,BP,
20948,GO:2000010,1,0.918021454348436,0,12,positive regulation of protein localization to cell surface,BP,
20949,GO:2000011,1,0.992197949708862,0,1,regulation of adaxial/abaxial pattern formation,BP,
20950,GO:2000015,1,0.977849849638165,0,3,regulation of determination of dorsal identity,BP,
20951,GO:2000016,1,0.992170027168696,0,1,negative regulation of determination of dorsal identity,BP,
20952,GO:2000017,1,0.985567690740784,0,2,positive regulation of determination of dorsal identity,BP,
20953,GO:2000018,1,0.938196183243166,0,9,regulation of male gonad development,BP,
20954,GO:2000019,1,0.993434523207477,0,1,negative regulation of male gonad development,BP,
20955,GO:2000020,1,0.944399379385647,0,8,positive regulation of male gonad development,BP,
20959,GO:2000035,1,0.961961279512384,0,5,regulation of stem cell division,BP,
20960,GO:2000036,1,0.859631296778784,0,22,regulation of stem cell population maintenance,BP,
20961,GO:2000040,1,0.986016848328799,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
20962,GO:2000041,1,0.986016848328799,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
20963,GO:2000042,1,0.960290844380732,0,6,negative regulation of double-strand break repair via homologous recombination,BP,
20964,GO:2000043,1,0.984799981318697,0,2,regulation of cardiac cell fate specification,BP,
20965,GO:2000044,1,0.992516661359673,0,1,negative regulation of cardiac cell fate specification,BP,
20966,GO:2000045,1,0.3738921190467,0,136,regulation of G1/S transition of mitotic cell cycle,BP,
20967,GO:2000047,1,0.919992961850999,0,11,regulation of cell-cell adhesion mediated by cadherin,BP,
20968,GO:2000048,1,0.969225891524546,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
20969,GO:2000049,1,0.949215945631126,0,7,positive regulation of cell-cell adhesion mediated by cadherin,BP,
20970,GO:2000050,1,0.872201315132126,0,20,regulation of non-canonical Wnt signaling pathway,BP,
20971,GO:2000051,1,0.960854786348285,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
20972,GO:2000052,1,0.926398398716555,0,11,positive regulation of non-canonical Wnt signaling pathway,BP,
20973,GO:2000053,1,0.980124474724629,0,3,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20974,GO:2000054,1,0.98605493066697,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20975,GO:2000055,1,0.99398633228511,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20976,GO:2000056,1,0.992171950877309,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20977,GO:2000057,1,0.992171950877309,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20979,GO:2000059,1,0.908908140794075,0,13,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
20981,GO:2000061,1,0.992170027168696,0,1,regulation of ureter smooth muscle cell differentiation,BP,
20982,GO:2000062,1,0.992170027168696,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
20983,GO:2000063,1,0.992170027168696,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
20984,GO:2000064,1,0.958522103385838,0,6,regulation of cortisol biosynthetic process,BP,
20985,GO:2000065,1,0.970818122381158,0,4,negative regulation of cortisol biosynthetic process,BP,
20986,GO:2000066,1,0.993434523207477,0,1,positive regulation of cortisol biosynthetic process,BP,
20987,GO:2000067,1,0.992170027168696,0,1,regulation of root morphogenesis,BP,
20988,GO:2000074,1,0.943249630981409,0,8,regulation of type B pancreatic cell development,BP,
20989,GO:2000077,1,0.986228062259861,0,2,negative regulation of type B pancreatic cell development,BP,
20990,GO:2000078,1,0.977198380492658,0,3,positive regulation of type B pancreatic cell development,BP,
20991,GO:2000079,1,0.986355115121337,0,2,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20992,GO:2000080,1,0.993792360530137,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20993,GO:2000081,1,0.992516661359673,0,1,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20994,GO:2000095,1,0.920099432454562,0,12,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20995,GO:2000096,1,0.952494133638757,0,7,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20996,GO:2000097,1,0.977338639039464,0,3,regulation of smooth muscle cell-matrix adhesion,BP,
20997,GO:2000098,1,0.984943307925741,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
20998,GO:2000101,1,0.992520582922431,0,1,regulation of mammary stem cell proliferation,BP,
20999,GO:2000103,1,0.992520582922431,0,1,positive regulation of mammary stem cell proliferation,BP,
21000,GO:2000104,1,0.882195443509805,0,18,negative regulation of DNA-dependent DNA replication,BP,
21001,GO:2000105,1,0.90612575707249,0,14,positive regulation of DNA-dependent DNA replication,BP,
21004,GO:2000108,1,0.80306086259616,0,30,positive regulation of leukocyte apoptotic process,BP,
21005,GO:2000109,1,0.95098385801233,0,7,regulation of macrophage apoptotic process,BP,
21006,GO:2000110,1,0.978306184837609,0,3,negative regulation of macrophage apoptotic process,BP,
21007,GO:2000111,1,0.97967605622414,0,3,positive regulation of macrophage apoptotic process,BP,
21010,GO:2000114,1,0.885447782010078,0,18,regulation of establishment of cell polarity,BP,
21013,GO:2000118,1,0.978526247345278,0,3,regulation of sodium-dependent phosphate transport,BP,
21014,GO:2000119,1,0.992550241336354,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21015,GO:2000120,1,0.99220653731591,0,1,positive regulation of sodium-dependent phosphate transport,BP,
21017,GO:2000124,1,0.986050344532168,0,2,regulation of endocannabinoid signaling pathway,BP,
21018,GO:2000134,1,0.515209211572757,0,92,negative regulation of G1/S transition of mitotic cell cycle,BP,
21019,GO:2000136,1,0.891192084548265,0,16,regulation of cell proliferation involved in heart morphogenesis,BP,
21020,GO:2000137,1,0.986203444039405,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21021,GO:2000138,1,0.95715180543291,0,6,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21023,GO:2000143,1,0.958159702122795,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21028,GO:2000152,1,0.970251368269678,0,4,regulation of ubiquitin-specific protease activity,BP,
21029,GO:2000156,1,0.985926311627966,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21030,GO:2000157,1,0.984400887813367,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21031,GO:2000158,1,0.98562801524979,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21032,GO:2000167,1,0.99398046318514,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21033,GO:2000169,1,0.961346332105304,0,6,regulation of peptidyl-cysteine S-nitrosylation,BP,
21034,GO:2000170,1,0.986750548465698,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21035,GO:2000171,1,0.835234480068623,0,27,negative regulation of dendrite development,BP,
21036,GO:2000172,1,0.972704705948816,0,4,regulation of branching morphogenesis of a nerve,BP,
21037,GO:2000173,1,0.993479727110809,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21038,GO:2000174,1,0.99349430163187,0,1,regulation of pro-T cell differentiation,BP,
21039,GO:2000176,1,0.99349430163187,0,1,positive regulation of pro-T cell differentiation,BP,
21040,GO:2000177,1,0.599662881713313,0,72,regulation of neural precursor cell proliferation,BP,
21041,GO:2000178,1,0.879224925640025,0,18,negative regulation of neural precursor cell proliferation,BP,
21042,GO:2000179,1,0.734598942310654,0,43,positive regulation of neural precursor cell proliferation,BP,
21043,GO:2000181,1,0.603114086928772,0,72,negative regulation of blood vessel morphogenesis,BP,
21044,GO:2000182,1,0.980663379369357,0,3,regulation of progesterone biosynthetic process,BP,
21045,GO:2000184,1,0.993986332267178,0,1,positive regulation of progesterone biosynthetic process,BP,
21046,GO:2000185,1,0.99220653731591,0,1,regulation of phosphate transmembrane transport,BP,
21047,GO:2000187,1,0.99220653731591,0,1,positive regulation of phosphate transmembrane transport,BP,
21048,GO:2000188,1,0.918640216441202,0,12,regulation of cholesterol homeostasis,BP,
21049,GO:2000189,1,0.972522189209915,0,4,positive regulation of cholesterol homeostasis,BP,
21050,GO:2000191,1,0.847357394288434,0,23,regulation of fatty acid transport,BP,
21051,GO:2000192,1,0.954007231988757,0,7,negative regulation of fatty acid transport,BP,
21052,GO:2000193,1,0.893268390711419,0,15,positive regulation of fatty acid transport,BP,
21053,GO:2000194,1,0.92283233697218,0,11,regulation of female gonad development,BP,
21054,GO:2000195,1,0.97151604850085,0,4,negative regulation of female gonad development,BP,
21055,GO:2000196,1,0.984400887813367,0,2,positive regulation of female gonad development,BP,
21056,GO:2000197,1,0.958946121117203,0,6,regulation of ribonucleoprotein complex localization,BP,
21057,GO:2000199,1,0.992658772623277,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21058,GO:2000200,1,0.992658772623277,0,1,regulation of ribosomal subunit export from nucleus,BP,
21059,GO:2000202,1,0.992658772623277,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21060,GO:2000206,1,0.992658772623277,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21061,GO:2000208,1,0.992658772623277,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21063,GO:2000210,1,0.949587965384169,0,7,positive regulation of anoikis,BP,
21064,GO:2000211,1,0.986187393219562,0,2,regulation of glutamate metabolic process,BP,
21065,GO:2000212,1,0.993950120304748,0,1,negative regulation of glutamate metabolic process,BP,
21066,GO:2000213,1,0.992190392480105,0,1,positive regulation of glutamate metabolic process,BP,
21067,GO:2000224,1,0.985655559082215,0,2,regulation of testosterone biosynthetic process,BP,
21068,GO:2000225,1,0.993434523207477,0,1,negative regulation of testosterone biosynthetic process,BP,
21069,GO:2000226,1,0.992170027168696,0,1,regulation of pancreatic A cell differentiation,BP,
21070,GO:2000227,1,0.992170027168696,0,1,negative regulation of pancreatic A cell differentiation,BP,
21071,GO:2000229,1,0.984402301603461,0,2,regulation of pancreatic stellate cell proliferation,BP,
21072,GO:2000230,1,0.992171452029609,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21073,GO:2000231,1,0.992170027168696,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21074,GO:2000232,1,0.945256688449312,0,8,regulation of rRNA processing,BP,
21075,GO:2000233,1,0.986488977982957,0,2,negative regulation of rRNA processing,BP,
21076,GO:2000234,1,0.958207339953861,0,6,positive regulation of rRNA processing,BP,
21077,GO:2000241,1,0.402746699771086,0,124,regulation of reproductive process,BP,
21078,GO:2000242,1,0.684820652525536,0,51,negative regulation of reproductive process,BP,
21079,GO:2000243,1,0.71228072367255,0,47,positive regulation of reproductive process,BP,
21080,GO:2000249,1,0.7950825597793,0,32,regulation of actin cytoskeleton reorganization,BP,
21081,GO:2000251,1,0.89309916082586,0,15,positive regulation of actin cytoskeleton reorganization,BP,
21082,GO:2000252,1,0.949132524577939,0,7,negative regulation of feeding behavior,BP,
21083,GO:2000253,1,0.95906202057677,0,6,positive regulation of feeding behavior,BP,
21084,GO:2000254,1,0.969164958321263,0,4,regulation of male germ cell proliferation,BP,
21085,GO:2000255,1,0.976814787232004,0,3,negative regulation of male germ cell proliferation,BP,
21086,GO:2000256,1,0.992170027168696,0,1,positive regulation of male germ cell proliferation,BP,
21088,GO:2000258,1,0.945004796366904,0,8,negative regulation of protein activation cascade,BP,
21089,GO:2000259,1,0.979469369389056,0,3,positive regulation of protein activation cascade,BP,
21090,GO:2000266,1,0.992170027168696,0,1,regulation of blood coagulation, intrinsic pathway,BP,
21091,GO:2000269,1,0.903480681074405,0,15,regulation of fibroblast apoptotic process,BP,
21092,GO:2000270,1,0.953728079631812,0,7,negative regulation of fibroblast apoptotic process,BP,
21093,GO:2000271,1,0.955932502746097,0,7,positive regulation of fibroblast apoptotic process,BP,
21094,GO:2000272,1,0.7840488140801,0,34,negative regulation of receptor activity,BP,
21095,GO:2000273,1,0.728616340568798,0,46,positive regulation of receptor activity,BP,
21096,GO:2000275,1,0.969094733964549,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21097,GO:2000276,1,0.984427403699062,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21098,GO:2000277,1,0.992170027168696,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21101,GO:2000280,1,0.992170027168696,0,1,regulation of root development,BP,
21102,GO:2000282,1,0.986203080787007,0,2,regulation of cellular amino acid biosynthetic process,BP,
21103,GO:2000283,1,0.993986332279396,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21104,GO:2000284,1,0.992170027168696,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21105,GO:2000286,1,0.978144187911178,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21106,GO:2000287,1,0.992204485640165,0,1,positive regulation of myotome development,BP,
21107,GO:2000288,1,0.955255687382183,0,6,positive regulation of myoblast proliferation,BP,
21108,GO:2000290,1,0.992204485640165,0,1,regulation of myotome development,BP,
21109,GO:2000291,1,0.926035735152081,0,10,regulation of myoblast proliferation,BP,
21110,GO:2000295,1,0.977236315589625,0,3,regulation of hydrogen peroxide catabolic process,BP,
21111,GO:2000296,1,0.984400887813367,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21112,GO:2000297,1,0.980339071278264,0,3,negative regulation of synapse maturation,BP,
21113,GO:2000298,1,0.985204153777275,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21114,GO:2000299,1,0.992911323486596,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21115,GO:2000300,1,0.830827956440417,0,27,regulation of synaptic vesicle exocytosis,BP,
21116,GO:2000301,1,0.970963702928702,0,4,negative regulation of synaptic vesicle exocytosis,BP,
21117,GO:2000302,1,0.981852439726999,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21118,GO:2000303,1,0.907774708725692,0,13,regulation of ceramide biosynthetic process,BP,
21119,GO:2000304,1,0.942453739424284,0,8,positive regulation of ceramide biosynthetic process,BP,
21120,GO:2000307,1,0.977280430587035,0,3,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21121,GO:2000308,1,0.992232086165117,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21122,GO:2000309,1,0.984932202766779,0,2,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21123,GO:2000310,1,0.8965159505301,0,16,regulation of NMDA receptor activity,BP,
21124,GO:2000311,1,0.876619487347823,0,19,regulation of AMPA receptor activity,BP,
21125,GO:2000312,1,0.979554851218353,0,3,regulation of kainate selective glutamate receptor activity,BP,
21126,GO:2000313,1,0.984403034189576,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21127,GO:2000314,1,0.992170027325964,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21128,GO:2000316,1,0.90607791026669,0,13,regulation of T-helper 17 type immune response,BP,
21129,GO:2000317,1,0.954929725495633,0,6,negative regulation of T-helper 17 type immune response,BP,
21130,GO:2000318,1,0.948860449735399,0,7,positive regulation of T-helper 17 type immune response,BP,
21131,GO:2000319,1,0.919831936568851,0,11,regulation of T-helper 17 cell differentiation,BP,
21132,GO:2000320,1,0.954929725495633,0,6,negative regulation of T-helper 17 cell differentiation,BP,
21133,GO:2000321,1,0.963258675870025,0,5,positive regulation of T-helper 17 cell differentiation,BP,
21134,GO:2000322,1,0.945550663178159,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21135,GO:2000323,1,0.95959092398058,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21136,GO:2000324,1,0.985373174262222,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21137,GO:2000325,1,0.99398633226644,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21138,GO:2000327,1,0.99398633226644,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21139,GO:2000328,1,0.954734979586798,0,6,regulation of T-helper 17 cell lineage commitment,BP,
21140,GO:2000329,1,0.984913854299002,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21141,GO:2000330,1,0.969362450166304,0,4,positive regulation of T-helper 17 cell lineage commitment,BP,
21142,GO:2000331,1,0.986344441851659,0,2,regulation of terminal button organization,BP,
21143,GO:2000332,1,0.984413066896963,0,2,regulation of blood microparticle formation,BP,
21144,GO:2000334,1,0.984413066896963,0,2,positive regulation of blood microparticle formation,BP,
21145,GO:2000338,1,0.984939506515982,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21146,GO:2000340,1,0.984939506515982,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21147,GO:2000341,1,0.940035308492493,0,8,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21148,GO:2000342,1,0.98480451874301,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21149,GO:2000343,1,0.954545314475792,0,6,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21150,GO:2000344,1,0.9367916874983,0,9,positive regulation of acrosome reaction,BP,
21151,GO:2000345,1,0.903137681464068,0,14,regulation of hepatocyte proliferation,BP,
21152,GO:2000346,1,0.970985314639759,0,4,negative regulation of hepatocyte proliferation,BP,
21153,GO:2000347,1,0.950071334496317,0,7,positive regulation of hepatocyte proliferation,BP,
21154,GO:2000348,1,0.958135361849714,0,6,regulation of CD40 signaling pathway,BP,
21155,GO:2000349,1,0.986003165406431,0,2,negative regulation of CD40 signaling pathway,BP,
21156,GO:2000350,1,0.992170027168696,0,1,positive regulation of CD40 signaling pathway,BP,
21157,GO:2000351,1,0.755891891971268,0,39,regulation of endothelial cell apoptotic process,BP,
21158,GO:2000352,1,0.828816266384868,0,26,negative regulation of endothelial cell apoptotic process,BP,
21159,GO:2000353,1,0.912137013901073,0,13,positive regulation of endothelial cell apoptotic process,BP,
21160,GO:2000354,1,0.970796039505703,0,4,regulation of ovarian follicle development,BP,
21161,GO:2000355,1,0.992178139269056,0,1,negative regulation of ovarian follicle development,BP,
21162,GO:2000356,1,0.992170027168696,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21163,GO:2000357,1,0.992170027168696,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21164,GO:2000358,1,0.992170027168696,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21165,GO:2000359,1,0.969077414192672,0,4,regulation of binding of sperm to zona pellucida,BP,
21166,GO:2000360,1,0.969077414192672,0,4,negative regulation of binding of sperm to zona pellucida,BP,
21167,GO:2000361,1,0.993803794797847,0,1,regulation of prostaglandin-E synthase activity,BP,
21168,GO:2000363,1,0.993803794797847,0,1,positive regulation of prostaglandin-E synthase activity,BP,
21169,GO:2000364,1,0.979273850577943,0,3,regulation of STAT protein import into nucleus,BP,
21170,GO:2000366,1,0.979273850577943,0,3,positive regulation of STAT protein import into nucleus,BP,
21171,GO:2000367,1,0.992170027168696,0,1,regulation of acrosomal vesicle exocytosis,BP,
21172,GO:2000368,1,0.992170027168696,0,1,positive regulation of acrosomal vesicle exocytosis,BP,
21173,GO:2000369,1,0.868758221848214,0,21,regulation of clathrin-dependent endocytosis,BP,
21174,GO:2000370,1,0.961544692759116,0,6,positive regulation of clathrin-dependent endocytosis,BP,
21175,GO:2000371,1,0.972004355628284,0,4,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21176,GO:2000373,1,0.972004355628284,0,4,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21177,GO:2000374,1,0.984410745552907,0,2,regulation of oxygen metabolic process,BP,
21178,GO:2000376,1,0.992170027168696,0,1,positive regulation of oxygen metabolic process,BP,
21182,GO:2000380,1,0.889407240072424,0,16,regulation of mesoderm development,BP,
21183,GO:2000381,1,0.942417928164682,0,8,negative regulation of mesoderm development,BP,
21184,GO:2000382,1,0.963563877918513,0,5,positive regulation of mesoderm development,BP,
21185,GO:2000383,1,0.993385508500084,0,1,regulation of ectoderm development,BP,
21186,GO:2000384,1,0.993385508500084,0,1,negative regulation of ectoderm development,BP,
21187,GO:2000386,1,0.992170027168696,0,1,positive regulation of ovarian follicle development,BP,
21188,GO:2000387,1,0.992170027168696,0,1,regulation of antral ovarian follicle growth,BP,
21189,GO:2000388,1,0.992170027168696,0,1,positive regulation of antral ovarian follicle growth,BP,
21190,GO:2000389,1,0.979291985024155,0,3,regulation of neutrophil extravasation,BP,
21191,GO:2000391,1,0.979291985024155,0,3,positive regulation of neutrophil extravasation,BP,
21192,GO:2000392,1,0.947415703634991,0,8,regulation of lamellipodium morphogenesis,BP,
21193,GO:2000393,1,0.993964201369658,0,1,negative regulation of lamellipodium morphogenesis,BP,
21194,GO:2000394,1,0.953171003555016,0,7,positive regulation of lamellipodium morphogenesis,BP,
21195,GO:2000395,1,0.984400887813367,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21196,GO:2000397,1,0.984400887813367,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21198,GO:2000402,1,0.949730688942537,0,7,negative regulation of lymphocyte migration,BP,
21201,GO:2000405,1,0.992170027168696,0,1,negative regulation of T cell migration,BP,
21205,GO:2000410,1,0.977235457167837,0,3,regulation of thymocyte migration,BP,
21206,GO:2000412,1,0.984932202766779,0,2,positive regulation of thymocyte migration,BP,
21207,GO:2000413,1,0.99270550262398,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21208,GO:2000415,1,0.99270550262398,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21209,GO:2000416,1,0.955353883615229,0,6,regulation of eosinophil migration,BP,
21210,GO:2000417,1,0.985188388019516,0,2,negative regulation of eosinophil migration,BP,
21211,GO:2000418,1,0.969720430590558,0,4,positive regulation of eosinophil migration,BP,
21212,GO:2000419,1,0.992961501433465,0,1,regulation of eosinophil extravasation,BP,
21213,GO:2000420,1,0.992961501433465,0,1,negative regulation of eosinophil extravasation,BP,
21214,GO:2000422,1,0.984557330454992,0,2,regulation of eosinophil chemotaxis,BP,
21215,GO:2000424,1,0.984557330454992,0,2,positive regulation of eosinophil chemotaxis,BP,
21216,GO:2000425,1,0.933181682596251,0,10,regulation of apoptotic cell clearance,BP,
21217,GO:2000426,1,0.992170230723253,0,1,negative regulation of apoptotic cell clearance,BP,
21218,GO:2000427,1,0.946066903223762,0,8,positive regulation of apoptotic cell clearance,BP,
21219,GO:2000434,1,0.984400887813367,0,2,regulation of protein neddylation,BP,
21220,GO:2000435,1,0.984400887813367,0,2,negative regulation of protein neddylation,BP,
21221,GO:2000437,1,0.979894534116847,0,3,regulation of monocyte extravasation,BP,
21222,GO:2000438,1,0.99398633226952,0,1,negative regulation of monocyte extravasation,BP,
21223,GO:2000439,1,0.985823609638815,0,2,positive regulation of monocyte extravasation,BP,
21224,GO:2000446,1,0.993733697226798,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21229,GO:2000458,1,0.984501914135142,0,2,regulation of astrocyte chemotaxis,BP,
21230,GO:2000463,1,0.857044626502776,0,23,positive regulation of excitatory postsynaptic potential,BP,
21231,GO:2000464,1,0.992271495764135,0,1,positive regulation of astrocyte chemotaxis,BP,
21232,GO:2000465,1,0.946704275510937,0,8,regulation of glycogen (starch) synthase activity,BP,
21233,GO:2000466,1,0.979098557226071,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21234,GO:2000467,1,0.966599382500262,0,5,positive regulation of glycogen (starch) synthase activity,BP,
21235,GO:2000468,1,0.986752541374062,0,2,regulation of peroxidase activity,BP,
21236,GO:2000469,1,0.993986332281396,0,1,negative regulation of peroxidase activity,BP,
21237,GO:2000470,1,0.992722786240047,0,1,positive regulation of peroxidase activity,BP,
21238,GO:2000471,1,0.986268079611093,0,2,regulation of hematopoietic stem cell migration,BP,
21239,GO:2000473,1,0.986268079611093,0,2,positive regulation of hematopoietic stem cell migration,BP,
21240,GO:2000474,1,0.985853055763788,0,2,regulation of opioid receptor signaling pathway,BP,
21241,GO:2000477,1,0.993835750309779,0,1,regulation of metanephric glomerular visceral epithelial cell development,BP,
21242,GO:2000478,1,0.993835750309779,0,1,positive regulation of metanephric glomerular visceral epithelial cell development,BP,
21243,GO:2000479,1,0.904558751917577,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21244,GO:2000480,1,0.942333725053259,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21245,GO:2000481,1,0.97541875995459,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21247,GO:2000483,1,0.95777969131855,0,6,negative regulation of interleukin-8 secretion,BP,
21249,GO:2000485,1,0.985287321235369,0,2,regulation of glutamine transport,BP,
21250,GO:2000486,1,0.992974590415791,0,1,negative regulation of glutamine transport,BP,
21251,GO:2000487,1,0.992258767215617,0,1,positive regulation of glutamine transport,BP,
21252,GO:2000489,1,0.958727320674915,0,6,regulation of hepatic stellate cell activation,BP,
21253,GO:2000490,1,0.985501057060095,0,2,negative regulation of hepatic stellate cell activation,BP,
21254,GO:2000491,1,0.972835419749016,0,4,positive regulation of hepatic stellate cell activation,BP,
21255,GO:2000492,1,0.992560919638709,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21256,GO:2000494,1,0.992560919638709,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21257,GO:2000501,1,0.931803362659715,0,9,regulation of natural killer cell chemotaxis,BP,
21258,GO:2000502,1,0.976814787232004,0,3,negative regulation of natural killer cell chemotaxis,BP,
21259,GO:2000503,1,0.953928449487835,0,6,positive regulation of natural killer cell chemotaxis,BP,
21260,GO:2000504,1,0.978498734226959,0,3,positive regulation of blood vessel remodeling,BP,
21261,GO:2000505,1,0.881568415827494,0,19,regulation of energy homeostasis,BP,
21262,GO:2000506,1,0.984601070940383,0,2,negative regulation of energy homeostasis,BP,
21263,GO:2000507,1,0.959581389631534,0,6,positive regulation of energy homeostasis,BP,
21264,GO:2000508,1,0.925183891902287,0,10,regulation of dendritic cell chemotaxis,BP,
21265,GO:2000510,1,0.932489227940008,0,9,positive regulation of dendritic cell chemotaxis,BP,
21266,GO:2000511,1,0.992170027168696,0,1,regulation of granzyme A production,BP,
21267,GO:2000513,1,0.992170027168696,0,1,positive regulation of granzyme A production,BP,
21268,GO:2000514,1,0.722746122883956,0,44,regulation of CD4-positive, alpha-beta T cell activation,BP,
21269,GO:2000515,1,0.876899543860701,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21270,GO:2000516,1,0.804631025472699,0,29,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21271,GO:2000517,1,0.992170027168696,0,1,regulation of T-helper 1 cell activation,BP,
21272,GO:2000518,1,0.992170027168696,0,1,negative regulation of T-helper 1 cell activation,BP,
21273,GO:2000520,1,0.97676390411012,0,3,regulation of immunological synapse formation,BP,
21274,GO:2000521,1,0.984450487528073,0,2,negative regulation of immunological synapse formation,BP,
21275,GO:2000522,1,0.992192957802479,0,1,positive regulation of immunological synapse formation,BP,
21276,GO:2000523,1,0.985287000669116,0,2,regulation of T cell costimulation,BP,
21277,GO:2000525,1,0.985287000669116,0,2,positive regulation of T cell costimulation,BP,
21278,GO:2000526,1,0.992192957802479,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21279,GO:2000527,1,0.992170027168696,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21280,GO:2000529,1,0.992170027168696,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21281,GO:2000532,1,0.986157038537517,0,2,regulation of renal albumin absorption,BP,
21282,GO:2000533,1,0.992274033099043,0,1,negative regulation of renal albumin absorption,BP,
21283,GO:2000534,1,0.993835750309779,0,1,positive regulation of renal albumin absorption,BP,
21284,GO:2000535,1,0.966666637996604,0,5,regulation of entry of bacterium into host cell,BP,
21285,GO:2000536,1,0.993986332270312,0,1,negative regulation of entry of bacterium into host cell,BP,
21286,GO:2000537,1,0.985956982248808,0,2,regulation of B cell chemotaxis,BP,
21287,GO:2000538,1,0.985956982248808,0,2,positive regulation of B cell chemotaxis,BP,
21288,GO:2000539,1,0.992272940552526,0,1,regulation of protein geranylgeranylation,BP,
21289,GO:2000541,1,0.992272940552526,0,1,positive regulation of protein geranylgeranylation,BP,
21290,GO:2000542,1,0.951145001448146,0,7,negative regulation of gastrulation,BP,
21291,GO:2000543,1,0.954506822829003,0,6,positive regulation of gastrulation,BP,
21293,GO:2000545,1,0.992170027168696,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21295,GO:2000547,1,0.976714688667567,0,3,regulation of dendritic cell dendrite assembly,BP,
21296,GO:2000548,1,0.992170027168696,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21297,GO:2000549,1,0.992170027168696,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21298,GO:2000551,1,0.941791435244469,0,8,regulation of T-helper 2 cell cytokine production,BP,
21299,GO:2000552,1,0.984400887813367,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21300,GO:2000553,1,0.956720544083941,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21301,GO:2000554,1,0.992170027168696,0,1,regulation of T-helper 1 cell cytokine production,BP,
21302,GO:2000556,1,0.992170027168696,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21303,GO:2000557,1,0.992170027168696,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21304,GO:2000558,1,0.992170027168696,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21305,GO:2000559,1,0.99398633226952,0,1,regulation of CD24 biosynthetic process,BP,
21306,GO:2000560,1,0.99398633226952,0,1,positive regulation of CD24 biosynthetic process,BP,
21307,GO:2000561,1,0.964480692133582,0,5,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21308,GO:2000562,1,0.977805570070642,0,3,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21309,GO:2000563,1,0.970986834490432,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21310,GO:2000564,1,0.970064846837905,0,4,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21311,GO:2000566,1,0.976796685832395,0,3,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21312,GO:2000567,1,0.985291958099893,0,2,regulation of memory T cell activation,BP,
21313,GO:2000568,1,0.985291958099893,0,2,positive regulation of memory T cell activation,BP,
21314,GO:2000569,1,0.985912839554994,0,2,regulation of T-helper 2 cell activation,BP,
21315,GO:2000570,1,0.985912839554994,0,2,positive regulation of T-helper 2 cell activation,BP,
21316,GO:2000571,1,0.99304012820112,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21317,GO:2000572,1,0.99304012820112,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21318,GO:2000573,1,0.630471246184396,0,63,positive regulation of DNA biosynthetic process,BP,
21319,GO:2000574,1,0.979491766966526,0,3,regulation of microtubule motor activity,BP,
21320,GO:2000583,1,0.98725993896301,0,2,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21321,GO:2000584,1,0.98725993896301,0,2,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21322,GO:2000586,1,0.935407125426017,0,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21323,GO:2000587,1,0.946935860552484,0,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21324,GO:2000588,1,0.987830379046482,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21325,GO:2000589,1,0.972977851157836,0,4,regulation of metanephric mesenchymal cell migration,BP,
21326,GO:2000590,1,0.993835750309779,0,1,negative regulation of metanephric mesenchymal cell migration,BP,
21327,GO:2000591,1,0.979013734015813,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21328,GO:2000592,1,0.987045028388714,0,2,regulation of metanephric DCT cell differentiation,BP,
21329,GO:2000594,1,0.987045028388714,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21330,GO:2000595,1,0.993596372063379,0,1,regulation of optic nerve formation,BP,
21331,GO:2000597,1,0.993596372063379,0,1,positive regulation of optic nerve formation,BP,
21332,GO:2000601,1,0.953141181980101,0,7,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21333,GO:2000606,1,0.992630651409286,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21334,GO:2000607,1,0.992630651409286,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21335,GO:2000609,1,0.963114282606923,0,5,regulation of thyroid hormone generation,BP,
21336,GO:2000611,1,0.978376707546373,0,3,positive regulation of thyroid hormone generation,BP,
21337,GO:2000612,1,0.993406763692654,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21338,GO:2000615,1,0.938642867785148,0,9,regulation of histone H3-K9 acetylation,BP,
21339,GO:2000616,1,0.993966172878724,0,1,negative regulation of histone H3-K9 acetylation,BP,
21340,GO:2000617,1,0.951622719308135,0,7,positive regulation of histone H3-K9 acetylation,BP,
21341,GO:2000618,1,0.966766937146723,0,5,regulation of histone H4-K16 acetylation,BP,
21342,GO:2000619,1,0.978502586403549,0,3,negative regulation of histone H4-K16 acetylation,BP,
21343,GO:2000620,1,0.988008547468304,0,2,positive regulation of histone H4-K16 acetylation,BP,
21344,GO:2000622,1,0.973505721538217,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21345,GO:2000623,1,0.973505721538217,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21346,GO:2000625,1,0.986262409848177,0,2,regulation of miRNA catabolic process,BP,
21347,GO:2000627,1,0.986262409848177,0,2,positive regulation of miRNA catabolic process,BP,
21348,GO:2000628,1,0.950460606944013,0,7,regulation of miRNA metabolic process,BP,
21349,GO:2000630,1,0.96477906413692,0,5,positive regulation of miRNA metabolic process,BP,
21350,GO:2000631,1,0.992795855711929,0,1,regulation of pre-miRNA processing,BP,
21351,GO:2000632,1,0.992795855711929,0,1,negative regulation of pre-miRNA processing,BP,
21352,GO:2000637,1,0.865998718160817,0,20,positive regulation of gene silencing by miRNA,BP,
21353,GO:2000638,1,0.993286808146977,0,1,regulation of SREBP signaling pathway,BP,
21354,GO:2000639,1,0.993286808146977,0,1,negative regulation of SREBP signaling pathway,BP,
21355,GO:2000641,1,0.887294394158932,0,17,regulation of early endosome to late endosome transport,BP,
21356,GO:2000642,1,0.984400887813367,0,2,negative regulation of early endosome to late endosome transport,BP,
21357,GO:2000643,1,0.948025082392282,0,8,positive regulation of early endosome to late endosome transport,BP,
21358,GO:2000644,1,0.951596954873109,0,7,regulation of receptor catabolic process,BP,
21359,GO:2000645,1,0.979841093376007,0,3,negative regulation of receptor catabolic process,BP,
21360,GO:2000646,1,0.978387574355917,0,3,positive regulation of receptor catabolic process,BP,
21361,GO:2000647,1,0.930348336039838,0,10,negative regulation of stem cell proliferation,BP,
21362,GO:2000648,1,0.774713799099987,0,36,positive regulation of stem cell proliferation,BP,
21364,GO:2000650,1,0.934123772944822,0,10,negative regulation of sodium ion transmembrane transporter activity,BP,
21365,GO:2000651,1,0.914883395029426,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21366,GO:2000653,1,0.97201278047771,0,4,regulation of genetic imprinting,BP,
21367,GO:2000654,1,0.993382379108709,0,1,regulation of cellular response to testosterone stimulus,BP,
21368,GO:2000655,1,0.993382379108709,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21369,GO:2000656,1,0.992171950877309,0,1,regulation of apolipoprotein binding,BP,
21370,GO:2000657,1,0.992171950877309,0,1,negative regulation of apolipoprotein binding,BP,
21371,GO:2000659,1,0.955647250068399,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
21372,GO:2000660,1,0.969071310961582,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
21373,GO:2000661,1,0.993928495965872,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21374,GO:2000662,1,0.956137466934236,0,6,regulation of interleukin-5 secretion,BP,
21375,GO:2000663,1,0.985407085700577,0,2,negative regulation of interleukin-5 secretion,BP,
21376,GO:2000664,1,0.970300286677468,0,4,positive regulation of interleukin-5 secretion,BP,
21377,GO:2000665,1,0.941217387517984,0,8,regulation of interleukin-13 secretion,BP,
21378,GO:2000666,1,0.985407085700577,0,2,negative regulation of interleukin-13 secretion,BP,
21379,GO:2000667,1,0.955160928241148,0,6,positive regulation of interleukin-13 secretion,BP,
21380,GO:2000668,1,0.958153671616251,0,6,regulation of dendritic cell apoptotic process,BP,
21381,GO:2000669,1,0.978777974986628,0,3,negative regulation of dendritic cell apoptotic process,BP,
21382,GO:2000670,1,0.978932011401531,0,3,positive regulation of dendritic cell apoptotic process,BP,
21383,GO:2000671,1,0.971983919673268,0,4,regulation of motor neuron apoptotic process,BP,
21384,GO:2000672,1,0.978542135844008,0,3,negative regulation of motor neuron apoptotic process,BP,
21385,GO:2000674,1,0.930180765687991,0,10,regulation of type B pancreatic cell apoptotic process,BP,
21386,GO:2000675,1,0.958104694198024,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21387,GO:2000676,1,0.970864635588067,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
21388,GO:2000677,1,0.710929548660611,0,47,regulation of transcription regulatory region DNA binding,BP,
21389,GO:2000678,1,0.857423036417934,0,21,negative regulation of transcription regulatory region DNA binding,BP,
21390,GO:2000679,1,0.850662729001234,0,22,positive regulation of transcription regulatory region DNA binding,BP,
21391,GO:2000680,1,0.96663510092134,0,5,regulation of rubidium ion transport,BP,
21392,GO:2000681,1,0.980160398552294,0,3,negative regulation of rubidium ion transport,BP,
21393,GO:2000682,1,0.993986332273918,0,1,positive regulation of rubidium ion transport,BP,
21394,GO:2000683,1,0.985127142201648,0,2,regulation of cellular response to X-ray,BP,
21395,GO:2000685,1,0.992441219375176,0,1,positive regulation of cellular response to X-ray,BP,
21396,GO:2000686,1,0.974265118499542,0,4,regulation of rubidium ion transmembrane transporter activity,BP,
21397,GO:2000687,1,0.980160398552294,0,3,negative regulation of rubidium ion transmembrane transporter activity,BP,
21398,GO:2000688,1,0.993986332273918,0,1,positive regulation of rubidium ion transmembrane transporter activity,BP,
21399,GO:2000690,1,0.993687028426764,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21400,GO:2000691,1,0.993687028426764,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21401,GO:2000696,1,0.882461873886572,0,18,regulation of epithelial cell differentiation involved in kidney development,BP,
21402,GO:2000697,1,0.970763583033056,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21403,GO:2000698,1,0.945643554484638,0,8,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21404,GO:2000699,1,0.992630651409286,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21405,GO:2000701,1,0.992630651409286,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21406,GO:2000702,1,0.992630651409286,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21407,GO:2000703,1,0.992630651409286,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21408,GO:2000705,1,0.979516500439729,0,3,regulation of dense core granule biogenesis,BP,
21409,GO:2000706,1,0.993210624977439,0,1,negative regulation of dense core granule biogenesis,BP,
21410,GO:2000707,1,0.986212994436194,0,2,positive regulation of dense core granule biogenesis,BP,
21411,GO:2000721,1,0.980786764628686,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21412,GO:2000722,1,0.986378223996721,0,2,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21413,GO:2000723,1,0.992346221798082,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21414,GO:2000724,1,0.993986332269654,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21415,GO:2000725,1,0.815260556844802,0,29,regulation of cardiac muscle cell differentiation,BP,
21416,GO:2000726,1,0.925661018728287,0,11,negative regulation of cardiac muscle cell differentiation,BP,
21417,GO:2000727,1,0.880800915077652,0,18,positive regulation of cardiac muscle cell differentiation,BP,
21418,GO:2000729,1,0.984581970873119,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21419,GO:2000733,1,0.992630651409286,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21420,GO:2000734,1,0.992630651409286,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21421,GO:2000736,1,0.758074005836994,0,40,regulation of stem cell differentiation,BP,
21422,GO:2000737,1,0.882587266058027,0,18,negative regulation of stem cell differentiation,BP,
21423,GO:2000738,1,0.90123524457956,0,15,positive regulation of stem cell differentiation,BP,
21424,GO:2000739,1,0.962785296585303,0,6,regulation of mesenchymal stem cell differentiation,BP,
21425,GO:2000740,1,0.993210624977439,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21426,GO:2000741,1,0.975234178826924,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21427,GO:2000742,1,0.984455748475411,0,2,regulation of anterior head development,BP,
21428,GO:2000744,1,0.984455748475411,0,2,positive regulation of anterior head development,BP,
21429,GO:2000751,1,0.99241553049716,0,1,histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore,BP,
21430,GO:2000752,1,0.992415854146785,0,1,regulation of glucosylceramide catabolic process,BP,
21431,GO:2000753,1,0.992415854146785,0,1,positive regulation of glucosylceramide catabolic process,BP,
21432,GO:2000754,1,0.992415854146785,0,1,regulation of sphingomyelin catabolic process,BP,
21433,GO:2000755,1,0.992415854146785,0,1,positive regulation of sphingomyelin catabolic process,BP,
21434,GO:2000756,1,0.676847559062144,0,54,regulation of peptidyl-lysine acetylation,BP,
21435,GO:2000757,1,0.872318822668286,0,19,negative regulation of peptidyl-lysine acetylation,BP,
21436,GO:2000758,1,0.804663901962849,0,30,positive regulation of peptidyl-lysine acetylation,BP,
21437,GO:2000759,1,0.993920433173404,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21438,GO:2000761,1,0.993920433173404,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21439,GO:2000763,1,0.992230290634377,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21440,GO:2000764,1,0.992230290634377,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21441,GO:2000765,1,0.912960131670509,0,13,regulation of cytoplasmic translation,BP,
21442,GO:2000766,1,0.948732940056766,0,8,negative regulation of cytoplasmic translation,BP,
21443,GO:2000767,1,0.969852775450226,0,4,positive regulation of cytoplasmic translation,BP,
21444,GO:2000768,1,0.978023415667168,0,3,positive regulation of nephron tubule epithelial cell differentiation,BP,
21445,GO:2000769,1,0.992170027168696,0,1,regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21446,GO:2000771,1,0.992170027168696,0,1,positive regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21447,GO:2000772,1,0.819837570585623,0,28,regulation of cellular senescence,BP,
21448,GO:2000773,1,0.926036127930994,0,11,negative regulation of cellular senescence,BP,
21449,GO:2000774,1,0.942167478525301,0,8,positive regulation of cellular senescence,BP,
21450,GO:2000775,1,0.992184048762491,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21451,GO:2000777,1,0.984465393477387,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21453,GO:2000779,1,0.758172758046212,0,39,regulation of double-strand break repair,BP,
21454,GO:2000780,1,0.90021440152438,0,15,negative regulation of double-strand break repair,BP,
21455,GO:2000781,1,0.946654619226123,0,8,positive regulation of double-strand break repair,BP,
21456,GO:2000782,1,0.992170027168696,0,1,regulation of establishment of cell polarity regulating cell shape,BP,
21457,GO:2000784,1,0.992170027168696,0,1,positive regulation of establishment of cell polarity regulating cell shape,BP,
21459,GO:2000786,1,0.934994633775921,0,10,positive regulation of autophagosome assembly,BP,
21460,GO:2000790,1,0.987409532322837,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21461,GO:2000791,1,0.987409532322837,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21462,GO:2000793,1,0.98027174082881,0,3,cell proliferation involved in heart valve development,BP,
21463,GO:2000794,1,0.945951427897788,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21464,GO:2000795,1,0.993986332276264,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21465,GO:2000797,1,0.993210624977439,0,1,regulation of amniotic stem cell differentiation,BP,
21466,GO:2000798,1,0.993210624977439,0,1,negative regulation of amniotic stem cell differentiation,BP,
21467,GO:2000800,1,0.992170027247971,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21468,GO:2000802,1,0.992170027247971,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21469,GO:2000804,1,0.993986332289148,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21470,GO:2000806,1,0.993986332289148,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21471,GO:2000807,1,0.957732943323138,0,7,regulation of synaptic vesicle clustering,BP,
21472,GO:2000808,1,0.993984910007831,0,1,negative regulation of synaptic vesicle clustering,BP,
21473,GO:2000809,1,0.969361175844847,0,5,positive regulation of synaptic vesicle clustering,BP,
21474,GO:2000810,1,0.894613741230471,0,16,regulation of bicellular tight junction assembly,BP,
21476,GO:2000812,1,0.985636695405172,0,2,regulation of barbed-end actin filament capping,BP,
21477,GO:2000814,1,0.992170027168696,0,1,positive regulation of barbed-end actin filament capping,BP,
21478,GO:2000816,1,0.803190541208612,0,30,negative regulation of mitotic sister chromatid separation,BP,
21479,GO:2000818,1,0.984662087584087,0,2,negative regulation of myoblast proliferation,BP,
21480,GO:2000819,1,0.985716742799982,0,2,regulation of nucleotide-excision repair,BP,
21481,GO:2000820,1,0.978698276709199,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21482,GO:2000821,1,0.973695953997029,0,4,regulation of grooming behavior,BP,
21483,GO:2000822,1,0.963712749421686,0,5,regulation of behavioral fear response,BP,
21484,GO:2000823,1,0.95706853745555,0,6,regulation of androgen receptor activity,BP,
21485,GO:2000824,1,0.985840968906421,0,2,negative regulation of androgen receptor activity,BP,
21486,GO:2000825,1,0.970817531578907,0,4,positive regulation of androgen receptor activity,BP,
21487,GO:2000826,1,0.794592384812747,0,32,regulation of heart morphogenesis,BP,
21488,GO:2000827,1,0.992265851840136,0,1,mitochondrial RNA surveillance,BP,
21489,GO:2000828,1,0.986204972344974,0,2,regulation of parathyroid hormone secretion,BP,
21490,GO:2000830,1,0.993985944700782,0,1,positive regulation of parathyroid hormone secretion,BP,
21491,GO:2000831,1,0.878999898952874,0,17,regulation of steroid hormone secretion,BP,
21492,GO:2000832,1,0.986844527870578,0,2,negative regulation of steroid hormone secretion,BP,
21493,GO:2000833,1,0.933177173223202,0,9,positive regulation of steroid hormone secretion,BP,
21494,GO:2000834,1,0.992827068341019,0,1,regulation of androgen secretion,BP,
21495,GO:2000836,1,0.992827068341019,0,1,positive regulation of androgen secretion,BP,
21496,GO:2000843,1,0.986898855507301,0,2,regulation of testosterone secretion,BP,
21497,GO:2000845,1,0.986898855507301,0,2,positive regulation of testosterone secretion,BP,
21498,GO:2000846,1,0.899390563434527,0,14,regulation of corticosteroid hormone secretion,BP,
21499,GO:2000847,1,0.986844527870578,0,2,negative regulation of corticosteroid hormone secretion,BP,
21500,GO:2000848,1,0.947343217982002,0,7,positive regulation of corticosteroid hormone secretion,BP,
21501,GO:2000849,1,0.941716452693658,0,8,regulation of glucocorticoid secretion,BP,
21502,GO:2000850,1,0.986844527870578,0,2,negative regulation of glucocorticoid secretion,BP,
21503,GO:2000851,1,0.961686158010476,0,5,positive regulation of glucocorticoid secretion,BP,
21504,GO:2000852,1,0.976816008884554,0,3,regulation of corticosterone secretion,BP,
21505,GO:2000854,1,0.984400887813367,0,2,positive regulation of corticosterone secretion,BP,
21506,GO:2000855,1,0.955075127577355,0,6,regulation of mineralocorticoid secretion,BP,
21507,GO:2000857,1,0.985090149213039,0,2,positive regulation of mineralocorticoid secretion,BP,
21508,GO:2000858,1,0.955075127577355,0,6,regulation of aldosterone secretion,BP,
21509,GO:2000860,1,0.985090149213039,0,2,positive regulation of aldosterone secretion,BP,
21510,GO:2000864,1,0.980079998126498,0,3,regulation of estradiol secretion,BP,
21511,GO:2000866,1,0.986010187073636,0,2,positive regulation of estradiol secretion,BP,
21512,GO:2000870,1,0.984408870872722,0,2,regulation of progesterone secretion,BP,
21513,GO:2000872,1,0.992170027168696,0,1,positive regulation of progesterone secretion,BP,
21514,GO:2000878,1,0.984567847130588,0,2,positive regulation of oligopeptide transport,BP,
21515,GO:2000880,1,0.984567847130588,0,2,positive regulation of dipeptide transport,BP,
21516,GO:2000896,1,0.99270922546378,0,1,amylopectin metabolic process,BP,
21517,GO:2000909,1,0.976814787232004,0,3,regulation of sterol import,BP,
21518,GO:2000910,1,0.984400887813367,0,2,negative regulation of sterol import,BP,
21519,GO:2000969,1,0.97420110373624,0,4,positive regulation of AMPA receptor activity,BP,
21520,GO:2000970,1,0.992243323265942,0,1,regulation of detection of glucose,BP,
21521,GO:2000971,1,0.992243323265942,0,1,negative regulation of detection of glucose,BP,
21522,GO:2000973,1,0.959368431965376,0,6,regulation of pro-B cell differentiation,BP,
21523,GO:2000974,1,0.978480302620419,0,3,negative regulation of pro-B cell differentiation,BP,
21524,GO:2000977,1,0.970231706450046,0,4,regulation of forebrain neuron differentiation,BP,
21525,GO:2000978,1,0.984400887813367,0,2,negative regulation of forebrain neuron differentiation,BP,
21526,GO:2000979,1,0.992631976713582,0,1,positive regulation of forebrain neuron differentiation,BP,
21527,GO:2000980,1,0.949152781879276,0,7,regulation of inner ear receptor cell differentiation,BP,
21528,GO:2000981,1,0.971496230396,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21529,GO:2000982,1,0.992170027168696,0,1,positive regulation of inner ear receptor cell differentiation,BP,
21530,GO:2000983,1,0.984400887813367,0,2,regulation of ATP citrate synthase activity,BP,
21531,GO:2000984,1,0.984400887813367,0,2,negative regulation of ATP citrate synthase activity,BP,
21532,GO:2000987,1,0.963712749421686,0,5,positive regulation of behavioral fear response,BP,
21533,GO:2001012,1,0.942663028584245,0,8,mesenchymal cell differentiation involved in renal system development,BP,
21534,GO:2001013,1,0.97463302409808,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21537,GO:2001016,1,0.966104447869965,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21538,GO:2001020,1,0.322446234179023,0,155,regulation of response to DNA damage stimulus,BP,
21539,GO:2001021,1,0.657370320221518,0,57,negative regulation of response to DNA damage stimulus,BP,
21540,GO:2001022,1,0.614498696089266,0,67,positive regulation of response to DNA damage stimulus,BP,
21541,GO:2001023,1,0.966663468507027,0,5,regulation of response to drug,BP,
21542,GO:2001025,1,0.993506247191203,0,1,positive regulation of response to drug,BP,
21544,GO:2001027,1,0.972599463690338,0,4,negative regulation of endothelial cell chemotaxis,BP,
21546,GO:2001029,1,0.993984539261174,0,1,regulation of cellular glucuronidation,BP,
21547,GO:2001031,1,0.993984539261174,0,1,positive regulation of cellular glucuronidation,BP,
21548,GO:2001032,1,0.94940935202188,0,7,regulation of double-strand break repair via nonhomologous end joining,BP,
21549,GO:2001033,1,0.977296812327838,0,3,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21550,GO:2001034,1,0.978872065114234,0,3,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21551,GO:2001035,1,0.986036772232189,0,2,regulation of tongue muscle cell differentiation,BP,
21552,GO:2001037,1,0.986036772232189,0,2,positive regulation of tongue muscle cell differentiation,BP,
21553,GO:2001038,1,0.986472654693776,0,2,regulation of cellular response to drug,BP,
21554,GO:2001044,1,0.924730389033437,0,11,regulation of integrin-mediated signaling pathway,BP,
21555,GO:2001045,1,0.987344075163688,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21556,GO:2001046,1,0.965478349815097,0,5,positive regulation of integrin-mediated signaling pathway,BP,
21557,GO:2001049,1,0.992176468081181,0,1,regulation of tendon cell differentiation,BP,
21558,GO:2001051,1,0.992176468081181,0,1,positive regulation of tendon cell differentiation,BP,
21559,GO:2001053,1,0.916406332621898,0,12,regulation of mesenchymal cell apoptotic process,BP,
21560,GO:2001054,1,0.930906556154025,0,10,negative regulation of mesenchymal cell apoptotic process,BP,
21561,GO:2001055,1,0.984432186514333,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21564,GO:2001065,1,0.984400887813367,0,2,mannan binding,MF,
21565,GO:2001069,1,0.977123368574346,0,3,glycogen binding,MF,
21566,GO:2001070,1,0.986283734347669,0,2,starch binding,MF,
21567,GO:2001074,1,0.984803595160034,0,2,regulation of metanephric ureteric bud development,BP,
21568,GO:2001076,1,0.984803595160034,0,2,positive regulation of metanephric ureteric bud development,BP,
21569,GO:2001106,1,0.9880085474682,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21570,GO:2001108,1,0.993986332267336,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21571,GO:2001109,1,0.986208667668789,0,2,regulation of lens epithelial cell proliferation,BP,
21572,GO:2001111,1,0.986208667668789,0,2,positive regulation of lens epithelial cell proliferation,BP,
21573,GO:2001112,1,0.993939481237836,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21574,GO:2001113,1,0.993939481237836,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21575,GO:2001135,1,0.940291168269923,0,9,regulation of endocytic recycling,BP,
21576,GO:2001136,1,0.992899334333019,0,1,negative regulation of endocytic recycling,BP,
21577,GO:2001137,1,0.974203240960691,0,4,positive regulation of endocytic recycling,BP,
21578,GO:2001138,1,0.945677570577025,0,8,regulation of phospholipid transport,BP,
21579,GO:2001140,1,0.945677570577025,0,8,positive regulation of phospholipid transport,BP,
21581,GO:2001142,1,0.992296702876046,0,1,nicotinate transport,BP,
21582,GO:2001144,1,0.992194735690875,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21583,GO:2001145,1,0.992194735690875,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21584,GO:2001148,1,0.984567847130588,0,2,regulation of dipeptide transmembrane transport,BP,
21585,GO:2001150,1,0.984567847130588,0,2,positive regulation of dipeptide transmembrane transport,BP,
21586,GO:2001151,1,0.99277171725997,0,1,regulation of renal water transport,BP,
21587,GO:2001153,1,0.99277171725997,0,1,positive regulation of renal water transport,BP,
21588,GO:2001160,1,0.985946742132801,0,2,regulation of histone H3-K79 methylation,BP,
21589,GO:2001162,1,0.985946742132801,0,2,positive regulation of histone H3-K79 methylation,BP,
21590,GO:2001163,1,0.992209909548993,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21591,GO:2001165,1,0.992209909548993,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21592,GO:2001166,1,0.973415013225827,0,4,regulation of histone H2B ubiquitination,BP,
21593,GO:2001168,1,0.973415013225827,0,4,positive regulation of histone H2B ubiquitination,BP,
21594,GO:2001169,1,0.938030874185693,0,9,regulation of ATP biosynthetic process,BP,
21595,GO:2001170,1,0.978412521246053,0,3,negative regulation of ATP biosynthetic process,BP,
21596,GO:2001171,1,0.951416262829971,0,7,positive regulation of ATP biosynthetic process,BP,
21597,GO:2001176,1,0.98463501215843,0,2,regulation of mediator complex assembly,BP,
21598,GO:2001178,1,0.98463501215843,0,2,positive regulation of mediator complex assembly,BP,
21600,GO:2001180,1,0.977984488633877,0,3,negative regulation of interleukin-10 secretion,BP,
21602,GO:2001182,1,0.950612662345974,0,7,regulation of interleukin-12 secretion,BP,
21603,GO:2001183,1,0.978453762072047,0,3,negative regulation of interleukin-12 secretion,BP,
21604,GO:2001184,1,0.978287236170844,0,3,positive regulation of interleukin-12 secretion,BP,
21605,GO:2001185,1,0.942467445466283,0,8,regulation of CD8-positive, alpha-beta T cell activation,BP,
21606,GO:2001186,1,0.984698956693236,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21607,GO:2001187,1,0.970394853678516,0,4,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21608,GO:2001188,1,0.961789374191574,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21609,GO:2001189,1,0.977032963901664,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21610,GO:2001190,1,0.984400888915038,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21611,GO:2001191,1,0.992466234349486,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21612,GO:2001193,1,0.992466234349486,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21613,GO:2001197,1,0.970285684798397,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21616,GO:2001200,1,0.971374155049607,0,4,positive regulation of dendritic cell differentiation,BP,
21617,GO:2001201,1,0.980542738967103,0,3,regulation of transforming growth factor-beta secretion,BP,
21618,GO:2001202,1,0.986497520403114,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21619,GO:2001203,1,0.99396435350466,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21620,GO:2001204,1,0.92175809978663,0,11,regulation of osteoclast development,BP,
21621,GO:2001205,1,0.9658652141045,0,5,negative regulation of osteoclast development,BP,
21622,GO:2001206,1,0.969472740228253,0,4,positive regulation of osteoclast development,BP,
21623,GO:2001207,1,0.9933511495648,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21624,GO:2001208,1,0.9933511495648,0,1,negative regulation of transcription elongation from RNA polymerase I promoter,BP,
21625,GO:2001212,1,0.905136691255811,0,14,regulation of vasculogenesis,BP,
21626,GO:2001213,1,0.993986311826297,0,1,negative regulation of vasculogenesis,BP,
21627,GO:2001214,1,0.930466797336686,0,10,positive regulation of vasculogenesis,BP,
21628,GO:2001222,1,0.836670308202218,0,27,regulation of neuron migration,BP,
21629,GO:2001223,1,0.948415082321237,0,8,negative regulation of neuron migration,BP,
21630,GO:2001224,1,0.942856036952648,0,9,positive regulation of neuron migration,BP,
21631,GO:2001225,1,0.94529910826378,0,8,regulation of chloride transport,BP,
21632,GO:2001226,1,0.97824646285995,0,3,negative regulation of chloride transport,BP,
21633,GO:2001228,1,0.993986332299066,0,1,regulation of response to gamma radiation,BP,
21634,GO:2001229,1,0.993986332299066,0,1,negative regulation of response to gamma radiation,BP,
21641,GO:2001239,1,0.707528426550485,0,47,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21642,GO:2001240,1,0.783095412575421,0,33,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21643,GO:2001241,1,0.903069418178138,0,14,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21646,GO:2001244,1,0.671479120688679,0,53,positive regulation of intrinsic apoptotic signaling pathway,BP,
21648,GO:2001246,1,0.993476453657424,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21649,GO:2001247,1,0.993721658922177,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21650,GO:2001248,1,0.992190392480105,0,1,regulation of ammonia assimilation cycle,BP,
21651,GO:2001250,1,0.992190392480105,0,1,positive regulation of ammonia assimilation cycle,BP,
21652,GO:2001251,1,0.449471580570886,0,113,negative regulation of chromosome organization,BP,
21653,GO:2001252,1,0.346473006108904,0,148,positive regulation of chromosome organization,BP,
21654,GO:2001253,1,0.992580124434787,0,1,regulation of histone H3-K36 trimethylation,BP,
21655,GO:2001256,1,0.960569070558188,0,6,regulation of store-operated calcium entry,BP,
21656,GO:2001257,1,0.422889125433541,0,122,regulation of cation channel activity,BP,
21657,GO:2001258,1,0.776626617015873,0,34,negative regulation of cation channel activity,BP,
21658,GO:2001259,1,0.755154463510107,0,41,positive regulation of cation channel activity,BP,
21659,GO:2001260,1,0.992230290634377,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21660,GO:2001262,1,0.992230290634377,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21661,GO:2001263,1,0.992170027168696,0,1,regulation of C-C chemokine binding,BP,
21662,GO:2001264,1,0.992170027168696,0,1,negative regulation of C-C chemokine binding,BP,
21664,GO:2001268,1,0.961666913315348,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21666,GO:2001270,1,0.972232504919268,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21667,GO:2001271,1,0.979906357176544,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21668,GO:2001272,1,0.992170027168696,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21670,GO:2001274,1,0.978773073254401,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21672,GO:2001279,1,0.958559499136547,0,6,regulation of unsaturated fatty acid biosynthetic process,BP,
21673,GO:2001280,1,0.972062532734861,0,4,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21674,GO:2001286,1,0.96573614166047,0,5,regulation of caveolin-mediated endocytosis,BP,
21675,GO:2001287,1,0.98560070775354,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21676,GO:2001288,1,0.986203080785074,0,2,positive regulation of caveolin-mediated endocytosis,BP,
21677,GO:2001293,1,0.980297710782847,0,3,malonyl-CoA metabolic process,BP,
21678,GO:2001294,1,0.992196309955591,0,1,malonyl-CoA catabolic process,BP,
21679,GO:2001295,1,0.988008547496917,0,2,malonyl-CoA biosynthetic process,BP,
21680,GO:2001300,1,0.954495484606081,0,6,lipoxin metabolic process,BP,
21681,GO:2001301,1,0.984643616889426,0,2,lipoxin biosynthetic process,BP,
21682,GO:2001302,1,0.984643616889426,0,2,lipoxin A4 metabolic process,BP,
21683,GO:2001303,1,0.984643616889426,0,2,lipoxin A4 biosynthetic process,BP,
21684,GO:2001304,1,0.992230544989512,0,1,lipoxin B4 metabolic process,BP,
21685,GO:2001306,1,0.992230544989512,0,1,lipoxin B4 biosynthetic process,BP,
21686,GO:2001311,1,0.992170709032338,0,1,lysobisphosphatidic acid metabolic process,BP,
5201,GO:0014044,1,0.841549036560338,0,25,Schwann cell development,BP,
1461,GO:0003170,1,0.767778543317179,0,38,heart valve development,BP,
259,GO:0000722,1.00000000000001,0.770662584245899,0,36,telomere maintenance via recombination,BP,
195,GO:0000407,1.00000000000002,0.82845667650428,0,27,pre-autophagosomal structure,CC,
